original_value,curated_ontology,match_level,stage,top1_match,top1_score,top2_match,top2_score,top3_match,top3_score,top4_match,top4_score,top5_match,top5_score,top6_match,top6_score,top7_match,top7_score,top8_match,top8_score,top9_match,top9_score,top10_match,top10_score,top11_match,top11_score,top12_match,top12_score,top13_match,top13_score,top14_match,top14_score,top15_match,top15_score,top16_match,top16_score,top17_match,top17_score,top18_match,top18_score,top19_match,top19_score,top20_match,top20_score,updated_value,top1_accuracy,top3_accuracy,top5_accuracy
25-30% DUCTAL COMPONENT,Prostate Ductal Adenocarcinoma,9,2,Ductal Eccrine Adenocarcinoma,0.6203,Oligometastatic Pancreatic Ductal Adenocarcinoma,0.6008,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,0.5990,Diffuse Intraductal Papillomatosis,0.5958,Intraductal Papilloma,0.5946,Breast Ductal Adenoma,0.5910,Intraductal Papillomatosis,0.5875,Focal Intraductal Papillomatosis,0.5861,Prostate Ductal Adenocarcinoma,0.5841,Salivary Gland Intraductal Carcinoma,0.5834,Early Stage Pancreatic Ductal Adenocarcinoma,0.5831,Breast Ductal Carcinoma,0.5830,Lepidic Adenocarcinoma,0.5829,Salivary Duct Carcinoma,0.5815,Pancreatic Mixed Acinar-Ductal Carcinoma,0.5807,Lipid-Rich Carcinoma,0.5775,Dermal Duct Tumor,0.5748,Distal Cholangiocarcinoma,0.5740,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,0.5728,Adenocarcinoma with Apocrine Metaplasia,0.5725,25-30% DUCTAL COMPONENT,False,False,False
82463 NEUROENDOCRINE CARCINOMA NOS,Neuroendocrine Carcinoma,1,2,Neuroendocrine Carcinoma,0.7585,Cervical Neuroendocrine Carcinoma,0.7151,Advanced Neuroendocrine Carcinoma,0.7141,Grade III Neuroendocrine Carcinoma,0.7064,Gastric Neuroendocrine Carcinoma,0.7034,Colorectal Neuroendocrine Carcinoma,0.6955,Pancreatic Neuroendocrine Carcinoma,0.6946,Adenocarcinoma with Neuroendocrine Differentiation,0.6901,Neuroendocrine Tumor G3,0.6860,Prostate Neuroendocrine Carcinoma,0.6838,Endometrial Neuroendocrine Carcinoma,0.6832,Salivary Gland Neuroendocrine Carcinoma,0.6814,Intestinal Neuroendocrine Carcinoma,0.6808,Small Cell Neuroendocrine Carcinoma,0.6802,Digestive System Neuroendocrine Carcinoma,0.6802,Colon Neuroendocrine Carcinoma,0.6756,Grade II Neuroendocrine Carcinoma,0.6752,Metastatic Neuroendocrine Carcinoma,0.6731,Gastroesophageal Junction Neuroendocrine Carcinoma,0.6725,Neuroendocrine Neoplasm,0.6670,82463 NEUROENDOCRINE CARCINOMA NOS,True,True,True
AB,Thymoma Type AB,8,2,Branchioma,0.6178,Blastoma,0.6003,Adult Acute Basophilic Leukemia,0.5979,Acute Basophilic Leukemia,0.5913,Barrett Adenocarcinoma,0.5850,Adenoma,0.5845,Breast Atypical Hyperplasia,0.5808,Thymoma Type AB,0.5753,Ciliary Body Adenocarcinoma,0.5709,Breast Adenocarcinoma,0.5699,Childhood Acute Basophilic Leukemia,0.5666,Anaplastic Medulloblastoma,0.5663,Adult Medulloblastoma,0.5650,Breast Atypical Lobular Hyperplasia,0.5604,Medulloblastoma,0.5602,Neuroblastoma,0.5599,Adenocarcinoma,0.5583,Breast Atypical Ductal Hyperplasia,0.5576,Advanced Breast Adenocarcinoma,0.5571,Atypical Adenoma,0.5567,AB,False,False,False
ACANTHOLYTIC,Skin Acantholytic Squamous Cell Carcinoma,9,2,Acantholytic Acanthoma,0.8033,Acanthoma,0.7408,Epidermolytic Acanthoma,0.7229,Clear Cell Acanthoma,0.6689,Large Cell Acanthoma,0.6590,Acantholytic Squamous Cell Carcinoma,0.6490,Acanthomatous Ameloblastoma,0.6363,Osteolytic Neoplasm,0.6258,Skin Acantholytic Squamous Cell Carcinoma,0.6183,Adenoma,0.6001,Pilar Sheath Acanthoma,0.5967,Ameloblastoma,0.5900,Breast Atypical Hyperplasia,0.5805,Benign Ameloblastoma,0.5794,Basal Cell Ameloblastoma,0.5790,Basal Cell Adenoma,0.5783,Lymphoma,0.5750,Secretory Meningioma,0.5699,AH Amyloidosis,0.5675,Inverted Follicular Keratosis,0.5675,ACANTHOLYTIC,False,False,False
ACC,Adrenal Cortical Carcinoma,1,2,Adrenal Cortical Carcinoma,0.9037,Advanced Adrenal Cortical Carcinoma,0.8379,Malignant Adrenal Cortical Neoplasm,0.8115,Metastatic Adrenal Cortical Carcinoma,0.8101,Adrenal Cortical Neoplasm,0.8089,Adrenal Cortical High Grade Carcinoma,0.7944,Adrenal Cortical Adenoma,0.7927,Adrenal Cortical Oncocytic Carcinoma,0.7924,Adrenal Cortical Low Grade Carcinoma,0.7893,Childhood Adrenal Cortical Carcinoma,0.7833,Adrenal Cortical Adenomatoid Tumor,0.7708,Locally Advanced Adrenal Cortical Carcinoma,0.7645,Metastatic Carcinoma in the Adrenal Cortex,0.7643,Adrenal Cortical Myxoid Carcinoma,0.7601,Unresectable Adrenal Cortical Carcinoma,0.7519,Adrenal Cortical Melanoma,0.7467,Adrenal Cortical Carcinoma by AJCC v8 Stage,0.7446,Adrenal Cortical Sarcomatoid Carcinoma,0.7358,Adrenal Cortical Compact Cell Adenoma,0.7350,Benign Adrenal Cortical Neoplasm,0.7345,Adrenocortical Carcinoma,True,True,True
ACINAR ADENOCARCINOMA 85513,Lung Acinar Adenocarcinoma,2,2,Prostate Acinar Adenocarcinoma,0.6614,Lung Acinar Adenocarcinoma,0.6432,Pancreatic Adenocarcinoma,0.6395,Adenocarcinoma,0.6316,Acinar Cell Carcinoma,0.6309,Anal Adenocarcinoma,0.6264,Appendix Adenocarcinoma,0.6215,Acinar Cell Adenoma,0.6208,Pancreatic Acinar Cell Cystadenocarcinoma,0.6203,Pancreatic Acinar Cell Carcinoma,0.6166,Prostate Adenocarcinoma,0.6157,Prostate Acinar Mucinous Adenocarcinoma,0.6138,Anal Canal Adenocarcinoma,0.6047,Prostate Acinar Oncocytic Adenocarcinoma,0.6026,Anal Glands Adenocarcinoma,0.6012,Pancreatic Ductal Adenocarcinoma,0.5972,Tubular Adenocarcinoma,0.5970,Papillary Adenocarcinoma,0.5958,Lung Adenocarcinoma,0.5949,Prostate Ductal Adenocarcinoma,0.5948,ACINAR ADENOCARCINOMA 85513,False,True,True
ACINAR CELL CARCINOMA,Acinar Cell Carcinoma,1,2,Acinar Cell Carcinoma,1.0000,Pancreatic Acinar Cell Carcinoma,0.9034,Acinar Cell Neoplasm,0.8874,Acinar Cell Adenoma,0.8750,Breast Acinic Cell Carcinoma,0.8287,Salivary Gland Acinic Cell Carcinoma,0.8285,Pancreatic Acinar Cell Neoplasm,0.8146,Lung Acinar Adenocarcinoma,0.8093,Pancreatic Acinar Cell Cystadenocarcinoma,0.8039,Major Salivary Gland Acinic Cell Carcinoma,0.7998,Prostate Acinar Adenocarcinoma,0.7962,Lacrimal Gland Acinic Cell Carcinoma,0.7792,Parotid Gland Acinic Cell Carcinoma,0.7788,Childhood Pancreatic Acinar Cell Carcinoma,0.7684,Minor Salivary Gland Acinic Cell Carcinoma,0.7619,Metastatic Pancreatic Acinar Cell Carcinoma,0.7583,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7567,Adenocarcinoma,0.7551,Submandibular Gland Acinic Cell Carcinoma,0.7416,Lepidic Adenocarcinoma,0.7412,ACINAR CELL CARCINOMA,True,True,True
ACINAR CELL CARCINOMA OF THE PANCREAS,Pancreatic Acinar Cell Carcinoma,1,2,Pancreatic Acinar Cell Carcinoma,0.9614,Acinar Cell Carcinoma,0.9023,Pancreatic Acinar Cell Neoplasm,0.8340,Childhood Pancreatic Acinar Cell Carcinoma,0.8240,Pancreatic Acinar Cell Cystadenocarcinoma,0.8187,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7916,Metastatic Pancreatic Acinar Cell Carcinoma,0.7868,Acinar Cell Adenoma,0.7848,Salivary Gland Acinic Cell Carcinoma,0.7828,Parotid Gland Acinic Cell Carcinoma,0.7818,Acinar Cell Neoplasm,0.7816,Prostate Acinar Adenocarcinoma,0.7718,Exocrine Pancreas Carcinoma,0.7665,Major Salivary Gland Acinic Cell Carcinoma,0.7642,Pancreatic Adenocarcinoma,0.7616,Pancreatic Ductal Adenocarcinoma,0.7562,Lung Acinar Adenocarcinoma,0.7443,Pancreatic Poorly Cohesive Adenocarcinoma,0.7327,Minor Salivary Gland Acinic Cell Carcinoma,0.7276,Breast Acinic Cell Carcinoma,0.7250,ACINAR CELL CARCINOMA OF THE PANCREAS,True,True,True
"ACINAR CELL CARCINOMA, NOS",Acinar Cell Carcinoma,1,2,Acinar Cell Carcinoma,0.9626,Pancreatic Acinar Cell Carcinoma,0.8781,Acinar Cell Neoplasm,0.8388,Acinar Cell Adenoma,0.8293,Salivary Gland Acinic Cell Carcinoma,0.8056,Breast Acinic Cell Carcinoma,0.7985,Pancreatic Acinar Cell Cystadenocarcinoma,0.7885,Pancreatic Acinar Cell Neoplasm,0.7782,Major Salivary Gland Acinic Cell Carcinoma,0.7772,Lung Acinar Adenocarcinoma,0.7758,Prostate Acinar Adenocarcinoma,0.7668,Parotid Gland Acinic Cell Carcinoma,0.7592,Lacrimal Gland Acinic Cell Carcinoma,0.7504,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7363,Minor Salivary Gland Acinic Cell Carcinoma,0.7358,Childhood Pancreatic Acinar Cell Carcinoma,0.7294,Submandibular Gland Acinic Cell Carcinoma,0.7248,Metastatic Pancreatic Acinar Cell Carcinoma,0.7248,Prostate Acinar Microcystic Adenocarcinoma,0.7107,Lepidic Adenocarcinoma,0.7040,"ACINAR CELL CARCINOMA, NOS",True,True,True
ACINIC CELL CARCINOMA,Acinar Cell Carcinoma,2,2,Breast Acinic Cell Carcinoma,0.9182,Acinar Cell Carcinoma,0.9055,Salivary Gland Acinic Cell Carcinoma,0.8879,Lacrimal Gland Acinic Cell Carcinoma,0.8509,Major Salivary Gland Acinic Cell Carcinoma,0.8498,Parotid Gland Acinic Cell Carcinoma,0.8468,Minor Salivary Gland Acinic Cell Carcinoma,0.8100,Acinar Cell Neoplasm,0.8024,Pancreatic Acinar Cell Carcinoma,0.7995,Submandibular Gland Acinic Cell Carcinoma,0.7980,Childhood Salivary Gland Acinic Cell Carcinoma,0.7667,Acinar Cell Adenoma,0.7658,Pancreatic Acinar Cell Neoplasm,0.7191,Lung Acinar Adenocarcinoma,0.7124,Pancreatic Acinar Cell Cystadenocarcinoma,0.7089,Apocrine Carcinoma,0.7039,Oncocytic Adenocarcinoma,0.7012,Exocrine Pancreas Carcinoma,0.6972,Adenoid Cystic Carcinoma,0.6966,Adenocarcinoma,0.6965,ACINIC CELL CARCINOMA,False,True,True
ACRAL,Acral Lentiginous Melanoma,3,2,Acral Nevus,0.7317,Acral Melanoma,0.7245,Acral Lentiginous Melanoma,0.5861,Astrocytoma,0.5796,Superficial Acral Fibromyxoma,0.5702,Adenoma,0.5528,Urachal Adenocarcinoma,0.5461,Cerebral Astrocytoma,0.5444,Anaplastic Lymphoma,0.5371,Primary Cutaneous Amyloidosis,0.5350,Epididymal Adenocarcinoma,0.5340,Advanced Adnexal Carcinoma,0.5317,AHL Amyloidosis,0.5291,ROSE Cluster 5,0.5276,Anal Lymphoma,0.5262,Anaplastic Astrocytoma,0.5262,Adenocarcinoma,0.5247,Atypical Adenoma,0.5237,ROSE Cluster 7,0.5187,Anal Melanoma,0.5186,ACRAL,False,True,True
ACRAL LENTIGINOUS,Acral Lentiginous Melanoma,1,2,Acral Lentiginous Melanoma,0.8197,Acral Nevus,0.7096,Lentiginous Nevus,0.7079,Metastatic Acral Lentiginous Melanoma,0.6915,Lentigo Maligna,0.6867,Acral Melanoma,0.6746,Recurrent Acral Lentiginous Melanoma,0.6519,Mucosal Lentiginous Melanoma,0.6459,Lentigo Maligna Melanoma,0.6248,Unresectable Acral Lentiginous Melanoma,0.6153,Stage II Acral Lentiginous Melanoma AJCC v6 and v7,0.5951,Inverted Follicular Keratosis,0.5916,Stage IV Acral Lentiginous Melanoma AJCC v6 and v7,0.5879,Stage I Acral Lentiginous Melanoma AJCC v7,0.5835,Stage III Acral Lentiginous Melanoma AJCC v7,0.5763,Skin Keratoacanthoma,0.5734,Skin Atypical Lipomatous Tumor,0.5649,Superficial Acral Fibromyxoma,0.5623,Lichen Planus-Like Keratosis,0.5600,Conjunctival Keratoacanthoma,0.5576,ACRAL LENTIGINOUS,True,True,True
ACRAL MELANOMA,Acral Lentiginous Melanoma,2,2,Acral Melanoma,1.0000,Acral Lentiginous Melanoma,0.8424,Acral Nevus,0.7821,Cutaneous Melanoma,0.7765,Metastatic Acral Lentiginous Melanoma,0.7363,Dermal Melanoma,0.7320,Melanoma,0.7175,Anal Melanoma,0.7154,Volar Melanoma,0.7059,Cutaneous Amelanotic Melanoma,0.7046,Amelanotic Melanoma,0.6976,Mucosal Melanoma,0.6966,Melanoacanthoma,0.6816,Superficial Acral Fibromyxoma,0.6781,Melanocytic Matricoma,0.6725,Cutaneous Melanoma of the Extremity,0.6704,Lentigo Maligna Melanoma,0.6688,Non-Cutaneous Melanoma,0.6683,Subungual Melanoma,0.6616,Eyelid Melanoma,0.6615,ACRAL MELANOMA,False,True,True
ACTIVATED B-CELL TYPE,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,1,2,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.6586,Advanced B-Cell Malignant Neoplasm,0.6495,Mature B-Cell Neoplasm,0.6196,Centroblastic Lymphoma,0.6177,B-Cell Neoplasm,0.6165,Aggressive B-Cell Non-Hodgkin Lymphoma,0.6063,B-Cell Malignant Neoplasm,0.6037,Centroblastic Lymphoma by Ann Arbor Stage,0.5940,Pre T-ALL,0.5919,Blastoma,0.5852,B-Cell Leukemia,0.5824,Mature T-ALL,0.5729,Cutaneous Mature B-Cell Neoplasm,0.5725,Adult B Lymphoblastic Lymphoma,0.5602,Anaplastic Lymphoma,0.5552,High Grade B-Cell Lymphoma,0.5540,Adult Immunoblastic Lymphoma,0.5515,Classical Burkitt Lymphoma,0.5515,Luminal A Breast Carcinoma,0.5505,Adult Acute Basophilic Leukemia,0.5485,ACTIVATED B-CELL TYPE,True,True,True
ACUTE BIPHENOTYPIC LEUKEMIA,Acute Biphenotypic Leukemia,1,2,Acute Biphenotypic Leukemia,1.0000,Infant Acute Biphenotypic Leukemia,0.8567,Recurrent Acute Biphenotypic Leukemia,0.7899,Acute Bilineal Leukemia,0.7685,Acute Basophilic Leukemia,0.7415,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.7339,Acute Leukemia,0.7286,Acute Monoblastic Leukemia,0.7282,Refractory Acute Biphenotypic Leukemia,0.7274,Acute Monoblastic and Monocytic Leukemia,0.7232,Hyperdiploid B Acute Lymphoblastic Leukemia,0.7202,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",0.7102,Acute Undifferentiated Leukemia,0.7099,Mixed Phenotype Acute Leukemia,0.7009,Acute Myeloid Leukemia,0.7006,Aleukemic Myeloid Leukemia,0.6992,Acute Monocytic Leukemia,0.6981,Aleukemic Acute Lymphoblastic Leukemia,0.6958,"Mixed Phenotype Acute Leukemia, B/T",0.6954,Aleukemic Leukemia,0.6937,ACUTE BIPHENOTYPIC LEUKEMIA,True,True,True
ACUTE ERYTHROID LEUKAEMIA,Acute Erythroid Leukemia,1,2,Acute Erythroid Leukemia,0.9836,Pure Erythroid Leukemia,0.8704,Childhood Acute Erythroid Leukemia,0.8681,Adult Acute Erythroid Leukemia,0.8618,Adult Pure Erythroid Leukemia,0.8164,Acute Eosinophilic Leukemia,0.8033,Acute Myeloid Leukemia,0.7709,Acute Leukemia,0.7667,Recurrent Acute Erythroid Leukemia,0.7508,Adult Erythroleukemia,0.7279,Adult Acute Eosinophilic Leukemia,0.7271,Childhood Acute Eosinophilic Leukemia,0.7234,Erythroleukemia,0.7231,Acute Undifferentiated Leukemia,0.7173,Myeloid Leukemia,0.7124,Acute Monocytic Leukemia,0.6945,Aleukemic Myeloid Leukemia,0.6815,Acute Megakaryoblastic Leukemia,0.6807,Acute Basophilic Leukemia,0.6768,Acute Myeloid Leukemia with EZH2 Mutation,0.6761,ACUTE ERYTHROID LEUKAEMIA,True,True,True
ACUTE ERYTHROID LEUKEMIA,Acute Erythroid Leukemia,1,2,Acute Erythroid Leukemia,1.0000,Pure Erythroid Leukemia,0.8829,Adult Acute Erythroid Leukemia,0.8791,Childhood Acute Erythroid Leukemia,0.8723,Adult Pure Erythroid Leukemia,0.8329,Acute Eosinophilic Leukemia,0.8098,Acute Leukemia,0.7898,Acute Myeloid Leukemia,0.7866,Recurrent Acute Erythroid Leukemia,0.7557,Adult Erythroleukemia,0.7373,Adult Acute Eosinophilic Leukemia,0.7369,Acute Undifferentiated Leukemia,0.7324,Erythroleukemia,0.7314,Childhood Acute Eosinophilic Leukemia,0.7251,Myeloid Leukemia,0.7237,Acute Monocytic Leukemia,0.7069,Acute Basophilic Leukemia,0.6933,Aleukemic Myeloid Leukemia,0.6912,Acute Megakaryoblastic Leukemia,0.6888,Aleukemic Acute Lymphoblastic Leukemia,0.6882,ACUTE ERYTHROID LEUKEMIA,True,True,True
ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE,Acute Leukemia of Ambiguous Lineage,1,2,Acute Leukemia of Ambiguous Lineage,0.9763,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0.9263,Acute Leukemia of Ambiguous Lineage with Defining Genetic Abnormalities,0.8532,Acute Undifferentiated Leukemia,0.8055,Acute Leukemia,0.7987,Recurrent Acute Leukemia of Ambiguous Lineage,0.7617,Aleukemic Acute Lymphoblastic Leukemia,0.7558,Refractory Acute Leukemia of Ambiguous Lineage,0.7506,Acute Lymphoblastic Leukemia,0.7407,"Acute Myeloid Leukemia, Not Otherwise Specified",0.7388,Acute Myeloid Leukemia,0.7359,Acute Leukemia of Ambiguous Lineage with BCL11B Rearrangement,0.7097,Aleukemic Lymphoid Leukemia,0.7057,Acute Bilineal Leukemia,0.7052,Acute Biphenotypic Leukemia,0.7010,Aleukemic Myeloid Leukemia,0.6894,Adult Acute Lymphoblastic Leukemia,0.6879,Infant Acute Undifferentiated Leukemia,0.6858,B Acute Lymphoblastic Leukemia,0.6838,Aleukemic Leukemia,0.6836,ACUTE LEUKAEMIAS OF AMBIGUOUS LINEAGE,True,True,True
ACUTE LEUKEMIAS OF AMBIGUOUS LINEAGE,Acute Leukemia of Ambiguous Lineage,1,2,Acute Leukemia of Ambiguous Lineage,0.9880,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0.9330,Acute Leukemia of Ambiguous Lineage with Defining Genetic Abnormalities,0.8720,Acute Undifferentiated Leukemia,0.8066,Acute Leukemia,0.8044,Recurrent Acute Leukemia of Ambiguous Lineage,0.7743,Refractory Acute Leukemia of Ambiguous Lineage,0.7670,Aleukemic Acute Lymphoblastic Leukemia,0.7654,Acute Lymphoblastic Leukemia,0.7492,Acute Myeloid Leukemia,0.7315,"Acute Myeloid Leukemia, Not Otherwise Specified",0.7280,Acute Leukemia of Ambiguous Lineage with BCL11B Rearrangement,0.7275,Aleukemic Lymphoid Leukemia,0.7263,Adult Acute Lymphoblastic Leukemia,0.7020,Acute Bilineal Leukemia,0.7005,B Acute Lymphoblastic Leukemia,0.6968,Leukemia,0.6965,Acute Biphenotypic Leukemia,0.6954,Aleukemic Myeloid Leukemia,0.6953,Infant Acute Undifferentiated Leukemia,0.6902,ACUTE LEUKEMIAS OF AMBIGUOUS LINEAGE,True,True,True
ACUTE LYMPHOBLASTIC LEUKEMIA,Acute Lymphoblastic Leukemia,1,2,Acute Lymphoblastic Leukemia,1.0000,Common Acute Lymphoblastic Leukemia,0.8806,Childhood Acute Lymphoblastic Leukemia,0.8794,B Acute Lymphoblastic Leukemia,0.8579,Infant Acute Lymphoblastic Leukemia,0.8547,Acute Leukemia,0.8480,Aleukemic Acute Lymphoblastic Leukemia,0.8428,T Acute Lymphoblastic Leukemia,0.8360,Adult Acute Lymphoblastic Leukemia,0.8345,Lymphoblastic Lymphoma,0.8336,L1 Acute Lymphoblastic Leukemia,0.8279,Lymphoid Leukemia,0.8200,L2 Acute Lymphoblastic Leukemia,0.8146,Childhood B Acute Lymphoblastic Leukemia,0.7966,Childhood Lymphoblastic Lymphoma,0.7902,Adult Lymphoblastic Lymphoma,0.7861,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7788,Childhood T Acute Lymphoblastic Leukemia,0.7770,B Lymphoblastic Leukemia/Lymphoma,0.7762,B Lymphoblastic Lymphoma,0.7708,ACUTE LYMPHOBLASTIC LEUKEMIA,True,True,True
"ACUTE LYMPHOBLASTIC LEUKEMIA ALL, B-CELL",B Acute Lymphoblastic Leukemia,1,2,B Acute Lymphoblastic Leukemia,0.9248,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.8764,Childhood B Acute Lymphoblastic Leukemia,0.8282,Acute Lymphoblastic Leukemia,0.8154,B Lymphoblastic Leukemia/Lymphoma,0.8129,B Lymphoblastic Lymphoma,0.8108,Adult B Acute Lymphoblastic Leukemia,0.7980,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.7963,Pre-B Acute Lymphoblastic Leukemia,0.7903,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified",0.7890,B-Cell Leukemia,0.7851,B Acute Lymphoblastic Leukemia Associated with Down Syndrome,0.7644,Common Acute Lymphoblastic Leukemia,0.7583,Near-Haploid B Acute Lymphoblastic Leukemia,0.7574,Burkitt Leukemia,0.7572,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7553,Childhood B Lymphoblastic Lymphoma,0.7513,Adult B Lymphoblastic Lymphoma,0.7478,T Acute Lymphoblastic Leukemia,0.7427,Childhood B Lymphoblastic Leukemia/Lymphoma,0.7412,"ACUTE LYMPHOBLASTIC LEUKEMIA ALL, B-CELL",True,True,True
"ACUTE LYMPHOBLASTIC LEUKEMIA ALL, T-CELL",T Acute Lymphoblastic Leukemia,1,2,T Acute Lymphoblastic Leukemia,0.9212,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.8872,T Lymphoblastic Leukemia/Lymphoma,0.8163,Childhood T Acute Lymphoblastic Leukemia,0.8159,T Acute Lymphoblastic Leukemia with TAL1 Rearrangement,0.8158,T Lymphoblastic Lymphoma,0.8077,Adult T Acute Lymphoblastic Leukemia,0.7987,T Acute Lymphoblastic Leukemia with TLX1 Rearrangement,0.7957,Early T Precursor Acute Lymphoblastic Leukemia,0.7823,Acute Lymphoblastic Leukemia,0.7775,Infant T Acute Lymphoblastic Leukemia,0.7763,"Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7725,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7721,Acute Adult T-Cell Leukemia/Lymphoma,0.7673,T Acute Lymphoblastic Leukemia with LMO1 Rearrangement,0.7597,T Acute Lymphoblastic Leukemia with LMO2 Rearrangement,0.7587,Adult T Lymphoblastic Lymphoma,0.7576,Adult T-Cell Leukemia/Lymphoma,0.7568,Childhood T Lymphoblastic Leukemia/Lymphoma,0.7557,Mature T-ALL,0.7552,"ACUTE LYMPHOBLASTIC LEUKEMIA ALL, T-CELL",True,True,True
ACUTE LYMPHOID LEUKEMIA,Acute Lymphoblastic Leukemia,1,2,Acute Lymphoblastic Leukemia,0.9074,Acute Leukemia,0.8944,Lymphoid Leukemia,0.8937,Aleukemic Acute Lymphoblastic Leukemia,0.8273,Aleukemic Lymphoid Leukemia,0.8159,Acute Myeloid Leukemia,0.8112,Leukemia,0.8096,B Acute Lymphoblastic Leukemia,0.8068,Acute Leukemia of Ambiguous Lineage,0.7994,Common Acute Lymphoblastic Leukemia,0.7985,Adult Acute Lymphoblastic Leukemia,0.7930,T Acute Lymphoblastic Leukemia,0.7922,Myeloid Leukemia,0.7759,L1 Acute Lymphoblastic Leukemia,0.7731,L2 Acute Lymphoblastic Leukemia,0.7664,Childhood Acute Lymphoblastic Leukemia,0.7611,Acute Undifferentiated Leukemia,0.7570,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0.7552,Infant Acute Lymphoblastic Leukemia,0.7458,"Acute Myeloid Leukemia, Not Otherwise Specified",0.7400,ACUTE LYMPHOID LEUKEMIA,True,True,True
ACUTE MEGAKARYOBLASTIC LEUKAEMIA,Acute Megakaryoblastic Leukemia,1,2,Acute Megakaryoblastic Leukemia,0.9901,Adult Acute Megakaryoblastic Leukemia,0.8938,Childhood Acute Megakaryoblastic Leukemia,0.8777,Acute Monocytic Leukemia,0.8261,Acute Myelomonocytic Leukemia,0.8195,Acute Myeloid Leukemia,0.7831,Aleukemic Myeloid Leukemia,0.7771,Megakaryocytic Neoplasm,0.7715,Acute Monoblastic and Monocytic Leukemia,0.7643,Recurrent Acute Megakaryoblastic Leukemia,0.7559,Acute Monoblastic Leukemia,0.7381,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,0.7379,Myeloid Leukemia,0.7364,"Mixed Phenotype Acute Leukemia, T/Megakaryocytic",0.7296,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.7266,Adult Acute Monocytic Leukemia,0.7185,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.7163,Adult Acute Myelomonocytic Leukemia,0.7101,Acute Myeloid Leukemia with Maturation,0.7077,"Acute Myeloid Leukemia, Not Otherwise Specified",0.7060,ACUTE MEGAKARYOBLASTIC LEUKAEMIA,True,True,True
ACUTE MEGAKARYOBLASTIC LEUKEMIA,Acute Megakaryoblastic Leukemia,1,2,Acute Megakaryoblastic Leukemia,1.0000,Adult Acute Megakaryoblastic Leukemia,0.9052,Childhood Acute Megakaryoblastic Leukemia,0.8813,Acute Monocytic Leukemia,0.8317,Acute Myelomonocytic Leukemia,0.8256,Acute Myeloid Leukemia,0.7897,Megakaryocytic Neoplasm,0.7752,Aleukemic Myeloid Leukemia,0.7728,Acute Monoblastic and Monocytic Leukemia,0.7653,Recurrent Acute Megakaryoblastic Leukemia,0.7573,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,0.7537,"Mixed Phenotype Acute Leukemia, T/Megakaryocytic",0.7484,Myeloid Leukemia,0.7405,Acute Monoblastic Leukemia,0.7363,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.7301,Adult Acute Monocytic Leukemia,0.7250,Adult Acute Myelomonocytic Leukemia,0.7182,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.7168,"Acute Myeloid Leukemia, Not Otherwise Specified",0.7112,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.7106,ACUTE MEGAKARYOBLASTIC LEUKEMIA,True,True,True
ACUTE MONOBLASTIC AND MONOCYTIC LEUKAEMIA,Acute Monoblastic and Monocytic Leukemia,1,2,Acute Monoblastic and Monocytic Leukemia,0.9899,Adult Acute Monoblastic and Monocytic Leukemia,0.8854,Acute Monoblastic Leukemia,0.8757,Childhood Acute Monoblastic and Monocytic Leukemia,0.8322,Acute Monocytic Leukemia,0.8252,Adult Acute Monoblastic Leukemia,0.8050,Acute Myelomonocytic Leukemia,0.7919,Childhood Acute Monoblastic Leukemia,0.7691,Acute Myeloid Leukemia with Maturation,0.7675,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7586,Adult Acute Monocytic Leukemia,0.7551,Acute Megakaryoblastic Leukemia,0.7543,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.7508,Aleukemic Myeloid Leukemia,0.7486,Acute Myeloid Leukemia,0.7461,Adult Acute Myelomonocytic Leukemia,0.7345,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7341,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.7289,Childhood Acute Monocytic Leukemia,0.7288,Acute Myeloid Leukemia without Maturation,0.7227,ACUTE MONOBLASTIC AND MONOCYTIC LEUKAEMIA,True,True,True
ACUTE MONOBLASTIC/MONOCYTIC LEUKEMIA,Acute Monoblastic and Monocytic Leukemia,1,2,Acute Monoblastic and Monocytic Leukemia,0.9765,Acute Monoblastic Leukemia,0.9081,Adult Acute Monoblastic and Monocytic Leukemia,0.8805,Acute Monocytic Leukemia,0.8642,Adult Acute Monoblastic Leukemia,0.8397,Childhood Acute Monoblastic and Monocytic Leukemia,0.8263,Acute Myelomonocytic Leukemia,0.8243,Childhood Acute Monoblastic Leukemia,0.7986,Acute Myeloid Leukemia with Maturation,0.7983,Adult Acute Monocytic Leukemia,0.7913,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.7845,Acute Megakaryoblastic Leukemia,0.7762,Acute Myeloid Leukemia with Minimal Differentiation,0.7758,Adult Acute Myelomonocytic Leukemia,0.7691,Acute Myeloid Leukemia without Maturation,0.7673,Acute Myeloid Leukemia,0.7645,Childhood Acute Monocytic Leukemia,0.7634,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7531,Aleukemic Myeloid Leukemia,0.7492,Adult Acute Megakaryoblastic Leukemia,0.7460,ACUTE MONOBLASTIC/MONOCYTIC LEUKEMIA,True,True,True
ACUTE MYELOBLASTIC LEUKEMIA,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9069,Acute Monocytic Leukemia,0.8732,Acute Myelomonocytic Leukemia,0.8586,Acute Megakaryoblastic Leukemia,0.8429,Myeloid Leukemia,0.8264,"Acute Myeloid Leukemia, Not Otherwise Specified",0.8249,Acute Monoblastic Leukemia,0.8122,Acute Monoblastic and Monocytic Leukemia,0.8098,Acute Myeloid Leukemia with Maturation,0.8091,Acute Leukemia,0.8041,Childhood Acute Megakaryoblastic Leukemia,0.7827,Aleukemic Myeloid Leukemia,0.7810,Childhood Acute Monocytic Leukemia,0.7736,Adult Acute Megakaryoblastic Leukemia,0.7716,Acute Myeloid Leukemia without Maturation,0.7700,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7692,Childhood Acute Myeloid Leukemia,0.7645,Adult Acute Monocytic Leukemia,0.7589,Adult Acute Myeloid Leukemia,0.7585,Childhood Acute Myelomonocytic Leukemia,0.7549,ACUTE MYELOBLASTIC LEUKEMIA,True,True,True
"ACUTE MYELOBLASTIC LEUKEMIA, IN RELAPSE",Recurrent Acute Myeloid Leukemia,1,2,Recurrent Acute Myeloid Leukemia,0.8141,Recurrent Acute Monocytic Leukemia,0.7991,Recurrent Acute Monoblastic and Monocytic Leukemia,0.7893,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,0.7859,Recurrent Acute Myelomonocytic Leukemia,0.7850,Recurrent Myeloid Leukemia,0.7654,"Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related",0.7612,Recurrent Acute Leukemia,0.7540,Recurrent Adult Acute Myeloid Leukemia,0.7511,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,0.7307,Recurrent Acute Megakaryoblastic Leukemia,0.7239,Recurrent Childhood Acute Myeloid Leukemia,0.7024,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.6984,Recurrent Acute Undifferentiated Leukemia,0.6784,Recurrent Acute Biphenotypic Leukemia,0.6757,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.6659,Recurrent Acute Lymphoblastic Leukemia,0.6634,Recurrent Myeloid Neoplasm,0.6622,Recurrent Leukemia,0.6617,Recurrent Acute Erythroid Leukemia,0.6611,"ACUTE MYELOBLASTIC LEUKEMIA, IN RELAPSE",True,True,True
ACUTE MYELOGENOUS LEUKEMIA AML,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9379,Acute Monocytic Leukemia,0.8556,"Acute Myeloid Leukemia, Not Otherwise Specified",0.8467,Acute Myelomonocytic Leukemia,0.8323,Myeloid Leukemia,0.8297,Acute Leukemia,0.8258,Adult Acute Myeloid Leukemia,0.8195,Aleukemic Myeloid Leukemia,0.8050,Acute Megakaryoblastic Leukemia,0.7915,Adult Acute Monocytic Leukemia,0.7852,Acute Myeloid Leukemia with Maturation,0.7672,Adult Acute Myelomonocytic Leukemia,0.7650,Adult Acute Megakaryoblastic Leukemia,0.7643,Childhood Acute Myeloid Leukemia,0.7588,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.7572,Acute Monoblastic and Monocytic Leukemia,0.7500,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.7496,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7481,Acute Erythroid Leukemia,0.7447,Acute Myeloid Leukemia without Maturation,0.7423,ACUTE MYELOGENOUS LEUKEMIA AML,True,True,True
"ACUTE MYELOGENOUS LEUKEMIA AML, M2 MYELOBLASTIC",Acute Myeloid Leukemia with Maturation,1,2,Acute Myeloid Leukemia with Maturation,0.6748,Acute Myelomonocytic Leukemia,0.6713,Acute Myeloid Leukemia with Minimal Differentiation,0.6693,Acute Monoblastic and Monocytic Leukemia,0.6487,Acute Myeloid Leukemia without Maturation,0.6432,Acute Monocytic Leukemia,0.6423,Acute Megakaryoblastic Leukemia,0.6341,Acute Myeloid Leukemia,0.6332,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.6317,Adult Acute Myelomonocytic Leukemia,0.6273,Adult Acute Megakaryoblastic Leukemia,0.6218,Adult Acute Myeloid Leukemia with Maturation,0.6207,Secondary Acute Myeloid Leukemia,0.6206,Adult Acute Myeloid Leukemia with Minimal Differentiation,0.6162,Acute Myeloid Leukemia with NPM1-MLF1,0.6129,Aleukemic Myeloid Leukemia,0.6114,Acute Monoblastic Leukemia,0.6101,Adult Acute Monoblastic and Monocytic Leukemia,0.6028,Adult Acute Monocytic Leukemia,0.5998,Acute Myeloid Leukemia with MECOM Rearrangement,0.5974,"ACUTE MYELOGENOUS LEUKEMIA AML, M2 MYELOBLASTIC",True,True,True
"ACUTE MYELOGENOUS LEUKEMIA AML, M3 PROMYELOCYTIC",Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,5,2,Typical Acute Promyelocytic Leukemia,0.7225,Acute Myeloid Leukemia with NPM1-MLF1,0.6875,Acute Myelomonocytic Leukemia,0.6714,Acute Promyelocytic Leukemia with STAT3-RARA,0.6709,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.6578,Microgranular Acute Promyelocytic Leukemia,0.6537,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.6485,Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA,0.6475,Acute Promyelocytic Leukemia with t(5;17)(q35;q21); NPM1-RARA,0.6475,Acute Myeloid Leukemia with NPM1 Mutation,0.6399,Acute Myeloid Leukemia,0.6392,Acute Monocytic Leukemia,0.6359,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.6294,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0.6258,Acute Myeloid Leukemia with Maturation,0.6256,Acute Promyelocytic Leukemia with FIP1L1-RARA,0.6228,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.6175,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.6156,Acute Megakaryoblastic Leukemia,0.6150,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6129,"ACUTE MYELOGENOUS LEUKEMIA AML, M3 PROMYELOCYTIC",False,False,True
"ACUTE MYELOGENOUS LEUKEMIA AML, M4 MYELOMONOCYTIC",Acute Myelomonocytic Leukemia,1,2,Acute Myelomonocytic Leukemia,0.7949,Adult Acute Myelomonocytic Leukemia,0.7494,Acute Myeloid Leukemia with NPM1-MLF1,0.6992,Acute Monoblastic and Monocytic Leukemia,0.6956,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.6950,Acute Myeloid Leukemia with Maturation,0.6930,Childhood Acute Myelomonocytic Leukemia,0.6862,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.6822,Acute Monocytic Leukemia,0.6816,Acute Myeloid Leukemia with Multilineage Dysplasia,0.6650,Adult Acute Monoblastic and Monocytic Leukemia,0.6643,Acute Megakaryoblastic Leukemia,0.6607,Acute Myeloid Leukemia with MECOM Rearrangement,0.6589,Adult Acute Monocytic Leukemia,0.6577,Adult Acute Megakaryoblastic Leukemia,0.6528,Myelodysplastic Chronic Myelomonocytic Leukemia,0.6517,Acute Monoblastic Leukemia,0.6433,Chronic Myelomonocytic Leukemia,0.6419,Adult Acute Myeloid Leukemia with Maturation,0.6412,Acute Myeloid Leukemia,0.6410,"ACUTE MYELOGENOUS LEUKEMIA AML, M4 MYELOMONOCYTIC",True,True,True
"ACUTE MYELOGENOUS LEUKEMIA AML, M5 EOSINOPHILIC/MONOCYTIC",Acute Monoblastic and Monocytic Leukemia,8,2,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.8089,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.7150,Chronic Myelomonocytic Leukemia with Eosinophilia,0.7104,Acute Eosinophilic Leukemia,0.6828,Acute Myelomonocytic Leukemia,0.6596,Acute Myeloid Leukemia with EZH2 Mutation,0.6502,Acute Megakaryoblastic Leukemia,0.6418,Acute Monoblastic and Monocytic Leukemia,0.6324,Acute Myeloid Leukemia with MECOM Rearrangement,0.6303,Acute Monocytic Leukemia,0.6240,Acute Erythroid Leukemia,0.6183,Chronic Myelomonocytic Leukemia with Eosinophilia Associated with t(5;12)(q31;p12),0.6135,Acute Myeloid Leukemia with RUNX1 Mutation,0.5986,Childhood Acute Eosinophilic Leukemia,0.5981,Acute Myeloid Leukemia,0.5976,Adult Acute Eosinophilic Leukemia,0.5965,Adult Acute Myelomonocytic Leukemia,0.5932,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.5912,Childhood Acute Megakaryoblastic Leukemia,0.5910,Childhood Acute Myelomonocytic Leukemia,0.5909,"ACUTE MYELOGENOUS LEUKEMIA AML, M5 EOSINOPHILIC/MONOCYTIC",False,False,False
"ACUTE MYELOGENOUS LEUKEMIA AML, M5 MONOCYTIC",Acute Monoblastic and Monocytic Leukemia,3,2,Acute Myelomonocytic Leukemia,0.7882,Acute Monocytic Leukemia,0.7767,Acute Monoblastic and Monocytic Leukemia,0.7473,Acute Myeloid Leukemia with Maturation,0.7182,Acute Myeloid Leukemia,0.7181,Adult Acute Myelomonocytic Leukemia,0.7156,Childhood Acute Myelomonocytic Leukemia,0.7131,Acute Megakaryoblastic Leukemia,0.7056,Adult Acute Monocytic Leukemia,0.6997,Childhood Acute Monocytic Leukemia,0.6988,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.6988,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.6930,Acute Monoblastic Leukemia,0.6854,Adult Acute Monoblastic and Monocytic Leukemia,0.6854,Childhood Acute Megakaryoblastic Leukemia,0.6734,Acute Myeloid Leukemia with NPM1-MLF1,0.6717,Aleukemic Myeloid Leukemia,0.6684,Adult Acute Megakaryoblastic Leukemia,0.6684,Childhood Acute Monoblastic and Monocytic Leukemia,0.6643,Acute Myeloid Leukemia with MECOM Rearrangement,0.6623,"ACUTE MYELOGENOUS LEUKEMIA AML, M5 MONOCYTIC",False,True,True
"ACUTE MYELOGENOUS LEUKEMIA AML, M6 ERYTHROLEUKEMIA",Acute Erythroid Leukemia,1,2,Acute Erythroid Leukemia,0.7126,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.6957,Adult Acute Erythroid Leukemia,0.6821,Acute Myelomonocytic Leukemia,0.6781,Aleukemic Myeloid Leukemia,0.6761,Adult Erythroleukemia,0.6745,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.6718,Adult Acute Megakaryoblastic Leukemia,0.6643,Acute Monocytic Leukemia,0.6640,Acute Megakaryoblastic Leukemia,0.6617,Acute Myeloid Leukemia,0.6537,Adult Pure Erythroid Leukemia,0.6479,Childhood Acute Erythroid Leukemia,0.6454,Adult Acute Myelomonocytic Leukemia,0.6452,Pure Erythroid Leukemia,0.6376,Acute Myeloid Leukemia with del(7q),0.6359,Adult Acute Monocytic Leukemia,0.6349,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.6311,Acute Monoblastic and Monocytic Leukemia,0.6283,Acute Myeloid Leukemia with EZH2 Mutation,0.6213,"ACUTE MYELOGENOUS LEUKEMIA AML, M6 ERYTHROLEUKEMIA",True,True,True
"ACUTE MYELOGENOUS LEUKEMIA AML, M7 MEGAKARYOBLASTIC",Acute Megakaryoblastic Leukemia,1,2,Acute Megakaryoblastic Leukemia,0.7789,Acute Myelomonocytic Leukemia,0.7443,Adult Acute Megakaryoblastic Leukemia,0.7282,Childhood Acute Megakaryoblastic Leukemia,0.7092,Acute Myeloid Leukemia with del(7q),0.6786,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.6690,Acute Monocytic Leukemia,0.6644,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.6591,Adult Acute Myelomonocytic Leukemia,0.6555,Aleukemic Myeloid Leukemia,0.6553,Acute Myeloid Leukemia,0.6530,Acute Myeloid Leukemia with NPM1-MLF1,0.6524,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6519,"Mixed Phenotype Acute Leukemia, T/Megakaryocytic",0.6463,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7,0.6406,Acute Monoblastic and Monocytic Leukemia,0.6375,Childhood Acute Myelomonocytic Leukemia,0.6357,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,0.6326,Acute Myeloid Leukemia with i(17q),0.6314,Acute Myeloid Leukemia with NPM1 Mutation,0.6299,"ACUTE MYELOGENOUS LEUKEMIA AML, M7 MEGAKARYOBLASTIC",True,True,True
ACUTE MYELOGENOUS LEUKEMIA M5A,Acute Monoblastic and Monocytic Leukemia,2,2,Acute Myelomonocytic Leukemia,0.7586,Acute Monoblastic and Monocytic Leukemia,0.7317,Acute Monocytic Leukemia,0.7305,Acute Myeloid Leukemia,0.7256,Acute Monoblastic Leukemia,0.7243,Acute Myeloid Leukemia with Maturation,0.7161,Childhood Acute Myelomonocytic Leukemia,0.7004,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.6997,Adult Acute Myelomonocytic Leukemia,0.6985,Acute Megakaryoblastic Leukemia,0.6923,Adult Acute Monoblastic Leukemia,0.6813,Childhood Acute Monoblastic Leukemia,0.6791,Childhood Acute Monocytic Leukemia,0.6767,Adult Acute Monocytic Leukemia,0.6764,Acute Myeloid Leukemia with NPM1-MLF1,0.6740,Aleukemic Myeloid Leukemia,0.6740,Childhood Acute Megakaryoblastic Leukemia,0.6738,Myeloid Leukemia,0.6727,Childhood Acute Monoblastic and Monocytic Leukemia,0.6709,Adult Acute Monoblastic and Monocytic Leukemia,0.6706,ACUTE MYELOGENOUS LEUKEMIA M5A,False,True,True
ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS,Acute Myeloid Leukemia,2,2,"Acute Myeloid Leukemia, Not Otherwise Specified",0.7318,Acute Myeloid Leukemia,0.7037,Acute Leukemia,0.6745,Myeloid Neoplasm,0.6399,Myeloid Leukemia,0.6384,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6351,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.6215,Acute Biphenotypic Leukemia,0.6195,Secondary Acute Myeloid Leukemia,0.6161,Acute Myeloid Leukemia Arising from Previous Myeloproliferative Neoplasm,0.6146,Acute Monocytic Leukemia,0.6142,Acute Myeloid Leukemia with Complex Karyotype,0.6139,Acute Myeloid Leukemia with NPM1-MLF1,0.6136,Acute Monoblastic and Monocytic Leukemia,0.6086,Acute Erythroid Leukemia,0.6084,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm,0.6061,Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA,0.6008,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.5976,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0.5976,Typical Acute Promyelocytic Leukemia,0.5957,ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS,False,True,True
ACUTE MYELOID LEUKAEMIA AML AND RELATED PRECURSOR NEOPLASMS,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.7573,"Acute Myeloid Leukemia, Not Otherwise Specified",0.7555,Acute Leukemia,0.7204,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.6892,Acute Myeloid Leukemia with Complex Karyotype,0.6849,Alkylating Agent-Related Acute Myeloid Leukemia,0.6841,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.6819,Adult Acute Myeloid Leukemia,0.6784,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.6733,Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome,0.6689,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6670,Acute Leukemia of Ambiguous Lineage,0.6666,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0.6658,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm,0.6648,Acute Monoblastic and Monocytic Leukemia,0.6609,Acute Myeloid Leukemia Arising from Previous Myeloproliferative Neoplasm,0.6604,Secondary Acute Myeloid Leukemia,0.6576,Acute Monocytic Leukemia,0.6572,Myeloid Leukemia,0.6563,Acute Myeloid Leukemia with NPM1-MLF1,0.6548,ACUTE MYELOID LEUKAEMIA AML AND RELATED PRECURSOR NEOPLASMS,True,True,True
"ACUTE MYELOID LEUKAEMIA, NOS",Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9347,"Acute Myeloid Leukemia, Not Otherwise Specified",0.9028,Myeloid Leukemia,0.8462,Acute Leukemia,0.8388,Acute Monocytic Leukemia,0.8386,Acute Myelomonocytic Leukemia,0.7842,Aleukemic Myeloid Leukemia,0.7811,Adult Acute Myeloid Leukemia,0.7731,Acute Myeloid Leukemia with Maturation,0.7670,Childhood Acute Myeloid Leukemia,0.7635,Acute Megakaryoblastic Leukemia,0.7572,Secondary Acute Myeloid Leukemia,0.7557,Acute Monoblastic and Monocytic Leukemia,0.7551,Acute Undifferentiated Leukemia,0.7528,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7521,Acute Monoblastic Leukemia,0.7428,Acute Myeloid Leukemia without Maturation,0.7410,Childhood Acute Monocytic Leukemia,0.7380,Adult Acute Monocytic Leukemia,0.7344,Childhood Acute Myeloid Leukemia Not Otherwise Specified,0.7306,"ACUTE MYELOID LEUKAEMIA, NOS",True,True,True
ACUTE MYELOID LEUKEMIA,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,1.0000,Acute Leukemia,0.9133,Myeloid Leukemia,0.9007,"Acute Myeloid Leukemia, Not Otherwise Specified",0.8953,Acute Monocytic Leukemia,0.8795,Adult Acute Myeloid Leukemia,0.8373,Acute Myelomonocytic Leukemia,0.8158,Aleukemic Myeloid Leukemia,0.8037,Childhood Acute Myeloid Leukemia,0.8032,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7944,Acute Undifferentiated Leukemia,0.7926,Secondary Acute Myeloid Leukemia,0.7920,Acute Megakaryoblastic Leukemia,0.7897,Acute Erythroid Leukemia,0.7866,Adult Acute Monocytic Leukemia,0.7808,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.7751,Acute Myeloid Leukemia with Maturation,0.7717,Acute Myeloid Leukemia without Maturation,0.7669,Childhood Acute Monocytic Leukemia,0.7630,Acute Lymphoblastic Leukemia,0.7605,ACUTE MYELOID LEUKEMIA,True,True,True
ACUTE MYELOID LEUKEMIA WITH MULTILINEAGE DYSPLASIA,Acute Myeloid Leukemia with Multilineage Dysplasia,1,2,Acute Myeloid Leukemia with Multilineage Dysplasia,1.0000,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.8076,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7926,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.7743,Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.7739,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.7672,Acute Myeloid Leukemia with Minimal Differentiation,0.7630,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.7606,Acute Monoblastic and Monocytic Leukemia,0.7592,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.7588,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,0.7518,Acute Myeloid Leukemia with Maturation,0.7474,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.7245,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.7026,Acute Myeloid Leukemia with MECOM Rearrangement,0.6989,Acute Myelomonocytic Leukemia,0.6954,Acute Monoblastic Leukemia,0.6949,Adult Acute Monoblastic and Monocytic Leukemia,0.6941,Adult Acute Myeloid Leukemia with Minimal Differentiation,0.6937,Myelodysplastic Chronic Myelomonocytic Leukemia,0.6914,ACUTE MYELOID LEUKEMIA WITH MULTILINEAGE DYSPLASIA,True,True,True
"ACUTE MYELOID LEUKEMIA WITH MULTILINEAGE DYSPLASIA, NOT HAVING ACHIEVED REMISSION",Acute Myeloid Leukemia with Multilineage Dysplasia,2,2,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,0.7068,Acute Myeloid Leukemia with Multilineage Dysplasia,0.6780,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.6659,Acute Myeloid Leukemia without Maturation,0.6622,Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.6579,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",0.6547,Acute Myeloid Leukemia with Minimal Differentiation,0.6471,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.6430,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.6425,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.6415,"Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related",0.6357,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6280,Refractory Acute Myelomonocytic Leukemia,0.6279,Refractory Acute Myeloid Leukemia Not Otherwise Specified,0.6269,Refractory Acute Monoblastic and Monocytic Leukemia,0.6113,Adult Acute Myeloid Leukemia without Maturation,0.6052,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.6051,Acute Myeloid Leukemia with MECOM Rearrangement,0.6010,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.6009,Acute Myeloid Leukemia with Maturation,0.5991,"ACUTE MYELOID LEUKEMIA WITH MULTILINEAGE DYSPLASIA, NOT HAVING ACHIEVED REMISSION",False,True,True
ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA RELATED CHANGES,"Acute Myeloid Leukemia, Myelodysplasia-Related",1,2,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.9037,Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.8900,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.8877,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.8574,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.8190,Acute Myeloid Leukemia with Multilineage Dysplasia,0.8153,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.8119,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.7898,"Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related",0.7633,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.7486,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0.7348,Acute Myeloid Leukemia with Minimal Differentiation,0.7322,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,0.7285,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",0.7267,Acute Myeloid Leukemia with MECOM Rearrangement,0.7248,Myelodysplastic Syndrome with Genetic Abnormalities,0.7237,Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome,0.7151,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Mutated TP53,0.7108,Acute Myeloid Leukemia with a Variant MECOM Rearrangement,0.7034,Acute Myeloid Leukemia,0.6935,ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA RELATED CHANGES,True,True,True
ACUTE MYELOID LEUKEMIAS,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9760,Acute Leukemia,0.8975,Myeloid Leukemia,0.8946,"Acute Myeloid Leukemia, Not Otherwise Specified",0.8913,Acute Monocytic Leukemia,0.8750,Acute Myelomonocytic Leukemia,0.8199,Aleukemic Myeloid Leukemia,0.8157,Adult Acute Myeloid Leukemia,0.8147,Childhood Acute Myeloid Leukemia,0.8004,Acute Megakaryoblastic Leukemia,0.7872,Acute Undifferentiated Leukemia,0.7839,Secondary Acute Myeloid Leukemia,0.7816,Acute Myeloid Leukemia with Maturation,0.7784,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7757,Adult Acute Monocytic Leukemia,0.7705,Childhood Acute Monocytic Leukemia,0.7677,Acute Erythroid Leukemia,0.7659,Acute Monoblastic and Monocytic Leukemia,0.7577,Acute Myeloid Leukemia without Maturation,0.7575,Acute Lymphoblastic Leukemia,0.7515,ACUTE MYELOID LEUKEMIAS,True,True,True
ACUTE MYELOMONOCYTIC LEUKAEMIA,Acute Myelomonocytic Leukemia,1,2,Acute Myelomonocytic Leukemia,0.9865,Adult Acute Myelomonocytic Leukemia,0.8739,Acute Monocytic Leukemia,0.8656,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.8278,Childhood Acute Myelomonocytic Leukemia,0.8222,Acute Megakaryoblastic Leukemia,0.8203,Acute Monoblastic and Monocytic Leukemia,0.8111,Acute Myeloid Leukemia,0.8078,Adult Acute Monocytic Leukemia,0.7849,Adult Acute Megakaryoblastic Leukemia,0.7769,Juvenile Myelomonocytic Leukemia,0.7730,Acute Monoblastic Leukemia,0.7729,Aleukemic Myeloid Leukemia,0.7677,Chronic Myelomonocytic Leukemia,0.7671,Acute Myeloid Leukemia with Maturation,0.7659,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.7596,Myeloid Leukemia,0.7522,Adult Acute Monoblastic and Monocytic Leukemia,0.7493,Childhood Acute Megakaryoblastic Leukemia,0.7438,Childhood Acute Monocytic Leukemia,0.7433,ACUTE MYELOMONOCYTIC LEUKAEMIA,True,True,True
ACUTE MYELOMONOCYTIC LEUKEMIA,Acute Myelomonocytic Leukemia,1,2,Acute Myelomonocytic Leukemia,1.0000,Adult Acute Myelomonocytic Leukemia,0.8804,Acute Monocytic Leukemia,0.8696,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.8285,Acute Megakaryoblastic Leukemia,0.8256,Childhood Acute Myelomonocytic Leukemia,0.8227,Acute Myeloid Leukemia,0.8158,Acute Monoblastic and Monocytic Leukemia,0.8059,Chronic Myelomonocytic Leukemia,0.7902,Adult Acute Monocytic Leukemia,0.7856,Juvenile Myelomonocytic Leukemia,0.7816,Adult Acute Megakaryoblastic Leukemia,0.7798,Aleukemic Myeloid Leukemia,0.7691,Myeloid Leukemia,0.7668,Acute Monoblastic Leukemia,0.7664,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.7554,Acute Myeloid Leukemia with Maturation,0.7535,Adult Acute Monoblastic and Monocytic Leukemia,0.7432,Childhood Acute Megakaryoblastic Leukemia,0.7409,Childhood Acute Monocytic Leukemia,0.7390,ACUTE MYELOMONOCYTIC LEUKEMIA,True,True,True
ACUTE PROMYELOCYTIC LEUKAEMIA WITH T(15;17)(Q22;Q12); PML-RARA,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,1,2,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9844,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.9144,Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9116,Acute Promyelocytic Leukemia with t(5;17)(q35;q21); NPM1-RARA,0.9055,Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA,0.9022,Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.8835,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.8435,Typical Acute Promyelocytic Leukemia,0.8036,Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.8008,Acute Promyelocytic Leukemia with STAT5B-RARA,0.7841,Acute Promyelocytic Leukemia with FIP1L1-RARA,0.7707,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.7707,Acute Promyelocytic Leukemia with TBL1XR1-RARA,0.7578,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7572,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.7535,Acute Promyelocytic Leukemia with BCOR-RARA,0.7504,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.7492,Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,0.7469,Acute Promyelocytic Leukemia with STAT3-RARA,0.7415,Acute Promyelocytic Leukemia with a Variant RARA Rearrangement,0.7412,ACUTE PROMYELOCYTIC LEUKAEMIA WITH T(15;17)(Q22;Q12); PML-RARA,True,True,True
ACUTE PROMYELOCYTIC LEUKAEMIA WITH T15;17Q22;Q12;  PML-RARA,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,1,2,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9452,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.8980,Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA,0.8881,Acute Promyelocytic Leukemia with t(5;17)(q35;q21); NPM1-RARA,0.8823,Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.8772,Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.8603,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.8237,Acute Promyelocytic Leukemia with TBL1XR1-RARA,0.7845,Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.7842,Typical Acute Promyelocytic Leukemia,0.7817,Acute Promyelocytic Leukemia with FIP1L1-RARA,0.7791,Acute Promyelocytic Leukemia with STAT5B-RARA,0.7780,Acute Promyelocytic Leukemia with a Variant RARA Rearrangement,0.7499,Acute Promyelocytic Leukemia with BCOR-RARA,0.7425,Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,0.7378,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.7348,Acute Promyelocytic Leukemia with STAT3-RARA,0.7340,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.7297,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7292,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.7273,ACUTE PROMYELOCYTIC LEUKAEMIA WITH T15;17Q22;Q12;  PML-RARA,True,True,True
ACUTE PROMYELOCYTIC LEUKAEMIA WITH T15;17Q22;Q12; PML-RARA,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,1,2,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.9452,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.8980,Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA,0.8881,Acute Promyelocytic Leukemia with t(5;17)(q35;q21); NPM1-RARA,0.8823,Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.8772,Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.8603,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.8237,Acute Promyelocytic Leukemia with TBL1XR1-RARA,0.7845,Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.7842,Typical Acute Promyelocytic Leukemia,0.7817,Acute Promyelocytic Leukemia with FIP1L1-RARA,0.7791,Acute Promyelocytic Leukemia with STAT5B-RARA,0.7780,Acute Promyelocytic Leukemia with a Variant RARA Rearrangement,0.7499,Acute Promyelocytic Leukemia with BCOR-RARA,0.7425,Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,0.7378,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.7348,Acute Promyelocytic Leukemia with STAT3-RARA,0.7340,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.7297,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7292,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.7273,ACUTE PROMYELOCYTIC LEUKAEMIA WITH T15;17Q22;Q12; PML-RARA,True,True,True
ACUTE UNDIFFERENTIATED LEUKAEMIA,Acute Undifferentiated Leukemia,1,2,Acute Undifferentiated Leukemia,0.9838,Infant Acute Undifferentiated Leukemia,0.8459,Acute Leukemia,0.8168,Acute Leukemia of Ambiguous Lineage,0.7977,Acute Myeloid Leukemia,0.7755,Recurrent Acute Undifferentiated Leukemia,0.7441,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0.7355,Aleukemic Acute Lymphoblastic Leukemia,0.7355,Refractory Acute Undifferentiated Leukemia,0.7322,Myeloid Leukemia,0.7237,Acute Erythroid Leukemia,0.7224,Acute Monocytic Leukemia,0.7219,"Acute Myeloid Leukemia, Not Otherwise Specified",0.7197,Leukemia,0.7164,Childhood Acute Leukemia,0.7158,Acute Lymphoblastic Leukemia,0.7130,Aleukemic Myeloid Leukemia,0.7049,Aleukemic Leukemia,0.7028,Adult Acute Myeloid Leukemia,0.6929,Childhood Acute Myeloid Leukemia,0.6918,ACUTE UNDIFFERENTIATED LEUKAEMIA,True,True,True
ACUTE UNDIFFERENTIATED LEUKEMIA,Acute Undifferentiated Leukemia,1,2,Acute Undifferentiated Leukemia,1.0000,Infant Acute Undifferentiated Leukemia,0.8459,Acute Leukemia,0.8396,Acute Leukemia of Ambiguous Lineage,0.8146,Acute Myeloid Leukemia,0.7926,Recurrent Acute Undifferentiated Leukemia,0.7573,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0.7567,Aleukemic Acute Lymphoblastic Leukemia,0.7518,Refractory Acute Undifferentiated Leukemia,0.7477,Acute Lymphoblastic Leukemia,0.7359,"Acute Myeloid Leukemia, Not Otherwise Specified",0.7341,Acute Erythroid Leukemia,0.7324,Childhood Acute Leukemia,0.7316,Myeloid Leukemia,0.7301,Acute Monocytic Leukemia,0.7293,Leukemia,0.7275,Adult Acute Myeloid Leukemia,0.7159,Acute Biphenotypic Leukemia,0.7099,Aleukemic Myeloid Leukemia,0.7080,Acute Leukemia of Ambiguous Lineage with Defining Genetic Abnormalities,0.7053,ACUTE UNDIFFERENTIATED LEUKEMIA,True,True,True
ACUTE_BIPHENOTYPIC_LEUKEMIA,Acute Biphenotypic Leukemia,1,2,Acute Biphenotypic Leukemia,0.9751,Infant Acute Biphenotypic Leukemia,0.8352,Recurrent Acute Biphenotypic Leukemia,0.7947,Acute Bilineal Leukemia,0.7298,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.7224,Acute Monoblastic and Monocytic Leukemia,0.7218,Acute Monoblastic Leukemia,0.7204,Acute Leukemia,0.7197,Refractory Acute Biphenotypic Leukemia,0.7194,Acute Basophilic Leukemia,0.7146,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",0.7002,Acute Myeloid Leukemia,0.6939,Acute Undifferentiated Leukemia,0.6903,Acute Monocytic Leukemia,0.6869,Aleukemic Myeloid Leukemia,0.6854,Hyperdiploid B Acute Lymphoblastic Leukemia,0.6836,Aleukemic Leukemia,0.6760,"Mixed Phenotype Acute Leukemia, B/T",0.6735,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.6719,"Acute Myeloid Leukemia, Not Otherwise Specified",0.6717,ACUTE_BIPHENOTYPIC_LEUKEMIA,True,True,True
ACUTE_LYMPHOBLASTIC_B_CELL_LEUKAEMIA,B Acute Lymphoblastic Leukemia,1,2,B Acute Lymphoblastic Leukemia,0.8772,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.8677,B-Cell Leukemia,0.8213,Acute Lymphoblastic Leukemia,0.8183,B Lymphoblastic Leukemia/Lymphoma,0.8090,Pre-B Acute Lymphoblastic Leukemia,0.7992,B Lymphoblastic Lymphoma,0.7939,Childhood B Acute Lymphoblastic Leukemia,0.7879,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7696,Near-Haploid B Acute Lymphoblastic Leukemia,0.7613,Burkitt Leukemia,0.7576,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified",0.7489,Childhood B Lymphoblastic Leukemia/Lymphoma,0.7444,Adult B Acute Lymphoblastic Leukemia,0.7443,Childhood B Lymphoblastic Lymphoma,0.7440,Common Acute Lymphoblastic Leukemia,0.7412,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.7396,Aleukemic Acute Lymphoblastic Leukemia,0.7345,Adult B Lymphoblastic Lymphoma,0.7235,Childhood Pre-B Acute Lymphoblastic Leukemia,0.7235,ACUTE_LYMPHOBLASTIC_B_CELL_LEUKAEMIA,True,True,True
ACUTE_LYMPHOBLASTIC_LEUKAEMIA,Acute Lymphoblastic Leukemia,1,2,Acute Lymphoblastic Leukemia,0.9283,Common Acute Lymphoblastic Leukemia,0.8174,Acute Leukemia,0.8150,Childhood Acute Lymphoblastic Leukemia,0.8113,Aleukemic Acute Lymphoblastic Leukemia,0.8028,B Acute Lymphoblastic Leukemia,0.8016,Infant Acute Lymphoblastic Leukemia,0.7961,Lymphoblastic Lymphoma,0.7826,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7812,L1 Acute Lymphoblastic Leukemia,0.7750,Lymphoid Leukemia,0.7725,Adult Acute Lymphoblastic Leukemia,0.7618,T Acute Lymphoblastic Leukemia,0.7585,B Lymphoblastic Leukemia/Lymphoma,0.7451,L2 Acute Lymphoblastic Leukemia,0.7440,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7421,Childhood B Acute Lymphoblastic Leukemia,0.7375,Leukemia,0.7372,Pre-B Acute Lymphoblastic Leukemia,0.7370,Acute Leukemia of Ambiguous Lineage,0.7357,ACUTE_LYMPHOBLASTIC_LEUKAEMIA,True,True,True
ACUTE_LYMPHOBLASTIC_T_CELL_LEUKAEMIA,T Acute Lymphoblastic Leukemia,1,2,T Acute Lymphoblastic Leukemia,0.8875,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.8791,Acute Lymphoblastic Leukemia,0.8185,T Lymphoblastic Leukemia/Lymphoma,0.7962,T Lymphoblastic Lymphoma,0.7900,Childhood T Acute Lymphoblastic Leukemia,0.7874,"Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7871,Early T Precursor Acute Lymphoblastic Leukemia,0.7825,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7681,Infant T Acute Lymphoblastic Leukemia,0.7638,Acute Adult T-Cell Leukemia/Lymphoma,0.7627,Adult T Acute Lymphoblastic Leukemia,0.7605,Common Acute Lymphoblastic Leukemia,0.7581,T Acute Lymphoblastic Leukemia with TAL1 Rearrangement,0.7485,Adult T-Cell Leukemia/Lymphoma,0.7466,Mature T-ALL,0.7463,Childhood T Lymphoblastic Leukemia/Lymphoma,0.7441,Pre T-ALL,0.7432,L1 Acute Lymphoblastic Leukemia,0.7431,Childhood T Lymphoblastic Lymphoma,0.7410,ACUTE_LYMPHOBLASTIC_T_CELL_LEUKAEMIA,True,True,True
ACUTE_MONOCYTIC_LEUKEMIA,Acute Monocytic Leukemia,1,2,Acute Monocytic Leukemia,0.9434,Acute Myeloid Leukemia,0.8455,Acute Myelomonocytic Leukemia,0.8311,Acute Monoblastic and Monocytic Leukemia,0.8264,"Acute Myeloid Leukemia, Not Otherwise Specified",0.8179,Adult Acute Monocytic Leukemia,0.8122,Myeloid Leukemia,0.8046,Acute Megakaryoblastic Leukemia,0.7960,Childhood Acute Monocytic Leukemia,0.7894,Acute Monoblastic Leukemia,0.7735,Aleukemic Myeloid Leukemia,0.7717,Acute Myeloid Leukemia with Maturation,0.7717,Acute Leukemia,0.7600,Adult Acute Monoblastic and Monocytic Leukemia,0.7371,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.7358,Adult Acute Megakaryoblastic Leukemia,0.7352,Acute Myeloid Leukemia without Maturation,0.7336,Adult Acute Myelomonocytic Leukemia,0.7259,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7122,Childhood Acute Megakaryoblastic Leukemia,0.7073,ACUTE_MONOCYTIC_LEUKEMIA,True,True,True
ACUTE_MYELOID_LEUKAEMIA,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,0.9170,"Acute Myeloid Leukemia, Not Otherwise Specified",0.8972,Myeloid Leukemia,0.8602,Acute Leukemia,0.8559,Acute Monocytic Leukemia,0.8218,Aleukemic Myeloid Leukemia,0.7689,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7684,Acute Myelomonocytic Leukemia,0.7667,Acute Myeloid Leukemia with Maturation,0.7604,Acute Undifferentiated Leukemia,0.7511,Acute Megakaryoblastic Leukemia,0.7504,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.7446,Acute Monoblastic and Monocytic Leukemia,0.7446,Secondary Acute Myeloid Leukemia,0.7436,Adult Acute Myeloid Leukemia,0.7394,Childhood Acute Myeloid Leukemia,0.7361,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.7323,Acute Myeloid Leukemia without Maturation,0.7323,Acute Monoblastic Leukemia,0.7320,Acute Erythroid Leukemia,0.7235,ACUTE_MYELOID_LEUKAEMIA,True,True,True
ACYC,Adenoid Cystic Carcinoma,1,2,Adenoid Cystic Carcinoma,1.0000,Cervical Adenoid Cystic Carcinoma,0.9202,Advanced Adenoid Cystic Carcinoma,0.9187,Lung Adenoid Cystic Carcinoma,0.8841,Salivary Gland Adenoid Cystic Carcinoma,0.8837,Breast Adenoid Cystic Carcinoma,0.8687,Nasopharyngeal Adenoid Cystic Carcinoma,0.8655,Prostate Adenoid Cystic Carcinoma,0.8612,Oral Cavity Adenoid Cystic Carcinoma,0.8573,Lacrimal Gland Adenoid Cystic Carcinoma,0.8530,Tracheal Adenoid Cystic Carcinoma,0.8518,Pharyngeal Adenoid Cystic Carcinoma,0.8498,Metastatic Adenoid Cystic Carcinoma,0.8405,Skin Adenoid Cystic Carcinoma,0.8374,Major Salivary Gland Adenoid Cystic Carcinoma,0.8349,Submandibular Gland Adenoid Cystic Carcinoma,0.8248,Minor Salivary Gland Adenoid Cystic Carcinoma,0.8220,Parotid Gland Adenoid Cystic Carcinoma,0.8199,Lacrimal Drainage System Adenoid Cystic Carcinoma,0.8179,Esophageal Adenoid Cystic Carcinoma,0.8139,Adenoid Cystic Carcinoma,True,True,True
ADAMANTINOMA,Adamantinoma,1,2,Adamantinoma,1.0000,Tibial Adamantinoma,0.8910,Adamantinomatous Craniopharyngioma,0.8052,Adult Adamantinomatous Craniopharyngioma,0.7908,Childhood Adamantinomatous Craniopharyngioma,0.7426,Ameloblastoma,0.7365,Adamantinoid Trichoblastoma,0.7130,Adenoid Ameloblastoma,0.7125,Conventional Ameloblastoma,0.6976,Benign Ameloblastoma,0.6932,Acanthomatous Ameloblastoma,0.6895,Desmoplastic Ameloblastoma,0.6750,Ameloblastic Fibrodentinoma,0.6707,Follicular Ameloblastoma,0.6669,Metastasizing Ameloblastoma,0.6636,Skin Adamantinoid Basal Cell Carcinoma,0.6607,Ameloblastic Fibroma,0.6582,Childhood Ameloblastoma,0.6528,Alveolar Adenoma,0.6455,Sinonasal Ameloblastoma,0.6450,ADAMANTINOMA,True,True,True
ADCA ACINAR WITH MUCIN PRODUCTION,Lung Colloid Adenocarcinoma,99,2,Acinar Cell Adenoma,0.7661,Mucin-Producing Adenocarcinoma,0.7401,Adenocarcinoma with Apocrine Metaplasia,0.7386,Pancreatic Acinar Cell Cystadenocarcinoma,0.7296,Mucinous Adenocarcinoma,0.7288,Prostate Acinar Mucinous Adenocarcinoma,0.7248,Salivary Gland Mucinous Adenocarcinoma,0.7221,Acinar Cell Carcinoma,0.7138,Goblet Cell Adenocarcinoma,0.7076,Acinar Cell Neoplasm,0.7059,Appendix Mucinous Adenocarcinoma,0.7022,Appendix Goblet Cell Adenocarcinoma,0.6994,Lung Acinar Adenocarcinoma,0.6934,Pancreatic Mixed Acinar-Ductal Carcinoma,0.6932,Prostate Acinar Adenocarcinoma,0.6914,Anal Mucinous Adenocarcinoma,0.6900,Mucinous Cystadenoma,0.6867,Appendix Mucinous Cystadenocarcinoma,0.6830,Mucinous Cystadenocarcinoma,0.6815,Prostate Acinar Microcystic Adenocarcinoma,0.6791,ADCA ACINAR WITH MUCIN PRODUCTION,False,False,False
ADENOCARCINOMA,Adenocarcinoma,1,2,Adenocarcinoma,1.0000,Carcinoma,0.8693,Advanced Adenocarcinoma,0.8556,Colon Adenocarcinoma,0.8241,Lung Adenocarcinoma,0.8190,Colorectal Adenocarcinoma,0.8185,Tubular Adenocarcinoma,0.8163,Cervical Adenocarcinoma,0.8095,Breast Adenocarcinoma,0.8067,Papillary Adenocarcinoma,0.8057,Gastric Adenocarcinoma,0.8045,Diffuse Type Adenocarcinoma,0.8021,Metastatic Adenocarcinoma,0.8020,Disseminated Adenocarcinoma,0.8000,Prostate Adenocarcinoma,0.7969,Thyroid Gland Adenocarcinoma,0.7962,Endometrial Adenocarcinoma,0.7934,Mucin-Producing Adenocarcinoma,0.7900,Adenocarcinoma with Metaplasia,0.7892,Ovarian Adenocarcinoma,0.7879,ADENOCARCINOMA,True,True,True
ADENOCARCINOMA OF GALLBLADDER,Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,0.9674,"Gallbladder Adenocarcinoma, Biliary Type",0.8958,Gallbladder Carcinoma,0.8913,Gallbladder Goblet Cell Adenocarcinoma,0.8726,"Gallbladder Adenocarcinoma, Intestinal-Type",0.8718,Malignant Gallbladder Neoplasm,0.8430,Gallbladder Clear Cell Adenocarcinoma,0.8428,Gallbladder Mucinous Adenocarcinoma,0.8416,Gallbladder Hepatoid Adenocarcinoma,0.8210,Gallbladder Adenoma,0.8200,Advanced Gallbladder Carcinoma,0.8158,Gallbladder Adenocarcinoma with Squamous Metaplasia,0.8132,Gallbladder Neoplasm,0.7847,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0.7799,Gastric Adenocarcinoma,0.7758,Unresectable Gallbladder Adenocarcinoma,0.7758,Gallbladder Undifferentiated Carcinoma,0.7676,Incidental Gallbladder Carcinoma,0.7630,Bile Duct Adenocarcinoma,0.7598,"Gallbladder Adenoma, Intestinal-Type",0.7593,ADENOCARCINOMA OF GALLBLADDER,True,True,True
ADENOCARCINOMA OF THE GASTROESOPHAGEAL JUNCTION,Gastroesophageal Junction Adenocarcinoma,1,2,Gastroesophageal Junction Adenocarcinoma,0.9594,Advanced Gastroesophageal Junction Adenocarcinoma,0.8720,Gastroesophageal Junction Carcinoma,0.8658,Gastric Adenocarcinoma,0.8017,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Clinical Stage,0.7877,Metastatic Gastroesophageal Junction Adenocarcinoma,0.7868,Localized Gastroesophageal Junction Adenocarcinoma,0.7856,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage,0.7848,Locally Advanced Gastroesophageal Junction Adenocarcinoma,0.7806,Gastroesophageal Cancer,0.7778,Gastric Cardia Adenocarcinoma,0.7694,Unresectable Gastroesophageal Junction Adenocarcinoma,0.7570,Gastroesophageal Junction Neuroendocrine Carcinoma,0.7535,Resectable Gastroesophageal Junction Adenocarcinoma,0.7493,Esophageal and Gastroesophageal Junction Carcinoma,0.7486,Advanced Gastric Adenocarcinoma,0.7414,Gastric Intestinal-Type Adenocarcinoma,0.7260,Esophageal Adenocarcinoma,0.7193,Gastric Intramucosal Adenocarcinoma,0.7156,Gastric Mucinous Adenocarcinoma,0.7070,ADENOCARCINOMA OF THE GASTROESOPHAGEAL JUNCTION,True,True,True
ADENOCARCINOMA PROSTATE WITH PROMINENT DUCTAL DIFFERENTIATION IDENTIFIED,Prostate Ductal Adenocarcinoma,1,2,Prostate Ductal Adenocarcinoma,0.8507,Prostate Poorly Differentiated Adenocarcinoma,0.7781,"Prostate Ductal Adenocarcinoma, Papillary Pattern",0.7755,Prostate Adenocarcinoma,0.7641,Prostate Well Differentiated Adenocarcinoma,0.7597,"Prostate Ductal Adenocarcinoma, Solid Pattern",0.7543,Advanced Pancreatic Ductal Adenocarcinoma,0.7474,Pancreatic Ductal Adenocarcinoma,0.7458,Prostate Acinar Adenocarcinoma,0.7413,Aggressive Prostate Adenocarcinoma,0.7410,Advanced Prostate Adenocarcinoma,0.7360,Advanced Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.7345,Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.7340,Prostate Adenocarcinoma without Neuroendocrine Differentiation,0.7278,Papillary Adenocarcinoma,0.7230,Prostate Acinar Pseudohyperplastic Adenocarcinoma,0.7213,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0.7151,Pancreatic Well Differentiated Ductal Adenocarcinoma,0.7105,Prostate Acinar Foamy Gland Adenocarcinoma,0.7088,Prostate Acinar Mucinous Adenocarcinoma,0.7015,ADENOCARCINOMA PROSTATE WITH PROMINENT DUCTAL DIFFERENTIATION IDENTIFIED,True,True,True
ADENOCARCINOMA WITH FOCAL MUCINOUS FEATURES,Mucinous Adenocarcinoma,1,2,Mucinous Adenocarcinoma,0.8343,Gastric Mucinous Adenocarcinoma,0.7798,Appendix Mucinous Adenocarcinoma,0.7760,Colorectal Mucinous Adenocarcinoma,0.7703,Colon Mucinous Adenocarcinoma,0.7691,Ovarian Mucinous Adenocarcinofibroma,0.7672,Mucinous Adenofibroma,0.7625,Mucinous Cystadenofibroma,0.7609,Anal Mucinous Adenocarcinoma,0.7552,Salivary Gland Mucinous Adenocarcinoma,0.7546,Endometrial Mucinous Adenocarcinoma,0.7478,Cervical Mucinous Adenocarcinoma,0.7444,Adenocarcinoma with Metaplasia,0.7423,Thyroid Gland Mucinous Follicular Adenoma,0.7400,Ovarian Mucinous Adenocarcinoma,0.7398,Mucin-Producing Adenocarcinoma,0.7365,Mucinous Neoplasm,0.7321,Prostate Acinar Mucinous Adenocarcinoma,0.7279,FIGO Grade 1 Endometrial Mucinous Adenocarcinoma,0.7278,FIGO Grade 3 Endometrial Mucinous Adenocarcinoma,0.7267,ADENOCARCINOMA WITH FOCAL MUCINOUS FEATURES,True,True,True
ADENOCARCINOMA WITH NE FEATURES,Adenocarcinoma with Neuroendocrine Differentiation,1,2,Adenocarcinoma with Neuroendocrine Differentiation,0.8230,Non-Small Cell Adenocarcinoma,0.7471,Prostate Adenocarcinoma without Neuroendocrine Differentiation,0.7436,Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.7436,Usual Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.7340,Adenocarcinoma,0.7317,Advanced Neuroendocrine Carcinoma,0.7149,Neuroendocrine Carcinoma,0.7031,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,0.6863,Advanced Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.6765,Prostate Adenocarcinoma with Paneth Cell-Like Neuroendocrine Differentiation,0.6738,Advanced Neuroendocrine Neoplasm,0.6708,Tubular Adenocarcinoma,0.6694,Diffuse Type Adenocarcinoma,0.6652,Small Cell Adenocarcinoma,0.6604,Advanced Adenocarcinoma,0.6593,Clear Cell Adenocarcinoma,0.6587,Carcinoma,0.6554,Endometrial Adenocarcinoma,0.6547,Endometrial Neuroendocrine Carcinoma,0.6544,ADENOCARCINOMA WITH NE FEATURES,True,True,True
"ADENOCARCINOMA, ENDOMETRIOID",Endometrioid Adenocarcinoma,1,2,Endometrioid Adenocarcinoma,0.9874,Endometrial Endometrioid Adenocarcinoma,0.9638,Ovarian Endometrioid Adenocarcinoma,0.9163,Endometrioid Tumor,0.9162,Advanced Endometrioid Adenocarcinoma,0.9060,Advanced Endometrial Endometrioid Adenocarcinoma,0.9008,High Grade Endometrioid Adenocarcinoma,0.8927,Low Grade Endometrioid Adenocarcinoma,0.8852,Cervical Endometrioid Adenocarcinoma,0.8815,Endometrial High Grade Endometrioid Adenocarcinoma,0.8776,Endometrial Low Grade Endometrioid Adenocarcinoma,0.8695,Malignant Ovarian Endometrioid Tumor,0.8655,Metastatic Endometrioid Adenocarcinoma,0.8609,Advanced Ovarian Endometrioid Adenocarcinoma,0.8570,Ovarian Endometrioid Tumor,0.8556,"Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.8552,Endometrial Endometrioid Adenocarcinoma with Metaplastic Changes,0.8414,Metastatic Endometrial Endometrioid Adenocarcinoma,0.8330,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.8303,Vaginal Endometrioid Adenocarcinoma,0.8267,"ADENOCARCINOMA, ENDOMETRIOID",True,True,True
"ADENOCARCINOMA, LOW GRADE SEROUS",Ovarian Low Grade Serous Adenocarcinoma,1,2,Ovarian Low Grade Serous Adenocarcinoma,0.9108,Serous Adenocarcinoma,0.8781,Primary Peritoneal Low Grade Serous Adenocarcinoma,0.8401,Ovarian Serous Adenocarcinoma,0.8222,Low Grade Broad Ligament Serous Adenocarcinoma,0.8111,Endometrial Serous Adenocarcinoma,0.8030,Serous Cystadenocarcinoma,0.7951,Cervical Serous Adenocarcinoma,0.7897,Low Grade Fallopian Tube Serous Adenocarcinoma,0.7802,Serous Neoplasm,0.7798,Micropapillary Serous Carcinoma,0.7766,Advanced Endometrial Serous Adenocarcinoma,0.7757,Ovarian High Grade Serous Adenocarcinoma,0.7745,Primary Peritoneal Serous Adenocarcinoma,0.7666,Serous Cystadenoma,0.7608,Uterine Ligament Serous Adenocarcinoma,0.7578,Ovarian Serous Cystadenocarcinoma,0.7575,Broad Ligament Serous Adenocarcinoma,0.7572,Locally Advanced Ovarian Serous Adenocarcinoma,0.7564,Advanced Ovarian Serous Adenocarcinoma,0.7532,"ADENOCARCINOMA, LOW GRADE SEROUS",True,True,True
"ADENOCARCINOMA, MIXED",Mixed Cell Adenocarcinoma,1,2,Mixed Cell Adenocarcinoma,0.9475,Mixed Carcinoma,0.8851,Gastric Mixed Adenocarcinoma,0.8488,Malignant Mixed Neoplasm,0.8291,"Lung Adenocarcinoma, Mixed Subtype",0.8179,Endometrial Mixed Cell Adenocarcinoma,0.8133,Mixed Cell Adenoma,0.8082,Ovarian Mixed Cell Adenocarcinoma,0.7934,Bladder Mixed Adenocarcinoma,0.7828,Breast Mixed Carcinoma,0.7688,Mixed Neoplasm,0.7671,Combined Carcinoid and Adenocarcinoma,0.7661,Adenocarcinoma with Metaplasia,0.7599,Adenocarcinoma,0.7580,Diffuse Type Adenocarcinoma,0.7578,Metastatic Adenocarcinoma,0.7532,Mucinous Adenocarcinoma,0.7497,Disseminated Adenocarcinoma,0.7321,Adrenal Cortical Mixed Cell Adenoma,0.7306,Metastatic Endometrial Mixed Cell Adenocarcinoma,0.7267,"ADENOCARCINOMA, MIXED",True,True,True
"ADENOCARCINOMA, MIXED SUBTYPES","Lung Adenocarcinoma, Mixed Subtype",2,2,Mixed Cell Adenocarcinoma,0.9194,"Lung Adenocarcinoma, Mixed Subtype",0.8304,Mixed Carcinoma,0.8287,Gastric Mixed Adenocarcinoma,0.8244,Malignant Mixed Neoplasm,0.7957,Adenocarcinoma with Metaplasia,0.7816,Metastatic Adenocarcinoma,0.7781,Mixed Cell Adenoma,0.7764,Ovarian Mixed Cell Adenocarcinoma,0.7732,Endometrial Mixed Cell Adenocarcinoma,0.7685,Diffuse Type Adenocarcinoma,0.7650,Combined Carcinoid and Adenocarcinoma,0.7533,Bladder Mixed Adenocarcinoma,0.7470,Adenocarcinoma,0.7441,Mucinous Adenocarcinoma,0.7367,Breast Mixed Carcinoma,0.7342,Adenocarcinoma with Squamous Metaplasia,0.7274,Disseminated Adenocarcinoma,0.7246,Mixed Neoplasm,0.7233,Adenocarcinoma with Cartilaginous and Osseous Metaplasia,0.7136,"ADENOCARCINOMA, MIXED SUBTYPES",False,True,True
"ADENOCARCINOMA, MUCINOUS",Mucinous Adenocarcinoma,1,2,Mucinous Adenocarcinoma,0.9711,Gastric Mucinous Adenocarcinoma,0.8745,Endometrial Mucinous Adenocarcinoma,0.8684,Appendix Mucinous Adenocarcinoma,0.8619,Colon Mucinous Adenocarcinoma,0.8596,Salivary Gland Mucinous Adenocarcinoma,0.8577,Cervical Mucinous Adenocarcinoma,0.8557,Ovarian Mucinous Adenocarcinoma,0.8542,Colorectal Mucinous Adenocarcinoma,0.8505,Mucinous Cystadenocarcinoma,0.8502,Mucinous Neoplasm,0.8476,Mucin-Producing Adenocarcinoma,0.8414,Mucinous Cystadenoma,0.8065,Anal Mucinous Adenocarcinoma,0.8014,"Cervical Mucinous Adenocarcinoma, Not Otherwise Specified",0.8011,Goblet Cell Adenocarcinoma,0.7967,Appendix Mucinous Cystadenocarcinoma,0.7939,Bladder Mucinous Adenocarcinoma,0.7923,"Endometrial Mucinous Adenocarcinoma, Gastric-Type",0.7900,Breast Mucinous Carcinoma,0.7884,"ADENOCARCINOMA, MUCINOUS",True,True,True
"ADENOCARCINOMA, NOS",Adenocarcinoma,1,2,Adenocarcinoma,0.9012,Mucin-Producing Adenocarcinoma,0.7814,Carcinoma,0.7810,Advanced Adenocarcinoma,0.7793,Carcinoma Unspecified Site,0.7740,Colon Adenocarcinoma,0.7514,Colorectal Adenocarcinoma,0.7437,Lung Adenocarcinoma,0.7365,Gastric Adenocarcinoma,0.7357,Diffuse Type Adenocarcinoma,0.7350,Intestinal-Type Adenocarcinoma,0.7324,Tubular Adenocarcinoma,0.7314,Thyroid Gland Adenocarcinoma,0.7293,Endometrial Adenocarcinoma,0.7271,Adenocarcinoma with Metaplasia,0.7246,Metastatic Adenocarcinoma,0.7190,Cervical Adenocarcinoma,0.7184,Pancreatic Adenocarcinoma,0.7152,Prostate Adenocarcinoma,0.7151,Papillary Adenocarcinoma,0.7149,"ADENOCARCINOMA, NOS",True,True,True
"ADENOCARCINOMA, NOS 81403",Adenocarcinoma,1,2,Adenocarcinoma,0.6846,Mucin-Producing Adenocarcinoma,0.6360,Carcinoma,0.6313,Endometrial Adenocarcinoma,0.6133,Tubular Adenocarcinoma,0.6047,Gastric Adenocarcinoma,0.6040,Water-Clear Cell Adenocarcinoma,0.6030,Mucin-Producing Carcinoma,0.5976,Advanced Adenocarcinoma,0.5964,Goblet Cell Adenocarcinoma,0.5945,Cervical Adenocarcinoma,0.5924,Papillary Adenocarcinoma,0.5923,Trabecular Adenocarcinoma,0.5901,Clear Cell Adenocarcinoma,0.5880,Mucinous Adenocarcinoma,0.5847,Type II Endometrial Adenocarcinoma,0.5838,Non-Small Cell Adenocarcinoma,0.5836,Colon Adenocarcinoma,0.5835,Breast Adenocarcinoma,0.5808,Prostate Adenocarcinoma,0.5786,"ADENOCARCINOMA, NOS 81403",True,True,True
"ADENOCARCINOMA, SEROUS",Serous Adenocarcinoma,1,2,Serous Adenocarcinoma,0.9756,Ovarian Serous Adenocarcinoma,0.9100,Endometrial Serous Adenocarcinoma,0.8964,Cervical Serous Adenocarcinoma,0.8649,Serous Cystadenocarcinoma,0.8606,Serous Neoplasm,0.8573,Advanced Endometrial Serous Adenocarcinoma,0.8479,Ovarian Serous Cystadenocarcinoma,0.8186,Advanced Ovarian Serous Adenocarcinoma,0.8164,Primary Peritoneal Serous Adenocarcinoma,0.8114,Malignant Ovarian Serous Tumor,0.8051,Serous Cystadenoma,0.8009,Serous Surface Papillary Carcinoma,0.8009,Ovarian Low Grade Serous Adenocarcinoma,0.7973,Ovarian High Grade Serous Adenocarcinoma,0.7945,Ovarian Serous Tumor,0.7926,Metastatic Endometrial Serous Adenocarcinoma,0.7806,Papillary Serous Cystadenocarcinoma,0.7799,Micropapillary Serous Carcinoma,0.7782,Advanced Ovarian Serous Cystadenocarcinoma,0.7753,"ADENOCARCINOMA, SEROUS",True,True,True
"ADENOCARCINOMA, SIGNET RING CELL",Signet Ring Cell Adenocarcinoma,1,2,Signet Ring Cell Adenocarcinoma,0.9791,Pancreatic Signet Ring Cell Adenocarcinoma,0.8813,Colorectal Signet Ring Cell Adenocarcinoma,0.8676,Colon Signet Ring Cell Adenocarcinoma,0.8624,Gastric Signet Ring Cell Adenocarcinoma,0.8603,Appendix Signet Ring Cell Adenocarcinoma,0.8591,Small Intestinal Signet Ring Cell Adenocarcinoma,0.8526,Metastatic Signet Ring Cell Adenocarcinoma,0.8447,Rectal Signet Ring Cell Adenocarcinoma,0.8300,Signet Ring Cell/Histiocytoid Carcinoma,0.8292,Prostate Acinar Signet Ring Cell-Like Adenocarcinoma,0.8254,Breast Signet Ring Cell Adenocarcinoma,0.8228,Lung Signet Ring Cell Carcinoma,0.8226,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell-Type",0.8182,Ovarian Signet Ring Cell Adenocarcinoma,0.8134,Gallbladder Signet Ring Cell Adenocarcinoma,0.7921,Bladder Signet Ring Cell Adenocarcinoma,0.7824,"Thyroid Gland Follicular Carcinoma, Signet Ring Cell Variant",0.7773,Rectosigmoid Signet Ring Cell Adenocarcinoma,0.7734,Extrahepatic Bile Duct Signet Ring Cell Adenocarcinoma,0.7652,"ADENOCARCINOMA, SIGNET RING CELL",True,True,True
"ADENOCARCINOMA, TUBULAR",Tubular Adenocarcinoma,1,2,Tubular Adenocarcinoma,0.9673,Adenocarcinoma in Tubular Adenoma,0.8916,Gastric Tubular Adenocarcinoma,0.8351,Tubular Neoplasm,0.7844,Adenocarcinoma,0.7793,Breast Tubular Carcinoma,0.7599,Colon Tubular Adenoma,0.7567,Trabecular Adenocarcinoma,0.7496,Adenocarcinoma In Situ in Tubular Adenoma,0.7362,Thyroid Gland Adenocarcinoma,0.7344,Papillary Adenocarcinoma,0.7297,Colorectal Tubular Adenoma,0.7260,Lepidic Adenocarcinoma,0.7200,Colon Adenocarcinoma,0.7188,Comedo-Type Adenocarcinoma,0.7178,Intestinal-Type Adenocarcinoma,0.7155,Urinary Tract Adenocarcinoma,0.7124,Sweat Gland Tubular Carcinoma,0.7118,Gastric Tubular Adenoma,0.7103,Acinar Cell Carcinoma,0.7101,"ADENOCARCINOMA, TUBULAR",True,True,True
ADENOCARCINOMA- MAMMARY GLAND,Breast Adenocarcinoma,1,2,Breast Adenocarcinoma,0.8664,Advanced Breast Adenocarcinoma,0.7769,Breast Carcinoma,0.7722,Salivary Gland Adenocarcinoma,0.7651,Major Salivary Gland Adenocarcinoma,0.7494,Adenocarcinoma,0.7489,Malignant Breast Neoplasm,0.7462,Thyroid Gland Adenocarcinoma,0.7394,Metastatic Breast Adenocarcinoma,0.7357,Breast Ductal Carcinoma,0.7346,Advanced Breast Carcinoma,0.7328,Adenocarcinoma with Apocrine Metaplasia,0.7288,Parotid Gland Adenocarcinoma,0.7264,Breast Adenoma,0.7141,Breast Adenocarcinoma with Squamous Metaplasia,0.7117,Submandibular Gland Adenocarcinoma,0.7099,Ductal Eccrine Adenocarcinoma,0.7040,Breast Acinic Cell Carcinoma,0.7030,Gastric Adenocarcinoma,0.7026,Malignant Apocrine Neoplasm,0.6997,ADENOCARCINOMA- MAMMARY GLAND,True,True,True
ADENOCARCINOMA- NOS,Adenocarcinoma,1,2,Adenocarcinoma,0.9242,Advanced Adenocarcinoma,0.8031,Carcinoma,0.8010,Carcinoma Unspecified Site,0.7922,Mucin-Producing Adenocarcinoma,0.7697,Colon Adenocarcinoma,0.7577,Adenocarcinoma with Metaplasia,0.7572,Diffuse Type Adenocarcinoma,0.7569,Metastatic Adenocarcinoma,0.7501,Lung Adenocarcinoma,0.7499,Colorectal Adenocarcinoma,0.7471,"Cervical Adenocarcinoma, Not Otherwise Specified",0.7449,Gastric Adenocarcinoma,0.7407,Non-Small Cell Adenocarcinoma,0.7404,Thyroid Gland Adenocarcinoma,0.7402,Malignant Neoplasm,0.7372,Disseminated Adenocarcinoma,0.7318,Tubular Adenocarcinoma,0.7315,Cervical Adenocarcinoma,0.7313,Advanced Carcinoma,0.7308,ADENOCARCINOMA- NOS,True,True,True
ADENOCARCINOMA- PROSTATE,Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,0.9633,Prostate Carcinoma,0.8871,Advanced Prostate Adenocarcinoma,0.8449,Malignant Prostate Neoplasm,0.8391,Aggressive Prostate Adenocarcinoma,0.8388,Prostate Poorly Differentiated Adenocarcinoma,0.8376,Prostate Ductal Adenocarcinoma,0.8322,Prostate Acinar Adenocarcinoma,0.8083,Advanced Prostate Carcinoma,0.8018,Prostate Neoplasm,0.7904,Prostate Adenoma,0.7860,Prostate Well Differentiated Adenocarcinoma,0.7811,Adenocarcinoma,0.7760,Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.7695,Prostate Adenocarcinoma without Neuroendocrine Differentiation,0.7691,Papillary Adenocarcinoma,0.7681,Metastatic Prostate Adenocarcinoma,0.7675,Invasive Prostate Carcinoma,0.7587,Localized Prostate Adenocarcinoma,0.7551,Parotid Gland Adenocarcinoma,0.7500,ADENOCARCINOMA- PROSTATE,True,True,True
ADENOCARCINOMA-MAMMARY GLAND,Breast Adenocarcinoma,1,2,Breast Adenocarcinoma,0.8664,Advanced Breast Adenocarcinoma,0.7769,Breast Carcinoma,0.7722,Salivary Gland Adenocarcinoma,0.7651,Major Salivary Gland Adenocarcinoma,0.7494,Adenocarcinoma,0.7489,Malignant Breast Neoplasm,0.7462,Thyroid Gland Adenocarcinoma,0.7394,Metastatic Breast Adenocarcinoma,0.7357,Breast Ductal Carcinoma,0.7346,Advanced Breast Carcinoma,0.7328,Adenocarcinoma with Apocrine Metaplasia,0.7288,Parotid Gland Adenocarcinoma,0.7264,Breast Adenoma,0.7141,Breast Adenocarcinoma with Squamous Metaplasia,0.7117,Submandibular Gland Adenocarcinoma,0.7099,Ductal Eccrine Adenocarcinoma,0.7040,Breast Acinic Cell Carcinoma,0.7030,Gastric Adenocarcinoma,0.7026,Malignant Apocrine Neoplasm,0.6997,ADENOCARCINOMA-MAMMARY GLAND,True,True,True
ADENOCARINOMA,Adenocarcinoma,99,2,Adenosarcoma,0.7867,Adenoid Cystic Carcinoma,0.7546,Adenomyoma,0.7434,Cervical Adenosarcoma,0.7352,Cervical Adenomyoma,0.7162,Clear Cell Adenofibroma,0.7072,Advanced Adenoid Cystic Carcinoma,0.7069,Salivary Gland Adenoid Cystic Carcinoma,0.7046,Cervical Adenoid Cystic Carcinoma,0.6965,Adenocarcinofibroma,0.6942,Breast Adenoid Cystic Carcinoma,0.6912,Mucinous Adenofibroma,0.6879,Cervical Adenofibroma,0.6864,Broad Ligament Adenosarcoma,0.6833,Major Salivary Gland Adenoid Cystic Carcinoma,0.6811,Unresectable Adenoid Cystic Carcinoma,0.6755,Oral Cavity Adenoid Cystic Carcinoma,0.6703,Pharyngeal Adenoid Cystic Carcinoma,0.6703,Metastatic Adenoid Cystic Carcinoma,0.6699,Adenomatoid Tumor,0.6682,ADENOCARINOMA,False,False,False
ADENOID CYSTIC BREAST CANCER,Breast Adenoid Cystic Carcinoma,1,2,Breast Adenoid Cystic Carcinoma,0.9657,Adenoid Cystic Carcinoma,0.8890,Cervical Adenoid Cystic Carcinoma,0.8419,Advanced Adenoid Cystic Carcinoma,0.8078,Bartholin Gland Adenoid Cystic Carcinoma,0.8051,Lung Adenoid Cystic Carcinoma,0.7989,Submandibular Gland Adenoid Cystic Carcinoma,0.7882,Salivary Gland Adenoid Cystic Carcinoma,0.7870,Metastatic Adenoid Cystic Carcinoma,0.7820,Tracheal Adenoid Cystic Carcinoma,0.7743,Prostate Adenoid Cystic Carcinoma,0.7721,Lacrimal Gland Adenoid Cystic Carcinoma,0.7711,Major Salivary Gland Adenoid Cystic Carcinoma,0.7682,Parotid Gland Adenoid Cystic Carcinoma,0.7670,Nasopharyngeal Adenoid Cystic Carcinoma,0.7666,Oral Cavity Adenoid Cystic Carcinoma,0.7606,Skin Adenoid Cystic Carcinoma,0.7590,Minor Salivary Gland Adenoid Cystic Carcinoma,0.7535,Pharyngeal Adenoid Cystic Carcinoma,0.7444,Lacrimal Drainage System Adenoid Cystic Carcinoma,0.7441,ADENOID CYSTIC BREAST CANCER,True,True,True
ADENOID CYSTIC CARCINOMA,Adenoid Cystic Carcinoma,1,2,Adenoid Cystic Carcinoma,1.0000,Cervical Adenoid Cystic Carcinoma,0.9202,Advanced Adenoid Cystic Carcinoma,0.9187,Lung Adenoid Cystic Carcinoma,0.8841,Salivary Gland Adenoid Cystic Carcinoma,0.8837,Breast Adenoid Cystic Carcinoma,0.8687,Nasopharyngeal Adenoid Cystic Carcinoma,0.8655,Prostate Adenoid Cystic Carcinoma,0.8612,Oral Cavity Adenoid Cystic Carcinoma,0.8573,Lacrimal Gland Adenoid Cystic Carcinoma,0.8530,Tracheal Adenoid Cystic Carcinoma,0.8518,Pharyngeal Adenoid Cystic Carcinoma,0.8498,Metastatic Adenoid Cystic Carcinoma,0.8405,Skin Adenoid Cystic Carcinoma,0.8374,Major Salivary Gland Adenoid Cystic Carcinoma,0.8349,Submandibular Gland Adenoid Cystic Carcinoma,0.8248,Minor Salivary Gland Adenoid Cystic Carcinoma,0.8220,Parotid Gland Adenoid Cystic Carcinoma,0.8199,Lacrimal Drainage System Adenoid Cystic Carcinoma,0.8179,Esophageal Adenoid Cystic Carcinoma,0.8139,ADENOID CYSTIC CARCINOMA,True,True,True
ADENOID CYSTIC CARCINOMA OF THE LUNG,Lung Adenoid Cystic Carcinoma,1,2,Lung Adenoid Cystic Carcinoma,0.9703,Adenoid Cystic Carcinoma,0.8829,Laryngeal Adenoid Cystic Carcinoma,0.8299,Tracheal Adenoid Cystic Carcinoma,0.8292,Advanced Adenoid Cystic Carcinoma,0.8234,Cervical Adenoid Cystic Carcinoma,0.8218,Prostate Adenoid Cystic Carcinoma,0.8195,Nasopharyngeal Adenoid Cystic Carcinoma,0.8101,Lacrimal Gland Adenoid Cystic Carcinoma,0.8091,Breast Adenoid Cystic Carcinoma,0.7977,Pharyngeal Adenoid Cystic Carcinoma,0.7938,Locally Advanced Adenoid Cystic Carcinoma,0.7877,Salivary Gland Adenoid Cystic Carcinoma,0.7805,Oral Cavity Adenoid Cystic Carcinoma,0.7793,Parotid Gland Adenoid Cystic Carcinoma,0.7784,Tongue Adenoid Cystic Carcinoma,0.7752,Lacrimal Drainage System Adenoid Cystic Carcinoma,0.7631,Paranasal Sinus Adenoid Cystic Carcinoma,0.7569,Thymus Carcinoma with Adenoid Cystic Carcinoma-Like Features,0.7524,Oropharyngeal Adenoid Cystic Carcinoma,0.7442,ADENOID CYSTIC CARCINOMA OF THE LUNG,True,True,True
ADENOSARCOMA,Adenosarcoma,1,2,Adenosarcoma,1.0000,Cervical Adenosarcoma,0.8341,Ovarian Adenosarcoma,0.8121,Broad Ligament Adenosarcoma,0.7758,Angiosarcoma,0.7638,Uterine Corpus Adenosarcoma,0.7532,Soft Tissue Angiosarcoma,0.7256,Chondrosarcoma,0.7242,Adult Angiosarcoma,0.7211,Conventional Angiosarcoma,0.7185,Vaginal Adenosarcoma,0.7178,Aortic Angiosarcoma,0.7070,Pericardial Angiosarcoma,0.7034,Poorly Differentiated Angiosarcoma,0.7026,Sarcomatoid Carcinoma,0.7002,Adenomyoma,0.6973,Bone Angiosarcoma,0.6959,Adenoid Cystic Carcinoma,0.6959,Localized Angiosarcoma,0.6939,Fallopian Tube Adenosarcoma,0.6936,ADENOSARCOMA,True,True,True
ADENOSQUAMOUS,Adenosquamous Carcinoma,1,2,Adenosquamous Carcinoma,0.8726,Endometrial Adenosquamous Carcinoma,0.7812,Cervical Adenosquamous Carcinoma,0.7791,Lung Adenosquamous Carcinoma,0.7768,Skin Adenosquamous Carcinoma,0.7698,Salivary Gland Adenosquamous Carcinoma,0.7695,Gastric Adenosquamous Carcinoma,0.7472,Breast Adenosquamous Carcinoma,0.7469,Laryngeal Adenosquamous Carcinoma,0.7444,Human Papillomavirus-Related Adenosquamous Carcinoma,0.7365,Tongue Adenosquamous Carcinoma,0.7339,Prostate Adenosquamous Carcinoma,0.7310,Conjunctival Adenosquamous Carcinoma,0.7184,Pancreatic Adenosquamous Carcinoma,0.7170,Thymus Adenosquamous Carcinoma,0.7128,Colon Adenosquamous Carcinoma,0.7048,Vaginal Adenosquamous Carcinoma,0.7022,Advanced Cervical Adenosquamous Carcinoma,0.7006,Esophageal Adenosquamous Carcinoma,0.6947,Occult Lung Adenosquamous Carcinoma,0.6901,ADENOSQUAMOUS,True,True,True
ADENOSQUAMOUS CARCINOMA,Adenosquamous Carcinoma,1,2,Adenosquamous Carcinoma,1.0000,Lung Adenosquamous Carcinoma,0.9060,Skin Adenosquamous Carcinoma,0.8872,Endometrial Adenosquamous Carcinoma,0.8725,Cervical Adenosquamous Carcinoma,0.8714,Salivary Gland Adenosquamous Carcinoma,0.8629,Breast Adenosquamous Carcinoma,0.8545,Conjunctival Adenosquamous Carcinoma,0.8391,Gastric Adenosquamous Carcinoma,0.8326,Prostate Adenosquamous Carcinoma,0.8294,Laryngeal Adenosquamous Carcinoma,0.8163,Colon Adenosquamous Carcinoma,0.8128,Tongue Adenosquamous Carcinoma,0.8028,Esophageal Adenosquamous Carcinoma,0.7986,Occult Lung Adenosquamous Carcinoma,0.7975,Advanced Cervical Adenosquamous Carcinoma,0.7883,Pancreatic Adenosquamous Carcinoma,0.7864,Advanced Lung Adenosquamous Carcinoma,0.7852,Thymus Adenosquamous Carcinoma,0.7851,Vaginal Adenosquamous Carcinoma,0.7822,ADENOSQUAMOUS CARCINOMA,True,True,True
ADENOSQUAMOUS CARCINOMA OF GALLBLADDER,Gallbladder Adenosquamous Carcinoma,1,2,Gallbladder Adenosquamous Carcinoma,0.9801,Gallbladder Squamous Cell Carcinoma,0.8497,Gallbladder Adenocarcinoma with Squamous Metaplasia,0.8315,Gallbladder Goblet Cell Adenocarcinoma,0.7977,Gastric Adenosquamous Carcinoma,0.7845,Gallbladder Mucinous Adenocarcinoma,0.7832,Gallbladder Clear Cell Adenocarcinoma,0.7743,Gallbladder Sarcomatoid Carcinoma,0.7638,Gallbladder Undifferentiated Carcinoma,0.7586,Gallbladder Adenocarcinoma,0.7543,Gallbladder Hepatoid Adenocarcinoma,0.7439,Gallbladder Carcinoma,0.7392,"Gallbladder Adenocarcinoma, Biliary Type",0.7354,Gallbladder Mixed Adenoneuroendocrine Carcinoma,0.7353,Conjunctival Adenosquamous Carcinoma,0.7349,Extrahepatic Bile Duct Adenosquamous Carcinoma,0.7337,Colon Adenosquamous Carcinoma,0.7276,Adenosquamous Carcinoma,0.7274,Bartholin Gland Adenosquamous Carcinoma,0.7267,"Gallbladder Adenocarcinoma, Intestinal-Type",0.7265,ADENOSQUAMOUS CARCINOMA OF GALLBLADDER,True,True,True
ADENOSQUAMOUS CARCINOMA OF THE GALLBLADDER,Gallbladder Adenosquamous Carcinoma,1,2,Gallbladder Adenosquamous Carcinoma,0.9660,Gallbladder Squamous Cell Carcinoma,0.8451,Gallbladder Adenocarcinoma with Squamous Metaplasia,0.8250,Gallbladder Goblet Cell Adenocarcinoma,0.7981,Gastric Adenosquamous Carcinoma,0.7828,Gallbladder Mucinous Adenocarcinoma,0.7729,Gallbladder Clear Cell Adenocarcinoma,0.7714,Gallbladder Adenocarcinoma,0.7501,Gallbladder Undifferentiated Carcinoma,0.7496,Gallbladder Sarcomatoid Carcinoma,0.7477,Gallbladder Hepatoid Adenocarcinoma,0.7436,"Gallbladder Adenocarcinoma, Biliary Type",0.7393,Gallbladder Carcinoma,0.7369,"Gallbladder Adenocarcinoma, Intestinal-Type",0.7325,Conjunctival Adenosquamous Carcinoma,0.7299,Gallbladder Mixed Adenoneuroendocrine Carcinoma,0.7257,Extrahepatic Bile Duct Adenosquamous Carcinoma,0.7241,Colon Adenosquamous Carcinoma,0.7204,Gallbladder Small Cell Neuroendocrine Carcinoma,0.7152,Adenosquamous Carcinoma,0.7116,ADENOSQUAMOUS CARCINOMA OF THE GALLBLADDER,True,True,True
ADENOSQUAMOUS CARCINOMA OF THE PANCREAS,Pancreatic Adenosquamous Carcinoma,1,2,Pancreatic Adenosquamous Carcinoma,0.9564,Advanced Pancreatic Adenosquamous Carcinoma,0.8974,Metastatic Pancreatic Adenosquamous Carcinoma,0.8676,Pancreatic Squamous Cell Carcinoma,0.7804,Resectable Pancreatic Adenosquamous Carcinoma,0.7730,Gastric Adenosquamous Carcinoma,0.7647,Adenosquamous Carcinoma,0.7627,Prostate Adenosquamous Carcinoma,0.7507,Salivary Gland Adenosquamous Carcinoma,0.7416,Pancreatic Acinar Cell Carcinoma,0.7311,Lung Adenosquamous Carcinoma,0.7260,Metastatic Pancreatic Squamous Cell Carcinoma,0.7216,Pancreatic Poorly Cohesive Adenocarcinoma,0.7154,Ampulla of Vater Adenosquamous Carcinoma,0.7141,Gallbladder Adenosquamous Carcinoma,0.7060,Penile Adenosquamous Carcinoma,0.7042,Exocrine Pancreas Carcinoma,0.7040,Pancreatic Acinar Cell Cystadenocarcinoma,0.6998,Pancreatic Mixed Acinar-Ductal Carcinoma,0.6976,Skin Adenosquamous Carcinoma,0.6941,ADENOSQUAMOUS CARCINOMA OF THE PANCREAS,True,True,True
ADENOSQUAMOUS CARCINOMA OF THE STOMACH,Gastric Adenosquamous Carcinoma,1,2,Gastric Adenosquamous Carcinoma,0.9445,Adenosquamous Carcinoma,0.7759,Gastric Squamous Cell Carcinoma,0.7706,Tongue Adenosquamous Carcinoma,0.7617,Salivary Gland Adenosquamous Carcinoma,0.7561,Gallbladder Adenosquamous Carcinoma,0.7417,Colon Adenosquamous Carcinoma,0.7410,Small Intestinal Adenosquamous Carcinoma,0.7275,Conjunctival Adenosquamous Carcinoma,0.7256,Endometrial Adenosquamous Carcinoma,0.7247,Cervical Adenosquamous Carcinoma,0.7244,Esophageal Adenosquamous Carcinoma,0.7227,Lung Adenosquamous Carcinoma,0.7083,Breast Adenosquamous Carcinoma,0.7028,Pancreatic Adenosquamous Carcinoma,0.7021,Colorectal Adenosquamous Carcinoma,0.6996,Skin Adenosquamous Carcinoma,0.6985,Gastric Poorly Cohesive Adenocarcinoma,0.6970,Vaginal Adenosquamous Carcinoma,0.6911,Prostate Adenosquamous Carcinoma,0.6901,ADENOSQUAMOUS CARCINOMA OF THE STOMACH,True,True,True
ADRENAL TUMOR,Adrenal Gland Neoplasm,1,2,Adrenal Gland Neoplasm,0.9316,Adrenal Cortical Neoplasm,0.8620,Adrenal Rest Tumor,0.8026,Adrenal Medulla Neoplasm,0.7965,Adrenal Gland Lymphoma,0.7821,Benign Adrenal Gland Neoplasm,0.7705,Malignant Adrenal Gland Neoplasm,0.7628,Adrenal Gland Sarcoma,0.7417,Adrenal Cortical Adenoma,0.7375,Adrenal Cortical Carcinoma,0.7369,Adrenal Cortical Adenomatoid Tumor,0.7348,Benign Adrenal Cortical Neoplasm,0.7331,Endocrine Neoplasm,0.7331,Malignant Adrenal Cortical Neoplasm,0.7208,Benign Adrenal Medulla Neoplasm,0.7075,Adrenal Gland Lipoma,0.7051,Adrenal Gland Lymphangioma,0.6970,Adrenal Gland Neuroblastoma,0.6861,Adrenal Cortical Melanoma,0.6802,Malignant Adrenal Medulla Neoplasm,0.6790,ADRENAL TUMOR,True,True,True
ADRENOCORTICAL ADENOMA,Adrenal Cortical Adenoma,1,2,Adrenal Cortical Adenoma,0.9046,Adrenal Cortical Adenomatoid Tumor,0.8417,Aldosterone-Producing Adrenal Cortical Adenoma,0.8081,Androgen-Producing Adrenal Cortical Adenoma,0.8078,Adrenal Cortical Oncocytic Adenoma,0.7702,Adrenal Cortical Neoplasm,0.7700,Cortisol-Producing Adrenal Cortical Adenoma,0.7630,Adrenal Cortical Compact Cell Adenoma,0.7532,Benign Adrenal Cortical Neoplasm,0.7530,Childhood Adrenal Cortical Adenoma,0.7510,Pigmented Adrenal Cortical Adenoma,0.7501,Adenoma,0.7344,Adrenal Cortical Carcinoma,0.7293,Adrenal Cortical Glomerulosa Cell Adenoma,0.7267,Advanced Adrenal Cortical Carcinoma,0.7205,Adrenal Cortical Mixed Cell Adenoma,0.7177,Acinar Cell Adenoma,0.7173,Adrenal Cortical Clear Cell Adenoma,0.7147,Estrogen-Producing Adrenal Cortical Adenoma,0.7097,Malignant Adrenal Cortical Neoplasm,0.7091,ADRENOCORTICAL ADENOMA,True,True,True
ADRENOCORTICAL CARCINOMA,Adrenal Cortical Carcinoma,1,2,Adrenal Cortical Carcinoma,0.9037,Advanced Adrenal Cortical Carcinoma,0.8379,Malignant Adrenal Cortical Neoplasm,0.8115,Metastatic Adrenal Cortical Carcinoma,0.8101,Adrenal Cortical Neoplasm,0.8089,Adrenal Cortical High Grade Carcinoma,0.7944,Adrenal Cortical Adenoma,0.7927,Adrenal Cortical Oncocytic Carcinoma,0.7924,Adrenal Cortical Low Grade Carcinoma,0.7893,Childhood Adrenal Cortical Carcinoma,0.7833,Adrenal Cortical Adenomatoid Tumor,0.7708,Locally Advanced Adrenal Cortical Carcinoma,0.7645,Metastatic Carcinoma in the Adrenal Cortex,0.7643,Adrenal Cortical Myxoid Carcinoma,0.7601,Unresectable Adrenal Cortical Carcinoma,0.7519,Adrenal Cortical Melanoma,0.7467,Adrenal Cortical Carcinoma by AJCC v8 Stage,0.7446,Adrenal Cortical Sarcomatoid Carcinoma,0.7358,Adrenal Cortical Compact Cell Adenoma,0.7350,Benign Adrenal Cortical Neoplasm,0.7345,ADRENOCORTICAL CARCINOMA,True,True,True
ADRENOCORTICAL CARCINOMA- MYXOID TYPE,Adrenal Cortical Myxoid Carcinoma,1,2,Adrenal Cortical Myxoid Carcinoma,0.9142,Adrenal Cortical Oncocytic Carcinoma,0.7245,Adrenal Cortical Mixed Cell Adenoma,0.7225,Adrenal Cortical Sarcomatoid Carcinoma,0.6981,Adrenal Cortical Melanoma,0.6895,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,0.6886,Adrenal Cortical Adenomatoid Tumor,0.6843,Cellular Myxoma,0.6789,Adrenal Cortical Oncocytic Adenoma,0.6721,Myxoid Chondrosarcoma NCI Grade 2,0.6548,Malignant Adrenal Cortical Neoplasm,0.6521,Metastatic Adrenal Cortical Carcinoma,0.6518,Adrenal Cortical Low Grade Carcinoma,0.6506,Adrenal Cortical High Grade Carcinoma,0.6488,Thyroid Gland Mixed Medullary and Papillary Carcinoma,0.6475,Myxosarcoma,0.6438,Myxoid Chondrosarcoma NCI Grade 1,0.6425,Adrenal Cortical Carcinoma,0.6414,Mixed Cell Adenoma,0.6380,Myxoma,0.6365,ADRENOCORTICAL CARCINOMA- MYXOID TYPE,True,True,True
ADRENOCORTICAL CARCINOMA- ONCOCYTIC TYPE,Adrenal Cortical Oncocytic Carcinoma,1,2,Adrenal Cortical Oncocytic Carcinoma,0.9260,Adrenal Cortical Oncocytic Adenoma,0.8748,Thyroid Gland Oncocytic Carcinoma,0.8388,Oncocytic Adenocarcinoma,0.8279,Oncocytic Adenoma,0.7949,Thyroid Gland Oncocytic Adenoma,0.7805,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.7669,Metastatic Thyroid Gland Oncocytic Carcinoma,0.7666,Thyroid Gland Oncocytic Neoplasm,0.7653,Kidney Oncocytoma,0.7590,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.7575,Locally Advanced Thyroid Gland Oncocytic Carcinoma,0.7539,Prostate Acinar Oncocytic Adenocarcinoma,0.7473,Oncocytic Neoplasm,0.7456,Spindle Cell Oncocytoma,0.7368,Adrenal Cortical Myxoid Carcinoma,0.7367,Cystic Oncocytic Neoplasm,0.7316,Salivary Gland Oncocytic Adenocarcinoma,0.7290,Breast Oncocytic Carcinoma,0.7285,Lacrimal Gland Oncocytic Adenocarcinoma,0.7253,ADRENOCORTICAL CARCINOMA- ONCOCYTIC TYPE,True,True,True
ADRENOCORTICAL CARCINOMA- USUAL TYPE,Adrenal Cortical Carcinoma,2,2,Adrenal Cortical Low Grade Carcinoma,0.7408,Adrenal Cortical Carcinoma,0.7339,Adrenal Cortical Myxoid Carcinoma,0.7200,Adrenal Cortical Adenomatoid Tumor,0.7082,Adrenal Cortical Oncocytic Carcinoma,0.6939,Adrenal Cortical High Grade Carcinoma,0.6863,Advanced Adrenal Cortical Carcinoma,0.6820,Adrenal Cortical Sarcomatoid Carcinoma,0.6802,Locally Advanced Adrenal Cortical Carcinoma,0.6768,Adrenal Cortical Clear Cell Adenoma,0.6703,Malignant Adrenal Cortical Neoplasm,0.6691,Unresectable Adrenal Cortical Carcinoma,0.6633,Adrenal Cortical Melanoma,0.6628,Metastatic Adrenal Cortical Carcinoma,0.6619,Adrenal Cortical Mixed Cell Adenoma,0.6606,Thyroid Gland Anaplastic Carcinoma,0.6583,Childhood Adrenal Cortical Carcinoma,0.6577,Adrenal Cortical Adenoma,0.6574,Non-Functioning Adrenal Cortical Adenoma,0.6543,Undifferentiated Carcinoma,0.6502,ADRENOCORTICAL CARCINOMA- USUAL TYPE,False,True,True
ADULT T-CELL LEUKEMIA/LYMPHOMA,Adult T-Cell Leukemia/Lymphoma,1,2,Adult T-Cell Leukemia/Lymphoma,1.0000,Acute Adult T-Cell Leukemia/Lymphoma,0.9562,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.9488,Chronic Adult T-Cell Leukemia/Lymphoma,0.9345,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.9085,Adult T Lymphoblastic Lymphoma,0.9043,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma,0.8697,Adult T Acute Lymphoblastic Leukemia,0.8627,T Lymphoblastic Leukemia/Lymphoma,0.8205,Smoldering Adult T-Cell Leukemia/Lymphoma,0.8024,Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage,0.7932,Adult Lymphoblastic Lymphoma,0.7887,Refractory Adult T-Cell Leukemia/Lymphoma,0.7745,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7716,T Acute Lymphoblastic Leukemia,0.7690,Childhood T Lymphoblastic Leukemia/Lymphoma,0.7659,Adult Acute Lymphoblastic Leukemia,0.7643,T Lymphoblastic Lymphoma,0.7627,T-Cell Chronic Lymphocytic Leukemia,0.7602,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7600,ADULT T-CELL LEUKEMIA/LYMPHOMA,True,True,True
ADULT_T_CELL_LYMPHOMA-LEUKAEMIA,Adult T-Cell Leukemia/Lymphoma,1,2,Adult T-Cell Leukemia/Lymphoma,0.9275,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.9116,Acute Adult T-Cell Leukemia/Lymphoma,0.8942,Adult T Lymphoblastic Lymphoma,0.8808,Chronic Adult T-Cell Leukemia/Lymphoma,0.8434,Adult T Acute Lymphoblastic Leukemia,0.8350,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.8178,Adult T-Cell Leukemia/Lymphoma by Ann Arbor Stage,0.7951,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma,0.7928,Smoldering Adult T-Cell Leukemia/Lymphoma,0.7898,Adult Lymphoblastic Lymphoma,0.7761,Ann Arbor Stage IV Adult T-Cell Leukemia/Lymphoma,0.7642,T Lymphoblastic Leukemia/Lymphoma,0.7607,Refractory Adult T-Cell Leukemia/Lymphoma,0.7572,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7529,T Acute Lymphoblastic Leukemia,0.7507,Recurrent Adult T-Cell Leukemia/Lymphoma,0.7484,T Lymphoblastic Lymphoma,0.7458,Adult Acute Lymphoblastic Leukemia,0.7347,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7303,ADULT_T_CELL_LYMPHOMA-LEUKAEMIA,True,True,True
AGGRESSIVE DIGITAL PAPILLARY ADENOCARCINOMA,Digital Papillary Adenocarcinoma,1,2,Digital Papillary Adenocarcinoma,0.9268,Papillary Adenocarcinoma,0.7756,Aggressive Papillary Tumor,0.7652,"Prostate Ductal Adenocarcinoma, Papillary Pattern",0.7283,Gastric Papillary Adenocarcinoma,0.7180,Lung Papillary Adenocarcinoma,0.7179,Invasive Papillary Adenocarcinoma,0.7165,Aggressive Prostate Adenocarcinoma,0.7082,Prostate Ductal Adenocarcinoma,0.6975,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0.6918,Prostate Poorly Differentiated Adenocarcinoma,0.6918,Papillary Carcinoma,0.6815,Pancreatic Ductal Adenocarcinoma,0.6711,Papillary Adenoma,0.6660,Prostate Acinar Adenocarcinoma,0.6658,Aggressive Variant Prostate Carcinoma,0.6640,Prostate Acinar Pseudohyperplastic Adenocarcinoma,0.6621,Prostate Adenocarcinoma,0.6576,Advanced Pancreatic Ductal Adenocarcinoma,0.6557,Thymus Low Grade Papillary Adenocarcinoma,0.6477,AGGRESSIVE DIGITAL PAPILLARY ADENOCARCINOMA,True,True,True
ALL,Acute Lymphoblastic Leukemia,2,2,Leukemia,0.7117,Acute Lymphoblastic Leukemia,0.7044,Common Acute Lymphoblastic Leukemia,0.6964,Lymphoid Leukemia,0.6883,Lymphoblastic Lymphoma,0.6854,Acute Leukemia,0.6825,Lymphoma,0.6654,Mature T-ALL,0.6616,Pre T-ALL,0.6531,Composite Lymphoma,0.6490,Adult Lymphoblastic Lymphoma,0.6449,T Acute Lymphoblastic Leukemia,0.6263,Lymphocytic Neoplasm,0.6216,Childhood Leukemia,0.6191,Myeloid Leukemia,0.6165,Childhood Acute Lymphoblastic Leukemia,0.6155,Childhood Lymphoblastic Lymphoma,0.6150,Chronic Lymphoblastic Lymphoma,0.6144,Acute Lymphoblastic Leukemia by Gene Expression Profile,0.6143,B Lymphoblastic Lymphoma,0.6137,ALL,False,True,True
ALVEOLAR RHABDOMYOSARCOMA,Alveolar Rhabdomyosarcoma,1,2,Alveolar Rhabdomyosarcoma,1.0000,Conventional Alveolar Rhabdomyosarcoma,0.9418,Solid Alveolar Rhabdomyosarcoma,0.9225,Childhood Alveolar Rhabdomyosarcoma,0.9129,Prostate Alveolar Rhabdomyosarcoma,0.8442,Fusion-Negative Alveolar Rhabdomyosarcoma,0.8172,Refractory Alveolar Rhabdomyosarcoma,0.8141,Recurrent Alveolar Rhabdomyosarcoma,0.8137,Orbital Alveolar Rhabdomyosarcoma,0.8095,Rhabdomyosarcoma,0.8054,Adult Rhabdomyosarcoma,0.7971,Bladder Alveolar Rhabdomyosarcoma,0.7868,Abdominal Rhabdomyosarcoma,0.7816,Lung Rhabdomyosarcoma,0.7807,Fusion-Positive Alveolar Rhabdomyosarcoma,0.7788,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.7765,Alveolar Soft Part Sarcoma,0.7728,Metastatic Alveolar Soft Part Sarcoma,0.7414,Adult Alveolar Soft Part Sarcoma,0.7367,Anaplastic Embryonal Rhabdomyosarcoma,0.7352,ALVEOLAR RHABDOMYOSARCOMA,True,True,True
ALVEOLAR SOFT PART SARCOMA,Alveolar Soft Part Sarcoma,1,2,Alveolar Soft Part Sarcoma,1.0000,Localized Alveolar Soft Part Sarcoma,0.9254,Adult Alveolar Soft Part Sarcoma,0.9186,Advanced Alveolar Soft Part Sarcoma,0.9088,Metastatic Alveolar Soft Part Sarcoma,0.8944,Childhood Alveolar Soft Part Sarcoma,0.8933,Lung Alveolar Soft Part Sarcoma,0.8587,Unresectable Alveolar Soft Part Sarcoma,0.8546,Locally Advanced Alveolar Soft Part Sarcoma,0.8377,Orbital Alveolar Soft Part Sarcoma,0.8374,Cervical Alveolar Soft Part Sarcoma,0.8359,Tongue Alveolar Soft Part Sarcoma',0.8130,Recurrent Alveolar Soft Part Sarcoma,0.8049,Solid Alveolar Rhabdomyosarcoma,0.7807,Refractory Alveolar Soft Part Sarcoma,0.7804,Alveolar Rhabdomyosarcoma,0.7728,Conventional Alveolar Rhabdomyosarcoma,0.7362,Bladder Alveolar Soft Part Sarcoma,0.7222,Soft Tissue Sarcoma,0.7215,Oral Cavity Soft Tissue Sarcoma,0.7130,ALVEOLAR SOFT PART SARCOMA,True,True,True
AMELANOTIC,Amelanotic Melanoma,1,2,Amelanotic Melanoma,0.8347,Cutaneous Amelanotic Melanoma,0.7652,Ameloblastoma,0.7538,Benign Ameloblastoma,0.7360,Acanthomatous Ameloblastoma,0.7354,Conventional Ameloblastoma,0.7334,Ameloblastic Carcinoma,0.7130,Unicystic Ameloblastoma,0.7102,Childhood Ameloblastoma,0.7029,Adenoid Ameloblastoma,0.6979,Basal Cell Ameloblastoma,0.6962,Follicular Ameloblastoma,0.6855,Granular Cell Ameloblastoma,0.6812,Ameloblastic Fibroma,0.6645,Sinonasal Ameloblastoma,0.6506,Ameloblastic Fibrosarcoma,0.6388,Ameloblastic Carcinoma-Primary Type,0.6347,Acanthoma,0.6323,Acantholytic Acanthoma,0.6310,Metastasizing Ameloblastoma,0.6281,AMELANOTIC,True,True,True
AMELANOTIC NODULAR,Cutaneous Nodular Melanoma,8,2,Amelanotic Melanoma,0.8204,Cutaneous Amelanotic Melanoma,0.7730,Acanthomatous Ameloblastoma,0.7482,Nodular Melanoma,0.7377,Ameloblastoma,0.7332,Unicystic Ameloblastoma,0.7279,Conventional Ameloblastoma,0.7257,Cutaneous Nodular Melanoma,0.7132,Follicular Ameloblastoma,0.7109,Benign Ameloblastoma,0.7057,Adenoid Ameloblastoma,0.7009,Childhood Ameloblastoma,0.7005,Mucosal Nodular Melanoma,0.6908,Ameloblastic Carcinoma,0.6778,Ameloblastic Fibroma,0.6741,Nodular Neoplasm,0.6723,Granular Cell Ameloblastoma,0.6696,Ameloblastic Fibrodentinoma,0.6674,Sinonasal Ameloblastoma,0.6573,Basal Cell Ameloblastoma,0.6550,AMELANOTIC NODULAR,False,False,False
AML,Acute Myeloid Leukemia,1,2,Acute Myeloid Leukemia,1.0000,Acute Leukemia,0.9133,Myeloid Leukemia,0.9007,"Acute Myeloid Leukemia, Not Otherwise Specified",0.8953,Acute Monocytic Leukemia,0.8795,Adult Acute Myeloid Leukemia,0.8373,Acute Myelomonocytic Leukemia,0.8158,Aleukemic Myeloid Leukemia,0.8037,Childhood Acute Myeloid Leukemia,0.8032,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7944,Acute Undifferentiated Leukemia,0.7926,Secondary Acute Myeloid Leukemia,0.7920,Acute Megakaryoblastic Leukemia,0.7897,Acute Erythroid Leukemia,0.7866,Adult Acute Monocytic Leukemia,0.7808,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.7751,Acute Myeloid Leukemia with Maturation,0.7717,Acute Myeloid Leukemia without Maturation,0.7669,Childhood Acute Monocytic Leukemia,0.7630,Acute Lymphoblastic Leukemia,0.7605,Acute Myeloid Leukemia,True,True,True
AML WITH BIALLELIC MUTATIONS OF CEBPA,Acute Myeloid Leukemia with Biallelic CEBPA Mutation,1,2,Acute Myeloid Leukemia with Biallelic CEBPA Mutation,0.9482,Acute Myeloid Leukemia with Monoallelic CEBPA Mutation,0.8472,Acute Myeloid Leukemia with CEBPA Mutation,0.8097,Acute Myeloid Leukemia with Germline CEBPA Mutation,0.7575,Acute Myeloid Leukemia with In-Frame bZIP CEBPA Mutation,0.7267,Acute Myeloid Leukemia with RUNX1 Mutation,0.6580,Acute Myeloid Leukemia with BCOR Mutation,0.6292,Aleukemic Myeloid Leukemia,0.6233,Acute Myeloid Leukemia,0.6199,Acute Myeloid Leukemia with EZH2 Mutation,0.6179,Acute Myeloid Leukemia with MECOM Rearrangement,0.6173,Acute Promyelocytic Leukemia with BCOR-RARA,0.6150,Myelodysplastic Syndrome with Biallelic TP53 Mutation,0.6130,Acute Myeloid Leukemia with KAT6A-CREBBP,0.6104,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.6057,Core Binding Factor Acute Myeloid Leukemia,0.6032,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.6029,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.5928,Acute Myeloid Leukemia with U2AF1 Mutation,0.5925,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.5923,AML WITH BIALLELIC MUTATIONS OF CEBPA,True,True,True
AML WITH INV(16)(P13.1Q22) OR T(16;16)(P13.1;Q22); CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.9521,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.9131,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.9069,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.8464,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.8439,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7783,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0.7307,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.7239,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.7157,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.7152,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.7075,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6893,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6843,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.6817,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6768,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.6755,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6743,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.6706,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.6682,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.6672,AML WITH INV(16)(P13.1Q22) OR T(16;16)(P13.1;Q22); CBFB-MYH11,True,True,True
AML WITH INV(3)(Q21Q26.2) OR T(3;3)(Q21;Q26.2); RPN1-EVI1,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7966,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.7622,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0.7614,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.7385,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.7163,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7119,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6914,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6873,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.6853,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6834,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6786,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.6775,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.6688,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.6630,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6617,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6512,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,0.6451,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.6447,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6446,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6395,AML WITH INV(3)(Q21Q26.2) OR T(3;3)(Q21;Q26.2); RPN1-EVI1,True,True,True
AML WITH INV16P13.1;Q22 OR T16:16P13.1:Q22;  CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.8870,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.8612,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.8357,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.8116,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.7976,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7551,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0.7159,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.7097,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.7008,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.6946,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6729,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6698,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6671,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6662,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.6609,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6578,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6572,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.6530,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.6501,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.6476,AML WITH INV16P13.1;Q22 OR T16:16P13.1:Q22;  CBFB-MYH11,True,True,True
AML WITH INV16P13.1Q22 OR T16;16P13.1;Q22; CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.8989,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.8698,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.8559,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.8258,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.8187,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7465,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0.7146,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.7071,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.7017,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.6929,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.6755,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6743,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6733,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6724,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6682,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6630,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.6625,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.6591,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.6552,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6510,AML WITH INV16P13.1Q22 OR T16;16P13.1;Q22; CBFB-MYH11,True,True,True
AML WITH INV16P13.1Q22 OR T16;16P13.1;Q22;CBFB-MYH11,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,1,2,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.8989,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.8698,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.8559,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.8258,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.8187,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7465,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0.7146,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.7071,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.7017,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.6929,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.6755,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6743,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6733,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6724,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6682,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6630,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.6625,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.6591,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.6552,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6510,AML WITH INV16P13.1Q22 OR T16;16P13.1;Q22;CBFB-MYH11,True,True,True
"AML WITH INV3Q21.3;Q26.2 OR T3;3Q21.3;Q26.2; GATA2, MECOM","Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9210,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0.9022,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8903,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.8032,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.7932,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.7604,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7525,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.7416,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.7024,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6902,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6816,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.6796,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.6779,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6775,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.6721,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6717,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6683,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.6614,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6440,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6424,"AML WITH INV3Q21.3;Q26.2 OR T3;3Q21.3;Q26.2; GATA2, MECOM",True,True,True
"AML WITH INV3Q21.3Q26.2 OR T3;3Q21.3;Q26.2; GATA2, MECOM","Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.9216,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0.9116,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.8985,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.8079,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.7990,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.7643,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7570,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.7529,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.7176,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6989,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6889,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.6870,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.6845,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6824,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.6802,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6728,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6717,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.6698,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,0.6520,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6487,"AML WITH INV3Q21.3Q26.2 OR T3;3Q21.3;Q26.2; GATA2, MECOM",True,True,True
AML WITH INV3Q21;Q26.2 OR T3;3Q21;Q26.2; RPN1-EVI1,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7752,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0.7478,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.7406,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.7193,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.6963,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.6876,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6763,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.6639,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.6577,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6568,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6564,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6486,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.6425,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6424,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.6386,Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6317,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6278,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.6223,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,0.6218,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6157,AML WITH INV3Q21;Q26.2 OR T3;3Q21;Q26.2; RPN1-EVI1,True,True,True
AML WITH INV3Q21Q26.2 OR T3;3Q21;Q26.2; RPN1-EVI1,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",1,2,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7672,"Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM",0.7456,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.7419,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.7195,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.6967,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6815,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.6798,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.6636,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6578,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.6549,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6542,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6528,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.6460,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.6384,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6372,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6328,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,0.6251,Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6238,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.6209,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6139,AML WITH INV3Q21Q26.2 OR T3;3Q21;Q26.2; RPN1-EVI1,True,True,True
AML WITH MATURATION,Acute Myeloid Leukemia with Maturation,1,2,Acute Myeloid Leukemia with Maturation,0.9068,Adult Acute Myeloid Leukemia with Maturation,0.8303,Childhood Acute Myeloid Leukemia with Maturation,0.8295,Acute Myeloid Leukemia without Maturation,0.8137,Childhood Acute Myeloid Leukemia without Maturation,0.7585,Adult Acute Myeloid Leukemia without Maturation,0.7494,Acute Monocytic Leukemia,0.7055,Acute Myeloid Leukemia with Minimal Differentiation,0.7034,Adult Acute Monocytic Leukemia,0.6878,Childhood Acute Monocytic Leukemia,0.6869,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0.6704,Adult Acute Myeloid Leukemia with Minimal Differentiation,0.6671,Acute Monoblastic and Monocytic Leukemia,0.6661,Acute Myeloid Leukemia,0.6656,Myeloid Leukemia,0.6631,Adult Acute Monoblastic and Monocytic Leukemia,0.6530,Childhood Acute Monoblastic and Monocytic Leukemia,0.6508,Adult Acute Myeloid Leukemia,0.6493,Immature Granulocytic Sarcoma,0.6484,Acute Panmyelosis with Myelofibrosis,0.6446,AML WITH MATURATION,True,True,True
AML WITH MINIMAL DIFFERENTIATION,Acute Myeloid Leukemia with Minimal Differentiation,1,2,Acute Myeloid Leukemia with Minimal Differentiation,0.9100,Adult Acute Myeloid Leukemia with Minimal Differentiation,0.8095,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0.7953,Acute Myeloid Leukemia without Maturation,0.7558,Acute Myeloid Leukemia with Maturation,0.7140,Myelodysplastic Syndrome with Low Blasts,0.6947,Adult Acute Myeloid Leukemia without Maturation,0.6695,Hypoplastic Myelodysplastic Syndrome,0.6644,Acute Monocytic Leukemia,0.6619,Childhood Acute Myeloid Leukemia without Maturation,0.6571,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.6568,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.6555,Childhood Myelodysplastic Syndrome with Low Blasts,0.6549,Acute Monoblastic Leukemia,0.6546,Differentiated Granulocytic Sarcoma,0.6459,Cytogenetically Normal Acute Myeloid Leukemia,0.6448,Acute Myeloid Leukemia with Multilineage Dysplasia,0.6436,Adult Acute Myeloid Leukemia with Maturation,0.6418,Acute Myeloid Leukemia,0.6378,Acute Monoblastic and Monocytic Leukemia,0.6372,AML WITH MINIMAL DIFFERENTIATION,True,True,True
AML WITH MUTATED CEBPA,Acute Myeloid Leukemia with CEBPA Mutation,1,2,Acute Myeloid Leukemia with CEBPA Mutation,0.9215,Acute Myeloid Leukemia with Monoallelic CEBPA Mutation,0.8296,Acute Myeloid Leukemia with In-Frame bZIP CEBPA Mutation,0.8189,Acute Myeloid Leukemia with Biallelic CEBPA Mutation,0.7854,Acute Myeloid Leukemia with Germline CEBPA Mutation,0.7789,Acute Myeloid Leukemia with RUNX1 Mutation,0.7262,Core Binding Factor Acute Myeloid Leukemia,0.7013,Acute Myeloid Leukemia with Mutated TP53,0.6848,Acute Myeloid Leukemia,0.6766,Acute Myeloid Leukemia with BCOR Mutation,0.6660,Acute Myeloid Leukemia with MECOM Rearrangement,0.6630,Acute Myeloid Leukemia with KAT6A-CREBBP,0.6630,Acute Myeloid Leukemia with U2AF1 Mutation,0.6538,Acute Myeloid Leukemia with EZH2 Mutation,0.6477,Myeloid Leukemia,0.6430,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.6396,Aleukemic Myeloid Leukemia,0.6312,Acute Myeloid Leukemia with a Variant MECOM Rearrangement,0.6226,Acute Myeloid Leukemia with NPM1-MLF1,0.6223,Acute Myeloid Leukemia with SF3B1 Mutation,0.6208,AML WITH MUTATED CEBPA,True,True,True
AML WITH MUTATED NPM1,Acute Myeloid Leukemia with NPM1 Mutation,1,2,Acute Myeloid Leukemia with NPM1 Mutation,0.9218,Acute Myeloid Leukemia with NPM1-MLF1,0.8582,Acute Myeloid Leukemia with Mutated TP53,0.7280,Myeloid Neoplasm with Mutated TP53,0.7057,Acute Myeloid Leukemia with RUNX1 Mutation,0.6833,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Mutated TP53,0.6778,Acute Myeloid Leukemia with CEBPA Mutation,0.6748,Acute Myeloid Leukemia,0.6657,Myeloid Leukemia,0.6636,Acute Myeloid Leukemia with MECOM Rearrangement,0.6592,Noonan Syndrome-Associated Myeloproliferative Disorder,0.6550,Acute Myeloid Leukemia with U2AF1 Mutation,0.6538,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.6527,Aleukemic Myeloid Leukemia,0.6398,"Acute Myeloid Leukemia, Not Otherwise Specified",0.6319,Cytogenetically Normal Acute Myeloid Leukemia,0.6282,Myeloid Neoplasm,0.6266,Myelodysplastic Syndrome with Mutated TP53,0.6257,Acute Myeloid Leukemia with a Variant MECOM Rearrangement,0.6227,Acute Myeloid Leukemia with ASXL1 Mutation,0.6197,AML WITH MUTATED NPM1,True,True,True
AML WITH MUTATED RUNX1,Acute Myeloid Leukemia with RUNX1 Mutation,1,2,Acute Myeloid Leukemia with RUNX1 Mutation,0.9224,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.7417,Acute Myeloid Leukemia with CEBPA Mutation,0.7285,Acute Myeloid Leukemia with MECOM Rearrangement,0.7230,Acute Myeloid Leukemia with EZH2 Mutation,0.7123,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.7096,Hematologic Neoplasm with Germline RUNX1 Mutation,0.7082,Acute Myeloid Leukemia with Mutated TP53,0.7078,Acute Myeloid Leukemia,0.7046,Core Binding Factor Acute Myeloid Leukemia,0.6886,Acute Myeloid Leukemia with KMT2A Rearrangement,0.6878,Acute Myeloid Leukemia with a Variant MECOM Rearrangement,0.6862,Acute Myeloid Leukemia with U2AF1 Mutation,0.6847,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.6827,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6817,Acute Myeloid Leukemia with ASXL1 Mutation,0.6812,Acute Myeloid Leukemia with FUS-ERG,0.6763,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.6745,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.6732,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.6714,AML WITH MUTATED RUNX1,True,True,True
AML WITH MYELODYSPLASIA-RELATED CHANGES,"Acute Myeloid Leukemia, Myelodysplasia-Related",1,2,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.8444,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.8261,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.8207,Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.8168,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.8065,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7778,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7544,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.7537,Myelodysplastic Syndrome with Genetic Abnormalities,0.7496,"Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related",0.7046,Myelodysplastic Syndrome,0.7038,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",0.7012,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Mutated TP53,0.6933,Acute Myeloid Leukemia with MECOM Rearrangement,0.6887,Acute Myeloid Leukemia with Minimal Differentiation,0.6850,De Novo Myelodysplastic Syndrome,0.6847,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0.6825,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.6823,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.6782,Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome,0.6777,AML WITH MYELODYSPLASIA-RELATED CHANGES,True,True,True
AML WITH RECURRENT GENETIC ABNORMALITIES,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1,2,Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.9058,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.8940,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.8220,Recurrent Acute Myeloid Leukemia,0.8052,Recurrent Acute Leukemia,0.7749,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,0.7690,Recurrent Myeloid Leukemia,0.7534,Recurrent Adult Acute Myeloid Leukemia,0.7475,Recurrent Atypical Chronic Myeloid Leukemia,0.7472,"Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related",0.7423,Recurrent Acute Monocytic Leukemia,0.7409,Recurrent Acute Leukemia of Ambiguous Lineage,0.7348,Recurrent Acute Erythroid Leukemia,0.7311,Recurrent Acute Undifferentiated Leukemia,0.7194,Recurrent Childhood Acute Myeloid Leukemia,0.7178,Recurrent Acute Monoblastic and Monocytic Leukemia,0.7171,Recurrent Acute Myelomonocytic Leukemia,0.7101,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,0.6998,Recurrent Acute Myeloid Leukemia with KMT2A Rearrangement,0.6943,Multiple Myeloma with Recurrent Genetic Abnormalities,0.6927,AML WITH RECURRENT GENETIC ABNORMALITIES,True,True,True
AML WITH T(6;9)(P23;Q34); DEK-NUP214,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,1,2,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.9487,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6753,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6720,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6619,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.6532,Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1,0.6514,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6411,Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,0.6281,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.6215,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6198,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6187,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.6186,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6181,Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A,0.6158,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.6157,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.6134,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6125,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,0.6098,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.6095,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.6085,AML WITH T(6;9)(P23;Q34); DEK-NUP214,True,True,True
AML WITH T(8;21)(Q22;Q22); RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,1,2,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.9559,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8482,Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.8248,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.8029,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.7458,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.7394,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7304,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.7189,Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,0.7065,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7031,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7017,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.7016,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.6996,Acute Myeloid Leukemia with RUNX1 Mutation,0.6993,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6992,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.6988,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6968,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6965,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.6918,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6910,AML WITH T(8;21)(Q22;Q22); RUNX1-RUNX1T1,True,True,True
AML WITH T(9;11)(P22;Q23); MLLT3-MLL,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.8842,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.8175,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,0.8007,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7984,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.7610,Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7580,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.7551,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.7529,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.7496,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.7411,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7322,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.7295,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.7192,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.7100,Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7071,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.7028,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.6970,Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA,0.6948,B Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3); KMT2A-AFF1,0.6938,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.6933,AML WITH T(9;11)(P22;Q23); MLLT3-MLL,True,True,True
AML WITH T6:9P23:Q34.1; DEK-NUP214,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,1,2,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.8620,Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A,0.6447,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6397,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6293,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.6241,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6195,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6175,Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,0.6112,Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1,0.6098,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.6068,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.6068,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6041,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6025,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.6002,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.5943,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.5862,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.5850,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.5801,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.5790,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.5775,AML WITH T6:9P23:Q34.1; DEK-NUP214,True,True,True
AML WITH T6;9P23;Q34.1;DEK-NUP214,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,1,2,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.8562,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6491,Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A,0.6445,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6356,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.6351,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6281,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.6249,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.6229,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.6184,Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,0.6133,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.6128,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6118,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.6091,Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1,0.6061,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.5982,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.5959,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.5925,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.5908,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.5875,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.5869,AML WITH T6;9P23;Q34.1;DEK-NUP214,True,True,True
AML WITH T6;9P23;Q34; DEK-NUP214,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,1,2,Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214,0.8411,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6350,Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A,0.6303,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6145,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.6074,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6073,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.5998,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.5939,Childhood Acute Myeloid Leukemia with t(11;15)(p15;q35); NUP98-JARID1A,0.5932,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.5931,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.5931,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.5921,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.5918,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.5904,Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1,0.5842,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.5781,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.5760,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.5745,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,0.5699,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.5683,AML WITH T6;9P23;Q34; DEK-NUP214,True,True,True
AML WITH T8;21Q22;Q22.1; RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,1,2,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8286,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.7438,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7389,Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7153,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.7149,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6837,Acute Myeloid Leukemia with RUNX1 Mutation,0.6754,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6687,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.6669,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6659,Acute Myeloid Leukemia with KMT2A Rearrangement,0.6650,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6576,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6558,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.6535,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.6526,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.6505,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,0.6499,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.6424,Acute Myeloid Leukemia with Trisomy 8,0.6396,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.6377,AML WITH T8;21Q22;Q22.1; RUNX1-RUNX1T1,True,True,True
AML WITH T8;21Q22;Q22.1;RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,1,2,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8286,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.7438,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7389,Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7153,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.7149,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6837,Acute Myeloid Leukemia with RUNX1 Mutation,0.6754,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6687,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.6669,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6659,Acute Myeloid Leukemia with KMT2A Rearrangement,0.6650,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6576,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6558,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.6535,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.6526,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.6505,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,0.6499,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.6424,Acute Myeloid Leukemia with Trisomy 8,0.6396,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,0.6377,AML WITH T8;21Q22;Q22.1;RUNX1-RUNX1T1,True,True,True
AML WITH T8;21Q22;Q22; RUNX1-RUNX1T1,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,1,2,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.8215,Acute Myeloid Leukemia with t(3;21)(q26.2;q22.1); MECOM-RUNX1,0.7394,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7312,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.7113,Childhood Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,0.7101,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6801,"Acute Myeloid Leukemia with t(3;8)(q26.2;q24); MYC, MECOM",0.6733,Acute Myeloid Leukemia with RUNX1 Mutation,0.6695,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.6663,Acute Myeloid Leukemia with KMT2A Rearrangement,0.6642,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6640,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.6607,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.6564,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.6560,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.6489,Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,0.6487,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.6469,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,0.6458,Acute Myeloid Leukemia with Trisomy 8,0.6456,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,0.6442,AML WITH T8;21Q22;Q22; RUNX1-RUNX1T1,True,True,True
AML WITH T9;11P22;Q23;  MLLT3-MLL,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.8633,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.8118,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7831,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,0.7783,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.7568,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.7512,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.7397,Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7373,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.7369,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.7206,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.7198,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7048,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged,0.6995,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.6994,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.6979,Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA,0.6970,Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6906,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.6903,Acute Myeloid Leukemia with KMT2A Rearrangement,0.6875,B Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3); KMT2A-AFF1,0.6838,AML WITH T9;11P22;Q23;  MLLT3-MLL,True,True,True
AML WITH T9;11P22;Q23; MLLT3-MLL,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.8633,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.8118,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7831,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,0.7783,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.1); KMT2A-ELL,0.7568,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.7512,Acute Myeloid Leukemia with t(6;11)(q27;q23.3); MLLT4-KMT2A,0.7397,Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.7373,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.7369,Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1,0.7206,Acute Myeloid Leukemia with t(4;11)(q21.3;q23.3); AFF1-KMT2A,0.7198,"Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",0.7048,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged,0.6995,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.6994,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",0.6979,Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA,0.6970,Recurrent Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6906,Acute Myeloid Leukemia with t(3;12)(q26.2;p13.2); ETV6-MECOM,0.6903,Acute Myeloid Leukemia with KMT2A Rearrangement,0.6875,B Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3); KMT2A-AFF1,0.6838,AML WITH T9;11P22;Q23; MLLT3-MLL,True,True,True
AML WITHOUT MATURATION,Acute Myeloid Leukemia without Maturation,1,2,Acute Myeloid Leukemia without Maturation,0.8943,Acute Myeloid Leukemia with Maturation,0.8311,Adult Acute Myeloid Leukemia without Maturation,0.8250,Childhood Acute Myeloid Leukemia without Maturation,0.8249,Adult Acute Myeloid Leukemia with Maturation,0.7756,Childhood Acute Myeloid Leukemia with Maturation,0.7613,Acute Myeloid Leukemia with Minimal Differentiation,0.7298,Adult Acute Myeloid Leukemia with Minimal Differentiation,0.7018,Childhood Acute Myeloid Leukemia with Minimal Differentiation,0.6921,Acute Monocytic Leukemia,0.6672,Adult Acute Monocytic Leukemia,0.6656,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.6604,Childhood Acute Monocytic Leukemia,0.6550,Cytogenetically Normal Acute Myeloid Leukemia,0.6533,"Acute Myeloid Leukemia, Not Otherwise Specified",0.6431,Acute Myeloid Leukemia,0.6425,Childhood Ameloblastic Fibroma,0.6410,Adult Acute Myeloid Leukemia,0.6391,Myeloid Leukemia,0.6366,Blastoma,0.6266,AML WITHOUT MATURATION,True,True,True
"AML, NOS","Acute Myeloid Leukemia, Not Otherwise Specified",1,2,"Acute Myeloid Leukemia, Not Otherwise Specified",0.7757,Acute Myeloid Leukemia,0.7498,Myeloid Leukemia,0.7338,Acute Monocytic Leukemia,0.7297,Myeloid Neoplasm,0.7169,Aleukemic Myeloid Leukemia,0.7124,Acute Leukemia,0.7086,Acute Megakaryoblastic Leukemia,0.6881,Acute Myeloid Leukemia with Maturation,0.6818,Acute Myelomonocytic Leukemia,0.6748,Acute Monoblastic and Monocytic Leukemia,0.6606,Acute Myeloid Leukemia without Maturation,0.6588,Acute Erythroid Leukemia,0.6584,Acute Undifferentiated Leukemia,0.6555,Acute Panmyelosis with Myelofibrosis,0.6527,Aleukemic Leukemia,0.6518,Myeloid Sarcoma,0.6497,Acute Myeloid Leukemia with Complex Karyotype,0.6440,Leukemia,0.6424,Adult Acute Myeloid Leukemia,0.6410,"AML, NOS",True,True,True
AMLM,Acute Myeloid Leukemia,2,2,Acute Myeloid Leukemia with MECOM Rearrangement,0.6732,Acute Myeloid Leukemia,0.6561,Acute Monocytic Leukemia,0.6536,Acute Myeloid Leukemia with Maturation,0.6525,Myeloid Leukemia,0.6459,Acute Myelomonocytic Leukemia,0.6448,Aleukemic Myeloid Leukemia,0.6384,Acute Myeloid Leukemia with a Variant MECOM Rearrangement,0.6279,Acute Myeloid Leukemia without Maturation,0.6259,Acute Myeloid Leukemia with RUNX1 Mutation,0.6255,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.6254,Acute Erythroid Leukemia,0.6238,Mast Cell Leukemia with an Associated Myeloid Neoplasm,0.6230,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.6219,Acute Megakaryoblastic Leukemia,0.6161,Acute Monoblastic and Monocytic Leukemia,0.6139,"Acute Myeloid Leukemia, Not Otherwise Specified",0.6115,Acute Myeloid Leukemia with Multilineage Dysplasia,0.6102,Acute Leukemia,0.6055,Secondary Acute Myeloid Leukemia,0.6047,AMLM,False,True,True
AMPULLARY CANCER,Ampulla of Vater Carcinoma,1,2,Ampulla of Vater Carcinoma,0.8228,Ampulla of Vater Neoplasm,0.8023,Ampulla of Vater Adenocarcinoma,0.7896,Ampulla of Vater Undifferentiated Carcinoma,0.7895,Malignant Ampulla of Vater Neoplasm,0.7729,Ampulla of Vater Intestinal-Type Adenocarcinoma,0.7723,Ampulla of Vater Neuroendocrine Carcinoma,0.7675,Advanced Ampulla of Vater Carcinoma,0.7629,Metastatic Ampulla of Vater Carcinoma,0.7615,Ampulla of Vater Invasive Papillary Adenocarcinoma,0.7597,Preinvasive Neoplasm of the Ampullary Region,0.7534,Ampulla of Vater Neuroendocrine Neoplasm,0.7432,Ampulla of Vater Neuroendocrine Tumor,0.7386,Periampullary Adenocarcinoma,0.7368,Ampulla of Vater Hepatoid Adenocarcinoma,0.7345,Locally Advanced Ampulla of Vater Carcinoma,0.7337,Ampulla of Vater Mucinous Adenocarcinoma,0.7236,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,0.7226,Unresectable Ampulla of Vater Carcinoma,0.7188,Ampulla of Vater Adenosquamous Carcinoma,0.7173,AMPULLARY CANCER,True,True,True
AMPULLARY CARCINOMA,Ampulla of Vater Carcinoma,1,2,Ampulla of Vater Carcinoma,0.8769,Ampulla of Vater Adenocarcinoma,0.8305,Ampulla of Vater Undifferentiated Carcinoma,0.8300,Ampulla of Vater Neuroendocrine Carcinoma,0.8187,Ampulla of Vater Intestinal-Type Adenocarcinoma,0.8176,Advanced Ampulla of Vater Carcinoma,0.8102,Metastatic Ampulla of Vater Carcinoma,0.7961,Ampulla of Vater Neoplasm,0.7961,Ampulla of Vater Invasive Papillary Adenocarcinoma,0.7960,Ampulla of Vater Squamous Cell Carcinoma,0.7900,Ampulla of Vater Mucinous Adenocarcinoma,0.7808,Locally Advanced Ampulla of Vater Carcinoma,0.7807,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,0.7787,Periampullary Adenocarcinoma,0.7780,Malignant Ampulla of Vater Neoplasm,0.7765,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,0.7745,Ampulla of Vater Adenosquamous Carcinoma,0.7745,Ampulla of Vater Hepatoid Adenocarcinoma,0.7724,Ampulla of Vater Clear Cell Adenocarcinoma,0.7717,Unresectable Ampulla of Vater Carcinoma,0.7586,AMPULLARY CARCINOMA,True,True,True
ANAL CANCER,Anal Carcinoma,1,2,Anal Carcinoma,0.9570,Anal Adenocarcinoma,0.9233,Anal Canal Carcinoma,0.9068,Anal Neoplasm,0.8984,Anal Canal Adenocarcinoma,0.8864,Malignant Anal Neoplasm,0.8688,Advanced Anal Carcinoma,0.8548,Anal Glands Adenocarcinoma,0.8540,Anal Margin Carcinoma,0.8155,Metastatic Anal Carcinoma,0.8043,Anal Melanoma,0.7803,Locally Advanced Anal Carcinoma,0.7782,Anal Lymphoma,0.7739,Anal Canal Undifferentiated Carcinoma,0.7699,Anal Canal Neuroendocrine Carcinoma,0.7674,Anal Squamous Cell Carcinoma,0.7632,Anal Cancer by AJCC v8 Stage,0.7627,Metastatic Anal Canal Carcinoma,0.7574,AIDS-Related Anal Carcinoma,0.7513,Anal Adenocarcinoma within Anorectal Fistula,0.7504,ANAL CANCER,True,True,True
ANAL GLAND ADENOCARCINOMA,Anal Glands Adenocarcinoma,1,2,Anal Glands Adenocarcinoma,0.9892,Anal Adenocarcinoma,0.9355,Anal Canal Adenocarcinoma,0.9089,Anal Carcinoma,0.8626,Anal Mucinous Adenocarcinoma,0.8428,Anal Canal Carcinoma,0.8175,Anal Neoplasm,0.8069,Advanced Anal Carcinoma,0.8032,Accessory Urethral Gland Adenocarcinoma,0.7989,Malignant Anal Neoplasm,0.7972,Anal Margin Carcinoma,0.7830,Anal Extramucosal (Perianal) Adenocarcinoma,0.7720,Anal Melanoma,0.7707,Metastatic Anal Carcinoma,0.7587,Anal Adenocarcinoma within Anorectal Fistula,0.7493,Prostate Acinar Adenocarcinoma,0.7364,Locally Advanced Anal Carcinoma,0.7315,Anal Basaloid Carcinoma,0.7293,Anal Lymphoma,0.7270,Anal Fibroadenoma,0.7244,ANAL GLAND ADENOCARCINOMA,True,True,True
ANAL SQUAMOUS CELL,Anal Squamous Cell Carcinoma,1,2,Anal Squamous Cell Carcinoma,0.9141,Anal Canal Squamous Cell Carcinoma,0.8807,Anal Margin Squamous Cell Carcinoma,0.8192,Advanced Anal Canal Squamous Cell Carcinoma,0.8088,Anal Carcinoma,0.7920,Metastatic Anal Squamous Cell Carcinoma,0.7737,Anal Adenocarcinoma,0.7525,Anal Basaloid Carcinoma,0.7432,Unresectable Anal Squamous Cell Carcinoma,0.7416,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,0.7336,Anal Canal Squamous Papilloma,0.7295,Metastatic Anal Canal Squamous Cell Carcinoma,0.7272,Anal Canal Carcinoma,0.7270,Anal Glands Adenocarcinoma,0.7155,Anal Margin Carcinoma,0.7149,Anal Sarcoma,0.7141,Anal Canal Undifferentiated Carcinoma,0.7137,Anal Canal Adenocarcinoma,0.7122,Advanced Anal Carcinoma,0.7109,Unresectable Anal Canal Squamous Cell Carcinoma,0.7012,ANAL SQUAMOUS CELL,True,True,True
ANAL SQUAMOUS CELL CARCINOMA,Anal Squamous Cell Carcinoma,1,2,Anal Squamous Cell Carcinoma,1.0000,Anal Canal Squamous Cell Carcinoma,0.9619,Anal Margin Squamous Cell Carcinoma,0.9009,Advanced Anal Canal Squamous Cell Carcinoma,0.8773,Anal Carcinoma,0.8455,Metastatic Anal Squamous Cell Carcinoma,0.8371,Unresectable Anal Squamous Cell Carcinoma,0.8173,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,0.8034,Metastatic Anal Canal Squamous Cell Carcinoma,0.7910,Anal Canal Carcinoma,0.7843,Unresectable Anal Canal Squamous Cell Carcinoma,0.7808,Anal Adenocarcinoma,0.7771,Anal Margin Carcinoma,0.7701,Anal Verrucous Carcinoma,0.7630,Advanced Anal Carcinoma,0.7514,Anal Basaloid Carcinoma,0.7482,Anal Canal Adenocarcinoma,0.7415,Anal Margin Basal Cell Carcinoma,0.7349,Anal Canal Undifferentiated Carcinoma,0.7332,Recurrent Anal Squamous Cell Carcinoma,0.7307,ANAL SQUAMOUS CELL CARCINOMA,True,True,True
ANAPLASTIC ASTROCYTOMA,Anaplastic Astrocytoma,1,2,Anaplastic Astrocytoma,1.0000,Adult Anaplastic Astrocytoma,0.9133,"Anaplastic Astrocytoma, Not Otherwise Specified",0.8768,Hemispheric Anaplastic Astrocytoma,0.8724,Childhood Anaplastic Astrocytoma,0.8665,Astrocytoma,0.8411,Childhood Cerebral Anaplastic Astrocytoma,0.8374,Childhood Brain Anaplastic Astrocytoma,0.8287,Brain Astrocytoma,0.8265,Cerebral Astrocytoma,0.8210,"Anaplastic Astrocytoma, IDH-Wildtype",0.8082,Diffuse Astrocytoma,0.8069,Anaplastic Oligodendroglioma,0.7993,Anaplastic Malignant Neoplasm,0.7982,Recurrent Anaplastic Astrocytoma,0.7975,Frontal Lobe Anaplastic Astrocytoma,0.7924,Temporal Lobe Anaplastic Astrocytoma,0.7868,Anaplastic Diencephalic Astrocytoma,0.7817,Childhood Cerebellar Anaplastic Astrocytoma,0.7796,Anaplastic Brain Stem Astrocytoma,0.7787,ANAPLASTIC ASTROCYTOMA,True,True,True
"ANAPLASTIC ASTROCYTOMA, IDH-MUTANT","Astrocytoma, IDH-Mutant, Grade 3",3,2,"Astrocytoma, IDH-Mutant",0.9286,"Anaplastic Astrocytoma, IDH-Wildtype",0.9076,"Astrocytoma, IDH-Mutant, Grade 3",0.8844,"Astrocytoma, IDH-Mutant, Grade 2",0.8745,"Gemistocytic Astrocytoma, IDH-Mutant",0.8614,"Astrocytoma, IDH-Mutant, Grade 4",0.8451,"Astrocytoma, IDH-Wildtype",0.8082,"Unresectable Astrocytoma, IDH-Mutant",0.7971,"Diffuse Astrocytoma, IDH-Wildtype",0.7869,Anaplastic Astrocytoma,0.7632,"Recurrent Astrocytoma, IDH-Mutant",0.7540,Hemispheric Anaplastic Astrocytoma,0.7399,"Anaplastic Astrocytoma, Not Otherwise Specified",0.7274,"Glioblastoma, IDH-Wildtype",0.7267,Anaplastic Diencephalic Astrocytoma,0.7087,"Anaplastic Astroblastoma, MN1-Altered",0.6991,"Recurrent Anaplastic Astrocytoma, IDH-Wildtype",0.6981,Adult Anaplastic Astrocytoma,0.6978,"Diffuse Astrocytoma, MYB-Altered",0.6969,"Diffuse Astrocytoma, MYBL1-Altered",0.6922,"ANAPLASTIC ASTROCYTOMA, IDH-MUTANT",False,True,True
"ANAPLASTIC ASTROCYTOMA, IDH-WILDTYPE","Anaplastic Astrocytoma, IDH-Wildtype",1,2,"Anaplastic Astrocytoma, IDH-Wildtype",1.0000,"Astrocytoma, IDH-Wildtype",0.9048,"Diffuse Astrocytoma, IDH-Wildtype",0.8851,"Astrocytoma, IDH-Mutant",0.8246,"Glioblastoma, IDH-Wildtype",0.8196,"Astrocytoma, IDH-Mutant, Grade 3",0.8152,Anaplastic Astrocytoma,0.8082,"Anaplastic Astrocytoma, Not Otherwise Specified",0.8080,"Astrocytoma, IDH-Mutant, Grade 2",0.7891,"Gemistocytic Astrocytoma, IDH-Mutant",0.7756,"Astrocytoma, IDH-Mutant, Grade 4",0.7714,Hemispheric Anaplastic Astrocytoma,0.7666,"Recurrent Anaplastic Astrocytoma, IDH-Wildtype",0.7601,Adult Anaplastic Astrocytoma,0.7522,Anaplastic Diencephalic Astrocytoma,0.7430,"Unresectable Astrocytoma, IDH-Mutant",0.7424,"Anaplastic Astroblastoma, MN1-Altered",0.7146,Brain Astrocytoma,0.7102,Anaplastic Oligodendroglioma,0.7050,Childhood Anaplastic Astrocytoma,0.7029,"ANAPLASTIC ASTROCYTOMA, IDH-WILDTYPE",True,True,True
ANAPLASTIC EPENDYMOMA,Anaplastic Ependymoma,1,2,Anaplastic Ependymoma,1.0000,Adult Anaplastic Ependymoma,0.9337,Childhood Anaplastic Ependymoma,0.9026,Ependymoma,0.8580,Adult Ependymoma,0.8575,Refractory Anaplastic Ependymoma,0.8446,Brain Ependymoma,0.8382,Cellular Ependymoma,0.8361,Papillary Ependymoma,0.8326,Recurrent Anaplastic Ependymoma,0.8315,Adult Brain Ependymoma,0.8282,Adult Ependymal Tumor,0.8090,Mixed Astrocytoma-Ependymoma,0.8087,Refractory Ependymoma,0.8016,Ependymal Tumor,0.7994,Clear Cell Ependymoma,0.7903,Childhood Ependymoma,0.7719,Myxopapillary Ependymoma,0.7712,Adult Myxopapillary Ependymoma,0.7700,Spinal Cord Ependymoma,0.7660,ANAPLASTIC EPENDYMOMA,True,True,True
ANAPLASTIC GANGLIOGLIOMA,Anaplastic Ganglioglioma,1,2,Anaplastic Ganglioglioma,1.0000,Adult Ganglioglioma,0.8770,Ganglioglioma,0.8744,Childhood Ganglioglioma,0.8220,Refractory Anaplastic Ganglioglioma,0.8161,Recurrent Anaplastic Ganglioglioma,0.7987,Gangliocytoma,0.7973,Anaplastic Oligodendroglioma,0.7686,Anaplastic Oligoastrocytoma,0.7566,Neural Glioblastoma,0.7473,Anaplastic Astrocytoma,0.7464,Childhood Anaplastic Oligodendroglioma,0.7464,Childhood Anaplastic Oligoastrocytoma,0.7426,Adult Anaplastic Oligodendroglioma,0.7399,Adult Mixed Glioma,0.7338,Desmoplastic Infantile Ganglioglioma,0.7310,Granular Cell Glioblastoma,0.7256,Glioma,0.7240,"Anaplastic Oligoastrocytoma, Not Otherwise Specified",0.7217,Giant Cell Glioblastoma,0.7203,ANAPLASTIC GANGLIOGLIOMA,True,True,True
ANAPLASTIC LARGE CELL LYMPHOMA,Anaplastic Large Cell Lymphoma,1,2,Anaplastic Large Cell Lymphoma,1.0000,Advanced Anaplastic Large Cell Lymphoma,0.9071,Common Variant Anaplastic Large Cell Lymphoma,0.9049,Systemic Anaplastic Large Cell Lymphoma,0.9047,Localized Anaplastic Large Cell Lymphoma,0.9022,Anaplastic Lymphoma,0.8957,Adult Anaplastic Large Cell Lymphoma,0.8924,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",0.8677,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,0.8613,Lung Anaplastic Large Cell Lymphoma,0.8613,Small Cell Variant Anaplastic Large Cell Lymphoma,0.8601,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology",0.8481,Childhood Anaplastic Large Cell Lymphoma,0.8475,Primary Central Nervous System Anaplastic Large Cell Lymphoma,0.8440,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",0.8315,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.8252,Primary Cutaneous Anaplastic Large Cell Lymphoma,0.8247,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.8179,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage,0.8124,Adult Systemic Anaplastic Large Cell Lymphoma,0.8066,ANAPLASTIC LARGE CELL LYMPHOMA,True,True,True
ANAPLASTIC LARGE-CELL LYMPHOMA ALK NEGATIVE,"Anaplastic Large Cell Lymphoma, ALK-Negative",1,2,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.9624,"Systemic Anaplastic Large Cell Lymphoma, ALK-Negative",0.9059,"Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative",0.9018,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.8557,"Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",0.8078,"Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",0.7943,"DUSP22-R Anaplastic Large Cell Lymphoma, ALK-Negative",0.7939,ALK-Positive Large B-Cell Lymphoma,0.7877,"Childhood Anaplastic Large Cell Lymphoma, ALK-Positive",0.7846,Anaplastic Large Cell Lymphoma,0.7424,ALK-Positive Histiocytosis,0.7201,Common Variant Anaplastic Large Cell Lymphoma,0.7121,Anaplastic Lymphoma,0.7094,Advanced Anaplastic Large Cell Lymphoma,0.7085,"Refractory Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",0.7003,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology",0.6953,Adult Anaplastic Large Cell Lymphoma,0.6943,Systemic Anaplastic Large Cell Lymphoma,0.6900,Primary Central Nervous System Anaplastic Large Cell Lymphoma,0.6851,Refractory ALK-Positive Large B-Cell Lymphoma,0.6779,ANAPLASTIC LARGE-CELL LYMPHOMA ALK NEGATIVE,True,True,True
ANAPLASTIC LARGE-CELL LYMPHOMA ALK POSITIVE,"Anaplastic Large Cell Lymphoma, ALK-Positive",1,2,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.9577,"Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",0.8990,"Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",0.8927,"Childhood Anaplastic Large Cell Lymphoma, ALK-Positive",0.8769,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.8628,ALK-Positive Large B-Cell Lymphoma,0.8504,"Systemic Anaplastic Large Cell Lymphoma, ALK-Negative",0.8012,"Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative",0.7929,ALK-Positive Histiocytosis,0.7813,Anaplastic Large Cell Lymphoma,0.7784,"Refractory Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",0.7499,"Recurrent Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",0.7459,Advanced Anaplastic Large Cell Lymphoma,0.7413,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology",0.7315,Systemic Anaplastic Large Cell Lymphoma,0.7217,Lung Anaplastic Large Cell Lymphoma,0.7163,Primary Central Nervous System Anaplastic Large Cell Lymphoma,0.7159,Common Variant Anaplastic Large Cell Lymphoma,0.7118,Localized Anaplastic Large Cell Lymphoma,0.7115,Anaplastic Lymphoma,0.7107,ANAPLASTIC LARGE-CELL LYMPHOMA ALK POSITIVE,True,True,True
ANAPLASTIC MEDULLOBLASTOMA,Anaplastic Medulloblastoma,1,2,Anaplastic Medulloblastoma,1.0000,Adult Medulloblastoma,0.8557,Medulloblastoma,0.8518,Large Cell/Anaplastic Medulloblastoma,0.8465,Classic Medulloblastoma,0.8260,Metastatic Medulloblastoma,0.8043,Childhood Medulloblastoma,0.8013,Refractory Medulloblastoma,0.7938,Medulloblastoma Molecular Subtypes,0.7926,"Medulloblastoma, WNT-Activated",0.7830,Anaplastic Astrocytoma,0.7707,Recurrent Medulloblastoma,0.7624,Large Cell Medulloblastoma,0.7582,Melanocytic Medulloblastoma,0.7553,Childhood Cerebellar Anaplastic Astrocytoma,0.7474,Anaplastic Ependymoma,0.7467,"Medulloblastoma, SHH-Activated",0.7422,Anaplastic Brain Stem Astrocytoma,0.7421,Childhood Brain Anaplastic Astrocytoma,0.7404,Anaplastic Oligodendroglioma,0.7337,ANAPLASTIC MEDULLOBLASTOMA,True,True,True
ANAPLASTIC MENINGIOMA,Anaplastic (Malignant) Meningioma,1,2,Anaplastic (Malignant) Meningioma,0.9382,Anaplastic (Malignant) Intracranial Meningioma,0.8850,Adult Anaplastic (Malignant) Meningioma,0.8699,Atypical Meningioma,0.8694,Adult Atypical Meningioma,0.8206,Anaplastic Astrocytoma,0.8180,Meningioma,0.8165,Anaplastic Malignant Neoplasm,0.8069,Metastatic Meningioma,0.8012,Anaplastic (Malignant) Spinal Cord Meningioma,0.7956,Adult Meningioma,0.7937,Grade 3 Meningioma,0.7892,Adult Grade 3 Meningioma,0.7875,Metaplastic Meningioma,0.7832,Recurrent Anaplastic (Malignant) Meningioma,0.7709,Recurrent Atypical Meningioma,0.7708,Anaplastic Medulloblastoma,0.7669,Transitional Meningioma,0.7667,Intracranial Meningioma,0.7651,Fibrous Meningioma,0.7649,ANAPLASTIC MENINGIOMA,True,True,True
ANAPLASTIC OLIGOASTROCYTOMA,Anaplastic Oligoastrocytoma,1,2,Anaplastic Oligoastrocytoma,1.0000,Oligoastrocytoma,0.9221,"Anaplastic Oligoastrocytoma, Not Otherwise Specified",0.9211,Childhood Anaplastic Oligoastrocytoma,0.9105,"Oligoastrocytoma, Not Otherwise Specified",0.8615,Childhood Oligoastrocytoma,0.8535,Recurrent Anaplastic Oligoastrocytoma,0.8331,Recurrent Oligoastrocytoma,0.8083,Anaplastic Oligodendroglioma,0.8030,Adult Anaplastic Oligodendroglioma,0.7660,Anaplastic Ganglioglioma,0.7566,Recurrent Childhood Anaplastic Oligoastrocytoma,0.7555,Recurrent Childhood Oligoastrocytoma,0.7528,Adult Mixed Glioma,0.7373,Childhood Anaplastic Oligodendroglioma,0.7361,Mixed Glioma,0.7330,Anaplastic Astrocytoma,0.7288,"Anaplastic Oligodendroglioma, Not Otherwise Specified",0.7194,Adult Oligodendroglioma,0.7187,Frontal Lobe Anaplastic Oligodendroglioma,0.7138,ANAPLASTIC OLIGOASTROCYTOMA,True,True,True
ANAPLASTIC OLIGODENDROGLIOMA,Anaplastic Oligodendroglioma,1,2,Anaplastic Oligodendroglioma,1.0000,Adult Anaplastic Oligodendroglioma,0.9190,"Anaplastic Oligodendroglioma, Not Otherwise Specified",0.9092,Childhood Anaplastic Oligodendroglioma,0.8930,Oligodendroglioma,0.8874,Adult Oligodendroglioma,0.8723,Brain Oligodendroglioma,0.8691,Frontal Lobe Anaplastic Oligodendroglioma,0.8557,Adult Brain Oligodendroglioma,0.8371,Oligodendroglial Tumor,0.8366,Adult Oligodendroglial Tumor,0.8282,Refractory Anaplastic Oligodendroglioma,0.8162,Recurrent Anaplastic Oligodendroglioma,0.8138,Childhood Oligodendroglioma,0.8135,Unresectable Oligodendroglioma,0.8127,Anaplastic Oligoastrocytoma,0.8030,Anaplastic Astrocytoma,0.7993,Childhood Brain Oligodendroglioma,0.7988,"Oligodendroglioma, Not Otherwise Specified",0.7921,Anaplastic Ganglioglioma,0.7686,ANAPLASTIC OLIGODENDROGLIOMA,True,True,True
"ANAPLASTIC OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q CO-DELETED","Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1,2,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9831,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.8961,"Anaplastic Oligodendroglioma, Not Otherwise Specified",0.7833,"Unresectable Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.7493,Anaplastic Oligodendroglioma,0.7323,"Recurrent Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.7169,Childhood Anaplastic Oligodendroglioma,0.7051,Frontal Lobe Anaplastic Oligodendroglioma,0.6927,Adult Anaplastic Oligodendroglioma,0.6864,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,0.6809,Diffuse Glioneuronal Tumor with Oligodendroglioma-Like Features and Nuclear Clusters,0.6765,Brain Oligodendroglioma,0.6733,"Anaplastic Oligoastrocytoma, Not Otherwise Specified",0.6706,"Anaplastic Astroblastoma, MN1-Altered",0.6703,Oligodendroglioma,0.6661,"Oligodendroglioma, Not Otherwise Specified",0.6645,"Anaplastic Astrocytoma, IDH-Wildtype",0.6541,Oligodendroglial Tumor,0.6531,Refractory Anaplastic Oligodendroglioma,0.6512,Adult Oligodendroglioma,0.6399,"ANAPLASTIC OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q CO-DELETED",True,True,True
"ANAPLASTIC OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q-CODELETED","Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1,2,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1.0000,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9176,"Anaplastic Oligodendroglioma, Not Otherwise Specified",0.8125,"Unresectable Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.7883,Anaplastic Oligodendroglioma,0.7568,"Recurrent Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.7404,Childhood Anaplastic Oligodendroglioma,0.7189,Frontal Lobe Anaplastic Oligodendroglioma,0.7097,Adult Anaplastic Oligodendroglioma,0.7070,"Anaplastic Oligoastrocytoma, Not Otherwise Specified",0.6973,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,0.6935,Diffuse Glioneuronal Tumor with Oligodendroglioma-Like Features and Nuclear Clusters,0.6874,"Oligodendroglioma, Not Otherwise Specified",0.6871,"Anaplastic Astroblastoma, MN1-Altered",0.6851,"Anaplastic Astrocytoma, IDH-Wildtype",0.6782,Oligodendroglioma,0.6780,Brain Oligodendroglioma,0.6777,Refractory Anaplastic Oligodendroglioma,0.6726,Oligodendroglial Tumor,0.6672,Adult Oligodendroglioma,0.6560,"ANAPLASTIC OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q-CODELETED",True,True,True
ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA,Anaplastic Pleomorphic Xanthoastrocytoma,1,2,Anaplastic Pleomorphic Xanthoastrocytoma,1.0000,Pleomorphic Xanthoastrocytoma,0.9521,Childhood Pleomorphic Xanthoastrocytoma,0.8553,Refractory Anaplastic Pleomorphic Xanthoastrocytoma,0.8426,Recurrent Anaplastic Pleomorphic Xanthoastrocytoma,0.8419,Temporal Lobe Pleomorphic Xanthoastrocytoma,0.8366,Recurrent Childhood Pleomorphic Xanthoastrocytoma,0.7696,Supratentorial Pleomorphic Xanthoastrocytoma,0.7517,Atypical Spindle Cell/Pleomorphic Lipomatous Tumor,0.7258,Pleomorphic Lipoma,0.6924,Spindle Cell/Pleomorphic Lipoma,0.6912,Pleomorphic Carcinoma,0.6713,Anaplastic Plasmacytoma,0.6642,Cellular Pleomorphic Adenoma,0.6639,Undifferentiated Pleomorphic Sarcoma,0.6616,Skin Pleomorphic Lipoma,0.6608,Advanced Pleomorphic Liposarcoma,0.6576,Pleomorphic Liposarcoma,0.6568,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.6562,Spindle Cell Atypical Fibroxanthoma,0.6551,ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA,True,True,True
ANAPLASTIC THYROID CANCER,Thyroid Gland Anaplastic Carcinoma,1,2,Thyroid Gland Anaplastic Carcinoma,0.9535,Advanced Thyroid Gland Anaplastic Carcinoma,0.9056,Metastatic Thyroid Gland Anaplastic Carcinoma,0.8503,Locally Advanced Thyroid Gland Anaplastic Carcinoma,0.8281,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",0.8249,Refractory Thyroid Gland Anaplastic Carcinoma,0.8113,Unresectable Thyroid Gland Anaplastic Carcinoma,0.8106,Anaplastic Malignant Neoplasm,0.7960,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,0.7898,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,0.7761,Anaplastic Lymphoma,0.7668,Recurrent Thyroid Gland Anaplastic Carcinoma,0.7665,Thyroid Gland Adenocarcinoma,0.7480,Advanced Thyroid Gland Carcinoma,0.7472,"Thyroid Gland Anaplastic Carcinoma, Squamous Cell Carcinoma Pattern",0.7440,Differentiated Thyroid Gland Carcinoma,0.7374,Thyroid Gland Carcinoma,0.7319,Poorly Differentiated Thyroid Gland Carcinoma,0.7288,Thyroid Gland Follicular Carcinoma,0.7280,Advanced Differentiated Thyroid Gland Carcinoma,0.7267,ANAPLASTIC THYROID CANCER,True,True,True
ANAPLASTIC THYROID CARCINOMA,Thyroid Gland Anaplastic Carcinoma,1,2,Thyroid Gland Anaplastic Carcinoma,0.9598,Advanced Thyroid Gland Anaplastic Carcinoma,0.9080,Metastatic Thyroid Gland Anaplastic Carcinoma,0.8465,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",0.8413,Locally Advanced Thyroid Gland Anaplastic Carcinoma,0.8349,Unresectable Thyroid Gland Anaplastic Carcinoma,0.8099,Refractory Thyroid Gland Anaplastic Carcinoma,0.8084,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,0.7847,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,0.7768,Anaplastic Malignant Neoplasm,0.7742,"Thyroid Gland Anaplastic Carcinoma, Squamous Cell Carcinoma Pattern",0.7663,Recurrent Thyroid Gland Anaplastic Carcinoma,0.7590,Anaplastic Lymphoma,0.7557,Differentiated Thyroid Gland Carcinoma,0.7401,Thyroid Gland Follicular Carcinoma,0.7400,Advanced Thyroid Gland Carcinoma,0.7398,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.7364,Thyroid Gland Carcinoma,0.7323,Poorly Differentiated Thyroid Gland Carcinoma,0.7315,Thyroid Gland Adenocarcinoma,0.7264,ANAPLASTIC THYROID CARCINOMA,True,True,True
ANAPLASTIC_LARGE_CELL_LYMPHOMA,Anaplastic Large Cell Lymphoma,1,2,Anaplastic Large Cell Lymphoma,0.9595,Advanced Anaplastic Large Cell Lymphoma,0.8779,Systemic Anaplastic Large Cell Lymphoma,0.8767,Common Variant Anaplastic Large Cell Lymphoma,0.8761,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",0.8620,Localized Anaplastic Large Cell Lymphoma,0.8593,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,0.8488,Adult Anaplastic Large Cell Lymphoma,0.8463,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology",0.8452,Anaplastic Lymphoma,0.8448,Primary Central Nervous System Anaplastic Large Cell Lymphoma,0.8339,Small Cell Variant Anaplastic Large Cell Lymphoma,0.8251,Lung Anaplastic Large Cell Lymphoma,0.8222,Primary Cutaneous Anaplastic Large Cell Lymphoma,0.8174,Childhood Anaplastic Large Cell Lymphoma,0.8114,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",0.8075,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.7973,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage,0.7963,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.7844,"Malignant Lymphoma, Large Cell Type",0.7813,ANAPLASTIC_LARGE_CELL_LYMPHOMA,True,True,True
ANGIOCENTRIC GLIOMA,Angiocentric Glioma,1,2,Angiocentric Glioma,1.0000,Glioma,0.7419,Tectal Glioma,0.7186,Cerebral Glioblastoma,0.7178,Astrocytoma,0.7151,Cerebral Astrocytoma,0.7075,Classical Glioblastoma,0.7024,Gliomatosis Cerebri,0.6993,Astrocytic Tumor,0.6990,Angiocentric Immunoproliferative Lesion,0.6909,Glioblastoma,0.6845,Visual Pathway Astrocytoma,0.6842,Neural Glioblastoma,0.6821,Tufted Hemangioma,0.6789,Visual Pathway Glioma,0.6775,Hemispheric Anaplastic Astrocytoma,0.6760,Brain Astrocytoma,0.6756,Giant Cell Glioblastoma,0.6725,Littoral Cell Angioma,0.6689,Fibrillary Astrocytoma,0.6666,ANGIOCENTRIC GLIOMA,True,True,True
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,"Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",1,2,"Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",0.8588,"Cutaneous Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",0.8378,Intestinal T-Cell Lymphoma,0.7523,"Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type by Ann Arbor Stage",0.7502,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",0.7380,"Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",0.7269,Indolent T-Cell Non-Hodgkin Lymphoma,0.7203,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.7192,Enteropathy-Associated T-Cell Lymphoma,0.7096,Low Grade T-Cell Lymphoma,0.7046,"Ann Arbor Stage IV Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",0.6948,Aggressive T-Cell Non-Hodgkin Lymphoma,0.6868,T Lymphoblastic Lymphoma,0.6856,"Ann Arbor Stage I Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",0.6846,Thymus Mucosa-Associated Lymphoid Tissue Lymphoma,0.6826,Angiocentric Immunoproliferative Lesion,0.6814,Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage,0.6772,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.6753,"Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",0.6739,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,0.6689,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,True,True,True
ANGIOSARCOMA,Angiosarcoma,1,2,Angiosarcoma,1.0000,Conventional Angiosarcoma,0.9549,Bone Angiosarcoma,0.9231,Cardiac Angiosarcoma,0.9026,Soft Tissue Angiosarcoma,0.8929,Localized Angiosarcoma,0.8884,Adult Angiosarcoma,0.8854,Advanced Angiosarcoma,0.8815,Angiosarcoma NCI Grade 3,0.8780,Angiosarcoma NCI Grade 2,0.8766,Skin Angiosarcoma,0.8703,Poorly Differentiated Angiosarcoma,0.8650,Kidney Angiosarcoma,0.8553,Childhood Angiosarcoma,0.8391,Breast Angiosarcoma,0.8352,Visceral Angiosarcoma,0.8338,Aortic Angiosarcoma,0.8236,Metastatic Angiosarcoma,0.8193,Central Nervous System Angiosarcoma,0.8146,Pericardial Angiosarcoma,0.8145,ANGIOSARCOMA,True,True,True
ANSC,Anal Squamous Cell Carcinoma,1,2,Anal Squamous Cell Carcinoma,1.0000,Anal Canal Squamous Cell Carcinoma,0.9619,Anal Margin Squamous Cell Carcinoma,0.9009,Advanced Anal Canal Squamous Cell Carcinoma,0.8773,Anal Carcinoma,0.8455,Metastatic Anal Squamous Cell Carcinoma,0.8371,Unresectable Anal Squamous Cell Carcinoma,0.8173,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,0.8034,Metastatic Anal Canal Squamous Cell Carcinoma,0.7910,Anal Canal Carcinoma,0.7843,Unresectable Anal Canal Squamous Cell Carcinoma,0.7808,Anal Adenocarcinoma,0.7771,Anal Margin Carcinoma,0.7701,Anal Verrucous Carcinoma,0.7630,Advanced Anal Carcinoma,0.7514,Anal Basaloid Carcinoma,0.7482,Anal Canal Adenocarcinoma,0.7415,Anal Margin Basal Cell Carcinoma,0.7349,Anal Canal Undifferentiated Carcinoma,0.7332,Recurrent Anal Squamous Cell Carcinoma,0.7307,Anal Squamous Cell Carcinoma,True,True,True
APAD,Appendix Adenocarcinoma,1,2,Appendix Adenocarcinoma,0.9169,Appendix Carcinoma,0.8473,Advanced Appendix Adenocarcinoma,0.8213,Malignant Appendix Neoplasm,0.8189,Appendix Adenoma,0.8131,Metastatic Appendix Adenocarcinoma,0.8062,Appendix Neoplasm,0.7842,Appendix Mucinous Adenocarcinoma,0.7830,Appendix Goblet Cell Adenocarcinoma,0.7813,Locally Advanced Appendix Adenocarcinoma,0.7480,Unresectable Appendix Adenocarcinoma,0.7466,Metastatic Appendix Carcinoma,0.7407,Appendix Undifferentiated Carcinoma,0.7393,Appendix Tubular Adenoma,0.7349,Appendix Signet Ring Cell Adenocarcinoma,0.7302,Appendix Lipoma,0.7191,Cecum Adenocarcinoma,0.7154,Appendix Neuroendocrine Carcinoma,0.7153,Appendix Lymphoma,0.7147,Broad Ligament Adenocarcinoma,0.7087,Appendiceal Adenocarcinoma,True,True,True
APL WITH PML-RARA,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,4,2,Acute Promyelocytic Leukemia with FIP1L1-RARA,0.7665,Acute Promyelocytic Leukemia with STAT5B-RARA,0.7661,Acute Promyelocytic Leukemia with STAT3-RARA,0.7622,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.7609,Acute Promyelocytic Leukemia with a Variant RARA Rearrangement,0.7603,Acute Promyelocytic Leukemia with BCOR-RARA,0.7465,Acute Promyelocytic Leukemia with t(11;17)(q23;q21); ZBTB16-RARA,0.7293,Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA,0.7268,Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.7190,Acute Promyelocytic Leukemia with TBL1XR1-RARA,0.7181,Typical Acute Promyelocytic Leukemia,0.7121,Acute Promyelocytic Leukemia with t(5;17)(q35;q21); NPM1-RARA,0.6899,Acute Promyelocytic Leukemia with t(1;17)(q42.3;q21.2); IRF2BP2-RARA,0.6533,Acute Myeloid Leukemia with KAT6A-CREBBP,0.6438,Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,0.6390,Acute Myeloid Leukemia with NPM1-MLF1,0.6363,Acute Myeloid Leukemia with RAM Immunophenotype,0.6279,Acute Myeloid Leukemia with del(12p),0.6234,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6226,Mixed Phenotype Acute Leukemia with KMT2A Rearrangement,0.6210,APL WITH PML-RARA,False,False,True
APPENDICEAL ADENOCARCINOMA,Appendix Adenocarcinoma,1,2,Appendix Adenocarcinoma,0.9169,Appendix Carcinoma,0.8473,Advanced Appendix Adenocarcinoma,0.8213,Malignant Appendix Neoplasm,0.8189,Appendix Adenoma,0.8131,Metastatic Appendix Adenocarcinoma,0.8062,Appendix Neoplasm,0.7842,Appendix Mucinous Adenocarcinoma,0.7830,Appendix Goblet Cell Adenocarcinoma,0.7813,Locally Advanced Appendix Adenocarcinoma,0.7480,Unresectable Appendix Adenocarcinoma,0.7466,Metastatic Appendix Carcinoma,0.7407,Appendix Undifferentiated Carcinoma,0.7393,Appendix Tubular Adenoma,0.7349,Appendix Signet Ring Cell Adenocarcinoma,0.7302,Appendix Lipoma,0.7191,Cecum Adenocarcinoma,0.7154,Appendix Neuroendocrine Carcinoma,0.7153,Appendix Lymphoma,0.7147,Broad Ligament Adenocarcinoma,0.7087,APPENDICEAL ADENOCARCINOMA,True,True,True
APPENDICEAL CANCER,Appendix Carcinoma,1,2,Appendix Carcinoma,0.8494,Appendix Neoplasm,0.8328,Malignant Appendix Neoplasm,0.8171,Appendix Adenocarcinoma,0.8107,Appendix Adenoma,0.7550,Metastatic Appendix Carcinoma,0.7440,Metastatic Appendix Adenocarcinoma,0.7379,Appendix Neuroendocrine Carcinoma,0.7285,Appendix Undifferentiated Carcinoma,0.7265,Appendix Neuroendocrine Neoplasm,0.7230,Advanced Appendix Adenocarcinoma,0.7221,Appendix Lymphoma,0.7119,Appendix Neuroendocrine Tumor,0.7073,Appendix Lipoma,0.6910,Benign Appendix Neoplasm,0.6885,Unresectable Appendix Adenocarcinoma,0.6882,Appendix Signet Ring Cell Adenocarcinoma,0.6865,Appendix Carcinoma by AJCC v8 Stage,0.6840,Appendix Leiomyoma,0.6793,Appendix Small Cell Neuroendocrine Carcinoma,0.6741,APPENDICEAL CANCER,True,True,True
ASPS,Alveolar Soft Part Sarcoma,1,2,Alveolar Soft Part Sarcoma,1.0000,Localized Alveolar Soft Part Sarcoma,0.9254,Adult Alveolar Soft Part Sarcoma,0.9186,Advanced Alveolar Soft Part Sarcoma,0.9088,Metastatic Alveolar Soft Part Sarcoma,0.8944,Childhood Alveolar Soft Part Sarcoma,0.8933,Lung Alveolar Soft Part Sarcoma,0.8587,Unresectable Alveolar Soft Part Sarcoma,0.8546,Locally Advanced Alveolar Soft Part Sarcoma,0.8377,Orbital Alveolar Soft Part Sarcoma,0.8374,Cervical Alveolar Soft Part Sarcoma,0.8359,Tongue Alveolar Soft Part Sarcoma',0.8130,Recurrent Alveolar Soft Part Sarcoma,0.8049,Solid Alveolar Rhabdomyosarcoma,0.7807,Refractory Alveolar Soft Part Sarcoma,0.7804,Alveolar Rhabdomyosarcoma,0.7728,Conventional Alveolar Rhabdomyosarcoma,0.7362,Bladder Alveolar Soft Part Sarcoma,0.7222,Soft Tissue Sarcoma,0.7215,Oral Cavity Soft Tissue Sarcoma,0.7130,Alveolar Soft Part Sarcoma,True,True,True
ASTROBLASTOMA,"Astroblastoma, MN1-Altered",1,2,"Astroblastoma, MN1-Altered",0.8286,Astrocytic Tumor,0.8023,"Anaplastic Astroblastoma, MN1-Altered",0.7949,"Childhood Astroblastoma, MN1-Altered",0.7941,"Adult Astroblastoma, MN1-Altered",0.7833,Astrocytoma,0.7500,Adamantinoid Trichoblastoma,0.7215,Adult Astrocytic Tumor,0.7185,Neural Glioblastoma,0.7154,Trichoblastoma,0.7152,Brain Astrocytoma,0.7140,Classical Glioblastoma,0.7135,Mesenchymal Glioblastoma,0.7065,Pineoblastoma,0.7059,Glioblastoma,0.7042,Medullomyoblastoma,0.7041,Glioma,0.7032,Childhood Astrocytic Tumor,0.6965,Gliosarcoma,0.6954,Ameloblastoma,0.6943,ASTROBLASTOMA,True,True,True
ASTROCYTOMA,Astrocytoma,1,2,Astrocytoma,1.0000,Cerebral Astrocytoma,0.9405,Brain Astrocytoma,0.9355,Fibrillary Astrocytoma,0.8581,Astrocytic Tumor,0.8511,Diffuse Astrocytoma,0.8424,Anaplastic Astrocytoma,0.8411,Glioma,0.8293,Childhood Astrocytoma,0.8264,Glioblastoma,0.8231,Cerebellar Astrocytoma,0.8191,"Astrocytoma, Not Otherwise Specified",0.8180,Retinal Astrocytoma,0.8110,Visual Pathway Astrocytoma,0.8045,Low Grade Astrocytoma,0.8027,Childhood Cerebral Astrocytoma,0.7964,Classical Glioblastoma,0.7926,Cerebral Glioblastoma,0.7917,Pilocytic Astrocytoma,0.7883,Granular Cell Astrocytoma,0.7787,ASTROCYTOMA,True,True,True
"ASTROCYTOMA, ANAPLASTIC",Anaplastic Astrocytoma,1,2,Anaplastic Astrocytoma,0.9791,"Anaplastic Astrocytoma, Not Otherwise Specified",0.9017,Adult Anaplastic Astrocytoma,0.8977,Hemispheric Anaplastic Astrocytoma,0.8563,Childhood Anaplastic Astrocytoma,0.8418,Childhood Cerebral Anaplastic Astrocytoma,0.8223,Astrocytoma,0.8176,"Anaplastic Astrocytoma, IDH-Wildtype",0.8169,Brain Astrocytoma,0.8162,Childhood Brain Anaplastic Astrocytoma,0.8134,Cerebral Astrocytoma,0.8060,Anaplastic Malignant Neoplasm,0.7942,Anaplastic Oligodendroglioma,0.7911,Recurrent Anaplastic Astrocytoma,0.7896,Anaplastic Diencephalic Astrocytoma,0.7855,Diffuse Astrocytoma,0.7853,Temporal Lobe Anaplastic Astrocytoma,0.7827,Secondary Supratentorial Anaplastic Astrocytoma,0.7822,Frontal Lobe Anaplastic Astrocytoma,0.7746,Anaplastic Brain Stem Astrocytoma,0.7711,"ASTROCYTOMA, ANAPLASTIC",True,True,True
"ASTROCYTOMA, SUBTYPE INDETERMINATE",Astrocytoma,2,2,Low Grade Astrocytoma,0.7524,Astrocytoma,0.7499,Diffuse Astrocytoma,0.7171,Brain Astrocytoma,0.7169,Cerebral Astrocytoma,0.7149,"Anaplastic Astrocytoma, IDH-Wildtype",0.7099,"Astrocytoma, Not Otherwise Specified",0.7078,Anaplastic Astrocytoma,0.7035,"Astrocytoma, IDH-Wildtype",0.6918,Fibrillary Astrocytoma,0.6853,Pilocytic Astrocytoma,0.6781,Astrocytic Tumor,0.6754,Granular Cell Astrocytoma,0.6725,"Anaplastic Astrocytoma, Not Otherwise Specified",0.6705,"Diffuse Astrocytoma, IDH-Wildtype",0.6677,Gemistocytic Astrocytoma,0.6622,Adult Infiltrating Astrocytic Tumor,0.6618,Protoplasmic Astrocytoma,0.6617,Low Grade Glioma,0.6606,Glioma,0.6551,"ASTROCYTOMA, SUBTYPE INDETERMINATE",False,True,True
ASTROCYTOMA_GRADE_III,Astrocytoma,2,2,WHO Grade 3 Glioma,0.8109,Astrocytoma,0.7898,Brain Astrocytoma,0.7854,Cerebral Astrocytoma,0.7851,Anaplastic Astrocytoma,0.7820,"Astrocytoma, Not Otherwise Specified",0.7484,Fibrillary Astrocytoma,0.7453,Diffuse Astrocytoma,0.7359,"Anaplastic Astrocytoma, Not Otherwise Specified",0.7351,Low Grade Astrocytoma,0.7203,"Astrocytoma, IDH-Mutant, Grade 3",0.7177,High Grade Astrocytic Tumor,0.7135,Third Ventricle Pilocytic Astrocytoma,0.7075,Grade 3 Meningioma,0.7068,Glioblastoma,0.7040,Classical Glioblastoma,0.7014,Grade 3 Malignant Neoplasm,0.6994,Malignant Glioma,0.6969,Advanced Glioblastoma,0.6961,Pilocytic Astrocytoma,0.6930,ASTROCYTOMA_GRADE_III,False,True,True
ASTROCYTOMA_GRADE_III-IV,High Grade Astrocytic Tumor,9,2,WHO Grade 3 Glioma,0.7620,Anaplastic Astrocytoma,0.7446,Astrocytoma,0.7442,Brain Astrocytoma,0.7437,Cerebral Astrocytoma,0.7392,Diffuse Astrocytoma,0.7298,"Astrocytoma, Not Otherwise Specified",0.7271,Advanced Glioblastoma,0.7213,High Grade Astrocytic Tumor,0.7152,Malignant Glioma,0.7065,"Anaplastic Astrocytoma, Not Otherwise Specified",0.7037,Fibrillary Astrocytoma,0.6972,Malignant Brain Glioma,0.6890,High Grade Astrocytoma with Piloid Features,0.6879,"Astrocytoma, IDH-Mutant, Grade 3",0.6859,Low Grade Astrocytoma,0.6840,WHO Grade 4 Glioma,0.6836,Classical Glioblastoma,0.6810,Third Ventricle Pilocytic Astrocytoma,0.6775,Metastatic Low Grade Astrocytoma,0.6765,ASTROCYTOMA_GRADE_III-IV,False,False,False
ASTROCYTOMA_GRADE_IV,Astrocytoma,1,2,Astrocytoma,0.7878,WHO Grade 4 Glioma,0.7766,Cerebral Astrocytoma,0.7752,Brain Astrocytoma,0.7735,Anaplastic Astrocytoma,0.7693,Diffuse Astrocytoma,0.7604,"Astrocytoma, IDH-Mutant, Grade 4",0.7596,High Grade Astrocytic Tumor,0.7550,"Astrocytoma, Not Otherwise Specified",0.7474,Fibrillary Astrocytoma,0.7383,Advanced Glioblastoma,0.7339,Malignant Glioma,0.7331,Glioblastoma,0.7314,Classical Glioblastoma,0.7303,"Anaplastic Astrocytoma, Not Otherwise Specified",0.7210,Granular Cell Astrocytoma,0.7159,High Grade Astrocytoma with Piloid Features,0.7158,Low Grade Astrocytoma,0.7121,Cerebral Glioblastoma,0.7115,Astrocytic Tumor,0.7067,ASTROCYTOMA_GRADE_IV,True,True,True
ATL,Adult T-Cell Leukemia/Lymphoma,19,2,Leukemia,0.6821,Anaplastic Lymphoma,0.6820,Lymphoma,0.6782,Composite Lymphoma,0.6575,Acute Leukemia,0.6569,Tracheal Lymphoma,0.6492,Anal Lymphoma,0.6388,Lymphoid Leukemia,0.6363,Adult Lymphoma,0.6347,Adult T Lymphoblastic Lymphoma,0.6318,T Acute Lymphoblastic Leukemia,0.6253,Advanced Transformed Non-Hodgkin Lymphoma,0.6253,T Lymphoblastic Lymphoma,0.6208,Acute Lymphoblastic Leukemia,0.6178,Advanced Lymphoma,0.6177,Temporal Lobe Anaplastic Astrocytoma,0.6172,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.6165,Acute Adult T-Cell Leukemia/Lymphoma,0.6120,Adult T-Cell Leukemia/Lymphoma,0.6116,T Lymphoblastic Leukemia/Lymphoma,0.6093,ATL,False,False,False
ATRT,Atypical Teratoid/Rhabdoid Tumor,1,2,Atypical Teratoid/Rhabdoid Tumor,1.0000,Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes,0.9454,Childhood Atypical Teratoid/Rhabdoid Tumor,0.9375,Atypical Teratoid/Rhabdoid Tumor-TYR,0.9184,Refractory Atypical Teratoid/Rhabdoid Tumor,0.9079,Advanced Rhabdoid Tumor,0.8544,Atypical Teratoid/Rhabdoid Tumor-MYC,0.8532,Rhabdoid Tumor,0.8531,Recurrent Atypical Teratoid/Rhabdoid Tumor,0.8519,Extrarenal Rhabdoid Tumor,0.8110,Atypical Teratoid/Rhabdoid Tumor-SHH,0.8077,Refractory Rhabdoid Tumor,0.8004,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.7960,Stage M4 Atypical Teratoid/Rhabdoid Tumor,0.7871,Metastatic Rhabdoid Tumor,0.7686,Unresectable Rhabdoid Tumor,0.7652,Refractory Extrarenal Rhabdoid Tumor,0.7581,Stage M3 Atypical Teratoid/Rhabdoid Tumor,0.7559,Rhabdoid Meningioma,0.7438,Recurrent Rhabdoid Tumor,0.7436,Atypical Teratoid/Rhabdoid Tumor,True,True,True
ATYPICAL CHOROID PLEXUS PAPILLOMA,Atypical Choroid Plexus Papilloma,1,2,Atypical Choroid Plexus Papilloma,1.0000,Childhood Atypical Choroid Plexus Papilloma,0.9313,Choroid Plexus Papilloma,0.8993,Childhood Choroid Plexus Papilloma,0.8282,Adult Choroid Plexus Neoplasm,0.7696,Choroid Plexus Neoplasm,0.7361,Choroid Plexus Carcinoma,0.7159,Breast Atypical Papilloma,0.7029,Benign Choroid Plexus Neoplasm,0.7020,Childhood Choroid Plexus Neoplasm,0.6919,Choroid Plexus Meningioma,0.6895,Malignant Choroid Plexus Neoplasm,0.6831,Breast Central Papilloma,0.6701,Papilloma,0.6671,Conjunctival Squamous Papilloma,0.6654,Childhood Choroid Plexus Carcinoma,0.6554,Eyelid Papilloma,0.6529,Papillary Adenoma,0.6475,Urothelial Papilloma,0.6474,Bladder Inverted Papilloma,0.6455,ATYPICAL CHOROID PLEXUS PAPILLOMA,True,True,True
"ATYPICAL CHRONIC MYELOID LEUKAEMIA, BCR-ABL1 NEGATIVE",Atypical Chronic Myeloid Leukemia,6,2,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,0.8859,"Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive",0.8823,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.8027,"Myeloproliferative Neoplasm, BCR-ABL1 Negative",0.7771,"Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7700,Atypical Chronic Myeloid Leukemia,0.7645,Cytogenetically Normal Acute Myeloid Leukemia,0.7592,"Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive",0.7516,"Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7506,"Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7440,Acute Myeloid Leukemia with BCR-ABL1,0.7322,"Chronic Phase Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive",0.7214,"Myeloid Leukemia, Philadelphia-Negative",0.7055,"Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.6948,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0.6870,Non-T Non-B CALLA Negative Adult Acute Lymphoblastic Leukemia,0.6734,"Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.6668,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.6650,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, JAK-STAT Activated",0.6532,Cytogenetically Normal Acute Myeloid Leukemia Post Cytotoxic Therapy,0.6499,"ATYPICAL CHRONIC MYELOID LEUKAEMIA, BCR-ABL1 NEGATIVE",False,False,False
"ATYPICAL CHRONIC MYELOID LEUKEMIA, BCR-ABL1-",Atypical Chronic Myeloid Leukemia,12,2,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.8793,"Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive",0.8645,Acute Myeloid Leukemia with BCR-ABL1,0.8536,"Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive",0.8422,"Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.8220,"Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.8155,"Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.8069,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,0.7977,"Chronic Phase Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive",0.7893,"Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7650,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.7639,Atypical Chronic Myeloid Leukemia,0.7494,Myeloid/Lymphoid Neoplasms with ETV6-ABL1,0.7399,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, JAK-STAT Activated",0.7317,Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion,0.7307,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.7276,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified",0.7233,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL1 Rearranged",0.7232,"Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7154,"Myeloproliferative Neoplasm, BCR-ABL1 Negative",0.7091,"ATYPICAL CHRONIC MYELOID LEUKEMIA, BCR-ABL1-",False,False,False
ATYPICAL LUNG CARCINOID,Lung Neuroendocrine Tumor G2,17,2,Lung Carcinoid Tumor,0.8901,Laryngeal Carcinoid Tumor,0.7839,Lung Neuroendocrine Tumor,0.7647,Lung Neuroendocrine Carcinoma,0.7645,Advanced Lung Neuroendocrine Carcinoma,0.7480,Advanced Lung Neuroendocrine Tumor,0.7444,Lung Neuroendocrine Neoplasm,0.7391,Lung Carcinosarcoma,0.7391,Carcinoid Tumor,0.7302,Locally Advanced Lung Neuroendocrine Carcinoma,0.7230,Advanced Lung Neuroendocrine Neoplasm,0.7197,Occult Lung Adenocarcinoma,0.7158,Intermediate Grade Lung Neuroendocrine Neoplasm,0.7103,Low Grade Lung Neuroendocrine Neoplasm,0.7087,Combined Carcinoid and Adenocarcinoma,0.7083,Lung Large Cell Neuroendocrine Carcinoma,0.7064,Lung Neuroendocrine Tumor G2,0.7051,Strumal Carcinoid,0.6977,Lung Adenoma,0.6964,Occult Lung Carcinoma,0.6913,ATYPICAL LUNG CARCINOID,False,False,False
ATYPICAL MENINGIOMA,Atypical Meningioma,1,2,Atypical Meningioma,1.0000,Adult Atypical Meningioma,0.9002,Meningioma,0.8373,Anaplastic (Malignant) Meningioma,0.8111,Atypical Adenoma,0.7974,Benign Meningioma,0.7892,Adult Meningioma,0.7799,Recurrent Atypical Meningioma,0.7691,Transitional Meningioma,0.7583,Intracranial Meningioma,0.7581,Ectopic Meningioma,0.7575,Adult Anaplastic (Malignant) Meningioma,0.7568,Papillary Meningioma,0.7558,Cerebral Meningioma,0.7540,Grade 3 Meningioma,0.7502,Anaplastic (Malignant) Intracranial Meningioma,0.7490,Metaplastic Meningioma,0.7466,Fibrous Meningioma,0.7425,Adult Grade 3 Meningioma,0.7376,Metastatic Meningioma,0.7311,ATYPICAL MENINGIOMA,True,True,True
ATYPICAL NEVUS,Cutaneous Dysplastic Nevus,7,2,Nevus,0.8333,Cutaneous Nevus,0.8095,Vulvar Atypical Nevus,0.8015,Dermal Nevus,0.7938,Cutaneous Compound Nevus,0.7621,Mucosal Nevus,0.7558,Cutaneous Dysplastic Nevus,0.7513,Congenital Cutaneous Nevus,0.7475,Atypical Adenoma,0.7462,Cutaneous Nonpigmented Nevus,0.7429,Acral Nevus,0.7426,Oral Nevus,0.7386,Cutaneous Intermediate Congenital Nevus,0.7356,Pigmented Nevus,0.7337,Childhood Cutaneous Nevus,0.7243,Eyelid Nevus,0.7212,Choroid Nevus,0.7195,Conjunctival Nevus,0.7149,Childhood Dermal Nevus,0.7131,Cutaneous Junctional Nevus,0.7102,ATYPICAL NEVUS,False,False,False
ATYPICAL TERATOID RHABDOID TUMOR ATRT,Atypical Teratoid/Rhabdoid Tumor,1,2,Atypical Teratoid/Rhabdoid Tumor,0.9154,Childhood Atypical Teratoid/Rhabdoid Tumor,0.8803,Atypical Teratoid/Rhabdoid Tumor-TYR,0.8672,Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes,0.8620,Refractory Atypical Teratoid/Rhabdoid Tumor,0.8441,Advanced Rhabdoid Tumor,0.8074,Rhabdoid Tumor,0.7878,Extrarenal Rhabdoid Tumor,0.7812,Atypical Teratoid/Rhabdoid Tumor-MYC,0.7798,Recurrent Atypical Teratoid/Rhabdoid Tumor,0.7714,Atypical Teratoid/Rhabdoid Tumor-SHH,0.7668,Refractory Rhabdoid Tumor,0.7464,Stage M4 Atypical Teratoid/Rhabdoid Tumor,0.7384,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.7365,Refractory Extrarenal Rhabdoid Tumor,0.7282,Unresectable Rhabdoid Tumor,0.7231,Metastatic Rhabdoid Tumor,0.7184,Rhabdoid Tumor of the Kidney,0.7062,Stage M3 Atypical Teratoid/Rhabdoid Tumor,0.7021,Extrarenal Rhabdoid Tumor of the Prostate,0.6900,ATYPICAL TERATOID RHABDOID TUMOR ATRT,True,True,True
ATYPICAL TERATOID/RHABDOID TUMOR,Atypical Teratoid/Rhabdoid Tumor,1,2,Atypical Teratoid/Rhabdoid Tumor,1.0000,Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes,0.9454,Childhood Atypical Teratoid/Rhabdoid Tumor,0.9375,Atypical Teratoid/Rhabdoid Tumor-TYR,0.9184,Refractory Atypical Teratoid/Rhabdoid Tumor,0.9079,Advanced Rhabdoid Tumor,0.8544,Atypical Teratoid/Rhabdoid Tumor-MYC,0.8532,Rhabdoid Tumor,0.8531,Recurrent Atypical Teratoid/Rhabdoid Tumor,0.8519,Extrarenal Rhabdoid Tumor,0.8110,Atypical Teratoid/Rhabdoid Tumor-SHH,0.8077,Refractory Rhabdoid Tumor,0.8004,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.7960,Stage M4 Atypical Teratoid/Rhabdoid Tumor,0.7871,Metastatic Rhabdoid Tumor,0.7686,Unresectable Rhabdoid Tumor,0.7652,Refractory Extrarenal Rhabdoid Tumor,0.7581,Stage M3 Atypical Teratoid/Rhabdoid Tumor,0.7559,Rhabdoid Meningioma,0.7438,Recurrent Rhabdoid Tumor,0.7436,ATYPICAL TERATOID/RHABDOID TUMOR,True,True,True
B-CELL ACUTE LYMPHOID LEUKEMIA,B Acute Lymphoblastic Leukemia,1,2,B Acute Lymphoblastic Leukemia,0.9190,B-Cell Leukemia,0.8987,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.8545,B Lymphoblastic Leukemia/Lymphoma,0.8405,Childhood B Acute Lymphoblastic Leukemia,0.8220,Adult B Acute Lymphoblastic Leukemia,0.8036,B Lymphoblastic Lymphoma,0.8032,Acute Lymphoblastic Leukemia,0.7982,Pre-B Acute Lymphoblastic Leukemia,0.7902,Lymphoid Leukemia,0.7777,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.7774,Burkitt Leukemia,0.7772,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified",0.7660,B Acute Lymphoblastic Leukemia with Germline Predisposition,0.7629,B Acute Lymphoblastic Leukemia with Germline IKZF1 Mutation,0.7605,B Acute Lymphoblastic Leukemia Associated with Down Syndrome,0.7575,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7557,Childhood B Lymphoblastic Leukemia/Lymphoma,0.7514,Common Acute Lymphoblastic Leukemia,0.7496,Aleukemic Acute Lymphoblastic Leukemia,0.7469,B-CELL ACUTE LYMPHOID LEUKEMIA,True,True,True
B-CELL NON-HODGKIN LYMPHOMA,B-Cell Non-Hodgkin Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma,1.0000,Non-Burkitt's Lymphoma,0.8525,Low Grade B-Cell Non-Hodgkin's Lymphoma,0.8486,Mature B-Cell Non-Hodgkin Lymphoma,0.8455,High Grade B-Cell Non-Hodgkin's Lymphoma,0.8090,Non-Hodgkin Lymphoma,0.8038,Indolent B-Cell Non-Hodgkin Lymphoma,0.7985,B-Cell Leukemia,0.7742,B Lymphoblastic Lymphoma,0.7635,B-Cell Neoplasm,0.7626,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7605,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.7527,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7513,Classical Burkitt Lymphoma,0.7469,B Lymphoblastic Leukemia/Lymphoma,0.7424,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.7393,Breast Non-Hodgkin Lymphoma,0.7340,Primary Central Nervous System B-Cell Non-Hodgkin Lymphoma,0.7335,Burkitt Lymphoma,0.7311,Aggressive B-Cell Non-Hodgkin Lymphoma,0.7273,B-CELL NON-HODGKIN LYMPHOMA,True,True,True
"B-CELL, HODGKINS",Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,0.7957,Classic Hodgkin Lymphoma,0.7583,Hodgkin's Granuloma,0.7269,Hodgkin's Sarcoma,0.7193,Cerebral Hodgkin Lymphoma,0.7091,Hodgkin Lymphoma by Clinical Course,0.7015,Hodgkin's Paragranuloma,0.6930,Adult Hodgkin Lymphoma,0.6929,Primary Bone Hodgkin Lymphoma,0.6927,Childhood Hodgkin Lymphoma,0.6879,Advanced Hodgkin Lymphoma,0.6830,Lung Hodgkin Lymphoma,0.6741,Gastric Hodgkin Lymphoma,0.6711,B-Cell Non-Hodgkin Lymphoma,0.6670,Hodgkin's Lymphoma (Antiquated),0.6668,Primary Central Nervous System Hodgkin Lymphoma,0.6657,High Grade B-Cell Lymphoma,0.6626,Pharyngeal Hodgkin Lymphoma,0.6604,Colon Hodgkin Lymphoma,0.6563,Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma,0.6554,"B-CELL, HODGKINS",True,True,True
"B-CELL, NON-HODGKINS",B-Cell Non-Hodgkin Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma,0.8975,Mature B-Cell Non-Hodgkin Lymphoma,0.7983,Non-Burkitt's Lymphoma,0.7616,Low Grade B-Cell Non-Hodgkin's Lymphoma,0.7582,High Grade B-Cell Non-Hodgkin's Lymphoma,0.7494,Indolent B-Cell Non-Hodgkin Lymphoma,0.7340,Non-Hodgkin Lymphoma,0.7308,B-Cell Neoplasm,0.7098,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.6922,B-Cell Leukemia,0.6907,Primary Central Nervous System B-Cell Non-Hodgkin Lymphoma,0.6878,Aggressive B-Cell Non-Hodgkin Lymphoma,0.6745,"Monoclonal B-Cell Lymphocytosis, Non-Chronic Lymphocytic Leukemia Type",0.6738,B-Cell Malignant Neoplasm,0.6595,Mature B-Cell Neoplasm,0.6588,Classical Burkitt Lymphoma,0.6563,"Malignant Lymphoma, Non-Cleaved Cell Type",0.6542,"Malignant Lymphoma, Non-Cleaved, Diffuse",0.6480,B Lymphoblastic Lymphoma,0.6471,B-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,0.6456,"B-CELL, NON-HODGKINS",True,True,True
B-CELL_ALL,B Acute Lymphoblastic Leukemia,11,2,B-Cell Leukemia,0.8260,B Lymphoblastic Lymphoma,0.7737,B-Cell Neoplasm,0.7682,B-Cell Malignant Neoplasm,0.7565,Burkitt Leukemia,0.7486,Classical Burkitt Lymphoma,0.7363,B Lymphoblastic Leukemia/Lymphoma,0.7340,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7290,Burkitt Lymphoma,0.7275,Pre T-ALL,0.7232,B Acute Lymphoblastic Leukemia,0.7203,B-Cell Non-Hodgkin Lymphoma,0.7203,Mature T-ALL,0.7128,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7041,Mature B-Cell Neoplasm,0.6993,Non-Burkitt's Lymphoma,0.6914,Advanced B-Cell Malignant Neoplasm,0.6769,Childhood B Lymphoblastic Lymphoma,0.6768,Cutaneous B Lymphoblastic Leukemia/Lymphoma,0.6741,Childhood Burkitt Leukemia,0.6734,B-CELL_ALL,False,False,False
B-CELL_LYMPHOMA_OTHER,B-Cell Neoplasm,2,2,B-Cell Non-Hodgkin Lymphoma,0.7796,B-Cell Neoplasm,0.7538,Non-Burkitt's Lymphoma,0.7339,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7172,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7156,B-Cell Leukemia,0.7041,B Lymphoblastic Lymphoma,0.7020,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.7017,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.6978,Classical Burkitt Lymphoma,0.6790,B-Cell Malignant Neoplasm,0.6766,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0.6764,"Transformed B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma",0.6644,Burkitt Lymphoma,0.6642,"EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.6638,B Lymphoblastic Leukemia/Lymphoma,0.6598,Low Grade B-Cell Non-Hodgkin's Lymphoma,0.6586,Lymphoma,0.6566,Mature B-Cell Neoplasm,0.6471,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",0.6465,B-CELL_LYMPHOMA_OTHER,False,True,True
B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,B Lymphoblastic Leukemia/Lymphoma,1,2,B Lymphoblastic Leukemia/Lymphoma,0.9933,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.9326,B Lymphoblastic Lymphoma,0.9320,Childhood B Lymphoblastic Leukemia/Lymphoma,0.8881,B Acute Lymphoblastic Leukemia,0.8719,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.8612,Childhood B Lymphoblastic Lymphoma,0.8549,B-Cell Leukemia,0.8513,Burkitt Leukemia,0.8154,Lymphoblastic Lymphoma,0.8093,Adult B Lymphoblastic Lymphoma,0.8026,Cutaneous B Lymphoblastic Leukemia/Lymphoma,0.7962,B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities,0.7937,Childhood B Acute Lymphoblastic Leukemia,0.7909,Hypodiploid B Lymphoblastic Leukemia/Lymphoma,0.7887,Hyperdiploid B Lymphoblastic Leukemia/Lymphoma,0.7860,Acute Lymphoblastic Leukemia,0.7729,Splenic B Lymphoblastic Lymphoma,0.7695,Childhood Burkitt Leukemia,0.7618,B Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1-Like Features,0.7601,B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,True,True,True
B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T9;22Q34.1;Q11.2,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,1,2,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.8401,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.8036,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.7782,B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged,0.7740,B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1,0.7704,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Lymphoid Only Involvement,0.7693,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.7481,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged,0.7447,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Multilineage Involvement,0.7391,B Lymphoblastic Leukemia/Lymphoma,0.7363,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.7327,B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); TCF3-PBX1,0.7312,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified",0.7146,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.7137,B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1,0.7107,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7082,B Lymphoblastic Leukemia/Lymphoma with TCF3-HLF Rearrangement,0.7076,B Acute Lymphoblastic Leukemia with TCF3-HLF Rearrangement,0.7044,Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.7043,B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities,0.7020,B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T9;22Q34.1;Q11.2,True,True,True
B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T9;22Q34.1;Q11.2;BCR-ABL1,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,1,2,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9739,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.9450,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Lymphoid Only Involvement,0.9142,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.8998,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.8810,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Multilineage Involvement,0.8763,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.8357,Refractory B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.8353,Recurrent B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.8340,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.8249,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL1 Rearranged",0.8138,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified",0.8011,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL Class Rearranged",0.7951,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged,0.7769,B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged,0.7752,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, JAK-STAT Activated",0.7546,B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1,0.7529,"Recurrent B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.7520,B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); TCF3-PBX1,0.7482,"Refractory B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.7373,B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA WITH T9;22Q34.1;Q11.2;BCR-ABL1,True,True,True
"B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, BCR-ABL1 LIKE","B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",1,2,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.9945,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.9518,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified",0.9378,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL1 Rearranged",0.9109,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL Class Rearranged",0.8763,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, JAK-STAT Activated",0.8571,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.8514,"Refractory B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.8362,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.8126,"Recurrent B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.8088,B Lymphoblastic Leukemia/Lymphoma,0.7749,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.7695,Acute Myeloid Leukemia with BCR-ABL1,0.7673,B Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1-Like Features,0.7667,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.7596,B Lymphoblastic Leukemia/Lymphoma with Intrachromosomal Amplification of Chromosome 21,0.7594,B Acute Lymphoblastic Leukemia,0.7590,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 with Lymphoid Only Involvement,0.7578,B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities,0.7559,B Acute Lymphoblastic Leukemia with ETV6-RUNX1-Like Features,0.7493,"B-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, BCR-ABL1 LIKE",True,True,True
B-PROLYMPHOCYTIC_LEUKEMIA,B-Cell Prolymphocytic Leukemia,1,2,B-Cell Prolymphocytic Leukemia,0.9494,Prolymphocytic Leukemia,0.8465,Refractory B-Cell Prolymphocytic Leukemia,0.7457,B-Cell Leukemia,0.7372,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0.7365,B Lymphoblastic Leukemia/Lymphoma,0.7339,Recurrent B-Cell Prolymphocytic Leukemia,0.7285,T-Cell Prolymphocytic Leukemia,0.7067,B Lymphoblastic Lymphoma,0.7000,B Acute Lymphoblastic Leukemia,0.6858,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.6847,Pre-B Acute Lymphoblastic Leukemia,0.6789,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.6619,B Acute Lymphoblastic Leukemia with Germline Predisposition,0.6618,Hyperdiploid B Lymphoblastic Leukemia/Lymphoma,0.6604,Splenic Manifestation of Prolymphocytic Leukemia,0.6552,Plasma Cell Leukemia,0.6542,Burkitt Leukemia,0.6523,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0.6427,Childhood B Lymphoblastic Leukemia/Lymphoma,0.6392,B-PROLYMPHOCYTIC_LEUKEMIA,True,True,True
B1,Thymoma Type B1,1,2,Thymoma Type B1,0.6544,Malignant Type B1 Thymoma,0.6472,Neuroblastoma,0.6139,Branchioma,0.5939,Medulloblastoma,0.5865,Bilateral Retinoblastoma,0.5837,Retinoblastoma,0.5833,Bronchial Intraepithelial Neoplasia,0.5832,Stage IB Retinoblastoma,0.5827,Biliary Intraepithelial Neoplasia-1,0.5820,Astler-Coller B1 Colon Carcinoma,0.5818,Hereditary Neuroblastoma,0.5807,Astler-Coller B1 Colorectal Carcinoma,0.5781,Biliary Intraepithelial Neoplasia,0.5754,Leukemia,0.5746,Metastatic Benign Neoplasm,0.5696,Blastoma,0.5691,Childhood Neuroblastoma,0.5683,Meningioma,0.5661,Breast Lobular Neoplasia,0.5634,B1,True,True,True
B2,Thymoma Type B2,2,2,Branchioma,0.6634,Thymoma Type B2,0.6550,Malignant Type B2 Thymoma,0.6423,Neuroblastoma,0.6335,Astler-Coller B2 Colorectal Carcinoma,0.6333,Astler-Coller B2 Colon Carcinoma,0.6294,Astler-Coller B2 Rectal Carcinoma,0.6166,Stage 2B Neuroblastoma,0.6141,Barrett Adenocarcinoma,0.6106,Stage IIB Retinoblastoma,0.6103,Bilateral Retinoblastoma,0.6086,Stage B Prostate Cancer,0.6053,Bilateral Carcinoma,0.6040,Bilateral Breast Carcinoma,0.6004,Medulloblastoma,0.5980,Luminal B Breast Carcinoma,0.5942,Luminal B Prostate Carcinoma,0.5915,Retinal Neuroblastoma,0.5904,Regional Neuroblastoma,0.5892,Contralateral Breast Carcinoma,0.5842,B2,False,True,True
B3,Thymoma Type B3,1,2,Thymoma Type B3,0.6662,Astler-Coller B3 Colon Carcinoma,0.6403,Astler-Coller B3 Colorectal Carcinoma,0.6254,Grade 3b Malignant Neoplasm,0.6052,Astler-Coller B3 Rectal Carcinoma,0.5977,Neuroblastoma,0.5848,Stage 3 Neuroblastoma,0.5827,Barrett Adenocarcinoma,0.5771,Anatomic Stage III Breast Cancer AJCC v8,0.5768,Stage III Bladder Cancer AJCC v8,0.5737,Branchioma,0.5710,Regional Neuroblastoma,0.5688,Breast Adenocarcinoma,0.5679,Metastatic Breast Adenocarcinoma,0.5677,Stage IVB Bladder Cancer AJCC v8,0.5673,Adenocarcinoma,0.5667,Stage III Breast Cancer AJCC v6,0.5653,Hereditary Neuroblastoma,0.5640,Stage IIIB Retinoblastoma,0.5601,Metastatic Adenocarcinoma,0.5595,B3,True,True,True
BARRETT_ASSOCIATED_ADENOCARCINOMA,Barrett Adenocarcinoma,1,2,Barrett Adenocarcinoma,0.9283,Intraepithelial Neoplasia in Barrett Esophagus,0.7341,Bile Duct Adenocarcinoma,0.7194,Bladder Adenocarcinoma,0.7153,Adenocarcinoma,0.7057,Esophageal Adenocarcinoma,0.6999,Gastric Adenocarcinoma,0.6804,Intramucosal Adenocarcinoma,0.6783,Esophageal Intramucosal Adenocarcinoma,0.6762,"Bladder Adenocarcinoma, Not Otherwise Specified",0.6752,Bladder Enteric Type Adenocarcinoma,0.6746,Gastroesophageal Junction Adenocarcinoma,0.6726,Adenocarcinoma with Metaplasia,0.6726,Breast Adenocarcinoma,0.6703,Gallbladder Adenocarcinoma,0.6701,Goblet Cell Adenocarcinoma,0.6625,"Extrahepatic Bile Duct Adenocarcinoma, Intestinal Type",0.6622,Extrahepatic Bile Duct Adenocarcinoma,0.6614,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type",0.6589,"Gallbladder Adenocarcinoma, Biliary Type",0.6553,BARRETT_ASSOCIATED_ADENOCARCINOMA,True,True,True
BASAL CELL ADENOCARCINOMA,Salivary Gland Basal Cell Adenocarcinoma,4,2,Basal Cell Carcinoma,0.9171,Basal Cell Adenoma,0.8907,Basaloid Carcinoma,0.8615,Salivary Gland Basal Cell Adenocarcinoma,0.8547,Basal Cell Neoplasm,0.8518,Advanced Basal Cell Carcinoma,0.8388,Superficial Basal Cell Carcinoma,0.8253,Skin Basal Cell Carcinoma,0.8141,Prostate Basal Cell Carcinoma,0.8105,Basaloid Squamous Cell Carcinoma,0.8016,Basal Cell Ameloblastoma,0.7906,Basal-Like Breast Carcinoma,0.7781,Eyelid Basal Cell Carcinoma,0.7774,Anal Margin Basal Cell Carcinoma,0.7647,Anal Basaloid Carcinoma,0.7641,Cervical Adenoid Basal Carcinoma,0.7599,Basal-Like Prostate Carcinoma,0.7581,Lip Basal Cell Carcinoma,0.7533,Locally Advanced Basal Cell Carcinoma,0.7446,Metastatic Basal Cell Carcinoma,0.7443,BASAL CELL ADENOCARCINOMA,False,False,True
BASAL CELL CARCINOMA,Basal Cell Carcinoma,1,2,Basal Cell Carcinoma,1.0000,Skin Basal Cell Carcinoma,0.9262,Basaloid Carcinoma,0.9226,Superficial Basal Cell Carcinoma,0.9198,Basal Cell Neoplasm,0.9183,Basaloid Squamous Cell Carcinoma,0.8705,Basal Cell Adenoma,0.8682,Advanced Basal Cell Carcinoma,0.8667,Prostate Basal Cell Carcinoma,0.8414,Skin Infiltrating Basal Cell Carcinoma,0.8299,Eyelid Basal Cell Carcinoma,0.8169,Basal-Like Breast Carcinoma,0.8123,Skin Basaloid Squamous Cell Carcinoma,0.8048,Skin Keratotic Basal Cell Carcinoma,0.8028,Skin Follicular Basal Cell Carcinoma,0.7945,External Ear Basal Cell Carcinoma,0.7898,Penile Basal Cell Carcinoma,0.7872,Metastatic Basal Cell Carcinoma,0.7829,Lip Basal Cell Carcinoma,0.7825,Locally Advanced Basal Cell Carcinoma,0.7778,BASAL CELL CARCINOMA,True,True,True
BASAL-LIKE,Basal-Like Breast Carcinoma,1,2,Basal-Like Breast Carcinoma,0.7227,Basaloid Carcinoma,0.7018,Basal-Like Prostate Carcinoma,0.6828,Basal Cell Neoplasm,0.6802,Basal Cell Carcinoma,0.6716,Basal Cell Adenoma,0.6705,Basal Cell Ameloblastoma,0.6475,Basaloid Squamous Cell Carcinoma,0.6175,Advanced Basal Cell Carcinoma,0.6094,Superficial Basal Cell Carcinoma,0.6079,Skin Basal Cell Carcinoma,0.6008,Prostate Basal Cell Carcinoma,0.5942,Basal Ganglia Neoplasm,0.5867,Lung Basaloid Large Cell Carcinoma,0.5808,Eyelid Basal Cell Carcinoma,0.5796,Salivary Gland Basal Cell Adenocarcinoma,0.5783,Atypical Burkitt/Burkitt-Like Lymphoma,0.5676,Acanthoma,0.5658,Anal Basaloid Carcinoma,0.5651,Lip Basal Cell Carcinoma,0.5623,BASAL-LIKE,True,True,True
BASALOID LARGE CELL CARCINOMA OF THE LUNG,Lung Basaloid Large Cell Carcinoma,1,2,Lung Basaloid Large Cell Carcinoma,0.9693,Lung Basaloid Squamous Cell Carcinoma,0.8420,Lung Large Cell Carcinoma,0.7659,Lung Diffuse Large B-Cell Lymphoma,0.7139,Laryngeal Basaloid Squamous Cell Carcinoma,0.7098,"Lung Large Cell Carcinoma, Clear Cell Variant",0.6916,Occult Lung Large Cell Carcinoma,0.6885,Lung Mucoepidermoid Carcinoma,0.6688,Lung Giant Cell Carcinoma,0.6609,Lung Large Cell Neuroendocrine Carcinoma,0.6600,Basal-Like Breast Carcinoma,0.6575,Lung Large Cell Carcinoma by AJCC v7 Stage,0.6543,Lung Keratinizing Squamous Cell Carcinoma,0.6527,Lung Non-Keratinizing Squamous Cell Carcinoma,0.6526,Lung Large Cell Carcinoma with Rhabdoid Phenotype,0.6508,Basaloid Squamous Cell Carcinoma,0.6448,Lung Anaplastic Large Cell Lymphoma,0.6443,Basaloid Carcinoma,0.6433,"Breast Squamous Cell Carcinoma, Large Cell Keratinizing Variant",0.6406,Lung Lymphoepithelial Carcinoma,0.6369,BASALOID LARGE CELL CARCINOMA OF THE LUNG,True,True,True
BASALOID PENILE SQUAMOUS CELL CARCINOMA,Penile Basaloid Squamous Cell Carcinoma,1,2,Penile Basaloid Squamous Cell Carcinoma,0.9875,Penile Basal Cell Carcinoma,0.8738,Penile Papillary-Basaloid Carcinoma,0.8439,Penile Warty-Basaloid Carcinoma,0.8246,Penile Squamous Cell Carcinoma,0.8176,Basaloid Squamous Cell Carcinoma,0.7955,Penile Acantholytic Squamous Cell Carcinoma,0.7922,Prostate Basal Cell Carcinoma,0.7608,Penile Adenosquamous Carcinoma,0.7547,Cervical Basaloid Squamous Cell Carcinoma,0.7484,Penile Clear Cell Squamous Cell Carcinoma,0.7421,Skin Basaloid Squamous Cell Carcinoma,0.7409,Penile Sarcomatoid Carcinoma,0.7387,Penile Mixed Squamous Cell Carcinoma,0.7383,"Penile Squamous Cell Carcinoma, Usual Type",0.7316,Basaloid Carcinoma,0.7313,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,0.7241,Penile Verrucous Carcinoma,0.7200,"Penile Squamous Cell Carcinoma, Not Otherwise Specified",0.7167,Head and Neck Basaloid Squamous Cell Carcinoma,0.7157,BASALOID PENILE SQUAMOUS CELL CARCINOMA,True,True,True
BCP-ALL,B Acute Lymphoblastic Leukemia,3,2,B-Cell Leukemia,0.7604,Burkitt Leukemia,0.7356,B Acute Lymphoblastic Leukemia,0.7327,B Lymphoblastic Lymphoma,0.7302,Pre T-ALL,0.7232,Common Acute Lymphoblastic Leukemia,0.7205,Pre-B Acute Lymphoblastic Leukemia,0.7144,Classical Burkitt Lymphoma,0.7114,Childhood Burkitt Leukemia,0.7062,B Lymphoblastic Leukemia/Lymphoma,0.7036,Childhood B Lymphoblastic Lymphoma,0.7032,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7016,Childhood B Acute Lymphoblastic Leukemia,0.6943,Acute Lymphoblastic Leukemia,0.6932,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0.6924,Cutaneous B Lymphoblastic Leukemia/Lymphoma,0.6821,B-Cell Prolymphocytic Leukemia,0.6803,Childhood B Lymphoblastic Leukemia/Lymphoma,0.6803,CALLA Positive Lymphoblastic Leukemia,0.6764,Childhood Pre-B Acute Lymphoblastic Leukemia,0.6749,BCP-ALL,False,True,True
BCR-ABL1,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",4,2,Acute Myeloid Leukemia with BCR-ABL1,0.8355,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7909,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL1 Rearranged",0.7750,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.7661,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.7623,Myeloid/Lymphoid Neoplasms with ETV6-ABL1,0.7601,"Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive",0.7589,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, ABL Class Rearranged",0.7430,"Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive",0.7397,"Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7183,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Not Otherwise Specified",0.7179,"Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7096,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, JAK-STAT Activated",0.7092,"Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7025,"Chronic Phase Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive",0.6799,"Myeloproliferative Neoplasm, BCR-ABL1 Negative",0.6786,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.6729,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.6708,"Refractory B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.6609,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,0.6565,BCR-ABL1,False,False,True
BENIGN PHYLLODES TUMOR OF THE BREAST,Benign Breast Phyllodes Tumor,1,2,Benign Breast Phyllodes Tumor,0.9768,Benign Phyllodes Tumor,0.9293,Breast Phyllodes Tumor,0.9157,Borderline Breast Phyllodes Tumor,0.8993,Childhood Breast Phyllodes Tumor,0.8770,Benign Prostate Phyllodes Tumor,0.8617,Borderline Phyllodes Tumor,0.8528,Malignant Breast Phyllodes Tumor,0.8525,Phyllodes Tumor,0.8489,Prostate Phyllodes Tumor,0.7992,Malignant Phyllodes Tumor,0.7955,Benign Vulvar Phyllodes Tumor,0.7864,Phyllodes Tumor of Anogenital Mammary-Type Glands,0.7604,Malignant Prostate Phyllodes Tumor,0.7308,Vulvar Phyllodes Tumor,0.7179,Borderline Vulvar Phyllodes Tumor,0.7124,Refractory Malignant Phyllodes Tumor,0.6802,Malignant Vulvar Phyllodes Tumor,0.6536,Benign Breast Adenomyoepithelioma,0.6222,Benign Breast Neoplasm,0.6124,BENIGN PHYLLODES TUMOR OF THE BREAST,True,True,True
BENIGN PT,Benign Breast Phyllodes Tumor,99,2,Benign Neoplasm,0.7844,Benign Prostate Neoplasm,0.6908,Benign Parathyroid Gland Neoplasm,0.6901,Benign Pancreatic Neoplasm,0.6873,Benign Pericytic Neoplasm,0.6866,Benign Pharyngeal Neoplasm,0.6786,Benign Epithelial Neoplasm,0.6781,Benign Peritoneal Neoplasm,0.6755,Benign Placental Neoplasm,0.6683,Benign Endocrine Neoplasm,0.6681,Benign Thyroid Gland Neoplasm,0.6642,Benign Pleural Neoplasm,0.6612,Benign Stromal Tumor,0.6612,Benign Thoracic Neoplasm,0.6609,Benign Parotid Gland Neoplasm,0.6603,Benign Breast Neoplasm,0.6527,Benign Meningioma,0.6445,Benign Lymph Node Neoplasm,0.6407,Benign PEComa,0.6392,Benign Bone Neoplasm,0.6362,BENIGN PT,False,False,False
BENIGN_NEOPLASIA,Benign Neoplasm,1,2,Benign Neoplasm,0.8438,Non-Malignant Neoplasm,0.7508,Benign Epithelial Neoplasm,0.7480,"Neoplasm, Uncertain Whether Benign or Malignant",0.7222,Benign Bone Neoplasm,0.7081,Benign Endocrine Neoplasm,0.7011,Benign Breast Neoplasm,0.6898,Benign Stromal Tumor,0.6844,Premalignant Neoplasm,0.6763,Benign Lymph Node Neoplasm,0.6745,Neoplasm by Morphology,0.6738,Metastatic Benign Neoplasm,0.6728,Benign Urinary Tract Neoplasm,0.6727,Benign Blood Vessel Neoplasm,0.6722,Neoplasm of Uncertain Histogenesis,0.6721,Benign Brain Neoplasm,0.6689,Neoplastic Polyp,0.6646,Benign Urinary System Neoplasm,0.6630,Benign Musculoskeletal Neoplasm,0.6608,Benign Vascular Neoplasm,0.6582,BENIGN_NEOPLASIA,True,True,True
BILIARY TRACT CANCER,Liver Carcinoma,99,2,Biliary Tract Carcinoma,0.9679,Bile Duct Carcinoma,0.8821,Bile Duct Neoplasm,0.8348,Bile Duct Adenocarcinoma,0.8340,Advanced Biliary Tract Carcinoma,0.8282,Hepatobiliary Neoplasm,0.7720,Metastatic Biliary Tract Carcinoma,0.7641,Advanced Bile Duct Carcinoma,0.7579,Liver and Intrahepatic Bile Duct Carcinoma,0.7570,Locally Advanced Biliary Tract Carcinoma,0.7458,Cholangiolocellular Carcinoma,0.7427,Pancreatobiliary Carcinoma,0.7403,Cholangiocarcinoma,0.7337,"Gallbladder Adenocarcinoma, Biliary Type",0.7310,Unresectable Biliary Tract Carcinoma,0.7291,Distal Bile Duct Carcinoma,0.7284,Bile Duct Adenoma,0.7235,Malignant Hepatobiliary Neoplasm,0.7214,Liver and Intrahepatic Bile Duct Neoplasm,0.7177,Gallbladder Carcinoma,0.7133,BILIARY TRACT CANCER,False,False,False
"BILIARY TRACT CANCER, NOS",Liver Carcinoma,99,2,Biliary Tract Carcinoma,0.9315,Bile Duct Carcinoma,0.8490,Bile Duct Neoplasm,0.7987,Bile Duct Adenocarcinoma,0.7942,Advanced Biliary Tract Carcinoma,0.7890,Hepatobiliary Neoplasm,0.7388,Liver and Intrahepatic Bile Duct Carcinoma,0.7311,Cholangiolocellular Carcinoma,0.7199,Advanced Bile Duct Carcinoma,0.7188,Metastatic Biliary Tract Carcinoma,0.7184,Pancreatobiliary Carcinoma,0.7108,Locally Advanced Biliary Tract Carcinoma,0.7087,Malignant Hepatobiliary Neoplasm,0.7015,Liver and Intrahepatic Bile Duct Neoplasm,0.6958,Unresectable Biliary Tract Carcinoma,0.6920,"Gallbladder Adenocarcinoma, Biliary Type",0.6870,Distal Bile Duct Carcinoma,0.6748,Bile Duct Adenoma,0.6700,Metastatic Bile Duct Carcinoma,0.6672,Recurrent Biliary Tract Carcinoma,0.6563,"BILIARY TRACT CANCER, NOS",False,False,False
BIPHASIC MESOTHELIOMA,Biphasic Mesothelioma,1,2,Biphasic Mesothelioma,1.0000,Pleural Biphasic Mesothelioma,0.8972,Peritoneal Biphasic Mesothelioma,0.8724,Mesothelioma,0.8248,Multicystic Mesothelioma,0.7969,Diffuse Malignant Mesothelioma,0.7844,Malignant Mesothelioma,0.7840,Paratesticular Biphasic Mesothelioma,0.7817,Sarcomatoid Mesothelioma,0.7813,Epithelioid Mesothelioma,0.7768,Unresectable Pleural Biphasic Mesothelioma,0.7715,Unresectable Peritoneal Biphasic Mesothelioma,0.7497,Desmoplastic Mesothelioma,0.7389,Metastatic Malignant Mesothelioma,0.7272,Biphasic Synovial Sarcoma,0.7255,Pleural Mesothelioma,0.7208,Peritoneal Multicystic Mesothelioma,0.7206,Pleural Biphasic Synovial Sarcoma,0.7190,Localized Malignant Mesothelioma,0.7179,Advanced Epithelioid Mesothelioma,0.7167,BIPHASIC MESOTHELIOMA,True,True,True
BLADDER ADENOCARCINOMA,Bladder Adenocarcinoma,1,2,Bladder Adenocarcinoma,1.0000,Bladder Carcinoma,0.9108,"Bladder Adenocarcinoma, Not Otherwise Specified",0.8841,Bladder Mucinous Adenocarcinoma,0.8411,Urinary Tract Adenocarcinoma,0.8349,Metastatic Bladder Adenocarcinoma,0.8198,Malignant Bladder Neoplasm,0.8137,Bladder Clear Cell Adenocarcinoma,0.8082,Unresectable Bladder Adenocarcinoma,0.8028,Advanced Bladder Carcinoma,0.8004,Bladder Urothelial Carcinoma,0.7950,Bladder Neoplasm,0.7902,Locally Advanced Bladder Adenocarcinoma,0.7867,Bladder Enteric Type Adenocarcinoma,0.7859,Gallbladder Adenocarcinoma,0.7858,Bladder Mixed Adenocarcinoma,0.7843,Ureter Adenocarcinoma,0.7835,Breast Adenocarcinoma,0.7771,Invasive Bladder Carcinoma,0.7648,Urothelial Carcinoma,0.7635,BLADDER ADENOCARCINOMA,True,True,True
BLADDER CANCER,Bladder Carcinoma,1,2,Bladder Carcinoma,0.9502,Bladder Adenocarcinoma,0.8826,Bladder Neoplasm,0.8764,Malignant Bladder Neoplasm,0.8759,Bladder Urothelial Carcinoma,0.8289,"Bladder Adenocarcinoma, Not Otherwise Specified",0.8137,Invasive Bladder Carcinoma,0.8030,Advanced Bladder Carcinoma,0.7900,Childhood Bladder Carcinoma,0.7878,Urothelial Carcinoma,0.7725,Bladder Lymphoma,0.7725,Bladder Melanoma,0.7682,Urinary Tract Carcinoma,0.7655,Muscle Invasive Bladder Carcinoma,0.7535,Metastatic Bladder Carcinoma,0.7466,Urinary System Carcinoma,0.7422,Benign Bladder Neoplasm,0.7379,Unresectable Bladder Carcinoma,0.7367,Bladder Neuroendocrine Carcinoma,0.7355,Advanced Bladder Urothelial Carcinoma,0.7246,BLADDER CANCER,True,True,True
BLADDER SQUAMOUS CELL CARCINOMA,Bladder Squamous Cell Carcinoma,1,2,Bladder Squamous Cell Carcinoma,1.0000,Urinary Tract Squamous Cell Carcinoma,0.8458,Locally Advanced Bladder Squamous Cell Carcinoma,0.8194,Metastatic Bladder Squamous Cell Carcinoma,0.8131,Bladder Urothelial Carcinoma,0.7951,Bladder Carcinoma,0.7907,Unresectable Bladder Squamous Cell Carcinoma,0.7869,Invasive Bladder Urothelial Carcinoma with Squamous Differentiation,0.7680,Ureter Squamous Cell Carcinoma,0.7618,Bladder Clear Cell Adenocarcinoma,0.7474,Recurrent Bladder Squamous Cell Carcinoma,0.7400,Bladder Squamous Papilloma,0.7367,Bladder Adenocarcinoma,0.7277,Urachal Squamous Cell Carcinoma,0.7240,Bladder Neuroendocrine Carcinoma,0.7147,Transitional Cell Carcinoma,0.7144,Bladder Small Cell Neuroendocrine Carcinoma,0.7130,Urothelial Carcinoma,0.7127,Squamous Cell Carcinoma,0.7112,Urethral Squamous Cell Carcinoma,0.7081,BLADDER SQUAMOUS CELL CARCINOMA,True,True,True
BLADDER UROTHELIAL,Bladder Urothelial Carcinoma,1,2,Bladder Urothelial Carcinoma,0.8629,Bladder Urothelial Dysplasia,0.7999,Urothelial Carcinoma,0.7934,Invasive Bladder Urothelial Carcinoma,0.7691,Bladder Flat Urothelial Carcinoma,0.7627,Non-Invasive Bladder Urothelial Neoplasm,0.7602,Bladder Carcinoma,0.7595,Bladder Urothelial Papilloma,0.7576,Bladder Melanoma,0.7503,Invasive Urothelial Carcinoma,0.7478,Bladder Lymphoma,0.7454,Early Stage Bladder Urothelial Carcinoma,0.7430,Urothelial Neoplasm,0.7396,Urothelial Carcinoma In Situ,0.7392,"Bladder Urothelial Carcinoma, High Grade",0.7392,Advanced Bladder Urothelial Carcinoma,0.7343,Bladder Adenocarcinoma,0.7341,Malignant Bladder Neoplasm,0.7269,Ureter Urothelial Carcinoma,0.7265,Bladder Papillary Urothelial Carcinoma,0.7263,BLADDER UROTHELIAL,True,True,True
BLADDER UROTHELIAL CARCINOMA,Bladder Urothelial Carcinoma,1,2,Bladder Urothelial Carcinoma,1.0000,Urothelial Carcinoma,0.9236,Bladder Carcinoma,0.8921,Invasive Bladder Urothelial Carcinoma,0.8840,Ureter Urothelial Carcinoma,0.8518,Advanced Bladder Urothelial Carcinoma,0.8458,Invasive Urothelial Carcinoma,0.8458,Bladder Papillary Urothelial Carcinoma,0.8431,"Bladder Urothelial Carcinoma, High Grade",0.8358,Early Stage Bladder Urothelial Carcinoma,0.8287,Muscle Invasive Bladder Urothelial Carcinoma,0.8283,Invasive Bladder Conventional Urothelial Carcinoma,0.8220,Urethral Urothelial Carcinoma,0.8185,Invasive Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,0.8098,Bladder Flat Urothelial Carcinoma,0.8082,Invasive Bladder Carcinoma,0.8080,Invasive Conventional Urothelial Carcinoma,0.8027,Invasive Bladder Microcystic Urothelial Carcinoma,0.8012,Non-Muscle Invasive Bladder Urothelial Carcinoma,0.7990,Invasive Bladder Tubular Urothelial Carcinoma,0.7973,BLADDER UROTHELIAL CARCINOMA,True,True,True
BLADDER/URINARY TRACT CANCER,Bladder Carcinoma,2,2,Urinary Tract Carcinoma,0.8409,Bladder Carcinoma,0.8010,Urinary System Carcinoma,0.7931,Bladder Neoplasm,0.7919,Urinary Tract Neoplasm,0.7752,Malignant Bladder Neoplasm,0.7605,Urinary Tract Adenocarcinoma,0.7542,Bladder Urothelial Carcinoma,0.7531,Malignant Urinary Tract Neoplasm,0.7521,Urinary System Neoplasm,0.7514,Bladder Adenocarcinoma,0.7296,Malignant Urinary System Neoplasm,0.7200,Urothelial Neoplasm,0.7159,"Bladder Adenocarcinoma, Not Otherwise Specified",0.7146,Urothelial Carcinoma,0.7116,Genitourinary System Carcinoma,0.7004,Childhood Bladder Carcinoma,0.6926,Kidney and Ureter Neoplasm,0.6884,Unresectable Bladder Carcinoma,0.6821,Urachal Urothelial Carcinoma,0.6784,BLADDER/URINARY TRACT CANCER,False,True,True
"BLADDER/URINARY TRACT CANCER, NOS",Malignant Urinary System Neoplasm,12,2,Urinary Tract Carcinoma,0.8018,Bladder Carcinoma,0.7718,Bladder Neoplasm,0.7703,Urinary System Carcinoma,0.7551,Urinary Tract Neoplasm,0.7412,Malignant Bladder Neoplasm,0.7409,Bladder Urothelial Carcinoma,0.7304,Malignant Urinary Tract Neoplasm,0.7208,"Bladder Adenocarcinoma, Not Otherwise Specified",0.7191,Urinary System Neoplasm,0.7156,Urinary Tract Adenocarcinoma,0.7089,Malignant Urinary System Neoplasm,0.6897,Bladder Adenocarcinoma,0.6891,Urothelial Neoplasm,0.6782,Genitourinary System Carcinoma,0.6724,Urothelial Carcinoma,0.6707,Childhood Bladder Carcinoma,0.6650,Unresectable Bladder Carcinoma,0.6512,Kidney and Ureter Neoplasm,0.6479,Renal Pelvis and Ureter Urothelial Carcinoma,0.6455,"BLADDER/URINARY TRACT CANCER, NOS",False,False,False
BLADDER_CANCER,Bladder Carcinoma,1,2,Bladder Carcinoma,0.8937,Malignant Bladder Neoplasm,0.8437,Bladder Neoplasm,0.8403,Bladder Adenocarcinoma,0.8235,"Bladder Adenocarcinoma, Not Otherwise Specified",0.8198,Bladder Urothelial Carcinoma,0.7869,Invasive Bladder Carcinoma,0.7531,Urinary Tract Carcinoma,0.7479,Bladder Lymphoma,0.7469,Childhood Bladder Carcinoma,0.7405,Advanced Bladder Carcinoma,0.7398,Bladder Melanoma,0.7336,Urothelial Carcinoma,0.7303,Urinary System Carcinoma,0.7253,Unresectable Bladder Carcinoma,0.7192,Muscle Invasive Bladder Carcinoma,0.7166,Bladder Neuroendocrine Carcinoma,0.7124,Benign Bladder Neoplasm,0.7075,Urinary Tract Adenocarcinoma,0.7044,Metastatic Bladder Carcinoma,0.7015,BLADDER_CANCER,True,True,True
BLADDER_CARCINOMA,Bladder Carcinoma,1,2,Bladder Carcinoma,0.9541,Bladder Adenocarcinoma,0.8677,Bladder Urothelial Carcinoma,0.8524,"Bladder Adenocarcinoma, Not Otherwise Specified",0.8420,Malignant Bladder Neoplasm,0.8352,Invasive Bladder Carcinoma,0.8086,Urothelial Carcinoma,0.8067,Bladder Neoplasm,0.7965,Urinary Tract Carcinoma,0.7914,Advanced Bladder Carcinoma,0.7873,Urinary System Carcinoma,0.7641,Childhood Bladder Carcinoma,0.7508,Unresectable Bladder Carcinoma,0.7484,Bladder Squamous Cell Carcinoma,0.7481,Muscle Invasive Bladder Carcinoma,0.7481,Invasive Bladder Urothelial Carcinoma,0.7457,Advanced Bladder Urothelial Carcinoma,0.7452,Metastatic Bladder Carcinoma,0.7417,Urinary Tract Adenocarcinoma,0.7378,Bladder Lymphoma,0.7374,BLADDER_CARCINOMA,True,True,True
BLADDER_SQUAMOUS,Bladder Squamous Cell Carcinoma,1,2,Bladder Squamous Cell Carcinoma,0.7845,Bladder Squamous Papilloma,0.7594,Bladder Carcinoma,0.6935,Invasive Bladder Urothelial Carcinoma with Squamous Differentiation,0.6838,Bladder Sarcoma,0.6806,Bladder Adenocarcinoma,0.6803,"Bladder Adenocarcinoma, Not Otherwise Specified",0.6798,Stage 0 Bladder Squamous Cell Carcinoma AJCC v6 and v7,0.6773,Malignant Bladder Neoplasm,0.6739,Benign Bladder Neoplasm,0.6724,Bladder Melanoma,0.6667,Urinary Tract Squamous Cell Carcinoma,0.6661,Bladder Lymphoma,0.6651,Bladder Urothelial Carcinoma,0.6479,Locally Advanced Bladder Squamous Cell Carcinoma,0.6473,Unresectable Bladder Squamous Cell Carcinoma,0.6449,Benign Squamous Cell Neoplasm,0.6432,Bladder Neoplasm,0.6428,Bladder Mucinous Adenocarcinoma,0.6405,Bladder Malignant PEComa,0.6371,BLADDER_SQUAMOUS,True,True,True
BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM,Blastic Plasmacytoid Dendritic Cell Neoplasm,1,2,Blastic Plasmacytoid Dendritic Cell Neoplasm,1.0000,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,0.8338,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,0.7677,Mature Plasmacytoid Dendritic Cell Proliferation Associated with Myeloid Neoplasm,0.7232,Plasmablastic Lymphoma,0.7070,Blastic Granulocytic Sarcoma,0.7069,Blast Phase Myeloproliferative Neoplasm,0.6908,Burkitt Lymphoma with Plasmacytoid Differentiation,0.6774,Blastoid Variant Mantle Cell Lymphoma,0.6659,Primary Cutaneous Plasmablastic Lymphoma,0.6635,Biphasic Pulmonary Blastoma,0.6550,Blastoma,0.6523,Plasma Cell Leukemia,0.6494,Anaplastic Plasmacytoma,0.6491,Plasmacytoma,0.6471,Plasma Cell Neoplasm,0.6410,Pleuropulmonary Blastoma,0.6387,Pulmonary Blastoma,0.6342,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,0.6339,High Grade B-Cell Lymphoma with Blastoid Morphologic Features,0.6322,BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM,True,True,True
BLAST_PHASE_CHRONIC_MYELOID_LEUKAEMIA,"Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",3,2,Blast Phase Myeloproliferative Neoplasm,0.7636,Blast Phase Primary Myelofibrosis,0.7313,"Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7218,Blastic Granulocytic Sarcoma,0.6630,"Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.6416,Chronic Phase Primary Myelofibrosis,0.6325,Leukemic Phase of Non-Hodgkin Lymphoma,0.6323,Chronic Leukemia,0.6181,Atypical Chronic Myeloid Leukemia,0.6179,Chronic Monocytic Leukemia,0.6155,"Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.6131,Myelodysplastic Chronic Myelomonocytic Leukemia,0.6070,Myeloproliferative Chronic Myelomonocytic Leukemia,0.6054,Accelerated Phase Primary Myelofibrosis,0.5965,Stage B Chronic Lymphocytic Leukemia,0.5936,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.5927,Blastoma,0.5926,Acute Myeloid Leukemia with Maturation,0.5847,Chronic Myelomonocytic Leukemia,0.5827,Accelerated Phase Myeloproliferative Neoplasm,0.5783,BLAST_PHASE_CHRONIC_MYELOID_LEUKAEMIA,False,True,True
BLCA,Bladder Urothelial Carcinoma,1,2,Bladder Urothelial Carcinoma,1.0000,Urothelial Carcinoma,0.9236,Bladder Carcinoma,0.8921,Invasive Bladder Urothelial Carcinoma,0.8840,Ureter Urothelial Carcinoma,0.8518,Advanced Bladder Urothelial Carcinoma,0.8458,Invasive Urothelial Carcinoma,0.8458,Bladder Papillary Urothelial Carcinoma,0.8431,"Bladder Urothelial Carcinoma, High Grade",0.8358,Early Stage Bladder Urothelial Carcinoma,0.8287,Muscle Invasive Bladder Urothelial Carcinoma,0.8283,Invasive Bladder Conventional Urothelial Carcinoma,0.8220,Urethral Urothelial Carcinoma,0.8185,Invasive Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,0.8098,Bladder Flat Urothelial Carcinoma,0.8082,Invasive Bladder Carcinoma,0.8080,Invasive Conventional Urothelial Carcinoma,0.8027,Invasive Bladder Microcystic Urothelial Carcinoma,0.8012,Non-Muscle Invasive Bladder Urothelial Carcinoma,0.7990,Invasive Bladder Tubular Urothelial Carcinoma,0.7973,Bladder Urothelial Carcinoma,True,True,True
BLL,B Lymphoblastic Leukemia/Lymphoma,1,2,B Lymphoblastic Leukemia/Lymphoma,0.9933,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.9326,B Lymphoblastic Lymphoma,0.9320,Childhood B Lymphoblastic Leukemia/Lymphoma,0.8881,B Acute Lymphoblastic Leukemia,0.8719,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.8612,Childhood B Lymphoblastic Lymphoma,0.8549,B-Cell Leukemia,0.8513,Burkitt Leukemia,0.8154,Lymphoblastic Lymphoma,0.8093,Adult B Lymphoblastic Lymphoma,0.8026,Cutaneous B Lymphoblastic Leukemia/Lymphoma,0.7962,B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities,0.7937,Childhood B Acute Lymphoblastic Leukemia,0.7909,Hypodiploid B Lymphoblastic Leukemia/Lymphoma,0.7887,Hyperdiploid B Lymphoblastic Leukemia/Lymphoma,0.7860,Acute Lymphoblastic Leukemia,0.7729,Splenic B Lymphoblastic Lymphoma,0.7695,Childhood Burkitt Leukemia,0.7618,B Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1-Like Features,0.7601,B-Lymphoblastic Leukemia/Lymphoma,True,True,True
BLOOD CANCER,Liquid Tumor,99,2,Malignant Blood Vessel Neoplasm,0.7235,Carcinoma,0.7106,Blood Vessel Neoplasm,0.7020,Carcinomatosis,0.6800,Malignant Neoplasm,0.6796,Breast Carcinoma,0.6761,Cardiovascular Neoplasm,0.6718,Ear Carcinoma,0.6690,Erythroid Neoplasm,0.6689,Bilateral Carcinoma,0.6625,Adenocarcinoma,0.6578,Bladder Carcinoma,0.6572,Eye Carcinoma,0.6560,Brain Stem Neoplasm,0.6514,Skin Carcinoma,0.6508,Secondary Carcinoma,0.6504,Malignant Cardiovascular Neoplasm,0.6474,Carcinoma Simplex,0.6441,Malignant Brain Stem Neoplasm,0.6410,Solid Carcinoma,0.6410,BLOOD CANCER,False,False,False
"BLOOD CANCER, NOS",Liquid Tumor,99,2,Malignant Blood Vessel Neoplasm,0.6882,Blood Vessel Neoplasm,0.6569,Erythroid Neoplasm,0.6256,Carcinoma Unspecified Site,0.6202,Malignant Neoplasm,0.6077,Cardiovascular Neoplasm,0.6061,Carcinomatosis,0.6045,Carcinoma,0.6040,Malignant Cardiovascular Neoplasm,0.5997,B-Cell Malignant Neoplasm,0.5992,Brain Stem Neoplasm,0.5976,Malignant Brain Stem Neoplasm,0.5962,Myeloid Neoplasm,0.5922,B-Cell Neoplasm,0.5897,Bone Marrow Neoplasm,0.5892,Breast Carcinoma,0.5796,Malignant Bone Neoplasm,0.5766,Skin Carcinoma,0.5761,B-Cell Leukemia,0.5747,Malignant Vascular Neoplasm,0.5727,"BLOOD CANCER, NOS",False,False,False
BLUE NEVUS,Blue Nevus,1,2,Blue Nevus,1.0000,Common Blue Nevus,0.9483,Childhood Blue Nevus,0.8824,Cellular Blue Nevus,0.8764,Vaginal Blue Nevus,0.8578,Conjunctival Blue Nevus,0.8558,Dendritic Blue Nevus,0.8528,Cervical Blue Nevus,0.8520,Melanoma Arising in Blue Nevus,0.8247,Sclerosing Blue Nevus,0.8224,Vulvar Blue Nevus,0.8127,Nevus,0.7973,Iris Nevus,0.7943,Pigmented Nevus,0.7712,Cutaneous Nevus,0.7627,Childhood Cutaneous Nevus,0.7393,Choroid Nevus,0.7333,Conjunctival Nevus,0.7291,Uveal Nevus,0.7258,Vaginal Nevus,0.7197,BLUE NEVUS,True,True,True
BONE CANCER,Malignant Bone Neoplasm,1,2,Malignant Bone Neoplasm,0.8589,Bone Neoplasm,0.8468,Metastatic Carcinoma in the Bone,0.7548,Osteogenic Neoplasm,0.7205,Osteoma,0.7196,Bone Osteosarcoma,0.7059,Metastatic Malignant Neoplasm in the Bone,0.7030,Jaw Osteoma,0.6968,Primary Bone Lymphoma,0.6868,Osteosarcoma,0.6819,Childhood Malignant Bone Neoplasm,0.6806,Osteoblastoma,0.6797,Jaw Osteosarcoma,0.6752,Breast Carcinoma with Osseous Metaplasia,0.6750,Central Osteoma,0.6747,Malignant Neoplasm,0.6731,Intermediate Bone Neoplasm,0.6711,Bone Cancer by AJCC v8 Stage,0.6692,Breast Carcinoma,0.6687,Malignant Bone Marrow Neoplasm,0.6686,BONE CANCER,True,True,True
BONE SARCOMA,Bone Sarcoma,1,2,Bone Sarcoma,1.0000,Sarcoma,0.9162,Sarcomatosis,0.8325,Childhood Bone Sarcoma,0.8131,Myeloid Sarcoma,0.8042,Advanced Bone Sarcoma,0.7953,Skin Sarcoma,0.7953,Soft Tissue Sarcoma,0.7951,Synovial Sarcoma,0.7908,Metastatic Bone Sarcoma,0.7859,Breast Sarcoma,0.7783,Stromal Sarcoma,0.7772,Childhood Sarcoma,0.7716,Unresectable Bone Sarcoma,0.7694,Brain Sarcoma,0.7660,Cardiac Sarcoma,0.7625,Kidney Sarcoma,0.7625,Sarcoma of the Extremity,0.7545,Sarcoma GX,0.7523,Prostate Sarcoma,0.7521,BONE SARCOMA,True,True,True
BONE SARCOMA OTHER,Bone Sarcoma,1,2,Bone Sarcoma,0.8579,Unresectable Bone Sarcoma,0.7688,Advanced Bone Sarcoma,0.7645,Sarcoma,0.7605,Metastatic Bone Sarcoma,0.7553,Sarcomatosis,0.7316,Unresectable Sarcoma,0.7263,Childhood Bone Sarcoma,0.7235,Brain Sarcoma,0.7000,Advanced Sarcoma,0.6994,"Undifferentiated Sarcoma, Not Otherwise Specified",0.6957,Bone Osteosarcoma,0.6950,Metastatic Sarcoma,0.6932,Conventional Osteosarcoma,0.6921,Breast Sarcoma,0.6822,Extraskeletal Osteosarcoma,0.6817,Secondary Osteosarcoma,0.6800,Myeloid Sarcoma,0.6781,Soft Tissue Sarcoma,0.6745,Osteosarcoma,0.6740,BONE SARCOMA OTHER,True,True,True
BONE_CANCER,Malignant Bone Neoplasm,1,2,Malignant Bone Neoplasm,0.8307,Bone Neoplasm,0.8082,Metastatic Carcinoma in the Bone,0.7307,Osteogenic Neoplasm,0.7009,Metastatic Malignant Neoplasm in the Bone,0.6848,Malignant Bone Marrow Neoplasm,0.6727,Bone Cancer by AJCC v8 Stage,0.6701,Bone Marrow Neoplasm,0.6687,Osteoma,0.6667,Bone Osteosarcoma,0.6656,Malignant Neoplasm,0.6627,Breast Carcinoma with Osseous Metaplasia,0.6565,Childhood Malignant Bone Neoplasm,0.6553,Osteosarcoma,0.6475,Primary Bone Lymphoma,0.6447,Intermediate Bone Neoplasm,0.6430,Adenocarcinoma with Osseous Metaplasia,0.6418,Vascular Bone Neoplasm,0.6387,Jaw Osteoma,0.6365,Bone Sarcoma,0.6360,BONE_CANCER,True,True,True
BORDERLINE PHYLLODES TUMOR OF THE BREAST,Borderline Breast Phyllodes Tumor,1,2,Borderline Breast Phyllodes Tumor,0.9771,Borderline Phyllodes Tumor,0.9187,Benign Breast Phyllodes Tumor,0.8915,Breast Phyllodes Tumor,0.8870,Childhood Breast Phyllodes Tumor,0.8583,Malignant Breast Phyllodes Tumor,0.8449,Benign Phyllodes Tumor,0.8277,Phyllodes Tumor,0.8029,Benign Prostate Phyllodes Tumor,0.7962,Malignant Phyllodes Tumor,0.7850,Prostate Phyllodes Tumor,0.7772,Borderline Vulvar Phyllodes Tumor,0.7725,Refractory Malignant Phyllodes Tumor,0.7460,Phyllodes Tumor of Anogenital Mammary-Type Glands,0.7385,Malignant Prostate Phyllodes Tumor,0.7308,Benign Vulvar Phyllodes Tumor,0.7009,Vulvar Phyllodes Tumor,0.6770,Borderline Broad Ligament Serous Tumor,0.6645,Malignant Vulvar Phyllodes Tumor,0.6378,Borderline Ovarian Brenner Tumor,0.6272,BORDERLINE PHYLLODES TUMOR OF THE BREAST,True,True,True
BORDERLINE PT,Borderline Breast Phyllodes Tumor,11,2,Borderline Exocrine Pancreatic Neoplasm,0.7001,Borderline Papillary Cystadenoma,0.6859,Borderline Ovarian Epithelial Tumor,0.6824,Borderline Peritoneal Serous Tumor,0.6797,Borderline Cystadenoma,0.6761,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,0.6709,Borderline Ovarian Serous Tumor,0.6522,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,0.6454,Borderline Ovarian Mucinous Tumor,0.6391,Borderline Papillary Mucinous Cystadenoma,0.6365,Borderline Breast Phyllodes Tumor,0.6364,Borderline Broad Ligament Serous Tumor,0.6337,Aggressive Papillary Tumor,0.6315,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,0.6309,Borderline Papillary Serous Cystadenoma,0.6295,Atypical Parathyroid Gland Tumor,0.6268,Borderline Ovarian Serous Surface Papillary Tumor,0.6262,Borderline Fallopian Tube Neoplasm,0.6223,Borderline Phyllodes Tumor,0.6151,Atypical Adenoma,0.6141,BORDERLINE PT,False,False,False
BOTRYOID,Botryoid-Type Embryonal Rhabdomyosarcoma,1,2,Botryoid-Type Embryonal Rhabdomyosarcoma,0.6902,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,0.6708,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,0.6269,Childhood Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma,0.5877,Childhood Vulvar Botryoid-Type Embryonal Rhabdomyosarcoma,0.5761,Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma,0.5708,Branchioma,0.5706,Intramuscular Myxoma,0.5615,Myxoma,0.5551,Rhabdomyoma,0.5454,Adult Vaginal Botryoid-Type Embryonal Rhabdomyosarcoma,0.5437,Cervical Rhabdomyoma,0.5410,Differentiated Retinoblastoma,0.5346,Cardiac Myxoma,0.5336,Intraocular Retinoblastoma,0.5332,Chordoma,0.5314,Retinoblastoma,0.5310,Teratoma,0.5290,Childhood Rhabdomyoma,0.5246,Classic Rhabdomyoma,0.5234,BOTRYOID,True,True,True
"BOWEL CANCER, NOS",Malignant Intestinal Neoplasm,1,2,Malignant Intestinal Neoplasm,0.7622,Intestinal Neoplasm,0.7571,Gastrointestinal Carcinomatosis,0.6983,Colorectal Neoplasm,0.6950,Colon Neoplasm,0.6908,Small Intestinal Carcinoma,0.6907,Intestinal-Type Adenocarcinoma,0.6888,Colorectal Carcinoma,0.6882,Colon Carcinoma,0.6820,Malignant Colorectal Neoplasm,0.6806,Malignant Colon Neoplasm,0.6760,Malignant Small Intestinal Neoplasm,0.6579,Small Intestinal Neoplasm,0.6571,Colorectal Adenocarcinoma,0.6511,Inflammatory Bowel Disease-Associated Colorectal Adenocarcinoma,0.6486,Colon Adenocarcinoma,0.6424,Small Intestinal Adenocarcinoma,0.6361,Cecum Neoplasm,0.6304,Digestive System Carcinoma,0.6296,Cecum Carcinoma,0.6186,"BOWEL CANCER, NOS",True,True,True
BRAIN CANCER,Malignant Brain Neoplasm,2,2,Brain Neoplasm,0.8861,Malignant Brain Neoplasm,0.8594,Cerebral Neoplasm,0.8146,Malignant Cerebral Neoplasm,0.7826,Brain Sarcoma,0.7707,Central Nervous System Carcinoma,0.7699,Intracranial Neoplasm,0.7597,Malignant Intracranial Neoplasm,0.7470,Childhood Malignant Brain Neoplasm,0.7415,Brain Glioblastoma,0.7384,Primary Brain Neoplasm,0.7384,Malignant Brain Glioma,0.7242,Metastatic Malignant Neoplasm in the Brain,0.7230,Localized Malignant Brain Neoplasm,0.7226,Adult Malignant Brain Neoplasm,0.7198,Childhood Brain Neoplasm,0.7158,Benign Brain Neoplasm,0.7057,Nervous System Neoplasm,0.7043,Central Nervous System Neoplasm,0.7038,Cerebral Glioblastoma,0.7014,BRAIN CANCER,False,True,True
BRAIN_CANCER,Malignant Brain Neoplasm,2,2,Brain Neoplasm,0.8227,Malignant Brain Neoplasm,0.8033,Cerebral Neoplasm,0.7467,Malignant Cerebral Neoplasm,0.7277,Brain Sarcoma,0.7264,Central Nervous System Carcinoma,0.7091,Intracranial Neoplasm,0.7005,Malignant Intracranial Neoplasm,0.6918,Childhood Malignant Brain Neoplasm,0.6888,Primary Brain Neoplasm,0.6808,Metastatic Malignant Neoplasm in the Brain,0.6793,Brain Glioblastoma,0.6781,Localized Malignant Brain Neoplasm,0.6710,Childhood Brain Neoplasm,0.6700,Malignant Brain Glioma,0.6646,Nervous System Neoplasm by Obsolete Classification,0.6638,Benign Brain Neoplasm,0.6615,Nervous System Neoplasm,0.6599,Intracranial Melanoma,0.6560,Malignant Nervous System Neoplasm,0.6555,BRAIN_CANCER,False,True,True
BRCA,Breast Carcinoma,4,2,Invasive Breast Carcinoma,1.0000,Invasive Breast Carcinoma of No Special Type,0.8875,Invasive Female Breast Carcinoma,0.8550,Breast Carcinoma,0.8507,Invasive Male Breast Carcinoma,0.8358,Invasive Carcinoma,0.8283,Invasive Breast Lobular Carcinoma,0.8229,Advanced Breast Carcinoma,0.7969,Invasive Breast Carcinoma by Histologic Grade,0.7901,Well Differentiated Invasive Breast Carcinoma,0.7897,Microinvasive Breast Carcinoma,0.7873,Breast Ductal Carcinoma,0.7833,Invasive Breast Papillary Carcinoma,0.7821,Poorly Differentiated Invasive Breast Carcinoma,0.7814,Sporadic Breast Carcinoma,0.7760,Invasive Bladder Carcinoma,0.7751,Early Stage Breast Carcinoma,0.7671,Breast Adenocarcinoma,0.7632,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7555,Invasive Cervical Carcinoma,0.7513,Invasive Breast Carcinoma,False,False,True
BRCA_HER2,HER2-Positive Breast Carcinoma,1,2,HER2-Positive Breast Carcinoma,0.7844,HER2-Negative Breast Carcinoma,0.7697,HER2-Low Breast Carcinoma,0.7571,Advanced HER2-Positive Breast Carcinoma,0.7245,Refractory HER2-Negative Breast Carcinoma,0.7197,Advanced HER2-Negative Breast Carcinoma,0.7169,Metastatic HER2-Negative Breast Carcinoma,0.7096,Bilateral Breast Carcinoma,0.7022,Refractory HER2-Positive Breast Carcinoma,0.7010,Unresectable HER2-Negative Breast Carcinoma,0.7006,Metastatic HER2-Positive Breast Carcinoma,0.6976,Early Stage HER2-Negative Breast Carcinoma,0.6950,Advanced HER2-Low Breast Carcinoma,0.6924,BRCA Hereditary Breast Carcinoma,0.6924,Metastatic HER2-Low Breast Carcinoma,0.6924,Metastatic BRCA Hereditary Breast Carcinoma,0.6897,Unresectable HER2-Positive Breast Carcinoma,0.6884,Recurrent HER2-Negative Breast Carcinoma,0.6871,Unresectable HER2-Low Breast Carcinoma,0.6825,BRCA-Associated Malignant Neoplasm,0.6745,BRCA_HER2,True,True,True
BRCA_LUMA,Luminal A Breast Carcinoma,99,2,BRCA-Associated Malignant Neoplasm,0.7479,BRCA Hereditary Breast Carcinoma,0.7042,Metastatic BRCA Hereditary Breast Carcinoma,0.6762,Breast Lymphoma,0.6581,BRCA Hereditary Ovarian Carcinoma,0.6508,Breast Sarcoma,0.6474,Basal-Like Breast Carcinoma,0.6319,Sporadic Breast Carcinoma,0.6318,Recurrent BRCA Hereditary Ovarian Carcinoma,0.6314,Breast Carcinoma,0.6306,Luminal B Breast Carcinoma,0.6291,Breast Burkitt Lymphoma,0.6269,Locally Recurrent Breast Carcinoma,0.6268,Locally Advanced Breast Carcinoma,0.6261,Breast Lobular Neoplasia,0.6245,Normal Breast-Like Subtype of Breast Carcinoma,0.6239,Breast Implant-Associated Anaplastic Large Cell Lymphoma,0.6217,Breast Diffuse Large B-Cell Lymphoma,0.6217,Bilateral Breast Carcinoma,0.6204,Breast Adenoma,0.6175,BRCA_LUMA,False,False,False
BRCA_LUMB,Luminal B Breast Carcinoma,9,2,BRCA-Associated Malignant Neoplasm,0.7208,BRCA Hereditary Breast Carcinoma,0.7096,Metastatic BRCA Hereditary Breast Carcinoma,0.6939,Breast Lymphoma,0.6689,Breast Burkitt Lymphoma,0.6462,BRCA Hereditary Ovarian Carcinoma,0.6455,Bilateral Breast Carcinoma,0.6437,Breast Diffuse Large B-Cell Lymphoma,0.6435,Luminal B Breast Carcinoma,0.6420,Breast Sarcoma,0.6373,Recurrent BRCA Hereditary Ovarian Carcinoma,0.6303,Basal-Like Breast Carcinoma,0.6302,Breast Lobular Neoplasia,0.6296,Normal Breast-Like Subtype of Breast Carcinoma,0.6292,Sporadic Breast Carcinoma,0.6288,Breast Carcinoma,0.6274,PALB2 Hereditary Breast Carcinoma,0.6235,Breast Melanoma,0.6203,Locally Recurrent Breast Carcinoma,0.6168,Breast Non-Hodgkin Lymphoma,0.6163,BRCA_LUMB,False,False,False
BRCA_NORMAL,Breast Carcinoma,99,2,BRCA-Associated Malignant Neoplasm,0.7301,Normal Breast-Like Subtype of Breast Carcinoma,0.7106,BRCA Hereditary Breast Carcinoma,0.7009,BRCA Hereditary Ovarian Carcinoma,0.6651,Metastatic BRCA Hereditary Breast Carcinoma,0.6518,Sporadic Breast Carcinoma,0.6482,Hereditary Breast Carcinoma,0.6351,Occult Breast Carcinoma,0.6291,Benign Neoplasm,0.6233,Recurrent BRCA Hereditary Ovarian Carcinoma,0.6194,Female Breast Carcinoma In Situ,0.6189,Benign Breast Neoplasm,0.6169,Male Breast Carcinoma In Situ,0.6140,Invasive Breast Carcinoma of No Special Type,0.6135,Hereditary Neuroblastoma,0.6079,Breast Lobular Neoplasia,0.6076,Stage 0 Breast Cancer AJCC v6 and v7,0.6071,Triple-Negative Breast Carcinoma,0.6070,Anatomic Stage 0 Breast Cancer AJCC v8,0.6041,Contralateral Breast Carcinoma,0.6025,BRCA_NORMAL,False,False,False
BREAST ANGIOSARCOMA,Breast Angiosarcoma,1,2,Breast Angiosarcoma,1.0000,Primary Breast Angiosarcoma,0.9593,Breast Angiomatosis,0.8641,Recurrent Breast Angiosarcoma,0.8536,Angiosarcoma,0.8352,Cardiac Angiosarcoma,0.8122,Bone Angiosarcoma,0.8083,Breast Hemangioma,0.8043,Conventional Angiosarcoma,0.8007,Uterine Angiosarcoma,0.7993,Postradiation Breast Angiosarcoma,0.7948,Adult Angiosarcoma,0.7869,Localized Angiosarcoma,0.7803,Bladder Angiosarcoma,0.7780,Breast Vascular Neoplasm,0.7746,Cervical Angiosarcoma,0.7720,Breast Capillary Hemangioma,0.7688,Soft Tissue Angiosarcoma,0.7609,Skin Angiosarcoma,0.7588,Breast Angiolipoma,0.7571,BREAST ANGIOSARCOMA,True,True,True
BREAST CANCER,Breast Carcinoma,1,2,Breast Carcinoma,0.9535,Breast Neoplasm,0.8752,Breast Adenocarcinoma,0.8751,Malignant Breast Neoplasm,0.8715,Female Breast Carcinoma,0.8381,Sporadic Breast Carcinoma,0.8379,Breast Ductal Carcinoma,0.8280,Invasive Breast Carcinoma,0.8148,Advanced Breast Carcinoma,0.8037,Childhood Breast Carcinoma,0.8030,Breast Lymphoma,0.8011,Occult Breast Carcinoma,0.7926,Male Breast Carcinoma,0.7804,Metastatic Breast Carcinoma,0.7749,Localized Breast Carcinoma,0.7725,Unresectable Breast Carcinoma,0.7649,Early Stage Breast Carcinoma,0.7648,Breast Inflammatory Carcinoma,0.7642,Childhood Malignant Breast Neoplasm,0.7604,Hereditary Breast Carcinoma,0.7582,BREAST CANCER,True,True,True
"BREAST CANCER, NOS",Breast Carcinoma,1,2,Breast Carcinoma,0.8861,Malignant Breast Neoplasm,0.8271,Breast Neoplasm,0.8127,Breast Adenocarcinoma,0.7913,Breast Ductal Carcinoma,0.7896,Invasive Breast Carcinoma,0.7732,Sporadic Breast Carcinoma,0.7646,Female Breast Carcinoma,0.7628,Advanced Breast Carcinoma,0.7324,Childhood Breast Carcinoma,0.7314,Invasive Breast Carcinoma of No Special Type,0.7277,Childhood Malignant Breast Neoplasm,0.7124,Male Breast Carcinoma,0.7100,Breast Lymphoma,0.7010,Metastatic Breast Carcinoma,0.7007,Occult Breast Carcinoma,0.7001,Hereditary Breast Carcinoma,0.6929,Early Stage Breast Carcinoma,0.6918,Childhood Breast Neoplasm,0.6875,Breast Inflammatory Carcinoma,0.6858,"BREAST CANCER, NOS",True,True,True
BREAST CARCINOMA,Breast Carcinoma,1,2,Breast Carcinoma,1.0000,Breast Adenocarcinoma,0.9011,Female Breast Carcinoma,0.8749,Breast Ductal Carcinoma,0.8735,Malignant Breast Neoplasm,0.8577,Invasive Breast Carcinoma,0.8507,Sporadic Breast Carcinoma,0.8425,Advanced Breast Carcinoma,0.8365,Breast Neoplasm,0.8363,Male Breast Carcinoma,0.8277,Childhood Breast Carcinoma,0.8246,Breast Inflammatory Carcinoma,0.8042,Localized Breast Carcinoma,0.8014,Breast Tubular Carcinoma,0.8010,Breast Medullary Carcinoma,0.7946,Unresectable Breast Carcinoma,0.7928,Metastatic Breast Carcinoma,0.7926,Occult Breast Carcinoma,0.7920,Breast Lymphoma,0.7862,Bilateral Breast Carcinoma,0.7858,BREAST CARCINOMA,True,True,True
BREAST CARCINOMA OTHER,Breast Carcinoma,1,2,Breast Carcinoma,0.8544,Occult Breast Carcinoma,0.8012,Contralateral Breast Carcinoma,0.7826,Sporadic Breast Carcinoma,0.7800,Invasive Breast Carcinoma of No Special Type,0.7710,Breast Adenocarcinoma,0.7692,Unresectable Breast Carcinoma,0.7649,Female Breast Carcinoma,0.7583,Metastatic Breast Carcinoma,0.7582,Invasive Breast Carcinoma,0.7534,Advanced Breast Carcinoma,0.7519,Breast Neoplasm,0.7452,Male Breast Carcinoma,0.7449,Childhood Breast Carcinoma,0.7443,Breast Carcinoma with Osseous Metaplasia,0.7420,Breast Ductal Carcinoma,0.7416,Bilateral Breast Carcinoma,0.7351,Malignant Breast Neoplasm,0.7294,Breast Neuroendocrine Carcinoma,0.7270,Breast Inflammatory Carcinoma,0.7212,BREAST CARCINOMA OTHER,True,True,True
BREAST DUCTAL CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,1.0000,Breast Carcinoma,0.8735,Breast Adenocarcinoma,0.8337,Metastatic Breast Ductal Carcinoma,0.8252,Breast Ductal Adenoma,0.8229,Breast Ductal Carcinoma In Situ,0.8198,Breast Lobular Carcinoma,0.8054,Breast Ductal Carcinoma with Squamous Metaplasia,0.7847,Breast Acinic Cell Carcinoma,0.7839,Invasive Breast Carcinoma,0.7833,Breast Tubular Carcinoma,0.7816,Advanced Breast Carcinoma,0.7752,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7728,Female Breast Carcinoma,0.7720,Breast Mixed Ductal and Lobular Carcinoma,0.7702,Breast Secretory Carcinoma,0.7614,Nipple Duct Carcinoma,0.7610,Breast Inflammatory Carcinoma,0.7576,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.7575,Poorly Differentiated Invasive Breast Carcinoma,0.7570,BREAST DUCTAL CARCINOMA,True,True,True
BREAST DUCTAL CARCINOMA IN SITU,Breast Ductal Carcinoma In Situ,1,2,Breast Ductal Carcinoma In Situ,1.0000,"Breast Ductal Carcinoma In Situ, Low Grade",0.9040,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.8812,"Breast Ductal Carcinoma In Situ, High Grade",0.8770,"Breast Ductal Carcinoma In Situ, Non-Comedo Type",0.8724,"Breast Ductal Carcinoma In Situ, Solid Type",0.8679,Breast Papillary Ductal Carcinoma In Situ,0.8671,"Breast Ductal Carcinoma In Situ, Intermediate Grade",0.8655,Breast Lobular Carcinoma In Situ,0.8529,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.8469,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.8450,Breast Classic Lobular Carcinoma In Situ,0.8356,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.8292,Recurrent Breast Ductal Carcinoma In Situ,0.8240,Breast Ductal Carcinoma,0.8198,Breast Micropapillary Ductal Carcinoma In Situ,0.8171,Female Breast Carcinoma In Situ,0.8138,"Breast Ductal Carcinoma In Situ, Comedo Type",0.8117,Breast Papillary Ductal Carcinoma In Situ with Invasion,0.8001,Breast Classic Lobular Carcinoma In Situ Type B,0.7892,BREAST DUCTAL CARCINOMA IN SITU,True,True,True
"BREAST INVASIVE CANCER, NOS",Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9333,Invasive Breast Carcinoma of No Special Type,0.8645,Invasive Female Breast Carcinoma,0.7631,Breast Carcinoma,0.7556,Invasive Male Breast Carcinoma,0.7555,Invasive Breast Lobular Carcinoma,0.7501,Invasive Carcinoma,0.7482,Microinvasive Breast Carcinoma,0.7259,Invasive Breast Carcinoma by Histologic Grade,0.7231,Well Differentiated Invasive Breast Carcinoma,0.7203,Advanced Breast Carcinoma,0.7186,Invasive Bladder Carcinoma,0.7144,Invasive Malignant Neoplasm,0.7135,Invasive Breast Papillary Carcinoma,0.7085,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7051,Malignant Breast Neoplasm,0.7050,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7035,Breast Ductal Carcinoma In Situ,0.7010,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.7006,Poorly Differentiated Invasive Breast Carcinoma,0.6990,"BREAST INVASIVE CANCER, NOS",True,True,True
BREAST INVASIVE CARCINOMA,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9878,Invasive Breast Carcinoma of No Special Type,0.8740,Invasive Female Breast Carcinoma,0.8410,Breast Carcinoma,0.8374,Invasive Male Breast Carcinoma,0.8298,Invasive Breast Lobular Carcinoma,0.8172,Invasive Carcinoma,0.8169,Microinvasive Breast Carcinoma,0.7919,Well Differentiated Invasive Breast Carcinoma,0.7866,Advanced Breast Carcinoma,0.7835,Invasive Bladder Carcinoma,0.7813,Poorly Differentiated Invasive Breast Carcinoma,0.7808,Breast Ductal Carcinoma,0.7774,Invasive Breast Papillary Carcinoma,0.7717,Invasive Breast Carcinoma by Histologic Grade,0.7706,Early Stage Breast Carcinoma,0.7568,Breast Adenocarcinoma,0.7547,Sporadic Breast Carcinoma,0.7544,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7531,Breast Metaplastic Carcinoma,0.7510,BREAST INVASIVE CARCINOMA,True,True,True
BREAST INVASIVE CARCINOMA BRCA,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.8701,BRCA Hereditary Breast Carcinoma,0.8114,Invasive Breast Carcinoma of No Special Type,0.8106,Breast Carcinoma,0.7993,Sporadic Breast Carcinoma,0.7826,BRCA-Associated Malignant Neoplasm,0.7714,Invasive Female Breast Carcinoma,0.7645,Metastatic BRCA Hereditary Breast Carcinoma,0.7635,Microinvasive Breast Carcinoma,0.7566,Invasive Breast Lobular Carcinoma,0.7514,Invasive Male Breast Carcinoma,0.7496,Breast Adenocarcinoma,0.7414,Breast Metaplastic Carcinoma,0.7367,Hereditary Breast Carcinoma,0.7319,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7234,Breast Ductal Carcinoma,0.7232,BRCA Hereditary Ovarian Carcinoma,0.7227,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7214,Childhood Breast Carcinoma,0.7210,Bilateral Breast Carcinoma,0.7205,BREAST INVASIVE CARCINOMA BRCA,True,True,True
BREAST INVASIVE CARCINOMA NOS,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9705,Invasive Breast Carcinoma of No Special Type,0.8844,Invasive Female Breast Carcinoma,0.8119,Breast Carcinoma,0.8040,Invasive Breast Lobular Carcinoma,0.7996,Invasive Male Breast Carcinoma,0.7995,Invasive Carcinoma,0.7874,Well Differentiated Invasive Breast Carcinoma,0.7678,Microinvasive Breast Carcinoma,0.7643,Invasive Breast Carcinoma by Histologic Grade,0.7626,Advanced Breast Carcinoma,0.7599,Poorly Differentiated Invasive Breast Carcinoma,0.7580,Invasive Bladder Carcinoma,0.7543,Invasive Breast Papillary Carcinoma,0.7533,Breast Ductal Carcinoma,0.7512,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7446,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7374,Invasive Breast Apocrine Carcinoma,0.7336,Breast Metaplastic Carcinoma,0.7280,Breast Ductal Carcinoma In Situ,0.7250,BREAST INVASIVE CARCINOMA NOS,True,True,True
"BREAST INVASIVE CARCINOMA, NOS",Invasive Breast Carcinoma of No Special Type,2,2,Invasive Breast Carcinoma,0.9504,Invasive Breast Carcinoma of No Special Type,0.8714,Breast Carcinoma,0.7879,Invasive Female Breast Carcinoma,0.7837,Invasive Breast Lobular Carcinoma,0.7822,Invasive Male Breast Carcinoma,0.7786,Invasive Carcinoma,0.7714,Well Differentiated Invasive Breast Carcinoma,0.7553,Invasive Breast Carcinoma by Histologic Grade,0.7521,Microinvasive Breast Carcinoma,0.7461,Poorly Differentiated Invasive Breast Carcinoma,0.7457,Breast Ductal Carcinoma,0.7451,Advanced Breast Carcinoma,0.7419,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7335,Invasive Bladder Carcinoma,0.7300,Invasive Breast Papillary Carcinoma,0.7286,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7268,Invasive Breast Apocrine Carcinoma,0.7220,Breast Metaplastic Carcinoma,0.7199,Breast Ductal Carcinoma In Situ,0.7162,"BREAST INVASIVE CARCINOMA, NOS",False,True,True
"BREAST INVASIVE CARCINOSARCOMA, NOS",Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,99,2,Invasive Breast Carcinoma of No Special Type,0.7464,Invasive Breast Carcinoma,0.7448,Breast Solid Neuroendocrine Carcinoma,0.7286,Breast Metaplastic Carcinoma,0.7256,Breast Sarcoma,0.7192,Breast Carcinoma with Neuroendocrine Differentiation,0.7162,Breast Neuroendocrine Carcinoma,0.6972,Carcinosarcoma,0.6874,Breast Carcinoma,0.6818,Metastatic Breast Carcinoma,0.6746,Breast Small Cell Neuroendocrine Carcinoma,0.6722,Sporadic Breast Carcinoma,0.6695,Microinvasive Breast Carcinoma,0.6680,Gallbladder Carcinosarcoma,0.6668,Breast Carcinoma with Chondroid Metaplasia,0.6653,Breast Medullary Carcinoma,0.6605,Breast Carcinoma with Osseous Metaplasia,0.6581,Uterine Carcinosarcoma,0.6558,Breast Secretory Carcinoma,0.6542,Breast Malignant Myoepithelioma,0.6496,"BREAST INVASIVE CARCINOSARCOMA, NOS",False,False,False
BREAST INVASIVE DUCTAL CARCINOMA,Invasive Breast Carcinoma of No Special Type,15,2,Breast Ductal Carcinoma,0.9054,Breast Ductal Carcinoma In Situ,0.8745,Invasive Breast Carcinoma,0.8687,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8460,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8318,Poorly Differentiated Invasive Breast Carcinoma,0.8280,Well Differentiated Invasive Breast Carcinoma,0.8256,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.8198,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.8175,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.8130,Invasive Breast Lobular Carcinoma,0.8080,Metastatic Breast Ductal Carcinoma,0.8003,"Breast Ductal Carcinoma In Situ, High Grade",0.7991,"Breast Ductal Carcinoma In Situ, Solid Type",0.7948,Invasive Breast Carcinoma of No Special Type,0.7899,"Breast Ductal Carcinoma In Situ, Non-Comedo Type",0.7878,"Breast Ductal Carcinoma In Situ, Comedo Type",0.7872,Breast Papillary Ductal Carcinoma In Situ,0.7818,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.7723,Breast Carcinoma,0.7686,BREAST INVASIVE DUCTAL CARCINOMA,False,False,False
BREAST INVASIVE LOBULAR CARCINOMA,Invasive Breast Lobular Carcinoma,1,2,Invasive Breast Lobular Carcinoma,0.9936,Breast Lobular Carcinoma,0.9018,Breast Lobular Carcinoma In Situ,0.8741,Breast Classic Lobular Carcinoma In Situ,0.8599,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8450,Breast Classic Lobular Carcinoma In Situ Type B,0.8360,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8336,"Invasive Breast Lobular Carcinoma, Alveolar Variant",0.8315,Metastatic Breast Lobular Carcinoma,0.8239,Invasive Breast Carcinoma,0.8220,Invasive Breast Lobular Carcinoma with Predominant In Situ Component,0.8203,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.8113,Breast Classic Lobular Carcinoma In Situ Type A,0.8083,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.8061,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.8029,"Invasive Breast Lobular Carcinoma, Solid Variant",0.8014,Invasive Breast Lobular Carcinoma with Extracellular Mucin,0.7717,"Invasive Breast Lobular Carcinoma, Tubulolobular Variant",0.7710,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.7668,Breast Lobular Neoplasia,0.7605,BREAST INVASIVE LOBULAR CARCINOMA,True,True,True
BREAST INVASIVE MIXED MUCINOUS CARCINOMA,Breast Mucinous Carcinoma,2,2,Breast Mixed Carcinoma,0.8439,Breast Mucinous Carcinoma,0.8356,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.8135,Invasive Bladder Mixed Carcinoma,0.7967,Breast Metaplastic Carcinoma,0.7719,Breast Columnar Cell Mucinous Carcinoma,0.7648,Invasive Breast Lobular Carcinoma with Extracellular Mucin,0.7611,Multifocal Breast Carcinoma,0.7464,Breast Mixed Ductal and Lobular Carcinoma,0.7373,Breast Mucinous Cystadenocarcinoma,0.7353,Breast Atypical Medullary Carcinoma,0.7325,Bladder Mixed Adenocarcinoma,0.7292,Mixed Carcinoma,0.7164,Invasive Lung Mucinous Adenocarcinoma,0.7147,Cervical Invasive Stratified Mucinous Adenocarcinoma,0.7117,Breast Medullary Carcinoma,0.7076,Moderately Differentiated Invasive Breast Carcinoma,0.7072,Mixed Cell Adenocarcinoma,0.7037,Minimally Invasive Lung Mucinous Adenocarcinoma,0.7022,Minimally Invasive Lung Mixed Non-Mucinous and Mucinous Adenocarcinoma,0.7019,BREAST INVASIVE MIXED MUCINOUS CARCINOMA,False,True,True
BREAST MICROINVASIVE CARCINOMA,Microinvasive Breast Carcinoma,1,2,Microinvasive Breast Carcinoma,0.9867,Breast Micropapillary Ductal Carcinoma In Situ,0.8113,Breast Lobular Carcinoma In Situ,0.7747,Male Breast Carcinoma In Situ,0.7721,Microinvasive Malignant Neoplasm,0.7710,Moderately Differentiated Invasive Breast Carcinoma,0.7707,Poorly Differentiated Invasive Breast Carcinoma,0.7700,Invasive Breast Carcinoma,0.7641,Breast Ductal Carcinoma In Situ,0.7624,"Breast Ductal Carcinoma In Situ, Low Grade",0.7568,Invasive Breast Micropapillary Carcinoma,0.7542,Well Differentiated Invasive Breast Carcinoma,0.7505,Breast Classic Lobular Carcinoma In Situ,0.7494,Invasive Breast Carcinoma of No Special Type,0.7446,Early Stage Breast Carcinoma,0.7446,"Breast Ductal Carcinoma In Situ, Intermediate Grade",0.7421,Localized Breast Carcinoma,0.7419,Multifocal Breast Carcinoma,0.7405,Breast Metaplastic Carcinoma,0.7396,Breast Medullary Carcinoma,0.7358,BREAST MICROINVASIVE CARCINOMA,True,True,True
BREAST MIXED DUCTAL AND LOBULAR CARCINOMA,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,1.0000,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8495,Breast Mixed Carcinoma,0.8322,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.8138,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7961,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.7793,Breast Ductal Carcinoma,0.7702,Breast Lobular Carcinoma,0.7608,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.7588,Metastatic Breast Lobular Carcinoma,0.7509,Metastatic Breast Ductal Carcinoma,0.7489,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.7399,Multifocal Breast Carcinoma,0.7336,Invasive Breast Lobular Carcinoma,0.7218,Breast Atypical Medullary Carcinoma,0.7094,"Breast Ductal Carcinoma In Situ, Comedo Type",0.7048,"Invasive Breast Lobular Carcinoma, Alveolar Variant",0.7017,Breast Ductal Carcinoma with Squamous Metaplasia,0.6857,Breast Metaplastic Carcinoma,0.6838,Pancreatic Mixed Acinar-Ductal Carcinoma,0.6838,BREAST MIXED DUCTAL AND LOBULAR CARCINOMA,True,True,True
"BREAST NEOPLASM, NOS",Breast Neoplasm,1,2,Breast Neoplasm,0.9355,Benign Breast Neoplasm,0.7736,Malignant Breast Neoplasm,0.7722,Childhood Breast Neoplasm,0.7562,Breast Adenoma,0.7430,Breast Carcinoma,0.7422,Breast Vascular Neoplasm,0.7338,Breast Lymphoma,0.7028,Breast Hyperplasia,0.6852,Breast Neuroendocrine Neoplasm,0.6842,Childhood Malignant Breast Neoplasm,0.6816,Breast Adenocarcinoma,0.6731,Breast Papillary Neoplasm,0.6574,Axillary Neoplasm,0.6568,Female Breast Carcinoma,0.6567,Childhood Benign Breast Neoplasm,0.6560,Breast Soft Tissue Neoplasm,0.6545,Nipple Neoplasm,0.6544,Breast Ductal Carcinoma,0.6535,Bladder Neoplasm,0.6508,"BREAST NEOPLASM, NOS",True,True,True
BREAST SARCOMA,Breast Sarcoma,1,2,Breast Sarcoma,1.0000,Recurrent Breast Sarcoma,0.8473,Breast Liposarcoma,0.8005,Breast Leiomyosarcoma,0.7972,Breast Rhabdomyosarcoma,0.7867,Breast Fibrosarcoma,0.7864,Bone Sarcoma,0.7783,Bladder Sarcoma,0.7757,Sarcoma,0.7653,Breast Extraskeletal Osteosarcoma,0.7512,Gallbladder Sarcoma,0.7492,Breast Lymphoma,0.7477,Brain Sarcoma,0.7472,Breast Angiosarcoma,0.7388,Cardiac Sarcoma,0.7304,Breast Neoplasm,0.7224,Chest Wall Sarcoma,0.7164,Breast Melanoma,0.7151,Primary Breast Angiosarcoma,0.7115,Breast Carcinoma,0.7110,BREAST SARCOMA,True,True,True
BREAST_ADENOCARCINOMA,Breast Adenocarcinoma,1,2,Breast Adenocarcinoma,0.9620,Breast Carcinoma,0.8700,Advanced Breast Adenocarcinoma,0.8458,Metastatic Breast Adenocarcinoma,0.8094,Malignant Breast Neoplasm,0.8014,Unresectable Breast Adenocarcinoma,0.7977,Breast Ductal Carcinoma,0.7936,Adenocarcinoma,0.7893,Advanced Breast Carcinoma,0.7855,Breast Adenoma,0.7779,Breast Neoplasm,0.7716,Breast Adenocarcinoma with Squamous Metaplasia,0.7634,Female Breast Carcinoma,0.7603,Bladder Adenocarcinoma,0.7603,Locally Advanced Breast Adenocarcinoma,0.7419,Sporadic Breast Carcinoma,0.7393,Gallbladder Adenocarcinoma,0.7330,Breast Ductal Adenoma,0.7329,Invasive Breast Carcinoma,0.7298,Male Breast Carcinoma,0.7281,BREAST_ADENOCARCINOMA,True,True,True
BREAST_CANCER,Breast Carcinoma,1,2,Breast Carcinoma,0.8829,Breast Neoplasm,0.8098,Malignant Breast Neoplasm,0.8015,Breast Adenocarcinoma,0.8005,Sporadic Breast Carcinoma,0.7740,Female Breast Carcinoma,0.7636,Occult Breast Carcinoma,0.7503,Childhood Breast Carcinoma,0.7496,Breast Ductal Carcinoma,0.7492,Invasive Breast Carcinoma,0.7472,Unresectable Breast Carcinoma,0.7393,Breast Lymphoma,0.7383,Metastatic Breast Carcinoma,0.7323,Advanced Breast Carcinoma,0.7321,BRCA-Associated Malignant Neoplasm,0.7282,Hereditary Breast Carcinoma,0.7275,Bilateral Breast Carcinoma,0.7225,Contralateral Breast Carcinoma,0.7205,Male Breast Carcinoma,0.7141,Recurrent Breast Carcinoma,0.7133,BREAST_CANCER,True,True,True
BREAST_CARCINOMA,Breast Carcinoma,1,2,Breast Carcinoma,0.9491,Breast Adenocarcinoma,0.8430,Malignant Breast Neoplasm,0.8256,Breast Ductal Carcinoma,0.8182,Female Breast Carcinoma,0.8173,Invasive Breast Carcinoma,0.8089,Breast Neoplasm,0.7966,Sporadic Breast Carcinoma,0.7877,Advanced Breast Carcinoma,0.7875,Male Breast Carcinoma,0.7774,Childhood Breast Carcinoma,0.7749,Breast Inflammatory Carcinoma,0.7683,Unresectable Breast Carcinoma,0.7659,Metastatic Breast Carcinoma,0.7652,Occult Breast Carcinoma,0.7638,Bilateral Breast Carcinoma,0.7600,Breast Metaplastic Carcinoma,0.7555,Breast Medullary Carcinoma,0.7526,Localized Breast Carcinoma,0.7519,Invasive Breast Carcinoma of No Special Type,0.7504,BREAST_CARCINOMA,True,True,True
BREAST_DUCTAL_CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.9515,Breast Carcinoma,0.8343,Metastatic Breast Ductal Carcinoma,0.8053,Breast Ductal Carcinoma In Situ,0.7988,Breast Adenocarcinoma,0.7883,Breast Ductal Adenoma,0.7671,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7559,Breast Ductal Carcinoma with Squamous Metaplasia,0.7552,Invasive Breast Carcinoma,0.7520,"Breast Ductal Carcinoma In Situ, Solid Type",0.7488,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.7462,Advanced Breast Carcinoma,0.7448,Breast Lobular Carcinoma,0.7428,Breast Mixed Ductal and Lobular Carcinoma,0.7427,"Breast Ductal Carcinoma In Situ, Non-Comedo Type",0.7424,"Breast Ductal Carcinoma In Situ, Comedo Type",0.7413,"Breast Ductal Carcinoma In Situ, High Grade",0.7333,Malignant Breast Neoplasm,0.7324,Breast Tubular Carcinoma,0.7206,Nipple Duct Carcinoma,0.7183,BREAST_DUCTAL_CARCINOMA,True,True,True
BRENNER TUMOR,Brenner Tumor,1,2,Brenner Tumor,1.0000,Ovarian Brenner Tumor,0.9333,Benign Ovarian Brenner Tumor,0.8897,Malignant Ovarian Brenner Tumor,0.8846,Borderline Ovarian Brenner Tumor,0.8572,Paratesticular Brenner Tumor,0.8564,Recurrent Malignant Ovarian Brenner Tumor,0.7897,Refractory Malignant Ovarian Brenner Tumor,0.7546,Regional Neuroblastoma,0.5983,Broad Ligament Wolffian Tumor,0.5908,Breast Melanoma,0.5821,Broad Ligament Adenocarcinoma,0.5790,Broad Ligament Neoplasm,0.5736,Krukenberg Tumor,0.5691,Ovarian Melanoma,0.5676,Retinoblastoma,0.5657,Mesothelioma,0.5648,Trichoblastoma,0.5642,Barrett Adenocarcinoma,0.5631,Ovarian Yolk Sac Tumor,0.5611,BRENNER TUMOR,True,True,True
BRENNER_TUMOR,Brenner Tumor,1,2,Brenner Tumor,0.9262,Ovarian Brenner Tumor,0.8558,Malignant Ovarian Brenner Tumor,0.8255,Benign Ovarian Brenner Tumor,0.8134,Borderline Ovarian Brenner Tumor,0.8018,Paratesticular Brenner Tumor,0.7842,Recurrent Malignant Ovarian Brenner Tumor,0.7748,Refractory Malignant Ovarian Brenner Tumor,0.7265,Neoplasm by Site,0.5890,Regional Neuroblastoma,0.5860,Breast Melanoma,0.5810,Broad Ligament Neoplasm,0.5763,Krukenberg Tumor,0.5731,Branchioma,0.5669,Broad Ligament Wolffian Tumor,0.5635,Bacterium-Related Malignant Neoplasm,0.5609,Breast Neuroendocrine Tumor,0.5607,Breast Neoplasm,0.5594,Barrett Adenocarcinoma,0.5591,Retinoblastoma,0.5590,BRENNER_TUMOR,True,True,True
BRENNER_TUMOUR,Brenner Tumor,1,2,Brenner Tumor,0.9401,Ovarian Brenner Tumor,0.8701,Malignant Ovarian Brenner Tumor,0.8361,Benign Ovarian Brenner Tumor,0.8284,Borderline Ovarian Brenner Tumor,0.8089,Paratesticular Brenner Tumor,0.7955,Recurrent Malignant Ovarian Brenner Tumor,0.7746,Refractory Malignant Ovarian Brenner Tumor,0.7304,Breast Melanoma,0.5871,Regional Neuroblastoma,0.5794,Neoplasm by Site,0.5774,Krukenberg Tumor,0.5768,Broad Ligament Neoplasm,0.5744,Breast Neuroendocrine Tumor,0.5687,Broad Ligament Wolffian Tumor,0.5686,Breast Neoplasm,0.5640,Ovarian Neuroectodermal-Type Tumor,0.5622,Barrett Adenocarcinoma,0.5622,Branchioma,0.5584,Ovarian Melanoma,0.5573,BRENNER_TUMOUR,True,True,True
BRONCHIOALVEOLAR_CARCINOMA,Lung Adenocarcinoma In Situ,99,2,Bronchogenic Carcinoma,0.7878,Lung Carcinoma,0.7698,Lung Adenocarcinoma,0.7417,Advanced Bronchogenic Carcinoma,0.7225,Malignant Bronchial Neoplasm,0.7171,Bladder Adenocarcinoma,0.7116,Bladder Carcinoma,0.7017,Biliary Tract Carcinoma,0.7015,Lung Adenoid Cystic Carcinoma,0.6883,Breast Carcinoma,0.6874,Bile Duct Carcinoma,0.6863,Lung Adenocarcinoma with Mixed Bronchioloalveolar and Invasive Components,0.6852,Bile Duct Adenocarcinoma,0.6815,Advanced Lung Carcinoma,0.6796,Breast Adenocarcinoma,0.6770,Lung Secretory Carcinoma,0.6769,Gallbladder Carcinoma,0.6716,Breast Acinic Cell Carcinoma,0.6711,Lung Acinar Adenocarcinoma,0.6659,Advanced Lung Adenocarcinoma,0.6655,BRONCHIOALVEOLAR_CARCINOMA,False,False,False
BRONCHIOLOALVEOLAR_ADENOCARCINOMA,Minimally Invasive Lung Adenocarcinoma,99,2,Lung Acinar Adenocarcinoma,0.8194,Lung Adenocarcinoma,0.8007,Lung Adenocarcinoma with Mixed Bronchioloalveolar and Invasive Components,0.7600,Advanced Lung Adenocarcinoma,0.7474,Bladder Adenocarcinoma,0.7239,Lung Papillary Adenocarcinoma,0.7170,Breast Adenocarcinoma,0.7138,Prostate Acinar Adenocarcinoma,0.7107,Alveolar Adenoma,0.7097,Lepidic Adenocarcinoma,0.7077,Solid Lung Adenocarcinoma,0.7033,Advanced Bronchogenic Carcinoma,0.7025,Bronchogenic Carcinoma,0.7005,Occult Lung Adenocarcinoma,0.6984,Lung Adenoma,0.6868,Bile Duct Adenocarcinoma,0.6835,Advanced Breast Adenocarcinoma,0.6821,Acinar Cell Carcinoma,0.6812,Lung Colloid Adenocarcinoma,0.6762,Tubular Adenocarcinoma,0.6743,BRONCHIOLOALVEOLAR_ADENOCARCINOMA,False,False,False
BURKITT LYMPHOMA,Burkitt Lymphoma,1,2,Burkitt Lymphoma,1.0000,Burkitt Leukemia,0.9462,Classical Burkitt Lymphoma,0.9417,Sporadic Burkitt Lymphoma,0.9036,Childhood Burkitt Lymphoma,0.8998,Breast Burkitt Lymphoma,0.8776,Endemic Burkitt Lymphoma,0.8747,Adult Burkitt Lymphoma,0.8680,Kidney Burkitt Lymphoma,0.8677,Childhood Burkitt Leukemia,0.8651,Non-Burkitt's Lymphoma,0.8533,Gastric Burkitt Lymphoma,0.8498,EBV-Negative Burkitt Lymphoma,0.8407,Cutaneous Burkitt Lymphoma,0.8407,Adult Burkitt Leukemia,0.8306,Immunodeficiency-Related Burkitt Lymphoma,0.8284,Atypical Burkitt/Burkitt-Like Lymphoma,0.8244,Colon Burkitt Lymphoma,0.8232,EBV-Related Burkitt Lymphoma,0.8197,B Lymphoblastic Lymphoma,0.8182,BURKITT LYMPHOMA,True,True,True
BURKITTS LYMPHOMA,Burkitt Lymphoma,1,2,Burkitt Lymphoma,0.9880,Classical Burkitt Lymphoma,0.9362,Burkitt Leukemia,0.9330,Sporadic Burkitt Lymphoma,0.9031,Childhood Burkitt Lymphoma,0.8901,Non-Burkitt's Lymphoma,0.8786,Endemic Burkitt Lymphoma,0.8688,Adult Burkitt Lymphoma,0.8614,Breast Burkitt Lymphoma,0.8611,Kidney Burkitt Lymphoma,0.8549,Childhood Burkitt Leukemia,0.8520,Gastric Burkitt Lymphoma,0.8458,EBV-Negative Burkitt Lymphoma,0.8358,Atypical Burkitt/Burkitt-Like Lymphoma,0.8306,Immunodeficiency-Related Burkitt Lymphoma,0.8304,Cutaneous Burkitt Lymphoma,0.8270,Adult Burkitt Leukemia,0.8209,Splenic Burkitt Lymphoma,0.8177,EBV-Related Burkitt Lymphoma,0.8175,Small Intestinal Burkitt Lymphoma,0.8103,BURKITTS LYMPHOMA,True,True,True
BURKITT_LYMPHOMA,Burkitt Lymphoma,1,2,Burkitt Lymphoma,0.9696,Burkitt Leukemia,0.9217,Classical Burkitt Lymphoma,0.9192,Sporadic Burkitt Lymphoma,0.8775,Non-Burkitt's Lymphoma,0.8739,Childhood Burkitt Lymphoma,0.8737,Breast Burkitt Lymphoma,0.8639,Endemic Burkitt Lymphoma,0.8508,Kidney Burkitt Lymphoma,0.8488,Childhood Burkitt Leukemia,0.8423,Adult Burkitt Lymphoma,0.8410,Gastric Burkitt Lymphoma,0.8304,Atypical Burkitt/Burkitt-Like Lymphoma,0.8242,Cutaneous Burkitt Lymphoma,0.8210,EBV-Negative Burkitt Lymphoma,0.8190,EBV-Related Burkitt Lymphoma,0.8183,Immunodeficiency-Related Burkitt Lymphoma,0.8119,Adult Burkitt Leukemia,0.8046,B Lymphoblastic Lymphoma,0.8017,High Grade Burkitt-Like Lymphoma,0.7982,BURKITT_LYMPHOMA,True,True,True
B_CELL_BURKITT,Burkitt Lymphoma,1,2,Burkitt Lymphoma,0.8667,Classical Burkitt Lymphoma,0.8408,Burkitt Leukemia,0.8352,Cutaneous Burkitt Lymphoma,0.7928,Childhood Burkitt Lymphoma,0.7824,Breast Burkitt Lymphoma,0.7810,Childhood Burkitt Leukemia,0.7672,Kidney Burkitt Lymphoma,0.7635,Non-Burkitt's Lymphoma,0.7566,Endemic Burkitt Lymphoma,0.7554,Sporadic Burkitt Lymphoma,0.7550,EBV-Negative Burkitt Lymphoma,0.7492,Adult Burkitt Lymphoma,0.7415,EBV-Related Burkitt Lymphoma,0.7388,Colorectal Burkitt Lymphoma,0.7334,B-Cell Malignant Neoplasm,0.7320,Gastric Burkitt Lymphoma,0.7319,Colon Burkitt Lymphoma,0.7318,Atypical Burkitt/Burkitt-Like Lymphoma,0.7306,Burkitt Lymphoma by Ann Arbor Stage,0.7233,B_CELL_BURKITT,True,True,True
B_CELL_FOLLICULAR,Follicular Lymphoma,2,2,"Malignant Lymphoma Centroblastic, Follicular",0.7345,Follicular Lymphoma,0.7132,Classic Follicular Lymphoma,0.6784,Grade 1 Follicular Lymphoma,0.6408,Thyroid Gland Follicular Lymphoma,0.6285,Breast Follicular Lymphoma,0.6226,"Follicular Helper T-Cell Lymphoma, Follicular-Type",0.6204,Grade 3b Follicular Lymphoma,0.6203,Grade 2 Follicular Lymphoma,0.6201,Grade 1 Diffuse Follicular Lymphoma,0.6201,Thyroid Gland Follicular Carcinoma,0.6192,Centroblastic Lymphoma,0.6189,Testicular Follicular Lymphoma,0.6186,Grade 3 Follicular Lymphoma,0.6140,Advanced Follicular Lymphoma,0.6089,Cutaneous Follicular Lymphoma,0.6082,Conjunctival Follicular Lymphoma,0.6076,B-Cell Neoplasm,0.6033,Grade 2 Diffuse Follicular Lymphoma,0.6003,Follicular Helper T-Cell Lymphoma,0.5998,B_CELL_FOLLICULAR,False,True,True
B_CELL_LYMPHOMA_UNSPECIFIED,B-Cell Non-Hodgkin Lymphoma,2,2,B-Cell Neoplasm,0.8192,B-Cell Non-Hodgkin Lymphoma,0.8048,B-Cell Malignant Neoplasm,0.7688,B-Cell Leukemia,0.7674,B Lymphoblastic Lymphoma,0.7527,Non-Burkitt's Lymphoma,0.7447,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7198,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.7163,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.7090,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7070,Burkitt Lymphoma,0.7047,Mature B-Cell Neoplasm,0.7036,B Lymphoblastic Leukemia/Lymphoma,0.7024,Lymphoma,0.6974,High Grade B-Cell Lymphoma,0.6937,Classical Burkitt Lymphoma,0.6820,Mature B-Cell Non-Hodgkin Lymphoma,0.6786,Diffuse Large B-Cell Lymphoma,0.6771,Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma,0.6771,Low Grade B-Cell Non-Hodgkin's Lymphoma,0.6762,B_CELL_LYMPHOMA_UNSPECIFIED,False,True,True
B_CELL_MANTLE_CELL,Mantle Cell Lymphoma,1,2,Mantle Cell Lymphoma,0.7956,Blastoid Variant Mantle Cell Lymphoma,0.7380,Cutaneous Mantle Cell Lymphoma,0.7073,Mature B-Cell Neoplasm,0.6976,Cutaneous Mature B-Cell Neoplasm,0.6867,B-Cell Malignant Neoplasm,0.6707,Mature B-Cell Non-Hodgkin Lymphoma,0.6620,Monoclonal B-Cell Lymphocytosis,0.6543,Lymphoplasmacytic Lymphoma,0.6529,Colorectal Mantle Cell Lymphoma,0.6527,Cyclin D1-Negative Mantle Cell Lymphoma,0.6485,In Situ Mantle Cell Neoplasia,0.6464,Ann Arbor Stage IV Mantle Cell Lymphoma,0.6457,Gastric Mantle Cell Lymphoma,0.6443,Marginal Zone Lymphoma,0.6442,Refractory Mantle Cell Lymphoma,0.6428,Colon Mantle Cell Lymphoma,0.6391,B-Cell Proliferation of Uncertain Malignant Potential,0.6366,Mantle Cell Lymphoma by Ann Arbor Stage,0.6337,Prostate Mantle Cell Lymphoma,0.6336,B_CELL_MANTLE_CELL,True,True,True
B_CELL_MEDIASTINAL_LARGE,Primary Mediastinal Large B-Cell Lymphoma,1,2,Primary Mediastinal Large B-Cell Lymphoma,0.8163,Primary Mediastinal Large B-Cell Lymphoma by Ann Arbor Stage,0.7438,Childhood Primary Mediastinal Large B-Cell Lymphoma,0.7388,Ann Arbor Stage IV Primary Mediastinal Large B-Cell Lymphoma,0.7075,Lung Mature B-Cell Neoplasm,0.6984,Mediastinal Lymphoma,0.6951,Recurrent Primary Mediastinal Large B-Cell Lymphoma,0.6861,Mediastinal Gray-Zone Lymphoma,0.6700,Mediastinal Non-Hodgkin Lymphoma,0.6658,Refractory Primary Mediastinal Large B-Cell Lymphoma,0.6599,Ann Arbor Stage III Primary Mediastinal Large B-Cell Lymphoma,0.6573,Monoclonal B-Cell Lymphocytosis,0.6518,Ann Arbor Stage I Primary Mediastinal Large B-Cell Lymphoma,0.6506,Ann Arbor Stage II Primary Mediastinal Large B-Cell Lymphoma,0.6440,Mediastinal Lymphangioma,0.6407,Malignant Mediastinal Germ Cell Tumor,0.6368,Mediastinal Germ Cell Tumor,0.6324,Benign Mediastinal Germ Cell Tumor,0.6252,Mediastinal Granular Cell Tumor,0.6188,Malignant Mediastinal Nongerminomatous Germ Cell Tumor,0.6180,B_CELL_MEDIASTINAL_LARGE,True,True,True
B_CELL_NON_HODGKIN_LYMPHOMA,B-Cell Non-Hodgkin Lymphoma,1,2,B-Cell Non-Hodgkin Lymphoma,0.9344,Non-Burkitt's Lymphoma,0.8220,Mature B-Cell Non-Hodgkin Lymphoma,0.8115,Low Grade B-Cell Non-Hodgkin's Lymphoma,0.7934,B-Cell Neoplasm,0.7931,High Grade B-Cell Non-Hodgkin's Lymphoma,0.7613,B-Cell Leukemia,0.7604,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7554,Indolent B-Cell Non-Hodgkin Lymphoma,0.7510,B Lymphoblastic Lymphoma,0.7408,Non-Hodgkin Lymphoma,0.7347,B-Cell Malignant Neoplasm,0.7258,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.7209,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7204,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.7200,Burkitt Lymphoma,0.7167,Classical Burkitt Lymphoma,0.7154,Mature B-Cell Neoplasm,0.7088,"Malignant Lymphoma, Non-Cleaved, Diffuse",0.7040,High Grade B-Cell Lymphoma,0.7030,B_CELL_NON_HODGKIN_LYMPHOMA,True,True,True
B_CELL_PRIMARY_EFFUSION,Primary Effusion Lymphoma,2,2,Body Cavity Primary Effusion Lymphoma,0.7529,Primary Effusion Lymphoma,0.7065,Extracavitary Primary Effusion Lymphoma,0.6745,B-Cell Proliferation of Uncertain Malignant Potential,0.6710,Pericardial Primary Effusion Lymphoma,0.6417,Peritoneal Primary Effusion Lymphoma,0.6341,Pleural Primary Effusion Lymphoma,0.6175,Recurrent Primary Effusion Lymphoma,0.5985,Refractory Primary Effusion Lymphoma,0.5948,Primary Cutaneous Plasmablastic Lymphoma,0.5947,B-Cell Neoplasm,0.5845,Pleuropulmonary Blastoma,0.5782,Blastoma,0.5760,Plasmablastic Lymphoma,0.5721,AIDS-Related Primary Effusion Lymphoma,0.5688,Plasma Cell Neoplasm,0.5670,Peritoneal Biphasic Mesothelioma,0.5640,Plasmacytoma,0.5639,Type I Pleuropulmonary Blastoma,0.5634,Primary Peritoneal Undifferentiated Carcinoma,0.5625,B_CELL_PRIMARY_EFFUSION,False,True,True
CAECUM ADENOCARCINOMA,Cecum Adenocarcinoma,1,2,Cecum Adenocarcinoma,0.8581,Colorectal Adenocarcinoma,0.8125,Colon Adenocarcinoma,0.8059,Cecum Carcinoma,0.7955,Crohn Disease-Associated Colorectal Adenocarcinoma,0.7726,Malignant Cecum Neoplasm,0.7706,Appendix Adenocarcinoma,0.7521,Colon Intramucosal Adenocarcinoma,0.7500,Colon Carcinoma,0.7404,Colorectal Mucinous Adenocarcinoma,0.7389,Intestinal-Type Adenocarcinoma,0.7375,Colon Mucinous Adenocarcinoma,0.7308,Colorectal Carcinoma,0.7274,Inflammatory Bowel Disease-Associated Colorectal Adenocarcinoma,0.7171,Gastric Cardia Adenocarcinoma,0.7156,Appendix Carcinoma,0.7143,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,0.7131,Colorectal Adenoma-Like Adenocarcinoma,0.7091,Gastric Adenocarcinoma,0.7040,Intramucosal Adenocarcinoma,0.7035,CAECUM ADENOCARCINOMA,True,True,True
CAECUM_ADENOCARCINOMA,Cecum Adenocarcinoma,1,2,Cecum Adenocarcinoma,0.8415,Colorectal Adenocarcinoma,0.8007,Colon Adenocarcinoma,0.7910,Crohn Disease-Associated Colorectal Adenocarcinoma,0.7788,Cecum Carcinoma,0.7780,Malignant Cecum Neoplasm,0.7621,Intestinal-Type Adenocarcinoma,0.7375,Colon Intramucosal Adenocarcinoma,0.7370,Colorectal Mucinous Adenocarcinoma,0.7306,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,0.7278,Inflammatory Bowel Disease-Associated Colorectal Adenocarcinoma,0.7257,Appendix Adenocarcinoma,0.7222,Colorectal Adenoma-Like Adenocarcinoma,0.7221,Adenoma of the Colon with Intramucosal Adenocarcinoma,0.7204,Colon Carcinoma,0.7189,Colon Mucinous Adenocarcinoma,0.7139,Colorectal Carcinoma,0.7109,Intramucosal Adenocarcinoma,0.6969,Periampullary Adenocarcinoma,0.6966,Gastric Intestinal-Type Adenocarcinoma,0.6962,CAECUM_ADENOCARCINOMA,True,True,True
CANCER IDENTIFICATION IDC,Invasive Breast Carcinoma of No Special Type,99,2,Carcinoma In Situ,0.6746,Invasive Carcinoma,0.6514,Breast Ductal Carcinoma In Situ,0.6347,Adenocarcinoma In Situ,0.6294,Early Invasive Cervical Adenocarcinoma,0.6282,Carcinoma,0.6243,Colorectal Intraepithelial Neoplasia,0.6172,Indeterminate Dendritic Cell Tumor,0.6172,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.6151,Cervical Adenocarcinoma In Situ,0.6095,Cutaneous Indeterminate Dendritic Cell Tumor,0.6081,Adenocarcinoma,0.6057,Intraepithelial Neoplasia,0.6027,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.6020,Breast Papillary Ductal Carcinoma In Situ with Invasion,0.6011,Poorly Differentiated Invasive Breast Carcinoma,0.6010,Digestive System Carcinoma In Situ,0.5997,Invasive Cervical Carcinoma,0.5973,Invasive Breast Carcinoma,0.5968,Disseminated Carcinoma,0.5968,CANCER IDENTIFICATION IDC,False,False,False
CANCER IDENTIFICATION ILC,Invasive Breast Lobular Carcinoma,6,2,Invasive Carcinoma,0.6301,Invasive Conventional Urothelial Carcinoma,0.6224,Cutaneous Indeterminate Dendritic Cell Tumor,0.6176,Intrahepatic Cholangiocarcinoma,0.6122,Large Duct Intrahepatic Cholangiocarcinoma,0.6092,Invasive Breast Lobular Carcinoma,0.6073,Carcinoma,0.6067,Invasive Urothelial Carcinoma,0.6046,Occult Lung Carcinoma,0.6043,Minimally Invasive Lung Adenocarcinoma,0.6037,Indeterminate Dendritic Cell Tumor,0.6031,Locally Advanced Intrahepatic Cholangiocarcinoma,0.6025,Liver and Intrahepatic Bile Duct Carcinoma,0.5999,Invasive Lymphoepithelioma-Like Urothelial Carcinoma,0.5976,Advanced Intrahepatic Cholangiocarcinoma,0.5953,Intestinal Intraepithelial Neoplasia,0.5939,Invasive Lipid-Rich Urothelial Carcinoma,0.5909,Urothelial Carcinoma In Situ,0.5906,Colorectal Intraepithelial Neoplasia,0.5898,Clear Cell Intrahepatic Cholangiocarcinoma,0.5886,CANCER IDENTIFICATION ILC,False,False,False
CANCER IDENTIFICATION MIDLC,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,99,2,Minimally Invasive Lung Adenocarcinoma,0.6122,Colorectal Medullary Carcinoma,0.6052,Colon Medullary Carcinoma,0.6034,Colorectal Intraepithelial Neoplasia,0.5986,Large Duct Intrahepatic Cholangiocarcinoma,0.5885,Colorectal Carcinoma,0.5864,Carcinoma,0.5863,Minimally Invasive Lung Mucinous Adenocarcinoma,0.5856,Kidney Carcinoma Molecular Subtypes,0.5846,Oligometastatic Intrahepatic Cholangiocarcinoma,0.5813,Cutaneous Indeterminate Dendritic Cell Tumor,0.5787,Mixed Carcinoma,0.5759,Ciliary Body Intermediate Cell Type Melanoma,0.5753,Indeterminate Dendritic Cell Tumor,0.5752,Metastatic Colorectal Carcinoma,0.5749,Childhood Colorectal Carcinoma,0.5745,Malignant Neoplasm,0.5742,Cholangiocarcinoma,0.5735,Metastatic Intrahepatic Cholangiocarcinoma,0.5729,Colorectal Adenocarcinoma,0.5727,CANCER IDENTIFICATION MIDLC,False,False,False
CANCER OF UNKNOWN PRIMARY,Malignant Neoplasm,99,2,Carcinoma of Unknown Primary,0.9826,Undifferentiated Carcinoma of Unknown Primary,0.8883,Malignant Neoplasm of Unknown Primary,0.8704,Adenocarcinoma of Unknown Primary,0.8510,Melanoma of Unknown Primary,0.8200,Squamous Cell Carcinoma of Unknown Primary,0.8113,Neuroendocrine Carcinoma of Unknown Primary,0.8018,Head and Neck Carcinoma of Unknown Primary,0.8013,Advanced Carcinoma Of Unknown Primary,0.7992,Recurrent Carcinoma of Unknown Primary,0.7332,Resectable Carcinoma of Unknown Primary,0.7120,Advanced Adenocarcinoma of Unknown Primary,0.7008,Neck Squamous Cell Carcinoma of Unknown Primary,0.7004,Locally Advanced Squamous Cell Carcinoma of Unknown Primary,0.6839,"Malignant Neoplasm, Uncertain Whether Primary or Metastatic",0.6676,Neoplasm of Uncertain Malignant Potential,0.6309,Primary Peritoneal Undifferentiated Carcinoma,0.6095,Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary,0.5977,Resectable Adenocarcinoma of Unknown Primary,0.5967,Undifferentiated Carcinoma,0.5966,CANCER OF UNKNOWN PRIMARY,False,False,False
"CANCER OF UNKNOWN PRIMARY, NOS",Carcinoma,99,2,Carcinoma of Unknown Primary,0.9564,Malignant Neoplasm of Unknown Primary,0.8719,Undifferentiated Carcinoma of Unknown Primary,0.8578,Adenocarcinoma of Unknown Primary,0.8251,Melanoma of Unknown Primary,0.7977,Squamous Cell Carcinoma of Unknown Primary,0.7824,Head and Neck Carcinoma of Unknown Primary,0.7780,Neuroendocrine Carcinoma of Unknown Primary,0.7726,Advanced Carcinoma Of Unknown Primary,0.7668,Recurrent Carcinoma of Unknown Primary,0.6997,Resectable Carcinoma of Unknown Primary,0.6845,"Malignant Neoplasm, Uncertain Whether Primary or Metastatic",0.6761,Advanced Adenocarcinoma of Unknown Primary,0.6700,Neck Squamous Cell Carcinoma of Unknown Primary,0.6684,Locally Advanced Squamous Cell Carcinoma of Unknown Primary,0.6575,Neoplasm of Uncertain Malignant Potential,0.6250,"Primary Intraosseous Carcinoma, Not Otherwise Specified",0.5815,Primary Malignant Neoplasm,0.5779,Primary Peritoneal Undifferentiated Carcinoma,0.5776,Primary Neoplasm,0.5684,"CANCER OF UNKNOWN PRIMARY, NOS",False,False,False
CARCINOID,Carcinoid Tumor,1,2,Carcinoid Tumor,0.9630,Combined Carcinoid and Adenocarcinoma,0.8051,Lung Carcinoid Tumor,0.7999,Strumal Carcinoid,0.7886,Carcinoid Tumor of Uncertain Malignant Potential,0.7769,Carcinosarcoma,0.7731,Neuroendocrine Tumor,0.7409,Laryngeal Carcinoid Tumor,0.7387,Neuroendocrine Carcinoma,0.7365,Colon Neuroendocrine Tumor,0.7234,Neuroendocrine Neoplasm,0.7145,Adenocarcinoma with Neuroendocrine Differentiation,0.7058,Ovarian Insular Carcinoid Tumor,0.7055,Gallbladder Tubular Carcinoid,0.7050,Cecum Neuroendocrine Tumor,0.6907,Ovarian Mucinous Carcinoid Tumor,0.6902,Colon Neuroendocrine Neoplasm,0.6896,Colorectal Neuroendocrine Tumor,0.6848,Endometrial Neuroendocrine Carcinoma,0.6834,Advanced Carcinosarcoma,0.6833,CARCINOID,True,True,True
CARCINOID TUMOR,Carcinoid Tumor,1,2,Carcinoid Tumor,1.0000,Lung Carcinoid Tumor,0.8327,Carcinoid Tumor of Uncertain Malignant Potential,0.8149,Strumal Carcinoid,0.7844,Combined Carcinoid and Adenocarcinoma,0.7803,Laryngeal Carcinoid Tumor,0.7753,Neuroendocrine Tumor,0.7749,Colon Neuroendocrine Tumor,0.7569,Carcinosarcoma,0.7426,Colorectal Neuroendocrine Tumor,0.7284,Neuroendocrine Neoplasm,0.7280,Cecum Neuroendocrine Tumor,0.7212,Neuroendocrine Carcinoma,0.7187,Ovarian Insular Carcinoid Tumor,0.7133,Colon Neuroendocrine Neoplasm,0.7057,Colon Neuroendocrine Tumor G1,0.7035,Ovarian Mucinous Carcinoid Tumor,0.6976,Neuroendocrine Tumor G1,0.6902,Colorectal Neuroendocrine Tumor G1,0.6901,Gallbladder Tubular Carcinoid,0.6901,CARCINOID TUMOR,True,True,True
CARCINOID-ENDOCRINE TUMOUR,Carcinoid Tumor,1,2,Carcinoid Tumor,0.8987,Neuroendocrine Tumor,0.7563,Carcinoid Tumor of Uncertain Malignant Potential,0.7380,Strumal Carcinoid,0.7380,Lung Carcinoid Tumor,0.7316,Endocrine Neoplasm,0.7307,Combined Carcinoid and Adenocarcinoma,0.7143,Neuroendocrine Neoplasm,0.7090,Corticotroph Pituitary Neuroendocrine Tumor,0.6963,Pituitary Neuroendocrine Tumor,0.6906,Ovarian Insular Carcinoid Tumor,0.6875,Laryngeal Carcinoid Tumor,0.6864,Colon Neuroendocrine Tumor,0.6855,Carcinosarcoma,0.6829,Colorectal Neuroendocrine Tumor,0.6777,Functioning Endocrine Neoplasm,0.6735,Ectopic Pituitary Neuroendocrine Tumor,0.6720,Neuroendocrine Carcinoma,0.6712,Malignant Endocrine Neoplasm,0.6699,Cecum Neuroendocrine Tumor,0.6692,CARCINOID-ENDOCRINE TUMOUR,True,True,True
CARCINOMA,Carcinoma,1,2,Carcinoma,1.0000,Adenocarcinoma,0.8693,Carcinoma Unspecified Site,0.8362,Solid Carcinoma,0.8030,Advanced Carcinoma,0.7995,Skin Carcinoma,0.7950,Invasive Carcinoma,0.7923,Carcinoma Simplex,0.7912,Carcinomatosis,0.7893,Secondary Carcinoma,0.7867,Cervical Carcinoma,0.7822,Malignant Neoplasm,0.7808,Metastatic Carcinoma,0.7668,Eye Carcinoma,0.7629,Papillary Carcinoma,0.7624,Undifferentiated Carcinoma,0.7597,Colorectal Carcinoma,0.7557,Gastric Carcinoma,0.7538,Colon Carcinoma,0.7530,Cervical Adenocarcinoma,0.7521,CARCINOMA,True,True,True
CARCINOMA OF UTERINE CERVIX,Cervical Carcinoma,1,2,Cervical Carcinoma,0.8325,Cervical Squamous Cell Carcinoma,0.7779,Cervical Adenocarcinoma,0.7457,Malignant Cervical Neoplasm,0.7250,Cervical Undifferentiated Carcinoma,0.7039,"Cervical Adenocarcinoma, Not Otherwise Specified",0.6772,Malignant Uterine Corpus Neoplasm,0.6769,Invasive Cervical Carcinoma,0.6734,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.6708,Carcinoma,0.6610,Cervical Non-Keratinizing Squamous Cell Carcinoma,0.6601,Malignant Uterine Neoplasm,0.6578,Early Stage Cervical Carcinoma,0.6554,Endometrial Carcinoma,0.6549,Advanced Cervical Carcinoma,0.6533,Tracheal Carcinoma,0.6532,Locally Advanced Cervical Carcinoma,0.6527,Uterine Corpus Neoplasm,0.6518,Cervical Keratinizing Squamous Cell Carcinoma,0.6484,Metastatic Carcinoma in the Uterine Cervix,0.6456,CARCINOMA OF UTERINE CERVIX,True,True,True
CARCINOMA SMALL CELL,Small Cell Neuroendocrine Carcinoma,5,2,Small Cell Adenocarcinoma,0.9059,"Malignant Tumor, Small Cell Type",0.8666,Lung Small Cell Carcinoma,0.8368,Small Cell Intermediate Cell Carcinoma,0.8354,Small Cell Neuroendocrine Carcinoma,0.8229,Non-Small Cell Carcinoma,0.8035,Ovarian Small Cell Carcinoma,0.7853,"Lung Small Cell Carcinoma, A Subtype",0.7673,Lung Small Cell Carcinoma Molecular Subtypes,0.7649,Non-Small Cell Adenocarcinoma,0.7546,Small Cell Sarcoma,0.7414,Kidney Small Cell Neuroendocrine Carcinoma,0.7392,Micropapillary Carcinoma,0.7357,Thyroid Gland Undifferentiated Small Cell Carcinoma,0.7341,Large Cell Carcinoma,0.7341,Occult Lung Small Cell Carcinoma,0.7337,Small Intestinal Small Cell Neuroendocrine Carcinoma,0.7259,"Lung Small Cell Carcinoma, I Subtype",0.7246,Gastric Small Cell Neuroendocrine Carcinoma,0.7237,Colon Small Cell Neuroendocrine Carcinoma,0.7230,CARCINOMA SMALL CELL,False,False,True
CARCINOMA WITH CHONDROID METAPLASIA,Breast Carcinoma with Chondroid Metaplasia,2,2,Adenocarcinoma with Cartilaginous Metaplasia,0.8908,Breast Carcinoma with Chondroid Metaplasia,0.8905,Adenocarcinoma with Cartilaginous and Osseous Metaplasia,0.8354,Chondroma,0.7766,Metaplastic Carcinoma,0.7548,Adenocarcinoma with Osseous Metaplasia,0.7526,Adenocarcinoma with Metaplasia,0.7451,Chondroid Chordoma,0.7432,Chondroid Lipoma,0.7327,Lung Chondroma,0.7290,Chondroblastoma,0.7219,Chondromatosis,0.7214,Chondrogenic Neoplasm,0.7213,Breast Carcinoma with Osseous Metaplasia,0.7174,Chondrosarcoma,0.7081,Intermediate Chondrogenic Neoplasm,0.7061,Soft Tissue Chondroma,0.7058,Laryngeal Chondroma,0.7052,Adenocarcinoma with Spindle Cell Metaplasia,0.7048,Sarcomatoid Carcinoma,0.7014,CARCINOMA WITH CHONDROID METAPLASIA,False,True,True
CARCINOMA WITH OSSEOUS METAPLASIA,Breast Carcinoma with Osseous Metaplasia,2,2,Adenocarcinoma with Osseous Metaplasia,0.9190,Breast Carcinoma with Osseous Metaplasia,0.8822,Adenocarcinoma with Cartilaginous and Osseous Metaplasia,0.8660,Adenocarcinoma with Cartilaginous Metaplasia,0.8119,Adenocarcinoma with Metaplasia,0.7668,Breast Carcinoma with Chondroid Metaplasia,0.7532,Metaplastic Carcinoma,0.7116,Metastatic Carcinoma in the Bone,0.6898,Osteogenic Neoplasm,0.6887,Carcinomatosis,0.6849,Adenocarcinoma with Squamous Metaplasia,0.6846,Osteoma,0.6787,Osteoblastoma,0.6780,Carcinoma,0.6777,Malignant Ossifying Fibromyxoid Tumor,0.6696,Conventional Osteosarcoma,0.6694,Odontogenic Carcinoma,0.6678,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.6661,Intermediate Osteogenic Neoplasm,0.6654,Adenocarcinoma with Spindle Cell Metaplasia,0.6652,CARCINOMA WITH OSSEOUS METAPLASIA,False,True,True
CARCINOMA WITH SQUAMOUS DIFFERENTIATION,Gallbladder Squamous Cell Carcinoma,99,2,Squamous Cell Carcinoma,0.8952,Squamous Cell Neoplasm,0.8025,Skin Squamous Cell Carcinoma,0.7728,Advanced Squamous Cell Carcinoma,0.7687,Adenocarcinoma with Squamous Metaplasia,0.7486,Spindle Cell Squamous Carcinoma,0.7311,Carcinoma,0.7247,Carcinoma Simplex,0.7155,Stage 0 Squamous Cell Carcinoma,0.7124,Benign Squamous Cell Neoplasm,0.7086,Cervical Squamous Cell Carcinoma,0.7025,"Squamous Cell Carcinoma, Clear Cell Type",0.6983,Superficial Spreading Adenocarcinoma,0.6980,Skin Carcinoma,0.6978,Adenosquamous Carcinoma,0.6926,Papillary Squamous Cell Carcinoma,0.6922,Cervical Squamous Neoplasm,0.6880,Keratinizing Squamous Cell Carcinoma,0.6877,Disseminated Squamous Cell Carcinoma,0.6851,Adenocarcinoma,0.6812,CARCINOMA WITH SQUAMOUS DIFFERENTIATION,False,False,False
"CARCINOMA, BRENNER",Brenner Tumor,1,2,Brenner Tumor,0.8926,Malignant Ovarian Brenner Tumor,0.8353,Ovarian Brenner Tumor,0.8305,Benign Ovarian Brenner Tumor,0.7851,Paratesticular Brenner Tumor,0.7741,Borderline Ovarian Brenner Tumor,0.7658,Recurrent Malignant Ovarian Brenner Tumor,0.7175,Refractory Malignant Ovarian Brenner Tumor,0.7052,Barrett Adenocarcinoma,0.6384,Breast Medullary Carcinoma,0.6331,Breast Carcinoma,0.6261,"Glycogen-Rich, Clear Cell Breast Carcinoma",0.6156,Breast Adenocarcinoma,0.6084,Broad Ligament Adenocarcinoma,0.6077,Colon Medullary Carcinoma,0.6077,Carcinoma,0.5989,Bilateral Carcinoma,0.5973,Male Breast Carcinoma,0.5965,Adenocarcinoma,0.5963,Endometrial Carcinoma,0.5941,"CARCINOMA, BRENNER",True,True,True
"CARCINOMA, FOLLICULAR",Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.8726,Childhood Thyroid Gland Follicular Carcinoma,0.7516,Thyroid Gland Papillary and Follicular Carcinoma,0.7395,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0.7341,Classic Follicular Lymphoma,0.7259,Thyroid Gland Carcinoma,0.7245,Follicular Lymphoma,0.7210,Cutaneous Follicular Lymphoma,0.7103,Follicular Variant Thyroid Gland Papillary Carcinoma,0.7025,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,0.7018,Skin Follicular Basal Cell Carcinoma,0.7002,Carcinoma,0.6969,Trichofollicular Carcinoma,0.6947,"Thyroid Gland Follicular Carcinoma, Clear Cell Variant",0.6888,Thyroid Gland Follicular Lymphoma,0.6853,Metastatic Thyroid Gland Follicular Carcinoma,0.6806,"Thyroid Gland Follicular Carcinoma, Minimally Invasive",0.6787,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,0.6726,"Malignant Lymphoma Follicular, Large Cleaved Cell Type",0.6694,Thyroid Gland Mixed Medullary and Follicular Carcinoma,0.6683,"CARCINOMA, FOLLICULAR",True,True,True
"CARCINOMA, GIANT CELL",Giant Cell Carcinoma,1,2,Giant Cell Carcinoma,0.9760,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.8292,Giant Cell and Spindle Cell Carcinoma,0.8205,Malignant Giant Cell Neoplasm,0.8166,Giant Cell Neoplasm,0.8136,Giant Cell Tumor,0.8135,Giant Cell Tumor of Bone,0.7750,Lung Giant Cell Carcinoma,0.7695,Malignancy in Giant Cell Tumor of Bone,0.7685,Laryngeal Giant Cell Carcinoma,0.7650,Glassy Cell Carcinoma,0.7566,Granular Cell Carcinoma,0.7502,Giant Cell Sarcoma,0.7221,Skin Squamous Cell Carcinoma with Osteoclast-Like Giant Cells,0.7219,Breast Carcinoma with Osteoclast-Like Stromal Giant Cells,0.7163,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,0.7155,Giant Cell Fibroblastoma,0.7142,Invasive Giant Cell Urothelial Carcinoma,0.7141,Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.7042,Giant Cell Tumor of Soft Tissue,0.6990,"CARCINOMA, GIANT CELL",True,True,True
"CARCINOMA, GINGIVAL",Gingival Carcinoma,1,2,Gingival Carcinoma,0.9654,Lower Gingival Carcinoma,0.8729,Upper Gingival Carcinoma,0.8665,Malignant Gingival Neoplasm,0.8388,Gingival Squamous Cell Carcinoma,0.8322,Gingival Neoplasm,0.7728,Upper Gingival Squamous Cell Carcinoma,0.7468,Gastric Carcinoma,0.7412,Lower Gingival Squamous Cell Carcinoma,0.7371,Tongue Carcinoma,0.7312,Salivary Gland Carcinoma,0.7147,Gingival Spindle Cell Carcinoma,0.7141,Carcinoma,0.6866,Upper Gingival Verrucous Carcinoma,0.6844,Giant Cell Carcinoma,0.6834,Lower Gingival Verrucous Carcinoma,0.6802,Odontogenic Carcinoma,0.6721,Gastric Adenocarcinoma,0.6703,Granular Cell Carcinoma,0.6694,Major Salivary Gland Carcinoma,0.6692,"CARCINOMA, GINGIVAL",True,True,True
"CARCINOMA, MUCOEPIDERMOID",Mucoepidermoid Carcinoma,1,2,Mucoepidermoid Carcinoma,0.9834,Skin Mucoepidermoid Carcinoma,0.9003,Salivary Gland Mucoepidermoid Carcinoma,0.8633,Lung Mucoepidermoid Carcinoma,0.8595,Breast Mucoepidermoid Carcinoma,0.8504,Cervical Mucoepidermoid Carcinoma,0.8497,Thyroid Gland Mucoepidermoid Carcinoma,0.8434,Major Salivary Gland Mucoepidermoid Carcinoma,0.8370,Parotid Gland Mucoepidermoid Carcinoma,0.8296,Paranasal Sinus Mucoepidermoid Carcinoma,0.8284,Lacrimal Gland Mucoepidermoid Carcinoma,0.8243,Esophageal Mucoepidermoid Carcinoma,0.8236,Oral Cavity Mucoepidermoid Carcinoma,0.8219,Minor Salivary Gland Mucoepidermoid Carcinoma,0.8180,Lacrimal Drainage System Mucoepidermoid Carcinoma,0.8159,Salivary Gland Low Grade Mucoepidermoid Carcinoma,0.8058,Salivary Gland High Grade Mucoepidermoid Carcinoma,0.7970,Submandibular Gland Mucoepidermoid Carcinoma,0.7958,Thymus Mucoepidermoid Carcinoma,0.7914,Laryngeal Mucoepidermoid Carcinoma,0.7875,"CARCINOMA, MUCOEPIDERMOID",True,True,True
"CARCINOMA, PAPILLARY",Papillary Carcinoma,1,2,Papillary Carcinoma,0.9636,Papillary Adenocarcinoma,0.8701,Thyroid Gland Papillary Carcinoma,0.8320,Papillary Squamous Cell Carcinoma,0.8161,Invasive Papillary Adenocarcinoma,0.8034,Papillary Neoplasm,0.7889,Breast Papillary Carcinoma,0.7845,Classic Thyroid Gland Papillary Carcinoma,0.7828,Papillary Transitional Cell Carcinoma,0.7822,Gastric Papillary Adenocarcinoma,0.7579,Lung Papillary Adenocarcinoma,0.7577,Papillary Epithelial Neoplasm,0.7545,Papillary Renal Cell Carcinoma,0.7511,Invasive Breast Papillary Carcinoma,0.7511,Carcinoma,0.7436,Penile Papillary Carcinoma,0.7429,Papillary Cystadenocarcinoma,0.7420,Papillary Adenoma,0.7379,Micropapillary Carcinoma,0.7310,Aggressive Papillary Tumor,0.7263,"CARCINOMA, PAPILLARY",True,True,True
"CARCINOMA, VULVAR",Vulvar Carcinoma,1,2,Vulvar Carcinoma,0.9714,Vulvar Adenocarcinoma,0.8898,Vulvar Squamous Cell Carcinoma,0.8803,Advanced Vulvar Carcinoma,0.8472,Vulvar Verrucous Carcinoma,0.8442,Malignant Vulvar Neoplasm,0.8349,Vulvar Neuroendocrine Carcinoma,0.8335,Vulvar Warty Carcinoma,0.8276,"Vulvar Squamous Cell Carcinoma, Not Otherwise Specified",0.8198,Vulvar Basal Cell Carcinoma,0.8168,Locally Advanced Vulvar Carcinoma,0.8153,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,0.8129,Vulvar Neoplasm,0.8126,Metastatic Vulvar Carcinoma,0.8121,Vulvar Melanoma,0.8114,Vulvar Sebaceous Carcinoma,0.8041,Vulvar Eccrine Carcinoma,0.7861,Recurrent Vulvar Carcinoma,0.7828,Vulvar Squamous Neoplasm,0.7822,Unresectable Vulvar Carcinoma,0.7819,"CARCINOMA, VULVAR",True,True,True
CARCINOSARCOMA-MALIGNANT_MESODERMAL_MIXED_TUMOUR,Carcinosarcoma,2,2,Metastatic Carcinosarcoma,0.7848,Carcinosarcoma,0.7788,Mixed Mesodermal (Mullerian) Tumor,0.7373,Advanced Carcinosarcoma,0.7313,"Malignant Mixed Tumor, Not Otherwise Specified",0.7199,Malignant Mixed Neoplasm,0.7070,"Uterine Carcinosarcoma, Heterologous Type",0.7039,Malignant Mesenchymoma,0.6999,Mixed Germ Cell-Sex Cord-Stromal Tumor,0.6664,Mixed Cell Type Gastrointestinal Stromal Tumor,0.6619,Lung Carcinosarcoma,0.6602,Uterine Carcinosarcoma,0.6587,"Uterine Carcinosarcoma, Homologous Type",0.6567,Cervical Carcinosarcoma,0.6533,Mesenchymoma,0.6522,Testicular Mixed Sex Cord-Stromal Tumor,0.6521,Combined Carcinoid and Adenocarcinoma,0.6515,Sarcomatoid Carcinoma,0.6507,Malignant Mixed Tumor of the Skin,0.6484,Ovarian Carcinosarcoma,0.6475,CARCINOSARCOMA-MALIGNANT_MESODERMAL_MIXED_TUMOUR,False,True,True
CARCINOSARCOMA-MAMMARY GLAND,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,99,2,Carcinosarcoma,0.8250,Salivary Gland Carcinosarcoma,0.7984,Metastatic Carcinosarcoma,0.7560,Parotid Gland Carcinosarcoma,0.7407,Uterine Carcinosarcoma,0.7407,Cervical Carcinosarcoma,0.7391,Advanced Carcinosarcoma,0.7381,Lung Carcinosarcoma,0.7251,Lacrimal Gland Carcinosarcoma,0.7189,Ovarian Carcinosarcoma,0.7153,Female Reproductive System Carcinosarcoma,0.7144,Gallbladder Carcinosarcoma,0.7031,Breast Sarcoma,0.7003,Breast Rhabdomyosarcoma,0.6736,Trichoblastic Carcinosarcoma,0.6724,Lymphosarcoma,0.6720,Fallopian Tube Carcinosarcoma,0.6700,Uterine Corpus Carcinosarcoma,0.6649,Metastatic Ovarian Carcinosarcoma,0.6633,Breast Secretory Carcinoma,0.6612,CARCINOSARCOMA-MAMMARY GLAND,False,False,False
CARCINOSARCOMA-MAMMARY GLAND; BREAST,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,99,2,Breast Sarcoma,0.7580,Breast Rhabdomyosarcoma,0.7336,Carcinosarcoma,0.7287,Salivary Gland Carcinosarcoma,0.7001,Breast Solid Neuroendocrine Carcinoma,0.6968,Metastatic Carcinosarcoma,0.6913,Breast Metaplastic Carcinoma,0.6891,Breast Malignant Myoepithelioma,0.6825,Gallbladder Carcinosarcoma,0.6823,Breast Adenocarcinoma with Squamous Metaplasia,0.6816,Metastatic Breast Carcinoma,0.6805,Breast Liposarcoma,0.6804,Breast Adenocarcinoma with Spindle Cell Metaplasia,0.6784,Breast Secretory Carcinoma,0.6758,Breast Carcinoma with Neuroendocrine Differentiation,0.6754,Breast Carcinoma with Chondroid Metaplasia,0.6747,Recurrent Breast Sarcoma,0.6725,Parotid Gland Carcinosarcoma,0.6697,Uterine Carcinosarcoma,0.6694,Breast Carcinoma with Osseous Metaplasia,0.6665,CARCINOSARCOMA-MAMMARY GLAND; BREAST,False,False,False
CASTRATION-RESISTANT PROSTATE CANCER,Castration-Resistant Prostate Carcinoma,1,2,Castration-Resistant Prostate Carcinoma,0.9854,Castration-Sensitive Prostate Carcinoma,0.9119,Unresectable Castration-Resistant Prostate Carcinoma,0.8700,Hormone-Resistant Prostate Carcinoma,0.8596,Castration-Naive Prostate Carcinoma,0.8476,Refractory Prostate Carcinoma,0.8286,Recurrent Castration-Sensitive Prostate Carcinoma,0.8260,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,0.8070,Refractory Prostate Adenocarcinoma,0.7928,Hormone-Resistant Breast Carcinoma,0.7191,Refractory Prostate Small Cell Neuroendocrine Carcinoma,0.7153,Refractory Adrenal Cortical Carcinoma,0.6933,Refractory Hormone Receptor-Positive Breast Carcinoma,0.6908,Advanced Prostate Carcinoma,0.6816,Biochemically Recurrent Prostate Carcinoma,0.6792,Refractory Penile Carcinoma,0.6784,Refractory Male Reproductive System Carcinoma,0.6697,Refractory Adenocarcinoma,0.6646,Refractory Triple-Negative Breast Carcinoma,0.6621,Refractory Carcinoma,0.6613,CASTRATION-RESISTANT PROSTATE CANCER,True,True,True
CCOV,Malignant Ovarian Clear Cell Tumor,3,2,Ovarian Clear Cell Tumor,0.9414,Ovarian Clear Cell Adenocarcinoma,0.9263,Malignant Ovarian Clear Cell Tumor,0.9194,Benign Ovarian Clear Cell Tumor,0.8656,Ovarian Clear Cell Cystadenocarcinoma,0.8418,Advanced Ovarian Clear Cell Adenocarcinoma,0.8276,Ovarian Carcinoma,0.8188,Borderline Ovarian Clear Cell Tumor,0.8027,Ovarian Clear Cell Adenocarcinofibroma,0.7924,Clear Cell Malignant Neoplasm,0.7835,Clear Cell Adenocarcinoma,0.7818,Ovarian Squamous Cell Carcinoma,0.7788,Clear Cell Neoplasm,0.7726,Metastatic Ovarian Clear Cell Adenocarcinoma,0.7679,Ovarian Transitional Cell Carcinoma,0.7610,Ovarian Small Cell Carcinoma,0.7560,Ovarian Adenocarcinoma,0.7539,Ovarian Undifferentiated Carcinoma,0.7468,Endometrial Clear Cell Adenocarcinoma,0.7419,Clear Cell Renal Cell Carcinoma,0.7386,Clear Cell Ovarian Cancer,False,True,True
CCRCC,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9873,Renal Cell Carcinoma,0.8902,Non-Clear Cell Renal Cell Carcinoma,0.8898,Advanced Clear Cell Renal Cell Carcinoma,0.8552,Early Stage Clear Cell Renal Cell Carcinoma,0.8477,Clear Cell Papillary Renal Tumor,0.8339,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.8272,Urinary Tract Clear Cell Adenocarcinoma,0.8240,Grade 1 Clear Cell Renal Cell Carcinoma,0.8199,Clear Cell Malignant Neoplasm,0.8094,Grade 2 Clear Cell Renal Cell Carcinoma,0.8085,Papillary Renal Cell Carcinoma,0.8072,Clear Cell Neoplasm,0.8060,Clear Cell Adenocarcinoma,0.8060,"Renal Cell Carcinoma, Not Otherwise Specified",0.8051,Hereditary Clear Cell Renal Cell Carcinoma,0.8045,Kidney Carcinoma,0.7994,Chromophobe Renal Cell Carcinoma,0.7935,Grade 3 Clear Cell Renal Cell Carcinoma,0.7896,Clear Cell Sarcoma of the Kidney,0.7894,Renal Clear Cell Carcinoma,True,True,True
CD30+_ANAPLASTIC_LARGE_CELL_LYMPHOMA,Anaplastic Large Cell Lymphoma,1,2,Anaplastic Large Cell Lymphoma,0.7287,Advanced Anaplastic Large Cell Lymphoma,0.7010,Systemic Anaplastic Large Cell Lymphoma,0.6993,Common Variant Anaplastic Large Cell Lymphoma,0.6987,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.6977,Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma,0.6842,"Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",0.6841,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage,0.6807,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",0.6679,Localized Anaplastic Large Cell Lymphoma,0.6668,Primary Cutaneous Anaplastic Large Cell Lymphoma,0.6642,Refractory Anaplastic Large Cell Lymphoma,0.6635,Adult Anaplastic Large Cell Lymphoma,0.6596,"Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",0.6568,ALK-Positive Large B-Cell Lymphoma,0.6554,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",0.6546,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.6521,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology",0.6498,Primary Central Nervous System Anaplastic Large Cell Lymphoma,0.6497,"Refractory Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",0.6464,CD30+_ANAPLASTIC_LARGE_CELL_LYMPHOMA,True,True,True
CELLULAR SCHWANNOMA,Cellular Schwannoma,1,2,Cellular Schwannoma,1.0000,Conventional Schwannoma,0.8974,Schwannoma,0.8896,Cellular Neurofibroma,0.8384,Skin Schwannoma,0.8247,Cardiac Schwannoma,0.8181,Bone Schwannoma,0.8173,Microcystic/Reticular Schwannoma,0.8168,Peripheral Nerve Schwannoma,0.8125,Ancient Schwannoma,0.8104,Schwannomatosis,0.8071,Plexiform Schwannoma,0.7946,Epithelioid Schwannoma,0.7911,Cellular Neurothekeoma,0.7858,Sympathetic Schwannoma,0.7822,Childhood Schwannoma,0.7790,Melanotic Schwannoma,0.7699,Intraocular Schwannoma,0.7595,Nerve Sheath Neoplasm,0.7483,Thyroid Gland Schwannoma,0.7463,CELLULAR SCHWANNOMA,True,True,True
CENTRAL NEUROCYTOMA,Central Neurocytoma,1,2,Central Neurocytoma,1.0000,Olfactory Neurocytoma,0.8001,Extraventricular Neurocytoma,0.7614,Sellar Neurocytoma,0.7343,Central Nervous System Ganglioneuroblastoma,0.7196,Cellular Neurothekeoma,0.7121,Central Nervous System Chondroma,0.7026,Neural Glioblastoma,0.6989,Central Nervous System Rhabdomyoma,0.6961,Neuroblastic Tumor,0.6841,Cerebellar Glioneuronal and Neuronal Tumors,0.6814,Central Nervous System Melanoma,0.6801,Central Nervous System Carcinoma,0.6778,Medullomyoblastoma,0.6755,Childhood Brain Ganglioneuroblastoma,0.6734,Central Nervous System Neoplasm,0.6713,Brain Neoplasm,0.6690,Central Nervous System Mesenchymal Chondrosarcoma,0.6640,Childhood Central Nervous System Ganglioneuroblastoma,0.6609,Central Nervous System Melanocytic Neoplasm,0.6605,CENTRAL NEUROCYTOMA,True,True,True
CENTROBLASTIC,Centroblastic Lymphoma,1,2,Centroblastic Lymphoma,0.9106,Diffuse Centroblastic-Centrocytic Lymphoma,0.7572,"Malignant Lymphoma Centroblastic, Follicular",0.7558,Refractory Centroblastic Lymphoma,0.6912,Centroblastic Lymphoma by Ann Arbor Stage,0.6752,Ann Arbor Stage IV Centroblastic Lymphoma,0.6715,Ann Arbor Stage I Centroblastic Lymphoma,0.6630,Recurrent Centroblastic Lymphoma,0.6580,Blastoma,0.6556,Plasmablastic Lymphoma,0.6517,Ann Arbor Stage III Centroblastic Lymphoma,0.6462,Ann Arbor Stage II Centroblastic Lymphoma,0.6214,Stage I Centroblastic Follicular Lymphoma,0.6214,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.6212,Classical Burkitt Lymphoma,0.6138,Blastic Granulocytic Sarcoma,0.6075,Chondroblastoma,0.5996,Advanced B-Cell Malignant Neoplasm,0.5990,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.5987,Lymphoplasmacytic Lymphoma,0.5942,CENTROBLASTIC,True,True,True
CERVICAL ADENOCARCINOMA,Cervical Adenocarcinoma,1,2,Cervical Adenocarcinoma,1.0000,Cervical Carcinoma,0.9112,"Cervical Adenocarcinoma, Not Otherwise Specified",0.8760,Advanced Cervical Adenocarcinoma,0.8679,Advanced Cervical Carcinoma,0.8232,Malignant Cervical Neoplasm,0.8173,Cervical Serous Adenocarcinoma,0.8165,Adenocarcinoma,0.8095,Cervical Esophagus Adenocarcinoma,0.8007,Cervical Mucinous Adenocarcinoma,0.7923,Metastatic Cervical Adenocarcinoma,0.7878,Human Papillomavirus-Related Cervical Adenocarcinoma,0.7872,Cervical Neoplasm,0.7825,Early Invasive Cervical Adenocarcinoma,0.7800,Cervical Squamous Cell Carcinoma,0.7732,Unresectable Cervical Adenocarcinoma,0.7724,Invasive Cervical Carcinoma,0.7676,Vaginal Adenocarcinoma,0.7634,Locally Advanced Cervical Adenocarcinoma,0.7569,Cervical Adenocarcinoma In Situ,0.7541,CERVICAL ADENOCARCINOMA,True,True,True
CERVICAL ADENOCARCINOMA IN SITU,Cervical Adenocarcinoma In Situ,1,2,Cervical Adenocarcinoma In Situ,1.0000,Adenocarcinoma In Situ,0.8475,Cervical Squamous Cell Carcinoma In Situ,0.8400,Human Papillomavirus-Independent Cervical Adenocarcinoma In Situ,0.8242,Carcinoma In Situ,0.8114,Human Papillomavirus-Related Cervical Adenocarcinoma In Situ,0.8100,Early Invasive Cervical Adenocarcinoma,0.8014,Cervical Intraepithelial Neoplasia,0.7611,Stage 0 Cervical Cancer AJCC v7,0.7557,Cervical Adenocarcinoma,0.7541,Stage 0 Cervical Cancer AJCC v6,0.7537,Tracheal Carcinoma In Situ,0.7513,Cervical Intraepithelial Neoplasia Grade 2/3,0.7426,Cervical Glandular Intraepithelial Neoplasia,0.7408,"Cervical Adenocarcinoma, Not Otherwise Specified",0.7327,Invasive Cervical Carcinoma,0.7298,Cervical Squamous Intraepithelial Neoplasia,0.7272,Lung Adenocarcinoma In Situ,0.7254,Low Grade Cervical Intraepithelial Neoplasia,0.7231,Cervical Squamous Intraepithelial Neoplasia 1,0.7150,CERVICAL ADENOCARCINOMA IN SITU,True,True,True
CERVICAL ADENOID CYSTIC CARCINOMA,Cervical Adenoid Cystic Carcinoma,1,2,Cervical Adenoid Cystic Carcinoma,1.0000,Adenoid Cystic Carcinoma,0.9202,Nasopharyngeal Adenoid Cystic Carcinoma,0.8568,Salivary Gland Adenoid Cystic Carcinoma,0.8541,Advanced Adenoid Cystic Carcinoma,0.8531,Breast Adenoid Cystic Carcinoma,0.8499,Tracheal Adenoid Cystic Carcinoma,0.8470,Lung Adenoid Cystic Carcinoma,0.8322,Submandibular Gland Adenoid Cystic Carcinoma,0.8210,Pharyngeal Adenoid Cystic Carcinoma,0.8198,Oral Cavity Adenoid Cystic Carcinoma,0.8175,Lacrimal Gland Adenoid Cystic Carcinoma,0.8155,Prostate Adenoid Cystic Carcinoma,0.8153,Laryngeal Adenoid Cystic Carcinoma,0.8147,Vaginal Adenoid Cystic Carcinoma,0.8146,Minor Salivary Gland Adenoid Cystic Carcinoma,0.8076,Major Salivary Gland Adenoid Cystic Carcinoma,0.8035,Skin Adenoid Cystic Carcinoma,0.8002,Tongue Adenoid Cystic Carcinoma,0.7962,Cervical Adenoid Basal Carcinoma,0.7913,CERVICAL ADENOID CYSTIC CARCINOMA,True,True,True
CERVICAL ADENOSQUAMOUS CARCINOMA,Cervical Adenosquamous Carcinoma,1,2,Cervical Adenosquamous Carcinoma,1.0000,Cervical Poorly Differentiated Adenosquamous Carcinoma,0.9028,Advanced Cervical Adenosquamous Carcinoma,0.9015,Adenosquamous Carcinoma,0.8714,Metastatic Cervical Adenosquamous Carcinoma,0.8460,Conjunctival Adenosquamous Carcinoma,0.8376,Vaginal Adenosquamous Carcinoma,0.8238,Endometrial Adenosquamous Carcinoma,0.8188,Skin Adenosquamous Carcinoma,0.8146,Salivary Gland Adenosquamous Carcinoma,0.8099,Breast Adenosquamous Carcinoma,0.8059,Laryngeal Adenosquamous Carcinoma,0.8047,Unresectable Cervical Adenosquamous Carcinoma,0.8047,Lung Adenosquamous Carcinoma,0.7960,Colon Adenosquamous Carcinoma,0.7935,Tongue Adenosquamous Carcinoma,0.7771,Gastric Adenosquamous Carcinoma,0.7700,Prostate Adenosquamous Carcinoma,0.7666,Human Papillomavirus-Related Adenosquamous Carcinoma,0.7638,Small Intestinal Adenosquamous Carcinoma,0.7633,CERVICAL ADENOSQUAMOUS CARCINOMA,True,True,True
CERVICAL CANCER,Cervical Carcinoma,1,2,Cervical Carcinoma,0.9626,Cervical Adenocarcinoma,0.8872,Cervical Neoplasm,0.8635,Malignant Cervical Neoplasm,0.8544,Invasive Cervical Carcinoma,0.8020,Cervical Squamous Cell Carcinoma,0.7987,Advanced Cervical Carcinoma,0.7922,Cervical Squamous Neoplasm,0.7878,"Cervical Adenocarcinoma, Not Otherwise Specified",0.7862,Early Stage Cervical Carcinoma,0.7611,Cervical Warty Carcinoma,0.7581,Human Papillomavirus-Related Cervical Carcinoma,0.7578,Cervical Glandular Neoplasm,0.7576,Cervical Melanoma,0.7477,Carcinoma,0.7425,Advanced Cervical Adenocarcinoma,0.7409,Human Papillomavirus-Related Cervical Adenocarcinoma,0.7360,Neck Carcinoma,0.7274,Metastatic Cervical Carcinoma,0.7209,Cervical Undifferentiated Carcinoma,0.7202,CERVICAL CANCER,True,True,True
"CERVICAL CANCER, NOS",Cervical Carcinoma,1,2,Cervical Carcinoma,0.9056,Malignant Cervical Neoplasm,0.8375,Cervical Adenocarcinoma,0.8283,Cervical Neoplasm,0.8117,"Cervical Adenocarcinoma, Not Otherwise Specified",0.8083,Cervical Squamous Cell Carcinoma,0.7702,Invasive Cervical Carcinoma,0.7602,Advanced Cervical Carcinoma,0.7479,Cervical Squamous Neoplasm,0.7424,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.7284,Carcinoma Unspecified Site,0.7188,Human Papillomavirus-Related Cervical Carcinoma,0.7120,Cervical Glandular Neoplasm,0.7081,Advanced Cervical Adenocarcinoma,0.6977,Early Stage Cervical Carcinoma,0.6948,Cervical Warty Carcinoma,0.6925,Human Papillomavirus-Related Cervical Adenocarcinoma,0.6871,Neck Carcinoma,0.6825,Cervical Melanoma,0.6807,Carcinoma,0.6758,"CERVICAL CANCER, NOS",True,True,True
CERVICAL CLEAR CELL CARCINOMA,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",4,2,Cervical Carcinoma,0.8011,Clear Cell Adenocarcinoma,0.7997,Cervical Squamous Cell Carcinoma,0.7944,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type",0.7574,"Squamous Cell Carcinoma, Clear Cell Type",0.7487,Vaginal Clear Cell Adenocarcinoma,0.7459,Clear Cell Neoplasm,0.7437,Clear Cell Malignant Neoplasm,0.7433,Salivary Gland Clear Cell Carcinoma,0.7403,Cervical Adenocarcinoma,0.7368,Endometrial Clear Cell Adenocarcinoma,0.7355,Urinary Tract Clear Cell Adenocarcinoma,0.7238,Clear Cell Renal Cell Carcinoma,0.7201,Cervical Non-Keratinizing Squamous Cell Carcinoma,0.7177,Water-Clear Cell Adenocarcinoma,0.7116,Cervical Undifferentiated Carcinoma,0.7113,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.7084,Clear Cell Odontogenic Carcinoma,0.7054,Cervical Papillary Squamous Cell Carcinoma,0.7052,Hepatocellular Clear Cell Carcinoma,0.7051,CERVICAL CLEAR CELL CARCINOMA,False,False,True
CERVICAL ENDOMETRIOID CARCINOMA,Cervical Endometrioid Adenocarcinoma,1,2,Cervical Endometrioid Adenocarcinoma,0.9611,Endometrioid Adenocarcinoma,0.8675,Endometrial Endometrioid Adenocarcinoma,0.8547,Endometrioid Tumor,0.8229,Ovarian Endometrioid Adenocarcinoma,0.8161,Endometrioid Stromal Sarcoma of the Cervix,0.7988,High Grade Endometrioid Adenocarcinoma,0.7849,Ovarian Endometrioid Tumor,0.7827,Malignant Ovarian Endometrioid Tumor,0.7798,Low Grade Endometrioid Adenocarcinoma,0.7794,Endometrial High Grade Endometrioid Adenocarcinoma,0.7755,Advanced Endometrial Endometrioid Adenocarcinoma,0.7750,Vaginal Endometrioid Adenocarcinoma,0.7724,Endometrial Low Grade Endometrioid Adenocarcinoma,0.7713,Advanced Endometrioid Adenocarcinoma,0.7698,"Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.7661,Endometrial Endometrioid Adenocarcinoma with Metaplastic Changes,0.7582,Metastatic Endometrioid Adenocarcinoma,0.7547,FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma,0.7531,FIGO Grade 2 Endometrioid Adenocarcinoma,0.7516,CERVICAL ENDOMETRIOID CARCINOMA,True,True,True
CERVICAL NEUROENDOCRINE TUMOR,Cervical Neuroendocrine Tumor,1,2,Cervical Neuroendocrine Tumor,1.0000,Cervical Neuroendocrine Neoplasm,0.9648,Cervical Neuroendocrine Carcinoma,0.8640,Cervical Neuroendocrine Tumor G1,0.8550,Cervical Neuroendocrine Tumor G2,0.8440,Neuroendocrine Tumor,0.8050,Neuroendocrine Neoplasm,0.7866,Head and Neck Neuroendocrine Tumor,0.7757,Cervical Small Cell Neuroendocrine Carcinoma,0.7708,Cecum Neuroendocrine Tumor,0.7639,Colorectal Neuroendocrine Tumor,0.7562,Colon Neuroendocrine Tumor,0.7542,Neuroendocrine Carcinoma,0.7496,Head and Neck Neuroendocrine Neoplasm,0.7460,Neuroendocrine Tumor G2,0.7453,Cervical Large Cell Neuroendocrine Carcinoma,0.7452,Cauda Equina Neuroendocrine Tumor,0.7400,Pituitary Neuroendocrine Tumor,0.7338,Colorectal Neuroendocrine Neoplasm,0.7331,Corticotroph Pituitary Neuroendocrine Tumor,0.7302,CERVICAL NEUROENDOCRINE TUMOR,True,True,True
CERVICAL SQUAMOUS CELL,Cervical Squamous Cell Carcinoma,1,2,Cervical Squamous Cell Carcinoma,0.9118,Cervical Squamous Neoplasm,0.8592,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.8195,Cervical Carcinoma,0.7777,Cervical Squamous Papilloma,0.7744,Advanced Cervical Squamous Cell Carcinoma,0.7646,Cervical Esophagus Squamous Cell Carcinoma,0.7606,Cervical Non-Keratinizing Squamous Cell Carcinoma,0.7546,Cervical Keratinizing Squamous Cell Carcinoma,0.7466,Cervical Squamous Cell Carcinoma In Situ,0.7465,Squamous Cell Carcinoma,0.7359,Cervical Papillary Squamous Cell Carcinoma,0.7312,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,0.7179,Cervical Adenocarcinoma,0.7165,Cervical Undifferentiated Carcinoma,0.7126,Cervical Adenosquamous Carcinoma,0.7091,Cervical Warty Carcinoma,0.7083,Cervical Serous Adenocarcinoma,0.7081,Cervical Basaloid Squamous Cell Carcinoma,0.7076,Squamous Cell Neoplasm,0.7044,CERVICAL SQUAMOUS CELL,True,True,True
CERVICAL SQUAMOUS CELL CARCINOMA,Cervical Squamous Cell Carcinoma,1,2,Cervical Squamous Cell Carcinoma,1.0000,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.8816,Cervical Carcinoma,0.8539,Cervical Squamous Neoplasm,0.8499,Advanced Cervical Squamous Cell Carcinoma,0.8340,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,0.8059,Cervical Esophagus Squamous Cell Carcinoma,0.8053,Cervical Non-Keratinizing Squamous Cell Carcinoma,0.8049,Cervical Papillary Squamous Cell Carcinoma,0.7995,Cervical Keratinizing Squamous Cell Carcinoma,0.7820,Cervical Adenocarcinoma,0.7732,Cervical Squamous Cell Carcinoma In Situ,0.7699,Squamous Cell Carcinoma,0.7591,Cervical Squamous Papilloma,0.7579,Locally Advanced Cervical Squamous Cell Carcinoma,0.7522,Cervical Adenosquamous Carcinoma,0.7408,Cervical Warty Carcinoma,0.7398,Cervical Serous Adenocarcinoma,0.7360,Vaginal Squamous Cell Carcinoma,0.7335,Cervical Undifferentiated Carcinoma,0.7262,CERVICAL SQUAMOUS CELL CARCINOMA,True,True,True
CERVICAL_ADENOCARCINOMA,Cervical Adenocarcinoma,1,2,Cervical Adenocarcinoma,0.9589,"Cervical Adenocarcinoma, Not Otherwise Specified",0.9056,Cervical Carcinoma,0.8669,Advanced Cervical Adenocarcinoma,0.8506,Adenocarcinoma,0.8113,Malignant Cervical Neoplasm,0.8076,Advanced Cervical Carcinoma,0.8021,Cervical Esophagus Adenocarcinoma,0.7776,Cervical Serous Adenocarcinoma,0.7742,Human Papillomavirus-Related Cervical Adenocarcinoma,0.7656,Cervical Mucinous Adenocarcinoma,0.7604,Metastatic Cervical Adenocarcinoma,0.7590,Unresectable Cervical Adenocarcinoma,0.7576,Early Invasive Cervical Adenocarcinoma,0.7530,Cervical Neoplasm,0.7514,Carcinoma,0.7506,Cervical Adenocarcinoma In Situ,0.7377,Vaginal Adenocarcinoma,0.7338,Invasive Cervical Carcinoma,0.7337,Locally Advanced Cervical Adenocarcinoma,0.7314,CERVICAL_ADENOCARCINOMA,True,True,True
CERVICAL_CARCINOMA,Cervical Carcinoma,1,2,Cervical Carcinoma,0.9428,Cervical Adenocarcinoma,0.8544,Malignant Cervical Neoplasm,0.8421,"Cervical Adenocarcinoma, Not Otherwise Specified",0.8164,Invasive Cervical Carcinoma,0.7968,Cervical Neoplasm,0.7956,Carcinoma,0.7908,Advanced Cervical Carcinoma,0.7899,Cervical Squamous Cell Carcinoma,0.7847,Carcinoma Unspecified Site,0.7686,Cervical Undifferentiated Carcinoma,0.7595,Neck Carcinoma,0.7429,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.7424,Advanced Cervical Adenocarcinoma,0.7348,Early Stage Cervical Carcinoma,0.7293,Human Papillomavirus-Related Cervical Carcinoma,0.7286,Unresectable Cervical Carcinoma,0.7205,Cervical Squamous Neoplasm,0.7200,Metastatic Cervical Carcinoma,0.7196,Cervical Warty Carcinoma,0.7185,CERVICAL_CARCINOMA,True,True,True
CERVICAL_SMALL_CELL,Cervical Small Cell Neuroendocrine Carcinoma,1,2,Cervical Small Cell Neuroendocrine Carcinoma,0.7585,Cervical Undifferentiated Carcinoma,0.7169,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.7067,Cervical Squamous Cell Carcinoma,0.6892,Early Stage Cervical Carcinoma,0.6858,Small Cell Adenocarcinoma,0.6761,Microinvasive Cervical Squamous Cell Carcinoma,0.6713,Cervical Carcinoma,0.6696,"Malignant Tumor, Small Cell Type",0.6691,Cervical Carcinosarcoma,0.6564,Cervical Squamous Cell Carcinoma In Situ,0.6552,Non-Small Cell Carcinoma,0.6484,Cervical Melanoma,0.6429,Cervical Neuroendocrine Carcinoma,0.6424,Small Cell Intermediate Cell Carcinoma,0.6415,Vaginal Small Cell Neuroendocrine Carcinoma,0.6391,Stage 0 Cervical Cancer AJCC v6,0.6377,Ovarian Small Cell Carcinoma,0.6370,Cervical Non-Keratinizing Squamous Cell Carcinoma,0.6354,Small Cell Neuroendocrine Carcinoma,0.6287,CERVICAL_SMALL_CELL,True,True,True
CERVICAL_SQUAMOUS,Cervical Squamous Neoplasm,1,2,Cervical Squamous Neoplasm,0.8398,Cervical Squamous Cell Carcinoma,0.8008,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.7720,Cervical Carcinoma,0.7550,Cervical Squamous Papilloma,0.7532,Advanced Cervical Squamous Cell Carcinoma,0.7229,Malignant Cervical Neoplasm,0.7171,Cervical Sarcoma,0.7093,Squamous Cell Carcinoma,0.7060,Cervical Adenocarcinoma,0.7047,Cervical Squamous Cell Carcinoma In Situ,0.7039,Cervical Undifferentiated Carcinoma,0.6947,Cervical Non-Keratinizing Squamous Cell Carcinoma,0.6940,"Cervical Adenocarcinoma, Not Otherwise Specified",0.6923,Cervical Warty Carcinoma,0.6897,Cervical Adenosquamous Carcinoma,0.6891,Cervical Squamous Intraepithelial Neoplasia,0.6871,Carcinoma Simplex,0.6843,Squamous Cell Neoplasm,0.6820,Advanced Cervical Carcinoma,0.6816,CERVICAL_SQUAMOUS,True,True,True
CESC,Cervical Squamous Cell Carcinoma,1,2,Cervical Squamous Cell Carcinoma,1.0000,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.8816,Cervical Carcinoma,0.8539,Cervical Squamous Neoplasm,0.8499,Advanced Cervical Squamous Cell Carcinoma,0.8340,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,0.8059,Cervical Esophagus Squamous Cell Carcinoma,0.8053,Cervical Non-Keratinizing Squamous Cell Carcinoma,0.8049,Cervical Papillary Squamous Cell Carcinoma,0.7995,Cervical Keratinizing Squamous Cell Carcinoma,0.7820,Cervical Adenocarcinoma,0.7732,Cervical Squamous Cell Carcinoma In Situ,0.7699,Squamous Cell Carcinoma,0.7591,Cervical Squamous Papilloma,0.7579,Locally Advanced Cervical Squamous Cell Carcinoma,0.7522,Cervical Adenosquamous Carcinoma,0.7408,Cervical Warty Carcinoma,0.7398,Cervical Serous Adenocarcinoma,0.7360,Vaginal Squamous Cell Carcinoma,0.7335,Cervical Undifferentiated Carcinoma,0.7262,Cervical Squamous Cell Carcinoma,True,True,True
CESC_SQUAMOUSCARCINOMA,Cervical Squamous Cell Carcinoma,99,2,Squamoid Eccrine Ductal Carcinoma,0.6783,Squamous Cell Carcinoma,0.6718,Cervical Undifferentiated Carcinoma,0.6706,Sebaceous Carcinoma,0.6659,Skin Adenoid Cystic Carcinoma,0.6621,Sarcomatoid Carcinoma,0.6598,Cervical Squamotransitional Carcinoma,0.6523,Carcinoma Simplex,0.6523,Spindle Cell Squamous Carcinoma,0.6437,Cervical Lymphoepithelioma-Like Carcinoma,0.6426,Carcinoma,0.6418,Conjunctival Sebaceous Carcinoma,0.6400,Skin Squamous Cell Carcinoma,0.6388,Acantholytic Squamous Cell Carcinoma,0.6388,Cervical Carcinosarcoma,0.6375,Cervical Adenosquamous Carcinoma,0.6345,Skin Adenosquamous Carcinoma,0.6338,Serous Endometrial Intraepithelial Carcinoma,0.6326,Extraocular Sebaceous Carcinoma,0.6271,Cervical Adenoid Cystic Carcinoma,0.6271,CESC_SQUAMOUSCARCINOMA,False,False,False
CHOL,Cholangiocarcinoma,1,2,Cholangiocarcinoma,1.0000,Intrahepatic Cholangiocarcinoma,0.9069,Advanced Cholangiocarcinoma,0.8789,Adult Cholangiocarcinoma,0.8763,Distal Cholangiocarcinoma,0.8687,Hilar Cholangiocarcinoma,0.8482,Advanced Intrahepatic Cholangiocarcinoma,0.8456,Unresectable Cholangiocarcinoma,0.8435,Metastatic Cholangiocarcinoma,0.8355,Clear Cell Intrahepatic Cholangiocarcinoma,0.8147,Small Duct Intrahepatic Cholangiocarcinoma,0.8052,Metastatic Intrahepatic Cholangiocarcinoma,0.8052,Locally Advanced Cholangiocarcinoma,0.8033,Large Duct Intrahepatic Cholangiocarcinoma,0.8029,Mucin-Producing Intrahepatic Cholangiocarcinoma,0.7998,Advanced Hilar Cholangiocarcinoma,0.7893,Unresectable Intrahepatic Cholangiocarcinoma,0.7881,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.7834,Advanced Distal Cholangiocarcinoma,0.7717,Locally Advanced Intrahepatic Cholangiocarcinoma,0.7687,Cholangiocarcinoma,True,True,True
CHOL EXTRA,Extrahepatic Bile Duct Adenocarcinoma,99,2,Cholangiocarcinoma,0.6108,Composite Lymphoma,0.5858,Metastatic Cholangiocarcinoma,0.5818,Gallbladder Lymphoma,0.5713,Advanced Cholangiocarcinoma,0.5696,Mixed Carcinoma,0.5694,Disseminated Adenocarcinoma,0.5554,Distal Cholangiocarcinoma,0.5510,Ectopic Meningioma,0.5496,Secondary Carcinoma,0.5487,Metastatic Carcinoma,0.5484,Disseminated Carcinoma,0.5480,Metastatic Gallbladder Carcinoma,0.5479,Gallbladder Carcinosarcoma,0.5475,Oligometastatic Intrahepatic Cholangiocarcinoma,0.5458,Advanced Gallbladder Carcinoma,0.5438,Multicystic Mesothelioma,0.5431,Gallbladder Undifferentiated Carcinoma,0.5428,Bilateral Carcinoma,0.5420,Cecum Lymphoma,0.5415,CHOL EXTRA,False,False,False
CHOL INTRA,Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,0.6843,Cholangiocarcinoma,0.6444,Advanced Intrahepatic Cholangiocarcinoma,0.6362,Liver and Intrahepatic Bile Duct Carcinoma,0.6167,Biliary Intraepithelial Neoplasia,0.6150,Large Duct Intrahepatic Cholangiocarcinoma,0.6131,Small Duct Intrahepatic Cholangiocarcinoma,0.6098,Advanced Cholangiocarcinoma,0.6024,Liver Carcinoma,0.6014,Locally Advanced Intrahepatic Cholangiocarcinoma,0.5956,Carcinoma In Situ,0.5948,Metastatic Intrahepatic Cholangiocarcinoma,0.5945,Clear Cell Intrahepatic Cholangiocarcinoma,0.5908,Mucin-Producing Intrahepatic Cholangiocarcinoma,0.5903,Intrahepatic Bile Duct Adenoma,0.5890,Distal Cholangiocarcinoma,0.5878,Hilar Cholangiocarcinoma,0.5847,Gallbladder Biliary Intraepithelial Neoplasia,0.5844,Gallbladder Lymphoma,0.5844,Invasive Carcinoma,0.5838,CHOL INTRA,True,True,True
CHOLANGIO EXTRAHEPATIC,Extrahepatic Bile Duct Adenocarcinoma,3,2,Extrahepatic Bile Duct Carcinoma,0.7303,Extrahepatic Bile Duct Undifferentiated Carcinoma,0.7004,Extrahepatic Bile Duct Adenocarcinoma,0.6970,Benign Extrahepatic Bile Duct Neoplasm,0.6889,Cholangiocarcinoma,0.6865,Distal Cholangiocarcinoma,0.6848,Extrahepatic Bile Duct Lymphoma,0.6801,Extrahepatic Bile Duct Neuroendocrine Carcinoma,0.6748,Metastatic Cholangiocarcinoma,0.6721,Unresectable Extrahepatic Bile Duct Carcinoma,0.6711,Metastatic Extrahepatic Bile Duct Carcinoma,0.6683,Malignant Extrahepatic Bile Duct Neoplasm,0.6648,Advanced Extrahepatic Bile Duct Carcinoma,0.6628,Extrahepatic Bile Duct Carcinosarcoma,0.6614,Extrahepatic Bile Duct Neoplasm,0.6568,Localized Extrahepatic Bile Duct Carcinoma,0.6553,Extrahepatic Bile Duct Adenoma,0.6538,Unresectable Cholangiocarcinoma,0.6529,Hilar Cholangiocarcinoma,0.6514,"Extrahepatic Bile Duct Adenocarcinoma, Biliary Type",0.6487,CHOLANGIO EXTRAHEPATIC,False,True,True
CHOLANGIO INTRAHEPATIC,Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,0.8354,Unresectable Intrahepatic Cholangiocarcinoma,0.7567,Small Duct Intrahepatic Cholangiocarcinoma,0.7537,Advanced Intrahepatic Cholangiocarcinoma,0.7502,Metastatic Intrahepatic Cholangiocarcinoma,0.7455,Clear Cell Intrahepatic Cholangiocarcinoma,0.7427,Cholangiocarcinoma,0.7378,Large Duct Intrahepatic Cholangiocarcinoma,0.7349,Mucin-Producing Intrahepatic Cholangiocarcinoma,0.7237,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,0.7208,Unresectable Cholangiocarcinoma,0.7207,Locally Advanced Intrahepatic Cholangiocarcinoma,0.7160,Stage I Intrahepatic Cholangiocarcinoma AJCC v7,0.7124,Hilar Cholangiocarcinoma,0.7123,Liver and Intrahepatic Bile Duct Carcinoma,0.7050,Stage IA Intrahepatic Cholangiocarcinoma AJCC v8,0.6929,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7,0.6928,Cholangiolocellular Carcinoma,0.6882,Stage I Intrahepatic Bile Duct Cancer AJCC v8,0.6882,Intrahepatic Bile Duct Adenoma,0.6848,CHOLANGIO INTRAHEPATIC,True,True,True
CHOLANGIOCARCINOMA,Cholangiocarcinoma,1,2,Cholangiocarcinoma,1.0000,Intrahepatic Cholangiocarcinoma,0.9069,Advanced Cholangiocarcinoma,0.8789,Adult Cholangiocarcinoma,0.8763,Distal Cholangiocarcinoma,0.8687,Hilar Cholangiocarcinoma,0.8482,Advanced Intrahepatic Cholangiocarcinoma,0.8456,Unresectable Cholangiocarcinoma,0.8435,Metastatic Cholangiocarcinoma,0.8355,Clear Cell Intrahepatic Cholangiocarcinoma,0.8147,Small Duct Intrahepatic Cholangiocarcinoma,0.8052,Metastatic Intrahepatic Cholangiocarcinoma,0.8052,Locally Advanced Cholangiocarcinoma,0.8033,Large Duct Intrahepatic Cholangiocarcinoma,0.8029,Mucin-Producing Intrahepatic Cholangiocarcinoma,0.7998,Advanced Hilar Cholangiocarcinoma,0.7893,Unresectable Intrahepatic Cholangiocarcinoma,0.7881,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.7834,Advanced Distal Cholangiocarcinoma,0.7717,Locally Advanced Intrahepatic Cholangiocarcinoma,0.7687,CHOLANGIOCARCINOMA,True,True,True
"CHOLANGIOCARCINOMA, INTRAHEPATIC",Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,0.9705,Clear Cell Intrahepatic Cholangiocarcinoma,0.8924,Advanced Intrahepatic Cholangiocarcinoma,0.8818,Small Duct Intrahepatic Cholangiocarcinoma,0.8698,Cholangiocarcinoma,0.8692,Unresectable Intrahepatic Cholangiocarcinoma,0.8663,Large Duct Intrahepatic Cholangiocarcinoma,0.8557,Mucin-Producing Intrahepatic Cholangiocarcinoma,0.8500,Metastatic Intrahepatic Cholangiocarcinoma,0.8468,Locally Advanced Intrahepatic Cholangiocarcinoma,0.8412,Hilar Cholangiocarcinoma,0.8258,Sarcomatoid Intrahepatic Cholangiocarcinoma,0.8211,Unresectable Cholangiocarcinoma,0.8166,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7,0.8023,Oligometastatic Intrahepatic Cholangiocarcinoma,0.7943,Signet Ring Cell Intrahepatic Cholangiocarcinoma,0.7803,Unresectable Hilar Cholangiocarcinoma,0.7795,Stage I Intrahepatic Cholangiocarcinoma AJCC v7,0.7783,Advanced Cholangiocarcinoma,0.7716,Distal Cholangiocarcinoma,0.7709,"CHOLANGIOCARCINOMA, INTRAHEPATIC",True,True,True
CHOLANGIOCARCINOMA; DISTAL,Distal Cholangiocarcinoma,1,2,Distal Cholangiocarcinoma,0.9586,Advanced Distal Cholangiocarcinoma,0.8977,Metastatic Distal Cholangiocarcinoma,0.8730,Unresectable Distal Cholangiocarcinoma,0.8259,Cholangiocarcinoma,0.8213,Advanced Cholangiocarcinoma,0.8173,Metastatic Cholangiocarcinoma,0.8131,Hilar Cholangiocarcinoma,0.7984,Distal Bile Duct Carcinoma,0.7935,Adult Cholangiocarcinoma,0.7879,Advanced Hilar Cholangiocarcinoma,0.7877,Large Duct Intrahepatic Cholangiocarcinoma,0.7862,Advanced Intrahepatic Cholangiocarcinoma,0.7855,Recurrent Distal Cholangiocarcinoma,0.7833,Metastatic Intrahepatic Cholangiocarcinoma,0.7734,Intrahepatic Cholangiocarcinoma,0.7725,Refractory Distal Cholangiocarcinoma,0.7677,Small Duct Intrahepatic Cholangiocarcinoma,0.7647,Metastatic Hilar Cholangiocarcinoma,0.7597,Unresectable Cholangiocarcinoma,0.7377,CHOLANGIOCARCINOMA; DISTAL,True,True,True
CHOLANGIOCARCINOMA; HILAR/PERIHILAR,Hilar Cholangiocarcinoma,1,2,Hilar Cholangiocarcinoma,0.8533,Advanced Hilar Cholangiocarcinoma,0.8190,Unresectable Hilar Cholangiocarcinoma,0.7774,Metastatic Hilar Cholangiocarcinoma,0.7571,Cholangiocarcinoma,0.7506,Hilar Cholangiocarcinoma by AJCC v7 Stage,0.7487,Intrahepatic Cholangiocarcinoma,0.7409,Locally Advanced Cholangiocarcinoma,0.7385,Advanced Cholangiocarcinoma,0.7356,Advanced Intrahepatic Cholangiocarcinoma,0.7345,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.7333,Hilar Cholangiocarcinoma by AJCC v8 Stage,0.7278,Stage 0 Hilar Cholangiocarcinoma AJCC v7,0.7273,Distal Cholangiocarcinoma,0.7264,Unresectable Cholangiocarcinoma,0.7150,Large Duct Intrahepatic Cholangiocarcinoma,0.7121,Clear Cell Intrahepatic Cholangiocarcinoma,0.7106,Adult Cholangiocarcinoma,0.7073,Locally Advanced Intrahepatic Cholangiocarcinoma,0.7073,Cholangiolocellular Carcinoma,0.7053,CHOLANGIOCARCINOMA; HILAR/PERIHILAR,True,True,True
CHOLANGIOCARCINOMA; INTRAHEPATIC,Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,0.9673,Advanced Intrahepatic Cholangiocarcinoma,0.8889,Clear Cell Intrahepatic Cholangiocarcinoma,0.8836,Cholangiocarcinoma,0.8720,Unresectable Intrahepatic Cholangiocarcinoma,0.8707,Small Duct Intrahepatic Cholangiocarcinoma,0.8662,Large Duct Intrahepatic Cholangiocarcinoma,0.8556,Metastatic Intrahepatic Cholangiocarcinoma,0.8518,Mucin-Producing Intrahepatic Cholangiocarcinoma,0.8498,Hilar Cholangiocarcinoma,0.8403,Locally Advanced Intrahepatic Cholangiocarcinoma,0.8380,Unresectable Cholangiocarcinoma,0.8296,Sarcomatoid Intrahepatic Cholangiocarcinoma,0.8077,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7,0.7996,Unresectable Hilar Cholangiocarcinoma,0.7967,Advanced Cholangiocarcinoma,0.7939,Oligometastatic Intrahepatic Cholangiocarcinoma,0.7914,Distal Cholangiocarcinoma,0.7855,Advanced Hilar Cholangiocarcinoma,0.7823,Locally Advanced Cholangiocarcinoma,0.7805,CHOLANGIOCARCINOMA; INTRAHEPATIC,True,True,True
CHONDROBLASTIC OSTEOSARCOMA,Chondroblastic Osteosarcoma,1,2,Chondroblastic Osteosarcoma,1.0000,Chondroblastoma,0.7750,Conventional Osteosarcoma,0.7706,Fibroblastic Osteosarcoma,0.7595,Osteoblastic Osteosarcoma,0.7481,Metastasizing Chondroblastoma,0.7442,Osteosarcoma,0.7425,Mixed Osteosarcoma,0.7309,Giant Cell-Rich Osteosarcoma,0.7296,Small Cell Osteosarcoma,0.7288,Cardiac Extraskeletal Osteosarcoma,0.7268,Bone Osteosarcoma,0.7205,Childhood Conventional Osteosarcoma,0.7149,Chondrosarcoma,0.7107,Extraskeletal Osteosarcoma,0.7059,Mesenchymal Chondrosarcoma of Bone,0.7024,Metastatic Osteosarcoma,0.6965,Childhood Chondroblastoma,0.6956,Clear Cell Chondrosarcoma,0.6943,Secondary Osteosarcoma,0.6915,CHONDROBLASTIC OSTEOSARCOMA,True,True,True
CHONDROBLASTOMA,Chondroblastoma,1,2,Chondroblastoma,1.0000,Childhood Chondroblastoma,0.8773,Maxillofacial Chondroblastoma,0.8227,Chondroma,0.8185,Metastasizing Chondroblastoma,0.8091,Chondroblastic Osteosarcoma,0.7750,Mediastinal Chondroma,0.7724,Soft Tissue Chondroma,0.7638,Chondrogenic Neoplasm,0.7637,Chondroid Chordoma,0.7631,Lung Chondroma,0.7546,Chondrosarcoma,0.7533,Mesenchymal Chondrosarcoma,0.7498,Chondromatosis,0.7489,Mesenchymal Chondrosarcoma of Bone,0.7451,Maxillofacial Chondroma,0.7449,Benign Chondrogenic Neoplasm,0.7285,Chondroid Lipoma,0.7280,Laryngeal Chondroma,0.7262,Central Nervous System Chondroma,0.7152,CHONDROBLASTOMA,True,True,True
CHONDROSARCOMA,Chondrosarcoma,1,2,Chondrosarcoma,1.0000,Mesenchymal Chondrosarcoma,0.9335,Mesenchymal Chondrosarcoma of Bone,0.9102,Synovial Chondrosarcoma,0.8977,Localized Chondrosarcoma,0.8650,Chondrosarcoma NCI Grade 1,0.8597,Secondary Chondrosarcoma,0.8537,"Chondrosarcoma, Grade 1",0.8535,Adult Mesenchymal Chondrosarcoma,0.8486,Childhood Chondrosarcoma,0.8412,Chondrosarcoma NCI Grade 2,0.8394,Clear Cell Chondrosarcoma,0.8378,Chondrosarcoma NCI Grade 3,0.8286,Mesenchymal Extraskeletal Chondrosarcoma,0.8257,"Chondrosarcoma, Grade 2",0.8248,"Chondrosarcoma, Grade 3",0.8172,Central Nervous System Mesenchymal Chondrosarcoma,0.8155,Childhood Mesenchymal Chondrosarcoma,0.8115,Primary Central Chondrosarcoma,0.8113,Periosteal Chondrosarcoma,0.7945,CHONDROSARCOMA,True,True,True
CHORDOMA,Chordoma,1,2,Chordoma,1.0000,Conventional Chordoma,0.9517,Spinal Chordoma,0.9364,Thoracic Chordoma,0.8896,Childhood Chordoma,0.8856,Advanced Chordoma,0.8776,Chondroid Chordoma,0.8721,Poorly Differentiated Chordoma,0.8480,Chordoid Glioma,0.8247,Metastatic Chordoma,0.8166,Sacral Chordoma,0.8084,Skull Base Chordoma,0.8045,Dedifferentiated Chordoma,0.8034,Chordoid Meningioma,0.8027,Sellar Chordoma,0.7921,Refractory Chordoma,0.7881,Unresectable Chordoma,0.7838,Clivus Chordoma,0.7719,Recurrent Chordoma,0.7645,Locally Advanced Chordoma,0.7612,CHORDOMA,True,True,True
"CHORDOMA, SACRAL",Sacral Chordoma,1,2,Sacral Chordoma,0.9750,Spinal Chordoma,0.8300,Chordoma,0.7792,Conventional Chordoma,0.7701,Thoracic Chordoma,0.7500,Advanced Chordoma,0.7426,Childhood Chordoma,0.7414,Skull Base Chordoma,0.7244,Sacral Spinal Cord Meningioma,0.7061,Sellar Chordoma,0.6992,Chondroid Chordoma,0.6956,Clivus Chordoma,0.6948,Unresectable Chordoma,0.6825,Locally Advanced Chordoma,0.6812,Poorly Differentiated Chordoma,0.6805,Chordoid Glioma,0.6741,Chordoid Meningioma,0.6688,Sacral Spine Neoplasm,0.6682,Metastatic Chordoma,0.6653,Clivus Chondroid Chordoma,0.6651,"CHORDOMA, SACRAL",True,True,True
CHORDOMA_SACRAL,Sacral Chordoma,1,2,Sacral Chordoma,0.9601,Spinal Chordoma,0.8345,Chordoma,0.7887,Conventional Chordoma,0.7793,Advanced Chordoma,0.7529,Thoracic Chordoma,0.7492,Childhood Chordoma,0.7416,Skull Base Chordoma,0.7323,Unresectable Chordoma,0.7167,Sacral Spinal Cord Meningioma,0.7102,Sellar Chordoma,0.6955,Metastatic Chordoma,0.6949,Locally Advanced Chordoma,0.6930,Clivus Chordoma,0.6922,Chondroid Chordoma,0.6906,Chordoid Meningioma,0.6842,Chordoid Glioma,0.6803,Refractory Chordoma,0.6787,Poorly Differentiated Chordoma,0.6748,Sacral Spine Neoplasm,0.6685,CHORDOMA_SACRAL,True,True,True
CHORIOCARCINOMA,Choriocarcinoma,1,2,Choriocarcinoma,1.0000,Placental Choriocarcinoma,0.9251,Gestational Choriocarcinoma,0.9066,Central Nervous System Choriocarcinoma,0.9014,Ovarian Choriocarcinoma,0.8879,Childhood Choriocarcinoma,0.8792,Testicular Choriocarcinoma,0.8783,Gastric Choriocarcinoma,0.8546,Uterine Corpus Choriocarcinoma,0.8508,Mediastinal Choriocarcinoma,0.8375,Childhood Central Nervous System Choriocarcinoma,0.8217,Ovarian Gestational Choriocarcinoma,0.8153,Pineal Region Choriocarcinoma,0.8104,Childhood Ovarian Choriocarcinoma,0.8060,Breast Carcinoma with Choriocarcinomatous Features,0.8048,Non-Gestational Ovarian Choriocarcinoma,0.7929,Adult Central Nervous System Choriocarcinoma,0.7924,Childhood Testicular Choriocarcinoma,0.7856,Pulmonary Artery Choriocarcinoma,0.7803,Sellar Choriocarcinoma,0.7599,CHORIOCARCINOMA,True,True,True
CHOROID PLEXUS PAPILLOMA,Choroid Plexus Papilloma,1,2,Choroid Plexus Papilloma,1.0000,Childhood Choroid Plexus Papilloma,0.9078,Atypical Choroid Plexus Papilloma,0.8993,Childhood Atypical Choroid Plexus Papilloma,0.8496,Choroid Plexus Neoplasm,0.8242,Adult Choroid Plexus Neoplasm,0.7889,Choroid Plexus Carcinoma,0.7849,Childhood Choroid Plexus Neoplasm,0.7668,Choroid Plexus Meningioma,0.7638,Benign Choroid Plexus Neoplasm,0.7541,Malignant Choroid Plexus Neoplasm,0.7267,Papilloma,0.7217,Breast Central Papilloma,0.7193,Eyelid Papilloma,0.7186,Childhood Choroid Plexus Carcinoma,0.7164,Skin Papilloma,0.6954,Nasal Cavity Papilloma,0.6927,Conjunctival Squamous Papilloma,0.6904,Middle Ear Papilloma,0.6900,Papillary Ependymoma,0.6870,CHOROID PLEXUS PAPILLOMA,True,True,True
CHOROID PLEXUS TUMOR,Choroid Plexus Neoplasm,1,2,Choroid Plexus Neoplasm,0.9735,Childhood Choroid Plexus Neoplasm,0.8912,Choroid Plexus Carcinoma,0.8758,Adult Choroid Plexus Neoplasm,0.8591,Malignant Choroid Plexus Neoplasm,0.8392,Choroid Plexus Papilloma,0.8288,Benign Choroid Plexus Neoplasm,0.8188,Choroid Plexus Meningioma,0.8162,Choroid Neoplasm,0.8131,Childhood Choroid Plexus Carcinoma,0.7981,Childhood Choroid Plexus Papilloma,0.7670,Atypical Choroid Plexus Papilloma,0.7473,Childhood Atypical Choroid Plexus Papilloma,0.7036,Papillary Tumor of the Pineal Region,0.6916,Nerve Plexus Neoplasm,0.6887,Recurrent Malignant Choroid Plexus Neoplasm,0.6881,Cerebral Neoplasm,0.6856,Pineal Parenchymal Cell Neoplasm,0.6839,Pineal Region Neoplasm,0.6753,Choroid Melanoma,0.6720,CHOROID PLEXUS TUMOR,True,True,True
CHROMOPHOBE,Chromophobe Renal Cell Carcinoma,3,2,Pituitary Gland Chromophobe Adenoma,0.7968,Hepatocellular Chromophobe Carcinoma,0.7674,Chromophobe Renal Cell Carcinoma,0.7377,Advanced Chromophobe Renal Cell Carcinoma,0.6857,Classic Variant of Chromophobe Renal Cell Carcinoma,0.6805,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.6671,Metastatic Chromophobe Renal Cell Carcinoma,0.6620,Melanocytoma,0.6540,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.6241,Retinocytoma,0.6123,Unresectable Chromophobe Renal Cell Carcinoma,0.6110,Clear Cell Adenofibroma,0.6070,Choroid Melanoma,0.6037,Locally Advanced Chromophobe Renal Cell Carcinoma,0.6005,Oncocytic Adenocarcinoma,0.5988,Pineocytoma,0.5983,Oncocytic Neoplasm,0.5914,Recurrent Chromophobe Renal Cell Carcinoma,0.5908,Choriocarcinoma,0.5907,Benign Choroid Neoplasm,0.5836,CHROMOPHOBE,False,True,True
CHROMOPHOBE KIDNEY RENAL CELL CARCINOMA,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,0.9849,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9183,Advanced Chromophobe Renal Cell Carcinoma,0.8977,Metastatic Chromophobe Renal Cell Carcinoma,0.8538,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.8370,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.8326,Hepatocellular Chromophobe Carcinoma,0.8315,Locally Advanced Chromophobe Renal Cell Carcinoma,0.8238,Unresectable Chromophobe Renal Cell Carcinoma,0.7978,Clear Cell Renal Cell Carcinoma,0.7819,Papillary Renal Cell Carcinoma,0.7672,Recurrent Chromophobe Renal Cell Carcinoma,0.7664,Renal Cell Carcinoma,0.7487,Non-Clear Cell Renal Cell Carcinoma,0.7467,Clear Cell Papillary Renal Tumor,0.7451,Childhood Renal Cell Carcinoma,0.7201,Kidney Carcinoma,0.7181,Pituitary Gland Chromophobe Adenoma,0.7179,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.7122,Advanced Clear Cell Renal Cell Carcinoma,0.7072,CHROMOPHOBE KIDNEY RENAL CELL CARCINOMA,True,True,True
CHROMOPHOBE RENAL CELL CARCINOMA,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,1.0000,Classic Variant of Chromophobe Renal Cell Carcinoma,0.9270,Advanced Chromophobe Renal Cell Carcinoma,0.9025,Metastatic Chromophobe Renal Cell Carcinoma,0.8611,Hepatocellular Chromophobe Carcinoma,0.8594,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.8543,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.8450,Locally Advanced Chromophobe Renal Cell Carcinoma,0.8307,Unresectable Chromophobe Renal Cell Carcinoma,0.8009,Clear Cell Renal Cell Carcinoma,0.7795,Recurrent Chromophobe Renal Cell Carcinoma,0.7722,Papillary Renal Cell Carcinoma,0.7616,Renal Cell Carcinoma,0.7516,Pituitary Gland Chromophobe Adenoma,0.7463,Non-Clear Cell Renal Cell Carcinoma,0.7408,Clear Cell Papillary Renal Tumor,0.7365,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.7049,Childhood Renal Cell Carcinoma,0.7031,Hereditary Clear Cell Renal Cell Carcinoma,0.7023,Hereditary Papillary Renal Cell Carcinoma,0.6992,CHROMOPHOBE RENAL CELL CARCINOMA,True,True,True
CHROMOPHOBE RENAL CELL CARCINOMAÃ‚Â ,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,0.8834,Classic Variant of Chromophobe Renal Cell Carcinoma,0.8505,Advanced Chromophobe Renal Cell Carcinoma,0.8261,Locally Advanced Chromophobe Renal Cell Carcinoma,0.8118,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.7863,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.7797,Unresectable Chromophobe Renal Cell Carcinoma,0.7755,Metastatic Chromophobe Renal Cell Carcinoma,0.7524,Clear Cell Renal Cell Carcinoma,0.7499,Renal Cell Carcinoma,0.7426,Hepatocellular Chromophobe Carcinoma,0.7393,Non-Clear Cell Renal Cell Carcinoma,0.7359,Papillary Renal Cell Carcinoma,0.7315,Recurrent Chromophobe Renal Cell Carcinoma,0.7175,Pituitary Gland Chromophobe Adenoma,0.7153,Adrenal Cortical Clear Cell Adenoma,0.6943,Clear Cell Papillary Renal Tumor,0.6937,Childhood Renal Cell Carcinoma,0.6912,Type 1 Papillary Renal Cell Carcinoma,0.6906,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.6876,CHROMOPHOBE RENAL CELL CARCINOMAÃ‚Â,True,True,True
"CHROMOPHOBE, CLASSIC",Classic Variant of Chromophobe Renal Cell Carcinoma,3,2,Pituitary Gland Chromophobe Adenoma,0.8058,Hepatocellular Chromophobe Carcinoma,0.7838,Classic Variant of Chromophobe Renal Cell Carcinoma,0.7700,Chromophobe Renal Cell Carcinoma,0.7415,Advanced Chromophobe Renal Cell Carcinoma,0.6947,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.6913,Metastatic Chromophobe Renal Cell Carcinoma,0.6700,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.6547,Melanocytoma,0.6409,Clear Cell Adenofibroma,0.6144,Clear Cell Adenoma,0.6090,Locally Advanced Chromophobe Renal Cell Carcinoma,0.6089,Unresectable Chromophobe Renal Cell Carcinoma,0.6075,Retinocytoma,0.5887,Adenocarcinofibroma,0.5880,Oncocytic Adenocarcinoma,0.5879,Pineocytoma,0.5852,Clear Cell Neoplasm,0.5841,Classic Thyroid Gland Papillary Carcinoma,0.5835,Oncocytic Adenoma,0.5816,"CHROMOPHOBE, CLASSIC",False,True,True
"CHROMOPHOBE, EOSINOPHILIC",Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,1,2,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.7894,Hepatocellular Chromophobe Carcinoma,0.7292,Pituitary Gland Chromophobe Adenoma,0.7055,Chromophobe Renal Cell Carcinoma,0.6778,Classic Variant of Chromophobe Renal Cell Carcinoma,0.6704,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.6605,Advanced Chromophobe Renal Cell Carcinoma,0.6424,Metastatic Chromophobe Renal Cell Carcinoma,0.6378,Melanocytoma,0.6333,Pineocytoma,0.6135,Eosinophilic Granuloma,0.6127,Pituitary Gland Mixed Acidophil-Basophil Carcinoma,0.5986,Clear Cell Adenoma,0.5918,Endometrial Neuroendocrine Carcinoma,0.5877,Clear Cell Neoplasm,0.5841,Oncocytic Adenocarcinoma,0.5837,Histiocytoma,0.5769,Cellular Ependymoma,0.5730,Endometrial Clear Cell Adenocarcinoma,0.5693,Adrenal Gland Composite Pheochromocytoma,0.5685,"CHROMOPHOBE, EOSINOPHILIC",True,True,True
"CHRONIC LYMPHOBLASTIC LEUKEMIA CLL, B-CELL",Chronic Lymphoblastic Lymphoma,4,2,B-Cell Leukemia,0.8165,Chronic Lymphocytic Leukemia,0.8050,B Lymphoblastic Leukemia/Lymphoma,0.8030,Chronic Lymphoblastic Lymphoma,0.7829,B Lymphoblastic Lymphoma,0.7789,Stage B Chronic Lymphocytic Leukemia,0.7715,"Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia Type",0.7711,Cutaneous B Lymphoblastic Leukemia/Lymphoma,0.7681,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,0.7536,B Acute Lymphoblastic Leukemia,0.7527,Aleukemic Chronic Lymphocytic Leukemia,0.7503,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7426,Childhood B Lymphoblastic Leukemia/Lymphoma,0.7395,Childhood B Lymphoblastic Lymphoma,0.7251,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7237,B-Cell Prolymphocytic Leukemia,0.7220,T-Cell Chronic Lymphocytic Leukemia,0.7181,Burkitt Leukemia,0.7158,Childhood B Acute Lymphoblastic Leukemia,0.6994,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.6955,"CHRONIC LYMPHOBLASTIC LEUKEMIA CLL, B-CELL",False,False,True
CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1,2,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1.0000,Chronic Lymphocytic Leukemia,0.8216,Small Lymphocytic Lymphoma,0.8201,Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.8192,Small Lymphocytic Lymphoma Variant,0.7805,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.7787,Chronic Lymphoblastic Lymphoma,0.7709,Cutaneous Chronic Lymphocytic Leukemia,0.7383,Splenic Small Lymphocytic Lymphoma,0.7238,Splenic Manifestation of Chronic Lymphocytic Leukemia,0.7220,Aleukemic Chronic Lymphocytic Leukemia,0.7192,Stage A Chronic Lymphocytic Leukemia,0.7110,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0.6982,Stage 0 Chronic Lymphocytic Leukemia,0.6980,Refractory Small Lymphocytic Lymphoma,0.6923,Refractory Chronic Lymphocytic Leukemia,0.6916,T-Cell Chronic Lymphocytic Leukemia,0.6894,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,0.6790,Recurrent Chronic Lymphocytic Leukemia,0.6708,Chronic Leukemia,0.6699,CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA,True,True,True
CHRONIC MYELOGENOUS LEUKEMIA,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",99,2,Chronic Monocytic Leukemia,0.8720,Chronic Myelomonocytic Leukemia,0.8568,Chronic Leukemia,0.8301,Atypical Chronic Myeloid Leukemia,0.7982,Myelodysplastic Chronic Myelomonocytic Leukemia,0.7767,Chronic Neutrophilic Leukemia,0.7756,Myeloproliferative Chronic Myelomonocytic Leukemia,0.7704,Chronic Lymphocytic Leukemia,0.7662,Myeloid Leukemia,0.7629,Chronic Myelomonocytic Leukemia-1,0.7538,Chronic Myelomonocytic Leukemia-2,0.7436,Myeloid Neoplasm,0.6779,Chronic Myelomonocytic Leukemia-0,0.6772,Aleukemic Chronic Lymphocytic Leukemia,0.6620,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,0.6518,Acute Myeloid Leukemia,0.6507,Chronic Myelomonocytic Leukemia with Eosinophilia,0.6499,"Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia Type",0.6433,Refractory Chronic Myelomonocytic Leukemia,0.6356,Leukemia,0.6348,CHRONIC MYELOGENOUS LEUKEMIA,False,False,False
CHRONIC MYELOGENOUS LEUKEMIA CML,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",11,2,Chronic Myelomonocytic Leukemia,0.7973,Chronic Monocytic Leukemia,0.7679,Atypical Chronic Myeloid Leukemia,0.7671,Chronic Leukemia,0.7575,Myeloproliferative Chronic Myelomonocytic Leukemia,0.7518,Myelodysplastic Chronic Myelomonocytic Leukemia,0.7448,Chronic Neutrophilic Leukemia,0.7331,Chronic Myelomonocytic Leukemia-1,0.7161,Chronic Myelomonocytic Leukemia-2,0.7006,Chronic Lymphocytic Leukemia,0.7002,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.6841,"Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.6727,Myeloid Leukemia,0.6677,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,0.6676,Aleukemic Chronic Lymphocytic Leukemia,0.6554,"Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive",0.6439,Chronic Myelomonocytic Leukemia-0,0.6368,"Chronic Phase Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive",0.6357,Refractory Chronic Myelomonocytic Leukemia,0.6352,"Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.6307,CHRONIC MYELOGENOUS LEUKEMIA CML,False,False,False
"CHRONIC MYELOID LEUKEMIA, BCR-ABL1+","Chronic Myeloid Leukemia, BCR-ABL1 Positive",1,2,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.9776,"Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.9287,"Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive",0.9223,"Chronic Myeloid Leukemia, Philadelphia Chromosome Negative, BCR-ABL1 Positive",0.9018,"Chronic Phase Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive",0.8817,"Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.8738,"Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.8631,Acute Myeloid Leukemia with BCR-ABL1,0.8365,"Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.8357,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,0.8160,"Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7916,"Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7456,"Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7428,"Splenic Manifestation of Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7408,Myeloid/Lymphoid Neoplasms with ETV6-ABL1,0.7240,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",0.7168,"Refractory Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",0.7106,Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion,0.7104,"Myeloproliferative Neoplasm, BCR-ABL1 Negative",0.7084,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.7050,"CHRONIC MYELOID LEUKEMIA, BCR-ABL1+",True,True,True
CHRONIC MYELOMONOCYTIC LEUKAEMIA,Chronic Myelomonocytic Leukemia,1,2,Chronic Myelomonocytic Leukemia,0.9859,Myelodysplastic Chronic Myelomonocytic Leukemia,0.8737,Chronic Monocytic Leukemia,0.8642,Myeloproliferative Chronic Myelomonocytic Leukemia,0.8500,Chronic Myelomonocytic Leukemia-1,0.8265,Chronic Myelomonocytic Leukemia-2,0.8079,Chronic Myelomonocytic Leukemia-0,0.7769,Chronic Myelomonocytic Leukemia with Eosinophilia,0.7691,Acute Myelomonocytic Leukemia,0.7630,Juvenile Myelomonocytic Leukemia,0.7532,Atypical Chronic Myeloid Leukemia,0.7370,Chronic Neutrophilic Leukemia,0.7137,Recurrent Chronic Myelomonocytic Leukemia,0.7136,Chronic Leukemia,0.6970,Adult Acute Myelomonocytic Leukemia,0.6947,Refractory Chronic Myelomonocytic Leukemia,0.6913,Juvenile Myelomonocytic Leukemia-Like Neoplasm,0.6738,Childhood Acute Myelomonocytic Leukemia,0.6726,Chronic Lymphocytic Leukemia,0.6646,Myeloid Leukemia,0.6620,CHRONIC MYELOMONOCYTIC LEUKAEMIA,True,True,True
CHRONIC MYELOMONOCYTIC LEUKEMIA,Chronic Myelomonocytic Leukemia,1,2,Chronic Myelomonocytic Leukemia,1.0000,Myelodysplastic Chronic Myelomonocytic Leukemia,0.8744,Chronic Monocytic Leukemia,0.8742,Myeloproliferative Chronic Myelomonocytic Leukemia,0.8611,Chronic Myelomonocytic Leukemia-1,0.8593,Chronic Myelomonocytic Leukemia-2,0.8290,Acute Myelomonocytic Leukemia,0.7902,Chronic Myelomonocytic Leukemia-0,0.7880,Chronic Myelomonocytic Leukemia with Eosinophilia,0.7721,Juvenile Myelomonocytic Leukemia,0.7634,Atypical Chronic Myeloid Leukemia,0.7502,Recurrent Chronic Myelomonocytic Leukemia,0.7196,Chronic Neutrophilic Leukemia,0.7187,Adult Acute Myelomonocytic Leukemia,0.7080,Chronic Leukemia,0.7046,Refractory Chronic Myelomonocytic Leukemia,0.7016,Juvenile Myelomonocytic Leukemia-Like Neoplasm,0.6981,Childhood Acute Myelomonocytic Leukemia,0.6859,Myeloid Leukemia,0.6843,Chronic Lymphocytic Leukemia,0.6651,CHRONIC MYELOMONOCYTIC LEUKEMIA,True,True,True
CHRONIC MYELOMONOCYTIC LEUKEMIA 1,Chronic Myelomonocytic Leukemia-1,1,2,Chronic Myelomonocytic Leukemia-1,0.9705,Chronic Myelomonocytic Leukemia,0.8888,Chronic Myelomonocytic Leukemia-2,0.8236,Myelodysplastic Chronic Myelomonocytic Leukemia,0.7996,Chronic Monocytic Leukemia,0.7964,Myeloproliferative Chronic Myelomonocytic Leukemia,0.7918,Chronic Myelomonocytic Leukemia-0,0.7516,Acute Myelomonocytic Leukemia,0.7343,Chronic Myelomonocytic Leukemia with Eosinophilia,0.7269,Juvenile Myelomonocytic Leukemia,0.7260,Atypical Chronic Myeloid Leukemia,0.6822,Juvenile Myelomonocytic Leukemia-Like Neoplasm,0.6765,Myeloid Leukemia,0.6736,Childhood Acute Myelomonocytic Leukemia,0.6683,Chronic Neutrophilic Leukemia,0.6537,Refractory Chronic Myelomonocytic Leukemia,0.6511,Recurrent Chronic Myelomonocytic Leukemia,0.6483,Adult Acute Myelomonocytic Leukemia,0.6348,Chronic Leukemia,0.6281,Mast Cell Leukemia,0.6215,CHRONIC MYELOMONOCYTIC LEUKEMIA 1,True,True,True
CHRONIC MYELOMONOCYTIC LEUKEMIA 2,Chronic Myelomonocytic Leukemia-2,1,2,Chronic Myelomonocytic Leukemia-2,0.9739,Chronic Myelomonocytic Leukemia,0.8491,Chronic Myelomonocytic Leukemia-1,0.8275,Chronic Monocytic Leukemia,0.7912,Myelodysplastic Chronic Myelomonocytic Leukemia,0.7852,Myeloproliferative Chronic Myelomonocytic Leukemia,0.7593,Chronic Myelomonocytic Leukemia with Eosinophilia,0.7143,Chronic Myelomonocytic Leukemia-0,0.6906,Acute Myelomonocytic Leukemia,0.6860,Recurrent Chronic Myelomonocytic Leukemia,0.6788,Refractory Chronic Myelomonocytic Leukemia,0.6786,Juvenile Myelomonocytic Leukemia,0.6779,Atypical Chronic Myeloid Leukemia,0.6772,Myeloid Leukemia,0.6602,Juvenile Myelomonocytic Leukemia-Like Neoplasm,0.6459,Chronic Leukemia,0.6299,Chronic Neutrophilic Leukemia,0.6292,Adult Acute Myelomonocytic Leukemia,0.6155,"Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia Type",0.6018,Childhood Acute Myelomonocytic Leukemia,0.5986,CHRONIC MYELOMONOCYTIC LEUKEMIA 2,True,True,True
CHRONIC_LYMPHOCYTIC_LEUKAEMIA-SMALL_LYMPHOCYTIC_LYMPHOMA,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1,2,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.8844,Small Lymphocytic Lymphoma,0.8106,Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.7683,Small Lymphocytic Lymphoma Variant,0.7680,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.7155,Chronic Lymphocytic Leukemia,0.7097,Refractory Small Lymphocytic Lymphoma,0.7086,Splenic Small Lymphocytic Lymphoma,0.7067,Chronic Lymphoblastic Lymphoma,0.6812,Splenic Manifestation of Chronic Lymphocytic Leukemia,0.6788,Recurrent Small Lymphocytic Lymphoma,0.6727,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene,0.6619,Stage 0 Chronic Lymphocytic Leukemia,0.6514,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,0.6484,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,0.6458,Stage B Chronic Lymphocytic Leukemia,0.6407,Stage A Chronic Lymphocytic Leukemia,0.6372,Aleukemic Chronic Lymphocytic Leukemia,0.6318,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0.6314,Small Lymphocytic Lymphoma by Ann Arbor Stage,0.6290,CHRONIC_LYMPHOCYTIC_LEUKAEMIA-SMALL_LYMPHOCYTIC_LYMPHOMA,True,True,True
CHRONIC_MYELOID_LEUKAEMIA,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",99,2,Chronic Leukemia,0.8588,Chronic Monocytic Leukemia,0.8236,Chronic Myelomonocytic Leukemia,0.7854,Atypical Chronic Myeloid Leukemia,0.7702,Chronic Neutrophilic Leukemia,0.7681,Chronic Lymphocytic Leukemia,0.7611,Myelodysplastic Chronic Myelomonocytic Leukemia,0.7313,Myeloid Leukemia,0.7219,Myeloproliferative Chronic Myelomonocytic Leukemia,0.6969,Aleukemic Chronic Lymphocytic Leukemia,0.6705,Chronic Myelomonocytic Leukemia-2,0.6703,Recurrent Chronic Leukemia,0.6655,Chronic Myelomonocytic Leukemia-1,0.6636,Myeloid Neoplasm,0.6573,Chronic Lymphoblastic Lymphoma,0.6563,Chronic Myelomonocytic Leukemia-0,0.6446,Refractory Chronic Leukemia,0.6444,"Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia Type",0.6351,Chronic Myelomonocytic Leukemia with Eosinophilia,0.6321,Refractory Chronic Myelomonocytic Leukemia,0.6287,CHRONIC_MYELOID_LEUKAEMIA,False,False,False
CILIATED MUCONODULAR PAPILLARY TUMOR OF THE LUNG,Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor,1,2,Bronchiolar Adenoma/Ciliated Muconodular Papillary Tumor,0.8128,Pulmonary Mucinous Cystic Tumor of Borderline Malignancy,0.6763,Lung Papillary Adenoma,0.6584,Papillary Cystic Neoplasm,0.6515,Lung Myoepithelial Tumor,0.6512,Lung Lymphoepithelial Carcinoma,0.6415,Lung Mucoepidermoid Carcinoma,0.6406,Well Differentiated Papillary Mesothelial Tumor,0.6403,Bronchial Papilloma,0.6387,Papillary Epithelial Neoplasm,0.6385,Papillary Neoplasm,0.6379,Lung Papillary Adenocarcinoma,0.6295,Pleural Well Differentiated Papillary Mesothelial Tumor,0.6293,Fallopian Tube Metaplastic Papillary Tumor,0.6232,Lung Mucous Gland Adenoma,0.6225,Papillary Urothelial Neoplasm,0.6207,Lung Myoepithelial Carcinoma,0.6135,Lung Myoepithelioma,0.6122,Breast Papillary Neoplasm,0.6095,Bronchial Glandular Papilloma,0.6090,CILIATED MUCONODULAR PAPILLARY TUMOR OF THE LUNG,True,True,True
CLASSICAL HCA,Hepatocellular Adenoma,7,2,Colon Conventional Adenoma,0.6944,Hereditary Colon Carcinoma,0.6701,Colorectal Conventional Adenoma,0.6692,Hepatocellular Carcinoma,0.6611,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.6440,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.6430,Hepatocellular Adenoma,0.6422,Colon Adenoma,0.6379,Advanced Hepatocellular Carcinoma,0.6320,Childhood Hepatocellular Carcinoma,0.6226,Colorectal Adenoma,0.6182,Hidroacanthoma Simplex,0.6171,Inflammatory Hepatocellular Adenoma,0.6153,Hereditary Prostate Carcinoma,0.6139,Alcohol-Related Hepatocellular Carcinoma,0.6138,Alpha Heavy Chain Disease,0.6122,Early Hepatocellular Carcinoma,0.6117,Classic Hodgkin Lymphoma,0.6109,Colon Serrated Adenocarcinoma,0.6073,Adult Hepatocellular Carcinoma,0.6050,CLASSICAL HCA,False,False,False
CLASSICAL HODGKIN LYMPHOMA,Classic Hodgkin Lymphoma,1,2,Classic Hodgkin Lymphoma,0.9816,Hodgkin Lymphoma,0.9295,Childhood Classic Hodgkin Lymphoma,0.8271,Adult Classic Hodgkin Lymphoma,0.8258,Hodgkin Lymphoma by Clinical Course,0.8243,Colon Hodgkin Lymphoma,0.8226,Childhood Hodgkin Lymphoma,0.8167,Advanced Hodgkin Lymphoma,0.7982,Lymphocyte-Depleted Classic Hodgkin Lymphoma,0.7980,Cerebral Hodgkin Lymphoma,0.7950,Primary Cutaneous Hodgkin Lymphoma,0.7905,Adult Hodgkin Lymphoma,0.7895,Colorectal Hodgkin Lymphoma,0.7860,Lung Hodgkin Lymphoma,0.7796,Hodgkin's Sarcoma,0.7691,Lymphocyte-Rich Classic Hodgkin Lymphoma,0.7667,Favorable Hodgkin Lymphoma,0.7660,Primary Central Nervous System Hodgkin Lymphoma,0.7644,Hodgkin's Granuloma,0.7559,Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma,0.7475,CLASSICAL HODGKIN LYMPHOMA,True,True,True
CLEAR CELL ADENOCARCINOMA,Clear Cell Adenocarcinoma,1,2,Clear Cell Adenocarcinoma,1.0000,Water-Clear Cell Adenocarcinoma,0.8853,Clear Cell Malignant Neoplasm,0.8663,Clear Cell Adenoma,0.8643,Ovarian Clear Cell Adenocarcinoma,0.8531,Lung Clear Cell Adenocarcinoma,0.8525,Endometrial Clear Cell Adenocarcinoma,0.8513,Clear Cell Neoplasm,0.8478,Urinary Tract Clear Cell Adenocarcinoma,0.8420,Bladder Clear Cell Adenocarcinoma,0.8222,Clear Cell Renal Cell Carcinoma,0.8050,"Squamous Cell Carcinoma, Clear Cell Type",0.8014,Gallbladder Clear Cell Adenocarcinoma,0.7973,Ovarian Clear Cell Cystadenocarcinoma,0.7914,Salivary Gland Clear Cell Carcinoma,0.7852,Broad Ligament Clear Cell Adenocarcinoma,0.7790,Bladder Diffuse Clear Cell Adenocarcinoma,0.7778,Bladder Papillary Clear Cell Adenocarcinoma,0.7686,Advanced Ovarian Clear Cell Adenocarcinoma,0.7656,Urethral Clear Cell Adenocarcinoma,0.7641,CLEAR CELL ADENOCARCINOMA,True,True,True
CLEAR CELL BORDERLINE OVARIAN TUMOR,Borderline Ovarian Clear Cell Tumor,1,2,Borderline Ovarian Clear Cell Tumor,0.9814,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,0.8576,Benign Ovarian Clear Cell Tumor,0.8517,Ovarian Clear Cell Tumor,0.8502,Borderline Ovarian Clear Cell Cystadenofibroma,0.8319,Malignant Ovarian Clear Cell Tumor,0.7980,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor with Intraepithelial Carcinoma,0.7965,Borderline Ovarian Epithelial Tumor,0.7942,Borderline Ovarian Clear Cell Adenofibroma,0.7842,Borderline Ovarian Serous Tumor,0.7703,Ovarian Clear Cell Adenocarcinoma,0.7582,Ovarian Clear Cell Cystadenocarcinoma,0.7523,Borderline Ovarian Serous Papillary Cystic Tumor,0.7448,Borderline Ovarian Mucinous Tumor,0.7385,Clear Cell Neoplasm,0.7292,Borderline Ovarian Brenner Tumor,0.7283,Ovarian Clear Cell Adenocarcinofibroma,0.7204,Advanced Ovarian Clear Cell Adenocarcinoma,0.7133,Ovarian Clear Cell Cystadenofibroma,0.7058,Borderline Ovarian Seromucinous Tumor,0.7048,CLEAR CELL BORDERLINE OVARIAN TUMOR,True,True,True
CLEAR CELL CARCINOMA,Clear Cell Adenocarcinoma,1,2,Clear Cell Adenocarcinoma,0.9345,Clear Cell Malignant Neoplasm,0.9082,Clear Cell Neoplasm,0.9057,Clear Cell Renal Cell Carcinoma,0.8854,Clear Cell Adenoma,0.8502,"Squamous Cell Carcinoma, Clear Cell Type",0.8425,Water-Clear Cell Adenocarcinoma,0.8205,Urinary Tract Clear Cell Adenocarcinoma,0.8165,Salivary Gland Clear Cell Carcinoma,0.8056,Hepatocellular Clear Cell Carcinoma,0.8014,Lung Clear Cell Adenocarcinoma,0.7957,Non-Clear Cell Renal Cell Carcinoma,0.7941,Hyalinizing Clear Cell Carcinoma,0.7934,Endometrial Clear Cell Adenocarcinoma,0.7908,Clear Cell Odontogenic Carcinoma,0.7905,Bladder Clear Cell Adenocarcinoma,0.7892,Ovarian Clear Cell Adenocarcinoma,0.7863,Ovarian Clear Cell Tumor,0.7839,Skin Clear Cell Squamous Cell Carcinoma,0.7697,Renal Cell Carcinoma,0.7642,CLEAR CELL CARCINOMA,True,True,True
CLEAR CELL CARCINOMA OF THE LUNG,"Lung Large Cell Carcinoma, Clear Cell Variant",3,2,Lung Clear Cell Adenocarcinoma,0.9021,Lung Clear Cell Tumor,0.8800,"Lung Large Cell Carcinoma, Clear Cell Variant",0.8567,"Lung Squamous Cell Carcinoma, Clear Cell Variant",0.8436,Lung Hyalinizing Clear Cell Carcinoma,0.8263,Clear Cell Renal Cell Carcinoma,0.7888,Clear Cell Adenocarcinoma,0.7565,Lung Non-Small Cell Carcinoma,0.7447,Lung Large Cell Carcinoma,0.7339,Lung Carcinoma,0.7336,Urinary Tract Clear Cell Adenocarcinoma,0.7333,Non-Clear Cell Renal Cell Carcinoma,0.7304,"Squamous Cell Carcinoma, Clear Cell Type",0.7297,Clear Cell Malignant Neoplasm,0.7251,Lung Squamous Cell Carcinoma,0.7194,Bladder Clear Cell Adenocarcinoma,0.7142,Hepatocellular Clear Cell Carcinoma,0.7110,Clear Cell Neoplasm,0.7061,Lung Non-Keratinizing Squamous Cell Carcinoma,0.7017,Thymus Clear Cell Carcinoma,0.6933,CLEAR CELL CARCINOMA OF THE LUNG,False,True,True
CLEAR CELL ODONTOGENIC CARCINOMA,Clear Cell Odontogenic Carcinoma,1,2,Clear Cell Odontogenic Carcinoma,1.0000,Odontogenic Carcinoma,0.8526,Clear Cell Calcifying Epithelial Odontogenic Tumor,0.8333,Ghost Cell Odontogenic Carcinoma,0.7713,Clear Cell Adenocarcinoma,0.7598,Sclerosing Odontogenic Carcinoma,0.7448,Ameloblastic Carcinoma Derived From Odontogenic Cyst,0.7410,Squamous Odontogenic Tumor,0.7388,Clear Cell Neoplasm,0.7273,Odontogenic Carcinosarcoma,0.7146,Malignant Odontogenic Neoplasm,0.7111,Salivary Gland Clear Cell Carcinoma,0.7070,Clear Cell Malignant Neoplasm,0.7033,"Squamous Cell Carcinoma, Clear Cell Type",0.7010,Clear Cell Adenoma,0.6961,Clear Cell Renal Cell Carcinoma,0.6951,Odontogenic Sarcoma,0.6943,Ovarian Clear Cell Tumor,0.6910,Clear Cell Chondrosarcoma,0.6843,Ovarian Clear Cell Cystadenocarcinoma,0.6790,CLEAR CELL ODONTOGENIC CARCINOMA,True,True,True
CLEAR CELL OVARIAN CANCER,Ovarian Clear Cell Tumor,1,2,Ovarian Clear Cell Tumor,0.9414,Ovarian Clear Cell Adenocarcinoma,0.9263,Malignant Ovarian Clear Cell Tumor,0.9194,Benign Ovarian Clear Cell Tumor,0.8656,Ovarian Clear Cell Cystadenocarcinoma,0.8418,Advanced Ovarian Clear Cell Adenocarcinoma,0.8276,Ovarian Carcinoma,0.8188,Borderline Ovarian Clear Cell Tumor,0.8027,Ovarian Clear Cell Adenocarcinofibroma,0.7924,Clear Cell Malignant Neoplasm,0.7835,Clear Cell Adenocarcinoma,0.7818,Ovarian Squamous Cell Carcinoma,0.7788,Clear Cell Neoplasm,0.7726,Metastatic Ovarian Clear Cell Adenocarcinoma,0.7679,Ovarian Transitional Cell Carcinoma,0.7610,Ovarian Small Cell Carcinoma,0.7560,Ovarian Adenocarcinoma,0.7539,Ovarian Undifferentiated Carcinoma,0.7468,Endometrial Clear Cell Adenocarcinoma,0.7419,Clear Cell Renal Cell Carcinoma,0.7386,CLEAR CELL OVARIAN CANCER,True,True,True
CLEAR CELL PAPILLARY RENAL CELL CARCINOMA,Clear Cell Papillary Renal Tumor,2,2,Papillary Renal Cell Carcinoma,0.9310,Clear Cell Papillary Renal Tumor,0.9243,Clear Cell Renal Cell Carcinoma,0.8866,Sporadic Papillary Renal Cell Carcinoma,0.8519,Type 1 Papillary Renal Cell Carcinoma,0.8492,Type 2 Papillary Renal Cell Carcinoma,0.8418,Advanced Papillary Renal Cell Carcinoma,0.8270,Non-Clear Cell Renal Cell Carcinoma,0.8172,Bladder Papillary Clear Cell Adenocarcinoma,0.8082,Renal Cell Carcinoma,0.7899,Advanced Clear Cell Renal Cell Carcinoma,0.7815,Chromophobe Renal Cell Carcinoma,0.7768,Metastatic Papillary Renal Cell Carcinoma,0.7763,Hereditary Papillary Renal Cell Carcinoma,0.7760,Early Stage Clear Cell Renal Cell Carcinoma,0.7706,Classic Variant of Chromophobe Renal Cell Carcinoma,0.7669,Unresectable Papillary Renal Cell Carcinoma,0.7649,Locally Advanced Papillary Renal Cell Carcinoma,0.7647,Clear Cell Papillary Cystadenoma,0.7633,Grade 1 Clear Cell Renal Cell Carcinoma,0.7620,CLEAR CELL PAPILLARY RENAL CELL CARCINOMA,False,True,True
CLEAR CELL RENAL CELL CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,1.0000,Non-Clear Cell Renal Cell Carcinoma,0.9067,Renal Cell Carcinoma,0.8818,Early Stage Clear Cell Renal Cell Carcinoma,0.8555,Advanced Clear Cell Renal Cell Carcinoma,0.8511,Grade 1 Clear Cell Renal Cell Carcinoma,0.8342,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.8339,Clear Cell Papillary Renal Tumor,0.8179,Urinary Tract Clear Cell Adenocarcinoma,0.8171,Grade 2 Clear Cell Renal Cell Carcinoma,0.8155,Clear Cell Malignant Neoplasm,0.8123,Hereditary Clear Cell Renal Cell Carcinoma,0.8060,Clear Cell Adenocarcinoma,0.8050,"Renal Cell Carcinoma, Not Otherwise Specified",0.8042,Clear Cell Neoplasm,0.8007,Grade 3 Clear Cell Renal Cell Carcinoma,0.7971,Papillary Renal Cell Carcinoma,0.7940,Clear Cell Sarcoma of the Kidney,0.7903,Grade 4 Clear Cell Renal Cell Carcinoma,0.7866,Locally Advanced Clear Cell Renal Cell Carcinoma,0.7808,CLEAR CELL RENAL CELL CARCINOMA,True,True,True
CLEAR CELL SARCOMA,Clear Cell Sarcoma of Soft Tissue,1,2,Clear Cell Sarcoma of Soft Tissue,0.9133,Clear Cell Sarcoma of the Kidney,0.8799,Clear Cell Malignant Neoplasm,0.8179,Clear Cell Neoplasm,0.8103,Childhood Clear Cell Sarcoma of Soft Tissue,0.7982,Adult Clear Cell Sarcoma of Soft Tissue,0.7981,Advanced Clear Cell Sarcoma of Soft Tissue,0.7961,Clear Cell Chondrosarcoma,0.7941,Sarcoma,0.7475,Metastatic Clear Cell Sarcoma of Soft Tissue,0.7448,"Squamous Cell Carcinoma, Clear Cell Type",0.7374,Clear Cell Adenocarcinoma,0.7351,Clear Cell Meningioma,0.7313,Small Cell Sarcoma,0.7208,Skin Clear Cell Squamous Cell Carcinoma,0.7190,Clear Cell Adenoma,0.7175,Hyalinizing Clear Cell Carcinoma,0.7135,Ovarian Clear Cell Tumor,0.7112,Histiocytic Sarcoma,0.7073,Malignant Ovarian Clear Cell Tumor,0.7008,CLEAR CELL SARCOMA,True,True,True
CLEAR_CELL_CARCINOMA,Clear Cell Adenocarcinoma,1,2,Clear Cell Adenocarcinoma,0.8506,Clear Cell Malignant Neoplasm,0.8499,Clear Cell Neoplasm,0.8457,"Squamous Cell Carcinoma, Clear Cell Type",0.8080,Clear Cell Renal Cell Carcinoma,0.7899,Water-Clear Cell Adenocarcinoma,0.7748,Clear Cell Adenoma,0.7646,Urinary Tract Clear Cell Adenocarcinoma,0.7633,Hyalinizing Clear Cell Carcinoma,0.7606,Skin Clear Cell Squamous Cell Carcinoma,0.7518,Salivary Gland Clear Cell Carcinoma,0.7485,Non-Clear Cell Renal Cell Carcinoma,0.7445,Endometrial Clear Cell Adenocarcinoma,0.7318,Carcinoma,0.7317,Clear Cell Odontogenic Carcinoma,0.7309,Hepatocellular Clear Cell Carcinoma,0.7226,Bladder Clear Cell Adenocarcinoma,0.7204,Invasive Clear Cell (Glycogen-Rich) Urothelial Carcinoma,0.7157,Lung Clear Cell Adenocarcinoma,0.7155,Renal Cell Carcinoma,0.7118,CLEAR_CELL_CARCINOMA,True,True,True
CLEAR_CELL_RENAL_CELL_CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9150,Non-Clear Cell Renal Cell Carcinoma,0.8723,Renal Cell Carcinoma,0.8170,Grade 1 Clear Cell Renal Cell Carcinoma,0.8061,Advanced Clear Cell Renal Cell Carcinoma,0.8048,Early Stage Clear Cell Renal Cell Carcinoma,0.8000,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.7987,Urinary Tract Clear Cell Adenocarcinoma,0.7973,"Renal Cell Carcinoma, Not Otherwise Specified",0.7877,Grade 3 Clear Cell Renal Cell Carcinoma,0.7814,Grade 4 Clear Cell Renal Cell Carcinoma,0.7802,Clear Cell Sarcoma of the Kidney,0.7798,Grade 2 Clear Cell Renal Cell Carcinoma,0.7779,Clear Cell Malignant Neoplasm,0.7718,Clear Cell Papillary Renal Tumor,0.7668,Resectable Clear Cell Renal Cell Carcinoma,0.7551,Clear Cell Neoplasm,0.7496,Hereditary Clear Cell Renal Cell Carcinoma,0.7480,Locally Advanced Clear Cell Renal Cell Carcinoma,0.7453,Clear Cell Adenocarcinoma,0.7453,CLEAR_CELL_RENAL_CELL_CARCINOMA,True,True,True
CLL,Chronic Lymphocytic Leukemia,1,2,Chronic Lymphocytic Leukemia,0.8151,Leukemia,0.7657,Chronic Leukemia,0.7642,Lymphoma,0.7510,Cutaneous Chronic Lymphocytic Leukemia,0.7436,Aleukemic Chronic Lymphocytic Leukemia,0.7371,Lymphoid Leukemia,0.7331,Chronic Lymphoblastic Lymphoma,0.7229,Composite Lymphoma,0.7107,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.7072,Lymphocytic Neoplasm,0.6994,B-Cell Leukemia,0.6932,Stage A Chronic Lymphocytic Leukemia,0.6878,Lymphoblastic Lymphoma,0.6839,Follicular Lymphoma,0.6801,Lung Lymphoma,0.6685,Classic Follicular Lymphoma,0.6666,Cutaneous Lymphoma,0.6602,Stage C Chronic Lymphocytic Leukemia,0.6578,Childhood Lymphoma,0.6554,CLL,True,True,True
CML,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",99,2,Chronic Monocytic Leukemia,0.8720,Chronic Myelomonocytic Leukemia,0.8568,Chronic Leukemia,0.8301,Atypical Chronic Myeloid Leukemia,0.7982,Myelodysplastic Chronic Myelomonocytic Leukemia,0.7767,Chronic Neutrophilic Leukemia,0.7756,Myeloproliferative Chronic Myelomonocytic Leukemia,0.7704,Chronic Lymphocytic Leukemia,0.7662,Myeloid Leukemia,0.7629,Chronic Myelomonocytic Leukemia-1,0.7538,Chronic Myelomonocytic Leukemia-2,0.7436,Myeloid Neoplasm,0.6779,Chronic Myelomonocytic Leukemia-0,0.6772,Aleukemic Chronic Lymphocytic Leukemia,0.6620,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,0.6518,Acute Myeloid Leukemia,0.6507,Chronic Myelomonocytic Leukemia with Eosinophilia,0.6499,"Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia Type",0.6433,Refractory Chronic Myelomonocytic Leukemia,0.6356,Leukemia,0.6348,Chronic Myelogenous Leukemia,False,False,False
CMML,Chronic Myelomonocytic Leukemia,1,2,Chronic Myelomonocytic Leukemia,1.0000,Myelodysplastic Chronic Myelomonocytic Leukemia,0.8744,Chronic Monocytic Leukemia,0.8742,Myeloproliferative Chronic Myelomonocytic Leukemia,0.8611,Chronic Myelomonocytic Leukemia-1,0.8593,Chronic Myelomonocytic Leukemia-2,0.8290,Acute Myelomonocytic Leukemia,0.7902,Chronic Myelomonocytic Leukemia-0,0.7880,Chronic Myelomonocytic Leukemia with Eosinophilia,0.7721,Juvenile Myelomonocytic Leukemia,0.7634,Atypical Chronic Myeloid Leukemia,0.7502,Recurrent Chronic Myelomonocytic Leukemia,0.7196,Chronic Neutrophilic Leukemia,0.7187,Adult Acute Myelomonocytic Leukemia,0.7080,Chronic Leukemia,0.7046,Refractory Chronic Myelomonocytic Leukemia,0.7016,Juvenile Myelomonocytic Leukemia-Like Neoplasm,0.6981,Childhood Acute Myelomonocytic Leukemia,0.6859,Myeloid Leukemia,0.6843,Chronic Lymphocytic Leukemia,0.6651,Chronic Myelomonocytic Leukemia,True,True,True
CNS,Malignant Central Nervous System Neoplasm,99,2,Nervous System Neoplasm by Obsolete Classification,0.7163,Nervous System Neoplasm,0.7084,Central Nervous System Neoplasm,0.7023,Central Nervous System Carcinoma,0.7007,Peripheral Nervous System,0.6909,Central Nervous System Sarcoma,0.6873,Cerebral Neoplasm,0.6808,Central Nervous System Leukemia,0.6772,Central Neurocytoma,0.6687,Intracranial Neoplasm,0.6659,Childhood Nervous System Neoplasm,0.6605,Malignant Nervous System Neoplasm,0.6549,Brain Sarcoma,0.6421,Cerebral Lymphoma,0.6411,Benign Nervous System Neoplasm,0.6394,Brain Neoplasm,0.6366,Central Nervous System CIC-Rearranged Sarcoma,0.6338,Central Nervous System Neuroblastoma,0.6297,Neuroblastoma,0.6274,Childhood Central Nervous System Neoplasm,0.6251,CNS,False,False,False
CNS CANCER,Malignant Central Nervous System Neoplasm,7,2,Central Nervous System Carcinoma,0.8662,Central Nervous System Neoplasm,0.7968,Cerebral Neoplasm,0.7787,Nervous System Neoplasm,0.7617,Intracranial Neoplasm,0.7418,Malignant Nervous System Neoplasm,0.7363,Malignant Central Nervous System Neoplasm,0.7354,Nervous System Neoplasm by Obsolete Classification,0.7307,Central Nervous System Sarcoma,0.7237,Malignant Cerebral Neoplasm,0.7221,Brain Neoplasm,0.7189,Central Nervous System Leukemia,0.7104,Malignant Intracranial Neoplasm,0.7099,Spinal Cord Neoplasm,0.7064,Malignant Brain Neoplasm,0.6842,Skull Neoplasm,0.6831,Central Neurocytoma,0.6812,Central Nervous System Melanoma,0.6748,Primary Central Nervous System Neoplasm,0.6715,Cerebellar Neoplasm,0.6601,CNS CANCER,False,False,False
CNS EMBRYONAL NOS,Central Nervous System Embryonal Tumor,1,2,Central Nervous System Embryonal Tumor,0.8713,Childhood Central Nervous System Embryonal Tumor,0.8257,"Central Nervous System Embryonal Tumor, Not Elsewhere Classified",0.8189,Embryonal Neoplasm,0.8186,Central Nervous System Embryonal Carcinoma,0.8162,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.8091,Childhood Central Nervous System Embryonal Carcinoma,0.7854,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7798,"Cerebral Embryonal Tumor, Not Otherwise Specified",0.7696,Adult Central Nervous System Embryonal Carcinoma,0.7561,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7503,"Brain Embryonal Tumor, Not Otherwise Specified",0.7382,Embryonal Carcinoma,0.7250,Childhood Embryonal Carcinoma,0.7231,Extragonadal Embryonal Carcinoma,0.6884,"Spinal Cord Embryonal Tumor, Not Otherwise Specified",0.6851,Childhood Nervous System Neoplasm,0.6803,Childhood Central Nervous System Neoplasm,0.6704,Childhood Malignant Nervous System Neoplasm,0.6700,Central Nervous System Neuroepithelial Neoplasm of Uncertain Origin,0.6591,CNS EMBRYONAL NOS,True,True,True
"CNS EMBRYONAL TUMOR, NOS","Central Nervous System Embryonal Tumor, Not Otherwise Specified",2,2,Central Nervous System Embryonal Tumor,0.9497,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.9133,"Central Nervous System Embryonal Tumor, Not Elsewhere Classified",0.8977,Childhood Central Nervous System Embryonal Tumor,0.8963,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.8771,"Cerebral Embryonal Tumor, Not Otherwise Specified",0.8659,Central Nervous System Embryonal Carcinoma,0.8497,"Brain Embryonal Tumor, Not Otherwise Specified",0.8403,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.8362,Embryonal Neoplasm,0.8188,Childhood Central Nervous System Embryonal Carcinoma,0.8013,"Spinal Cord Embryonal Tumor, Not Otherwise Specified",0.7693,Adult Central Nervous System Embryonal Carcinoma,0.7670,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",0.7295,Embryonal Carcinoma,0.7223,Childhood Embryonal Carcinoma,0.7219,Extragonadal Embryonal Carcinoma,0.7116,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7088,Primitive Neuroectodermal Tumor,0.6944,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",0.6882,"CNS EMBRYONAL TUMOR, NOS",False,True,True
CNS GERMINOMA,Central Nervous System Germinoma,1,2,Central Nervous System Germinoma,0.9677,Brain Germinoma,0.9252,Intracranial Germinoma,0.9151,Adult Central Nervous System Germinoma,0.8756,Childhood Central Nervous System Germinoma,0.8633,Childhood Brain Germinoma,0.8564,Central Nervous System Germ Cell Tumor,0.8416,Central Nervous System Nongerminomatous Germ Cell Tumor,0.8135,Germinomatous Germ Cell Tumor,0.8088,Pineal Region Germinoma,0.8080,Malignant Central Nervous System Germ Cell Tumor,0.8032,Malignant Brain Germ Cell Tumor,0.7881,Third Ventricle Germinoma,0.7669,Adult Intracranial Germ Cell Tumor,0.7647,Adult Central Nervous System Germ Cell Tumor,0.7629,Childhood Central Nervous System Germ Cell Tumor,0.7601,Central Nervous System Ganglioneuroblastoma,0.7458,Childhood Brain Germ Cell Tumor,0.7385,Central Nervous System Mixed Germ Cell Tumor,0.7376,Childhood Germinomatous Germ Cell Tumor,0.7364,CNS GERMINOMA,True,True,True
COAD,Colon Adenocarcinoma,1,2,Colon Adenocarcinoma,1.0000,Colorectal Adenocarcinoma,0.9220,Colon Carcinoma,0.9174,Advanced Colon Adenocarcinoma,0.8739,Cecum Adenocarcinoma,0.8520,Metastatic Colon Adenocarcinoma,0.8316,Malignant Colon Neoplasm,0.8297,Adenocarcinoma,0.8241,Colon Mucinous Adenocarcinoma,0.8240,Colon Adenoma,0.8240,Colorectal Carcinoma,0.8214,Distal Colon Carcinoma,0.8197,Colon Poorly Differentiated Adenocarcinoma,0.8194,Advanced Colon Carcinoma,0.8093,Colon Neoplasm,0.8066,Crohn Disease-Associated Colorectal Adenocarcinoma,0.7983,Advanced Colorectal Adenocarcinoma,0.7969,Colon Well Differentiated Adenocarcinoma,0.7965,Intestinal-Type Adenocarcinoma,0.7853,Colon Intramucosal Adenocarcinoma,0.7836,Colon Adenocarcinoma,True,True,True
COAD_GS,Colon Adenocarcinoma,99,2,Colorectal Adenoma with Severe Dysplasia,0.5779,Hybrid Salivary Gland Carcinoma,0.5681,Disseminated Adenocarcinoma,0.5651,Colon Adenoma with Severe Dysplasia,0.5599,Sporadic Gastric Adenocarcinoma,0.5549,Crohn Disease-Associated Colorectal Adenocarcinoma,0.5518,Sporadic Gastric Diffuse Adenocarcinoma,0.5505,Gastric Mixed Adenocarcinoma,0.5502,Disseminated Carcinoma,0.5474,Aggressive Systemic Mastocytosis with an Associated Germ Cell Tumor,0.5427,Systemic Mastocytosis with an Associated Germ Cell Tumor,0.5418,Gastric Cancer by AJCC v8 Clinical Stage,0.5394,Colorectal Serrated Adenocarcinoma,0.5381,Germ Cell,0.5361,Gallbladder Adenocarcinoma,0.5357,Adenocarcinoma,0.5350,Carcinoma,0.5318,Advanced Digestive System Carcinoma,0.5305,Neoplasm by Special Category,0.5302,Combined Carcinoid and Adenocarcinoma,0.5294,COAD_GS,False,False,False
COLLECTING DUCT RENAL CELL CARCINOMA,Collecting Duct Carcinoma,1,2,Collecting Duct Carcinoma,0.9001,Renal Cell Carcinoma,0.8176,Tubulocystic Renal Cell Carcinoma,0.7953,Clear Cell Renal Cell Carcinoma,0.7703,Kidney Medullary Carcinoma,0.7684,Kidney Carcinoma,0.7683,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma,0.7573,Papillary Renal Cell Carcinoma,0.7433,Non-Clear Cell Renal Cell Carcinoma,0.7389,Acquired Cystic Disease-Associated Renal Cell Carcinoma,0.7342,Childhood Renal Cell Carcinoma,0.7300,Granular Renal Cell Carcinoma,0.7251,"Renal Cell Carcinoma, Not Otherwise Specified",0.7175,Urinary Tract Clear Cell Adenocarcinoma,0.7158,Cholangiolocellular Carcinoma,0.7109,Renal Cell Carcinoma with MiT Translocations,0.7086,Urothelial Carcinoma,0.7044,Advanced Renal Cell Carcinoma,0.6996,Prostatic Duct Urothelial Carcinoma,0.6983,Childhood Kidney Carcinoma,0.6939,COLLECTING DUCT RENAL CELL CARCINOMA,True,True,True
COLON ADENOCARCINOMA,Colon Adenocarcinoma,1,2,Colon Adenocarcinoma,1.0000,Colorectal Adenocarcinoma,0.9220,Colon Carcinoma,0.9174,Advanced Colon Adenocarcinoma,0.8739,Cecum Adenocarcinoma,0.8520,Metastatic Colon Adenocarcinoma,0.8316,Malignant Colon Neoplasm,0.8297,Adenocarcinoma,0.8241,Colon Mucinous Adenocarcinoma,0.8240,Colon Adenoma,0.8240,Colorectal Carcinoma,0.8214,Distal Colon Carcinoma,0.8197,Colon Poorly Differentiated Adenocarcinoma,0.8194,Advanced Colon Carcinoma,0.8093,Colon Neoplasm,0.8066,Crohn Disease-Associated Colorectal Adenocarcinoma,0.7983,Advanced Colorectal Adenocarcinoma,0.7969,Colon Well Differentiated Adenocarcinoma,0.7965,Intestinal-Type Adenocarcinoma,0.7853,Colon Intramucosal Adenocarcinoma,0.7836,COLON ADENOCARCINOMA,True,True,True
COLON ADENOCARCINOMA IN SITU,Colon Adenocarcinoma,9,2,Adenocarcinoma In Situ,0.8474,Cecum Carcinoma In Situ,0.8029,Cervical Adenocarcinoma In Situ,0.7839,Carcinoma In Situ,0.7786,Stage 0 Colon Cancer AJCC v8,0.7681,Lung Adenocarcinoma In Situ,0.7620,Colon Well Differentiated Adenocarcinoma,0.7521,Stage 0 Colon Cancer AJCC v6 and v7,0.7423,Colon Adenocarcinoma,0.7392,Adenocarcinoma In Situ in Tubular Adenoma,0.7342,Digestive System Carcinoma In Situ,0.7305,Submucosal Invasive Colon Adenocarcinoma,0.7240,Benign Colon Neoplasm,0.7156,Colon Conventional Adenoma,0.7133,Colon Adenoma,0.7000,Lung Non-Mucinous Adenocarcinoma In Situ,0.6992,Colorectal Adenocarcinoma,0.6964,Adenocarcinoma In Situ in Adenomatous Polyp,0.6930,Advanced Colon Adenocarcinoma,0.6880,Colorectal Well Differentiated Adenocarcinoma,0.6879,COLON ADENOCARCINOMA IN SITU,False,False,False
COLON CANCER,Colon Carcinoma,1,2,Colon Carcinoma,0.9604,Colon Neoplasm,0.8995,Malignant Colon Neoplasm,0.8986,Colon Adenocarcinoma,0.8880,Colorectal Carcinoma,0.8680,Colorectal Adenocarcinoma,0.8149,Colorectal Neoplasm,0.8076,Advanced Colon Carcinoma,0.8014,Malignant Colorectal Neoplasm,0.7980,Distal Colon Carcinoma,0.7794,Hereditary Colon Carcinoma,0.7789,Colon Lymphoma,0.7735,Proximal Colon Carcinoma,0.7728,Advanced Colon Adenocarcinoma,0.7679,Cecum Carcinoma,0.7665,Colon Adenoma,0.7626,Metastatic Colon Carcinoma,0.7596,Cecum Adenocarcinoma,0.7504,Colon Medullary Carcinoma,0.7452,Childhood Colorectal Carcinoma,0.7422,COLON CANCER,True,True,True
COLON CARCINOMA,Colon Carcinoma,1,2,Colon Carcinoma,1.0000,Colon Adenocarcinoma,0.9174,Colorectal Carcinoma,0.9028,Malignant Colon Neoplasm,0.8920,Colon Neoplasm,0.8634,Colorectal Adenocarcinoma,0.8407,Distal Colon Carcinoma,0.8401,Advanced Colon Carcinoma,0.8396,Cecum Carcinoma,0.8256,Proximal Colon Carcinoma,0.8168,Advanced Colon Adenocarcinoma,0.8046,Metastatic Colon Carcinoma,0.8023,Sigmoid Colon Carcinoma,0.7963,Colon Medullary Carcinoma,0.7956,Colon Squamous Cell Carcinoma,0.7939,Cecum Adenocarcinoma,0.7900,Malignant Colorectal Neoplasm,0.7890,Colon Lymphoma,0.7857,Hereditary Colon Carcinoma,0.7820,Colon Undifferentiated Carcinoma,0.7819,COLON CARCINOMA,True,True,True
COLON MUCINOUS ADENOCARCINOMA,Colon Mucinous Adenocarcinoma,1,2,Colon Mucinous Adenocarcinoma,1.0000,Colorectal Mucinous Adenocarcinoma,0.9397,Mucinous Adenocarcinoma,0.8913,Appendix Mucinous Adenocarcinoma,0.8668,Cervical Mucinous Adenocarcinoma,0.8469,Metastatic Colorectal Mucinous Adenocarcinoma,0.8459,Ovarian Mucinous Adenocarcinoma,0.8428,Gastric Mucinous Adenocarcinoma,0.8359,Colon Adenocarcinoma,0.8240,Endometrial Mucinous Adenocarcinoma,0.8212,Anal Mucinous Adenocarcinoma,0.8167,Rectal Mucinous Adenocarcinoma,0.8060,Colon Intramucosal Adenocarcinoma,0.8044,Small Intestinal Mucinous Adenocarcinoma,0.8001,Gallbladder Mucinous Adenocarcinoma,0.7904,Broad Ligament Mucinous Adenocarcinoma,0.7873,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.7863,Appendix Mucinous Cystadenocarcinoma,0.7811,Mucinous Cystadenocarcinoma,0.7809,Mucin-Producing Adenocarcinoma,0.7807,COLON MUCINOUS ADENOCARCINOMA,True,True,True
COLONIC TYPE ADENOCARCINOMA OF THE APPENDIX,Appendix Adenocarcinoma,2,2,Appendix Goblet Cell Adenocarcinoma,0.7849,Appendix Adenocarcinoma,0.7752,Colon Mucinous Adenocarcinoma,0.7577,Colon Adenocarcinoma,0.7532,Appendix Mucinous Adenocarcinoma,0.7402,Crohn Disease-Associated Colorectal Adenocarcinoma,0.7254,Colorectal Mucinous Adenocarcinoma,0.7225,Appendix Carcinoma,0.7152,Cecum Adenocarcinoma,0.7128,Advanced Appendix Adenocarcinoma,0.7081,Colorectal Adenocarcinoma,0.7073,Colorectal Adenoma-Like Adenocarcinoma,0.7024,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,0.6983,High Grade Appendix Mucinous Adenocarcinoma,0.6979,Metastatic Appendix Adenocarcinoma,0.6972,Metastatic Colon Adenocarcinoma,0.6945,Colon Poorly Differentiated Adenocarcinoma,0.6933,Adenoma of the Colon with Intramucosal Adenocarcinoma,0.6902,Colon Adenoma,0.6861,Advanced Colon Adenocarcinoma,0.6853,COLONIC TYPE ADENOCARCINOMA OF THE APPENDIX,False,True,True
COLON_CANCER,Colon Carcinoma,1,2,Colon Carcinoma,0.8897,Malignant Colon Neoplasm,0.8514,Colon Neoplasm,0.8469,Colorectal Carcinoma,0.8257,Colon Adenocarcinoma,0.8184,Colorectal Neoplasm,0.7846,Malignant Colorectal Neoplasm,0.7791,Colorectal Adenocarcinoma,0.7684,Hereditary Colon Carcinoma,0.7487,Advanced Colon Carcinoma,0.7449,Colon Lymphoma,0.7276,Metastatic Colon Carcinoma,0.7160,Carcinoma Unspecified Site,0.7154,Colon Undifferentiated Carcinoma,0.7153,Cecum Carcinoma,0.7152,Carcinoma,0.7111,Distal Colon Carcinoma,0.7103,Advanced Colon Adenocarcinoma,0.7091,Colon Medullary Carcinoma,0.7042,Cecum Neoplasm,0.7035,COLON_CANCER,True,True,True
COLON_CARCINOMA,Colon Carcinoma,1,2,Colon Carcinoma,0.9392,Colorectal Carcinoma,0.8717,Malignant Colon Neoplasm,0.8611,Colon Adenocarcinoma,0.8547,Colon Neoplasm,0.8221,Colorectal Adenocarcinoma,0.7997,Malignant Colorectal Neoplasm,0.7859,Advanced Colon Carcinoma,0.7836,Cecum Carcinoma,0.7830,Carcinoma,0.7822,Carcinoma Unspecified Site,0.7660,Distal Colon Carcinoma,0.7659,Colon Undifferentiated Carcinoma,0.7641,Colon Medullary Carcinoma,0.7591,Metastatic Colon Carcinoma,0.7582,Colorectal Neoplasm,0.7521,Proximal Colon Carcinoma,0.7481,Advanced Colon Adenocarcinoma,0.7466,Hereditary Colon Carcinoma,0.7451,Cecum Adenocarcinoma,0.7404,COLON_CARCINOMA,True,True,True
COLORECTAL ADENOCARCINOMA,Colorectal Adenocarcinoma,1,2,Colorectal Adenocarcinoma,1.0000,Colon Adenocarcinoma,0.9220,Colorectal Carcinoma,0.9077,Advanced Colorectal Adenocarcinoma,0.8824,Crohn Disease-Associated Colorectal Adenocarcinoma,0.8554,Colon Carcinoma,0.8407,Cecum Adenocarcinoma,0.8387,Colorectal Adenoma,0.8369,Metastatic Colorectal Adenocarcinoma,0.8320,Colorectal Adenoma-Like Adenocarcinoma,0.8319,Advanced Colorectal Carcinoma,0.8306,Advanced Colon Adenocarcinoma,0.8280,Colorectal Mucinous Adenocarcinoma,0.8252,Colorectal Poorly Differentiated Adenocarcinoma,0.8210,Malignant Colorectal Neoplasm,0.8201,Adenocarcinoma,0.8185,Colorectal Well Differentiated Adenocarcinoma,0.8121,Rectal Adenocarcinoma,0.7997,Intestinal-Type Adenocarcinoma,0.7973,Unresectable Colorectal Adenocarcinoma,0.7957,COLORECTAL ADENOCARCINOMA,True,True,True
COLORECTAL CANCER,Colorectal Carcinoma,1,2,Colorectal Carcinoma,0.9624,Colorectal Neoplasm,0.8954,Malignant Colorectal Neoplasm,0.8897,Colorectal Adenocarcinoma,0.8763,Colon Carcinoma,0.8621,Advanced Colorectal Carcinoma,0.8255,Childhood Colorectal Carcinoma,0.8232,Colon Neoplasm,0.7894,Malignant Colon Neoplasm,0.7874,Colon Adenocarcinoma,0.7874,Metastatic Colorectal Carcinoma,0.7851,Colorectal Lymphoma,0.7836,Colorectal Undifferentiated Carcinoma,0.7724,Advanced Colorectal Adenocarcinoma,0.7687,Colorectal Adenoma,0.7676,Colorectal Medullary Carcinoma,0.7666,Unresectable Colorectal Carcinoma,0.7607,Early Stage Colorectal Carcinoma,0.7597,Hereditary Colon Carcinoma,0.7593,Rectal Carcinoma,0.7574,COLORECTAL CANCER,True,True,True
COLORECTAL CARCINOMA,Colorectal Carcinoma,1,2,Colorectal Carcinoma,1.0000,Colorectal Adenocarcinoma,0.9077,Colon Carcinoma,0.9028,Malignant Colorectal Neoplasm,0.8801,Colorectal Neoplasm,0.8634,Advanced Colorectal Carcinoma,0.8599,Childhood Colorectal Carcinoma,0.8408,Colon Adenocarcinoma,0.8214,Colorectal Squamous Cell Carcinoma,0.8147,Metastatic Colorectal Carcinoma,0.8131,Colorectal Medullary Carcinoma,0.8127,Cecum Carcinoma,0.8073,Colorectal Undifferentiated Carcinoma,0.8061,Advanced Colorectal Adenocarcinoma,0.8035,Colon Medullary Carcinoma,0.7911,Malignant Colon Neoplasm,0.7866,Early Stage Colorectal Carcinoma,0.7833,Unresectable Colorectal Carcinoma,0.7806,Rectal Carcinoma,0.7773,Colorectal Neuroendocrine Carcinoma,0.7753,COLORECTAL CARCINOMA,True,True,True
COLORECTAL CARCINOMA OTHER,Colorectal Carcinoma,1,2,Colorectal Carcinoma,0.8556,Colorectal Neoplasm,0.8179,Childhood Colorectal Carcinoma,0.7705,Colorectal Adenocarcinoma,0.7697,Colon Carcinoma,0.7672,Malignant Colorectal Neoplasm,0.7600,Colorectal Undifferentiated Carcinoma,0.7551,Metastatic Colorectal Carcinoma,0.7474,Unresectable Colorectal Carcinoma,0.7471,Colorectal Neuroendocrine Carcinoma,0.7435,Advanced Colorectal Carcinoma,0.7389,Colorectal Lymphoma,0.7275,Colorectal Medullary Carcinoma,0.7262,Colon Neoplasm,0.7188,Colorectal Neuroendocrine Neoplasm,0.7103,Colon Neuroendocrine Carcinoma,0.7084,Metastatic Malignant Colorectal Neoplasm,0.7054,Unresectable Colon Carcinoma,0.7043,Colon Medullary Carcinoma,0.7015,Colon Adenocarcinoma,0.7000,COLORECTAL CARCINOMA OTHER,True,True,True
COLORECTAL HYPERMUTATED,Microsatellite Stable Colorectal Carcinoma,99,2,Hypermutated Colorectal Carcinoma,0.8667,Hereditary Colon Carcinoma,0.6599,Colorectal High Grade Intraepithelial Neoplasia,0.6552,Hereditary Malignant Neoplasm,0.6506,Colorectal Hodgkin Lymphoma,0.6448,Malignant Colorectal Neoplasm,0.6433,Colorectal Villous Adenoma,0.6420,Colorectal Adenoma,0.6303,Colorectal Well Differentiated Adenocarcinoma,0.6288,Colorectal Conventional Adenoma,0.6256,Colorectal Poorly Differentiated Adenocarcinoma,0.6245,Colorectal Mucinous Adenocarcinoma,0.6179,Colorectal Undifferentiated Carcinoma,0.6144,Advanced Colorectal Carcinoma,0.6128,Colorectal Carcinoma,0.6104,Hereditary Meningioma,0.6101,Colorectal Sarcoma,0.6092,Colorectal Leiomyoma,0.6088,Polyposis,0.6076,Colorectal Serrated Adenocarcinoma,0.6070,COLORECTAL HYPERMUTATED,False,False,False
COLORECTAL MSS,Microsatellite Stable Colorectal Carcinoma,1,2,Microsatellite Stable Colorectal Carcinoma,0.7978,Microsatellite Stable Colon Carcinoma,0.7866,Colorectal Sarcoma,0.7577,Metastatic Microsatellite Stable Colorectal Carcinoma,0.7549,Metastatic Microsatellite Stable Colon Carcinoma,0.7412,Unresectable Microsatellite Stable Colorectal Carcinoma,0.7216,Advanced Microsatellite Stable Colorectal Carcinoma,0.7198,Colorectal Leiomyosarcoma,0.7191,Microsatellite Stable Rectal Carcinoma,0.7081,Colorectal Conventional Adenoma,0.7072,Malignant Colorectal Neoplasm,0.7004,Colorectal Carcinoma,0.6969,Colorectal Adenoma,0.6933,Colorectal Gastrointestinal Stromal Tumor,0.6914,Colorectal Traditional Serrated Adenoma,0.6888,Colon Sarcoma,0.6867,Benign Colorectal Neoplasm,0.6865,Hypermutated Colorectal Carcinoma,0.6857,Refractory Microsatellite Stable Colorectal Carcinoma,0.6847,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0.6803,COLORECTAL MSS,True,True,True
COLORECTAL NEUROENDOCRINE TUMOR,Colorectal Neuroendocrine Tumor,1,2,Colorectal Neuroendocrine Tumor,1.0000,Colorectal Neuroendocrine Neoplasm,0.9593,Colon Neuroendocrine Tumor,0.9252,Colorectal Neuroendocrine Carcinoma,0.8880,Colon Neuroendocrine Neoplasm,0.8861,Cecum Neuroendocrine Tumor,0.8712,Colorectal Neuroendocrine Tumor G1,0.8636,Intestinal Neuroendocrine Tumor,0.8570,Rectal Neuroendocrine Tumor,0.8441,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0.8402,Transverse Colon Neuroendocrine Tumor,0.8279,Midgut Neuroendocrine Tumor,0.8254,Intestinal Neuroendocrine Neoplasm,0.8250,Colorectal Neuroendocrine Tumor G2,0.8170,Colon Neuroendocrine Carcinoma,0.8133,Rectal Neuroendocrine Neoplasm,0.8126,Descending Colon Neuroendocrine Tumor,0.8094,Colon Neuroendocrine Tumor G1,0.8073,Sigmoid Colon Neuroendocrine Tumor,0.8010,Colorectal Neuroendocrine Tumor G3,0.8006,COLORECTAL NEUROENDOCRINE TUMOR,True,True,True
COLORECTAL_ADENOCARCINOMA,Colorectal Adenocarcinoma,1,2,Colorectal Adenocarcinoma,0.9531,Colon Adenocarcinoma,0.8779,Colorectal Carcinoma,0.8610,Advanced Colorectal Adenocarcinoma,0.8465,Crohn Disease-Associated Colorectal Adenocarcinoma,0.8334,Adenocarcinoma,0.8218,Colorectal Adenoma-Like Adenocarcinoma,0.8151,Malignant Colorectal Neoplasm,0.8067,Intestinal-Type Adenocarcinoma,0.8025,Metastatic Colorectal Adenocarcinoma,0.8003,Rectal Adenocarcinoma,0.7991,Advanced Colorectal Carcinoma,0.7964,Colorectal Poorly Differentiated Adenocarcinoma,0.7956,Cecum Adenocarcinoma,0.7913,Colorectal Mucinous Adenocarcinoma,0.7907,Colon Carcinoma,0.7906,Colorectal Adenoma,0.7887,Advanced Colon Adenocarcinoma,0.7849,Colorectal Well Differentiated Adenocarcinoma,0.7804,Colorectal Neoplasm,0.7776,COLORECTAL_ADENOCARCINOMA,True,True,True
COLORECTAL_CANCER,Colorectal Carcinoma,1,2,Colorectal Carcinoma,0.8864,Colorectal Neoplasm,0.8557,Malignant Colorectal Neoplasm,0.8417,Colorectal Adenocarcinoma,0.7996,Colon Carcinoma,0.7861,Advanced Colorectal Carcinoma,0.7611,Childhood Colorectal Carcinoma,0.7547,Colorectal Undifferentiated Carcinoma,0.7497,Colorectal Lymphoma,0.7459,Rectal Carcinoma,0.7440,Colon Neoplasm,0.7416,Malignant Colon Neoplasm,0.7323,Metastatic Colorectal Carcinoma,0.7312,Unresectable Colorectal Carcinoma,0.7282,Colorectal Neuroendocrine Carcinoma,0.7235,Refractory Colorectal Carcinoma,0.7223,Colon Adenocarcinoma,0.7146,Metastatic Malignant Colorectal Neoplasm,0.7118,Resectable Colorectal Carcinoma,0.7113,Colorectal Medullary Carcinoma,0.7108,COLORECTAL_CANCER,True,True,True
COLUMNAR CELL VARIANT,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.7431,Breast Columnar Cell Lesion,0.7387,Columnar Cell Change of the Breast,0.7122,Polygonal Cell Carcinoma,0.6736,Breast Columnar Cell Hyperplasia,0.6721,Columnar Cell Change of the Breast with Atypia,0.6531,Breast Columnar Cell Mucinous Carcinoma,0.6340,Transitional Cell Neoplasm,0.6300,Columnar Trichoblastoma,0.6271,Goblet Cell Adenocarcinoma,0.6247,Mixed Carcinoma,0.6191,Glassy Cell Carcinoma,0.6147,Adenocarcinoma with Spindle Cell Metaplasia,0.6146,Transitional Cell Carcinoma,0.6143,Breast Columnar Cell Hyperplasia with Atypia,0.6101,Conjunctival Spindle Cell Carcinoma,0.6067,Vaginal Neuroendocrine Carcinoma,0.6036,Mixed Cell Adenoma,0.6031,Choroid Spindle Cell Melanoma,0.5990,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0.5980,COLUMNAR CELL VARIANT,True,True,True
COMBINED SMALL CELL LUNG CARCINOMA,Combined Lung Small Cell Carcinoma,1,2,Combined Lung Small Cell Carcinoma,0.9912,Combined Lung Small Cell and Squamous Cell Carcinoma,0.9114,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.8871,Combined Lung Carcinoma,0.8450,Lung Small Cell Carcinoma,0.8145,Combined Lung Large Cell Neuroendocrine Carcinoma,0.7815,Lung Small Cell Carcinoma Molecular Subtypes,0.7795,Occult Lung Small Cell Carcinoma,0.7670,Metastatic Lung Small Cell Carcinoma,0.7576,Advanced Lung Small Cell Carcinoma,0.7507,"Lung Small Cell Carcinoma, A Subtype",0.7281,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.7210,Extensive Stage Lung Small Cell Carcinoma,0.7177,Lung Non-Small Cell Carcinoma,0.7158,Oligometastatic Lung Carcinoma,0.7126,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.7124,Childhood Lung Small Cell Carcinoma,0.7098,Limited Stage Lung Small Cell Carcinoma,0.7021,"Lung Small Cell Carcinoma, P Subtype",0.6943,Locally Advanced Lung Small Cell Carcinoma,0.6918,COMBINED SMALL CELL LUNG CARCINOMA,True,True,True
CONGENITAL FIBROSARCOMA,Congenital Peribronchial Myofibroblastic Tumor,19,2,Childhood Fibrosarcoma,0.8499,Infantile Fibrosarcoma,0.8498,Conventional Fibrosarcoma,0.8123,Fibrosarcoma,0.8085,Localized Fibrosarcoma,0.7774,Cardiac Fibrosarcoma,0.7766,Cellular Fibroma,0.7541,Infantile Myofibroma,0.7514,Adult Fibrosarcoma,0.7505,Fibroma,0.7464,Soft Tissue Fibrosarcoma,0.7450,Fascial Fibrosarcoma,0.7393,Fibromatosis,0.7375,Advanced Fibrosarcoma,0.7374,Cardiac Fibroma,0.7340,Bone Fibrosarcoma,0.7312,Myofibromatosis,0.7264,Unresectable Fibrosarcoma,0.7176,Congenital Peribronchial Myofibroblastic Tumor,0.7144,Fibrous Hamartoma of Infancy,0.7141,CONGENITAL FIBROSARCOMA,False,False,False
CONVENTIONAL LEIOMYOSARCOMA,Conventional Leiomyosarcoma,1,2,Conventional Leiomyosarcoma,1.0000,Leiomyosarcoma,0.9201,Well Differentiated Leiomyosarcoma,0.8790,Non-Cutaneous Leiomyosarcoma,0.8747,Adult Leiomyosarcoma,0.8589,Bone Leiomyosarcoma,0.8571,Myxoid Leiomyosarcoma,0.8551,Localized Leiomyosarcoma,0.8537,Advanced Leiomyosarcoma,0.8529,Inflammatory Leiomyosarcoma,0.8455,Granular Cell Leiomyosarcoma,0.8438,Cardiac Leiomyosarcoma,0.8435,Colorectal Leiomyosarcoma,0.8391,Digestive System Leiomyosarcoma,0.8344,Pleomorphic Leiomyosarcoma,0.8222,Colon Leiomyosarcoma,0.8197,Gastric Leiomyosarcoma,0.8184,Leiomyosarcoma of Deep Soft Tissue,0.8177,Leiomyosarcoma NCI Grade 2,0.8170,Epithelioid Leiomyosarcoma,0.8161,CONVENTIONAL LEIOMYOSARCOMA,True,True,True
COPY-NUMBER HIGH SEROUS-LIKE,Endometrial Serous Adenocarcinoma,99,2,"Nodular Sclerosis Classic Hodgkin Lymphoma, Syncytial Variant",0.6103,Nodular Sclerosis Classic Hodgkin Lymphoma,0.5991,High Grade Cervical Squamous Intraepithelial Neoplasia,0.5842,Hairy Cell Leukemia Variant,0.5809,Secondary Choroidal Non-Hodgkin Lymphoma,0.5785,Colorectal High Grade Intraepithelial Neoplasia,0.5679,High Grade Corneal Squamous Intraepithelial Neoplasia,0.5663,High Grade Squamous Intraepithelial Neoplasia,0.5651,Childhood Nodular Sclerosis Classic Hodgkin Lymphoma,0.5645,High Grade Cervical Intraepithelial Neoplasia,0.5638,Colorectal Hodgkin Lymphoma,0.5620,Hairy Cell Leukemia,0.5548,High Grade Intraepithelial Neoplasia,0.5540,Classic Hodgkin Lymphoma,0.5535,"Uterine Carcinosarcoma, Homologous Type",0.5512,"Nodular Sclerosis Classic Hodgkin Lymphoma, Cellular Phase",0.5511,Adult Nodular Sclerosis Classic Hodgkin Lymphoma,0.5502,Cerebral Hodgkin Lymphoma,0.5500,Nasopharyngeal Hodgkin Lymphoma,0.5465,Non-Hodgkin Lymphoma,0.5435,COPY-NUMBER HIGH SEROUS-LIKE,False,False,False
COPY-NUMBER LOW ENDOMETRIOD,Endometrial Endometrioid Adenocarcinoma,99,2,Low Grade Endometrioid Adenocarcinoma,0.6566,Endometrial Low Grade Endometrioid Adenocarcinoma,0.6339,Ovarian Low Grade Endometrioid Adenocarcinoma,0.6205,Endometrioid Tumor,0.6019,No Specific Molecular Profile Endometrial Endometrioid Adenocarcinoma,0.6002,Uterine Ligament Ependymoma,0.5894,Borderline Ovarian Endometrioid Tumor,0.5886,Fallopian Tube Endometrioid Polyp,0.5881,Endometrial Endometrioid Adenocarcinoma with Small Nonvillous Papillae,0.5850,Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia,0.5824,Low Grade Endometrioid Stromal Sarcoma,0.5817,Endometrioid Adenocarcinoma,0.5814,Ovarian Endometrioid Tumor,0.5797,Ovarian Low Grade Endometrioid Stromal Sarcoma,0.5788,Benign Ovarian Endometrioid Tumor,0.5729,Cervical Low Grade Endometrioid Stromal Sarcoma,0.5718,Locally Advanced Endometrioid Adenocarcinoma,0.5696,Ovarian Endometrioid Cystadenoma,0.5696,High Grade Endometrioid Adenocarcinoma,0.5676,Complex Endometrial Hyperplasia,0.5661,COPY-NUMBER LOW ENDOMETRIOD,False,False,False
CRANIOPHARYNGIOMA,Craniopharyngioma,1,2,Craniopharyngioma,1.0000,Childhood Craniopharyngioma,0.9409,Adult Craniopharyngioma,0.9205,Papillary Craniopharyngioma,0.9133,Carcinoma Arising from Craniopharyngioma,0.8868,Unresectable Craniopharyngioma,0.8608,Recurrent Craniopharyngioma,0.8352,Adamantinomatous Craniopharyngioma,0.7929,Childhood Adamantinomatous Craniopharyngioma,0.7374,Retropharyngeal Neoplasm,0.7165,Adult Adamantinomatous Craniopharyngioma,0.7058,Benign Retropharyngeal Neoplasm,0.6757,Cerebellopontine Angle Neoplasm,0.6460,Recurrent Adamantinomatous Craniopharyngioma,0.6403,Malignant Retropharyngeal Neoplasm,0.6360,Sphenocavernous Meningioma,0.6107,Sellar Paraganglioma,0.5948,Sellar Neurocytoma,0.5930,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified",0.5894,Petroclival Meningioma,0.5874,CRANIOPHARYNGIOMA,True,True,True
"CRANIOPHARYNGIOMA, ADAMANTINOMATOUS TYPE",Adamantinomatous Craniopharyngioma,1,2,Adamantinomatous Craniopharyngioma,0.9569,Adult Adamantinomatous Craniopharyngioma,0.9206,Childhood Adamantinomatous Craniopharyngioma,0.8880,Adamantinoma,0.7832,Recurrent Adamantinomatous Craniopharyngioma,0.7603,Adult Craniopharyngioma,0.7458,Craniopharyngioma,0.7436,Tibial Adamantinoma,0.7269,Papillary Craniopharyngioma,0.7112,Childhood Craniopharyngioma,0.7081,Adamantinoid Trichoblastoma,0.6920,Adenoid Ameloblastoma,0.6813,Desmoplastic Ameloblastoma,0.6717,Carcinoma Arising from Craniopharyngioma,0.6642,Ameloblastoma,0.6571,Conventional Ameloblastoma,0.6517,Acanthomatous Ameloblastoma,0.6438,Recurrent Craniopharyngioma,0.6385,Benign Ameloblastoma,0.6322,Unresectable Craniopharyngioma,0.6233,"CRANIOPHARYNGIOMA, ADAMANTINOMATOUS TYPE",True,True,True
CRC HM,Microsatellite Stable Colorectal Carcinoma,99,2,Hypermutated Colorectal Carcinoma,0.7161,Hereditary Colon Carcinoma,0.6880,Colorectal Hodgkin Lymphoma,0.6739,Colorectal Medullary Carcinoma,0.6708,Refractory Mixed Cellularity Classic Hodgkin Lymphoma,0.6692,Malignant Colorectal Neoplasm,0.6619,Hereditary Meningioma,0.6569,Colorectal Undifferentiated Carcinoma,0.6569,Hereditary Malignant Neoplasm,0.6567,Colorectal Carcinoma,0.6541,Colon Medullary Carcinoma,0.6530,Hereditary Thyroid Gland Medullary Carcinoma,0.6521,Metastatic Malignant Colorectal Neoplasm,0.6513,Metastatic Colorectal Carcinoma,0.6511,Rectal Medullary Carcinoma,0.6470,Refractory Colorectal Carcinoma,0.6418,Hereditary Melanoma,0.6372,Colorectal Lymphoma,0.6359,Colorectal Mantle Cell Lymphoma,0.6249,Colorectal Adenocarcinoma,0.6228,CRC HM,False,False,False
CRC MSS,Microsatellite Stable Colorectal Carcinoma,2,2,Microsatellite Stable Colon Carcinoma,0.7710,Microsatellite Stable Colorectal Carcinoma,0.7689,Metastatic Microsatellite Stable Colorectal Carcinoma,0.7297,Metastatic Microsatellite Stable Colon Carcinoma,0.7272,Unresectable Microsatellite Stable Colorectal Carcinoma,0.7060,Microsatellite Stable Rectal Carcinoma,0.6941,Advanced Microsatellite Stable Colorectal Carcinoma,0.6874,Refractory Microsatellite Stable Colorectal Carcinoma,0.6736,Recurrent Microsatellite Stable Colorectal Carcinoma,0.6609,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0.6495,Hypermutated Colorectal Carcinoma,0.6482,Colorectal Sarcoma,0.6480,Locally Advanced Microsatellite Stable Colon Carcinoma,0.6452,Resectable Colorectal Carcinoma,0.6431,Colorectal Carcinoma,0.6428,Colorectal Conventional Adenoma,0.6409,Stage 0 Colorectal Cancer AJCC v8,0.6398,Microsatellite Stable Ovarian Carcinoma,0.6361,Benign Colorectal Neoplasm,0.6300,Unresectable Colorectal Carcinoma,0.6240,CRC MSS,False,True,True
CRIBIFORM MORULAR,Thyroid Gland Cribriform Morular Carcinoma,1,2,Thyroid Gland Cribriform Morular Carcinoma,0.6963,Cribriform Carcinoma,0.6434,Invasive Breast Cribriform Carcinoma,0.6181,Gallbladder Cribriform Carcinoma,0.6035,Non-Invasive Cribriform Carcinoma,0.5936,Cribriform Trichoblastoma,0.5889,Cribriform Neuroepithelial Tumor,0.5881,Adnexal Cribriform Tumor,0.5649,Cribriform Adenocarcinoma of Minor Salivary Gland,0.5574,Cellular Myxoma,0.5565,Inclusion Body Fibromatosis,0.5498,Cribriform Comedo-Type Adenocarcinoma,0.5362,Intraocular Retinoblastoma,0.5358,Ovarian Fetiform Teratoma,0.5355,"Breast Ductal Carcinoma In Situ, Cribriform Pattern",0.5333,Peritoneal Implant,0.5320,Glomuvenous Malformation,0.5301,Follicular Myxoma,0.5294,Polar Spongioblastoma,0.5290,Iris Spindle Cell Melanoma,0.5288,CRIBIFORM MORULAR,True,True,True
CSCC,Skin Squamous Cell Carcinoma,1,2,Skin Squamous Cell Carcinoma,0.9493,Squamous Cell Carcinoma,0.8285,Skin Carcinoma,0.8013,Skin Clear Cell Squamous Cell Carcinoma,0.7969,Advanced Skin Squamous Cell Carcinoma,0.7638,Skin Spindle Cell Squamous Cell Carcinoma,0.7636,Head and Neck Cutaneous Squamous Cell Carcinoma,0.7585,Squamous Cell Neoplasm,0.7568,Cutaneous Merkel Cell Carcinoma,0.7444,Skin Acantholytic Squamous Cell Carcinoma,0.7432,Skin Squamous Cell Carcinoma In Situ,0.7382,Corneal Squamous Cell Carcinoma,0.7266,Solar Radiation-Related Skin Squamous Cell Carcinoma,0.7192,Locally Advanced Skin Squamous Cell Carcinoma,0.7114,Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation,0.7044,Skin Adnexal Carcinoma,0.7031,Skin Adenosquamous Carcinoma,0.7012,Skin Basaloid Squamous Cell Carcinoma,0.7000,Skin Basosquamous Cell Carcinoma,0.6966,Cervical Squamous Cell Carcinoma,0.6964,Cutaneous Squamous Cell Carcinoma,True,True,True
CUTANEOUS MALIGNANCY OF HAIR MATRIX CELLS,Pilomatrical Carcinoma,8,2,Malignant Hair Follicle Neoplasm,0.7402,Hairy Cell Leukemia,0.6370,Cutaneous Hematopoietic and Lymphoid Cell Neoplasm,0.6347,Trichoblastic Carcinoma,0.6334,Hair Follicle Neoplasm,0.6333,Malignant Skin Neoplasm,0.6278,Malignant Proliferating Trichilemmal Tumor,0.6245,Pilomatrical Carcinoma,0.6237,Malignant Outer Hair Sheath and Infundibulum Neoplasm,0.6232,Hairy Cell Leukemia Variant,0.6186,Mast Cell Neoplasm,0.6143,Malignant Dermal Neoplasm,0.6129,Malignant Mixed Tumor of the Skin,0.6113,Malignant Sweat Gland Neoplasm,0.6108,Sweat Gland Carcinoma,0.6085,Cutaneous Melanoma,0.6062,Skin Carcinoma,0.6029,Pilomatricoma,0.6028,Trichilemmoma,0.5990,Trichogerminoma,0.5971,CUTANEOUS MALIGNANCY OF HAIR MATRIX CELLS,False,False,False
CUTANEOUS MELANOMA,Cutaneous Melanoma,1,2,Cutaneous Melanoma,1.0000,Dermal Melanoma,0.9082,Melanoma,0.8940,Non-Cutaneous Melanoma,0.8348,Ocular Melanoma,0.8171,Cutaneous Melanocytic Neoplasm,0.8168,Childhood Cutaneous Melanoma,0.7994,Mucosal Melanoma,0.7951,Invasive Cutaneous Melanoma,0.7902,Corneal Melanoma,0.7876,Metastatic Cutaneous Melanoma,0.7812,Uveal Melanoma,0.7809,Cutaneous Melanoma of the Extremity,0.7788,Acral Melanoma,0.7765,Retinal Melanoma,0.7712,Melanocytic Neoplasm,0.7691,Lentigo Maligna Melanoma,0.7675,Conjunctival Melanoma,0.7661,Childhood Melanoma,0.7591,Choroid Melanoma,0.7561,CUTANEOUS MELANOMA,True,True,True
CUTANEOUS SQUAMOUS CELL,Skin Squamous Cell Carcinoma,1,2,Skin Squamous Cell Carcinoma,0.8627,Squamous Cell Neoplasm,0.7987,Squamous Cell Carcinoma,0.7837,Skin Carcinoma,0.7304,Skin Spindle Cell Squamous Cell Carcinoma,0.7264,Benign Squamous Cell Neoplasm,0.7190,Skin Clear Cell Squamous Cell Carcinoma,0.7186,Skin Acantholytic Squamous Cell Carcinoma,0.7119,Skin Squamous Cell Carcinoma In Situ,0.7057,Cutaneous Merkel Cell Carcinoma,0.6947,Skin Adenosquamous Carcinoma,0.6886,Skin Basaloid Squamous Cell Carcinoma,0.6885,Spindle Cell Squamous Carcinoma,0.6878,Advanced Skin Squamous Cell Carcinoma,0.6859,Skin Basosquamous Cell Carcinoma,0.6852,Head and Neck Cutaneous Squamous Cell Carcinoma,0.6829,Superficial Basal Cell Carcinoma,0.6749,Acantholytic Squamous Cell Carcinoma,0.6726,Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation,0.6704,Cutaneous Lymphoma,0.6681,CUTANEOUS SQUAMOUS CELL,True,True,True
CUTANEOUS SQUAMOUS CELL CARCINOMA,Skin Squamous Cell Carcinoma,1,2,Skin Squamous Cell Carcinoma,0.9493,Squamous Cell Carcinoma,0.8285,Skin Carcinoma,0.8013,Skin Clear Cell Squamous Cell Carcinoma,0.7969,Advanced Skin Squamous Cell Carcinoma,0.7638,Skin Spindle Cell Squamous Cell Carcinoma,0.7636,Head and Neck Cutaneous Squamous Cell Carcinoma,0.7585,Squamous Cell Neoplasm,0.7568,Cutaneous Merkel Cell Carcinoma,0.7444,Skin Acantholytic Squamous Cell Carcinoma,0.7432,Skin Squamous Cell Carcinoma In Situ,0.7382,Corneal Squamous Cell Carcinoma,0.7266,Solar Radiation-Related Skin Squamous Cell Carcinoma,0.7192,Locally Advanced Skin Squamous Cell Carcinoma,0.7114,Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation,0.7044,Skin Adnexal Carcinoma,0.7031,Skin Adenosquamous Carcinoma,0.7012,Skin Basaloid Squamous Cell Carcinoma,0.7000,Skin Basosquamous Cell Carcinoma,0.6966,Cervical Squamous Cell Carcinoma,0.6964,CUTANEOUS SQUAMOUS CELL CARCINOMA,True,True,True
CUTANEOUS T CELL LYMPHOMA,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,2,2,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.8674,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.8614,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.8039,Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7983,Primary Cutaneous Gamma-Delta T-Cell Lymphoma,0.7870,"Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7719,Cutaneous Lymphoma,0.7676,T-Cell Chronic Lymphocytic Leukemia,0.7653,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",0.7509,Cutaneous Chronic Lymphocytic Leukemia,0.7500,Low Grade T-Cell Lymphoma,0.7427,T-Cell Non-Hodgkin Lymphoma,0.7421,T Lymphoblastic Lymphoma,0.7345,Cutaneous Mature T-Cell and NK-Cell Neoplasm,0.7318,Intestinal T-Cell Lymphoma,0.7191,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,0.7191,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.7167,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.7067,"Peripheral T-Cell Lymphoma, Large Cell",0.7062,T-Cell Large Granular Lymphocyte Leukemia,0.7035,CUTANEOUS T CELL LYMPHOMA,False,True,True
CYSTADENOCARCINOMA,Cystadenocarcinoma,1,2,Cystadenocarcinoma,1.0000,Mucinous Cystadenocarcinoma,0.8910,Papillary Cystadenocarcinoma,0.8898,Ovarian Cystadenocarcinoma,0.8870,Cystadenoma,0.8780,Salivary Gland Cystadenocarcinoma,0.8575,Serous Cystadenocarcinoma,0.8457,Pancreatic Cystadenocarcinoma,0.8417,Papillary Mucinous Cystadenocarcinoma,0.8232,Breast Mucinous Cystadenocarcinoma,0.8145,Mucinous Cystadenoma,0.7940,Ovarian Mucinous Cystadenocarcinoma,0.7897,Pancreatic Mucinous Cystadenocarcinoma,0.7815,Appendix Mucinous Cystadenocarcinoma,0.7799,Pancreatic Acinar Cell Cystadenocarcinoma,0.7764,Ovarian Cystadenoma,0.7683,Prostate Cystadenoma,0.7646,Serous Cystadenoma,0.7583,Papillary Cystadenoma,0.7552,Papillary Serous Cystadenocarcinoma,0.7514,CYSTADENOCARCINOMA,True,True,True
"CYSTADENOCARCINOMA, CLEAR CELL",Ovarian Clear Cell Cystadenocarcinoma,1,2,Ovarian Clear Cell Cystadenocarcinoma,0.8906,Clear Cell Adenocarcinoma,0.8315,Clear Cell Papillary Cystadenoma,0.8303,Clear Cell Adenoma,0.8264,Cystadenocarcinoma,0.8023,Urinary Tract Clear Cell Adenocarcinoma,0.7761,Clear Cell Cystadenofibroma,0.7761,Water-Clear Cell Adenocarcinoma,0.7760,Clear Cell Neoplasm,0.7724,Clear Cell Malignant Neoplasm,0.7690,Ovarian Clear Cell Adenocarcinoma,0.7667,Ovarian Cystadenocarcinoma,0.7512,Papillary Cystadenocarcinoma,0.7488,Ovarian Clear Cell Cystadenofibroma,0.7471,Endometrial Clear Cell Adenocarcinoma,0.7469,Mucinous Cystadenocarcinoma,0.7357,Serous Cystadenocarcinoma,0.7357,Clear Cell Renal Cell Carcinoma,0.7349,Bladder Clear Cell Adenocarcinoma,0.7294,Gallbladder Clear Cell Adenocarcinoma,0.7270,"CYSTADENOCARCINOMA, CLEAR CELL",True,True,True
"CYSTADENOCARCINOMA, MUCINOUS",Mucinous Cystadenocarcinoma,1,2,Mucinous Cystadenocarcinoma,0.9830,Mucinous Cystadenoma,0.9180,Appendix Mucinous Cystadenocarcinoma,0.8878,Ovarian Mucinous Cystadenocarcinoma,0.8842,Papillary Mucinous Cystadenocarcinoma,0.8807,Breast Mucinous Cystadenocarcinoma,0.8744,Mucinous Adenocarcinoma,0.8691,Cystadenocarcinoma,0.8621,Pancreatic Mucinous Cystadenocarcinoma,0.8499,Ovarian Mucinous Cystadenoma,0.8252,Mucinous Cystadenofibroma,0.8219,Appendix Mucinous Cystadenoma,0.8199,Papillary Mucinous Cystadenoma,0.8145,Mucinous Neoplasm,0.8066,Endometrial Mucinous Adenocarcinoma,0.8046,Cervical Mucinous Adenocarcinoma,0.8008,Serous Cystadenocarcinoma,0.7992,Salivary Gland Mucinous Adenocarcinoma,0.7972,Ovarian Mucinous Adenocarcinoma,0.7926,Pancreatic Mucinous Cystadenoma,0.7896,"CYSTADENOCARCINOMA, MUCINOUS",True,True,True
DEDIFFERENTIATED,Dedifferentiated Chondrosarcoma,7,2,Endometrial Dedifferentiated Carcinoma,0.7849,Dedifferentiated Chordoma,0.7630,Dedifferentiated Liposarcoma,0.7539,Ovarian Dedifferentiated Carcinoma,0.7396,Dedifferentiated Leiomyosarcoma,0.7389,Dedifferentiated Gastrointestinal Stromal Tumor,0.7290,Dedifferentiated Chondrosarcoma,0.7264,Recurrent Endometrial Dedifferentiated Carcinoma,0.7032,Poorly Differentiated Malignant Neoplasm,0.6995,Dedifferentiated Solitary Fibrous Tumor,0.6937,Advanced Dedifferentiated Liposarcoma,0.6871,Metastatic Dedifferentiated Liposarcoma,0.6625,Recurrent Dedifferentiated Chordoma,0.6512,Refractory Dedifferentiated Chordoma,0.6437,Dedifferentiated Dermatofibrosarcoma Protuberans,0.6415,Refractory Endometrial Dedifferentiated Carcinoma,0.6403,Recurrent Dedifferentiated Liposarcoma,0.6387,Undifferentiated Malignant Neoplasm,0.6384,Refractory Dedifferentiated Liposarcoma,0.6351,Locally Advanced Dedifferentiated Liposarcoma,0.6345,DEDIFFERENTIATED,False,False,False
DEDIFFERENTIATED CHONDROSARCOMA,Dedifferentiated Chondrosarcoma,1,2,Dedifferentiated Chondrosarcoma,1.0000,Mesenchymal Chondrosarcoma,0.8003,Chondrosarcoma,0.7903,Dedifferentiated Chordoma,0.7711,Mesenchymal Chondrosarcoma of Bone,0.7696,"Chondrosarcoma, Grade 3",0.7694,Secondary Chondrosarcoma,0.7648,Synovial Chondrosarcoma,0.7643,Clear Cell Chondrosarcoma,0.7608,Chondrosarcoma NCI Grade 3,0.7590,Adult Mesenchymal Chondrosarcoma,0.7506,"Chondrosarcoma, Grade 1",0.7474,"Chondrosarcoma, Grade 2",0.7472,Endometrial Dedifferentiated Carcinoma,0.7380,Localized Chondrosarcoma,0.7373,Chondrosarcoma NCI Grade 2,0.7336,Chondrosarcoma NCI Grade 1,0.7318,Mesenchymal Extraskeletal Chondrosarcoma,0.7309,Metastatic Chondrosarcoma,0.7283,Myxoid Chondrosarcoma NCI Grade 2,0.7228,DEDIFFERENTIATED CHONDROSARCOMA,True,True,True
DEDIFFERENTIATED LIPOSARCOMA,Dedifferentiated Liposarcoma,1,2,Dedifferentiated Liposarcoma,1.0000,Advanced Dedifferentiated Liposarcoma,0.9119,Metastatic Dedifferentiated Liposarcoma,0.9040,Locally Advanced Dedifferentiated Liposarcoma,0.8731,Dedifferentiated Leiomyosarcoma,0.8391,Unresectable Dedifferentiated Liposarcoma,0.8314,Pleomorphic Liposarcoma,0.8311,Recurrent Dedifferentiated Liposarcoma,0.8308,Resectable Dedifferentiated Liposarcoma,0.8269,Liposarcoma,0.8261,Myxoid Liposarcoma,0.8170,Mixed Liposarcoma,0.8101,Metastatic Liposarcoma,0.8092,Refractory Dedifferentiated Liposarcoma,0.8084,Fibroblastic Liposarcoma,0.8032,Localized Liposarcoma,0.7972,Advanced Liposarcoma,0.7921,Bone Liposarcoma,0.7902,Myxoid Pleomorphic Liposarcoma,0.7855,Adult Liposarcoma,0.7810,DEDIFFERENTIATED LIPOSARCOMA,True,True,True
DERMATOFIBROMA,Skin Fibrous Histiocytoma,13,2,Dermatomyofibroma,0.9412,Elastofibroma,0.8259,Dermal Fibroma,0.8218,Skin Fibroblastic Fibrous Histiocytoma,0.7646,Gliofibroma,0.7589,Skin Fibroblastic Neoplasm,0.7526,Classic Dermatofibrosarcoma Protuberans,0.7508,Desmoplastic Fibroblastoma,0.7467,Myofibroma,0.7454,Fascial Fibroma,0.7436,Dermatofibrosarcoma Protuberans,0.7430,Skin Myxofibrosarcoma,0.7421,Skin Fibrous Histiocytoma,0.7398,Fibromatosis,0.7331,Myofibroblastoma,0.7315,Superficial Fibromatosis,0.7260,Fibroma,0.7255,Angiomyofibroblastoma,0.7241,Plaque-Like Dermatofibrosarcoma Protuberans,0.7216,Fibrofolliculoma,0.7196,DERMATOFIBROMA,False,False,False
DERMATOFIBROSARCOMA PROTUBERANS,Dermatofibrosarcoma Protuberans,1,2,Dermatofibrosarcoma Protuberans,1.0000,Classic Dermatofibrosarcoma Protuberans,0.9727,Pigmented Dermatofibrosarcoma Protuberans,0.9446,Fibrosarcomatous Dermatofibrosarcoma Protuberans,0.9354,Plaque-Like Dermatofibrosarcoma Protuberans,0.9337,Myxoid Dermatofibrosarcoma Protuberans,0.9330,Dedifferentiated Dermatofibrosarcoma Protuberans,0.9323,Myoid Dermatofibrosarcoma Protuberans,0.9217,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0.8948,Dermatomyofibroma,0.6873,Dedifferentiated Solitary Fibrous Tumor,0.6762,Pleomorphic Dermal Sarcoma,0.6669,Periosteal Fibrosarcoma,0.6538,Desmoplastic Fibroblastoma,0.6532,Deep Fibrous Histiocytoma,0.6501,Skin Myxofibrosarcoma,0.6413,Poorly Differentiated Fibrosarcoma,0.6363,Skin Fibroblastic Fibrous Histiocytoma,0.6353,Gliofibroma,0.6307,Central Nervous System Dedifferentiated Solitary Fibrous Tumor,0.6289,DERMATOFIBROSARCOMA PROTUBERANS,True,True,True
DESMOID FIBROMATOSIS,Desmoid Fibromatosis,1,2,Desmoid Fibromatosis,1.0000,Desmoplastic Fibroma,0.9401,Desmoplastic Fibroblastoma,0.8955,Locally Invasive Desmoid-Type Fibromatosis,0.8802,Jaw Desmoplastic Fibroma,0.8789,Central Nervous System Desmoid Fibromatosis,0.8330,Sinonasal Desmoid Fibromatosis,0.8317,Recurrent Desmoid Fibromatosis,0.8287,Unresectable Desmoid Fibromatosis,0.8218,Maxillofacial Desmoplastic Fibroma,0.8171,Refractory Desmoid Fibromatosis,0.8165,Fibromatosis,0.8007,Cutaneous Desmoplastic Nevus,0.7736,Superficial Fibromatosis,0.7633,Dermal Fibroma,0.7506,Desmoplastic Mesothelioma,0.7475,Desmoplastic Melanoma,0.7457,Fibroma,0.7214,Fascial Fibroma,0.7120,Desmoplastic Infantile Astrocytoma,0.7109,DESMOID FIBROMATOSIS,True,True,True
DESMOID TUMOR,Desmoid Fibromatosis,1,2,Desmoid Fibromatosis,0.9255,Desmoplastic Fibroma,0.8945,Desmoplastic Fibroblastoma,0.8888,Locally Invasive Desmoid-Type Fibromatosis,0.8332,Jaw Desmoplastic Fibroma,0.8157,Unresectable Desmoid Fibromatosis,0.8008,Refractory Desmoid Fibromatosis,0.7946,Desmoplastic Melanoma,0.7927,Cutaneous Desmoplastic Nevus,0.7839,Desmoplastic Mesothelioma,0.7785,Sinonasal Desmoid Fibromatosis,0.7784,Central Nervous System Desmoid Fibromatosis,0.7764,Recurrent Desmoid Fibromatosis,0.7764,Maxillofacial Desmoplastic Fibroma,0.7525,Desmoplastic Trichilemmoma,0.7464,Desmoplastic Ameloblastoma,0.7368,Desmoplastic Infantile Astrocytoma,0.7329,Desmoplastic Small Round Cell Tumor,0.7289,Desmoplastic Neurotropic Melanoma,0.7243,Fibromatosis,0.7242,DESMOID TUMOR,True,True,True
DESMOID/AGGRESSIVE FIBROMATOSIS,Desmoid Fibromatosis,1,2,Desmoid Fibromatosis,0.9229,Desmoplastic Fibroma,0.9094,Desmoplastic Fibroblastoma,0.8780,Locally Invasive Desmoid-Type Fibromatosis,0.8727,Jaw Desmoplastic Fibroma,0.8667,Refractory Desmoid Fibromatosis,0.8434,Recurrent Desmoid Fibromatosis,0.8254,Maxillofacial Desmoplastic Fibroma,0.8238,Unresectable Desmoid Fibromatosis,0.8222,Sinonasal Desmoid Fibromatosis,0.8202,Central Nervous System Desmoid Fibromatosis,0.7796,Fibromatosis,0.7697,Cutaneous Desmoplastic Nevus,0.7586,Desmoplastic Infantile Astrocytoma,0.7547,Desmoplastic Ameloblastoma,0.7510,Desmoplastic Mesothelioma,0.7462,Desmoplastic Melanoma,0.7403,Superficial Fibromatosis,0.7303,Dermal Fibroma,0.7275,Desmoplastic Neurotropic Melanoma,0.7184,DESMOID/AGGRESSIVE FIBROMATOSIS,True,True,True
DESMOPLASTIC MELANOMA,Desmoplastic Melanoma,1,2,Desmoplastic Melanoma,1.0000,Desmoplastic Neurotropic Melanoma,0.8576,Desmoplastic Mesothelioma,0.8296,Cutaneous Desmoplastic Nevus,0.8184,Desmoplastic Fibroblastoma,0.7943,Desmoplastic Fibroma,0.7605,Desmoplastic Trichilemmoma,0.7588,Desmoid Fibromatosis,0.7457,Desmoplastic Ameloblastoma,0.7228,Locally Invasive Desmoid-Type Fibromatosis,0.7164,Desmoplastic Small Round Cell Tumor,0.7147,Pleural Desmoplastic Mesothelioma,0.7112,Cutaneous Desmoplastic Spitz Nevus,0.7093,Desmoplastic Infantile Astrocytoma,0.6876,Sinonasal Desmoid Fibromatosis,0.6813,Unresectable Desmoid Fibromatosis,0.6781,Jaw Desmoplastic Fibroma,0.6761,Minimal Deviation Melanoma,0.6718,Refractory Desmoid Fibromatosis,0.6648,Metastatic Desmoplastic Small Round Cell Tumor,0.6614,DESMOPLASTIC MELANOMA,True,True,True
DESMOPLASTIC SMALL ROUND CELL TUMOR,Desmoplastic Small Round Cell Tumor,1,2,Desmoplastic Small Round Cell Tumor,1.0000,Adult Desmoplastic Small Round Cell Tumor,0.9348,Childhood Desmoplastic Small Round Cell Tumor,0.8959,Metastatic Desmoplastic Small Round Cell Tumor,0.8867,Unresectable Desmoplastic Small Round Cell Tumor,0.8604,Peritoneal Desmoplastic Small Round Cell Tumor,0.8591,Refractory Desmoplastic Small Round Cell Tumor,0.8493,Locally Advanced Desmoplastic Small Round Cell Tumor,0.8474,Recurrent Desmoplastic Small Round Cell Tumor,0.8305,Desmoplastic Fibroblastoma,0.7423,Desmoplastic Fibroma,0.7157,Desmoplastic Melanoma,0.7147,Desmoplastic Mesothelioma,0.7095,Desmoplastic Neurotropic Melanoma,0.7014,Undifferentiated Round Cell Sarcoma,0.6908,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.6862,Refractory Desmoid Fibromatosis,0.6795,Sinonasal Desmoid Fibromatosis,0.6753,Round Cell Liposarcoma,0.6709,EWSR1-Negative Small Round Cell Tumor,0.6676,DESMOPLASTIC SMALL ROUND CELL TUMOR,True,True,True
DESMOPLASTIC SMALL-ROUND-CELL TUMOR,Desmoplastic Small Round Cell Tumor,1,2,Desmoplastic Small Round Cell Tumor,0.9859,Adult Desmoplastic Small Round Cell Tumor,0.9280,Childhood Desmoplastic Small Round Cell Tumor,0.8884,Metastatic Desmoplastic Small Round Cell Tumor,0.8722,Unresectable Desmoplastic Small Round Cell Tumor,0.8548,Refractory Desmoplastic Small Round Cell Tumor,0.8498,Peritoneal Desmoplastic Small Round Cell Tumor,0.8421,Locally Advanced Desmoplastic Small Round Cell Tumor,0.8307,Recurrent Desmoplastic Small Round Cell Tumor,0.8155,Desmoplastic Fibroblastoma,0.7201,Desmoplastic Fibroma,0.7007,Desmoplastic Melanoma,0.6959,Desmoplastic Neurotropic Melanoma,0.6945,Desmoplastic Mesothelioma,0.6924,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.6809,Undifferentiated Round Cell Sarcoma,0.6784,EWSR1-Negative Small Round Cell Tumor,0.6731,Refractory Desmoid Fibromatosis,0.6685,Sinonasal Desmoid Fibromatosis,0.6622,Small Cell Sarcoma,0.6595,DESMOPLASTIC SMALL-ROUND-CELL TUMOR,True,True,True
DESMOPLASTIC/NODULAR MEDULLOBLASTOMA,Desmoplastic/Nodular Medulloblastoma,1,2,Desmoplastic/Nodular Medulloblastoma,1.0000,Medulloblastoma with Extensive Nodularity,0.7941,"Medulloblastoma, Non-WNT/Non-SHH",0.7775,Medulloblastoma,0.7568,Classic Medulloblastoma,0.7445,Anaplastic Medulloblastoma,0.7235,"Medulloblastoma, WNT-Activated",0.7223,Childhood Medulloblastoma,0.7208,Medulloblastoma Molecular Subtypes,0.7199,"Medulloblastoma, Not Otherwise Specified",0.7153,Adult Medulloblastoma,0.7148,"Medulloblastoma, Non-WNT/Non-SHH, Group 4",0.7103,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",0.7058,"Medulloblastoma, SHH-Activated",0.7020,Metastatic Medulloblastoma,0.6847,Large Cell Medulloblastoma,0.6793,Desmoplastic Neurotropic Melanoma,0.6786,"Medulloblastoma, SHH-2",0.6780,"Medulloblastoma, SHH-4",0.6771,Cerebellar Vermis Medulloblastoma,0.6768,DESMOPLASTIC/NODULAR MEDULLOBLASTOMA,True,True,True
DIFFSE LARGE B-CELL LYMPHOMA,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.8567,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.8216,Childhood Diffuse Large B-Cell Lymphoma,0.7951,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.7930,Digestive System Diffuse Large B-Cell Lymphoma,0.7893,MCD Diffuse Large B-Cell Lymphoma,0.7886,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,0.7825,Advanced Diffuse Large B-Cell Lymphoma,0.7818,EZB Diffuse Large B-Cell Lymphoma,0.7810,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0.7806,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,0.7692,Childhood Diffuse Large Cell Lymphoma,0.7630,Gastric Diffuse Large B-Cell Lymphoma,0.7611,"EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.7577,Small Intestinal Diffuse Large B-Cell Lymphoma,0.7547,Testicular Diffuse Large B-Cell Lymphoma,0.7546,Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation,0.7542,Liver Diffuse Large B-Cell Lymphoma,0.7530,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.7522,Colorectal Diffuse Large B-Cell Lymphoma,0.7509,DIFFSE LARGE B-CELL LYMPHOMA,True,True,True
DIFFUSE ASTROCYTOMA,Diffuse Astrocytoma,1,2,Diffuse Astrocytoma,1.0000,Adult Diffuse Astrocytoma,0.9007,Diffuse Glioma,0.8649,Childhood Diffuse Astrocytoma,0.8614,Astrocytoma,0.8424,"Diffuse Astrocytoma, Not Otherwise Specified",0.8392,Childhood Cerebral Diffuse Astrocytoma,0.8260,Cerebral Astrocytoma,0.8079,Anaplastic Astrocytoma,0.8069,Brain Astrocytoma,0.8069,Diencephalic Astrocytoma,0.8009,Fibrillary Astrocytoma,0.7852,Anaplastic Diencephalic Astrocytoma,0.7823,Low Grade Astrocytoma,0.7711,Gemistocytic Astrocytoma,0.7564,Astrocytic Tumor,0.7551,"Diffuse Astrocytoma, IDH-Wildtype",0.7532,Diffuse Midline Glioma,0.7524,"Diffuse Astrocytoma, MYB-Altered",0.7483,"Diffuse Astrocytoma, MYBL1-Altered",0.7458,DIFFUSE ASTROCYTOMA,True,True,True
"DIFFUSE ASTROCYTOMA, IDH-MUTANT","Astrocytoma, IDH-Mutant, Grade 2",3,2,"Astrocytoma, IDH-Mutant",0.9526,"Gemistocytic Astrocytoma, IDH-Mutant",0.8864,"Astrocytoma, IDH-Mutant, Grade 2",0.8858,"Diffuse Astrocytoma, IDH-Wildtype",0.8811,"Astrocytoma, IDH-Mutant, Grade 3",0.8758,"Astrocytoma, IDH-Mutant, Grade 4",0.8570,"Astrocytoma, IDH-Wildtype",0.8373,"Anaplastic Astrocytoma, IDH-Wildtype",0.8228,"Glioblastoma, IDH-Wildtype",0.7629,"Unresectable Astrocytoma, IDH-Mutant",0.7566,"Diffuse Astrocytoma, MYBL1-Altered",0.7296,"Recurrent Astrocytoma, IDH-Mutant",0.7258,"Diffuse Astrocytoma, MYB-Altered",0.7244,Diffuse Astrocytoma,0.7100,Anaplastic Diencephalic Astrocytoma,0.6907,"Childhood Diffuse Astrocytoma, MYBL1-Altered",0.6858,"Childhood Diffuse Astrocytoma, MYB-Altered",0.6814,Diencephalic Astrocytoma,0.6793,"Diffuse Astrocytoma, Not Otherwise Specified",0.6673,"Diffuse Low Grade Glioma, FGFR1-Mutant",0.6585,"DIFFUSE ASTROCYTOMA, IDH-MUTANT",False,True,True
DIFFUSE GLIOMA,Diffuse Glioma,1,2,Diffuse Glioma,1.0000,Diffuse Astrocytoma,0.8649,Glioma,0.8574,Diffuse Midline Glioma,0.8516,Unresectable Diffuse Glioma,0.8078,Malignant Glioma,0.7987,Adult Diffuse Astrocytoma,0.7804,Glioblastoma,0.7780,Classical Glioblastoma,0.7680,Mixed Glioma,0.7677,Recurrent Diffuse Glioma,0.7673,Low Grade Glioma,0.7583,Metastatic Glioma,0.7551,Malignant Brain Glioma,0.7515,Gliomatosis Cerebri,0.7506,Childhood Diffuse Astrocytoma,0.7421,Advanced Glioblastoma,0.7419,Diencephalic Glioblastoma,0.7416,Brain Glioblastoma,0.7414,"Diffuse Astrocytoma, Not Otherwise Specified",0.7395,DIFFUSE GLIOMA,True,True,True
DIFFUSE INTRINSIC PONTINE GLIOMA,Diffuse Intrinsic Pontine Glioma,1,2,Diffuse Intrinsic Pontine Glioma,1.0000,Adult Diffuse Intrinsic Pontine Glioma,0.9099,Childhood Diffuse Intrinsic Pontine Glioma,0.9020,Refractory Diffuse Intrinsic Pontine Glioma,0.8435,Recurrent Diffuse Intrinsic Pontine Glioma,0.8385,Diffuse Non-Pontine Midline Glioma,0.7715,Diffuse Midline Glioma,0.7170,Diffuse Glioma,0.7164,Unresectable Diffuse Glioma,0.7049,Unresectable Diffuse Midline Glioma,0.7043,Diencephalic Glioblastoma,0.6869,Proneural Glioblastoma,0.6422,Glioblastoma with Primitive Neuronal Component,0.6398,Diffuse Leptomeningeal Glioneuronal Tumor,0.6291,Gliomatosis Cerebri,0.6255,Visual Pathway Glioma,0.6231,Brain Stem Glioma,0.6225,Glioma,0.6219,Diencephalic Astrocytoma,0.6211,Primary Central Nervous System Lymphoma,0.6188,DIFFUSE INTRINSIC PONTINE GLIOMA,True,True,True
DIFFUSE LARGE B-CELL LYMPHOMA,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,1.0000,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.9301,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.8908,Breast Diffuse Large B-Cell Lymphoma,0.8711,Adult Diffuse Large B-Cell Lymphoma,0.8688,Diffuse Large B-Cell Lymphoma Unclassifiable,0.8682,Childhood Diffuse Large B-Cell Lymphoma,0.8638,Advanced Diffuse Large B-Cell Lymphoma,0.8557,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.8548,Gastric Diffuse Large B-Cell Lymphoma,0.8450,MCD Diffuse Large B-Cell Lymphoma,0.8378,Lacrimal Gland Diffuse Large B-Cell Lymphoma,0.8351,Tonsillar Diffuse Large B-Cell Lymphoma,0.8328,Lacrimal System Diffuse Large B-Cell Lymphoma,0.8312,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.8297,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,0.8296,Kidney Diffuse Large B-Cell Lymphoma,0.8246,Lung Diffuse Large B-Cell Lymphoma,0.8240,Digestive System Diffuse Large B-Cell Lymphoma,0.8187,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0.8185,DIFFUSE LARGE B-CELL LYMPHOMA,True,True,True
DIFFUSE LARGE B-CELL LYMPHOMA DLBCL,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9320,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.8784,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.8479,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.8371,Breast Diffuse Large B-Cell Lymphoma,0.8326,Adult Diffuse Large B-Cell Lymphoma,0.8268,Advanced Diffuse Large B-Cell Lymphoma,0.8191,Diffuse Large B-Cell Lymphoma Unclassifiable,0.8160,Childhood Diffuse Large B-Cell Lymphoma,0.8117,Tonsillar Diffuse Large B-Cell Lymphoma,0.8049,Gastric Diffuse Large B-Cell Lymphoma,0.8045,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.8045,"EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.8039,Lung Diffuse Large B-Cell Lymphoma,0.7922,EZB Diffuse Large B-Cell Lymphoma,0.7920,Lacrimal Gland Diffuse Large B-Cell Lymphoma,0.7886,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0.7884,Lacrimal System Diffuse Large B-Cell Lymphoma,0.7878,Testicular Diffuse Large B-Cell Lymphoma,0.7867,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,0.7861,DIFFUSE LARGE B-CELL LYMPHOMA DLBCL,True,True,True
DIFFUSE LARGE B-CELL LYMPHOMA DLBCL NOS ANY ANATOMIC SITE NODAL OR EXTRANODAL,Diffuse Large B-Cell Lymphoma,4,2,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.8391,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.8311,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0.8049,Diffuse Large B-Cell Lymphoma,0.7998,"EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.7662,Advanced Diffuse Large B-Cell Lymphoma,0.7439,Digestive System Diffuse Large B-Cell Lymphoma,0.7295,Breast Diffuse Large B-Cell Lymphoma,0.7291,Diffuse Large B-Cell Lymphoma Unclassifiable,0.7212,"Adult EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.7206,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",0.7187,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.7172,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.7145,"Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.7136,Testicular Diffuse Large B-Cell Lymphoma,0.7013,Gastric Diffuse Large B-Cell Lymphoma,0.6982,Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma,0.6959,Adult Diffuse Large B-Cell Lymphoma,0.6944,Primary Bone Diffuse Large B-Cell Lymphoma,0.6932,"Childhood EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.6911,DIFFUSE LARGE B-CELL LYMPHOMA DLBCL NOS ANY ANATOMIC SITE NODAL OR EXTRANODAL,False,False,True
"DIFFUSE LARGE B-CELL LYMPHOMA, NOS",Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9866,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.9379,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.8958,Diffuse Large B-Cell Lymphoma Unclassifiable,0.8565,Childhood Diffuse Large B-Cell Lymphoma,0.8505,Adult Diffuse Large B-Cell Lymphoma,0.8477,Breast Diffuse Large B-Cell Lymphoma,0.8472,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.8353,Advanced Diffuse Large B-Cell Lymphoma,0.8349,MCD Diffuse Large B-Cell Lymphoma,0.8269,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.8242,Gastric Diffuse Large B-Cell Lymphoma,0.8232,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,0.8224,Tonsillar Diffuse Large B-Cell Lymphoma,0.8139,Lacrimal Gland Diffuse Large B-Cell Lymphoma,0.8129,Lacrimal System Diffuse Large B-Cell Lymphoma,0.8125,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0.8109,Lung Diffuse Large B-Cell Lymphoma,0.8048,Kidney Diffuse Large B-Cell Lymphoma,0.8035,Transformed Lymphoplasmacytic Lymphoma to Diffuse Large B-Cell Lymphoma,0.8007,"DIFFUSE LARGE B-CELL LYMPHOMA, NOS",True,True,True
DIFFUSE LEPTOMENINGEAL  GLIONEURONAL TUMOR,Diffuse Leptomeningeal Glioneuronal Tumor,1,2,Diffuse Leptomeningeal Glioneuronal Tumor,1.0000,Diffuse Non-Pontine Midline Glioma,0.7924,Glioneuronal and Neuronal Tumors,0.7555,Diffuse Midline Glioma,0.7464,Meningeal Gliomatosis,0.7420,Diffuse Glioma,0.7382,Diencephalic Glioblastoma,0.7372,Leptomeningeal Neoplasm,0.7258,Papillary Glioneuronal Tumor,0.7168,Diffuse Glioneuronal Tumor with Oligodendroglioma-Like Features and Nuclear Clusters,0.7102,Glioneuronal Tumor with Neuropil-Like Islands,0.7063,Myxoid Glioneuronal Tumor,0.7027,Gliomatosis Cerebri,0.6982,Cerebellar Glioneuronal and Neuronal Tumors,0.6946,Central Nervous System Ganglioneuroblastoma,0.6802,"Diffuse Low Grade Glioma, MAPK Pathway-Altered",0.6801,Neural Glioblastoma,0.6784,Medulloblastoma with Leptomeningeal Spread,0.6746,Dysembryoplastic Neuroepithelial Tumor,0.6732,Primary Low Grade B-Cell Dural Lymphoma,0.6709,DIFFUSE LEPTOMENINGEAL  GLIONEURONAL TUMOR,True,True,True
DIFFUSE MALIGNANT MESOTHELIOMA - NOS,Diffuse Malignant Mesothelioma,1,2,Diffuse Malignant Mesothelioma,0.9632,Malignant Mesothelioma,0.8402,Metastatic Malignant Mesothelioma,0.7965,Advanced Malignant Mesothelioma,0.7784,Sarcomatoid Mesothelioma,0.7603,Mesothelioma,0.7581,Advanced Epithelioid Mesothelioma,0.7477,Epithelioid Mesothelioma,0.7422,Asbestos-Related Malignant Mesothelioma,0.7329,Peritoneal Malignant Mesothelioma,0.7311,Desmoplastic Mesothelioma,0.7294,Localized Malignant Mesothelioma,0.7261,Pleural Malignant Mesothelioma,0.7241,Biphasic Mesothelioma,0.7220,Lymphohistiocytoid Mesothelioma,0.7050,Pericardial Malignant Mesothelioma,0.6998,Metastatic Peritoneal Malignant Mesothelioma,0.6994,Peritoneal Sarcomatoid Mesothelioma,0.6989,Pleural Mesothelioma,0.6912,Ovarian Malignant Mesothelioma,0.6894,DIFFUSE MALIGNANT MESOTHELIOMA - NOS,True,True,True
DIFFUSE MIDLINE GLIOMA,Diffuse Midline Glioma,1,2,Diffuse Midline Glioma,1.0000,Diffuse Non-Pontine Midline Glioma,0.8656,Diffuse Glioma,0.8516,Unresectable Diffuse Midline Glioma,0.8245,Recurrent Diffuse Midline Glioma,0.7914,Diffuse Midline Glioma with EZHIP Overexpression,0.7870,Diffuse Astrocytoma,0.7524,Diffuse Leptomeningeal Glioneuronal Tumor,0.7464,Mixed Glioma,0.7365,Malignant Glioma,0.7239,Unresectable Diffuse Glioma,0.7213,Malignant Brain Glioma,0.7179,Diencephalic Glioblastoma,0.7175,Diffuse Intrinsic Pontine Glioma,0.7170,"Diffuse Midline Glioma, EGFR-Mutant",0.7120,Glioma,0.7110,Adult Mixed Glioma,0.7104,Childhood Mixed Glioma,0.6931,Gliomatosis Cerebri,0.6852,Diffuse Malignant Lymphoma,0.6807,DIFFUSE MIDLINE GLIOMA,True,True,True
"DIFFUSE MIDLINE GLIOMA, H3K27M MUTANT","Diffuse Midline Glioma, H3 K27M-Mutant",1,2,"Diffuse Midline Glioma, H3 K27M-Mutant",0.8738,"Diffuse Midline Glioma, H3 K27-Altered",0.7696,"Unresectable Diffuse Midline Glioma, H3 K27M-Mutant",0.7543,"Childhood Diffuse Midline Glioma, H3 K27-Altered",0.7448,"Adult Diffuse Midline Glioma, H3 K27-Altered",0.7422,"Recurrent Diffuse Midline Glioma, H3 K27M-Mutant",0.7352,"Diffuse Midline Glioma, EGFR-Mutant",0.7221,Diffuse Midline Glioma with EZHIP Overexpression,0.6719,"Diffuse Hemispheric Glioma, H3 G34-Mutant",0.6616,"Astrocytoma, IDH-Mutant",0.6464,Diffuse Midline Glioma,0.6458,"Astrocytoma, IDH-Mutant, Grade 3",0.6445,MGMT-Methylated Glioblastoma,0.6431,"Gemistocytic Astrocytoma, IDH-Mutant",0.6399,"Childhood Diffuse Hemispheric Glioma, H3 G34-Mutant",0.6363,"Adult Diffuse Hemispheric Glioma, H3 G34-Mutant",0.6252,Malignant Brain Glioma,0.6187,"Diffuse Low Grade Glioma, FGFR1-Mutant",0.6115,Diffuse Non-Pontine Midline Glioma,0.6105,"Astrocytoma, IDH-Mutant, Grade 2",0.6105,"DIFFUSE MIDLINE GLIOMA, H3K27M MUTANT",True,True,True
DIFFUSE SCLEROSING VARIANT,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,1,2,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.7073,Sclerosing Epithelioid Fibrosarcoma,0.6589,Sclerosing Rhabdomyosarcoma,0.6562,Sclerosing Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.6352,Sclerosing Pneumocytoma,0.6333,Sclerosing PEComa,0.6208,Dedifferentiated Solitary Fibrous Tumor,0.6173,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.6057,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.6057,Sclerosing Thymoma,0.6047,Sclerosing Odontogenic Carcinoma,0.6008,Pleomorphic Dermal Sarcoma,0.5969,Poorly Differentiated Synovial Sarcoma,0.5967,Classic Dermatofibrosarcoma Protuberans,0.5905,Sclerosing Angiomatoid Nodular Transformation of Spleen,0.5903,"Tenosynovial Giant Cell Tumor, Diffuse Type",0.5894,Follicular Lymphoma with Predominantly Diffuse Growth Pattern,0.5893,Ovarian Sclerosing Stromal Tumor,0.5863,Plaque-Like Dermatofibrosarcoma Protuberans,0.5858,Desmoplastic Melanoma,0.5844,DIFFUSE SCLEROSING VARIANT,True,True,True
DIFFUSE TYPE STOMACH ADENOCARCINOMA,Gastric Diffuse Adenocarcinoma,1,2,Gastric Diffuse Adenocarcinoma,0.9437,Sporadic Gastric Diffuse Adenocarcinoma,0.8814,Diffuse Type Adenocarcinoma,0.8654,Gastric Adenocarcinoma,0.8140,Hereditary Gastric Diffuse Adenocarcinoma,0.7764,Gastric Intestinal-Type Adenocarcinoma,0.7732,Advanced Gastric Adenocarcinoma,0.7704,Sporadic Gastric Adenocarcinoma,0.7663,Gastric Mixed Adenocarcinoma,0.7447,Gastric Tubular Adenocarcinoma,0.7396,Gastric Poorly Cohesive Adenocarcinoma,0.7390,Proximal Gastric Adenocarcinoma,0.7274,Gastric Carcinoma,0.7250,Metastatic Gastric Adenocarcinoma,0.7212,Gastric Cardia Adenocarcinoma,0.7148,Advanced Gastric Carcinoma,0.7132,Gastric Hepatoid Adenocarcinoma,0.7121,Localized Gastric Adenocarcinoma,0.7028,"Gastric Adenoma, Gastric-Type",0.7013,Disseminated Adenocarcinoma,0.6982,DIFFUSE TYPE STOMACH ADENOCARCINOMA,True,True,True
DIFFUSE_ADENOCARCINOMA,Gastric Diffuse Adenocarcinoma,3,2,Diffuse Type Adenocarcinoma,0.9282,Disseminated Adenocarcinoma,0.8419,Gastric Diffuse Adenocarcinoma,0.8299,Adenocarcinoma,0.8242,Advanced Adenocarcinoma,0.7790,Sporadic Gastric Diffuse Adenocarcinoma,0.7692,Adenocarcinoma with Metaplasia,0.7454,Metastatic Adenocarcinoma,0.7360,Disseminated Carcinoma,0.7233,Diffuse Malignant Lymphoma,0.7147,Hereditary Gastric Diffuse Adenocarcinoma,0.6986,Lung Adenocarcinoma,0.6984,Small Cell Adenocarcinoma,0.6978,Gastric Adenocarcinoma,0.6964,Mixed Cell Adenocarcinoma,0.6959,Trabecular Adenocarcinoma,0.6950,Adenocarcinoma with Neuroendocrine Differentiation,0.6930,Diffuse Astrocytoma,0.6926,Superficial Spreading Adenocarcinoma,0.6900,Non-Small Cell Adenocarcinoma,0.6899,DIFFUSE_ADENOCARCINOMA,False,True,True
DIFFUSE_GASTRIC,Gastric Diffuse Adenocarcinoma,1,2,Gastric Diffuse Adenocarcinoma,0.8156,Sporadic Gastric Diffuse Adenocarcinoma,0.7528,Gastric Lymphoma,0.7282,Hereditary Gastric Diffuse Adenocarcinoma,0.7071,Diffuse Glioma,0.7033,Gastric Diffuse Large B-Cell Lymphoma,0.7028,Malignant Gastric Neoplasm,0.6777,Gastric Carcinoma,0.6734,Gastric Melanoma,0.6716,Diffuse Malignant Lymphoma,0.6597,Gastric Neoplasm,0.6593,Advanced Gastric Carcinoma,0.6571,Metastatic Gastric Carcinoma,0.6548,Diffuse Type Adenocarcinoma,0.6540,Digestive System Lymphoma,0.6527,Gastric Adenocarcinoma,0.6498,Advanced Gastric Adenocarcinoma,0.6450,Gastric Undifferentiated Carcinoma,0.6443,Metastatic Gastric Adenocarcinoma,0.6430,Disseminated Carcinoma,0.6429,DIFFUSE_GASTRIC,True,True,True
DIFFUSE_HISTIOCYTIC_LYMPHOMA,"Malignant Lymphoma, Histiocytic, Diffuse",1,2,"Malignant Lymphoma, Histiocytic, Diffuse",0.9460,True Histiocytic Lymphoma,0.8465,Diffuse Malignant Lymphoma,0.7690,Malignant Histiocytosis,0.7675,Histiocytic and Dendritic Cell Neoplasm,0.7552,Histiocytic Sarcoma,0.7470,"Langerhans Cell Histiocytosis, Disseminated",0.7305,Histiocytosis,0.7174,Transformed Lymphoplasmacytic Lymphoma to Diffuse Large B-Cell Lymphoma,0.6935,Histiocytoma,0.6911,Lymphoplasmacytic Lymphoma,0.6897,Diffuse Mixed Cell Lymphoma,0.6869,"Langerhans Cell Histiocytosis, Polyostotic",0.6797,Diffuse Large B-Cell Lymphoma,0.6770,Deep Fibrous Histiocytoma,0.6732,Langerhans Cell Histiocytosis,0.6708,Lymphohistiocytoid Mesothelioma,0.6585,"Malignant Lymphoma, Non-Cleaved, Diffuse",0.6539,"Langerhans Cell Histiocytosis, Monostotic",0.6534,Cutaneous Histiocytic and Dendritic Cell Neoplasm,0.6520,DIFFUSE_HISTIOCYTIC_LYMPHOMA,True,True,True
DIFFUSE_LARGE_B_CELL_LYMPHOMA,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.9335,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.8968,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.8719,MCD Diffuse Large B-Cell Lymphoma,0.8174,Diffuse Large B-Cell Lymphoma Unclassifiable,0.8165,Advanced Diffuse Large B-Cell Lymphoma,0.8081,Childhood Diffuse Large B-Cell Lymphoma,0.8036,Breast Diffuse Large B-Cell Lymphoma,0.8016,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0.8005,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.7984,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,0.7981,Transformed Lymphoplasmacytic Lymphoma to Diffuse Large B-Cell Lymphoma,0.7953,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.7883,Diffuse Malignant Lymphoma,0.7845,Gastric Diffuse Large B-Cell Lymphoma,0.7816,Adult Diffuse Large B-Cell Lymphoma,0.7793,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,0.7721,Digestive System Diffuse Large B-Cell Lymphoma,0.7710,EZB Diffuse Large B-Cell Lymphoma,0.7709,Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation,0.7709,DIFFUSE_LARGE_B_CELL_LYMPHOMA,True,True,True
DIPG,Diffuse Intrinsic Pontine Glioma,1,2,Diffuse Intrinsic Pontine Glioma,1.0000,Adult Diffuse Intrinsic Pontine Glioma,0.9099,Childhood Diffuse Intrinsic Pontine Glioma,0.9020,Refractory Diffuse Intrinsic Pontine Glioma,0.8435,Recurrent Diffuse Intrinsic Pontine Glioma,0.8385,Diffuse Non-Pontine Midline Glioma,0.7715,Diffuse Midline Glioma,0.7170,Diffuse Glioma,0.7164,Unresectable Diffuse Glioma,0.7049,Unresectable Diffuse Midline Glioma,0.7043,Diencephalic Glioblastoma,0.6869,Proneural Glioblastoma,0.6422,Glioblastoma with Primitive Neuronal Component,0.6398,Diffuse Leptomeningeal Glioneuronal Tumor,0.6291,Gliomatosis Cerebri,0.6255,Visual Pathway Glioma,0.6231,Brain Stem Glioma,0.6225,Glioma,0.6219,Diencephalic Astrocytoma,0.6211,Primary Central Nervous System Lymphoma,0.6188,Diffuse Intrinsic Pontine Glioma,True,True,True
DISSEMINATED JUVENILE XANTHOGRANULOMA,Disseminated Juvenile Xanthogranuloma,1,2,Disseminated Juvenile Xanthogranuloma,1.0000,Juvenile Xanthogranuloma,0.9462,Cutaneous Juvenile Xanthogranuloma,0.9251,Head and Neck Juvenile Xanthogranuloma,0.8851,Cutaneous Adult Xanthogranuloma,0.8442,Childhood Pleomorphic Xanthoastrocytoma,0.6708,Pleomorphic Xanthoastrocytoma,0.6356,Recurrent Childhood Pleomorphic Xanthoastrocytoma,0.6236,Cerebellar Liponeurocytoma,0.6021,Anaplastic Pleomorphic Xanthoastrocytoma,0.5967,"Langerhans Cell Histiocytosis, Disseminated",0.5848,Juvenile Granulosa Cell Tumor,0.5833,Deep Lipoma,0.5764,Juvenile Myelomonocytic Leukemia,0.5758,Diffuse Lipomatosis,0.5737,Lipidized Glioblastoma,0.5729,Temporal Lobe Pleomorphic Xanthoastrocytoma,0.5726,Childhood Langerhans Cell Histiocytosis,0.5661,Histiocytosis,0.5644,Childhood Lymphomatoid Granulomatosis,0.5641,DISSEMINATED JUVENILE XANTHOGRANULOMA,True,True,True
DLBC,Diffuse Large B-Cell Lymphoma,2,2,Diffuse Centroblastic-Centrocytic Lymphoma,0.6980,Diffuse Large B-Cell Lymphoma,0.6968,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.6767,Advanced Diffuse Large B-Cell Lymphoma,0.6721,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.6709,Diffuse Large B-Cell Lymphoma Unclassifiable,0.6600,Breast Diffuse Large B-Cell Lymphoma,0.6480,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.6452,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.6418,Primary Cerebral Diffuse Large B-Cell Lymphoma,0.6397,Cardiac Diffuse Large B-Cell Lymphoma,0.6391,Lacrimal System Diffuse Large B-Cell Lymphoma,0.6381,MCD Diffuse Large B-Cell Lymphoma,0.6368,Lacrimal Gland Diffuse Large B-Cell Lymphoma,0.6344,A53 Diffuse Large B-Cell Lymphoma,0.6331,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0.6330,Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation,0.6324,Adult Diffuse Large B-Cell Lymphoma,0.6278,Breast Mixed Ductal and Lobular Carcinoma,0.6277,Lacrimal Drainage System Diffuse Large B-Cell Lymphoma,0.6251,DLBC,False,True,True
DLBCL,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.7649,Lymphoma,0.7608,EZB Diffuse Large B-Cell Lymphoma,0.7358,Diffuse Malignant Lymphoma,0.7228,Classical Burkitt Lymphoma,0.7214,Composite Lymphoma,0.7180,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.7171,Burkitt Lymphoma,0.7140,Breast Lymphoma,0.7117,Follicular Lymphoma,0.7103,Centroblastic Lymphoma,0.7095,Tonsillar Diffuse Large B-Cell Lymphoma,0.7077,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.7051,Advanced Diffuse Large B-Cell Lymphoma,0.7040,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.7031,Breast Diffuse Large B-Cell Lymphoma,0.7007,BN2 Diffuse Large B-Cell Lymphoma,0.7002,B Lymphoblastic Lymphoma,0.6997,Adult Diffuse Large B-Cell Lymphoma,0.6945,Diffuse Retinoblastoma,0.6913,DLBCL,True,True,True
DOWN SYNDROME; ACUTE MEGAKARYOBLASTIC LEUKAEMIA,Myeloid Leukemia Associated with Down Syndrome,2,2,Acute Megakaryoblastic Leukemia,0.8109,Myeloid Leukemia Associated with Down Syndrome,0.7856,Transient Abnormal Myelopoiesis Associated with Down Syndrome,0.7383,Childhood Acute Megakaryoblastic Leukemia,0.7349,Adult Acute Megakaryoblastic Leukemia,0.7307,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7009,"Mixed Phenotype Acute Leukemia, T/Megakaryocytic",0.6941,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,0.6706,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.6648,Acute Monocytic Leukemia,0.6574,Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1,0.6568,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6525,Acute Myelomonocytic Leukemia,0.6457,Aleukemic Myeloid Leukemia,0.6453,Acute Myeloid Leukemia with Multilineage Dysplasia,0.6432,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.6423,B Acute Lymphoblastic Leukemia Associated with Down Syndrome,0.6410,Myelodysplastic Syndrome,0.6376,Recurrent Acute Megakaryoblastic Leukemia,0.6370,Myelodysplastic Syndrome with Genetic Abnormalities,0.6361,DOWN SYNDROME; ACUTE MEGAKARYOBLASTIC LEUKAEMIA,False,True,True
DUCTAL ADENOCARCINOMA,Pancreatic Ductal Adenocarcinoma,2,2,Prostate Ductal Adenocarcinoma,0.8792,Pancreatic Ductal Adenocarcinoma,0.8677,Adenocarcinoma,0.8456,Breast Adenocarcinoma,0.8215,Breast Ductal Carcinoma,0.8209,Ductal Eccrine Adenocarcinoma,0.8056,Diffuse Type Adenocarcinoma,0.8003,Tubular Adenocarcinoma,0.7978,Breast Ductal Adenoma,0.7974,Bile Duct Adenocarcinoma,0.7940,Papillary Adenocarcinoma,0.7791,Pancreatic Adenocarcinoma,0.7768,Advanced Adenocarcinoma,0.7719,Advanced Pancreatic Ductal Adenocarcinoma,0.7700,Acinar Cell Carcinoma,0.7640,Duodenal Adenocarcinoma,0.7631,Pancreatic Well Differentiated Ductal Adenocarcinoma,0.7502,Thyroid Gland Adenocarcinoma,0.7477,Advanced Breast Adenocarcinoma,0.7464,Disseminated Adenocarcinoma,0.7444,DUCTAL ADENOCARCINOMA,False,True,True
DUCTAL AND LOBULAR,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,0.7091,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.6977,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.6931,Breast Ductal Hyperplasia,0.6742,Breast Ductal Adenoma,0.6622,Diffuse Lipomatosis,0.6610,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.6586,Breast Ductal Carcinoma,0.6535,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.6411,Breast Lobular Neoplasia,0.6405,Breast Usual Ductal Hyperplasia,0.6398,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.6393,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.6362,Breast Lobular Carcinoma,0.6347,Breast Ductal Carcinoma In Situ,0.6181,Diffuse Type Adenocarcinoma,0.6110,Deep Lipoma,0.6102,Disseminated Adenocarcinoma,0.6073,Breast Atypical Ductal Hyperplasia,0.6044,Diffuse Intraductal Papillomatosis,0.6036,DUCTAL AND LOBULAR,True,True,True
DUCTAL AND LOBULAR FEATURES,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,0.6915,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.6812,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.6711,Breast Ductal Hyperplasia,0.6607,Diffuse Lipomatosis,0.6413,Breast Lobular Neoplasia,0.6392,Breast Usual Ductal Hyperplasia,0.6379,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.6371,Breast Ductal Adenoma,0.6325,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.6285,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.6230,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.6194,Breast Ductal Carcinoma,0.6165,Breast Lobular Carcinoma,0.6158,Breast Atypical Ductal Hyperplasia,0.6127,Breast Atypical Lobular Hyperplasia,0.6059,Follicular Lymphoma with Predominantly Diffuse Growth Pattern,0.6005,Diffuse Type Adenocarcinoma,0.5957,Diffuse Intraductal Papillomatosis,0.5948,Lipomatosis,0.5943,DUCTAL AND LOBULAR FEATURES,True,True,True
DUCTAL CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.9192,Prostate Ductal Adenocarcinoma,0.7838,Breast Carcinoma,0.7791,Breast Adenocarcinoma,0.7675,Carcinoma,0.7665,Salivary Duct Carcinoma,0.7662,Ductal Eccrine Adenocarcinoma,0.7658,Breast Ductal Adenoma,0.7613,Pancreatic Ductal Adenocarcinoma,0.7586,Adenocarcinoma,0.7542,Metastatic Breast Ductal Carcinoma,0.7521,Nipple Duct Carcinoma,0.7455,Bile Duct Carcinoma,0.7390,Breast Ductal Carcinoma In Situ,0.7373,Breast Ductal Carcinoma with Squamous Metaplasia,0.7318,Acinar Cell Carcinoma,0.7211,Collecting Duct Carcinoma,0.7211,Breast Acinic Cell Carcinoma,0.7205,Diffuse Type Adenocarcinoma,0.7198,Bile Duct Adenocarcinoma,0.7153,DUCTAL CARCINOMA,True,True,True
DUCTAL CARCINOMA IN SITU DCIS,Breast Ductal Carcinoma In Situ,1,2,Breast Ductal Carcinoma In Situ,0.8930,"Breast Ductal Carcinoma In Situ, Low Grade",0.8418,"Breast Ductal Carcinoma In Situ, Non-Comedo Type",0.8347,"Breast Ductal Carcinoma In Situ, High Grade",0.8228,"Breast Ductal Carcinoma In Situ, Solid Type",0.8191,"Breast Ductal Carcinoma In Situ, Intermediate Grade",0.8188,Breast Papillary Ductal Carcinoma In Situ,0.8048,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.7973,"Breast Ductal Carcinoma In Situ, Comedo Type",0.7890,Breast Micropapillary Ductal Carcinoma In Situ,0.7741,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.7703,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.7700,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.7682,Breast Classic Lobular Carcinoma In Situ,0.7571,Breast Papillary Ductal Carcinoma In Situ with Invasion,0.7561,Recurrent Breast Ductal Carcinoma In Situ,0.7498,Breast Lobular Carcinoma In Situ,0.7365,Carcinoma In Situ,0.7332,Breast Ductal Carcinoma,0.7298,Well Differentiated Invasive Breast Carcinoma,0.7275,DUCTAL CARCINOMA IN SITU DCIS,True,True,True
DUCTAL CARCINOMA- MAMMARY GLAND,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.9175,Metastatic Breast Ductal Carcinoma,0.7899,Breast Carcinoma,0.7834,Breast Adenocarcinoma,0.7635,Breast Ductal Adenoma,0.7634,Breast Ductal Carcinoma with Squamous Metaplasia,0.7528,Breast Acinic Cell Carcinoma,0.7514,Breast Ductal Carcinoma In Situ,0.7421,Advanced Breast Carcinoma,0.7359,Breast Mixed Ductal and Lobular Carcinoma,0.7355,Ductal Eccrine Adenocarcinoma,0.7341,Breast Tubular Carcinoma,0.7232,Breast Lobular Carcinoma,0.7214,Salivary Duct Carcinoma,0.7189,Nipple Duct Carcinoma,0.7185,Breast Secretory Carcinoma,0.7169,Malignant Breast Neoplasm,0.7160,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7136,Invasive Breast Carcinoma,0.7135,Advanced Breast Adenocarcinoma,0.7091,DUCTAL CARCINOMA- MAMMARY GLAND,True,True,True
DUCTAL/LOBULAR,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,0.7139,Breast Ductal Hyperplasia,0.6900,Breast Ductal Adenoma,0.6866,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.6810,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.6773,Diffuse Lipomatosis,0.6632,Breast Ductal Carcinoma,0.6620,Breast Usual Ductal Hyperplasia,0.6604,Breast Lobular Neoplasia,0.6537,Breast Lobular Carcinoma,0.6497,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.6484,Breast Ductal Carcinoma In Situ,0.6243,Breast Atypical Ductal Hyperplasia,0.6237,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.6210,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.6198,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.6195,Diffuse Intraductal Papillomatosis,0.6163,Deep Lipoma,0.6160,Breast Atypical Lobular Hyperplasia,0.6098,Lipomatosis,0.6098,DUCTAL/LOBULAR,True,True,True
DUCTAL/NST,Breast Ductal Carcinoma,99,2,Dermal Duct Tumor,0.6708,Double Pituitary Neuroendocrine Tumors of Distinct Lineages,0.6253,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Tumor,0.6242,Duodenal Neuroendocrine Tumor,0.6240,Stroma-Derived Neoplasm of Lymphoid Tissues,0.6215,Dedifferentiated Gastrointestinal Stromal Tumor,0.6140,Digestive System Neuroendocrine Tumor,0.6108,Childhood Digestive System Neuroendocrine Tumor,0.6052,Diffuse Intraductal Papillomatosis,0.6050,Intraductal Papilloma,0.6045,Breast Ductal Adenoma,0.6009,Duodenal Somatostatin-Producing Neuroendocrine Tumor,0.5997,Oligometastatic Pancreatic Ductal Adenocarcinoma,0.5996,Intraductal Papillomatosis,0.5982,Breast Usual Ductal Hyperplasia,0.5974,Breast Ductal Hyperplasia,0.5953,Advanced Digestive System Neuroendocrine Tumor,0.5911,Hybrid Salivary Gland Tumor,0.5900,Functioning Pancreatic Neuroendocrine Tumor,0.5900,Nipple Syringomatous Tumor,0.5861,DUCTAL/NST,False,False,False
DUCTAL_CARCINOMA,Breast Ductal Carcinoma,1,2,Breast Ductal Carcinoma,0.8682,Carcinoma,0.7438,Prostate Ductal Adenocarcinoma,0.7397,Salivary Duct Carcinoma,0.7361,Breast Carcinoma,0.7340,Ductal Eccrine Adenocarcinoma,0.7310,Bile Duct Carcinoma,0.7273,Adenocarcinoma,0.7241,Breast Adenocarcinoma,0.7210,Metastatic Breast Ductal Carcinoma,0.7207,Pancreatic Ductal Adenocarcinoma,0.7190,Nipple Duct Carcinoma,0.7165,Breast Ductal Adenoma,0.7123,Breast Ductal Carcinoma In Situ,0.7083,Breast Ductal Carcinoma with Squamous Metaplasia,0.7044,Bile Duct Adenocarcinoma,0.7011,Diffuse Type Adenocarcinoma,0.6855,Collecting Duct Carcinoma,0.6818,Distal Bile Duct Carcinoma,0.6791,Duodenal Carcinoma,0.6786,DUCTAL_CARCINOMA,True,True,True
DUODENAL ADENOCARCINOMA,Duodenal Adenocarcinoma,1,2,Duodenal Adenocarcinoma,1.0000,Duodenal Carcinoma,0.9162,Duodenal Adenoma,0.8581,Malignant Duodenal Neoplasm,0.8368,Duodenal Neoplasm,0.8053,Pancreatic Ductal Adenocarcinoma,0.7675,Jejunal Adenocarcinoma,0.7385,Pancreatic Adenocarcinoma,0.7332,Intestinal-Type Adenocarcinoma,0.7169,Gastric Adenocarcinoma,0.7160,Duodenal Neuroendocrine Tumor,0.7142,Gastric Diffuse Adenocarcinoma,0.7141,Colorectal Adenocarcinoma,0.7094,Bile Duct Adenocarcinoma,0.7094,Adenocarcinoma,0.7085,Periampullary Adenocarcinoma,0.7020,Gastric Intestinal-Type Adenocarcinoma,0.7001,Resectable Duodenal Carcinoma,0.6984,Pancreatic Delta Cell Adenoma,0.6951,Diffuse Type Adenocarcinoma,0.6880,DUODENAL ADENOCARCINOMA,True,True,True
DUODENAL_ADENOCARCINOMA,Duodenal Adenocarcinoma,1,2,Duodenal Adenocarcinoma,0.9678,Duodenal Carcinoma,0.8773,Malignant Duodenal Neoplasm,0.8361,Duodenal Adenoma,0.8302,Duodenal Neoplasm,0.7750,Pancreatic Ductal Adenocarcinoma,0.7302,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,0.7152,Pancreatic Adenocarcinoma,0.7041,Gastric Diffuse Adenocarcinoma,0.7034,Intestinal-Type Adenocarcinoma,0.7013,Duodenal Neuroendocrine Tumor,0.7002,Gastric Adenocarcinoma,0.6973,Jejunal Adenocarcinoma,0.6928,Resectable Duodenal Carcinoma,0.6919,Gastric Intestinal-Type Adenocarcinoma,0.6901,Duodenal Neuroendocrine Tumor G3,0.6897,Adenocarcinoma,0.6861,Periampullary Adenocarcinoma,0.6810,Diffuse Type Adenocarcinoma,0.6777,Duodenal-Type Follicular Lymphoma,0.6731,DUODENAL_ADENOCARCINOMA,True,True,True
DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR,Dysembryoplastic Neuroepithelial Tumor,1,2,Dysembryoplastic Neuroepithelial Tumor,1.0000,Childhood Dysembryoplastic Neuroepithelial Tumor,0.9469,Adult Dysembryoplastic Neuroepithelial Tumor,0.9351,Neuroepithelial Neoplasm,0.7735,Dysembryoplastic Neuroepithelial-Like Tumor of the Septum Pellucidum,0.7623,Neuroblastic Tumor,0.7495,Primitive Neuroectodermal Tumor,0.7341,Glioneuronal and Neuronal Tumors,0.7164,Localized Primitive Neuroectodermal Tumor,0.6983,"Brain Embryonal Tumor, Not Otherwise Specified",0.6880,Childhood Neuroendocrine Tumor,0.6843,Childhood Digestive System Neuroendocrine Tumor,0.6795,Peripheral Primitive Neuroectodermal Tumor,0.6743,Cerebellar Glioneuronal and Neuronal Tumors,0.6741,Diffuse Leptomeningeal Glioneuronal Tumor,0.6732,Diffuse Glioneuronal Tumor with Oligodendroglioma-Like Features and Nuclear Clusters,0.6714,Testicular Polyembryoma,0.6598,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues,0.6555,Childhood Neuroendocrine Neoplasm,0.6540,Childhood Myoepithelial Tumor,0.6482,DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR,True,True,True
DYSGERMINOMA,Ovarian Dysgerminoma,1,2,Ovarian Dysgerminoma,0.8365,Pineal Region Dysgerminoma,0.8034,Childhood Ovarian Dysgerminoma,0.7642,Enteroglucagonoma,0.6607,Glomangiomyoma,0.6480,Malignant Enteroglucagonoma,0.6352,Dysplastic Cerebellar Gangliocytoma,0.6334,Glomangiomatosis,0.6323,Gemistocytic Astrocytoma,0.6313,Ganglioneuromatosis,0.6259,Gonadoblastoma,0.6259,Gastroblastoma,0.6234,Ameloblastic Fibrodentinoma,0.6167,Gastric Teratoma,0.6148,Granular Cell Ameloblastoma,0.6128,Stage IV Ovarian Dysgerminoma AJCC v6 and v7,0.6116,Spiradenocylindroma,0.6116,Ameloblastoma,0.6079,Stage II Ovarian Dysgerminoma AJCC v6 and v7,0.6062,Stage III Ovarian Dysgerminoma AJCC v6 and v7,0.6046,DYSGERMINOMA,True,True,True
EARLY T-CELL PRECURSOR LYMPHOBLASTIC LEUKEMIA,Early T Precursor Acute Lymphoblastic Leukemia,2,2,Early T Precursor Lymphoblastic Leukemia/Lymphoma,0.9467,Early T Precursor Acute Lymphoblastic Leukemia,0.9373,"Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.9001,T Acute Lymphoblastic Leukemia,0.7871,T Lymphoblastic Lymphoma,0.7625,T Lymphoblastic Leukemia/Lymphoma,0.7596,Childhood T Lymphoblastic Lymphoma,0.7548,Childhood T Acute Lymphoblastic Leukemia,0.7469,Childhood T Lymphoblastic Leukemia/Lymphoma,0.7443,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7330,Infant T Acute Lymphoblastic Leukemia,0.7215,Adult T Lymphoblastic Lymphoma,0.7192,Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7186,Early T Precursor Acute Lymphoblastic Leukemia with BCL11B Rearrangement,0.7151,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.7089,Pre T-ALL,0.7025,Acute Lymphoblastic Leukemia,0.6992,Childhood TdT Positive Acute Lymphoblastic Leukemia,0.6988,Adult T Acute Lymphoblastic Leukemia,0.6980,TdT Positive Acute Lymphoblastic Leukemia,0.6925,EARLY T-CELL PRECURSOR LYMPHOBLASTIC LEUKEMIA,False,True,True
EBV-ASSOCIATED,EBV-Related Lymphoma,2,2,EBV-Related Carcinoma,0.7825,EBV-Related Lymphoma,0.7776,EBV-Related Malignant Neoplasm,0.7757,EBV-Related Sarcoma,0.7514,EBV-Related Burkitt Lymphoma,0.7002,EBV-Related Gastric Carcinoma,0.6868,EBV-Related Leiomyosarcoma,0.6820,EBV-Related Hodgkin Lymphoma,0.6811,EBV-Related Non-Hodgkin Lymphoma,0.6792,EBV-Negative Burkitt Lymphoma,0.6696,EBV-Positive Mucocutaneous Ulcer,0.6592,Recurrent EBV-Related Lymphoma,0.6503,EBV-Associated Smooth Muscle Tumor,0.6432,Refractory EBV-Related Lymphoma,0.6093,Childhood EBV-Associated Smooth Muscle Tumor,0.5912,"EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.5866,HHV-8 and EBV-Negative Primary Effusion-Based Lymphoma,0.5785,Head and Neck EBV-Associated Smooth Muscle Tumor,0.5588,"Adult EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.5477,"EBV-Positive Polymorphic B-Cell Lymphoproliferative Disorder, Not Otherwise Specified",0.5380,EBV-ASSOCIATED,False,True,True
EMBRYONAL,Embryonal Carcinoma,2,2,Embryonal Neoplasm,0.8730,Embryonal Carcinoma,0.8279,Childhood Embryonal Carcinoma,0.7777,Ovarian Embryonal Carcinoma,0.7286,Childhood Central Nervous System Embryonal Tumor,0.7078,Central Nervous System Embryonal Tumor,0.7059,Childhood Ovarian Embryonal Carcinoma,0.7058,Extragonadal Embryonal Carcinoma,0.6983,Childhood Central Nervous System Embryonal Carcinoma,0.6978,Testicular Embryonal Carcinoma,0.6960,Central Nervous System Embryonal Carcinoma,0.6935,Childhood Testicular Embryonal Carcinoma,0.6717,Adult Central Nervous System Embryonal Carcinoma,0.6684,Intratubular Embryonal Carcinoma,0.6632,Childhood Extraocular Retinoblastoma,0.6482,Embryonal Rhabdomyosarcoma,0.6465,Childhood Embryonal Rhabdomyosarcoma,0.6463,Mediastinal Embryonal Carcinoma,0.6429,Extracranial Neuroblastoma,0.6371,Sellar Embryonal Carcinoma,0.6210,EMBRYONAL,False,True,True
EMBRYONAL CARCINOMA,Embryonal Carcinoma,1,2,Embryonal Carcinoma,1.0000,Childhood Embryonal Carcinoma,0.9275,Embryonal Neoplasm,0.8903,Central Nervous System Embryonal Carcinoma,0.8750,Ovarian Embryonal Carcinoma,0.8610,Childhood Central Nervous System Embryonal Carcinoma,0.8510,Testicular Embryonal Carcinoma,0.8389,Extragonadal Embryonal Carcinoma,0.8264,Childhood Ovarian Embryonal Carcinoma,0.8161,Childhood Testicular Embryonal Carcinoma,0.7936,Intratubular Embryonal Carcinoma,0.7911,Adult Central Nervous System Embryonal Carcinoma,0.7894,Central Nervous System Embryonal Tumor,0.7774,Childhood Central Nervous System Embryonal Tumor,0.7640,Mediastinal Embryonal Carcinoma,0.7511,Sellar Embryonal Carcinoma,0.7340,Mixed Embryonal Carcinoma and Teratoma,0.7129,Childhood Esophageal Carcinoma,0.6938,Childhood Carcinoma,0.6911,Epididymal Carcinoma,0.6884,EMBRYONAL CARCINOMA,True,True,True
EMBRYONAL CARCINOMA[NOT AVAILABLE],Embryonal Carcinoma,1,2,Embryonal Carcinoma,0.8491,Childhood Embryonal Carcinoma,0.7952,Central Nervous System Embryonal Carcinoma,0.7947,Extragonadal Embryonal Carcinoma,0.7832,Embryonal Neoplasm,0.7663,Childhood Central Nervous System Embryonal Carcinoma,0.7633,Adult Central Nervous System Embryonal Carcinoma,0.7517,Ovarian Embryonal Carcinoma,0.7462,Testicular Embryonal Carcinoma,0.7361,"Central Nervous System Embryonal Tumor, Not Elsewhere Classified",0.7324,Central Nervous System Embryonal Tumor,0.7250,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7129,Childhood Ovarian Embryonal Carcinoma,0.7041,Childhood Testicular Embryonal Carcinoma,0.6953,Childhood Central Nervous System Embryonal Tumor,0.6910,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.6721,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.6665,"Cerebral Embryonal Tumor, Not Otherwise Specified",0.6642,Intratubular Embryonal Carcinoma,0.6605,"Brain Embryonal Tumor, Not Otherwise Specified",0.6577,EMBRYONAL CARCINOMA[NOT AVAILABLE],True,True,True
EMBRYONAL CARCINOMA[NOT AVAILABLE][NOT AVAILABLE][NOT AVAILABLE],Embryonal Carcinoma,1,2,Embryonal Carcinoma,0.7464,Extragonadal Embryonal Carcinoma,0.7256,Central Nervous System Embryonal Carcinoma,0.7185,"Central Nervous System Embryonal Tumor, Not Elsewhere Classified",0.7165,Childhood Embryonal Carcinoma,0.7022,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7001,Childhood Central Nervous System Embryonal Carcinoma,0.6899,Embryonal Neoplasm,0.6784,Adult Central Nervous System Embryonal Carcinoma,0.6771,Ovarian Embryonal Carcinoma,0.6666,Central Nervous System Embryonal Tumor,0.6663,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.6541,Testicular Embryonal Carcinoma,0.6529,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.6466,"Cerebral Embryonal Tumor, Not Otherwise Specified",0.6356,Childhood Central Nervous System Embryonal Tumor,0.6335,Childhood Ovarian Embryonal Carcinoma,0.6280,"Brain Embryonal Tumor, Not Otherwise Specified",0.6277,Childhood Testicular Embryonal Carcinoma,0.6160,"Spinal Cord Embryonal Tumor, Not Otherwise Specified",0.6032,EMBRYONAL CARCINOMA[NOT AVAILABLE][NOT AVAILABLE][NOT AVAILABLE],True,True,True
EMBRYONAL RHABDOMYOSARCOMA,Embryonal Rhabdomyosarcoma,1,2,Embryonal Rhabdomyosarcoma,1.0000,Childhood Embryonal Rhabdomyosarcoma,0.9326,Anaplastic Embryonal Rhabdomyosarcoma,0.8639,Metastatic Embryonal Rhabdomyosarcoma,0.8499,Orbital Embryonal Rhabdomyosarcoma,0.8126,Bladder Embryonal Rhabdomyosarcoma,0.8106,Childhood Rhabdomyosarcoma,0.8090,Rhabdomyosarcoma,0.8030,Central Nervous System Rhabdomyosarcoma,0.7952,Esophageal Rhabdomyosarcoma,0.7874,Prostate Embryonal Rhabdomyosarcoma,0.7859,Middle Ear Embryonal Rhabdomyosarcoma,0.7857,Rectal Rhabdomyosarcoma,0.7762,Refractory Rhabdomyosarcoma,0.7709,Adult Rhabdomyosarcoma,0.7699,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.7672,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.7600,Refractory Childhood Rhabdomyosarcoma,0.7546,Kidney Rhabdomyosarcoma,0.7472,Cardiac Rhabdomyosarcoma,0.7465,EMBRYONAL RHABDOMYOSARCOMA,True,True,True
EMBRYONAL TUMOR,Embryonal Neoplasm,1,2,Embryonal Neoplasm,0.9802,Embryonal Carcinoma,0.9024,Central Nervous System Embryonal Tumor,0.8740,Childhood Central Nervous System Embryonal Tumor,0.8493,Childhood Embryonal Carcinoma,0.8468,Central Nervous System Embryonal Carcinoma,0.8039,Childhood Central Nervous System Embryonal Carcinoma,0.7823,Testicular Embryonal Carcinoma,0.7712,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7712,Extragonadal Embryonal Carcinoma,0.7657,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7650,"Brain Embryonal Tumor, Not Otherwise Specified",0.7648,Ovarian Embryonal Carcinoma,0.7572,"Central Nervous System Embryonal Tumor, Not Elsewhere Classified",0.7466,Childhood Testicular Embryonal Carcinoma,0.7417,"Cerebral Embryonal Tumor, Not Otherwise Specified",0.7406,Adult Central Nervous System Embryonal Carcinoma,0.7388,Intratubular Embryonal Carcinoma,0.7316,Childhood Ovarian Embryonal Carcinoma,0.7290,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7231,EMBRYONAL TUMOR,True,True,True
EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",8,2,Embryonal Tumor with Multilayered Rosettes,0.8046,Rosette-Forming Glioneuronal Tumor,0.7874,Embryonal Tumor with Multilayered Rosettes of the Fourth Ventricle,0.7720,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.7635,Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle,0.7516,"Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated",0.7504,Embryonal Tumor with Multilayered Rosettes without C19MC Alteration,0.7426,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.7084,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.7045,Central Nervous System Embryonal Tumor,0.7041,Atypical Teratoid/Rhabdoid Tumor,0.6952,Refractory Extrarenal Rhabdoid Tumor,0.6947,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6944,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.6909,Extrarenal Rhabdoid Tumor,0.6887,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.6879,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6878,Refractory Atypical Teratoid/Rhabdoid Tumor,0.6826,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.6825,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.6808,EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES,False,False,False
EMBRYO_CARCINOMA,Embryonal Carcinoma,1,2,Embryonal Carcinoma,0.8913,Childhood Embryonal Carcinoma,0.8179,Embryonal Neoplasm,0.7687,Ovarian Embryonal Carcinoma,0.7680,Extragonadal Embryonal Carcinoma,0.7363,Childhood Ovarian Embryonal Carcinoma,0.7273,Central Nervous System Embryonal Carcinoma,0.7198,Childhood Central Nervous System Embryonal Carcinoma,0.7178,Endometrial Carcinoma,0.7161,Testicular Embryonal Carcinoma,0.7072,Childhood Carcinoma,0.7071,Epididymal Carcinoma,0.6940,Carcinoma,0.6928,Childhood Esophageal Carcinoma,0.6896,Intratubular Embryonal Carcinoma,0.6869,Endometrial Undifferentiated Carcinoma,0.6843,Choriocarcinoma,0.6794,Childhood Testicular Embryonal Carcinoma,0.6653,Mixed Embryonal Carcinoma and Teratoma,0.6624,Mediastinal Embryonal Carcinoma,0.6591,EMBRYO_CARCINOMA,True,True,True
EMBT,Embryonal Neoplasm,1,2,Embryonal Neoplasm,0.9802,Embryonal Carcinoma,0.9024,Central Nervous System Embryonal Tumor,0.8740,Childhood Central Nervous System Embryonal Tumor,0.8493,Childhood Embryonal Carcinoma,0.8468,Central Nervous System Embryonal Carcinoma,0.8039,Childhood Central Nervous System Embryonal Carcinoma,0.7823,Testicular Embryonal Carcinoma,0.7712,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7712,Extragonadal Embryonal Carcinoma,0.7657,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7650,"Brain Embryonal Tumor, Not Otherwise Specified",0.7648,Ovarian Embryonal Carcinoma,0.7572,"Central Nervous System Embryonal Tumor, Not Elsewhere Classified",0.7466,Childhood Testicular Embryonal Carcinoma,0.7417,"Cerebral Embryonal Tumor, Not Otherwise Specified",0.7406,Adult Central Nervous System Embryonal Carcinoma,0.7388,Intratubular Embryonal Carcinoma,0.7316,Childhood Ovarian Embryonal Carcinoma,0.7290,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.7231,Embryonal Tumor,True,True,True
ENCAPSULATED GLIOMA,Glioma,1,2,Glioma,0.8001,Encapsulated Neoplasm,0.7637,Unresectable Glioma,0.7631,Neural Glioblastoma,0.7558,Cerebral Glioblastoma,0.7453,Glioblastoma,0.7292,Gliomatosis Cerebri,0.7198,Small Cell Glioblastoma,0.7169,Angiocentric Glioma,0.7167,Classical Glioblastoma,0.7159,Brain Glioblastoma,0.7141,Adult Glioblastoma,0.7136,Refractory Glioma,0.7132,Tectal Glioma,0.7126,Giant Cell Glioblastoma,0.7124,Unresectable Glioblastoma,0.7102,Low Grade Glioma,0.7101,Diffuse Glioma,0.7092,Resectable Glioma,0.7024,Mixed Glioma,0.7003,ENCAPSULATED GLIOMA,True,True,True
ENDOCERVICAL ADENOCARCINOMA,Cervical Adenocarcinoma,3,2,"Endocervical Adenocarcinoma, Usual-Type",0.8731,Malignant Endocervical Neoplasm,0.8635,Cervical Adenocarcinoma,0.7649,Endocervical Polyp,0.7396,"Cervical Adenomyoma, Endocervical-Type",0.7340,Endometrial Adenocarcinoma,0.7321,Cervical Mucinous Adenocarcinoma,0.7101,Endocervical Undifferentiated Sarcoma,0.7023,Cervical Esophagus Adenocarcinoma,0.6987,Cervical Carcinoma,0.6944,Cervical Endometrioid Adenocarcinoma,0.6904,Endometrial Carcinoma,0.6883,Type II Endometrial Adenocarcinoma,0.6879,"Cervical Adenocarcinoma, Not Otherwise Specified",0.6817,Vaginal Adenocarcinoma,0.6677,Cervical Villoglandular Adenocarcinoma,0.6670,Human Papillomavirus-Related Cervical Adenocarcinoma,0.6578,Early Invasive Cervical Adenocarcinoma,0.6565,Ureter Adenocarcinoma,0.6552,Esophageal Adenocarcinoma,0.6489,ENDOCERVICAL ADENOCARCINOMA,False,True,True
ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE,Cervical Adenocarcinoma,16,2,"Endocervical Adenocarcinoma, Usual-Type",0.9825,Malignant Endocervical Neoplasm,0.7504,Endocervical Undifferentiated Sarcoma,0.7408,"Recurrent Endocervical Adenocarcinoma, Usual-Type",0.7268,"Cervical Adenomyoma, Endocervical-Type",0.6925,Cervical Undifferentiated Carcinoma,0.6792,Type II Endometrial Adenocarcinoma,0.6634,"Cervical Mucinous Adenocarcinoma, Not Otherwise Specified",0.6563,Endocervical Polyp,0.6536,Cervical Villoglandular Adenocarcinoma,0.6501,"Cervical Adenocarcinoma, Not Otherwise Specified",0.6500,Cervical Mucinous Adenocarcinoma,0.6404,Endometrial Undifferentiated Carcinoma,0.6384,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",0.6337,Cervical Endometrioid Adenocarcinoma,0.6302,Cervical Adenocarcinoma,0.6210,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0.6207,"Endometrial Endometrioid Adenocarcinoma with Small Glands, Tubules or Cords",0.6198,Type I Endometrial Adenocarcinoma,0.6169,Ureter Adenocarcinoma,0.6158,ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE,False,False,False
ENDOCERVICAL TYPE OF ADENOCARCINOMA,Cervical Adenocarcinoma,4,2,"Endocervical Adenocarcinoma, Usual-Type",0.8795,Malignant Endocervical Neoplasm,0.8514,"Cervical Adenomyoma, Endocervical-Type",0.7379,Cervical Adenocarcinoma,0.7257,Type II Endometrial Adenocarcinoma,0.7070,Endocervical Polyp,0.7014,Cervical Endometrioid Adenocarcinoma,0.6955,Endometrial Adenocarcinoma,0.6940,Cervical Mucinous Adenocarcinoma,0.6939,Endocervical Undifferentiated Sarcoma,0.6848,"Cervical Adenocarcinoma, Not Otherwise Specified",0.6713,Endometrial Carcinoma,0.6663,Cervical Carcinoma,0.6658,Cervical Esophagus Adenocarcinoma,0.6595,Cervical Villoglandular Adenocarcinoma,0.6469,Goblet Cell Adenocarcinoma,0.6458,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.6378,Type I Endometrial Adenocarcinoma,0.6363,"Cervical Mucinous Adenocarcinoma, Not Otherwise Specified",0.6361,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",0.6345,ENDOCERVICAL TYPE OF ADENOCARCINOMA,False,False,True
ENDOMETRIAL ADENOCARCINOMA,Endometrial Adenocarcinoma,1,2,Endometrial Adenocarcinoma,1.0000,Endometrial Carcinoma,0.8980,Type II Endometrial Adenocarcinoma,0.8531,Advanced Endometrial Adenocarcinoma,0.8505,Type I Endometrial Adenocarcinoma,0.8466,Endometrial Endometrioid Adenocarcinoma,0.8435,Endometrial Serous Adenocarcinoma,0.8253,Endometrial Mucinous Adenocarcinoma,0.8160,Endometrioid Adenocarcinoma,0.8122,Advanced Endometrial Endometrioid Adenocarcinoma,0.8049,Endometrial Clear Cell Adenocarcinoma,0.8034,Malignant Endometrial Neoplasm,0.8005,Adenocarcinoma,0.7934,Esophageal Adenocarcinoma,0.7888,Advanced Endometrial Carcinoma,0.7872,Endometrial High Grade Endometrioid Adenocarcinoma,0.7832,Metastatic Endometrial Adenocarcinoma,0.7820,Endometrial Neoplasm,0.7792,No Specific Molecular Profile Endometrial Endometrioid Adenocarcinoma,0.7682,Cervical Endometrioid Adenocarcinoma,0.7675,ENDOMETRIAL ADENOCARCINOMA,True,True,True
ENDOMETRIAL ADENOSQUAMOUS CARCINOMA,Endometrial Adenosquamous Carcinoma,1,2,Endometrial Adenosquamous Carcinoma,1.0000,Adenosquamous Carcinoma,0.8725,Metastatic Endometrial Adenosquamous Carcinoma,0.8534,Cervical Adenosquamous Carcinoma,0.8188,Esophageal Adenosquamous Carcinoma,0.8161,Skin Adenosquamous Carcinoma,0.7893,Breast Adenosquamous Carcinoma,0.7870,Conjunctival Adenosquamous Carcinoma,0.7842,Colon Adenosquamous Carcinoma,0.7802,Recurrent Endometrial Adenosquamous Carcinoma,0.7783,Gastric Adenosquamous Carcinoma,0.7779,Endometrial Squamous Cell Carcinoma,0.7753,Vaginal Adenosquamous Carcinoma,0.7745,Lung Adenosquamous Carcinoma,0.7696,Prostate Adenosquamous Carcinoma,0.7648,Salivary Gland Adenosquamous Carcinoma,0.7486,Bartholin Gland Adenosquamous Carcinoma,0.7469,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.7433,Laryngeal Adenosquamous Carcinoma,0.7428,Cervical Poorly Differentiated Adenosquamous Carcinoma,0.7323,ENDOMETRIAL ADENOSQUAMOUS CARCINOMA,True,True,True
ENDOMETRIAL CANCER,Endometrial Carcinoma,1,2,Endometrial Carcinoma,0.9469,Endometrial Neoplasm,0.8641,Endometrial Adenocarcinoma,0.8640,Malignant Endometrial Neoplasm,0.8353,Endometrial Undifferentiated Carcinoma,0.7990,Early Stage Endometrial Carcinoma,0.7840,Endometrial Squamous Cell Carcinoma,0.7805,High Grade Endometrial Carcinoma,0.7721,Advanced Endometrial Carcinoma,0.7697,Endometrial Neuroendocrine Carcinoma,0.7566,Type I Endometrial Adenocarcinoma,0.7399,Unresectable Endometrial Carcinoma,0.7273,Type II Endometrial Adenocarcinoma,0.7228,Esophageal Carcinoma,0.7215,Metastatic Endometrial Carcinoma,0.7173,Advanced Endometrial Adenocarcinoma,0.7170,Endometrial Endometrioid Adenocarcinoma,0.7111,Advanced Endometrial Undifferentiated Carcinoma,0.7096,Endometrial Serous Adenocarcinoma,0.7066,Endometrioid Tumor,0.7053,ENDOMETRIAL CANCER,True,True,True
ENDOMETRIAL CARCINOMA,Endometrial Carcinoma,1,2,Endometrial Carcinoma,1.0000,Endometrial Adenocarcinoma,0.8980,Endometrial Squamous Cell Carcinoma,0.8323,Endometrial Undifferentiated Carcinoma,0.8204,Malignant Endometrial Neoplasm,0.8154,Endometrial Neoplasm,0.8117,Advanced Endometrial Carcinoma,0.8080,High Grade Endometrial Carcinoma,0.8038,Early Stage Endometrial Carcinoma,0.8006,Endometrial Transitional Cell Carcinoma,0.7697,Endometrial Neuroendocrine Carcinoma,0.7682,Type I Endometrial Adenocarcinoma,0.7672,Type II Endometrial Adenocarcinoma,0.7662,Advanced Endometrial Adenocarcinoma,0.7511,Esophageal Carcinoma,0.7484,Endometrial Clear Cell Adenocarcinoma,0.7473,Metastatic Endometrial Carcinoma,0.7426,Endometrial Endometrioid Adenocarcinoma,0.7424,Unresectable Endometrial Carcinoma,0.7414,Carcinoma,0.7403,ENDOMETRIAL CARCINOMA,True,True,True
ENDOMETRIAL SQUAMOUS CELL CARCINOMA,Endometrial Squamous Cell Carcinoma,1,2,Endometrial Squamous Cell Carcinoma,1.0000,Endometrial Carcinoma,0.8323,Endometrial Adenosquamous Carcinoma,0.7753,Endometrial Undifferentiated Carcinoma,0.7555,Endometrial Transitional Cell Carcinoma,0.7493,Endometrial Adenocarcinoma,0.7444,Esophageal Squamous Cell Carcinoma,0.7441,Squamous Cell Carcinoma,0.7332,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.7184,Endometrial Serous Adenocarcinoma,0.7173,Type I Endometrial Adenocarcinoma,0.7125,Endometrial Small Cell Neuroendocrine Carcinoma,0.7105,Endometrial Clear Cell Adenocarcinoma,0.7101,Epididymal Squamous Cell Carcinoma,0.7092,Recurrent Endometrial Squamous Cell Carcinoma,0.7043,Early Stage Endometrial Carcinoma,0.7019,Cervical Esophagus Squamous Cell Carcinoma,0.6992,Ovarian Squamous Cell Carcinoma,0.6976,Endometrial Neuroendocrine Carcinoma,0.6924,"Endometrioid Tumor, Variant with Squamous Differentiation",0.6872,ENDOMETRIAL SQUAMOUS CELL CARCINOMA,True,True,True
ENDOMETRIAL STROMAL SARCOMA,Endometrioid Stromal Sarcoma,1,2,Endometrioid Stromal Sarcoma,0.8955,Stromal Sarcoma,0.8637,Uterine Corpus Endometrial Stromal Sarcoma,0.8513,Low Grade Endometrioid Stromal Sarcoma,0.8324,Undifferentiated Stromal Sarcoma,0.8047,Endometrioid Stromal Sarcoma of the Vagina,0.7721,Epithelial Synovial Sarcoma,0.7667,Endometrioid Stromal Sarcoma of the Cervix,0.7650,Cervical Low Grade Endometrioid Stromal Sarcoma,0.7637,Uterine Corpus High Grade Endometrial Stromal Sarcoma,0.7591,Uterine Corpus Low Grade Endometrial Stromal Sarcoma,0.7585,Endometrial Stromal Nodule,0.7551,Mixed Endometrial Stromal and Smooth Muscle Neoplasm,0.7506,Ovarian Low Grade Endometrioid Stromal Sarcoma,0.7408,Esophageal Sarcoma,0.7383,Epithelioid Sarcoma,0.7267,Esophageal Synovial Sarcoma,0.7264,Vaginal Low Grade Endometrioid Stromal Sarcoma,0.7205,Peritoneal Low Grade Endometrioid Stromal Sarcoma,0.7186,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage,0.7111,ENDOMETRIAL STROMAL SARCOMA,True,True,True
ENDOMETRIAL_ADENOCARCINOMA,Endometrial Adenocarcinoma,1,2,Endometrial Adenocarcinoma,0.9601,Endometrial Carcinoma,0.8593,Advanced Endometrial Adenocarcinoma,0.8371,Type II Endometrial Adenocarcinoma,0.8358,Endometrial Endometrioid Adenocarcinoma,0.8264,Type I Endometrial Adenocarcinoma,0.8214,Malignant Endometrial Neoplasm,0.8052,Endometrioid Adenocarcinoma,0.8044,Advanced Endometrial Endometrioid Adenocarcinoma,0.8009,Endometrial Serous Adenocarcinoma,0.7933,Endometrial Mucinous Adenocarcinoma,0.7895,Endometrial High Grade Endometrioid Adenocarcinoma,0.7836,No Specific Molecular Profile Endometrial Endometrioid Adenocarcinoma,0.7811,Adenocarcinoma,0.7794,Advanced Endometrial Carcinoma,0.7779,Advanced Endometrioid Adenocarcinoma,0.7711,Endometrial Clear Cell Adenocarcinoma,0.7686,Metastatic Endometrial Adenocarcinoma,0.7663,High Grade Endometrioid Adenocarcinoma,0.7655,Endometrial Neoplasm,0.7575,ENDOMETRIAL_ADENOCARCINOMA,True,True,True
ENDOMETRIAL_ADENOSQUAMOUS,Endometrial Adenosquamous Carcinoma,1,2,Endometrial Adenosquamous Carcinoma,0.8984,Adenosquamous Carcinoma,0.7880,Metastatic Endometrial Adenosquamous Carcinoma,0.7795,Recurrent Endometrial Adenosquamous Carcinoma,0.7513,Cervical Adenosquamous Carcinoma,0.7283,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.7281,"Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.7065,Skin Adenosquamous Carcinoma,0.7041,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant",0.6953,Esophageal Adenosquamous Carcinoma,0.6907,Endometrial Mucinous Adenocarcinoma,0.6888,"Endometrioid Tumor, Variant with Squamous Differentiation",0.6887,Endometrial Endometrioid Adenocarcinoma with Metaplastic Changes,0.6878,Vaginal Adenosquamous Carcinoma,0.6849,Breast Adenosquamous Carcinoma,0.6826,Endometrial Serous Adenocarcinoma,0.6822,Conjunctival Adenosquamous Carcinoma,0.6821,Gastric Adenosquamous Carcinoma,0.6749,Prostate Adenosquamous Carcinoma,0.6728,Human Papillomavirus-Related Adenosquamous Carcinoma,0.6709,ENDOMETRIAL_ADENOSQUAMOUS,True,True,True
ENDOMETRIAL_SQUAMOUS,Endometrial Squamous Cell Carcinoma,1,2,Endometrial Squamous Cell Carcinoma,0.7907,"Endometrioid Tumor, Variant with Squamous Differentiation",0.7276,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.7176,Endometrial Carcinoma,0.7034,Endometrial Adenosquamous Carcinoma,0.6993,Malignant Endometrial Neoplasm,0.6959,Endometrial Undifferentiated Carcinoma,0.6885,"Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.6874,Endometrial Serous Adenocarcinoma,0.6819,Endometrioid Tumor,0.6811,Endometrial Adenocarcinoma,0.6809,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,0.6787,Type I Endometrial Adenocarcinoma,0.6678,Endometrial Neoplasm,0.6578,Endometrial Endometrioid Adenocarcinoma,0.6555,Epithelioid Sarcoma,0.6542,Endometrial Stromal Nodule,0.6534,Endometrioid Stromal Sarcoma,0.6515,Benign Endometrial Neoplasm,0.6511,FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma,0.6504,ENDOMETRIAL_SQUAMOUS,True,True,True
ENDOMETRIAL_STROMAL_SARCOMA,Endometrioid Stromal Sarcoma,1,2,Endometrioid Stromal Sarcoma,0.8757,Stromal Sarcoma,0.8354,Uterine Corpus Endometrial Stromal Sarcoma,0.8243,Low Grade Endometrioid Stromal Sarcoma,0.8028,Undifferentiated Stromal Sarcoma,0.7857,Endometrioid Stromal Sarcoma of the Vagina,0.7627,Uterine Corpus High Grade Endometrial Stromal Sarcoma,0.7519,Endometrioid Stromal Sarcoma of the Cervix,0.7489,Mixed Endometrial Stromal and Smooth Muscle Neoplasm,0.7425,Epithelial Synovial Sarcoma,0.7403,Cervical Low Grade Endometrioid Stromal Sarcoma,0.7372,Endometrial Stromal Nodule,0.7298,Uterine Corpus Low Grade Endometrial Stromal Sarcoma,0.7259,Ovarian Low Grade Endometrioid Stromal Sarcoma,0.7192,Uterine Corpus Endometrial Stromal Sarcoma by AJCC v8 Stage,0.7144,Sarcoma,0.7068,Peritoneal Low Grade Endometrioid Stromal Sarcoma,0.7057,Epithelioid Sarcoma,0.7056,Esophageal Sarcoma,0.7034,Sarcoma of the Extremity,0.6979,ENDOMETRIAL_STROMAL_SARCOMA,True,True,True
ENDOMETRIOID,Endometrioid Tumor,1,2,Endometrioid Tumor,0.9540,Endometrioid Adenocarcinoma,0.9268,Endometrial Endometrioid Adenocarcinoma,0.8869,Ovarian Endometrioid Tumor,0.8628,Benign Ovarian Endometrioid Tumor,0.8388,Ovarian Endometrioid Adenocarcinoma,0.8378,Malignant Ovarian Endometrioid Tumor,0.8346,Low Grade Endometrioid Adenocarcinoma,0.8319,High Grade Endometrioid Adenocarcinoma,0.8313,Advanced Endometrioid Adenocarcinoma,0.8213,Endometrial High Grade Endometrioid Adenocarcinoma,0.8147,Endometrial Low Grade Endometrioid Adenocarcinoma,0.8119,Advanced Endometrial Endometrioid Adenocarcinoma,0.8117,Cervical Endometrioid Adenocarcinoma,0.7990,Endometrial Endometrioid Adenocarcinoma with Metaplastic Changes,0.7949,"Endometrioid Tumor, Variant with Squamous Differentiation",0.7928,Metastatic Endometrioid Adenocarcinoma,0.7886,Borderline Ovarian Endometrioid Tumor,0.7875,"Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.7841,Endometrioid Stromal Sarcoma,0.7829,ENDOMETRIOID,True,True,True
ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX,Cervical Endometrioid Adenocarcinoma,1,2,Cervical Endometrioid Adenocarcinoma,0.8821,Endometrial Endometrioid Adenocarcinoma,0.8316,Endometrioid Adenocarcinoma,0.8094,Endometrial High Grade Endometrioid Adenocarcinoma,0.7743,Ovarian Endometrioid Adenocarcinoma,0.7659,Endometrial Low Grade Endometrioid Adenocarcinoma,0.7655,"Endocervical Adenocarcinoma, Usual-Type",0.7647,Vaginal Endometrioid Adenocarcinoma,0.7616,"Endometrial Endometrioid Adenocarcinoma, Ciliated Variant",0.7590,Endometrioid Tumor,0.7522,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0.7519,High Grade Endometrioid Adenocarcinoma,0.7512,Type II Endometrial Adenocarcinoma,0.7474,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.7474,Advanced Endometrial Endometrioid Adenocarcinoma,0.7462,Endometrial Endometrioid Adenocarcinoma with Metaplastic Changes,0.7454,Low Grade Endometrioid Adenocarcinoma,0.7447,Endometrial Adenocarcinoma,0.7446,"Endometrial Endometrioid Adenocarcinoma with Small Glands, Tubules or Cords",0.7388,"Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.7372,ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX,True,True,True
ENDOMETRIOID CARCINOMA,Endometrioid Adenocarcinoma,1,2,Endometrioid Adenocarcinoma,0.9680,Endometrioid Tumor,0.9429,Endometrial Endometrioid Adenocarcinoma,0.9227,Ovarian Endometrioid Adenocarcinoma,0.8888,Cervical Endometrioid Adenocarcinoma,0.8702,Ovarian Endometrioid Tumor,0.8701,High Grade Endometrioid Adenocarcinoma,0.8669,Malignant Ovarian Endometrioid Tumor,0.8618,Advanced Endometrioid Adenocarcinoma,0.8599,Low Grade Endometrioid Adenocarcinoma,0.8445,Advanced Endometrial Endometrioid Adenocarcinoma,0.8445,Endometrial High Grade Endometrioid Adenocarcinoma,0.8399,Metastatic Endometrioid Adenocarcinoma,0.8331,"Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.8223,Endometrial Endometrioid Adenocarcinoma with Metaplastic Changes,0.8148,Endometrial Low Grade Endometrioid Adenocarcinoma,0.8147,Advanced Ovarian Endometrioid Adenocarcinoma,0.8130,Benign Ovarian Endometrioid Tumor,0.8120,"Endometrioid Tumor, Variant with Squamous Differentiation",0.8054,FIGO Grade 2 Endometrioid Adenocarcinoma,0.7952,ENDOMETRIOID CARCINOMA,True,True,True
ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA,Endometrial Endometrioid Adenocarcinoma,1,2,Endometrial Endometrioid Adenocarcinoma,0.9908,Endometrioid Adenocarcinoma,0.9731,Ovarian Endometrioid Adenocarcinoma,0.9217,Advanced Endometrial Endometrioid Adenocarcinoma,0.9053,Endometrial High Grade Endometrioid Adenocarcinoma,0.9040,Endometrioid Tumor,0.9032,Endometrial Low Grade Endometrioid Adenocarcinoma,0.8948,High Grade Endometrioid Adenocarcinoma,0.8838,Cervical Endometrioid Adenocarcinoma,0.8826,Low Grade Endometrioid Adenocarcinoma,0.8770,Advanced Endometrioid Adenocarcinoma,0.8761,Ovarian Endometrioid Tumor,0.8632,Malignant Ovarian Endometrioid Tumor,0.8582,Endometrial Endometrioid Adenocarcinoma with Metaplastic Changes,0.8570,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.8532,"Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.8460,Metastatic Endometrial Endometrioid Adenocarcinoma,0.8445,Endometrial Adenocarcinoma,0.8438,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant",0.8421,Mucin-Rich Endometrial Endometrioid Adenocarcinoma,0.8412,ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA,True,True,True
ENDOMETRIOID OVARIAN CANCER,Ovarian Endometrioid Adenocarcinoma,1,2,Ovarian Endometrioid Adenocarcinoma,0.9495,Ovarian Endometrioid Tumor,0.9285,Endometrioid Adenocarcinoma,0.9220,Malignant Ovarian Endometrioid Tumor,0.9169,Endometrioid Tumor,0.8971,Endometrial Endometrioid Adenocarcinoma,0.8831,Benign Ovarian Endometrioid Tumor,0.8767,Advanced Ovarian Endometrioid Adenocarcinoma,0.8689,Ovarian High Grade Endometrioid Adenocarcinoma,0.8637,Ovarian Low Grade Endometrioid Adenocarcinoma,0.8508,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,0.8319,High Grade Endometrioid Adenocarcinoma,0.8314,Metastatic Ovarian Endometrioid Adenocarcinoma,0.8297,Cervical Endometrioid Adenocarcinoma,0.8219,Ovarian Endometrioid Cystadenoma,0.8197,Low Grade Endometrioid Adenocarcinoma,0.8158,Advanced Endometrioid Adenocarcinoma,0.8154,Metastatic Endometrioid Adenocarcinoma,0.8089,Borderline Ovarian Endometrioid Tumor,0.8084,Endometrial High Grade Endometrioid Adenocarcinoma,0.8032,ENDOMETRIOID OVARIAN CANCER,True,True,True
ENDOMETRIOID_CARCINOMA,Endometrioid Adenocarcinoma,1,2,Endometrioid Adenocarcinoma,0.9318,Endometrioid Tumor,0.9157,Endometrial Endometrioid Adenocarcinoma,0.8936,Ovarian Endometrioid Adenocarcinoma,0.8536,High Grade Endometrioid Adenocarcinoma,0.8514,Cervical Endometrioid Adenocarcinoma,0.8416,Ovarian Endometrioid Tumor,0.8406,Advanced Endometrioid Adenocarcinoma,0.8384,Malignant Ovarian Endometrioid Tumor,0.8377,Endometrial High Grade Endometrioid Adenocarcinoma,0.8272,Advanced Endometrial Endometrioid Adenocarcinoma,0.8257,Metastatic Endometrioid Adenocarcinoma,0.8164,Low Grade Endometrioid Adenocarcinoma,0.8134,Endometrial Endometrioid Adenocarcinoma with Metaplastic Changes,0.8085,"Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.8008,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0.8004,Endometrial Carcinoma,0.7937,Advanced Ovarian Endometrioid Adenocarcinoma,0.7889,"Endometrioid Tumor, Variant with Squamous Differentiation",0.7869,Endometrial Low Grade Endometrioid Adenocarcinoma,0.7868,ENDOMETRIOID_CARCINOMA,True,True,True
EPENDYMOBLASTOMA,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",99,2,Ependymoma,0.9135,Ependymal Tumor,0.8828,Brain Ependymoma,0.8822,Adult Ependymoma,0.8341,Childhood Ependymal Tumor,0.8302,Anaplastic Ependymoma,0.8284,Childhood Ependymoma,0.8267,Adult Ependymal Tumor,0.8195,Adult Brain Ependymoma,0.8182,Cellular Ependymoma,0.8158,Papillary Ependymoma,0.8151,Spinal Cord Ependymoma,0.7881,Brain Stem Ependymoma,0.7848,Childhood Anaplastic Ependymoma,0.7817,Posterior Fossa Ependymoma,0.7812,Clear Cell Ependymoma,0.7791,Ependymal Pituicytoma,0.7757,Refractory Ependymoma,0.7647,Adult Anaplastic Ependymoma,0.7643,Supratentorial Ependymoma,0.7534,EPENDYMOBLASTOMA,False,False,False
EPENDYMOMA,Ependymoma,1,2,Ependymoma,1.0000,Brain Ependymoma,0.9440,Ependymal Tumor,0.9260,Papillary Ependymoma,0.9032,Cellular Ependymoma,0.8954,Adult Ependymoma,0.8889,Spinal Cord Ependymoma,0.8801,Childhood Ependymoma,0.8768,Adult Brain Ependymoma,0.8592,Anaplastic Ependymoma,0.8580,Clear Cell Ependymoma,0.8409,Childhood Ependymal Tumor,0.8350,Adult Ependymal Tumor,0.8278,Posterior Fossa Ependymoma,0.8271,Supratentorial Ependymoma,0.8257,Brain Stem Ependymoma,0.8150,Myxopapillary Ependymoma,0.8105,Ependymal Pituicytoma,0.8050,Refractory Ependymoma,0.7991,Broad Ligament Ependymoma,0.7975,EPENDYMOMA,True,True,True
EPENDYMOMAL TUMOR,Ependymal Tumor,1,2,Ependymal Tumor,0.9327,Ependymoma,0.9134,Brain Ependymoma,0.8714,Papillary Ependymoma,0.8447,Adult Ependymal Tumor,0.8392,Cellular Ependymoma,0.8388,Adult Ependymoma,0.8330,Childhood Ependymal Tumor,0.8280,Spinal Cord Ependymoma,0.8226,Adult Brain Ependymoma,0.8071,Ependymal Pituicytoma,0.8001,Childhood Ependymoma,0.7995,Clear Cell Ependymoma,0.7897,Broad Ligament Ependymoma,0.7839,Anaplastic Ependymoma,0.7821,Myxopapillary Ependymoma,0.7814,Supratentorial Ependymoma,0.7774,Tanycytic Ependymoma,0.7771,Posterior Fossa Ependymoma,0.7653,Uterine Ligament Ependymoma,0.7612,EPENDYMOMAL TUMOR,True,True,True
EPITHELIAL-MYOEPITHELIAL CARCINOMA,Epithelial-Myoepithelial Carcinoma,1,2,Epithelial-Myoepithelial Carcinoma,1.0000,Myoepithelial Tumor,0.8238,Salivary Gland Epithelial-Myoepithelial Carcinoma,0.8152,Malignant Myoepithelioma,0.7923,Salivary Gland Myoepithelial Carcinoma,0.7807,Lung Epithelial-Myoepithelial Carcinoma,0.7551,Lacrimal Gland Epithelial-Myoepithelial Carcinoma,0.7542,Breast Myoepithelial Tumor,0.7381,Lacrimal Gland Myoepithelial Carcinoma,0.7336,Benign Myoepithelioma,0.7315,Lung Myoepithelial Carcinoma,0.7277,Mucoepidermoid Carcinoma,0.7270,Childhood Myoepithelial Tumor,0.7120,Esophageal Mucoepidermoid Carcinoma,0.7100,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.7063,Skin Myoepithelioma,0.7063,Endometrial Undifferentiated Carcinoma,0.6948,Endometrial Carcinoma,0.6903,Salivary Gland Myoepithelial Tumor,0.6843,Breast Myoepitheliosis,0.6830,EPITHELIAL-MYOEPITHELIAL CARCINOMA,True,True,True
EPITHELIOID CELL TUMOR,Malignant PEComa,99,2,Epithelioid Sarcoma,0.8473,Epithelioid Cell Melanoma,0.8441,Epithelioid Mesothelioma,0.8116,Epithelioid Trophoblastic Tumor,0.8019,Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.7646,Epithelioid Sarcoma NCI Grade 2,0.7593,Epithelioid Sarcoma NCI Grade 3,0.7584,Epithelioid Glioblastoma,0.7542,Localized Epithelioid Sarcoma,0.7410,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.7383,Undifferentiated Sarcoma with Epithelioid Features,0.7372,Epithelioid Cell Nevus,0.7353,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.7253,Adult Epithelioid Sarcoma,0.7068,Epithelioid Hemangioma,0.7041,Epithelioid Leiomyosarcoma,0.6973,Adenomatoid Tumor,0.6946,Metastatic Epithelioid Sarcoma,0.6937,Advanced Epithelioid Sarcoma,0.6883,Advanced Epithelioid Mesothelioma,0.6870,EPITHELIOID CELL TUMOR,False,False,False
EPITHELIOID FIBROSARCOMA,Sclerosing Epithelioid Fibrosarcoma,1,2,Sclerosing Epithelioid Fibrosarcoma,0.8210,Epithelioid Sarcoma,0.8170,Epithelioid Myxofibrosarcoma,0.8127,Epithelioid Mesothelioma,0.7620,Epithelioid Sarcoma NCI Grade 3,0.7499,Undifferentiated Sarcoma with Epithelioid Features,0.7382,Fibrosarcoma,0.7368,Localized Epithelioid Sarcoma,0.7368,Epithelioid Leiomyosarcoma,0.7364,Epithelioid Sarcoma NCI Grade 2,0.7343,Conventional Fibrosarcoma,0.7321,Fibromyxoid Tumor,0.7317,Localized Fibrosarcoma,0.7241,Poorly Differentiated Fibrosarcoma,0.7224,Skin Epithelioid Fibrous Histiocytoma,0.7192,Ameloblastic Fibrosarcoma,0.7191,Adult Epithelioid Sarcoma,0.7170,Epithelioid Cell Melanoma,0.7166,Childhood Sclerosing Epithelioid Fibrosarcoma,0.7162,Well Differentiated Fibrosarcoma,0.7141,EPITHELIOID FIBROSARCOMA,True,True,True
EPITHELIOID HEMANGIOENDOTHELIOMA,Epithelioid Hemangioendothelioma,1,2,Epithelioid Hemangioendothelioma,1.0000,Hemangioendothelioma,0.9078,Advanced Epithelioid Hemangioendothelioma,0.8994,Benign Hemangioendothelioma,0.8974,Bone Epithelioid Hemangioendothelioma,0.8821,Epithelioid Hemangioma,0.8786,Adult Epithelioid Hemangioendothelioma,0.8640,Metastatic Epithelioid Hemangioendothelioma,0.8527,Composite Hemangioendothelioma,0.8335,Skin Hemangioendothelioma,0.8292,Childhood Epithelioid Hemangioendothelioma,0.8264,Skin Epithelioid Hemangioma,0.8230,Polymorphus Hemangioendothelioma,0.8215,Kaposiform Hemangioendothelioma,0.8171,Cardiac Epithelioid Hemangioendothelioma,0.8132,Unresectable Epithelioid Hemangioendothelioma,0.8112,Locally Advanced Epithelioid Hemangioendothelioma,0.8060,Bone Epithelioid Hemangioma,0.7942,Pseudomyogenic Hemangioendothelioma,0.7878,Head and Neck Epithelioid Hemangioendothelioma,0.7866,EPITHELIOID HEMANGIOENDOTHELIOMA,True,True,True
EPITHELIOID MESOTHELIOMA,Epithelioid Mesothelioma,1,2,Epithelioid Mesothelioma,1.0000,Advanced Epithelioid Mesothelioma,0.8843,Pleural Epithelioid Mesothelioma,0.8577,Peritoneal Epithelioid Mesothelioma,0.8267,Mesothelioma,0.8231,Malignant Mesothelioma,0.8215,Sarcomatoid Mesothelioma,0.8213,Epithelioid Cell Melanoma,0.8139,Epithelioid Sarcoma,0.7800,Biphasic Mesothelioma,0.7768,Diffuse Malignant Mesothelioma,0.7707,Epithelioid Leiomyosarcoma,0.7561,Recurrent Epithelioid Mesothelioma,0.7519,Localized Malignant Mesothelioma,0.7486,Paratesticular Epithelioid Mesothelioma,0.7471,Desmoplastic Mesothelioma,0.7443,Lymphohistiocytoid Mesothelioma,0.7348,Pleural Mesothelioma,0.7278,Epithelioid Myxofibrosarcoma,0.7188,Multicystic Mesothelioma,0.7172,EPITHELIOID MESOTHELIOMA,True,True,True
EPITHELIOID SARCOMA,Epithelioid Sarcoma,1,2,Epithelioid Sarcoma,1.0000,Localized Epithelioid Sarcoma,0.8789,Epithelioid Sarcoma NCI Grade 2,0.8772,Epithelioid Sarcoma NCI Grade 3,0.8730,Adult Epithelioid Sarcoma,0.8589,Undifferentiated Sarcoma with Epithelioid Features,0.8474,Metastatic Epithelioid Sarcoma,0.8471,Advanced Epithelioid Sarcoma,0.8419,Proximal-Type Epithelioid Sarcoma,0.8170,Childhood Epithelioid Sarcoma,0.8119,Epithelioid Leiomyosarcoma,0.7963,Distal-Type Epithelioid Sarcoma,0.7878,Epithelioid Cell Melanoma,0.7839,Epithelioid Mesothelioma,0.7800,Epithelioid Myxofibrosarcoma,0.7765,Unresectable Epithelioid Sarcoma,0.7656,Endometrioid Stromal Sarcoma,0.7535,Locally Advanced Epithelioid Sarcoma,0.7532,Recurrent Epithelioid Sarcoma,0.7508,Refractory Epithelioid Sarcoma,0.7441,EPITHELIOID SARCOMA,True,True,True
EPITHELIOID TROPHOBLASTIC TUMOR,Epithelioid Trophoblastic Tumor,1,2,Epithelioid Trophoblastic Tumor,1.0000,Trophoblastic Tumor,0.7895,Mixed Trophoblastic Tumor,0.7355,Testicular Trophoblastic Tumor,0.7331,Epithelioid Mesothelioma,0.7112,Placental Site Trophoblastic Tumor,0.7095,Gestational Trophoblastic Tumor,0.7029,Cystic Trophoblastic Tumor,0.7000,Epithelioid Cell Melanoma,0.6947,Epithelioid Sarcoma,0.6908,Epithelioid Glioblastoma,0.6891,Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.6879,Adenomatoid Tumor,0.6669,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.6630,Testicular Cystic Trophoblastic Tumor,0.6594,Epithelioid Hemangioendothelioma,0.6563,Epithelioid Hemangioma,0.6525,Epididymal Adenomatoid Tumor,0.6489,Childhood Ependymal Tumor,0.6477,Ependymal Tumor,0.6405,EPITHELIOID TROPHOBLASTIC TUMOR,True,True,True
EPITHELIOID_SARCOMA,Epithelioid Sarcoma,1,2,Epithelioid Sarcoma,0.9637,Epithelioid Sarcoma NCI Grade 2,0.8740,Epithelioid Sarcoma NCI Grade 3,0.8722,Undifferentiated Sarcoma with Epithelioid Features,0.8658,Localized Epithelioid Sarcoma,0.8454,Metastatic Epithelioid Sarcoma,0.8446,Advanced Epithelioid Sarcoma,0.8291,Adult Epithelioid Sarcoma,0.8227,Proximal-Type Epithelioid Sarcoma,0.8045,Unresectable Epithelioid Sarcoma,0.7781,Childhood Epithelioid Sarcoma,0.7713,Recurrent Epithelioid Sarcoma,0.7662,Distal-Type Epithelioid Sarcoma,0.7640,Epithelioid Leiomyosarcoma,0.7614,Refractory Epithelioid Sarcoma,0.7575,Epithelioid Myxofibrosarcoma,0.7493,Epithelial Synovial Sarcoma,0.7461,Epithelioid Mesothelioma,0.7457,Endometrioid Stromal Sarcoma,0.7423,Locally Advanced Epithelioid Sarcoma,0.7417,EPITHELIOID_SARCOMA,True,True,True
EPM,Ependymoma,1,2,Ependymoma,1.0000,Brain Ependymoma,0.9440,Ependymal Tumor,0.9260,Papillary Ependymoma,0.9032,Cellular Ependymoma,0.8954,Adult Ependymoma,0.8889,Spinal Cord Ependymoma,0.8801,Childhood Ependymoma,0.8768,Adult Brain Ependymoma,0.8592,Anaplastic Ependymoma,0.8580,Clear Cell Ependymoma,0.8409,Childhood Ependymal Tumor,0.8350,Adult Ependymal Tumor,0.8278,Posterior Fossa Ependymoma,0.8271,Supratentorial Ependymoma,0.8257,Brain Stem Ependymoma,0.8150,Myxopapillary Ependymoma,0.8105,Ependymal Pituicytoma,0.8050,Refractory Ependymoma,0.7991,Broad Ligament Ependymoma,0.7975,Ependymoma,True,True,True
ERDHEIM-CHESTER DISEASE,Erdheim-Chester Disease,1,2,Erdheim-Chester Disease,1.0000,Bone Erdheim-Chester Disease,0.9685,Cutaneous Erdheim-Chester Disease,0.8982,Central Nervous System Erdheim-Chester Disease,0.8202,Head and Neck Erdheim-Chester Disease,0.8119,Refractory Erdheim-Chester Disease,0.8038,Lymphomatoid Granulomatosis,0.5888,Dentinogenic Ghost Cell Tumor,0.5875,Adult Langerhans Cell Histiocytosis,0.5862,Bone Langerhans Cell Histiocytosis,0.5860,Pulmonary Langerhans Cell Histiocytosis,0.5807,"Langerhans Cell Histiocytosis, Disseminated",0.5795,Pagetoid Reticulosis,0.5757,"Langerhans Cell Histiocytosis, Polyostotic",0.5752,Histiocytic and Dendritic Cell Neoplasm,0.5631,Refractory Langerhans Cell Histiocytosis,0.5625,Pulmonary Lymphomatoid Granulomatosis,0.5585,ALK-Positive Histiocytosis,0.5571,Hodgkin's Granuloma,0.5571,Histiocytosis,0.5565,ERDHEIM-CHESTER DISEASE,True,True,True
ERYTHROLEUKEMIA,Erythroleukemia,1,2,Erythroleukemia,1.0000,Adult Erythroleukemia,0.8576,Pure Erythroid Leukemia,0.7793,Acute Erythroid Leukemia,0.7314,Leukemia,0.7077,Myeloid Leukemia,0.7060,Aleukemic Leukemia,0.7029,Erythroid Neoplasm,0.6870,Aleukemic Myeloid Leukemia,0.6713,Childhood Acute Erythroid Leukemia,0.6495,Adult Pure Erythroid Leukemia,0.6453,Aleukemic Lymphoid Leukemia,0.6425,Refractory Leukemia,0.6381,Lymphoid Leukemia,0.6322,Myeloid Neoplasm,0.6222,Mast Cell Leukemia,0.6219,Acute Leukemia,0.6212,Acute Undifferentiated Leukemia,0.6156,Childhood Leukemia,0.6147,Aleukemic Acute Lymphoblastic Leukemia,0.6114,ERYTHROLEUKEMIA,True,True,True
ES,Ewing Sarcoma,1,2,Ewing Sarcoma,1.0000,Ewing Sarcoma of Bone,0.9594,Childhood Ewing Sarcoma,0.9135,Extraskeletal Ewing Sarcoma,0.9023,Atypical Ewing Sarcoma,0.8802,Skin Ewing Sarcoma,0.8699,Localized Ewing Sarcoma,0.8568,Kidney Ewing Sarcoma,0.8517,Central Nervous System Ewing Sarcoma,0.8428,Localized Bone Ewing Sarcoma,0.8273,Metastatic Ewing Sarcoma,0.8254,Sinonasal Ewing Sarcoma,0.8077,Unresectable Ewing Sarcoma,0.7976,Refractory Ewing Sarcoma,0.7887,Childhood Kidney Ewing Sarcoma,0.7785,Recurrent Ewing Sarcoma,0.7711,Localized Extraskeletal Ewing Sarcoma,0.7711,Metastatic Bone Ewing Sarcoma,0.7537,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7432,Head and Neck Ewing Sarcoma,0.7418,Ewing Sarcoma,True,True,True
ESCA,Esophageal Carcinoma,2,2,Esophageal Adenocarcinoma,1.0000,Esophageal Carcinoma,0.8854,Advanced Esophageal Adenocarcinoma,0.8837,Cervical Esophagus Adenocarcinoma,0.8597,Thoracic Esophagus Adenocarcinoma,0.8503,Distal Esophagus Adenocarcinoma,0.8376,Advanced Esophageal Carcinoma,0.8048,Metastatic Esophageal Adenocarcinoma,0.7909,Endometrial Adenocarcinoma,0.7888,Esophageal Intramucosal Adenocarcinoma,0.7880,Locally Advanced Esophageal Adenocarcinoma,0.7761,Malignant Esophageal Neoplasm,0.7722,Unresectable Esophageal Adenocarcinoma,0.7720,Esophageal Neoplasm,0.7691,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage,0.7605,Esophageal Adenocarcinoma by AJCC v8 Stage,0.7593,Adenocarcinoma,0.7569,Esophageal Melanoma,0.7484,Esophageal Undifferentiated Carcinoma,0.7467,Anal Adenocarcinoma,0.7421,Esophageal Adenocarcinoma,False,True,True
ESCA_GS,Esophageal Adenocarcinoma,99,2,Serous Endometrial Intraepithelial Carcinoma,0.5902,Refractory Endometrial Serous Adenocarcinoma,0.5756,Subependymal Giant Cell Astrocytoma,0.5711,Aggressive Systemic Mastocytosis with an Associated Germ Cell Tumor,0.5681,Childhood Subependymal Giant Cell Astrocytoma,0.5638,Systemic Mastocytosis with an Associated Germ Cell Tumor,0.5616,Advanced Microsatellite Stable Endometrial Carcinoma,0.5586,Epithelial Synovial Sarcoma,0.5549,AESOP Syndrome,0.5530,Unresectable Endometrial Carcinoma,0.5519,Salivary Gland Epithelial-Myoepithelial Carcinoma,0.5509,Sarcoma G3,0.5469,Superficial Spreading Adenocarcinoma,0.5437,Endometrial Serous Adenocarcinoma,0.5432,Platinum-Sensitive Endometrial Serous Adenocarcinoma,0.5429,Sarcoma G2,0.5418,Microsatellite Stable Endometrial Carcinoma,0.5417,Unresectable Epithelioid Sarcoma,0.5385,Serous Adenocarcinoma,0.5385,Epicardial Neoplasm,0.5380,ESCA_GS,False,False,False
ESOPHAGEAL ADENOCARCINOMA,Esophageal Adenocarcinoma,1,2,Esophageal Adenocarcinoma,1.0000,Esophageal Carcinoma,0.8854,Advanced Esophageal Adenocarcinoma,0.8837,Cervical Esophagus Adenocarcinoma,0.8597,Thoracic Esophagus Adenocarcinoma,0.8503,Distal Esophagus Adenocarcinoma,0.8376,Advanced Esophageal Carcinoma,0.8048,Metastatic Esophageal Adenocarcinoma,0.7909,Endometrial Adenocarcinoma,0.7888,Esophageal Intramucosal Adenocarcinoma,0.7880,Locally Advanced Esophageal Adenocarcinoma,0.7761,Malignant Esophageal Neoplasm,0.7722,Unresectable Esophageal Adenocarcinoma,0.7720,Esophageal Neoplasm,0.7691,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage,0.7605,Esophageal Adenocarcinoma by AJCC v8 Stage,0.7593,Adenocarcinoma,0.7569,Esophageal Melanoma,0.7484,Esophageal Undifferentiated Carcinoma,0.7467,Anal Adenocarcinoma,0.7421,ESOPHAGEAL ADENOCARCINOMA,True,True,True
ESOPHAGEAL ADENOCARINOMA,Esophageal Adenocarcinoma,2,2,Esophageal Adenoid Cystic Carcinoma,0.8309,Esophageal Adenocarcinoma,0.7254,Esophageal Mixed Adenoneuroendocrine Carcinoma,0.7084,Esophageal Lipoma,0.7021,Esophageal Fibroma,0.6929,Esophageal Carcinoma,0.6916,Esophageal Adenosquamous Carcinoma,0.6818,Esophageal Undifferentiated Carcinoma,0.6773,Esophageal Neoplasm,0.6757,Cervical Esophagus Adenocarcinoma,0.6689,Esophageal Lymphoma,0.6650,Esophageal Neuroendocrine Carcinoma,0.6637,Esophageal Melanoma,0.6594,Thoracic Esophagus Adenocarcinoma,0.6552,Esophageal Neuroendocrine Neoplasm,0.6529,Esophageal Leiomyoma,0.6497,Childhood Esophageal Carcinoma,0.6456,Esophageal Liposarcoma,0.6451,Adenoid Cystic Carcinoma,0.6450,Esophageal Schwannoma,0.6410,ESOPHAGEAL ADENOCARINOMA,False,True,True
ESOPHAGEAL ADENOSQUAMOUS CARCINOMA,Esophageal Adenosquamous Carcinoma,1,2,Esophageal Adenosquamous Carcinoma,1.0000,Endometrial Adenosquamous Carcinoma,0.8161,Adenosquamous Carcinoma,0.7986,Gastric Adenosquamous Carcinoma,0.7667,Laryngeal Adenosquamous Carcinoma,0.7643,Cervical Adenosquamous Carcinoma,0.7550,Esophageal Squamous Cell Carcinoma,0.7493,Lung Adenosquamous Carcinoma,0.7428,Esophageal Adenoid Cystic Carcinoma,0.7404,Colon Adenosquamous Carcinoma,0.7249,Esophageal Poorly Differentiated Squamous Cell Carcinoma,0.7242,Vaginal Adenosquamous Carcinoma,0.7213,Small Intestinal Adenosquamous Carcinoma,0.7198,Conjunctival Adenosquamous Carcinoma,0.7181,Skin Adenosquamous Carcinoma,0.7157,Esophageal Undifferentiated Carcinoma,0.7110,Liver Adenosquamous Carcinoma,0.7104,Esophageal Spindle Cell Carcinoma,0.7073,Extrahepatic Bile Duct Adenosquamous Carcinoma,0.7039,Salivary Gland Adenosquamous Carcinoma,0.7023,ESOPHAGEAL ADENOSQUAMOUS CARCINOMA,True,True,True
ESOPHAGEAL CANCER,Esophageal Carcinoma,1,2,Esophageal Carcinoma,0.9520,Esophageal Neoplasm,0.8830,Esophageal Adenocarcinoma,0.8520,Malignant Esophageal Neoplasm,0.8422,Advanced Esophageal Carcinoma,0.8001,Childhood Esophageal Carcinoma,0.7993,Esophageal Undifferentiated Carcinoma,0.7845,Esophageal Squamous Cell Carcinoma,0.7798,Early Stage Esophageal Carcinoma,0.7791,Esophageal Lymphoma,0.7723,Localized Esophageal Carcinoma,0.7696,Esophageal Neuroendocrine Carcinoma,0.7663,Thoracic Esophagus Adenocarcinoma,0.7595,Esophageal Sarcoma,0.7580,Esophageal Melanoma,0.7570,Cervical Esophagus Adenocarcinoma,0.7537,Malignant Esophageal Neoplasm by Anatomic Region,0.7515,Advanced Esophageal Adenocarcinoma,0.7471,Metastatic Esophageal Carcinoma,0.7408,Malignant Esophageal Neoplasm by Topographic Region,0.7379,ESOPHAGEAL CANCER,True,True,True
ESOPHAGEAL CARCINOMA,Esophageal Carcinoma,1,2,Esophageal Carcinoma,1.0000,Esophageal Adenocarcinoma,0.8854,Advanced Esophageal Carcinoma,0.8363,Esophageal Squamous Cell Carcinoma,0.8326,Childhood Esophageal Carcinoma,0.8250,Esophageal Neoplasm,0.8169,Esophageal Undifferentiated Carcinoma,0.8154,Malignant Esophageal Neoplasm,0.8087,Early Stage Esophageal Carcinoma,0.7995,Localized Esophageal Carcinoma,0.7994,Cervical Esophagus Adenocarcinoma,0.7947,Esophageal Neuroendocrine Carcinoma,0.7875,Advanced Esophageal Adenocarcinoma,0.7844,Thoracic Esophagus Adenocarcinoma,0.7752,Metastatic Esophageal Carcinoma,0.7651,Locally Advanced Esophageal Carcinoma,0.7571,Unresectable Esophageal Carcinoma,0.7563,Esophageal and Gastroesophageal Junction Carcinoma,0.7545,Esophageal Lymphoma,0.7514,Endometrial Carcinoma,0.7484,ESOPHAGEAL CARCINOMA,True,True,True
ESOPHAGEAL CARCINOMA OTHER,Esophageal Carcinoma,1,2,Esophageal Carcinoma,0.8486,Esophageal Undifferentiated Carcinoma,0.7737,Esophageal Neuroendocrine Carcinoma,0.7611,Childhood Esophageal Carcinoma,0.7443,Esophageal Adenocarcinoma,0.7428,Advanced Esophageal Carcinoma,0.7379,Unresectable Esophageal Carcinoma,0.7339,Esophageal Neoplasm,0.7326,Metastatic Esophageal Carcinoma,0.7297,Esophageal and Gastroesophageal Junction Carcinoma,0.7227,Early Stage Esophageal Carcinoma,0.7168,Localized Esophageal Carcinoma,0.7102,Esophageal Lymphoma,0.7005,Esophageal Large Cell Neuroendocrine Carcinoma,0.6997,Esophageal Squamous Cell Carcinoma,0.6946,Unresectable Esophageal Adenocarcinoma,0.6841,Esophageal Melanoma,0.6835,Esophageal Neuroendocrine Neoplasm,0.6833,Advanced Esophageal Adenocarcinoma,0.6797,Esophageal Small Cell Neuroendocrine Carcinoma,0.6782,ESOPHAGEAL CARCINOMA OTHER,True,True,True
ESOPHAGEAL NEUROENDOCRINE TUMOR,Esophageal Neuroendocrine Tumor,1,2,Esophageal Neuroendocrine Tumor,1.0000,Esophageal Neuroendocrine Neoplasm,0.9740,Esophageal Neuroendocrine Carcinoma,0.8804,Esophageal Neuroendocrine Tumor G1,0.8753,Esophageal Neuroendocrine Tumor G2,0.8243,Esophageal Neuroendocrine Tumor G3,0.8125,Neuroendocrine Tumor,0.7875,Esophageal Schwannoma,0.7746,Esophageal Small Cell Neuroendocrine Carcinoma,0.7669,Esophageal Malignant Peripheral Nerve Sheath Tumor,0.7581,Esophageal Neoplasm,0.7579,Esophageal Gastrointestinal Stromal Tumor,0.7578,Intestinal Neuroendocrine Tumor,0.7539,Esophageal Large Cell Neuroendocrine Carcinoma,0.7538,Neuroendocrine Neoplasm,0.7538,Rectal Neuroendocrine Tumor,0.7525,Esophageal Granular Cell Tumor,0.7524,Endometrial Neuroendocrine Carcinoma,0.7510,Midgut Neuroendocrine Tumor,0.7431,Esophageal Neurofibroma,0.7389,ESOPHAGEAL NEUROENDOCRINE TUMOR,True,True,True
ESOPHAGEAL POORLY DIFFERENTIATED CARCINOMA,Esophageal Carcinoma,4,2,Esophageal Poorly Differentiated Squamous Cell Carcinoma,0.9199,Esophageal Undifferentiated Carcinoma,0.7957,Esophageal Well Differentiated Squamous Cell Carcinoma,0.7951,Esophageal Carcinoma,0.7691,Advanced Esophageal Carcinoma,0.7638,Esophageal Adenocarcinoma,0.7581,Advanced Esophageal Adenocarcinoma,0.7423,Esophageal Small Cell Neuroendocrine Carcinoma,0.7401,Localized Esophageal Carcinoma,0.7394,Early Stage Esophageal Carcinoma,0.7327,Esophageal Neuroendocrine Carcinoma,0.7309,Esophageal Squamous Cell Carcinoma,0.7295,Advanced Esophageal Squamous Cell Carcinoma,0.7141,Esophageal Moderately Differentiated Squamous Cell Carcinoma,0.7098,Alcohol-Related Esophageal Squamous Cell Carcinoma,0.7071,Locally Advanced Esophageal Carcinoma,0.7065,Metastatic Esophageal Carcinoma,0.7002,Esophageal Adenosquamous Carcinoma,0.6928,Distal Esophagus Adenocarcinoma,0.6910,Esophageal Large Cell Neuroendocrine Carcinoma,0.6870,ESOPHAGEAL POORLY DIFFERENTIATED CARCINOMA,False,False,True
ESOPHAGEAL SQUAMOUS CELL CARCINOMA,Esophageal Squamous Cell Carcinoma,1,2,Esophageal Squamous Cell Carcinoma,1.0000,Advanced Esophageal Squamous Cell Carcinoma,0.8537,Cervical Esophagus Squamous Cell Carcinoma,0.8488,Esophageal Carcinoma,0.8326,Thoracic Esophagus Squamous Cell Carcinoma,0.8295,Alcohol-Related Esophageal Squamous Cell Carcinoma,0.8082,Esophageal Spindle Cell Carcinoma,0.8076,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage,0.8050,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,0.8042,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage,0.8030,Esophageal Poorly Differentiated Squamous Cell Carcinoma,0.7969,Esophageal Well Differentiated Squamous Cell Carcinoma,0.7865,Locally Advanced Esophageal Squamous Cell Carcinoma,0.7713,Esophageal Undifferentiated Carcinoma,0.7710,Metastatic Esophageal Squamous Cell Carcinoma,0.7533,Esophageal Adenosquamous Carcinoma,0.7493,Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma,0.7458,Unresectable Esophageal Squamous Cell Carcinoma,0.7445,Endometrial Squamous Cell Carcinoma,0.7441,Esophageal Neuroendocrine Carcinoma,0.7317,ESOPHAGEAL SQUAMOUS CELL CARCINOMA,True,True,True
"ESOPHAGEAL/STOMACH CANCER, NOS",Esophageal Carcinoma,3,2,Esophageal and Gastroesophageal Junction Carcinoma,0.7639,Gastroesophageal Cancer,0.7490,Esophageal Carcinoma,0.7024,Gastric Carcinoma,0.6863,Digestive System Carcinoma,0.6775,Esophageal Neoplasm,0.6747,Gastric Neoplasm,0.6613,Malignant Gastric Neoplasm,0.6467,Early Gastric Cancer,0.6404,Gastroesophageal Junction Carcinoma,0.6369,Malignant Esophageal Neoplasm,0.6328,Esophageal Adenocarcinoma,0.6269,Malignant Esophageal Neoplasm by Anatomic Region,0.6209,Malignant Esophageal Neoplasm by Topographic Region,0.6070,Gastric Adenocarcinoma,0.6039,Advanced Esophageal Carcinoma,0.6028,Esophageal Gastrointestinal Stromal Tumor,0.6025,Digestive System Neoplasm,0.5996,Esophageal Neuroendocrine Carcinoma,0.5992,Gastrointestinal Carcinomatosis,0.5987,"ESOPHAGEAL/STOMACH CANCER, NOS",False,True,True
ESOPHAGOGASTRIC ADENOCARCINOMA,Gastroesophageal Junction Adenocarcinoma,1,2,Gastroesophageal Junction Adenocarcinoma,0.8619,Gastric Adenocarcinoma,0.8255,Esophageal Adenocarcinoma,0.7994,Gastroesophageal Cancer,0.7933,Gastroesophageal Junction Carcinoma,0.7723,Advanced Gastroesophageal Junction Adenocarcinoma,0.7621,Esophageal and Gastroesophageal Junction Carcinoma,0.7503,Gastric Carcinoma,0.7441,Gastric Intestinal-Type Adenocarcinoma,0.7388,Advanced Gastric Adenocarcinoma,0.7340,Distal Esophagus Adenocarcinoma,0.7320,Advanced Esophageal Adenocarcinoma,0.7312,Gastric Tubular Adenocarcinoma,0.7309,Localized Gastroesophageal Junction Adenocarcinoma,0.7250,Gastric Cardia Adenocarcinoma,0.7222,Thoracic Esophagus Adenocarcinoma,0.7170,Cervical Esophagus Adenocarcinoma,0.7165,Malignant Gastric Neoplasm,0.7163,Sporadic Gastric Adenocarcinoma,0.7134,Metastatic Gastroesophageal Junction Adenocarcinoma,0.7104,ESOPHAGOGASTRIC ADENOCARCINOMA,True,True,True
"ESOPHAGUS ADENOCARCINOMA, NOS",Esophageal Adenocarcinoma,1,2,Esophageal Adenocarcinoma,0.9088,Cervical Esophagus Adenocarcinoma,0.8440,Thoracic Esophagus Adenocarcinoma,0.8420,Distal Esophagus Adenocarcinoma,0.8162,Esophageal Carcinoma,0.8136,Advanced Esophageal Adenocarcinoma,0.8118,Malignant Esophageal Neoplasm,0.7613,Advanced Esophageal Carcinoma,0.7440,Metastatic Esophageal Adenocarcinoma,0.7437,Esophageal Adenocarcinoma by AJCC v8 Stage,0.7299,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage,0.7196,Unresectable Esophageal Adenocarcinoma,0.7191,Esophageal Intramucosal Adenocarcinoma,0.7191,Endometrial Adenocarcinoma,0.7136,Esophageal Melanoma,0.7024,Locally Advanced Esophageal Adenocarcinoma,0.7013,Esophageal Neoplasm,0.6926,Esophageal Adenocarcinoma by AJCC v7 Stage,0.6912,Malignant Esophageal Neoplasm by Anatomic Region,0.6874,Esophageal Undifferentiated Carcinoma,0.6847,"ESOPHAGUS ADENOCARCINOMA, NOS",True,True,True
ESOPHAGUS SQUAMOUS CELL CARCINOMA,Esophageal Squamous Cell Carcinoma,1,2,Esophageal Squamous Cell Carcinoma,0.9647,Cervical Esophagus Squamous Cell Carcinoma,0.8687,Thoracic Esophagus Squamous Cell Carcinoma,0.8446,Advanced Esophageal Squamous Cell Carcinoma,0.8154,Esophageal Carcinoma,0.8018,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage,0.7747,Alcohol-Related Esophageal Squamous Cell Carcinoma,0.7735,Esophageal Spindle Cell Carcinoma,0.7713,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,0.7701,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage,0.7670,Esophageal Poorly Differentiated Squamous Cell Carcinoma,0.7601,Endometrial Squamous Cell Carcinoma,0.7543,Distal Esophagus Squamous Cell Carcinoma,0.7534,Esophageal Well Differentiated Squamous Cell Carcinoma,0.7493,Esophageal Undifferentiated Carcinoma,0.7481,Metastatic Esophageal Squamous Cell Carcinoma,0.7470,Squamous Cell Carcinoma,0.7400,Locally Advanced Esophageal Squamous Cell Carcinoma,0.7249,Unresectable Esophageal Squamous Cell Carcinoma,0.7200,Esophageal Adenosquamous Carcinoma,0.7188,ESOPHAGUS SQUAMOUS CELL CARCINOMA,True,True,True
ESOPHAGUS/STOMACH,Esophageal Carcinoma,99,2,Gastroesophageal Cancer,0.6798,Esophageal and Gastroesophageal Junction Carcinoma,0.6570,Benign Esophageal Neoplasm,0.6243,Benign Gastric Neoplasm,0.6218,Malignant Esophageal Neoplasm,0.6098,Esophageal Gastrointestinal Stromal Tumor,0.6076,Malignant Gastric Neoplasm,0.6065,High Grade Esophageal Glandular Intraepithelial Neoplasia,0.6000,Esophageal Glandular Intraepithelial Neoplasia,0.5997,Early Gastric Cancer,0.5906,Low Risk Esophageal Gastrointestinal Stromal Tumor,0.5906,Gastric Lymphoma,0.5904,High Risk Esophageal Gastrointestinal Stromal Tumor,0.5898,Esophageal Neuroendocrine Tumor G2,0.5881,Low Grade Esophageal Glandular Intraepithelial Neoplasia,0.5876,Esophageal Lymphoma,0.5866,Esophageal Neoplasm,0.5859,Esophageal Neuroendocrine Neoplasm,0.5836,Gastric Neoplasm,0.5815,Gastric Sarcoma,0.5801,ESOPHAGUS/STOMACH,False,False,False
ESOPHAGUS_ADENOCARCINOMA,Esophageal Adenocarcinoma,1,2,Esophageal Adenocarcinoma,0.9256,Cervical Esophagus Adenocarcinoma,0.8335,Thoracic Esophagus Adenocarcinoma,0.8314,Advanced Esophageal Adenocarcinoma,0.8262,Distal Esophagus Adenocarcinoma,0.8209,Esophageal Carcinoma,0.8204,Endometrial Adenocarcinoma,0.7789,Adenocarcinoma,0.7658,Malignant Esophageal Neoplasm,0.7619,Advanced Esophageal Carcinoma,0.7563,Metastatic Esophageal Adenocarcinoma,0.7532,Esophageal Adenocarcinoma by AJCC v8 Clinical Stage,0.7504,Esophageal Adenocarcinoma by AJCC v8 Stage,0.7490,Unresectable Esophageal Adenocarcinoma,0.7459,Esophageal Intramucosal Adenocarcinoma,0.7413,Esophageal Neoplasm,0.7260,Malignant Esophageal Neoplasm by Anatomic Region,0.7208,Barrett Adenocarcinoma,0.7160,Esophageal Adenocarcinoma by AJCC v7 Stage,0.7151,Esophageal Undifferentiated Carcinoma,0.7127,ESOPHAGUS_ADENOCARCINOMA,True,True,True
ESOPHAGUS_SQUAMOUS,Esophageal Squamous Cell Carcinoma,1,2,Esophageal Squamous Cell Carcinoma,0.7473,Esophageal Carcinoma,0.7112,Malignant Esophageal Neoplasm,0.7086,Esophageal Sarcoma,0.6933,Esophageal Squamous Papilloma,0.6909,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage,0.6906,Esophageal Adenocarcinoma,0.6881,Cervical Esophagus Squamous Cell Carcinoma,0.6880,Esophageal Undifferentiated Carcinoma,0.6868,Esophageal Squamous Intraepithelial Neoplasia,0.6853,Advanced Esophageal Squamous Cell Carcinoma,0.6808,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,0.6755,Benign Esophageal Neoplasm,0.6753,Esophageal Neoplasm,0.6750,Esophageal Melanoma,0.6735,Squamous Cell Carcinoma,0.6714,Thoracic Esophagus Squamous Cell Carcinoma,0.6699,Esophageal Lymphoma,0.6662,Squamous Cell Neoplasm,0.6608,Esophageal Adenosquamous Carcinoma,0.6572,ESOPHAGUS_SQUAMOUS,True,True,True
ESSENTIAL THROMBOCYTHAEMIA,Essential Thrombocythemia,1,2,Essential Thrombocythemia,0.9725,Post-Essential Thrombocythemia Myelofibrosis,0.6189,Refractory Thrombocytopenia,0.6075,Hemangiomatosis with Thrombocytopenia,0.6068,Polycythemia Vera,0.6032,"Polycythemia Vera, Polycythemic Phase",0.5422,Pure Erythroid Leukemia,0.5406,Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions,0.5271,Megakaryocytic Neoplasm,0.5257,Bone Epithelioid Hemangioma,0.5202,Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis,0.5194,Epithelioid Hemangioma,0.5181,Myeloid/Lymphoid Neoplasms with ETV6-ABL1,0.5144,Erythroleukemia,0.5120,Complex Endometrial Hyperplasia,0.5117,Hemolymphangioma,0.5075,Acute Eosinophilic Leukemia,0.5062,Adult Pure Erythroid Leukemia,0.5060,Erythroid Neoplasm,0.5028,Acute Erythroid Leukemia,0.5027,ESSENTIAL THROMBOCYTHAEMIA,True,True,True
ESSENTIAL THROMBOCYTHEMIA,Essential Thrombocythemia,1,2,Essential Thrombocythemia,1.0000,Post-Essential Thrombocythemia Myelofibrosis,0.6584,Refractory Thrombocytopenia,0.6139,Polycythemia Vera,0.6026,Hemangiomatosis with Thrombocytopenia,0.5987,Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions,0.5690,Pure Erythroid Leukemia,0.5568,Megakaryocytic Neoplasm,0.5561,Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis,0.5470,"Polycythemia Vera, Polycythemic Phase",0.5448,Myeloid/Lymphoid Neoplasms with ETV6-ABL1,0.5394,Erythroleukemia,0.5314,Adult Pure Erythroid Leukemia,0.5290,Bone Epithelioid Hemangioma,0.5261,Epithelioid Hemangioma,0.5261,Acute Eosinophilic Leukemia,0.5245,Acute Erythroid Leukemia,0.5237,Adult Erythroleukemia,0.5225,Adult Acute Eosinophilic Leukemia,0.5215,Erythroid Neoplasm,0.5215,ESSENTIAL THROMBOCYTHEMIA,True,True,True
ESSENTIAL_THROMBOCYTHAEMIA,Essential Thrombocythemia,1,2,Essential Thrombocythemia,0.9494,Post-Essential Thrombocythemia Myelofibrosis,0.6155,Hemangiomatosis with Thrombocytopenia,0.6108,Refractory Thrombocytopenia,0.6072,Polycythemia Vera,0.5814,Myeloid/Lymphoid Neoplasms with ETV6-ABL1,0.5450,"Polycythemia Vera, Polycythemic Phase",0.5369,Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis,0.5308,Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions,0.5302,Megakaryocytic Neoplasm,0.5225,Pure Erythroid Leukemia,0.5214,Bone Epithelioid Hemangioma,0.5098,Epithelioid Hemangioma,0.5086,Erythroid Neoplasm,0.5068,Hemolymphangioma,0.5058,Advanced Epithelioid Hemangioendothelioma,0.5048,Epithelioid Trophoblastic Tumor,0.5007,"Chronic Eosinophilic Leukemia, Not Otherwise Specified",0.4979,Hematologic Neoplasm with Germline ETV6 Mutation,0.4975,Bone Epithelioid Hemangioendothelioma,0.4973,ESSENTIAL_THROMBOCYTHAEMIA,True,True,True
ETMR,Embryonal Tumor with Multilayered Rosettes,99,2,"Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated",0.6236,Refractory Mucosal Melanoma,0.5738,Refractory Endometrial Carcinoma,0.5686,Refractory Ewing Sarcoma,0.5624,Ependymoma,0.5577,Refractory Endocrine Carcinoma,0.5576,Refractory Thrombocytopenia,0.5568,Refractory Melanoma,0.5542,Refractory Ependymoma,0.5541,Refractory Endometrial Adenocarcinoma,0.5523,Embryonal Rhabdomyosarcoma,0.5501,Ependymal Tumor,0.5491,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,0.5474,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.5460,Refractory Wilms Tumor,0.5447,Embryonal Tumor with Multilayered Rosettes without C19MC Alteration,0.5444,Refractory Endometrial Mucinous Adenocarcinoma,0.5414,Refractory Meningioma,0.5414,Ewing Sarcoma,0.5393,Refractory Epithelioid Sarcoma,0.5385,ETMR,False,False,False
ETP-ALL,Early T Precursor Acute Lymphoblastic Leukemia,3,2,Early T Precursor Lymphoblastic Leukemia/Lymphoma,0.6873,"Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.6766,Early T Precursor Acute Lymphoblastic Leukemia,0.6656,Acute Lymphoblastic Leukemia by Gene Expression Profile,0.6439,Pre T-ALL,0.6208,Myeloid/Lymphoid Neoplasms with ETV6-ABL1,0.6082,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.6063,Mature T-ALL,0.6047,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.5846,Common Acute Lymphoblastic Leukemia,0.5810,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.5794,Systemic EBV-Positive T-Cell Lymphoma of Childhood,0.5790,EBV-Positive T-Cell/NK-Cell Lymphoproliferative Disorder of Childhood,0.5788,Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA,0.5768,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,0.5749,Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.5731,Acute Eosinophilic Leukemia,0.5692,"Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.5691,CALLA Positive Lymphoblastic Leukemia,0.5679,AESOP Syndrome,0.5631,ETP-ALL,False,True,True
EWING FAMILY TUMOR,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,3,2,Ewing Sarcoma of Bone,0.8619,Ewing Sarcoma,0.8516,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7861,Childhood Ewing Sarcoma,0.7773,Extraskeletal Ewing Sarcoma,0.7763,Atypical Ewing Sarcoma,0.7705,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0.7670,Localized Ewing Sarcoma,0.7668,Localized Bone Ewing Sarcoma,0.7487,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7453,Skin Ewing Sarcoma,0.7423,Kidney Ewing Sarcoma,0.7419,Central Nervous System Ewing Sarcoma,0.7360,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7326,Unresectable Ewing Sarcoma,0.7248,Ependymal Tumor,0.7164,Refractory Ewing Sarcoma,0.7083,Metastatic Ewing Sarcoma,0.7068,Localized Extraskeletal Ewing Sarcoma,0.6996,Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.6990,EWING FAMILY TUMOR,False,True,True
EWING SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,1.0000,Ewing Sarcoma of Bone,0.9594,Childhood Ewing Sarcoma,0.9135,Extraskeletal Ewing Sarcoma,0.9023,Atypical Ewing Sarcoma,0.8802,Skin Ewing Sarcoma,0.8699,Localized Ewing Sarcoma,0.8568,Kidney Ewing Sarcoma,0.8517,Central Nervous System Ewing Sarcoma,0.8428,Localized Bone Ewing Sarcoma,0.8273,Metastatic Ewing Sarcoma,0.8254,Sinonasal Ewing Sarcoma,0.8077,Unresectable Ewing Sarcoma,0.7976,Refractory Ewing Sarcoma,0.7887,Childhood Kidney Ewing Sarcoma,0.7785,Recurrent Ewing Sarcoma,0.7711,Localized Extraskeletal Ewing Sarcoma,0.7711,Metastatic Bone Ewing Sarcoma,0.7537,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7432,Head and Neck Ewing Sarcoma,0.7418,EWING SARCOMA,True,True,True
EWING'S SARCOMA,Ewing Sarcoma,2,2,Ewing Sarcoma of Bone,0.9613,Ewing Sarcoma,0.9565,Extraskeletal Ewing Sarcoma,0.8912,Childhood Ewing Sarcoma,0.8864,Atypical Ewing Sarcoma,0.8425,Central Nervous System Ewing Sarcoma,0.8417,Skin Ewing Sarcoma,0.8357,Metastatic Ewing Sarcoma,0.8215,Localized Ewing Sarcoma,0.8191,Kidney Ewing Sarcoma,0.8132,Localized Bone Ewing Sarcoma,0.8045,Unresectable Ewing Sarcoma,0.7910,Refractory Ewing Sarcoma,0.7799,Sinonasal Ewing Sarcoma,0.7798,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7645,Recurrent Ewing Sarcoma,0.7644,Metastatic Bone Ewing Sarcoma,0.7611,Localized Extraskeletal Ewing Sarcoma,0.7566,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0.7566,Childhood Kidney Ewing Sarcoma,0.7516,EWING'S SARCOMA,False,True,True
EWING-LIKE SARCOMA,Round Cell Sarcoma with EWSR1-non-ETS Fusion,99,2,Ewing Sarcoma,0.9376,Ewing Sarcoma of Bone,0.9152,Extraskeletal Ewing Sarcoma,0.8763,Localized Ewing Sarcoma,0.8600,Atypical Ewing Sarcoma,0.8545,Childhood Ewing Sarcoma,0.8453,Localized Bone Ewing Sarcoma,0.8335,Kidney Ewing Sarcoma,0.8191,Skin Ewing Sarcoma,0.8144,Central Nervous System Ewing Sarcoma,0.8103,Localized Extraskeletal Ewing Sarcoma,0.8073,Metastatic Ewing Sarcoma,0.7933,Sinonasal Ewing Sarcoma,0.7832,Unresectable Ewing Sarcoma,0.7721,Refractory Ewing Sarcoma,0.7720,Locally Advanced Ewing Sarcoma,0.7621,Recurrent Ewing Sarcoma,0.7588,Childhood Kidney Ewing Sarcoma,0.7366,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7341,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0.7164,EWING-LIKE SARCOMA,False,False,False
EWINGS SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,0.9825,Ewing Sarcoma of Bone,0.9682,Extraskeletal Ewing Sarcoma,0.9066,Childhood Ewing Sarcoma,0.8987,Atypical Ewing Sarcoma,0.8594,Skin Ewing Sarcoma,0.8546,Central Nervous System Ewing Sarcoma,0.8508,Localized Ewing Sarcoma,0.8482,Kidney Ewing Sarcoma,0.8301,Localized Bone Ewing Sarcoma,0.8279,Metastatic Ewing Sarcoma,0.8278,Unresectable Ewing Sarcoma,0.8027,Sinonasal Ewing Sarcoma,0.7998,Refractory Ewing Sarcoma,0.7887,Localized Extraskeletal Ewing Sarcoma,0.7766,Recurrent Ewing Sarcoma,0.7720,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7635,Metastatic Bone Ewing Sarcoma,0.7628,Childhood Kidney Ewing Sarcoma,0.7584,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0.7527,EWINGS SARCOMA,True,True,True
EWINGS SARCOMA-PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOUR,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1,2,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9365,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0.9090,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.9076,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8759,Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8094,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8091,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8035,Peripheral Primitive Neuroectodermal Tumor,0.7975,Ewing Sarcoma of Bone,0.7974,Primitive Neuroectodermal Tumor,0.7684,Central Nervous System Ewing Sarcoma,0.7577,Ewing Sarcoma,0.7559,Peripheral Primitive Neuroectodermal Tumor of Bone,0.7529,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues,0.7447,Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7359,Extraskeletal Ewing Sarcoma,0.7345,Refractory Peripheral Primitive Neuroectodermal Tumor,0.7121,Atypical Ewing Sarcoma,0.7102,Childhood Ewing Sarcoma,0.7098,Localized Peripheral Primitive Neuroectodermal Tumor,0.7098,EWINGS SARCOMA-PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOUR,True,True,True
EWINGS_SARCOMA,Ewing Sarcoma,2,2,Ewing Sarcoma of Bone,0.9442,Ewing Sarcoma,0.9428,Extraskeletal Ewing Sarcoma,0.8860,Childhood Ewing Sarcoma,0.8672,Skin Ewing Sarcoma,0.8319,Central Nervous System Ewing Sarcoma,0.8309,Atypical Ewing Sarcoma,0.8307,Metastatic Ewing Sarcoma,0.8164,Localized Ewing Sarcoma,0.8081,Unresectable Ewing Sarcoma,0.8070,Kidney Ewing Sarcoma,0.8037,Localized Bone Ewing Sarcoma,0.7907,Sinonasal Ewing Sarcoma,0.7812,Refractory Ewing Sarcoma,0.7778,Recurrent Ewing Sarcoma,0.7650,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7620,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0.7562,Metastatic Bone Ewing Sarcoma,0.7545,Localized Extraskeletal Ewing Sarcoma,0.7492,Childhood Kidney Ewing Sarcoma,0.7389,EWINGS_SARCOMA,False,True,True
EWING_SARCOMA,Ewing Sarcoma,1,2,Ewing Sarcoma,0.9701,Ewing Sarcoma of Bone,0.9524,Extraskeletal Ewing Sarcoma,0.8992,Childhood Ewing Sarcoma,0.8885,Atypical Ewing Sarcoma,0.8561,Skin Ewing Sarcoma,0.8508,Central Nervous System Ewing Sarcoma,0.8331,Metastatic Ewing Sarcoma,0.8282,Kidney Ewing Sarcoma,0.8260,Localized Ewing Sarcoma,0.8240,Unresectable Ewing Sarcoma,0.8028,Localized Bone Ewing Sarcoma,0.7984,Sinonasal Ewing Sarcoma,0.7976,Refractory Ewing Sarcoma,0.7886,Recurrent Ewing Sarcoma,0.7763,Metastatic Bone Ewing Sarcoma,0.7580,Childhood Kidney Ewing Sarcoma,0.7567,Localized Extraskeletal Ewing Sarcoma,0.7557,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7547,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0.7455,EWING_SARCOMA,True,True,True
EXTRA GONADAL GERM CELL TUMOR,Extragonadal Germ Cell Tumor,1,2,Extragonadal Germ Cell Tumor,0.9171,Ovarian Germ Cell Tumor,0.8646,Germ Cell Tumor,0.8564,Testicular Germ Cell Tumor,0.8523,Childhood Gonadal Germ Cell Tumor,0.8479,Childhood Extragonadal Malignant Germ Cell Tumor,0.8321,Benign Extragonadal Germ Cell Tumor,0.8315,Ovarian Primitive Germ Cell Tumor,0.8260,Testicular Granulosa Cell Tumor,0.8195,Malignant Extragonadal Germ Cell Tumor,0.8185,Adult Germ Cell Tumor,0.8085,Childhood Ovarian Germ Cell Tumor,0.8033,Ovarian Non-Dysgerminomatous Germ Cell Tumor,0.8024,Cardiac Germ Cell Tumor,0.7995,Gastric Germ Cell Tumor,0.7969,Childhood Extracranial Germ Cell Tumor,0.7947,Testicular Pure Germ Cell Tumor,0.7938,Childhood Testicular Germ Cell Tumor,0.7829,Nongerminomatous Germ Cell Tumor,0.7824,Central Nervous System Germ Cell Tumor,0.7821,EXTRA GONADAL GERM CELL TUMOR,True,True,True
EXTRA-ADRENAL PHEOCHROMOCYTOMA,Extra-Adrenal Sympathetic Paraganglioma,17,2,Adrenal Gland Pheochromocytoma,0.9224,Regional Adrenal Gland Pheochromocytoma,0.8782,Non-Metastatic Adrenal Gland Pheochromocytoma,0.8687,Advanced Adrenal Gland Pheochromocytoma,0.8615,Adrenal Gland Composite Pheochromocytoma,0.8555,Metastatic Adrenal Gland Pheochromocytoma,0.8477,Non-Metastatic Adrenal Gland Composite Pheochromocytoma,0.8461,Hereditary Adrenal Gland Pheochromocytoma,0.8275,Metastatic Adrenal Gland Composite Pheochromocytoma,0.8119,Locally Advanced Adrenal Gland Pheochromocytoma,0.8097,Unresectable Adrenal Gland Pheochromocytoma,0.7986,Childhood Adrenal Gland Pheochromocytoma,0.7976,Refractory Adrenal Gland Pheochromocytoma,0.7792,Recurrent Adrenal Gland Pheochromocytoma,0.7780,Extra-Adrenal Paraganglioma,0.7720,Metastatic Extra-Adrenal Paraganglioma,0.7064,Extra-Adrenal Sympathetic Paraganglioma,0.7013,Pineocytoma,0.6883,Composite Paraganglioma,0.6825,Melanocytoma,0.6755,EXTRA-ADRENAL PHEOCHROMOCYTOMA,False,False,False
EXTRAGONADAL GERM CELL TUMOR,Extragonadal Germ Cell Tumor,1,2,Extragonadal Germ Cell Tumor,1.0000,Benign Extragonadal Germ Cell Tumor,0.9092,Malignant Extragonadal Germ Cell Tumor,0.8976,Childhood Extragonadal Malignant Germ Cell Tumor,0.8781,Malignant Extragonadal Nongerminomatous Germ Cell Tumor,0.8553,Nongerminomatous Germ Cell Tumor,0.8172,Germ Cell Tumor,0.8107,Ovarian Germ Cell Tumor,0.7820,Extragonadal Embryonal Carcinoma,0.7799,Ovarian Non-Dysgerminomatous Germ Cell Tumor,0.7795,Central Nervous System Germ Cell Tumor,0.7681,Childhood Extracranial Germ Cell Tumor,0.7650,Ovarian Primitive Germ Cell Tumor,0.7632,Central Nervous System Nongerminomatous Germ Cell Tumor,0.7577,Germinomatous Germ Cell Tumor,0.7566,Extragonadal Teratoma,0.7514,Extragonadal Seminoma,0.7503,Adult Germ Cell Tumor,0.7489,Testicular Germ Cell Tumor,0.7465,Testicular Non-Seminomatous Germ Cell Tumor,0.7453,EXTRAGONADAL GERM CELL TUMOR,True,True,True
EXTRAHEPATIC CHOLANGIOCARCINOMA,Extrahepatic Bile Duct Adenocarcinoma,10,2,Cholangiocarcinoma,0.8690,Distal Cholangiocarcinoma,0.8363,Adult Cholangiocarcinoma,0.8321,Intrahepatic Cholangiocarcinoma,0.8256,Extrahepatic Bile Duct Carcinoma,0.8241,Hilar Cholangiocarcinoma,0.8078,Metastatic Cholangiocarcinoma,0.8041,Unresectable Cholangiocarcinoma,0.8021,Advanced Cholangiocarcinoma,0.7936,Extrahepatic Bile Duct Adenocarcinoma,0.7880,Extrahepatic Bile Duct Undifferentiated Carcinoma,0.7872,Metastatic Intrahepatic Cholangiocarcinoma,0.7783,Advanced Intrahepatic Cholangiocarcinoma,0.7778,Extrahepatic Bile Duct Neuroendocrine Carcinoma,0.7703,Localized Extrahepatic Bile Duct Carcinoma,0.7671,Clear Cell Intrahepatic Cholangiocarcinoma,0.7635,Unresectable Intrahepatic Cholangiocarcinoma,0.7597,Small Duct Intrahepatic Cholangiocarcinoma,0.7587,Unresectable Distal Cholangiocarcinoma,0.7586,Extrahepatic Bile Duct Clear Cell Adenocarcinoma,0.7526,EXTRAHEPATIC CHOLANGIOCARCINOMA,False,False,False
EXTRAMAMMARY PAGET DISEASE,Extramammary Paget Disease,1,2,Extramammary Paget Disease,1.0000,Metastatic Extramammary Paget Disease,0.9381,Advanced Extramammary Paget Disease,0.9333,Recurrent Extramammary Paget Disease,0.8727,Refractory Extramammary Paget Disease,0.8546,Paget Disease,0.8506,Breast Paget Disease,0.8243,Penile Paget Disease,0.7638,Anal Paget Disease,0.7435,Anal Canal Paget Disease,0.7421,Anal Margin Paget Disease,0.7378,Scrotal Paget Disease,0.7284,Nipple Paget Disease,0.7272,Osteosarcoma Arising in Paget Disease of Bone,0.7194,Breast Paget Disease without Invasive Carcinoma,0.7124,Recurrent Breast Paget Disease,0.7086,Vulvar Paget Disease,0.7051,Pagetoid Reticulosis,0.6777,Extraosseous Plasmacytoma,0.6496,Breast Paget Disease and Intraductal Carcinoma,0.6412,EXTRAMAMMARY PAGET DISEASE,True,True,True
EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE MALT LYMPHOMA,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1,2,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.9563,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Involving the Digestive System,0.8826,Childhood Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.8557,Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.8409,Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.8208,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue by Ann Arbor Stage,0.8171,Head and Neck Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.7960,Ann Arbor Stage IV Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.7917,Gastric Mucosa-Associated Lymphoid Tissue Lymphoma,0.7814,Nodal Marginal Zone Lymphoma,0.7700,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0.7571,Marginal Zone Lymphoma,0.7558,Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.7554,Endometrial Mucosa-Associated Lymphoid Tissue Lymphoma,0.7543,Colon Mucosa-Associated Lymphoid Tissue Lymphoma,0.7485,Thymus Mucosa-Associated Lymphoid Tissue Lymphoma,0.7440,Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma,0.7356,Thyroid Gland Mucosa-Associated Lymphoid Tissue Lymphoma,0.7296,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0.7295,Gastric Mantle Cell Lymphoma,0.7255,EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE MALT LYMPHOMA,True,True,True
EXTRARENAL RHABDOID TUMOR,Extrarenal Rhabdoid Tumor,1,2,Extrarenal Rhabdoid Tumor,1.0000,Refractory Extrarenal Rhabdoid Tumor,0.9004,Rhabdoid Tumor,0.8755,Unresectable Extrarenal Rhabdoid Tumor,0.8752,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.8693,Extrarenal Rhabdoid Tumor of the Prostate,0.8651,Rhabdoid Tumor of the Kidney,0.8495,Recurrent Extrarenal Rhabdoid Tumor,0.8419,Extrarenal Rhabdoid Tumor of the Ovary,0.8378,Unresectable Rhabdoid Tumor,0.8372,Refractory Rhabdoid Tumor,0.8332,Advanced Rhabdoid Tumor,0.8322,Metastatic Rhabdoid Tumor,0.8227,Extrarenal Rhabdoid Tumor of the Liver,0.8164,Atypical Teratoid/Rhabdoid Tumor,0.8110,Refractory Rhabdoid Tumor of the Kidney,0.8094,Atypical Teratoid/Rhabdoid Tumor-TYR,0.7813,Recurrent Rhabdoid Tumor,0.7813,Refractory Extrarenal Rhabdoid Tumor of the Ovary,0.7771,Refractory Atypical Teratoid/Rhabdoid Tumor,0.7706,EXTRARENAL RHABDOID TUMOR,True,True,True
EXTRASKELETAL MYXOID CHONDROSARCOMA,Extraskeletal Myxoid Chondrosarcoma,1,2,Extraskeletal Myxoid Chondrosarcoma,1.0000,Conventional Extraskeletal Myxoid Chondrosarcoma,0.9695,Mesenchymal Extraskeletal Chondrosarcoma,0.8994,Adult Extraskeletal Myxoid Chondrosarcoma,0.8977,Childhood Extraskeletal Myxoid Chondrosarcoma,0.8901,Brain Extraskeletal Myxoid Chondrosarcoma,0.8426,Orbital Extraskeletal Myxoid Chondrosarcoma,0.8276,Head and Neck Extraskeletal Myxoid Chondrosarcoma,0.8163,Metastatic Extraskeletal Myxoid Chondrosarcoma,0.8143,Myxoid Chondrosarcoma NCI Grade 1,0.7796,Mesenchymal Chondrosarcoma,0.7783,Central Nervous System Mesenchymal Chondrosarcoma,0.7709,Refractory Extraskeletal Myxoid Chondrosarcoma,0.7703,Myxoid Chondrosarcoma NCI Grade 2,0.7607,Locally Advanced Extraskeletal Myxoid Chondrosarcoma,0.7563,Mesenchymal Chondrosarcoma of Bone,0.7520,Adult Mesenchymal Chondrosarcoma,0.7512,Chondrosarcoma,0.7500,Synovial Chondrosarcoma,0.7384,Clear Cell Chondrosarcoma,0.7218,EXTRASKELETAL MYXOID CHONDROSARCOMA,True,True,True
EXTRASKELETAL OSTEOSARCOMA,Extraskeletal Osteosarcoma,1,2,Extraskeletal Osteosarcoma,1.0000,Childhood Extraskeletal Osteosarcoma,0.8974,Adult Extraskeletal Osteosarcoma,0.8874,Kidney Extraskeletal Osteosarcoma,0.8587,Bone Osteosarcoma,0.8578,Metastatic Extraskeletal Osteosarcoma,0.8575,Localized Extraskeletal Osteosarcoma,0.8561,Osteosarcoma,0.8513,Central Nervous System Extraskeletal Osteosarcoma,0.8503,Osteoblastic Osteosarcoma,0.8448,Cardiac Extraskeletal Osteosarcoma,0.8312,Conventional Osteosarcoma,0.8221,Secondary Osteosarcoma,0.8163,Jaw Osteosarcoma,0.8080,Primary Bone Osteosarcoma,0.8033,Extraskeletal Osteoma,0.8002,Breast Extraskeletal Osteosarcoma,0.7940,Liver Extraskeletal Osteosarcoma,0.7860,Metastatic Osteosarcoma,0.7755,Fibroblastic Osteosarcoma,0.7748,EXTRASKELETAL OSTEOSARCOMA,True,True,True
EXTRAVENTRICULAR NEUROCYTOMA,Extraventricular Neurocytoma,1,2,Extraventricular Neurocytoma,1.0000,Central Neurocytoma,0.7614,Brain Ependymoma,0.7003,Intraventricular Meningioma,0.6965,Ependymal Pituicytoma,0.6956,Intraventricular Brain Neoplasm,0.6929,Subependymoma,0.6867,Ependymoma,0.6810,Cellular Ependymoma,0.6780,Olfactory Neurocytoma,0.6744,Tanycytic Ependymoma,0.6583,Fourth Ventricle Medulloblastoma,0.6576,Childhood Infratentorial Ependymoma,0.6522,Clear Cell Ependymoma,0.6485,Sellar Neurocytoma,0.6468,Posterior Fossa Ependymoma,0.6420,Adult Brain Ependymoma,0.6406,Adult Ependymoma,0.6387,Extracranial Neuroblastoma,0.6374,Childhood Ependymoma,0.6368,EXTRAVENTRICULAR NEUROCYTOMA,True,True,True
FH-DEFICIENT RENAL CELL CARCINOMA,Fumarate Hydratase-Deficient Renal Cell Carcinoma,1,2,Fumarate Hydratase-Deficient Renal Cell Carcinoma,0.8951,Hereditary Renal Cell Carcinoma,0.8152,Hereditary Clear Cell Renal Cell Carcinoma,0.7784,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,0.7765,Renal Cell Carcinoma,0.7562,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.7483,Hereditary Papillary Renal Cell Carcinoma,0.7408,Kidney Carcinoma,0.7302,BAP1-Mutated Clear Cell Renal Cell Carcinoma,0.7025,Non-Clear Cell Renal Cell Carcinoma,0.6938,Clear Cell Renal Cell Carcinoma,0.6888,ELOC-Mutated Renal Cell Carcinoma,0.6853,Localized Renal Cell Carcinoma,0.6840,TFE3-Rearranged Renal Cell Carcinoma,0.6822,Advanced Renal Cell Carcinoma,0.6759,"Renal Cell Carcinoma, Not Otherwise Specified",0.6700,TFEB-Rearranged Renal Cell Carcinoma,0.6685,SMARCB1-Deficient Kidney Medullary Carcinoma,0.6679,Childhood Renal Cell Carcinoma,0.6649,Granular Renal Cell Carcinoma,0.6638,FH-DEFICIENT RENAL CELL CARCINOMA,True,True,True
FIBROBLASTIC MYOFIBROBLASTIC TUMOR,Inflammatory Myofibroblastic Tumor,3,2,Myofibroblastoma,0.8973,Myofibromatosis,0.8769,Inflammatory Myofibroblastic Tumor,0.8466,Myofibroma,0.8436,Mammary-Type Myofibroblastoma,0.7993,Fibroblastic Neoplasm,0.7895,Adult Myofibroma,0.7894,Fibromyxoid Tumor,0.7833,Fibroma,0.7792,Breast Myofibroblastoma,0.7700,Fibromatosis,0.7696,Low Grade Myofibroblastic Sarcoma,0.7640,Cellular Fibroma,0.7621,Infantile Myofibroma,0.7610,Angiomyofibroblastoma,0.7594,Cardiac Inflammatory Myofibroblastic Tumor,0.7571,Infantile Myofibromatosis 1,0.7468,Desmoplastic Fibroblastoma,0.7411,Bladder Inflammatory Myofibroblastic Tumor,0.7408,Benign Fibroblastic Neoplasm,0.7399,FIBROBLASTIC MYOFIBROBLASTIC TUMOR,False,True,True
FIBROBLASTIC OSTEOSARCOMA,Fibroblastic Osteosarcoma,1,2,Fibroblastic Osteosarcoma,1.0000,Osteoblastic Osteosarcoma,0.8530,Osteosarcoma,0.8444,Conventional Osteosarcoma,0.8440,Bone Osteosarcoma,0.8148,Osteoblastoma,0.7791,Small Cell Osteosarcoma,0.7786,Mixed Osteosarcoma,0.7764,Extraskeletal Osteosarcoma,0.7748,Multifocal Osteosarcoma,0.7727,Low Grade Osteosarcoma,0.7694,Jaw Osteosarcoma,0.7641,Primary Bone Osteosarcoma,0.7640,Localized Osteosarcoma,0.7629,High Grade Osteosarcoma,0.7597,Chondroblastic Osteosarcoma,0.7595,Secondary Osteosarcoma,0.7566,Giant Cell-Rich Osteosarcoma,0.7511,Childhood Conventional Osteosarcoma,0.7487,Maxillofacial Osteosarcoma,0.7480,FIBROBLASTIC OSTEOSARCOMA,True,True,True
FIBROBLAST_SKIN,Skin Fibroblastic Neoplasm,1,2,Skin Fibroblastic Neoplasm,0.8532,Benign Skin Fibroblastic Neoplasm,0.8032,Skin Fibroblastic Fibrous Histiocytoma,0.7196,Fibroblastic Neoplasm,0.7176,Skin Cellular Fibrous Histiocytoma,0.6724,Skin Fibrous Histiocytoma,0.6635,Benign Fibroblastic Neoplasm,0.6591,Dermal Fibroma,0.6452,Skin Sarcoma,0.6407,Skin Fibroepithelial Basal Cell Carcinoma,0.6405,Skin Myxofibrosarcoma,0.6383,Dermatomyofibroma,0.6372,Skin Neoplasm,0.6364,Benign Skin Neoplasm,0.6323,Skin Fibrohistiocytic Neoplasm,0.6280,Cellular Fibroma,0.6274,Desmoplastic Fibroblastoma,0.6240,Skin Mixed Tumor,0.6192,Skin Histiocytic Fibrous Histiocytoma,0.6189,Dermal Neoplasm,0.6178,FIBROBLAST_SKIN,True,True,True
FIBROLAMELLAR CARCINOMA,Fibrolamellar Carcinoma,1,2,Fibrolamellar Carcinoma,1.0000,Adult Fibrolamellar Carcinoma,0.9375,Advanced Fibrolamellar Carcinoma,0.9309,Childhood Fibrolamellar Carcinoma,0.9075,Metastatic Fibrolamellar Carcinoma,0.8923,Unresectable Fibrolamellar Carcinoma,0.8748,Refractory Fibrolamellar Carcinoma,0.8254,Recurrent Fibrolamellar Carcinoma,0.8150,Pilomatrical Carcinoma,0.6665,Hyalinizing Clear Cell Carcinoma,0.6603,Eyelid Carcinoma,0.6528,Adenoid Cystic Carcinoma,0.6520,Bartholin Gland Adenoid Cystic Carcinoma,0.6509,Adenocarcinofibroma,0.6491,Fibrofolliculoma,0.6467,Clear Cell Cystadenofibroma,0.6451,Trichofollicular Carcinoma,0.6446,Fibrolipoma,0.6425,Follicular Myxoma,0.6374,Lung Adenoid Cystic Carcinoma,0.6357,FIBROLAMELLAR CARCINOMA,True,True,True
FIBROLAMELLAR HEPATOCELLUAR CARCINOMA,Fibrolamellar Carcinoma,1,2,Fibrolamellar Carcinoma,0.8105,Adult Fibrolamellar Carcinoma,0.7990,Advanced Fibrolamellar Carcinoma,0.7904,Childhood Fibrolamellar Carcinoma,0.7762,Metastatic Fibrolamellar Carcinoma,0.7630,Unresectable Fibrolamellar Carcinoma,0.7558,Hepatocellular Pleomorphic Carcinoma,0.7076,Adult Hepatocellular Pleomorphic Carcinoma,0.7024,Hepatocellular Lymphocyte-Rich Carcinoma,0.6966,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.6943,Hepatocellular Clear Cell Carcinoma,0.6936,Hepatocellular Carcinoma,0.6926,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.6922,Refractory Fibrolamellar Carcinoma,0.6905,Hepatocellular Large Cell Change,0.6897,BCLC Stage C Adult Hepatocellular Carcinoma,0.6892,Adult Hepatocellular Carcinoma,0.6874,Hepatocellular Scirrhous Carcinoma,0.6851,Locally Advanced Hepatocellular Carcinoma,0.6851,Hepatocellular Poorly Differentiated Carcinoma,0.6785,FIBROLAMELLAR HEPATOCELLUAR CARCINOMA,True,True,True
FIBROMATOSIS,Fibromatosis,1,2,Fibromatosis,1.0000,Fibroma,0.9245,Superficial Fibromatosis,0.8970,Fascial Fibroma,0.8270,Myofibromatosis,0.8224,Cellular Fibroma,0.8206,Dermal Fibroma,0.8115,Desmoplastic Fibroma,0.8109,Fibromyxoid Tumor,0.8026,Desmoid Fibromatosis,0.8007,Myofibroma,0.7806,Myofibroblastoma,0.7644,Desmoplastic Fibroblastoma,0.7598,Jaw Desmoplastic Fibroma,0.7586,Locally Invasive Desmoid-Type Fibromatosis,0.7550,Cardiac Fibroma,0.7539,Fibrous Dysplasia,0.7482,Maxillofacial Desmoplastic Fibroma,0.7466,Palmar Fibromatosis,0.7440,Fibrosarcoma,0.7429,FIBROMATOSIS,True,True,True
FIBROSARCOMA,Fibrosarcoma,1,2,Fibrosarcoma,1.0000,Conventional Fibrosarcoma,0.9296,Advanced Fibrosarcoma,0.8842,Localized Fibrosarcoma,0.8800,Soft Tissue Fibrosarcoma,0.8708,Bone Fibrosarcoma,0.8623,Adult Fibrosarcoma,0.8598,Poorly Differentiated Fibrosarcoma,0.8438,Infantile Fibrosarcoma,0.8346,Kidney Fibrosarcoma,0.8341,Fascial Fibrosarcoma,0.8295,Well Differentiated Fibrosarcoma,0.8284,Metastatic Fibrosarcoma,0.8272,Cardiac Fibrosarcoma,0.8222,Unresectable Fibrosarcoma,0.8214,Locally Advanced Fibrosarcoma,0.8209,Childhood Fibrosarcoma,0.8176,Breast Fibrosarcoma,0.8120,Ovarian Fibrosarcoma,0.7967,Liver Fibrosarcoma,0.7951,FIBROSARCOMA,True,True,True
FIBROSARCOMA_CANCER,Fibrosarcoma,1,2,Fibrosarcoma,0.9320,Conventional Fibrosarcoma,0.8758,Advanced Fibrosarcoma,0.8186,Soft Tissue Fibrosarcoma,0.8090,Bone Fibrosarcoma,0.7938,Localized Fibrosarcoma,0.7875,Metastatic Fibrosarcoma,0.7836,Cardiac Fibrosarcoma,0.7817,Adult Fibrosarcoma,0.7811,Unresectable Fibrosarcoma,0.7792,Kidney Fibrosarcoma,0.7786,Infantile Fibrosarcoma,0.7669,Childhood Fibrosarcoma,0.7668,Fascial Fibrosarcoma,0.7658,Poorly Differentiated Fibrosarcoma,0.7589,Refractory Fibrosarcoma,0.7563,Fibrosarcoma NCI Grade 2,0.7549,Recurrent Fibrosarcoma,0.7485,Locally Advanced Fibrosarcoma,0.7442,Breast Fibrosarcoma,0.7435,FIBROSARCOMA_CANCER,True,True,True
FL,Follicular Lymphoma,1,2,Follicular Lymphoma,1.0000,Classic Follicular Lymphoma,0.9240,Splenic Follicular Lymphoma,0.8357,Advanced Follicular Lymphoma,0.8334,Cutaneous Follicular Lymphoma,0.8270,Thyroid Gland Follicular Lymphoma,0.8246,Pediatric-Type Follicular Lymphoma,0.8209,Intestinal Follicular Lymphoma,0.8170,Lacrimal Gland Follicular Lymphoma,0.8014,Testicular Follicular Lymphoma,0.7942,Grade 1 Follicular Lymphoma,0.7897,Conjunctival Follicular Lymphoma,0.7892,Breast Follicular Lymphoma,0.7866,Lung Follicular Lymphoma,0.7783,Prostate Follicular Lymphoma,0.7763,Salivary Gland Follicular Lymphoma,0.7733,Grade 3 Follicular Lymphoma,0.7730,Duodenal-Type Follicular Lymphoma,0.7695,Recurrent Follicular Lymphoma,0.7664,Grade 3a Follicular Lymphoma,0.7629,Follicular Lymphoma,True,True,True
FOCAL NEUROENDOCRINE COMPONENT,Neuroendocrine Neoplasm,2,2,Functioning Pituitary Neuroendocrine Tumor,0.7840,Neuroendocrine Neoplasm,0.7773,Neuroendocrine Tumor,0.7681,Functioning Pancreatic Neuroendocrine Tumor,0.7623,Functioning Lung Neuroendocrine Tumor,0.7441,Neuroendocrine Carcinoma,0.7290,Pituitary Neuroendocrine Tumor,0.7054,Functioning Pancreatic Neuroendocrine Tumor G2,0.7045,Functioning Endocrine Neoplasm,0.7033,Advanced Neuroendocrine Tumor,0.7026,Advanced Neuroendocrine Neoplasm,0.7015,Foregut Neuroendocrine Tumor,0.7005,Non-Functioning Pituitary Neuroendocrine Tumor,0.6988,Non-Functioning Pancreatic Neuroendocrine Tumor,0.6973,Non-Functioning Endocrine Neoplasm,0.6941,Null Cell Pituitary Neuroendocrine Tumor,0.6904,Adenocarcinoma with Neuroendocrine Differentiation,0.6868,Grade II Neuroendocrine Carcinoma,0.6843,Non-Functioning Corticotroph Pituitary Neuroendocrine Tumor,0.6832,Advanced Neuroendocrine Carcinoma,0.6830,FOCAL NEUROENDOCRINE COMPONENT,False,True,True
FOLLICULAR CARCINOMA,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.8780,Childhood Thyroid Gland Follicular Carcinoma,0.7670,Follicular Lymphoma,0.7604,Classic Follicular Lymphoma,0.7569,Thyroid Gland Papillary and Follicular Carcinoma,0.7447,Carcinoma,0.7358,Cutaneous Follicular Lymphoma,0.7336,Follicular Variant Thyroid Gland Papillary Carcinoma,0.7256,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0.7240,Thyroid Gland Carcinoma,0.7236,Skin Follicular Basal Cell Carcinoma,0.7117,Papillary Carcinoma,0.7058,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,0.7048,NUT Carcinoma,0.7004,Advanced Follicular Lymphoma,0.6976,Trichofollicular Carcinoma,0.6971,Thyroid Gland Follicular Lymphoma,0.6954,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,0.6950,Unresectable Thyroid Gland Follicular Carcinoma,0.6889,Metastatic Thyroid Gland Follicular Carcinoma,0.6887,FOLLICULAR CARCINOMA,True,True,True
FOLLICULAR DENDRITIC CELL SARCOMA,Follicular Dendritic Cell Sarcoma,1,2,Follicular Dendritic Cell Sarcoma,1.0000,Conventional Follicular Dendritic Cell Sarcoma,0.9692,Thyroid Gland Follicular Dendritic Cell Sarcoma,0.8758,Head and Neck Follicular Dendritic Cell Sarcoma,0.8587,Mediastinal Follicular Dendritic Cell Sarcoma,0.8503,Interdigitating Dendritic Cell Sarcoma,0.7190,Fibroblastic Reticular Cell Sarcoma,0.7130,Cutaneous Follicular Lymphoma,0.6952,Classic Follicular Lymphoma,0.6905,Follicular Lymphoma,0.6779,Fibrous Synovial Sarcoma,0.6491,Langerhans Cell Sarcoma,0.6416,Skin Sarcoma,0.6356,Myeloid Sarcoma,0.6341,Pleomorphic Dermal Sarcoma,0.6319,Grade 2 Diffuse Follicular Lymphoma,0.6313,Sarcoma,0.6307,Grade 1 Diffuse Follicular Lymphoma,0.6296,Myxoinflammatory Fibroblastic Sarcoma,0.6296,Classic Dermatofibrosarcoma Protuberans,0.6290,FOLLICULAR DENDRITIC CELL SARCOMA,True,True,True
FOLLICULAR LYMPHOMA,Follicular Lymphoma,1,2,Follicular Lymphoma,1.0000,Classic Follicular Lymphoma,0.9240,Splenic Follicular Lymphoma,0.8357,Advanced Follicular Lymphoma,0.8334,Cutaneous Follicular Lymphoma,0.8270,Thyroid Gland Follicular Lymphoma,0.8246,Pediatric-Type Follicular Lymphoma,0.8209,Intestinal Follicular Lymphoma,0.8170,Lacrimal Gland Follicular Lymphoma,0.8014,Testicular Follicular Lymphoma,0.7942,Grade 1 Follicular Lymphoma,0.7897,Conjunctival Follicular Lymphoma,0.7892,Breast Follicular Lymphoma,0.7866,Lung Follicular Lymphoma,0.7783,Prostate Follicular Lymphoma,0.7763,Salivary Gland Follicular Lymphoma,0.7733,Grade 3 Follicular Lymphoma,0.7730,Duodenal-Type Follicular Lymphoma,0.7695,Recurrent Follicular Lymphoma,0.7664,Grade 3a Follicular Lymphoma,0.7629,FOLLICULAR LYMPHOMA,True,True,True
FOLLICULAR THYROID CANCER,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.9538,Childhood Thyroid Gland Follicular Carcinoma,0.8528,Thyroid Gland Follicular Lymphoma,0.8272,Thyroid Gland Papillary and Follicular Carcinoma,0.8149,Metastatic Thyroid Gland Follicular Carcinoma,0.7975,Thyroid Gland Follicular Adenoma,0.7879,Follicular Variant Thyroid Gland Papillary Carcinoma,0.7878,"Thyroid Gland Follicular Carcinoma, Minimally Invasive",0.7872,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0.7767,Thyroid Gland Carcinoma,0.7738,Refractory Thyroid Gland Follicular Carcinoma,0.7716,Thyroid Gland Mixed Medullary and Follicular Carcinoma,0.7714,"Thyroid Gland Follicular Carcinoma, Clear Cell Variant",0.7642,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,0.7603,Unresectable Thyroid Gland Follicular Carcinoma,0.7586,Thyroid Gland Clear Cell Follicular Adenoma,0.7543,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,0.7514,Differentiated Thyroid Gland Carcinoma,0.7493,Thyroid Gland Anaplastic Carcinoma,0.7451,Recurrent Thyroid Gland Follicular Carcinoma,0.7450,FOLLICULAR THYROID CANCER,True,True,True
FOLLICULAR THYROID CARCINOMA,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.9700,Childhood Thyroid Gland Follicular Carcinoma,0.8523,Thyroid Gland Papillary and Follicular Carcinoma,0.8361,Follicular Variant Thyroid Gland Papillary Carcinoma,0.8219,"Thyroid Gland Follicular Carcinoma, Minimally Invasive",0.8057,Metastatic Thyroid Gland Follicular Carcinoma,0.7991,Thyroid Gland Follicular Lymphoma,0.7969,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0.7954,"Thyroid Gland Follicular Carcinoma, Clear Cell Variant",0.7938,Thyroid Gland Mixed Medullary and Follicular Carcinoma,0.7855,Thyroid Gland Carcinoma,0.7771,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,0.7705,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,0.7692,Thyroid Gland Follicular Adenoma,0.7680,Unresectable Thyroid Gland Follicular Carcinoma,0.7676,Refractory Thyroid Gland Follicular Carcinoma,0.7652,Thyroid Gland Anaplastic Carcinoma,0.7559,High Grade Follicular Cell-Derived Non-Anaplastic Thyroid Gland Carcinoma,0.7552,Thyroid Gland Clear Cell Follicular Adenoma,0.7507,Differentiated Thyroid Gland Carcinoma,0.7496,FOLLICULAR THYROID CARCINOMA,True,True,True
"FOLLICULAR, PAPILLARY",Thyroid Gland Papillary and Follicular Carcinoma,99,2,Papillary Neoplasm,0.7224,Papillary Adenoma,0.7050,Thyroid Gland Follicular Adenoma with Papillary Architecture,0.6905,Papillary Adenofibroma,0.6885,Papillary Epithelial Neoplasm,0.6715,Papillary Adenocarcinoma,0.6659,Papillary Carcinoma,0.6657,Parotid Gland Follicular Lymphoma,0.6639,Follicular Myxoma,0.6637,Prostate Follicular Lymphoma,0.6576,Papillary Meningioma,0.6532,Papillary Cystic Neoplasm,0.6530,Follicular Lymphoma,0.6444,Thyroid Gland Follicular Lymphoma,0.6406,Breast Papillary Neoplasm,0.6360,Ovarian Papillary Tumor,0.6340,Papillary Cystadenoma,0.6319,Classic Follicular Lymphoma,0.6302,Thyroid Gland Follicular Adenoma,0.6266,Glandular Papilloma,0.6250,"FOLLICULAR, PAPILLARY",False,False,False
FOLLICULAR_CARCINOMA,Thyroid Gland Follicular Carcinoma,1,2,Thyroid Gland Follicular Carcinoma,0.8427,Thyroid Gland Papillary and Follicular Carcinoma,0.7455,Childhood Thyroid Gland Follicular Carcinoma,0.7320,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,0.7300,Follicular Lymphoma,0.7234,Carcinoma,0.7232,Classic Follicular Lymphoma,0.7196,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0.7178,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,0.7102,Thyroid Gland Carcinoma,0.7051,Cutaneous Follicular Lymphoma,0.7042,Follicular Variant Thyroid Gland Papillary Carcinoma,0.6936,Metastatic Thyroid Gland Follicular Carcinoma,0.6761,Trichofollicular Carcinoma,0.6727,Advanced Follicular Lymphoma,0.6727,Thyroid Gland Follicular Lymphoma,0.6725,Refractory Thyroid Gland Follicular Carcinoma,0.6713,NUT Carcinoma,0.6693,Skin Follicular Basal Cell Carcinoma,0.6670,Unresectable Thyroid Gland Follicular Carcinoma,0.6647,FOLLICULAR_CARCINOMA,True,True,True
FUSION+ RMS,Fusion-Positive Rhabdomyosarcoma,1,2,Fusion-Positive Rhabdomyosarcoma,0.8571,Fusion-Positive Alveolar Rhabdomyosarcoma,0.8062,Fusion-Negative Rhabdomyosarcoma,0.7995,Fusion-Negative Alveolar Rhabdomyosarcoma,0.7438,CIC-Rearranged Sarcoma,0.6422,Rhabdomyosarcoma with TFCP2 Rearrangement,0.6332,Refractory Rhabdomyosarcoma,0.6278,Intraosseous Spindle Cell Rhabdomyosarcoma with TFCP2/NCOA2 Rearrangements,0.6276,Rhabdomyosarcoma,0.6234,Fetal Rhabdomyoma,0.6228,Round Cell Sarcoma with FUS-NFATC2 Gene Fusion,0.6199,Round Cell Sarcoma with EWSR1-PATZ1 Gene Fusion,0.6178,Childhood CIC-Rearranged Sarcoma,0.6172,Refractory Sarcoma,0.6171,Refractory Solitary Fibrous Tumor,0.6142,Rhabdomyoma,0.6123,Refractory Alveolar Rhabdomyosarcoma,0.6120,Reticulosarcoma,0.6096,Maxillofacial Rhabdomyosarcoma with TFCP2 Rearrangement,0.6086,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.6052,FUSION+ RMS,True,True,True
FUSION- RMS,Fusion-Negative Rhabdomyosarcoma,2,2,Fusion-Positive Rhabdomyosarcoma,0.8590,Fusion-Negative Rhabdomyosarcoma,0.8293,Fusion-Positive Alveolar Rhabdomyosarcoma,0.8292,Fusion-Negative Alveolar Rhabdomyosarcoma,0.7954,Rhabdomyosarcoma,0.6698,Alveolar Rhabdomyosarcoma,0.6644,CIC-Rearranged Sarcoma,0.6538,Refractory Alveolar Rhabdomyosarcoma,0.6514,Refractory Rhabdomyosarcoma,0.6511,Conventional Alveolar Rhabdomyosarcoma,0.6414,Intraosseous Spindle Cell Rhabdomyosarcoma with TFCP2/NCOA2 Rearrangements,0.6398,Rhabdomyoma,0.6371,Refractory Sarcoma,0.6309,Pleomorphic Rhabdomyosarcoma,0.6291,Childhood CIC-Rearranged Sarcoma,0.6256,Retroperitoneal Rhabdomyosarcoma,0.6247,Round Cell Sarcoma with FUS-NFATC2 Gene Fusion,0.6233,Round Cell Sarcoma with EWSR1-PATZ1 Gene Fusion,0.6232,Anaplastic Embryonal Rhabdomyosarcoma,0.6216,Fetal Rhabdomyoma,0.6186,FUSION- RMS,False,True,True
GALLBLADDER ADENOCARCINOMA,Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,1.0000,Gallbladder Carcinoma,0.9251,"Gallbladder Adenocarcinoma, Biliary Type",0.9026,"Gallbladder Adenocarcinoma, Intestinal-Type",0.8741,Gallbladder Goblet Cell Adenocarcinoma,0.8728,Gallbladder Adenoma,0.8660,Gallbladder Mucinous Adenocarcinoma,0.8646,Gallbladder Clear Cell Adenocarcinoma,0.8563,Malignant Gallbladder Neoplasm,0.8477,Gallbladder Hepatoid Adenocarcinoma,0.8422,Advanced Gallbladder Carcinoma,0.8381,Gallbladder Adenocarcinoma with Squamous Metaplasia,0.8299,Gallbladder Neoplasm,0.8264,Unresectable Gallbladder Adenocarcinoma,0.8159,Incidental Gallbladder Carcinoma,0.8086,Bile Duct Adenocarcinoma,0.8027,Gallbladder Lymphoma,0.7992,Gallbladder Melanoma,0.7970,Gallbladder Undifferentiated Carcinoma,0.7957,Bladder Adenocarcinoma,0.7858,GALLBLADDER ADENOCARCINOMA,True,True,True
"GALLBLADDER ADENOCARCINOMA, NOS",Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,0.9480,"Gallbladder Adenocarcinoma, Biliary Type",0.9069,Gallbladder Carcinoma,0.8910,"Gallbladder Adenocarcinoma, Intestinal-Type",0.8870,Gallbladder Goblet Cell Adenocarcinoma,0.8390,Malignant Gallbladder Neoplasm,0.8370,Gallbladder Clear Cell Adenocarcinoma,0.8290,Gallbladder Hepatoid Adenocarcinoma,0.8287,Gallbladder Mucinous Adenocarcinoma,0.8259,Gallbladder Adenocarcinoma with Squamous Metaplasia,0.8168,Gallbladder Adenoma,0.8112,Advanced Gallbladder Carcinoma,0.7910,Gallbladder Neoplasm,0.7881,"Gallbladder Adenoma, Intestinal-Type",0.7721,Bile Duct Adenocarcinoma,0.7692,Gallbladder Squamous Cell Carcinoma,0.7576,Unresectable Gallbladder Adenocarcinoma,0.7569,Gallbladder Undifferentiated Carcinoma,0.7568,Gallbladder Melanoma,0.7480,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",0.7478,"GALLBLADDER ADENOCARCINOMA, NOS",True,True,True
GALLBLADDER ADENOSQUAMOUS CARCINOMA,Gallbladder Adenosquamous Carcinoma,1,2,Gallbladder Adenosquamous Carcinoma,1.0000,Gallbladder Squamous Cell Carcinoma,0.8499,Gallbladder Adenocarcinoma with Squamous Metaplasia,0.8361,Gallbladder Goblet Cell Adenocarcinoma,0.8052,Gastric Adenosquamous Carcinoma,0.8031,Gallbladder Mucinous Adenocarcinoma,0.7957,Gallbladder Sarcomatoid Carcinoma,0.7873,Gallbladder Clear Cell Adenocarcinoma,0.7830,Gallbladder Undifferentiated Carcinoma,0.7707,Gallbladder Adenocarcinoma,0.7669,Gallbladder Hepatoid Adenocarcinoma,0.7584,Conjunctival Adenosquamous Carcinoma,0.7571,Colon Adenosquamous Carcinoma,0.7569,Breast Adenosquamous Carcinoma,0.7564,Gallbladder Mixed Adenoneuroendocrine Carcinoma,0.7521,Gallbladder Carcinoma,0.7516,Liver Adenosquamous Carcinoma,0.7501,Bartholin Gland Adenosquamous Carcinoma,0.7497,Adenosquamous Carcinoma,0.7496,Extrahepatic Bile Duct Adenosquamous Carcinoma,0.7487,GALLBLADDER ADENOSQUAMOUS CARCINOMA,True,True,True
GALLBLADDER CANCER,Gallbladder Carcinoma,1,2,Gallbladder Carcinoma,0.9672,Gallbladder Adenocarcinoma,0.9295,Gallbladder Neoplasm,0.8851,Malignant Gallbladder Neoplasm,0.8710,"Gallbladder Adenocarcinoma, Biliary Type",0.8485,Advanced Gallbladder Carcinoma,0.8318,Gallbladder Adenoma,0.8282,Gallbladder Lymphoma,0.8250,Incidental Gallbladder Carcinoma,0.8184,Localized Gallbladder Carcinoma,0.8184,Gallbladder Clear Cell Adenocarcinoma,0.8106,"Gallbladder Adenocarcinoma, Intestinal-Type",0.8099,Gallbladder Goblet Cell Adenocarcinoma,0.8023,Gallbladder Undifferentiated Carcinoma,0.8019,Gallbladder Neuroendocrine Carcinoma,0.8011,Localized Malignant Gallbladder Neoplasm,0.7975,Gallbladder Melanoma,0.7885,Metastatic Gallbladder Carcinoma,0.7873,Gallbladder Mucinous Adenocarcinoma,0.7861,Gallbladder Hepatoid Adenocarcinoma,0.7846,GALLBLADDER CANCER,True,True,True
GALLBLADDER CARCINOMA,Gallbladder Carcinoma,1,2,Gallbladder Carcinoma,1.0000,Gallbladder Adenocarcinoma,0.9251,Advanced Gallbladder Carcinoma,0.8633,"Gallbladder Adenocarcinoma, Biliary Type",0.8586,Malignant Gallbladder Neoplasm,0.8491,Localized Gallbladder Carcinoma,0.8420,Gallbladder Neoplasm,0.8408,Gallbladder Undifferentiated Carcinoma,0.8284,Gallbladder Clear Cell Adenocarcinoma,0.8281,Gallbladder Neuroendocrine Carcinoma,0.8280,Gallbladder Goblet Cell Adenocarcinoma,0.8170,Gallbladder Squamous Cell Carcinoma,0.8160,"Gallbladder Adenocarcinoma, Intestinal-Type",0.8147,Incidental Gallbladder Carcinoma,0.8134,Metastatic Gallbladder Carcinoma,0.8066,Gallbladder Adenoma,0.8054,Locally Advanced Gallbladder Carcinoma,0.8047,Gallbladder Mucinous Adenocarcinoma,0.7996,Gallbladder Lymphoma,0.7970,Gallbladder Hepatoid Adenocarcinoma,0.7906,GALLBLADDER CARCINOMA,True,True,True
GALLBLADDER CARCINOMA OTHER,Gallbladder Carcinoma,1,2,Gallbladder Carcinoma,0.8463,Incidental Gallbladder Carcinoma,0.7925,Gallbladder Neoplasm,0.7850,Gallbladder Adenocarcinoma,0.7808,Gallbladder Undifferentiated Carcinoma,0.7614,Gallbladder Neuroendocrine Carcinoma,0.7589,Advanced Gallbladder Carcinoma,0.7583,Unresectable Gallbladder Carcinoma,0.7572,Localized Gallbladder Carcinoma,0.7486,Metastatic Gallbladder Carcinoma,0.7475,Gallbladder Lymphoma,0.7333,"Gallbladder Adenocarcinoma, Biliary Type",0.7322,Unresectable Gallbladder Adenocarcinoma,0.7313,Malignant Gallbladder Neoplasm,0.7230,Gallbladder Neuroendocrine Neoplasm,0.7202,Gallbladder Clear Cell Adenocarcinoma,0.7126,Locally Advanced Gallbladder Carcinoma,0.7118,Gallbladder Large Cell Neuroendocrine Carcinoma,0.7068,Gallbladder Neuroendocrine Tumor,0.7064,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0.7056,GALLBLADDER CARCINOMA OTHER,True,True,True
GALLBLADDER NEUROENDOCRINE TUMOR,Gallbladder Neuroendocrine Tumor,1,2,Gallbladder Neuroendocrine Tumor,1.0000,Gallbladder Neuroendocrine Neoplasm,0.9770,Gallbladder Neuroendocrine Carcinoma,0.9012,Gallbladder Neuroendocrine Tumor G1,0.8867,Gallbladder Neuroendocrine Tumor G2,0.8690,Gallbladder Neuroendocrine Tumor G3,0.8505,Gallbladder Small Cell Neuroendocrine Carcinoma,0.8306,Gallbladder Large Cell Neuroendocrine Carcinoma,0.8278,Gallbladder Tubular Carcinoid,0.8254,Gastric Neuroendocrine Tumor,0.8117,Benign Gallbladder Granular Cell Tumor,0.7930,Gastrin-Producing Neuroendocrine Tumor,0.7922,Bladder Neuroendocrine Tumor,0.7885,Gastric Gastrin-Producing Neuroendocrine Tumor,0.7875,Gallbladder Neoplasm,0.7849,Gallbladder Carcinosarcoma,0.7798,Gastric Neuroendocrine Neoplasm,0.7770,Gallbladder Adenoma,0.7753,Gallbladder Lymphoma,0.7718,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0.7711,GALLBLADDER NEUROENDOCRINE TUMOR,True,True,True
GALLBLADDER_ADENOCARCINOMA,Gallbladder Adenocarcinoma,1,2,Gallbladder Adenocarcinoma,0.9630,"Gallbladder Adenocarcinoma, Biliary Type",0.8904,Gallbladder Carcinoma,0.8788,"Gallbladder Adenocarcinoma, Intestinal-Type",0.8738,Gallbladder Goblet Cell Adenocarcinoma,0.8680,Gallbladder Mucinous Adenocarcinoma,0.8540,Gallbladder Adenoma,0.8418,Gallbladder Adenocarcinoma with Squamous Metaplasia,0.8342,Malignant Gallbladder Neoplasm,0.8323,Gallbladder Hepatoid Adenocarcinoma,0.8235,Gallbladder Clear Cell Adenocarcinoma,0.8232,Advanced Gallbladder Carcinoma,0.8069,Gallbladder Neoplasm,0.8041,Unresectable Gallbladder Adenocarcinoma,0.8010,"Gallbladder Adenoma, Intestinal-Type",0.7899,Gallbladder Undifferentiated Carcinoma,0.7776,Bile Duct Adenocarcinoma,0.7770,Incidental Gallbladder Carcinoma,0.7745,Gallbladder Melanoma,0.7682,Resectable Gallbladder Adenocarcinoma,0.7677,GALLBLADDER_ADENOCARCINOMA,True,True,True
GANGLIOGLIOMA,Ganglioglioma,1,2,Ganglioglioma,1.0000,Adult Ganglioglioma,0.9110,Childhood Ganglioglioma,0.9047,Gangliocytoma,0.8999,Anaplastic Ganglioglioma,0.8744,Hypothalamic Gangliocytoma,0.7769,Ganglioneuroma,0.7456,Sellar Gangliocytoma,0.7425,Recurrent Gangliocytoma,0.7382,Desmoplastic Infantile Ganglioglioma,0.7366,Dysplastic Cerebellar Gangliocytoma,0.7339,Childhood Ganglioneuroma,0.7309,Glioma,0.7249,Adult Ganglioneuroma,0.7224,Mature Ganglioneuroma,0.7193,Maturing Ganglioneuroma,0.7156,Neural Glioblastoma,0.7156,Ganglioneuromatosis,0.7088,Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor,0.7043,Gliomatosis Cerebri,0.7020,GANGLIOGLIOMA,True,True,True
GANGLIONEUROBLASTOMA,Ganglioneuroblastoma,1,2,Ganglioneuroblastoma,1.0000,Peripheral Ganglioneuroblastoma,0.9174,"Ganglioneuroblastoma, Nodular",0.9004,Central Nervous System Ganglioneuroblastoma,0.8868,Childhood Ganglioneuroblastoma,0.8570,Adrenal Gland Ganglioneuroblastoma,0.8340,Recurrent Ganglioneuroblastoma,0.8331,"Ganglioneuroblastoma, Intermixed",0.8318,Mediastinal Ganglioneuroblastoma,0.8217,Childhood Brain Ganglioneuroblastoma,0.8210,Ganglioneuroma,0.8131,Refractory Ganglioneuroblastoma,0.8041,Childhood Central Nervous System Ganglioneuroblastoma,0.7958,Mature Ganglioneuroma,0.7921,"Childhood Ganglioneuroblastoma, Nodular",0.7752,Adult Ganglioneuroma,0.7731,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",0.7642,Ganglioneuromatosis,0.7574,"Childhood Ganglioneuroblastoma, Intermixed",0.7551,"Adrenal Gland Ganglioneuroblastoma, Nodular",0.7423,GANGLIONEUROBLASTOMA,True,True,True
"GANGLIONEUROBLASTOMA, INTERMIXED","Ganglioneuroblastoma, Intermixed",1,2,"Ganglioneuroblastoma, Intermixed",1.0000,"Childhood Ganglioneuroblastoma, Intermixed",0.8973,"Adrenal Gland Ganglioneuroblastoma, Intermixed",0.8590,Ganglioneuroblastoma,0.8318,"Ganglioneuroblastoma, Nodular",0.8013,Peripheral Ganglioneuroblastoma,0.7829,Recurrent Ganglioneuroblastoma,0.7652,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",0.7579,Central Nervous System Ganglioneuroblastoma,0.7578,Childhood Ganglioneuroblastoma,0.7464,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",0.7407,Childhood Brain Ganglioneuroblastoma,0.7209,Mediastinal Ganglioneuroblastoma,0.7147,Adrenal Gland Ganglioneuroblastoma,0.7125,Refractory Ganglioneuroblastoma,0.7118,Mature Ganglioneuroma,0.7072,"Childhood Ganglioneuroblastoma, Nodular",0.7044,Ganglioneuroma,0.7000,Myxoid Glioneuronal Tumor,0.6957,Childhood Central Nervous System Ganglioneuroblastoma,0.6956,"GANGLIONEUROBLASTOMA, INTERMIXED",True,True,True
"GANGLIONEUROBLASTOMA, NODULAR","Ganglioneuroblastoma, Nodular",1,2,"Ganglioneuroblastoma, Nodular",1.0000,Ganglioneuroblastoma,0.9004,"Childhood Ganglioneuroblastoma, Nodular",0.8958,Peripheral Ganglioneuroblastoma,0.8820,Childhood Ganglioneuroblastoma,0.8521,"Adrenal Gland Ganglioneuroblastoma, Nodular",0.8379,Central Nervous System Ganglioneuroblastoma,0.8346,Recurrent Ganglioneuroblastoma,0.8331,Mature Ganglioneuroma,0.8042,Childhood Brain Ganglioneuroblastoma,0.8042,Adrenal Gland Ganglioneuroblastoma,0.8016,"Ganglioneuroblastoma, Intermixed",0.8013,Childhood Central Nervous System Ganglioneuroblastoma,0.7938,Ganglioneuroma,0.7923,Adult Ganglioneuroma,0.7914,Mediastinal Ganglioneuroblastoma,0.7849,"Childhood Ganglioneuroblastoma, Intermixed",0.7742,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",0.7731,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",0.7720,Refractory Ganglioneuroblastoma,0.7605,"GANGLIONEUROBLASTOMA, NODULAR",True,True,True
GANGLIONEUROMA,Ganglioneuroma,1,2,Ganglioneuroma,1.0000,Mature Ganglioneuroma,0.9226,Ganglioneuromatosis,0.9199,Adult Ganglioneuroma,0.9199,Skin Ganglioneuroma,0.9045,Childhood Ganglioneuroma,0.8961,Maturing Ganglioneuroma,0.8921,Adrenal Gland Ganglioneuroma,0.8612,Colon Ganglioneuroma,0.8588,Choroidal Ganglioneuroma,0.8507,Colorectal Ganglioneuroma,0.8300,Mediastinal Ganglioneuroma,0.8192,Ganglioneuroblastoma,0.8131,"Ganglioneuroblastoma, Nodular",0.7923,Retroperitoneal Ganglioneuroma,0.7906,Childhood Ganglioneuroblastoma,0.7635,Peripheral Ganglioneuroblastoma,0.7539,Ganglioglioma,0.7456,Central Nervous System Ganglioneuroblastoma,0.7404,Adrenal Gland Ganglioneuroblastoma,0.7393,GANGLIONEUROMA,True,True,True
GASTRIC ADENOCARCINOMA,Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,1.0000,Gastric Carcinoma,0.9040,Advanced Gastric Adenocarcinoma,0.8573,Sporadic Gastric Adenocarcinoma,0.8499,Gastric Diffuse Adenocarcinoma,0.8487,Gastric Tubular Adenocarcinoma,0.8475,Proximal Gastric Adenocarcinoma,0.8401,Gastric Cardia Adenocarcinoma,0.8355,Gastric Intestinal-Type Adenocarcinoma,0.8354,Gastric Adenoma,0.8164,Malignant Gastric Neoplasm,0.8086,Gastric Mucinous Adenocarcinoma,0.8074,Adenocarcinoma,0.8045,Advanced Gastric Carcinoma,0.8038,Gastric Papillary Adenocarcinoma,0.8035,Gastroesophageal Junction Adenocarcinoma,0.8030,Gastric Intramucosal Adenocarcinoma,0.8017,Metastatic Gastric Adenocarcinoma,0.7963,Localized Gastric Adenocarcinoma,0.7824,Gallbladder Adenocarcinoma,0.7790,GASTRIC ADENOCARCINOMA,True,True,True
GASTRIC CANCER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.9643,Gastric Neoplasm,0.8791,Gastric Adenocarcinoma,0.8745,Malignant Gastric Neoplasm,0.8621,Early Gastric Cancer,0.8147,Childhood Gastric Carcinoma,0.7935,Advanced Gastric Carcinoma,0.7906,Sporadic Gastric Adenocarcinoma,0.7772,Gastroesophageal Cancer,0.7738,Gastric Lymphoma,0.7702,Gastric Body Carcinoma,0.7693,Gastric Adenoma,0.7657,Digestive System Carcinoma,0.7620,Localized Gastric Carcinoma,0.7513,Advanced Gastric Adenocarcinoma,0.7500,Gastric Undifferentiated Carcinoma,0.7439,Gastric Melanoma,0.7418,Proximal Gastric Adenocarcinoma,0.7413,Gastric Neuroendocrine Carcinoma,0.7353,Metastatic Gastric Carcinoma,0.7315,GASTRIC CANCER,True,True,True
GASTRIC CARCINOMA OTHER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.8358,Gastric Neoplasm,0.7572,Gastric Adenocarcinoma,0.7527,Gastric Undifferentiated Carcinoma,0.7523,Childhood Gastric Carcinoma,0.7418,Gastric Neuroendocrine Carcinoma,0.7381,Metastatic Gastric Carcinoma,0.7346,Advanced Gastric Carcinoma,0.7224,Early Gastric Cancer,0.7180,Unresectable Gastric Carcinoma,0.7155,Sporadic Gastric Adenocarcinoma,0.7116,Malignant Gastric Neoplasm,0.7111,Gastric Lymphoma,0.7022,Localized Gastric Carcinoma,0.6988,Advanced Gastric Neuroendocrine Carcinoma,0.6934,Gastric Body Carcinoma,0.6868,Gastroesophageal Cancer,0.6842,Gastric Neuroendocrine Neoplasm,0.6811,Unresectable Gastric Adenocarcinoma,0.6776,Gastrointestinal Carcinomatosis,0.6753,GASTRIC CARCINOMA OTHER,True,True,True
GASTRIC NEUROENDOCRINE TUMOR,Gastric Neuroendocrine Tumor,1,2,Gastric Neuroendocrine Tumor,1.0000,Gastric Neuroendocrine Neoplasm,0.9697,Gastric Gastrin-Producing Neuroendocrine Tumor,0.8990,Gastric Neuroendocrine Tumor G1,0.8812,Gastric Neuroendocrine Carcinoma,0.8732,Digestive System Neuroendocrine Tumor,0.8654,Gastric Neuroendocrine Tumor G2,0.8589,Gastrin-Producing Neuroendocrine Tumor,0.8456,Digestive System Neuroendocrine Neoplasm,0.8357,Gastric Neuroendocrine Tumor G3,0.8233,Gallbladder Neuroendocrine Tumor,0.8117,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0.8074,Neuroendocrine Tumor,0.8051,Neuroendocrine Tumor G2,0.8047,Digestive System Neuroendocrine Tumor G1,0.8046,Digestive System Neuroendocrine Tumor G2,0.8041,Gastric Granular Cell Tumor,0.7950,Intestinal Neuroendocrine Tumor G2,0.7896,Foregut Neuroendocrine Tumor,0.7888,Advanced Digestive System Neuroendocrine Tumor,0.7884,GASTRIC NEUROENDOCRINE TUMOR,True,True,True
GASTRIC_ADENOCARCINOMA,Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,0.9631,Gastric Carcinoma,0.8728,Gastric Intestinal-Type Adenocarcinoma,0.8295,Advanced Gastric Adenocarcinoma,0.8272,Gastric Diffuse Adenocarcinoma,0.8235,Sporadic Gastric Adenocarcinoma,0.8117,Malignant Gastric Neoplasm,0.8033,Gastric Tubular Adenocarcinoma,0.8006,Proximal Gastric Adenocarcinoma,0.7973,Gastric Cardia Adenocarcinoma,0.7910,Adenocarcinoma,0.7842,Gastric Adenoma,0.7838,Gastric Mucinous Adenocarcinoma,0.7809,Gastric Intramucosal Adenocarcinoma,0.7777,Metastatic Gastric Adenocarcinoma,0.7757,Advanced Gastric Carcinoma,0.7751,Gastroesophageal Junction Adenocarcinoma,0.7723,Gastric Papillary Adenocarcinoma,0.7625,Gastric Parietal Cell Adenocarcinoma,0.7621,"Gastric Adenoma, Gastric-Type",0.7604,GASTRIC_ADENOCARCINOMA,True,True,True
GASTRIC_CANCER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.8968,Gastric Neoplasm,0.8459,Malignant Gastric Neoplasm,0.8186,Gastric Adenocarcinoma,0.7989,Early Gastric Cancer,0.7579,Gastroesophageal Cancer,0.7442,Childhood Gastric Carcinoma,0.7420,Digestive System Carcinoma,0.7417,Gastric Lymphoma,0.7359,Advanced Gastric Carcinoma,0.7272,Gastric Undifferentiated Carcinoma,0.7263,Gastric Neuroendocrine Carcinoma,0.7185,Gastric Melanoma,0.7162,Gastrointestinal Carcinomatosis,0.7125,Sporadic Gastric Adenocarcinoma,0.7119,Gastric Body Carcinoma,0.7050,Gastric Adenoma,0.6978,Metastatic Gastric Carcinoma,0.6942,Gastric Cancer by AJCC v8 Clinical Stage,0.6925,Gastric Neuroendocrine Neoplasm,0.6886,GASTRIC_CANCER,True,True,True
GASTRIC_SMALL_CELL,Gastric Small Cell Neuroendocrine Carcinoma,1,2,Gastric Small Cell Neuroendocrine Carcinoma,0.8054,Advanced Gastric Small Cell Neuroendocrine Carcinoma,0.7246,Gastric Undifferentiated Carcinoma,0.7217,Gastric Neuroendocrine Carcinoma,0.7018,Gastric Squamous Cell Carcinoma,0.6939,"Malignant Tumor, Small Cell Type",0.6924,Small Cell Adenocarcinoma,0.6915,Early Gastric Cancer,0.6913,Gastric Carcinoma,0.6863,Gastric Granular Cell Tumor,0.6828,Digestive System Small Cell Neuroendocrine Carcinoma,0.6809,Gastric Signet Ring Cell Adenocarcinoma,0.6787,Gastric Large Cell Neuroendocrine Carcinoma,0.6720,Malignant Gastric Granular Cell Tumor,0.6642,Small Cell Neuroendocrine Carcinoma,0.6640,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,0.6605,Gastric Poorly Cohesive Adenocarcinoma,0.6591,Gastric Melanoma,0.6573,Benign Gastric Granular Cell Tumor,0.6566,Localized Gastric Carcinoma,0.6519,GASTRIC_SMALL_CELL,True,True,True
GASTROINTESTINAL NEUROENDOCRINE,Digestive System Neuroendocrine Tumor,4,2,Digestive System Neuroendocrine Neoplasm,0.8449,Gastric Neuroendocrine Neoplasm,0.8428,Gastric Neuroendocrine Tumor,0.8276,Digestive System Neuroendocrine Tumor,0.8244,Intestinal Neuroendocrine Neoplasm,0.8217,Intestinal Neuroendocrine Tumor,0.8085,Midgut Neuroendocrine Tumor,0.7855,Neuroendocrine Neoplasm,0.7846,Intestinal Neuroendocrine Tumor G3,0.7756,Digestive System Neuroendocrine Carcinoma,0.7740,Intestinal Neuroendocrine Tumor G2,0.7693,Neuroendocrine Tumor,0.7685,Intestinal Neuroendocrine Tumor G1,0.7667,Gastric Neuroendocrine Carcinoma,0.7638,Advanced Digestive System Neuroendocrine Neoplasm,0.7631,Midgut Neuroendocrine Tumor G3,0.7605,Colorectal Neuroendocrine Neoplasm,0.7601,Digestive System Neuroendocrine Tumor G1,0.7558,Digestive System Neuroendocrine Tumor G3,0.7530,Midgut Neuroendocrine Tumor G2,0.7528,GASTROINTESTINAL NEUROENDOCRINE,False,False,True
GASTROINTESTINAL NEUROENDOCRINE TUMOR,Digestive System Neuroendocrine Tumor,1,2,Digestive System Neuroendocrine Tumor,0.9243,Gastric Neuroendocrine Tumor,0.9183,Intestinal Neuroendocrine Tumor,0.8954,Digestive System Neuroendocrine Neoplasm,0.8893,Gastric Neuroendocrine Neoplasm,0.8829,Midgut Neuroendocrine Tumor,0.8745,Intestinal Neuroendocrine Neoplasm,0.8606,Neuroendocrine Tumor,0.8460,Colorectal Neuroendocrine Tumor,0.8443,Childhood Digestive System Neuroendocrine Tumor,0.8348,Hindgut Neuroendocrine Tumor,0.8343,Intestinal Neuroendocrine Tumor G1,0.8264,Advanced Digestive System Neuroendocrine Tumor,0.8261,Gastric Gastrin-Producing Neuroendocrine Tumor,0.8236,Ileal Neuroendocrine Tumor,0.8204,Intestinal Neuroendocrine Tumor G2,0.8184,Digestive System Neuroendocrine Tumor G1,0.8170,Jejunal Neuroendocrine Tumor,0.8147,Foregut Neuroendocrine Tumor,0.8139,Neuroendocrine Neoplasm,0.8134,GASTROINTESTINAL NEUROENDOCRINE TUMOR,True,True,True
GASTROINTESTINAL NEUROENDOCRINE TUMORS,Digestive System Neuroendocrine Tumor,1,2,Digestive System Neuroendocrine Tumor,0.9165,Gastric Neuroendocrine Tumor,0.9060,Intestinal Neuroendocrine Tumor,0.8892,Digestive System Neuroendocrine Neoplasm,0.8863,Gastric Neuroendocrine Neoplasm,0.8766,Midgut Neuroendocrine Tumor,0.8601,Intestinal Neuroendocrine Neoplasm,0.8600,Neuroendocrine Tumor,0.8392,Colorectal Neuroendocrine Tumor,0.8359,Childhood Digestive System Neuroendocrine Tumor,0.8235,Hindgut Neuroendocrine Tumor,0.8224,Advanced Digestive System Neuroendocrine Tumor,0.8190,Gastric Gastrin-Producing Neuroendocrine Tumor,0.8135,Neuroendocrine Neoplasm,0.8114,Intestinal Neuroendocrine Tumor G1,0.8106,Ileal Neuroendocrine Tumor,0.8101,Pancreatic Neuroendocrine Tumor,0.8062,Gastrin-Producing Neuroendocrine Tumor,0.8056,Foregut Neuroendocrine Tumor,0.8024,Jejunal Neuroendocrine Tumor,0.8015,GASTROINTESTINAL NEUROENDOCRINE TUMORS,True,True,True
GASTROINTESTINAL STROMAL,Gastrointestinal Stromal Tumor,1,2,Gastrointestinal Stromal Tumor,0.8893,Malignant Gastrointestinal Stromal Tumor,0.8451,Gastric Gastrointestinal Stromal Tumor,0.8396,Benign Gastrointestinal Stromal Tumor,0.8357,Gastrointestinal Stromal Tumor of the Gastrointestinal Tract,0.8306,Colorectal Gastrointestinal Stromal Tumor,0.7948,Extragastrointestinal Gastrointestinal Stromal Tumor,0.7850,Small Intestinal Gastrointestinal Stromal Tumor,0.7846,Spindle Cell Type Gastrointestinal Stromal Tumor,0.7752,Malignant Gastric Gastrointestinal Stromal Tumor,0.7710,Benign Gastric Gastrointestinal Stromal Tumor,0.7670,Stromal Sarcoma,0.7645,Esophageal Gastrointestinal Stromal Tumor,0.7645,Mesenteric Gastrointestinal Stromal Tumor,0.7632,Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.7571,Intermediate Risk Gastrointestinal Stromal Tumor,0.7533,Peritoneal Gastrointestinal Stromal Tumor,0.7513,Advanced Gastrointestinal Stromal Tumor,0.7510,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.7474,Stromal Neoplasm,0.7453,GASTROINTESTINAL STROMAL,True,True,True
GASTROINTESTINAL STROMAL TUMOR,Gastrointestinal Stromal Tumor,1,2,Gastrointestinal Stromal Tumor,1.0000,Gastrointestinal Stromal Tumor of the Gastrointestinal Tract,0.9484,Gastric Gastrointestinal Stromal Tumor,0.9205,Malignant Gastrointestinal Stromal Tumor,0.9009,Benign Gastrointestinal Stromal Tumor,0.9004,Extragastrointestinal Gastrointestinal Stromal Tumor,0.8878,Colorectal Gastrointestinal Stromal Tumor,0.8835,Small Intestinal Gastrointestinal Stromal Tumor,0.8768,Rectal Gastrointestinal Stromal Tumor,0.8462,Esophageal Gastrointestinal Stromal Tumor,0.8438,Spindle Cell Type Gastrointestinal Stromal Tumor,0.8438,Mesenteric Gastrointestinal Stromal Tumor,0.8399,Advanced Gastrointestinal Stromal Tumor,0.8396,Peritoneal Gastrointestinal Stromal Tumor,0.8369,Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.8340,Childhood Gastrointestinal Stromal Tumor,0.8327,Metastatic Gastrointestinal Stromal Tumor,0.8272,Low Risk Gastrointestinal Stromal Tumor,0.8239,Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,0.8116,Benign Gastric Gastrointestinal Stromal Tumor,0.8110,GASTROINTESTINAL STROMAL TUMOR,True,True,True
GB,Glioblastoma,1,2,Glioblastoma,1.0000,Brain Glioblastoma,0.9357,Classical Glioblastoma,0.9294,Cerebral Glioblastoma,0.9259,Glioma,0.8866,Adult Glioblastoma,0.8776,Neural Glioblastoma,0.8722,Advanced Glioblastoma,0.8715,Mesenchymal Glioblastoma,0.8661,Secondary Glioblastoma,0.8561,Giant Cell Glioblastoma,0.8435,Malignant Glioma,0.8390,Granular Cell Glioblastoma,0.8291,Metastatic Glioblastoma,0.8289,Cerebellar Glioblastoma,0.8282,Childhood Glioblastoma,0.8278,Adult Brain Glioblastoma,0.8275,"Glioblastoma, Not Otherwise Specified",0.8268,Astrocytoma,0.8231,Small Cell Glioblastoma,0.8082,Glioblastoma,True,True,True
GBC,Gallbladder Carcinoma,1,2,Gallbladder Carcinoma,0.9672,Gallbladder Adenocarcinoma,0.9295,Gallbladder Neoplasm,0.8851,Malignant Gallbladder Neoplasm,0.8710,"Gallbladder Adenocarcinoma, Biliary Type",0.8485,Advanced Gallbladder Carcinoma,0.8318,Gallbladder Adenoma,0.8282,Gallbladder Lymphoma,0.8250,Incidental Gallbladder Carcinoma,0.8184,Localized Gallbladder Carcinoma,0.8184,Gallbladder Clear Cell Adenocarcinoma,0.8106,"Gallbladder Adenocarcinoma, Intestinal-Type",0.8099,Gallbladder Goblet Cell Adenocarcinoma,0.8023,Gallbladder Undifferentiated Carcinoma,0.8019,Gallbladder Neuroendocrine Carcinoma,0.8011,Localized Malignant Gallbladder Neoplasm,0.7975,Gallbladder Melanoma,0.7885,Metastatic Gallbladder Carcinoma,0.7873,Gallbladder Mucinous Adenocarcinoma,0.7861,Gallbladder Hepatoid Adenocarcinoma,0.7846,Gallbladder Cancer,True,True,True
GBM,Glioblastoma,3,2,Multifocal Glioblastomas,0.8320,Metastatic Glioblastoma,0.8166,Glioblastoma,0.8135,Mesenchymal Glioblastoma,0.8128,Classical Glioblastoma,0.7958,Brain Glioblastoma,0.7913,Cerebral Glioblastoma,0.7813,Advanced Glioblastoma,0.7803,Malignant Glioma,0.7772,Secondary Glioblastoma,0.7675,Malignant Brain Glioma,0.7531,Adult Glioblastoma,0.7368,Supratentorial Glioblastoma,0.7350,Granular Cell Glioblastoma,0.7333,Neural Glioblastoma,0.7224,Adult Brain Glioblastoma,0.7211,"Glioblastoma, Not Otherwise Specified",0.7207,Metastatic Glioma,0.7147,Proneural Glioblastoma,0.7121,Giant Cell Glioblastoma,0.7110,Glioblastoma Multiforme,False,True,True
GERM CELL TUMOR,Germ Cell Tumor,1,2,Germ Cell Tumor,1.0000,Testicular Germ Cell Tumor,0.8822,Childhood Germ Cell Tumor,0.8757,Malignant Germ Cell Tumor,0.8748,Germ Cell Tumor by Obsolete Classification,0.8637,Adult Germ Cell Tumor,0.8600,Central Nervous System Germ Cell Tumor,0.8522,Benign Germ Cell Tumor,0.8487,Cardiac Germ Cell Tumor,0.8432,Germinomatous Germ Cell Tumor,0.8390,Ovarian Germ Cell Tumor,0.8390,Nongerminomatous Germ Cell Tumor,0.8314,Gastric Germ Cell Tumor,0.8291,Cervical Germ Cell Tumor,0.8284,Childhood Gonadal Germ Cell Tumor,0.8274,Childhood Malignant Germ Cell Tumor,0.8120,Extragonadal Germ Cell Tumor,0.8107,Germ Cell,0.8075,Vaginal Germ Cell Tumor,0.8063,Lung Germ Cell Tumor,0.8059,GERM CELL TUMOR,True,True,True
GERM CELL TUMOR (EMBRYONAL CARCINOMA),Embryonal Carcinoma,1,2,Embryonal Carcinoma,0.8257,Testicular Embryonal Carcinoma,0.8244,Extragonadal Embryonal Carcinoma,0.8091,Germ Cell Tumor,0.7835,Childhood Testicular Embryonal Carcinoma,0.7743,Embryonal Neoplasm,0.7676,Extragonadal Germ Cell Tumor,0.7665,Central Nervous System Embryonal Carcinoma,0.7633,Childhood Embryonal Carcinoma,0.7608,Malignant Germ Cell Tumor,0.7537,Childhood Extragonadal Malignant Germ Cell Tumor,0.7501,Ovarian Embryonal Carcinoma,0.7437,Childhood Germ Cell Tumor,0.7418,Childhood Extracranial Germ Cell Tumor,0.7370,Malignant Extragonadal Germ Cell Tumor,0.7365,Childhood Malignant Germ Cell Tumor,0.7312,Testicular Germ Cell Tumor,0.7295,Central Nervous System Embryonal Tumor,0.7286,Cardiac Germ Cell Tumor,0.7252,Central Nervous System Germ Cell Tumor,0.7226,GERM CELL TUMOR (EMBRYONAL CARCINOMA),True,True,True
GERM CELL TUMOR WITH SOMATIC-TYPE MALIGNANCY,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,1,2,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,0.8071,Somatic-Type Malignancy,0.7858,Germ Cell Tumor,0.7857,Malignant Germ Cell Tumor,0.7816,Germinomatous Germ Cell Tumor,0.7596,Nongerminomatous Germ Cell Tumor,0.7503,Yolk Sac Tumor with Somatic-Type Malignancy,0.7425,Germ Cell Tumor by Obsolete Classification,0.7333,Adult Germ Cell Tumor,0.7290,Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7266,Systemic Mastocytosis with an Associated Germ Cell Tumor,0.7248,Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7189,Testicular Teratoma with Somatic-Type Malignancy,0.7163,Malignant Extragonadal Germ Cell Tumor,0.7141,Testicular Germ Cell Tumor,0.7131,Childhood Malignant Germ Cell Tumor,0.7121,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0.7119,Mixed Germ Cell Tumor,0.7064,Metastatic Malignant Germ Cell Tumor,0.7064,Testicular Non-Seminomatous Germ Cell Tumor,0.7007,GERM CELL TUMOR WITH SOMATIC-TYPE MALIGNANCY,True,True,True
"GERM CELL TUMOR, BRAIN",Childhood Brain Germ Cell Tumor,1,2,Childhood Brain Germ Cell Tumor,0.9044,Malignant Brain Germ Cell Tumor,0.8844,Central Nervous System Germ Cell Tumor,0.8797,Brain Germinoma,0.8308,Childhood Central Nervous System Germ Cell Tumor,0.8178,Central Nervous System Nongerminomatous Germ Cell Tumor,0.8095,Adult Intracranial Germ Cell Tumor,0.7956,Childhood Brain Germinoma,0.7941,Germ Cell Tumor,0.7936,Central Nervous System Germinoma,0.7932,Childhood Extracranial Germ Cell Tumor,0.7837,Adult Central Nervous System Germ Cell Tumor,0.7791,Malignant Central Nervous System Germ Cell Tumor,0.7727,Intracranial Germinoma,0.7725,Nasopharyngeal Germ Cell Tumor,0.7525,Childhood Germ Cell Tumor,0.7512,Germinomatous Germ Cell Tumor,0.7470,Benign Extragonadal Germ Cell Tumor,0.7434,Extragonadal Germ Cell Tumor,0.7356,Benign Germ Cell Tumor,0.7355,"GERM CELL TUMOR, BRAIN",True,True,True
GERMINAL CENTER B-CELL TYPE,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,1,2,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.7442,Centroblastic Lymphoma,0.6620,Germ Cell,0.6384,Gray-Zone Lymphoma,0.6136,"Malignant Lymphoma Centroblastic, Follicular",0.6113,Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.6031,Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.6020,High Grade B-Cell Lymphoma,0.5934,Mature B-Cell Neoplasm,0.5932,Benign Germ Cell Tumor,0.5914,Germ Cell Tumor by Obsolete Classification,0.5839,Childhood Benign Germ Cell Tumor,0.5812,Childhood Brain Germ Cell Tumor,0.5742,Blastoma,0.5732,Diffuse Centroblastic-Centrocytic Lymphoma,0.5732,Centroblastic Lymphoma by Ann Arbor Stage,0.5697,B-Cell Neoplasm,0.5656,Childhood Germ Cell Tumor,0.5585,Germ Cell Tumor,0.5572,Refractory Centroblastic Lymphoma,0.5555,GERMINAL CENTER B-CELL TYPE,True,True,True
GERMINAL CENTER B-CELL-LIKE GCB DLBCL,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,1,2,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.8604,Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.7485,Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.7480,Centroblastic Lymphoma,0.7003,High Grade B-Cell Lymphoma,0.6926,EZB Diffuse Large B-Cell Lymphoma,0.6862,Gastric Diffuse Large B-Cell Lymphoma,0.6706,Diffuse Centroblastic-Centrocytic Lymphoma,0.6574,Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation,0.6547,High Grade Burkitt-Like Lymphoma,0.6516,Classical Burkitt Lymphoma,0.6485,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.6473,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0.6428,Diffuse Large B-Cell Lymphoma,0.6418,"Malignant Lymphoma Centroblastic, Follicular",0.6385,Refractory Centroblastic Lymphoma,0.6385,High Grade B-Cell Non-Hodgkin's Lymphoma,0.6367,Low Grade B-Cell Non-Hodgkin's Lymphoma,0.6345,Diffuse Large B-Cell Lymphoma Activated B-Cell Type,0.6345,High Grade B-Cell Lymphoma with Blastoid Morphologic Features,0.6341,GERMINAL CENTER B-CELL-LIKE GCB DLBCL,True,True,True
GIANT CELL 'MFH' / UNDIFFERENTIATED PLEOMORPHIC SARCOMA WITH GIANT CELLS,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,1,2,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7776,Giant Cell Sarcoma,0.7694,Giant Cell Fibroblastoma,0.7599,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7263,Malignant Giant Cell Neoplasm,0.7185,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0.6965,Fibroblastic Reticular Cell Sarcoma,0.6910,Giant Cell Tumor,0.6909,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 3,0.6869,Giant Cell Neoplasm,0.6800,Undifferentiated Pleomorphic Sarcoma,0.6775,Giant Cell Tumor of Soft Tissue,0.6759,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 2,0.6700,Malignancy in Giant Cell Tumor of Bone,0.6613,Giant Cell Angioblastoma,0.6587,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.6552,"Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant",0.6552,Giant Cell Tumor of Bone,0.6526,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,0.6514,Fibrous Histiocytoma of Bone,0.6478,GIANT CELL 'MFH' / UNDIFFERENTIATED PLEOMORPHIC SARCOMA WITH GIANT CELLS,True,True,True
GIANT CELL TUMOR OF BONE,Giant Cell Tumor of Bone,1,2,Giant Cell Tumor of Bone,1.0000,Giant Cell Tumor,0.9449,Giant Cell Neoplasm,0.9359,Malignancy in Giant Cell Tumor of Bone,0.9143,Osteoclastic Giant Cell-Rich Tumor of Bone,0.8885,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,0.8712,Giant Cell Tumor of Soft Tissue,0.8640,Giant Cell Lesion of Small Bones,0.8422,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,0.8321,Malignant Giant Cell Neoplasm,0.8306,Childhood Giant Cell Tumor of Bone,0.8185,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone,0.7923,Giant Cell Fibroblastoma,0.7832,Giant Cell Carcinoma,0.7750,Giant Cell Sarcoma,0.7526,Giant Cell-Rich Osteosarcoma,0.7493,Giant Cell Angioblastoma,0.7482,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.7073,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7061,Tenosynovial Giant Cell Tumor,0.7014,GIANT CELL TUMOR OF BONE,True,True,True
GIANT CELL TUMOUR,Giant Cell Tumor,1,2,Giant Cell Tumor,0.9965,Giant Cell Neoplasm,0.9718,Giant Cell Tumor of Bone,0.9455,Giant Cell Tumor of Soft Tissue,0.8848,Malignancy in Giant Cell Tumor of Bone,0.8648,Malignant Giant Cell Neoplasm,0.8500,Giant Cell Fibroblastoma,0.8390,Osteoclastic Giant Cell-Rich Tumor of Bone,0.8340,Giant Cell Carcinoma,0.8321,Giant Cell Lesion of Small Bones,0.8165,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,0.8108,Childhood Giant Cell Tumor of Bone,0.7982,Giant Cell Sarcoma,0.7955,Giant Cell Angioblastoma,0.7742,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,0.7725,Tenosynovial Giant Cell Tumor,0.7568,Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone,0.7549,Giant Cell-Rich Osteosarcoma,0.7365,Granular Cell Tumor,0.7312,Giant Cell Angiofibroma,0.7257,GIANT CELL TUMOUR,True,True,True
GIANT_CELL_TUMOUR,Giant Cell Tumor,1,2,Giant Cell Tumor,0.9270,Giant Cell Neoplasm,0.9079,Giant Cell Tumor of Bone,0.8607,Malignancy in Giant Cell Tumor of Bone,0.8225,Giant Cell Carcinoma,0.8207,Giant Cell Tumor of Soft Tissue,0.8089,Malignant Giant Cell Neoplasm,0.8050,Giant Cell Fibroblastoma,0.7654,Osteoclastic Giant Cell-Rich Tumor of Bone,0.7615,Giant Cell Lesion of Small Bones,0.7533,Granular Cell Tumor,0.7369,Giant Cell Sarcoma,0.7349,Giant Cell Angioblastoma,0.7315,Benign Osteoclastic Giant Cell-Rich Tumor of Bone,0.7285,Tenosynovial Giant Cell Tumor,0.7253,Giant Cell and Spindle Cell Carcinoma,0.7203,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,0.7184,Childhood Giant Cell Tumor of Bone,0.7128,Granulosa Cell Tumor,0.7056,Juvenile Granulosa Cell Tumor,0.6986,GIANT_CELL_TUMOUR,True,True,True
GINET,Digestive System Neuroendocrine Tumor,1,2,Digestive System Neuroendocrine Tumor,0.9165,Gastric Neuroendocrine Tumor,0.9060,Intestinal Neuroendocrine Tumor,0.8892,Digestive System Neuroendocrine Neoplasm,0.8863,Gastric Neuroendocrine Neoplasm,0.8766,Midgut Neuroendocrine Tumor,0.8601,Intestinal Neuroendocrine Neoplasm,0.8600,Neuroendocrine Tumor,0.8392,Colorectal Neuroendocrine Tumor,0.8359,Childhood Digestive System Neuroendocrine Tumor,0.8235,Hindgut Neuroendocrine Tumor,0.8224,Advanced Digestive System Neuroendocrine Tumor,0.8190,Gastric Gastrin-Producing Neuroendocrine Tumor,0.8135,Neuroendocrine Neoplasm,0.8114,Intestinal Neuroendocrine Tumor G1,0.8106,Ileal Neuroendocrine Tumor,0.8101,Pancreatic Neuroendocrine Tumor,0.8062,Gastrin-Producing Neuroendocrine Tumor,0.8056,Foregut Neuroendocrine Tumor,0.8024,Jejunal Neuroendocrine Tumor,0.8015,Gastrointestinal Neuroendocrine Tumors,True,True,True
GIST,Gastrointestinal Stromal Tumor,1,2,Gastrointestinal Stromal Tumor,1.0000,Gastrointestinal Stromal Tumor of the Gastrointestinal Tract,0.9484,Gastric Gastrointestinal Stromal Tumor,0.9205,Malignant Gastrointestinal Stromal Tumor,0.9009,Benign Gastrointestinal Stromal Tumor,0.9004,Extragastrointestinal Gastrointestinal Stromal Tumor,0.8878,Colorectal Gastrointestinal Stromal Tumor,0.8835,Small Intestinal Gastrointestinal Stromal Tumor,0.8768,Rectal Gastrointestinal Stromal Tumor,0.8462,Esophageal Gastrointestinal Stromal Tumor,0.8438,Spindle Cell Type Gastrointestinal Stromal Tumor,0.8438,Mesenteric Gastrointestinal Stromal Tumor,0.8399,Advanced Gastrointestinal Stromal Tumor,0.8396,Peritoneal Gastrointestinal Stromal Tumor,0.8369,Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.8340,Childhood Gastrointestinal Stromal Tumor,0.8327,Metastatic Gastrointestinal Stromal Tumor,0.8272,Low Risk Gastrointestinal Stromal Tumor,0.8239,Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,0.8116,Benign Gastric Gastrointestinal Stromal Tumor,0.8110,Gastrointestinal Stromal Tumor,True,True,True
GLIOBLASTOMA,Glioblastoma,1,2,Glioblastoma,1.0000,Brain Glioblastoma,0.9357,Classical Glioblastoma,0.9294,Cerebral Glioblastoma,0.9259,Glioma,0.8866,Adult Glioblastoma,0.8776,Neural Glioblastoma,0.8722,Advanced Glioblastoma,0.8715,Mesenchymal Glioblastoma,0.8661,Secondary Glioblastoma,0.8561,Giant Cell Glioblastoma,0.8435,Malignant Glioma,0.8390,Granular Cell Glioblastoma,0.8291,Metastatic Glioblastoma,0.8289,Cerebellar Glioblastoma,0.8282,Childhood Glioblastoma,0.8278,Adult Brain Glioblastoma,0.8275,"Glioblastoma, Not Otherwise Specified",0.8268,Astrocytoma,0.8231,Small Cell Glioblastoma,0.8082,GLIOBLASTOMA,True,True,True
GLIOBLASTOMA MULTIFORME,Glioblastoma,3,2,Multifocal Glioblastomas,0.8320,Metastatic Glioblastoma,0.8166,Glioblastoma,0.8135,Mesenchymal Glioblastoma,0.8128,Classical Glioblastoma,0.7958,Brain Glioblastoma,0.7913,Cerebral Glioblastoma,0.7813,Advanced Glioblastoma,0.7803,Malignant Glioma,0.7772,Secondary Glioblastoma,0.7675,Malignant Brain Glioma,0.7531,Adult Glioblastoma,0.7368,Supratentorial Glioblastoma,0.7350,Granular Cell Glioblastoma,0.7333,Neural Glioblastoma,0.7224,Adult Brain Glioblastoma,0.7211,"Glioblastoma, Not Otherwise Specified",0.7207,Metastatic Glioma,0.7147,Proneural Glioblastoma,0.7121,Giant Cell Glioblastoma,0.7110,GLIOBLASTOMA MULTIFORME,False,True,True
GLIOBLASTOMA MULTIFORME GBM,Glioblastoma,4,2,Multifocal Glioblastomas,0.8239,Metastatic Glioblastoma,0.8220,Mesenchymal Glioblastoma,0.8147,Glioblastoma,0.8073,Brain Glioblastoma,0.8019,Classical Glioblastoma,0.7960,Advanced Glioblastoma,0.7800,Cerebral Glioblastoma,0.7699,Malignant Glioma,0.7672,Malignant Brain Glioma,0.7645,Supratentorial Glioblastoma,0.7643,Secondary Glioblastoma,0.7632,Granular Cell Glioblastoma,0.7449,Adult Glioblastoma,0.7434,Adult Brain Glioblastoma,0.7423,"Glioblastoma, Not Otherwise Specified",0.7389,MGMT-Methylated Glioblastoma,0.7286,Giant Cell Glioblastoma,0.7217,Metastatic Glioma,0.7170,Neural Glioblastoma,0.7156,GLIOBLASTOMA MULTIFORME GBM,False,False,True
"GLIOBLASTOMA, IDH-MUTANT","Astrocytoma, IDH-Mutant, Grade 4",6,2,"Astrocytoma, IDH-Mutant",0.9287,"Glioblastoma, IDH-Wildtype",0.8786,"Astrocytoma, IDH-Mutant, Grade 2",0.8629,"Astrocytoma, IDH-Mutant, Grade 3",0.8592,"Gemistocytic Astrocytoma, IDH-Mutant",0.8490,"Astrocytoma, IDH-Mutant, Grade 4",0.8346,"Astrocytoma, IDH-Wildtype",0.8070,"Unresectable Astrocytoma, IDH-Mutant",0.7788,"Anaplastic Astrocytoma, IDH-Wildtype",0.7573,"Diffuse Astrocytoma, IDH-Wildtype",0.7480,"Recurrent Astrocytoma, IDH-Mutant",0.7296,MGMT-Methylated Glioblastoma,0.7152,Brain Glioblastoma,0.7025,"Recurrent Glioblastoma, IDH-Wildtype",0.7020,Metastatic Glioblastoma,0.6992,MGMT-Unmethylated Glioblastoma,0.6925,Classical Glioblastoma,0.6924,Mesenchymal Glioblastoma,0.6912,Glioblastoma,0.6896,Cerebral Glioblastoma,0.6888,"GLIOBLASTOMA, IDH-MUTANT",False,False,False
"GLIOBLASTOMA, IDH-WILDTPYE","Glioblastoma, IDH-Wildtype",1,2,"Glioblastoma, IDH-Wildtype",0.9004,"Astrocytoma, IDH-Wildtype",0.8540,"Astrocytoma, IDH-Mutant",0.8051,"Anaplastic Astrocytoma, IDH-Wildtype",0.7923,"Diffuse Astrocytoma, IDH-Wildtype",0.7693,"Astrocytoma, IDH-Mutant, Grade 3",0.7612,"Astrocytoma, IDH-Mutant, Grade 2",0.7484,"Gemistocytic Astrocytoma, IDH-Mutant",0.7478,"Astrocytoma, IDH-Mutant, Grade 4",0.7293,"Unresectable Astrocytoma, IDH-Mutant",0.7175,"Recurrent Glioblastoma, IDH-Wildtype",0.7140,MGMT-Unmethylated Glioblastoma,0.6906,MGMT-Methylated Glioblastoma,0.6746,Glioblastoma,0.6729,Brain Glioblastoma,0.6711,Classical Glioblastoma,0.6709,Infratentorial Glioblastoma,0.6606,Neural Glioblastoma,0.6587,Cerebral Glioblastoma,0.6560,Adult Glioblastoma,0.6453,"GLIOBLASTOMA, IDH-WILDTPYE",True,True,True
"GLIOBLASTOMA, IDH-WILDTYPE","Glioblastoma, IDH-Wildtype",1,2,"Glioblastoma, IDH-Wildtype",1.0000,"Astrocytoma, IDH-Wildtype",0.9145,"Diffuse Astrocytoma, IDH-Wildtype",0.8470,"Anaplastic Astrocytoma, IDH-Wildtype",0.8196,"Astrocytoma, IDH-Mutant",0.7944,"Astrocytoma, IDH-Mutant, Grade 3",0.7681,"Recurrent Glioblastoma, IDH-Wildtype",0.7662,"Astrocytoma, IDH-Mutant, Grade 2",0.7586,"Gemistocytic Astrocytoma, IDH-Mutant",0.7403,"Astrocytoma, IDH-Mutant, Grade 4",0.7328,MGMT-Unmethylated Glioblastoma,0.7155,Classical Glioblastoma,0.7051,Glioblastoma,0.6990,"Unresectable Astrocytoma, IDH-Mutant",0.6979,"Glioblastoma, Not Otherwise Specified",0.6956,Brain Glioblastoma,0.6890,"Medulloblastoma, SHH-Activated, TP53-Wildtype",0.6754,Neural Glioblastoma,0.6736,MGMT-Methylated Glioblastoma,0.6713,Cerebral Glioblastoma,0.6662,"GLIOBLASTOMA, IDH-WILDTYPE",True,True,True
GLIOBLASTOMA_MULTIFORME,Glioblastoma,3,2,Multifocal Glioblastomas,0.8249,Metastatic Glioblastoma,0.8164,Glioblastoma,0.7953,Mesenchymal Glioblastoma,0.7818,Brain Glioblastoma,0.7777,Classical Glioblastoma,0.7759,Advanced Glioblastoma,0.7745,Secondary Glioblastoma,0.7719,Cerebral Glioblastoma,0.7617,"Glioblastoma, Not Otherwise Specified",0.7549,Malignant Glioma,0.7531,Malignant Brain Glioma,0.7359,Supratentorial Glioblastoma,0.7239,Metastatic Glioma,0.7171,Adult Glioblastoma,0.7166,Recurrent Glioblastoma,0.7138,Adult Brain Glioblastoma,0.7076,Recurrent Brain Glioblastoma,0.6989,Neural Glioblastoma,0.6978,Granular Cell Glioblastoma,0.6969,GLIOBLASTOMA_MULTIFORME,False,True,True
GLIOMA,Glioma,1,2,Glioma,1.0000,Glioblastoma,0.8866,Diffuse Glioma,0.8574,Malignant Glioma,0.8566,Cerebral Glioblastoma,0.8343,Neural Glioblastoma,0.8340,Gliomatosis Cerebri,0.8302,Brain Glioblastoma,0.8297,Astrocytoma,0.8293,Classical Glioblastoma,0.8287,Visual Pathway Glioma,0.8116,Adult Glioblastoma,0.7968,Low Grade Glioma,0.7903,Granular Cell Glioblastoma,0.7890,Gliosarcoma,0.7882,Giant Cell Glioblastoma,0.7851,Malignant Brain Glioma,0.7765,Tectal Glioma,0.7762,Cerebral Astrocytoma,0.7742,Brain Astrocytoma,0.7696,GLIOMA,True,True,True
GLIONEURONAL TUMOR,Glioneuronal and Neuronal Tumors,1,2,Glioneuronal and Neuronal Tumors,0.9193,Papillary Glioneuronal Tumor,0.8703,Cerebellar Glioneuronal and Neuronal Tumors,0.8223,Glioneuronal Tumor with Neuropil-Like Islands,0.8221,Diffuse Leptomeningeal Glioneuronal Tumor,0.8056,Myxoid Glioneuronal Tumor,0.8054,Neural Glioblastoma,0.8015,Unresectable Glioneuronal and Neuronal Tumors,0.7923,Non-Neural Granular Cell Tumor,0.7799,Glioma,0.7615,Rosette-Forming Glioneuronal Tumor,0.7615,Recurrent Glioneuronal and Neuronal Tumors,0.7517,Gliomatosis Cerebri,0.7403,Gliosarcoma,0.7374,Glioblastoma with Primitive Neuronal Component,0.7350,Central Nervous System Ganglioneuroblastoma,0.7294,Adult Gliosarcoma,0.7207,Malignant Glioma,0.7206,Ganglioneuroblastoma,0.7186,Granular Cell Tumor,0.7164,GLIONEURONAL TUMOR,True,True,True
GLIOSARCOMA,Gliosarcoma,1,2,Gliosarcoma,1.0000,Adult Gliosarcoma,0.8884,Childhood Gliosarcoma,0.8704,Recurrent Gliosarcoma,0.8189,Refractory Gliosarcoma,0.8136,Glioma,0.7882,Supratentorial Gliosarcoma,0.7867,Mesenchymal Glioblastoma,0.7803,Gliofibroma,0.7696,Classical Glioblastoma,0.7519,Glioblastoma,0.7508,Malignant Glioma,0.7473,Recurrent Childhood Gliosarcoma,0.7390,Rhabdomyosarcoma,0.7360,Childhood Brain Stem Gliosarcoma,0.7236,Lymphosarcoma,0.7179,Adult Brain Stem Gliosarcoma,0.7179,Neural Glioblastoma,0.7157,Astrocytoma,0.7110,Sarcoma G2,0.7074,GLIOSARCOMA,True,True,True
GLOMANGIOSARCOMA,Malignant Glomus Tumor,4,2,Glomangiomyoma,0.8533,Glomangiomatosis,0.8215,Gliosarcoma,0.7703,Malignant Glomus Tumor,0.7635,Glomus Tumor,0.7472,Solid Glomus Tumor,0.7342,Sinonasal Glomangiopericytoma,0.7156,Sarcoma GX,0.7153,Sarcoma G2,0.7142,Gastric Glomus Tumor,0.7128,Granular Cell Leiomyosarcoma,0.7125,Bone Glomus Tumor,0.7109,Metastatic Malignant Glomus Tumor,0.7082,Adult Gliosarcoma,0.7037,Sarcoma G1,0.6977,Lymphosarcoma,0.6916,Gastric Sarcoma,0.6885,Refractory Malignant Glomus Tumor,0.6870,Skin Glomus Tumor,0.6860,Digestive System Rhabdomyosarcoma,0.6832,GLOMANGIOSARCOMA,False,False,True
GOBLET CELL ADENOCARCINOMA OF THE APPENDIX,Appendix Goblet Cell Adenocarcinoma,1,2,Appendix Goblet Cell Adenocarcinoma,0.9692,Goblet Cell Adenocarcinoma,0.8768,Appendix Mucinous Adenocarcinoma,0.8332,Gallbladder Goblet Cell Adenocarcinoma,0.8019,Appendix Adenocarcinoma,0.7897,Gastric Mucinous Adenocarcinoma,0.7709,Colon Mucinous Adenocarcinoma,0.7676,High Grade Appendix Mucinous Adenocarcinoma,0.7637,Colorectal Mucinous Adenocarcinoma,0.7515,Appendix Mucinous Cystadenocarcinoma,0.7513,Gallbladder Mucinous Adenocarcinoma,0.7492,Mucinous Adenocarcinoma,0.7482,Appendix Mucinous Neoplasm,0.7381,Mucin-Producing Adenocarcinoma,0.7378,Metastatic Appendix Mucinous Adenocarcinoma,0.7315,Appendix Mucinous Cystadenoma,0.7305,"Endometrial Mucinous Adenocarcinoma, Gastric-Type",0.7252,Anal Mucinous Adenocarcinoma,0.7243,Appendix Carcinoma,0.7185,Low Grade Appendix Mucinous Neoplasm,0.7123,GOBLET CELL ADENOCARCINOMA OF THE APPENDIX,True,True,True
GOBLET CELL CARCINOID OF THE APPENDIX,Appendix Goblet Cell Adenocarcinoma,1,2,Appendix Goblet Cell Adenocarcinoma,0.8603,Goblet Cell Adenocarcinoma,0.7841,Gallbladder Goblet Cell Adenocarcinoma,0.7320,Appendix Mucinous Neoplasm,0.7319,Appendix Neuroendocrine Tumor G2,0.7308,Appendix Neuroendocrine Carcinoma,0.7265,Appendix Mucinous Adenocarcinoma,0.7229,Appendix Small Cell Neuroendocrine Carcinoma,0.7199,Appendix Large Cell Neuroendocrine Carcinoma,0.7171,Gallbladder Tubular Carcinoid,0.7170,Low Grade Appendix Mucinous Neoplasm,0.7147,Appendix Neuroendocrine Tumor G1,0.7113,Appendix Neuroendocrine Tumor G3,0.7106,Ovarian Mucinous Carcinoid Tumor,0.7033,Appendix Undifferentiated Carcinoma,0.7008,Appendix Neuroendocrine Tumor,0.6999,Appendix Mixed Adenoneuroendocrine Carcinoma,0.6978,Appendix Mucinous Cystadenocarcinoma,0.6908,Appendix Tubular Neuroendocrine Tumor,0.6906,Combined Carcinoid and Adenocarcinoma,0.6874,GOBLET CELL CARCINOID OF THE APPENDIX,True,True,True
GRANULAR CELL TUMOR,Granular Cell Tumor,1,2,Granular Cell Tumor,1.0000,Non-Neural Granular Cell Tumor,0.8963,Gastric Granular Cell Tumor,0.8838,Benign Granular Cell Tumor,0.8825,Childhood Granular Cell Tumor,0.8736,Granular Cell Carcinoma,0.8557,Skin Granular Cell Tumor,0.8527,Malignant Granular Cell Tumor,0.8500,Cardiac Granular Cell Tumor,0.8497,Breast Granular Cell Tumor,0.8226,Prostate Granular Cell Tumor,0.8198,Benign Gastric Granular Cell Tumor,0.8096,Oral Cavity Granular Cell Tumor,0.8069,Benign Peripheral Nerve Granular Cell Tumor,0.8036,Bladder Granular Cell Tumor,0.8018,Granular Cell Astrocytoma,0.8012,Laryngeal Granular Cell Tumor,0.7907,Granular Cell Glioblastoma,0.7846,Esophageal Granular Cell Tumor,0.7660,Benign Anal Granular Cell Tumor,0.7619,GRANULAR CELL TUMOR,True,True,True
GRANULOSA CELL TUMOR,Granulosa Cell Tumor,1,2,Granulosa Cell Tumor,1.0000,Ovarian Granulosa Cell Tumor,0.9167,Testicular Granulosa Cell Tumor,0.9049,Adult Granulosa Cell Tumor,0.8671,Malignant Granulosa Cell Tumor,0.8462,Juvenile Granulosa Cell Tumor,0.8455,Ovarian Granulosa-Stromal Cell Tumor,0.8445,Granulosa Cell-Theca Cell Tumor,0.8283,Adult Ovarian Granulosa Cell Tumor,0.8257,Adult Testicular Granulosa Cell Tumor,0.8257,Juvenile Testicular Granulosa Cell Tumor,0.8110,Juvenile Ovarian Granulosa Cell Tumor,0.8010,Germ Cell Tumor,0.7928,Malignant Ovarian Granulosa Cell Tumor,0.7864,Ovarian Germ Cell Tumor,0.7784,Testicular Germ Cell Tumor,0.7626,Granular Cell Tumor,0.7560,Nongerminomatous Germ Cell Tumor,0.7516,Childhood Ovarian Germ Cell Tumor,0.7430,Germ Cell Tumor by Obsolete Classification,0.7423,GRANULOSA CELL TUMOR,True,True,True
GRANULOSA_CELL_TUMOR,Granulosa Cell Tumor,1,2,Granulosa Cell Tumor,0.9474,Ovarian Granulosa Cell Tumor,0.8676,Testicular Granulosa Cell Tumor,0.8445,Granulosa Cell-Theca Cell Tumor,0.8254,Malignant Granulosa Cell Tumor,0.8250,Ovarian Granulosa-Stromal Cell Tumor,0.8213,Adult Granulosa Cell Tumor,0.7947,Juvenile Granulosa Cell Tumor,0.7841,Malignant Ovarian Granulosa Cell Tumor,0.7708,Adult Ovarian Granulosa Cell Tumor,0.7638,Juvenile Ovarian Granulosa Cell Tumor,0.7540,Adult Testicular Granulosa Cell Tumor,0.7539,Germ Cell Tumor,0.7509,Juvenile Testicular Granulosa Cell Tumor,0.7500,Ovarian Germ Cell Tumor,0.7401,Germ Cell Tumor by Obsolete Classification,0.7356,Nongerminomatous Germ Cell Tumor,0.7288,Ovarian Non-Dysgerminomatous Germ Cell Tumor,0.7122,Germinomatous Germ Cell Tumor,0.7073,Ovarian Primitive Germ Cell Tumor,0.7063,GRANULOSA_CELL_TUMOR,True,True,True
GRANULOSA_CELL_TUMOUR,Granulosa Cell Tumor,1,2,Granulosa Cell Tumor,0.9439,Ovarian Granulosa Cell Tumor,0.8648,Testicular Granulosa Cell Tumor,0.8429,Granulosa Cell-Theca Cell Tumor,0.8219,Malignant Granulosa Cell Tumor,0.8188,Ovarian Granulosa-Stromal Cell Tumor,0.8169,Adult Granulosa Cell Tumor,0.7896,Juvenile Granulosa Cell Tumor,0.7817,Malignant Ovarian Granulosa Cell Tumor,0.7647,Adult Ovarian Granulosa Cell Tumor,0.7591,Juvenile Ovarian Granulosa Cell Tumor,0.7511,Adult Testicular Granulosa Cell Tumor,0.7499,Germ Cell Tumor,0.7491,Juvenile Testicular Granulosa Cell Tumor,0.7486,Ovarian Germ Cell Tumor,0.7363,Germ Cell Tumor by Obsolete Classification,0.7358,Nongerminomatous Germ Cell Tumor,0.7260,Ovarian Non-Dysgerminomatous Germ Cell Tumor,0.7102,Germinomatous Germ Cell Tumor,0.7062,Glandular Cell Neoplasm,0.7025,GRANULOSA_CELL_TUMOUR,True,True,True
HAEMATOPOIETIC NEOPLASM,Hematopoietic and Lymphoid Cell Neoplasm,3,2,Myeloid Neoplasm,0.8018,Bone Marrow Neoplasm,0.7897,Hematopoietic and Lymphoid Cell Neoplasm,0.7830,Hematopoietic and Lymphatic System Neoplasm,0.7814,Erythroid Neoplasm,0.7585,Non-Hematologic Malignancy,0.6731,Central Nervous System Hematopoietic and Lymphoid Cell Neoplasm,0.6722,Bone Neoplasm,0.6710,Hemolymphangioma,0.6682,Hematopoietic and Lymphoid Neoplasm by Obsolete Classification,0.6647,Childhood Hematopoietic and Lymphoid Cell Neoplasm,0.6646,Cutaneous Hematopoietic and Lymphoid Cell Neoplasm,0.6476,Malignant Bone Marrow Neoplasm,0.6441,Megakaryocytic Neoplasm,0.6401,Cardiovascular Neoplasm,0.6315,Vascular Neoplasm,0.6251,Hair Follicle Neoplasm,0.6239,Blood Vessel Neoplasm,0.6227,Vascular Bone Neoplasm,0.6186,Myeloproliferative Neoplasm,0.6140,HAEMATOPOIETIC NEOPLASM,False,True,True
HAIRY CELL LEUKEMIA,Hairy Cell Leukemia,1,2,Hairy Cell Leukemia,1.0000,Hairy Cell Leukemia Variant,0.9200,Refractory Hairy Cell Leukemia,0.7780,Recurrent Hairy Cell Leukemia,0.7502,Splenic Manifestation of Hairy Cell Leukemia,0.7292,Recurrent Hairy Cell Leukemia Variant,0.7192,Progressive Hairy Cell Leukemia Initial Treatment,0.7188,Refractory Hairy Cell Leukemia Variant,0.7148,Lymphoid Leukemia,0.6727,Mast Cell Leukemia,0.6628,Leukemia,0.6592,B-Cell Leukemia,0.6497,Cutaneous Chronic Lymphocytic Leukemia,0.6447,Cutaneous Hematopoietic and Lymphoid Cell Neoplasm,0.6380,Chronic Lymphocytic Leukemia,0.6380,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.6321,Leukemia Cutis,0.6308,Testicular Leukemia,0.6274,Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma,0.6251,CALLA Positive Lymphoblastic Leukemia,0.6218,HAIRY CELL LEUKEMIA,True,True,True
HAIRY_CELL_LEUKEMIA,Hairy Cell Leukemia,1,2,Hairy Cell Leukemia,0.9543,Hairy Cell Leukemia Variant,0.8780,Refractory Hairy Cell Leukemia,0.7688,Recurrent Hairy Cell Leukemia,0.7510,Progressive Hairy Cell Leukemia Initial Treatment,0.7210,Recurrent Hairy Cell Leukemia Variant,0.7184,Splenic Manifestation of Hairy Cell Leukemia,0.7161,Refractory Hairy Cell Leukemia Variant,0.7072,B-Cell Leukemia,0.6882,Lymphoid Leukemia,0.6874,Leukemia,0.6774,Cutaneous Hematopoietic and Lymphoid Cell Neoplasm,0.6613,Leukemia Cutis,0.6596,Mast Cell Leukemia,0.6571,Hematopoietic and Lymphoid Cell Neoplasm,0.6541,Chronic Lymphocytic Leukemia,0.6458,Chronic Leukemia,0.6414,Cutaneous Chronic Lymphocytic Leukemia,0.6359,Lymphoblastic Lymphoma,0.6309,Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma,0.6290,HAIRY_CELL_LEUKEMIA,True,True,True
HCC,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,1.0000,Liver Carcinoma,0.8963,Advanced Hepatocellular Carcinoma,0.8738,Small Hepatocellular Carcinoma,0.8473,Adult Hepatocellular Carcinoma,0.8338,Early Hepatocellular Carcinoma,0.8331,Childhood Hepatocellular Carcinoma,0.8297,Hepatocellular Poorly Differentiated Carcinoma,0.8289,Hepatocellular Clear Cell Carcinoma,0.8263,Hepatocellular Adenoma,0.8205,Hepatocellular Well Differentiated Carcinoma,0.8068,Early Stage Hepatocellular Carcinoma,0.8022,Metastatic Hepatocellular Carcinoma,0.8009,Unresectable Hepatocellular Carcinoma,0.7859,Hepatoid Adenocarcinoma,0.7833,Locally Advanced Hepatocellular Carcinoma,0.7784,Hepatocellular Lymphocyte-Rich Carcinoma,0.7782,Adult Liver Carcinoma,0.7731,"Hepatocellular Malignant Neoplasm, Not Otherwise Specified",0.7721,Hepatocellular Neutrophil-Rich Carcinoma,0.7717,Hepatocellular Carcinoma,True,True,True
HEAD & NECK SQUAMOUS CELL CARCINOMA,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.9748,Head and Neck Cutaneous Squamous Cell Carcinoma,0.8722,Head and Neck Carcinoma,0.8661,Head and Neck Sebaceous Carcinoma,0.8020,Advanced Head and Neck Squamous Cell Carcinoma,0.7954,Head and Neck Neuroendocrine Carcinoma,0.7819,Head and Neck Small Cell Neuroendocrine Carcinoma,0.7563,Advanced Head and Neck Cutaneous Squamous Cell Carcinoma,0.7528,Metastatic Head and Neck Squamous Cell Carcinoma,0.7458,Head and Neck Neoplasm,0.7449,Head and Neck Sarcoma,0.7423,Head and Neck Keratinizing Squamous Cell Carcinoma,0.7401,ASPH-Positive Head and Neck Squamous Cell Carcinoma,0.7351,Head and Neck NUT Carcinoma,0.7301,Resectable Head and Neck Squamous Cell Carcinoma,0.7266,Head and Neck Merkel Cell Carcinoma,0.7198,Head and Neck Basaloid Squamous Cell Carcinoma,0.7182,Malignant Head and Neck Neoplasm,0.7162,Advanced Head and Neck Carcinoma,0.7158,Locally Advanced Head and Neck Squamous Cell Carcinoma,0.7145,HEAD & NECK SQUAMOUS CELL CARCINOMA,True,True,True
HEAD & NECK SQUAMOUS CELL CARCINOMA BASALOID TYPE,Head and Neck Basaloid Squamous Cell Carcinoma,1,2,Head and Neck Basaloid Squamous Cell Carcinoma,0.9240,Basaloid Squamous Cell Carcinoma,0.8348,Cervical Basaloid Squamous Cell Carcinoma,0.7942,Skin Basaloid Squamous Cell Carcinoma,0.7883,Basaloid Carcinoma,0.7804,Hypopharyngeal Basaloid Squamous Cell Carcinoma,0.7750,Esophageal Basaloid Squamous Cell Carcinoma,0.7115,Basal Cell Carcinoma,0.7109,Nasopharyngeal Basaloid Squamous Cell Carcinoma,0.7070,Skin Basal Cell Carcinoma,0.7033,Superficial Basal Cell Carcinoma,0.7011,Penile Basaloid Squamous Cell Carcinoma,0.7003,Laryngeal Basaloid Squamous Cell Carcinoma,0.6951,Floor of Mouth Basaloid Squamous Cell Carcinoma,0.6923,Oropharyngeal Basaloid Squamous Cell Carcinoma,0.6850,Vaginal Basaloid Squamous Cell Carcinoma,0.6825,Lung Basaloid Squamous Cell Carcinoma,0.6755,Vulvar Basaloid Squamous Cell Carcinoma,0.6643,Head and Neck Keratinizing Squamous Cell Carcinoma,0.6641,Skin Basal Cell Carcinoma with Sarcomatoid Differentiation,0.6573,HEAD & NECK SQUAMOUS CELL CARCINOMA BASALOID TYPE,True,True,True
HEAD AND NECK CANCER,Malignant Head and Neck Neoplasm,3,2,Head and Neck Carcinoma,0.9685,Head and Neck Neoplasm,0.9201,Malignant Head and Neck Neoplasm,0.8789,Head and Neck Squamous Cell Carcinoma,0.8130,Head and Neck Neuroendocrine Carcinoma,0.7988,Advanced Head and Neck Carcinoma,0.7964,Head and Neck Lymphoma,0.7950,Head and Neck Neuroendocrine Neoplasm,0.7881,Childhood Head and Neck Neoplasm,0.7862,Head and Neck Neuroendocrine Tumor,0.7718,Childhood Malignant Head and Neck Neoplasm,0.7573,Head and Neck Hematopoietic and Lymphoid Cell Neoplasm,0.7568,Head and Neck NUT Carcinoma,0.7556,Benign Head and Neck Neoplasm,0.7454,Advanced Malignant Head and Neck Neoplasm,0.7432,Head and Neck Non-Hodgkin Lymphoma,0.7418,Metastatic Head and Neck Carcinoma,0.7383,Head and Neck Sarcoma,0.7326,Head and Neck Follicular Lymphoma,0.7306,Neck Carcinoma,0.7176,HEAD AND NECK CANCER,False,True,True
"HEAD AND NECK CANCER, NOS",Malignant Head and Neck Neoplasm,3,2,Head and Neck Carcinoma,0.9408,Head and Neck Neoplasm,0.8937,Malignant Head and Neck Neoplasm,0.8641,Head and Neck Squamous Cell Carcinoma,0.8005,Advanced Head and Neck Carcinoma,0.7680,Head and Neck Neuroendocrine Carcinoma,0.7648,Childhood Head and Neck Neoplasm,0.7625,Head and Neck Lymphoma,0.7523,Childhood Malignant Head and Neck Neoplasm,0.7467,Head and Neck Neuroendocrine Neoplasm,0.7460,Head and Neck Hematopoietic and Lymphoid Cell Neoplasm,0.7430,Head and Neck Neuroendocrine Tumor,0.7242,Head and Neck NUT Carcinoma,0.7207,Advanced Malignant Head and Neck Neoplasm,0.7207,Metastatic Head and Neck Carcinoma,0.7132,Benign Head and Neck Neoplasm,0.7131,Head and Neck Non-Hodgkin Lymphoma,0.7101,Head and Neck Sarcoma,0.7062,Head and Neck Cutaneous Squamous Cell Carcinoma,0.6947,Head and Neck Sebaceous Carcinoma,0.6901,"HEAD AND NECK CANCER, NOS",False,True,True
HEAD AND NECK CARCINOMA,Head and Neck Carcinoma,1,2,Head and Neck Carcinoma,1.0000,Head and Neck Neoplasm,0.8878,Malignant Head and Neck Neoplasm,0.8632,Head and Neck Squamous Cell Carcinoma,0.8580,Head and Neck Neuroendocrine Carcinoma,0.8333,Advanced Head and Neck Carcinoma,0.8233,Head and Neck NUT Carcinoma,0.7960,Head and Neck Lymphoma,0.7950,Neck Carcinoma,0.7894,Head and Neck Neuroendocrine Neoplasm,0.7842,Metastatic Head and Neck Carcinoma,0.7704,Head and Neck Neuroendocrine Tumor,0.7656,Childhood Head and Neck Neoplasm,0.7550,Head and Neck Sebaceous Carcinoma,0.7543,Head and Neck Cutaneous Squamous Cell Carcinoma,0.7509,Localized Head and Neck Carcinoma,0.7488,Advanced Malignant Head and Neck Neoplasm,0.7381,Advanced Head and Neck Squamous Cell Carcinoma,0.7354,Head and Neck Non-Hodgkin Lymphoma,0.7332,Head and Neck Follicular Lymphoma,0.7329,HEAD AND NECK CARCINOMA,True,True,True
HEAD AND NECK CARCINOMA OTHER,Malignant Head and Neck Neoplasm,14,2,Head and Neck Carcinoma,0.8501,Head and Neck Neoplasm,0.7986,Head and Neck Neuroendocrine Carcinoma,0.7961,Head and Neck Neuroendocrine Neoplasm,0.7568,Head and Neck NUT Carcinoma,0.7393,Head and Neck Hematopoietic and Lymphoid Cell Neoplasm,0.7351,Head and Neck Carcinoma of Unknown Primary,0.7348,Head and Neck Squamous Cell Carcinoma,0.7327,Head and Neck Neuroendocrine Tumor,0.7277,Advanced Head and Neck Carcinoma,0.7205,Head and Neck Non-Hodgkin Lymphoma,0.7188,Head and Neck Lymphoma,0.7132,Metastatic Head and Neck Carcinoma,0.7105,Malignant Head and Neck Neoplasm,0.7084,Head and Neck Germ Cell Tumor,0.7052,Childhood Head and Neck Neoplasm,0.7046,Unresectable Head and Neck Carcinoma,0.7006,Childhood Head and Neck NUT Carcinoma,0.6921,Head and Neck Small Cell Neuroendocrine Carcinoma,0.6916,Head and Neck Large Cell Neuroendocrine Carcinoma,0.6909,HEAD AND NECK CARCINOMA OTHER,False,False,False
"HEAD AND NECK CARCINOMA, OTHER",Malignant Head and Neck Neoplasm,15,2,Head and Neck Carcinoma,0.8337,Head and Neck Neuroendocrine Carcinoma,0.7907,Head and Neck Neoplasm,0.7783,Head and Neck Neuroendocrine Neoplasm,0.7471,Head and Neck Carcinoma of Unknown Primary,0.7424,Head and Neck NUT Carcinoma,0.7262,Head and Neck Squamous Cell Carcinoma,0.7240,Head and Neck Neuroendocrine Tumor,0.7192,Head and Neck Hematopoietic and Lymphoid Cell Neoplasm,0.7176,Advanced Head and Neck Carcinoma,0.7054,Head and Neck Germ Cell Tumor,0.6936,Head and Neck Large Cell Neuroendocrine Carcinoma,0.6933,Head and Neck Non-Hodgkin Lymphoma,0.6921,Metastatic Head and Neck Carcinoma,0.6894,Malignant Head and Neck Neoplasm,0.6880,Childhood Head and Neck Neoplasm,0.6878,Head and Neck Small Cell Neuroendocrine Carcinoma,0.6875,Head and Neck Lymphoma,0.6859,Unresectable Head and Neck Carcinoma,0.6843,Childhood Head and Neck NUT Carcinoma,0.6819,"HEAD AND NECK CARCINOMA, OTHER",False,False,False
HEAD AND NECK MUCOSAL MELANOMA,Head and Neck Mucosal Melanoma,1,2,Head and Neck Mucosal Melanoma,1.0000,Head and Neck Melanocytic Neoplasm,0.8198,Mucosal Melanoma,0.7933,Head and Neck Mucosal Melanoma by AJCC v7 Stage,0.7739,Metastatic Mucosal Melanoma,0.7449,Mucosal Nodular Melanoma,0.7440,Nasopharyngeal Mucosal Melanoma,0.7376,Malignant Head and Neck Neoplasm,0.7206,Oral Cavity Mucosal Melanoma,0.7205,Mucosal Lentiginous Melanoma,0.7144,Digestive System Mucosal Melanoma,0.7086,Head and Neck Myeloid Sarcoma,0.7076,Head and Neck Mantle Cell Lymphoma,0.7018,Pharyngeal Mucosal Melanoma,0.6990,Genitourinary System Mucosal Melanoma,0.6902,Sinonasal Mucosal Melanoma,0.6744,Head and Neck Cutaneous Nevus,0.6720,Stage IVA Head and Neck Mucosal Melanoma AJCC v7,0.6709,Head and Neck Carcinoma,0.6681,Advanced Mucosal Melanoma,0.6670,HEAD AND NECK MUCOSAL MELANOMA,True,True,True
HEAD AND NECK NEUROENDOCRINE CARCINOMA,Head and Neck Neuroendocrine Carcinoma,1,2,Head and Neck Neuroendocrine Carcinoma,1.0000,Head and Neck Neuroendocrine Neoplasm,0.9087,Head and Neck Small Cell Neuroendocrine Carcinoma,0.9015,Head and Neck Neuroendocrine Tumor,0.8929,Head and Neck Large Cell Neuroendocrine Carcinoma,0.8733,Head and Neck Carcinoma,0.8333,Head and Neck NUT Carcinoma,0.7928,Head and Neck Neuroendocrine Tumor G1,0.7879,Head and Neck Neuroendocrine Tumor G2,0.7785,Head and Neck Squamous Cell Carcinoma,0.7752,Nasopharyngeal Neuroendocrine Carcinoma,0.7625,Neuroendocrine Carcinoma,0.7589,Childhood Head and Neck NUT Carcinoma,0.7476,Advanced Head and Neck Carcinoma,0.7441,Cervical Neuroendocrine Carcinoma,0.7432,Head and Neck Neoplasm,0.7311,Head and Neck Sebaceous Carcinoma,0.7267,Head and Neck Merkel Cell Carcinoma,0.7137,Advanced Neuroendocrine Carcinoma,0.7127,Metastatic Head and Neck Carcinoma,0.7123,HEAD AND NECK NEUROENDOCRINE CARCINOMA,True,True,True
HEAD AND NECK SQUAMOUS,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.8723,Head and Neck Sarcoma,0.7918,Head and Neck Carcinoma,0.7896,Head and Neck Cutaneous Squamous Cell Carcinoma,0.7653,Head and Neck Sebaceous Carcinoma,0.7487,Head and Neck Synovial Sarcoma,0.7408,Head and Neck Neoplasm,0.7364,Malignant Head and Neck Neoplasm,0.7236,Advanced Head and Neck Squamous Cell Carcinoma,0.7178,Head and Neck Keratinizing Squamous Cell Carcinoma,0.7092,Head and Neck Neuroendocrine Carcinoma,0.6987,Head and Neck Myeloid Sarcoma,0.6947,Head and Neck Basaloid Squamous Cell Carcinoma,0.6934,Head and Neck Neuroendocrine Neoplasm,0.6889,Head and Neck Lymphoma,0.6888,ASPH-Positive Head and Neck Squamous Cell Carcinoma,0.6830,Benign Head and Neck Neoplasm,0.6821,Head and Neck Undifferentiated Pleomorphic Sarcoma,0.6815,Head and Neck Neuroendocrine Tumor,0.6777,Head and Neck Liposarcoma,0.6749,HEAD AND NECK SQUAMOUS,True,True,True
HEAD AND NECK SQUAMOUS CELL CARCINOMA,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,1.0000,Head and Neck Cutaneous Squamous Cell Carcinoma,0.8900,Head and Neck Carcinoma,0.8580,Head and Neck Sebaceous Carcinoma,0.8135,Advanced Head and Neck Squamous Cell Carcinoma,0.8110,Head and Neck Neuroendocrine Carcinoma,0.7752,Advanced Head and Neck Cutaneous Squamous Cell Carcinoma,0.7678,Head and Neck Keratinizing Squamous Cell Carcinoma,0.7630,Locally Advanced Head and Neck Squamous Cell Carcinoma,0.7509,Head and Neck Small Cell Neuroendocrine Carcinoma,0.7505,ASPH-Positive Head and Neck Squamous Cell Carcinoma,0.7423,Metastatic Head and Neck Squamous Cell Carcinoma,0.7368,Head and Neck Sarcoma,0.7324,Locally Advanced Head and Neck Cutaneous Squamous Cell Carcinoma,0.7281,Resectable Head and Neck Squamous Cell Carcinoma,0.7258,Head and Neck Neoplasm,0.7253,Locally Recurrent Head and Neck Squamous Cell Carcinoma,0.7246,Head and Neck Basaloid Squamous Cell Carcinoma,0.7242,Head and Neck NUT Carcinoma,0.7238,Head and Neck Merkel Cell Carcinoma,0.7168,HEAD AND NECK SQUAMOUS CELL CARCINOMA,True,True,True
HEAD AND NECK SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY,Head and Neck Squamous Cell Carcinoma,6,2,Head and Neck Carcinoma of Unknown Primary,0.9247,Neck Squamous Cell Carcinoma of Unknown Primary,0.8733,Squamous Cell Carcinoma of Unknown Primary,0.8351,Human Papillomavirus-Negative Neck Squamous Cell Carcinoma of Unknown Primary,0.7784,Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary,0.7760,Head and Neck Squamous Cell Carcinoma,0.7310,Undifferentiated Carcinoma of Unknown Primary,0.7291,Carcinoma of Unknown Primary,0.7203,Head and Neck Cutaneous Squamous Cell Carcinoma,0.7045,Neuroendocrine Carcinoma of Unknown Primary,0.7024,Recurrent Neck Squamous Cell Carcinoma of Unknown Primary,0.6853,Unresectable Head and Neck Cutaneous Squamous Cell Carcinoma,0.6839,Locally Advanced Head and Neck Cutaneous Squamous Cell Carcinoma,0.6769,Locally Advanced Squamous Cell Carcinoma of Unknown Primary,0.6696,Unresectable Head and Neck Squamous Cell Carcinoma,0.6685,Locally Advanced Head and Neck Squamous Cell Carcinoma,0.6604,Unresectable Head and Neck Carcinoma,0.6430,Head and Neck Neuroendocrine Carcinoma,0.6407,Head and Neck Sebaceous Carcinoma,0.6392,Advanced Head and Neck Cutaneous Squamous Cell Carcinoma,0.6311,HEAD AND NECK SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY,False,False,False
HEAD AND NECK SQUAMOUS CELL CARCINOMAÃƒÅ ,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.7226,Unresectable Head and Neck Squamous Cell Carcinoma,0.6717,Advanced Head and Neck Squamous Cell Carcinoma,0.6661,Head and Neck Cutaneous Squamous Cell Carcinoma,0.6587,Head and Neck Carcinoma,0.6564,Resectable Head and Neck Squamous Cell Carcinoma,0.6558,Unresectable Head and Neck Cutaneous Squamous Cell Carcinoma,0.6539,Unresectable Head and Neck Carcinoma,0.6524,Advanced Head and Neck Cutaneous Squamous Cell Carcinoma,0.6479,Head and Neck Sebaceous Carcinoma,0.6325,ASPH-Positive Head and Neck Squamous Cell Carcinoma,0.6319,Locally Advanced Head and Neck Squamous Cell Carcinoma,0.6302,Resectable Head and Neck Cutaneous Squamous Cell Carcinoma,0.6292,Recurrent Head and Neck Squamous Cell Carcinoma,0.6255,Head and Neck Neuroendocrine Carcinoma,0.6224,Head and Neck Carcinoma of Unknown Primary,0.6201,Locally Advanced Head and Neck Cutaneous Squamous Cell Carcinoma,0.6135,Head and Neck Cutaneous Squamous Cell Carcinoma by AJCC v8 Stage,0.6122,Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma,0.6070,Metastatic Head and Neck Squamous Cell Carcinoma,0.6048,HEAD AND NECK SQUAMOUS CELL CARCINOMAÃƒÅ,True,True,True
HEAD_NECK_CANCER,Head and Neck Carcinoma,1,2,Head and Neck Carcinoma,0.9038,Head and Neck Neoplasm,0.8615,Malignant Head and Neck Neoplasm,0.8178,Head and Neck Neuroendocrine Carcinoma,0.7844,Head and Neck Neuroendocrine Neoplasm,0.7631,Head and Neck Squamous Cell Carcinoma,0.7526,Head and Neck Neuroendocrine Tumor,0.7470,Head and Neck Lymphoma,0.7374,Head and Neck NUT Carcinoma,0.7328,Childhood Head and Neck Neoplasm,0.7309,Advanced Head and Neck Carcinoma,0.7295,Neck Carcinoma,0.7245,Head and Neck Hematopoietic and Lymphoid Cell Neoplasm,0.7161,Head and Neck Germ Cell Tumor,0.7120,Metastatic Head and Neck Carcinoma,0.7051,Neck Neoplasm,0.6983,Childhood Malignant Head and Neck Neoplasm,0.6955,Head and Neck Sarcoma,0.6910,Benign Head and Neck Neoplasm,0.6876,Head and Neck Non-Hodgkin Lymphoma,0.6853,HEAD_NECK_CANCER,True,True,True
HEMANGIOBLASTOMA,Hemangioblastoma,1,2,Hemangioblastoma,1.0000,Hemangioma,0.9001,Cerebral Hemangioblastoma,0.8568,Medullary Hemangioblastoma,0.8532,Peripheral Hemangioblastoma,0.8474,Retinal Hemangioblastoma,0.8353,Kidney Hemangioblastoma,0.8224,Bone Hemangioma,0.8195,Venous Hemangioma,0.8180,Giant Hemangioma,0.8151,Capillary Hemangioma,0.8100,Infantile Hemangioma,0.8073,Congenital Hemangioma,0.8040,Hemangioblastic Meningioma,0.7904,Cerebellar Hemangioblastoma,0.7898,Deep Hemangioma,0.7880,Skin Hemangioma,0.7866,Hemangioendothelioma,0.7856,Cerebral Hemangioma,0.7829,Angiomatosis,0.7812,HEMANGIOBLASTOMA,True,True,True
HEMANGIOMA,Hemangioma,1,2,Hemangioma,1.0000,Skin Hemangioma,0.9051,Hemangioblastoma,0.9001,Venous Hemangioma,0.8888,Capillary Hemangioma,0.8883,Bone Hemangioma,0.8852,Congenital Hemangioma,0.8553,Cavernous Hemangioma,0.8527,Angiomatosis,0.8417,Giant Hemangioma,0.8332,Infantile Hemangioma,0.8322,Deep Hemangioma,0.8260,Intracranial Hemangioma,0.8124,Cardiac Hemangioma,0.8105,Cerebral Hemangioma,0.8099,Epithelioid Hemangioma,0.8096,Intramuscular Hemangioma,0.8075,Hemolymphangioma,0.8062,Acquired Hemangioma,0.8055,Anastomosing Hemangioma,0.8047,HEMANGIOMA,True,True,True
HEMANGIOPERICYTOMA OF THE CENTRAL NERVOUS SYSTEM,Meningeal Solitary Fibrous Tumor,99,2,Hemangiopericytoma,0.8036,Conventional Malignant Hemangiopericytoma,0.7613,Benign Hemangiopericytoma,0.7603,Hemangiopericytic Neoplasm,0.7571,Infantile Hemangiopericytoma,0.7519,Skin Hemangiopericytoma,0.7433,Malignant Hemangiopericytoma,0.7425,Primary Malignant Hemangiopericytoma,0.7378,Malignant Childhood Hemangiopericytoma,0.7356,Malignant Adult Hemangiopericytoma,0.7355,Orbit Hemangiopericytoma,0.7275,Central Nervous System Hemangioblastoma,0.7127,Kidney Hemangiopericytoma,0.7119,Well Differentiated Malignant Hemangiopericytoma,0.7119,Malignant Hemangiopericytoma NCI Grade 2,0.7111,Central Nervous System Hemangioma,0.7057,Malignant Skin Hemangiopericytoma,0.7036,Malignant Hemangiopericytoma NCI Grade 3,0.6929,Benign Kidney Hemangiopericytoma,0.6892,Benign Orbit Hemangiopericytoma,0.6889,HEMANGIOPERICYTOMA OF THE CENTRAL NERVOUS SYSTEM,False,False,False
HEPATOBILIARY CANCER,Liver Carcinoma,6,2,Hepatobiliary Neoplasm,0.8974,Malignant Hepatobiliary Neoplasm,0.8705,Biliary Tract Carcinoma,0.8218,Bile Duct Carcinoma,0.8117,Bile Duct Adenocarcinoma,0.7954,Liver Carcinoma,0.7900,Liver and Intrahepatic Bile Duct Carcinoma,0.7839,Bile Duct Neoplasm,0.7670,Liver and Intrahepatic Bile Duct Neoplasm,0.7534,Hepatoid Adenocarcinoma,0.7440,Hepatocellular Carcinoma,0.7341,Cholangiocarcinoma,0.7315,Malignant Liver Neoplasm,0.7308,Gallbladder Hepatoid Adenocarcinoma,0.7303,Bile Duct Adenoma,0.7219,Pancreatobiliary Carcinoma,0.7206,Liver Neoplasm,0.7200,Cholangiolocellular Carcinoma,0.7163,Advanced Biliary Tract Carcinoma,0.7096,Bladder Hepatoid Adenocarcinoma,0.7077,HEPATOBILIARY CANCER,False,False,False
HEPATOBLASTOMA,Hepatoblastoma,1,2,Hepatoblastoma,1.0000,Epithelial Hepatoblastoma,0.9266,Metastatic Hepatoblastoma,0.8405,Teratoid Hepatoblastoma,0.8375,Non-Teratoid Hepatoblastoma,0.8288,Unresectable Hepatoblastoma,0.8145,Hepatoblastoma with Pure Fetal Epithelial Differentiation,0.8079,Small Cell Undifferentiated Hepatoblastoma,0.8002,Mixed Epithelial and Mesenchymal Hepatoblastoma,0.7986,Refractory Hepatoblastoma,0.7862,PRETEXT III Hepatoblastoma,0.7705,PRETEXT II Hepatoblastoma,0.7663,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,0.7660,Macrotrabecular Hepatoblastoma,0.7619,PRETEXT IV Hepatoblastoma,0.7572,PRETEXT I Hepatoblastoma,0.7544,Hepatocellular Adenoma,0.7518,Hepatoid Adenocarcinoma,0.7502,Epithelial Hepatoblastoma with Pleomorphic Pattern,0.7493,Resectable Hepatoblastoma,0.7480,HEPATOBLASTOMA,True,True,True
HEPATOCELLULAR ADENOMA,Hepatocellular Adenoma,1,2,Hepatocellular Adenoma,1.0000,Inflammatory Hepatocellular Adenoma,0.8716,Hepatocellular Carcinoma,0.8205,HNF1alpha-Inactivated Hepatocellular Adenoma,0.7965,Hepatoid Adenocarcinoma,0.7746,Advanced Hepatocellular Carcinoma,0.7633,Unclassified Hepatocellular Adenoma,0.7631,Liver Neoplasm,0.7588,Adult Hepatocellular Carcinoma,0.7578,Liver Carcinoma,0.7534,Hepatoblastoma,0.7518,Locally Advanced Hepatocellular Carcinoma,0.7427,Beta-Catenin-Activated Hepatocellular Adenoma,0.7403,Hepatocellular Well Differentiated Carcinoma,0.7399,Small Hepatocellular Carcinoma,0.7399,Early Hepatocellular Carcinoma,0.7334,"Hepatocellular Malignant Neoplasm, Not Otherwise Specified",0.7267,Beta-Catenin-Activated Inflammatory Hepatocellular Adenoma,0.7267,Hepatocellular Poorly Differentiated Carcinoma,0.7264,Early Stage Hepatocellular Carcinoma,0.7250,HEPATOCELLULAR ADENOMA,True,True,True
HEPATOCELLULAR CARCINOMA,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,1.0000,Liver Carcinoma,0.8963,Advanced Hepatocellular Carcinoma,0.8738,Small Hepatocellular Carcinoma,0.8473,Adult Hepatocellular Carcinoma,0.8338,Early Hepatocellular Carcinoma,0.8331,Childhood Hepatocellular Carcinoma,0.8297,Hepatocellular Poorly Differentiated Carcinoma,0.8289,Hepatocellular Clear Cell Carcinoma,0.8263,Hepatocellular Adenoma,0.8205,Hepatocellular Well Differentiated Carcinoma,0.8068,Early Stage Hepatocellular Carcinoma,0.8022,Metastatic Hepatocellular Carcinoma,0.8009,Unresectable Hepatocellular Carcinoma,0.7859,Hepatoid Adenocarcinoma,0.7833,Locally Advanced Hepatocellular Carcinoma,0.7784,Hepatocellular Lymphocyte-Rich Carcinoma,0.7782,Adult Liver Carcinoma,0.7731,"Hepatocellular Malignant Neoplasm, Not Otherwise Specified",0.7721,Hepatocellular Neutrophil-Rich Carcinoma,0.7717,HEPATOCELLULAR CARCINOMA,True,True,True
HEPATOCELLULAR_CANCER,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.9106,"Hepatocellular Malignant Neoplasm, Not Otherwise Specified",0.8407,Liver Carcinoma,0.8326,Advanced Hepatocellular Carcinoma,0.7753,Malignant Liver Neoplasm,0.7681,Small Hepatocellular Carcinoma,0.7638,Childhood Hepatocellular Carcinoma,0.7608,Early Hepatocellular Carcinoma,0.7563,Hepatocellular Adenoma,0.7536,Hepatoid Adenocarcinoma,0.7515,Unresectable Hepatocellular Carcinoma,0.7470,Liver Neoplasm,0.7465,Hepatocellular Clear Cell Carcinoma,0.7413,Hepatocellular Poorly Differentiated Carcinoma,0.7368,Early Stage Hepatocellular Carcinoma,0.7346,Metastatic Hepatocellular Carcinoma,0.7336,Liver Undifferentiated Carcinoma,0.7331,Adult Hepatocellular Carcinoma,0.7226,Hepatocellular Well Differentiated Carcinoma,0.7174,Hepatocellular Sarcomatoid Carcinoma,0.7163,HEPATOCELLULAR_CANCER,True,True,True
HEPATOCELLULAR_CARCINOMA,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.9574,Liver Carcinoma,0.8689,Advanced Hepatocellular Carcinoma,0.8293,Small Hepatocellular Carcinoma,0.8170,"Hepatocellular Malignant Neoplasm, Not Otherwise Specified",0.7992,Early Hepatocellular Carcinoma,0.7985,Hepatocellular Clear Cell Carcinoma,0.7962,Hepatocellular Poorly Differentiated Carcinoma,0.7937,Childhood Hepatocellular Carcinoma,0.7855,Adult Hepatocellular Carcinoma,0.7767,Early Stage Hepatocellular Carcinoma,0.7729,Unresectable Hepatocellular Carcinoma,0.7699,Hepatoid Adenocarcinoma,0.7695,Hepatocellular Well Differentiated Carcinoma,0.7694,Metastatic Hepatocellular Carcinoma,0.7678,Hepatocellular Lymphocyte-Rich Carcinoma,0.7673,Hepatocellular Neutrophil-Rich Carcinoma,0.7660,Hepatocellular Adenoma,0.7622,Hepatocellular Sarcomatoid Carcinoma,0.7530,Hepatitis Virus-Related Hepatocellular Carcinoma,0.7486,HEPATOCELLULAR_CARCINOMA,True,True,True
HEPATOCHOLANGIOCARCINOMA MIXED,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,4,2,Mixed Carcinoma,0.7074,Mixed Cell Adenocarcinoma,0.6878,Mixed Cell Adenoma,0.6729,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,0.6719,Breast Mixed Carcinoma,0.6627,Gallbladder Mixed Adenoneuroendocrine Carcinoma,0.6588,Liver Mixed Adenoneuroendocrine Carcinoma,0.6582,Gastric Mixed Adenocarcinoma,0.6534,Hybrid Salivary Gland Carcinoma,0.6492,Gallbladder Hepatoid Adenocarcinoma,0.6474,Chondroid Chordoma,0.6313,Chondroid Lipoma,0.6286,Testicular Mixed Choriocarcinoma and Teratoma,0.6260,Hepatoid Adenocarcinoma,0.6225,Breast Mixed Ductal and Lobular Carcinoma,0.6206,Oligometastatic Intrahepatic Cholangiocarcinoma,0.6162,Gastric Hepatoid Adenocarcinoma,0.6153,Mixed Glioma,0.6151,Adrenal Cortical Mixed Cell Adenoma,0.6139,Bladder Hepatoid Adenocarcinoma,0.6100,HEPATOCHOLANGIOCARCINOMA MIXED,False,False,True
HEPTOCELLULAR CARCINOMA,Hepatocellular Carcinoma,7,2,Carcinoma,0.7286,Hepatocellular Chromophobe Carcinoma,0.6922,Squamous Cell Carcinoma,0.6890,Clear Cell Adenocarcinoma,0.6881,Water-Clear Cell Adenocarcinoma,0.6833,Papillary Carcinoma,0.6786,Hepatocellular Carcinoma,0.6711,Carcinoma Simplex,0.6655,Hepatocellular Clear Cell Carcinoma,0.6646,Papillary Squamous Cell Carcinoma,0.6580,Parathyroid Gland Carcinoma,0.6559,Glassy Cell Carcinoma,0.6551,Transitional Cell Carcinoma,0.6541,Lung Secretory Carcinoma,0.6525,Throat Carcinoma,0.6507,Adenocarcinoma,0.6493,Giant Cell Carcinoma,0.6474,Conjunctival Carcinoma,0.6463,Pilomatrical Carcinoma,0.6431,Small Hepatocellular Carcinoma,0.6406,HEPTOCELLULAR CARCINOMA,False,False,False
HER2,HER2-Positive Breast Carcinoma,1,2,HER2-Positive Breast Carcinoma,0.8027,HER2-Negative Breast Carcinoma,0.7605,HER2-Low Breast Carcinoma,0.7417,Advanced HER2-Positive Breast Carcinoma,0.7222,Advanced HER2-Negative Breast Carcinoma,0.6895,Metastatic HER2-Positive Breast Carcinoma,0.6804,Early Stage HER2-Negative Breast Carcinoma,0.6790,Advanced HER2-Low Breast Carcinoma,0.6670,Metastatic HER2-Negative Breast Carcinoma,0.6657,Refractory HER2-Positive Breast Carcinoma,0.6637,Refractory HER2-Negative Breast Carcinoma,0.6637,Recurrent HER2-Positive Breast Carcinoma,0.6517,Metastatic HER2-Low Breast Carcinoma,0.6508,Recurrent HER2-Negative Breast Carcinoma,0.6405,Locally Advanced HER2-Positive Breast Carcinoma,0.6378,Unresectable HER2-Positive Breast Carcinoma,0.6257,Unresectable HER2-Negative Breast Carcinoma,0.6246,Unresectable HER2-Low Breast Carcinoma,0.6079,Locally Advanced HER2-Negative Breast Carcinoma,0.5953,Triple-Negative Breast Carcinoma,0.5866,HER2,True,True,True
HER2-ENRICHED,HER2-Positive Breast Carcinoma,1,2,HER2-Positive Breast Carcinoma,0.8181,Advanced HER2-Positive Breast Carcinoma,0.7676,HER2-Negative Breast Carcinoma,0.7546,HER2-Low Breast Carcinoma,0.7386,Refractory HER2-Positive Breast Carcinoma,0.7328,Advanced HER2-Negative Breast Carcinoma,0.7185,Refractory HER2-Negative Breast Carcinoma,0.7165,Metastatic HER2-Positive Breast Carcinoma,0.7151,Advanced HER2-Low Breast Carcinoma,0.6976,Early Stage HER2-Negative Breast Carcinoma,0.6965,Recurrent HER2-Positive Breast Carcinoma,0.6898,Metastatic HER2-Negative Breast Carcinoma,0.6822,Locally Advanced HER2-Positive Breast Carcinoma,0.6772,Metastatic HER2-Low Breast Carcinoma,0.6663,Unresectable HER2-Positive Breast Carcinoma,0.6595,Recurrent HER2-Negative Breast Carcinoma,0.6573,Unresectable HER2-Negative Breast Carcinoma,0.6444,Unresectable HER2-Low Breast Carcinoma,0.6331,Locally Advanced HER2-Negative Breast Carcinoma,0.6235,Hormone Receptor-Positive Breast Carcinoma,0.6192,HER2-ENRICHED,True,True,True
HGGNOS,Malignant Glioma,4,2,High Grade Astrocytic Tumor,0.8232,High Grade Lymphoma,0.7980,High Grade Malignant Neoplasm,0.7770,Malignant Glioma,0.7323,Low Grade Glioma,0.7216,"Glioblastoma, Not Otherwise Specified",0.7109,Glioma,0.7034,Classical Glioblastoma,0.6986,Glioblastoma,0.6960,High Grade Sarcoma,0.6934,WHO Grade 1 Glioma,0.6873,Diffuse Glioma,0.6861,High Grade B-Cell Lymphoma,0.6861,Malignant Brain Glioma,0.6843,High Grade Adult Non-Hodgkin's Lymphoma,0.6823,WHO Grade 4 Glioma,0.6821,Supratentorial Glioblastoma,0.6804,WHO Grade 2 Glioma,0.6790,Advanced Glioblastoma,0.6741,Low Grade Astrocytoma,0.6657,"High-Grade Glioma, NOS",False,False,True
HGS,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.6497,Gastric Sarcoma,0.6404,Serous Neoplasm,0.6391,Gastric Synovial Sarcoma,0.6317,Gliosarcoma,0.6276,Ovarian Serous Tumor,0.6215,Sarcoma G1,0.6133,Malignant Ovarian Serous Tumor,0.6035,Benign Ovarian Serous Tumor,0.6023,High Grade Squamous Intraepithelial Neoplasia,0.5984,Sarcoma G2,0.5979,Sarcoma GX,0.5969,Serous Adenocarcinoma,0.5968,Primary Peritoneal High Grade Serous Adenocarcinoma,0.5965,Glioma,0.5964,Glioblastoma,0.5938,Sarcoma G3,0.5936,Advanced Ovarian High Grade Serous Adenocarcinoma,0.5900,High Grade Sarcoma,0.5883,Benign Gastric Gastrointestinal Stromal Tumor,0.5873,HGS,True,True,True
HGSOC,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.9176,Advanced Ovarian High Grade Serous Adenocarcinoma,0.8494,Malignant Ovarian Serous Tumor,0.8070,Ovarian Serous Adenocarcinoma,0.8038,Unresectable Ovarian High Grade Serous Adenocarcinoma,0.7953,Metastatic Ovarian High Grade Serous Adenocarcinoma,0.7941,Ovarian Serous Cystadenocarcinoma,0.7935,Ovarian Serous Tumor,0.7871,Advanced Ovarian Serous Adenocarcinoma,0.7760,Advanced Ovarian Serous Cystadenocarcinoma,0.7742,Ovarian Low Grade Serous Adenocarcinoma,0.7728,Primary Peritoneal High Grade Serous Adenocarcinoma,0.7671,Serous Adenocarcinoma,0.7582,Benign Ovarian Serous Tumor,0.7565,Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma,0.7493,Serous Neoplasm,0.7419,Recurrent Ovarian High Grade Serous Adenocarcinoma,0.7411,Ovarian Serous Cystadenoma,0.7335,Serous Cystadenocarcinoma,0.7327,Advanced Primary Peritoneal High Grade Serous Adenocarcinoma,0.7326,High-Grade Serous Ovarian Cancer,True,True,True
"HIGH-GRADE B-CELL LYMPHOMA, NOS","High Grade B-Cell Lymphoma, Not Otherwise Specified",2,2,High Grade B-Cell Lymphoma,0.9812,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.9320,High Grade B-Cell Non-Hodgkin's Lymphoma,0.9192,High Grade Burkitt-Like Lymphoma,0.8616,High Grade B-Cell Lymphoma with Blastoid Morphologic Features,0.8394,High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements,0.8257,High Grade Lymphoma,0.8098,"High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements",0.8075,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.7940,High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements,0.7882,High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements,0.7870,Low Grade B-Cell Non-Hodgkin's Lymphoma,0.7658,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7481,Recurrent High Grade B-Cell Lymphoma,0.7450,Refractory High Grade B-Cell Lymphoma,0.7429,"Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7380,"Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7288,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7270,B-Cell Non-Hodgkin Lymphoma,0.7237,Aggressive B-Cell Non-Hodgkin Lymphoma,0.7109,"HIGH-GRADE B-CELL LYMPHOMA, NOS",False,True,True
"HIGH-GRADE B-CELL LYMPHOMA, WITH MYC AND BCL2 AND/OR BCL6 REARRANGEMENTS",High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,3,2,High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements,0.9921,"High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements",0.9816,High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.9769,High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements,0.9600,High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements,0.9482,"Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements",0.8688,"Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements",0.8641,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.8604,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0.8478,High Grade B-Cell Lymphoma,0.8315,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.8168,High Grade B-Cell Non-Hodgkin's Lymphoma,0.8156,High Grade Burkitt-Like Lymphoma,0.7614,"Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7531,High Grade B-Cell Lymphoma with Blastoid Morphologic Features,0.7502,Refractory High Grade B-Cell Lymphoma,0.7457,"Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7260,Recurrent High Grade B-Cell Lymphoma,0.7210,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",0.7136,Refractory High Grade Burkitt-Like Lymphoma,0.7086,"HIGH-GRADE B-CELL LYMPHOMA, WITH MYC AND BCL2 AND/OR BCL6 REARRANGEMENTS",False,True,True
"HIGH-GRADE GLIOMA, NOS",Malignant Glioma,4,2,High Grade Astrocytic Tumor,0.8232,High Grade Lymphoma,0.7980,High Grade Malignant Neoplasm,0.7770,Malignant Glioma,0.7323,Low Grade Glioma,0.7216,"Glioblastoma, Not Otherwise Specified",0.7109,Glioma,0.7034,Classical Glioblastoma,0.6986,Glioblastoma,0.6960,High Grade Sarcoma,0.6934,WHO Grade 1 Glioma,0.6873,Diffuse Glioma,0.6861,High Grade B-Cell Lymphoma,0.6861,Malignant Brain Glioma,0.6843,High Grade Adult Non-Hodgkin's Lymphoma,0.6823,WHO Grade 4 Glioma,0.6821,Supratentorial Glioblastoma,0.6804,WHO Grade 2 Glioma,0.6790,Advanced Glioblastoma,0.6741,Low Grade Astrocytoma,0.6657,"HIGH-GRADE GLIOMA, NOS",False,False,True
HIGH-GRADE NEUROENDOCRINE CARCINOMA OF THE COLON AND RECTUM,Colorectal Neuroendocrine Carcinoma,2,2,Colon Neuroendocrine Carcinoma,0.7820,Colorectal Neuroendocrine Carcinoma,0.7774,Colon Large Cell Neuroendocrine Carcinoma,0.7682,Colorectal Large Cell Neuroendocrine Carcinoma,0.7680,Rectal Large Cell Neuroendocrine Carcinoma,0.7553,Rectal Neuroendocrine Carcinoma,0.7495,Colon Neuroendocrine Tumor G3,0.7248,Colon Neuroendocrine Neoplasm,0.7214,Colon Neuroendocrine Tumor,0.7171,Colorectal Neuroendocrine Neoplasm,0.7170,Colorectal Neuroendocrine Tumor G3,0.7090,Colon Neuroendocrine Tumor G2,0.7083,Colon Small Cell Neuroendocrine Carcinoma,0.7081,Colorectal Neuroendocrine Tumor,0.7079,Colorectal Neuroendocrine Tumor G2,0.7031,Colon Neuroendocrine Tumor G1,0.6997,Colorectal Neuroendocrine Tumor G1,0.6976,Rectal Neuroendocrine Tumor G3,0.6948,Colorectal Small Cell Neuroendocrine Carcinoma,0.6911,Digestive System Large Cell Neuroendocrine Carcinoma,0.6828,HIGH-GRADE NEUROENDOCRINE CARCINOMA OF THE COLON AND RECTUM,False,True,True
HIGH-GRADE SEROUS FALLOPIAN TUBE CANCER,Fallopian Tube High Grade Serous Adenocarcinoma,1,2,Fallopian Tube High Grade Serous Adenocarcinoma,0.9398,Advanced Fallopian Tube High Grade Serous Adenocarcinoma,0.8866,Metastatic Fallopian Tube High Grade Serous Adenocarcinoma,0.8576,Low Grade Fallopian Tube Serous Adenocarcinoma,0.8486,Platinum-Resistant Fallopian Tube High Grade Serous Adenocarcinoma,0.8336,Recurrent Fallopian Tube High Grade Serous Adenocarcinoma,0.8335,Fallopian Tube Serous Adenocarcinoma,0.8331,Fallopian Tube Serous Neoplasm,0.8265,Unresectable Fallopian Tube High Grade Serous Adenocarcinoma,0.8232,Platinum-Refractory Fallopian Tube High Grade Serous Adenocarcinoma,0.7925,Refractory Fallopian Tube High Grade Serous Adenocarcinoma,0.7859,Borderline Fallopian Tube Serous Tumor,0.7733,Fallopian Tube Serous Papilloma,0.7572,Ovarian High Grade Serous Adenocarcinoma,0.7558,Fallopian Tube Serous Cystadenofibroma,0.7350,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,0.7319,Recurrent Platinum-Resistant Fallopian Tube High Grade Serous Adenocarcinoma,0.7296,Fallopian Tube Carcinosarcoma,0.7173,Advanced Fallopian Tube Carcinoma,0.7150,Fallopian Tube Adenosarcoma,0.7140,HIGH-GRADE SEROUS FALLOPIAN TUBE CANCER,True,True,True
HIGH-GRADE SEROUS OVARIAN CANCER,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.9176,Advanced Ovarian High Grade Serous Adenocarcinoma,0.8494,Malignant Ovarian Serous Tumor,0.8070,Ovarian Serous Adenocarcinoma,0.8038,Unresectable Ovarian High Grade Serous Adenocarcinoma,0.7953,Metastatic Ovarian High Grade Serous Adenocarcinoma,0.7941,Ovarian Serous Cystadenocarcinoma,0.7935,Ovarian Serous Tumor,0.7871,Advanced Ovarian Serous Adenocarcinoma,0.7760,Advanced Ovarian Serous Cystadenocarcinoma,0.7742,Ovarian Low Grade Serous Adenocarcinoma,0.7728,Primary Peritoneal High Grade Serous Adenocarcinoma,0.7671,Serous Adenocarcinoma,0.7582,Benign Ovarian Serous Tumor,0.7565,Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma,0.7493,Serous Neoplasm,0.7419,Recurrent Ovarian High Grade Serous Adenocarcinoma,0.7411,Ovarian Serous Cystadenoma,0.7335,Serous Cystadenocarcinoma,0.7327,Advanced Primary Peritoneal High Grade Serous Adenocarcinoma,0.7326,HIGH-GRADE SEROUS OVARIAN CANCER,True,True,True
HIGH_GRADE_SEROUS,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.7958,Primary Peritoneal High Grade Serous Adenocarcinoma,0.7629,Serous Neoplasm,0.7534,Advanced Ovarian High Grade Serous Adenocarcinoma,0.7463,High Grade Sarcoma,0.7408,Advanced Primary Peritoneal High Grade Serous Adenocarcinoma,0.7355,High Grade Lymphoma,0.7253,Serous Adenocarcinoma,0.7106,Metastatic Ovarian High Grade Serous Adenocarcinoma,0.7098,Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma,0.7055,Unresectable Ovarian High Grade Serous Adenocarcinoma,0.7032,Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma,0.7017,Malignant Ovarian Serous Tumor,0.6971,Recurrent Ovarian High Grade Serous Adenocarcinoma,0.6968,Serous Cystadenocarcinoma,0.6904,Advanced Endometrial Serous Adenocarcinoma,0.6886,High Grade Malignant Neoplasm,0.6873,Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma,0.6855,Metastatic Primary Peritoneal High Grade Serous Adenocarcinoma,0.6846,Refractory Ovarian High Grade Serous Adenocarcinoma,0.6830,HIGH_GRADE_SEROUS,True,True,True
HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS,Histiocytic and Dendritic Cell Neoplasm,1,2,Histiocytic and Dendritic Cell Neoplasm,0.9910,Cutaneous Histiocytic and Dendritic Cell Neoplasm,0.8795,Central Nervous System Histiocytic and Dendritic Cell Neoplasm,0.8401,Head and Neck Histiocytic and Dendritic Cell Neoplasm,0.8182,Thyroid Gland Histiocytic and Dendritic Cell Neoplasm,0.7861,True Histiocytic Lymphoma,0.7774,Histiocytosis,0.7610,Malignant Histiocytosis,0.7486,Recurrent Histiocytic and Dendritic Cell Neoplasm,0.7256,Langerhans Cell Histiocytosis,0.7182,"Malignant Lymphoma, Histiocytic, Diffuse",0.7161,Refractory Histiocytic and Dendritic Cell Neoplasm,0.7147,Hematopoietic and Lymphoid Cell Neoplasm,0.7107,Histiocytoma,0.7081,"Langerhans Cell Histiocytosis, Disseminated",0.7002,"Dendritic Cell Tumor, Not Otherwise Specified",0.6985,Histiocytic Sarcoma,0.6961,Cutaneous Hematopoietic and Lymphoid Cell Neoplasm,0.6863,Cutaneous Langerhans Cell Histiocytosis,0.6809,Bone Langerhans Cell Histiocytosis,0.6786,HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS,True,True,True
HISTIOCYTIC DENDRITIC CELL SARCOMA,Histiocytic and Dendritic Cell Neoplasm,2,2,Histiocytic Sarcoma,0.8684,Histiocytic and Dendritic Cell Neoplasm,0.7707,Follicular Dendritic Cell Sarcoma,0.7699,Interdigitating Dendritic Cell Sarcoma,0.7603,Malignant Histiocytosis,0.7519,"Malignant Lymphoma, Histiocytic, Diffuse",0.7454,True Histiocytic Lymphoma,0.7449,Conventional Follicular Dendritic Cell Sarcoma,0.7432,Central Nervous System Histiocytic Sarcoma,0.7335,Histiocytosis,0.7171,Cutaneous Histiocytic and Dendritic Cell Neoplasm,0.7106,Skin Histiocytic Fibrous Histiocytoma,0.7057,Histiocytoma,0.6993,Thyroid Gland Follicular Dendritic Cell Sarcoma,0.6966,Langerhans Cell Sarcoma,0.6957,Differentiated Granulocytic Sarcoma,0.6938,"Langerhans Cell Histiocytosis, Disseminated",0.6935,Myeloid Sarcoma,0.6883,Fibroblastic Reticular Cell Sarcoma,0.6785,"Langerhans Cell Histiocytosis, Polyostotic",0.6780,HISTIOCYTIC DENDRITIC CELL SARCOMA,False,True,True
HISTIOCYTIC SARCOMA,Histiocytic Sarcoma,1,2,Histiocytic Sarcoma,1.0000,True Histiocytic Lymphoma,0.8393,Histiocytoma,0.8321,Malignant Histiocytosis,0.8278,Histiocytosis,0.7876,Sarcoma,0.7727,Fibrous Histiocytoma,0.7708,Myeloid Sarcoma,0.7666,Granulocytic Sarcoma,0.7644,"Malignant Lymphoma, Histiocytic, Diffuse",0.7641,Central Nervous System Histiocytic Sarcoma,0.7590,Skin Histiocytic Fibrous Histiocytoma,0.7585,Giant Cell Sarcoma,0.7215,Bone Sarcoma,0.7155,Skin Fibrous Histiocytoma,0.7133,Fibroblastic Reticular Cell Sarcoma,0.7115,Differentiated Granulocytic Sarcoma,0.7078,High Grade Sarcoma,0.7048,Deep Fibrous Histiocytoma,0.7042,Fibrous Histiocytoma of Bone,0.7031,HISTIOCYTIC SARCOMA,True,True,True
HISTIOCYTIC_LYMPHOMA,True Histiocytic Lymphoma,1,2,True Histiocytic Lymphoma,0.9395,"Malignant Lymphoma, Histiocytic, Diffuse",0.8460,Histiocytic Sarcoma,0.8388,Malignant Histiocytosis,0.8377,Histiocytosis,0.8326,Histiocytoma,0.8063,Histiocytic and Dendritic Cell Neoplasm,0.7824,Langerhans Cell Histiocytosis,0.7104,Lymphoma,0.7016,Lymphoplasmacytic Lymphoma,0.6974,Cutaneous Histiocytic and Dendritic Cell Neoplasm,0.6846,Bone Langerhans Cell Histiocytosis,0.6720,Fibrous Histiocytoma,0.6711,"Langerhans Cell Histiocytosis, Polyostotic",0.6680,Cutaneous Langerhans Cell Histiocytosis,0.6647,Central Nervous System Histiocytic Sarcoma,0.6640,Thyroid Gland Histiocytic and Dendritic Cell Neoplasm,0.6605,Skin Histiocytic Fibrous Histiocytoma,0.6586,"Langerhans Cell Histiocytosis, Disseminated",0.6563,"Malignant Lymphoma, Large Cell Type",0.6469,HISTIOCYTIC_LYMPHOMA,True,True,True
HNSC,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,1.0000,Head and Neck Cutaneous Squamous Cell Carcinoma,0.8900,Head and Neck Carcinoma,0.8580,Head and Neck Sebaceous Carcinoma,0.8135,Advanced Head and Neck Squamous Cell Carcinoma,0.8110,Head and Neck Neuroendocrine Carcinoma,0.7752,Advanced Head and Neck Cutaneous Squamous Cell Carcinoma,0.7678,Head and Neck Keratinizing Squamous Cell Carcinoma,0.7630,Locally Advanced Head and Neck Squamous Cell Carcinoma,0.7509,Head and Neck Small Cell Neuroendocrine Carcinoma,0.7505,ASPH-Positive Head and Neck Squamous Cell Carcinoma,0.7423,Metastatic Head and Neck Squamous Cell Carcinoma,0.7368,Head and Neck Sarcoma,0.7324,Locally Advanced Head and Neck Cutaneous Squamous Cell Carcinoma,0.7281,Resectable Head and Neck Squamous Cell Carcinoma,0.7258,Head and Neck Neoplasm,0.7253,Locally Recurrent Head and Neck Squamous Cell Carcinoma,0.7246,Head and Neck Basaloid Squamous Cell Carcinoma,0.7242,Head and Neck NUT Carcinoma,0.7238,Head and Neck Merkel Cell Carcinoma,0.7168,Head and Neck Squamous Cell Carcinoma,True,True,True
HODGKIN LYMPHOMA,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,1.0000,Classic Hodgkin Lymphoma,0.9222,Hodgkin Lymphoma by Clinical Course,0.8548,Adult Hodgkin Lymphoma,0.8326,Cerebral Hodgkin Lymphoma,0.8264,Childhood Hodgkin Lymphoma,0.8209,Advanced Hodgkin Lymphoma,0.8199,Lung Hodgkin Lymphoma,0.8146,Hodgkin's Sarcoma,0.8128,Hodgkin's Granuloma,0.8010,Colon Hodgkin Lymphoma,0.8000,Gastric Hodgkin Lymphoma,0.7957,Digestive System Hodgkin Lymphoma,0.7916,Pharyngeal Hodgkin Lymphoma,0.7673,Salivary Gland Hodgkin Lymphoma,0.7657,Colorectal Hodgkin Lymphoma,0.7619,Thymus Hodgkin Lymphoma,0.7586,Adult Classic Hodgkin Lymphoma,0.7546,Splenic Hodgkin Lymphoma,0.7536,Nasopharyngeal Hodgkin Lymphoma,0.7530,HODGKIN LYMPHOMA,True,True,True
HODGKINS,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,0.8911,Classic Hodgkin Lymphoma,0.8436,Hodgkin's Granuloma,0.8278,Hodgkin's Sarcoma,0.8169,Hodgkin Lymphoma by Clinical Course,0.7740,Cerebral Hodgkin Lymphoma,0.7737,Advanced Hodgkin Lymphoma,0.7656,Pharyngeal Hodgkin Lymphoma,0.7553,Lung Hodgkin Lymphoma,0.7514,Hodgkin's Paragranuloma,0.7504,Adult Hodgkin Lymphoma,0.7477,Colon Hodgkin Lymphoma,0.7431,Childhood Hodgkin Lymphoma,0.7364,Gastric Hodgkin Lymphoma,0.7287,Digestive System Hodgkin Lymphoma,0.7260,Splenic Hodgkin Lymphoma,0.7244,Colorectal Hodgkin Lymphoma,0.7121,Nasopharyngeal Hodgkin Lymphoma,0.7079,Hodgkin's Lymphoma (Antiquated),0.7077,Salivary Gland Hodgkin Lymphoma,0.7038,HODGKINS,True,True,True
HODGKIN_LYMPHOMA,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,0.9540,Classic Hodgkin Lymphoma,0.8824,Hodgkin Lymphoma by Clinical Course,0.8554,Hodgkin's Sarcoma,0.8070,Cerebral Hodgkin Lymphoma,0.7997,Advanced Hodgkin Lymphoma,0.7969,Adult Hodgkin Lymphoma,0.7947,Hodgkin's Granuloma,0.7886,Childhood Hodgkin Lymphoma,0.7873,Lung Hodgkin Lymphoma,0.7871,Digestive System Hodgkin Lymphoma,0.7768,Gastric Hodgkin Lymphoma,0.7699,Colon Hodgkin Lymphoma,0.7654,Non-Hodgkin Lymphoma,0.7582,Pharyngeal Hodgkin Lymphoma,0.7517,Recurrent Hodgkin Lymphoma,0.7509,Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma,0.7456,Transformed Small Lymphocytic Lymphoma to Hodgkin Lymphoma,0.7450,Colorectal Hodgkin Lymphoma,0.7378,Salivary Gland Hodgkin Lymphoma,0.7362,HODGKIN_LYMPHOMA,True,True,True
HURTHLE,Thyroid Gland Oncocytic Carcinoma,99,2,Branchioma,0.5847,Leukemia,0.5588,Acute Leukemia,0.5487,Myeloid Leukemia,0.5472,Glioblastoma,0.5470,Liquid Tumor,0.5436,Acute Undifferentiated Leukemia,0.5414,Hepatoblastoma,0.5401,Halo Nevus,0.5396,Aleukemic Leukemia,0.5352,Astrocytoma,0.5288,Meningioma,0.5276,Acute Monocytic Leukemia,0.5269,Adenoma,0.5248,Sialoblastoma,0.5220,Unfavorable Hodgkin Lymphoma,0.5190,Ovarian Hilus Cell Tumor,0.5183,Early Unfavorable Hodgkin Lymphoma,0.5174,Neuroblastoma,0.5161,Aleukemic Myeloid Leukemia,0.5156,HURTHLE,False,False,False
HURTHLE CELL THYROID CANCER,Thyroid Gland Oncocytic Carcinoma,1,2,Thyroid Gland Oncocytic Carcinoma,0.7098,Thyroid Gland Anaplastic Carcinoma,0.6877,Thyroid Gland Oncocytic Neoplasm,0.6779,Thyroid Gland Adenocarcinoma,0.6748,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.6696,Thyroid Gland Carcinoma,0.6682,Thyroid Gland Histiocytic and Dendritic Cell Neoplasm,0.6607,Hobnail Variant Thyroid Gland Papillary Carcinoma,0.6575,Thyroid Gland Clear Cell Follicular Adenoma,0.6561,Thyroid Gland Follicular Carcinoma,0.6458,Thyroid Gland Langerhans Cell Histiocytosis,0.6422,Thyroid Gland Oncocytic Adenoma,0.6385,Thyroid Gland Undifferentiated Small Cell Carcinoma,0.6384,Differentiated Thyroid Gland Carcinoma,0.6367,Thyroid Gland Secretory Carcinoma,0.6362,"Thyroid Gland Follicular Carcinoma, Clear Cell Variant",0.6346,Thyroid Gland Mucinous Carcinoma,0.6339,Poorly Differentiated Thyroid Gland Carcinoma,0.6338,Thyroid Gland Medullary Carcinoma,0.6334,Oncocytic Adenocarcinoma,0.6312,HURTHLE CELL THYROID CANCER,True,True,True
HYPERMUTATED,Hypermutated Colorectal Carcinoma,1,2,Hypermutated Colorectal Carcinoma,0.6924,High Grade Malignant Neoplasm,0.6209,Hypermutated/MMRd Endometrial Endometrioid Adenocarcinoma,0.6036,Multiple Myeloma with Hyperdiploidy,0.5946,Hereditary Malignant Neoplasm,0.5830,High Grade Sarcoma,0.5680,Hereditary Melanoma,0.5627,Somatic-Type Malignancy,0.5621,High Grade Lymphoma,0.5620,Hereditary Meningioma,0.5584,Aggravated Malignant Neoplasm,0.5571,MGMT-Unmethylated Glioblastoma,0.5547,Undifferentiated Malignant Neoplasm,0.5512,Malignant Neoplasm,0.5503,Advanced Malignant Neoplasm,0.5463,High Grade Appendix Mucinous Neoplasm,0.5459,Multifocal Glioblastomas,0.5449,Disseminated Malignant Neoplasm,0.5441,High-CSD Melanoma,0.5438,Malignant Glioma,0.5436,HYPERMUTATED,True,True,True
HYPOPHARYNGEAL,Hypopharyngeal Squamous Cell Carcinoma,7,2,Benign Hypopharyngeal Neoplasm,0.8429,Hypopharyngeal Carcinoma,0.8102,Malignant Hypopharyngeal Neoplasm,0.8016,Hypopharyngeal Neoplasm,0.7900,Hypopharyngeal Verrucous Carcinoma,0.6963,Benign Parapharyngeal Neoplasm,0.6815,Hypopharyngeal Squamous Cell Carcinoma,0.6782,Metastatic Malignant Neoplasm in the Hypopharynx,0.6590,Locally Advanced Hypopharyngeal Carcinoma,0.6589,Metastatic Hypopharyngeal Carcinoma,0.6571,Hypopharyngeal Carcinoma by AJCC v6 Stage,0.6535,Stage I Hypopharyngeal Carcinoma AJCC v6,0.6485,Recurrent Hypopharyngeal Carcinoma,0.6484,Recurrent Malignant Hypopharyngeal Neoplasm,0.6428,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8",0.6399,Stage II Hypopharyngeal Carcinoma AJCC v8,0.6343,Stage I Hypopharyngeal Carcinoma AJCC v7,0.6327,Hypopharyngeal Carcinoma by AJCC v8 Stage,0.6326,Stage I Hypopharyngeal Carcinoma AJCC v8,0.6321,Hypopharyngeal Carcinoma by AJCC v7 Stage,0.6316,HYPOPHARYNGEAL,False,False,False
HYPOPHARYNX SQUAMOUS CELL CARCINOMA,Hypopharyngeal Squamous Cell Carcinoma,1,2,Hypopharyngeal Squamous Cell Carcinoma,0.9792,Hypopharyngeal Spindle Cell Squamous Carcinoma,0.8868,Hypopharyngeal Carcinoma,0.8736,Hypopharyngeal Papillary Squamous Cell Carcinoma,0.8562,Hypopharyngeal Basaloid Squamous Cell Carcinoma,0.8046,Advanced Hypopharyngeal Squamous Cell Carcinoma,0.8022,Metastatic Hypopharyngeal Squamous Cell Carcinoma,0.7713,Locally Advanced Hypopharyngeal Squamous Cell Carcinoma,0.7554,Hypopharyngeal Verrucous Carcinoma,0.7537,Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma,0.7169,Hypopharyngeal Neoplasm,0.7143,Recurrent Hypopharyngeal Squamous Cell Carcinoma,0.7090,Hypopharyngeal Carcinoma by AJCC v6 Stage,0.6917,Metastatic Hypopharyngeal Carcinoma,0.6887,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7,0.6861,Malignant Hypopharyngeal Neoplasm,0.6814,Unresectable Hypopharyngeal Squamous Cell Carcinoma,0.6773,Hypopharyngeal Carcinoma by AJCC v7 Stage,0.6773,Refractory Hypopharyngeal Squamous Cell Carcinoma,0.6772,Locally Advanced Hypopharyngeal Carcinoma,0.6771,HYPOPHARYNX SQUAMOUS CELL CARCINOMA,True,True,True
IDC,Invasive Breast Carcinoma of No Special Type,15,2,Breast Ductal Carcinoma,0.9054,Breast Ductal Carcinoma In Situ,0.8745,Invasive Breast Carcinoma,0.8687,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8460,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8318,Poorly Differentiated Invasive Breast Carcinoma,0.8280,Well Differentiated Invasive Breast Carcinoma,0.8256,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.8198,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.8175,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.8130,Invasive Breast Lobular Carcinoma,0.8080,Metastatic Breast Ductal Carcinoma,0.8003,"Breast Ductal Carcinoma In Situ, High Grade",0.7991,"Breast Ductal Carcinoma In Situ, Solid Type",0.7948,Invasive Breast Carcinoma of No Special Type,0.7899,"Breast Ductal Carcinoma In Situ, Non-Comedo Type",0.7878,"Breast Ductal Carcinoma In Situ, Comedo Type",0.7872,Breast Papillary Ductal Carcinoma In Situ,0.7818,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.7723,Breast Carcinoma,0.7686,Breast Invasive Ductal Carcinoma,False,False,False
IMMATURE TERATOMA,Immature Teratoma,1,2,Immature Teratoma,1.0000,Childhood Immature Teratoma,0.9459,Central Nervous System Immature Teratoma,0.9149,Mature Teratoma,0.9085,Teratoma,0.9054,Childhood Teratoma,0.8964,Childhood Mature Teratoma,0.8905,Childhood Central Nervous System Immature Teratoma,0.8879,Testicular Immature Teratoma,0.8877,Benign Teratoma,0.8836,Intermediate Immature Teratoma,0.8809,Immature Ovarian Teratoma,0.8791,Adult Central Nervous System Immature Teratoma,0.8718,Adult Teratoma,0.8692,Immature Extragonadal Teratoma,0.8560,Childhood Testicular Immature Teratoma,0.8533,Childhood Ovarian Immature Teratoma,0.8428,Mediastinal Immature Teratoma,0.8425,Childhood Central Nervous System Mature Teratoma,0.8344,Grade 1 Teratoma,0.8298,IMMATURE TERATOMA,True,True,True
IMMUNOBLASTIC,Immunoblastic Lymphoma,1,2,Immunoblastic Lymphoma,0.9535,Adult Immunoblastic Lymphoma,0.8219,Childhood Immunoblastic Lymphoma,0.7951,Thyroid Gland Immunoblastic Lymphoma,0.7147,Recurrent Immunoblastic Lymphoma,0.7114,AIDS-Related Immunoblastic Lymphoma,0.7096,Refractory Immunoblastic Lymphoma,0.7039,Intravascular Large B-Cell Lymphoma,0.6884,Ann Arbor Stage I Adult Immunoblastic Lymphoma,0.6873,Ann Arbor Stage IV Adult Immunoblastic Lymphoma,0.6650,Blastoma,0.6532,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0.6459,Centroblastic Lymphoma,0.6317,High Grade B-Cell Lymphoma,0.6314,Lymphoma,0.6300,Recurrent Adult Immunoblastic Lymphoma,0.6296,Ann Arbor Stage III Adult Immunoblastic Lymphoma,0.6245,Intermediate Grade Lymphoma,0.6175,Ann Arbor Stage II Adult Immunoblastic Lymphoma,0.6086,High Grade B-Cell Lymphoma with Blastoid Morphologic Features,0.6071,IMMUNOBLASTIC,True,True,True
INFANTILE FIBROSARCOMA,Infantile Fibrosarcoma,1,2,Infantile Fibrosarcoma,1.0000,Childhood Fibrosarcoma,0.9023,Fibrosarcoma,0.8346,Infantile Myofibroma,0.8234,Conventional Fibrosarcoma,0.8146,Adult Fibrosarcoma,0.8046,Advanced Fibrosarcoma,0.7961,Localized Fibrosarcoma,0.7923,Small Intestinal Fibrosarcoma,0.7848,Infantile Myofibromatosis 1,0.7551,Fibrous Hamartoma of Infancy,0.7550,Kidney Fibrosarcoma,0.7525,Unresectable Fibrosarcoma,0.7510,Cardiac Fibrosarcoma,0.7503,Locally Advanced Fibrosarcoma,0.7471,Soft Tissue Fibrosarcoma,0.7462,Well Differentiated Fibrosarcoma,0.7455,Bone Fibrosarcoma,0.7439,Fascial Fibrosarcoma,0.7380,Childhood Inflammatory Myofibroblastic Tumor,0.7377,INFANTILE FIBROSARCOMA,True,True,True
INFANTILE MYOFIBROMA,Infantile Myofibroma,1,2,Infantile Myofibroma,1.0000,Infantile Myofibromatosis 1,0.8964,Infantile Myofibromatosis 2,0.8689,Myofibroma,0.8505,Myofibromatosis,0.8359,Childhood Inflammatory Myofibroblastic Tumor,0.8301,Myofibroblastoma,0.8260,Infantile Fibrosarcoma,0.8234,Adult Myofibroma,0.8219,Fibrous Hamartoma of Infancy,0.7977,Inflammatory Myofibroblastic Tumor,0.7589,Infantile Hemangioma,0.7487,Childhood Low Grade Myofibroblastic Sarcoma,0.7433,Childhood Fibrosarcoma,0.7394,Cellular Fibroma,0.7347,Childhood Fibrous Histiocytoma,0.7298,Congenital Peribronchial Myofibroblastic Tumor,0.7285,Fibroma,0.7279,Angiomyofibroblastoma,0.7253,Fibromatosis,0.7220,INFANTILE MYOFIBROMA,True,True,True
INFANTILE SARCOMA,Infantile Fibrosarcoma,2,2,Childhood Sarcoma,0.8621,Infantile Fibrosarcoma,0.8086,Sarcoma,0.7855,Childhood Bone Sarcoma,0.7796,Intimal Sarcoma,0.7638,Childhood Soft Tissue Sarcoma,0.7559,Childhood Synovial Sarcoma,0.7478,Cerebellar Sarcoma,0.7401,Infantile Myofibroma,0.7391,Small Intestinal Sarcoma,0.7386,Sarcomatosis,0.7375,Small Intestinal Myeloid Sarcoma,0.7335,Myeloid Sarcoma,0.7297,Sarcoma G1,0.7271,Localized Childhood Soft Tissue Sarcoma,0.7232,Infantile Hemangioma,0.7224,Childhood Kaposi Sarcoma,0.7165,Localized Sarcoma,0.7163,Bone Sarcoma,0.7161,Childhood Gastrointestinal Stromal Tumor,0.7133,INFANTILE SARCOMA,False,True,True
INFILTRATING CARCINOMA NOS,Invasive Breast Carcinoma,5,2,Invasive Carcinoma,0.8694,Invasive Malignant Neoplasm,0.7609,Invasive Cervical Carcinoma,0.7482,Carcinoma,0.7330,Invasive Breast Carcinoma,0.7221,Invasive Urothelial Carcinoma,0.7065,Invasive Prostate Carcinoma,0.7047,Submucosal Invasive Colon Adenocarcinoma,0.6914,Advanced Carcinoma,0.6891,Invasive Bladder Carcinoma,0.6873,Invasive Conventional Urothelial Carcinoma,0.6861,Invasive Papillary Adenocarcinoma,0.6824,Invasive Breast Carcinoma of No Special Type,0.6810,Intramucosal Adenocarcinoma,0.6781,Invasive Cutaneous Melanoma,0.6745,Adenocarcinoma,0.6713,Carcinoma Unspecified Site,0.6698,Poorly Differentiated Invasive Breast Carcinoma,0.6552,Invasive Breast Lobular Carcinoma,0.6510,Early Invasive Cervical Adenocarcinoma,0.6478,INFILTRATING CARCINOMA NOS,False,False,True
INFILTRATING DUCTAL & LOBULAR,Breast Mixed Ductal and Lobular Carcinoma,7,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8078,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8003,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.7842,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.7817,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.7761,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.7566,Breast Mixed Ductal and Lobular Carcinoma,0.7371,Invasive Breast Lobular Carcinoma,0.6994,Breast Intraductal Neoplasm,0.6851,Breast Ductal Carcinoma In Situ,0.6819,Diffuse Intraductal Papillomatosis,0.6754,Breast Ductal Hyperplasia,0.6711,Well Differentiated Invasive Breast Carcinoma,0.6681,Breast Lobular Neoplasia,0.6651,Breast Intraductal Proliferative Lesion,0.6632,Infiltrating Lipoma,0.6607,Poorly Differentiated Invasive Breast Carcinoma,0.6555,"Breast Ductal Carcinoma In Situ, High Grade",0.6549,Breast Lobular Carcinoma In Situ,0.6540,Breast Intraductal Papillomatosis,0.6522,INFILTRATING DUCTAL & LOBULAR,False,False,False
INFILTRATING DUCTAL AND LOBULAR CARCINOMA,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,1,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9456,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9235,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.9100,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.9036,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.8953,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.8517,Invasive Breast Lobular Carcinoma,0.8355,Breast Mixed Ductal and Lobular Carcinoma,0.8285,Breast Lobular Carcinoma,0.7694,Breast Ductal Carcinoma,0.7540,Breast Lobular Carcinoma In Situ,0.7515,Breast Classic Lobular Carcinoma In Situ,0.7501,Breast Ductal Carcinoma In Situ,0.7467,Breast Classic Lobular Carcinoma In Situ Type B,0.7415,"Invasive Breast Lobular Carcinoma, Alveolar Variant",0.7378,Poorly Differentiated Invasive Breast Carcinoma,0.7302,Invasive Breast Lobular Carcinoma with Predominant In Situ Component,0.7291,Well Differentiated Invasive Breast Carcinoma,0.7274,Invasive Breast Carcinoma,0.7273,Breast Classic Lobular Carcinoma In Situ Type A,0.7185,INFILTRATING DUCTAL AND LOBULAR CARCINOMA,True,True,True
INFILTRATING DUCTAL CARCINOMA,Invasive Breast Carcinoma of No Special Type,19,2,Breast Ductal Carcinoma,0.8583,Breast Ductal Carcinoma In Situ,0.7955,Poorly Differentiated Invasive Breast Carcinoma,0.7916,Invasive Breast Carcinoma,0.7840,Well Differentiated Invasive Breast Carcinoma,0.7726,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7701,"Breast Ductal Carcinoma In Situ, Comedo Type",0.7535,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7518,Invasive Breast Lobular Carcinoma,0.7498,Invasive Carcinoma,0.7476,Metastatic Breast Ductal Carcinoma,0.7452,"Breast Ductal Carcinoma In Situ, High Grade",0.7408,"Breast Ductal Carcinoma In Situ, Solid Type",0.7359,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.7354,"Breast Ductal Carcinoma In Situ, Non-Comedo Type",0.7353,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.7351,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.7333,Salivary Gland Intraductal Carcinoma,0.7327,Invasive Breast Carcinoma of No Special Type,0.7242,Breast Papillary Ductal Carcinoma In Situ,0.7218,INFILTRATING DUCTAL CARCINOMA,False,False,False
INFILTRATING LOBULAR CARCINOMA,Invasive Breast Lobular Carcinoma,1,2,Invasive Breast Lobular Carcinoma,0.9204,Breast Lobular Carcinoma,0.8643,Breast Lobular Carcinoma In Situ,0.7974,Breast Classic Lobular Carcinoma In Situ,0.7889,Invasive Breast Lobular Carcinoma with Predominant In Situ Component,0.7655,"Invasive Breast Lobular Carcinoma, Alveolar Variant",0.7643,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7634,Breast Classic Lobular Carcinoma In Situ Type B,0.7595,Metastatic Breast Lobular Carcinoma,0.7573,Breast Classic Lobular Carcinoma In Situ Type A,0.7543,"Invasive Breast Lobular Carcinoma, Solid Variant",0.7530,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7490,"Invasive Breast Lobular Carcinoma, Tubulolobular Variant",0.7374,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.7280,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.7278,Invasive Breast Lobular Carcinoma with Extracellular Mucin,0.7241,Infiltrating Lipoma,0.7225,Invasive Breast Carcinoma,0.7197,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.7183,Breast Florid Lobular Carcinoma In Situ,0.7116,INFILTRATING LOBULAR CARCINOMA,True,True,True
INFILTRATING TUBULAR CARCINOMA,Breast Tubular Carcinoma,3,2,Invasive Tubular Urothelial Carcinoma,0.8428,Tubular Adenocarcinoma,0.8425,Breast Tubular Carcinoma,0.7760,Invasive Bladder Tubular Urothelial Carcinoma,0.7753,Adenocarcinoma in Tubular Adenoma,0.7557,Invasive Carcinoma,0.7518,Gastric Tubular Adenocarcinoma,0.7415,Tubular Neoplasm,0.7218,Adenocarcinoma In Situ in Tubular Adenoma,0.7122,"Invasive Breast Lobular Carcinoma, Tubulolobular Variant",0.6926,Invasive Urothelial Carcinoma,0.6920,Invasive Conventional Urothelial Carcinoma,0.6889,Colon Tubular Adenoma,0.6870,Sweat Gland Tubular Carcinoma,0.6852,Invasive Prostate Carcinoma,0.6846,Colorectal Tubular Adenoma,0.6793,Invasive Cervical Carcinoma,0.6753,Intramucosal Adenocarcinoma,0.6685,Invasive Papillary Adenocarcinoma,0.6669,Transitional Cell Carcinoma,0.6660,INFILTRATING TUBULAR CARCINOMA,False,True,True
INFLAMMATORY BREAST CANCER,Breast Inflammatory Carcinoma,1,2,Breast Inflammatory Carcinoma,0.9682,Metastatic Breast Inflammatory Carcinoma,0.8558,Unresectable Breast Inflammatory Carcinoma,0.8514,Recurrent Breast Inflammatory Carcinoma,0.8204,Breast Carcinoma,0.7902,Breast Inflammatory Myofibroblastic Tumor,0.7463,Invasive Breast Carcinoma,0.7454,Breast Adenocarcinoma,0.7355,Breast Secretory Carcinoma,0.7339,Breast Ductal Carcinoma,0.7323,Sporadic Breast Carcinoma,0.7318,Stage IV Breast Inflammatory Carcinoma,0.7304,Breast Lymphoma,0.7181,Breast Tubular Carcinoma,0.7179,Childhood Breast Carcinoma,0.7171,Breast Metaplastic Carcinoma,0.7126,Metastatic Triple-Negative Breast Inflammatory Carcinoma,0.7094,Breast Neoplasm,0.7054,Female Breast Carcinoma,0.7049,Breast Oncocytic Carcinoma,0.7039,INFLAMMATORY BREAST CANCER,True,True,True
INFLAMMATORY MYOFIBROBLASTIC LUNG TUMOR,Lung Inflammatory Myofibroblastic Tumor,1,2,Lung Inflammatory Myofibroblastic Tumor,0.9860,Inflammatory Myofibroblastic Tumor,0.8594,Laryngeal Inflammatory Myofibroblastic Tumor,0.8410,Liver Inflammatory Myofibroblastic Tumor,0.8217,Cardiac Inflammatory Myofibroblastic Tumor,0.7904,Bladder Inflammatory Myofibroblastic Tumor,0.7887,Prostate Inflammatory Myofibroblastic Tumor,0.7878,Breast Inflammatory Myofibroblastic Tumor,0.7667,Gastric Inflammatory Myofibroblastic Tumor,0.7533,Lung Fibroma,0.7527,Abdominal Inflammatory Myofibroblastic Tumor,0.7474,Congenital Peribronchial Myofibroblastic Tumor,0.7462,Childhood Inflammatory Myofibroblastic Tumor,0.7391,Digestive System Inflammatory Myofibroblastic Tumor,0.7267,Retroperitoneal Inflammatory Myofibroblastic Tumor,0.7267,Lung Myoepithelial Tumor,0.7247,Myofibroblastoma,0.7207,Myofibromatosis,0.7143,Myofibroma,0.7067,Central Nervous System Inflammatory Myofibroblastic Tumor,0.7064,INFLAMMATORY MYOFIBROBLASTIC LUNG TUMOR,True,True,True
INFLAMMATORY MYOFIBROBLASTIC TUMOR,Inflammatory Myofibroblastic Tumor,1,2,Inflammatory Myofibroblastic Tumor,1.0000,Bladder Inflammatory Myofibroblastic Tumor,0.8556,Cardiac Inflammatory Myofibroblastic Tumor,0.8542,Lung Inflammatory Myofibroblastic Tumor,0.8452,Breast Inflammatory Myofibroblastic Tumor,0.8443,Gastric Inflammatory Myofibroblastic Tumor,0.8438,Liver Inflammatory Myofibroblastic Tumor,0.8386,Prostate Inflammatory Myofibroblastic Tumor,0.8372,Childhood Inflammatory Myofibroblastic Tumor,0.8225,Abdominal Inflammatory Myofibroblastic Tumor,0.8219,Digestive System Inflammatory Myofibroblastic Tumor,0.8201,Myofibromatosis,0.8064,Central Nervous System Inflammatory Myofibroblastic Tumor,0.8014,Myofibroma,0.7988,Myofibroblastoma,0.7980,Retroperitoneal Inflammatory Myofibroblastic Tumor,0.7880,Head and Neck Inflammatory Myofibroblastic Tumor,0.7852,Uterine Corpus Inflammatory Myofibroblastic Tumor,0.7721,Laryngeal Inflammatory Myofibroblastic Tumor,0.7685,Infantile Myofibroma,0.7589,INFLAMMATORY MYOFIBROBLASTIC TUMOR,True,True,True
INITIAL CNS TUMOR,Central Nervous System Neoplasm,11,2,Intracranial Neoplasm,0.7127,Primary Brain Neoplasm,0.7029,Primary Central Nervous System Neoplasm,0.6992,Cerebral Neoplasm,0.6746,Brain Neoplasm,0.6617,Childhood Intracranial Neoplasm,0.6587,Primary Neoplasm,0.6559,Localized Cerebral Neoplasm,0.6496,Intracranial Germinoma,0.6457,Localized Brain Neoplasm,0.6417,Central Nervous System Neoplasm,0.6317,Secondary Neoplasm,0.6231,Unresectable Glioneuronal and Neuronal Tumors,0.6227,Childhood Brain Neoplasm,0.6222,Neuroblastic Tumor,0.6218,Recurrent Intracranial Neoplasm,0.6210,Malignant Intracranial Neoplasm,0.6200,Intracranial Melanoma,0.6199,Childhood Infratentorial Neoplasm,0.6198,Localized Malignant Brain Neoplasm,0.6195,INITIAL CNS TUMOR,False,False,False
INITIAL CNS TUMOR FIRST HGG RECORD,Central Nervous System Neoplasm,99,2,Gliomatosis Cerebri Type I,0.6272,Refractory WHO Grade 1 Glioma,0.6080,WHO Grade 1 Glioma,0.5956,Resectable Glioma,0.5947,Recurrent WHO Grade 1 Glioma,0.5899,Gliomatosis Cerebri,0.5881,Adult Intracranial Germ Cell Tumor,0.5798,Childhood Glioblastoma,0.5773,Glioma,0.5771,Childhood Gliomatosis Cerebri,0.5746,Rosette-Forming Glioneuronal Tumor,0.5715,Infant-Type Hemispheric Glioma,0.5681,Resectable Glioblastoma,0.5655,Unresectable Glioma,0.5621,Classical Glioblastoma,0.5619,Cerebral Glioblastoma,0.5616,Grade 1 Intracranial Meningioma,0.5605,Intracranial Germinoma,0.5596,Childhood Granular Cell Tumor,0.5591,Unresectable Glioneuronal and Neuronal Tumors,0.5559,INITIAL CNS TUMOR FIRST HGG RECORD,False,False,False
INITIAL CNS TUMOR LAST INITIAL,Central Nervous System Neoplasm,99,2,Progressive Hairy Cell Leukemia Initial Treatment,0.6218,Localized Brain Neoplasm,0.6078,Localized Cerebral Neoplasm,0.6058,Intracranial Germinoma,0.5899,Localized Malignant Brain Neoplasm,0.5790,Cerebral Lymphoma,0.5730,Gliomatosis Cerebri,0.5655,Brain Low Grade Glioma,0.5642,Intracranial Neoplasm,0.5637,Locally Advanced Glioma,0.5591,Localized Lymphoma,0.5591,Adult Intracranial Germ Cell Tumor,0.5560,Intracranial Melanoma,0.5544,Gliomatosis Cerebri Type I,0.5514,Unresectable Low Grade Glioma,0.5512,Low Grade Glioma,0.5497,Glioma,0.5493,Recurrent Intracranial Neoplasm,0.5489,Unresectable Glioma,0.5488,Unresectable Glioneuronal and Neuronal Tumors,0.5479,INITIAL CNS TUMOR LAST INITIAL,False,False,False
INITIAL CNS TUMOR NEW LOCATION,Central Nervous System Neoplasm,99,2,Recurrent Intracranial Neoplasm,0.6699,Secondary Neoplasm,0.6586,Intracranial Neoplasm,0.6454,Recurrent Brain Neoplasm,0.6386,Primary Brain Neoplasm,0.6292,Recurrent Primary Central Nervous System Neoplasm,0.6234,Recurrent Childhood Central Nervous System Neoplasm,0.6226,Localized Brain Neoplasm,0.6221,Primary Central Nervous System Neoplasm,0.6213,Recurrent Childhood Brain Neoplasm,0.6192,Recurrent Glioneuronal and Neuronal Tumors,0.6178,Refractory Brain Neoplasm,0.6155,Neoplasm by Site,0.6145,Recurrent Nervous System Neoplasm,0.6109,Localized Cerebral Neoplasm,0.6086,Primary Neoplasm,0.6068,Refractory Childhood Brain Neoplasm,0.6032,Unresectable Glioneuronal and Neuronal Tumors,0.6029,Brain Neoplasm,0.6021,Nervous System Neoplasm by Obsolete Classification,0.5986,INITIAL CNS TUMOR NEW LOCATION,False,False,False
INTESTINAL TYPE MUCINOUS CARCINOMA,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",1,2,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.8602,Colorectal Mucinous Adenocarcinoma,0.8455,Mucinous Adenocarcinoma,0.8372,Small Intestinal Mucinous Adenocarcinoma,0.8362,"Endometrial Mucinous Adenocarcinoma, Intestinal-Type",0.8318,Colon Mucinous Adenocarcinoma,0.8295,Gastric Mucinous Adenocarcinoma,0.7859,"Sinonasal Adenocarcinoma, Intestinal-Type with Mucinous Pattern",0.7782,Mucin-Producing Carcinoma,0.7773,Appendix Mucinous Adenocarcinoma,0.7710,Cervical Mucinous Adenocarcinoma,0.7696,Metastatic Colorectal Mucinous Adenocarcinoma,0.7694,"Vaginal Mucinous Adenocarcinoma, Intestinal-Type",0.7684,Intestinal-Type Adenocarcinoma,0.7682,Mucin-Producing Adenocarcinoma,0.7631,Mucinous Neoplasm,0.7628,Invasive Lung Mucinous Adenocarcinoma,0.7582,Goblet Cell Adenocarcinoma,0.7550,Ovarian Mucinous Adenocarcinoma,0.7537,Gastric Intestinal-Type Adenocarcinoma,0.7510,INTESTINAL TYPE MUCINOUS CARCINOMA,True,True,True
INTESTINAL TYPE STOMACH ADENOCARCINOMA,Gastric Intestinal-Type Adenocarcinoma,1,2,Gastric Intestinal-Type Adenocarcinoma,0.9667,Intestinal-Type Adenocarcinoma,0.8869,"Gastric Adenoma, Intestinal-Type",0.8337,Gastric Adenocarcinoma,0.8321,Salivary Gland Intestinal-Type Adenocarcinoma,0.7962,Gastric Tubular Adenocarcinoma,0.7847,Sporadic Gastric Adenocarcinoma,0.7814,Small Intestinal Adenocarcinoma,0.7779,Gastric Intramucosal Adenocarcinoma,0.7769,Gastric Diffuse Adenocarcinoma,0.7754,Gastric Mixed Adenocarcinoma,0.7550,"Gallbladder Adenocarcinoma, Intestinal-Type",0.7480,Sporadic Gastric Diffuse Adenocarcinoma,0.7479,Gastric Carcinoma,0.7476,Goblet Cell Adenocarcinoma,0.7474,"Sinonasal Adenocarcinoma, Intestinal-Type",0.7456,Proximal Gastric Adenocarcinoma,0.7431,"Gastrointestinal Tract Adenoma, Intestinal-Type",0.7429,Intramucosal Adenocarcinoma,0.7310,Small Intestinal Mucinous Adenocarcinoma,0.7225,INTESTINAL TYPE STOMACH ADENOCARCINOMA,True,True,True
INTESTINAL_ADENOCARCINOMA,Gastric Intestinal-Type Adenocarcinoma,2,2,Intestinal-Type Adenocarcinoma,0.9330,Gastric Intestinal-Type Adenocarcinoma,0.8417,Small Intestinal Adenocarcinoma,0.8372,Colorectal Adenocarcinoma,0.8032,Malignant Intestinal Neoplasm,0.7966,Inflammatory Bowel Disease-Associated Colorectal Adenocarcinoma,0.7875,Colon Adenocarcinoma,0.7865,Adenocarcinoma,0.7804,Intestinal Neoplasm,0.7595,Salivary Gland Intestinal-Type Adenocarcinoma,0.7579,Cecum Adenocarcinoma,0.7557,Intramucosal Adenocarcinoma,0.7482,Small Intestinal Carcinoma,0.7453,"Sinonasal Adenocarcinoma, Intestinal-Type",0.7453,Malignant Ileal Neoplasm,0.7424,Jejunal Adenocarcinoma,0.7405,Crohn Disease-Associated Colorectal Adenocarcinoma,0.7343,Gastric Adenocarcinoma,0.7330,Colon Intramucosal Adenocarcinoma,0.7328,"Gastrointestinal Tract Adenoma, Intestinal-Type",0.7302,INTESTINAL_ADENOCARCINOMA,False,True,True
INTIMAL SARCOMA,Intimal Sarcoma,1,2,Intimal Sarcoma,1.0000,Pulmonary Artery Intimal Sarcoma,0.7605,Sarcoma,0.7341,Stromal Sarcoma,0.7220,Skin Sarcoma,0.7075,Kidney Sarcoma,0.7045,Epithelial Synovial Sarcoma,0.7035,Synovial Sarcoma,0.7007,Undifferentiated Stromal Sarcoma,0.6995,Conjunctival Sarcoma,0.6977,Small Intestinal Sarcoma,0.6954,Orbital Sarcoma,0.6896,Tracheal Sarcoma,0.6875,Ovarian Sarcoma,0.6822,Myeloid Sarcoma,0.6817,Sarcomatosis,0.6769,Odontogenic Sarcoma,0.6741,Small Intestinal Myeloid Sarcoma,0.6725,Cardiac Sarcoma,0.6712,Childhood Sarcoma,0.6710,INTIMAL SARCOMA,True,True,True
INTRACHOLECYSTIC PAPILLARY NEOPLASM,Gallbladder Intracholecystic Papillary Neoplasm,1,2,Gallbladder Intracholecystic Papillary Neoplasm,0.9051,"Gallbladder Intracholecystic Papillary Neoplasm, Low Grade",0.7850,Papillary Cystic Neoplasm,0.7831,"Gallbladder Intracholecystic Papillary Neoplasm, High Grade",0.7652,Gallbladder Intracholecystic Papillary Neoplasm with an Associated Invasive Carcinoma,0.7106,Papillary Cystadenoma,0.7068,Papillary Neoplasm,0.7028,Breast Intracystic Papillary Carcinoma,0.6989,Pancreatic Cystic Neoplasm,0.6972,Papillary Epithelial Neoplasm,0.6902,Intraductal Papilloma,0.6872,Papillary Cystadenocarcinoma,0.6745,Breast Papillary Neoplasm,0.6661,Intraductal Papillomatosis,0.6659,Lacrimal Drainage System Inverted Papilloma,0.6618,Gallbladder Papillary Adenoma,0.6611,Cystic Neoplasm,0.6584,Papillary Adenoma,0.6566,Clear Cell Papillary Cystadenoma,0.6565,Syringocystadenoma Papilliferum,0.6484,INTRACHOLECYSTIC PAPILLARY NEOPLASM,True,True,True
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,Pancreatic Intraductal Papillary-Mucinous Neoplasm,1,2,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.9316,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.8882,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.8864,Minor Salivary Gland Intraductal Papillary-Mucinous Neoplasm,0.8843,Intraductal Papillomatosis,0.8500,Breast Intraductal Papillary Neoplasm,0.8485,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0.8479,Pancreatic Intraductal Papillary-Mucinous Carcinoma,0.8472,Intraductal Papilloma,0.8454,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.8419,"Pancreatic Intraductal Papillary-Mucinous Neoplasm, Low Grade",0.8304,"Pancreatic Intraductal Papillary-Mucinous Neoplasm, High Grade",0.8264,Minor Salivary Gland Intraductal Papillary Neoplasm,0.8181,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0.8155,Bile Duct Intraductal Papillary Neoplasm,0.8145,Pancreatic Intraductal Papillary-Mucinous Neoplasm with Intermediate Grade Dysplasia,0.8126,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",0.8087,Breast Intraductal Papilloma,0.8080,Pancreatic Intraductal Neoplasm,0.8072,Intrahepatic Bile Duct Intraductal Papillary Neoplasm,0.8017,INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,True,True,True
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM WITH AN ASSOCIATED INVASIVE CARCINOMA,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,1,2,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.9473,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,0.8668,Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma,0.8466,Intrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma,0.8459,Pancreatic Intraductal Papillary-Mucinous Carcinoma,0.8405,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0.8331,Intrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0.8084,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.7932,Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0.7887,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0.7722,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.7638,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.7578,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.7531,Pancreatic Intraductal Papillary-Mucinous Neoplasm with Intermediate Grade Dysplasia,0.7520,Minor Salivary Gland Intraductal Papillary-Mucinous Neoplasm,0.7502,Invasive Breast Carcinoma of No Special Type with Predominant Intraductal Component,0.7494,Gallbladder Intracholecystic Papillary Neoplasm with an Associated Invasive Carcinoma,0.7470,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0.7455,Extrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma,0.7365,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0.7307,INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM WITH AN ASSOCIATED INVASIVE CARCINOMA,True,True,True
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM WITH INVASION,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,2,2,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.8608,Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma,0.8515,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0.8406,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.8205,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.8157,Pancreatic Intraductal Papillary-Mucinous Carcinoma,0.8117,Pancreatic Intraductal Papillary-Mucinous Neoplasm with Intermediate Grade Dysplasia,0.8099,Minor Salivary Gland Intraductal Papillary-Mucinous Neoplasm,0.8049,Breast Intraductal Papillary Neoplasm,0.7998,"Pancreatic Intraductal Papillary-Mucinous Neoplasm, High Grade",0.7898,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.7872,Intraductal Papillomatosis,0.7820,Pancreatic Intraductal Neoplasm,0.7771,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0.7763,Intrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma,0.7705,Intraductal Papilloma,0.7689,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0.7621,Breast Intraductal Papilloma,0.7619,Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma,0.7610,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",0.7599,INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM WITH INVASION,False,True,True
INTRADUCTAL TUBULOPAPILLARY NEOPLASM,Pancreatic Intraductal Tubulopapillary Neoplasm,1,2,Pancreatic Intraductal Tubulopapillary Neoplasm,0.9427,Intraductal Papilloma,0.8223,Bile Duct Intraductal Papillary Neoplasm,0.8181,Intraductal Papillomatosis,0.8179,Minor Salivary Gland Intraductal Papillary Neoplasm,0.8080,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,0.7993,Intrahepatic Bile Duct Intraductal Papillary Neoplasm,0.7965,Pancreatic Intraductal Neoplasm,0.7961,Salivary Gland Intraductal Papilloma,0.7828,Breast Intraductal Papillary Neoplasm,0.7811,Focal Intraductal Papillomatosis,0.7686,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.7670,Diffuse Intraductal Papillomatosis,0.7668,Minor Salivary Gland Intraductal Papillary-Mucinous Neoplasm,0.7643,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.7588,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.7537,Breast Intraductal Papilloma,0.7533,Extrahepatic Bile Duct Intraductal Papillary Neoplasm,0.7505,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0.7338,"Bile Duct Intraductal Papillary Neoplasm, Low Grade",0.7283,INTRADUCTAL TUBULOPAPILLARY NEOPLASM,True,True,True
INTRAHEPATIC CHOLANGIOCARCINOMA,Intrahepatic Cholangiocarcinoma,1,2,Intrahepatic Cholangiocarcinoma,1.0000,Cholangiocarcinoma,0.9069,Advanced Intrahepatic Cholangiocarcinoma,0.9050,Clear Cell Intrahepatic Cholangiocarcinoma,0.8996,Small Duct Intrahepatic Cholangiocarcinoma,0.8914,Unresectable Intrahepatic Cholangiocarcinoma,0.8905,Large Duct Intrahepatic Cholangiocarcinoma,0.8721,Metastatic Intrahepatic Cholangiocarcinoma,0.8593,Locally Advanced Intrahepatic Cholangiocarcinoma,0.8575,Hilar Cholangiocarcinoma,0.8515,Mucin-Producing Intrahepatic Cholangiocarcinoma,0.8498,Unresectable Cholangiocarcinoma,0.8485,Sarcomatoid Intrahepatic Cholangiocarcinoma,0.8201,Distal Cholangiocarcinoma,0.8127,Advanced Cholangiocarcinoma,0.8089,Adult Cholangiocarcinoma,0.8081,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7,0.7991,Unresectable Hilar Cholangiocarcinoma,0.7990,Oligometastatic Intrahepatic Cholangiocarcinoma,0.7987,Locally Advanced Cholangiocarcinoma,0.7958,INTRAHEPATIC CHOLANGIOCARCINOMA,True,True,True
INVASIVE BREAST CANCER,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,0.9758,Invasive Breast Carcinoma of No Special Type,0.8711,Invasive Female Breast Carcinoma,0.8284,Breast Carcinoma,0.8239,Invasive Male Breast Carcinoma,0.8128,Invasive Carcinoma,0.7995,Invasive Breast Lobular Carcinoma,0.7803,Advanced Breast Carcinoma,0.7766,Sporadic Breast Carcinoma,0.7677,Microinvasive Breast Carcinoma,0.7642,Invasive Breast Carcinoma by Histologic Grade,0.7627,Invasive Malignant Neoplasm,0.7588,Well Differentiated Invasive Breast Carcinoma,0.7580,Breast Adenocarcinoma,0.7565,Invasive Breast Papillary Carcinoma,0.7548,Early Stage Breast Carcinoma,0.7545,Invasive Bladder Carcinoma,0.7517,Malignant Breast Neoplasm,0.7517,Breast Ductal Carcinoma,0.7419,Poorly Differentiated Invasive Breast Carcinoma,0.7395,INVASIVE BREAST CANCER,True,True,True
INVASIVE BREAST CARCINOMA,Invasive Breast Carcinoma,1,2,Invasive Breast Carcinoma,1.0000,Invasive Breast Carcinoma of No Special Type,0.8875,Invasive Female Breast Carcinoma,0.8550,Breast Carcinoma,0.8507,Invasive Male Breast Carcinoma,0.8358,Invasive Carcinoma,0.8283,Invasive Breast Lobular Carcinoma,0.8229,Advanced Breast Carcinoma,0.7969,Invasive Breast Carcinoma by Histologic Grade,0.7901,Well Differentiated Invasive Breast Carcinoma,0.7897,Microinvasive Breast Carcinoma,0.7873,Breast Ductal Carcinoma,0.7833,Invasive Breast Papillary Carcinoma,0.7821,Poorly Differentiated Invasive Breast Carcinoma,0.7814,Sporadic Breast Carcinoma,0.7760,Invasive Bladder Carcinoma,0.7751,Early Stage Breast Carcinoma,0.7671,Breast Adenocarcinoma,0.7632,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7555,Invasive Cervical Carcinoma,0.7513,INVASIVE BREAST CARCINOMA,True,True,True
INVASIVE DUCTAL AND LOBULAR CARCINOMA,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,1,2,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.9588,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.9348,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.9085,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.9033,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.9014,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.8487,Invasive Breast Lobular Carcinoma,0.8474,Breast Mixed Ductal and Lobular Carcinoma,0.8254,Invasive Breast Carcinoma,0.7627,Breast Ductal Carcinoma,0.7609,Breast Lobular Carcinoma,0.7576,"Invasive Breast Lobular Carcinoma, Alveolar Variant",0.7531,Breast Classic Lobular Carcinoma In Situ,0.7527,Breast Ductal Carcinoma In Situ,0.7506,Breast Lobular Carcinoma In Situ,0.7479,Well Differentiated Invasive Breast Carcinoma,0.7461,Poorly Differentiated Invasive Breast Carcinoma,0.7357,Breast Classic Lobular Carcinoma In Situ Type B,0.7347,Invasive Breast Carcinoma of No Special Type,0.7307,Invasive Breast Lobular Carcinoma with Predominant In Situ Component,0.7262,INVASIVE DUCTAL AND LOBULAR CARCINOMA,True,True,True
INVASIVE MIXED DUCTAL AND LOBULAR CARCINOMA,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,3,2,Breast Mixed Ductal and Lobular Carcinoma,0.9166,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.8793,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8759,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.8281,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.8162,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.8145,Invasive Breast Lobular Carcinoma,0.7657,Breast Mixed Carcinoma,0.7601,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.7555,"Invasive Breast Lobular Carcinoma, Alveolar Variant",0.7440,Poorly Differentiated Invasive Breast Carcinoma,0.7218,Well Differentiated Invasive Breast Carcinoma,0.7209,Invasive Bladder Mixed Carcinoma,0.7162,Lung Adenocarcinoma with Mixed Bronchioloalveolar and Invasive Components,0.7136,Invasive Breast Lobular Carcinoma with Extracellular Mucin,0.7100,"Breast Ductal Carcinoma In Situ, Comedo Type",0.7069,"Invasive Breast Lobular Carcinoma, Pleomorphic Variant",0.7065,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7048,Breast Ductal Carcinoma,0.7037,Mixed Carcinoma,0.7020,INVASIVE MIXED DUCTAL AND LOBULAR CARCINOMA,False,True,True
INVASIVE MUCINOUS ADCA,Invasive Lung Mucinous Adenocarcinoma,2,2,Mucinous Adenocarcinoma,0.8297,Invasive Lung Mucinous Adenocarcinoma,0.8291,Cervical Invasive Stratified Mucinous Adenocarcinoma,0.8104,Appendix Mucinous Adenocarcinoma,0.8058,Salivary Gland Mucinous Adenocarcinoma,0.7900,Gastric Mucinous Adenocarcinoma,0.7862,Minimally Invasive Lung Mucinous Adenocarcinoma,0.7805,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.7798,Ovarian Mucinous Adenocarcinoma,0.7706,Anal Mucinous Adenocarcinoma,0.7687,Colorectal Mucinous Adenocarcinoma,0.7680,"Sinonasal Adenocarcinoma, Intestinal-Type with Mucinous Pattern",0.7667,Cervical Mucinous Adenocarcinoma,0.7655,Mucinous Cystadenocarcinoma,0.7643,"Endometrial Mucinous Adenocarcinoma, Intestinal-Type",0.7636,Small Intestinal Mucinous Adenocarcinoma,0.7621,Appendix Mucinous Cystadenocarcinoma,0.7610,Gallbladder Mucinous Adenocarcinoma,0.7554,Colon Mucinous Adenocarcinoma,0.7495,Endometrial Mucinous Adenocarcinoma,0.7464,INVASIVE MUCINOUS ADCA,False,True,True
INVASIVE MUCINOUS ADENOCARCINOMA 82533,Invasive Lung Mucinous Adenocarcinoma,3,2,Cervical Invasive Stratified Mucinous Adenocarcinoma,0.6863,Mucinous Adenocarcinoma,0.6853,Invasive Lung Mucinous Adenocarcinoma,0.6849,Salivary Gland Mucinous Adenocarcinoma,0.6703,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.6622,Gallbladder Mucinous Adenocarcinoma,0.6589,Appendix Mucinous Adenocarcinoma,0.6537,Mucin-Producing Adenocarcinoma,0.6529,Gastric Mucinous Adenocarcinoma,0.6522,Cervical Mucinous Adenocarcinoma,0.6492,Colorectal Mucinous Adenocarcinoma,0.6462,Mucinous Cystadenocarcinoma,0.6451,Goblet Cell Adenocarcinoma,0.6436,"Endometrial Mucinous Adenocarcinoma, Intestinal-Type",0.6425,Appendix Mucinous Cystadenocarcinoma,0.6357,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0.6342,Mucin-Producing Carcinoma,0.6321,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,0.6317,Bladder Mucinous Adenocarcinoma,0.6301,Colon Mucinous Adenocarcinoma,0.6282,INVASIVE MUCINOUS ADENOCARCINOMA 82533,False,True,True
INVASIVE-MUCINOUS,Invasive Lung Mucinous Adenocarcinoma,1,2,Invasive Lung Mucinous Adenocarcinoma,0.8008,Mucinous Neoplasm,0.7937,Mucinous Adenocarcinoma,0.7873,Cervical Invasive Stratified Mucinous Adenocarcinoma,0.7718,Invasive Carcinoma,0.7622,Invasive Malignant Neoplasm,0.7519,Salivary Gland Mucinous Adenocarcinoma,0.7237,Appendix Mucinous Neoplasm,0.7216,Endometrial Mucinous Adenocarcinoma,0.7115,Minimally Invasive Lung Mucinous Adenocarcinoma,0.7109,"Endometrial Mucinous Adenocarcinoma, Intestinal-Type",0.7108,Gastric Mucinous Adenocarcinoma,0.7093,Appendix Mucinous Adenocarcinoma,0.7084,Ovarian Mucinous Tumor,0.7026,Colorectal Mucinous Adenocarcinoma,0.7026,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.7017,Breast Mucinous Carcinoma,0.6986,Ovarian Mucinous Adenocarcinoma,0.6949,Mucinous Cystadenocarcinoma,0.6940,Intramucosal Adenocarcinoma,0.6921,INVASIVE-MUCINOUS,True,True,True
INVASIVE_DUCTAL_CARCINOMA,Invasive Breast Carcinoma of No Special Type,9,2,Breast Ductal Carcinoma,0.8225,Breast Ductal Carcinoma In Situ,0.7866,Invasive Breast Carcinoma,0.7802,Invasive Carcinoma,0.7721,Poorly Differentiated Invasive Breast Carcinoma,0.7550,"Breast Ductal Carcinoma In Situ, Solid Type",0.7461,Well Differentiated Invasive Breast Carcinoma,0.7457,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7454,Invasive Breast Carcinoma of No Special Type,0.7369,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7342,"Breast Ductal Carcinoma In Situ, Comedo Type",0.7263,Metastatic Breast Ductal Carcinoma,0.7260,"Breast Ductal Carcinoma In Situ, High Grade",0.7231,"Breast Ductal Carcinoma In Situ, Non-Comedo Type",0.7227,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.7214,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.7144,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.7086,Salivary Gland Intraductal Carcinoma,0.7033,Breast Papillary Ductal Carcinoma In Situ,0.6944,Salivary Duct Carcinoma,0.6924,INVASIVE_DUCTAL_CARCINOMA,False,False,False
ISLET CELL TUMOR,Pancreatic Neuroendocrine Tumor,5,2,Islet Cell Adenoma,0.8823,Pancreatic Insulinoma,0.8385,Pancreatic Insulin-Producing Neuroendocrine Tumor,0.8003,Pancreatic Polypeptide Tumor,0.7747,Pancreatic Neuroendocrine Tumor,0.7397,Pancreatic Beta Cell Adenoma,0.7353,Malignant Pancreatic Insulinoma,0.7305,Intestinal Neuroendocrine Tumor,0.7180,Pancreatic Glucagonoma,0.7102,Pancreatic Somatostatinoma,0.7000,Acinar Cell Neoplasm,0.6977,Pancreatic Acinar Cell Neoplasm,0.6971,Granular Cell Tumor,0.6968,Pancreatic Glucagon-Producing Neuroendocrine Tumor,0.6934,Pancreatic Exocrine Neoplasm,0.6905,Neuroendocrine Tumor,0.6903,Functioning Pancreatic Neuroendocrine Tumor,0.6901,Pancreatoblastoma,0.6874,Pancreatic G-Cell Adenoma,0.6871,Ileal Neuroendocrine Tumor,0.6865,ISLET CELL TUMOR,False,False,True
JUVENILE GRANULOSA CELL TUMOR,Juvenile Testicular Granulosa Cell Tumor,2,2,Juvenile Granulosa Cell Tumor,1.0000,Juvenile Testicular Granulosa Cell Tumor,0.9391,Juvenile Ovarian Granulosa Cell Tumor,0.9355,Granulosa Cell Tumor,0.8455,Adult Granulosa Cell Tumor,0.8079,Juvenile Bilateral Ovarian Granulosa Cell Tumor,0.7836,Testicular Granulosa Cell Tumor,0.7834,Ovarian Granulosa Cell Tumor,0.7827,Adult Testicular Granulosa Cell Tumor,0.7605,Childhood Granular Cell Tumor,0.7549,Adult Ovarian Granulosa Cell Tumor,0.7542,Childhood Nongerminomatous Germ Cell Tumor,0.7534,Childhood Germ Cell Tumor,0.7495,Granular Cell Tumor,0.7353,Granulosa Cell-Theca Cell Tumor,0.7345,Childhood Benign Germ Cell Tumor,0.7245,Non-Neural Granular Cell Tumor,0.7225,Childhood Gonadal Germ Cell Tumor,0.7204,Giant Cell Tumor,0.7189,Ovarian Granulosa-Stromal Cell Tumor,0.7186,JUVENILE GRANULOSA CELL TUMOR,False,True,True
JUVENILE SECRETORY CARCINOMA OF THE BREAST,Breast Secretory Carcinoma,1,2,Breast Secretory Carcinoma,0.8623,Breast Mucinous Carcinoma,0.7523,Childhood Breast Carcinoma,0.7346,Breast Columnar Cell Mucinous Carcinoma,0.7305,Breast Sebaceous Carcinoma,0.7291,Breast Apocrine Carcinoma,0.7243,Breast Metaplastic Carcinoma,0.7239,Breast Inflammatory Carcinoma,0.7149,Breast Squamous Cell Carcinoma,0.7113,Breast Adenoid Cystic Carcinoma,0.7083,Breast Ductal Carcinoma,0.7066,Sporadic Breast Carcinoma,0.7023,Invasive Breast Apocrine Carcinoma,0.6997,Breast Ductal Carcinoma with Squamous Metaplasia,0.6967,Breast Adenosquamous Carcinoma,0.6958,Breast Acinic Cell Carcinoma,0.6955,Breast Carcinoma,0.6926,Low Grade Breast Adenosquamous Carcinoma,0.6919,Breast Solid Neuroendocrine Carcinoma,0.6918,Juvenile Breast Fibroadenoma,0.6911,JUVENILE SECRETORY CARCINOMA OF THE BREAST,True,True,True
KERATOACANTHOMA,Skin Keratoacanthoma,1,2,Skin Keratoacanthoma,0.9679,Conjunctival Keratoacanthoma,0.8783,Melanoacanthoma,0.8177,Vulvar Keratoacanthoma,0.7997,Syringoacanthoma,0.7614,Skin Adnexal Adenoma,0.6628,Skin Keratotic Basal Cell Carcinoma,0.6616,Parotid Gland Keratocystoma,0.6472,Acanthoma,0.6468,Warty Dyskeratoma,0.6434,Epidermolytic Acanthoma,0.6431,Skin Papilloma,0.6345,Pilomatricoma,0.6314,Skin Adamantinoid Basal Cell Carcinoma,0.6313,Skin Adenosquamous Carcinoma,0.6282,Basal Cell Adenoma,0.6235,Cutaneous Amelanotic Melanoma,0.6185,Warty Carcinoma,0.6150,Childhood Pilomatricoma,0.6124,Superficial Acral Fibromyxoma,0.6104,KERATOACANTHOMA,True,True,True
KICH,Chromophobe Renal Cell Carcinoma,99,2,Intrahepatic Cholangiocarcinoma,0.6225,Cholangiocarcinoma,0.5964,Small Duct Intrahepatic Cholangiocarcinoma,0.5798,Advanced Intrahepatic Cholangiocarcinoma,0.5629,Iris Melanoma,0.5579,Sarcomatoid Intrahepatic Cholangiocarcinoma,0.5528,Clear Cell Intrahepatic Cholangiocarcinoma,0.5491,Lymphoma/Leukemia by Kiel Classification (Antiquated),0.5447,Hilar Cholangiocarcinoma,0.5434,Metastatic Intrahepatic Cholangiocarcinoma,0.5422,Early Hepatocellular Carcinoma,0.5412,Childhood Hepatocellular Carcinoma,0.5401,Childhood Kidney Carcinoma,0.5397,Retinoblastoma,0.5396,Distal Cholangiocarcinoma,0.5389,Unresectable Intrahepatic Cholangiocarcinoma,0.5381,Inverted Follicular Keratosis,0.5372,Oligometastatic Intrahepatic Cholangiocarcinoma,0.5335,Retinocytoma,0.5332,Littoral Cell Angioma,0.5330,KICH,False,False,False
KIDNEY CANCER,Kidney Carcinoma,1,2,Kidney Carcinoma,0.9605,Kidney Neoplasm,0.8823,Malignant Kidney Neoplasm,0.8723,Renal Cell Carcinoma,0.8574,Childhood Kidney Carcinoma,0.8203,Advanced Kidney Carcinoma,0.8060,Kidney Medullary Carcinoma,0.7881,Unresectable Kidney Carcinoma,0.7727,Kidney Adenoma,0.7708,Metastatic Kidney Carcinoma,0.7694,Kidney Carcinoma Molecular Subtypes,0.7689,Childhood Kidney Neoplasm,0.7682,Childhood Malignant Kidney Neoplasm,0.7603,Kidney Neuroendocrine Carcinoma,0.7599,"Renal Cell Carcinoma, Not Otherwise Specified",0.7572,Papillary Renal Cell Carcinoma,0.7534,Hereditary Renal Cell Carcinoma,0.7527,Refractory Kidney Carcinoma,0.7426,Advanced Renal Cell Carcinoma,0.7418,Childhood Renal Cell Carcinoma,0.7402,KIDNEY CANCER,True,True,True
"KIDNEY CANCER, NOS",Kidney Carcinoma,1,2,Kidney Carcinoma,0.9052,Malignant Kidney Neoplasm,0.8429,Kidney Neoplasm,0.8402,Renal Cell Carcinoma,0.8055,Childhood Kidney Carcinoma,0.7657,"Renal Cell Carcinoma, Not Otherwise Specified",0.7651,Advanced Kidney Carcinoma,0.7445,Childhood Kidney Neoplasm,0.7346,Childhood Malignant Kidney Neoplasm,0.7330,Kidney Medullary Carcinoma,0.7312,Malignant Kidney Neoplasm Except Renal Pelvis,0.7113,Unresectable Kidney Carcinoma,0.7055,Metastatic Kidney Carcinoma,0.6999,Kidney Adenoma,0.6959,Papillary Renal Cell Carcinoma,0.6932,Hereditary Renal Cell Carcinoma,0.6921,Kidney Carcinoma Molecular Subtypes,0.6895,Childhood Renal Cell Carcinoma,0.6889,Kidney Neuroendocrine Carcinoma,0.6851,Advanced Renal Cell Carcinoma,0.6820,"KIDNEY CANCER, NOS",True,True,True
KIDNEY CHROMOPHOBE,Chromophobe Renal Cell Carcinoma,1,2,Chromophobe Renal Cell Carcinoma,0.8471,Hepatocellular Chromophobe Carcinoma,0.7953,Advanced Chromophobe Renal Cell Carcinoma,0.7894,Classic Variant of Chromophobe Renal Cell Carcinoma,0.7882,Pituitary Gland Chromophobe Adenoma,0.7790,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.7519,Metastatic Chromophobe Renal Cell Carcinoma,0.7439,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.7112,Unresectable Chromophobe Renal Cell Carcinoma,0.7034,Locally Advanced Chromophobe Renal Cell Carcinoma,0.7006,Recurrent Chromophobe Renal Cell Carcinoma,0.6738,Kidney Oncocytoma,0.6734,Clear Cell Papillary Renal Tumor,0.6606,Childhood Kidney Carcinoma,0.6475,Childhood Cystic Nephroma,0.6450,Kidney Carcinoma,0.6437,Melanocytoma,0.6408,Papillary Renal Cell Carcinoma,0.6400,Metanephric Adenoma,0.6353,Renal Cell Carcinoma,0.6328,KIDNEY CHROMOPHOBE,True,True,True
KIDNEY CLEAR CELL RENAL CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9708,Non-Clear Cell Renal Cell Carcinoma,0.8753,Renal Cell Carcinoma,0.8719,Advanced Clear Cell Renal Cell Carcinoma,0.8397,Early Stage Clear Cell Renal Cell Carcinoma,0.8374,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.8224,Clear Cell Papillary Renal Tumor,0.8172,Kidney Carcinoma,0.8151,Grade 1 Clear Cell Renal Cell Carcinoma,0.8101,Urinary Tract Clear Cell Adenocarcinoma,0.8058,Hereditary Clear Cell Renal Cell Carcinoma,0.8028,Grade 2 Clear Cell Renal Cell Carcinoma,0.7994,Papillary Renal Cell Carcinoma,0.7953,Chromophobe Renal Cell Carcinoma,0.7860,"Renal Cell Carcinoma, Not Otherwise Specified",0.7851,Clear Cell Sarcoma of the Kidney,0.7808,Grade 3 Clear Cell Renal Cell Carcinoma,0.7783,Grade 4 Clear Cell Renal Cell Carcinoma,0.7772,Granular Renal Cell Carcinoma,0.7711,Locally Advanced Clear Cell Renal Cell Carcinoma,0.7709,KIDNEY CLEAR CELL RENAL CARCINOMA,True,True,True
KIDNEY PAPILLARY RENAL CELL CARCINOMA,Papillary Renal Cell Carcinoma,1,2,Papillary Renal Cell Carcinoma,0.9728,Sporadic Papillary Renal Cell Carcinoma,0.8883,Type 1 Papillary Renal Cell Carcinoma,0.8663,Type 2 Papillary Renal Cell Carcinoma,0.8576,Advanced Papillary Renal Cell Carcinoma,0.8573,Clear Cell Papillary Renal Tumor,0.8454,Hereditary Papillary Renal Cell Carcinoma,0.8286,Locally Advanced Papillary Renal Cell Carcinoma,0.8217,Renal Pelvis Papillary Urothelial Carcinoma,0.8166,Metastatic Papillary Renal Cell Carcinoma,0.8016,Renal Cell Carcinoma,0.7976,Renal Pelvis Urothelial Carcinoma,0.7968,Kidney Carcinoma,0.7965,Unresectable Papillary Renal Cell Carcinoma,0.7887,Papillary Transitional Cell Carcinoma,0.7687,Renal Papillary Adenoma,0.7574,Renal Pelvis Carcinoma,0.7525,Clear Cell Renal Cell Carcinoma,0.7515,Renal Pelvis and Ureter Urothelial Carcinoma,0.7441,Kidney Medullary Carcinoma,0.7410,KIDNEY PAPILLARY RENAL CELL CARCINOMA,True,True,True
KIDNEY RENAL CELL CARCINOMA,Renal Cell Carcinoma,1,2,Renal Cell Carcinoma,0.9628,Kidney Carcinoma,0.9275,Clear Cell Renal Cell Carcinoma,0.8679,"Renal Cell Carcinoma, Not Otherwise Specified",0.8542,Non-Clear Cell Renal Cell Carcinoma,0.8474,Papillary Renal Cell Carcinoma,0.8472,Childhood Renal Cell Carcinoma,0.8223,Advanced Renal Cell Carcinoma,0.8194,Localized Renal Cell Carcinoma,0.8133,Kidney Medullary Carcinoma,0.8084,Granular Renal Cell Carcinoma,0.8072,Hereditary Renal Cell Carcinoma,0.7956,Childhood Kidney Carcinoma,0.7900,Malignant Kidney Neoplasm,0.7850,Advanced Kidney Carcinoma,0.7758,Metastatic Renal Cell Carcinoma,0.7690,Locally Advanced Renal Cell Carcinoma,0.7661,Kidney Neuroendocrine Carcinoma,0.7653,Tubulocystic Renal Cell Carcinoma,0.7652,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.7649,KIDNEY RENAL CELL CARCINOMA,True,True,True
KIDNEY RENAL CELL CARCINOMA OTHER,Renal Cell Carcinoma,2,2,"Renal Cell Carcinoma, Not Otherwise Specified",0.8651,Renal Cell Carcinoma,0.8464,Kidney Carcinoma,0.8259,Non-Clear Cell Renal Cell Carcinoma,0.8135,Unclassified Renal Cell Carcinoma,0.8085,"Metastatic Renal Cell Carcinoma, Not Otherwise Specified",0.7802,Clear Cell Renal Cell Carcinoma,0.7717,Childhood Renal Cell Carcinoma,0.7706,"Advanced Renal Cell Carcinoma, Not Otherwise Specified",0.7608,Papillary Renal Cell Carcinoma,0.7565,Advanced Renal Cell Carcinoma,0.7533,Metastatic Renal Cell Carcinoma,0.7520,Hereditary Renal Cell Carcinoma,0.7520,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.7494,Metastatic Kidney Carcinoma,0.7416,Transplant-Related Renal Cell Carcinoma,0.7388,Unresectable Kidney Carcinoma,0.7388,Childhood Kidney Carcinoma,0.7380,Renal Cell Carcinoma with MiT Translocations,0.7375,Kidney Medullary Carcinoma,0.7374,KIDNEY RENAL CELL CARCINOMA OTHER,False,True,True
KIDNEY_CANCER,Kidney Carcinoma,1,2,Kidney Carcinoma,0.8885,Malignant Kidney Neoplasm,0.8352,Kidney Neoplasm,0.8197,Renal Cell Carcinoma,0.8033,Childhood Kidney Carcinoma,0.7672,"Renal Cell Carcinoma, Not Otherwise Specified",0.7643,Advanced Kidney Carcinoma,0.7488,Kidney Carcinoma Molecular Subtypes,0.7435,Unresectable Kidney Carcinoma,0.7397,Kidney Medullary Carcinoma,0.7393,Metastatic Kidney Carcinoma,0.7346,Kidney Neuroendocrine Carcinoma,0.7307,Childhood Malignant Kidney Neoplasm,0.7248,Refractory Kidney Carcinoma,0.7247,Childhood Kidney Neoplasm,0.7238,Hereditary Renal Cell Carcinoma,0.7214,Kidney and Ureter Neoplasm,0.7129,Kidney Oncocytoma,0.7054,Kidney Sarcoma,0.7050,Malignant Kidney Neoplasm Except Renal Pelvis,0.7037,KIDNEY_CANCER,True,True,True
KIRC,Clear Cell Renal Cell Carcinoma,99,2,Cholangiocarcinoma,0.5924,Kidney Neuroendocrine Carcinoma,0.5866,Childhood SMARCB1-Deficient Kidney Medullary Carcinoma,0.5840,SMARCB1-Deficient Kidney Medullary Carcinoma,0.5781,Anaplastic Lymphoma,0.5775,Clear Cell Intrahepatic Cholangiocarcinoma,0.5747,Childhood Kidney Carcinoma,0.5740,Signet Ring Cell Intrahepatic Cholangiocarcinoma,0.5731,Urothelial Carcinoma,0.5713,Intrahepatic Cholangiocarcinoma,0.5704,Kidney Carcinoma Molecular Subtypes,0.5698,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.5670,Kidney Medullary Carcinoma,0.5654,Childhood Renal Cell Carcinoma with MiT Translocations,0.5653,Refractory Kidney Medullary Carcinoma,0.5646,Renal Cell Carcinoma with MiT Translocations,0.5644,Childhood ALK-Rearranged Renal Cell Carcinoma,0.5643,Unresectable Kidney Carcinoma,0.5630,Kidney Carcinoma,0.5607,Granular Renal Cell Carcinoma,0.5606,KIRC,False,False,False
KIRP,Papillary Renal Cell Carcinoma,10,2,Kidney Carcinoma Molecular Subtypes,0.5388,Kidney Neuroendocrine Tumor,0.5382,Kidney Neuroendocrine Carcinoma,0.5361,Renal Pelvis Urothelial Carcinoma,0.5323,Kidney Sarcoma,0.5297,Cholangiocarcinoma,0.5291,Kidney Carcinoma,0.5278,Kidney Neuroendocrine Neoplasm,0.5268,Papillary Urothelial Neoplasm,0.5260,Papillary Renal Cell Carcinoma,0.5247,Clear Cell Papillary Renal Tumor,0.5221,Anaplastic Lymphoma,0.5220,Anaplastic Sarcoma of the Kidney,0.5201,Retinoblastoma,0.5188,Intrahepatic Cholangiocarcinoma,0.5179,Sporadic Papillary Renal Cell Carcinoma,0.5172,Refractory Kidney Carcinoma,0.5171,Childhood Kidney Carcinoma,0.5169,Renal Pelvis Papillary Urothelial Neoplasm,0.5167,Undifferentiated Retinoblastoma,0.5165,KIRP,False,False,False
LAML,Acute Myeloid Leukemia,99,2,Lymphangiomatosis,0.6435,Lung Lymphangioleiomyomatosis,0.6334,Liver Lymphangiomatosis,0.6237,Aleukemic Lymphoid Leukemia,0.5944,Lymphangioleiomyomatosis,0.5943,Diffuse Pulmonary Lymphangiomatosis,0.5927,Lung Mucosa-Associated Lymphoid Tissue Lymphoma,0.5926,Lymphangioma,0.5923,Aleukemic Myeloid Leukemia,0.5837,Liver Lymphangioma,0.5812,Leukemia,0.5772,Liver Mucosa-Associated Lymphoid Tissue Lymphoma,0.5728,Skin Lymphangioleiomyomatosis,0.5715,Lipomatosis,0.5687,Kidney Lymphangioma,0.5684,Meningeal Leukemia,0.5656,Lung Meningioma,0.5648,Stage 0 Low Grade Appendix Mucinous Neoplasm (LAMN) AJCC v8,0.5634,Lymphoma,0.5616,Aleukemic Leukemia,0.5604,LAML,False,False,False
LANGERHANS CELL HISTIOCYTOSIS,Langerhans Cell Histiocytosis,1,2,Langerhans Cell Histiocytosis,1.0000,Bone Langerhans Cell Histiocytosis,0.9183,Cutaneous Langerhans Cell Histiocytosis,0.9076,Central Nervous System Langerhans Cell Histiocytosis,0.8974,Adult Langerhans Cell Histiocytosis,0.8955,"Langerhans Cell Histiocytosis, Monostotic",0.8851,"Langerhans Cell Histiocytosis, Disseminated",0.8825,Childhood Langerhans Cell Histiocytosis,0.8631,Pulmonary Langerhans Cell Histiocytosis,0.8428,Head and Neck Langerhans Cell Histiocytosis,0.8334,"Langerhans Cell Histiocytosis, Polyostotic",0.8108,Histiocytosis,0.8083,Thyroid Gland Langerhans Cell Histiocytosis,0.8012,Langerhans Cell Sarcoma,0.7926,Recurrent Langerhans Cell Histiocytosis,0.7865,Oral Cavity Langerhans Cell Histiocytosis,0.7843,Tumors Derived from Langerhans Cells,0.7581,Refractory Langerhans Cell Histiocytosis,0.7558,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,0.7450,Malignant Histiocytosis,0.7428,LANGERHANS CELL HISTIOCYTOSIS,True,True,True
LARGE CELL LUNG CARCINOMA,Lung Large Cell Carcinoma,1,2,Lung Large Cell Carcinoma,0.9870,Occult Lung Large Cell Carcinoma,0.8694,Large Cell Carcinoma,0.8451,"Lung Large Cell Carcinoma, Clear Cell Variant",0.8368,Lung Large Cell Carcinoma by AJCC v7 Stage,0.8366,Lung Large Cell Neuroendocrine Carcinoma,0.8132,Lung Non-Small Cell Carcinoma,0.8109,Lung Small Cell Carcinoma,0.7973,Lung Carcinoma,0.7888,Lung Basaloid Large Cell Carcinoma,0.7700,Combined Lung Large Cell Neuroendocrine Carcinoma,0.7594,Lung Squamous Cell Carcinoma,0.7474,Advanced Lung Large Cell Neuroendocrine Carcinoma,0.7472,Lung Anaplastic Large Cell Lymphoma,0.7450,"Lung Small Cell Carcinoma, A Subtype",0.7413,Lung Giant Cell Carcinoma,0.7341,Lung Clear Cell Adenocarcinoma,0.7280,Locally Advanced Lung Large Cell Neuroendocrine Carcinoma,0.7259,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.7228,Lung Small Cell Carcinoma Molecular Subtypes,0.7222,LARGE CELL LUNG CARCINOMA,True,True,True
LARGE CELL NEUROENDOCRINE CARCINOMA,Large Cell Neuroendocrine Carcinoma,1,2,Large Cell Neuroendocrine Carcinoma,1.0000,Lung Large Cell Neuroendocrine Carcinoma,0.9018,Gastric Large Cell Neuroendocrine Carcinoma,0.8873,Advanced Large Cell Neuroendocrine Carcinoma,0.8821,Pancreatic Large Cell Neuroendocrine Carcinoma,0.8773,Cervical Large Cell Neuroendocrine Carcinoma,0.8761,Extrapulmonary Large Cell Neuroendocrine Carcinoma,0.8720,Kidney Large Cell Neuroendocrine Carcinoma,0.8669,Endometrial Large Cell Neuroendocrine Carcinoma,0.8668,Sinonasal Large Cell Neuroendocrine Carcinoma,0.8657,Digestive System Large Cell Neuroendocrine Carcinoma,0.8641,Nasal Cavity Large Cell Neuroendocrine Carcinoma,0.8614,Nasopharyngeal Large Cell Neuroendocrine Carcinoma,0.8586,Prostate Large Cell Neuroendocrine Carcinoma,0.8582,Laryngeal Large Cell Neuroendocrine Carcinoma,0.8552,Colorectal Large Cell Neuroendocrine Carcinoma,0.8475,Colon Large Cell Neuroendocrine Carcinoma,0.8452,Locally Advanced Large Cell Neuroendocrine Carcinoma,0.8448,Salivary Gland Large Cell Neuroendocrine Carcinoma,0.8429,Esophageal Large Cell Neuroendocrine Carcinoma,0.8402,LARGE CELL NEUROENDOCRINE CARCINOMA,True,True,True
LARGE CELL NEUROENDOCRINE CARCINOMA OF GALLBLADDER,Gallbladder Large Cell Neuroendocrine Carcinoma,1,2,Gallbladder Large Cell Neuroendocrine Carcinoma,0.9847,Gallbladder Neuroendocrine Carcinoma,0.9038,Gallbladder Small Cell Neuroendocrine Carcinoma,0.8895,Gastric Large Cell Neuroendocrine Carcinoma,0.8178,Gallbladder Neuroendocrine Neoplasm,0.8048,Gallbladder Neuroendocrine Tumor G3,0.8044,Bladder Large Cell Neuroendocrine Carcinoma,0.8025,Gallbladder Neuroendocrine Tumor,0.7937,Gallbladder Neuroendocrine Tumor G2,0.7832,Gallbladder Undifferentiated Carcinoma,0.7784,Large Cell Neuroendocrine Carcinoma,0.7782,Breast Large Cell Neuroendocrine Carcinoma,0.7741,Gallbladder Carcinoma,0.7715,Extrahepatic Bile Duct Large Cell Neuroendocrine Carcinoma,0.7658,Digestive System Large Cell Neuroendocrine Carcinoma,0.7647,Gallbladder Neuroendocrine Tumor G1,0.7532,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,0.7478,Gallbladder Mixed Adenoneuroendocrine Carcinoma,0.7470,Advanced Gastric Large Cell Neuroendocrine Carcinoma,0.7469,Colorectal Large Cell Neuroendocrine Carcinoma,0.7454,LARGE CELL NEUROENDOCRINE CARCINOMA OF GALLBLADDER,True,True,True
LARGE CELL/ANAPLASTIC MEDULLOBLASTOMA,Large Cell/Anaplastic Medulloblastoma,1,2,Large Cell/Anaplastic Medulloblastoma,1.0000,Large Cell Medulloblastoma,0.8669,Anaplastic Medulloblastoma,0.8465,Classic Medulloblastoma,0.7481,Adult Medulloblastoma,0.7359,Medulloblastoma,0.7291,Metastatic Medulloblastoma,0.6977,Medulloblastoma Molecular Subtypes,0.6973,Childhood Medulloblastoma,0.6897,Childhood Cerebellar Anaplastic Astrocytoma,0.6896,"Medulloblastoma, WNT-Activated",0.6854,Refractory Medulloblastoma,0.6828,Medulloblastoma with Leptomeningeal Spread,0.6780,Anaplastic Astrocytoma,0.6747,Anaplastic Oligodendroglioma,0.6709,Melanocytic Medulloblastoma,0.6685,Localized Childhood Medulloblastoma by Toronto Guidelines v2,0.6663,Childhood Brain Anaplastic Astrocytoma,0.6659,Anaplastic Brain Stem Glioma,0.6625,Anaplastic Large Cell Lymphoma,0.6602,LARGE CELL/ANAPLASTIC MEDULLOBLASTOMA,True,True,True
LARGE_CELL_CARCINOMA,Large Cell Carcinoma,1,2,Large Cell Carcinoma,0.9467,Lung Large Cell Carcinoma,0.7760,"Malignant Lymphoma, Large Cell Type",0.7703,Large Cell Neuroendocrine Carcinoma,0.7530,Salivary Gland Large Cell Carcinoma,0.7380,Occult Lung Large Cell Carcinoma,0.7027,Carcinoma,0.6968,Non-Keratinizing Large Cell Squamous Cell Carcinoma,0.6922,Colon Large Cell Neuroendocrine Carcinoma,0.6913,Colorectal Large Cell Neuroendocrine Carcinoma,0.6883,Lipid-Rich Carcinoma,0.6763,Non-Small Cell Carcinoma,0.6723,Advanced Large Cell Neuroendocrine Carcinoma,0.6685,Cervical Large Cell Neuroendocrine Carcinoma,0.6654,Gastric Large Cell Neuroendocrine Carcinoma,0.6646,"Malignant Lymphoma, Large Cell, Cleaved",0.6644,Digestive System Large Cell Neuroendocrine Carcinoma,0.6641,Locally Advanced Large Cell Neuroendocrine Carcinoma,0.6620,Nasal Cavity Large Cell Neuroendocrine Carcinoma,0.6616,"Malignant Lymphoma, Large Cell, Cleaved and Non-Cleaved",0.6592,LARGE_CELL_CARCINOMA,True,True,True
LARGE_CELL_LUNG_CANCER,Lung Large Cell Carcinoma,1,2,Lung Large Cell Carcinoma,0.9073,Occult Lung Large Cell Carcinoma,0.8241,Lung Large Cell Carcinoma by AJCC v7 Stage,0.8038,Large Cell Carcinoma,0.7910,Lung Large Cell Neuroendocrine Carcinoma,0.7716,"Lung Large Cell Carcinoma, Clear Cell Variant",0.7691,Lung Non-Small Cell Carcinoma,0.7661,Lung Carcinoma,0.7583,Lung Small Cell Carcinoma,0.7262,"Malignant Lymphoma, Large Cell Type",0.7126,Combined Lung Large Cell Neuroendocrine Carcinoma,0.7102,Advanced Lung Large Cell Neuroendocrine Carcinoma,0.7054,Lung Anaplastic Large Cell Lymphoma,0.7048,"Lung Small Cell Carcinoma, A Subtype",0.7023,Lung Basaloid Large Cell Carcinoma,0.6960,Locally Advanced Lung Large Cell Neuroendocrine Carcinoma,0.6878,Lung Clear Cell Tumor,0.6870,Large Cell Neuroendocrine Carcinoma,0.6860,Lung Small Cell Carcinoma Molecular Subtypes,0.6842,Lung Lymphoepithelial Carcinoma,0.6808,LARGE_CELL_LUNG_CANCER,True,True,True
LARYNX SQUAMOUS CELL CARCINOMA,Laryngeal Squamous Cell Carcinoma,1,2,Laryngeal Squamous Cell Carcinoma,0.9411,Laryngeal Spindle Cell Squamous Carcinoma,0.8080,Laryngeal Carcinoma,0.7765,Laryngeal Papillary Squamous Cell Carcinoma,0.7751,Laryngeal Acantholytic Squamous Cell Carcinoma,0.7713,Advanced Laryngeal Squamous Cell Carcinoma,0.7711,Supraglottic Squamous Cell Carcinoma,0.7602,Locally Advanced Laryngeal Squamous Cell Carcinoma,0.7601,Subglottic Squamous Cell Carcinoma,0.7552,Laryngeal Adenosquamous Carcinoma,0.7386,Metastatic Laryngeal Squamous Cell Carcinoma,0.7290,Lung Squamous Cell Carcinoma,0.7275,Laryngeal Undifferentiated Carcinoma,0.7230,Laryngeal Basaloid Squamous Cell Carcinoma,0.7076,Laryngeal Giant Cell Carcinoma,0.6961,Tongue Squamous Cell Carcinoma,0.6933,Supraglottic Carcinoma,0.6920,Laryngeal Chondrosarcoma,0.6895,Epiglottic Squamous Cell Carcinoma,0.6873,Laryngeal Neuroendocrine Carcinoma,0.6871,LARYNX SQUAMOUS CELL CARCINOMA,True,True,True
LEIOMYOSARCOMA,Leiomyosarcoma,1,2,Leiomyosarcoma,1.0000,Conventional Leiomyosarcoma,0.9201,Bone Leiomyosarcoma,0.8998,Digestive System Leiomyosarcoma,0.8722,Cardiac Leiomyosarcoma,0.8705,Leiomyosarcoma of Vessels,0.8701,Localized Leiomyosarcoma,0.8657,Inflammatory Leiomyosarcoma,0.8626,Adult Leiomyosarcoma,0.8612,Leiomyoma,0.8608,Lung Leiomyosarcoma,0.8598,Non-Cutaneous Leiomyosarcoma,0.8587,Leiomyomatosis,0.8555,Gastric Leiomyosarcoma,0.8552,Breast Leiomyosarcoma,0.8543,Myxoid Leiomyosarcoma,0.8525,Advanced Leiomyosarcoma,0.8498,Kidney Leiomyosarcoma,0.8493,Well Differentiated Leiomyosarcoma,0.8459,Pleomorphic Leiomyosarcoma,0.8449,LEIOMYOSARCOMA,True,True,True
LEIOMYOSARCOMA LMS,Leiomyosarcoma,1,2,Leiomyosarcoma,0.8577,Laryngeal Leiomyosarcoma,0.8324,Conventional Leiomyosarcoma,0.8276,Lung Leiomyosarcoma,0.8160,Localized Leiomyosarcoma,0.8151,Central Nervous System Leiomyosarcoma,0.8099,Bone Leiomyosarcoma,0.8069,Non-Cutaneous Leiomyosarcoma,0.8019,Mediastinal Leiomyosarcoma,0.8006,Liver Leiomyosarcoma,0.7970,Cardiac Leiomyosarcoma,0.7961,Myxoid Leiomyosarcoma,0.7917,Digestive System Leiomyosarcoma,0.7883,Leiomyosarcoma of Vessels,0.7792,Breast Leiomyosarcoma,0.7782,Colon Leiomyosarcoma,0.7770,Adult Leiomyosarcoma,0.7764,Gastric Leiomyosarcoma,0.7764,Broad Ligament Leiomyosarcoma,0.7763,Leiomyosarcoma of Deep Soft Tissue,0.7756,LEIOMYOSARCOMA LMS,True,True,True
LENTIGO MALIGNA,Lentigo Maligna,1,2,Lentigo Maligna,1.0000,Lentigo Maligna Melanoma,0.8707,Mucosal Lentiginous Melanoma,0.7751,Lentiginous Nevus,0.7612,Acral Lentiginous Melanoma,0.7084,Recurrent Lentigo Maligna Melanoma,0.6816,Cutaneous Melanocytic Neoplasm,0.6649,Cutaneous Melanoma,0.6645,Uveal Melanocytic Neoplasm,0.6561,Melanoma,0.6517,Melanocytic Neoplasm,0.6501,Metastatic Acral Lentiginous Melanoma,0.6488,Ocular Melanoma,0.6462,Uveal Melanoma,0.6448,Uveal Melanocytoma,0.6379,Corneal Melanoma,0.6375,Eye Melanocytoma,0.6352,Pigmented Nevus,0.6304,Nevoid Melanoma,0.6294,Mucosal Melanoma,0.6220,LENTIGO MALIGNA,True,True,True
LENTIGO MALIGNA MELANOMA,Lentigo Maligna Melanoma,1,2,Lentigo Maligna Melanoma,1.0000,Mucosal Lentiginous Melanoma,0.8993,Lentigo Maligna,0.8707,Acral Lentiginous Melanoma,0.8192,Cutaneous Melanoma,0.7675,Metastatic Acral Lentiginous Melanoma,0.7469,Uveal Melanoma,0.7340,Lentiginous Nevus,0.7326,Dermal Melanoma,0.7213,Nevoid Melanoma,0.7182,Low-CSD Melanoma,0.7108,Melanoma,0.7076,Mucosal Melanoma,0.7038,Corneal Melanoma,0.6988,Ocular Melanoma,0.6943,Recurrent Lentigo Maligna Melanoma,0.6903,Non-Cutaneous Melanoma,0.6846,Nail Apparatus Melanoma,0.6819,Uveal Melanocytic Neoplasm,0.6806,Cutaneous Melanocytic Neoplasm,0.6791,LENTIGO MALIGNA MELANOMA,True,True,True
LEPIDIC,Lepidic Adenocarcinoma,1,2,Lepidic Adenocarcinoma,0.8070,Astrocytoma,0.6136,Oncocytic Adenocarcinoma,0.6083,Pineocytoma,0.6013,Lung Secretory Carcinoma,0.5949,Low Grade Astrocytoma,0.5924,Oncocytic Neoplasm,0.5923,Oncocytic Adenoma,0.5905,Fibrolamellar Carcinoma,0.5890,Cerebral Astrocytoma,0.5885,Childhood Astrocytoma,0.5873,Childhood Fibrolamellar Carcinoma,0.5873,Lymphoma,0.5853,Cystic Oncocytic Neoplasm,0.5812,Lung Meningioma,0.5802,Leukemia,0.5792,Lacrimal Gland Oncocytic Adenocarcinoma,0.5780,Hepatocellular Large Cell Change,0.5776,Pilocytic Astrocytoma,0.5769,Lung Acinar Adenocarcinoma,0.5767,LEPIDIC,True,True,True
LEPIDIC ADENOCARCINOMA 82503,Lepidic Adenocarcinoma,1,2,Lepidic Adenocarcinoma,0.7295,Goblet Cell Adenocarcinoma,0.6269,Acinar Cell Carcinoma,0.6229,Lung Secretory Carcinoma,0.6088,Comedo-Type Adenocarcinoma,0.6060,Papillary Adenocarcinoma,0.6021,Salivary Gland Mucinous Adenocarcinoma,0.6012,Salivary Gland Intestinal-Type Adenocarcinoma,0.6009,Lacrimal Gland Adenocarcinoma,0.6003,Adenocarcinoma,0.5975,Gallbladder Goblet Cell Adenocarcinoma,0.5973,Tubular Adenocarcinoma,0.5967,Prostate Acinar Mucinous Adenocarcinoma,0.5960,Lung Adenocarcinoma,0.5955,Lung Acinar Adenocarcinoma,0.5954,Mucin-Producing Adenocarcinoma,0.5950,Scirrhous Adenocarcinoma,0.5941,Lacrimal Gland Acinic Cell Carcinoma,0.5922,Adenocarcinoma with Apocrine Metaplasia,0.5920,Collecting Duct Carcinoma,0.5911,LEPIDIC ADENOCARCINOMA 82503,True,True,True
LEUKAEMIA,Leukemia,1,2,Leukemia,0.9732,Myeloid Leukemia,0.8610,Lymphoid Leukemia,0.8570,Acute Leukemia,0.8341,Childhood Leukemia,0.7585,Infant Leukemia,0.7379,Acute Lymphoblastic Leukemia,0.7340,Chronic Leukemia,0.7330,B-Cell Leukemia,0.7302,Aleukemic Leukemia,0.7274,Testicular Leukemia,0.7249,Lymphoma,0.7228,Aleukemic Lymphoid Leukemia,0.7213,Acute Undifferentiated Leukemia,0.7204,Erythroleukemia,0.7198,Acute Myeloid Leukemia,0.7186,Neonatal Leukemia,0.7029,Leukemia Cutis,0.6966,Pure Erythroid Leukemia,0.6962,Lymphoblastic Lymphoma,0.6915,LEUKAEMIA,True,True,True
LEUKEMIA,Leukemia,1,2,Leukemia,1.0000,Lymphoid Leukemia,0.8977,Myeloid Leukemia,0.8678,Acute Leukemia,0.8569,Childhood Leukemia,0.7791,Acute Lymphoblastic Leukemia,0.7638,Testicular Leukemia,0.7607,Chronic Leukemia,0.7573,B-Cell Leukemia,0.7525,Infant Leukemia,0.7503,Aleukemic Lymphoid Leukemia,0.7500,Lymphoma,0.7442,Aleukemic Leukemia,0.7405,Acute Undifferentiated Leukemia,0.7275,Acute Myeloid Leukemia,0.7274,Lymphoblastic Lymphoma,0.7270,Chronic Lymphocytic Leukemia,0.7249,Neonatal Leukemia,0.7223,Aleukemic Acute Lymphoblastic Leukemia,0.7114,Leukemia Cutis,0.7100,LEUKEMIA,True,True,True
LEUKEMIA_OTHER,Leukemia,1,2,Leukemia,0.7715,Lymphoid Leukemia,0.6937,Myeloid Leukemia,0.6867,Acute Leukemia,0.6759,"Acute Myeloid Leukemia, Not Otherwise Specified",0.6521,Testicular Leukemia,0.6501,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.6326,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",0.6313,Neonatal Leukemia,0.6286,Childhood Leukemia,0.6231,B-Cell Leukemia,0.6194,Leukemia Cutis,0.6191,Aleukemic Leukemia,0.6189,Myeloid Neoplasm,0.6163,Lymphoblastic Lymphoma,0.6159,Lymphoma,0.6151,Non-Hematologic Malignancy,0.6141,Acute Undifferentiated Leukemia,0.6140,"B Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.6135,Infant Leukemia,0.6126,LEUKEMIA_OTHER,True,True,True
LGG,Low Grade Glioma,2,2,Glioma,0.7045,Low Grade Glioma,0.6946,Diffuse Glioma,0.6570,Granular Cell Glioblastoma,0.6419,Brain Low Grade Glioma,0.6396,Low Grade Glandular Intraepithelial Neoplasia,0.6395,Mixed Glioma,0.6353,Low Grade Lymphoma,0.6334,Low Grade Gastric Intraepithelial Neoplasia,0.6299,Childhood Low Grade Glioma,0.6283,Glioblastoma,0.6247,Granular Cell Astrocytoma,0.6172,Low Grade Astrocytoma,0.6140,Giant Cell Glioblastoma,0.6123,Tectal Glioma,0.6079,Locally Advanced Glioma,0.6077,Densely Granulated Lactotroph Pituitary Neuroendocrine Tumor,0.6069,Anaplastic Ganglioglioma,0.6018,Adult Mixed Glioma,0.6005,Gastric Lymphoma,0.5985,LGG,False,True,True
LGSOC,Ovarian Low Grade Serous Adenocarcinoma,1,2,Ovarian Low Grade Serous Adenocarcinoma,0.9142,Ovarian Serous Adenocarcinoma,0.7922,Ovarian High Grade Serous Adenocarcinoma,0.7723,Ovarian Serous Tumor,0.7648,Ovarian Serous Cystadenocarcinoma,0.7591,Locally Advanced Ovarian Serous Adenocarcinoma,0.7572,Serous Adenocarcinoma,0.7556,Locally Advanced Ovarian Serous Cystadenocarcinoma,0.7476,Malignant Ovarian Serous Tumor,0.7469,Ovarian Serous Cystadenoma,0.7464,Primary Peritoneal Low Grade Serous Adenocarcinoma,0.7414,Borderline Ovarian Serous Tumor,0.7374,Benign Ovarian Serous Tumor,0.7357,Unresectable Ovarian Serous Adenocarcinoma,0.7340,Advanced Ovarian Serous Adenocarcinoma,0.7335,Micropapillary Serous Carcinoma,0.7297,Low Grade Broad Ligament Serous Adenocarcinoma,0.7244,Advanced Ovarian Serous Cystadenocarcinoma,0.7215,Serous Neoplasm,0.7212,Microsatellite Stable Ovarian Carcinoma,0.7144,Low-Grade Serous Ovarian Cancer,True,True,True
LIHB,Hepatoblastoma,1,2,Hepatoblastoma,1.0000,Epithelial Hepatoblastoma,0.9266,Metastatic Hepatoblastoma,0.8405,Teratoid Hepatoblastoma,0.8375,Non-Teratoid Hepatoblastoma,0.8288,Unresectable Hepatoblastoma,0.8145,Hepatoblastoma with Pure Fetal Epithelial Differentiation,0.8079,Small Cell Undifferentiated Hepatoblastoma,0.8002,Mixed Epithelial and Mesenchymal Hepatoblastoma,0.7986,Refractory Hepatoblastoma,0.7862,PRETEXT III Hepatoblastoma,0.7705,PRETEXT II Hepatoblastoma,0.7663,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,0.7660,Macrotrabecular Hepatoblastoma,0.7619,PRETEXT IV Hepatoblastoma,0.7572,PRETEXT I Hepatoblastoma,0.7544,Hepatocellular Adenoma,0.7518,Hepatoid Adenocarcinoma,0.7502,Epithelial Hepatoblastoma with Pleomorphic Pattern,0.7493,Resectable Hepatoblastoma,0.7480,Hepatoblastoma,True,True,True
LIHC,Hepatocellular Carcinoma,99,2,Hepatocellular Large Cell Change,0.6189,Large Duct Intrahepatic Cholangiocarcinoma,0.5993,Hepatocellular Lymphocyte-Rich Carcinoma,0.5923,Intrahepatic Cholangiocarcinoma,0.5893,Light and Heavy Chain Deposition Disease,0.5721,Breast Classic Lobular Carcinoma In Situ,0.5699,Cholangiocarcinoma,0.5684,Liver Lymphangiomatosis,0.5662,Laryngeal Undifferentiated Carcinoma,0.5642,Childhood Hepatocellular Carcinoma,0.5635,Small Hepatocellular Carcinoma,0.5633,Invasive Breast Lobular Carcinoma,0.5619,Liver Undifferentiated Carcinoma,0.5615,Lung Hilum Carcinoma,0.5615,Lymphoma,0.5603,Breast Lobular Carcinoma In Situ,0.5593,Early Hepatocellular Carcinoma,0.5590,Locally Advanced Hepatocellular Carcinoma,0.5587,Childhood Fibrolamellar Carcinoma,0.5580,Hepatocellular Well Differentiated Carcinoma,0.5576,LIHC,False,False,False
LIPOFIBROMATOSIS-LIKE NEURAL TUMOR,NTRK-Rearranged Spindle Cell Neoplasm,99,2,Lipofibromatosis,0.8309,Neurofibroma,0.7190,Skin Neurofibroma,0.7113,Cellular Neurofibroma,0.7056,Diffuse Neurofibroma,0.6910,Lipomatosis of Nerve,0.6873,Schwannoma,0.6802,Breast Neurofibroma,0.6757,Neurofibroma with Atypia,0.6731,Epithelioid Neurofibroma,0.6660,Schwannomatosis,0.6653,Spinal Cord Neurofibroma,0.6643,Conventional Schwannoma,0.6600,Plexiform Neurofibroma,0.6572,Melanotic Neurofibroma,0.6560,Nonossifying Fibromyxoid Tumor,0.6558,Non-Functioning Lung Neuroendocrine Tumor,0.6554,Nuchal-Type Fibroma,0.6547,Tongue Neurofibroma,0.6536,Gallbladder Neurofibroma,0.6518,LIPOFIBROMATOSIS-LIKE NEURAL TUMOR,False,False,False
LIPOSARCOMA,Liposarcoma,1,2,Liposarcoma,1.0000,Bone Liposarcoma,0.9094,Skin Liposarcoma,0.9008,Localized Liposarcoma,0.8977,Fibroblastic Liposarcoma,0.8829,Adult Liposarcoma,0.8828,Breast Liposarcoma,0.8783,Childhood Liposarcoma,0.8696,Mixed Liposarcoma,0.8675,Advanced Liposarcoma,0.8614,Metastatic Liposarcoma,0.8613,Myxoid Liposarcoma,0.8439,Pleomorphic Liposarcoma,0.8344,Lymphosarcoma,0.8314,Round Cell Liposarcoma,0.8288,Gastric Liposarcoma,0.8276,Dedifferentiated Liposarcoma,0.8261,Locally Advanced Liposarcoma,0.8219,Ovarian Liposarcoma,0.8211,Colon Liposarcoma,0.8200,LIPOSARCOMA,True,True,True
"LIVER CANCER, NOS",Liver Carcinoma,1,2,Liver Carcinoma,0.8999,Malignant Liver Neoplasm,0.8536,Liver Neoplasm,0.8356,Hepatocellular Carcinoma,0.7992,Primary Malignant Liver Neoplasm,0.7663,"Hepatocellular Malignant Neoplasm, Not Otherwise Specified",0.7641,Childhood Malignant Liver Neoplasm,0.7500,Liver Epithelial Neoplasm,0.7412,Malignant Liver Non-Epithelial Neoplasm,0.7361,Childhood Liver Neoplasm,0.7260,Metastatic Carcinoma in the Liver,0.7247,Liver Undifferentiated Carcinoma,0.7235,Adult Liver Carcinoma,0.7199,Liver and Intrahepatic Bile Duct Carcinoma,0.7166,Hepatoid Adenocarcinoma,0.7102,Metastatic Liver Carcinoma,0.7020,Liver Non-Epithelial Neoplasm,0.7013,Liver Lymphoma,0.6982,Benign Liver Neoplasm,0.6929,Unresectable Liver Carcinoma,0.6922,"LIVER CANCER, NOS",True,True,True
LIVER HEPATOCELLULAR CARCINOMA,Hepatocellular Carcinoma,1,2,Hepatocellular Carcinoma,0.9531,Liver Carcinoma,0.9238,Advanced Hepatocellular Carcinoma,0.8556,Childhood Hepatocellular Carcinoma,0.8317,Adult Hepatocellular Carcinoma,0.8272,Small Hepatocellular Carcinoma,0.8256,Hepatocellular Poorly Differentiated Carcinoma,0.8188,Adult Liver Carcinoma,0.8183,Hepatocellular Adenoma,0.8154,Locally Advanced Hepatocellular Carcinoma,0.8128,Hepatocellular Clear Cell Carcinoma,0.8123,Early Hepatocellular Carcinoma,0.8016,Malignant Liver Neoplasm,0.7982,Metastatic Hepatocellular Carcinoma,0.7955,Hepatocellular Well Differentiated Carcinoma,0.7930,Liver Undifferentiated Carcinoma,0.7817,Early Stage Hepatocellular Carcinoma,0.7815,Unresectable Hepatocellular Carcinoma,0.7812,Liver Neoplasm,0.7798,Hepatocellular Lymphocyte-Rich Carcinoma,0.7754,LIVER HEPATOCELLULAR CARCINOMA,True,True,True
LIVER TUMOR,Liver Neoplasm,1,2,Liver Neoplasm,0.9608,Liver Epithelial Neoplasm,0.8534,Liver Carcinoma,0.8506,Childhood Liver Neoplasm,0.8169,Malignant Liver Neoplasm,0.8146,Liver Lymphoma,0.8074,Liver Non-Epithelial Neoplasm,0.8048,Primary Malignant Liver Neoplasm,0.7929,Benign Liver Neoplasm,0.7927,Hepatoblastoma,0.7808,Hepatobiliary Neoplasm,0.7776,Liver Fibrosarcoma,0.7712,Liver Neuroendocrine Tumor,0.7699,Liver Neuroendocrine Neoplasm,0.7671,Hepatocellular Adenoma,0.7622,Liver Lipoma,0.7615,Liver Germ Cell Tumor,0.7494,Liver Sarcoma,0.7438,Benign Liver Epithelial Neoplasm,0.7412,Childhood Malignant Liver Neoplasm,0.7401,LIVER TUMOR,True,True,True
LIVER_CANCER,Liver Carcinoma,1,2,Liver Carcinoma,0.8750,Malignant Liver Neoplasm,0.8273,Liver Neoplasm,0.8192,Hepatocellular Carcinoma,0.7769,Liver Undifferentiated Carcinoma,0.7543,Liver Lymphoma,0.7479,Liver Epithelial Neoplasm,0.7466,Malignant Liver Non-Epithelial Neoplasm,0.7416,Primary Malignant Liver Neoplasm,0.7401,Liver Neuroendocrine Carcinoma,0.7350,Childhood Malignant Liver Neoplasm,0.7337,"Hepatocellular Malignant Neoplasm, Not Otherwise Specified",0.7275,Childhood Liver Neoplasm,0.7220,Hepatoid Adenocarcinoma,0.7209,Liver Non-Epithelial Neoplasm,0.7186,Liver Fibrosarcoma,0.7147,Liver Carcinosarcoma,0.7108,Metastatic Liver Carcinoma,0.7091,Liver Sarcoma,0.7066,Liver and Intrahepatic Bile Duct Carcinoma,0.7058,LIVER_CANCER,True,True,True
LNET,Lung Neuroendocrine Tumor,1,2,Lung Neuroendocrine Tumor,1.0000,Lung Neuroendocrine Neoplasm,0.9692,Functioning Lung Neuroendocrine Tumor,0.9069,Advanced Lung Neuroendocrine Tumor,0.8871,Lung Neuroendocrine Carcinoma,0.8871,Low Grade Lung Neuroendocrine Neoplasm,0.8847,Metastatic Lung Neuroendocrine Tumor,0.8787,Lung Neuroendocrine Tumor G1,0.8602,Laryngeal Neuroendocrine Tumor,0.8556,Non-Functioning Lung Neuroendocrine Tumor,0.8552,Advanced Lung Neuroendocrine Neoplasm,0.8500,Metastatic Lung Neuroendocrine Neoplasm,0.8453,Unresectable Lung Neuroendocrine Tumor,0.8411,Intermediate Grade Lung Neuroendocrine Neoplasm,0.8369,Lung Carcinoid Tumor,0.8341,Lung Neuroendocrine Tumor G2,0.8325,Neuroendocrine Tumor,0.8227,Laryngeal Neuroendocrine Neoplasm,0.8147,Locally Advanced Lung Neuroendocrine Neoplasm,0.8141,Advanced Lung Neuroendocrine Carcinoma,0.8089,Lung Neuroendocrine Tumor,True,True,True
LOBULAR CARCINOMA,Breast Lobular Carcinoma,1,2,Breast Lobular Carcinoma,0.9187,Invasive Breast Lobular Carcinoma,0.8382,Lip Carcinoma,0.7885,Metastatic Breast Lobular Carcinoma,0.7639,Breast Ductal Carcinoma,0.7502,Breast Classic Lobular Carcinoma In Situ,0.7407,Breast Lobular Carcinoma In Situ,0.7392,Breast Acinic Cell Carcinoma,0.7261,"Invasive Breast Lobular Carcinoma, Alveolar Variant",0.7233,Acinar Cell Carcinoma,0.7197,Breast Classic Lobular Carcinoma In Situ Type A,0.7184,Breast Lobular Neoplasia,0.7157,Breast Classic Lobular Carcinoma In Situ Type B,0.7123,Recurrent Lobular Breast Carcinoma,0.7120,Breast Carcinoma,0.7099,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7083,Breast Mixed Ductal and Lobular Carcinoma,0.7003,"Invasive Breast Lobular Carcinoma, Solid Variant",0.6997,"Invasive Breast Lobular Carcinoma, Tubulolobular Variant",0.6989,Carcinoma,0.6979,LOBULAR CARCINOMA,True,True,True
LOBULAR CARCINOMA WITH DUCTAL FEATURES,Breast Mixed Ductal and Lobular Carcinoma,2,2,Breast Lobular Carcinoma,0.8246,Breast Mixed Ductal and Lobular Carcinoma,0.8077,Breast Ductal Carcinoma,0.8064,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7800,Invasive Breast Lobular Carcinoma,0.7658,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.7656,Breast Classic Lobular Carcinoma In Situ Type A,0.7402,Breast Classic Lobular Carcinoma In Situ,0.7370,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7191,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.7182,Breast Classic Lobular Carcinoma In Situ Type B,0.7160,Breast Ductal Adenoma,0.7154,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.7127,Breast Lobular Carcinoma In Situ,0.7121,Metastatic Breast Lobular Carcinoma,0.7096,"Breast Ductal Carcinoma In Situ, Comedo Type",0.7082,Breast Acinic Cell Carcinoma,0.7081,"Invasive Breast Lobular Carcinoma, Alveolar Variant",0.7066,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.7057,Breast Ductal Carcinoma In Situ,0.6950,LOBULAR CARCINOMA WITH DUCTAL FEATURES,False,True,True
LOBULAR/DUCTAL,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,0.7140,Breast Ductal Adenoma,0.6897,Breast Lobular Carcinoma,0.6819,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.6763,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.6763,Breast Ductal Hyperplasia,0.6736,Breast Ductal Carcinoma,0.6715,Breast Lobular Neoplasia,0.6582,Diffuse Lipomatosis,0.6567,Breast Usual Ductal Hyperplasia,0.6530,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.6471,Deep Lipoma,0.6276,Lipoma,0.6224,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.6204,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.6192,Invasive Breast Lobular Carcinoma,0.6189,Lipomatosis,0.6177,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.6161,Breast Ductal Carcinoma In Situ,0.6160,Breast Lobular Carcinoma In Situ,0.6155,LOBULAR/DUCTAL,True,True,True
LOCALLY ADVANCED,Locally Advanced Malignant Neoplasm,1,2,Locally Advanced Malignant Neoplasm,0.9076,Locally Advanced Carcinoma,0.9015,Locally Advanced Lymphoma,0.8886,Locally Advanced Adenocarcinoma,0.8847,Locally Advanced Melanoma,0.8350,Locally Advanced Glioma,0.8302,Locally Advanced Sarcoma,0.8169,Locally Advanced Prostate Adenocarcinoma,0.8110,Locally Advanced Liver Carcinoma,0.8037,Locally Advanced Unresectable Malignant Neoplasm,0.8029,Locally Advanced Lung Adenocarcinoma,0.7995,Locally Advanced Gastric Adenocarcinoma,0.7994,Locally Advanced Malignant Skin Neoplasm,0.7968,Locally Advanced Malignant Solid Neoplasm,0.7944,Locally Advanced Prostate Carcinoma,0.7905,Locally Advanced Gastric Carcinoma,0.7897,Locally Advanced Lung Carcinoma,0.7883,Locally Advanced Cutaneous Melanoma,0.7842,Locally Advanced Unresectable Carcinoma,0.7839,Locally Advanced Pancreatic Adenocarcinoma,0.7825,LOCALLY ADVANCED,True,True,True
LOCOREGIONAL RECURRENCE,Locally Recurrent Malignant Neoplasm,1,2,Locally Recurrent Malignant Neoplasm,0.7991,Locally Recurrent Carcinoma,0.7790,Recurrent Neoplasm,0.7337,Recurrent Lymphoma,0.7238,Recurrent Leukemia,0.7176,Recurrent Laryngeal Carcinoma,0.7162,Locally Recurrent Breast Carcinoma,0.7111,Recurrent Carcinoma,0.6848,Recurrent Malignant Lymphoid Neoplasm,0.6846,Recurrent Follicular Lymphoma,0.6794,Locally Recurrent Colorectal Carcinoma,0.6751,Recurrent Lobular Breast Carcinoma,0.6720,Recurrent Breast Lymphoma,0.6713,Locally Recurrent Endometrial Carcinoma,0.6661,Recurrent Lymphoid Leukemia,0.6653,Recurrent Malignant Neoplasm,0.6640,Recurrent Liposarcoma,0.6636,Recurrent Lung Carcinoma,0.6590,Recurrent Retinoblastoma,0.6569,Locally Recurrent Ovarian Carcinoma,0.6556,LOCOREGIONAL RECURRENCE,True,True,True
LOW GRADE FIBROMYXOID SARCOMA,Low Grade Fibromyxoid Sarcoma,1,2,Low Grade Fibromyxoid Sarcoma,1.0000,Classical Low Grade Fibromyxoid Sarcoma,0.9610,Low Grade Myofibroblastic Sarcoma,0.8881,Childhood Low Grade Fibromyxoid Sarcoma,0.8619,Low Grade Sarcoma,0.8385,Childhood Low Grade Myofibroblastic Sarcoma,0.7872,Fibromyxoid Tumor,0.7829,Gingival Low Grade Myofibroblastic Sarcoma,0.7721,Localized Soft Tissue Sarcoma,0.7488,Superficial Fibromatosis,0.7366,Well Differentiated Fibrosarcoma,0.7346,Myxoinflammatory Fibroblastic Sarcoma,0.7339,Tongue Low Grade Myofibroblastic Sarcoma,0.7303,Fibroblastic Liposarcoma,0.7239,Soft Tissue Fibrosarcoma,0.7223,Pleomorphic Fibroma,0.7209,Poorly Differentiated Fibrosarcoma,0.7193,Myxofibrosarcoma,0.7169,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,0.7136,Soft Tissue Sarcoma,0.7130,LOW GRADE FIBROMYXOID SARCOMA,True,True,True
LOW HYPODIPLOID,Hypodiploid B Lymphoblastic Leukemia/Lymphoma,1,2,Hypodiploid B Lymphoblastic Leukemia/Lymphoma,0.7318,Hypodiploid B Acute Lymphoblastic Leukemia,0.7041,Low-Hypodiploid B Acute Lymphoblastic Leukemia,0.6945,Hypoplastic Myelodysplastic Syndrome,0.6406,Low Grade Lymphoma,0.6395,Hyperdiploid B Lymphoblastic Leukemia/Lymphoma,0.6007,Myelodysplastic Syndrome with Low Blasts,0.5927,Hyperdiploid B Acute Lymphoblastic Leukemia,0.5776,Low Grade Liver Dysplastic Nodule,0.5748,Unfavorable Hodgkin Lymphoma,0.5725,Childhood Unfavorable Prognosis Hodgkin Lymphoma,0.5683,Low Grade Glioma,0.5649,Low Grade Intraepithelial Neoplasia,0.5623,Poorly Differentiated Neuroblastoma,0.5593,Low Grade Malignant Neoplasm,0.5569,Poorly Differentiated Chordoma,0.5560,Adult Unfavorable Prognosis Hodgkin Lymphoma,0.5539,"Childhood Myelodysplastic Syndrome with Low Blasts, Hypocellular",0.5530,Poorly Differentiated Malignant Neoplasm,0.5526,Early Unfavorable Hodgkin Lymphoma,0.5471,LOW HYPODIPLOID,True,True,True
LOW-GRADE ENDOMETRIAL STROMAL SARCOMA,Low Grade Endometrioid Stromal Sarcoma,1,2,Low Grade Endometrioid Stromal Sarcoma,0.9174,Uterine Corpus Low Grade Endometrial Stromal Sarcoma,0.8510,Cervical Low Grade Endometrioid Stromal Sarcoma,0.8309,Ovarian Low Grade Endometrioid Stromal Sarcoma,0.8305,Vaginal Low Grade Endometrioid Stromal Sarcoma,0.8059,Endometrioid Stromal Sarcoma,0.7897,Low Grade Sarcoma,0.7813,Stromal Sarcoma,0.7786,Peritoneal Low Grade Endometrioid Stromal Sarcoma,0.7767,Undifferentiated Stromal Sarcoma,0.7661,Uterine Corpus Endometrial Stromal Sarcoma,0.7465,Uterine Corpus High Grade Endometrial Stromal Sarcoma,0.7268,Localized Epithelioid Sarcoma,0.7241,Low Risk Esophageal Gastrointestinal Stromal Tumor,0.7239,Low Risk Gastrointestinal Stromal Tumor,0.7082,Endometrioid Stromal Sarcoma of the Cervix,0.7018,Low Grade Fibromyxoid Sarcoma,0.6962,Localized Sarcoma,0.6959,Esophageal Gastrointestinal Stromal Tumor,0.6946,Endometrioid Stromal Sarcoma of the Vagina,0.6904,LOW-GRADE ENDOMETRIAL STROMAL SARCOMA,True,True,True
LOW-GRADE FIBROMYXOID SARCOMA,Low Grade Fibromyxoid Sarcoma,1,2,Low Grade Fibromyxoid Sarcoma,0.9948,Classical Low Grade Fibromyxoid Sarcoma,0.9590,Low Grade Myofibroblastic Sarcoma,0.8920,Childhood Low Grade Fibromyxoid Sarcoma,0.8616,Low Grade Sarcoma,0.8359,Childhood Low Grade Myofibroblastic Sarcoma,0.7925,Gingival Low Grade Myofibroblastic Sarcoma,0.7815,Fibromyxoid Tumor,0.7619,Localized Soft Tissue Sarcoma,0.7447,Myxoinflammatory Fibroblastic Sarcoma,0.7405,Tongue Low Grade Myofibroblastic Sarcoma,0.7373,Superficial Fibromatosis,0.7251,Well Differentiated Fibrosarcoma,0.7228,Fibroblastic Liposarcoma,0.7186,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,0.7182,Undifferentiated Soft Tissue Sarcoma,0.7159,Soft Tissue Fibrosarcoma,0.7140,Soft Tissue Sarcoma,0.7135,Myxofibrosarcoma,0.7130,Oral Cavity Low Grade Myofibroblastic Sarcoma,0.7112,LOW-GRADE FIBROMYXOID SARCOMA,True,True,True
LOW-GRADE GLIOMA NOS,Low Grade Glioma,1,2,Low Grade Glioma,0.9716,Brain Low Grade Glioma,0.9102,Low Grade Astrocytoma,0.8787,Childhood Low Grade Glioma,0.8332,Low Grade Lymphoma,0.8184,Unresectable Low Grade Glioma,0.7636,Metastatic Low Grade Glioma,0.7578,WHO Grade 1 Glioma,0.7488,Low Grade Malignant Neoplasm,0.7430,Glioma,0.7212,Low Grade Sarcoma,0.7135,Diffuse Glioma,0.7097,WHO Grade 2 Glioma,0.7044,Recurrent Low Grade Glioma,0.7019,Refractory Low Grade Glioma,0.6972,Low Grade Adult Non-Hodgkin's Lymphoma,0.6969,Metastatic Low Grade Astrocytoma,0.6956,Small Cell Glioblastoma,0.6945,Gliomatosis Cerebri,0.6838,Low Grade Intraepithelial Neoplasia,0.6789,LOW-GRADE GLIOMA NOS,True,True,True
"LOW-GRADE GLIOMA, NOS",Low Grade Glioma,1,2,Low Grade Glioma,0.9498,Brain Low Grade Glioma,0.8850,Low Grade Astrocytoma,0.8663,Childhood Low Grade Glioma,0.8100,Low Grade Lymphoma,0.7922,WHO Grade 1 Glioma,0.7493,Unresectable Low Grade Glioma,0.7365,Low Grade Malignant Neoplasm,0.7296,Metastatic Low Grade Glioma,0.7281,Glioma,0.7131,Low Grade Sarcoma,0.7048,WHO Grade 2 Glioma,0.7033,Diffuse Glioma,0.7001,Small Cell Glioblastoma,0.6875,Gliomatosis Cerebri,0.6866,Low Grade Adult Non-Hodgkin's Lymphoma,0.6802,Refractory Low Grade Glioma,0.6796,Recurrent Low Grade Glioma,0.6756,Metastatic Low Grade Astrocytoma,0.6737,WHO Grade 4 Glioma,0.6717,"LOW-GRADE GLIOMA, NOS",True,True,True
LOW-GRADE NEUROEPITHELIAL TUMOR,Polymorphous Low Grade Neuroepithelial Tumor of the Young,6,2,Dysembryoplastic Neuroepithelial Tumor,0.8047,Adult Dysembryoplastic Neuroepithelial Tumor,0.7719,Neuroepithelial Neoplasm,0.7602,Childhood Dysembryoplastic Neuroepithelial Tumor,0.7567,Glioneuronal and Neuronal Tumors,0.7381,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.7370,Low Grade Lung Neuroendocrine Neoplasm,0.7352,Localized Primitive Neuroectodermal Tumor,0.7202,Brain Low Grade Glioma,0.7191,Low Grade Intraepithelial Neoplasia,0.7074,Low Risk Gastrointestinal Stromal Tumor,0.7034,Low Grade Glioma,0.7031,Non-Neural Granular Cell Tumor,0.7017,Low Risk Gastric Gastrointestinal Stromal Tumor,0.6937,Low Grade Malignant Neoplasm,0.6930,Neuroblastic Tumor,0.6922,Low Risk Esophageal Gastrointestinal Stromal Tumor,0.6900,Primitive Neuroectodermal Tumor,0.6839,Unresectable Glioneuronal and Neuronal Tumors,0.6832,Glioneuronal Tumor with Neuropil-Like Islands,0.6826,LOW-GRADE NEUROEPITHELIAL TUMOR,False,False,False
LOW-GRADE SEROUS OVARIAN CANCER,Ovarian Low Grade Serous Adenocarcinoma,1,2,Ovarian Low Grade Serous Adenocarcinoma,0.9142,Ovarian Serous Adenocarcinoma,0.7922,Ovarian High Grade Serous Adenocarcinoma,0.7723,Ovarian Serous Tumor,0.7648,Ovarian Serous Cystadenocarcinoma,0.7591,Locally Advanced Ovarian Serous Adenocarcinoma,0.7572,Serous Adenocarcinoma,0.7556,Locally Advanced Ovarian Serous Cystadenocarcinoma,0.7476,Malignant Ovarian Serous Tumor,0.7469,Ovarian Serous Cystadenoma,0.7464,Primary Peritoneal Low Grade Serous Adenocarcinoma,0.7414,Borderline Ovarian Serous Tumor,0.7374,Benign Ovarian Serous Tumor,0.7357,Unresectable Ovarian Serous Adenocarcinoma,0.7340,Advanced Ovarian Serous Adenocarcinoma,0.7335,Micropapillary Serous Carcinoma,0.7297,Low Grade Broad Ligament Serous Adenocarcinoma,0.7244,Advanced Ovarian Serous Cystadenocarcinoma,0.7215,Serous Neoplasm,0.7212,Microsatellite Stable Ovarian Carcinoma,0.7144,LOW-GRADE SEROUS OVARIAN CANCER,True,True,True
LOW_GRADE_SEROUS,Ovarian Low Grade Serous Adenocarcinoma,1,2,Ovarian Low Grade Serous Adenocarcinoma,0.7886,Low Grade Sarcoma,0.7514,Primary Peritoneal Low Grade Serous Adenocarcinoma,0.7421,Serous Neoplasm,0.7340,Low Grade Lymphoma,0.7331,Low Grade Broad Ligament Serous Adenocarcinoma,0.7228,Micropapillary Serous Carcinoma,0.7039,Borderline Serous Cystadenoma,0.7017,Serous Adenocarcinoma,0.7003,Borderline Peritoneal Serous Tumor,0.6938,Borderline Ovarian Serous Tumor,0.6843,Low Grade Endometrioid Stromal Sarcoma,0.6801,Low Grade Fallopian Tube Serous Adenocarcinoma,0.6795,Low Grade Osteosarcoma,0.6772,Salivary Gland Low Grade Carcinoma,0.6730,Low Grade Malignant Neoplasm,0.6708,Low Grade Glioma,0.6669,Ovarian Serous Tumor,0.6647,Borderline Broad Ligament Serous Tumor,0.6642,Low Grade Endometrioid Adenocarcinoma,0.6610,LOW_GRADE_SEROUS,True,True,True
LUAD,Lung Adenocarcinoma,1,2,Lung Adenocarcinoma,1.0000,Lung Carcinoma,0.9020,Advanced Lung Adenocarcinoma,0.8790,Lung Acinar Adenocarcinoma,0.8650,Solid Lung Adenocarcinoma,0.8556,Occult Lung Adenocarcinoma,0.8424,Lung Papillary Adenocarcinoma,0.8297,Metastatic Lung Adenocarcinoma,0.8280,Adenocarcinoma,0.8190,Advanced Lung Carcinoma,0.8144,Lung Adenoma,0.8101,Lung Enteric Adenocarcinoma,0.8036,Lung Clear Cell Adenocarcinoma,0.8004,Lung Colloid Adenocarcinoma,0.7951,Malignant Lung Neoplasm,0.7944,Locally Advanced Lung Adenocarcinoma,0.7789,Lung Neoplasm,0.7742,Unresectable Lung Adenocarcinoma,0.7698,Minimally Invasive Lung Adenocarcinoma,0.7694,Lung Fetal Adenocarcinoma,0.7638,Lung Adenocarcinoma,True,True,True
LUMA,Luminal A Breast Carcinoma,4,2,Lumbosacral Lipoma,0.6822,Lipoma,0.6461,Breast Lipoma,0.6326,Luminal A Breast Carcinoma,0.6236,Lipomatosis,0.6230,Breast Adenoma,0.6172,Breast Lobular Neoplasia,0.6152,Lipoblastoma,0.6135,Bone Lipoma,0.6094,Deep Lipoma,0.6050,Lumbar Spine Neoplasm,0.6041,Leiomyomatosis,0.6019,Leukemia,0.6017,Intramuscular Lipoma,0.6013,Breast Lymphoma,0.5994,Breast Flat Ductal Epithelial Atypia,0.5968,Leiomyoma,0.5962,Lumbosacral Spine Neoplasm,0.5961,Locally Advanced Breast Adenocarcinoma,0.5956,Lymphangiomatosis,0.5955,LUMA,False,False,True
LUMB,Luminal B Breast Carcinoma,5,2,Breast Lobular Neoplasia,0.6449,Breast Lymphoma,0.6374,Lumbosacral Lipoma,0.6311,Lipomatosis,0.6277,Luminal B Breast Carcinoma,0.6185,Lymphangiomatosis,0.6182,Diffuse Lipomatosis,0.6180,Breast Lipoma,0.6150,Mediastinal Lipomatosis,0.6138,Lymphoma,0.6123,Breast Lobular Carcinoma In Situ,0.6120,Bladder Lymphoma,0.6101,Bladder Leiomyoma,0.6063,Leiomyomatosis,0.6051,Basal-Like Breast Carcinoma,0.6047,Breast Leiomyoma,0.6026,Breast Hyperplasia,0.6010,Lung Lymphangioleiomyomatosis,0.5997,Leukemia,0.5990,Breast Liposarcoma,0.5976,LUMB,False,False,True
LUMINAL A,Luminal A Breast Carcinoma,1,2,Luminal A Breast Carcinoma,0.8226,Luminal A Prostate Carcinoma,0.8025,Luminal B Breast Carcinoma,0.7043,Luminal B Prostate Carcinoma,0.6693,Breast Flat Ductal Epithelial Atypia,0.6331,Anal Lymphoma,0.5978,Breast Atypical Lobular Hyperplasia,0.5930,Lymphoma,0.5902,Cecum Villous Adenoma,0.5862,Breast Atypical Hyperplasia,0.5817,Benign Ameloblastoma,0.5791,Leukemia,0.5745,Breast Classic Lobular Carcinoma In Situ Type A,0.5743,Vaginal Adenoma,0.5721,Breast Lobular Neoplasia,0.5699,Vaginal Villous Adenoma,0.5698,Breast Lymphoma,0.5696,Flat Adenoma,0.5655,Stage IVA Vulvar Cancer AJCC v8,0.5643,Breast Ductal Adenoma,0.5616,LUMINAL A,True,True,True
LUMINAL B,Luminal B Breast Carcinoma,1,2,Luminal B Breast Carcinoma,0.8536,Luminal B Prostate Carcinoma,0.7907,Luminal A Breast Carcinoma,0.7885,Luminal A Prostate Carcinoma,0.7225,Breast Lymphoma,0.6581,Basal-Like Breast Carcinoma,0.6438,Lymphoma,0.6332,Normal Breast-Like Subtype of Breast Carcinoma,0.6331,Refractory Breast Lymphoma,0.6287,Breast Follicular Lymphoma,0.6282,Breast Lobular Neoplasia,0.6254,Breast Burkitt Lymphoma,0.6132,Immunoblastic Lymphoma,0.6132,Breast Atypical Hyperplasia,0.6129,Breast Atypical Lobular Hyperplasia,0.6114,Breast Hyperplasia,0.6016,Bladder Lymphoma,0.6014,Cecum Lymphoma,0.5910,Endemic Burkitt Lymphoma,0.5907,Leukemia,0.5898,LUMINAL B,True,True,True
LUMINALA,Luminal A Breast Carcinoma,2,2,Luminal A Prostate Carcinoma,0.7472,Luminal A Breast Carcinoma,0.7360,Luminal B Prostate Carcinoma,0.6552,Luminal B Breast Carcinoma,0.6540,Lymphoma,0.6182,Anal Lymphoma,0.5990,Breast Flat Ductal Epithelial Atypia,0.5834,Leukemia,0.5801,Cecum Lymphoma,0.5687,Follicular Lymphoma,0.5609,Benign Ameloblastoma,0.5584,Cecum Villous Adenoma,0.5557,Localized Lymphoma,0.5552,Bladder Lymphoma,0.5526,Intestinal Follicular Lymphoma,0.5510,Esophageal Lymphoma,0.5493,Breast Atypical Lobular Hyperplasia,0.5488,Gastric Lymphoma,0.5470,Protoplasmic Astrocytoma,0.5443,Liver Lymphoma,0.5439,LUMINALA,False,True,True
LUMINALB,Luminal B Breast Carcinoma,1,2,Luminal B Breast Carcinoma,0.7725,Luminal B Prostate Carcinoma,0.7340,Luminal A Breast Carcinoma,0.7225,Luminal A Prostate Carcinoma,0.6816,Lymphoma,0.6120,Breast Lymphoma,0.6057,Bladder Lymphoma,0.5966,Breast Lobular Neoplasia,0.5955,Breast Atypical Lobular Hyperplasia,0.5880,Basal-Like Breast Carcinoma,0.5805,Cecum Lymphoma,0.5804,Normal Breast-Like Subtype of Breast Carcinoma,0.5783,Leukemia,0.5754,Anal Lymphoma,0.5738,Breast Follicular Lymphoma,0.5710,Immunoblastic Lymphoma,0.5691,Breast Atypical Hyperplasia,0.5655,Refractory Breast Lymphoma,0.5647,EZB Diffuse Large B-Cell Lymphoma,0.5640,Breast Classic Lobular Carcinoma In Situ Type B,0.5604,LUMINALB,True,True,True
LUNG ACINAR ADENOCARCINOMA,Lung Acinar Adenocarcinoma,1,2,Lung Acinar Adenocarcinoma,1.0000,Lung Adenocarcinoma,0.8650,Prostate Acinar Adenocarcinoma,0.8636,Acinar Cell Carcinoma,0.8093,Lung Papillary Adenocarcinoma,0.8009,Acinar Cell Adenoma,0.7868,Advanced Lung Adenocarcinoma,0.7833,Pancreatic Acinar Cell Carcinoma,0.7800,Locally Advanced Lung Adenocarcinoma,0.7683,Prostate Acinar Oncocytic Adenocarcinoma,0.7678,Solid Lung Adenocarcinoma,0.7618,Lung Colloid Adenocarcinoma,0.7550,Lung Adenoma,0.7549,Alveolar Adenoma,0.7454,Minimally Invasive Lung Adenocarcinoma,0.7452,Pancreatic Acinar Cell Cystadenocarcinoma,0.7438,Lepidic Adenocarcinoma,0.7429,Prostate Acinar Mucinous Adenocarcinoma,0.7397,Prostate Acinar Microcystic Adenocarcinoma,0.7377,"Lung Adenocarcinoma, Mixed Subtype",0.7330,LUNG ACINAR ADENOCARCINOMA,True,True,True
LUNG ADENOCARCINOMA,Lung Adenocarcinoma,1,2,Lung Adenocarcinoma,1.0000,Lung Carcinoma,0.9020,Advanced Lung Adenocarcinoma,0.8790,Lung Acinar Adenocarcinoma,0.8650,Solid Lung Adenocarcinoma,0.8556,Occult Lung Adenocarcinoma,0.8424,Lung Papillary Adenocarcinoma,0.8297,Metastatic Lung Adenocarcinoma,0.8280,Adenocarcinoma,0.8190,Advanced Lung Carcinoma,0.8144,Lung Adenoma,0.8101,Lung Enteric Adenocarcinoma,0.8036,Lung Clear Cell Adenocarcinoma,0.8004,Lung Colloid Adenocarcinoma,0.7951,Malignant Lung Neoplasm,0.7944,Locally Advanced Lung Adenocarcinoma,0.7789,Lung Neoplasm,0.7742,Unresectable Lung Adenocarcinoma,0.7698,Minimally Invasive Lung Adenocarcinoma,0.7694,Lung Fetal Adenocarcinoma,0.7638,LUNG ADENOCARCINOMA,True,True,True
LUNG ADENOCARCINOMA IN SITU,Lung Adenocarcinoma In Situ,1,2,Lung Adenocarcinoma In Situ,1.0000,Lung Non-Mucinous Adenocarcinoma In Situ,0.8957,Adenocarcinoma In Situ,0.8312,Lung Mucinous Adenocarcinoma In Situ,0.8095,Minimally Invasive Lung Adenocarcinoma,0.7940,Stage 0 Lung Adenocarcinoma AJCC v6 and v7,0.7846,Lung Squamous Cell Carcinoma In Situ,0.7712,Invasive Lung Non-Mucinous Adenocarcinoma,0.7577,Stage 0 Lung Cancer AJCC v8,0.7384,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.7349,Lung Adenocarcinoma,0.7322,Adenocarcinoma In Situ in Adenomatous Polyp,0.7312,Cervical Adenocarcinoma In Situ,0.7254,Occult Lung Adenocarcinoma,0.7252,Carcinoma In Situ,0.7215,Stage 0 Lung Cancer AJCC v6 and v7,0.7179,Adenocarcinoma In Situ in Tubular Adenoma,0.7158,Tracheal Carcinoma In Situ,0.7152,Unresectable Lung Adenocarcinoma,0.7078,Localized Lung Carcinoma,0.7036,LUNG ADENOCARCINOMA IN SITU,True,True,True
LUNG ADENOCARCINOMA MIXED SUBTYPE,"Lung Adenocarcinoma, Mixed Subtype",1,2,"Lung Adenocarcinoma, Mixed Subtype",0.9872,Mixed Cell Adenocarcinoma,0.8244,Lung Adenocarcinoma with Mixed Bronchioloalveolar and Invasive Components,0.7902,Minimally Invasive Lung Mixed Non-Mucinous and Mucinous Adenocarcinoma,0.7730,Metastatic Lung Adenocarcinoma,0.7705,Bladder Mixed Adenocarcinoma,0.7496,Gastric Mixed Adenocarcinoma,0.7477,Mixed Carcinoma,0.7402,Lung Adenocarcinoma,0.7355,Ovarian Mixed Cell Adenocarcinoma,0.7251,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.7220,Combined Lung Carcinoma,0.7169,Malignant Mixed Neoplasm,0.7128,Lung Acinar Adenocarcinoma,0.7122,Breast Mixed Carcinoma,0.7021,Mixed Cell Adenoma,0.6977,Advanced Lung Adenocarcinoma,0.6939,Occult Lung Adenocarcinoma,0.6901,Minimally Invasive Lung Mucinous Adenocarcinoma,0.6857,Solid Lung Adenocarcinoma,0.6850,LUNG ADENOCARCINOMA MIXED SUBTYPE,True,True,True
LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED NOS,Lung Adenocarcinoma,1,2,Lung Adenocarcinoma,0.8816,Lung Carcinoma,0.7979,Advanced Lung Adenocarcinoma,0.7884,Lung Acinar Adenocarcinoma,0.7670,Solid Lung Adenocarcinoma,0.7514,Occult Lung Adenocarcinoma,0.7508,Advanced Lung Carcinoma,0.7446,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.7391,Lung Non-Small Cell Carcinoma,0.7387,Metastatic Lung Adenocarcinoma,0.7385,Lung Clear Cell Adenocarcinoma,0.7311,Lung Adenocarcinoma by AJCC v7 Stage,0.7295,Locally Advanced Lung Adenocarcinoma,0.7246,"Lung Adenocarcinoma, Mixed Subtype",0.7180,Malignant Lung Neoplasm,0.7130,Lung Papillary Adenocarcinoma,0.7122,Lung Adenoma,0.7015,Non-Small Cell Adenocarcinoma,0.6977,Lung Enteric Adenocarcinoma,0.6931,Locally Advanced Lung Carcinoma,0.6884,LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED NOS,True,True,True
LUNG ADENOSQUAMOUS CARCINOMA,Lung Adenosquamous Carcinoma,1,2,Lung Adenosquamous Carcinoma,1.0000,Adenosquamous Carcinoma,0.9060,Occult Lung Adenosquamous Carcinoma,0.9026,Advanced Lung Adenosquamous Carcinoma,0.8922,Metastatic Lung Adenosquamous Carcinoma,0.8758,Laryngeal Adenosquamous Carcinoma,0.8565,Locally Advanced Lung Adenosquamous Carcinoma,0.8556,Lung Adenosquamous Carcinoma by AJCC v7 Stage,0.8257,Breast Adenosquamous Carcinoma,0.8149,Tongue Adenosquamous Carcinoma,0.8121,Prostate Adenosquamous Carcinoma,0.7967,Salivary Gland Adenosquamous Carcinoma,0.7961,Cervical Adenosquamous Carcinoma,0.7960,Skin Adenosquamous Carcinoma,0.7926,Colon Adenosquamous Carcinoma,0.7830,Thymus Adenosquamous Carcinoma,0.7816,Conjunctival Adenosquamous Carcinoma,0.7796,Gastric Adenosquamous Carcinoma,0.7740,Liver Adenosquamous Carcinoma,0.7705,Endometrial Adenosquamous Carcinoma,0.7696,LUNG ADENOSQUAMOUS CARCINOMA,True,True,True
LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS,Minimally Invasive Lung Mucinous Adenocarcinoma,2,2,Invasive Lung Mucinous Adenocarcinoma,0.8175,Minimally Invasive Lung Mucinous Adenocarcinoma,0.8174,Lung Mucinous Cystadenoma,0.8016,Bladder Mucinous Adenocarcinoma,0.7999,Breast Mucinous Carcinoma,0.7908,Lung Mucinous Adenocarcinoma In Situ,0.7614,Breast Columnar Cell Mucinous Carcinoma,0.7509,Mucinous Adenocarcinoma,0.7490,Gallbladder Mucinous Adenocarcinoma,0.7472,Breast Mucinous Cystadenocarcinoma,0.7441,Lung Adenocarcinoma with Mixed Bronchioloalveolar and Invasive Components,0.7409,Lung Colloid Adenocarcinoma,0.7270,Invasive Lung Non-Mucinous Adenocarcinoma,0.7236,Appendix Mucinous Adenocarcinoma,0.7198,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.7155,Minimally Invasive Lung Mixed Non-Mucinous and Mucinous Adenocarcinoma,0.7122,Lung Adenoid Cystic Carcinoma,0.7119,Broad Ligament Mucinous Adenocarcinoma,0.7087,Mucinous Cystadenocarcinoma,0.7037,Lung Mucous Gland Adenoma,0.7035,LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS,False,True,True
LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,2,2,Invasive Lung Non-Mucinous Adenocarcinoma,0.7424,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.7408,Lung Adenocarcinoma with Mixed Bronchioloalveolar and Invasive Components,0.7392,Lung Non-Mucinous Adenocarcinoma In Situ,0.7207,Lung Non-Small Cell Carcinoma,0.7001,Minimally Invasive Lung Mucinous Adenocarcinoma,0.6993,Minimally Invasive Lung Mixed Non-Mucinous and Mucinous Adenocarcinoma,0.6877,Lung Non-Squamous Non-Small Cell Carcinoma,0.6788,Occult Lung Adenosquamous Carcinoma,0.6785,Lung Non-Keratinizing Squamous Cell Carcinoma,0.6768,Occult Lung Adenocarcinoma,0.6739,Occult Lung Non-Small Cell Carcinoma,0.6729,Minimally Invasive Lung Adenocarcinoma,0.6723,Lung Adenosquamous Carcinoma,0.6706,Lung Mucinous Adenocarcinoma In Situ,0.6694,Lung Adenocarcinoma,0.6681,Lung Adenoid Cystic Carcinoma,0.6669,Lung Micropapillary Adenocarcinoma,0.6626,Lung Myoepithelial Carcinoma,0.6595,Bronchogenic Carcinoma,0.6588,LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS,False,True,True
LUNG CANCER,Lung Carcinoma,1,2,Lung Carcinoma,0.9492,Lung Neoplasm,0.8781,Malignant Lung Neoplasm,0.8747,Lung Adenocarcinoma,0.8723,Occult Lung Carcinoma,0.8224,Advanced Lung Carcinoma,0.8056,Occult Lung Adenocarcinoma,0.7834,Localized Lung Carcinoma,0.7733,Metastatic Lung Carcinoma,0.7689,Lung Lymphoma,0.7650,Advanced Lung Adenocarcinoma,0.7492,Combined Lung Carcinoma,0.7484,Lung Adenoma,0.7476,Lung Non-Small Cell Carcinoma,0.7457,Metastatic Carcinoma in the Lung,0.7442,Solid Lung Adenocarcinoma,0.7435,Superior Sulcus Lung Carcinoma,0.7394,Lung Neuroendocrine Carcinoma,0.7388,Lung Melanoma,0.7378,Childhood Lung Neoplasm,0.7364,LUNG CANCER,True,True,True
"LUNG CANCER, NOS",Lung Carcinoma,1,2,Lung Carcinoma,0.9014,Malignant Lung Neoplasm,0.8401,Lung Neoplasm,0.8348,Lung Adenocarcinoma,0.8037,Advanced Lung Carcinoma,0.7595,Occult Lung Carcinoma,0.7549,Lung Non-Small Cell Carcinoma,0.7429,Metastatic Carcinoma in the Lung,0.7414,Metastatic Lung Carcinoma,0.7348,Localized Lung Carcinoma,0.7133,Combined Lung Carcinoma,0.7130,Lung Squamous Cell Carcinoma,0.7061,Lung Large Cell Carcinoma,0.7057,Occult Lung Adenocarcinoma,0.7037,Childhood Lung Neoplasm,0.6971,Lung Lymphoma,0.6964,Childhood Malignant Lung Neoplasm,0.6951,Superior Sulcus Lung Carcinoma,0.6930,Locally Advanced Lung Carcinoma,0.6874,Lung Neuroendocrine Carcinoma,0.6858,"LUNG CANCER, NOS",True,True,True
LUNG CARCINOID,Lung Neuroendocrine Tumor,5,2,Lung Carcinoid Tumor,0.9763,Laryngeal Carcinoid Tumor,0.8302,Carcinoid Tumor,0.8292,Lung Carcinosarcoma,0.8252,Lung Neuroendocrine Tumor,0.7999,Lung Neuroendocrine Carcinoma,0.7989,Lung Neuroendocrine Neoplasm,0.7754,Strumal Carcinoid,0.7427,Lung Large Cell Neuroendocrine Carcinoma,0.7323,Lung Neuroendocrine Tumor G1,0.7200,Advanced Lung Neuroendocrine Carcinoma,0.7186,Combined Carcinoid and Adenocarcinoma,0.7165,Metastatic Lung Neuroendocrine Carcinoma,0.7153,Advanced Lung Neuroendocrine Tumor,0.7118,Metastatic Lung Neuroendocrine Tumor,0.7081,Lung Carcinoma,0.7052,Lung Neuroendocrine Tumor G2,0.6966,Functioning Lung Neuroendocrine Tumor,0.6958,Low Grade Lung Neuroendocrine Neoplasm,0.6939,Lung Adenocarcinoma,0.6916,LUNG CARCINOID,False,False,True
LUNG MICROPAPILLARY ADENOCARCINOMA,Lung Micropapillary Adenocarcinoma,1,2,Lung Micropapillary Adenocarcinoma,1.0000,Micropapillary Carcinoma,0.8546,Colon Micropapillary Adenocarcinoma,0.8417,Cervical Micropapillary Adenocarcinoma,0.8303,Colorectal Micropapillary Adenocarcinoma,0.8237,Invasive Pancreatic Micropapillary Adenocarcinoma,0.8154,Lung Papillary Adenocarcinoma,0.7998,Invasive Breast Micropapillary Carcinoma,0.7711,Rectal Micropapillary Adenocarcinoma,0.7641,Lung Colloid Adenocarcinoma,0.7627,Minimally Invasive Lung Mucinous Adenocarcinoma,0.7393,Lung Adenocarcinoma,0.7353,Micropapillary Transitional Cell Carcinoma,0.7347,Minimally Invasive Lung Adenocarcinoma,0.7333,Metastatic Micropapillary Urothelial Carcinoma,0.7288,Invasive Micropapillary Urothelial Carcinoma,0.7236,Prostate Acinar Microcystic Adenocarcinoma,0.7231,Solid Lung Adenocarcinoma,0.7229,Metastatic Lung Adenocarcinoma,0.7204,Lung Acinar Adenocarcinoma,0.7203,LUNG MICROPAPILLARY ADENOCARCINOMA,True,True,True
LUNG MUCINOUS ADENOCARCINOMA,Lung Colloid Adenocarcinoma,5,2,Invasive Lung Mucinous Adenocarcinoma,0.9160,Minimally Invasive Lung Mucinous Adenocarcinoma,0.8818,Mucinous Adenocarcinoma,0.8779,Lung Mucinous Cystadenoma,0.8612,Lung Colloid Adenocarcinoma,0.8487,Appendix Mucinous Adenocarcinoma,0.8440,Colon Mucinous Adenocarcinoma,0.8249,Ovarian Mucinous Adenocarcinoma,0.8210,Lung Mucinous Adenocarcinoma In Situ,0.8172,Gastric Mucinous Adenocarcinoma,0.8135,Bladder Mucinous Adenocarcinoma,0.8077,Colorectal Mucinous Adenocarcinoma,0.8034,Endometrial Mucinous Adenocarcinoma,0.7923,Salivary Gland Mucinous Adenocarcinoma,0.7871,Invasive Lung Non-Mucinous Adenocarcinoma,0.7866,Lung Adenocarcinoma,0.7854,Gallbladder Mucinous Adenocarcinoma,0.7854,Cervical Mucinous Adenocarcinoma,0.7814,Lung Mucous Gland Adenoma,0.7809,Breast Mucinous Carcinoma,0.7784,LUNG MUCINOUS ADENOCARCINOMA,False,False,True
LUNG NEUROENDOCRINE,Lung Neuroendocrine Tumor,2,2,Lung Neuroendocrine Neoplasm,0.9127,Lung Neuroendocrine Tumor,0.8935,Lung Neuroendocrine Carcinoma,0.8612,Functioning Lung Neuroendocrine Tumor,0.8435,Low Grade Lung Neuroendocrine Neoplasm,0.8214,Advanced Lung Neuroendocrine Neoplasm,0.8120,Advanced Lung Neuroendocrine Tumor,0.8057,Intermediate Grade Lung Neuroendocrine Neoplasm,0.8009,Advanced Lung Neuroendocrine Carcinoma,0.7953,Lung Neuroendocrine Tumor G1,0.7943,Metastatic Lung Neuroendocrine Neoplasm,0.7864,Lung Neuroendocrine Tumor G2,0.7777,Metastatic Lung Neuroendocrine Tumor,0.7719,Lung Large Cell Neuroendocrine Carcinoma,0.7695,Laryngeal Neuroendocrine Neoplasm,0.7608,Locally Advanced Lung Neuroendocrine Neoplasm,0.7608,Neuroendocrine Neoplasm,0.7604,Non-Functioning Lung Neuroendocrine Tumor,0.7604,Metastatic Lung Neuroendocrine Carcinoma,0.7572,Laryngeal Neuroendocrine Tumor,0.7500,LUNG NEUROENDOCRINE,False,True,True
LUNG NEUROENDOCRINE TUMOR,Lung Neuroendocrine Tumor,1,2,Lung Neuroendocrine Tumor,1.0000,Lung Neuroendocrine Neoplasm,0.9692,Functioning Lung Neuroendocrine Tumor,0.9069,Advanced Lung Neuroendocrine Tumor,0.8871,Lung Neuroendocrine Carcinoma,0.8871,Low Grade Lung Neuroendocrine Neoplasm,0.8847,Metastatic Lung Neuroendocrine Tumor,0.8787,Lung Neuroendocrine Tumor G1,0.8602,Laryngeal Neuroendocrine Tumor,0.8556,Non-Functioning Lung Neuroendocrine Tumor,0.8552,Advanced Lung Neuroendocrine Neoplasm,0.8500,Metastatic Lung Neuroendocrine Neoplasm,0.8453,Unresectable Lung Neuroendocrine Tumor,0.8411,Intermediate Grade Lung Neuroendocrine Neoplasm,0.8369,Lung Carcinoid Tumor,0.8341,Lung Neuroendocrine Tumor G2,0.8325,Neuroendocrine Tumor,0.8227,Laryngeal Neuroendocrine Neoplasm,0.8147,Locally Advanced Lung Neuroendocrine Neoplasm,0.8141,Advanced Lung Neuroendocrine Carcinoma,0.8089,LUNG NEUROENDOCRINE TUMOR,True,True,True
LUNG PAPILLARY ADENOCARCINOMA,Lung Papillary Adenocarcinoma,1,2,Lung Papillary Adenocarcinoma,1.0000,Lung Papillary Adenoma,0.8859,Papillary Adenocarcinoma,0.8694,Lung Adenocarcinoma,0.8297,Lung Acinar Adenocarcinoma,0.8009,Lung Micropapillary Adenocarcinoma,0.7998,Gastric Papillary Adenocarcinoma,0.7875,Invasive Papillary Adenocarcinoma,0.7871,Papillary Carcinoma,0.7775,Digital Papillary Adenocarcinoma,0.7695,Papillary Adenoma,0.7693,Advanced Lung Adenocarcinoma,0.7648,Solid Lung Adenocarcinoma,0.7621,Lung Adenoma,0.7588,Occult Lung Adenocarcinoma,0.7517,Lung Colloid Adenocarcinoma,0.7511,"Prostate Ductal Adenocarcinoma, Papillary Pattern",0.7467,Lung Carcinoma,0.7432,Renal Papillary Adenoma,0.7373,Prostate Acinar Adenocarcinoma,0.7309,LUNG PAPILLARY ADENOCARCINOMA,True,True,True
LUNG SQUAMOUS CELL CARCINOMA,Lung Squamous Cell Carcinoma,1,2,Lung Squamous Cell Carcinoma,1.0000,Lung Non-Small Cell Squamous Carcinoma,0.8854,Lung Non-Keratinizing Squamous Cell Carcinoma,0.8398,Advanced Lung Squamous Cell Carcinoma,0.8279,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.8245,"Lung Squamous Cell Carcinoma, Clear Cell Variant",0.8160,Occult Lung Squamous Cell Carcinoma,0.8129,Lung Squamous Cell Carcinoma by AJCC v7 Stage,0.8096,Lung Non-Small Cell Carcinoma,0.8044,Lung Keratinizing Squamous Cell Carcinoma,0.7990,Lung Spindle Cell Carcinoma,0.7963,Locally Advanced Lung Squamous Cell Carcinoma,0.7950,Metastatic Lung Squamous Cell Carcinoma,0.7932,Lung Small Cell Carcinoma,0.7920,Lung Carcinoma,0.7887,Lung Non-Squamous Non-Small Cell Carcinoma,0.7882,Laryngeal Squamous Cell Carcinoma,0.7729,Squamous Cell Carcinoma,0.7723,Combined Lung Small Cell and Squamous Cell Carcinoma,0.7685,Superior Sulcus Lung Carcinoma,0.7682,LUNG SQUAMOUS CELL CARCINOMA,True,True,True
LUNG_CANCER,Lung Carcinoma,1,2,Lung Carcinoma,0.8957,Malignant Lung Neoplasm,0.8272,Lung Neoplasm,0.8191,Lung Adenocarcinoma,0.8159,Occult Lung Carcinoma,0.7817,Advanced Lung Carcinoma,0.7503,Lung Non-Small Cell Carcinoma,0.7475,Metastatic Lung Carcinoma,0.7447,Occult Lung Adenocarcinoma,0.7388,Lung Lymphoma,0.7388,Occult Lung Cancer AJCC v8,0.7343,Lung Melanoma,0.7317,Lung Neuroendocrine Carcinoma,0.7291,Combined Lung Carcinoma,0.7275,Lung Large Cell Carcinoma,0.7263,Metastatic Carcinoma in the Lung,0.7244,Localized Lung Carcinoma,0.7214,Occult Lung Large Cell Carcinoma,0.7117,Lung Clear Cell Tumor,0.7100,Superior Sulcus Lung Carcinoma,0.7054,LUNG_CANCER,True,True,True
LUNG_CARCINOID,Lung Neuroendocrine Tumor,5,2,Lung Carcinoid Tumor,0.9490,Carcinoid Tumor,0.8297,Lung Carcinosarcoma,0.7976,Laryngeal Carcinoid Tumor,0.7955,Lung Neuroendocrine Tumor,0.7569,Lung Neuroendocrine Carcinoma,0.7542,Lung Neuroendocrine Neoplasm,0.7414,Strumal Carcinoid,0.7312,Combined Carcinoid and Adenocarcinoma,0.7260,Lung Large Cell Neuroendocrine Carcinoma,0.6974,Carcinoid Tumor of Uncertain Malignant Potential,0.6895,Advanced Lung Neuroendocrine Carcinoma,0.6826,Lung Neuroendocrine Tumor G1,0.6796,Advanced Lung Neuroendocrine Tumor,0.6767,Metastatic Lung Neuroendocrine Carcinoma,0.6747,Metastatic Lung Neuroendocrine Tumor,0.6681,Lung Carcinoma,0.6635,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.6627,Functioning Lung Neuroendocrine Tumor,0.6599,Lung Neuroendocrine Tumor G2,0.6563,LUNG_CARCINOID,False,False,True
LUNG_CARCINOMA,Lung Carcinoma,1,2,Lung Carcinoma,0.9577,Lung Adenocarcinoma,0.8604,Malignant Lung Neoplasm,0.8218,Advanced Lung Carcinoma,0.7999,Lung Non-Small Cell Carcinoma,0.7935,Lung Neoplasm,0.7876,Metastatic Lung Carcinoma,0.7829,Occult Lung Carcinoma,0.7815,Lung Large Cell Carcinoma,0.7757,Superior Sulcus Lung Carcinoma,0.7634,Metastatic Carcinoma in the Lung,0.7629,Lung Squamous Cell Carcinoma,0.7584,Localized Lung Carcinoma,0.7582,Combined Lung Carcinoma,0.7570,Carcinoma,0.7530,Lung Secretory Carcinoma,0.7488,Lung Neuroendocrine Carcinoma,0.7441,Advanced Lung Adenocarcinoma,0.7406,Unresectable Lung Carcinoma,0.7381,Occult Lung Adenocarcinoma,0.7361,LUNG_CARCINOMA,True,True,True
LUNG_NSC,Lung Non-Small Cell Carcinoma,2,2,Lung Carcinoma,0.7021,Lung Non-Small Cell Carcinoma,0.6979,Lung Neoplasm,0.6954,Lung Lymphoma,0.6884,Benign Lung Neoplasm,0.6880,Lung Neuroendocrine Neoplasm,0.6876,Lung Non-Hodgkin Lymphoma,0.6846,Malignant Lung Neoplasm,0.6712,Stage 0 Lung Cancer AJCC v6 and v7,0.6626,Lung Neuroendocrine Carcinoma,0.6608,Occult Lung Carcinoma,0.6592,Lung Non-Squamous Non-Small Cell Carcinoma,0.6543,Occult Lung Non-Small Cell Carcinoma,0.6525,Lung Neuroendocrine Tumor,0.6515,Stage 0 Lung Cancer AJCC v8,0.6500,Childhood Lung Neoplasm,0.6484,Occult Lung Cancer AJCC v8,0.6480,Advanced Lung Carcinoma,0.6479,Lung Non-Small Cell Squamous Carcinoma,0.6454,Childhood Lung Non-Small Cell Carcinoma,0.6423,LUNG_NSC,False,True,True
LUNG_SMALL_CELL,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.8646,"Lung Small Cell Carcinoma, A Subtype",0.8241,Lung Small Cell Carcinoma Molecular Subtypes,0.8108,Occult Lung Small Cell Carcinoma,0.7910,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.7774,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.7761,"Lung Small Cell Carcinoma, Neuroendocrine-Low Subtype",0.7722,Lung Non-Small Cell Carcinoma,0.7680,Limited Stage Lung Small Cell Carcinoma,0.7597,Lung Small Cell Carcinoma by AJCC v7 Stage,0.7574,"Lung Small Cell Carcinoma, I Subtype",0.7569,"Lung Small Cell Carcinoma, N Subtype",0.7519,Advanced Lung Small Cell Carcinoma,0.7353,"Lung Small Cell Carcinoma, P Subtype",0.7331,Childhood Lung Small Cell Carcinoma,0.7217,"Lung Small Cell Carcinoma, Neuroendocrine-High Subtype",0.7176,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.7152,"Malignant Tumor, Small Cell Type",0.7132,Metastatic Lung Small Cell Carcinoma,0.7055,Combined Lung Small Cell and Squamous Cell Carcinoma,0.7036,LUNG_SMALL_CELL,True,True,True
LUSC,Lung Squamous Cell Carcinoma,1,2,Lung Squamous Cell Carcinoma,1.0000,Lung Non-Small Cell Squamous Carcinoma,0.8854,Lung Non-Keratinizing Squamous Cell Carcinoma,0.8398,Advanced Lung Squamous Cell Carcinoma,0.8279,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.8245,"Lung Squamous Cell Carcinoma, Clear Cell Variant",0.8160,Occult Lung Squamous Cell Carcinoma,0.8129,Lung Squamous Cell Carcinoma by AJCC v7 Stage,0.8096,Lung Non-Small Cell Carcinoma,0.8044,Lung Keratinizing Squamous Cell Carcinoma,0.7990,Lung Spindle Cell Carcinoma,0.7963,Locally Advanced Lung Squamous Cell Carcinoma,0.7950,Metastatic Lung Squamous Cell Carcinoma,0.7932,Lung Small Cell Carcinoma,0.7920,Lung Carcinoma,0.7887,Lung Non-Squamous Non-Small Cell Carcinoma,0.7882,Laryngeal Squamous Cell Carcinoma,0.7729,Squamous Cell Carcinoma,0.7723,Combined Lung Small Cell and Squamous Cell Carcinoma,0.7685,Superior Sulcus Lung Carcinoma,0.7682,Lung Squamous Cell Carcinoma,True,True,True
"LYMPHATIC CANCER, NOS",Lymphoma,8,2,Lymphatic Vessel Neoplasm,0.7034,Lymphangitic Carcinomatosis,0.6987,Hematopoietic and Lymphatic System Neoplasm,0.6837,Lymphocytic Neoplasm,0.6710,Lymphangioma,0.6348,Malignant Lymph Node Neoplasm,0.6306,Lymphangiosarcoma,0.6296,Lymphoma,0.6224,Lymphoma by Site,0.6180,Lymphangiomatosis,0.6151,Hematopoietic and Lymphoid Cell Neoplasm,0.6127,Carcinoma Unspecified Site,0.6099,Lymph Node Neoplasm,0.6069,Skin Lymphangioma,0.5998,"Malignant Lymphoma, Large Cell Type",0.5981,Lacrimal System Carcinoma,0.5972,Cutaneous Lymphoma,0.5966,Lymphoid Leukemia,0.5960,Hematopoietic and Lymphoid Neoplasm by Obsolete Classification,0.5924,Cutaneous Hematopoietic and Lymphoid Cell Neoplasm,0.5903,"LYMPHATIC CANCER, NOS",False,False,False
LYMPHOBLASTIC LYMPHOMA,Lymphoblastic Lymphoma,1,2,Lymphoblastic Lymphoma,1.0000,B Lymphoblastic Lymphoma,0.8880,Childhood Lymphoblastic Lymphoma,0.8818,Chronic Lymphoblastic Lymphoma,0.8597,Lymphoid Leukemia,0.8346,Acute Lymphoblastic Leukemia,0.8336,Adult Lymphoblastic Lymphoma,0.8301,T Lymphoblastic Lymphoma,0.8212,B Lymphoblastic Leukemia/Lymphoma,0.8103,Splenic Lymphoblastic Lymphoma,0.8039,Lymphoma,0.8015,Childhood B Lymphoblastic Lymphoma,0.7938,Lymphocytic Neoplasm,0.7915,Childhood Lymphoma,0.7802,Childhood T Lymphoblastic Lymphoma,0.7660,T Lymphoblastic Leukemia/Lymphoma,0.7567,Refractory Lymphoblastic Lymphoma,0.7483,Composite Lymphoma,0.7441,Childhood B Lymphoblastic Leukemia/Lymphoma,0.7397,Common Acute Lymphoblastic Leukemia,0.7382,LYMPHOBLASTIC LYMPHOMA,True,True,True
LYMPHOBLASTIC_LYMPHOMA,Lymphoblastic Lymphoma,1,2,Lymphoblastic Lymphoma,0.9670,B Lymphoblastic Lymphoma,0.8658,Childhood Lymphoblastic Lymphoma,0.8466,Chronic Lymphoblastic Lymphoma,0.8235,B Lymphoblastic Leukemia/Lymphoma,0.8006,Lymphoid Leukemia,0.7959,T Lymphoblastic Lymphoma,0.7900,Acute Lymphoblastic Leukemia,0.7891,Lymphoma,0.7853,Adult Lymphoblastic Lymphoma,0.7836,Childhood B Lymphoblastic Lymphoma,0.7650,Lymphocytic Neoplasm,0.7644,Splenic Lymphoblastic Lymphoma,0.7643,Childhood Lymphoma,0.7564,"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7499,Refractory Lymphoblastic Lymphoma,0.7396,"Non-Hodgkin's Lymphoma, Lymphoblastic (WF)",0.7387,T Lymphoblastic Leukemia/Lymphoma,0.7367,Childhood T Lymphoblastic Lymphoma,0.7338,Childhood B Lymphoblastic Leukemia/Lymphoma,0.7233,LYMPHOBLASTIC_LYMPHOMA,True,True,True
LYMPHOEPITHELIOMA-LIKE CARCINOMA OF THE LUNG,Lung Lymphoepithelial Carcinoma,1,2,Lung Lymphoepithelial Carcinoma,0.9445,Lymphoepithelial Carcinoma,0.8078,Laryngeal Lymphoepithelial Carcinoma,0.7952,Cervical Lymphoepithelioma-Like Carcinoma,0.7786,Lung Epithelial-Myoepithelial Carcinoma,0.7778,Sinonasal Lymphoepithelial Carcinoma,0.7565,Thymus Lymphoepithelial Carcinoma,0.7471,Penile Lymphoepithelioma-Like Carcinoma,0.7465,Lung Mucoepidermoid Carcinoma,0.7462,Invasive Lymphoepithelioma-Like Urothelial Carcinoma,0.7440,Lung Myoepithelial Carcinoma,0.7406,Lung Large Cell Neuroendocrine Carcinoma,0.7349,Lung Large Cell Carcinoma,0.7251,Lacrimal Drainage System Lymphoepithelial Carcinoma,0.7245,Lung Neuroendocrine Carcinoma,0.7186,Skin Lymphoepithelial Carcinoma,0.7166,Occult Lung Large Cell Carcinoma,0.7138,Lung Adenoid Cystic Carcinoma,0.7134,Invasive Bladder Lymphoepithelioma-Like Carcinoma,0.7058,Lung Clear Cell Tumor,0.6909,LYMPHOEPITHELIOMA-LIKE CARCINOMA OF THE LUNG,True,True,True
LYMPHOID CANCER,Lymphoma,3,2,Lymphocytic Neoplasm,0.8482,Lymphoid Leukemia,0.8020,Lymphoma,0.7812,Lymphoblastic Lymphoma,0.7524,Composite Lymphoma,0.7449,Leukemia,0.7283,Lymphoma by Site,0.7072,Hematopoietic and Lymphoid Cell Neoplasm,0.7022,Colon Lymphoma,0.6995,Cecum Lymphoma,0.6957,Chronic Lymphoblastic Lymphoma,0.6934,B-Cell Neoplasm,0.6904,Precursor Lymphoid Neoplasm,0.6871,Lacrimal System Carcinoma,0.6867,Cardiac Lymphoma,0.6857,Carcinoma,0.6822,Childhood Lymphoma,0.6813,Lip Carcinoma,0.6803,Chronic Lymphocytic Leukemia,0.6794,Thymus Lymphoma,0.6773,LYMPHOID CANCER,False,True,True
LYMPHOID NEOPLASM,Lymphocytic Neoplasm,1,2,Lymphocytic Neoplasm,0.9095,Precursor Lymphoid Neoplasm,0.8168,Lymph Node Neoplasm,0.8091,Lymphoma,0.7969,Lymphoid Leukemia,0.7647,Lymphatic Vessel Neoplasm,0.7603,Lymphoblastic Lymphoma,0.7483,Hematopoietic and Lymphoid Cell Neoplasm,0.7477,B-Cell Neoplasm,0.7284,Hematopoietic and Lymphatic System Neoplasm,0.7242,Composite Lymphoma,0.7173,Lymphoma by Site,0.7138,Stroma-Derived Neoplasm of Lymphoid Tissues,0.7118,Lacrimal System Neoplasm,0.7110,Lip Neoplasm,0.6992,Localized Lymphoma,0.6958,Immunodeficiency-Related Neoplasm,0.6932,Lymphangiomatosis,0.6931,Lymphangioma,0.6918,Thymus Lymphoma,0.6916,LYMPHOID NEOPLASM,True,True,True
LYMPHOMA,Lymphoma,1,2,Lymphoma,1.0000,Composite Lymphoma,0.8500,Diffuse Malignant Lymphoma,0.8050,Lymphoblastic Lymphoma,0.8015,Lymphoma by Site,0.7986,Lymphocytic Neoplasm,0.7921,Childhood Lymphoma,0.7895,Localized Lymphoma,0.7893,Adult Lymphoma,0.7868,Breast Lymphoma,0.7662,Lymphosarcoma,0.7648,Cerebral Lymphoma,0.7642,Colorectal Lymphoma,0.7587,Ovarian Lymphoma,0.7578,Orbital Lymphoma,0.7575,Gastric Lymphoma,0.7571,Advanced Lymphoma,0.7568,Eye Lymphoma,0.7563,Cardiac Lymphoma,0.7557,Lymphoid Leukemia,0.7519,LYMPHOMA,True,True,True
LYMPHOMA_BURKITT,Burkitt Lymphoma,1,2,Burkitt Lymphoma,0.9504,Classical Burkitt Lymphoma,0.9076,Burkitt Leukemia,0.9024,Non-Burkitt's Lymphoma,0.8653,Sporadic Burkitt Lymphoma,0.8642,Breast Burkitt Lymphoma,0.8585,Childhood Burkitt Lymphoma,0.8523,Kidney Burkitt Lymphoma,0.8360,Adult Burkitt Lymphoma,0.8300,Endemic Burkitt Lymphoma,0.8300,Childhood Burkitt Leukemia,0.8212,Gastric Burkitt Lymphoma,0.8210,Atypical Burkitt/Burkitt-Like Lymphoma,0.8121,EBV-Negative Burkitt Lymphoma,0.8110,Cutaneous Burkitt Lymphoma,0.8059,EBV-Related Burkitt Lymphoma,0.8030,Adult Burkitt Leukemia,0.7935,Burkitt Lymphoma by Ann Arbor Stage,0.7906,High Grade Burkitt-Like Lymphoma,0.7848,Immunodeficiency-Related Burkitt Lymphoma,0.7823,LYMPHOMA_BURKITT,True,True,True
LYMPHOMA_DLBCL,Diffuse Large B-Cell Lymphoma,1,2,Diffuse Large B-Cell Lymphoma,0.8126,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.7959,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.7738,EZB Diffuse Large B-Cell Lymphoma,0.7602,Diffuse Malignant Lymphoma,0.7575,"EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.7563,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,0.7441,Diffuse Large B-Cell Lymphoma Unclassifiable,0.7431,Tonsillar Diffuse Large B-Cell Lymphoma,0.7379,Lymphoma,0.7376,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0.7354,Breast Diffuse Large B-Cell Lymphoma,0.7347,Advanced Diffuse Large B-Cell Lymphoma,0.7328,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0.7284,Adult Diffuse Large B-Cell Lymphoma,0.7259,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma,0.7234,Classical Burkitt Lymphoma,0.7219,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,0.7212,Gastric Diffuse Large B-Cell Lymphoma,0.7187,Testicular Diffuse Large B-Cell Lymphoma,0.7170,LYMPHOMA_DLBCL,True,True,True
LYMPHOMA_HODGKIN,Hodgkin Lymphoma,1,2,Hodgkin Lymphoma,0.9261,Classic Hodgkin Lymphoma,0.8651,Hodgkin Lymphoma by Clinical Course,0.8305,Hodgkin's Sarcoma,0.7973,Cerebral Hodgkin Lymphoma,0.7929,Adult Hodgkin Lymphoma,0.7881,Hodgkin's Granuloma,0.7843,Lung Hodgkin Lymphoma,0.7822,Non-Hodgkin Lymphoma,0.7800,Advanced Hodgkin Lymphoma,0.7781,Digestive System Hodgkin Lymphoma,0.7722,Gastric Hodgkin Lymphoma,0.7668,Childhood Hodgkin Lymphoma,0.7651,Pharyngeal Hodgkin Lymphoma,0.7645,Transformed Small Lymphocytic Lymphoma to Hodgkin Lymphoma,0.7583,Colon Hodgkin Lymphoma,0.7535,Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma,0.7447,Salivary Gland Hodgkin Lymphoma,0.7421,Primary Bone Hodgkin Lymphoma,0.7418,Nasopharyngeal Hodgkin Lymphoma,0.7325,LYMPHOMA_HODGKIN,True,True,True
LYMPHOMA_UNSPECIFIED,Lymphoma,1,2,Lymphoma,0.8487,Diffuse Malignant Lymphoma,0.7575,Lymphoma by Site,0.7317,Composite Lymphoma,0.7054,Lymphoma by Stage,0.7015,Non-Hodgkin Lymphoma,0.6989,Lymphocytic Neoplasm,0.6977,Lymphoblastic Lymphoma,0.6789,Lymphosarcoma,0.6732,"Malignant Lymphoma, Large Cell Type",0.6719,Virus-Related Lymphoma,0.6679,Extranodal Lymphoma,0.6677,"Malignant Lymphoma, Non-Cleaved, Diffuse",0.6659,Malignant Lymphoma by Cell Type (Working Formulation),0.6627,Non-Hodgkin Lymphoma by Clinical Course,0.6585,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0.6550,Childhood Lymphoma,0.6526,Adult Lymphoma,0.6501,Localized Lymphoma,0.6493,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0.6416,LYMPHOMA_UNSPECIFIED,True,True,True
M0,Acute Myeloid Leukemia with Minimal Differentiation,99,2,Stage M0 Medulloblastoma,0.6989,Stage M0 Pineoblastoma,0.6460,Clinical Stage 0 Cutaneous Melanoma AJCC v8,0.6299,Stage M0 Childhood Medulloblastoma by Toronto Guidelines v2,0.6174,Pathologic Stage 0 Cutaneous Melanoma AJCC v8,0.6135,Stage M0 Atypical Teratoid/Rhabdoid Tumor,0.6050,Stage 0 Cutaneous Melanoma AJCC v6 and v7,0.6042,Chronic Myelomonocytic Leukemia-0,0.6005,Prognostic Stage 0 Breast Cancer AJCC v8,0.5977,Grade 1 Malignant Neoplasm,0.5879,Clinical Stage 0 Gastric Cancer AJCC v8,0.5790,Anatomic Stage 0 Breast Cancer AJCC v8,0.5762,Stage M0 Embryonal Tumor with Multilayered Rosettes,0.5753,Stage M0 Childhood Ependymoma by Toronto Guidelines v2,0.5733,Stage 0 Colorectal Cancer AJCC v8,0.5688,Minimal Deviation Melanoma,0.5680,Well Differentiated Malignant Neoplasm,0.5607,Stage 0 Colon Cancer AJCC v8,0.5597,Stage 0 Low Grade Appendix Mucinous Neoplasm (LAMN) AJCC v8,0.5590,Carcinoma In Situ,0.5587,M0,False,False,False
M2,Acute Myeloid Leukemia with Maturation,99,2,Grade 2 Meningioma,0.6576,Stage M2 Medulloblastoma,0.6546,Mesothelioma,0.6329,Meningioma,0.6297,Minimal Deviation Melanoma,0.6177,Biphasic Mesothelioma,0.6143,Myxosarcoma,0.6118,Grade 2 Malignant Neoplasm,0.6089,Myoma,0.6074,Melanoma,0.6068,Clinical Stage II Cutaneous Melanoma AJCC v8,0.5975,Malignant Mesothelioma,0.5932,Metastatic Meningioma,0.5929,Adult Grade 2 Meningioma,0.5875,Myxoma,0.5856,Localized Malignant Mesothelioma,0.5847,Metastatic Melanoma,0.5835,Spindle Cell Melanoma,0.5801,Childhood Grade 2 Meningioma,0.5796,Metastatic Malignant Mesothelioma,0.5792,M2,False,False,False
M3,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,99,2,Stage M3 Medulloblastoma,0.6860,Grade 3 Meningioma,0.6771,Grade 3 Malignant Neoplasm,0.6670,Myoma,0.6436,Meningioma,0.6358,Grade 3a Malignant Neoplasm,0.6341,Grade 3b Malignant Neoplasm,0.6306,Mesothelioma,0.6267,Melanoma,0.6233,Sarcoma NCI Grade 3,0.6200,Myxosarcoma,0.6138,Clinical Stage III Cutaneous Melanoma AJCC v8,0.6130,Ann Arbor Stage III Lymphoma,0.6121,Adult Grade 3 Meningioma,0.6118,Malignant Mesothelioma,0.6113,Sarcoma G3,0.6106,Secretory Meningioma,0.6081,Malignant Mastocytosis,0.6025,Childhood Grade 3 Meningioma,0.6024,Malignant Submandibular Gland Mixed Tumor,0.5978,M3,False,False,False
M4,Acute Myelomonocytic Leukemia,99,2,Stage M4 Medulloblastoma,0.6769,Myoma,0.6430,Metastatic Melanoma,0.6370,Multiple Myeloma,0.6343,Meningioma,0.6310,Mesothelioma,0.6296,Ann Arbor Stage IV Lymphoma,0.6184,Metastatic Meningioma,0.6177,Stage M3 Medulloblastoma,0.6128,Metaplastic Meningioma,0.6117,Malignant Mastocytosis,0.6116,Melanoma,0.6114,AJCC Grade 4 Sarcoma,0.6106,Diffuse Malignant Mesothelioma,0.6093,Grade 4 Malignant Neoplasm,0.6080,Secretory Meningioma,0.6055,Myxosarcoma,0.6051,Metastatic Mucosal Melanoma,0.6037,Grade 3 Meningioma,0.6031,Clinical Stage IV Cutaneous Melanoma AJCC v8,0.6013,M4,False,False,False
M5,Acute Monoblastic and Monocytic Leukemia,8,2,Mesothelioma,0.6565,Acute Monocytic Leukemia,0.6510,Myeloid Leukemia,0.6436,Melanoma,0.6392,Acute Myelomonocytic Leukemia,0.6336,Meningioma,0.6213,Myeloid Neoplasm,0.6143,Acute Monoblastic and Monocytic Leukemia,0.6113,Myeloid Sarcoma,0.6102,Iris Melanoma,0.6098,Acute Myeloid Leukemia with Maturation,0.6093,Chronic Monocytic Leukemia,0.6074,Childhood Acute Monocytic Leukemia,0.6045,Malignant Mesothelioma,0.6025,Metastatic Melanoma,0.6017,Granulocytic Sarcoma,0.6001,Multiple Myeloma,0.5993,Childhood Acute Myelomonocytic Leukemia,0.5987,Myoma,0.5952,Biphasic Mesothelioma,0.5935,M5,False,False,False
M5A,Acute Monoblastic and Monocytic Leukemia,3,2,Acute Monocytic Leukemia,0.6603,Acute Myelomonocytic Leukemia,0.6414,Acute Monoblastic and Monocytic Leukemia,0.6359,Acute Monoblastic Leukemia,0.6269,Childhood Acute Monocytic Leukemia,0.6260,Uveal Class 1a Melanoma,0.6188,Myeloid Leukemia,0.6151,Acute Myeloid Leukemia with Maturation,0.6083,Adult Acute Monocytic Leukemia,0.6081,Childhood Acute Myelomonocytic Leukemia,0.6076,Childhood Acute Monoblastic Leukemia,0.6024,Childhood Acute Monoblastic and Monocytic Leukemia,0.6010,Type A Spindle Cell Melanoma,0.5950,Amelanotic Melanoma,0.5937,Stage IVA Lung Cancer AJCC v8,0.5917,Acute Myeloid Leukemia,0.5890,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.5854,Adult Acute Myelomonocytic Leukemia,0.5853,Stage IVA Bone Cancer AJCC v8,0.5853,Acute Myeloid Leukemia without Maturation,0.5839,M5A,False,True,True
M6,Acute Erythroid Leukemia,99,2,Mesothelioma,0.6032,Meningioma,0.5989,Myoma,0.5911,Malignant Mesothelioma,0.5738,Melanoma,0.5712,Mucosal Melanoma,0.5642,Biphasic Mesothelioma,0.5631,Iris Melanoma,0.5573,Alveolar Rhabdomyosarcoma,0.5572,Atypical Meningioma,0.5564,ROSE Cluster 6,0.5562,Rhabdomyosarcoma,0.5556,Acute Monocytic Leukemia,0.5554,Hemangioblastic Meningioma,0.5549,Multifocal Osteosarcoma,0.5544,Surface Osteoma,0.5538,Osteosarcoma,0.5533,ROSE Cluster 7,0.5533,Acute Myelomonocytic Leukemia,0.5520,Conventional Alveolar Rhabdomyosarcoma,0.5514,M6,False,False,False
M7,Acute Megakaryoblastic Leukemia,99,2,ROSE Cluster 7,0.5980,Melanoma,0.5517,Mesothelioma,0.5298,Mucosal Melanoma,0.5293,Meningioma,0.5288,ROSE Cluster 8,0.5277,Iris Melanoma,0.5262,ROSE Cluster 6,0.5256,Myeloid Leukemia,0.5238,Astrocytoma,0.5197,Acute Myelomonocytic Leukemia,0.5192,Jejunal Melanoma,0.5168,Lung Melanoma,0.5166,Cutaneous Melanoma,0.5161,Urethral Melanoma,0.5150,Sialoblastoma,0.5147,Mediastinal Myeloid Sarcoma,0.5145,Cutaneous Melanoma by AJCC v7 Stage,0.5143,Myxoma,0.5141,Mediastinal Lymphoma,0.5132,M7,False,False,False
MALIGNANT AMELANOTIC MELANOMA,Amelanotic Melanoma,1,2,Amelanotic Melanoma,0.9473,Cutaneous Amelanotic Melanoma,0.9360,Cutaneous Melanoma,0.7223,Dermal Melanoma,0.6991,Anal Melanoma,0.6960,Melanoma,0.6871,Acral Melanoma,0.6780,Melanoacanthoma,0.6769,Nevoid Melanoma,0.6760,Ameloblastic Carcinoma,0.6748,Ameloblastoma,0.6737,Acral Lentiginous Melanoma,0.6708,Acanthomatous Ameloblastoma,0.6688,Conventional Ameloblastoma,0.6676,Metastasizing Ameloblastoma,0.6655,Mucosal Melanoma,0.6647,Ocular Melanoma,0.6604,Corneal Melanoma,0.6583,Eyelid Melanoma,0.6563,Melanocytic Matricoma,0.6537,MALIGNANT AMELANOTIC MELANOMA,True,True,True
MALIGNANT FIBROUS HISTIOCYTOMA,Undifferentiated Pleomorphic Sarcoma,99,2,Fibrous Histiocytoma,0.8927,Fibrous Histiocytoma of Bone,0.8345,Skin Fibrous Histiocytoma,0.8218,Deep Fibrous Histiocytoma,0.8199,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 3,0.8111,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 2,0.7977,Angiomatoid Fibrous Histiocytoma,0.7951,Malignant Solitary Fibrous Tumor,0.7902,Skin Fibroblastic Fibrous Histiocytoma,0.7871,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 3,0.7832,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 2,0.7808,Skin Cellular Fibrous Histiocytoma,0.7745,Skin Histiocytic Fibrous Histiocytoma,0.7686,Histiocytic Sarcoma,0.7565,Histiocytoma,0.7532,Malignant Histiocytosis,0.7512,Malignant Fibrohistiocytic Neoplasm,0.7450,Childhood Fibrous Histiocytoma,0.7387,Pleomorphic Fibroma,0.7231,Intracranial Fibrous Histiocytoma,0.7157,MALIGNANT FIBROUS HISTIOCYTOMA,False,False,False
MALIGNANT FIBROUS HISTIOCYTOMA-PLEOMORPHIC SARCOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.8108,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 2,0.7850,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 3,0.7803,Pleomorphic Dermal Sarcoma,0.7799,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7776,Pleomorphic Rhabdomyosarcoma,0.7592,Pleomorphic Fibroma,0.7517,Fibrous Histiocytoma,0.7419,Metastatic Undifferentiated Pleomorphic Sarcoma,0.7341,Pleomorphic Liposarcoma,0.7290,Histiocytic Sarcoma,0.7288,Myxoid Pleomorphic Liposarcoma,0.7281,Prostate Undifferentiated Pleomorphic Sarcoma,0.7178,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 3,0.7177,Advanced Undifferentiated Pleomorphic Sarcoma,0.7167,Deep Fibrous Histiocytoma,0.7138,Adult Undifferentiated Pleomorphic Sarcoma,0.7107,Pleomorphic Leiomyosarcoma,0.7071,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 2,0.7059,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7058,MALIGNANT FIBROUS HISTIOCYTOMA-PLEOMORPHIC SARCOMA,True,True,True
MALIGNANT LYMPHOMA,Lymphoma,1,2,Lymphoma,0.9154,Diffuse Malignant Lymphoma,0.8671,Composite Lymphoma,0.7942,"Malignant Lymphoma, Large Cell Type",0.7689,Lymphocytic Neoplasm,0.7664,Lymphoma by Site,0.7545,Lymphosarcoma,0.7541,Malignant Lymphoma by Cell Type (Working Formulation),0.7522,Advanced Lymphoma,0.7488,Malignant Neoplasm,0.7411,Anaplastic Lymphoma,0.7291,Lymphoblastic Lymphoma,0.7287,Adult Lymphoma,0.7278,Breast Lymphoma,0.7246,Colon Lymphoma,0.7165,Childhood Lymphoma,0.7156,Colorectal Lymphoma,0.7121,Lymphoma by Stage,0.7110,Cardiac Lymphoma,0.7106,Gastric Lymphoma,0.7062,MALIGNANT LYMPHOMA,True,True,True
MALIGNANT MELANOMA,Melanoma,1,2,Melanoma,0.9261,Cutaneous Melanoma,0.8847,Dermal Melanoma,0.8282,Ocular Melanoma,0.7878,Retinal Melanoma,0.7785,Metastatic Melanoma,0.7761,Mucosal Melanoma,0.7702,Invasive Cutaneous Melanoma,0.7668,Non-Cutaneous Melanoma,0.7665,Uveal Melanoma,0.7564,Advanced Melanoma,0.7557,Melanocytic Neoplasm,0.7500,Malignant Neoplasm,0.7415,Malignant Skin Neoplasm,0.7345,Breast Melanoma,0.7339,Metastatic Cutaneous Melanoma,0.7331,Cervical Melanoma,0.7284,Choroid Melanoma,0.7259,Childhood Melanoma,0.7254,Advanced Cutaneous Melanoma,0.7229,MALIGNANT MELANOMA,True,True,True
MALIGNANT MELANOTIC MELANOMA,Melanoma,3,2,Cutaneous Melanoma,0.8166,Melanocytic Neoplasm,0.7877,Melanoma,0.7862,Cutaneous Melanocytic Neoplasm,0.7676,Dermal Melanoma,0.7533,Lentigo Maligna Melanoma,0.7428,Nevoid Melanoma,0.7388,Amelanotic Melanoma,0.7327,Malignant Melanotic Peripheral Nerve Sheath Tumor,0.7302,Melanocytic Matricoma,0.7262,Melanocytoma,0.7222,Mucosal Melanoma,0.7208,Non-Cutaneous Melanoma,0.7199,Cutaneous Amelanotic Melanoma,0.7163,Melanoma in Precancerous Melanosis,0.7157,Pigmented Epithelioid Melanocytoma,0.7143,Cutaneous Spitz Melanocytoma,0.7137,Uveal Melanocytoma,0.7097,Balloon Cell Melanoma,0.7087,Ocular Melanoma,0.7086,MALIGNANT MELANOTIC MELANOMA,False,True,True
MALIGNANT MIXED MULLERIAN TUMOR MMMT,Female Reproductive System Carcinosarcoma,99,2,Mixed Mesodermal (Mullerian) Tumor,0.8723,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0.7654,"Malignant Mixed Tumor, Not Otherwise Specified",0.7563,Malignant Mixed Neoplasm,0.7455,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0.7129,Malignant Mesenchymoma,0.7050,Malignant Mixed Epithelial and Stromal Tumor of the Kidney,0.6914,Malignant Mixed Epithelial and Mesenchymal Neoplasm of the Cervix,0.6833,Adult Malignant Mesenchymoma,0.6750,Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm,0.6738,Malignant Mesothelioma,0.6702,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0.6689,Malignant Mixed Tumor of the Skin,0.6650,Mixed Endometrial Stromal and Smooth Muscle Neoplasm,0.6646,Diffuse Malignant Mesothelioma,0.6575,Mesenchymoma,0.6488,Malignant Myoepithelioma,0.6420,Cervical Mixed Epithelial and Mesenchymal Neoplasm,0.6403,Malignant Mixed Tumor of the Major Salivary Gland,0.6393,Malignant Muscle Neoplasm,0.6372,MALIGNANT MIXED MULLERIAN TUMOR MMMT,False,False,False
MALIGNANT PERIPHERAL NERVE SHEATH TUMOR,Malignant Peripheral Nerve Sheath Tumor,1,2,Malignant Peripheral Nerve Sheath Tumor,1.0000,Sporadic Malignant Peripheral Nerve Sheath Tumor,0.9272,Bone Malignant Peripheral Nerve Sheath Tumor,0.9066,Adult Malignant Peripheral Nerve Sheath Tumor,0.9064,Advanced Malignant Peripheral Nerve Sheath Tumor,0.9046,Metastatic Malignant Peripheral Nerve Sheath Tumor,0.8913,Low Grade Malignant Peripheral Nerve Sheath Tumor,0.8864,Malignant Peripheral Nerve Sheath Tumor of the Skin,0.8814,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,0.8780,Penile Malignant Peripheral Nerve Sheath Tumor,0.8724,High Grade Malignant Peripheral Nerve Sheath Tumor,0.8661,Malignant Peripheral Nerve Sheath Tumor with Perineurial Differentiation,0.8539,Cervical Malignant Peripheral Nerve Sheath Tumor,0.8493,Glandular Malignant Peripheral Nerve Sheath Tumor,0.8456,Sinonasal Malignant Peripheral Nerve Sheath Tumor,0.8414,Malignant Melanotic Peripheral Nerve Sheath Tumor,0.8355,Childhood Malignant Peripheral Nerve Sheath Tumor,0.8333,Mediastinal Malignant Peripheral Nerve Sheath Tumor,0.8328,Unresectable Malignant Peripheral Nerve Sheath Tumor,0.8304,NF1-Associated Malignant Peripheral Nerve Sheath Tumor,0.8220,MALIGNANT PERIPHERAL NERVE SHEATH TUMOR,True,True,True
MALIGNANT PERIPHERAL NERVE SHEATH TUMORS MPNST,Malignant Peripheral Nerve Sheath Tumor,1,2,Malignant Peripheral Nerve Sheath Tumor,0.8725,Sporadic Malignant Peripheral Nerve Sheath Tumor,0.8546,High Grade Malignant Peripheral Nerve Sheath Tumor,0.8354,Low Grade Malignant Peripheral Nerve Sheath Tumor,0.8349,Bone Malignant Peripheral Nerve Sheath Tumor,0.8236,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,0.8177,NF1-Associated Malignant Peripheral Nerve Sheath Tumor,0.8071,Sinonasal Malignant Peripheral Nerve Sheath Tumor,0.8001,Metastatic Malignant Peripheral Nerve Sheath Tumor,0.7992,Advanced Malignant Peripheral Nerve Sheath Tumor,0.7949,Malignant Peripheral Nerve Sheath Tumor of the Skin,0.7853,Malignant Peripheral Nerve Sheath Tumor with Perineurial Differentiation,0.7823,Malignant Melanotic Peripheral Nerve Sheath Tumor,0.7820,Adult Malignant Peripheral Nerve Sheath Tumor,0.7819,Glandular Malignant Peripheral Nerve Sheath Tumor,0.7785,Penile Malignant Peripheral Nerve Sheath Tumor,0.7687,Epithelioid Malignant Peripheral Nerve Sheath Tumor,0.7588,Esophageal Malignant Peripheral Nerve Sheath Tumor,0.7542,Mediastinal Malignant Peripheral Nerve Sheath Tumor,0.7540,Malignant Melanotic Psammomatous Peripheral Nerve Sheath Tumor,0.7488,MALIGNANT PERIPHERAL NERVE SHEATH TUMORS MPNST,True,True,True
MALIGNANT PHYLLODES TUMOR OF THE BREAST,Malignant Breast Phyllodes Tumor,1,2,Malignant Breast Phyllodes Tumor,0.9758,Malignant Phyllodes Tumor,0.9188,Breast Phyllodes Tumor,0.9018,Malignant Prostate Phyllodes Tumor,0.8582,Borderline Breast Phyllodes Tumor,0.8495,Childhood Breast Phyllodes Tumor,0.8489,Benign Breast Phyllodes Tumor,0.8475,Phyllodes Tumor,0.8355,Borderline Phyllodes Tumor,0.8180,Prostate Phyllodes Tumor,0.8108,Benign Phyllodes Tumor,0.7964,Phyllodes Tumor of Anogenital Mammary-Type Glands,0.7757,Benign Prostate Phyllodes Tumor,0.7717,Malignant Vulvar Phyllodes Tumor,0.7675,Refractory Malignant Phyllodes Tumor,0.7459,Vulvar Phyllodes Tumor,0.7003,Benign Vulvar Phyllodes Tumor,0.6661,Borderline Vulvar Phyllodes Tumor,0.6636,Malignant Breast Adenomyoepithelioma,0.6140,Breast Melanoma,0.6133,MALIGNANT PHYLLODES TUMOR OF THE BREAST,True,True,True
MALIGNANT PT,Malignant Breast Phyllodes Tumor,99,2,Malignant Neoplasm,0.8014,Primary Malignant Neoplasm,0.7864,Malignant Prostate Neoplasm,0.7227,Malignant Pancreatic Neoplasm,0.7224,Malignant Parathyroid Gland Neoplasm,0.7194,Malignant Placental Neoplasm,0.7144,Advanced Malignant Neoplasm,0.7091,Carcinoma,0.6959,Invasive Malignant Neoplasm,0.6942,Malignant PEComa,0.6906,Malignant Peritoneal Neoplasm,0.6892,Malignant Pharyngeal Neoplasm,0.6880,Malignant Thoracic Neoplasm,0.6860,Malignant Pericytic Neoplasm,0.6852,Malignant Pleural Neoplasm,0.6830,Malignant Neoplasm by Grade,0.6781,Papillary Carcinoma,0.6769,Advanced Malignant PEComa,0.6728,Poorly Differentiated Malignant Neoplasm,0.6705,Metastatic Malignant Neoplasm,0.6665,MALIGNANT PT,False,False,False
MALIGNANT RHABDOID TUMOR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9414,Metastatic Rhabdoid Tumor,0.9013,Advanced Rhabdoid Tumor,0.8953,Rhabdoid Meningioma,0.8763,Refractory Rhabdoid Tumor,0.8631,Unresectable Rhabdoid Tumor,0.8483,Extrarenal Rhabdoid Tumor,0.8339,Atypical Teratoid/Rhabdoid Tumor,0.8260,Recurrent Rhabdoid Tumor,0.8215,Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes,0.8160,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.8148,Rhabdoid Tumor of the Kidney,0.8002,Refractory Extrarenal Rhabdoid Tumor,0.7876,Refractory Atypical Teratoid/Rhabdoid Tumor,0.7798,Atypical Teratoid/Rhabdoid Tumor-TYR,0.7758,Childhood Atypical Teratoid/Rhabdoid Tumor,0.7699,Refractory Rhabdoid Tumor of the Kidney,0.7509,Extrarenal Rhabdoid Tumor of the Prostate,0.7310,Atypical Teratoid/Rhabdoid Tumor-MYC,0.7302,Unresectable Extrarenal Rhabdoid Tumor,0.7264,MALIGNANT RHABDOID TUMOR,True,True,True
MALIGNANT SACROCOCCYGEAL TERATOMA,Sacrococcygeal Teratoma,1,2,Sacrococcygeal Teratoma,0.9282,Malignant Coccygeal Neoplasm,0.7179,Malignant Teratoma,0.6980,Gonadal Teratoma,0.6710,Coccygeal Neoplasm,0.6590,Pericardial Mature Teratoma,0.6462,Pericardial Teratoma,0.6424,Malignant Ovarian Teratoma,0.6406,Mature Gastric Teratoma,0.6341,Mature Teratoma,0.6282,Central Nervous System Teratoma,0.6279,Gastric Teratoma,0.6241,Central Nervous System Mature Teratoma,0.6230,Cardiac Teratoma,0.6196,Sellar Mature Teratoma,0.6195,Sellar Teratoma,0.6170,Intramedullary Spinal Cord Teratoma,0.6158,Teratoma with Somatic-Type Malignancy,0.6153,Malignant Trophoblastic Teratoma,0.6144,Testicular Teratoma,0.6128,MALIGNANT SACROCOCCYGEAL TERATOMA,True,True,True
MALIGNANT SMALL CELL TUMOR,"Malignant Tumor, Small Cell Type",1,2,"Malignant Tumor, Small Cell Type",0.9619,Small Cell Adenocarcinoma,0.8227,Small Cell Intermediate Cell Carcinoma,0.7589,Small Cell Sarcoma,0.7539,Lung Small Cell Carcinoma,0.7434,Small Cell Neuroendocrine Carcinoma,0.7293,Non-Small Cell Carcinoma,0.7269,Lung Small Cell Carcinoma Molecular Subtypes,0.7149,Poorly Differentiated Malignant Neoplasm,0.7121,Ovarian Small Cell Carcinoma,0.7101,Non-Small Cell Adenocarcinoma,0.6960,"Lung Small Cell Carcinoma, A Subtype",0.6941,Thyroid Gland Undifferentiated Small Cell Carcinoma,0.6800,Metastatic Small Cell Neuroendocrine Carcinoma,0.6740,Occult Lung Small Cell Carcinoma,0.6695,Malignant Small Intestinal Neoplasm,0.6681,Small Cell Osteosarcoma,0.6654,Low Grade Malignant Neoplasm,0.6577,"Malignant Non-Hodgkin's Lymphoma, Small Cleaved Cell",0.6576,Well Differentiated Malignant Neoplasm,0.6562,MALIGNANT SMALL CELL TUMOR,True,True,True
MALIGNANT TUMOR,Malignant Neoplasm,1,2,Malignant Neoplasm,0.9864,Primary Malignant Neoplasm,0.8426,Malignant Bone Neoplasm,0.8104,Malignant Solid Neoplasm,0.7976,Advanced Malignant Neoplasm,0.7795,Malignant Neoplasm by Grade,0.7767,Carcinoma,0.7761,Malignant Musculoskeletal Neoplasm,0.7731,High Grade Malignant Neoplasm,0.7712,Malignant Vascular Neoplasm,0.7706,Malignant Skin Neoplasm,0.7703,Anaplastic Malignant Neoplasm,0.7634,Malignant Muscle Neoplasm,0.7580,Adenocarcinoma,0.7556,Undifferentiated Malignant Neoplasm,0.7517,Malignant Thoracic Neoplasm,0.7491,Invasive Malignant Neoplasm,0.7483,Malignant Cardiac Neoplasm,0.7478,Malignant Abdominal Neoplasm,0.7340,Malignant Oral Neoplasm,0.7336,MALIGNANT TUMOR,True,True,True
MALIGNANT_FIBROUS_HISTIOCYTOMA,Undifferentiated Pleomorphic Sarcoma,99,2,Fibrous Histiocytoma,0.8650,Fibrous Histiocytoma of Bone,0.8190,Skin Fibrous Histiocytoma,0.8006,Angiomatoid Fibrous Histiocytoma,0.8002,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 3,0.7893,Deep Fibrous Histiocytoma,0.7845,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 2,0.7795,Skin Fibroblastic Fibrous Histiocytoma,0.7670,Skin Histiocytic Fibrous Histiocytoma,0.7619,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 3,0.7595,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 2,0.7572,Malignant Histiocytosis,0.7553,Malignant Solitary Fibrous Tumor,0.7533,Histiocytoma,0.7532,Histiocytic Sarcoma,0.7485,Skin Cellular Fibrous Histiocytoma,0.7460,Malignant Fibrohistiocytic Neoplasm,0.7392,Childhood Fibrous Histiocytoma,0.7210,Intracranial Fibrous Histiocytoma,0.6947,Skin Epithelioid Fibrous Histiocytoma,0.6924,MALIGNANT_FIBROUS_HISTIOCYTOMA,False,False,False
MALIGNANT_MELANOMA,Melanoma,1,2,Melanoma,0.8890,Cutaneous Melanoma,0.8570,Dermal Melanoma,0.7972,Non-Cutaneous Melanoma,0.7766,Mucosal Melanoma,0.7711,Metastatic Melanoma,0.7672,Ocular Melanoma,0.7576,Uveal Melanoma,0.7471,Retinal Melanoma,0.7381,Invasive Cutaneous Melanoma,0.7308,Metastatic Cutaneous Melanoma,0.7292,Lentigo Maligna Melanoma,0.7254,Metastatic Melanoma in the Skin,0.7220,Malignant Neoplasm,0.7209,Melanocytic Neoplasm,0.7148,Malignant Skin Neoplasm,0.7106,Advanced Melanoma,0.7096,Cutaneous Melanoma of the Extremity,0.7065,Choroid Melanoma,0.7060,High-CSD Melanoma,0.7052,MALIGNANT_MELANOMA,True,True,True
MALIGNANT_PAPILLARY_SEROUS_ADENOCARCINOMA,Papillary Serous Cystadenocarcinoma,1,2,Papillary Serous Cystadenocarcinoma,0.8100,Serous Adenocarcinoma,0.8065,Primary Peritoneal Serous Adenocarcinoma,0.8039,Ovarian Serous Surface Papillary Adenocarcinoma,0.7894,Serous Surface Papillary Carcinoma,0.7891,Primary Peritoneal Serous Papillary Adenocarcinoma,0.7730,Metastatic Primary Peritoneal Serous Adenocarcinoma,0.7596,Micropapillary Serous Carcinoma,0.7504,Ovarian Serous Adenocarcinoma,0.7462,Papillary Serous Cystadenoma,0.7451,Serous Cystadenocarcinoma,0.7446,Papillary Adenocarcinoma,0.7416,Pancreatic Serous Cystadenocarcinoma,0.7360,Endometrial Serous Adenocarcinoma,0.7338,Primary Peritoneal High Grade Serous Adenocarcinoma,0.7255,Primary Peritoneal Low Grade Serous Adenocarcinoma,0.7215,Platinum-Sensitive Endometrial Serous Adenocarcinoma,0.7191,Advanced Endometrial Serous Adenocarcinoma,0.7179,Malignant Ovarian Serous Tumor,0.7173,Cervical Serous Adenocarcinoma,0.7106,MALIGNANT_PAPILLARY_SEROUS_ADENOCARCINOMA,True,True,True
MALIGNANT_RHABDOID_TUMOR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9029,Metastatic Rhabdoid Tumor,0.8767,Advanced Rhabdoid Tumor,0.8596,Unresectable Rhabdoid Tumor,0.8342,Refractory Rhabdoid Tumor,0.8338,Rhabdoid Meningioma,0.8330,Extrarenal Rhabdoid Tumor,0.8070,Recurrent Rhabdoid Tumor,0.7982,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.7901,Rhabdoid Tumor of the Kidney,0.7886,Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes,0.7872,Atypical Teratoid/Rhabdoid Tumor,0.7871,Refractory Extrarenal Rhabdoid Tumor,0.7687,Atypical Teratoid/Rhabdoid Tumor-TYR,0.7605,Refractory Atypical Teratoid/Rhabdoid Tumor,0.7519,Refractory Rhabdoid Tumor of the Kidney,0.7451,Childhood Atypical Teratoid/Rhabdoid Tumor,0.7316,Extrarenal Rhabdoid Tumor of the Prostate,0.7221,Unresectable Extrarenal Rhabdoid Tumor,0.7191,Recurrent Extrarenal Rhabdoid Tumor,0.7113,MALIGNANT_RHABDOID_TUMOR,True,True,True
MAMMARY ANALOGUE SECRETORY CARCINOMA OF SALIVARY GLAND ORIGIN,Salivary Gland Secretory Carcinoma,1,2,Salivary Gland Secretory Carcinoma,0.8508,Salivary Gland Microsecretory Adenocarcinoma,0.7978,Salivary Gland Mucinous Adenocarcinoma,0.7923,Metastatic Salivary Gland Secretory Carcinoma,0.7831,Salivary Gland Epithelial-Myoepithelial Carcinoma,0.7827,Salivary Gland Adenosquamous Carcinoma,0.7726,Salivary Gland Carcinoma,0.7697,Breast Secretory Carcinoma,0.7677,Salivary Gland Undifferentiated Carcinoma,0.7656,Submandibular Gland Acinic Cell Carcinoma,0.7636,Salivary Gland Sebaceous Carcinoma,0.7632,Salivary Gland Myoepithelial Carcinoma,0.7608,Salivary Gland Acinic Cell Carcinoma,0.7530,Salivary Gland Adenocarcinoma,0.7484,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",0.7459,Major Salivary Gland Acinic Cell Carcinoma,0.7362,Salivary Gland Carcinosarcoma,0.7359,Salivary Duct Carcinoma,0.7357,Salivary Gland Squamous Cell Carcinoma,0.7325,Salivary Gland Cystadenocarcinoma,0.7324,MAMMARY ANALOGUE SECRETORY CARCINOMA OF SALIVARY GLAND ORIGIN,True,True,True
MANTLE CELL LYMPHOMA,Mantle Cell Lymphoma,1,2,Mantle Cell Lymphoma,1.0000,Cutaneous Mantle Cell Lymphoma,0.8767,Colorectal Mantle Cell Lymphoma,0.8539,Gastric Mantle Cell Lymphoma,0.8507,Colon Mantle Cell Lymphoma,0.8497,Splenic Mantle Cell Lymphoma,0.8330,Prostate Mantle Cell Lymphoma,0.8307,Tonsillar Mantle Cell Lymphoma,0.8187,Small Intestinal Mantle Cell Lymphoma,0.8105,Leukemic Nonnodal Mantle Cell Lymphoma,0.8078,Blastoid Variant Mantle Cell Lymphoma,0.7844,Cyclin D1-Negative Mantle Cell Lymphoma,0.7819,Lymphoplasmacytic Lymphoma,0.7799,Parotid Gland Mantle Cell Lymphoma,0.7775,Marginal Zone Lymphoma,0.7745,Cyclin D1-Positive Mantle Cell Lymphoma,0.7721,Mantle Cell Lymphoma by Ann Arbor Stage,0.7608,Mantle Cell Lymphoma with CCND3 Rearrangement,0.7565,Mantle Cell Lymphoma with CCND2 Rearrangement,0.7553,Ann Arbor Stage IV Mantle Cell Lymphoma,0.7544,MANTLE CELL LYMPHOMA,True,True,True
MANTLE_CELL_LYMPHOMA,Mantle Cell Lymphoma,1,2,Mantle Cell Lymphoma,0.9457,Cutaneous Mantle Cell Lymphoma,0.8368,Colorectal Mantle Cell Lymphoma,0.8010,Gastric Mantle Cell Lymphoma,0.8003,Colon Mantle Cell Lymphoma,0.7831,Leukemic Nonnodal Mantle Cell Lymphoma,0.7745,Prostate Mantle Cell Lymphoma,0.7743,Splenic Mantle Cell Lymphoma,0.7636,Refractory Mantle Cell Lymphoma,0.7591,Tonsillar Mantle Cell Lymphoma,0.7539,Recurrent Mantle Cell Lymphoma,0.7497,Blastoid Variant Mantle Cell Lymphoma,0.7496,Lymphoplasmacytic Lymphoma,0.7472,Small Intestinal Mantle Cell Lymphoma,0.7444,Ann Arbor Stage IV Mantle Cell Lymphoma,0.7423,Mantle Cell Lymphoma with CCND3 Rearrangement,0.7411,Cyclin D1-Negative Mantle Cell Lymphoma,0.7405,Cyclin D1-Positive Mantle Cell Lymphoma,0.7382,Mantle Cell Lymphoma by Ann Arbor Stage,0.7381,Marginal Zone Lymphoma,0.7369,MANTLE_CELL_LYMPHOMA,True,True,True
MARGINAL ZONE LYMPHOMA,Marginal Zone Lymphoma,1,2,Marginal Zone Lymphoma,1.0000,Nodal Marginal Zone Lymphoma,0.9419,Advanced Marginal Zone Lymphoma,0.9089,Splenic Marginal Zone Lymphoma,0.8783,Refractory Marginal Zone Lymphoma,0.8605,Gray-Zone Lymphoma,0.8378,Recurrent Marginal Zone Lymphoma,0.8363,Pediatric Nodal Marginal Zone Lymphoma,0.8148,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.8104,Marginal Zone Lymphoma by Ann Arbor Stage,0.8094,Refractory Nodal Marginal Zone Lymphoma,0.8066,Mediastinal Gray-Zone Lymphoma,0.8057,Ann Arbor Stage IV Marginal Zone Lymphoma,0.8041,Ann Arbor Stage IV Nodal Marginal Zone Lymphoma,0.7775,Recurrent Nodal Marginal Zone Lymphoma,0.7772,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0.7751,Mantle Cell Lymphoma,0.7745,Nodal Marginal Zone Lymphoma by Ann Arbor Stage,0.7744,Ann Arbor Stage I Marginal Zone Lymphoma,0.7670,Refractory Splenic Marginal Zone Lymphoma,0.7653,MARGINAL ZONE LYMPHOMA,True,True,True
MASKED LOW HYPODIPLOID,Hypodiploid B Lymphoblastic Leukemia/Lymphoma,1,2,Hypodiploid B Lymphoblastic Leukemia/Lymphoma,0.6965,Hypodiploid B Acute Lymphoblastic Leukemia,0.6848,Low-Hypodiploid B Acute Lymphoblastic Leukemia,0.6807,Hypoplastic Myelodysplastic Syndrome,0.6460,Myelodysplastic Syndrome with Low Blasts,0.6172,Low Grade Liver Dysplastic Nodule,0.6079,Low Grade Lymphoma,0.6034,Hyperdiploid B Lymphoblastic Leukemia/Lymphoma,0.5969,Hyperdiploid B Acute Lymphoblastic Leukemia,0.5932,"Childhood Myelodysplastic Syndrome with Low Blasts, Hypocellular",0.5922,Unfavorable Hodgkin Lymphoma,0.5861,Adult Unfavorable Prognosis Hodgkin Lymphoma,0.5848,Acute Myeloid Leukemia with Minimal Differentiation,0.5812,Childhood Myelodysplastic Syndrome with Low Blasts,0.5782,Low Grade Intraepithelial Neoplasia,0.5773,Childhood Unfavorable Prognosis Hodgkin Lymphoma,0.5760,Early Unfavorable Hodgkin Lymphoma,0.5759,Low Grade Malignant Neoplasm,0.5719,Multiple Myeloma with Hyperdiploidy,0.5697,Transient Abnormal Myelopoiesis Associated with Down Syndrome,0.5696,MASKED LOW HYPODIPLOID,True,True,True
MASTOCYTOSIS,Mastocytosis,1,2,Mastocytosis,1.0000,Malignant Mastocytosis,0.9097,Systemic Mastocytosis,0.8943,Cutaneous Mastocytosis,0.8625,Bone Marrow Mastocytosis,0.8584,Mast Cell Leukemia,0.8271,Pure Cutaneous Mastocytosis,0.8215,Mastocytoma,0.8210,Mast Cell Neoplasm,0.8147,Diffuse Cutaneous Mastocytosis,0.8030,Aggressive Systemic Mastocytosis,0.7846,Mast Cell Sarcoma,0.7593,Indolent Systemic Mastocytosis,0.7500,Mastocytoma of the Skin,0.7224,Histiocytosis,0.7084,Extracutaneous Mastocytoma,0.6986,Recurrent Malignant Mastocytosis,0.6896,Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis,0.6849,Solitary Mastocytoma of the Skin,0.6795,Malignant Histiocytosis,0.6739,MASTOCYTOSIS,True,True,True
MATURE B-CELL LYMPHOMA,Mature B-Cell Non-Hodgkin Lymphoma,2,2,Mature B-Cell Neoplasm,0.8973,Mature B-Cell Non-Hodgkin Lymphoma,0.8964,Monoclonal B-Cell Lymphocytosis,0.8280,B-Cell Malignant Neoplasm,0.7876,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0.7808,Cutaneous Mature B-Cell Neoplasm,0.7743,B-Cell Neoplasm,0.7666,Mantle Cell Lymphoma,0.7601,Advanced B-Cell Malignant Neoplasm,0.7588,B-Cell Non-Hodgkin Lymphoma,0.7438,B-Cell Leukemia,0.7357,"Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia Type",0.7349,Lung Mature B-Cell Neoplasm,0.7305,Classical Burkitt Lymphoma,0.7275,Non-Burkitt's Lymphoma,0.7254,MCD Diffuse Large B-Cell Lymphoma,0.7233,"Monoclonal B-Cell Lymphocytosis, Non-Chronic Lymphocytic Leukemia Type",0.7219,High Grade B-Cell Lymphoma,0.7189,B Lymphoblastic Lymphoma,0.7175,Centroblastic Lymphoma,0.7158,MATURE B-CELL LYMPHOMA,False,True,True
MATURE B-CELL NEOPLASMS,Mature B-Cell Neoplasm,1,2,Mature B-Cell Neoplasm,0.9917,B-Cell Neoplasm,0.8653,Mature B-Cell Non-Hodgkin Lymphoma,0.8442,B-Cell Malignant Neoplasm,0.8358,Cutaneous Mature B-Cell Neoplasm,0.8149,Advanced B-Cell Malignant Neoplasm,0.7820,Monoclonal B-Cell Lymphocytosis,0.7811,Lung Mature B-Cell Neoplasm,0.7589,B-Cell Leukemia,0.6873,B-Cell Non-Hodgkin Lymphoma,0.6809,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0.6733,Plasma Cell Neoplasm,0.6690,Mature T-ALL,0.6565,Refractory B-Cell Malignant Neoplasm,0.6542,Non-Burkitt's Lymphoma,0.6542,B-Cell Proliferation of Uncertain Malignant Potential,0.6519,"Monoclonal B-Cell Lymphocytosis, Non-Chronic Lymphocytic Leukemia Type",0.6516,High Grade B-Cell Lymphoma,0.6466,Aggressive B-Cell Non-Hodgkin Lymphoma,0.6453,B Lymphoblastic Lymphoma,0.6443,MATURE B-CELL NEOPLASMS,True,True,True
MATURE T AND NK NEOPLASMS,Mature T-Cell and NK-Cell Neoplasm,1,2,Mature T-Cell and NK-Cell Neoplasm,0.9446,T-Cell and NK-Cell Neoplasm,0.8702,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0.8427,Cutaneous Mature T-Cell and NK-Cell Neoplasm,0.8210,Primary Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0.7825,Mature T- and NK-Cell Lymphoma by Ann Arbor Stage,0.7713,Refractory Mature T-Cell and NK-Cell Neoplasm,0.7525,Mature T-ALL,0.7359,Childhood Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0.7238,Recurrent Mature T-Cell and NK-Cell Neoplasm,0.7111,Ann Arbor Stage IV Mature T- and NK-Cell Lymphoma,0.7060,Refractory T-Cell and NK-Cell Neoplasm,0.6965,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0.6933,Mature B-Cell Neoplasm,0.6790,Mediastinal/Thymus NUT Carcinoma,0.6745,Thymus Neuroendocrine Neoplasm,0.6675,Ann Arbor Stage III Mature T- and NK-Cell Lymphoma,0.6673,Testicular Nasal Type Extranodal NK/T-Cell Lymphoma,0.6658,Ann Arbor Stage II Mature T- and NK-Cell Lymphoma,0.6638,Aggressive T-Cell Non-Hodgkin Lymphoma,0.6637,MATURE T AND NK NEOPLASMS,True,True,True
MATURE TERATOMA,Mature Teratoma,1,2,Mature Teratoma,1.0000,Childhood Mature Teratoma,0.9298,Adult Teratoma,0.9118,Central Nervous System Mature Teratoma,0.9104,Teratoma,0.9093,Immature Teratoma,0.9085,Testicular Mature Teratoma,0.8905,Adult Central Nervous System Mature Teratoma,0.8815,Benign Teratoma,0.8766,Malignant Teratoma,0.8758,Mature Ovarian Teratoma,0.8736,Childhood Central Nervous System Mature Teratoma,0.8721,Mediastinal Mature Teratoma,0.8624,Adult Central Nervous System Immature Teratoma,0.8617,Childhood Teratoma,0.8594,Childhood Testicular Mature Teratoma,0.8531,Childhood Immature Teratoma,0.8497,Pericardial Mature Teratoma,0.8487,Adult Central Nervous System Teratoma,0.8390,Central Nervous System Immature Teratoma,0.8381,MATURE TERATOMA,True,True,True
MBL,Medulloblastoma,1,2,Medulloblastoma,1.0000,Classic Medulloblastoma,0.9324,Childhood Medulloblastoma,0.9262,Medulloblastoma Molecular Subtypes,0.8764,Adult Medulloblastoma,0.8667,Melanocytic Medulloblastoma,0.8569,Cerebellar Vermis Medulloblastoma,0.8523,Anaplastic Medulloblastoma,0.8518,"Medulloblastoma, Not Otherwise Specified",0.8475,Metastatic Medulloblastoma,0.8405,Large Cell Medulloblastoma,0.8315,Fourth Ventricle Medulloblastoma,0.8097,"Medulloblastoma, WNT-Activated",0.8050,Medullomyoblastoma,0.7901,"Medulloblastoma, SHH-Activated",0.7871,Medulloblastoma with Extensive Nodularity,0.7850,Recurrent Medulloblastoma,0.7781,Refractory Medulloblastoma,0.7779,"Medulloblastoma, Non-WNT/Non-SHH",0.7768,"Medulloblastoma, SHH-4",0.7751,Medulloblastoma,True,True,True
MCRC METASTASIS,Metastatic Colorectal Carcinoma,2,2,Metastatic Malignant Colorectal Neoplasm,0.7538,Metastatic Colorectal Carcinoma,0.7504,Metastatic Carcinoma,0.7192,Colorectal Medullary Carcinoma,0.7078,Metastatic Colorectal Adenocarcinoma,0.6966,Metastatic Renal Cell Carcinoma,0.6875,Metastatic Kidney Medullary Carcinoma,0.6868,Colon Medullary Carcinoma,0.6844,Metastatic Melanoma,0.6820,Metastatic Adrenal Cortical Carcinoma,0.6768,Metastatic Thyroid Gland Medullary Carcinoma,0.6746,Metastatic Colorectal Mucinous Adenocarcinoma,0.6738,Metastatic Adenocarcinoma,0.6729,Metastatic Malignant Neoplasm,0.6651,Metastatic Carcinoma in the Adrenal Medulla,0.6634,Rectal Medullary Carcinoma,0.6628,Metastatic Rectal Carcinoma,0.6625,"Metastatic Renal Cell Carcinoma, Not Otherwise Specified",0.6614,Renal Cell Carcinoma with MiT Translocations,0.6601,Metastatic Colon Carcinoma,0.6595,MCRC METASTASIS,False,True,True
MDS,Myelodysplastic Syndrome,1,2,Myelodysplastic Syndrome,0.9896,"Myelodysplastic Syndrome, Not Otherwise Specified",0.9045,Hereditary Myelodysplastic Syndrome,0.8964,Secondary Myelodysplastic Syndrome,0.8482,Myelodysplastic Syndrome with Somatic Mutation,0.8356,Hypoplastic Myelodysplastic Syndrome,0.8303,Myelodysplastic Syndrome with Genetic Abnormalities,0.8250,Adult Myelodysplastic Syndrome,0.8224,De Novo Myelodysplastic Syndrome,0.8159,Childhood Myelodysplastic Syndrome,0.8017,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7910,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.7721,Myelodysplastic Syndrome with Low Blasts,0.7708,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.7629,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.7570,"Myelodysplastic Syndrome, Unclassifiable",0.7497,Myelodysplastic/Myeloproliferative Neoplasm,0.7458,Recurrent Myelodysplastic Syndrome,0.7449,Refractory Myelodysplastic Syndrome,0.6957,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.6940,Myelodysplastic Syndromes,True,True,True
MDS WITH EXCESS BLASTS,Myelodysplastic Syndrome with Excess Blasts,1,2,Myelodysplastic Syndrome with Excess Blasts,0.9421,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,0.8508,Childhood Myelodysplastic Syndrome with Excess Blasts,0.8429,Myelodysplastic Syndrome with Low Blasts,0.7694,"Myelodysplastic Syndrome, Unclassifiable, with 1 Percent Blasts",0.6768,Childhood Myelodysplastic Syndrome with Low Blasts,0.6733,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.6645,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.6640,Myelodysplastic Syndrome with Genetic Abnormalities,0.6385,Refractory Anemia with Excess Blasts in Transformation,0.6317,Myelodysplastic Syndrome,0.6273,"Childhood Myelodysplastic Syndrome with Low Blasts, Hypocellular",0.6259,De Novo Myelodysplastic Syndrome,0.6252,Acute Monoblastic Leukemia,0.6227,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6190,Acute Erythroid Leukemia,0.6143,Pure Erythroid Leukemia,0.6099,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.6087,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.6084,"Childhood Myelodysplastic Syndrome with Low Blasts, Not Otherwise Specified",0.6064,MDS WITH EXCESS BLASTS,True,True,True
MDS WITH EXCESS BLASTS-2,Myelodysplastic Syndrome/Acute Myeloid Leukemia,6,2,Myelodysplastic Syndrome with Excess Blasts,0.8069,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,0.7561,Childhood Myelodysplastic Syndrome with Excess Blasts,0.7268,Myelodysplastic Syndrome with Low Blasts,0.6596,Childhood Myelodysplastic Syndrome with Low Blasts,0.5876,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.5850,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.5781,"Childhood Myelodysplastic Syndrome with Low Blasts, Hypocellular",0.5781,Refractory Anemia with Excess Blasts in Transformation,0.5669,Pure Erythroid Leukemia,0.5659,"Myelodysplastic Syndrome, Unclassifiable, with 1 Percent Blasts",0.5649,Acute Erythroid Leukemia,0.5628,Acute Myeloid Leukemia with EZH2 Mutation,0.5596,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.5568,Secondary Myelodysplastic Syndrome,0.5524,Myelodysplastic Syndrome,0.5459,Hypoplastic Myelodysplastic Syndrome,0.5453,Acute Eosinophilic Leukemia,0.5373,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,0.5359,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.5329,MDS WITH EXCESS BLASTS-2,False,False,False
MDS WITH ISOLATED DEL5Q,Myelodysplastic Syndrome with del(5q),1,2,Myelodysplastic Syndrome with del(5q),0.8108,Acute Myeloid Leukemia with del(5q),0.6961,Myelodysplastic Syndrome with TP53 Inactivation,0.6409,Myelodysplastic/Myeloproliferative Neoplasm with Isolated Isochromosome 17q,0.6034,Myelodysplastic Syndrome with Low Blasts,0.6011,Myelodysplastic Syndrome with Monoallelic TP53 Mutation,0.5990,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q,0.5973,Myelodysplastic Syndrome with Biallelic TP53 Inactivation,0.5893,Myelodysplastic Syndrome,0.5538,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,0.5538,Myelodysplastic Syndrome with Somatic Mutation,0.5530,"Myelodysplastic Syndrome, Unclassifiable, with 1 Percent Blasts",0.5497,DS Stage I Multiple Myeloma,0.5490,Myelodysplastic Syndrome with Biallelic TP53 Mutation,0.5475,Childhood Myelodysplastic Syndrome with Low Blasts,0.5474,Myelodysplastic Syndrome with Mutated TP53,0.5459,Hypoplastic Myelodysplastic Syndrome,0.5434,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.5428,DS Stage IA Multiple Myeloma,0.5421,De Novo Myelodysplastic Syndrome,0.5419,MDS WITH ISOLATED DEL5Q,True,True,True
MDS WITH MULTILINEAGE DYSPLASIA,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",1,2,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.8931,Acute Myeloid Leukemia with Multilineage Dysplasia,0.8369,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.7781,Myelodysplastic Syndrome,0.7448,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.7244,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.7234,Myelodysplastic Syndrome with Genetic Abnormalities,0.7144,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7069,Myelodysplastic Syndrome with Somatic Mutation,0.7046,Myelodysplastic Syndrome with Low Blasts,0.6994,Myelodysplastic/Myeloproliferative Neoplasm,0.6962,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6915,"Myelodysplastic Syndrome, Not Otherwise Specified",0.6888,Myelodysplastic Chronic Myelomonocytic Leukemia,0.6851,De Novo Myelodysplastic Syndrome,0.6790,Adult Myelodysplastic Syndrome,0.6787,Hypoplastic Myelodysplastic Syndrome,0.6726,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.6719,Hereditary Myelodysplastic Syndrome,0.6718,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.6716,MDS WITH MULTILINEAGE DYSPLASIA,True,True,True
MDS WITH RING SIDEROBLASTS,Myelodysplastic Syndrome with Ring Sideroblasts,1,2,Myelodysplastic Syndrome with Ring Sideroblasts,0.9425,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.8001,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.7945,Refractory Myelodysplastic Syndrome,0.6973,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",0.6778,Recurrent Myelodysplastic Syndrome,0.6327,Refractory Splenic Marginal Zone Lymphoma,0.6157,Splenic Diffuse Red Pulp Small B-Cell Lymphoma,0.6059,Refractory Anemia,0.5874,Refractory Malignant Mastocytosis,0.5871,Reticulosarcoma,0.5862,Refractory Alveolar Rhabdomyosarcoma,0.5808,Refractory Rhabdomyosarcoma,0.5780,Refractory Sarcoma,0.5762,Refractory Cytopenia of Childhood,0.5757,Virus-Related Sarcoma,0.5733,Refractory Mycosis Fungoides and Sezary Syndrome,0.5724,Signet Ring Melanoma,0.5709,Refractory Marginal Zone Lymphoma,0.5691,Reticulosarcoma Involving Spleen,0.5688,MDS WITH RING SIDEROBLASTS,True,True,True
MDS WITH RING SIDEROBLASTS AND MULTILINEAGE DYSPLASIA,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,1,2,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.9670,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.8876,Myelodysplastic Syndrome with Ring Sideroblasts,0.8107,Refractory Myelodysplastic Syndrome,0.7170,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.7051,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",0.6846,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.6507,Recurrent Myelodysplastic Syndrome,0.6311,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.6144,Triple-Class Refractory Multiple Myeloma,0.6010,Refractory Malignant Mastocytosis,0.5920,Multiple Myeloma with NSD2 Translocation,0.5873,Myelodysplastic Syndrome with Somatic Mutation,0.5822,Secondary Myelodysplastic Syndrome,0.5769,Refractory Splenic Marginal Zone Lymphoma,0.5765,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",0.5751,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.5702,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.5670,Refractory Acute Monoblastic and Monocytic Leukemia,0.5599,Myelodysplastic Syndrome,0.5596,MDS WITH RING SIDEROBLASTS AND MULTILINEAGE DYSPLASIA,True,True,True
MDS WITH RING SIDEROBLASTS AND SINGLE LINEAGE DYSPLASIA,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1,2,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.9661,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.8965,Myelodysplastic Syndrome with Ring Sideroblasts,0.8209,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.7260,Refractory Myelodysplastic Syndrome,0.7162,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.6825,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.6769,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",0.6652,Myelodysplastic Syndrome with Somatic Mutation,0.6331,Recurrent Myelodysplastic Syndrome,0.6290,Secondary Myelodysplastic Syndrome,0.6288,Splenic Diffuse Red Pulp Small B-Cell Lymphoma,0.6051,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.6010,Myelodysplastic Syndrome with Mutated SF3B1,0.5999,Myelodysplastic Syndrome,0.5924,De Novo Myelodysplastic Syndrome,0.5917,Refractory Splenic Marginal Zone Lymphoma,0.5881,Multiple Myeloma with NSD2 Translocation,0.5864,"Myelodysplastic Syndrome, Not Otherwise Specified",0.5839,Myelodysplastic Syndrome with Genetic Abnormalities,0.5805,MDS WITH RING SIDEROBLASTS AND SINGLE LINEAGE DYSPLASIA,True,True,True
MDS WITH SINGLE LINEAGE DYSPLASIA,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",1,2,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.9100,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.8718,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.8055,Myelodysplastic Syndrome with Somatic Mutation,0.7459,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.7291,Acute Myeloid Leukemia with Multilineage Dysplasia,0.7273,Myelodysplastic Syndrome with Low Blasts,0.7146,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7109,Myelodysplastic Syndrome,0.7088,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.7052,De Novo Myelodysplastic Syndrome,0.7024,Myelodysplastic Syndrome with Genetic Abnormalities,0.7016,"Myelodysplastic Syndrome, Not Otherwise Specified",0.6929,Secondary Myelodysplastic Syndrome,0.6892,Adult Myelodysplastic Syndrome,0.6767,Hypoplastic Myelodysplastic Syndrome,0.6759,Myeloid Leukemia Associated with Down Syndrome,0.6583,"Myelodysplastic Syndrome, Unclassifiable",0.6533,"Myelodysplastic Syndrome, Unclassifiable, with Defining Cytogenetic Abnormality",0.6522,Hereditary Myelodysplastic Syndrome,0.6513,MDS WITH SINGLE LINEAGE DYSPLASIA,True,True,True
"MDS, UNCLASSIFIABLE","Myelodysplastic Syndrome, Unclassifiable",1,2,"Myelodysplastic Syndrome, Unclassifiable",0.9086,"Myelodysplastic Syndrome, Unclassifiable, with Defining Cytogenetic Abnormality",0.8453,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.7474,Clonal Monocytosis of Undetermined Significance,0.7190,"Myelodysplastic Syndrome, Unclassifiable, with 1 Percent Blasts",0.7034,Clonal Cytopenia with Monocytosis of Undetermined Significance,0.6776,De Novo Myelodysplastic Syndrome,0.6565,"Myelodysplastic Syndrome, Not Otherwise Specified",0.6548,"IgM Monoclonal Gammopathy of Undetermined Significance, Not Otherwise Specified",0.6469,Monoclonal Gammopathy of Undetermined Significance,0.6363,IgM Monoclonal Gammopathy of Undetermined Significance,0.6226,Non-IgM Monoclonal Gammopathy of Undetermined Significance,0.6191,"NK-Cell Lymphoma, Unclassifiable",0.6157,Myelodysplastic Syndrome,0.6059,Myelodysplastic Syndrome with Somatic Mutation,0.6052,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.6032,Non-Secretory Multiple Myeloma,0.6025,"Splenic B-Cell Lymphoma/Leukemia, Unclassifiable",0.5983,Unclassified Hepatocellular Adenoma,0.5940,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.5928,"MDS, UNCLASSIFIABLE",True,True,True
MDS-U,"Myelodysplastic Syndrome, Unclassifiable",1,2,"Myelodysplastic Syndrome, Unclassifiable",0.8033,"Myelodysplastic Syndrome, Unclassifiable, with Defining Cytogenetic Abnormality",0.7342,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.6946,De Novo Myelodysplastic Syndrome,0.6725,Myelodysplastic Syndrome with Somatic Mutation,0.6666,Myelodysplastic Syndrome,0.6647,"Myelodysplastic Syndrome, Not Otherwise Specified",0.6635,"Myelodysplastic Syndrome, Unclassifiable, with 1 Percent Blasts",0.6562,Clonal Monocytosis of Undetermined Significance,0.6396,Hereditary Myelodysplastic Syndrome,0.6188,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.6176,Secondary Myelodysplastic Syndrome,0.6056,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.6045,Clonal Cytopenia with Monocytosis of Undetermined Significance,0.6034,Myelodysplastic Syndrome with Low Blasts,0.5936,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.5903,Myelodysplastic/Myeloproliferative Neoplasm,0.5895,Non-Secretory Multiple Myeloma,0.5868,Recurrent Myelodysplastic Syndrome,0.5780,Myelodysplastic Syndrome with Mutated SF3B1,0.5748,MDS-U,True,True,True
MDS/MPN WITH RING SIDEROBLASTS AND THROMBOCYTOSIS,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",1,2,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",0.9054,Myelodysplastic Syndrome with Ring Sideroblasts,0.7682,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.7595,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.7400,Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis,0.7153,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.6504,Refractory Myelodysplastic Syndrome,0.6259,Recurrent Myelodysplastic Syndrome,0.6066,Smoldering Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.6021,Refractory Mycosis Fungoides and Sezary Syndrome,0.6013,Refractory Myeloproliferative Neoplasm,0.5969,Refractory Mature T-Cell and NK-Cell Neoplasm,0.5938,Refractory Thrombocytopenia,0.5862,Triple-Class Refractory Multiple Myeloma,0.5839,Multiple Myeloma with NSD2 Translocation,0.5812,Myelodysplastic Syndrome with Somatic Mutation,0.5737,Reticulosarcoma Involving Spleen,0.5721,Recurrent Myelodysplastic/Myeloproliferative Neoplasm,0.5719,Testicular Signet Ring Stromal Tumor,0.5718,Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.5705,MDS/MPN WITH RING SIDEROBLASTS AND THROMBOCYTOSIS,True,True,True
"MDS/MPN, UNCLASSIFIABLE","Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",9,2,"Myelodysplastic Syndrome, Unclassifiable",0.8896,"Myelodysplastic Syndrome, Unclassifiable, with Defining Cytogenetic Abnormality",0.8401,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.7528,Clonal Monocytosis of Undetermined Significance,0.7391,Clonal Cytopenia with Monocytosis of Undetermined Significance,0.7191,"Myelodysplastic Syndrome, Unclassifiable, with 1 Percent Blasts",0.7004,"IgM Monoclonal Gammopathy of Undetermined Significance, Not Otherwise Specified",0.6782,"Myelodysplastic Syndrome, Not Otherwise Specified",0.6599,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.6510,IgM Monoclonal Gammopathy of Undetermined Significance,0.6499,De Novo Myelodysplastic Syndrome,0.6472,Non-IgM Monoclonal Gammopathy of Undetermined Significance,0.6451,Monoclonal Gammopathy of Undetermined Significance,0.6437,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.6403,Myelodysplastic Syndrome with Somatic Mutation,0.6347,Myelodysplastic/Myeloproliferative Neoplasm,0.6154,"IgM Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Type",0.6142,"Multiple Myeloma, Not Otherwise Specified",0.6137,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.6112,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6030,"MDS/MPN, UNCLASSIFIABLE",False,False,False
MDSMPN,Myelodysplastic/Myeloproliferative Neoplasm,1,2,Myelodysplastic/Myeloproliferative Neoplasm,0.7088,Myeloproliferative Neoplasm,0.6775,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.6536,Myelodysplastic Syndrome,0.6056,"Myeloproliferative Neoplasm, Not Otherwise Specified",0.6009,Myelodysplastic Syndrome with Somatic Mutation,0.5904,Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis,0.5892,Myelodysplastic Syndrome with Mutated TP53,0.5871,"Myelodysplastic Syndrome, Not Otherwise Specified",0.5730,Mature Plasmacytoid Dendritic Cell Proliferation Associated with Myeloid Neoplasm,0.5707,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.5694,Noonan Syndrome-Associated Myeloproliferative Disorder,0.5692,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.5623,Accelerated Phase Myeloproliferative Neoplasm,0.5593,Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.5563,Megakaryocytic Neoplasm,0.5461,Bone Marrow Mastocytosis,0.5459,Smoldering Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.5448,Myelodysplastic Syndrome with TP53 Inactivation,0.5444,Myeloid Neoplasm,0.5441,MDSMPN,True,True,True
MDSMPN DIAGNOSIS AT ACQUISITION,Myelodysplastic/Myeloproliferative Neoplasm,4,2,De Novo Myelodysplastic Syndrome,0.6355,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6034,Mature Plasmacytoid Dendritic Cell Proliferation Associated with Myeloid Neoplasm,0.6009,Myelodysplastic/Myeloproliferative Neoplasm,0.5948,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.5938,Adult Myelodysplastic Syndrome,0.5934,Myelodysplastic Syndrome with Genetic Abnormalities,0.5831,Myelodysplastic Syndrome,0.5770,Noonan Syndrome-Associated Myeloproliferative Disorder,0.5758,Myelodysplastic Syndrome with Somatic Mutation,0.5744,Accelerated Phase Myeloproliferative Neoplasm,0.5686,Myelodysplastic Syndrome with TP53 Inactivation,0.5678,"Myelodysplastic Syndrome, Unclassifiable, with Defining Cytogenetic Abnormality",0.5657,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.5631,DS Stage IA Multiple Myeloma,0.5563,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Neoplasm,0.5560,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0.5511,"Diffuse Astrocytoma, MYBL1-Altered",0.5471,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.5467,Myelodysplastic/Myeloproliferative Neoplasm with Isolated Isochromosome 17q,0.5447,MDSMPN DIAGNOSIS AT ACQUISITION,False,False,True
MEDULLARY,"Medullary Carcinoma, Not Otherwise Specified",7,2,Medullary Hemangioblastoma,0.6926,Kidney Medullary Carcinoma,0.6766,Advanced Kidney Medullary Carcinoma,0.6585,Meningioma,0.6444,Thyroid Gland Medullary Carcinoma,0.6435,Breast Medullary Carcinoma,0.6388,"Medullary Carcinoma, Not Otherwise Specified",0.6335,Malignant Adrenal Medulla Neoplasm,0.6313,Metastatic Kidney Medullary Carcinoma,0.6312,Colorectal Medullary Carcinoma,0.6276,Advanced Thyroid Gland Medullary Carcinoma,0.6271,Rectal Medullary Carcinoma,0.6259,Benign Adrenal Medulla Neoplasm,0.6238,Myoma,0.6213,Adrenal Medulla Neoplasm,0.6193,Unresectable Kidney Medullary Carcinoma,0.6183,Medullomyoblastoma,0.6149,Colon Medullary Carcinoma,0.6139,Sporadic Thyroid Gland Medullary Carcinoma,0.6132,Breast Atypical Medullary Carcinoma,0.6062,MEDULLARY,False,False,False
MEDULLARY BREAST CARCINOMA,Breast Medullary Carcinoma,1,2,Breast Medullary Carcinoma,0.9857,Breast Atypical Medullary Carcinoma,0.8820,Recurrent Breast Medullary Carcinoma,0.8175,Breast Carcinoma,0.7920,Breast Tubular Carcinoma,0.7772,Multifocal Breast Carcinoma,0.7771,Breast Mucinous Carcinoma,0.7758,Female Breast Carcinoma,0.7750,Breast Metaplastic Carcinoma,0.7707,Thyroid Gland Medullary Carcinoma,0.7675,Male Breast Carcinoma,0.7665,Kidney Medullary Carcinoma,0.7528,Metastatic Breast Carcinoma,0.7507,Sporadic Breast Carcinoma,0.7501,Breast Mixed Carcinoma,0.7493,Colorectal Medullary Carcinoma,0.7485,Breast Lobular Carcinoma,0.7479,Breast Papillary Carcinoma,0.7473,Breast Adenocarcinoma,0.7472,Invasive Breast Carcinoma,0.7424,MEDULLARY BREAST CARCINOMA,True,True,True
MEDULLARY CARCINOMA,"Medullary Carcinoma, Not Otherwise Specified",3,2,Colorectal Medullary Carcinoma,0.8809,Kidney Medullary Carcinoma,0.8799,"Medullary Carcinoma, Not Otherwise Specified",0.8789,Thyroid Gland Medullary Carcinoma,0.8764,Colon Medullary Carcinoma,0.8591,Breast Medullary Carcinoma,0.8507,Pancreatic Medullary Carcinoma,0.8408,Sporadic Thyroid Gland Medullary Carcinoma,0.8062,Small Intestinal Medullary Carcinoma,0.8010,Advanced Kidney Medullary Carcinoma,0.7886,Rectal Medullary Carcinoma,0.7842,Advanced Thyroid Gland Medullary Carcinoma,0.7822,Metastatic Kidney Medullary Carcinoma,0.7695,Carcinoma,0.7608,Breast Atypical Medullary Carcinoma,0.7538,Hereditary Thyroid Gland Medullary Carcinoma,0.7523,Unresectable Kidney Medullary Carcinoma,0.7509,Metastatic Thyroid Gland Medullary Carcinoma,0.7452,Childhood Thyroid Gland Medullary Carcinoma,0.7441,Adrenal Cortical Carcinoma,0.7362,MEDULLARY CARCINOMA,False,True,True
MEDULLARY CARCINOMA OF THE COLON,Colon Medullary Carcinoma,1,2,Colon Medullary Carcinoma,0.9494,Colorectal Medullary Carcinoma,0.9044,Small Intestinal Medullary Carcinoma,0.7835,Rectal Medullary Carcinoma,0.7803,Colon Carcinoma,0.7710,Colorectal Carcinoma,0.7601,Colon Undifferentiated Carcinoma,0.7545,Colon Mucinous Adenocarcinoma,0.7507,Colon Intramucosal Adenocarcinoma,0.7352,Colorectal Mucinous Adenocarcinoma,0.7344,Colon Adenocarcinoma,0.7272,Kidney Medullary Carcinoma,0.7254,Colorectal Undifferentiated Carcinoma,0.7206,Colorectal Adenocarcinoma,0.7154,Breast Medullary Carcinoma,0.7057,"Medullary Carcinoma, Not Otherwise Specified",0.7056,Thyroid Gland Medullary Carcinoma,0.7032,Metastatic Colon Carcinoma,0.7023,Colon Neuroendocrine Carcinoma,0.7022,Distal Colon Carcinoma,0.7007,MEDULLARY CARCINOMA OF THE COLON,True,True,True
MEDULLARY THYROID CANCER,Thyroid Gland Medullary Carcinoma,1,2,Thyroid Gland Medullary Carcinoma,0.9525,Sporadic Thyroid Gland Medullary Carcinoma,0.8810,Metastatic Thyroid Gland Medullary Carcinoma,0.8503,Advanced Thyroid Gland Medullary Carcinoma,0.8458,Hereditary Thyroid Gland Medullary Carcinoma,0.8283,Thyroid Gland Mixed Medullary and Papillary Carcinoma,0.8274,Childhood Thyroid Gland Medullary Carcinoma,0.8238,Thyroid Gland Mixed Medullary and Follicular Carcinoma,0.8222,Thyroid Gland Carcinoma,0.7978,Thyroid Gland Mixed Medullary and Follicular Cell-Derived Carcinoma,0.7941,"Medullary Carcinoma, Not Otherwise Specified",0.7905,Unresectable Thyroid Gland Medullary Carcinoma,0.7804,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,0.7782,Locally Advanced Thyroid Gland Medullary Carcinoma,0.7744,Refractory Thyroid Gland Medullary Carcinoma,0.7728,Thyroid Gland Follicular Carcinoma,0.7650,Unresectable Hereditary Thyroid Gland Medullary Carcinoma,0.7643,Kidney Medullary Carcinoma,0.7620,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,0.7505,Differentiated Thyroid Gland Carcinoma,0.7488,MEDULLARY THYROID CANCER,True,True,True
MEDULLARY THYROID CARCINOMA,Thyroid Gland Medullary Carcinoma,1,2,Thyroid Gland Medullary Carcinoma,0.9702,Sporadic Thyroid Gland Medullary Carcinoma,0.8919,Advanced Thyroid Gland Medullary Carcinoma,0.8635,Metastatic Thyroid Gland Medullary Carcinoma,0.8523,Thyroid Gland Mixed Medullary and Papillary Carcinoma,0.8476,Hereditary Thyroid Gland Medullary Carcinoma,0.8402,Thyroid Gland Mixed Medullary and Follicular Carcinoma,0.8352,Childhood Thyroid Gland Medullary Carcinoma,0.8338,"Medullary Carcinoma, Not Otherwise Specified",0.8150,Locally Advanced Thyroid Gland Medullary Carcinoma,0.8047,Thyroid Gland Mixed Medullary and Follicular Cell-Derived Carcinoma,0.7996,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,0.7943,Unresectable Thyroid Gland Medullary Carcinoma,0.7907,Thyroid Gland Carcinoma,0.7866,Kidney Medullary Carcinoma,0.7855,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,0.7753,Unresectable Hereditary Thyroid Gland Medullary Carcinoma,0.7750,Refractory Thyroid Gland Medullary Carcinoma,0.7728,Colorectal Medullary Carcinoma,0.7692,Thyroid Gland Follicular Carcinoma,0.7689,MEDULLARY THYROID CARCINOMA,True,True,True
MEDULLA_CARCINOMA,Thyroid Gland Medullary Carcinoma,5,2,"Medullary Carcinoma, Not Otherwise Specified",0.8272,Kidney Medullary Carcinoma,0.8230,Breast Medullary Carcinoma,0.7687,Colon Medullary Carcinoma,0.7644,Thyroid Gland Medullary Carcinoma,0.7637,Colorectal Medullary Carcinoma,0.7611,Advanced Kidney Medullary Carcinoma,0.7519,Pancreatic Medullary Carcinoma,0.7456,Carcinoma,0.7365,Metastatic Kidney Medullary Carcinoma,0.7360,Unresectable Kidney Medullary Carcinoma,0.7315,Small Intestinal Medullary Carcinoma,0.7166,Adrenal Medulla Neoplasm,0.7165,Malignant Adrenal Medulla Neoplasm,0.7043,Rectal Medullary Carcinoma,0.7040,Metastatic Carcinoma,0.7027,Locally Advanced Kidney Medullary Carcinoma,0.7019,Advanced Thyroid Gland Medullary Carcinoma,0.7000,Solid Carcinoma,0.6935,Breast Atypical Medullary Carcinoma,0.6915,MEDULLA_CARCINOMA,False,False,True
MEDULLOBLASTOMA,Medulloblastoma,1,2,Medulloblastoma,1.0000,Classic Medulloblastoma,0.9324,Childhood Medulloblastoma,0.9262,Medulloblastoma Molecular Subtypes,0.8764,Adult Medulloblastoma,0.8667,Melanocytic Medulloblastoma,0.8569,Cerebellar Vermis Medulloblastoma,0.8523,Anaplastic Medulloblastoma,0.8518,"Medulloblastoma, Not Otherwise Specified",0.8475,Metastatic Medulloblastoma,0.8405,Large Cell Medulloblastoma,0.8315,Fourth Ventricle Medulloblastoma,0.8097,"Medulloblastoma, WNT-Activated",0.8050,Medullomyoblastoma,0.7901,"Medulloblastoma, SHH-Activated",0.7871,Medulloblastoma with Extensive Nodularity,0.7850,Recurrent Medulloblastoma,0.7781,Refractory Medulloblastoma,0.7779,"Medulloblastoma, Non-WNT/Non-SHH",0.7768,"Medulloblastoma, SHH-4",0.7751,MEDULLOBLASTOMA,True,True,True
MED_GROUP_3,"Medulloblastoma, Non-WNT/Non-SHH, Group 3",99,2,Grade 3 Meningioma,0.6157,Grade 3 Malignant Neoplasm,0.6085,WHO Grade 3 Glioma,0.5876,ROSE Cluster 3,0.5812,Adult Grade 3 Meningioma,0.5724,Malignant Neoplasm by Grade,0.5695,Sarcoma G3,0.5559,Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group,0.5535,Grade 3b Malignant Neoplasm,0.5510,Masaoka-Koga Stage III,0.5509,ISS Stage III Multiple Myeloma,0.5467,Prognostic Stage III Breast Cancer AJCC v8,0.5456,Sarcoma NCI Grade 3,0.5438,Childhood Grade 3 Meningioma,0.5427,Neuroendocrine Tumor G3,0.5421,Grade 3 Follicular Lymphoma,0.5356,Mixed Glioma,0.5351,Meningioma by Site,0.5346,Colorectal Neuroendocrine Tumor G3,0.5321,ROSE Cluster 8,0.5303,MED_GROUP_3,False,False,False
MELANOMA,Melanoma,1,2,Melanoma,1.0000,Cutaneous Melanoma,0.8940,Dermal Melanoma,0.8436,Retinal Melanoma,0.8239,Ocular Melanoma,0.8167,Mucosal Melanoma,0.7989,Non-Cutaneous Melanoma,0.7909,Breast Melanoma,0.7858,Cervical Melanoma,0.7828,Metastatic Melanoma,0.7773,Melanocytic Neoplasm,0.7713,Low-CSD Melanoma,0.7696,Iris Melanoma,0.7676,Childhood Melanoma,0.7643,Choroid Melanoma,0.7621,Balloon Cell Melanoma,0.7597,Uveal Melanoma,0.7586,Nail Apparatus Melanoma,0.7536,Lung Melanoma,0.7532,Melanocytoma,0.7521,MELANOMA,True,True,True
MELANOMA CUTANEOUS,Cutaneous Melanoma,1,2,Cutaneous Melanoma,0.9889,Dermal Melanoma,0.9001,Melanoma,0.8921,Non-Cutaneous Melanoma,0.8250,Ocular Melanoma,0.7974,Cutaneous Melanocytic Neoplasm,0.7955,Childhood Cutaneous Melanoma,0.7869,Mucosal Melanoma,0.7829,Invasive Cutaneous Melanoma,0.7741,Cutaneous Melanoma of the Extremity,0.7721,Acral Melanoma,0.7709,Corneal Melanoma,0.7702,Metastatic Cutaneous Melanoma,0.7657,Uveal Melanoma,0.7638,Retinal Melanoma,0.7532,Lentigo Maligna Melanoma,0.7515,Melanocytic Neoplasm,0.7508,Childhood Melanoma,0.7506,Conjunctival Melanoma,0.7492,Choroid Melanoma,0.7451,MELANOMA CUTANEOUS,True,True,True
MELANOMA MUCOSAL,Mucosal Melanoma,1,2,Mucosal Melanoma,0.9851,Metastatic Mucosal Melanoma,0.8891,Digestive System Mucosal Melanoma,0.8440,Oral Cavity Mucosal Melanoma,0.8309,Mucosal Lentiginous Melanoma,0.8267,Mucosal Nodular Melanoma,0.8232,Pharyngeal Mucosal Melanoma,0.8151,Urinary System Mucosal Melanoma,0.8067,Genitourinary System Mucosal Melanoma,0.8053,Melanoma,0.8044,Nasopharyngeal Mucosal Melanoma,0.8043,Advanced Mucosal Melanoma,0.7952,Cutaneous Melanoma,0.7946,Head and Neck Mucosal Melanoma,0.7812,Sinonasal Mucosal Melanoma,0.7728,Gastric Melanoma,0.7490,Penile Mucosal Melanoma,0.7447,Jejunal Melanoma,0.7441,Female Genital Tract Mucosal Melanoma,0.7428,Dermal Melanoma,0.7425,MELANOMA MUCOSAL,True,True,True
MELANOMA OF UNKNOWN PRIMARY,Melanoma of Unknown Primary,1,2,Melanoma of Unknown Primary,1.0000,Malignant Neoplasm of Unknown Primary,0.8808,Carcinoma of Unknown Primary,0.8064,Adenocarcinoma of Unknown Primary,0.7674,Undifferentiated Carcinoma of Unknown Primary,0.7521,"Malignant Neoplasm, Uncertain Whether Primary or Metastatic",0.7207,Neuroendocrine Carcinoma of Unknown Primary,0.6837,Squamous Cell Carcinoma of Unknown Primary,0.6741,Advanced Carcinoma Of Unknown Primary,0.6624,Neoplasm of Uncertain Malignant Potential,0.6535,Advanced Adenocarcinoma of Unknown Primary,0.6513,Urethral Melanoma,0.6313,Head and Neck Carcinoma of Unknown Primary,0.6253,Melanoma in Precancerous Melanosis,0.6240,Melanoma,0.6203,Bladder Urothelial Proliferation of Uncertain Malignant Potential,0.6186,Ocular Melanoma,0.6136,Unresectable Melanoma,0.6118,Uveal Melanoma,0.6086,Non-Cutaneous Melanoma,0.6046,MELANOMA OF UNKNOWN PRIMARY,True,True,True
MELANOMA OTHER,Melanoma,1,2,Melanoma,0.8256,Ocular Melanoma,0.7523,Cutaneous Melanoma,0.7509,Non-Cutaneous Melanoma,0.7508,Metastatic Melanoma,0.7355,Retinal Melanoma,0.7076,Advanced Melanoma,0.7017,Dermal Melanoma,0.6925,Invasive Cutaneous Melanoma,0.6901,Metastatic Ocular Melanoma,0.6846,Balloon Cell Melanoma,0.6827,Intracranial Melanoma,0.6815,Metastatic Cutaneous Melanoma,0.6771,Unresectable Melanoma,0.6763,Orbital Melanoma,0.6758,Advanced Ocular Melanoma,0.6756,Uveal Melanoma,0.6687,Ovarian Melanoma,0.6682,Lung Melanoma,0.6676,Childhood Melanoma,0.6674,MELANOMA OTHER,True,True,True
MELANOMA UVEAL,Uveal Melanoma,1,2,Uveal Melanoma,0.9870,Uveal Melanocytic Neoplasm,0.8675,Uveal Melanocytoma,0.8596,Metastatic Uveal Melanoma,0.8582,Uveal Epithelioid Cell Melanoma,0.8540,Malignant Uveal Neoplasm,0.8483,Uveal Class 1 Melanoma,0.8334,Ocular Melanoma,0.8265,Uveal Class 2 Melanoma,0.8142,Uveal Intermediate Cell Type Melanoma,0.8050,Advanced Uveal Melanoma,0.8019,Choroid Melanoma,0.7911,Uveal Necrotic Melanoma,0.7817,Uveal Class 1b Melanoma,0.7781,Uveal Class 1a Melanoma,0.7759,Uveal Spindle Cell Melanoma,0.7749,Uveal Spindle Cell Type B Melanoma,0.7647,Cutaneous Melanoma,0.7647,Uveal Mixed Epithelioid and Spindle Cell Melanoma,0.7639,Retinal Melanoma,0.7610,MELANOMA UVEAL,True,True,True
"MELANOMA, AMELANOTIC",Amelanotic Melanoma,1,2,Amelanotic Melanoma,0.9744,Cutaneous Amelanotic Melanoma,0.9403,Cutaneous Melanoma,0.7146,Acral Lentiginous Melanoma,0.7037,Acral Melanoma,0.6980,Melanoacanthoma,0.6926,Dermal Melanoma,0.6920,Nevoid Melanoma,0.6914,Anal Melanoma,0.6854,Melanoma,0.6844,Melanocytic Matricoma,0.6703,Mucosal Melanoma,0.6693,Acanthomatous Ameloblastoma,0.6676,Mucosal Lentiginous Melanoma,0.6655,Ameloblastoma,0.6637,Lentigo Maligna Melanoma,0.6632,Ocular Melanoma,0.6584,Eyelid Melanoma,0.6569,Corneal Melanoma,0.6546,Adrenal Cortical Melanoma,0.6532,"MELANOMA, AMELANOTIC",True,True,True
MELANOTIC MELANOMA,Melanoma,3,2,Melanocytic Neoplasm,0.8410,Cutaneous Melanoma,0.8393,Melanoma,0.8233,Cutaneous Melanocytic Neoplasm,0.8204,Melanocytoma,0.7881,Dermal Melanoma,0.7734,Nevoid Melanoma,0.7715,Melanoacanthoma,0.7677,Melanocytic Matricoma,0.7675,Eye Melanocytoma,0.7656,Uveal Melanocytoma,0.7633,Amelanotic Melanoma,0.7626,Pigmented Epithelioid Melanocytoma,0.7609,Lentigo Maligna Melanoma,0.7595,Cutaneous Spitz Melanocytoma,0.7565,Retinal Melanoma,0.7450,Non-Cutaneous Melanoma,0.7447,Uveal Melanocytic Neoplasm,0.7406,Mucosal Melanoma,0.7404,Melanoma in Precancerous Melanosis,0.7398,MELANOTIC MELANOMA,False,True,True
MELANOTIC SCHWANNOMA,Melanotic Schwannoma,1,2,Melanotic Schwannoma,1.0000,Skin Schwannoma,0.8616,Melanotic Neurofibroma,0.8606,Mediastinal Melanotic Schwannoma,0.8519,Schwannoma,0.8189,Malignant Melanotic Peripheral Nerve Sheath Tumor,0.8151,Conventional Schwannoma,0.7940,Ancient Schwannoma,0.7883,Plexiform Schwannoma,0.7838,Circumscribed Meningeal Melanocytic Neoplasm,0.7821,Peripheral Nerve Schwannoma,0.7762,Sympathetic Schwannoma,0.7706,Melanocytic Neoplasm,0.7700,Cellular Schwannoma,0.7699,Intraocular Schwannoma,0.7663,Bone Schwannoma,0.7590,Microcystic/Reticular Schwannoma,0.7561,Epithelioid Schwannoma,0.7536,Melanocytoma,0.7495,Meningeal Melanocytoma,0.7472,MELANOTIC SCHWANNOMA,True,True,True
MENINGIOMA,Meningioma,1,2,Meningioma,1.0000,Cerebral Meningioma,0.9146,Intracranial Meningioma,0.9044,Benign Meningioma,0.8722,Meningiomatosis,0.8443,Atypical Meningioma,0.8373,Adult Meningioma,0.8349,Fibrous Meningioma,0.8288,Spinal Meningioma,0.8230,Papillary Meningioma,0.8206,Childhood Meningioma,0.8152,Grade 1 Meningioma,0.8147,Meningothelial Meningioma,0.8130,Secretory Meningioma,0.8087,Metaplastic Meningioma,0.8040,Orbital Meningioma,0.8013,Olfactory Groove Meningioma,0.7935,Meningioma by Site,0.7918,Visual Pathway Meningioma,0.7913,Hereditary Meningioma,0.7892,MENINGIOMA,True,True,True
MENINGOTHELIAL TUMOR,Meningioma,20,2,Meningothelial Cell Neoplasm,0.9671,Meningeal Neoplasm,0.8526,Meningothelial Meningioma,0.8434,Meningeal Lymphoma,0.7876,Benign Meningeal Neoplasm,0.7771,Leptomeningeal Neoplasm,0.7686,Meningeal Gliomatosis,0.7672,Malignant Meningeal Neoplasm,0.7629,Meningeal Carcinomatosis,0.7538,Meningeal Melanomatosis,0.7355,Meningeal Sarcomatosis,0.7341,Meningeal Melanoma,0.7337,Meningeal Sarcoma,0.7305,Meningeal Leukemia,0.7113,Mesothelial Neoplasm,0.7113,Malignant Leptomeningeal Neoplasm,0.7068,Meningeal Solitary Fibrous Tumor,0.6920,Adult Meningeal Melanoma,0.6815,"Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",0.6745,Meningioma,0.6736,MENINGOTHELIAL TUMOR,False,False,False
MERKEL CELL CARCINOMA,Merkel Cell Carcinoma,1,2,Merkel Cell Carcinoma,1.0000,Cutaneous Merkel Cell Carcinoma,0.9504,Advanced Merkel Cell Carcinoma,0.8885,Head and Neck Merkel Cell Carcinoma,0.8746,Extracutaneous Merkel Cell Carcinoma,0.8628,Metastatic Merkel Cell Carcinoma,0.8478,Merkel Cell Polyoma Virus-Positive Merkel Cell Carcinoma,0.8372,Locally Advanced Merkel Cell Carcinoma,0.8200,Merkel Cell Polyoma Virus-Negative Merkel Cell Carcinoma,0.8159,Unresectable Merkel Cell Carcinoma,0.8090,Vulvar Merkel Cell Carcinoma,0.7983,Cutaneous Merkel Cell Carcinoma by AJCC v8 Clinical Stage,0.7895,Cutaneous Merkel Cell Carcinoma by AJCC v8 Stage,0.7844,Cutaneous Merkel Cell Carcinoma by AJCC v7 Stage,0.7832,Locally Recurrent Merkel Cell Carcinoma,0.7771,Refractory Merkel Cell Carcinoma,0.7692,Resectable Merkel Cell Carcinoma,0.7628,Recurrent Merkel Cell Carcinoma,0.7624,Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v7,0.7476,Cutaneous Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,0.7335,MERKEL CELL CARCINOMA,True,True,True
MERKEL_CELL_CARCINOMA,Merkel Cell Carcinoma,1,2,Merkel Cell Carcinoma,0.9468,Cutaneous Merkel Cell Carcinoma,0.9045,Advanced Merkel Cell Carcinoma,0.8483,Head and Neck Merkel Cell Carcinoma,0.8458,Extracutaneous Merkel Cell Carcinoma,0.8446,Metastatic Merkel Cell Carcinoma,0.8186,Cutaneous Merkel Cell Carcinoma by AJCC v8 Clinical Stage,0.8039,Merkel Cell Polyoma Virus-Positive Merkel Cell Carcinoma,0.8024,Unresectable Merkel Cell Carcinoma,0.7984,Cutaneous Merkel Cell Carcinoma by AJCC v8 Stage,0.7935,Merkel Cell Polyoma Virus-Negative Merkel Cell Carcinoma,0.7879,Locally Advanced Merkel Cell Carcinoma,0.7877,Cutaneous Merkel Cell Carcinoma by AJCC v7 Stage,0.7824,Refractory Merkel Cell Carcinoma,0.7718,Locally Recurrent Merkel Cell Carcinoma,0.7672,Recurrent Merkel Cell Carcinoma,0.7626,Resectable Merkel Cell Carcinoma,0.7552,Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v7,0.7502,Cutaneous Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,0.7486,Clinical Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v8,0.7291,MERKEL_CELL_CARCINOMA,True,True,True
MESENCHYMAL CHONDROSARCOMA,Mesenchymal Chondrosarcoma,1,2,Mesenchymal Chondrosarcoma,1.0000,Mesenchymal Chondrosarcoma of Bone,0.9685,Chondrosarcoma,0.9335,Adult Mesenchymal Chondrosarcoma,0.9128,Mesenchymal Extraskeletal Chondrosarcoma,0.8939,Central Nervous System Mesenchymal Chondrosarcoma,0.8855,Childhood Mesenchymal Chondrosarcoma,0.8701,Synovial Chondrosarcoma,0.8440,Maxillofacial Mesenchymal Chondrosarcoma,0.8387,Soft Tissue Chondroma,0.8234,Localized Chondrosarcoma,0.8204,Chondrosarcoma NCI Grade 1,0.8168,"Chondrosarcoma, Grade 1",0.8163,Chondrosarcoma NCI Grade 2,0.8072,Conventional Extraskeletal Myxoid Chondrosarcoma,0.8051,"Chondrosarcoma, Grade 2",0.8021,Dedifferentiated Chondrosarcoma,0.8003,Secondary Chondrosarcoma,0.7994,Chondrosarcoma NCI Grade 3,0.7978,Clear Cell Chondrosarcoma,0.7949,MESENCHYMAL CHONDROSARCOMA,True,True,True
MESENCHYMAL NEOPLASM,Mesenchymal Cell Neoplasm,1,2,Mesenchymal Cell Neoplasm,0.9233,Soft Tissue Neoplasm,0.7721,Musculoskeletal Neoplasm,0.7645,Connective and Soft Tissue Neoplasm,0.7440,Stromal Neoplasm,0.7339,Mesenchymoma,0.7245,Mesenchymal Chondrosarcoma,0.7222,Fibroblastic Neoplasm,0.7141,Malignant Soft Tissue Neoplasm,0.7072,Neoplasm by Morphology,0.7062,Mediastinal Soft Tissue Neoplasm,0.7012,Benign Mesenchymoma,0.6937,Soft Tissue Sarcoma,0.6902,Fibrocartilaginous Mesenchymoma,0.6897,Intermediate Soft Tissue Neoplasm,0.6883,Myofibroma,0.6863,Ectomesenchymoma,0.6861,Skin Soft Tissue Neoplasm,0.6850,Spindle Cell Neoplasm,0.6843,Soft Tissue Fibrosarcoma,0.6841,MESENCHYMAL NEOPLASM,True,True,True
MESONEPHRIC CARCINOMA,Mesonephric Adenocarcinoma,1,2,Mesonephric Adenocarcinoma,0.9602,Mesonephric-Like Adenocarcinoma,0.8999,Cervical Mesonephric Adenocarcinoma,0.8923,Metastatic Mesonephric Adenocarcinoma,0.8757,Ovarian Mesonephric-Like Adenocarcinoma,0.8327,Endometrial Mesonephric-Like Adenocarcinoma,0.8208,Vaginal Mesonephric Adenocarcinoma,0.8194,Recurrent Mesonephric Adenocarcinoma,0.7811,Metanephric Tumor,0.7718,"Cervical Adenomyoma, Mesonephric-Type",0.7513,Metanephric Adenoma,0.7402,Wolffian Tumor,0.6908,Metanephric Stromal Tumor,0.6860,Metanephric Adenofibroma,0.6728,Renal Pelvis Carcinoma,0.6723,Classic Congenital Mesoblastic Nephroma,0.6712,Congenital Mesoblastic Nephroma,0.6661,Kidney Carcinoma,0.6615,Renal Cell Carcinoma,0.6600,Mixed Congenital Mesoblastic Nephroma,0.6586,MESONEPHRIC CARCINOMA,True,True,True
METAPLASTIC BREAST CANCER,Breast Metaplastic Carcinoma,1,2,Breast Metaplastic Carcinoma,0.9749,Metaplastic Carcinoma,0.8956,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.8119,Breast Mixed Carcinoma,0.7722,Breast Carcinoma with Osseous Metaplasia,0.7696,Metaplastic Meningioma,0.7660,Breast Adenocarcinoma with Squamous Metaplasia,0.7657,Breast Carcinoma,0.7614,Sporadic Breast Carcinoma,0.7582,Breast Ductal Carcinoma with Squamous Metaplasia,0.7552,Breast Carcinoma with Chondroid Metaplasia,0.7545,Breast Mucinous Carcinoma,0.7540,Multifocal Breast Carcinoma,0.7524,Invasive Breast Carcinoma,0.7489,Metastatic Breast Carcinoma,0.7445,Breast Medullary Carcinoma,0.7405,Breast Atypical Medullary Carcinoma,0.7367,Invasive Breast Carcinoma of No Special Type,0.7349,Microinvasive Breast Carcinoma,0.7273,Breast Oncocytic Carcinoma,0.7267,METAPLASTIC BREAST CANCER,True,True,True
METAPLASTIC CARCINOMA,Metaplastic Carcinoma,1,2,Metaplastic Carcinoma,1.0000,Breast Metaplastic Carcinoma,0.8836,Metaplastic Meningioma,0.8098,Adenocarcinoma with Metaplasia,0.7800,Mixed Carcinoma,0.7381,Adenocarcinoma with Squamous Metaplasia,0.7366,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.7359,Carcinoma,0.7261,Adenocarcinoma with Cartilaginous Metaplasia,0.7223,Adenocarcinoma with Spindle Cell Metaplasia,0.6989,Breast Mucinous Carcinoma,0.6977,Invasive Carcinoma,0.6946,Secondary Carcinoma,0.6933,Breast Columnar Cell Mucinous Carcinoma,0.6929,Breast Carcinoma with Chondroid Metaplasia,0.6921,Undifferentiated Carcinoma,0.6858,Mucinous Adenocarcinoma,0.6855,Breast Ductal Carcinoma with Squamous Metaplasia,0.6833,Metastatic Carcinoma,0.6831,Breast Mixed Carcinoma,0.6814,METAPLASTIC CARCINOMA,True,True,True
METAPLASTIC_BREAST_CARCINOMA,Breast Metaplastic Carcinoma,1,2,Breast Metaplastic Carcinoma,0.9608,Metaplastic Carcinoma,0.8678,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.8020,Breast Carcinoma,0.7683,Breast Carcinoma with Osseous Metaplasia,0.7660,Breast Carcinoma with Chondroid Metaplasia,0.7634,Breast Mucinous Carcinoma,0.7545,Breast Adenocarcinoma with Squamous Metaplasia,0.7452,Breast Mixed Carcinoma,0.7432,Breast Ductal Carcinoma with Squamous Metaplasia,0.7398,Metastatic Breast Carcinoma,0.7384,Invasive Breast Carcinoma,0.7371,Invasive Breast Carcinoma of No Special Type,0.7346,Multifocal Breast Carcinoma,0.7317,Breast Medullary Carcinoma,0.7283,Sporadic Breast Carcinoma,0.7272,Breast Ductal Carcinoma,0.7240,Breast Atypical Medullary Carcinoma,0.7088,Advanced Breast Carcinoma,0.7067,Breast Secretory Carcinoma,0.7062,METAPLASTIC_BREAST_CARCINOMA,True,True,True
METAPLASTIC_CARCINOMA,Metaplastic Carcinoma,1,2,Metaplastic Carcinoma,0.9725,Breast Metaplastic Carcinoma,0.8539,Adenocarcinoma with Metaplasia,0.7789,Metaplastic Meningioma,0.7738,Carcinoma,0.7362,Adenocarcinoma with Cartilaginous Metaplasia,0.7259,Adenocarcinoma with Squamous Metaplasia,0.7252,Breast Mixed Epithelial/Mesenchymal Metaplastic Carcinoma,0.7119,Mixed Carcinoma,0.7048,Secondary Carcinoma,0.6959,Adenocarcinoma with Cartilaginous and Osseous Metaplasia,0.6959,Invasive Carcinoma,0.6945,Breast Carcinoma with Chondroid Metaplasia,0.6910,Metastatic Carcinoma,0.6876,Carcinoma Unspecified Site,0.6865,Undifferentiated Carcinoma,0.6836,Adenocarcinoma with Spindle Cell Metaplasia,0.6823,Breast Mucinous Carcinoma,0.6792,Carcinomatosis,0.6785,Adenocarcinoma with Osseous Metaplasia,0.6781,METAPLASTIC_CARCINOMA,True,True,True
METASTATIC CARCINOMA,Carcinoma,99,2,Metastatic Carcinoma,1.0000,Metastatic Adenocarcinoma,0.8870,Metastatic Malignant Neoplasm,0.8764,Secondary Carcinoma,0.8640,Metastatic Neoplasm,0.8613,Metastatic Cervical Carcinoma,0.8400,Disseminated Carcinoma,0.8344,Advanced Carcinoma,0.8176,Metastatic Colorectal Carcinoma,0.7997,Metastatic Breast Carcinoma,0.7946,Metastatic Thyroid Gland Carcinoma,0.7938,Metastatic Cervical Adenocarcinoma,0.7913,Distantly Metastatic Malignant Neoplasm,0.7854,Metastatic Melanoma,0.7839,Disseminated Adenocarcinoma,0.7827,Metastatic Lung Carcinoma,0.7825,Metastatic Prostate Carcinoma,0.7786,Metastatic Endometrial Carcinoma,0.7764,Metastatic Gastric Carcinoma,0.7763,Metastatic Colon Carcinoma,0.7760,METASTATIC CARCINOMA,False,False,False
METASTATIC HORMONE-SENSITIVE,Castration-Sensitive Prostate Carcinoma,12,2,Metastatic High Grade Sarcoma,0.6762,Hormone-Resistant Prostate Carcinoma,0.6742,Metastatic Neoplasm,0.6687,Advanced Carcinosarcoma,0.6672,Hormone Therapy Refractory Neoplasm,0.6633,Metastatic Malignant Neoplasm,0.6623,Metastatic Carcinosarcoma,0.6539,Refractory Malignant Neoplasm,0.6398,Metastatic Somatotroph Pituitary Neuroendocrine Tumor,0.6395,Metastatic Carcinoma,0.6370,Hormone-Resistant Breast Carcinoma,0.6362,Castration-Sensitive Prostate Carcinoma,0.6347,Refractory Neoplasm,0.6337,Metastatic Malignant Solid Neoplasm,0.6314,Refractory Sarcoma,0.6310,Refractory Adenocarcinoma,0.6255,Refractory Malignant Solid Neoplasm,0.6251,Metastatic Hormone Receptor-Positive Breast Carcinoma,0.6245,Refractory Endocrine Carcinoma,0.6226,Advanced Sarcoma,0.6223,METASTATIC HORMONE-SENSITIVE,False,False,False
"METASTATIC, VARIANT HISTOLOGY",Aggressive Variant Prostate Carcinoma,99,2,Metastatic High Grade Sarcoma,0.7069,Metastatic Neoplasm,0.6821,Metastatic Malignant Neoplasm,0.6786,Metastatic Carcinoma,0.6729,Metastatic Carcinosarcoma,0.6560,Metastatic Hepatoblastoma,0.6554,Metastatic Adenocarcinoma,0.6491,Metastatic Fibrosarcoma,0.6444,Metastatic Sarcoma,0.6404,Distantly Metastatic Malignant Neoplasm,0.6404,Metastatic Melanoma,0.6386,Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma,0.6274,Metastatic Myxofibrosarcoma,0.6261,Metastatic Benign Neoplasm,0.6256,Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage,0.6193,Advanced Carcinosarcoma,0.6148,High Grade Malignant Neoplasm,0.6135,Mixed Cellularity Classic Hodgkin Lymphoma,0.6070,Metastatic Undifferentiated Pleomorphic Sarcoma,0.6066,Metastatic Rhabdoid Tumor,0.6055,"METASTATIC, VARIANT HISTOLOGY",False,False,False
METASTATIC_OVARIAN_CANCER,Metastatic Ovarian Carcinoma,1,2,Metastatic Ovarian Carcinoma,0.9228,Metastatic Malignant Neoplasm in the Ovary,0.8927,Metastatic Ovarian Undifferentiated Carcinoma,0.8217,Advanced Ovarian Carcinoma,0.7792,Metastatic Ovarian Carcinosarcoma,0.7780,Metastatic Malignant Ovarian Germ Cell Tumor,0.7685,Metastatic Ovarian Mucinous Adenocarcinoma,0.7413,Malignant Ovarian Neoplasm,0.7320,Advanced Ovarian Carcinosarcoma,0.7315,Stage IV Ovarian Cancer AJCC v6 and v7,0.7270,Ovarian Carcinoma,0.7226,Metastatic Ovarian Clear Cell Adenocarcinoma,0.7192,Stage IV Ovarian Cancer AJCC v8,0.7039,Metastatic Ovarian Serous Adenocarcinoma,0.7034,Recurrent Ovarian Carcinoma,0.7004,Metastatic Carcinoma,0.6909,Unresectable Ovarian Carcinoma,0.6903,Metastatic Microsatellite Stable Ovarian Carcinoma,0.6899,Malignant Ovarian Epithelial Tumor,0.6885,Metastatic Adenocarcinoma,0.6827,METASTATIC_OVARIAN_CANCER,True,True,True
MGUS,Monoclonal Gammopathy of Undetermined Significance,1,2,Monoclonal Gammopathy of Undetermined Significance,1.0000,IgM Monoclonal Gammopathy of Undetermined Significance,0.9629,"IgM Monoclonal Gammopathy of Undetermined Significance, Not Otherwise Specified",0.9402,Non-IgM Monoclonal Gammopathy of Undetermined Significance,0.9388,"IgM Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Type",0.8677,Clonal Monocytosis of Undetermined Significance,0.7985,Monoclonal Gammopathy of Renal Significance,0.7933,Clonal Cytopenia with Monocytosis of Undetermined Significance,0.7180,Non-Secretory Multiple Myeloma,0.7085,"Multiple Myeloma, Not Otherwise Specified",0.6888,Smoldering Multiple Myeloma,0.6472,Smoldering Waldenstrom Macroglobulinemia,0.6420,Waldenstrom Macroglobulinemia,0.6232,Multiple Myeloma,0.6221,In Situ Mantle Cell Neoplasia,0.6107,Familial Waldenstrom Macroglobulinemia,0.6068,Monoclonal Immunoglobulin Deposition Disease,0.5969,Melanoma of Unknown Primary,0.5968,"Myelodysplastic Syndrome, Unclassifiable",0.5924,Uterine Corpus Myxoid Smooth Muscle Tumor of Uncertain Malignant Potential,0.5840,Monoclonal Gammopathy of Undetermined Significance,True,True,True
MICROPAPILLARY ADENOCARCINOMA 82653,Lung Micropapillary Adenocarcinoma,7,2,Cervical Micropapillary Adenocarcinoma,0.6970,Micropapillary Carcinoma,0.6941,Invasive Pancreatic Micropapillary Adenocarcinoma,0.6878,Colorectal Micropapillary Adenocarcinoma,0.6825,Colon Micropapillary Adenocarcinoma,0.6680,Micropapillary Serous Carcinoma,0.6443,Lung Micropapillary Adenocarcinoma,0.6413,Micropapillary Transitional Cell Carcinoma,0.6339,Invasive Breast Micropapillary Carcinoma,0.6306,Papillary Adenocarcinoma,0.6304,Rectal Micropapillary Adenocarcinoma,0.6232,Retinal Pigment Epithelium Adenocarcinoma,0.6081,Invasive Papillary Adenocarcinoma,0.6043,Prostate Acinar Mucinous Adenocarcinoma,0.6019,Trabecular Adenocarcinoma,0.6012,Invasive Micropapillary Urothelial Carcinoma,0.5996,Papillary Carcinoma,0.5971,Salivary Gland Microsecretory Adenocarcinoma,0.5959,Gastric Papillary Adenocarcinoma,0.5946,Digital Papillary Adenocarcinoma,0.5933,MICROPAPILLARY ADENOCARCINOMA 82653,False,False,False
"MINIMALLY INVASIVE ADENOCARCINOMA, NON-MUCINOUS 82502",Minimally Invasive Lung Non-Mucinous Adenocarcinoma,1,2,Minimally Invasive Lung Non-Mucinous Adenocarcinoma,0.7289,Minimally Invasive Lung Mucinous Adenocarcinoma,0.6843,Invasive Lung Non-Mucinous Adenocarcinoma,0.6831,"Sinonasal Adenocarcinoma, Intestinal-Type with Mucinous Pattern",0.6807,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.6707,Pancreatic Non-Invasive Mucinous Cystadenocarcinoma,0.6703,Minimally Invasive Lung Mixed Non-Mucinous and Mucinous Adenocarcinoma,0.6670,Cervical Invasive Stratified Mucinous Adenocarcinoma,0.6558,Small Intestinal Mucinous Adenocarcinoma,0.6511,Mucin-Producing Adenocarcinoma,0.6428,Minimally Invasive Lung Adenocarcinoma,0.6399,Lung Non-Mucinous Adenocarcinoma In Situ,0.6393,Salivary Gland Intestinal-Type Adenocarcinoma,0.6386,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0.6344,"Sinonasal Adenocarcinoma, Intestinal-Type with Mixed Pattern",0.6330,Colorectal Micropapillary Adenocarcinoma,0.6324,Lung Mucinous Adenocarcinoma In Situ,0.6301,"Endometrial Mucinous Adenocarcinoma, Intestinal-Type",0.6277,Mucinous Adenocarcinoma,0.6264,Intramucosal Adenocarcinoma,0.6258,"MINIMALLY INVASIVE ADENOCARCINOMA, NON-MUCINOUS 82502",True,True,True
MISCELLANEOUS BRAIN TUMOR,Brain Neoplasm,1,2,Brain Neoplasm,0.7734,Miscellaneous Neoplasm,0.7438,"Brain Embryonal Tumor, Not Otherwise Specified",0.6962,Malignant Brain Neoplasm,0.6801,"Medulloblastoma, Not Otherwise Specified",0.6595,Primary Brain Neoplasm,0.6572,Localized Malignant Brain Neoplasm,0.6564,Intracranial Neoplasm,0.6503,Intraventricular Brain Neoplasm,0.6449,Adult Brain Neoplasm,0.6442,Benign Brain Neoplasm,0.6357,Cerebral Neoplasm,0.6342,Localized Brain Neoplasm,0.6233,Childhood Brain Neoplasm,0.6229,Adult Malignant Brain Neoplasm,0.6227,Metastatic Malignant Neoplasm in the Brain,0.6222,Malignant Brain Glioma,0.6137,Neuroblastic Tumor,0.6133,Childhood Malignant Brain Neoplasm,0.6106,Malignant Brain Germ Cell Tumor,0.6093,MISCELLANEOUS BRAIN TUMOR,True,True,True
MISCELLANEOUS NEUROEPITHELIAL TUMOR,Neuroepithelial Neoplasm,1,2,Neuroepithelial Neoplasm,0.8266,Central Nervous System Neuroepithelial Neoplasm of Uncertain Origin,0.7655,Dysembryoplastic Neuroepithelial Tumor,0.7458,"Neuroepithelial, Perineurial, and Schwann Cell Neoplasm",0.7215,Glioneuronal and Neuronal Tumors,0.7113,Miscellaneous Neoplasm,0.7027,"Brain Embryonal Tumor, Not Otherwise Specified",0.6987,Adult Dysembryoplastic Neuroepithelial Tumor,0.6972,Primitive Neuroectodermal Tumor,0.6850,Neuroblastic Tumor,0.6846,Myoepithelial Tumor,0.6738,Childhood Dysembryoplastic Neuroepithelial Tumor,0.6722,Mixed Neuroendocrine Non-Neuroendocrine Neoplasm,0.6660,Melanotic Neuroectodermal Tumor,0.6658,Medulloepithelioma Not Otherwise Specified,0.6657,Neuroendocrine Tumor,0.6630,Neuroendocrine Neoplasm,0.6605,Middle Ear Neuroendocrine Tumor,0.6538,Unresectable Glioneuronal and Neuronal Tumors,0.6524,Peripheral Primitive Neuroectodermal Tumor,0.6488,MISCELLANEOUS NEUROEPITHELIAL TUMOR,True,True,True
MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA,Renal Cell Carcinoma with MiT Translocations,1,2,Renal Cell Carcinoma with MiT Translocations,0.8955,Childhood Renal Cell Carcinoma with MiT Translocations,0.8303,Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations,0.7623,TFE3-Rearranged Renal Cell Carcinoma,0.7451,TFEB-Rearranged Renal Cell Carcinoma,0.7277,Transplant-Related Renal Cell Carcinoma,0.7185,ELOC-Mutated Renal Cell Carcinoma,0.7108,Renal Cell Carcinoma Associated with inv(X)(p11;q12),0.6709,Hereditary Renal Cell Carcinoma,0.6674,Renal Cell Carcinoma,0.6632,Renomedullary Interstitial Cell Tumor,0.6631,Kidney Medullary Carcinoma,0.6620,Refractory Kidney Medullary Carcinoma,0.6547,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34),0.6497,Hereditary Leiomyomatosis and Renal Cell Carcinoma,0.6477,Tubulocystic Renal Cell Carcinoma,0.6442,Clear Cell Tumor with Melanocytic Differentiation and MITF-CREM Translocation,0.6433,Transplant-Related Lung Carcinoma,0.6421,Acquired Cystic Disease-Associated Renal Cell Carcinoma,0.6379,SMARCB1-Deficient Kidney Medullary Carcinoma,0.6339,MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA,True,True,True
MIXED 80% ALVEOLAR,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,99,2,Alveolar Adenoma,0.5934,Mixed Cell Adenoma,0.5819,"Lung Adenocarcinoma, Mixed Subtype",0.5733,Conventional Alveolar Rhabdomyosarcoma,0.5725,Adult Mixed Glioma,0.5720,Mixed Cell Adenocarcinoma,0.5696,Mixed Neoplasm,0.5681,Mixed Glioma,0.5574,Mixed Carcinoma,0.5527,Alveolar Soft Part Sarcoma,0.5463,Adult Alveolar Soft Part Sarcoma,0.5455,Advanced Alveolar Soft Part Sarcoma,0.5445,Gastric Mixed Adenocarcinoma,0.5389,Unresectable Alveolar Soft Part Sarcoma,0.5382,Anaplastic Oligoastrocytoma,0.5368,Solid Alveolar Rhabdomyosarcoma,0.5324,Alveolar Rhabdomyosarcoma,0.5322,Malignant Mixed Neoplasm,0.5319,Mixed Cell Lymphoma,0.5303,Lung Adenocarcinoma with Mixed Bronchioloalveolar and Invasive Components,0.5275,MIXED 80% ALVEOLAR,False,False,False
MIXED ACINAR-DUCTAL CARCINOMA,Pancreatic Mixed Acinar-Ductal Carcinoma,1,2,Pancreatic Mixed Acinar-Ductal Carcinoma,0.9255,Mixed Cell Adenocarcinoma,0.8160,Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma,0.8076,Acinar Cell Carcinoma,0.8068,Breast Mixed Ductal and Lobular Carcinoma,0.7939,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma,0.7761,Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma,0.7635,Mixed Carcinoma,0.7472,Mixed Cell Adenoma,0.7393,Pancreatic Acinar Cell Carcinoma,0.7359,Acinar Cell Adenoma,0.7313,Gastric Mixed Adenocarcinoma,0.7287,"Lung Adenocarcinoma, Mixed Subtype",0.7277,Comedo-Type Adenocarcinoma,0.7269,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Neoplasm,0.7242,Breast Mixed Carcinoma,0.7228,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,0.7215,Metastatic Pancreatic Acinar Cell Carcinoma,0.7209,Oligometastatic Pancreatic Ductal Adenocarcinoma,0.7158,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Tumor,0.7155,MIXED ACINAR-DUCTAL CARCINOMA,True,True,True
MIXED ACINAR-NEUROENDOCRINE CARCINOMA,Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma,1,2,Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma,0.9279,Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma,0.8897,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma,0.8743,Pancreatic Mixed Adenoneuroendocrine Carcinoma,0.8609,Gastric Mixed Adenoneuroendocrine Carcinoma,0.8266,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Neoplasm,0.8207,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Tumor,0.8162,Digestive System Mixed Adenoneuroendocrine Carcinoma,0.8017,Adenocarcinoma with Neuroendocrine Differentiation,0.7983,Appendix Mixed Adenoneuroendocrine Carcinoma,0.7980,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7971,Gallbladder Mixed Adenoneuroendocrine Carcinoma,0.7930,Colorectal Mixed Adenoneuroendocrine Carcinoma,0.7861,Esophageal Mixed Adenoneuroendocrine Carcinoma,0.7780,Liver Mixed Adenoneuroendocrine Carcinoma,0.7766,Anal Canal Mixed Adenoneuroendocrine Carcinoma,0.7759,Mixed Cell Adenocarcinoma,0.7676,Acinar Cell Carcinoma,0.7549,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,0.7523,Neuroendocrine Carcinoma,0.7506,MIXED ACINAR-NEUROENDOCRINE CARCINOMA,True,True,True
MIXED ADENOCARCINOMA AND NEUROENDOCRINE CARCINOMA,Digestive System Mixed Adenoneuroendocrine Carcinoma,5,2,Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma,0.8625,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma,0.8434,Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma,0.8391,Adenocarcinoma with Neuroendocrine Differentiation,0.8323,Digestive System Mixed Adenoneuroendocrine Carcinoma,0.8306,Colorectal Mixed Adenoneuroendocrine Carcinoma,0.8294,Gastric Mixed Adenoneuroendocrine Carcinoma,0.8271,Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma,0.8217,Pancreatic Mixed Adenoneuroendocrine Carcinoma,0.8169,Combined Carcinoid and Adenocarcinoma,0.8055,Esophageal Mixed Adenoneuroendocrine Carcinoma,0.8020,Neuroendocrine Carcinoma,0.7911,Mixed Cell Adenocarcinoma,0.7896,Anal Canal Mixed Adenoneuroendocrine Carcinoma,0.7828,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Tumor,0.7815,Mixed Carcinoma,0.7808,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Neoplasm,0.7806,Appendix Mixed Adenoneuroendocrine Carcinoma,0.7794,Gallbladder Mixed Adenoneuroendocrine Carcinoma,0.7751,Advanced Neuroendocrine Carcinoma,0.7720,MIXED ADENOCARCINOMA AND NEUROENDOCRINE CARCINOMA,False,False,True
MIXED CANCER TYPES,Mixed Carcinoma,1,2,Mixed Carcinoma,0.8995,Malignant Mixed Neoplasm,0.8518,Mixed Neoplasm,0.8489,Mixed Cell Adenocarcinoma,0.8053,Mixed Cell Lymphoma,0.7982,Breast Mixed Carcinoma,0.7830,Mixed Germ Cell Tumor,0.7826,Skin Mixed Tumor,0.7787,"Malignant Mixed Tumor, Not Otherwise Specified",0.7710,"Mixed Tumor, Not Otherwise Specified",0.7681,Mixed Cell Adenoma,0.7570,Malignant Mixed Tumor of the Skin,0.7525,Mixed Glioma,0.7507,Diffuse Mixed Cell Lymphoma,0.7145,Mixed Trophoblastic Tumor,0.7121,Mixed Osteosarcoma,0.7057,Gastric Mixed Adenocarcinoma,0.7056,Mixed Cell Type Gastrointestinal Stromal Tumor,0.7027,Childhood Mixed Germ Cell Tumor,0.7008,Testicular Mixed Choriocarcinoma and Teratoma,0.6969,MIXED CANCER TYPES,True,True,True
MIXED CARCINOMA,Mixed Carcinoma,1,2,Mixed Carcinoma,1.0000,Mixed Cell Adenocarcinoma,0.8902,Breast Mixed Carcinoma,0.8513,Malignant Mixed Neoplasm,0.8505,Mixed Neoplasm,0.8322,Mixed Cell Adenoma,0.8037,Gastric Mixed Adenocarcinoma,0.7845,Bladder Mixed Adenocarcinoma,0.7716,Mixed Cell Lymphoma,0.7716,Mixed Glioma,0.7647,Hybrid Salivary Gland Carcinoma,0.7569,Endometrial Mixed Cell Adenocarcinoma,0.7513,Invasive Bladder Mixed Carcinoma,0.7458,Metaplastic Carcinoma,0.7381,Undifferentiated Carcinoma,0.7355,Ovarian Mixed Cell Adenocarcinoma,0.7332,Malignant Mixed Tumor of the Skin,0.7307,Combined Lung Carcinoma,0.7261,Skin Mixed Tumor,0.7254,"Lung Adenocarcinoma, Mixed Subtype",0.7222,MIXED CARCINOMA,True,True,True
MIXED GERM CELL TUMOR,Mixed Germ Cell Tumor,1,2,Mixed Germ Cell Tumor,1.0000,Testicular Mixed Germ Cell Tumor,0.9173,Childhood Mixed Germ Cell Tumor,0.9094,Central Nervous System Mixed Germ Cell Tumor,0.8908,Ovarian Mixed Germ Cell Tumor,0.8609,Childhood Testicular Mixed Germ Cell Tumor,0.8558,Childhood Central Nervous System Mixed Germ Cell Tumor,0.8405,Mediastinal Mixed Germ Cell Tumor,0.8262,Mixed Germ Cell-Sex Cord-Stromal Tumor,0.8228,Adult Central Nervous System Mixed Germ Cell Tumor,0.8227,Sellar Mixed Germ Cell Tumor,0.8109,Childhood Ovarian Mixed Germ Cell Tumor,0.8021,Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7900,Germ Cell Tumor,0.7790,Mixed Trophoblastic Tumor,0.7780,Malignant Germ Cell Tumor,0.7768,Mixed Glioma,0.7732,Mixed Neoplasm,0.7723,"Mixed Tumor, Not Otherwise Specified",0.7633,Testicular Pure Germ Cell Tumor,0.7586,MIXED GERM CELL TUMOR,True,True,True
MIXED INFILTRATING LOBULAR AND GRADE 1 DUCTAL CARCINOMA,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,0.8321,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.7654,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7587,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.7539,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.7429,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.7412,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.7215,Breast Classic Lobular Carcinoma In Situ Type A,0.7084,"Breast Ductal Carcinoma In Situ, Low Grade",0.7045,Minimally Invasive Lung Mixed Non-Mucinous and Mucinous Adenocarcinoma,0.7030,Invasive Breast Lobular Carcinoma,0.7026,Breast Classic Lobular Carcinoma In Situ,0.6991,"Breast Ductal Carcinoma In Situ, Intermediate Grade",0.6981,"Invasive Breast Lobular Carcinoma, Alveolar Variant",0.6924,"Breast Ductal Carcinoma In Situ, High Grade",0.6892,Invasive Breast Lobular Carcinoma with Predominant In Situ Component,0.6843,Breast Mixed Carcinoma,0.6824,Pancreatic Mixed Acinar-Ductal Carcinoma,0.6812,Well Differentiated Invasive Breast Carcinoma,0.6807,Moderately Differentiated Invasive Breast Carcinoma,0.6781,MIXED INFILTRATING LOBULAR AND GRADE 1 DUCTAL CARCINOMA,True,True,True
MIXED INVASIVE DUCTAL AND INVASIVE LOBULAR,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,1,2,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.8315,Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ,0.7899,Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma,0.7893,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.7853,Breast Mixed Ductal and Lobular Carcinoma,0.7669,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.7462,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,0.7333,Lung Adenocarcinoma with Mixed Bronchioloalveolar and Invasive Components,0.7327,Well Differentiated Invasive Breast Carcinoma,0.7080,"Breast Ductal Carcinoma In Situ, Intermediate Grade",0.7006,Minimally Invasive Lung Mixed Non-Mucinous and Mucinous Adenocarcinoma,0.6995,Invasive Breast Lobular Carcinoma,0.6981,Poorly Differentiated Invasive Breast Carcinoma,0.6961,Moderately Differentiated Invasive Breast Carcinoma,0.6837,"Invasive Breast Lobular Carcinoma, Alveolar Variant",0.6797,Invasive Bladder Mixed Carcinoma,0.6785,Invasive Breast Lobular Carcinoma with Predominant In Situ Component,0.6695,Breast Ductal Carcinoma In Situ,0.6638,"Breast Ductal Carcinoma In Situ, High Grade",0.6558,"Breast Ductal Carcinoma In Situ, Low Grade",0.6529,MIXED INVASIVE DUCTAL AND INVASIVE LOBULAR,True,True,True
"MIXED PHENOTYPE ACUTE LEUKAEMIA, B/MYELOID, NOS","Mixed Phenotype Acute Leukemia, B/Myeloid",1,2,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.9809,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",0.9345,"Mixed Phenotype Acute Leukemia, B/T",0.9078,Mixed Phenotype Acute Leukemia,0.8469,"Mixed Phenotype Acute Leukemia, Rare Types",0.8090,Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion,0.8008,"Mixed Phenotype Acute Leukemia, T/Myeloid",0.7767,Mixed Phenotype Acute Leukemia with KMT2A Rearrangement,0.7540,"Mixed Phenotype Acute Leukemia, T/Megakaryocytic",0.7288,Acute Monoblastic and Monocytic Leukemia,0.7219,Recurrent Mixed Phenotype Acute Leukemia,0.7042,Acute Biphenotypic Leukemia,0.7025,Acute Monoblastic Leukemia,0.6853,Refractory Mixed Phenotype Acute Leukemia,0.6684,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.6484,Acute Myeloid Leukemia with Multilineage Dysplasia,0.6420,Acute Myeloid Leukemia with NPM1-MLF1,0.6350,Typical Acute Promyelocytic Leukemia,0.6336,Acute Myeloid Leukemia with Maturation,0.6312,Acute Myeloid Leukemia,0.6285,"MIXED PHENOTYPE ACUTE LEUKAEMIA, B/MYELOID, NOS",True,True,True
"MIXED PHENOTYPE ACUTE LEUKAEMIA, T/MYELOID, NOS","Mixed Phenotype Acute Leukemia, T/Myeloid",1,2,"Mixed Phenotype Acute Leukemia, T/Myeloid",0.9833,"Mixed Phenotype Acute Leukemia, T/Megakaryocytic",0.9193,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",0.8742,"Mixed Phenotype Acute Leukemia, B/T",0.8631,Mixed Phenotype Acute Leukemia,0.8432,"Mixed Phenotype Acute Leukemia, Rare Types",0.8191,Mixed Phenotype Acute Leukemia with KMT2A Rearrangement,0.8047,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.7869,Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion,0.7502,Recurrent Mixed Phenotype Acute Leukemia,0.6831,Refractory Mixed Phenotype Acute Leukemia,0.6559,Acute Myeloid Leukemia with Complex Karyotype,0.6285,T Acute Lymphoblastic Leukemia,0.6281,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.6203,Acute Myeloid Leukemia with KMT2A Rearrangement,0.6185,Typical Acute Promyelocytic Leukemia,0.6174,Acute Myeloid Leukemia with a Variant KMT2A Rearrangement,0.6169,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.6161,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.6149,Mixed Trophoblastic Tumor,0.6144,"MIXED PHENOTYPE ACUTE LEUKAEMIA, T/MYELOID, NOS",True,True,True
"MIXED PHENOTYPE ACUTE LEUKEMIA, B/MYELOID, NOS","Mixed Phenotype Acute Leukemia, B/Myeloid",1,2,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.9897,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",0.9523,"Mixed Phenotype Acute Leukemia, B/T",0.9217,Mixed Phenotype Acute Leukemia,0.8606,"Mixed Phenotype Acute Leukemia, Rare Types",0.8282,Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion,0.8059,"Mixed Phenotype Acute Leukemia, T/Myeloid",0.8002,Mixed Phenotype Acute Leukemia with KMT2A Rearrangement,0.7676,"Mixed Phenotype Acute Leukemia, T/Megakaryocytic",0.7455,Acute Monoblastic and Monocytic Leukemia,0.7313,Acute Biphenotypic Leukemia,0.7186,Recurrent Mixed Phenotype Acute Leukemia,0.7150,Acute Monoblastic Leukemia,0.6898,Refractory Mixed Phenotype Acute Leukemia,0.6808,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.6621,Typical Acute Promyelocytic Leukemia,0.6515,Acute Myeloid Leukemia with Multilineage Dysplasia,0.6484,Acute Myeloid Leukemia with NPM1-MLF1,0.6482,Acute Myeloid Leukemia,0.6448,Acute Myeloid Leukemia with Complex Karyotype,0.6439,"MIXED PHENOTYPE ACUTE LEUKEMIA, B/MYELOID, NOS",True,True,True
"MIXED PHENOTYPE ACUTE LEUKEMIA, T/MYELOID, NOS","Mixed Phenotype Acute Leukemia, T/Myeloid",1,2,"Mixed Phenotype Acute Leukemia, T/Myeloid",0.9910,"Mixed Phenotype Acute Leukemia, T/Megakaryocytic",0.9236,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",0.8859,"Mixed Phenotype Acute Leukemia, B/T",0.8709,Mixed Phenotype Acute Leukemia,0.8496,"Mixed Phenotype Acute Leukemia, Rare Types",0.8328,Mixed Phenotype Acute Leukemia with KMT2A Rearrangement,0.8093,"Mixed Phenotype Acute Leukemia, B/Myeloid",0.7965,Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion,0.7524,Recurrent Mixed Phenotype Acute Leukemia,0.6892,Refractory Mixed Phenotype Acute Leukemia,0.6659,Acute Myeloid Leukemia with Complex Karyotype,0.6368,T Acute Lymphoblastic Leukemia,0.6364,Typical Acute Promyelocytic Leukemia,0.6293,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.6278,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.6242,Acute Myeloid Leukemia with KMT2A Rearrangement,0.6237,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.6236,Acute Monoblastic and Monocytic Leukemia,0.6209,Acute Myeloid Leukemia with NPM1-MLF1,0.6197,"MIXED PHENOTYPE ACUTE LEUKEMIA, T/MYELOID, NOS",True,True,True
MIXED SEROUS AND ENDOMETRIOID,Endometrial Serous Adenocarcinoma,18,2,"Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.7351,Endometrioid Stromal Sarcoma,0.7350,Endometrioid Tumor,0.7347,"Endometrioid Tumor, Variant with Squamous Differentiation",0.7274,Endometrial Endometrioid Adenocarcinoma with Metaplastic Changes,0.7233,Metastatic Endometrioid Adenocarcinoma,0.7197,Endometrioid Adenocarcinoma,0.7196,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",0.7171,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant",0.7137,Metastatic Endometrial Serous Adenocarcinoma,0.7091,Endometrial Mixed Cell Adenocarcinoma,0.7071,Low Grade Endometrioid Stromal Sarcoma,0.6941,Endometrial Endometrioid Adenocarcinoma,0.6917,Low Grade Endometrioid Adenocarcinoma,0.6892,Mixed Endometrial Stromal and Smooth Muscle Neoplasm,0.6851,Metastatic Endometrial Endometrioid Adenocarcinoma,0.6825,Mixed Epithelioid and Spindle Cell Melanoma,0.6810,Endometrial Serous Adenocarcinoma,0.6763,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,0.6750,Advanced Endometrioid Adenocarcinoma,0.6749,MIXED SEROUS AND ENDOMETRIOID,False,False,False
MIXED_ADENOSQUAMOUS_CARCINOMA,Adenosquamous Carcinoma,1,2,Adenosquamous Carcinoma,0.8672,Lung Adenosquamous Carcinoma,0.7815,Mixed Cell Adenocarcinoma,0.7673,Endometrial Adenosquamous Carcinoma,0.7610,Skin Adenosquamous Carcinoma,0.7599,Cervical Adenosquamous Carcinoma,0.7588,Mixed Carcinoma,0.7574,Breast Adenosquamous Carcinoma,0.7425,Prostate Adenosquamous Carcinoma,0.7400,Salivary Gland Adenosquamous Carcinoma,0.7378,Metastatic Cervical Adenosquamous Carcinoma,0.7311,Colon Adenosquamous Carcinoma,0.7311,"Lung Adenocarcinoma, Mixed Subtype",0.7285,Metastatic Lung Adenosquamous Carcinoma,0.7252,Metastatic Endometrial Adenosquamous Carcinoma,0.7224,Gastric Adenosquamous Carcinoma,0.7055,Occult Lung Adenosquamous Carcinoma,0.7036,Conjunctival Adenosquamous Carcinoma,0.6996,Colorectal Adenosquamous Carcinoma,0.6992,Advanced Cervical Adenosquamous Carcinoma,0.6966,MIXED_ADENOSQUAMOUS_CARCINOMA,True,True,True
MIXED_CARCINOMA,Mixed Carcinoma,1,2,Mixed Carcinoma,0.9561,Mixed Cell Adenocarcinoma,0.8472,Malignant Mixed Neoplasm,0.8331,Breast Mixed Carcinoma,0.8140,Mixed Neoplasm,0.7905,Mixed Cell Adenoma,0.7424,Bladder Mixed Adenocarcinoma,0.7391,Gastric Mixed Adenocarcinoma,0.7391,Undifferentiated Carcinoma,0.7371,Malignant Mixed Tumor of the Skin,0.7358,"Malignant Mixed Tumor, Not Otherwise Specified",0.7350,Endometrial Mixed Cell Adenocarcinoma,0.7318,Carcinoma,0.7312,Metaplastic Carcinoma,0.7258,Mixed Cell Lymphoma,0.7244,Hybrid Salivary Gland Carcinoma,0.7227,Thyroid Gland Mixed Medullary and Papillary Carcinoma,0.7117,Invasive Bladder Mixed Carcinoma,0.7111,Metastatic Carcinoma,0.7012,Mixed Glioma,0.7008,MIXED_CARCINOMA,True,True,True
MIXED_GERM_CELL,Mixed Germ Cell Tumor,1,2,Mixed Germ Cell Tumor,0.8516,Childhood Mixed Germ Cell Tumor,0.7517,Germ Cell,0.7502,Testicular Mixed Germ Cell Tumor,0.7417,Central Nervous System Mixed Germ Cell Tumor,0.7412,Ovarian Mixed Germ Cell Tumor,0.7237,Mixed Glioma,0.7102,Childhood Central Nervous System Mixed Germ Cell Tumor,0.6996,Mixed Cell Adenoma,0.6969,Mixed Cell Lymphoma,0.6915,Childhood Testicular Mixed Germ Cell Tumor,0.6839,Adult Central Nervous System Mixed Germ Cell Tumor,0.6810,Mixed Neoplasm,0.6785,Mediastinal Mixed Germ Cell Tumor,0.6773,Malignant Germ Cell Tumor,0.6760,Mixed Germ Cell-Sex Cord-Stromal Tumor,0.6757,Childhood Ovarian Mixed Germ Cell Tumor,0.6719,Mixed Carcinoma,0.6709,Malignant Mixed Neoplasm,0.6688,Sellar Mixed Germ Cell Tumor,0.6615,MIXED_GERM_CELL,True,True,True
"MLL TRANSLOCATION, T9;11",Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1,2,Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.6576,Acute Leukemia of Ambiguous Lineage with BCL11B Rearrangement,0.6371,B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged,0.6286,Acute Myeloid Leukemia with t(11;19)(q23.3;p13.3); KMT2A-MLLT1,0.6091,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged,0.6080,Acute Myeloid Leukemia with t(10;11)(p12.3;q23.3); MLLT10-KMT2A,0.6057,Early T Precursor Acute Lymphoblastic Leukemia with BCL11B Rearrangement,0.6005,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,0.5998,T Acute Lymphoblastic Leukemia with LMO1 Rearrangement,0.5863,Acute Myeloid Leukemia with t(10;11)(q21.3;q23.3); TET1-KMT2A,0.5847,T Acute Lymphoblastic Leukemia with TAL1 Rearrangement,0.5799,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.5795,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,0.5778,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,0.5755,Childhood Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,0.5733,T Acute Lymphoblastic Leukemia with LMO2 Rearrangement,0.5709,Acute Myeloid Leukemia with KMT2A Rearrangement,0.5691,T Acute Lymphoblastic Leukemia with TLX1 Rearrangement,0.5656,Acute Promyelocytic Leukemia with t(11;17)(q13;q21); NUMA1-RARA,0.5619,Infant Acute Lymphoblastic Leukemia with KMT2A Rearrangement,0.5600,"MLL TRANSLOCATION, T9;11",True,True,True
MLL-ALL,Acute Myeloid Leukemia with KMT2A Rearrangement,6,2,Acute Lymphoblastic Leukemia,0.7252,Common Acute Lymphoblastic Leukemia,0.7063,Lymphoid Leukemia,0.7035,L1 Acute Lymphoblastic Leukemia,0.6935,B Acute Lymphoblastic Leukemia with TCF4-HLF Rearrangement,0.6925,Acute Myeloid Leukemia with KMT2A Rearrangement,0.6879,Acute Leukemia,0.6859,T Acute Lymphoblastic Leukemia,0.6795,B Acute Lymphoblastic Leukemia with TCF3-HLF Rearrangement,0.6775,T Acute Lymphoblastic Leukemia with LMO2 Rearrangement,0.6770,B Acute Lymphoblastic Leukemia with HLF Rearrangement,0.6738,B Acute Lymphoblastic Leukemia with t(4;11)(q21;23.3); KMT2A-AFF1,0.6723,B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged,0.6722,Leukemia,0.6687,"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like",0.6630,B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged,0.6620,Acute Leukemia of Ambiguous Lineage,0.6620,Infant Acute Lymphoblastic Leukemia with KMT2A Rearrangement,0.6618,Myeloid Leukemia,0.6599,Aleukemic Acute Lymphoblastic Leukemia,0.6593,MLL-ALL,False,False,False
MMMT,Female Reproductive System Carcinosarcoma,99,2,Myoma,0.6470,Multiple Myeloma with MAF Family Translocation,0.6350,Multiple Myeloma,0.6232,Malignant Mesothelioma,0.6193,Mesothelioma,0.6189,Meningioma,0.6141,MGMT-Methylated Glioblastoma,0.6073,Melanoma,0.6060,"Malignant Mixed Tumor, Not Otherwise Specified",0.6057,Mucosal Melanoma,0.6006,Myoepithelial Tumor,0.5986,Minimal Deviation Melanoma,0.5984,Diffuse Malignant Mesothelioma,0.5941,Transitional Meningioma,0.5932,Meningothelial Meningioma,0.5931,Multicystic Mesothelioma,0.5904,Malignant Mixed Neoplasm,0.5896,Malignant Mastocytosis,0.5879,Multiple Myeloma with NSD2 Translocation,0.5874,Metastatic Mucosal Melanoma,0.5833,MMMT,False,False,False
MONOCLONAL B-CELL LYMPHOCYTOSIS,Monoclonal B-Cell Lymphocytosis,1,2,Monoclonal B-Cell Lymphocytosis,1.0000,"Monoclonal B-Cell Lymphocytosis, Non-Chronic Lymphocytic Leukemia Type",0.8583,"Monoclonal B-Cell Lymphocytosis, Chronic Lymphocytic Leukemia Type",0.8448,Mature B-Cell Non-Hodgkin Lymphoma,0.7907,Mature B-Cell Neoplasm,0.7758,MCD Diffuse Large B-Cell Lymphoma,0.7030,Primary Mediastinal Large B-Cell Lymphoma,0.7019,Cutaneous Mature B-Cell Neoplasm,0.6836,Centroblastic Lymphoma,0.6751,B-Cell Leukemia,0.6681,B-Cell Neoplasm,0.6677,Mantle Cell Lymphoma,0.6658,Lung Mature B-Cell Neoplasm,0.6655,B-Cell Malignant Neoplasm,0.6642,Childhood Primary Mediastinal Large B-Cell Lymphoma,0.6630,Advanced B-Cell Malignant Neoplasm,0.6613,Leukemic Nonnodal Mantle Cell Lymphoma,0.6608,B-Cell Non-Hodgkin Lymphoma,0.6592,Plasmablastic Lymphoma,0.6528,Classical Burkitt Lymphoma,0.6462,MONOCLONAL B-CELL LYMPHOCYTOSIS,True,True,True
MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,1,2,Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma,1.0000,Small Intestinal Monomorphic Epitheliotropic T-Cell Lymphoma,0.9298,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,0.8682,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,0.8575,Intestinal T-Cell Lymphoma,0.7910,Enteropathy-Associated T-Cell Lymphoma,0.7799,Small Intestinal Enteropathy-Associated T-Cell Lymphoma,0.7563,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",0.7488,Recurrent Enteropathy-Associated T-Cell Lymphoma,0.7349,Refractory Enteropathy-Associated T-Cell Lymphoma,0.7325,Ann Arbor Stage I Enteropathy-Associated T-Cell Lymphoma,0.7235,Small Intestinal T-Cell Non-Hodgkin Lymphoma,0.6992,Enteropathy-Associated T-Cell Lymphoma by Ann Arbor Stage,0.6931,Small Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma,0.6913,Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma,0.6885,Ann Arbor Stage II Enteropathy-Associated T-Cell Lymphoma,0.6838,Ann Arbor Stage IV Enteropathy-Associated T-Cell Lymphoma,0.6818,Ann Arbor Stage III Enteropathy-Associated T-Cell Lymphoma,0.6717,Indolent Clonal T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract,0.6641,Thymus Mucosa-Associated Lymphoid Tissue Lymphoma,0.6488,MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA,True,True,True
MORPHEAN,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,1,2,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.5103,Desmoplastic Melanoma,0.5052,Nodular Melanoma,0.5046,Iris Mixed Epithelioid and Spindle Cell Melanoma,0.4897,Mucosal Nodular Melanoma,0.4861,Neoplasm by Morphology,0.4829,Smoldering Systemic Mastocytosis,0.4815,Myeloid Neoplasm,0.4792,Smoldering Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.4783,Myoma,0.4774,Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.4763,Mediastinal Myeloid Sarcoma,0.4754,Telangiectatic Osteosarcoma,0.4740,Malignant Mixed Neoplasm,0.4740,Mixed Osteosarcoma,0.4738,Cutaneous Nodular Melanoma,0.4734,Mixed Neoplasm,0.4723,Mixed Epithelioid and Spindle Cell Melanoma,0.4721,Volar Melanoma,0.4709,Malignant Thalamic Neoplasm,0.4705,MORPHEAN,True,True,True
MUCINOUS ADENOCARCINOMA OF THE APPENDIX,Appendix Mucinous Adenocarcinoma,1,2,Appendix Mucinous Adenocarcinoma,0.9586,Mucinous Adenocarcinoma,0.8820,Appendix Mucinous Cystadenocarcinoma,0.8633,Colon Mucinous Adenocarcinoma,0.8598,Gastric Mucinous Adenocarcinoma,0.8565,Appendix Mucinous Cystadenoma,0.8534,Metastatic Appendix Mucinous Adenocarcinoma,0.8495,Appendix Mucinous Neoplasm,0.8483,Endometrial Mucinous Adenocarcinoma,0.8481,Ovarian Mucinous Adenocarcinoma,0.8443,Colorectal Mucinous Adenocarcinoma,0.8430,High Grade Appendix Mucinous Adenocarcinoma,0.8409,Anal Mucinous Adenocarcinoma,0.8255,Appendix Goblet Cell Adenocarcinoma,0.8244,Cervical Mucinous Adenocarcinoma,0.7967,"Endometrial Mucinous Adenocarcinoma, Intestinal-Type",0.7898,"Endometrial Mucinous Adenocarcinoma, Gastric-Type",0.7875,Broad Ligament Mucinous Adenocarcinoma,0.7832,Mucinous Cystadenocarcinoma,0.7824,Gallbladder Mucinous Adenocarcinoma,0.7822,MUCINOUS ADENOCARCINOMA OF THE APPENDIX,True,True,True
MUCINOUS CARCINOMA,Mucinous Adenocarcinoma,1,2,Mucinous Adenocarcinoma,0.9525,Mucinous Neoplasm,0.8729,Colon Mucinous Adenocarcinoma,0.8671,Mucinous Cystadenocarcinoma,0.8632,Colorectal Mucinous Adenocarcinoma,0.8561,Breast Mucinous Carcinoma,0.8558,Gastric Mucinous Adenocarcinoma,0.8503,Cervical Mucinous Adenocarcinoma,0.8495,Endometrial Mucinous Adenocarcinoma,0.8423,Mucin-Producing Carcinoma,0.8358,Appendix Mucinous Adenocarcinoma,0.8298,Thyroid Gland Mucinous Carcinoma,0.8290,Mucin-Producing Adenocarcinoma,0.8208,Salivary Gland Mucinous Adenocarcinoma,0.8189,Ovarian Mucinous Adenocarcinoma,0.8184,Mucinous Cystadenoma,0.8019,Primary Cutaneous Mucinous Carcinoma,0.8016,Bladder Mucinous Adenocarcinoma,0.7993,Breast Columnar Cell Mucinous Carcinoma,0.7959,Goblet Cell Adenocarcinoma,0.7943,MUCINOUS CARCINOMA,True,True,True
MUCINOUS COLLOID ADENOCARCINOMA,Gastric Mucinous Adenocarcinoma,2,2,Mucinous Adenocarcinoma,0.9189,Gastric Mucinous Adenocarcinoma,0.8676,Cervical Mucinous Adenocarcinoma,0.8579,Salivary Gland Mucinous Adenocarcinoma,0.8552,Appendix Mucinous Adenocarcinoma,0.8501,Ovarian Mucinous Adenocarcinoma,0.8370,Endometrial Mucinous Adenocarcinoma,0.8345,Mucinous Cystadenocarcinoma,0.8270,Colorectal Mucinous Adenocarcinoma,0.8232,Lung Colloid Adenocarcinoma,0.8193,Colon Mucinous Adenocarcinoma,0.8180,Mucinous Neoplasm,0.8072,Mucinous Cystadenoma,0.7987,Breast Mucinous Carcinoma,0.7971,Thyroid Gland Mucinous Carcinoma,0.7968,Appendix Mucinous Cystadenocarcinoma,0.7885,Prostate Acinar Mucinous Adenocarcinoma,0.7835,Appendix Mucinous Neoplasm,0.7823,Pancreatic Colloid Carcinoma,0.7768,Gallbladder Mucinous Adenocarcinoma,0.7735,MUCINOUS COLLOID ADENOCARCINOMA,False,True,True
MUCINOUS CYSTADENOCARCINOMA,Mucinous Cystadenocarcinoma,1,2,Mucinous Cystadenocarcinoma,1.0000,Mucinous Cystadenoma,0.9225,Appendix Mucinous Cystadenocarcinoma,0.9161,Ovarian Mucinous Cystadenocarcinoma,0.9124,Breast Mucinous Cystadenocarcinoma,0.8983,Papillary Mucinous Cystadenocarcinoma,0.8981,Cystadenocarcinoma,0.8910,Pancreatic Mucinous Cystadenocarcinoma,0.8782,Mucinous Adenocarcinoma,0.8724,Ovarian Mucinous Cystadenoma,0.8435,Appendix Mucinous Cystadenoma,0.8352,Mucinous Cystadenofibroma,0.8238,Serous Cystadenocarcinoma,0.8220,Papillary Mucinous Cystadenoma,0.8194,Ovarian Cystadenocarcinoma,0.8134,Pancreatic Mucinous Cystadenoma,0.8059,Mucinous Neoplasm,0.8042,Ovarian Mucinous Adenocarcinoma,0.8026,Cervical Mucinous Adenocarcinoma,0.8018,Papillary Cystadenocarcinoma,0.7976,MUCINOUS CYSTADENOCARCINOMA,True,True,True
MUCINOUS CYSTIC NEOPLASM,Pancreatic Mucinous-Cystic Neoplasm,1,2,Pancreatic Mucinous-Cystic Neoplasm,0.8951,Mucinous Neoplasm,0.8817,Mucinous Cystadenoma,0.8553,Cystic Neoplasm,0.8346,Gallbladder Mucinous Cystic Neoplasm,0.8304,Mucinous Cystadenocarcinoma,0.8230,Bile Duct Mucinous Cystic Neoplasm,0.8055,Appendix Mucinous Neoplasm,0.7866,Mucinous Adenocarcinoma,0.7848,Mucinous Cystadenofibroma,0.7775,Papillary Mucinous Cystadenoma,0.7774,Papillary Cystic Neoplasm,0.7749,"Pancreatic Mucinous-Cystic Neoplasm, Low Grade",0.7647,Appendix Mucinous Cystadenoma,0.7604,Pancreatic Mucinous Cystadenoma,0.7582,Ovarian Mucinous Tumor,0.7573,Pancreatic Cystic Neoplasm,0.7556,Cystic Oncocytic Neoplasm,0.7534,Papillary Mucinous Cystadenocarcinoma,0.7520,Ovarian Mucinous Cystadenoma,0.7494,MUCINOUS CYSTIC NEOPLASM,True,True,True
MUCINOUS OVARIAN CANCER,Malignant Ovarian Mucinous Tumor,2,2,Ovarian Mucinous Adenocarcinoma,0.9296,Malignant Ovarian Mucinous Tumor,0.8762,Ovarian Mucinous Tumor,0.8619,Mucinous Adenocarcinoma,0.8570,Ovarian Mucinous Cystadenocarcinoma,0.8545,Ovarian Mucinous Cystadenoma,0.8317,Metastatic Ovarian Mucinous Adenocarcinoma,0.8172,Colon Mucinous Adenocarcinoma,0.8063,Breast Mucinous Carcinoma,0.8013,Mucinous Neoplasm,0.7998,Endometrial Mucinous Adenocarcinoma,0.7955,Ovarian Mucinous Adenocarcinofibroma,0.7926,Appendix Mucinous Adenocarcinoma,0.7877,Benign Ovarian Mucinous Tumor,0.7862,Mucinous Cystadenocarcinoma,0.7806,Colorectal Mucinous Adenocarcinoma,0.7772,Ovarian Mucinous Carcinoid Tumor,0.7735,Gastric Mucinous Adenocarcinoma,0.7689,Cervical Mucinous Adenocarcinoma,0.7672,Appendix Mucinous Neoplasm,0.7607,MUCINOUS OVARIAN CANCER,False,True,True
MUCINOUS STOMACH ADENOCARCINOMA,Gastric Mucinous Adenocarcinoma,1,2,Gastric Mucinous Adenocarcinoma,0.9680,Mucinous Adenocarcinoma,0.8731,"Endometrial Mucinous Adenocarcinoma, Gastric-Type",0.8417,Salivary Gland Mucinous Adenocarcinoma,0.8398,Appendix Mucinous Adenocarcinoma,0.8378,Gallbladder Mucinous Adenocarcinoma,0.8269,Colon Mucinous Adenocarcinoma,0.8265,Colorectal Mucinous Adenocarcinoma,0.8181,Gastric Adenocarcinoma,0.8124,Gastric Mixed Adenocarcinoma,0.8071,Endometrial Mucinous Adenocarcinoma,0.8024,Ovarian Mucinous Adenocarcinoma,0.7986,Cervical Mucinous Adenocarcinoma,0.7930,Gastric Intramucosal Adenocarcinoma,0.7925,Goblet Cell Adenocarcinoma,0.7861,Small Intestinal Mucinous Adenocarcinoma,0.7761,Gastric Diffuse Adenocarcinoma,0.7724,Anal Mucinous Adenocarcinoma,0.7707,Appendix Goblet Cell Adenocarcinoma,0.7704,Gastric Poorly Cohesive Adenocarcinoma,0.7639,MUCINOUS STOMACH ADENOCARCINOMA,True,True,True
MUCINOUS_CARCINOMA,Mucinous Adenocarcinoma,1,2,Mucinous Adenocarcinoma,0.9085,Mucinous Neoplasm,0.8520,Mucinous Cystadenocarcinoma,0.8412,Breast Mucinous Carcinoma,0.8335,Mucin-Producing Carcinoma,0.8311,Colon Mucinous Adenocarcinoma,0.8233,Cervical Mucinous Adenocarcinoma,0.8139,Endometrial Mucinous Adenocarcinoma,0.8113,Mucin-Producing Adenocarcinoma,0.8102,Colorectal Mucinous Adenocarcinoma,0.8083,Gastric Mucinous Adenocarcinoma,0.8059,Thyroid Gland Mucinous Carcinoma,0.7975,Ovarian Mucinous Adenocarcinoma,0.7888,Appendix Mucinous Adenocarcinoma,0.7852,Bladder Mucinous Adenocarcinoma,0.7805,Primary Cutaneous Mucinous Carcinoma,0.7767,Salivary Gland Mucinous Adenocarcinoma,0.7749,Mucinous Cystadenoma,0.7715,"Cervical Mucinous Adenocarcinoma, Not Otherwise Specified",0.7685,Breast Columnar Cell Mucinous Carcinoma,0.7666,MUCINOUS_CARCINOMA,True,True,True
MUCM,Mucosal Melanoma,1,2,Mucosal Melanoma,0.6563,Metastatic Mucosal Melanoma,0.6397,Mucinous Neoplasm,0.6331,Mucinous Adenocarcinoma,0.6329,Malignant Mastocytosis,0.6135,Secretory Meningioma,0.6109,Endometrial Mucinous Adenocarcinoma,0.6095,Invasive Breast Lobular Carcinoma with Extracellular Mucin,0.6087,Mucin-Producing Carcinoma,0.6083,Salivary Gland Mucinous Adenocarcinoma,0.6050,Mesothelioma,0.6047,Malignant Ovarian Mucinous Tumor,0.6042,Sinonasal Mucosal Melanoma,0.6037,Appendix Mucinous Neoplasm,0.6031,Non-Secretory Multiple Myeloma,0.6012,Cervical Mucinous Adenocarcinoma,0.5980,Bone Marrow Mastocytosis,0.5964,Appendix Mucinous Adenocarcinoma,0.5955,Urinary System Mucosal Melanoma,0.5950,Mucin-Producing Adenocarcinoma,0.5941,MUCM,True,True,True
MUCOEPIDERMOID CARCINOMA,Mucoepidermoid Carcinoma,1,2,Mucoepidermoid Carcinoma,1.0000,Skin Mucoepidermoid Carcinoma,0.9074,Lung Mucoepidermoid Carcinoma,0.8709,Salivary Gland Mucoepidermoid Carcinoma,0.8687,Breast Mucoepidermoid Carcinoma,0.8637,Cervical Mucoepidermoid Carcinoma,0.8546,Major Salivary Gland Mucoepidermoid Carcinoma,0.8402,Thyroid Gland Mucoepidermoid Carcinoma,0.8400,Paranasal Sinus Mucoepidermoid Carcinoma,0.8395,Esophageal Mucoepidermoid Carcinoma,0.8380,Lacrimal Gland Mucoepidermoid Carcinoma,0.8372,Lacrimal Drainage System Mucoepidermoid Carcinoma,0.8312,Parotid Gland Mucoepidermoid Carcinoma,0.8299,Oral Cavity Mucoepidermoid Carcinoma,0.8283,Minor Salivary Gland Mucoepidermoid Carcinoma,0.8234,Salivary Gland Low Grade Mucoepidermoid Carcinoma,0.8109,Thymus Mucoepidermoid Carcinoma,0.8073,Submandibular Gland Mucoepidermoid Carcinoma,0.8062,Salivary Gland High Grade Mucoepidermoid Carcinoma,0.7991,Salivary Gland Intermediate Grade Mucoepidermoid Carcinoma,0.7921,MUCOEPIDERMOID CARCINOMA,True,True,True
MUCOEPIDERMOID CARCINOMA OF THE LUNG,Lung Mucoepidermoid Carcinoma,1,2,Lung Mucoepidermoid Carcinoma,0.9626,Mucoepidermoid Carcinoma,0.8336,Laryngeal Mucoepidermoid Carcinoma,0.7808,Lung Lymphoepithelial Carcinoma,0.7566,Breast Mucoepidermoid Carcinoma,0.7530,Lacrimal Gland Mucoepidermoid Carcinoma,0.7509,Skin Mucoepidermoid Carcinoma,0.7501,Thymus Mucoepidermoid Carcinoma,0.7456,Lung Epithelial-Myoepithelial Carcinoma,0.7441,Esophageal Mucoepidermoid Carcinoma,0.7312,Thyroid Gland Mucoepidermoid Carcinoma,0.7310,Lung Myoepithelial Carcinoma,0.7272,Parotid Gland Mucoepidermoid Carcinoma,0.7239,Paranasal Sinus Mucoepidermoid Carcinoma,0.7237,Lacrimal Drainage System Mucoepidermoid Carcinoma,0.7199,Oral Cavity Mucoepidermoid Carcinoma,0.7060,Salivary Gland Mucoepidermoid Carcinoma,0.6947,Breast Low Grade Mucoepidermoid Carcinoma,0.6916,Cervical Mucoepidermoid Carcinoma,0.6870,Extrahepatic Bile Duct Mucoepidermoid Carcinoma,0.6863,MUCOEPIDERMOID CARCINOMA OF THE LUNG,True,True,True
MUCOEPIDERMOID_CARCINOMA,Mucoepidermoid Carcinoma,1,2,Mucoepidermoid Carcinoma,0.9826,Skin Mucoepidermoid Carcinoma,0.9068,Salivary Gland Mucoepidermoid Carcinoma,0.8506,Lung Mucoepidermoid Carcinoma,0.8495,Breast Mucoepidermoid Carcinoma,0.8481,Cervical Mucoepidermoid Carcinoma,0.8393,Major Salivary Gland Mucoepidermoid Carcinoma,0.8282,Oral Cavity Mucoepidermoid Carcinoma,0.8242,Thyroid Gland Mucoepidermoid Carcinoma,0.8203,Esophageal Mucoepidermoid Carcinoma,0.8195,Paranasal Sinus Mucoepidermoid Carcinoma,0.8190,Parotid Gland Mucoepidermoid Carcinoma,0.8117,Lacrimal Gland Mucoepidermoid Carcinoma,0.8063,Minor Salivary Gland Mucoepidermoid Carcinoma,0.8060,Lacrimal Drainage System Mucoepidermoid Carcinoma,0.8052,Salivary Gland Low Grade Mucoepidermoid Carcinoma,0.7888,Thymus Mucoepidermoid Carcinoma,0.7869,Salivary Gland High Grade Mucoepidermoid Carcinoma,0.7805,Submandibular Gland Mucoepidermoid Carcinoma,0.7766,Childhood Mucoepidermoid Carcinoma,0.7755,MUCOEPIDERMOID_CARCINOMA,True,True,True
MUCOSAL MELANOMA OF THE ESOPHAGUS,Esophageal Melanoma,1,2,Esophageal Melanoma,0.8231,Mucosal Melanoma,0.7364,Digestive System Mucosal Melanoma,0.7128,Metastatic Mucosal Melanoma,0.6901,Esophageal Mucoepidermoid Carcinoma,0.6848,Pharyngeal Mucosal Melanoma,0.6663,Oral Cavity Mucosal Melanoma,0.6541,Malignant Esophageal Neoplasm,0.6506,Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma,0.6471,Cutaneous Melanoma of the Extremity,0.6465,Nasopharyngeal Mucosal Melanoma,0.6385,Head and Neck Mucosal Melanoma,0.6378,Urinary System Mucosal Melanoma,0.6361,Mucosal Nodular Melanoma,0.6328,Sinonasal Mucosal Melanoma,0.6307,Metastatic Malignant Neoplasm in the Esophagus,0.6307,Mucosal Lentiginous Melanoma,0.6290,Jejunal Melanoma,0.6282,Genitourinary System Mucosal Melanoma,0.6272,Metastatic Esophageal Adenocarcinoma,0.6197,MUCOSAL MELANOMA OF THE ESOPHAGUS,True,True,True
MUCOSAL MELANOMA OF THE URETHRA,Urethral Melanoma,1,2,Urethral Melanoma,0.8268,Urinary System Mucosal Melanoma,0.7700,Genitourinary System Mucosal Melanoma,0.7566,Penile Mucosal Melanoma,0.7362,Male Urethral Malignant Neoplasm,0.7086,Mucosal Melanoma,0.7009,Oral Cavity Mucosal Melanoma,0.6736,Malignant Urethral Neoplasm,0.6709,Female Genital Tract Mucosal Melanoma,0.6692,Metastatic Mucosal Melanoma,0.6684,Bulbomembranous Urethral Malignant Neoplasm,0.6681,Metastatic Malignant Neoplasm in the Urethra,0.6647,Digestive System Mucosal Melanoma,0.6507,Sinonasal Mucosal Melanoma,0.6474,Skene Gland Adenocarcinoma of the Urethra,0.6448,Pharyngeal Mucosal Melanoma,0.6438,Female Urethral Malignant Neoplasm,0.6396,Urethral Adenocarcinoma,0.6368,Nasopharyngeal Mucosal Melanoma,0.6354,Urethral Carcinoma,0.6309,MUCOSAL MELANOMA OF THE URETHRA,True,True,True
MUCOSAL MELANOMA OF THE VULVA/VAGINA,Vaginal Melanoma,2,2,Vulvar Melanoma,0.8246,Vaginal Melanoma,0.7923,Female Genital Tract Mucosal Melanoma,0.7709,Vulvar Melanocytic Neoplasm,0.7247,Genitourinary System Mucosal Melanoma,0.7231,Mucosal Melanoma,0.6723,Malignant Vulvar Neoplasm,0.6710,"Vulvar Mucinous Adenocarcinoma, Intestinal-Type",0.6673,Digestive System Mucosal Melanoma,0.6657,Vulvar Adenocarcinoma of Mammary Gland Type,0.6600,Head and Neck Mucosal Melanoma,0.6547,Metastatic Malignant Neoplasm in the Vulva,0.6432,Metastatic Mucosal Melanoma,0.6415,Mucosal Lentiginous Melanoma,0.6408,Urinary System Mucosal Melanoma,0.6401,Vulvar Adenocarcinoma,0.6281,Metastatic Vulvar Carcinoma,0.6276,Vaginal Mucinous Adenocarcinoma,0.6244,Vulvar Carcinoma,0.6202,Vulvar Nevus,0.6202,MUCOSAL MELANOMA OF THE VULVA/VAGINA,False,True,True
MULLERIAN CARCINOMA,Female Reproductive System Carcinosarcoma,7,2,Mixed Mesodermal (Mullerian) Tumor,0.7272,Mullerian Papilloma,0.7125,Male Reproductive System Carcinoma,0.7002,Female Reproductive System Carcinoma,0.6946,Cervical Mullerian Papilloma,0.6899,Uterine Corpus Carcinosarcoma,0.6839,Female Reproductive System Carcinosarcoma,0.6814,Uterine Carcinosarcoma,0.6693,Malignant Uterine Neoplasm,0.6587,Metaplastic Carcinoma,0.6543,Uterine Corpus Rhabdomyosarcoma,0.6508,Breast Mucinous Carcinoma,0.6492,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0.6477,Endometrial Carcinoma,0.6472,Epididymal Carcinoma,0.6451,Malignant Reproductive System Neoplasm,0.6433,Urachal Carcinoma,0.6418,Epithelial-Myoepithelial Carcinoma,0.6403,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0.6385,Uterine Corpus Malignant PEComa,0.6379,MULLERIAN CARCINOMA,False,False,False
MULLERIAN_CARCINOMA,Female Reproductive System Carcinosarcoma,5,2,Mixed Mesodermal (Mullerian) Tumor,0.7275,Male Reproductive System Carcinoma,0.6950,Female Reproductive System Carcinoma,0.6925,Mullerian Papilloma,0.6839,Female Reproductive System Carcinosarcoma,0.6757,Uterine Corpus Carcinosarcoma,0.6699,Malignant Uterine Neoplasm,0.6661,Cervical Mullerian Papilloma,0.6639,Carcinoma,0.6620,Uterine Carcinosarcoma,0.6603,Metaplastic Carcinoma,0.6573,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0.6532,Endometrial Carcinoma,0.6523,Epithelial-Myoepithelial Carcinoma,0.6517,Mucin-Producing Carcinoma,0.6515,Malignant Neoplasm,0.6476,Urinary System Carcinoma,0.6468,Breast Mucinous Carcinoma,0.6446,Malignant Reproductive System Neoplasm,0.6430,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0.6399,MULLERIAN_CARCINOMA,False,False,True
MULTIPLE MYELOMA,Multiple Myeloma,1,2,Multiple Myeloma,1.0000,"Multiple Myeloma, Not Otherwise Specified",0.8704,Smoldering Multiple Myeloma,0.8147,Non-Secretory Multiple Myeloma,0.8139,Osteosclerotic Multiple Myeloma,0.8094,Recurrent Multiple Myeloma,0.7627,Multiple Myeloma Myeloma by DS Stage,0.7394,Multiple Myeloma with Hyperdiploidy,0.7379,Multiple Myeloma with Recurrent Genetic Abnormalities,0.7262,Multiple Myeloma by ISS Stage,0.7255,Multiple Solitary Plasmacytoma of Bone,0.7159,Refractory Multiple Myeloma,0.7068,Multiple Myeloma with CCND Family Translocation,0.6963,Extramedullary Disease in Multiple Myeloma,0.6918,Solitary Plasmacytoma,0.6856,Plasma Cell Myeloma-Induced Bone Disease,0.6839,Plasmacytoma,0.6804,Multiple Myeloma with NSD2 Translocation,0.6738,ISS Stage III Multiple Myeloma,0.6689,Malignant Mastocytosis,0.6654,MULTIPLE MYELOMA,True,True,True
MULTIPLE_MYELOMA,Multiple Myeloma,1,2,Multiple Myeloma,0.9589,"Multiple Myeloma, Not Otherwise Specified",0.9008,Smoldering Multiple Myeloma,0.8033,Non-Secretory Multiple Myeloma,0.7990,Osteosclerotic Multiple Myeloma,0.7793,Recurrent Multiple Myeloma,0.7597,Multiple Myeloma Myeloma by DS Stage,0.7346,Multiple Myeloma with Hyperdiploidy,0.7295,Multiple Myeloma with Recurrent Genetic Abnormalities,0.7292,Extramedullary Disease in Multiple Myeloma,0.7226,Multiple Myeloma by ISS Stage,0.7218,Refractory Multiple Myeloma,0.6984,Multiple Solitary Plasmacytoma of Bone,0.6939,Multiple Myeloma with CCND Family Translocation,0.6927,Malignant Mastocytosis,0.6714,Plasma Cell Myeloma-Induced Bone Disease,0.6695,ISS Stage III Multiple Myeloma,0.6654,Smoldering Systemic Mastocytosis,0.6613,Multiple Myeloma with NSD2 Translocation,0.6607,Malignant Neoplasm of Multiple Primary Sites,0.6584,MULTIPLE_MYELOMA,True,True,True
MUSCLE INVASIVE UROTHELIAL CARCINOMA PT2 OR ABOVE,Invasive Urothelial Carcinoma,3,2,Muscle Invasive Bladder Urothelial Carcinoma,0.7230,Muscle Invasive Bladder Carcinoma,0.7082,Invasive Urothelial Carcinoma,0.6939,Invasive Micropapillary Urothelial Carcinoma,0.6901,Invasive Renal Pelvis and Ureter Urothelial Carcinoma,0.6845,Metastatic Urothelial Carcinoma,0.6716,Invasive Conventional Urothelial Carcinoma,0.6703,Invasive Poorly Differentiated Urothelial Carcinoma,0.6679,Invasive Bladder Micropapillary Urothelial Carcinoma,0.6666,Invasive Bladder Urothelial Carcinoma,0.6629,Non-Muscle Invasive Bladder Urothelial Carcinoma,0.6569,Invasive Tubular Urothelial Carcinoma,0.6466,Metastatic Bladder Urothelial Carcinoma,0.6455,Non-Muscle Invasive Bladder Carcinoma,0.6454,Invasive Large Nested Urothelial Carcinoma,0.6411,Metastatic Micropapillary Urothelial Carcinoma,0.6406,Invasive Microcystic Urothelial Carcinoma,0.6396,"Urothelial Carcinoma, High Grade",0.6388,Advanced Urothelial Carcinoma,0.6381,Non-Invasive Papillary Urothelial Carcinoma,0.6374,MUSCLE INVASIVE UROTHELIAL CARCINOMA PT2 OR ABOVE,False,True,True
MYCOSIS FUNGOIDES,Mycosis Fungoides,1,2,Mycosis Fungoides,1.0000,Mycosis Fungoides (Working Formulation),0.9395,Mycosis Fungoides Variant,0.9059,Transformed Mycosis Fungoides,0.8849,Folliculotropic Mycosis Fungoides,0.8727,Recurrent Mycosis Fungoides,0.8251,Recurrent Transformed Mycosis Fungoides,0.8149,Refractory Mycosis Fungoides,0.7928,Refractory Transformed Mycosis Fungoides,0.7660,Stage IV Mycosis Fungoides AJCC v7,0.7524,Mycosis Fungoides by AJCC v7 Stage,0.7378,Mycosis Fungoides and Sezary Syndrome,0.7369,Stage I Mycosis Fungoides AJCC v7,0.7300,Stage III Mycosis Fungoides AJCC v7,0.7152,Stage IA Mycosis Fungoides AJCC v7,0.7098,Stage II Mycosis Fungoides AJCC v7,0.6577,Recurrent Mycosis Fungoides and Sezary Syndrome,0.6488,Stage IB Mycosis Fungoides AJCC v7,0.6473,Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage,0.6222,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6142,MYCOSIS FUNGOIDES,True,True,True
MYCOSIS_FUNGOIDES,Mycosis Fungoides,1,2,Mycosis Fungoides,0.9689,Mycosis Fungoides (Working Formulation),0.9356,Mycosis Fungoides Variant,0.8783,Transformed Mycosis Fungoides,0.8624,Folliculotropic Mycosis Fungoides,0.8494,Recurrent Mycosis Fungoides,0.8227,Recurrent Transformed Mycosis Fungoides,0.8060,Refractory Mycosis Fungoides,0.7814,Refractory Transformed Mycosis Fungoides,0.7548,Mycosis Fungoides and Sezary Syndrome,0.7429,Stage IV Mycosis Fungoides AJCC v7,0.7363,Stage I Mycosis Fungoides AJCC v7,0.7195,Mycosis Fungoides by AJCC v7 Stage,0.7177,Stage III Mycosis Fungoides AJCC v7,0.6972,Stage IA Mycosis Fungoides AJCC v7,0.6893,Recurrent Mycosis Fungoides and Sezary Syndrome,0.6674,Stage II Mycosis Fungoides AJCC v7,0.6481,Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage,0.6431,Stage IB Mycosis Fungoides AJCC v7,0.6279,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6225,MYCOSIS_FUNGOIDES,True,True,True
MYCOSIS_FUNGOIDES-SEZARY_SYNDROME,Mycosis Fungoides and Sezary Syndrome,1,2,Mycosis Fungoides and Sezary Syndrome,0.9448,Recurrent Mycosis Fungoides and Sezary Syndrome,0.8815,Refractory Mycosis Fungoides and Sezary Syndrome,0.8142,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8,0.8122,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,0.7938,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8,0.7913,Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8,0.7864,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v7,0.7862,Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage,0.7760,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7,0.7674,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7,0.7649,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,0.7629,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8,0.7624,Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8,0.7598,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8,0.7573,Mycosis Fungoides and Sezary Syndrome by AJCC v7 Stage,0.7495,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7,0.7466,Mycosis Fungoides,0.7458,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7,0.7395,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7,0.7234,MYCOSIS_FUNGOIDES-SEZARY_SYNDROME,True,True,True
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q),Myelodysplastic Syndrome with del(5q),1,2,Myelodysplastic Syndrome with del(5q),0.8706,Acute Myeloid Leukemia with del(5q),0.7143,Myelodysplastic Syndrome with TP53 Inactivation,0.6702,Myelodysplastic Syndrome with Low Blasts,0.6487,Myelodysplastic/Myeloproliferative Neoplasm with Isolated Isochromosome 17q,0.6308,Myelodysplastic Syndrome with Monoallelic TP53 Mutation,0.6258,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q,0.6163,Myelodysplastic Syndrome with Biallelic TP53 Inactivation,0.6154,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.6149,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.6101,Myelodysplastic Syndrome,0.6085,Myelodysplastic Syndrome with Somatic Mutation,0.6082,Adult Myelodysplastic Syndrome,0.5993,Secondary Myelodysplastic Syndrome,0.5992,Myelodysplastic Syndrome with Genetic Abnormalities,0.5979,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.5938,Childhood Myelodysplastic Syndrome with Low Blasts,0.5936,De Novo Myelodysplastic Syndrome,0.5882,Hypoplastic Myelodysplastic Syndrome,0.5860,Alkylating Agent-Related Myelodysplastic Syndrome,0.5843,MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q),True,True,True
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL5Q,Myelodysplastic Syndrome with del(5q),1,2,Myelodysplastic Syndrome with del(5q),0.8734,Acute Myeloid Leukemia with del(5q),0.7114,Myelodysplastic Syndrome with TP53 Inactivation,0.6778,Myelodysplastic Syndrome with Low Blasts,0.6531,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q,0.6307,Myelodysplastic Syndrome with Monoallelic TP53 Mutation,0.6258,Myelodysplastic Syndrome with Somatic Mutation,0.6241,Myelodysplastic Syndrome with Biallelic TP53 Inactivation,0.6225,Myelodysplastic Syndrome,0.6209,Myelodysplastic/Myeloproliferative Neoplasm with Isolated Isochromosome 17q,0.6119,Childhood Myelodysplastic Syndrome with Low Blasts,0.6098,Myelodysplastic Syndrome with Genetic Abnormalities,0.6098,Secondary Myelodysplastic Syndrome,0.6042,Adult Myelodysplastic Syndrome,0.6014,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.5998,Hypoplastic Myelodysplastic Syndrome,0.5983,"Childhood Myelodysplastic Syndrome with Low Blasts, Hypocellular",0.5973,Alkylating Agent-Related Myelodysplastic Syndrome,0.5968,Myelodysplastic Syndrome with Mutated TP53,0.5966,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.5939,MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL5Q,True,True,True
"MYELODYSPLASTIC SYNDROME, UNCLASSIFIABLE","Myelodysplastic Syndrome, Unclassifiable",1,2,"Myelodysplastic Syndrome, Unclassifiable",1.0000,"Myelodysplastic Syndrome, Unclassifiable, with Defining Cytogenetic Abnormality",0.8984,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.8519,"Myelodysplastic Syndrome, Not Otherwise Specified",0.8022,De Novo Myelodysplastic Syndrome,0.7726,"Myelodysplastic Syndrome, Unclassifiable, with 1 Percent Blasts",0.7686,Myelodysplastic Syndrome,0.7524,Myelodysplastic Syndrome with Somatic Mutation,0.7393,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.7268,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.7227,Hereditary Myelodysplastic Syndrome,0.7015,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6766,Secondary Myelodysplastic Syndrome,0.6743,Myelodysplastic Syndrome with Low Blasts,0.6688,Myelodysplastic Syndrome with Genetic Abnormalities,0.6585,Clonal Monocytosis of Undetermined Significance,0.6550,Hypoplastic Myelodysplastic Syndrome,0.6541,Adult Myelodysplastic Syndrome,0.6532,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.6478,Clonal Cytopenia with Monocytosis of Undetermined Significance,0.6327,"MYELODYSPLASTIC SYNDROME, UNCLASSIFIABLE",True,True,True
MYELODYSPLASTIC SYNDROMES,Myelodysplastic Syndrome,1,2,Myelodysplastic Syndrome,0.9896,"Myelodysplastic Syndrome, Not Otherwise Specified",0.9045,Hereditary Myelodysplastic Syndrome,0.8964,Secondary Myelodysplastic Syndrome,0.8482,Myelodysplastic Syndrome with Somatic Mutation,0.8356,Hypoplastic Myelodysplastic Syndrome,0.8303,Myelodysplastic Syndrome with Genetic Abnormalities,0.8250,Adult Myelodysplastic Syndrome,0.8224,De Novo Myelodysplastic Syndrome,0.8159,Childhood Myelodysplastic Syndrome,0.8017,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7910,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.7721,Myelodysplastic Syndrome with Low Blasts,0.7708,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.7629,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.7570,"Myelodysplastic Syndrome, Unclassifiable",0.7497,Myelodysplastic/Myeloproliferative Neoplasm,0.7458,Recurrent Myelodysplastic Syndrome,0.7449,Refractory Myelodysplastic Syndrome,0.6957,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.6940,MYELODYSPLASTIC SYNDROMES,True,True,True
"MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE","Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",1,2,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.8428,"Myelodysplastic Syndrome, Unclassifiable",0.8367,Myelodysplastic/Myeloproliferative Neoplasm,0.8201,"Myelodysplastic Syndrome, Unclassifiable, with Defining Cytogenetic Abnormality",0.7896,"Myeloproliferative Neoplasm, Not Otherwise Specified",0.7408,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.7245,Myeloproliferative Neoplasm,0.7186,"Myelodysplastic Syndrome, Unclassifiable, with 1 Percent Blasts",0.6841,"Myelodysplastic Syndrome, Not Otherwise Specified",0.6691,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.6605,De Novo Myelodysplastic Syndrome,0.6547,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6395,"IgM Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Type",0.6348,Non-IgM Monoclonal Gammopathy of Undetermined Significance,0.6229,"IgM Monoclonal Gammopathy of Undetermined Significance, Not Otherwise Specified",0.6213,"Myeloid Leukemia, Philadelphia-Negative",0.6212,Myelodysplastic/Myeloproliferative Neoplasm with Isolated Isochromosome 17q,0.6199,Myelodysplastic Syndrome,0.6181,Clonal Monocytosis of Undetermined Significance,0.6164,IgM Monoclonal Gammopathy of Undetermined Significance,0.6151,"MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE",True,True,True
MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS,Myelodysplastic/Myeloproliferative Neoplasm,1,2,Myelodysplastic/Myeloproliferative Neoplasm,0.9940,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.9289,Myeloproliferative Neoplasm,0.8445,"Myeloproliferative Neoplasm, Not Otherwise Specified",0.7751,Myelodysplastic Syndrome,0.7716,"Myelodysplastic Syndrome, Not Otherwise Specified",0.7352,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.7264,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7169,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.7154,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.7114,Recurrent Myelodysplastic/Myeloproliferative Neoplasm,0.7089,Myeloproliferative Chronic Myelomonocytic Leukemia,0.6966,Myelodysplastic/Myeloproliferative Neoplasm Post Cytotoxic Therapy,0.6962,Hereditary Myelodysplastic Syndrome,0.6905,Blast Phase Myeloproliferative Neoplasm,0.6867,Myelodysplastic Syndrome with Somatic Mutation,0.6866,Accelerated Phase Myeloproliferative Neoplasm,0.6801,De Novo Myelodysplastic Syndrome,0.6775,Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis,0.6708,Secondary Myelodysplastic Syndrome,0.6691,MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS,True,True,True
MYELOID ATYPICAL,Atypical Chronic Myeloid Leukemia,1,2,Atypical Chronic Myeloid Leukemia,0.7819,Acute Myeloid Leukemia,0.7290,Myeloid Neoplasm,0.7218,Atypical Meningioma,0.7136,Atypical Adenoma,0.7134,Myeloid Leukemia,0.7122,Acute Monocytic Leukemia,0.6987,Acute Megakaryoblastic Leukemia,0.6849,Acute Undifferentiated Leukemia,0.6808,Adult Atypical Meningioma,0.6789,Aleukemic Myeloid Leukemia,0.6781,Acute Myelomonocytic Leukemia,0.6704,"Acute Myeloid Leukemia, Not Otherwise Specified",0.6700,Acute Leukemia,0.6695,Adult Acute Megakaryoblastic Leukemia,0.6664,Acute Myelomonocytic Leukemia with Abnormal Eosinophils,0.6623,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.6599,Adult Acute Myeloid Leukemia,0.6590,Acute Myeloid Leukemia with Maturation,0.6571,Granulocytic Sarcoma,0.6547,MYELOID ATYPICAL,True,True,True
MYELOID LEUKAEMIA ASSOCIATED WITH DOWN SYNDROME,Myeloid Leukemia Associated with Down Syndrome,1,2,Myeloid Leukemia Associated with Down Syndrome,0.9821,B Acute Lymphoblastic Leukemia Associated with Down Syndrome,0.7941,Hematologic Neoplasm Associated with Down Syndrome,0.7771,Transient Abnormal Myelopoiesis Associated with Down Syndrome,0.7300,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7073,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6825,Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.6816,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.6804,Myeloid Leukemia,0.6753,Myelodysplastic Syndrome,0.6607,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.6588,Myelodysplastic Syndrome with Genetic Abnormalities,0.6553,Hypoplastic Myelodysplastic Syndrome,0.6474,Hypodiploid B Lymphoblastic Leukemia/Lymphoma,0.6430,Acute Leukemia,0.6369,Leukemia,0.6344,Hypodiploid B Acute Lymphoblastic Leukemia,0.6323,Lymphoid Leukemia,0.6297,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.6294,Secondary Myelodysplastic Syndrome,0.6292,MYELOID LEUKAEMIA ASSOCIATED WITH DOWN SYNDROME,True,True,True
MYELOID LEUKEMIA ASSOCIATED WITH DOWN SYNDROME,Myeloid Leukemia Associated with Down Syndrome,1,2,Myeloid Leukemia Associated with Down Syndrome,1.0000,B Acute Lymphoblastic Leukemia Associated with Down Syndrome,0.8013,Hematologic Neoplasm Associated with Down Syndrome,0.7643,Transient Abnormal Myelopoiesis Associated with Down Syndrome,0.7521,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.7353,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.7153,Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.7106,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.7106,"Acute Myeloid Leukemia, Myelodysplasia-Related",0.7000,Myeloid Leukemia,0.6853,Myelodysplastic Syndrome,0.6718,Myelodysplastic Syndrome with Genetic Abnormalities,0.6711,Hypoplastic Myelodysplastic Syndrome,0.6693,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.6550,Acute Myeloid Leukemia with Multilineage Dysplasia,0.6546,Acute Leukemia,0.6488,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.6481,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0.6456,Hypodiploid B Lymphoblastic Leukemia/Lymphoma,0.6450,Leukemia,0.6420,MYELOID LEUKEMIA ASSOCIATED WITH DOWN SYNDROME,True,True,True
MYELOID NEOPLASM,Myeloid Neoplasm,1,2,Myeloid Neoplasm,1.0000,Myeloid Leukemia,0.8312,Bone Marrow Neoplasm,0.8220,Myeloproliferative Neoplasm,0.7717,Megakaryocytic Neoplasm,0.7607,Myeloid Sarcoma,0.7568,Erythroid Neoplasm,0.7334,Acute Myeloid Leukemia,0.7329,Malignant Bone Marrow Neoplasm,0.7275,"Acute Myeloid Leukemia, Not Otherwise Specified",0.7169,Acute Monocytic Leukemia,0.6966,"Myeloproliferative Neoplasm, Not Otherwise Specified",0.6894,Leukemia,0.6837,Granulocytic Sarcoma,0.6827,Chronic Monocytic Leukemia,0.6818,Neoplasm by Morphology,0.6778,Non-Hematologic Malignancy,0.6770,Recurrent Myeloid Neoplasm,0.6742,Immature Granulocytic Sarcoma,0.6734,Aleukemic Myeloid Leukemia,0.6712,MYELOID NEOPLASM,True,True,True
MYELOID SARCOMA,Myeloid Sarcoma,1,2,Myeloid Sarcoma,1.0000,Granulocytic Sarcoma,0.8491,Sarcoma,0.8426,Cardiac Myeloid Sarcoma,0.8250,Bone Sarcoma,0.8042,Intracranial Myeloid Sarcoma,0.8025,Immature Granulocytic Sarcoma,0.8015,Testicular Myeloid Sarcoma,0.7981,Small Intestinal Myeloid Sarcoma,0.7828,Mediastinal Myeloid Sarcoma,0.7803,Prostate Myeloid Sarcoma,0.7803,Histiocytic Sarcoma,0.7666,Myeloid Neoplasm,0.7568,Sarcomatosis,0.7561,Differentiated Granulocytic Sarcoma,0.7533,Sarcoma GX,0.7515,Stromal Sarcoma,0.7443,Lung Sarcoma,0.7443,Skin Sarcoma,0.7431,Liver Sarcoma,0.7409,MYELOID SARCOMA,True,True,True
MYELOMA,Multiple Myeloma,1,2,Multiple Myeloma,0.9073,"Multiple Myeloma, Not Otherwise Specified",0.7938,Osteosclerotic Multiple Myeloma,0.7761,Non-Secretory Multiple Myeloma,0.7751,Plasmacytoma,0.7581,Smoldering Multiple Myeloma,0.7580,Plasma Cell Neoplasm,0.7396,Solitary Plasmacytoma,0.7324,Plasma Cell Myeloma-Induced Bone Disease,0.7225,Recurrent Multiple Myeloma,0.7113,Multiple Myeloma Myeloma by DS Stage,0.7007,Multiple Myeloma by ISS Stage,0.6934,Anaplastic Plasmacytoma,0.6911,Plasma Cell Leukemia,0.6867,Multiple Solitary Plasmacytoma of Bone,0.6865,Refractory Multiple Myeloma,0.6862,Malignant Mastocytosis,0.6824,Multiple Myeloma with Hyperdiploidy,0.6785,Solitary Plasmacytoma of Bone,0.6777,Cutaneous Plasmacytoma,0.6732,MYELOMA,True,True,True
MYELOPROLIFERATIVE NEOPLASMS,Myeloproliferative Neoplasm,1,2,Myeloproliferative Neoplasm,0.9950,"Myeloproliferative Neoplasm, Not Otherwise Specified",0.9042,Myelodysplastic/Myeloproliferative Neoplasm,0.8575,"Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",0.8163,Myeloid Neoplasm,0.7647,Accelerated Phase Myeloproliferative Neoplasm,0.7533,Blast Phase Myeloproliferative Neoplasm,0.7526,Recurrent Myeloproliferative Neoplasm,0.7179,Megakaryocytic Neoplasm,0.7056,Myeloproliferative Chronic Myelomonocytic Leukemia,0.6922,Refractory Myeloproliferative Neoplasm,0.6870,"Myeloproliferative Neoplasm, BCR-ABL1 Negative",0.6684,Mature Plasmacytoid Dendritic Cell Proliferation Associated with Myeloid Neoplasm,0.6660,Myelodysplastic Syndrome,0.6631,Bone Marrow Neoplasm,0.6571,Primary Myelofibrosis,0.6504,Myelodysplastic/Myeloproliferative Neoplasm Post Cytotoxic Therapy,0.6496,Noonan Syndrome-Associated Myeloproliferative Disorder,0.6349,Myeloid Leukemia,0.6324,"Myelodysplastic Syndrome, Not Otherwise Specified",0.6318,MYELOPROLIFERATIVE NEOPLASMS,True,True,True
MYOEPITHELIAL CARCINOMA,Malignant Myoepithelioma,4,2,Epithelial-Myoepithelial Carcinoma,0.9127,Myoepithelial Tumor,0.8845,Salivary Gland Myoepithelial Carcinoma,0.8346,Malignant Myoepithelioma,0.8341,Lung Myoepithelial Carcinoma,0.7945,Benign Myoepithelioma,0.7846,Breast Myoepithelial Tumor,0.7825,Salivary Gland Epithelial-Myoepithelial Carcinoma,0.7798,Lacrimal Gland Myoepithelial Carcinoma,0.7745,Breast Myoepitheliosis,0.7496,Childhood Myoepithelial Tumor,0.7430,Breast Malignant Myoepithelioma,0.7406,Skin Myoepithelioma,0.7333,Lung Epithelial-Myoepithelial Carcinoma,0.7309,Salivary Gland Myoepithelial Tumor,0.7174,Metaplastic Carcinoma,0.7139,Lacrimal Gland Epithelial-Myoepithelial Carcinoma,0.7117,Lung Myoepithelial Tumor,0.7073,Mucoepidermoid Carcinoma,0.7001,Salivary Gland Myoepithelioma,0.6987,MYOEPITHELIAL CARCINOMA,False,False,True
MYOFIBROMA,Myofibroma,1,2,Myofibroma,1.0000,Myofibroblastoma,0.9323,Myofibromatosis,0.9259,Adult Myofibroma,0.8904,Infantile Myofibroma,0.8505,Mammary-Type Myofibroblastoma,0.8101,Cellular Fibroma,0.8018,Fibroma,0.7994,Inflammatory Myofibroblastic Tumor,0.7988,Breast Myofibroblastoma,0.7909,Fibromatosis,0.7806,Infantile Myofibromatosis 1,0.7757,Myoma,0.7670,Angiomyofibroblastoma,0.7617,Infantile Myofibromatosis 2,0.7599,Dermatomyofibroma,0.7499,Fascial Fibroma,0.7452,Desmoplastic Fibroblastoma,0.7420,Superficial Fibromatosis,0.7402,Cardiac Inflammatory Myofibroblastic Tumor,0.7330,MYOFIBROMA,True,True,True
MYXOFIBROSARCOMA,Myxofibrosarcoma,1,2,Myxofibrosarcoma,1.0000,Myxosarcoma,0.8883,Skin Myxofibrosarcoma,0.8784,Metastatic Myxofibrosarcoma,0.8605,Cardiac Myxofibrosarcoma,0.8595,Advanced Myxofibrosarcoma,0.8470,Epithelioid Myxofibrosarcoma,0.8013,Locally Advanced Myxofibrosarcoma,0.7864,Myxoid Leiomyosarcoma,0.7843,Myxoid Liposarcoma,0.7832,Myxoinflammatory Fibroblastic Sarcoma,0.7729,Unresectable Myxofibrosarcoma,0.7423,Myxoid Pleomorphic Liposarcoma,0.7396,Soft Tissue Fibrosarcoma,0.7314,Fibroblastic Liposarcoma,0.7298,Myxoid Leiomyoma,0.7283,Cellular Myxoma,0.7227,Angiomyofibroblastoma,0.7201,Myxoma,0.7170,Low Grade Fibromyxoid Sarcoma,0.7169,MYXOFIBROSARCOMA,True,True,True
MYXOID CHONDROSARCOMA,Extraskeletal Myxoid Chondrosarcoma,4,2,Myxoid Chondrosarcoma NCI Grade 1,0.9118,Myxoid Chondrosarcoma NCI Grade 2,0.8950,Conventional Extraskeletal Myxoid Chondrosarcoma,0.8793,Extraskeletal Myxoid Chondrosarcoma,0.8644,Mesenchymal Chondrosarcoma,0.8504,Chondrosarcoma,0.8325,Mesenchymal Chondrosarcoma of Bone,0.8079,Clear Cell Chondrosarcoma,0.7977,Adult Mesenchymal Chondrosarcoma,0.7909,Synovial Chondrosarcoma,0.7895,Adult Extraskeletal Myxoid Chondrosarcoma,0.7783,Mesenchymal Extraskeletal Chondrosarcoma,0.7777,"Chondrosarcoma, Grade 1",0.7766,"Chondrosarcoma, Grade 3",0.7761,Chondrosarcoma NCI Grade 3,0.7695,Dedifferentiated Chondrosarcoma,0.7691,Chondrosarcoma NCI Grade 1,0.7690,Cellular Myxoma,0.7689,Localized Chondrosarcoma,0.7681,Childhood Extraskeletal Myxoid Chondrosarcoma,0.7577,MYXOID CHONDROSARCOMA,False,False,True
MYXOID FIBROSARCOMA,Myxofibrosarcoma,1,2,Myxofibrosarcoma,0.8601,Myxosarcoma,0.8099,Fibromyxoid Tumor,0.7962,Soft Tissue Fibrosarcoma,0.7939,Conventional Fibrosarcoma,0.7825,Poorly Differentiated Fibrosarcoma,0.7772,Skin Myxofibrosarcoma,0.7640,Cardiac Myxofibrosarcoma,0.7638,Myxoinflammatory Fibroblastic Sarcoma,0.7633,Fibrosarcoma,0.7616,Epithelioid Myxofibrosarcoma,0.7613,Myxoid Leiomyosarcoma,0.7597,Well Differentiated Fibrosarcoma,0.7550,Myxoid Liposarcoma,0.7501,Myxoid Leiomyoma,0.7446,Fascial Fibrosarcoma,0.7442,Advanced Myxofibrosarcoma,0.7436,Pleomorphic Fibroma,0.7384,Myxoid Pleomorphic Liposarcoma,0.7319,Myxoma,0.7315,MYXOID FIBROSARCOMA,True,True,True
MYXOID LIPOSARCOMA,Myxoid Liposarcoma,1,2,Myxoid Liposarcoma,1.0000,Myxoid Pleomorphic Liposarcoma,0.8780,Metastatic Myxoid Liposarcoma,0.8655,Advanced Myxoid Liposarcoma,0.8643,Mixed Liposarcoma,0.8578,Fibroblastic Liposarcoma,0.8449,Liposarcoma,0.8439,Pleomorphic Liposarcoma,0.8383,Myxosarcoma,0.8332,Myxoid Leiomyosarcoma,0.8243,Dedifferentiated Liposarcoma,0.8170,Metastatic Liposarcoma,0.8076,Localized Liposarcoma,0.8074,Ovarian Myxoid Liposarcoma,0.8033,Bone Liposarcoma,0.7998,Round Cell Liposarcoma,0.7952,Skin Liposarcoma,0.7920,Adult Liposarcoma,0.7888,Myxofibrosarcoma,0.7832,Skin Pleomorphic Liposarcoma,0.7811,MYXOID LIPOSARCOMA,True,True,True
MYXOINFLAMMATORY FIBROBLASTIC SARCOMA,Myxoinflammatory Fibroblastic Sarcoma,1,2,Myxoinflammatory Fibroblastic Sarcoma,1.0000,Myxofibrosarcoma,0.7729,Fibroblastic Reticular Cell Sarcoma,0.7462,Low Grade Fibromyxoid Sarcoma,0.7339,Skin Myxofibrosarcoma,0.7287,Low Grade Myofibroblastic Sarcoma,0.7128,Classical Low Grade Fibromyxoid Sarcoma,0.7117,Myxosarcoma,0.7108,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 3,0.6957,Fibroblastic Liposarcoma,0.6956,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 2,0.6939,Intermediate Fibroblastic Neoplasm,0.6918,Soft Tissue Fibrosarcoma,0.6903,Inflammatory Myofibroblastic Tumor,0.6889,Maxillofacial Sarcoma,0.6839,Myofibromatosis,0.6819,Cardiac Myxofibrosarcoma,0.6814,Fibrous Synovial Sarcoma,0.6813,Conventional Fibrosarcoma,0.6812,Superficial Fibromatosis,0.6811,MYXOINFLAMMATORY FIBROBLASTIC SARCOMA,True,True,True
MYXOMA,Myxoma,1,2,Myxoma,1.0000,Cardiac Myxoma,0.9197,Skin Myxoma,0.8997,Cellular Myxoma,0.8749,Atrial Myxoma,0.8728,Intramuscular Myxoma,0.8631,Follicular Myxoma,0.8529,Ovarian Myxoma,0.8319,Myxosarcoma,0.8218,Ventricular Myxoma,0.8161,Conjunctival Myxoma,0.8032,Odontogenic Myxoma,0.7895,Myxoid Leiomyoma,0.7863,Left Atrial Myxoma,0.7720,Angiomyxoma,0.7704,Sinonasal Tract Myxoma,0.7652,Juxta-Articular Myxoma,0.7500,Right Atrial Myxoma,0.7426,Teratoma,0.7353,Childhood Odontogenic Myxoma,0.7348,MYXOMA,True,True,True
MYXOPAPILLARY EPENDYMOMA,Myxopapillary Ependymoma,1,2,Myxopapillary Ependymoma,1.0000,Adult Myxopapillary Ependymoma,0.9287,Childhood Myxopapillary Ependymoma,0.9116,Papillary Ependymoma,0.8383,Ependymoma,0.8105,Ependymal Tumor,0.7743,Cellular Ependymoma,0.7720,Anaplastic Ependymoma,0.7712,Ependymal Pituicytoma,0.7622,Tanycytic Ependymoma,0.7600,Brain Ependymoma,0.7548,Spinal Cord Ependymoma,0.7538,Adult Ependymoma,0.7503,Clear Cell Ependymoma,0.7404,Mixed Astrocytoma-Ependymoma,0.7328,Broad Ligament Ependymoma,0.7313,Posterior Fossa Ependymoma,0.7310,Childhood Ependymoma,0.7274,Adult Ependymal Tumor,0.7222,Supratentorial Ependymoma,0.7211,MYXOPAPILLARY EPENDYMOMA,True,True,True
NASOPHARYNGEAL CARCINOMA,Nasopharyngeal Carcinoma,1,2,Nasopharyngeal Carcinoma,1.0000,Nasopharyngeal Undifferentiated Carcinoma,0.8668,Advanced Nasopharyngeal Carcinoma,0.8607,Nasopharyngeal Neuroendocrine Carcinoma,0.8592,Childhood Nasopharyngeal Carcinoma,0.8552,Nasopharyngeal Differentiated Carcinoma,0.8538,Nasopharyngeal Squamous Cell Carcinoma,0.8501,Unresectable Nasopharyngeal Carcinoma,0.8293,Nasopharyngeal Neoplasm,0.8274,Nasopharyngeal Non-Keratinizing Carcinoma,0.8265,Metastatic Nasopharyngeal Carcinoma,0.8072,Nasopharyngeal Adenoid Cystic Carcinoma,0.7997,Nasopharyngeal Lymphoma,0.7948,Refractory Nasopharyngeal Carcinoma,0.7942,Malignant Nasopharyngeal Neoplasm,0.7929,Nasal Cavity Carcinoma,0.7819,Nasopharyngeal Large Cell Neuroendocrine Carcinoma,0.7762,Recurrent Nasopharyngeal Carcinoma,0.7636,Advanced Nasopharyngeal Squamous Cell Carcinoma,0.7602,Nasopharyngeal Small Cell Neuroendocrine Carcinoma,0.7596,NASOPHARYNGEAL CARCINOMA,True,True,True
NATURAL KILLER CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,1,2,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,1.0000,Aggressive NK-Cell Leukemia,0.7320,"NK-Cell Lymphoma, Unclassifiable",0.7139,T Lymphoblastic Leukemia/Lymphoma,0.6818,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0.6770,Lymphoblastic Lymphoma,0.6767,B Lymphoblastic Leukemia/Lymphoma,0.6726,Childhood T Lymphoblastic Leukemia/Lymphoma,0.6645,T Lymphoblastic Lymphoma,0.6639,Chronic Lymphoblastic Lymphoma,0.6615,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.6591,Cutaneous B Lymphoblastic Leukemia/Lymphoma,0.6587,B Lymphoblastic Lymphoma,0.6585,Chronic Lymphoproliferative Disorder of NK-Cells,0.6538,T-Cell Large Granular Lymphocyte Leukemia,0.6524,Nasal Cavity Extranodal NK/T-Cell Lymphoma,0.6489,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.6454,T-Cell Non-Hodgkin Lymphoma,0.6450,Childhood Nasal Type Extranodal NK/T-Cell Lymphoma,0.6399,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.6398,NATURAL KILLER CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,True,True,True
NATURAL KILLER NK CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,1,2,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.9844,Aggressive NK-Cell Leukemia,0.7373,"NK-Cell Lymphoma, Unclassifiable",0.7185,T Lymphoblastic Leukemia/Lymphoma,0.6680,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0.6629,Nasal Cavity Extranodal NK/T-Cell Lymphoma,0.6583,Childhood T Lymphoblastic Leukemia/Lymphoma,0.6580,Childhood Nasal Type Extranodal NK/T-Cell Lymphoma,0.6548,Sinonasal Extranodal NK/T-Cell Lymphoma,0.6527,Chronic Lymphoproliferative Disorder of NK-Cells,0.6521,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.6513,T Lymphoblastic Lymphoma,0.6512,B Lymphoblastic Leukemia/Lymphoma,0.6509,T-Cell Large Granular Lymphocyte Leukemia,0.6476,Lymphoblastic Lymphoma,0.6471,Nasal Type Extranodal NK/T-Cell Lymphoma,0.6462,Cutaneous B Lymphoblastic Leukemia/Lymphoma,0.6452,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.6407,Lung Anaplastic Large Cell Lymphoma,0.6362,Chronic Lymphoblastic Lymphoma,0.6344,NATURAL KILLER NK CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,True,True,True
NBL,Neuroblastoma,1,2,Neuroblastoma,1.0000,Childhood Neuroblastoma,0.9225,Childhood Brain Neuroblastoma,0.8825,Regional Neuroblastoma,0.8748,Peripheral Neuroblastoma,0.8732,Central Nervous System Neuroblastoma,0.8700,Undifferentiated Neuroblastoma,0.8545,Differentiating Neuroblastoma,0.8506,Poorly Differentiated Neuroblastoma,0.8496,Retinal Neuroblastoma,0.8490,Olfactory Neuroblastoma,0.8460,Hereditary Neuroblastoma,0.8427,Mediastinal Neuroblastoma,0.8410,Adrenal Gland Neuroblastoma,0.8379,Metastatic Neuroblastoma,0.8321,Extracranial Neuroblastoma,0.8212,Unresectable Neuroblastoma,0.8141,Stage 1 Neuroblastoma,0.7980,Intraspinal Neuroblastoma,0.7833,Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System,0.7801,Neuroblastoma,True,True,True
NERVE SHEATH TUMOR,Nerve Sheath Neoplasm,1,2,Nerve Sheath Neoplasm,0.9737,Schwannoma,0.8437,Hybrid Nerve Sheath Tumor,0.8400,Peripheral Nerve Schwannoma,0.8211,Conventional Schwannoma,0.8127,Malignant Peripheral Nerve Sheath Tumor,0.8105,Nerve Sheath Myxoma,0.8098,Sporadic Malignant Peripheral Nerve Sheath Tumor,0.8076,Schwannomatosis,0.7913,Skin Schwannoma,0.7896,Ancient Schwannoma,0.7798,NF1-Associated Malignant Peripheral Nerve Sheath Tumor,0.7791,Adult Malignant Peripheral Nerve Sheath Tumor,0.7774,Childhood Malignant Peripheral Nerve Sheath Tumor,0.7681,Bone Schwannoma,0.7680,Plexiform Schwannoma,0.7670,Low Grade Malignant Peripheral Nerve Sheath Tumor,0.7612,Optic Nerve Sheath Solitary Fibrous Tumor,0.7577,Skin Neural Neoplasm,0.7510,Cellular Schwannoma,0.7481,NERVE SHEATH TUMOR,True,True,True
NESTED STROMAL EPITHELIAL TUMOR OF THE LIVER,Calcifying Nested Stromal-Epithelial Tumor,2,2,Calcifying Nested Stromal-Epithelial Tumor of the Liver,0.9037,Calcifying Nested Stromal-Epithelial Tumor,0.7287,Liver Neuroendocrine Tumor,0.7138,Liver Epithelial Neoplasm,0.7084,Liver Non-Epithelial Neoplasm,0.6960,Liver Solitary Fibrous Tumor,0.6912,Benign Liver Epithelial Neoplasm,0.6901,Liver Epithelioid Hemangioendothelioma,0.6841,Extrarenal Rhabdoid Tumor of the Liver,0.6790,Liver Embryonal Sarcoma,0.6773,Liver Neuroendocrine Neoplasm,0.6756,Adult Liver Embryonal Sarcoma,0.6716,Liver Carcinosarcoma,0.6677,Epithelial Hepatoblastoma,0.6629,Ovarian Stromal-Leydig Cell Tumor,0.6617,Liver Neuroendocrine Tumor G1,0.6474,Liver Sarcoma,0.6471,"Ovarian Yolk Sac Tumor, Hepatoid Pattern",0.6438,Low Risk Esophageal Gastrointestinal Stromal Tumor,0.6426,Esophageal Gastrointestinal Stromal Tumor,0.6390,NESTED STROMAL EPITHELIAL TUMOR OF THE LIVER,False,True,True
NEUROBLASTOMA,Neuroblastoma,1,2,Neuroblastoma,1.0000,Childhood Neuroblastoma,0.9225,Childhood Brain Neuroblastoma,0.8825,Regional Neuroblastoma,0.8748,Peripheral Neuroblastoma,0.8732,Central Nervous System Neuroblastoma,0.8700,Undifferentiated Neuroblastoma,0.8545,Differentiating Neuroblastoma,0.8506,Poorly Differentiated Neuroblastoma,0.8496,Retinal Neuroblastoma,0.8490,Olfactory Neuroblastoma,0.8460,Hereditary Neuroblastoma,0.8427,Mediastinal Neuroblastoma,0.8410,Adrenal Gland Neuroblastoma,0.8379,Metastatic Neuroblastoma,0.8321,Extracranial Neuroblastoma,0.8212,Unresectable Neuroblastoma,0.8141,Stage 1 Neuroblastoma,0.7980,Intraspinal Neuroblastoma,0.7833,Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System,0.7801,NEUROBLASTOMA,True,True,True
NEUROBLASTOMAÃ‚Â ,Neuroblastoma,1,2,Neuroblastoma,0.8311,Childhood Neuroblastoma,0.7845,Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System,0.7825,Stage 2A Neuroblastoma,0.7798,Adrenal Gland Neuroblastoma,0.7795,Central Nervous System Neuroblastoma,0.7788,Regional Neuroblastoma,0.7692,Peripheral Neuroblastoma,0.7659,Childhood Brain Neuroblastoma,0.7618,Retinal Neuroblastoma,0.7581,Differentiating Neuroblastoma,0.7567,Poorly Differentiated Neuroblastoma,0.7556,Undifferentiated Neuroblastoma,0.7541,Locally Advanced Neuroblastoma,0.7487,Stage 1 Neuroblastoma,0.7412,Olfactory Neuroblastoma,0.7396,Mediastinal Neuroblastoma,0.7328,Unresectable Neuroblastoma,0.7283,Extracranial Neuroblastoma,0.7177,Metastatic Neuroblastoma,0.7088,NEUROBLASTOMAÃ‚Â,True,True,True
NEUROENDOCRINE,Neuroendocrine Neoplasm,1,2,Neuroendocrine Neoplasm,0.8746,Neuroendocrine Tumor,0.8451,Neuroendocrine Carcinoma,0.7973,Pituitary Neuroendocrine Tumor,0.7792,Advanced Neuroendocrine Neoplasm,0.7530,Advanced Neuroendocrine Tumor,0.7464,Functioning Pituitary Neuroendocrine Tumor,0.7383,Childhood Neuroendocrine Neoplasm,0.7366,Metastatic Neuroendocrine Neoplasm,0.7364,Advanced Neuroendocrine Carcinoma,0.7316,Null Cell Pituitary Neuroendocrine Tumor,0.7294,Adenocarcinoma with Neuroendocrine Differentiation,0.7218,Neuroendocrine Tumor G3,0.7171,Prostate Neuroendocrine Tumor,0.7162,Sinonasal Neuroendocrine Neoplasm,0.7109,Childhood Neuroendocrine Tumor,0.7099,Neuroendocrine Tumor G1,0.7064,Metastatic Neuroendocrine Tumor,0.7060,Unresectable Neuroendocrine Neoplasm,0.7058,Pancreatic Neuroendocrine Tumor,0.7054,NEUROENDOCRINE,True,True,True
NEUROENDOCRINE CARCINOMA,Neuroendocrine Carcinoma,1,2,Neuroendocrine Carcinoma,1.0000,Advanced Neuroendocrine Carcinoma,0.8816,Neuroendocrine Neoplasm,0.8619,Pancreatic Neuroendocrine Carcinoma,0.8600,Neuroendocrine Tumor,0.8543,Prostate Neuroendocrine Carcinoma,0.8542,Small Cell Neuroendocrine Carcinoma,0.8535,Metastatic Neuroendocrine Carcinoma,0.8535,Cervical Neuroendocrine Carcinoma,0.8502,Lung Neuroendocrine Carcinoma,0.8459,Endometrial Neuroendocrine Carcinoma,0.8448,Adenocarcinoma with Neuroendocrine Differentiation,0.8413,Gastric Neuroendocrine Carcinoma,0.8393,Colorectal Neuroendocrine Carcinoma,0.8378,Intestinal Neuroendocrine Carcinoma,0.8359,Nasopharyngeal Neuroendocrine Carcinoma,0.8358,Large Cell Neuroendocrine Carcinoma,0.8322,Unresectable Neuroendocrine Carcinoma,0.8321,Digestive System Neuroendocrine Carcinoma,0.8298,Kidney Neuroendocrine Carcinoma,0.8286,NEUROENDOCRINE CARCINOMA,True,True,True
NEUROENDOCRINE CARCINOMA NOS,Neuroendocrine Carcinoma,1,2,Neuroendocrine Carcinoma,0.9760,Advanced Neuroendocrine Carcinoma,0.8629,Small Cell Neuroendocrine Carcinoma,0.8464,Neuroendocrine Neoplasm,0.8427,Adenocarcinoma with Neuroendocrine Differentiation,0.8344,Pancreatic Neuroendocrine Carcinoma,0.8339,Metastatic Neuroendocrine Carcinoma,0.8335,Neuroendocrine Tumor,0.8273,Cervical Neuroendocrine Carcinoma,0.8247,Prostate Neuroendocrine Carcinoma,0.8246,Large Cell Neuroendocrine Carcinoma,0.8240,Endometrial Neuroendocrine Carcinoma,0.8237,Lung Neuroendocrine Carcinoma,0.8211,Unresectable Neuroendocrine Carcinoma,0.8183,Digestive System Neuroendocrine Carcinoma,0.8179,Colorectal Neuroendocrine Carcinoma,0.8160,Gastric Neuroendocrine Carcinoma,0.8139,Intestinal Neuroendocrine Carcinoma,0.8065,Kidney Neuroendocrine Carcinoma,0.8058,Nasopharyngeal Neuroendocrine Carcinoma,0.8056,NEUROENDOCRINE CARCINOMA NOS,True,True,True
"NEUROENDOCRINE CARCINOMA, NOS",Neuroendocrine Carcinoma,1,2,Neuroendocrine Carcinoma,0.9428,Advanced Neuroendocrine Carcinoma,0.8326,Small Cell Neuroendocrine Carcinoma,0.8248,Adenocarcinoma with Neuroendocrine Differentiation,0.8185,Pancreatic Neuroendocrine Carcinoma,0.8100,Neuroendocrine Neoplasm,0.8100,Metastatic Neuroendocrine Carcinoma,0.7989,Large Cell Neuroendocrine Carcinoma,0.7986,Endometrial Neuroendocrine Carcinoma,0.7966,Digestive System Neuroendocrine Carcinoma,0.7959,Neuroendocrine Tumor,0.7941,Prostate Neuroendocrine Carcinoma,0.7935,Grade III Neuroendocrine Carcinoma,0.7914,Colorectal Neuroendocrine Carcinoma,0.7903,Gastric Neuroendocrine Carcinoma,0.7900,Unresectable Neuroendocrine Carcinoma,0.7896,Lung Neuroendocrine Carcinoma,0.7891,Grade I Neuroendocrine Carcinoma,0.7890,Cervical Neuroendocrine Carcinoma,0.7888,Grade II Neuroendocrine Carcinoma,0.7785,"NEUROENDOCRINE CARCINOMA, NOS",True,True,True
NEUROENDOCRINE TUMOR,Neuroendocrine Tumor,1,2,Neuroendocrine Tumor,1.0000,Neuroendocrine Neoplasm,0.9655,Pituitary Neuroendocrine Tumor,0.9013,Pancreatic Neuroendocrine Tumor,0.8806,Prostate Neuroendocrine Tumor,0.8596,Neuroendocrine Carcinoma,0.8543,Advanced Neuroendocrine Tumor,0.8387,Childhood Neuroendocrine Tumor,0.8374,Intestinal Neuroendocrine Tumor,0.8346,Kidney Neuroendocrine Tumor,0.8246,Metastatic Neuroendocrine Tumor,0.8239,Lung Neuroendocrine Tumor,0.8227,Pancreatic Neuroendocrine Neoplasm,0.8204,Neuroendocrine Tumor G1,0.8203,Digestive System Neuroendocrine Tumor,0.8171,Functioning Pituitary Neuroendocrine Tumor,0.8150,Childhood Neuroendocrine Neoplasm,0.8112,Sinonasal Neuroendocrine Tumor,0.8094,Thymus Neuroendocrine Tumor,0.8076,Gastric Neuroendocrine Tumor,0.8051,NEUROENDOCRINE TUMOR,True,True,True
"NEUROENDOCRINE TUMOR, NOS",Neuroendocrine Tumor,1,2,Neuroendocrine Tumor,0.9441,Neuroendocrine Neoplasm,0.9210,Pituitary Neuroendocrine Tumor,0.8404,Pancreatic Neuroendocrine Tumor,0.8270,Prostate Neuroendocrine Tumor,0.7951,"Pituitary Neuroendocrine Tumor, Not Otherwise Specified",0.7940,Pancreatic Neuroendocrine Neoplasm,0.7784,Neuroendocrine Carcinoma,0.7761,Childhood Neuroendocrine Tumor,0.7754,Intestinal Neuroendocrine Tumor,0.7730,Neuroendocrine Tumor G1,0.7698,Digestive System Neuroendocrine Tumor,0.7695,Advanced Neuroendocrine Tumor,0.7660,Childhood Neuroendocrine Neoplasm,0.7581,Thymus Neuroendocrine Tumor,0.7555,Kidney Neuroendocrine Tumor,0.7550,Carcinoid Tumor,0.7547,Pituitary Neuroendocrine Tumor without Distinct Lineage Differentiation,0.7528,Lung Neuroendocrine Tumor,0.7524,Somatostatin-Producing Neuroendocrine Tumor,0.7523,"NEUROENDOCRINE TUMOR, NOS",True,True,True
NEUROEPITHELIAL TUMOR,Neuroepithelial Neoplasm,1,2,Neuroepithelial Neoplasm,0.9519,Dysembryoplastic Neuroepithelial Tumor,0.8272,Neuroendocrine Tumor,0.7927,Primitive Neuroectodermal Tumor,0.7912,Neuroendocrine Neoplasm,0.7770,Neuroblastic Tumor,0.7760,Childhood Dysembryoplastic Neuroepithelial Tumor,0.7647,"Neuroepithelial, Perineurial, and Schwann Cell Neoplasm",0.7639,Adult Dysembryoplastic Neuroepithelial Tumor,0.7625,Central Nervous System Neuroepithelial Neoplasm of Uncertain Origin,0.7587,Peripheral Primitive Neuroectodermal Tumor,0.7396,Childhood Neuroendocrine Tumor,0.7388,Kidney Neuroendocrine Tumor,0.7215,Pituitary Neuroendocrine Tumor,0.7162,Childhood Neuroendocrine Neoplasm,0.7161,"Brain Embryonal Tumor, Not Otherwise Specified",0.7152,Olfactory Neurogenic Tumor,0.7136,Localized Primitive Neuroectodermal Tumor,0.7123,Glioneuronal and Neuronal Tumors,0.7107,Breast Neuroendocrine Tumor,0.7083,NEUROEPITHELIAL TUMOR,True,True,True
NEUROEPITHELIOMA,Primitive Neuroectodermal Tumor,5,2,Neuroepithelial Neoplasm,0.8823,Neuroblastic Tumor,0.7516,Neuroendocrine Neoplasm,0.7498,Dysembryoplastic Neuroepithelial Tumor,0.7481,Primitive Neuroectodermal Tumor,0.7449,Neuroendocrine Tumor,0.7434,Medulloepithelioma Not Otherwise Specified,0.7404,Central Nervous System Medulloepithelioma,0.7403,"Neuroepithelial, Perineurial, and Schwann Cell Neoplasm",0.7291,Benign Myoepithelioma,0.7275,Visual Pathway Medulloepithelioma,0.7263,Central Nervous System Neuroepithelial Neoplasm of Uncertain Origin,0.7162,Kidney Neuroendocrine Neoplasm,0.7116,Neural Glioblastoma,0.7056,Kidney Neuroendocrine Tumor,0.7053,Peripheral Primitive Neuroectodermal Tumor,0.7044,Childhood Dysembryoplastic Neuroepithelial Tumor,0.7038,Childhood Neuroendocrine Neoplasm,0.7016,Neuronevus,0.7000,Glioneuronal and Neuronal Tumors,0.6991,NEUROEPITHELIOMA,False,False,True
NEUROFIBROMA,Neurofibroma,1,2,Neurofibroma,1.0000,Skin Neurofibroma,0.9404,Cellular Neurofibroma,0.9023,Diffuse Neurofibroma,0.8807,Spinal Cord Neurofibroma,0.8738,Childhood Neurofibroma,0.8694,Cardiac Neurofibroma,0.8567,Plexiform Neurofibroma,0.8536,Epithelioid Neurofibroma,0.8254,Breast Neurofibroma,0.8244,Melanotic Neurofibroma,0.8147,Sinonasal Neurofibroma,0.8031,Penile Neurofibroma,0.8023,Neurofibroma with Atypia,0.7997,Mediastinal Neurofibroma,0.7939,Schwannoma,0.7893,Oral Cavity Neurofibroma,0.7729,Pacinian Neurofibroma,0.7719,Gallbladder Neurofibroma,0.7664,Tongue Neurofibroma,0.7636,NEUROFIBROMA,True,True,True
NEUROTROPIC,Desmoplastic Neurotropic Melanoma,99,2,Benign Nervous System Neoplasm,0.6326,Neuroblastic Tumor,0.6322,Peripheral Nervous System,0.6275,Nervous System Neoplasm,0.6238,Cellular Neurothekeoma,0.6123,Benign Cranial Nerve Neoplasm,0.5988,Neuroendocrine Tumor,0.5868,Glioneuronal and Neuronal Tumors,0.5867,Malignant Nervous System Neoplasm,0.5831,Neural Glioblastoma,0.5830,Neuroepithelial Neoplasm,0.5817,Neurofibroma,0.5812,Nervous System Neoplasm by Obsolete Classification,0.5803,Neuroendocrine Neoplasm,0.5786,Neuroblastoma,0.5770,Neuronevus,0.5769,Schwannomatosis,0.5745,Glioma,0.5741,Schwannoma,0.5738,Astrocytoma,0.5736,NEUROTROPIC,False,False,False
NHL,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,1.0000,Non-Hodgkin Lymphoma by Clinical Course,0.8183,B-Cell Non-Hodgkin Lymphoma,0.8038,Childhood Non-Hodgkin Lymphoma,0.8006,Adult Non-Hodgkin Lymphoma,0.7967,Extranodal Non-Hodgkin Lymphoma,0.7936,Transformed Non-Hodgkin Lymphoma,0.7739,Gastric Non-Hodgkin Lymphoma,0.7733,Nasopharyngeal Non-Hodgkin Lymphoma,0.7703,Indolent Non-Hodgkin Lymphoma,0.7690,Cerebral Non-Hodgkin Lymphoma,0.7611,Non-Burkitt's Lymphoma,0.7439,Digestive System Non-Hodgkin Lymphoma,0.7411,Head and Neck Non-Hodgkin Lymphoma,0.7408,Sinonasal Non-Hodgkin Lymphoma,0.7396,Non-Hodgkin Lymphoma with Variable Clinical Course,0.7308,Splenic Non-Hodgkin Lymphoma,0.7300,Lung Non-Hodgkin Lymphoma,0.7273,Colon Non-Hodgkin Lymphoma,0.7269,Aggressive Non-Hodgkin Lymphoma,0.7266,Non-Hodgkin Lymphoma,True,True,True
NKC,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,12,2,Kidney Neuroendocrine Carcinoma,0.6433,Sinonasal Neuroendocrine Carcinoma,0.6207,Neuroendocrine Carcinoma,0.6193,Aggressive NK-Cell Leukemia,0.6141,Nasopharyngeal Neuroendocrine Carcinoma,0.6095,Cholangiocarcinoma,0.6015,Gastric Neuroendocrine Carcinoma,0.5971,Nasal Cavity Neuroendocrine Carcinoma,0.5930,Anaplastic Lymphoma,0.5866,"NK-Cell Lymphoma, Unclassifiable",0.5820,Kidney Small Cell Neuroendocrine Carcinoma,0.5800,Natural Killer Cell Lymphoblastic Leukemia/Lymphoma,0.5780,Bladder Neuroendocrine Carcinoma,0.5773,Kidney Large Cell Neuroendocrine Carcinoma,0.5772,Prostate Neuroendocrine Carcinoma,0.5743,Chronic Lymphoproliferative Disorder of NK-Cells,0.5716,Oropharyngeal Neuroendocrine Carcinoma,0.5692,Kidney Neuroendocrine Tumor,0.5653,Thymus Neuroendocrine Carcinoma,0.5638,Eosinophilic Granuloma,0.5629,NKC,False,False,False
NODAL MARGINAL ZONE LYMPHOMA,Nodal Marginal Zone Lymphoma,1,2,Nodal Marginal Zone Lymphoma,1.0000,Marginal Zone Lymphoma,0.9419,Advanced Marginal Zone Lymphoma,0.8842,Pediatric Nodal Marginal Zone Lymphoma,0.8808,Refractory Nodal Marginal Zone Lymphoma,0.8759,Splenic Marginal Zone Lymphoma,0.8614,Nodal Marginal Zone Lymphoma by Ann Arbor Stage,0.8527,Recurrent Nodal Marginal Zone Lymphoma,0.8523,Ann Arbor Stage IV Nodal Marginal Zone Lymphoma,0.8383,Refractory Marginal Zone Lymphoma,0.8281,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.8257,Recurrent Marginal Zone Lymphoma,0.8159,Marginal Zone Lymphoma by Ann Arbor Stage,0.8113,Mediastinal Gray-Zone Lymphoma,0.8041,Ann Arbor Stage IV Marginal Zone Lymphoma,0.7951,Ann Arbor Stage II Nodal Marginal Zone Lymphoma,0.7904,Ann Arbor Stage I Nodal Marginal Zone Lymphoma,0.7847,Ann Arbor Stage III Nodal Marginal Zone Lymphoma,0.7824,Gray-Zone Lymphoma,0.7819,Refractory Splenic Marginal Zone Lymphoma,0.7528,NODAL MARGINAL ZONE LYMPHOMA,True,True,True
NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE,Follicular Helper T-Cell Lymphoma,4,2,Primary Nodal EBV-Positive T-Cell/NK-Cell Lymphoma,0.7287,T-Zone Variant Peripheral T-Cell Lymphoma,0.7127,T-Cell Non-Hodgkin Lymphoma,0.7120,Follicular Helper T-Cell Lymphoma,0.7037,Indolent T-Cell Non-Hodgkin Lymphoma,0.7000,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6990,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6937,Primary Central Nervous System T-Cell Non-Hodgkin Lymphoma,0.6910,"Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6832,"Follicular Helper T-Cell Lymphoma, Not Otherwise Specified",0.6820,Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6735,Primary CD30-Positive T-Cell Lymphoproliferative Disorder,0.6704,Gastric T-Cell Non-Hodgkin Lymphoma,0.6676,Nasal Type Extranodal NK/T-Cell Lymphoma,0.6659,"Follicular Helper T-Cell Lymphoma, Follicular-Type",0.6625,Primary Cutaneous Gamma-Delta T-Cell Lymphoma,0.6605,Testicular Nasal Type Extranodal NK/T-Cell Lymphoma,0.6595,"Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6572,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",0.6571,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder,0.6559,NODAL PERIPHERAL T-CELL LYMPHOMA WITH TFH PHENOTYPE,False,False,True
NODULAR,Nodular Neoplasm,1,2,Nodular Neoplasm,0.9073,Nodular Melanoma,0.7889,Cutaneous Nodular Melanoma,0.7468,Nodular Fasciitis,0.7458,Mucosal Nodular Melanoma,0.6996,Cranial Nodular Fasciitis,0.6854,Intravascular Nodular Fasciitis,0.6544,De Novo Nodular Melanoma,0.6514,Subcutaneous Nodular Fasciitis,0.6446,Neurofibroma,0.6338,Salivary Gland Nodular Fasciitis,0.6332,Adenoma,0.6310,Head and Neck Nodular Fasciitis,0.6290,Lymph Node Neoplasm,0.6279,Parotid Gland Nodular Fasciitis,0.6256,Necrotic Neoplasm,0.6209,Cellular Neurofibroma,0.6201,Neuroendocrine Tumor,0.6171,Diffuse Neurofibroma,0.6156,Neoplasm by Site,0.6142,NODULAR,True,True,True
NON AML MDSMPN DIAGNOSIS AT ACQUISITION,Myelodysplastic/Myeloproliferative Neoplasm,99,2,De Novo Myelodysplastic Syndrome,0.6290,Acute Myeloid Leukemia without Maturation,0.6171,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.6136,Adult Acute Myeloid Leukemia without Maturation,0.5986,Acute Myeloid Leukemia with Minimal Differentiation,0.5929,Cytogenetically Normal Acute Myeloid Leukemia,0.5823,Adult Acute Myeloid Leukemia with Minimal Differentiation,0.5815,"Myelodysplastic Syndrome, Unclassifiable, with Defining Cytogenetic Abnormality",0.5807,Noonan Syndrome-Associated Myeloproliferative Disorder,0.5768,Acute Myeloid Leukemia with NPM1-MLF1,0.5759,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.5754,"Diffuse Astrocytoma, MYBL1-Altered",0.5656,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,0.5644,"Childhood Diffuse Astrocytoma, MYBL1-Altered",0.5622,"Childhood Diffuse Astrocytoma, MYB-Altered",0.5602,Acute Myeloid Leukemia with Maturation,0.5581,"Diffuse Astrocytoma, MYB-Altered",0.5576,Childhood Acute Myeloid Leukemia without Maturation,0.5567,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm,0.5540,Acute Myeloid Leukemia with Multilineage Dysplasia,0.5513,NON AML MDSMPN DIAGNOSIS AT ACQUISITION,False,False,False
NON SMALL CELL LUNG CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9337,Lung Non-Squamous Non-Small Cell Carcinoma,0.8862,Lung Non-Small Cell Squamous Carcinoma,0.8583,Lung Small Cell Carcinoma,0.8344,Non-Small Cell Carcinoma,0.8309,Occult Lung Non-Small Cell Carcinoma,0.8268,Occult Lung Small Cell Carcinoma,0.7984,Lung Non-Keratinizing Squamous Cell Carcinoma,0.7977,Childhood Lung Non-Small Cell Carcinoma,0.7894,Early Stage Lung Non-Small Cell Carcinoma,0.7853,"Lung Small Cell Carcinoma, A Subtype",0.7841,Lung Small Cell Carcinoma Molecular Subtypes,0.7790,Advanced Lung Non-Small Cell Carcinoma,0.7778,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.7773,"Lung Small Cell Carcinoma, N Subtype",0.7750,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.7721,Occult Lung Squamous Cell Carcinoma,0.7687,Lung Squamous Cell Carcinoma,0.7618,Metastatic Lung Non-Small Cell Carcinoma,0.7598,"Lung Small Cell Carcinoma, Neuroendocrine-Low Subtype",0.7591,NON SMALL CELL LUNG CANCER,True,True,True
NON SMALL CELL LUNG CANCER OTHER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.8642,Lung Non-Squamous Non-Small Cell Carcinoma,0.8325,Occult Lung Non-Small Cell Carcinoma,0.8230,Lung Non-Small Cell Squamous Carcinoma,0.7892,Non-Small Cell Carcinoma,0.7588,Occult Lung Small Cell Carcinoma,0.7527,Metastatic Lung Non-Small Cell Carcinoma,0.7514,Childhood Lung Non-Small Cell Carcinoma,0.7511,Advanced Lung Non-Small Cell Carcinoma,0.7365,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma,0.7356,Occult Lung Squamous Cell Carcinoma,0.7343,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.7319,Lung Non-Keratinizing Squamous Cell Carcinoma,0.7296,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.7254,Lung Small Cell Carcinoma,0.7249,Early Stage Lung Non-Small Cell Carcinoma,0.7241,Occult Lung Large Cell Carcinoma,0.7190,Metastatic Lung Non-Small Cell Squamous Carcinoma,0.7181,Combined Lung Small Cell and Squamous Cell Carcinoma,0.7117,Lung Small Cell Carcinoma Molecular Subtypes,0.7106,NON SMALL CELL LUNG CANCER OTHER,True,True,True
NON-GERMINOMATOUS GERM CELL TUMOR,Nongerminomatous Germ Cell Tumor,1,2,Nongerminomatous Germ Cell Tumor,0.9641,Germinomatous Germ Cell Tumor,0.9088,Testicular Non-Seminomatous Germ Cell Tumor,0.8591,Central Nervous System Nongerminomatous Germ Cell Tumor,0.8546,Childhood Nongerminomatous Germ Cell Tumor,0.8376,Germ Cell Tumor,0.8213,Childhood Testicular Non-Seminomatous Germ Cell Tumor,0.8022,Extragonadal Germ Cell Tumor,0.8007,Benign Extragonadal Germ Cell Tumor,0.7968,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0.7907,Benign Germ Cell Tumor,0.7851,Central Nervous System Germ Cell Tumor,0.7850,Malignant Extragonadal Nongerminomatous Germ Cell Tumor,0.7809,Testicular Germ Cell Tumor,0.7719,Ovarian Non-Dysgerminomatous Germ Cell Tumor,0.7712,Adult Germ Cell Tumor,0.7635,Childhood Germinomatous Germ Cell Tumor,0.7568,Malignant Germ Cell Tumor,0.7565,Malignant Extragonadal Germ Cell Tumor,0.7558,Germ Cell Tumor by Obsolete Classification,0.7488,NON-GERMINOMATOUS GERM CELL TUMOR,True,True,True
NON-HODGKIN LYMPHOMA,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,1.0000,Non-Hodgkin Lymphoma by Clinical Course,0.8183,B-Cell Non-Hodgkin Lymphoma,0.8038,Childhood Non-Hodgkin Lymphoma,0.8006,Adult Non-Hodgkin Lymphoma,0.7967,Extranodal Non-Hodgkin Lymphoma,0.7936,Transformed Non-Hodgkin Lymphoma,0.7739,Gastric Non-Hodgkin Lymphoma,0.7733,Nasopharyngeal Non-Hodgkin Lymphoma,0.7703,Indolent Non-Hodgkin Lymphoma,0.7690,Cerebral Non-Hodgkin Lymphoma,0.7611,Non-Burkitt's Lymphoma,0.7439,Digestive System Non-Hodgkin Lymphoma,0.7411,Head and Neck Non-Hodgkin Lymphoma,0.7408,Sinonasal Non-Hodgkin Lymphoma,0.7396,Non-Hodgkin Lymphoma with Variable Clinical Course,0.7308,Splenic Non-Hodgkin Lymphoma,0.7300,Lung Non-Hodgkin Lymphoma,0.7273,Colon Non-Hodgkin Lymphoma,0.7269,Aggressive Non-Hodgkin Lymphoma,0.7266,NON-HODGKIN LYMPHOMA,True,True,True
NON-HODGKINS LYMPHOMA,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,0.9849,B-Cell Non-Hodgkin Lymphoma,0.8110,Extranodal Non-Hodgkin Lymphoma,0.8032,Non-Hodgkin Lymphoma by Clinical Course,0.7998,Adult Non-Hodgkin Lymphoma,0.7875,Childhood Non-Hodgkin Lymphoma,0.7830,Nasopharyngeal Non-Hodgkin Lymphoma,0.7729,Transformed Non-Hodgkin Lymphoma,0.7692,Indolent Non-Hodgkin Lymphoma,0.7686,Gastric Non-Hodgkin Lymphoma,0.7676,Non-Burkitt's Lymphoma,0.7513,Cerebral Non-Hodgkin Lymphoma,0.7479,Digestive System Non-Hodgkin Lymphoma,0.7391,Sinonasal Non-Hodgkin Lymphoma,0.7363,"Malignant Lymphoma, Non-Cleaved, Diffuse",0.7337,Head and Neck Non-Hodgkin Lymphoma,0.7335,Splenic Non-Hodgkin Lymphoma,0.7270,Extranodal Lymphoma,0.7236,Lung Non-Hodgkin Lymphoma,0.7209,Kidney Non-Hodgkin Lymphoma,0.7192,NON-HODGKINS LYMPHOMA,True,True,True
NON-SEMINOMA,Nongerminomatous Germ Cell Tumor,19,2,Seminoma,0.8655,Extragonadal Seminoma,0.8194,Testicular Typical Seminoma,0.8115,Testicular Seminoma,0.8070,Mediastinal Seminoma,0.8014,Intratubular Non-Seminoma,0.7738,Testicular Non-Seminomatous Germ Cell Tumor,0.7712,Childhood Seminoma,0.7692,"Testicular Seminoma, Pseudoglandular Variant",0.7510,Intratubular Seminoma,0.7493,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0.7456,"Testicular Seminoma, Tubular Variant",0.7437,Mixed Teratoma and Seminoma,0.7403,Testicular Seminoma with Syncytiotrophoblastic Cells,0.7100,Testicular Seminoma with High Mitotic Index,0.7021,Testicular Spermatocytic Tumor,0.7012,Childhood Testicular Non-Seminomatous Germ Cell Tumor,0.6796,Suprasellar Germ Cell Tumor,0.6764,Nongerminomatous Germ Cell Tumor,0.6641,Testicular Spermatocytic Tumor with Sarcoma,0.6612,NON-SEMINOMA,False,False,False
NON-SEMINOMATOUS GERM CELL TUMO,Nongerminomatous Germ Cell Tumor,3,2,Testicular Non-Seminomatous Germ Cell Tumor,0.8721,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0.8363,Nongerminomatous Germ Cell Tumor,0.8139,Childhood Testicular Non-Seminomatous Germ Cell Tumor,0.7988,Germinomatous Germ Cell Tumor,0.7884,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0.7652,Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7426,Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7403,Extragonadal Seminoma,0.7371,Childhood Nongerminomatous Germ Cell Tumor,0.7347,Ovarian Non-Dysgerminomatous Germ Cell Tumor,0.7328,"Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0.7318,Extragonadal Germ Cell Tumor,0.7310,Germ Cell Tumor,0.7310,Malignant Extragonadal Nongerminomatous Germ Cell Tumor,0.7283,Testicular Germ Cell Tumor,0.7263,Central Nervous System Nongerminomatous Germ Cell Tumor,0.7261,Malignant Extragonadal Germ Cell Tumor,0.7235,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7169,Testicular Typical Seminoma,0.7165,NON-SEMINOMATOUS GERM CELL TUMO,False,True,True
NON-SEMINOMATOUS GERM CELL TUMOR,Nongerminomatous Germ Cell Tumor,2,2,Testicular Non-Seminomatous Germ Cell Tumor,0.9430,Nongerminomatous Germ Cell Tumor,0.8687,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0.8686,Childhood Testicular Non-Seminomatous Germ Cell Tumor,0.8526,Germinomatous Germ Cell Tumor,0.8097,Germ Cell Tumor,0.7806,Testicular Germ Cell Tumor,0.7751,Extragonadal Germ Cell Tumor,0.7742,Ovarian Non-Dysgerminomatous Germ Cell Tumor,0.7725,Childhood Nongerminomatous Germ Cell Tumor,0.7652,Benign Extragonadal Germ Cell Tumor,0.7652,Extragonadal Seminoma,0.7624,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0.7591,Benign Germ Cell Tumor,0.7590,Testicular Typical Seminoma,0.7552,Testicular Pure Germ Cell Tumor,0.7529,Suprasellar Germ Cell Tumor,0.7514,Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7482,Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7469,Central Nervous System Nongerminomatous Germ Cell Tumor,0.7427,NON-SEMINOMATOUS GERM CELL TUMOR,False,True,True
NON-SMALL CELL LUNG,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.8615,Lung Non-Squamous Non-Small Cell Carcinoma,0.8232,Lung Non-Small Cell Squamous Carcinoma,0.7945,Non-Small Cell Carcinoma,0.7850,Lung Small Cell Carcinoma,0.7831,Early Stage Lung Non-Small Cell Carcinoma,0.7799,Occult Lung Non-Small Cell Carcinoma,0.7719,"Lung Small Cell Carcinoma, Neuroendocrine-Low Subtype",0.7686,Occult Lung Small Cell Carcinoma,0.7586,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.7570,"Lung Small Cell Carcinoma, N Subtype",0.7502,Lung Non-Keratinizing Squamous Cell Carcinoma,0.7441,"Lung Small Cell Carcinoma, A Subtype",0.7420,Lung Non-Hodgkin Lymphoma,0.7376,Childhood Lung Non-Small Cell Carcinoma,0.7333,"Lung Small Cell Carcinoma, Neuroendocrine-High Subtype",0.7243,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.7227,Lung Small Cell Carcinoma Molecular Subtypes,0.7204,Advanced Lung Non-Small Cell Carcinoma,0.7155,Non-Small Cell Adenocarcinoma,0.7153,NON-SMALL CELL LUNG,True,True,True
NON-SMALL CELL LUNG CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9459,Lung Non-Squamous Non-Small Cell Carcinoma,0.9007,Lung Non-Small Cell Squamous Carcinoma,0.8620,Occult Lung Non-Small Cell Carcinoma,0.8271,Non-Small Cell Carcinoma,0.8236,Lung Small Cell Carcinoma,0.8110,Lung Non-Keratinizing Squamous Cell Carcinoma,0.8071,Childhood Lung Non-Small Cell Carcinoma,0.8022,Early Stage Lung Non-Small Cell Carcinoma,0.7925,Advanced Lung Non-Small Cell Carcinoma,0.7818,"Lung Small Cell Carcinoma, A Subtype",0.7717,Occult Lung Small Cell Carcinoma,0.7688,"Lung Small Cell Carcinoma, N Subtype",0.7659,Metastatic Lung Non-Small Cell Carcinoma,0.7652,Lung Squamous Cell Carcinoma,0.7623,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.7583,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.7572,Lung Carcinoma,0.7572,Lung Large Cell Carcinoma,0.7539,Occult Lung Squamous Cell Carcinoma,0.7538,NON-SMALL CELL LUNG CANCER,True,True,True
"NON-SMALL CELL LUNG CANCER NSCLC, SQUAMOUS CELL CARCINOMA",Lung Squamous Cell Carcinoma,5,2,Lung Non-Small Cell Squamous Carcinoma,0.8991,Lung Non-Squamous Non-Small Cell Carcinoma,0.8629,Lung Non-Small Cell Carcinoma,0.8112,Lung Non-Keratinizing Squamous Cell Carcinoma,0.8069,Lung Squamous Cell Carcinoma,0.8039,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0.7899,Advanced Lung Non-Small Cell Squamous Carcinoma,0.7797,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.7649,"Lung Squamous Cell Carcinoma, Clear Cell Variant",0.7643,Metastatic Lung Non-Small Cell Squamous Carcinoma,0.7426,Occult Lung Squamous Cell Carcinoma,0.7367,Locally Advanced Lung Squamous Cell Carcinoma,0.7207,"Lung Small Cell Carcinoma, N Subtype",0.7194,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,0.7174,Early Stage Lung Non-Small Cell Carcinoma,0.7170,Locally Advanced Lung Non-Small Cell Carcinoma,0.7091,Lung Squamous Cell Carcinoma by AJCC v7 Stage,0.7088,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,0.7084,Advanced Lung Squamous Cell Carcinoma,0.7070,Unresectable Lung Non-Small Cell Squamous Carcinoma,0.7054,"NON-SMALL CELL LUNG CANCER NSCLC, SQUAMOUS CELL CARCINOMA",False,False,True
"NON-SMALL CELL LUNG CANCER NSCLC, UNSPECIFIED",Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.8615,Lung Non-Squamous Non-Small Cell Carcinoma,0.8582,Lung Non-Small Cell Squamous Carcinoma,0.7966,Early Stage Lung Non-Small Cell Carcinoma,0.7630,Occult Lung Non-Small Cell Carcinoma,0.7625,"Lung Small Cell Carcinoma, N Subtype",0.7542,Advanced Lung Non-Small Cell Carcinoma,0.7506,Lung Non-Keratinizing Squamous Cell Carcinoma,0.7481,Locally Advanced Lung Non-Small Cell Carcinoma,0.7357,Childhood Lung Non-Small Cell Carcinoma,0.7356,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,0.7345,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma,0.7181,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.7107,"Lung Small Cell Carcinoma, Neuroendocrine-Low Subtype",0.7101,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,0.7096,Advanced Lung Non-Small Cell Squamous Carcinoma,0.7086,Non-Small Cell Carcinoma,0.7063,Metastatic Lung Non-Small Cell Carcinoma,0.7054,Lung Large Cell Neuroendocrine Carcinoma,0.7041,Lung Non-Hodgkin Lymphoma,0.6997,"NON-SMALL CELL LUNG CANCER NSCLC, UNSPECIFIED",True,True,True
NON-SMALL_CELL LUNG_CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9185,Lung Non-Squamous Non-Small Cell Carcinoma,0.8758,Lung Non-Small Cell Squamous Carcinoma,0.8339,Non-Small Cell Carcinoma,0.8174,Occult Lung Non-Small Cell Carcinoma,0.8089,Lung Non-Keratinizing Squamous Cell Carcinoma,0.7860,Lung Small Cell Carcinoma,0.7843,Childhood Lung Non-Small Cell Carcinoma,0.7710,"Lung Small Cell Carcinoma, A Subtype",0.7554,Early Stage Lung Non-Small Cell Carcinoma,0.7531,Metastatic Lung Non-Small Cell Carcinoma,0.7514,Occult Lung Small Cell Carcinoma,0.7478,Lung Carcinoma,0.7456,Advanced Lung Non-Small Cell Carcinoma,0.7435,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.7414,Lung Small Cell Carcinoma Molecular Subtypes,0.7385,Lung Squamous Cell Carcinoma,0.7382,Occult Lung Squamous Cell Carcinoma,0.7359,"Lung Small Cell Carcinoma, N Subtype",0.7355,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.7346,NON-SMALL_CELL LUNG_CANCER,True,True,True
NON_HODGKIN_LYMPHOMA,Non-Hodgkin Lymphoma,1,2,Non-Hodgkin Lymphoma,0.9473,Non-Hodgkin Lymphoma by Clinical Course,0.8084,B-Cell Non-Hodgkin Lymphoma,0.7874,Extranodal Non-Hodgkin Lymphoma,0.7765,Childhood Non-Hodgkin Lymphoma,0.7536,Transformed Non-Hodgkin Lymphoma,0.7497,Non-Burkitt's Lymphoma,0.7409,"Malignant Lymphoma, Non-Cleaved, Diffuse",0.7277,Adult Non-Hodgkin Lymphoma,0.7277,Non-Hodgkin Lymphoma with Variable Clinical Course,0.7260,Lymphoma,0.7222,Extranodal Lymphoma,0.7219,Cerebral Non-Hodgkin Lymphoma,0.7188,Gastric Non-Hodgkin Lymphoma,0.7158,Indolent Non-Hodgkin Lymphoma,0.7118,Nasopharyngeal Non-Hodgkin Lymphoma,0.7034,"Malignant Lymphoma, Non-Cleaved Cell Type",0.7014,Digestive System Non-Hodgkin Lymphoma,0.6973,Head and Neck Non-Hodgkin Lymphoma,0.6943,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0.6882,NON_HODGKIN_LYMPHOMA,True,True,True
NON_SMALL_CELL_CARCINOMA,Non-Small Cell Carcinoma,1,2,Non-Small Cell Carcinoma,0.9545,Non-Small Cell Adenocarcinoma,0.8490,Small Cell Neuroendocrine Carcinoma,0.7934,Non-Keratinizing Small Cell Squamous Cell Carcinoma,0.7736,Lung Non-Small Cell Carcinoma,0.7710,Metastatic Non-Small Cell Carcinoma,0.7659,Small Cell Adenocarcinoma,0.7486,Lung Non-Squamous Non-Small Cell Carcinoma,0.7390,"Malignant Tumor, Small Cell Type",0.7372,Sinonasal Small Cell Neuroendocrine Carcinoma,0.7320,Nasal Cavity Small Cell Neuroendocrine Carcinoma,0.7275,Lung Small Cell Carcinoma,0.7125,Cervical Small Cell Neuroendocrine Carcinoma,0.7057,Lung Non-Small Cell Squamous Carcinoma,0.6924,Small Intestinal Small Cell Neuroendocrine Carcinoma,0.6899,Small Cell Intermediate Cell Carcinoma,0.6891,Colorectal Small Cell Neuroendocrine Carcinoma,0.6883,Nasopharyngeal Small Cell Neuroendocrine Carcinoma,0.6845,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.6835,Salivary Gland Small Cell Neuroendocrine Carcinoma,0.6835,NON_SMALL_CELL_CARCINOMA,True,True,True
NON_SMALL_CELL_LUNG_CANCER,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.8946,Lung Non-Squamous Non-Small Cell Carcinoma,0.8536,Non-Small Cell Carcinoma,0.8355,Lung Non-Small Cell Squamous Carcinoma,0.8124,Lung Small Cell Carcinoma,0.7960,Occult Lung Non-Small Cell Carcinoma,0.7909,Lung Non-Keratinizing Squamous Cell Carcinoma,0.7703,"Lung Small Cell Carcinoma, A Subtype",0.7604,Occult Lung Small Cell Carcinoma,0.7599,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.7481,Non-Small Cell Adenocarcinoma,0.7459,"Lung Small Cell Carcinoma, N Subtype",0.7382,Childhood Lung Non-Small Cell Carcinoma,0.7379,"Lung Small Cell Carcinoma, Neuroendocrine-Low Subtype",0.7376,Early Stage Lung Non-Small Cell Carcinoma,0.7372,Lung Small Cell Carcinoma Molecular Subtypes,0.7364,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.7300,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.7261,Metastatic Lung Non-Small Cell Carcinoma,0.7260,Occult Lung Squamous Cell Carcinoma,0.7231,NON_SMALL_CELL_LUNG_CANCER,True,True,True
NORMAL-LIKE,Normal Breast-Like Subtype of Breast Carcinoma,11,2,Indolent Non-Hodgkin Lymphoma,0.6050,Benign Neoplasm,0.5955,Favorable Non-Hodgkin Lymphoma,0.5951,Well Differentiated Malignant Neoplasm,0.5747,Favorable Hodgkin Lymphoma,0.5686,Early Favorable Non-Hodgkin Lymphoma,0.5685,Hereditary Neuroblastoma,0.5658,Chronic Neutrophilic Leukemia,0.5633,Non-Malignant Neoplasm,0.5585,Indolent Adult Non-Hodgkin Lymphoma,0.5584,Normal Breast-Like Subtype of Breast Carcinoma,0.5582,Non-Hodgkin Lymphoma,0.5562,Neonatal Leukemia,0.5534,Low Grade Intraepithelial Neoplasia,0.5526,Cytogenetically Normal Acute Myeloid Leukemia,0.5520,Non-Functioning Lung Neuroendocrine Tumor,0.5481,Neuroblastoma,0.5477,Juvenile Myelomonocytic Leukemia-Like Neoplasm,0.5473,Low Grade Lymphoma,0.5471,Lymphoma,0.5448,NORMAL-LIKE,False,False,False
NO_FUSION,Ewing Sarcoma,99,2,Fusion-Negative Rhabdomyosarcoma,0.6507,Fusion-Negative Alveolar Rhabdomyosarcoma,0.6352,Fusion-Positive Rhabdomyosarcoma,0.5853,Fusion-Positive Alveolar Rhabdomyosarcoma,0.5811,Non-Functioning Endocrine Neoplasm,0.5733,Non-Malignant Neoplasm,0.5710,In Situ Follicular Neoplasia,0.5619,Non-Functioning Pituitary Neuroendocrine Tumor,0.5580,Neurofibroma,0.5521,Non-Ossifying Fibroma,0.5514,Advanced Non-Functioning Neuroendocrine Tumor,0.5468,Non-Functioning Pancreatic Neuroendocrine Tumor,0.5423,Fibrous Dysplasia,0.5405,Neuroblastoma,0.5398,Non-Functioning Pituitary Neuroendocrine Tumor/Macroadenoma,0.5383,Myoma,0.5378,Polyposis,0.5365,Solitary Fibrous Tumor,0.5348,Kidney Solitary Fibrous Tumor,0.5321,Favorable Non-Hodgkin Lymphoma,0.5318,NO_FUSION,False,False,False
NSCLC,Lung Non-Small Cell Carcinoma,1,2,Lung Non-Small Cell Carcinoma,0.9459,Lung Non-Squamous Non-Small Cell Carcinoma,0.9007,Lung Non-Small Cell Squamous Carcinoma,0.8620,Occult Lung Non-Small Cell Carcinoma,0.8271,Non-Small Cell Carcinoma,0.8236,Lung Small Cell Carcinoma,0.8110,Lung Non-Keratinizing Squamous Cell Carcinoma,0.8071,Childhood Lung Non-Small Cell Carcinoma,0.8022,Early Stage Lung Non-Small Cell Carcinoma,0.7925,Advanced Lung Non-Small Cell Carcinoma,0.7818,"Lung Small Cell Carcinoma, A Subtype",0.7717,Occult Lung Small Cell Carcinoma,0.7688,"Lung Small Cell Carcinoma, N Subtype",0.7659,Metastatic Lung Non-Small Cell Carcinoma,0.7652,Lung Squamous Cell Carcinoma,0.7623,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.7583,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.7572,Lung Carcinoma,0.7572,Lung Large Cell Carcinoma,0.7539,Occult Lung Squamous Cell Carcinoma,0.7538,Non-Small Cell Lung Cancer,True,True,True
NSCLC_SQUAMOUS,Lung Squamous Cell Carcinoma,1,2,Lung Squamous Cell Carcinoma,0.7841,Lung Non-Small Cell Squamous Carcinoma,0.7726,Occult Lung Squamous Cell Carcinoma,0.7505,Lung Non-Keratinizing Squamous Cell Carcinoma,0.7244,Lung Non-Squamous Non-Small Cell Carcinoma,0.7210,Advanced Lung Squamous Cell Carcinoma,0.7051,Lung Non-Small Cell Carcinoma,0.7044,"Lung Squamous Cell Carcinoma, Clear Cell Variant",0.7011,Lung Squamous Cell Carcinoma by AJCC v7 Stage,0.6910,Lung Squamous Cell Carcinoma In Situ,0.6894,Squamous Cell Carcinoma,0.6888,Advanced Lung Non-Small Cell Squamous Carcinoma,0.6860,Transformed EGFR-Positive Lung Adenocarcinoma to Squamous Cell Carcinoma,0.6851,Locally Advanced Lung Squamous Cell Carcinoma,0.6849,Lung Squamous Papilloma,0.6843,Lung Adenosquamous Carcinoma,0.6833,Lung Carcinoma,0.6833,Superior Sulcus Lung Carcinoma,0.6820,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0.6787,Squamous Cell Neoplasm,0.6782,NSCLC_SQUAMOUS,True,True,True
OCULAR MELANOMA,Ocular Melanoma,1,2,Ocular Melanoma,1.0000,Metastatic Ocular Melanoma,0.8661,Retinal Melanoma,0.8606,Orbital Melanoma,0.8533,Uveal Melanoma,0.8500,Advanced Ocular Melanoma,0.8222,Cutaneous Melanoma,0.8171,Melanoma,0.8167,Conjunctival Melanoma,0.8147,Corneal Melanoma,0.8036,Eyelid Melanoma,0.7894,Ovarian Melanoma,0.7865,Malignant Eye Neoplasm,0.7821,Eye Melanocytoma,0.7731,Locally Advanced Ocular Melanoma,0.7666,Choroid Melanoma,0.7625,Uveal Melanocytic Neoplasm,0.7620,Iris Melanoma,0.7552,Uveal Melanocytoma,0.7551,Eye Carcinoma,0.7435,OCULAR MELANOMA,True,True,True
ODONTOGENIC CARCINOMA,Odontogenic Carcinoma,1,2,Odontogenic Carcinoma,1.0000,Malignant Odontogenic Neoplasm,0.8605,Clear Cell Odontogenic Carcinoma,0.8526,Odontogenic Neoplasm,0.8404,Ghost Cell Odontogenic Carcinoma,0.8101,Squamous Odontogenic Tumor,0.8075,Odontogenic Carcinosarcoma,0.8073,Odontogenic Sarcoma,0.7988,Childhood Odontogenic Neoplasm,0.7958,Sclerosing Odontogenic Carcinoma,0.7904,Ameloblastic Carcinoma Derived From Odontogenic Cyst,0.7812,Odontogenic Fibroma,0.7322,Primordial Odontogenic Tumor,0.7304,Odontogenic Myxoma,0.7268,Adenomatoid Odontogenic Tumor,0.7252,Calcifying Epithelial Odontogenic Tumor,0.7224,Ameloblastic Carcinoma,0.7209,Benign Odontogenic Neoplasm,0.7208,Odontoameloblastoma,0.7180,Central Odontogenic Fibroma,0.7127,ODONTOGENIC CARCINOMA,True,True,True
OESOPHAGEAL SQUAMOUS CELL CARCINOMA,Esophageal Squamous Cell Carcinoma,1,2,Esophageal Squamous Cell Carcinoma,0.9685,Advanced Esophageal Squamous Cell Carcinoma,0.8305,Esophageal Carcinoma,0.8150,Thoracic Esophagus Squamous Cell Carcinoma,0.8149,Cervical Esophagus Squamous Cell Carcinoma,0.8104,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage,0.7967,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,0.7938,Esophageal Spindle Cell Carcinoma,0.7935,Alcohol-Related Esophageal Squamous Cell Carcinoma,0.7934,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage,0.7930,Esophageal Poorly Differentiated Squamous Cell Carcinoma,0.7625,Esophageal Undifferentiated Carcinoma,0.7514,Esophageal Well Differentiated Squamous Cell Carcinoma,0.7411,Metastatic Esophageal Squamous Cell Carcinoma,0.7343,Locally Advanced Esophageal Squamous Cell Carcinoma,0.7309,Unresectable Esophageal Squamous Cell Carcinoma,0.7265,Esophageal Adenocarcinoma,0.7183,Esophageal Adenosquamous Carcinoma,0.7177,Esophageal Neuroendocrine Carcinoma,0.7167,Distal Esophagus Squamous Cell Carcinoma,0.7131,OESOPHAGEAL SQUAMOUS CELL CARCINOMA,True,True,True
OLFACTORY NEUROBLASTOMA,Olfactory Neuroblastoma,1,2,Olfactory Neuroblastoma,1.0000,Nasal Cavity Olfactory Neuroblastoma,0.8842,Sinonasal Olfactory Neuroblastoma,0.8824,Metastatic Olfactory Neuroblastoma,0.8787,Paranasal Sinus Olfactory Neuroblastoma,0.8590,Neuroblastoma,0.8460,Sellar Olfactory Neuroblastoma,0.8452,Retinal Neuroblastoma,0.8237,Olfactory Neurogenic Tumor,0.8193,Locally Advanced Olfactory Neuroblastoma,0.8155,Childhood Brain Neuroblastoma,0.7935,Recurrent Olfactory Neuroblastoma,0.7911,Peripheral Neuroblastoma,0.7903,Adrenal Gland Neuroblastoma,0.7901,Childhood Neuroblastoma,0.7869,Central Nervous System Neuroblastoma,0.7830,Regional Neuroblastoma,0.7780,Mediastinal Neuroblastoma,0.7697,Undifferentiated Neuroblastoma,0.7614,Unresectable Neuroblastoma,0.7562,OLFACTORY NEUROBLASTOMA,True,True,True
OLIGOASTROCYTOMA,Oligoastrocytoma,1,2,Oligoastrocytoma,1.0000,"Oligoastrocytoma, Not Otherwise Specified",0.9223,Anaplastic Oligoastrocytoma,0.9221,Childhood Oligoastrocytoma,0.9141,"Anaplastic Oligoastrocytoma, Not Otherwise Specified",0.8390,Childhood Anaplastic Oligoastrocytoma,0.8347,Recurrent Oligoastrocytoma,0.8191,Recurrent Childhood Oligoastrocytoma,0.7513,Recurrent Anaplastic Oligoastrocytoma,0.7259,Mixed Glioma,0.7021,Small Cell Glioblastoma,0.6914,Oligodendroglioma,0.6854,Composite Paraganglioma,0.6780,Adult Mixed Glioma,0.6762,Oligometastatic Gastric Adenocarcinoma,0.6754,Anaplastic Oligodendroglioma,0.6699,Astrocytoma,0.6657,Gemistocytic Astrocytoma,0.6655,Mixed Cell Adenoma,0.6620,Adult Oligodendroglioma,0.6591,OLIGOASTROCYTOMA,True,True,True
OLIGODENDROGLIOMA,Oligodendroglioma,1,2,Oligodendroglioma,1.0000,Brain Oligodendroglioma,0.9532,Oligodendroglial Tumor,0.9318,"Oligodendroglioma, Not Otherwise Specified",0.8891,Anaplastic Oligodendroglioma,0.8874,Childhood Oligodendroglioma,0.8854,Adult Oligodendroglioma,0.8783,Childhood Brain Oligodendroglioma,0.8710,Adult Brain Oligodendroglioma,0.8533,Adult Oligodendroglial Tumor,0.8329,Spinal Cord Oligodendroglioma,0.8293,"Anaplastic Oligodendroglioma, Not Otherwise Specified",0.8102,Unresectable Oligodendroglioma,0.8079,Childhood Anaplastic Oligodendroglioma,0.7970,Adult Anaplastic Oligodendroglioma,0.7844,Resectable Oligodendroglioma,0.7736,Frontal Lobe Anaplastic Oligodendroglioma,0.7731,Oligodendroblastoma,0.7511,Recurrent Oligodendroglioma,0.7502,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.7329,OLIGODENDROGLIOMA,True,True,True
"OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q-CODELETED","Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1,2,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1.0000,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.9176,"Unresectable Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.8253,"Recurrent Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0.7858,"Oligodendroglioma, Not Otherwise Specified",0.7659,Oligodendroglioma,0.7329,"Anaplastic Oligodendroglioma, Not Otherwise Specified",0.7287,Oligodendroglial Tumor,0.7277,Brain Oligodendroglioma,0.7194,Diffuse Glioneuronal Tumor with Oligodendroglioma-Like Features and Nuclear Clusters,0.6920,Anaplastic Oligodendroglioma,0.6851,Childhood Oligodendroglioma,0.6839,Childhood Brain Oligodendroglioma,0.6734,Unresectable Oligodendroglioma,0.6632,Adult Oligodendroglioma,0.6603,Adult Oligodendroglial Tumor,0.6598,Adult Brain Oligodendroglioma,0.6457,Childhood Anaplastic Oligodendroglioma,0.6405,Spinal Cord Oligodendroglioma,0.6403,Frontal Lobe Anaplastic Oligodendroglioma,0.6288,"OLIGODENDROGLIOMA, IDH-MUTANT AND 1P/19Q-CODELETED",True,True,True
ONCOCYTIC,Oncocytic Neoplasm,1,2,Oncocytic Neoplasm,0.9265,Oncocytic Adenocarcinoma,0.8670,Oncocytic Adenoma,0.8387,Cystic Oncocytic Neoplasm,0.7981,Thyroid Gland Oncocytic Neoplasm,0.7903,Thyroid Gland Oncocytic Carcinoma,0.7734,Breast Oncocytic Carcinoma,0.7687,Spindle Cell Oncocytoma,0.7467,Thyroid Gland Oncocytic Adenoma,0.7381,Salivary Gland Oncocytic Adenocarcinoma,0.7300,Salivary Gland Oncocytoma,0.7230,Kidney Oncocytoma,0.7204,Adrenal Cortical Oncocytic Adenoma,0.7170,Adrenal Cortical Oncocytic Carcinoma,0.7137,Lacrimal Gland Oncocytic Adenocarcinoma,0.7007,Lacrimal Gland Oncocytoma,0.6998,Conjunctival Oncocytoma,0.6991,Parathyroid Gland Oncocytic Adenoma,0.6913,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.6905,Prostate Acinar Oncocytic Adenocarcinoma,0.6842,ONCOCYTIC,True,True,True
ONCOCYTIC ADENOMA OF THE THYROID,Thyroid Gland Oncocytic Adenoma,1,2,Thyroid Gland Oncocytic Adenoma,0.9794,Thyroid Gland Oncocytic Neoplasm,0.9154,Oncocytic Adenoma,0.9026,Thyroid Gland Oncocytic Carcinoma,0.8867,Parathyroid Gland Oncocytic Adenoma,0.8442,Adrenal Cortical Oncocytic Adenoma,0.8371,Oncocytic Adenocarcinoma,0.8244,Locally Advanced Thyroid Gland Oncocytic Carcinoma,0.8223,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.7921,Oncocytic Neoplasm,0.7852,Unresectable Thyroid Gland Oncocytic Carcinoma,0.7809,Metastatic Thyroid Gland Oncocytic Carcinoma,0.7797,Salivary Gland Oncocytic Adenocarcinoma,0.7754,Salivary Gland Oncocytoma,0.7642,Lacrimal Gland Oncocytic Adenocarcinoma,0.7501,Cystic Oncocytic Neoplasm,0.7489,Prostate Acinar Oncocytic Adenocarcinoma,0.7444,Adrenal Cortical Oncocytic Carcinoma,0.7436,Lacrimal Gland Oncocytoma,0.7410,Conjunctival Oncocytoma,0.7370,ONCOCYTIC ADENOMA OF THE THYROID,True,True,True
ONCOCYTOMA,Oncocytic Neoplasm,2,2,Kidney Oncocytoma,0.8955,Oncocytic Neoplasm,0.8832,Oncocytic Adenoma,0.8691,Salivary Gland Oncocytoma,0.8626,Spindle Cell Oncocytoma,0.8599,Cystic Oncocytic Neoplasm,0.8417,Oncocytic Adenocarcinoma,0.8415,Lacrimal Gland Oncocytoma,0.8364,Conjunctival Oncocytoma,0.8118,Adrenal Cortical Oncocytic Carcinoma,0.8103,Thyroid Gland Oncocytic Neoplasm,0.8071,Thyroid Gland Oncocytic Carcinoma,0.8017,Adrenal Cortical Oncocytic Adenoma,0.7997,Thyroid Gland Oncocytic Adenoma,0.7788,Pineocytoma,0.7597,Hereditary Kidney Oncocytoma,0.7591,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.7438,Parathyroid Gland Oncocytic Adenoma,0.7437,Breast Oncocytic Carcinoma,0.7426,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.7349,ONCOCYTOMA,False,True,True
OPTIC NERVE GLIOMA,Optic Nerve Glioma,1,2,Optic Nerve Glioma,1.0000,Optic Nerve Astrocytoma,0.8801,Optic Nerve Neoplasm,0.8262,Visual Pathway Glioma,0.7734,Glioma,0.7467,Malignant Optic Nerve Neoplasm,0.7449,Tectal Glioma,0.7371,Recurrent Childhood Optic Nerve Glioma,0.7318,Optic Tract Neoplasm,0.7216,Intraocular Schwannoma,0.7199,Cranial Nerve Neoplasm,0.7064,Neural Glioblastoma,0.7008,Gliomatosis Cerebri,0.6921,Childhood Visual Pathway Glioma,0.6842,Oculomotor Nerve Neoplasm,0.6785,Visual Pathway Astrocytoma,0.6760,Hypoglossal Nerve Neoplasm,0.6757,Trochlear Nerve Neoplasm,0.6737,Gliomatosis Cerebri Type II,0.6719,Papillary Glioneuronal Tumor,0.6706,OPTIC NERVE GLIOMA,True,True,True
OPTIC PATHWAY GLIOMA,Visual Pathway Glioma,1,2,Visual Pathway Glioma,0.8893,Optic Nerve Glioma,0.8874,Optic Nerve Astrocytoma,0.7887,Visual Pathway Astrocytoma,0.7852,Childhood Visual Pathway Glioma,0.7843,Glioma,0.7686,Tectal Glioma,0.7507,Optic Tract Neoplasm,0.7404,Refractory Visual Pathway Glioma,0.7355,Visual Pathway Neoplasm,0.7124,Recurrent Visual Pathway Glioma,0.7113,Diffuse Glioma,0.6988,Optic Nerve Neoplasm,0.6923,Childhood Visual Pathway Astrocytoma,0.6916,Gliomatosis Cerebri,0.6898,Papillary Glioneuronal Tumor,0.6842,Neural Glioblastoma,0.6782,Visual Pathway Meningioma,0.6775,Brain Stem Glioma,0.6610,Gliomatosis Cerebri Type II,0.6605,OPTIC PATHWAY GLIOMA,True,True,True
ORAL CAVITY SQUAMOUS CELL CARCINOMA,Oral Cavity Squamous Cell Carcinoma,1,2,Oral Cavity Squamous Cell Carcinoma,1.0000,Oral Cavity Carcinoma,0.8266,Advanced Oral Cavity Squamous Cell Carcinoma,0.8167,Locally Advanced Oral Cavity Squamous Cell Carcinoma,0.8057,Lip and Oral Cavity Squamous Cell Carcinoma,0.7807,Buccal Mucosa Squamous Cell Carcinoma,0.7689,Metastatic Oral Cavity Squamous Cell Carcinoma,0.7687,Oropharyngeal Squamous Cell Carcinoma,0.7507,Oral Cavity Sarcoma,0.7497,Oral Cavity Adenocarcinoma,0.7483,Oral Cavity Verrucous Carcinoma,0.7459,Locally Recurrent Oral Cavity Squamous Cell Carcinoma,0.7419,Unresectable Oral Cavity Squamous Cell Carcinoma,0.7314,Tongue Squamous Cell Carcinoma,0.7304,Nasal Cavity Squamous Cell Carcinoma,0.7255,Recurrent Oral Cavity Squamous Cell Carcinoma,0.7236,Floor of Mouth Squamous Cell Carcinoma,0.7232,Squamous Cell Carcinoma,0.7218,Refractory Oral Cavity Squamous Cell Carcinoma,0.7101,Palate Squamous Cell Carcinoma,0.7085,ORAL CAVITY SQUAMOUS CELL CARCINOMA,True,True,True
OROPHARYNX SQUAMOUS CELL CARCINOMA,Oropharyngeal Squamous Cell Carcinoma,1,2,Oropharyngeal Squamous Cell Carcinoma,0.9081,Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma,0.7977,Advanced Oropharyngeal Squamous Cell Carcinoma,0.7969,Oropharyngeal Carcinoma,0.7939,Locally Advanced Oropharyngeal Squamous Cell Carcinoma,0.7608,Oropharyngeal Keratinizing Squamous Cell Carcinoma,0.7398,Pharyngeal Squamous Cell Carcinoma,0.7389,Oropharyngeal Undifferentiated Carcinoma,0.7257,Human Papillomavirus-Related Oropharyngeal Keratinizing Squamous Cell Carcinoma,0.7153,Oropharyngeal Basaloid Squamous Cell Carcinoma,0.7139,Metastatic Oropharyngeal Squamous Cell Carcinoma,0.7034,Oropharyngeal Poorly Differentiated Carcinoma,0.7013,Human Papillomavirus-Related Oropharyngeal Non-Keratinizing Squamous Cell Carcinoma,0.6939,Human Papillomavirus-Independent Oropharyngeal Squamous Cell Carcinoma,0.6939,Hard Palate Squamous Cell Carcinoma,0.6926,Unresectable Oropharyngeal Squamous Cell Carcinoma,0.6902,Advanced Oropharyngeal Carcinoma,0.6855,Oropharyngeal Squamous Papilloma,0.6789,Resectable Oropharyngeal Squamous Cell Carcinoma,0.6777,Oropharyngeal Carcinoma by AJCC v6 Stage,0.6775,OROPHARYNX SQUAMOUS CELL CARCINOMA,True,True,True
OS,Osteosarcoma,1,2,Osteosarcoma,1.0000,Bone Osteosarcoma,0.9524,Osteoblastic Osteosarcoma,0.9283,Conventional Osteosarcoma,0.9161,Jaw Osteosarcoma,0.8749,Secondary Osteosarcoma,0.8688,Primary Bone Osteosarcoma,0.8659,Extraskeletal Osteosarcoma,0.8513,Fibroblastic Osteosarcoma,0.8444,Childhood Osteosarcoma,0.8370,Small Cell Osteosarcoma,0.8277,Localized Osteosarcoma,0.8276,Metastatic Osteosarcoma,0.8260,Multifocal Osteosarcoma,0.8205,Lung Osteosarcoma,0.8179,Mixed Osteosarcoma,0.8163,Childhood Conventional Osteosarcoma,0.8133,Childhood Bone Osteosarcoma,0.8058,High Grade Osteosarcoma,0.8051,Unresectable Osteosarcoma,0.7983,Osteosarcoma,True,True,True
OSSIFYING FIBROMYXOID TUMOR,Ossifying Fibromyxoid Tumor,1,2,Ossifying Fibromyxoid Tumor,1.0000,Ossifying Fibroma,0.9369,Malignant Ossifying Fibromyxoid Tumor,0.8865,"Odontogenic Fibroma, Ossifying Subtype",0.8743,Non-Ossifying Fibroma,0.8411,Juvenile Trabecular Ossifying Fibroma,0.8337,Childhood Ossifying Fibroma,0.8044,Cemento-Ossifying Fibroma,0.7832,Nonossifying Fibromyxoid Tumor,0.7712,Odontogenic Fibroma,0.7593,Fibromyxoid Tumor,0.7521,Psammomatoid Ossifying Fibroma,0.7494,"Odontogenic Fibroma, Amyloid Subtype",0.7270,Osteoid Osteoma,0.7259,Peripheral Odontogenic Fibroma,0.7210,Calcifying Fibrous Tumor,0.7192,Maxillofacial Osteoid Osteoma,0.7173,Childhood Non-Ossifying Fibroma,0.7149,Osteogenic Neoplasm,0.7121,Hybrid Odontogenic Fibroma,0.7114,OSSIFYING FIBROMYXOID TUMOR,True,True,True
OSTEOBLASTIC OSTEOSARCOMA,Osteoblastic Osteosarcoma,1,2,Osteoblastic Osteosarcoma,1.0000,Bone Osteosarcoma,0.9313,Osteosarcoma,0.9283,Primary Bone Osteosarcoma,0.8856,Conventional Osteosarcoma,0.8838,Jaw Osteosarcoma,0.8603,Fibroblastic Osteosarcoma,0.8530,Extraskeletal Osteosarcoma,0.8448,Osteoblastoma,0.8169,Childhood Bone Osteosarcoma,0.8165,Secondary Osteosarcoma,0.8152,Localized Osteosarcoma,0.8099,Childhood Osteosarcoma,0.8091,Osteogenic Neoplasm,0.8072,Childhood Conventional Osteosarcoma,0.8067,High Grade Osteosarcoma,0.8052,Periosteal Osteosarcoma,0.8017,Mixed Osteosarcoma,0.8017,Multifocal Osteosarcoma,0.8015,Small Cell Osteosarcoma,0.7970,OSTEOBLASTIC OSTEOSARCOMA,True,True,True
OSTEOSARCOMA,Osteosarcoma,1,2,Osteosarcoma,1.0000,Bone Osteosarcoma,0.9524,Osteoblastic Osteosarcoma,0.9283,Conventional Osteosarcoma,0.9161,Jaw Osteosarcoma,0.8749,Secondary Osteosarcoma,0.8688,Primary Bone Osteosarcoma,0.8659,Extraskeletal Osteosarcoma,0.8513,Fibroblastic Osteosarcoma,0.8444,Childhood Osteosarcoma,0.8370,Small Cell Osteosarcoma,0.8277,Localized Osteosarcoma,0.8276,Metastatic Osteosarcoma,0.8260,Multifocal Osteosarcoma,0.8205,Lung Osteosarcoma,0.8179,Mixed Osteosarcoma,0.8163,Childhood Conventional Osteosarcoma,0.8133,Childhood Bone Osteosarcoma,0.8058,High Grade Osteosarcoma,0.8051,Unresectable Osteosarcoma,0.7983,OSTEOSARCOMA,True,True,True
OTHER UTERINE TUMOR,Uterine Neoplasm,1,2,Uterine Neoplasm,0.8193,Uterine Corpus Neoplasm,0.6965,Endometrial Neoplasm,0.6698,Malignant Uterine Neoplasm,0.6692,Uterine Corpus Neuroendocrine Neoplasm,0.6575,Uterine Ligament Neoplasm,0.6559,Benign Uterine Neoplasm,0.6471,Uterine Corpus Endometrial Stromal and Related Neoplasms,0.6444,Miscellaneous Neoplasm,0.6350,Uterine Corpus Adenomatoid Tumor,0.6217,Urinary Tract Neoplasm,0.6213,Urinary System Neoplasm,0.6194,Eye Neoplasm,0.6132,Reproductive System Neoplasm,0.6105,Uterine Corpus Smooth Muscle Neoplasm,0.6076,Uterine Corpus Germ Cell Tumor,0.6069,Uterine Corpus Tumor Resembling Ovarian Sex Cord Tumor,0.6036,Uterine Corpus PEComa,0.6026,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0.6001,Uterine Corpus Central Primitive Neuroectodermal Tumor,0.5983,OTHER UTERINE TUMOR,True,True,True
OV,Ovarian Carcinoma,11,2,Ovarian Lymphoma,0.6635,Ovarian Neoplasm,0.6458,Ovarian Melanoma,0.6347,Childhood Ovarian Neoplasm,0.6223,Benign Ovarian Neoplasm,0.6213,Ovarian Neuroendocrine Tumor,0.6196,Ovarian Neuroendocrine Neoplasm,0.6130,Oropharyngeal Lymphoma,0.6075,Osteolytic Neoplasm,0.6060,Childhood Benign Ovarian Neoplasm,0.6029,Ovarian Carcinoma,0.6021,Osteosarcoma,0.5995,Malignant Ovarian Neoplasm,0.5989,Ovarian Sarcoma,0.5963,Struma Ovarii,0.5911,Ovarian Neuroendocrine Carcinoma,0.5908,Ovarian Undifferentiated Carcinoma,0.5907,Childhood Malignant Ovarian Neoplasm,0.5903,Oropharyngeal Polyp,0.5836,Ovarian Epithelial Tumor,0.5835,OV,False,False,False
OVARIAN ADENOCARCINOMA,Ovarian Adenocarcinoma,1,2,Ovarian Adenocarcinoma,1.0000,Ovarian Carcinoma,0.9027,Ovarian Clear Cell Adenocarcinoma,0.8280,Malignant Ovarian Neoplasm,0.8187,Advanced Ovarian Carcinoma,0.8090,Ovarian Cystadenocarcinoma,0.7989,Ovarian Mucinous Adenocarcinoma,0.7906,Ovarian Neoplasm,0.7892,Adenocarcinoma,0.7879,Malignant Ovarian Epithelial Tumor,0.7879,Ovarian Serous Adenocarcinoma,0.7850,Breast Adenocarcinoma,0.7601,Malignant Ovarian Cyst,0.7571,Advanced Ovarian Clear Cell Adenocarcinoma,0.7558,Ovarian Epithelial Tumor,0.7536,Colon Adenocarcinoma,0.7440,Epididymal Adenocarcinoma,0.7425,Endometrial Adenocarcinoma,0.7406,Ovarian Melanoma,0.7405,Serous Adenocarcinoma,0.7400,OVARIAN ADENOCARCINOMA,True,True,True
OVARIAN CANCER,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9574,Ovarian Adenocarcinoma,0.8792,Ovarian Neoplasm,0.8764,Malignant Ovarian Neoplasm,0.8708,Malignant Ovarian Epithelial Tumor,0.8213,Ovarian Epithelial Tumor,0.8072,Advanced Ovarian Carcinoma,0.8035,Ovarian Lymphoma,0.7918,Hereditary Ovarian Carcinoma,0.7904,Childhood Malignant Ovarian Neoplasm,0.7702,Malignant Ovarian Cyst,0.7625,Childhood Ovarian Neoplasm,0.7591,Metastatic Ovarian Carcinoma,0.7582,Ovarian Undifferentiated Carcinoma,0.7547,Ovarian Melanoma,0.7486,Ovarian Clear Cell Tumor,0.7485,Unresectable Ovarian Carcinoma,0.7419,Malignant Ovarian Steroid Cell Tumor,0.7406,Ovarian Sarcoma,0.7390,Ovarian Neuroendocrine Carcinoma,0.7346,OVARIAN CANCER,True,True,True
"OVARIAN CANCER, OTHER",Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.7952,Ovarian Neoplasm,0.7742,Hereditary Ovarian Carcinoma,0.7208,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.7163,Ovarian Epithelial Tumor,0.7094,Metastatic Ovarian Carcinoma,0.7091,Childhood Ovarian Neoplasm,0.7071,Ovarian Adenocarcinoma,0.7050,Malignant Ovarian Neoplasm,0.7036,Advanced Ovarian Carcinoma,0.7011,Ovarian Lymphoma,0.6973,Ovarian Neuroendocrine Carcinoma,0.6971,Unresectable Ovarian Carcinoma,0.6960,Ovarian Undifferentiated Carcinoma,0.6910,Childhood Malignant Ovarian Neoplasm,0.6802,Ovarian Clear Cell Tumor,0.6801,Malignant Ovarian Epithelial Tumor,0.6787,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",0.6661,Ovarian Neuroendocrine Neoplasm,0.6634,Ovarian Embryonal Carcinoma,0.6619,"OVARIAN CANCER, OTHER",True,True,True
OVARIAN CARCINOMA,Ovarian Carcinoma,1,2,Ovarian Carcinoma,1.0000,Ovarian Adenocarcinoma,0.9027,Malignant Ovarian Neoplasm,0.8356,Ovarian Neoplasm,0.8322,Advanced Ovarian Carcinoma,0.8243,Malignant Ovarian Epithelial Tumor,0.8112,Hereditary Ovarian Carcinoma,0.7955,Ovarian Squamous Cell Carcinoma,0.7948,Ovarian Epithelial Tumor,0.7915,Ovarian Undifferentiated Carcinoma,0.7898,Metastatic Ovarian Carcinoma,0.7830,Ovarian Clear Cell Tumor,0.7759,Ovarian Clear Cell Adenocarcinoma,0.7709,Ovarian Transitional Cell Carcinoma,0.7708,Malignant Ovarian Cyst,0.7616,Ovarian Lymphoma,0.7594,Ovarian Small Cell Carcinoma,0.7583,Ovarian Neuroendocrine Carcinoma,0.7570,Unresectable Ovarian Carcinoma,0.7554,Malignant Ovarian Clear Cell Tumor,0.7504,OVARIAN CARCINOMA,True,True,True
OVARIAN CARCINOMA OTHER,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.8586,Ovarian Neoplasm,0.7713,Ovarian Adenocarcinoma,0.7536,Hereditary Ovarian Carcinoma,0.7478,Ovarian Undifferentiated Carcinoma,0.7446,Metastatic Ovarian Carcinoma,0.7408,Advanced Ovarian Carcinoma,0.7400,Ovarian Neuroendocrine Carcinoma,0.7352,Unresectable Ovarian Carcinoma,0.7337,Ovarian Clear Cell Tumor,0.7256,Ovarian Epithelial Tumor,0.7168,Malignant Ovarian Neoplasm,0.7141,Ovarian Lymphoma,0.7063,Ovarian Embryonal Carcinoma,0.7034,Childhood Ovarian Neoplasm,0.7031,Malignant Ovarian Epithelial Tumor,0.6958,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.6950,Ovarian Large Cell Neuroendocrine Carcinoma,0.6933,Ovarian Squamous Cell Carcinoma,0.6899,Ovarian Small Cell Carcinoma,0.6827,OVARIAN CARCINOMA OTHER,True,True,True
OVARIAN CARCINOSARCOMA/MALIGNANT MIXED MESODERMAL TUMOR,Ovarian Carcinosarcoma,1,2,Ovarian Carcinosarcoma,0.8176,Metastatic Ovarian Carcinosarcoma,0.7823,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7505,Advanced Ovarian Carcinosarcoma,0.7472,Ovarian Mixed Germ Cell Tumor,0.7399,Mixed Mesodermal (Mullerian) Tumor,0.7392,Ovarian Mucinous Carcinoid Tumor,0.7254,Ovarian Malignant Mesothelioma,0.7195,Malignant Ovarian Sex Cord-Stromal Tumor,0.7169,"Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0.7155,Ovarian Teratoma with Carcinoid Tumor,0.7154,Childhood Ovarian Mixed Germ Cell Tumor,0.7074,Ovarian Mixed Cell Adenocarcinoma,0.7020,Ovarian Rhabdomyosarcoma,0.7001,"Malignant Mixed Tumor, Not Otherwise Specified",0.6983,Ovarian Undifferentiated Sarcoma,0.6948,Recurrent Ovarian Carcinosarcoma,0.6926,Ovarian Sarcoma,0.6918,Ovarian Melanoma,0.6913,Malignant Mixed Neoplasm,0.6911,OVARIAN CARCINOSARCOMA/MALIGNANT MIXED MESODERMAL TUMOR,True,True,True
OVARIAN CLEAR CELL,Malignant Ovarian Clear Cell Tumor,2,2,Ovarian Clear Cell Tumor,0.9335,Malignant Ovarian Clear Cell Tumor,0.8964,Benign Ovarian Clear Cell Tumor,0.8941,Ovarian Clear Cell Adenocarcinoma,0.8883,Ovarian Clear Cell Cystadenocarcinoma,0.8106,Borderline Ovarian Clear Cell Tumor,0.8058,Clear Cell Neoplasm,0.8035,Advanced Ovarian Clear Cell Adenocarcinoma,0.7998,Clear Cell Malignant Neoplasm,0.7925,Ovarian Clear Cell Adenocarcinofibroma,0.7848,Clear Cell Adenocarcinoma,0.7697,Ovarian Carcinoma,0.7618,Clear Cell Adenoma,0.7466,Ovarian Undifferentiated Carcinoma,0.7438,Ovarian Clear Cell Cystadenofibroma,0.7402,Metastatic Ovarian Clear Cell Adenocarcinoma,0.7319,Endometrial Clear Cell Adenocarcinoma,0.7249,Ovarian Adenocarcinoma,0.7209,Ovarian Squamous Cell Carcinoma,0.7103,Clear Cell Renal Cell Carcinoma,0.7077,OVARIAN CLEAR CELL,False,True,True
OVARIAN EPITHELIAL CARCINOMA OVCA,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.7965,Ovarian Adenocarcinoma,0.7693,Malignant Ovarian Epithelial Tumor,0.7521,Ovarian Squamous Cell Carcinoma,0.7286,Ovarian Undifferentiated Carcinoma,0.7268,Ovarian Epithelial Tumor,0.7196,Ovarian Embryonal Carcinoma,0.7170,Malignant Ovarian Neoplasm,0.7145,Malignant Ovarian Cyst,0.7054,Ovarian Neuroendocrine Carcinoma,0.7016,Ovarian Clear Cell Adenocarcinoma,0.7011,Ovarian Small Cell Carcinoma,0.6982,Advanced Ovarian Carcinoma,0.6950,Childhood Ovarian Embryonal Carcinoma,0.6800,Ovarian Neoplasm,0.6765,Ovarian Transitional Cell Carcinoma,0.6763,Ovarian Melanoma,0.6755,Ovarian Large Cell Neuroendocrine Carcinoma,0.6732,Childhood Malignant Ovarian Neoplasm,0.6716,Ovarian Clear Cell Tumor,0.6700,OVARIAN EPITHELIAL CARCINOMA OVCA,True,True,True
OVARIAN EPITHELIAL TUMOR,Ovarian Epithelial Tumor,1,2,Ovarian Epithelial Tumor,1.0000,Ovarian Neoplasm,0.8755,Benign Ovarian Epithelial Tumor,0.8738,Malignant Ovarian Epithelial Tumor,0.8675,Borderline Ovarian Epithelial Tumor,0.7989,Ovarian Carcinoma,0.7915,Ovarian Adenomatoid Tumor,0.7909,Ovarian Steroid Cell Tumor,0.7888,Ovarian Neuroendocrine Tumor,0.7757,Ovarian Neuroectodermal-Type Tumor,0.7735,Ovarian Papillary Tumor,0.7673,Malignant Ovarian Neoplasm,0.7631,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.7542,Ovarian Adenocarcinoma,0.7536,Childhood Ovarian Neoplasm,0.7460,Ovarian Neuroendocrine Neoplasm,0.7456,Ovarian Lymphoma,0.7453,Ovarian Granulosa Cell Tumor,0.7440,Benign Ovarian Neoplasm,0.7412,Ovarian Serous Tumor,0.7374,OVARIAN EPITHELIAL TUMOR,True,True,True
OVARIAN GERM CELL TUMOR,Ovarian Germ Cell Tumor,1,2,Ovarian Germ Cell Tumor,1.0000,Childhood Ovarian Germ Cell Tumor,0.9283,Malignant Ovarian Germ Cell Tumor,0.9078,Ovarian Primitive Germ Cell Tumor,0.9032,Benign Ovarian Germ Cell Tumor,0.8901,Ovarian Non-Dysgerminomatous Germ Cell Tumor,0.8798,Childhood Malignant Ovarian Germ Cell Tumor,0.8784,Childhood Ovarian Nongerminomatous Germ Cell Tumor,0.8714,Ovarian Granulosa Cell Tumor,0.8640,Testicular Germ Cell Tumor,0.8499,Ovarian Mixed Germ Cell Tumor,0.8407,Germ Cell Tumor,0.8390,Childhood Gonadal Germ Cell Tumor,0.8307,Testicular Granulosa Cell Tumor,0.8196,Childhood Ovarian Mixed Germ Cell Tumor,0.8153,Liver Germ Cell Tumor,0.7924,Gastric Germ Cell Tumor,0.7921,Ovarian Granulosa-Stromal Cell Tumor,0.7906,Extragonadal Germ Cell Tumor,0.7820,Granulosa Cell Tumor,0.7784,OVARIAN GERM CELL TUMOR,True,True,True
OVARIAN GRANULOSA CELL TUMOR,Ovarian Granulosa Cell Tumor,1,2,Ovarian Granulosa Cell Tumor,1.0000,Granulosa Cell Tumor,0.9167,Ovarian Granulosa-Stromal Cell Tumor,0.9141,Adult Ovarian Granulosa Cell Tumor,0.8893,Testicular Granulosa Cell Tumor,0.8848,Ovarian Germ Cell Tumor,0.8640,Malignant Ovarian Granulosa Cell Tumor,0.8616,Juvenile Ovarian Granulosa Cell Tumor,0.8611,Childhood Ovarian Germ Cell Tumor,0.8383,Childhood Ovarian Nongerminomatous Germ Cell Tumor,0.8210,Ovarian Primitive Germ Cell Tumor,0.8188,Adult Granulosa Cell Tumor,0.8165,Adult Testicular Granulosa Cell Tumor,0.8159,Ovarian Non-Dysgerminomatous Germ Cell Tumor,0.7970,Juvenile Testicular Granulosa Cell Tumor,0.7875,Benign Ovarian Germ Cell Tumor,0.7835,Juvenile Granulosa Cell Tumor,0.7827,Granulosa Cell-Theca Cell Tumor,0.7783,Ovarian Steroid Cell Tumor,0.7739,Childhood Malignant Ovarian Germ Cell Tumor,0.7680,OVARIAN GRANULOSA CELL TUMOR,True,True,True
OVARIAN HIGH-GRADE SEROUS,Ovarian High Grade Serous Adenocarcinoma,1,2,Ovarian High Grade Serous Adenocarcinoma,0.9032,Advanced Ovarian High Grade Serous Adenocarcinoma,0.8449,Metastatic Ovarian High Grade Serous Adenocarcinoma,0.7897,Malignant Ovarian Serous Tumor,0.7807,Unresectable Ovarian High Grade Serous Adenocarcinoma,0.7765,Benign Ovarian Serous Tumor,0.7674,Ovarian Serous Tumor,0.7593,Recurrent Ovarian High Grade Serous Adenocarcinoma,0.7530,Ovarian Low Grade Serous Adenocarcinoma,0.7528,Primary Peritoneal High Grade Serous Adenocarcinoma,0.7394,Refractory Ovarian High Grade Serous Adenocarcinoma,0.7345,Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma,0.7295,Ovarian Serous Adenocarcinoma,0.7189,Advanced Ovarian Serous Adenocarcinoma,0.7158,Ovarian High Grade Endometrioid Adenocarcinoma,0.7156,Advanced Primary Peritoneal High Grade Serous Adenocarcinoma,0.7032,Platinum-Refractory Ovarian High Grade Serous Adenocarcinoma,0.6998,Locally Advanced Unresectable Ovarian High Grade Serous Adenocarcinoma,0.6994,Serous Neoplasm,0.6972,Borderline Ovarian Serous Tumor,0.6947,OVARIAN HIGH-GRADE SEROUS,True,True,True
OVARIAN LOW-GRADE SEROUS,Ovarian Low Grade Serous Adenocarcinoma,1,2,Ovarian Low Grade Serous Adenocarcinoma,0.8931,Benign Ovarian Serous Tumor,0.7583,Ovarian High Grade Serous Adenocarcinoma,0.7531,Borderline Ovarian Serous Tumor,0.7508,Ovarian Serous Tumor,0.7507,Malignant Ovarian Serous Tumor,0.7477,Ovarian Low Grade Endometrioid Stromal Sarcoma,0.7418,Recurrent Ovarian Low Grade Serous Adenocarcinoma,0.7230,Ovarian Serous Adenocarcinoma,0.7226,Low Grade Osteosarcoma,0.7077,Refractory Ovarian Low Grade Serous Adenocarcinoma,0.7074,Primary Peritoneal Low Grade Serous Adenocarcinoma,0.7051,Ovarian Low Grade Endometrioid Adenocarcinoma,0.7026,Locally Advanced Ovarian Serous Adenocarcinoma,0.7012,Ovarian Undifferentiated Sarcoma,0.6940,Advanced Ovarian Serous Adenocarcinoma,0.6899,Low Grade Lymphoma,0.6872,Serous Neoplasm,0.6872,Ovarian Sarcoma,0.6860,Ovarian Lymphoma,0.6830,OVARIAN LOW-GRADE SEROUS,True,True,True
OVARIAN SEROMUCINOUS CARCINOMA,Ovarian Seromucinous Carcinoma,1,2,Ovarian Seromucinous Carcinoma,1.0000,Ovarian Seromucinous Tumor,0.9362,Benign Ovarian Seromucinous Tumor,0.8831,Ovarian Seromucinous Cystadenoma,0.8702,Recurrent Ovarian Seromucinous Carcinoma,0.8535,Borderline Ovarian Seromucinous Tumor,0.8431,Refractory Ovarian Seromucinous Carcinoma,0.8015,Ovarian Seromucinous Adenofibroma,0.7945,Ovarian Serous Adenocarcinofibroma,0.7257,Malignant Ovarian Serous Tumor,0.7160,Ovarian Mucinous Adenocarcinoma,0.7143,Ovarian Mucinous Tumor,0.7132,Ovarian Serous Adenocarcinoma,0.7111,Ovarian Serous Tumor,0.7100,Serous Neoplasm,0.7089,Ovarian Mucinous Adenocarcinofibroma,0.7068,Malignant Ovarian Mucinous Tumor,0.7028,Serous Adenocarcinoma,0.6997,Ovarian Serous Cystadenocarcinoma,0.6906,Serous Cystadenocarcinoma,0.6841,OVARIAN SEROMUCINOUS CARCINOMA,True,True,True
OVARIAN SEROUS CARCINOMA,Ovarian Serous Adenocarcinoma,1,2,Ovarian Serous Adenocarcinoma,0.9014,Ovarian Serous Tumor,0.8628,Malignant Ovarian Serous Tumor,0.8513,Serous Adenocarcinoma,0.8488,Ovarian Serous Cystadenocarcinoma,0.8390,Serous Surface Papillary Carcinoma,0.8130,Advanced Ovarian Serous Adenocarcinoma,0.8037,Serous Neoplasm,0.8021,Cervical Serous Adenocarcinoma,0.7943,Ovarian Serous Cystadenoma,0.7914,Ovarian High Grade Serous Adenocarcinoma,0.7894,Ovarian Low Grade Serous Adenocarcinoma,0.7856,Endometrial Serous Adenocarcinoma,0.7816,Advanced Ovarian Serous Cystadenocarcinoma,0.7730,Micropapillary Serous Carcinoma,0.7716,Serous Cystadenocarcinoma,0.7705,Benign Ovarian Serous Tumor,0.7691,Metastatic Ovarian Serous Adenocarcinoma,0.7669,Ovarian Carcinoma,0.7610,Unresectable Ovarian Serous Adenocarcinoma,0.7608,OVARIAN SEROUS CARCINOMA,True,True,True
OVARIAN_CANCER,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.8898,Ovarian Neoplasm,0.8213,Malignant Ovarian Neoplasm,0.8070,Ovarian Adenocarcinoma,0.7997,Hereditary Ovarian Carcinoma,0.7660,Malignant Ovarian Epithelial Tumor,0.7630,Ovarian Epithelial Tumor,0.7550,Ovarian Undifferentiated Carcinoma,0.7434,Advanced Ovarian Carcinoma,0.7383,Unresectable Ovarian Carcinoma,0.7237,Ovarian Neuroendocrine Carcinoma,0.7236,Ovarian Lymphoma,0.7226,Childhood Malignant Ovarian Neoplasm,0.7179,Ovarian Melanoma,0.7160,Metastatic Ovarian Carcinoma,0.7136,Malignant Ovarian Cyst,0.7133,Childhood Ovarian Neoplasm,0.7125,Ovarian Sarcoma,0.7066,Ovarian Embryonal Carcinoma,0.7001,Malignant Ovarian Steroid Cell Tumor,0.6980,OVARIAN_CANCER,True,True,True
OVARIAN_CARCINOMA,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9483,Ovarian Adenocarcinoma,0.8493,Malignant Ovarian Neoplasm,0.8087,Ovarian Neoplasm,0.7969,Advanced Ovarian Carcinoma,0.7841,Malignant Ovarian Epithelial Tumor,0.7819,Ovarian Undifferentiated Carcinoma,0.7783,Hereditary Ovarian Carcinoma,0.7718,Ovarian Epithelial Tumor,0.7558,Ovarian Squamous Cell Carcinoma,0.7496,Metastatic Ovarian Carcinoma,0.7485,Unresectable Ovarian Carcinoma,0.7414,Malignant Ovarian Cyst,0.7334,Ovarian Neuroendocrine Carcinoma,0.7325,Ovarian Clear Cell Tumor,0.7260,Ovarian Transitional Cell Carcinoma,0.7190,Malignant Ovarian Steroid Cell Tumor,0.7178,Ovarian Small Cell Carcinoma,0.7158,Ovarian Clear Cell Adenocarcinoma,0.7151,Ovarian Embryonal Carcinoma,0.7142,OVARIAN_CARCINOMA,True,True,True
OVARY_ADENOCARCINOMA,Ovarian Adenocarcinoma,1,2,Ovarian Adenocarcinoma,0.9410,Ovarian Carcinoma,0.8226,Adenocarcinoma,0.7970,Malignant Ovarian Neoplasm,0.7818,Ovarian Cystadenocarcinoma,0.7588,Ovarian Clear Cell Adenocarcinoma,0.7575,Advanced Ovarian Carcinoma,0.7553,Malignant Ovarian Epithelial Tumor,0.7534,Ovarian Mucinous Adenocarcinoma,0.7524,Ovarian Dermoid Cyst with Adenocarcinoma,0.7474,Ovarian Neoplasm,0.7451,Ovarian Serous Adenocarcinoma,0.7343,Endometrial Adenocarcinoma,0.7328,Epididymal Adenocarcinoma,0.7309,Oral Cavity Adenocarcinoma,0.7272,Advanced Ovarian Endometrioid Adenocarcinoma,0.7250,Breast Adenocarcinoma,0.7240,Ovarian Adenomatoid Tumor,0.7237,Malignant Ovarian Cyst,0.7189,Ovarian Endometrioid Adenocarcinoma,0.7168,OVARY_ADENOCARCINOMA,True,True,True
OVARY_CARCINOMA,Ovarian Carcinoma,1,2,Ovarian Carcinoma,0.9260,Ovarian Adenocarcinoma,0.8403,Malignant Ovarian Neoplasm,0.7931,Ovarian Neoplasm,0.7795,Ovarian Undifferentiated Carcinoma,0.7716,Malignant Ovarian Epithelial Tumor,0.7702,Advanced Ovarian Carcinoma,0.7626,Hereditary Ovarian Carcinoma,0.7578,Ovarian Epithelial Tumor,0.7446,Metastatic Ovarian Carcinoma,0.7327,Unresectable Ovarian Carcinoma,0.7279,Malignant Ovarian Cyst,0.7269,Carcinoma,0.7184,Ovarian Squamous Cell Carcinoma,0.7177,Porocarcinoma,0.7163,Malignant Ovarian Steroid Cell Tumor,0.7122,Ovarian Choriocarcinoma,0.7081,Ovarian Neuroendocrine Carcinoma,0.7075,Ovarian Clear Cell Tumor,0.7072,Ovarian Melanoma,0.7043,OVARY_CARCINOMA,True,True,True
PAAD,Pancreatic Adenocarcinoma,1,2,Pancreatic Adenocarcinoma,1.0000,Pancreatic Ductal Adenocarcinoma,0.9173,Pancreatic Carcinoma,0.9055,Advanced Pancreatic Adenocarcinoma,0.8824,Advanced Pancreatic Carcinoma,0.8516,Advanced Pancreatic Ductal Adenocarcinoma,0.8322,Metastatic Pancreatic Adenocarcinoma,0.8312,Malignant Pancreatic Neoplasm,0.8311,Pancreatic Acinar Cell Carcinoma,0.8295,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0.8224,Exocrine Pancreas Carcinoma,0.8070,Prostate Adenocarcinoma,0.7940,Periampullary Adenocarcinoma,0.7887,Pancreatic Neoplasm,0.7877,Pancreatic Acinar Cell Neoplasm,0.7870,Adenocarcinoma,0.7869,Metastatic Pancreatic Ductal Adenocarcinoma,0.7802,Localized Pancreatic Adenocarcinoma,0.7788,Papillary Adenocarcinoma,0.7766,Prostate Ductal Adenocarcinoma,0.7757,Pancreatic Adenocarcinoma,True,True,True
PAGET DISEASE OF THE NIPPLE,Nipple Paget Disease,1,2,Nipple Paget Disease,0.9635,Breast Paget Disease,0.8246,Paget Disease,0.7397,Breast Paget Disease without Invasive Carcinoma,0.7396,Breast Paget Disease with Invasive Ductal Carcinoma,0.7308,Breast Paget Disease and Intraductal Carcinoma,0.7125,Recurrent Breast Paget Disease,0.7064,Extramammary Paget Disease,0.7026,Penile Paget Disease,0.6955,Anal Margin Paget Disease,0.6921,Vulvar Paget Disease,0.6887,Anal Canal Paget Disease,0.6870,Scrotal Paget Disease,0.6752,Nipple Neoplasm,0.6735,Anal Paget Disease,0.6637,Nipple Adenoma,0.6613,Metastatic Extramammary Paget Disease,0.6533,Malignant Nipple Neoplasm,0.6488,Nipple Duct Carcinoma,0.6451,Advanced Extramammary Paget Disease,0.6444,PAGET DISEASE OF THE NIPPLE,True,True,True
PANCREAS-ADENOCARCINOMA DUCTAL TYPE,Pancreatic Ductal Adenocarcinoma,1,2,Pancreatic Ductal Adenocarcinoma,0.9338,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0.8760,Pancreatic Well Differentiated Ductal Adenocarcinoma,0.8731,Advanced Pancreatic Ductal Adenocarcinoma,0.8565,Pancreatic Adenocarcinoma,0.8418,Prostate Ductal Adenocarcinoma,0.8142,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,0.8043,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7998,Metastatic Pancreatic Ductal Adenocarcinoma,0.7921,Early Stage Pancreatic Ductal Adenocarcinoma,0.7758,Advanced Pancreatic Adenocarcinoma,0.7746,Pancreatic Foamy Gland Adenocarcinoma,0.7642,Pancreatic Acinar Cell Carcinoma,0.7637,Localized Pancreatic Ductal Adenocarcinoma,0.7623,Diffuse Type Adenocarcinoma,0.7564,Locally Advanced Pancreatic Ductal Adenocarcinoma,0.7321,Pancreatic Acinar Cell Neoplasm,0.7284,Exocrine Pancreas Carcinoma,0.7273,Duodenal Adenocarcinoma,0.7270,Pancreatic Hepatoid Adenocarcinoma,0.7181,PANCREAS-ADENOCARCINOMA DUCTAL TYPE,True,True,True
PANCREAS-ADENOCARCINOMA-OTHER SUBTYPE,Pancreatic Adenocarcinoma,1,2,Pancreatic Adenocarcinoma,0.7751,Metastatic Pancreatic Adenocarcinoma,0.7076,Advanced Pancreatic Adenocarcinoma,0.7053,Pancreatic Carcinoma,0.7009,Pancreatic Ductal Adenocarcinoma,0.6968,Advanced Pancreatic Carcinoma,0.6822,Pancreatic Acinar Cell Neoplasm,0.6794,Malignant Pancreatic Neoplasm,0.6729,Prostate Adenocarcinoma without Neuroendocrine Differentiation,0.6689,Pancreatic Neoplasm,0.6639,Pancreatic Acinar Cell Carcinoma,0.6636,Metastatic Pancreatic Ductal Adenocarcinoma,0.6625,Exocrine Pancreas Carcinoma,0.6561,Advanced Pancreatic Ductal Adenocarcinoma,0.6559,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0.6517,Pancreatic Exocrine Neoplasm,0.6446,Adenocarcinoma,0.6429,Unresectable Pancreatic Adenocarcinoma,0.6422,Papillary Adenocarcinoma,0.6408,Pancreatic Poorly Cohesive Adenocarcinoma,0.6408,PANCREAS-ADENOCARCINOMA-OTHER SUBTYPE,True,True,True
PANCREAS-COLLOID MUCINOUS NON-CYSTIC CARCINOMA,Pancreatic Colloid Carcinoma,1,2,Pancreatic Colloid Carcinoma,0.8529,Pancreatic Mucinous-Cystic Neoplasm,0.8323,"Pancreatic Mucinous-Cystic Neoplasm, Low Grade",0.8270,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,0.8258,Pancreatic Non-Invasive Mucinous Cystadenocarcinoma,0.7913,"Pancreatic Mucinous-Cystic Neoplasm, High Grade",0.7745,Pancreatic Mucinous Cystadenocarcinoma,0.7596,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,0.7478,Pancreatic Intraductal Papillary-Mucinous Carcinoma,0.7388,Pancreatic Mucinous Cystadenoma,0.7337,Pancreatic Mucinous-Cystic Neoplasm with Intermediate Grade Dysplasia,0.7043,Gallbladder Mucinous Cystic Neoplasm,0.7028,Papillary Mucinous Cystadenocarcinoma,0.6973,"Gallbladder Mucinous Cystic Neoplasm, Low Grade",0.6952,Primary Cutaneous Mucinous Carcinoma,0.6938,Thyroid Gland Mucinous Carcinoma,0.6914,Pancreatic Medullary Carcinoma,0.6912,Bile Duct Mucinous Cystic Neoplasm,0.6793,Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma,0.6739,Mucinous Cystadenocarcinoma,0.6666,PANCREAS-COLLOID MUCINOUS NON-CYSTIC CARCINOMA,True,True,True
PANCREAS-UNDIFFERENTIATED CARCINOMA,Pancreatic Undifferentiated Carcinoma,1,2,Pancreatic Undifferentiated Carcinoma,0.9642,Pancreatic Carcinoma,0.7823,Parotid Gland Undifferentiated Carcinoma,0.7770,Pancreatic Neuroendocrine Carcinoma,0.7718,Undifferentiated Carcinoma,0.7717,Prostate Undifferentiated Carcinoma,0.7715,Exocrine Pancreas Carcinoma,0.7645,Pancreatic Medullary Carcinoma,0.7601,Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.7547,Pancreatic Undifferentiated Carcinoma with Rhabdoid Cells,0.7363,Pancreatic Colloid Carcinoma,0.7305,Primary Peritoneal Undifferentiated Carcinoma,0.7267,Pancreatic Poorly Cohesive Adenocarcinoma,0.7263,Unresectable Pancreatic Carcinoma,0.7261,Pancreatic Adenocarcinoma,0.7249,Unresectable Pancreatic Neuroendocrine Carcinoma,0.7186,Pancreatic Squamous Cell Carcinoma,0.7152,Unresectable Pancreatic Adenocarcinoma,0.7143,Pancreatic Small Cell Neuroendocrine Carcinoma,0.7134,Gastric Undifferentiated Carcinoma,0.7097,PANCREAS-UNDIFFERENTIATED CARCINOMA,True,True,True
PANCREATIC ADENOCARCINOMA,Pancreatic Adenocarcinoma,1,2,Pancreatic Adenocarcinoma,1.0000,Pancreatic Ductal Adenocarcinoma,0.9173,Pancreatic Carcinoma,0.9055,Advanced Pancreatic Adenocarcinoma,0.8824,Advanced Pancreatic Carcinoma,0.8516,Advanced Pancreatic Ductal Adenocarcinoma,0.8322,Metastatic Pancreatic Adenocarcinoma,0.8312,Malignant Pancreatic Neoplasm,0.8311,Pancreatic Acinar Cell Carcinoma,0.8295,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0.8224,Exocrine Pancreas Carcinoma,0.8070,Prostate Adenocarcinoma,0.7940,Periampullary Adenocarcinoma,0.7887,Pancreatic Neoplasm,0.7877,Pancreatic Acinar Cell Neoplasm,0.7870,Adenocarcinoma,0.7869,Metastatic Pancreatic Ductal Adenocarcinoma,0.7802,Localized Pancreatic Adenocarcinoma,0.7788,Papillary Adenocarcinoma,0.7766,Prostate Ductal Adenocarcinoma,0.7757,PANCREATIC ADENOCARCINOMA,True,True,True
PANCREATIC CANCER,Exocrine Pancreas Carcinoma,11,2,Pancreatic Carcinoma,0.9616,Pancreatic Neoplasm,0.8917,Pancreatic Adenocarcinoma,0.8853,Malignant Pancreatic Neoplasm,0.8821,Advanced Pancreatic Carcinoma,0.8403,Metastatic Pancreatic Carcinoma,0.8011,Pancreatic Neuroendocrine Carcinoma,0.7871,Advanced Pancreatic Adenocarcinoma,0.7796,Pancreatic Undifferentiated Carcinoma,0.7738,Hereditary Pancreatic Carcinoma,0.7683,Exocrine Pancreas Carcinoma,0.7677,Pancreatic Exocrine Neoplasm,0.7638,Pancreatic Lymphoma,0.7637,Pancreatic Ductal Adenocarcinoma,0.7586,Metastatic Malignant Pancreatic Neoplasm,0.7535,Pancreatic Polypeptide Tumor,0.7510,Pancreatic Neuroendocrine Neoplasm,0.7509,Metastatic Pancreatic Adenocarcinoma,0.7499,Pancreatic Medullary Carcinoma,0.7470,Unresectable Pancreatic Carcinoma,0.7460,PANCREATIC CANCER,False,False,False
PANCREATIC CANCER OTHER,Exocrine Pancreas Carcinoma,18,2,Pancreatic Carcinoma,0.8248,Pancreatic Neoplasm,0.7976,Pancreatic Neuroendocrine Carcinoma,0.7422,Metastatic Pancreatic Carcinoma,0.7420,Advanced Pancreatic Carcinoma,0.7334,Pancreatic Adenocarcinoma,0.7329,Malignant Pancreatic Neoplasm,0.7305,Pancreatic Undifferentiated Carcinoma,0.7244,Unresectable Pancreatic Carcinoma,0.7160,Pancreatic Neuroendocrine Neoplasm,0.7142,Hereditary Pancreatic Carcinoma,0.7074,Pancreatic Lymphoma,0.6994,Metastatic Malignant Pancreatic Neoplasm,0.6986,Pancreatic Exocrine Neoplasm,0.6925,Metastatic Carcinoma in the Pancreas,0.6869,Pancreatic Neuroendocrine Tumor,0.6869,Unresectable Pancreatic Neuroendocrine Carcinoma,0.6844,Exocrine Pancreas Carcinoma,0.6809,Pancreatic Cystic Neoplasm,0.6754,Pancreatic Polypeptide Tumor,0.6750,PANCREATIC CANCER OTHER,False,False,False
"PANCREATIC CANCER, NOS",Exocrine Pancreas Carcinoma,12,2,Pancreatic Carcinoma,0.9025,Malignant Pancreatic Neoplasm,0.8539,Pancreatic Neoplasm,0.8344,Pancreatic Adenocarcinoma,0.8147,Advanced Pancreatic Carcinoma,0.7900,Metastatic Pancreatic Carcinoma,0.7389,Advanced Pancreatic Adenocarcinoma,0.7187,Pancreatic Undifferentiated Carcinoma,0.7169,Pancreatic Neuroendocrine Carcinoma,0.7161,Hereditary Pancreatic Carcinoma,0.7104,Pancreatobiliary Carcinoma,0.7069,Exocrine Pancreas Carcinoma,0.7062,Metastatic Malignant Pancreatic Neoplasm,0.7047,Metastatic Carcinoma in the Pancreas,0.7021,Pancreatic Exocrine Neoplasm,0.6944,Unresectable Pancreatic Carcinoma,0.6930,Pancreatic Ductal Adenocarcinoma,0.6908,Locally Advanced Pancreatic Carcinoma,0.6899,Metastatic Malignant Neoplasm in the Pancreas,0.6875,Pancreatic Lymphoma,0.6862,"PANCREATIC CANCER, NOS",False,False,False
PANCREATIC DUCTAL ADENOCARCINOMA,Pancreatic Ductal Adenocarcinoma,1,2,Pancreatic Ductal Adenocarcinoma,1.0000,Pancreatic Adenocarcinoma,0.9173,Advanced Pancreatic Ductal Adenocarcinoma,0.9079,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0.8982,Prostate Ductal Adenocarcinoma,0.8669,Pancreatic Well Differentiated Ductal Adenocarcinoma,0.8651,Metastatic Pancreatic Ductal Adenocarcinoma,0.8442,Advanced Pancreatic Adenocarcinoma,0.8318,Early Stage Pancreatic Ductal Adenocarcinoma,0.8290,Pancreatic Acinar Cell Carcinoma,0.8088,Localized Pancreatic Ductal Adenocarcinoma,0.8085,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,0.8071,Pancreatic Mixed Acinar-Ductal Carcinoma,0.8001,Pancreatic Carcinoma,0.7918,Locally Advanced Pancreatic Ductal Adenocarcinoma,0.7894,Unresectable Pancreatic Ductal Adenocarcinoma,0.7845,Pancreatic Foamy Gland Adenocarcinoma,0.7777,Advanced Pancreatic Carcinoma,0.7755,Exocrine Pancreas Carcinoma,0.7718,Duodenal Adenocarcinoma,0.7675,PANCREATIC DUCTAL ADENOCARCINOMA,True,True,True
PANCREATIC NEUROENDOCRINE,Pancreatic Neuroendocrine Tumor,2,2,Pancreatic Neuroendocrine Neoplasm,0.8934,Pancreatic Neuroendocrine Tumor,0.8802,Pancreatic Neuroendocrine Carcinoma,0.8481,Functioning Pancreatic Neuroendocrine Tumor,0.8224,Pancreatic Insulin-Producing Neuroendocrine Tumor,0.8141,Neuroendocrine Neoplasm,0.8049,Pancreatic Neuroendocrine Microtumor,0.7883,Neuroendocrine Tumor,0.7860,Pancreatic Somatostatin-Producing Neuroendocrine Tumor,0.7750,Advanced Pancreatic Neuroendocrine Neoplasm,0.7681,Advanced Pancreatic Neuroendocrine Tumor,0.7680,Pancreatic Serotonin-Producing Neuroendocrine Tumor,0.7616,Pancreatic Neuroendocrine Tumor G3,0.7610,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0.7599,Pancreatic Neuroendocrine Tumor G1,0.7594,Metastatic Pancreatic Neuroendocrine Neoplasm,0.7589,Pancreatic Delta Cell Neuroendocrine Tumor,0.7573,Pancreatic ACTH-Producing Neuroendocrine Tumor,0.7533,Pituitary Neuroendocrine Tumor,0.7527,Pancreatic VIP-Producing Neuroendocrine Tumor,0.7447,PANCREATIC NEUROENDOCRINE,False,True,True
PANCREATIC NEUROENDOCRINE TUMOR,Pancreatic Neuroendocrine Tumor,1,2,Pancreatic Neuroendocrine Tumor,1.0000,Pancreatic Neuroendocrine Neoplasm,0.9561,Pancreatic Insulin-Producing Neuroendocrine Tumor,0.8992,Functioning Pancreatic Neuroendocrine Tumor,0.8955,Neuroendocrine Tumor,0.8806,Pancreatic Neuroendocrine Carcinoma,0.8671,Pancreatic Somatostatin-Producing Neuroendocrine Tumor,0.8623,Advanced Pancreatic Neuroendocrine Tumor,0.8598,Prostate Neuroendocrine Tumor,0.8595,Pancreatic Serotonin-Producing Neuroendocrine Tumor,0.8561,Metastatic Pancreatic Neuroendocrine Tumor,0.8518,Pituitary Neuroendocrine Tumor,0.8471,Pancreatic Delta Cell Neuroendocrine Tumor,0.8461,Neuroendocrine Neoplasm,0.8457,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0.8358,Pancreatic Neuroendocrine Microtumor,0.8324,Non-Functioning Pancreatic Neuroendocrine Tumor,0.8293,Intestinal Neuroendocrine Tumor,0.8254,Pancreatic ACTH-Producing Neuroendocrine Tumor,0.8254,Pancreatic Neuroendocrine Tumor G1,0.8249,PANCREATIC NEUROENDOCRINE TUMOR,True,True,True
PANCREATIC_CANCER,Exocrine Pancreas Carcinoma,18,2,Pancreatic Carcinoma,0.9104,Pancreatic Neoplasm,0.8570,Malignant Pancreatic Neoplasm,0.8437,Pancreatic Adenocarcinoma,0.8237,Advanced Pancreatic Carcinoma,0.7916,Pancreatic Neuroendocrine Carcinoma,0.7747,Pancreatic Undifferentiated Carcinoma,0.7696,Metastatic Pancreatic Carcinoma,0.7654,Hereditary Pancreatic Carcinoma,0.7440,Pancreatic Lymphoma,0.7353,Pancreatic Neuroendocrine Neoplasm,0.7342,Metastatic Malignant Pancreatic Neoplasm,0.7307,Advanced Pancreatic Adenocarcinoma,0.7262,Unresectable Pancreatic Carcinoma,0.7223,Pancreatic Exocrine Neoplasm,0.7219,Pancreatic Neuroendocrine Tumor,0.7218,Pancreatic Polypeptide Tumor,0.7202,Exocrine Pancreas Carcinoma,0.7195,Pancreatic Medullary Carcinoma,0.7162,Pancreatic Precancerous Condition,0.7149,PANCREATIC_CANCER,False,False,False
PANCREATOBILIARY,Pancreatobiliary Carcinoma,1,2,Pancreatobiliary Carcinoma,0.8265,Advanced Pancreatobiliary Carcinoma,0.7573,Metastatic Pancreatobiliary Carcinoma,0.7176,Locally Advanced Pancreatobiliary Carcinoma,0.7002,Benign Pancreatic Neoplasm,0.6955,Refractory Pancreatobiliary Carcinoma,0.6695,Pancreatoblastoma,0.6485,Malignant Pancreatic Neoplasm,0.6482,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0.6419,Pancreatic Carcinoma,0.6376,Benign Exocrine Pancreas Neoplasm,0.6284,Pancreatic Adenocarcinoma,0.6234,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0.6227,Advanced Pancreatic Carcinoma,0.6226,Pancreatic Ductal Adenocarcinoma,0.6217,Childhood Pancreatoblastoma,0.6157,Malignant Pancreatic Gastrinoma,0.6146,Pancreatic Gastrinoma,0.6141,Pancreatic Neoplasm,0.6121,Benign Periampullary Neoplasm,0.6113,PANCREATOBILIARY,True,True,True
PANCREATOBILIARY AMPULLARY CARCINOMA,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,1,2,Ampulla of Vater Pancreatobiliary Type Adenocarcinoma,0.8503,Pancreatobiliary Carcinoma,0.8284,Advanced Pancreatobiliary Carcinoma,0.7867,Ampulla of Vater Carcinoma,0.7854,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",0.7751,Advanced Ampulla of Vater Carcinoma,0.7682,Metastatic Ampulla of Vater Carcinoma,0.7649,Locally Advanced Pancreatobiliary Carcinoma,0.7488,Ampulla of Vater Undifferentiated Carcinoma,0.7476,Ampulla of Vater Invasive Papillary Adenocarcinoma,0.7461,Metastatic Pancreatobiliary Carcinoma,0.7438,Ampulla of Vater Neuroendocrine Carcinoma,0.7423,Ampulla of Vater Adenocarcinoma,0.7346,Pancreatic Intraductal Papillary-Mucinous Carcinoma,0.7298,Periampullary Adenocarcinoma,0.7266,Locally Advanced Ampulla of Vater Carcinoma,0.7256,Ampulla of Vater Mucinous Adenocarcinoma,0.7212,Ampulla of Vater Intestinal-Type Adenocarcinoma,0.7169,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0.7081,Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,0.7045,PANCREATOBILIARY AMPULLARY CARCINOMA,True,True,True
PANCREATOBLASTOMA,Pancreatoblastoma,1,2,Pancreatoblastoma,1.0000,Childhood Pancreatoblastoma,0.8841,Pancreatic Gastrinoma,0.7522,Pancreatic Beta Cell Adenoma,0.7521,Pancreatic G-Cell Adenoma,0.7393,Pancreatic Insulinoma,0.7271,Pancreatic Carcinoma,0.7171,Pancreatobiliary Carcinoma,0.7117,Pancreatic Lymphoma,0.7106,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0.7090,Pancreatic Acinar Cell Neoplasm,0.7063,Malignant Pancreatic Gastrinoma,0.7048,Pancreatic Adenocarcinoma,0.7024,Islet Cell Adenoma,0.7004,Benign Pancreatic Neoplasm,0.6994,Pancreatic Neoplasm,0.6960,Gastroblastoma,0.6947,Pancreatic Glucagonoma,0.6929,Pancreatic Neuroendocrine Tumor,0.6929,Pancreatic Neuroendocrine Neoplasm,0.6928,PANCREATOBLASTOMA,True,True,True
PANET,Pancreatic Neuroendocrine Tumor,1,2,Pancreatic Neuroendocrine Tumor,1.0000,Pancreatic Neuroendocrine Neoplasm,0.9561,Pancreatic Insulin-Producing Neuroendocrine Tumor,0.8992,Functioning Pancreatic Neuroendocrine Tumor,0.8955,Neuroendocrine Tumor,0.8806,Pancreatic Neuroendocrine Carcinoma,0.8671,Pancreatic Somatostatin-Producing Neuroendocrine Tumor,0.8623,Advanced Pancreatic Neuroendocrine Tumor,0.8598,Prostate Neuroendocrine Tumor,0.8595,Pancreatic Serotonin-Producing Neuroendocrine Tumor,0.8561,Metastatic Pancreatic Neuroendocrine Tumor,0.8518,Pituitary Neuroendocrine Tumor,0.8471,Pancreatic Delta Cell Neuroendocrine Tumor,0.8461,Neuroendocrine Neoplasm,0.8457,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0.8358,Pancreatic Neuroendocrine Microtumor,0.8324,Non-Functioning Pancreatic Neuroendocrine Tumor,0.8293,Intestinal Neuroendocrine Tumor,0.8254,Pancreatic ACTH-Producing Neuroendocrine Tumor,0.8254,Pancreatic Neuroendocrine Tumor G1,0.8249,Pancreatic Neuroendocrine Tumor,True,True,True
PAPILLARY ADENOCARCINOMA 82603,Papillary Adenocarcinoma,1,2,Papillary Adenocarcinoma,0.6486,Invasive Papillary Adenocarcinoma,0.6322,Papillary Carcinoma,0.6155,Gastric Papillary Adenocarcinoma,0.6066,Papillary Cystadenocarcinoma,0.6056,Parotid Gland Adenocarcinoma,0.5885,Aggressive Papillary Tumor,0.5869,Digital Papillary Adenocarcinoma,0.5816,Papillary Mucinous Cystadenocarcinoma,0.5748,Prostate Ductal Adenocarcinoma,0.5740,Papillary Adenoma,0.5730,Prostate Adenocarcinoma,0.5729,Adenocarcinoma,0.5725,Pancreatic Adenocarcinoma,0.5721,Lung Papillary Adenocarcinoma,0.5701,Parotid Gland Adenoid Cystic Carcinoma,0.5678,Prostate Acinar Mucinous Adenocarcinoma,0.5673,Invasive Adenocarcinoma in Adenomatous Polyp,0.5662,Papillary Serous Cystadenocarcinoma,0.5655,Papillary Eccrine Carcinoma,0.5647,PAPILLARY ADENOCARCINOMA 82603,True,True,True
PAPILLARY CARCINOMA,Papillary Carcinoma,1,2,Papillary Carcinoma,1.0000,Papillary Adenocarcinoma,0.9039,Thyroid Gland Papillary Carcinoma,0.8479,Invasive Papillary Adenocarcinoma,0.8283,Papillary Squamous Cell Carcinoma,0.8275,Papillary Neoplasm,0.8229,Breast Papillary Carcinoma,0.8224,Classic Thyroid Gland Papillary Carcinoma,0.8027,Papillary Transitional Cell Carcinoma,0.7987,Aggressive Papillary Tumor,0.7802,Gastric Papillary Adenocarcinoma,0.7794,Papillary Epithelial Neoplasm,0.7779,Lung Papillary Adenocarcinoma,0.7775,Invasive Breast Papillary Carcinoma,0.7766,Penile Papillary Carcinoma,0.7745,Papillary Adenoma,0.7726,Papillary Renal Cell Carcinoma,0.7669,Carcinoma,0.7624,Papillary Cystadenocarcinoma,0.7599,Prostate Carcinoma,0.7502,PAPILLARY CARCINOMA,True,True,True
"PAPILLARY CARCINOMA, DIFFUSE SCLEROSING VARIANT",Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,1,2,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.9083,Papillary Squamous Cell Carcinoma,0.7154,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0.7093,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,0.7000,Non-Invasive Papillary Squamous Cell Carcinoma,0.6702,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.6697,"Lung Squamous Cell Carcinoma, Papillary Variant",0.6627,Papillary Carcinoma,0.6610,Sclerosing Polycystic Adenoma,0.6555,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0.6541,Sclerosing Pneumocytoma,0.6508,Micropapillary Serous Carcinoma,0.6489,Sclerosing Odontogenic Carcinoma,0.6480,Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma,0.6472,Papillary Adenocarcinoma,0.6426,Breast Sclerosing Papilloma,0.6424,Micropapillary Carcinoma,0.6414,Skin Sclerosing/Morphoeic Basal Cell Carcinoma,0.6281,Serous Surface Papillary Carcinoma,0.6271,Encapsulated Variant Thyroid Gland Papillary Carcinoma,0.6267,"PAPILLARY CARCINOMA, DIFFUSE SCLEROSING VARIANT",True,True,True
PAPILLARY CARCINOMA: MIXED PAPILLARY AND FOLLICULAR VARIANT,Follicular Variant Thyroid Gland Papillary Carcinoma,1,2,Follicular Variant Thyroid Gland Papillary Carcinoma,0.7796,Thyroid Gland Papillary and Follicular Carcinoma,0.7765,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,0.7681,Thyroid Gland Mixed Medullary and Papillary Carcinoma,0.7325,Thyroid Gland Mixed Medullary and Follicular Carcinoma,0.7128,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.7100,Invasive Follicular Variant Thyroid Gland Papillary Carcinoma,0.7091,Invasive Encapsulated Follicular Variant Thyroid Gland Papillary Carcinoma,0.7002,Multicentric Thyroid Gland Papillary Carcinoma,0.6984,Thyroid Gland Mixed Medullary and Follicular Cell-Derived Carcinoma,0.6980,Encapsulated Variant Thyroid Gland Papillary Carcinoma,0.6918,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,0.6905,Papillary Carcinoma,0.6873,Classic Thyroid Gland Papillary Carcinoma,0.6834,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0.6765,Thyroid Gland Papillary Carcinoma,0.6729,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like/Desmoid-Type Stroma,0.6690,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.6639,Metastatic Thyroid Gland Papillary Carcinoma,0.6491,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0.6482,PAPILLARY CARCINOMA: MIXED PAPILLARY AND FOLLICULAR VARIANT,True,True,True
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND,Breast Papillary Ductal Carcinoma In Situ with Invasion,3,2,Invasive Breast Papillary Carcinoma,0.8527,Breast Papillary Ductal Carcinoma In Situ,0.8164,Breast Papillary Ductal Carcinoma In Situ with Invasion,0.8091,Breast Papillary Carcinoma,0.7931,Invasive Breast Carcinoma of No Special Type with Predominant Intraductal Component,0.7602,Invasive Breast Solid Papillary Carcinoma,0.7570,Poorly Differentiated Invasive Breast Carcinoma,0.7553,Breast Intracystic Papillary Carcinoma,0.7541,Breast Micropapillary Ductal Carcinoma In Situ,0.7521,Invasive Breast Micropapillary Carcinoma,0.7486,Prostate Intraductal Carcinoma,0.7425,Breast Ductal Carcinoma,0.7416,Invasive Papillary Adenocarcinoma,0.7404,Breast Solid Papillary Carcinoma,0.7247,Encapsulated Breast Papillary Carcinoma with Invasion,0.7229,Salivary Gland Intraductal Carcinoma,0.7113,Breast Intraductal Papilloma,0.7071,Pancreatic Intraductal Papillary-Mucinous Carcinoma,0.7051,Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma,0.7038,Invasive Breast Lobular Carcinoma with Predominant In Situ Component,0.6899,PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND,False,True,True
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND; BREAST,Breast Papillary Ductal Carcinoma In Situ with Invasion,3,2,Invasive Breast Papillary Carcinoma,0.8595,Breast Papillary Ductal Carcinoma In Situ,0.8355,Breast Papillary Ductal Carcinoma In Situ with Invasion,0.8260,Breast Papillary Carcinoma,0.8149,Breast Intracystic Papillary Carcinoma,0.7711,Invasive Breast Solid Papillary Carcinoma,0.7678,Invasive Breast Carcinoma of No Special Type with Predominant Intraductal Component,0.7579,Breast Micropapillary Ductal Carcinoma In Situ,0.7506,Breast Solid Papillary Carcinoma,0.7469,Breast Ductal Carcinoma,0.7438,Poorly Differentiated Invasive Breast Carcinoma,0.7404,Invasive Breast Micropapillary Carcinoma,0.7367,Encapsulated Breast Papillary Carcinoma with Invasion,0.7338,Breast Intraductal Papilloma,0.7297,Breast Solid Papillary Carcinoma In Situ,0.7204,Breast Intraductal Papillary Neoplasm,0.7107,Breast Intraductal Papillomatosis,0.7086,Prostate Intraductal Carcinoma,0.7009,Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma,0.6962,Breast Papillary Neoplasm,0.6915,PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND; BREAST,False,True,True
PAPILLARY KIDNEY RENAL CELL CARCINOMA,Papillary Renal Cell Carcinoma,1,2,Papillary Renal Cell Carcinoma,0.9777,Sporadic Papillary Renal Cell Carcinoma,0.8925,Type 1 Papillary Renal Cell Carcinoma,0.8699,Advanced Papillary Renal Cell Carcinoma,0.8630,Type 2 Papillary Renal Cell Carcinoma,0.8624,Clear Cell Papillary Renal Tumor,0.8565,Hereditary Papillary Renal Cell Carcinoma,0.8319,Renal Cell Carcinoma,0.8181,Locally Advanced Papillary Renal Cell Carcinoma,0.8181,Kidney Carcinoma,0.8137,Metastatic Papillary Renal Cell Carcinoma,0.8055,Renal Pelvis Papillary Urothelial Carcinoma,0.8023,Renal Pelvis Urothelial Carcinoma,0.7909,Unresectable Papillary Renal Cell Carcinoma,0.7887,Clear Cell Renal Cell Carcinoma,0.7716,Renal Papillary Adenoma,0.7622,Papillary Transitional Cell Carcinoma,0.7619,Renal Pelvis Carcinoma,0.7552,Kidney Medullary Carcinoma,0.7515,Granular Renal Cell Carcinoma,0.7501,PAPILLARY KIDNEY RENAL CELL CARCINOMA,True,True,True
PAPILLARY RENAL CELL CARCINOMA,Papillary Renal Cell Carcinoma,1,2,Papillary Renal Cell Carcinoma,1.0000,Sporadic Papillary Renal Cell Carcinoma,0.9125,Type 1 Papillary Renal Cell Carcinoma,0.8879,Advanced Papillary Renal Cell Carcinoma,0.8845,Type 2 Papillary Renal Cell Carcinoma,0.8839,Clear Cell Papillary Renal Tumor,0.8717,Renal Cell Carcinoma,0.8499,Hereditary Papillary Renal Cell Carcinoma,0.8437,Locally Advanced Papillary Renal Cell Carcinoma,0.8294,Metastatic Papillary Renal Cell Carcinoma,0.8265,Unresectable Papillary Renal Cell Carcinoma,0.8055,Kidney Carcinoma,0.8006,Clear Cell Renal Cell Carcinoma,0.7940,Renal Pelvis Papillary Urothelial Carcinoma,0.7908,Papillary Transitional Cell Carcinoma,0.7890,Renal Pelvis Urothelial Carcinoma,0.7809,Non-Clear Cell Renal Cell Carcinoma,0.7744,Renal Papillary Adenoma,0.7734,Renal Pelvis Carcinoma,0.7683,Papillary Carcinoma,0.7669,PAPILLARY RENAL CELL CARCINOMA,True,True,True
PAPILLARY STOMACH ADENOCARCINOMA,Gastric Papillary Adenocarcinoma,1,2,Gastric Papillary Adenocarcinoma,0.9565,Proximal Gastric Adenocarcinoma,0.8331,Papillary Adenocarcinoma,0.8321,Gastric Adenocarcinoma,0.8157,Sporadic Gastric Adenocarcinoma,0.7939,Gastric Parietal Cell Adenocarcinoma,0.7868,Helicobacter Pylori-Related Gastric Adenocarcinoma,0.7629,Lung Papillary Adenocarcinoma,0.7583,Gastric Tubular Adenocarcinoma,0.7542,Invasive Papillary Adenocarcinoma,0.7462,Gastric Diffuse Adenocarcinoma,0.7460,Gastric Adenoma,0.7414,Papillary Carcinoma,0.7403,Advanced Gastric Adenocarcinoma,0.7363,Sporadic Gastric Diffuse Adenocarcinoma,0.7344,Gastric Pyloric Gland Adenoma,0.7316,Gastric Cardia Adenocarcinoma,0.7226,Digital Papillary Adenocarcinoma,0.7202,Gastric Carcinoma,0.7199,Gastric Poorly Cohesive Adenocarcinoma,0.7181,PAPILLARY STOMACH ADENOCARCINOMA,True,True,True
PAPILLARY THROID CARCINOMA,Thyroid Gland Papillary Carcinoma,1,2,Thyroid Gland Papillary Carcinoma,0.7631,Classic Thyroid Gland Papillary Carcinoma,0.7613,Papillary Carcinoma,0.7609,Papillary Transitional Cell Carcinoma,0.7285,Papillary Adenocarcinoma,0.7191,Aggressive Papillary Tumor,0.7165,Papillary Squamous Cell Carcinoma,0.7154,Trichoepithelial Carcinoma,0.7119,Thyroid Gland Carcinoma,0.7112,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0.7025,Trichoblastic Carcinoma,0.7009,Thyroid Gland Mucinous Carcinoma,0.6977,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.6976,Papillary Cystadenocarcinoma,0.6933,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,0.6930,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.6921,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,0.6905,Thyroid Gland Secretory Carcinoma,0.6886,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.6876,Digital Papillary Adenocarcinoma,0.6834,PAPILLARY THROID CARCINOMA,True,True,True
PAPILLARY THYROID CANCER,Thyroid Gland Papillary Carcinoma,1,2,Thyroid Gland Papillary Carcinoma,0.9468,Classic Thyroid Gland Papillary Carcinoma,0.9104,Thyroid Gland Papillary and Follicular Carcinoma,0.8260,Papillary Carcinoma,0.8249,Thyroid Gland Carcinoma,0.7934,Childhood Thyroid Gland Papillary Carcinoma,0.7910,Metastatic Thyroid Gland Papillary Carcinoma,0.7801,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.7684,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.7648,Poorly Differentiated Thyroid Gland Carcinoma,0.7648,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0.7635,Papillary Adenocarcinoma,0.7559,Follicular Variant Thyroid Gland Papillary Carcinoma,0.7535,Differentiated Thyroid Gland Carcinoma,0.7468,Multicentric Thyroid Gland Papillary Carcinoma,0.7429,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.7410,Unresectable Thyroid Gland Papillary Carcinoma,0.7370,Thyroid Gland Follicular Carcinoma,0.7360,Thyroid Gland Mixed Medullary and Papillary Carcinoma,0.7326,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,0.7305,PAPILLARY THYROID CANCER,True,True,True
"PAPILLARY, FOLLICULAR",Thyroid Gland Papillary and Follicular Carcinoma,99,2,Papillary Neoplasm,0.7143,Papillary Adenoma,0.6970,Papillary Adenofibroma,0.6899,Thyroid Gland Follicular Adenoma with Papillary Architecture,0.6814,Papillary Epithelial Neoplasm,0.6757,Follicular Myxoma,0.6593,Papillary Carcinoma,0.6576,Papillary Adenocarcinoma,0.6574,Parotid Gland Follicular Lymphoma,0.6551,Papillary Cystic Neoplasm,0.6521,Papillary Meningioma,0.6434,Prostate Follicular Lymphoma,0.6410,Breast Papillary Neoplasm,0.6409,Follicular Lymphoma,0.6379,Thyroid Gland Follicular Lymphoma,0.6326,Papillary Cystadenoma,0.6311,Glandular Papilloma,0.6303,Serous Surface Papilloma,0.6259,Ovarian Papillary Tumor,0.6250,Classic Follicular Lymphoma,0.6224,"PAPILLARY, FOLLICULAR",False,False,False
"PAPILLARY, TALL CELL VARIANT",Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.8665,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0.7105,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0.7028,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.7026,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,0.6731,Classic Thyroid Gland Papillary Carcinoma,0.6621,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.6616,Hobnail Variant Thyroid Gland Papillary Carcinoma,0.6612,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,0.6605,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,0.6585,Follicular Variant Thyroid Gland Papillary Carcinoma,0.6512,Aggressive Papillary Tumor,0.6478,Thyroid Gland Papillary Carcinoma,0.6462,Papillary Carcinoma,0.6383,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.6370,"Lung Squamous Cell Carcinoma, Papillary Variant",0.6264,Papillary Transitional Cell Carcinoma,0.6240,"T-Cell Prolymphocytic Leukemia, Small Cell Variant",0.6203,Papillary Neoplasm,0.6154,Papillary Adenoma,0.6088,"PAPILLARY, TALL CELL VARIANT",True,True,True
PAPILLARY_ADENOCARCINOMA,Papillary Adenocarcinoma,1,2,Papillary Adenocarcinoma,0.9585,Invasive Papillary Adenocarcinoma,0.8556,Papillary Carcinoma,0.8535,Lung Papillary Adenocarcinoma,0.8299,Gastric Papillary Adenocarcinoma,0.8281,Papillary Adenoma,0.8015,Digital Papillary Adenocarcinoma,0.7944,"Prostate Ductal Adenocarcinoma, Papillary Pattern",0.7827,Papillary Cystadenocarcinoma,0.7742,Adenocarcinoma,0.7702,Papillary Neoplasm,0.7625,Prostate Adenocarcinoma,0.7565,Adenocarcinoma in Adenomatous Polyp,0.7512,Prostate Ductal Adenocarcinoma,0.7488,Aggressive Papillary Tumor,0.7464,Prostate Acinar Adenocarcinoma,0.7361,Pancreatic Adenocarcinoma,0.7319,Papillary Mucinous Cystadenocarcinoma,0.7316,Tubular Adenocarcinoma,0.7189,Parotid Gland Adenocarcinoma,0.7176,PAPILLARY_ADENOCARCINOMA,True,True,True
PAPILLARY_CARCINOMA,Papillary Carcinoma,1,2,Papillary Carcinoma,0.9559,Papillary Adenocarcinoma,0.8575,Thyroid Gland Papillary Carcinoma,0.8090,Papillary Neoplasm,0.8016,Breast Papillary Carcinoma,0.7910,Papillary Squamous Cell Carcinoma,0.7897,Invasive Papillary Adenocarcinoma,0.7859,Papillary Transitional Cell Carcinoma,0.7690,Papillary Epithelial Neoplasm,0.7639,Classic Thyroid Gland Papillary Carcinoma,0.7543,Carcinoma,0.7475,Papillary Cystadenocarcinoma,0.7424,Invasive Breast Papillary Carcinoma,0.7393,Lung Papillary Adenocarcinoma,0.7330,Gastric Papillary Adenocarcinoma,0.7324,Papillary Adenoma,0.7319,Aggressive Papillary Tumor,0.7273,Papillary Renal Cell Carcinoma,0.7267,Papillary Urothelial Neoplasm,0.7230,Penile Papillary Carcinoma,0.7227,PAPILLARY_CARCINOMA,True,True,True
PAPILLARY_TRANSITIONAL_CELL_CARCINOMA,Papillary Transitional Cell Carcinoma,1,2,Papillary Transitional Cell Carcinoma,0.9434,Micropapillary Transitional Cell Carcinoma,0.8379,Transitional Cell Carcinoma,0.8186,Transitional Cell Papilloma,0.7840,Papillary Carcinoma,0.7786,Bladder Papillary Urothelial Carcinoma,0.7634,Papillary Squamous Cell Carcinoma,0.7594,Advanced Transitional Cell Carcinoma,0.7561,Endometrial Transitional Cell Carcinoma,0.7488,Urothelial Carcinoma,0.7409,Prostatic Duct Urothelial Carcinoma,0.7361,Transitional Cell Neoplasm,0.7354,Invasive Micropapillary Urothelial Carcinoma,0.7304,Primary Peritoneal Transitional Cell Carcinoma,0.7276,Sarcomatoid Transitional Cell Carcinoma,0.7247,Papillary Urothelial Neoplasm,0.7204,Urothelial Papilloma,0.7184,Papillary Renal Cell Carcinoma,0.7149,Non-Invasive Papillary Urothelial Carcinoma,0.7090,Locally Advanced Transitional Cell Carcinoma,0.7059,PAPILLARY_TRANSITIONAL_CELL_CARCINOMA,True,True,True
PAPILLOMA,Papilloma,1,2,Papilloma,1.0000,Skin Papilloma,0.9080,Papillomatosis,0.9072,Glandular Papilloma,0.8688,Squamous Papilloma,0.8436,Inverted Papilloma,0.8128,Glandular Papillomatosis,0.8122,Squamous Papillomatosis,0.8060,Eyelid Papilloma,0.8033,Urothelial Papilloma,0.8006,Transitional Cell Papilloma,0.7727,Papillary Neoplasm,0.7666,Bronchial Papilloma,0.7666,Papillary Adenoma,0.7586,Papillary Epithelial Neoplasm,0.7401,Sinonasal Papilloma,0.7394,Laryngeal Papillomatosis,0.7386,Intraductal Papilloma,0.7334,Salivary Gland Ductal Papilloma,0.7329,Breast Peripheral Papilloma,0.7329,PAPILLOMA,True,True,True
PARAGANGLIOMA,Paraganglioma,1,2,Paraganglioma,1.0000,Parasympathetic Paraganglioma,0.9218,Composite Paraganglioma,0.9049,Extra-Adrenal Paraganglioma,0.9044,Central Nervous System Paraganglioma,0.9014,Sympathetic Paraganglioma,0.8941,Advanced Paraganglioma,0.8842,Kidney Paraganglioma,0.8708,Hereditary Paraganglioma,0.8707,Prostate Paraganglioma,0.8698,Thyroid Gland Paraganglioma,0.8549,Vagal Paraganglioma,0.8541,Childhood Paraganglioma,0.8534,Cardiac Paraganglioma,0.8502,Extra-Adrenal Sympathetic Paraganglioma,0.8437,Metastatic Paraganglioma,0.8301,Carotid Body Paraganglioma,0.8277,Non-Metastatic Paraganglioma,0.8261,Childhood Parasympathetic Paraganglioma,0.8259,Nasopharyngeal Paraganglioma,0.8237,PARAGANGLIOMA,True,True,True
PARAGANGLIOMA; EXTRA-ADRENAL PHEOCHROMOCYTOMA,Extra-Adrenal Sympathetic Paraganglioma,4,2,Extra-Adrenal Paraganglioma,0.8818,Paraganglioma,0.8287,Adrenal Gland Pheochromocytoma,0.8245,Extra-Adrenal Sympathetic Paraganglioma,0.8112,Composite Paraganglioma,0.8039,Metastatic Extra-Adrenal Paraganglioma,0.7952,Non-Metastatic Adrenal Gland Pheochromocytoma,0.7812,Regional Adrenal Gland Pheochromocytoma,0.7789,Central Nervous System Paraganglioma,0.7764,Prostate Paraganglioma,0.7717,Advanced Paraganglioma,0.7669,Advanced Adrenal Gland Pheochromocytoma,0.7621,Adrenal Gland Composite Pheochromocytoma,0.7610,Non-Metastatic Adrenal Gland Composite Pheochromocytoma,0.7598,Metastatic Paraganglioma,0.7575,Sympathetic Paraganglioma,0.7555,Metastatic Adrenal Gland Pheochromocytoma,0.7528,Hereditary Paraganglioma,0.7520,Parasympathetic Paraganglioma,0.7518,Kidney Paraganglioma,0.7473,PARAGANGLIOMA; EXTRA-ADRENAL PHEOCHROMOCYTOMA,False,False,True
PARAOSTEAL OSTEOSARCOMA,Parosteal Osteosarcoma,1,2,Parosteal Osteosarcoma,0.8216,Periosteal Osteosarcoma,0.7886,Childhood Parosteal Osteosarcoma,0.7722,Osteosarcoma,0.7674,Primary Bone Osteosarcoma,0.7664,Osteoblastic Osteosarcoma,0.7604,Conventional Osteosarcoma,0.7529,Bone Osteosarcoma,0.7483,Secondary Osteosarcoma,0.7333,Prostate Osteosarcoma,0.7322,Bone Surface (Peripheral) Osteosarcoma,0.7282,Childhood Periosteal Osteosarcoma,0.7274,Localized Osteosarcoma,0.7132,Mixed Osteosarcoma,0.7128,Multifocal Osteosarcoma,0.7121,Extraskeletal Osteosarcoma,0.7109,Metastatic Osteosarcoma,0.7090,Jaw Osteosarcoma,0.7080,Lung Osteosarcoma,0.6954,Osteoblastoma,0.6945,PARAOSTEAL OSTEOSARCOMA,True,True,True
PAST,Pilocytic Astrocytoma,1,2,Pilocytic Astrocytoma,1.0000,Brain Pilocytic Astrocytoma,0.9530,Adult Pilocytic Astrocytoma,0.8974,Juvenile Pilocytic Astrocytoma,0.8877,Childhood Pilocytic Astrocytoma,0.8712,Pilomyxoid Astrocytoma,0.8529,Cerebellar Pilocytic Astrocytoma,0.8467,Spinal Cord Pilocytic Astrocytoma,0.8377,High Grade Astrocytoma with Piloid Features,0.8372,Third Ventricle Pilocytic Astrocytoma,0.8240,Unresectable Pilocytic Astrocytoma,0.8228,Childhood Pilomyxoid Astrocytoma,0.8075,Astrocytoma,0.7883,Fibrillary Astrocytoma,0.7859,Cerebral Astrocytoma,0.7667,Brain Astrocytoma,0.7641,Recurrent Pilocytic Astrocytoma,0.7531,Pineal Gland Astrocytoma,0.7381,Diffuse Astrocytoma,0.7355,Gemistocytic Astrocytoma,0.7342,Pilocytic Astrocytoma,True,True,True
PDA -  SIGNET RING,Pancreatic Signet Ring Cell Adenocarcinoma,2,2,Signet Ring Melanoma,0.7256,Pancreatic Signet Ring Cell Adenocarcinoma,0.6381,Signet Ring Cell Adenocarcinoma,0.6335,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",0.6041,Thyroid Gland Signet Ring Cell Follicular Adenoma,0.6014,Appendix Signet Ring Cell Adenocarcinoma,0.5918,Testicular Signet Ring Stromal Tumor,0.5912,Ampulla of Vater Signet Ring Cell Adenocarcinoma,0.5896,Prostate Acinar Signet Ring Cell-Like Adenocarcinoma,0.5856,Rectal Signet Ring Cell Adenocarcinoma,0.5854,Small Intestinal Signet Ring Cell Adenocarcinoma,0.5848,Ovarian Signet Ring Stromal Tumor,0.5732,Lung Signet Ring Cell Carcinoma,0.5669,Metastatic Signet Ring Cell Adenocarcinoma,0.5647,Gastric Signet Ring Cell Adenocarcinoma,0.5608,Colon Signet Ring Cell Adenocarcinoma,0.5579,Colorectal Signet Ring Cell Adenocarcinoma,0.5576,Rectosigmoid Signet Ring Cell Adenocarcinoma,0.5574,Breast Signet Ring Cell Adenocarcinoma,0.5557,Extrahepatic Bile Duct Signet Ring Cell Adenocarcinoma,0.5500,PDA -  SIGNET RING,False,True,True
PDA - MIXED DUCTAL ENDOCRINE CARCINOMA,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma,1,2,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma,0.7897,Pancreatic Mixed Acinar-Ductal Carcinoma,0.7765,Pancreatic Mixed Adenoneuroendocrine Carcinoma,0.7591,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Tumor,0.7579,Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma,0.7514,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Neoplasm,0.7486,Digestive System Mixed Adenoneuroendocrine Carcinoma,0.7376,Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma,0.7126,Oligometastatic Pancreatic Ductal Adenocarcinoma,0.7014,Mixed Cell Adenocarcinoma,0.6987,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma,0.6939,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,0.6896,Mixed Carcinoma,0.6849,Esophageal Mixed Adenoneuroendocrine Carcinoma,0.6841,Gastric Mixed Adenoneuroendocrine Carcinoma,0.6833,Metastatic Digestive System Mixed Adenoneuroendocrine Carcinoma,0.6800,Ductal Eccrine Adenocarcinoma,0.6742,Unresectable Digestive System Mixed Adenoneuroendocrine Carcinoma,0.6731,Gallbladder Mixed Adenoneuroendocrine Carcinoma,0.6679,Colorectal Mixed Adenoneuroendocrine Carcinoma,0.6675,PDA - MIXED DUCTAL ENDOCRINE CARCINOMA,True,True,True
PDA - MUCINOUS NON-CYSTIC CARCINOMA,Pancreatic Colloid Carcinoma,99,2,Pancreatic Non-Invasive Mucinous Cystadenocarcinoma,0.7793,Pancreatic Mucinous Cystadenocarcinoma,0.7740,Papillary Mucinous Cystadenocarcinoma,0.7583,Pancreatic Mucinous-Cystic Neoplasm,0.7583,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,0.7414,Primary Cutaneous Mucinous Carcinoma,0.7364,Mucinous Cystadenocarcinoma,0.7352,Mucinous Adenocarcinoma,0.7292,"Pancreatic Mucinous-Cystic Neoplasm, Low Grade",0.7216,Pancreatic Mucinous Cystadenoma,0.7160,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,0.7148,Pancreatic Cystadenocarcinoma,0.7125,Mucin-Producing Adenocarcinoma,0.7120,Mucin-Producing Carcinoma,0.7012,Pancreatic Mixed Acinar-Ductal Carcinoma,0.6972,Adenoid Cystic Carcinoma,0.6947,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma,0.6937,Papillary Mucinous Cystadenoma,0.6932,Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma,0.6927,"Pancreatic Mucinous-Cystic Neoplasm, High Grade",0.6919,PDA - MUCINOUS NON-CYSTIC CARCINOMA,False,False,False
PDA - UNDIFFERENTIATED ANAPLASTIC CARCINOMA,Pancreatic Undifferentiated Carcinoma,4,2,Undifferentiated Carcinoma,0.7767,Anaplastic Malignant Neoplasm,0.7663,Prostate Undifferentiated Carcinoma,0.7346,Pancreatic Undifferentiated Carcinoma,0.7292,Undifferentiated Malignant Neoplasm,0.7208,Parotid Gland Undifferentiated Carcinoma,0.6918,Usual Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.6914,Poorly Differentiated Malignant Neoplasm,0.6873,Thyroid Gland Anaplastic Carcinoma,0.6850,Anaplastic Plasmacytoma,0.6840,Pleomorphic Carcinoma,0.6824,Anaplastic Lymphoma,0.6800,Gastric Undifferentiated Carcinoma,0.6791,Adenocarcinoma with Neuroendocrine Differentiation,0.6772,Primary Peritoneal Undifferentiated Carcinoma,0.6725,Poorly Differentiated Thyroid Gland Carcinoma,0.6675,Papillary Adenocarcinoma,0.6658,Diffuse Type Adenocarcinoma,0.6656,Anaplastic Astrocytoma,0.6638,Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.6631,PDA - UNDIFFERENTIATED ANAPLASTIC CARCINOMA,False,False,True
PDA - UNDIFFERENTIATED CARCINOMA SOME MULTINUCLEATED BUT NOT OSTEOCLAST,Pancreatic Undifferentiated Carcinoma,6,2,Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.7604,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.7339,Adenocarcinoma with Neuroendocrine Differentiation,0.6502,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.6499,Undifferentiated Carcinoma,0.6495,Pancreatic Undifferentiated Carcinoma,0.6484,Usual Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.6424,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma,0.6419,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",0.6372,Giant Cell Carcinoma,0.6336,Glassy Cell Carcinoma,0.6330,Prostate Adenocarcinoma without Neuroendocrine Differentiation,0.6300,Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.6295,Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma,0.6227,Adenocarcinoma with Osseous Metaplasia,0.6149,Parotid Gland Undifferentiated Carcinoma,0.6143,Pancreatic Undifferentiated Carcinoma with Rhabdoid Cells,0.6121,Carcinoma ex Pleomorphic Adenoma,0.6108,Skin Squamous Cell Carcinoma with Osteoclast-Like Giant Cells,0.6103,"Primary Intraosseous Carcinoma, Not Otherwise Specified",0.6077,PDA - UNDIFFERENTIATED CARCINOMA SOME MULTINUCLEATED BUT NOT OSTEOCLAST,False,False,False
PDA - UNDIFFERENTIATED CARCINOMA WITH OSTEOCLAST LIKE GIANT CELLS,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1,2,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.8604,Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.8307,Giant Cell Carcinoma,0.7431,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.7327,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.7140,Skin Squamous Cell Carcinoma with Osteoclast-Like Giant Cells,0.7066,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,0.7036,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",0.6968,Glassy Cell Carcinoma,0.6858,Breast Carcinoma with Osteoclast-Like Stromal Giant Cells,0.6748,Malignancy in Giant Cell Tumor of Bone,0.6684,Osteoclastic Giant Cell-Rich Tumor of Bone,0.6670,Malignant Giant Cell Neoplasm,0.6662,Undifferentiated Carcinoma,0.6647,Giant Cell Tumor of Bone,0.6645,Aggressive Osteoblastoma,0.6586,Ghost Cell Odontogenic Carcinoma,0.6470,Lung Giant Cell Carcinoma,0.6421,Pancreatic Undifferentiated Carcinoma with Rhabdoid Cells,0.6401,Usual Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.6401,PDA - UNDIFFERENTIATED CARCINOMA WITH OSTEOCLAST LIKE GIANT CELLS,True,True,True
PENILE CANCER,Penile Carcinoma,1,2,Penile Carcinoma,0.9585,Penile Neoplasm,0.8992,Malignant Penile Neoplasm,0.8688,Adult Penile Carcinoma,0.8482,Advanced Penile Carcinoma,0.8361,Penile Papillary Carcinoma,0.8346,Penile Squamous Cell Carcinoma,0.7984,Childhood Malignant Penile Neoplasm,0.7878,Metastatic Penile Carcinoma,0.7874,Unresectable Penile Carcinoma,0.7857,Penile Lymphoma,0.7788,Penile Melanoma,0.7738,Locally Advanced Penile Carcinoma,0.7684,Penile Warty Carcinoma,0.7676,Penile Basal Cell Carcinoma,0.7642,Benign Penile Neoplasm,0.7604,Penile Sarcoma,0.7554,Penile Urethral Malignant Neoplasm,0.7508,Prostate Carcinoma,0.7446,Refractory Penile Carcinoma,0.7422,PENILE CANCER,True,True,True
PENILE SQUAMOUS CELL CARCINOMA,Penile Squamous Cell Carcinoma,1,2,Penile Squamous Cell Carcinoma,1.0000,"Penile Squamous Cell Carcinoma, Not Otherwise Specified",0.9086,Penile Clear Cell Squamous Cell Carcinoma,0.8958,Penile Carcinoma,0.8554,"Penile Squamous Cell Carcinoma, Usual Type",0.8410,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,0.8383,Penile Acantholytic Squamous Cell Carcinoma,0.8318,Penile Basaloid Squamous Cell Carcinoma,0.8300,Locally Advanced Penile Squamous Cell Carcinoma,0.8286,Metastatic Penile Squamous Cell Carcinoma,0.8100,Prostate Squamous Cell Carcinoma,0.8013,Penile Sarcomatoid Carcinoma,0.7961,Penile Basal Cell Carcinoma,0.7944,Penile Papillary Carcinoma,0.7907,Penile Mixed Squamous Cell Carcinoma,0.7902,Unresectable Penile Squamous Cell Carcinoma,0.7826,Penile Adenosquamous Carcinoma,0.7816,Adult Penile Carcinoma,0.7722,Penile Warty Carcinoma,0.7555,Advanced Penile Carcinoma,0.7535,PENILE SQUAMOUS CELL CARCINOMA,True,True,True
PERIHILAR CHOLANGIOCARCINOMA,Hilar Cholangiocarcinoma,1,2,Hilar Cholangiocarcinoma,0.8166,Cholangiocarcinoma,0.7818,Advanced Hilar Cholangiocarcinoma,0.7801,Advanced Cholangiocarcinoma,0.7637,Locally Advanced Cholangiocarcinoma,0.7585,Distal Cholangiocarcinoma,0.7582,Intrahepatic Cholangiocarcinoma,0.7570,Advanced Intrahepatic Cholangiocarcinoma,0.7536,Adult Cholangiocarcinoma,0.7493,Unresectable Hilar Cholangiocarcinoma,0.7217,Small Duct Intrahepatic Cholangiocarcinoma,0.7203,Unresectable Cholangiocarcinoma,0.7195,Large Duct Intrahepatic Cholangiocarcinoma,0.7167,Locally Advanced Intrahepatic Cholangiocarcinoma,0.7161,Advanced Distal Cholangiocarcinoma,0.7146,Clear Cell Intrahepatic Cholangiocarcinoma,0.7067,Metastatic Hilar Cholangiocarcinoma,0.6967,Mucin-Producing Intrahepatic Cholangiocarcinoma,0.6965,Metastatic Cholangiocarcinoma,0.6924,Unresectable Intrahepatic Cholangiocarcinoma,0.6870,PERIHILAR CHOLANGIOCARCINOMA,True,True,True
PERIOSTEAL OSTEOSARCOMA,Periosteal Osteosarcoma,1,2,Periosteal Osteosarcoma,1.0000,Childhood Periosteal Osteosarcoma,0.8977,Parosteal Osteosarcoma,0.8192,Osteoblastic Osteosarcoma,0.8017,Primary Bone Osteosarcoma,0.7993,Bone Surface (Peripheral) Osteosarcoma,0.7957,Bone Osteosarcoma,0.7897,Osteosarcoma,0.7862,Conventional Osteosarcoma,0.7835,Periosteal Fibroma,0.7783,Periosteal Chondrosarcoma,0.7668,Periosteal Fibrosarcoma,0.7609,Childhood Parosteal Osteosarcoma,0.7538,Fibroblastic Osteosarcoma,0.7468,Osteoblastoma,0.7450,Jaw Osteosarcoma,0.7441,Periosteal Chondroma,0.7342,Extraskeletal Osteosarcoma,0.7250,Secondary Osteosarcoma,0.7236,Multifocal Osteosarcoma,0.7202,PERIOSTEAL OSTEOSARCOMA,True,True,True
PERIPHERAL MEDULLOEPITHELIOMA,Central Nervous System Medulloepithelioma,1,2,Central Nervous System Medulloepithelioma,0.9341,Medulloepithelioma Not Otherwise Specified,0.8980,Visual Pathway Medulloepithelioma,0.8962,Ciliary Body Medulloepithelioma,0.8509,Benign Ciliary Body Medulloepithelioma,0.8135,Malignant Ciliary Body Medulloepithelioma,0.7938,Medullomyoblastoma,0.7706,Ciliary Body Teratoid Medulloepithelioma,0.7595,Peripheral Primitive Neuroectodermal Tumor,0.7449,Benign Ciliary Body Teratoid Medulloepithelioma,0.7342,Primitive Neuroectodermal Tumor,0.7219,Localized Peripheral Primitive Neuroectodermal Tumor,0.7143,Peripheral Ganglioneuroblastoma,0.7108,Localized Primitive Neuroectodermal Tumor,0.6873,Melanocytic Medulloblastoma,0.6838,Peripheral Primitive Neuroectodermal Tumor of Bone,0.6787,Central Nervous System Ganglioneuroblastoma,0.6783,Peripheral Primitive Neuroectodermal Tumor of Kidney,0.6737,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues,0.6732,Localized Peripheral Primitive Neuroectodermal Tumor of Bone,0.6691,PERIPHERAL MEDULLOEPITHELIOMA,True,True,True
PERIPHERAL NEUROECTODERMAL TUMOR,Peripheral Primitive Neuroectodermal Tumor,1,2,Peripheral Primitive Neuroectodermal Tumor,0.9649,Primitive Neuroectodermal Tumor,0.9076,Peripheral Primitive Neuroectodermal Tumor of Bone,0.8791,Localized Peripheral Primitive Neuroectodermal Tumor,0.8574,Localized Peripheral Primitive Neuroectodermal Tumor of Bone,0.8091,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues,0.8002,Peripheral Primitive Neuroectodermal Tumor of Kidney,0.7953,Localized Primitive Neuroectodermal Tumor,0.7952,Refractory Peripheral Primitive Neuroectodermal Tumor,0.7862,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7753,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7654,Recurrent Peripheral Primitive Neuroectodermal Tumor,0.7609,Peripheral Nervous System Neoplasm,0.7529,Refractory Primitive Neuroectodermal Tumor,0.7491,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7452,Neuroepithelial Neoplasm,0.7433,Peripheral Neuroblastoma,0.7432,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0.7278,"Neuroepithelial, Perineurial, and Schwann Cell Neoplasm",0.7248,Melanotic Neuroectodermal Tumor,0.7171,PERIPHERAL NEUROECTODERMAL TUMOR,True,True,True
"PERIPHERAL T-CELL LYMPHOMA, NOS","Peripheral T-Cell Lymphoma, Not Otherwise Specified",1,2,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9402,"Peripheral T-Cell Lymphoma, Large Cell",0.8734,"Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.8280,T-Zone Variant Peripheral T-Cell Lymphoma,0.8040,"Childhood Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.8028,T-Cell Non-Hodgkin Lymphoma,0.7971,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",0.7797,Primary Central Nervous System T-Cell Non-Hodgkin Lymphoma,0.7765,"Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7689,T-Cell Prolymphocytic Leukemia,0.7401,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7395,T Lymphoblastic Lymphoma,0.7376,"Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7103,Primary Cutaneous Gamma-Delta T-Cell Lymphoma,0.7094,Low Grade T-Cell Lymphoma,0.7058,T-Cell Chronic Lymphocytic Leukemia,0.7027,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.7016,Methotrexate-Associated Peripheral T-Cell Lymphoma,0.6972,Subcutaneous Panniculitis-Like T-Cell Lymphoma,0.6856,"T-Cell Prolymphocytic Leukemia, Small Cell Variant",0.6852,"PERIPHERAL T-CELL LYMPHOMA, NOS",True,True,True
PERIPHERAL_T_CELL_LYMPHOMA_UNSPECIFIED,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",1,2,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.9171,"Peripheral T-Cell Lymphoma, Large Cell",0.8277,"Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.8157,"Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7762,"Childhood Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7722,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",0.7715,T-Zone Variant Peripheral T-Cell Lymphoma,0.7700,"Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7644,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7362,T-Cell Non-Hodgkin Lymphoma,0.7340,Primary Central Nervous System T-Cell Non-Hodgkin Lymphoma,0.7190,Methotrexate-Associated Peripheral T-Cell Lymphoma,0.6993,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6888,T-Cell Prolymphocytic Leukemia,0.6795,Subcutaneous Panniculitis-Like T-Cell Lymphoma,0.6578,T Lymphoblastic Lymphoma,0.6577,"T-Cell Prolymphocytic Leukemia, Small Cell Variant",0.6566,T-Cell Proliferation of Uncertain Malignant Potential,0.6566,Low Grade T-Cell Lymphoma,0.6564,Primary Cutaneous Gamma-Delta T-Cell Lymphoma,0.6510,PERIPHERAL_T_CELL_LYMPHOMA_UNSPECIFIED,True,True,True
"PERITONEAL CANCER, NOS",Malignant Peritoneal Neoplasm,2,2,Primary Peritoneal Carcinoma,0.8871,Malignant Peritoneal Neoplasm,0.8750,Peritoneal Carcinomatosis,0.8733,Peritoneal Neoplasm,0.8668,Primary Peritoneal Adenocarcinoma,0.8063,Metastatic Carcinoma in the Peritoneum,0.7838,Primary Peritoneal Undifferentiated Carcinoma,0.7598,Advanced Primary Peritoneal Carcinoma,0.7591,Metastatic Primary Peritoneal Carcinoma,0.7582,Peritoneal Malignant Mesothelioma,0.7543,Peritoneal Sarcomatosis,0.7472,Metastatic Malignant Neoplasm in the Peritoneum,0.7471,Malignant Peritoneal Germ Cell Tumor,0.7441,Primary Peritoneal Cancer by AJCC v8 Stage,0.7379,Peritoneal Mesothelial Neoplasm,0.7277,Primary Peritoneal Clear Cell Adenocarcinoma,0.7273,Primary Peritoneal Carcinosarcoma,0.7218,Benign Peritoneal Neoplasm,0.7134,Unresectable Primary Peritoneal Carcinoma,0.7038,Peritoneal Primary Effusion Lymphoma,0.6991,"PERITONEAL CANCER, NOS",False,True,True
PERITONEAL MESOTHELIOMA,Peritoneal Mesothelial Neoplasm,4,2,Peritoneal Malignant Mesothelioma,0.9712,Peritoneal Epithelioid Mesothelioma,0.8890,Metastatic Peritoneal Malignant Mesothelioma,0.8829,Peritoneal Mesothelial Neoplasm,0.8722,Advanced Peritoneal Malignant Mesothelioma,0.8693,Pleural Mesothelioma,0.8674,Peritoneal Sarcomatoid Mesothelioma,0.8622,Peritoneal Biphasic Mesothelioma,0.8503,Pleural Malignant Mesothelioma,0.8335,Malignant Peritoneal Neoplasm,0.8225,Mesothelioma,0.8181,Peritoneal Neoplasm,0.8109,Peritoneal Well Differentiated Papillary Mesothelial Tumor,0.7949,Peritoneal Multicystic Mesothelioma,0.7941,Peritoneal Adenomatoid Tumor,0.7925,Pleural Mesothelial Neoplasm,0.7884,Unresectable Peritoneal Malignant Mesothelioma,0.7857,Pleural Epithelioid Mesothelioma,0.7793,Malignant Mesothelioma,0.7758,Peritoneal Primary Effusion Lymphoma,0.7708,PERITONEAL MESOTHELIOMA,False,False,True
PERITONEAL SEROUS CARCINOMA,Malignant Peritoneal Neoplasm,99,2,Primary Peritoneal Serous Adenocarcinoma,0.8697,Serous Surface Papillary Carcinoma,0.8612,Primary Peritoneal Carcinoma,0.7986,Primary Peritoneal High Grade Serous Adenocarcinoma,0.7954,Borderline Peritoneal Serous Tumor,0.7914,Serous Adenocarcinoma,0.7914,Serous Neoplasm,0.7911,Micropapillary Serous Carcinoma,0.7901,Primary Peritoneal Low Grade Serous Adenocarcinoma,0.7899,Pancreatic Serous Neoplasm,0.7895,Primary Peritoneal Serous Papillary Adenocarcinoma,0.7786,Metastatic Primary Peritoneal Serous Adenocarcinoma,0.7714,Peritoneal Carcinomatosis,0.7563,Primary Peritoneal Carcinosarcoma,0.7553,Serous Cystadenocarcinoma,0.7544,Peritoneal Sarcomatosis,0.7536,Primary Peritoneal Adenocarcinoma,0.7530,Ovarian Serous Adenocarcinoma,0.7505,Ovarian Serous Tumor,0.7460,Endometrial Serous Adenocarcinoma,0.7411,PERITONEAL SEROUS CARCINOMA,False,False,False
PERIVASCULAR EPITHELIOID CELL TUMOR,PEComa,11,2,Epithelioid Trophoblastic Tumor,0.7411,Epithelioid Hemangioendothelioma,0.6777,Epithelioid Sarcoma,0.6774,Pleural Epithelioid Mesothelioma,0.6748,Peritoneal Epithelioid Mesothelioma,0.6743,Pleural Epithelioid Hemangioendothelioma,0.6740,Epithelioid Cell Melanoma,0.6726,Epithelioid Mesothelioma,0.6724,Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.6667,Pleural Proximal-Type Epithelioid Sarcoma,0.6665,PEComa,0.6640,Epithelioid Hemangioma,0.6593,Proximal-Type Epithelioid Sarcoma,0.6505,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.6349,Epithelioid Glioblastoma,0.6337,Ependymal Tumor,0.6252,Penile Epithelioid Hemangioendothelioma,0.6248,Epithelioid Cell Nevus,0.6244,Extrapulmonary Neuroendocrine Carcinoma,0.6239,Epithelioid Malignant Peripheral Nerve Sheath Tumor,0.6233,PERIVASCULAR EPITHELIOID CELL TUMOR,False,False,False
PFA,"Posterior Fossa Ependymoma, Group A (PFA)",15,2,Primary Amyloidosis,0.5818,Lung Fetal Adenocarcinoma,0.5764,Proliferative Fasciitis,0.5739,Familial Adenomatous Polyposis Associated Medulloblastoma,0.5648,Fibrosarcoma,0.5633,Plantar Fibromatosis,0.5609,Prostate Follicular Lymphoma,0.5568,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,0.5564,Bone Fibrosarcoma,0.5530,Retinoblastoma,0.5515,Fibrous Meningioma,0.5512,Polyposis,0.5502,Adenoma,0.5501,Follicular Lymphoma,0.5501,"Posterior Fossa Ependymoma, Group A (PFA)",0.5495,Adenomatous Polyp,0.5480,Fibroma,0.5474,Fibrous Dysplasia,0.5459,Refractory Primary Amyloidosis,0.5443,Advanced Fibrosarcoma,0.5442,PFA,False,False,False
PFB,"Posterior Fossa Ependymoma, Group B (PFB)",1,2,"Posterior Fossa Ependymoma, Group B (PFB)",0.5551,Familial Adenomatous Polyposis Associated Medulloblastoma,0.5509,Proliferative Fasciitis,0.5431,Peripheral Neuroblastoma,0.5361,Prostate Follicular Lymphoma,0.5209,Breast Follicular Lymphoma,0.5116,Branchioma,0.5099,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,0.5090,Diffuse Retinoblastoma,0.5080,Pleuropulmonary Blastoma,0.5042,Papillary Adenofibroma,0.5021,Differentiating Neuroblastoma,0.5019,PALB2 Hereditary Breast Carcinoma,0.5015,Neuroblastoma,0.5000,Diffuse Neurofibroma,0.4995,Polyposis,0.4994,Epithelial Predominant Pulmonary Blastoma,0.4992,Pterygium,0.4986,Penile Neurofibroma,0.4985,Retinoblastoma,0.4972,PFB,True,True,True
PH+-ALL,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,99,2,"Myeloid Leukemia, Philadelphia-Positive",0.6812,CALLA Positive Lymphoblastic Leukemia,0.6214,"Myeloid Leukemia, Philadelphia-Negative",0.6141,AHL Amyloidosis,0.5917,Pre T-ALL,0.5874,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",0.5852,"Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive",0.5840,Common Acute Lymphoblastic Leukemia,0.5820,Progressive Hairy Cell Leukemia Initial Treatment,0.5716,Acute Leukemia,0.5634,Prolymphocytic Leukemia,0.5621,Hematopoietic and Lymphoid Neoplasm by Obsolete Classification,0.5609,Hairy Cell Leukemia Variant,0.5599,Mature T-ALL,0.5572,Hairy Cell Leukemia,0.5555,Hematologic Neoplasm with Germline Predisposition,0.5532,Mixed Phenotype Acute Leukemia,0.5515,Leukemia,0.5475,B-Cell Prolymphocytic Leukemia,0.5463,AH Amyloidosis,0.5463,PH+-ALL,False,False,False
PH-LIKEALL,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,99,2,Prolymphocytic Leukemia,0.6463,"Myeloid Leukemia, Philadelphia-Positive",0.6062,Unfavorable Hodgkin Lymphoma,0.5909,B-Cell Prolymphocytic Leukemia,0.5905,Favorable Hodgkin Lymphoma,0.5783,AHL Amyloidosis,0.5764,Primary Effusion Lymphoma,0.5735,Early Unfavorable Hodgkin Lymphoma,0.5722,Plasma Cell Leukemia,0.5682,Childhood Unfavorable Prognosis Hodgkin Lymphoma,0.5667,"Myeloid Leukemia, Philadelphia-Negative",0.5650,Hyperdiploid B Lymphoblastic Leukemia/Lymphoma,0.5628,Pharyngeal Hodgkin Lymphoma,0.5620,Prostate Non-Hodgkin Lymphoma,0.5606,Childhood Favorable Prognosis Hodgkin Lymphoma,0.5594,Childhood Hodgkin Lymphoma,0.5573,Leukemia,0.5557,Progressive Hairy Cell Leukemia Initial Treatment,0.5555,Advanced Unfavorable Hodgkin Lymphoma,0.5553,Helicobacter Pylori-Related Non-Hodgkin Lymphoma,0.5543,PH-LIKEALL,False,False,False
PHEOCHROMOCYTOMA,Adrenal Gland Pheochromocytoma,1,2,Adrenal Gland Pheochromocytoma,0.9517,Regional Adrenal Gland Pheochromocytoma,0.8755,Adrenal Gland Composite Pheochromocytoma,0.8634,Advanced Adrenal Gland Pheochromocytoma,0.8590,Hereditary Adrenal Gland Pheochromocytoma,0.8312,Non-Metastatic Adrenal Gland Pheochromocytoma,0.8268,Childhood Adrenal Gland Pheochromocytoma,0.8260,Metastatic Adrenal Gland Pheochromocytoma,0.8157,Non-Metastatic Adrenal Gland Composite Pheochromocytoma,0.8102,Locally Advanced Adrenal Gland Pheochromocytoma,0.8085,Unresectable Adrenal Gland Pheochromocytoma,0.7932,Metastatic Adrenal Gland Composite Pheochromocytoma,0.7863,Melanocytoma,0.7659,Pineocytoma,0.7613,Recurrent Adrenal Gland Pheochromocytoma,0.7574,Refractory Adrenal Gland Pheochromocytoma,0.7520,Paraganglioma,0.7382,Extra-Adrenal Paraganglioma,0.7246,Composite Paraganglioma,0.7244,Mastocytoma,0.7086,PHEOCHROMOCYTOMA,True,True,True
PHYLLODES,Phyllodes Tumor,1,2,Phyllodes Tumor,0.8226,Benign Phyllodes Tumor,0.7901,Malignant Phyllodes Tumor,0.7758,Prostate Phyllodes Tumor,0.7681,Breast Phyllodes Tumor,0.7585,Benign Prostate Phyllodes Tumor,0.7528,Benign Breast Phyllodes Tumor,0.7491,Borderline Phyllodes Tumor,0.7228,Malignant Breast Phyllodes Tumor,0.7221,Malignant Prostate Phyllodes Tumor,0.7181,Childhood Breast Phyllodes Tumor,0.7143,Vulvar Phyllodes Tumor,0.6856,Borderline Breast Phyllodes Tumor,0.6810,Benign Vulvar Phyllodes Tumor,0.6775,Refractory Malignant Phyllodes Tumor,0.6529,Malignant Vulvar Phyllodes Tumor,0.6500,Phyllodes Tumor of Anogenital Mammary-Type Glands,0.6268,Borderline Vulvar Phyllodes Tumor,0.6032,Precursor Lymphoid Neoplasm,0.5453,Leukemia,0.5396,PHYLLODES,True,True,True
PILOCYTIC ASTROCYTOMA,Pilocytic Astrocytoma,1,2,Pilocytic Astrocytoma,1.0000,Brain Pilocytic Astrocytoma,0.9530,Adult Pilocytic Astrocytoma,0.8974,Juvenile Pilocytic Astrocytoma,0.8877,Childhood Pilocytic Astrocytoma,0.8712,Pilomyxoid Astrocytoma,0.8529,Cerebellar Pilocytic Astrocytoma,0.8467,Spinal Cord Pilocytic Astrocytoma,0.8377,High Grade Astrocytoma with Piloid Features,0.8372,Third Ventricle Pilocytic Astrocytoma,0.8240,Unresectable Pilocytic Astrocytoma,0.8228,Childhood Pilomyxoid Astrocytoma,0.8075,Astrocytoma,0.7883,Fibrillary Astrocytoma,0.7859,Cerebral Astrocytoma,0.7667,Brain Astrocytoma,0.7641,Recurrent Pilocytic Astrocytoma,0.7531,Pineal Gland Astrocytoma,0.7381,Diffuse Astrocytoma,0.7355,Gemistocytic Astrocytoma,0.7342,PILOCYTIC ASTROCYTOMA,True,True,True
PILOMATRIX CARCINOMA,Pilomatrical Carcinoma,1,2,Pilomatrical Carcinoma,0.9103,Pilomatricoma,0.8727,Childhood Pilomatricoma,0.7755,Sebaceous Carcinoma,0.6963,Pilomyxoid Astrocytoma,0.6913,Polygonal Cell Carcinoma,0.6836,Trichoblastic Carcinoma,0.6825,Pilar Sheath Acanthoma,0.6815,Trichilemmal Carcinoma,0.6769,Bartholin Gland Carcinoma,0.6723,Pilar-Associated Mesenchyme Neoplasm,0.6696,Conjunctival Sebaceous Carcinoma,0.6684,Pilar Leiomyoma,0.6652,Sweat Gland Carcinoma,0.6626,Papillary Eccrine Carcinoma,0.6602,Bartholin Gland Adenosquamous Carcinoma,0.6560,Eyelid Sebaceous Gland Carcinoma,0.6538,Primary Cutaneous Mucinous Carcinoma,0.6528,Keratinizing Squamous Cell Carcinoma,0.6514,Clitoral Carcinoma,0.6490,PILOMATRIX CARCINOMA,True,True,True
PILOMYXOID ASTROCYTOMA,Pilomyxoid Astrocytoma,1,2,Pilomyxoid Astrocytoma,1.0000,Childhood Pilomyxoid Astrocytoma,0.9034,Pilocytic Astrocytoma,0.8529,High Grade Astrocytoma with Piloid Features,0.8069,Brain Pilocytic Astrocytoma,0.8027,Hypothalamic-Chiasmatic Pilomyxoid Astrocytoma,0.7736,Adult Pilocytic Astrocytoma,0.7734,Juvenile Pilocytic Astrocytoma,0.7493,Spinal Cord Pilocytic Astrocytoma,0.7402,Childhood Pilocytic Astrocytoma,0.7385,Recurrent Childhood Pilomyxoid Astrocytoma,0.7364,Fibrillary Astrocytoma,0.7264,Unresectable Pilocytic Astrocytoma,0.7158,Astrocytoma,0.7157,Cerebellar Pilocytic Astrocytoma,0.7145,Third Ventricle Pilocytic Astrocytoma,0.7130,Pilomatricoma,0.7105,Cerebral Astrocytoma,0.6935,Childhood Pilomatricoma,0.6863,Brain Astrocytoma,0.6858,PILOMYXOID ASTROCYTOMA,True,True,True
PINEAL GERM CELL TUMOR,Pineal Region Germ Cell Tumor,1,2,Pineal Region Germ Cell Tumor,0.9804,Malignant Pineal Region Germ Cell Tumor,0.8995,Pineal Region Germinoma,0.8666,Pineal Parenchymal Cell Neoplasm,0.8411,Childhood Pineal Parenchymal Cell Neoplasm,0.8280,Adult Pineal Parenchymal Cell Neoplasm,0.7845,Pineal Region Neoplasm,0.7725,Pineal Parenchymal Tumor of Intermediate Differentiation,0.7697,Pineal Gland Astrocytoma,0.7642,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,0.7600,Pineal Region Yolk Sac Tumor,0.7592,Pineal Region Dysgerminoma,0.7540,Pineal Region Teratoma,0.7524,Pineal Region Immature Teratoma,0.7520,Ovarian Primitive Germ Cell Tumor,0.7400,Childhood Gonadal Germ Cell Tumor,0.7375,Pineal Region Choriocarcinoma,0.7368,Lung Germ Cell Tumor,0.7367,Germ Cell Tumor,0.7342,Papillary Tumor of the Pineal Region,0.7315,PINEAL GERM CELL TUMOR,True,True,True
PINEAL PARENCHYMAL TUMOR OF INTERMEDIATE DIFFERENTIATION,Pineal Parenchymal Tumor of Intermediate Differentiation,1,2,Pineal Parenchymal Tumor of Intermediate Differentiation,1.0000,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,0.9430,Pineal Parenchymal Cell Neoplasm,0.8312,Childhood Pineal Parenchymal Cell Neoplasm,0.7929,Papillary Tumor of the Pineal Region,0.7898,Pineal Gland Astrocytoma,0.7830,Pineal Region Immature Teratoma,0.7820,Adult Pineal Parenchymal Cell Neoplasm,0.7809,Pineal Region Neoplasm,0.7728,Pineal Region Germinoma,0.7715,Pineal Region Germ Cell Tumor,0.7634,Malignant Pineal Region Neoplasm,0.7569,Pineal Region Meningioma,0.7492,Pineal Region Teratoma,0.7484,Benign Pineal Region Neoplasm,0.7440,Pineal Region Mature Teratoma,0.7409,Malignant Pineal Region Germ Cell Tumor,0.7396,Pineal Region Dysgerminoma,0.7250,Adult Pineal Gland Astrocytoma,0.7240,Pineal Region Choriocarcinoma,0.6919,PINEAL PARENCHYMAL TUMOR OF INTERMEDIATE DIFFERENTIATION,True,True,True
PINEAL TUMOR,Pineal Region Neoplasm,1,2,Pineal Region Neoplasm,0.9268,Pineal Parenchymal Cell Neoplasm,0.9044,Pineal Gland Astrocytoma,0.8592,Childhood Pineal Parenchymal Cell Neoplasm,0.8589,Papillary Tumor of the Pineal Region,0.8470,Pineal Region Germ Cell Tumor,0.8436,Malignant Pineal Region Neoplasm,0.8326,Pineal Parenchymal Tumor of Intermediate Differentiation,0.8293,Benign Pineal Region Neoplasm,0.8229,Pineal Region Yolk Sac Tumor,0.8085,Pineal Region Meningioma,0.8079,Pineal Region Germinoma,0.8072,Adult Pineal Parenchymal Cell Neoplasm,0.8067,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,0.8029,Pineal Region Teratoma,0.8021,Pineal Region Immature Teratoma,0.7943,Pineal Region Choriocarcinoma,0.7828,Pineoblastoma,0.7787,Malignant Pineal Region Germ Cell Tumor,0.7775,Pineal Region Mature Teratoma,0.7698,PINEAL TUMOR,True,True,True
PINEOBLASTOMA,Pineoblastoma,1,2,Pineoblastoma,1.0000,Childhood Pineoblastoma,0.9194,Adult Pineoblastoma,0.9116,Pineoblastoma Molecular Subtypes,0.9063,Pineocytoma,0.8723,"Pineoblastoma, RB1-Altered",0.8703,Adult Pineocytoma,0.8211,"Pineoblastoma, MYC/FOXR2-Activated",0.8027,Stage M3 Pineoblastoma,0.7889,Stage M4 Pineoblastoma,0.7611,Stage M2 Pineoblastoma,0.7586,Recurrent Childhood Pineoblastoma,0.7578,Pineal Parenchymal Cell Neoplasm,0.7232,Stage M1 Pineoblastoma,0.7196,Pineal Gland Astrocytoma,0.7143,Stage M0 Pineoblastoma,0.7091,Pineoblastoma miRNA Processing Altered 1,0.7010,Neuroendocrine Tumor,0.6946,Prostate Neuroendocrine Tumor,0.6938,Childhood Pineal Parenchymal Cell Neoplasm,0.6929,PINEOBLASTOMA,True,True,True
PITUICYTOMA,Pituicytoma,1,2,Pituicytoma,1.0000,Ependymal Pituicytoma,0.8154,Sellar Neurocytoma,0.7745,Pituitary Gland Neoplasm,0.7420,Sellar Gangliocytoma,0.7249,Pituitary Neuroendocrine Tumor,0.6945,Sellar Chordoma,0.6876,Somatotroph Pituitary Neuroendocrine Tumor,0.6795,Benign Pituitary Gland Neoplasm,0.6769,Hypothalamic Gangliocytoma,0.6768,Pituitary Gland Basophil Carcinoma,0.6615,Pituitary Stalk Meningioma,0.6611,Malignant Pituitary Gland Neoplasm,0.6599,Pituitary Neuroendocrine Tumor without Distinct Lineage Differentiation,0.6596,Functioning Pituitary Neuroendocrine Tumor,0.6584,Anterior Pituitary Gland Neoplasm,0.6578,Sellar Germ Cell Tumor,0.6547,Sellar Paraganglioma,0.6534,Gonadotroph Pituitary Neuroendocrine Tumor,0.6514,Granular Cell Tumor of the Sellar Region,0.6505,PITUICYTOMA,True,True,True
PITUITARY ADENOMA,Pituitary Neuroendocrine Tumor,18,2,Anterior Pituitary Gland Neoplasm,0.8097,Pituitary Gland Neoplasm,0.8000,Adenoma,0.7840,Pituitary Gland Acidophil Adenoma,0.7771,Parathyroid Gland Adenoma,0.7626,Benign Pituitary Gland Neoplasm,0.7594,Prostate Adenoma,0.7545,Papillary Adenoma,0.7439,Pituitary Gland Basophil Adenoma,0.7055,Pituicytoma,0.6996,Pituitary Gland Neoplasm (Antiquated),0.6950,Atypical Pituitary Neuroendocrine Tumor,0.6943,Malignant Pituitary Gland Neoplasm,0.6932,Lung Adenoma,0.6897,Salivary Gland Adenoma,0.6868,Gastric Adenoma,0.6829,Pituitary Neuroendocrine Tumor/Macroadenoma,0.6820,Pituitary Neuroendocrine Tumor,0.6817,Pancreatic Alpha Cell Adenoma,0.6817,Functioning Pituitary Neuroendocrine Tumor/Microadenoma,0.6776,PITUITARY ADENOMA,False,False,False
PLASMA CELL MYELOMA,Multiple Myeloma,3,2,Plasmacytoma,0.8627,Plasma Cell Neoplasm,0.8539,Multiple Myeloma,0.8514,Plasma Cell Leukemia,0.8202,Solitary Plasmacytoma,0.8181,Plasma Cell Myeloma-Induced Bone Disease,0.7946,Plasmablastic Lymphoma,0.7772,Multiple Solitary Plasmacytoma of Bone,0.7684,Solitary Plasmacytoma of Bone,0.7604,Cutaneous Plasmacytoma,0.7562,Anaplastic Plasmacytoma,0.7546,Non-Secretory Multiple Myeloma,0.7545,Secondary Plasma Cell Leukemia,0.7480,"Multiple Myeloma, Not Otherwise Specified",0.7429,Extraosseous Plasmacytoma,0.7421,Osteosclerotic Multiple Myeloma,0.7281,Testicular Plasmacytoma,0.7233,Smoldering Multiple Myeloma,0.7223,Lung Plasmacytoma,0.7195,Primary Cutaneous Plasmablastic Lymphoma,0.6977,PLASMA CELL MYELOMA,False,True,True
PLASMACYTOMA,Plasmacytoma,1,2,Plasmacytoma,1.0000,Plasma Cell Neoplasm,0.9261,Solitary Plasmacytoma,0.9015,Cutaneous Plasmacytoma,0.8671,Plasma Cell Leukemia,0.8522,Anaplastic Plasmacytoma,0.8423,Testicular Plasmacytoma,0.8313,Lung Plasmacytoma,0.8208,Plasmablastic Lymphoma,0.8173,Extraosseous Plasmacytoma,0.8148,Solitary Plasmacytoma of Bone,0.8143,Splenic Plasmacytoma,0.7964,Chest Wall Solitary Plasmacytoma,0.7818,Liver Plasmacytoma,0.7815,Sinonasal Plasmacytoma,0.7749,Multiple Solitary Plasmacytoma of Bone,0.7701,Secondary Plasma Cell Leukemia,0.7643,Primary Cutaneous Plasmablastic Lymphoma,0.7449,Recurrent Plasma Cell Neoplasm,0.7411,Recurrent Solitary Plasmacytoma,0.7319,PLASMACYTOMA,True,True,True
PLASMA_CELL_LEUKEMIA,Plasma Cell Leukemia,1,2,Plasma Cell Leukemia,0.9312,Plasma Cell Neoplasm,0.8138,Secondary Plasma Cell Leukemia,0.8120,Plasmacytoma,0.7977,Plasmablastic Lymphoma,0.7399,Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation,0.7366,Recurrent Plasma Cell Leukemia,0.7246,Lung Plasmacytoma,0.7208,Solitary Plasmacytoma,0.7127,Cutaneous Plasmacytoma,0.7092,Anaplastic Plasmacytoma,0.6949,Primary Cutaneous Plasmablastic Lymphoma,0.6910,Liver Plasmacytoma,0.6885,Prolymphocytic Leukemia,0.6788,Testicular Plasmacytoma,0.6677,Solitary Plasmacytoma of Bone,0.6587,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder,0.6578,Extraosseous Plasmacytoma,0.6567,B-Cell Prolymphocytic Leukemia,0.6514,Refractory Plasma Cell Neoplasm,0.6501,PLASMA_CELL_LEUKEMIA,True,True,True
PLASMA_CELL_MYELOMA,Multiple Myeloma,3,2,Plasma Cell Neoplasm,0.8318,Plasmacytoma,0.8266,Multiple Myeloma,0.8089,Plasma Cell Myeloma-Induced Bone Disease,0.7909,Solitary Plasmacytoma,0.7766,"Multiple Myeloma, Not Otherwise Specified",0.7642,Plasma Cell Leukemia,0.7588,Multiple Solitary Plasmacytoma of Bone,0.7528,Solitary Plasmacytoma of Bone,0.7348,Plasmablastic Lymphoma,0.7320,Extraosseous Plasmacytoma,0.7294,Cutaneous Plasmacytoma,0.7241,Non-Secretory Multiple Myeloma,0.7222,Anaplastic Plasmacytoma,0.7166,Recurrent Plasma Cell Neoplasm,0.7018,Smoldering Multiple Myeloma,0.7006,Secondary Plasma Cell Leukemia,0.6995,Osteosclerotic Multiple Myeloma,0.6983,"IgM Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Type",0.6803,Testicular Plasmacytoma,0.6786,PLASMA_CELL_MYELOMA,False,True,True
PLEOMORPHIC 'MFH' / UNDIFFERENTIATED PLEOMORPHIC SARCOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.8548,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.8229,Metastatic Undifferentiated Pleomorphic Sarcoma,0.7789,Advanced Undifferentiated Pleomorphic Sarcoma,0.7770,Adult Undifferentiated Pleomorphic Sarcoma,0.7523,"Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant",0.7458,Prostate Undifferentiated Pleomorphic Sarcoma,0.7442,Pleomorphic Dermal Sarcoma,0.7426,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7410,Pleomorphic Rhabdomyosarcoma,0.7397,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 2,0.7268,Pleomorphic Fibroma,0.7258,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 3,0.7246,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7200,Recurrent Undifferentiated Pleomorphic Sarcoma,0.7174,Undifferentiated Spindle Cell Sarcoma,0.7171,Locally Advanced Undifferentiated Pleomorphic Sarcoma,0.7127,Childhood Undifferentiated Pleomorphic Sarcoma,0.7077,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7021,Sinonasal Undifferentiated Pleomorphic Sarcoma,0.6986,PLEOMORPHIC 'MFH' / UNDIFFERENTIATED PLEOMORPHIC SARCOMA,True,True,True
PLEOMORPHIC CARCINOMA OF THE LUNG,Lung Pleomorphic Carcinoma,1,2,Lung Pleomorphic Carcinoma,0.9688,Pleomorphic Carcinoma,0.8404,Lung Pleomorphic Adenoma,0.8394,Breast Pleomorphic Carcinoma,0.8070,Lung Spindle Cell Carcinoma,0.7381,Hepatocellular Pleomorphic Carcinoma,0.7351,Cellular Pleomorphic Adenoma,0.7285,Carcinoma ex Pleomorphic Adenoma,0.7280,"Invasive Breast Lobular Carcinoma, Pleomorphic Variant",0.7195,Lung Sarcomatoid Carcinoma,0.7187,Lung Giant Cell Carcinoma,0.7078,Pleomorphic Adenoma,0.7017,Pleomorphic Lipoma,0.6987,Adult Hepatocellular Pleomorphic Carcinoma,0.6952,Lung Carcinoma,0.6803,Pleomorphic Liposarcoma,0.6786,Laryngeal Pleomorphic Adenoma,0.6778,Breast Pleomorphic Adenoma,0.6774,Pleomorphic Fibroma,0.6750,Parotid Gland Carcinoma ex Pleomorphic Adenoma,0.6714,PLEOMORPHIC CARCINOMA OF THE LUNG,True,True,True
PLEOMORPHIC HEPATOCELLULAR CARCINOMA,Hepatocellular Pleomorphic Carcinoma,1,2,Hepatocellular Pleomorphic Carcinoma,0.9870,Adult Hepatocellular Pleomorphic Carcinoma,0.8962,Hepatocellular Poorly Differentiated Carcinoma,0.8125,Pleomorphic Carcinoma,0.7767,Hepatocellular Sarcomatoid Carcinoma,0.7688,Hepatocellular Carcinoma,0.7629,Hepatocellular Well Differentiated Carcinoma,0.7528,Epithelial Hepatoblastoma with Pleomorphic Pattern,0.7389,Cellular Pleomorphic Adenoma,0.7371,Lung Pleomorphic Carcinoma,0.7358,Small Progressed Hepatocellular Carcinoma,0.7250,Small Hepatocellular Carcinoma,0.7222,Hepatocellular Moderately Differentiated Carcinoma,0.7204,Hepatocellular Clear Cell Carcinoma,0.7183,Hepatocellular Adenoma,0.7169,Advanced Hepatocellular Carcinoma,0.7125,Hepatocellular Neutrophil-Rich Carcinoma,0.7118,Hepatocellular Lymphocyte-Rich Carcinoma,0.6994,Hepatocellular Chromophobe Carcinoma,0.6981,Hepatocellular Scirrhous Carcinoma,0.6956,PLEOMORPHIC HEPATOCELLULAR CARCINOMA,True,True,True
PLEOMORPHIC LIPOSARCOMA,Pleomorphic Liposarcoma,1,2,Pleomorphic Liposarcoma,1.0000,Myxoid Pleomorphic Liposarcoma,0.9222,Pleomorphic Lipoma,0.9051,Advanced Pleomorphic Liposarcoma,0.9042,Skin Pleomorphic Liposarcoma,0.9033,Metastatic Pleomorphic Liposarcoma,0.8980,Fibroblastic Liposarcoma,0.8609,Spindle Cell/Pleomorphic Lipoma,0.8537,Skin Pleomorphic Lipoma,0.8449,Mixed Liposarcoma,0.8440,Myxoid Liposarcoma,0.8383,Pleomorphic Rhabdomyosarcoma,0.8373,Liposarcoma,0.8344,Dedifferentiated Liposarcoma,0.8311,Pleomorphic Leiomyosarcoma,0.8210,Atypical Spindle Cell/Pleomorphic Lipomatous Tumor,0.8046,Bone Liposarcoma,0.8019,Localized Liposarcoma,0.8015,Undifferentiated Pleomorphic Sarcoma,0.7920,Refractory Pleomorphic Liposarcoma,0.7862,PLEOMORPHIC LIPOSARCOMA,True,True,True
PLEOMORPHIC RHABDOMYOSARCOMA,Pleomorphic Rhabdomyosarcoma,1,2,Pleomorphic Rhabdomyosarcoma,1.0000,Adult Pleomorphic Rhabdomyosarcoma,0.8932,Childhood Pleomorphic Rhabdomyosarcoma,0.8743,Pleomorphic Liposarcoma,0.8373,Undifferentiated Pleomorphic Sarcoma,0.8281,Myxoid Pleomorphic Liposarcoma,0.8102,Spindle Cell Rhabdomyosarcoma,0.8055,Pleomorphic Leiomyosarcoma,0.7970,Rhabdomyosarcoma,0.7877,Metastatic Pleomorphic Liposarcoma,0.7789,Advanced Pleomorphic Liposarcoma,0.7731,Pleomorphic Dermal Sarcoma,0.7546,Sclerosing Rhabdomyosarcoma,0.7493,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.7486,Resectable Undifferentiated Pleomorphic Sarcoma,0.7481,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7477,Metastatic Undifferentiated Pleomorphic Sarcoma,0.7447,Adult Undifferentiated Pleomorphic Sarcoma,0.7369,Prostate Rhabdomyosarcoma,0.7350,Pleomorphic Carcinoma,0.7299,PLEOMORPHIC RHABDOMYOSARCOMA,True,True,True
PLEOMORPHIC SARCOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.9219,Pleomorphic Dermal Sarcoma,0.8782,Pleomorphic Rhabdomyosarcoma,0.8648,Pleomorphic Liposarcoma,0.8482,Pleomorphic Fibroma,0.8425,Pleomorphic Carcinoma,0.8416,Pleomorphic Leiomyosarcoma,0.8212,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.8080,Metastatic Undifferentiated Pleomorphic Sarcoma,0.8045,Adult Undifferentiated Pleomorphic Sarcoma,0.8029,Prostate Undifferentiated Pleomorphic Sarcoma,0.8003,Advanced Undifferentiated Pleomorphic Sarcoma,0.7883,Pleomorphic Lipoma,0.7791,Pleomorphic Adenoma,0.7759,Myxoid Pleomorphic Liposarcoma,0.7745,Cellular Pleomorphic Adenoma,0.7711,Metastatic Pleomorphic Liposarcoma,0.7709,Advanced Pleomorphic Liposarcoma,0.7663,Breast Pleomorphic Carcinoma,0.7638,Spindle Cell/Pleomorphic Lipoma,0.7625,PLEOMORPHIC SARCOMA,True,True,True
PLEOMORPHIC XANTHOASTROCYTOMA,Pleomorphic Xanthoastrocytoma,1,2,Pleomorphic Xanthoastrocytoma,1.0000,Anaplastic Pleomorphic Xanthoastrocytoma,0.9521,Childhood Pleomorphic Xanthoastrocytoma,0.8902,Temporal Lobe Pleomorphic Xanthoastrocytoma,0.8512,Recurrent Anaplastic Pleomorphic Xanthoastrocytoma,0.7763,Recurrent Childhood Pleomorphic Xanthoastrocytoma,0.7752,Supratentorial Pleomorphic Xanthoastrocytoma,0.7735,Refractory Anaplastic Pleomorphic Xanthoastrocytoma,0.7561,Pleomorphic Lipoma,0.7386,Spindle Cell/Pleomorphic Lipoma,0.7235,Atypical Spindle Cell/Pleomorphic Lipomatous Tumor,0.7199,Skin Pleomorphic Lipoma,0.7095,Skin Spindle Cell/Pleomorphic Lipoma,0.6788,Pleomorphic Liposarcoma,0.6755,Juvenile Xanthogranuloma,0.6720,Pleomorphic Carcinoma,0.6667,Pleomorphic Fibroma,0.6651,Myxoid Pleomorphic Liposarcoma,0.6612,Cellular Pleomorphic Adenoma,0.6601,Skin Pleomorphic Liposarcoma,0.6587,PLEOMORPHIC XANTHOASTROCYTOMA,True,True,True
PLEOMORPHIC_SARCOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.9040,Pleomorphic Dermal Sarcoma,0.8361,Pleomorphic Rhabdomyosarcoma,0.8313,Pleomorphic Liposarcoma,0.8115,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.8093,Pleomorphic Fibroma,0.8085,Pleomorphic Carcinoma,0.8007,Metastatic Undifferentiated Pleomorphic Sarcoma,0.7989,Pleomorphic Leiomyosarcoma,0.7882,Advanced Undifferentiated Pleomorphic Sarcoma,0.7830,Prostate Undifferentiated Pleomorphic Sarcoma,0.7814,Adult Undifferentiated Pleomorphic Sarcoma,0.7787,Sarcoma,0.7522,Resectable Undifferentiated Pleomorphic Sarcoma,0.7485,Metastatic Pleomorphic Liposarcoma,0.7476,Spindle Cell Sarcoma,0.7459,Undifferentiated Spindle Cell Sarcoma,0.7425,"Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant",0.7406,Spindle Cell/Pleomorphic Lipoma,0.7401,Sinonasal Undifferentiated Pleomorphic Sarcoma,0.7400,PLEOMORPHIC_SARCOMA,True,True,True
"PLEURAL CANCER, NOS",Malignant Pleural Neoplasm,3,2,Pleural Carcinomatosis,0.8757,Pleural Neoplasm,0.8660,Malignant Pleural Neoplasm,0.8538,Malignant Lung and Pleural Neoplasm,0.7487,Pleural Mesothelioma,0.7398,Pleural Mesothelial Neoplasm,0.7357,Pleural Malignant Mesothelioma,0.7261,Benign Pleural Neoplasm,0.7164,Metastatic Malignant Neoplasm in the Pleura,0.6964,Pleural Primary Effusion Lymphoma,0.6884,Pericardial Carcinomatosis,0.6863,Pleural Adenomatoid Tumor,0.6839,Pericardial Neoplasm,0.6704,Pleural Non-Hodgkin Lymphoma,0.6608,Malignant Pericardial Neoplasm,0.6553,Localized Pleural Malignant Mesothelioma,0.6494,Primary Peritoneal Carcinoma,0.6474,Pleural Lipoma,0.6446,Pleural Malignant Mesothelioma by AJCC v8 Stage,0.6442,Peritoneal Carcinomatosis,0.6405,"PLEURAL CANCER, NOS",False,True,True
PLEURAL MESOTHELIOMA,Pleural Mesothelial Neoplasm,4,2,Pleural Mesothelioma,1.0000,Pleural Malignant Mesothelioma,0.9598,Pleural Epithelioid Mesothelioma,0.8786,Pleural Mesothelial Neoplasm,0.8776,Localized Pleural Malignant Mesothelioma,0.8714,Advanced Pleural Malignant Mesothelioma,0.8445,Metastatic Pleural Malignant Mesothelioma,0.8402,Pleural Sarcomatoid Mesothelioma,0.8378,Malignant Pleural Neoplasm,0.8371,Mesothelioma,0.8304,Pleural Neoplasm,0.8234,Pleural Biphasic Mesothelioma,0.8233,Peritoneal Malignant Mesothelioma,0.8183,Pleural Adenomatoid Tumor,0.8036,Locally Advanced Pleural Malignant Mesothelioma,0.7950,Malignant Mesothelioma,0.7921,Pleural Well Differentiated Papillary Mesothelial Tumor,0.7835,Pleural Desmoplastic Mesothelioma,0.7795,Pleural Carcinomatosis,0.7746,Pleural Malignant Mesothelioma by AJCC v8 Stage,0.7744,PLEURAL MESOTHELIOMA,False,False,True
"PLEURAL MESOTHELIOMA, BIPHASIC TYPE",Pleural Biphasic Mesothelioma,1,2,Pleural Biphasic Mesothelioma,0.9608,Peritoneal Biphasic Mesothelioma,0.8812,Biphasic Mesothelioma,0.8707,Unresectable Pleural Biphasic Mesothelioma,0.8169,Pleural Mesothelioma,0.7935,Pleural Malignant Mesothelioma,0.7813,Pleural Sarcomatoid Mesothelioma,0.7772,Paratesticular Biphasic Mesothelioma,0.7768,Pleural Epithelioid Mesothelioma,0.7762,Pleural Biphasic Synovial Sarcoma,0.7756,Metastatic Pleural Malignant Mesothelioma,0.7706,Pleural Well Differentiated Papillary Mesothelial Tumor,0.7537,Unresectable Peritoneal Biphasic Mesothelioma,0.7431,Pleural Desmoplastic Mesothelioma,0.7385,Localized Pleural Malignant Mesothelioma,0.7251,Advanced Pleural Malignant Mesothelioma,0.7134,Pleural Mesothelial Neoplasm,0.7034,Well Differentiated Papillary Mesothelial Tumor,0.7015,Diffuse Malignant Mesothelioma,0.6935,Peritoneal Malignant Mesothelioma,0.6933,"PLEURAL MESOTHELIOMA, BIPHASIC TYPE",True,True,True
"PLEURAL MESOTHELIOMA, EPITHELIOID TYPE",Pleural Epithelioid Mesothelioma,1,2,Pleural Epithelioid Mesothelioma,0.9654,Peritoneal Epithelioid Mesothelioma,0.8561,Pleural Mesothelioma,0.8559,Epithelioid Mesothelioma,0.8489,Pleural Malignant Mesothelioma,0.8489,Pleural Proximal-Type Epithelioid Sarcoma,0.8252,Pleural Sarcomatoid Mesothelioma,0.8102,Localized Pleural Malignant Mesothelioma,0.7864,Advanced Epithelioid Mesothelioma,0.7824,Pleural Adenomatoid Tumor,0.7791,Pleural Mesothelial Neoplasm,0.7785,Advanced Pleural Malignant Mesothelioma,0.7762,Pleural Biphasic Mesothelioma,0.7676,Metastatic Pleural Malignant Mesothelioma,0.7662,Paratesticular Epithelioid Mesothelioma,0.7587,Unresectable Pleural Epithelioid Mesothelioma,0.7540,Locally Advanced Pleural Malignant Mesothelioma,0.7506,Pleural Well Differentiated Papillary Mesothelial Tumor,0.7488,Pleural Desmoplastic Mesothelioma,0.7430,Peritoneal Malignant Mesothelioma,0.7354,"PLEURAL MESOTHELIOMA, EPITHELIOID TYPE",True,True,True
"PLEURAL MESOTHELIOMA, SARCOMATOID TYPE",Pleural Sarcomatoid Mesothelioma,1,2,Pleural Sarcomatoid Mesothelioma,0.9723,Peritoneal Sarcomatoid Mesothelioma,0.8726,Sarcomatoid Mesothelioma,0.8655,Pleural Mesothelioma,0.8285,Pleural Malignant Mesothelioma,0.8172,Pleural Epithelioid Mesothelioma,0.8120,Pleural Proximal-Type Epithelioid Sarcoma,0.8096,Pleural Monophasic Synovial Sarcoma,0.8044,Pleural Synovial Sarcoma,0.7942,Pleural Desmoplastic Mesothelioma,0.7834,Pleural Leiomyosarcoma,0.7808,Pleural Adenomatoid Tumor,0.7683,Paratesticular Sarcomatoid Mesothelioma,0.7675,Metastatic Pleural Malignant Mesothelioma,0.7653,Pleural Biphasic Mesothelioma,0.7586,Unresectable Pleural Sarcomatoid Mesothelioma,0.7560,Pleural Biphasic Synovial Sarcoma,0.7478,Pleural Solitary Fibrous Tumor,0.7426,Localized Pleural Malignant Mesothelioma,0.7380,Pleural Mesothelial Neoplasm,0.7193,"PLEURAL MESOTHELIOMA, SARCOMATOID TYPE",True,True,True
PLEUROPULMONARY BLASTOMA,Pleuropulmonary Blastoma,1,2,Pleuropulmonary Blastoma,1.0000,Type I Pleuropulmonary Blastoma,0.9341,Type II Pleuropulmonary Blastoma,0.9139,Type III Pleuropulmonary Blastoma,0.8752,Pulmonary Blastoma,0.8430,Biphasic Pulmonary Blastoma,0.8188,Epithelial Predominant Pulmonary Blastoma,0.7724,Lung Plasmacytoma,0.6936,Blastoma,0.6859,Pleural Biphasic Mesothelioma,0.6784,Pleural Neoplasm,0.6657,Benign Pleural Neoplasm,0.6587,Pituitary Gland Blastoma,0.6575,Lung Pleomorphic Adenoma,0.6507,Pleural Mesothelioma,0.6504,Pleural Lipoma,0.6457,Lung Pleomorphic Carcinoma,0.6415,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.6387,Metastatic Malignant Neoplasm in the Pleura,0.6356,Pleural Primary Effusion Lymphoma,0.6325,PLEUROPULMONARY BLASTOMA,True,True,True
PLEUROPULMONARY BLASTOMA PPB,Pleuropulmonary Blastoma,1,2,Pleuropulmonary Blastoma,0.9382,Type I Pleuropulmonary Blastoma,0.8692,Type II Pleuropulmonary Blastoma,0.8465,Type III Pleuropulmonary Blastoma,0.8261,Biphasic Pulmonary Blastoma,0.7530,Pulmonary Blastoma,0.7481,Epithelial Predominant Pulmonary Blastoma,0.7203,Lung Plasmacytoma,0.6798,Pleural Biphasic Mesothelioma,0.6474,Plasmablastic Lymphoma,0.6335,Benign Pleural Neoplasm,0.6318,Pleural Neoplasm,0.6304,Metastatic Malignant Neoplasm in the Pleura,0.6259,Lung Pleomorphic Adenoma,0.6186,Pleural Primary Effusion Lymphoma,0.6177,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.6157,Unresectable Pleural Biphasic Mesothelioma,0.6149,Lung Pleomorphic Carcinoma,0.6134,Pleural Mesothelioma,0.6125,Lung Mature B-Cell Neoplasm,0.6113,PLEUROPULMONARY BLASTOMA PPB,True,True,True
PLEUROPULMORY BLASTOMA PPB,Pleuropulmonary Blastoma,1,2,Pleuropulmonary Blastoma,0.9004,Type I Pleuropulmonary Blastoma,0.8576,Type II Pleuropulmonary Blastoma,0.8309,Type III Pleuropulmonary Blastoma,0.8001,Pulmonary Blastoma,0.7362,Biphasic Pulmonary Blastoma,0.7143,Epithelial Predominant Pulmonary Blastoma,0.6842,Lung Plasmacytoma,0.6831,Plasmablastic Lymphoma,0.6787,Blastic Plasmacytoid Dendritic Cell Neoplasm,0.6469,Chest Wall Solitary Plasmacytoma,0.6450,Peripheral Ganglioneuroblastoma,0.6355,Plasmacytoma,0.6347,Blastoma,0.6315,Pleural Biphasic Mesothelioma,0.6280,Metastatic Malignant Neoplasm in the Pleura,0.6274,Pituitary Gland Blastoma,0.6249,Primary Cutaneous Plasmablastic Lymphoma,0.6189,Unresectable Pleural Biphasic Mesothelioma,0.6173,Anaplastic Plasmacytoma,0.6155,PLEUROPULMORY BLASTOMA PPB,True,True,True
PLEXIFORM FIBROHISTIOCYTIC TUMOR,Plexiform Fibrohistiocytic Tumor,1,2,Plexiform Fibrohistiocytic Tumor,1.0000,Childhood Plexiform Fibrohistiocytic Tumor,0.8867,Chest Wall Plexiform Fibrohistiocytic Tumor,0.8151,Plexiform Neurofibroma,0.7790,Plexiform Schwannoma,0.7180,Fibrohistiocytic Neoplasm,0.7137,Gastric Plexiform Fibromyxoma,0.7052,Skin Fibrohistiocytic Neoplasm,0.6964,Intranodal Palisaded Myofibroblastoma,0.6911,Malignant Fibrohistiocytic Neoplasm,0.6871,Intermediate Fibrohistiocytic Neoplasm,0.6859,Cellular Neurofibroma,0.6803,Perifollicular Fibroma,0.6727,Benign Fibrohistiocytic Neoplasm,0.6715,Pleomorphic Fibroma,0.6702,Plexiform Spindle Cell Melanocytoma,0.6679,Skin Intermediate Fibrohistiocytic Neoplasm,0.6629,Fibrofolliculoma,0.6627,Benign Skin Fibrohistiocytic Neoplasm,0.6540,Fibromyxoid Tumor,0.6410,PLEXIFORM FIBROHISTIOCYTIC TUMOR,True,True,True
PLEXIFORM NEUROFIBROMA,Plexiform Neurofibroma,1,2,Plexiform Neurofibroma,1.0000,Plexiform Schwannoma,0.8841,Neurofibroma,0.8536,Skin Neurofibroma,0.8468,Melanotic Neurofibroma,0.8150,Cellular Neurofibroma,0.8098,Penile Neurofibroma,0.8003,Unresectable Plexiform Neurofibroma,0.7970,Diffuse Neurofibroma,0.7916,Spinal Cord Neurofibroma,0.7860,Plexiform Fibrohistiocytic Tumor,0.7790,Childhood Neurofibroma,0.7764,Epithelioid Neurofibroma,0.7695,Cardiac Neurofibroma,0.7652,Bladder Neurofibroma,0.7596,Breast Neurofibroma,0.7586,Pacinian Neurofibroma,0.7571,Sinonasal Neurofibroma,0.7449,Childhood Plexiform Fibrohistiocytic Tumor,0.7391,Plexiform Ameloblastoma,0.7325,PLEXIFORM NEUROFIBROMA,True,True,True
PLEXIFORM SCHWANNOMA,Plexiform Schwannoma,1,2,Plexiform Schwannoma,1.0000,Plexiform Neurofibroma,0.8841,Schwannoma,0.8377,Peripheral Nerve Schwannoma,0.8299,Conventional Schwannoma,0.8271,Cellular Schwannoma,0.7946,Skin Schwannoma,0.7852,Ancient Schwannoma,0.7847,Melanotic Schwannoma,0.7838,Nerve Sheath Myxoma,0.7809,Bone Schwannoma,0.7786,Intraocular Schwannoma,0.7726,Unresectable Plexiform Neurofibroma,0.7708,Cardiac Schwannoma,0.7680,Microcystic/Reticular Schwannoma,0.7680,Schwannomatosis,0.7679,Trigeminal Schwannoma,0.7654,Sympathetic Schwannoma,0.7634,Vestibular Schwannoma,0.7619,Nerve Sheath Neoplasm,0.7600,PLEXIFORM SCHWANNOMA,True,True,True
PLMESO,Pleural Mesothelial Neoplasm,4,2,Pleural Mesothelioma,1.0000,Pleural Malignant Mesothelioma,0.9598,Pleural Epithelioid Mesothelioma,0.8786,Pleural Mesothelial Neoplasm,0.8776,Localized Pleural Malignant Mesothelioma,0.8714,Advanced Pleural Malignant Mesothelioma,0.8445,Metastatic Pleural Malignant Mesothelioma,0.8402,Pleural Sarcomatoid Mesothelioma,0.8378,Malignant Pleural Neoplasm,0.8371,Mesothelioma,0.8304,Pleural Neoplasm,0.8234,Pleural Biphasic Mesothelioma,0.8233,Peritoneal Malignant Mesothelioma,0.8183,Pleural Adenomatoid Tumor,0.8036,Locally Advanced Pleural Malignant Mesothelioma,0.7950,Malignant Mesothelioma,0.7921,Pleural Well Differentiated Papillary Mesothelial Tumor,0.7835,Pleural Desmoplastic Mesothelioma,0.7795,Pleural Carcinomatosis,0.7746,Pleural Malignant Mesothelioma by AJCC v8 Stage,0.7744,Pleural Mesothelioma,False,False,True
PNET,Primitive Neuroectodermal Tumor,1,2,Primitive Neuroectodermal Tumor,1.0000,Peripheral Primitive Neuroectodermal Tumor,0.9411,Localized Primitive Neuroectodermal Tumor,0.8765,Peripheral Primitive Neuroectodermal Tumor of Bone,0.8551,Localized Peripheral Primitive Neuroectodermal Tumor,0.8464,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues,0.8093,Refractory Primitive Neuroectodermal Tumor,0.8069,Peripheral Primitive Neuroectodermal Tumor of Kidney,0.7990,Localized Peripheral Primitive Neuroectodermal Tumor of Bone,0.7943,Refractory Peripheral Primitive Neuroectodermal Tumor,0.7786,Recurrent Primitive Neuroectodermal Tumor,0.7780,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7595,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7591,Recurrent Peripheral Primitive Neuroectodermal Tumor,0.7542,Neuroepithelial Neoplasm,0.7458,Dysembryoplastic Neuroepithelial Tumor,0.7341,"Brain Embryonal Tumor, Not Otherwise Specified",0.7272,Neuroblastic Tumor,0.7261,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7255,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0.7242,Primitive Neuroectodermal Tumor,True,True,True
POLE ULTRA-MUTATED,POLEm Endometrial Endometrioid Adenocarcinoma,14,2,Melanoma of Unknown Primary,0.6077,Neoplasm of Uncertain Malignant Potential,0.6042,Papillary Urothelial Neoplasm of Low Malignant Potential,0.5876,"Malignant Neoplasm, Uncertain Whether Primary or Metastatic",0.5861,PRKAR1A-Inactivated Pigmented Epithelioid Melanocytoma,0.5844,Malignant Neoplasm of Unknown Primary,0.5786,Bladder Urothelial Proliferation of Uncertain Malignant Potential,0.5717,Uveal Melanoma by Gene Expression Profile,0.5629,Myeloid Neoplasm with Mutated TP53,0.5467,Bladder Papillary Urothelial Neoplasm of Low Malignant Potential,0.5362,Prostate Stromal Tumor of Uncertain Malignant Potential,0.5357,Neuroendocrine Carcinoma of Unknown Primary,0.5340,Undifferentiated Carcinoma of Unknown Primary,0.5335,POLEm Endometrial Endometrioid Adenocarcinoma,0.5319,Pigmented Epithelioid Melanocytoma,0.5317,Pancreatic Neuroendocrine Microtumor,0.5301,T-Cell Proliferation of Uncertain Malignant Potential,0.5275,Pancreatic Undifferentiated Carcinoma,0.5268,Uveal Necrotic Melanoma,0.5241,Ureter Polyp,0.5209,POLE ULTRA-MUTATED,False,False,False
POLYCYTHEMIA VERA,Polycythemia Vera,1,2,Polycythemia Vera,1.0000,"Polycythemia Vera, Polycythemic Phase",0.8769,"Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase",0.6394,Essential Thrombocythemia,0.6026,Erythroleukemia,0.5942,Verruca Vulgaris,0.5868,Erythroid Neoplasm,0.5717,Peripheral Hemangioblastoma,0.5709,Adult Erythroleukemia,0.5618,Verrucous Venous Malformation,0.5550,"Refractory Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase",0.5470,Verrucous Lesion,0.5462,Oral Verruca Vulgaris,0.5365,Hemangioblastoma,0.5293,Verruca Plana,0.5272,Cerebellar Hemangioblastoma,0.5249,Spinal Hemangioblastoma,0.5243,Brain Stem Hemangioblastoma,0.5238,Deep Hemangioma,0.5238,Medullary Hemangioblastoma,0.5198,POLYCYTHEMIA VERA,True,True,True
POORLY DIFFERENTIATED ONCOCYTIC CARCINOMA,Oncocytic Variant Thyroid Gland Papillary Carcinoma,5,2,Oncocytic Adenocarcinoma,0.9028,Thyroid Gland Oncocytic Carcinoma,0.8642,Oncocytic Neoplasm,0.8408,Oncocytic Adenoma,0.8235,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.8186,Salivary Gland Oncocytic Adenocarcinoma,0.8170,Breast Oncocytic Carcinoma,0.8142,Adrenal Cortical Oncocytic Carcinoma,0.7978,Thyroid Gland Oncocytic Neoplasm,0.7802,Metastatic Thyroid Gland Oncocytic Carcinoma,0.7770,Cystic Oncocytic Neoplasm,0.7735,Locally Advanced Thyroid Gland Oncocytic Carcinoma,0.7722,Lacrimal Gland Oncocytic Adenocarcinoma,0.7679,Salivary Gland Oncocytoma,0.7663,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.7638,Spindle Cell Oncocytoma,0.7623,Prostate Acinar Oncocytic Adenocarcinoma,0.7586,Thyroid Gland Oncocytic Adenoma,0.7538,Unresectable Thyroid Gland Oncocytic Carcinoma,0.7528,Poorly Differentiated Thyroid Gland Carcinoma,0.7416,POORLY DIFFERENTIATED ONCOCYTIC CARCINOMA,False,False,True
POORLY DIFFERENTIATED OR PLEOMORPHIC OR EPITHELIOID LEIOMYOSARCOMA,Leiomyosarcoma,7,2,Pleomorphic Leiomyosarcoma,0.8673,Dedifferentiated Leiomyosarcoma,0.8299,Epithelioid Leiomyosarcoma,0.8163,Well Differentiated Leiomyosarcoma,0.8148,Myxoid Leiomyosarcoma,0.7995,Conventional Leiomyosarcoma,0.7655,Leiomyosarcoma,0.7527,Localized Leiomyosarcoma,0.7509,Inflammatory Leiomyosarcoma,0.7361,Granular Cell Leiomyosarcoma,0.7358,Myxoid Leiomyoma,0.7282,Advanced Leiomyosarcoma,0.7240,Leiomyosarcoma of Deep Soft Tissue,0.7236,Pleural Leiomyosarcoma,0.7217,Leiomyosarcoma NCI Grade 2,0.7216,Leiomyosarcoma NCI Grade 3,0.7188,Metastatic Leiomyosarcoma,0.7184,Bone Leiomyosarcoma,0.7169,Non-Cutaneous Leiomyosarcoma,0.7095,Myxoid Pleomorphic Liposarcoma,0.7040,POORLY DIFFERENTIATED OR PLEOMORPHIC OR EPITHELIOID LEIOMYOSARCOMA,False,False,False
POORLY DIFFERENTIATED THYROID CANCER,Poorly Differentiated Thyroid Gland Carcinoma,1,2,Poorly Differentiated Thyroid Gland Carcinoma,0.9689,Differentiated Thyroid Gland Carcinoma,0.8672,Differentiated High Grade Thyroid Gland Carcinoma,0.7995,Metastatic Poorly Differentiated Thyroid Gland Carcinoma,0.7953,Poorly Differentiated Malignant Neoplasm,0.7952,Advanced Differentiated Thyroid Gland Carcinoma,0.7840,Unresectable Poorly Differentiated Thyroid Gland Carcinoma,0.7700,Thyroid Gland Carcinoma,0.7653,Thyroid Gland Adenocarcinoma,0.7557,Classic Thyroid Gland Papillary Carcinoma,0.7475,Thyroid Gland Anaplastic Carcinoma,0.7473,Thyroid Gland Papillary Carcinoma,0.7462,Advanced Thyroid Gland Carcinoma,0.7343,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.7275,Salivary Gland Poorly Differentiated Carcinoma,0.7272,Hepatocellular Poorly Differentiated Carcinoma,0.7227,Locally Advanced Differentiated Thyroid Gland Carcinoma,0.7203,Thyroid Gland Undifferentiated Small Cell Carcinoma,0.7179,Poorly Differentiated Chordoma,0.7151,Well Differentiated Malignant Neoplasm,0.7147,POORLY DIFFERENTIATED THYROID CANCER,True,True,True
POORLY DIFFERENTIATED THYROID CARCINOMA,Poorly Differentiated Thyroid Gland Carcinoma,1,2,Poorly Differentiated Thyroid Gland Carcinoma,0.9844,Differentiated Thyroid Gland Carcinoma,0.8693,Metastatic Poorly Differentiated Thyroid Gland Carcinoma,0.8013,Differentiated High Grade Thyroid Gland Carcinoma,0.7936,Poorly Differentiated Malignant Neoplasm,0.7897,Advanced Differentiated Thyroid Gland Carcinoma,0.7838,Classic Thyroid Gland Papillary Carcinoma,0.7800,Thyroid Gland Papillary Carcinoma,0.7797,Thyroid Gland Carcinoma,0.7770,Unresectable Poorly Differentiated Thyroid Gland Carcinoma,0.7730,Thyroid Gland Anaplastic Carcinoma,0.7586,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.7512,Thyroid Gland Adenocarcinoma,0.7510,Salivary Gland Poorly Differentiated Carcinoma,0.7493,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0.7441,Advanced Thyroid Gland Carcinoma,0.7397,Hepatocellular Poorly Differentiated Carcinoma,0.7366,Locally Advanced Differentiated Thyroid Gland Carcinoma,0.7269,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.7248,Thyroid Gland Follicular Carcinoma,0.7224,POORLY DIFFERENTIATED THYROID CARCINOMA,True,True,True
POORLY_COHESIVE,Gastric Poorly Cohesive Adenocarcinoma,1,2,Gastric Poorly Cohesive Adenocarcinoma,0.6566,Colorectal Poorly Cohesive Adenocarcinoma,0.6114,Pancreatic Poorly Cohesive Adenocarcinoma,0.5994,Poorly Differentiated Malignant Neoplasm,0.5622,Pleomorphic Carcinoma,0.5452,Cellular Pleomorphic Adenoma,0.5433,Poorly Differentiated Chordoma,0.5427,Undifferentiated Carcinoma,0.5259,Undifferentiated Pleomorphic Sarcoma,0.5131,Well Differentiated Malignant Neoplasm,0.5095,Poorly Differentiated Fibrosarcoma,0.5059,Prognostic Stage IIIB Breast Cancer AJCC v8,0.4962,Colorectal Poorly Differentiated Adenocarcinoma,0.4942,Gastric Undifferentiated Carcinoma,0.4930,Undifferentiated Malignant Neoplasm,0.4928,Salivary Gland Poorly Differentiated Carcinoma,0.4919,Mixed Cell Adenoma,0.4908,Poorly Differentiated Thyroid Gland Carcinoma,0.4880,Sinonasal Poorly Differentiated Carcinoma,0.4870,Advanced Undifferentiated Pleomorphic Sarcoma,0.4847,POORLY_COHESIVE,True,True,True
POROCARCINOMA/SPIROADENOCARCINOMA,Porocarcinoma,1,2,Porocarcinoma,0.8080,Serous Cystadenocarcinoma,0.7519,Cystadenocarcinoma,0.7310,Ovarian Cystadenocarcinoma,0.7243,Papillary Serous Cystadenocarcinoma,0.7234,Ovarian Serous Cystadenocarcinoma,0.7207,Papillary Cystadenocarcinoma,0.7148,Carcinoma Arising from Spiradenocylindroma,0.7038,Pancreatic Serous Cystadenocarcinoma,0.6976,Salivary Gland Cystadenocarcinoma,0.6866,Serous Adenocarcinoma,0.6851,Papillary Mucinous Cystadenocarcinoma,0.6800,Paratesticular Serous Cystadenocarcinoma,0.6760,Apocrine Poroma,0.6723,Mucinous Cystadenocarcinoma,0.6717,Syringocystadenocarcinoma Papilliferum,0.6687,Spiradenoma,0.6685,Poroma,0.6683,Pancreatic Cystadenocarcinoma,0.6631,Advanced Ovarian Serous Cystadenocarcinoma,0.6618,POROCARCINOMA/SPIROADENOCARCINOMA,True,True,True
PRAD,Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,1.0000,Prostate Carcinoma,0.9126,Prostate Ductal Adenocarcinoma,0.8818,Advanced Prostate Adenocarcinoma,0.8758,Aggressive Prostate Adenocarcinoma,0.8671,Prostate Acinar Adenocarcinoma,0.8593,Prostate Poorly Differentiated Adenocarcinoma,0.8494,Malignant Prostate Neoplasm,0.8273,Advanced Prostate Carcinoma,0.8247,Metastatic Prostate Adenocarcinoma,0.8199,Prostate Adenoma,0.8178,Papillary Adenocarcinoma,0.8014,Prostate Neoplasm,0.7984,Prostate Well Differentiated Adenocarcinoma,0.7969,Adenocarcinoma,0.7969,Parotid Gland Adenocarcinoma,0.7947,Pancreatic Adenocarcinoma,0.7940,Localized Prostate Adenocarcinoma,0.7924,Invasive Prostate Carcinoma,0.7863,Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.7859,Prostate Adenocarcinoma,True,True,True
PRE-T,T Lymphoblastic Leukemia/Lymphoma,99,2,Pre T-ALL,0.7007,Pre-Pre-B Acute Lymphoblastic Leukemia,0.5756,PRETEXT I Hepatoblastoma,0.5691,Hepatoblastoma by PRETEXT Stage,0.5629,PRETEXT IV Hepatoblastoma,0.5519,Localized PRETEXT I Hepatoblastoma,0.5492,PRETEXT III Hepatoblastoma,0.5459,Pre-B Acute Lymphoblastic Leukemia,0.5428,Primary Neoplasm,0.5406,Blastoma,0.5389,PRETEXT II Hepatoblastoma,0.5381,Precursor Lymphoid Neoplasm,0.5359,Localized PRETEXT IV Hepatoblastoma,0.5349,Localized PRETEXT III Hepatoblastoma,0.5339,Post-Transplant Lymphoproliferative Disorder,0.5273,Localized PRETEXT II Hepatoblastoma,0.5241,Metastatic PRETEXT I Hepatoblastoma,0.5214,Liquid Tumor,0.5186,Childhood Pre-B Acute Lymphoblastic Leukemia,0.5134,Neoplastic Post-Transplant Lymphoproliferative Disorder,0.5058,PRE-T,False,False,False
PRIMARY CNS MELANOMA,Central Nervous System Melanoma,1,2,Central Nervous System Melanoma,0.7992,Intracranial Melanoma,0.7511,Metastatic Primary Malignant Central Nervous System Neoplasm,0.7256,Metastatic Melanoma in the Central Nervous System,0.7204,Primary Central Nervous System Lymphoma,0.6994,Primary Central Nervous System Neoplasm,0.6991,Spinal Cord Melanoma,0.6813,Meningeal Melanoma,0.6686,Primary Cutaneous Meningioma,0.6657,Central Nervous System Melanocytic Neoplasm,0.6586,Metastatic Melanoma in the Brain,0.6572,Metastatic Primary Malignant Brain Neoplasm,0.6522,Meningeal Melanomatosis,0.6511,Metastatic Melanoma,0.6509,Melanoma,0.6501,Choroid Melanoma,0.6487,Cutaneous Melanoma,0.6477,Metastatic Cutaneous Melanoma,0.6452,Primary Brain Neoplasm,0.6415,Metastatic Malignant Neoplasm in the Central Nervous System,0.6413,PRIMARY CNS MELANOMA,True,True,True
PRIMARY CUTANEOUS CD30 POSITIVE T-CELL LYMPHOPROLIFERATIVE DISORDERS,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,1,2,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.9855,Primary CD30-Positive T-Cell Lymphoproliferative Disorder,0.9207,Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.8398,Primary Oral Cavity CD30-Positive T-Cell Lymphoproliferative Disorder,0.7824,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7799,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,0.7683,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",0.7597,Primary Head and Neck Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder,0.7595,"Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7558,Primary Cutaneous Gamma-Delta T-Cell Lymphoma,0.7524,Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7484,Primary Cutaneous Acral CD8-Positive T-Cell Lymphoproliferative Disorder,0.7214,Cutaneous Precursor Lymphoid Neoplasm,0.7097,Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6977,Primary Cutaneous Lymphoma,0.6873,Refractory Primary Cutaneous Gamma-Delta T-Cell Lymphoma,0.6829,Primary Cutaneous Non-Hodgkin Lymphoma,0.6725,Primary Cutaneous Marginal Zone Lymphoproliferative Disorder,0.6547,IgG-Positive Primary Cutaneous Marginal Zone Lymphoproliferative Disorder,0.6546,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6464,PRIMARY CUTANEOUS CD30 POSITIVE T-CELL LYMPHOPROLIFERATIVE DISORDERS,True,True,True
PRIMARY CUTANEOUS CD8 POSITIVE AGGRESSIVE EPIDERMOTROPIC CYTOTOXIC T-CELL LYMPHOMA,Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,1,2,Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,0.9941,Refractory Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,0.8531,Recurrent Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,0.8463,Primary Cutaneous Acral CD8-Positive T-Cell Lymphoproliferative Disorder,0.7589,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6876,Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6796,Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6646,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",0.6604,Aggressive T-Cell Non-Hodgkin Lymphoma,0.6486,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.6482,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,0.6463,Primary Cutaneous Anaplastic Large Cell Lymphoma,0.6333,"Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6329,Primary Cutaneous Gamma-Delta T-Cell Lymphoma,0.6328,"Peripheral T-Cell Lymphoma, Large Cell",0.6229,Cutaneous Mature T-Cell and NK-Cell Neoplasm,0.6144,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.6074,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,0.6017,"Cutaneous Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type",0.5958,Enteropathy-Associated T-Cell Lymphoma,0.5947,PRIMARY CUTANEOUS CD8 POSITIVE AGGRESSIVE EPIDERMOTROPIC CYTOTOXIC T-CELL LYMPHOMA,True,True,True
PRIMARY DLBCL OF THE CNS,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1,2,Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.8388,Primary Central Nervous System Lymphoma,0.7990,Primary Cerebral Diffuse Large B-Cell Lymphoma,0.7785,Primary Central Nervous System B-Cell Non-Hodgkin Lymphoma,0.7710,AIDS-Related Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.7532,Primary Central Nervous System Non-Hodgkin Lymphoma,0.7289,Primary Low Grade B-Cell Dural Lymphoma,0.7236,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.6955,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0.6876,Cerebral Lymphoma,0.6856,Primary Pituitary Gland Diffuse Large B-Cell Lymphoma,0.6845,Immunodeficiency-Related Primary Central Nervous System Lymphoma,0.6816,Primary Brain Neoplasm,0.6625,AIDS-Related Primary Central Nervous System Lymphoma,0.6527,Primary Large B-Cell Lymphoma of Immune-Privileged Site,0.6428,Primary Central Nervous System Neoplasm,0.6401,Primary Central Nervous System Anaplastic Large Cell Lymphoma,0.6393,Secondary Central Nervous System Lymphoma,0.6389,Diffuse Intrinsic Pontine Glioma,0.6342,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",0.6324,PRIMARY DLBCL OF THE CNS,True,True,True
PRIMARY EFFUSION LYMPHOMA,Primary Effusion Lymphoma,1,2,Primary Effusion Lymphoma,1.0000,Peritoneal Primary Effusion Lymphoma,0.9217,Pleural Primary Effusion Lymphoma,0.9069,Pericardial Primary Effusion Lymphoma,0.8864,Extracavitary Primary Effusion Lymphoma,0.8482,Body Cavity Primary Effusion Lymphoma,0.8376,Recurrent Primary Effusion Lymphoma,0.7924,Refractory Primary Effusion Lymphoma,0.7774,AIDS-Related Primary Effusion Lymphoma,0.7750,Pleural Mesothelioma,0.6964,Lymphomatoid Papulosis,0.6908,Pyothorax-Associated Lymphoma,0.6843,Pleural Non-Hodgkin Lymphoma,0.6645,HHV-8 and EBV-Negative Primary Effusion-Based Lymphoma,0.6637,Primary Peritoneal Adenocarcinoma,0.6607,Primary Bone Lymphoma,0.6600,Pleural Neoplasm,0.6592,Peritoneal Malignant Mesothelioma,0.6514,Primary Peritoneal Carcinoma,0.6509,Pleural Malignant Mesothelioma,0.6479,PRIMARY EFFUSION LYMPHOMA,True,True,True
PRIMARY MEDIASTINAL THYMIC DLBCL,Primary Mediastinal Large B-Cell Lymphoma,1,2,Primary Mediastinal Large B-Cell Lymphoma,0.7820,Mediastinal Thymoma,0.7469,Mediastinal Lymphoma,0.7464,Childhood Primary Mediastinal Large B-Cell Lymphoma,0.7317,Thymoma Type B,0.7213,Mediastinal Gray-Zone Lymphoma,0.7058,Thymoma Type B1,0.6906,Mediastinal T Lymphoblastic Lymphoma,0.6906,Thymus Lymphoma,0.6862,Mediastinal Non-Hodgkin Lymphoma,0.6845,Thymoma,0.6819,Thymoma Type B3,0.6787,Thymoma Type A,0.6752,Microscopic Thymoma,0.6733,Thymoma Type AB,0.6730,Intrapulmonary Thymoma,0.6664,Thymoma Type B2,0.6640,Malignant Type B1 Thymoma,0.6563,Mediastinal T Acute Lymphoblastic Leukemia,0.6563,Atypical Type A Thymoma,0.6540,PRIMARY MEDIASTINAL THYMIC DLBCL,True,True,True
PRIMARY MEDIASTINAL THYMIC LARGE B-CELL LYMPHOMA,Primary Mediastinal Large B-Cell Lymphoma,1,2,Primary Mediastinal Large B-Cell Lymphoma,0.9324,Childhood Primary Mediastinal Large B-Cell Lymphoma,0.8772,Primary Mediastinal Large B-Cell Lymphoma by Ann Arbor Stage,0.7878,Mediastinal Lymphoma,0.7683,Mediastinal T Lymphoblastic Lymphoma,0.7646,Recurrent Primary Mediastinal Large B-Cell Lymphoma,0.7453,Mediastinal T Lymphoblastic Leukemia/Lymphoma,0.7416,Ann Arbor Stage IV Primary Mediastinal Large B-Cell Lymphoma,0.7357,Mediastinal Non-Hodgkin Lymphoma,0.7326,Testicular Diffuse Large B-Cell Lymphoma,0.7185,Mediastinal T Acute Lymphoblastic Leukemia,0.7163,Refractory Primary Mediastinal Large B-Cell Lymphoma,0.7156,Mediastinal Thymoma,0.7150,Mediastinal Gray-Zone Lymphoma,0.7096,Ann Arbor Stage I Primary Mediastinal Large B-Cell Lymphoma,0.7079,Thymoma Type B,0.7012,Lung Mature B-Cell Neoplasm,0.6904,Thymus Mucosa-Associated Lymphoid Tissue Lymphoma,0.6817,Thymus Lymphoma,0.6761,Ann Arbor Stage III Primary Mediastinal Large B-Cell Lymphoma,0.6727,PRIMARY MEDIASTINAL THYMIC LARGE B-CELL LYMPHOMA,True,True,True
PRIMARY MYELOFIBROSIS,Primary Myelofibrosis,1,2,Primary Myelofibrosis,1.0000,Prefibrotic Primary Myelofibrosis,0.9108,Overt Primary Myelofibrosis,0.9077,Chronic Phase Primary Myelofibrosis,0.8621,Blast Phase Primary Myelofibrosis,0.8309,Accelerated Phase Primary Myelofibrosis,0.7932,Acute Panmyelosis with Myelofibrosis,0.7659,Refractory Primary Myelofibrosis,0.7559,Recurrent Primary Myelofibrosis,0.7463,Gliofibroma,0.6727,Post-Essential Thrombocythemia Myelofibrosis,0.6700,Recurrent Acute Panmyelosis with Myelofibrosis,0.6562,Myeloproliferative Neoplasm,0.6528,Advanced Myxofibrosarcoma,0.6430,"Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase",0.6272,Myxofibrosarcoma,0.6245,Myofibromatosis,0.6135,Blast Phase Myeloproliferative Neoplasm,0.6113,Myeloid Neoplasm,0.6047,Dermatomyofibroma,0.5947,PRIMARY MYELOFIBROSIS,True,True,True
"PRIMARY MYELOFIBROSIS,OVERT FIBROTIC STAGE",Overt Primary Myelofibrosis,1,2,Overt Primary Myelofibrosis,0.8958,Chronic Phase Primary Myelofibrosis,0.8338,Prefibrotic Primary Myelofibrosis,0.8242,Primary Myelofibrosis,0.8087,Blast Phase Primary Myelofibrosis,0.7853,Accelerated Phase Primary Myelofibrosis,0.7810,Refractory Primary Myelofibrosis,0.6975,Advanced Myxofibrosarcoma,0.6943,Post-Essential Thrombocythemia Myelofibrosis,0.6903,Acute Panmyelosis with Myelofibrosis,0.6623,"Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase",0.6588,Recurrent Primary Myelofibrosis,0.6573,Blast Phase Myeloproliferative Neoplasm,0.5908,Advanced Fibrosarcoma,0.5849,Accelerated Phase Myeloproliferative Neoplasm,0.5796,Refractory Post-Essential Thrombocythemia Myelofibrosis,0.5762,Locally Advanced Myxofibrosarcoma,0.5721,Advanced Undifferentiated Pleomorphic Sarcoma,0.5690,"Refractory Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase",0.5676,Unresectable Myxofibrosarcoma,0.5648,"PRIMARY MYELOFIBROSIS,OVERT FIBROTIC STAGE",True,True,True
PRIMARY NEUROEPITHELIAL TUMOR,Neuroepithelial Neoplasm,1,2,Neuroepithelial Neoplasm,0.8506,Primitive Neuroectodermal Tumor,0.8319,Peripheral Primitive Neuroectodermal Tumor,0.8201,Dysembryoplastic Neuroepithelial Tumor,0.7744,Localized Primitive Neuroectodermal Tumor,0.7663,Localized Peripheral Primitive Neuroectodermal Tumor,0.7653,Neuroendocrine Tumor,0.7581,Prostate Neuroendocrine Tumor,0.7471,Childhood Dysembryoplastic Neuroepithelial Tumor,0.7352,Neuroendocrine Neoplasm,0.7342,Peripheral Primitive Neuroectodermal Tumor of Bone,0.7339,Childhood Neuroendocrine Tumor,0.7317,Pituitary Neuroendocrine Tumor,0.7233,Nasopharyngeal Pituitary Neuroendocrine Tumor,0.7228,Peripheral Primitive Neuroectodermal Tumor of Kidney,0.7222,Polymorphous Low Grade Neuroepithelial Tumor of the Young,0.7194,"Neuroepithelial, Perineurial, and Schwann Cell Neoplasm",0.7175,Neuroblastic Tumor,0.7174,Adult Dysembryoplastic Neuroepithelial Tumor,0.7162,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues,0.7157,PRIMARY NEUROEPITHELIAL TUMOR,True,True,True
PRIMARY RESIDUAL,Primary Neoplasm,19,2,Recurrent Primary Malignant Neoplasm,0.6754,Recurrent Retinoblastoma,0.6655,Refractory Primary Peritoneal Carcinoma,0.6562,Refractory Neoplasm,0.6549,Refractory Lymphoma,0.6525,Refractory Melanoma,0.6484,Refractory Primary Effusion Lymphoma,0.6460,Refractory Primary Amyloidosis,0.6439,Refractory Primary Cutaneous Lymphoma,0.6434,Refractory Primary Peritoneal Undifferentiated Carcinoma,0.6425,Refractory Primary Peritoneal Adenocarcinoma,0.6390,Sporadic Retinoblastoma,0.6382,Refractory Primary Bone Lymphoma,0.6327,Refractory Malignant Neoplasm,0.6297,Recurrent Neoplasm,0.6280,Refractory Sarcoma,0.6258,Refractory Carcinoma,0.6254,Recurrent Malignant Neoplasm,0.6248,Primary Neoplasm,0.6232,Refractory Multiple Myeloma,0.6214,PRIMARY RESIDUAL,False,False,False
PRIMARY TUMOUR,Primary Neoplasm,1,2,Primary Neoplasm,0.9481,Primary Malignant Neoplasm,0.8499,Primary Brain Neoplasm,0.7253,Second Primary Neoplasm,0.7046,Secondary Neoplasm,0.6961,Neoplastic Polyp,0.6840,Primary Peritoneal Adenocarcinoma,0.6802,Primary Central Nervous System Neoplasm,0.6799,Neoplasm by Site,0.6740,Pancreatic Polypeptide Tumor,0.6589,Thoracic Neoplasm,0.6572,Localized Malignant Neoplasm,0.6569,Primary Peritoneal Carcinoma,0.6562,Localized Neoplasm,0.6554,Malignant Neoplasm,0.6494,Peritoneal Neoplasm,0.6474,Neoplasm by Cause,0.6470,Placental Neoplasm,0.6467,Placental Site Trophoblastic Tumor,0.6464,Second Primary Malignant Neoplasm,0.6457,PRIMARY TUMOUR,True,True,True
PRIMITIVE NEUROECTODERMAL TUMOR,Primitive Neuroectodermal Tumor,1,2,Primitive Neuroectodermal Tumor,1.0000,Peripheral Primitive Neuroectodermal Tumor,0.9411,Localized Primitive Neuroectodermal Tumor,0.8765,Peripheral Primitive Neuroectodermal Tumor of Bone,0.8551,Localized Peripheral Primitive Neuroectodermal Tumor,0.8464,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues,0.8093,Refractory Primitive Neuroectodermal Tumor,0.8069,Peripheral Primitive Neuroectodermal Tumor of Kidney,0.7990,Localized Peripheral Primitive Neuroectodermal Tumor of Bone,0.7943,Refractory Peripheral Primitive Neuroectodermal Tumor,0.7786,Recurrent Primitive Neuroectodermal Tumor,0.7780,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7595,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7591,Recurrent Peripheral Primitive Neuroectodermal Tumor,0.7542,Neuroepithelial Neoplasm,0.7458,Dysembryoplastic Neuroepithelial Tumor,0.7341,"Brain Embryonal Tumor, Not Otherwise Specified",0.7272,Neuroblastic Tumor,0.7261,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7255,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0.7242,PRIMITIVE NEUROECTODERMAL TUMOR,True,True,True
PRIMITIVE NEUROECTODERMAL TUMOR PNET,Primitive Neuroectodermal Tumor,2,2,Peripheral Primitive Neuroectodermal Tumor,0.8813,Primitive Neuroectodermal Tumor,0.8729,Localized Peripheral Primitive Neuroectodermal Tumor,0.8040,Localized Primitive Neuroectodermal Tumor,0.7813,Peripheral Primitive Neuroectodermal Tumor of Bone,0.7713,Extraskeletal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7661,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7582,Peripheral Primitive Neuroectodermal Tumor of Soft Tissues,0.7567,Central Nervous System Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7428,Refractory Peripheral Primitive Neuroectodermal Tumor,0.7338,Peripheral Primitive Neuroectodermal Tumor of Kidney,0.7313,Refractory Primitive Neuroectodermal Tumor,0.7291,Localized Peripheral Primitive Neuroectodermal Tumor of Bone,0.7271,Recurrent Peripheral Primitive Neuroectodermal Tumor,0.7248,Neuroendocrine Tumor,0.7221,Recurrent Primitive Neuroectodermal Tumor,0.7086,Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.7042,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,0.7000,Pancreatic Neuroendocrine Tumor,0.6941,Metastatic Neuroendocrine Tumor,0.6893,PRIMITIVE NEUROECTODERMAL TUMOR PNET,False,True,True
PRO MYELOCYTIC LEUKEMIA,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,99,2,Myeloid Leukemia,0.7901,Typical Acute Promyelocytic Leukemia,0.7789,Acute Myeloid Leukemia,0.7520,Acute Monocytic Leukemia,0.7392,Prolymphocytic Leukemia,0.7253,"Myeloid Leukemia, Philadelphia-Positive",0.7190,Myeloproliferative Neoplasm,0.7125,Blast Phase Myeloproliferative Neoplasm,0.7028,Myeloid Neoplasm,0.7015,Acute Myelomonocytic Leukemia,0.6994,Acute Myeloid Leukemia with Maturation,0.6941,Acute Leukemia,0.6865,Myeloproliferative Chronic Myelomonocytic Leukemia,0.6846,"Myeloid Leukemia, Philadelphia-Negative",0.6831,Aleukemic Myeloid Leukemia,0.6808,Acute Megakaryoblastic Leukemia,0.6798,Chronic Monocytic Leukemia,0.6785,Acute Myeloid Leukemia without Maturation,0.6707,Microgranular Acute Promyelocytic Leukemia,0.6685,Accelerated Phase Myeloproliferative Neoplasm,0.6678,PRO MYELOCYTIC LEUKEMIA,False,False,False
PROSTATE ADENOCARCINOMA,Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,1.0000,Prostate Carcinoma,0.9126,Prostate Ductal Adenocarcinoma,0.8818,Advanced Prostate Adenocarcinoma,0.8758,Aggressive Prostate Adenocarcinoma,0.8671,Prostate Acinar Adenocarcinoma,0.8593,Prostate Poorly Differentiated Adenocarcinoma,0.8494,Malignant Prostate Neoplasm,0.8273,Advanced Prostate Carcinoma,0.8247,Metastatic Prostate Adenocarcinoma,0.8199,Prostate Adenoma,0.8178,Papillary Adenocarcinoma,0.8014,Prostate Neoplasm,0.7984,Prostate Well Differentiated Adenocarcinoma,0.7969,Adenocarcinoma,0.7969,Parotid Gland Adenocarcinoma,0.7947,Pancreatic Adenocarcinoma,0.7940,Localized Prostate Adenocarcinoma,0.7924,Invasive Prostate Carcinoma,0.7863,Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.7859,PROSTATE ADENOCARCINOMA,True,True,True
PROSTATE ADENOCARCINOMA ACINAR TYPE,Prostate Acinar Adenocarcinoma,1,2,Prostate Acinar Adenocarcinoma,0.9660,"Prostate Acinar Adenocarcinoma, Atrophic Pattern",0.8828,Lung Acinar Adenocarcinoma,0.8444,Prostate Acinar Oncocytic Adenocarcinoma,0.8444,Prostate Acinar Mucinous Adenocarcinoma,0.8222,Prostate Acinar Microcystic Adenocarcinoma,0.8033,Prostate Ductal Adenocarcinoma,0.8011,Prostate Adenocarcinoma,0.7991,Prostate Acinar Foamy Gland Adenocarcinoma,0.7927,Prostate Acinar Pseudohyperplastic Adenocarcinoma,0.7915,Pancreatic Acinar Cell Carcinoma,0.7897,Acinar Cell Carcinoma,0.7892,Acinar Cell Adenoma,0.7811,Prostate Poorly Differentiated Adenocarcinoma,0.7725,Pancreatic Acinar Cell Cystadenocarcinoma,0.7655,Aggressive Prostate Adenocarcinoma,0.7537,Papillary Adenocarcinoma,0.7368,Prostate Well Differentiated Adenocarcinoma,0.7367,"Prostate Ductal Adenocarcinoma, Papillary Pattern",0.7347,Pancreatic Ductal Adenocarcinoma,0.7343,PROSTATE ADENOCARCINOMA ACINAR TYPE,True,True,True
"PROSTATE ADENOCARCINOMA, NOT OTHERWISED SPECIFIED, WITH DUCTAL FEATUES",Prostate Ductal Adenocarcinoma,1,2,Prostate Ductal Adenocarcinoma,0.7843,"Prostate Ductal Adenocarcinoma, Papillary Pattern",0.7614,Prostate Acinar Foamy Gland Adenocarcinoma,0.7137,Pancreatic Ductal Adenocarcinoma,0.7126,"Prostate Ductal Adenocarcinoma, Solid Pattern",0.7116,Prostate Acinar Adenocarcinoma,0.7085,Prostate Adenocarcinoma,0.7030,Prostate Acinar Pseudohyperplastic Adenocarcinoma,0.6999,Prostate Adenocarcinoma without Neuroendocrine Differentiation,0.6957,Prostate Poorly Differentiated Adenocarcinoma,0.6903,Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.6866,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,0.6849,"Prostate Acinar Adenocarcinoma, Atrophic Pattern",0.6795,Papillary Adenocarcinoma,0.6762,Prostate Adenocarcinoma with Paneth Cell-Like Neuroendocrine Differentiation,0.6735,Pancreatic Foamy Gland Adenocarcinoma,0.6727,Prostate Acinar Lymphoepithelioma-Like Adenocarcinoma,0.6703,Advanced Pancreatic Ductal Adenocarcinoma,0.6700,Prostate Acinar Mucinous Adenocarcinoma,0.6639,Usual Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.6633,"PROSTATE ADENOCARCINOMA, NOT OTHERWISED SPECIFIED, WITH DUCTAL FEATUES",True,True,True
"PROSTATE ADENOCARCINOMA, OTHER SUBTYPE",Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,0.7941,Prostate Adenocarcinoma without Neuroendocrine Differentiation,0.7715,Metastatic Prostate Adenocarcinoma,0.7275,Advanced Prostate Adenocarcinoma,0.7254,Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.7228,Prostate Carcinoma,0.7182,Usual Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.7163,Prostate Poorly Differentiated Adenocarcinoma,0.7147,Prostate Acinar Adenocarcinoma,0.7138,Prostate Acinar Oncocytic Adenocarcinoma,0.7051,Aggressive Prostate Adenocarcinoma,0.7041,Prostate Ductal Adenocarcinoma,0.6977,Advanced Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.6976,Localized Prostate Adenocarcinoma,0.6796,Papillary Adenocarcinoma,0.6784,Advanced Prostate Carcinoma,0.6778,Prostate Adenocarcinoma with Paneth Cell-Like Neuroendocrine Differentiation,0.6775,Prostate Adenoma,0.6774,Prostate Well Differentiated Adenocarcinoma,0.6749,Prostate Acinar Mucinous Adenocarcinoma,0.6681,"PROSTATE ADENOCARCINOMA, OTHER SUBTYPE",True,True,True
PROSTATE CANCER,Prostate Carcinoma,1,2,Prostate Carcinoma,0.9581,Prostate Adenocarcinoma,0.8904,Malignant Prostate Neoplasm,0.8763,Prostate Neoplasm,0.8734,Advanced Prostate Carcinoma,0.8420,Invasive Prostate Carcinoma,0.8151,Aggressive Prostate Adenocarcinoma,0.7945,Advanced Prostate Adenocarcinoma,0.7911,Localized Prostate Carcinoma,0.7762,Metastatic Prostate Carcinoma,0.7666,Hereditary Prostate Carcinoma,0.7625,Prostate Adenoma,0.7616,Unresectable Prostate Carcinoma,0.7581,Prostate Poorly Differentiated Adenocarcinoma,0.7545,Prostate Melanoma,0.7517,Prostate Ductal Adenocarcinoma,0.7511,Benign Prostate Neoplasm,0.7502,Prostate Undifferentiated Carcinoma,0.7494,Prostate Squamous Cell Carcinoma,0.7452,Prostate Neuroendocrine Carcinoma,0.7407,PROSTATE CANCER,True,True,True
"PROSTATE CANCER, NOS",Prostate Carcinoma,1,2,Prostate Carcinoma,0.9101,Malignant Prostate Neoplasm,0.8476,Prostate Adenocarcinoma,0.8354,Prostate Neoplasm,0.8222,Advanced Prostate Carcinoma,0.8038,Invasive Prostate Carcinoma,0.7892,Advanced Prostate Adenocarcinoma,0.7431,Aggressive Prostate Adenocarcinoma,0.7311,Prostate Squamous Cell Carcinoma,0.7283,Hereditary Prostate Carcinoma,0.7182,Metastatic Prostate Carcinoma,0.7129,Localized Prostate Carcinoma,0.7088,Prostate Ductal Adenocarcinoma,0.7024,Locally Advanced Prostate Carcinoma,0.7017,Prostate Undifferentiated Carcinoma,0.7005,Unresectable Prostate Carcinoma,0.6994,Prostate Poorly Differentiated Adenocarcinoma,0.6929,Prostate Adenoma,0.6886,Benign Prostate Neoplasm,0.6851,Prostate Melanoma,0.6800,"PROSTATE CANCER, NOS",True,True,True
PROSTATE NEUROENDOCRINE CARCINOMA,Prostate Neuroendocrine Carcinoma,1,2,Prostate Neuroendocrine Carcinoma,1.0000,Prostate Small Cell Neuroendocrine Carcinoma,0.8792,Prostate Large Cell Neuroendocrine Carcinoma,0.8755,Metastatic Prostate Neuroendocrine Carcinoma,0.8574,Prostate Neuroendocrine Tumor,0.8543,Neuroendocrine Carcinoma,0.8542,Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.8489,Prostate Neuroendocrine Neoplasm,0.8467,Pancreatic Neuroendocrine Carcinoma,0.8449,Advanced Prostate Small Cell Neuroendocrine Carcinoma,0.8202,Locally Advanced Prostate Neuroendocrine Carcinoma,0.8175,Treatment-Related Prostate Neuroendocrine Carcinoma,0.8167,Prostate Adenocarcinoma without Neuroendocrine Differentiation,0.8099,Usual Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.8090,Advanced Neuroendocrine Carcinoma,0.8030,Extrapulmonary Neuroendocrine Carcinoma,0.7945,Lung Neuroendocrine Carcinoma,0.7853,Kidney Neuroendocrine Carcinoma,0.7761,Prostate Carcinoma,0.7756,Prostate Undifferentiated Carcinoma,0.7744,PROSTATE NEUROENDOCRINE CARCINOMA,True,True,True
PROSTATE SMALL CELL CARCINOMA,Prostate Small Cell Neuroendocrine Carcinoma,1,2,Prostate Small Cell Neuroendocrine Carcinoma,0.8960,Advanced Prostate Small Cell Neuroendocrine Carcinoma,0.8199,Metastatic Prostate Small Cell Neuroendocrine Carcinoma,0.7813,Prostate Squamous Cell Carcinoma,0.7700,Small Cell Adenocarcinoma,0.7511,Prostate Undifferentiated Carcinoma,0.7499,Refractory Prostate Small Cell Neuroendocrine Carcinoma,0.7381,Prostate Large Cell Neuroendocrine Carcinoma,0.7351,Prostate Carcinoma,0.7351,Unresectable Prostate Small Cell Neuroendocrine Carcinoma,0.7314,Prostate Neuroendocrine Carcinoma,0.7220,Small Cell Neuroendocrine Carcinoma,0.7200,Lung Small Cell Carcinoma,0.7172,Kidney Small Cell Neuroendocrine Carcinoma,0.7018,Prostate Poorly Differentiated Adenocarcinoma,0.6996,Ovarian Small Cell Carcinoma,0.6970,Pancreatic Small Cell Neuroendocrine Carcinoma,0.6899,"Lung Small Cell Carcinoma, P Subtype",0.6888,Platinum-Sensitive Lung Small Cell Carcinoma,0.6836,Small Cell Intermediate Cell Carcinoma,0.6829,PROSTATE SMALL CELL CARCINOMA,True,True,True
PROSTATE SQUAMOUS CELL CARCINOMA,Prostate Squamous Cell Carcinoma,1,2,Prostate Squamous Cell Carcinoma,1.0000,Penile Squamous Cell Carcinoma,0.8013,Prostate Carcinoma,0.7957,Prostate Adenosquamous Carcinoma,0.7723,Penile Clear Cell Squamous Cell Carcinoma,0.7695,Parotid Gland Squamous Cell Carcinoma,0.7650,Seminal Vesicle Squamous Cell Carcinoma,0.7413,Squamous Cell Carcinoma,0.7396,"Penile Squamous Cell Carcinoma, Not Otherwise Specified",0.7360,Papillary Squamous Cell Carcinoma,0.7324,Penile Acantholytic Squamous Cell Carcinoma,0.7299,Prostate Undifferentiated Carcinoma,0.7245,Urethral Squamous Cell Carcinoma,0.7209,Prostate Adenocarcinoma,0.7180,Prostate Basal Cell Carcinoma,0.7145,Locally Advanced Penile Squamous Cell Carcinoma,0.7125,Penile Adenosquamous Carcinoma,0.7119,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,0.7057,Prostate Small Cell Neuroendocrine Carcinoma,0.7047,Renal Pelvis Squamous Cell Carcinoma,0.7038,PROSTATE SQUAMOUS CELL CARCINOMA,True,True,True
PROSTATE_ADENOCARCINOMA,Prostate Adenocarcinoma,1,2,Prostate Adenocarcinoma,0.9610,Prostate Carcinoma,0.8676,Advanced Prostate Adenocarcinoma,0.8472,Aggressive Prostate Adenocarcinoma,0.8433,Prostate Ductal Adenocarcinoma,0.8381,Prostate Poorly Differentiated Adenocarcinoma,0.8273,Prostate Acinar Adenocarcinoma,0.8271,Malignant Prostate Neoplasm,0.8050,Adenocarcinoma,0.7932,Prostate Adenocarcinoma without Neuroendocrine Differentiation,0.7911,Advanced Prostate Carcinoma,0.7908,Prostate Adenoma,0.7902,Papillary Adenocarcinoma,0.7884,Metastatic Prostate Adenocarcinoma,0.7872,Prostate Well Differentiated Adenocarcinoma,0.7798,Prostate Adenocarcinoma with Neuroendocrine Differentiation,0.7795,Pancreatic Adenocarcinoma,0.7794,Localized Prostate Adenocarcinoma,0.7765,Prostate Neoplasm,0.7724,Parotid Gland Adenocarcinoma,0.7633,PROSTATE_ADENOCARCINOMA,True,True,True
PROSTATE_CANCER,Prostate Carcinoma,1,2,Prostate Carcinoma,0.8934,Prostate Neoplasm,0.8296,Prostate Adenocarcinoma,0.8238,Malignant Prostate Neoplasm,0.8236,Advanced Prostate Carcinoma,0.7687,Invasive Prostate Carcinoma,0.7543,Hereditary Prostate Carcinoma,0.7445,Prostate Undifferentiated Carcinoma,0.7416,Aggressive Prostate Adenocarcinoma,0.7334,Unresectable Prostate Carcinoma,0.7297,Prostate Melanoma,0.7290,Localized Prostate Carcinoma,0.7264,Prostate Neuroendocrine Carcinoma,0.7254,Advanced Prostate Adenocarcinoma,0.7209,Metastatic Prostate Carcinoma,0.7145,Prostate Lymphoma,0.7076,Benign Prostate Neoplasm,0.7021,Locally Advanced Prostate Carcinoma,0.7009,Prostate Squamous Cell Carcinoma,0.6969,Prostate Adenoma,0.6951,PROSTATE_CANCER,True,True,True
PROSTATE_SMALL_CELL,Prostate Small Cell Neuroendocrine Carcinoma,1,2,Prostate Small Cell Neuroendocrine Carcinoma,0.7938,Advanced Prostate Small Cell Neuroendocrine Carcinoma,0.7416,Prostate Undifferentiated Carcinoma,0.7092,Small Cell Adenocarcinoma,0.7066,Metastatic Prostate Small Cell Neuroendocrine Carcinoma,0.6896,Prostate Small Lymphocytic Lymphoma,0.6859,Refractory Prostate Small Cell Neuroendocrine Carcinoma,0.6849,Unresectable Prostate Small Cell Neuroendocrine Carcinoma,0.6734,Prostate Squamous Cell Carcinoma,0.6732,"Malignant Tumor, Small Cell Type",0.6696,Prostate Poorly Differentiated Adenocarcinoma,0.6644,Prostate Carcinoma,0.6619,Aggressive Variant Prostate Carcinoma,0.6612,Prostate Neuroendocrine Carcinoma,0.6586,Small Cell Neuroendocrine Carcinoma,0.6528,Prostate Large Cell Neuroendocrine Carcinoma,0.6490,Localized Prostate Carcinoma,0.6481,Oligometastatic Prostate Carcinoma,0.6418,Basal-Like Prostate Carcinoma,0.6394,Intermediate Atypical Prostate Carcinoma,0.6393,PROSTATE_SMALL_CELL,True,True,True
PROXIMAL-TYPE EPITHELIOID SARCOMA,Proximal-Type Epithelioid Sarcoma,1,2,Proximal-Type Epithelioid Sarcoma,1.0000,Distal-Type Epithelioid Sarcoma,0.8681,Pleural Proximal-Type Epithelioid Sarcoma,0.8218,Epithelioid Sarcoma,0.8170,Localized Epithelioid Sarcoma,0.7916,Advanced Epithelioid Sarcoma,0.7491,Adult Epithelioid Sarcoma,0.7473,Epithelioid Sarcoma NCI Grade 2,0.7428,Undifferentiated Sarcoma with Epithelioid Features,0.7373,Epithelioid Sarcoma NCI Grade 3,0.7331,Metastatic Epithelioid Sarcoma,0.7318,Vulvar Proximal-Type Epithelioid Sarcoma,0.7183,Epithelial Synovial Sarcoma,0.7051,Childhood Epithelioid Sarcoma,0.7042,Locally Advanced Epithelioid Sarcoma,0.6923,Unresectable Epithelioid Sarcoma,0.6908,Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.6902,Endometrioid Stromal Sarcoma,0.6854,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor,0.6846,Epithelioid Leiomyosarcoma,0.6793,PROXIMAL-TYPE EPITHELIOID SARCOMA,True,True,True
PROXIMAL-TYPE EPITHELIOID SARCOMA PTES,Proximal-Type Epithelioid Sarcoma,1,2,Proximal-Type Epithelioid Sarcoma,0.8653,Pleural Proximal-Type Epithelioid Sarcoma,0.7802,Distal-Type Epithelioid Sarcoma,0.7164,Epithelioid Sarcoma,0.6732,Epithelial Synovial Sarcoma,0.6444,Prostate Stromal Sarcoma,0.6437,Localized Epithelioid Sarcoma,0.6417,Vulvar Proximal-Type Epithelioid Sarcoma,0.6344,Advanced Epithelioid Sarcoma,0.6258,Epithelioid Sarcoma NCI Grade 3,0.6249,Prostate Sarcoma,0.6224,Epithelioid Sarcoma NCI Grade 2,0.6181,Adult Epithelioid Sarcoma,0.6129,Undifferentiated Sarcoma with Epithelioid Features,0.6086,Platinum-Sensitive Endometrial Serous Adenocarcinoma,0.6067,Metastatic Epithelioid Sarcoma,0.6055,Prostate Myeloid Sarcoma,0.6049,Platinum-Sensitive Endometrial Carcinoma,0.5993,Prostate Synovial Sarcoma,0.5967,Childhood Epithelioid Sarcoma,0.5953,PROXIMAL-TYPE EPITHELIOID SARCOMA PTES,True,True,True
PSEUDOMYOGENIC HEMANGIOENDOTHELIOMA,Pseudomyogenic Hemangioendothelioma,1,2,Pseudomyogenic Hemangioendothelioma,1.0000,Childhood Pseudomyogenic Hemangioendothelioma,0.8452,Hemangioendothelioma,0.8446,Benign Hemangioendothelioma,0.8390,Polymorphus Hemangioendothelioma,0.8032,Composite Hemangioendothelioma,0.7971,Epithelioid Hemangioendothelioma,0.7878,Kaposiform Hemangioendothelioma,0.7556,Skin Hemangioendothelioma,0.7534,Bone Epithelioid Hemangioendothelioma,0.7386,Retiform Hemangioendothelioma,0.7230,Advanced Epithelioid Hemangioendothelioma,0.7202,Cardiac Epithelioid Hemangioendothelioma,0.7199,Mediastinal Epithelioid Hemangioendothelioma,0.7173,Pleural Epithelioid Hemangioendothelioma,0.7131,Metastatic Epithelioid Hemangioendothelioma,0.7064,Epithelioid Hemangioma,0.6979,Adult Epithelioid Hemangioendothelioma,0.6974,Sinonasal Epithelioid Hemangioendothelioma,0.6917,Benign Myoepithelioma,0.6870,PSEUDOMYOGENIC HEMANGIOENDOTHELIOMA,True,True,True
PURE ERYTHROID LEUKEMIA,Pure Erythroid Leukemia,1,2,Pure Erythroid Leukemia,1.0000,Acute Erythroid Leukemia,0.8829,Adult Pure Erythroid Leukemia,0.8802,Erythroleukemia,0.7793,Childhood Acute Erythroid Leukemia,0.7755,Adult Acute Erythroid Leukemia,0.7634,Adult Erythroleukemia,0.7412,Acute Eosinophilic Leukemia,0.7399,Erythroid Neoplasm,0.7199,Myeloid Leukemia,0.7147,Leukemia,0.7003,Acute Leukemia,0.6835,Aleukemic Leukemia,0.6767,Recurrent Acute Erythroid Leukemia,0.6654,Adult Acute Eosinophilic Leukemia,0.6652,Aleukemic Myeloid Leukemia,0.6644,Childhood Acute Eosinophilic Leukemia,0.6633,Acute Myeloid Leukemia,0.6578,Aleukemic Acute Lymphoblastic Leukemia,0.6482,Lymphoid Leukemia,0.6452,PURE ERYTHROID LEUKEMIA,True,True,True
RA,Refractory Anemia,1,2,Refractory Anemia,0.6997,Retinoblastoma,0.6352,Differentiated Retinoblastoma,0.6296,Retinocytoma,0.6212,ROSE Cluster 7,0.6163,ROSE Cluster 1,0.6084,Undifferentiated Retinoblastoma,0.6061,Retinal Astrocytoma,0.6042,Sporadic Retinoblastoma,0.6002,Lymphoma,0.5974,ROSE Cluster 3,0.5961,Spontaneously Regressed Retinoblastoma,0.5947,ROSE Cluster 8,0.5917,ROSE Cluster 6,0.5877,Rhabdomyoma,0.5868,Diffuse Retinoblastoma,0.5868,Refractory Leukemia,0.5812,Benign Retinal Neoplasm,0.5809,Adenoma,0.5808,ROSE Cluster 2,0.5806,RA,True,True,True
RAEB,Myelodysplastic Syndrome with Excess Blasts,10,2,Acute Erythroid Leukemia,0.6943,Adult Erythroleukemia,0.6898,Erythroleukemia,0.6865,Refractory Anemia with Excess Blasts in Transformation,0.6840,Pure Erythroid Leukemia,0.6639,Adult Acute Erythroid Leukemia,0.6586,Adult Pure Erythroid Leukemia,0.6516,Childhood Acute Erythroid Leukemia,0.6504,Refractory Anemia,0.6463,Myelodysplastic Syndrome with Excess Blasts,0.6426,Refractory Acute Leukemia,0.6342,Refractory Leukemia,0.6325,Acute Undifferentiated Leukemia,0.6322,Refractory Acute Undifferentiated Leukemia,0.6295,Acute Leukemia,0.6267,Blastoma,0.6261,Acute Eosinophilic Leukemia,0.6237,Acute Lymphoblastic Leukemia by ROSE Cluster,0.6237,Differentiated Retinoblastoma,0.6221,Retinoblastoma,0.6217,RAEB,False,False,False
RARS,Myelodysplastic Syndrome with Ring Sideroblasts,20,2,Refractory Anemia,0.6259,CIC-Rearranged Sarcoma,0.6185,Reticulosarcoma,0.6069,Childhood CIC-Rearranged Sarcoma,0.6055,Refractory Synovial Sarcoma,0.6031,Refractory Sarcoma,0.5936,Fusion-Negative Alveolar Rhabdomyosarcoma,0.5901,Alveolar Rhabdomyosarcoma,0.5844,Refractory Alveolar Soft Part Sarcoma,0.5831,Refractory Alveolar Rhabdomyosarcoma,0.5824,Gliosarcoma,0.5810,Radiation-Related Sarcoma,0.5770,Refractory Leukemia,0.5763,Fusion-Positive Alveolar Rhabdomyosarcoma,0.5754,Central Nervous System CIC-Rearranged Sarcoma,0.5754,Fusion-Negative Rhabdomyosarcoma,0.5706,Anal Rhabdomyosarcoma,0.5700,Rhabdomyosarcoma,0.5682,Virus-Related Sarcoma,0.5677,Myelodysplastic Syndrome with Ring Sideroblasts,0.5655,RARS,False,False,False
RARS-T,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",99,2,Atypical Teratoid/Rhabdoid Tumor-MYC,0.6040,CIC-Rearranged Sarcoma,0.5906,Reticulosarcoma,0.5786,Refractory Atypical Teratoid/Rhabdoid Tumor,0.5719,Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes,0.5658,Refractory Sarcoma,0.5651,Childhood CIC-Rearranged Sarcoma,0.5643,Refractory Synovial Sarcoma,0.5580,Round Cell Sarcoma with FUS-NFATC2 Gene Fusion,0.5562,Fusion-Negative Rhabdomyosarcoma,0.5549,Refractory Thrombocytopenia,0.5543,Refractory Solitary Fibrous Tumor,0.5524,Fusion-Negative Alveolar Rhabdomyosarcoma,0.5510,Refractory Rhabdoid Tumor,0.5498,Fusion-Positive Alveolar Rhabdomyosarcoma,0.5497,Fusion-Positive Rhabdomyosarcoma,0.5496,Acute Myeloid Leukemia with ZRSR2 Mutation,0.5480,Central Nervous System CIC-Rearranged Sarcoma,0.5457,Acute Promyelocytic Leukemia with STAT3-RARA,0.5451,Atypical Teratoid/Rhabdoid Tumor,0.5451,RARS-T,False,False,False
RBL,Retinoblastoma,1,2,Retinoblastoma,1.0000,Sporadic Retinoblastoma,0.9067,Intraocular Retinoblastoma,0.9001,Differentiated Retinoblastoma,0.8896,Diffuse Retinoblastoma,0.8885,Undifferentiated Retinoblastoma,0.8692,Hereditary Retinoblastoma,0.8639,Extraocular Retinoblastoma,0.8595,Spontaneously Regressed Retinoblastoma,0.8398,Childhood Intraocular Retinoblastoma,0.8340,Bilateral Retinoblastoma,0.8331,Unilateral Retinoblastoma,0.8187,Recurrent Retinoblastoma,0.8167,Childhood Extraocular Retinoblastoma,0.8158,Stage I Retinoblastoma,0.7673,Retinal Neuroblastoma,0.7605,Stage IA Retinoblastoma,0.7531,Trilateral Retinoblastoma,0.7382,Stage III Retinoblastoma,0.7289,Retinocytoma,0.7270,Retinoblastoma,True,True,True
RCMD,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",99,2,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.6062,Cardiac Rhabdomyoma,0.6021,Refractory Cytopenia of Childhood,0.6014,Classic Rhabdomyoma,0.5966,Rhabdomyoma,0.5963,Refractory Malignant Mastocytosis,0.5923,Childhood Cardiac Rhabdomyoma,0.5889,Differentiated Retinoblastoma,0.5863,Conventional Cardiac Rhabdomyoma,0.5850,Diffuse Retinoblastoma,0.5843,Multiple Myeloma with CCND Family Translocation,0.5784,Refractory Chronic Myelomonocytic Leukemia,0.5772,Childhood Rhabdomyoma,0.5763,Refractory Myelodysplastic Syndrome,0.5736,Refractory Chronic Leukemia,0.5711,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.5709,Rhabdoid Meningioma,0.5651,Intermediate Rhabdomyoma,0.5641,Retinoblastoma,0.5631,Refractory Centroblastic Lymphoma,0.5631,RCMD,False,False,False
RCMD-RS,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,1,2,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.6605,Refractory Myelodysplastic Syndrome,0.6528,Refractory Malignant Mastocytosis,0.6190,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.6187,Refractory Cytopenia of Childhood,0.6064,Refractory Chronic Myelomonocytic Leukemia,0.5925,Myelodysplastic Syndrome with Ring Sideroblasts,0.5925,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.5829,Refractory Childhood Rhabdomyosarcoma,0.5803,Recurrent Myelodysplastic Syndrome,0.5797,Refractory Rhabdomyosarcoma,0.5794,Refractory Chronic Leukemia,0.5705,Refractory Desmoplastic Small Round Cell Tumor,0.5704,Cardiac Rhabdomyosarcoma,0.5673,Refractory Multiple Myeloma,0.5669,Refractory Mucosal Melanoma,0.5665,Refractory Centroblastic Lymphoma,0.5665,Cardiac Rhabdomyoma,0.5638,Refractory Mediastinal Lymphoma,0.5620,Refractory Round Cell Liposarcoma,0.5606,RCMD-RS,True,True,True
READ,Rectal Adenocarcinoma,1,2,Rectal Adenocarcinoma,1.0000,Rectal Carcinoma,0.9143,Advanced Rectal Adenocarcinoma,0.8875,Rectal Poorly Differentiated Adenocarcinoma,0.8638,Metastatic Rectal Adenocarcinoma,0.8505,Rectal Mucinous Adenocarcinoma,0.8457,Rectal Adenoma,0.8413,Advanced Rectal Carcinoma,0.8335,Rectal Well Differentiated Adenocarcinoma,0.8239,Unresectable Rectal Adenocarcinoma,0.8211,Refractory Rectal Adenocarcinoma,0.8189,Malignant Rectal Neoplasm,0.8114,Rectal Neoplasm,0.8113,Rectal Conventional Adenoma,0.8065,Rectal Undifferentiated Carcinoma,0.8050,Rectosigmoid Adenocarcinoma,0.8001,Colorectal Adenocarcinoma,0.7997,Locally Advanced Rectal Adenocarcinoma,0.7956,Rectal Serrated Adenocarcinoma,0.7909,Metastatic Rectal Carcinoma,0.7906,Rectal Adenocarcinoma,True,True,True
READ_GS,Rectal Adenocarcinoma,99,2,Sarcoma GX,0.5424,Reticulosarcoma,0.5262,Sarcoma by NCI Grade,0.5258,Refractory Gliosarcoma,0.5203,Refractory Glioma,0.5184,Recurrent Gliosarcoma,0.5170,Glioma,0.5143,Refractory Sarcoma,0.5138,Refractory Small Cell Glioblastoma,0.5137,Sarcoma G2,0.5083,Giant Cell Sarcoma,0.5044,Refractory Glioblastoma,0.5022,Refractory Giant Cell Glioblastoma,0.5022,Gliosarcoma,0.5019,Sarcoma G1,0.5004,Gastric Synovial Sarcoma,0.4999,Recurrent Glioma,0.4973,Adult Gliosarcoma,0.4967,Radiation-Related Sarcoma,0.4954,Refractory Synovial Sarcoma,0.4947,READ_GS,False,False,False
RECTAL ADENOCARCINOMA,Rectal Adenocarcinoma,1,2,Rectal Adenocarcinoma,1.0000,Rectal Carcinoma,0.9143,Advanced Rectal Adenocarcinoma,0.8875,Rectal Poorly Differentiated Adenocarcinoma,0.8638,Metastatic Rectal Adenocarcinoma,0.8505,Rectal Mucinous Adenocarcinoma,0.8457,Rectal Adenoma,0.8413,Advanced Rectal Carcinoma,0.8335,Rectal Well Differentiated Adenocarcinoma,0.8239,Unresectable Rectal Adenocarcinoma,0.8211,Refractory Rectal Adenocarcinoma,0.8189,Malignant Rectal Neoplasm,0.8114,Rectal Neoplasm,0.8113,Rectal Conventional Adenoma,0.8065,Rectal Undifferentiated Carcinoma,0.8050,Rectosigmoid Adenocarcinoma,0.8001,Colorectal Adenocarcinoma,0.7997,Locally Advanced Rectal Adenocarcinoma,0.7956,Rectal Serrated Adenocarcinoma,0.7909,Metastatic Rectal Carcinoma,0.7906,RECTAL ADENOCARCINOMA,True,True,True
RECTAL MUCINOUS ADENOCARCINOMA,Rectal Mucinous Adenocarcinoma,1,2,Rectal Mucinous Adenocarcinoma,1.0000,Rectosigmoid Mucinous Adenocarcinoma,0.8582,Rectal Adenocarcinoma,0.8457,Colorectal Mucinous Adenocarcinoma,0.8321,Anal Mucinous Adenocarcinoma,0.8268,Colon Mucinous Adenocarcinoma,0.8060,Rectal Medullary Carcinoma,0.7931,Rectal Micropapillary Adenocarcinoma,0.7884,Rectal Poorly Differentiated Adenocarcinoma,0.7865,Rectal Well Differentiated Adenocarcinoma,0.7850,Metastatic Rectal Adenocarcinoma,0.7849,Mucinous Adenocarcinoma,0.7846,Rectal Moderately Differentiated Adenocarcinoma,0.7842,Endometrial Mucinous Adenocarcinoma,0.7768,Metastatic Colorectal Mucinous Adenocarcinoma,0.7636,Rectosigmoid Adenocarcinoma,0.7578,Rectal Serrated Adenocarcinoma,0.7572,Rectal Adenoma,0.7547,Advanced Rectal Adenocarcinoma,0.7529,Refractory Endometrial Mucinous Adenocarcinoma,0.7515,RECTAL MUCINOUS ADENOCARCINOMA,True,True,True
RECURRENCE FIRST HGG RECORD,Recurrent Malignant Glioma,17,2,Recurrent Glioma,0.6785,Recurrent WHO Grade 1 Glioma,0.6737,Recurrent Gastric Carcinoma,0.6398,Recurrent Glioblastoma,0.6303,Recurrent Digestive System Neuroendocrine Tumor G1,0.6300,Recurrent Malignant Gastric Neoplasm,0.6224,Recurrent Gliomatosis Cerebri,0.6162,Recurrent Childhood Glioblastoma,0.6140,Recurrent Low Grade Glioma,0.6104,Recurrent Gastric Adenocarcinoma,0.6091,Recurrent Giant Cell Glioblastoma,0.6081,Recurrent Childhood Fibrillary Astrocytoma,0.6068,Recurrent Visual Pathway Glioma,0.6057,Recurrent Childhood Giant Cell Glioblastoma,0.6037,Recurrent Grade 1 Follicular Lymphoma,0.6032,Recurrent Diffuse Glioma,0.5994,Recurrent Malignant Glioma,0.5988,Recurrent Gestational Trophoblastic Tumor,0.5963,Recurrent Gallbladder Carcinoma,0.5921,Recurrent Tectal Glioma,0.5916,RECURRENCE FIRST HGG RECORD,False,False,False
RECURRENT_ENDOMETRIAL_CARCINOMA,Recurrent Endometrial Carcinoma,1,2,Recurrent Endometrial Carcinoma,0.9496,Recurrent Endometrial Undifferentiated Carcinoma,0.8746,Recurrent Endometrial Adenocarcinoma,0.8474,Locally Recurrent Endometrial Carcinoma,0.8332,Recurrent Endometrial Squamous Cell Carcinoma,0.8112,Recurrent Carcinoma,0.7905,Recurrent Endocrine Carcinoma,0.7857,Recurrent Esophageal Carcinoma,0.7810,Recurrent Endometrial Transitional Cell Carcinoma,0.7648,Refractory Endometrial Carcinoma,0.7537,Recurrent Endometrial Endometrioid Adenocarcinoma,0.7497,Recurrent Endometrioid Adenocarcinoma,0.7485,Recurrent Endometrial Serous Adenocarcinoma,0.7369,Recurrent Endometrial Mucinous Adenocarcinoma,0.7324,Recurrent Adenocarcinoma,0.7296,Recurrent Endometrial High Grade Endometrioid Adenocarcinoma,0.7239,Recurrent Esophageal Adenocarcinoma,0.7233,Recurrent Female Reproductive System Carcinoma,0.7226,Recurrent Endometrial Clear Cell Adenocarcinoma,0.7201,Recurrent High Grade Endometrioid Adenocarcinoma,0.7198,RECURRENT_ENDOMETRIAL_CARCINOMA,True,True,True
REFRACTORY ANAEMIA WITH EXCESS BLASTS,Myelodysplastic Syndrome with Excess Blasts,3,2,Refractory Anemia with Excess Blasts in Transformation,0.8651,Refractory Anemia,0.7886,Myelodysplastic Syndrome with Excess Blasts,0.7391,Refractory Acute Leukemia,0.6868,Refractory Acute Myeloid Leukemia,0.6765,Refractory Acute Biphenotypic Leukemia,0.6759,Recurrent Acute Erythroid Leukemia,0.6735,Childhood Myelodysplastic Syndrome with Excess Blasts,0.6701,Refractory Acute Undifferentiated Leukemia,0.6678,Refractory Acute Bilineal Leukemia,0.6582,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,0.6568,Refractory Acute Leukemia of Ambiguous Lineage,0.6506,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",0.6437,Refractory Acute Monoblastic and Monocytic Leukemia,0.6408,Refractory Acute Myeloid Leukemia Not Otherwise Specified,0.6339,Refractory B Acute Lymphoblastic Leukemia,0.6326,Acute Erythroid Leukemia,0.6298,Refractory Acute Myelomonocytic Leukemia,0.6223,Refractory Leukemia,0.6214,Adult Acute Erythroid Leukemia,0.6196,REFRACTORY ANAEMIA WITH EXCESS BLASTS,False,True,True
REFRACTORY ANEMIA,Refractory Anemia,1,2,Refractory Anemia,1.0000,Refractory Acute Leukemia,0.8177,Refractory Leukemia,0.7881,Refractory Acute Myeloid Leukemia,0.7838,Refractory Hematologic Malignancy,0.7657,Refractory Acute Undifferentiated Leukemia,0.7602,Refractory Neutropenia,0.7498,Refractory Acute Myeloid Leukemia Not Otherwise Specified,0.7462,Refractory Acute Leukemia of Ambiguous Lineage,0.7427,Refractory Myeloid Neoplasm,0.7321,Refractory Lymphoma,0.7273,Refractory Anaplastic Astrocytoma,0.7132,Refractory Acute Monoblastic and Monocytic Leukemia,0.7102,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",0.7096,Refractory Anemia with Excess Blasts in Transformation,0.7040,Refractory Acute Myelomonocytic Leukemia,0.7007,Refractory Thrombocytopenia,0.7004,Refractory Myelodysplastic Syndrome,0.7003,Refractory Acute Lymphoblastic Leukemia,0.6979,Refractory Malignant Mastocytosis,0.6944,REFRACTORY ANEMIA,True,True,True
REFRACTORY ANEMIA WITH EXCESS BLASTS-2,Myelodysplastic Syndrome/Acute Myeloid Leukemia,99,2,Refractory Anemia with Excess Blasts in Transformation,0.7708,Myelodysplastic Syndrome with Excess Blasts,0.6999,Refractory Anemia,0.6838,Childhood Myelodysplastic Syndrome with Excess Blasts,0.6395,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,0.6363,Recurrent Acute Erythroid Leukemia,0.6221,Refractory Acute Biphenotypic Leukemia,0.5942,Refractory Acute Leukemia,0.5932,Refractory Acute Myeloid Leukemia,0.5898,ROSE Cluster 2,0.5839,Refractory Acute Monoblastic and Monocytic Leukemia,0.5833,Acute Erythroid Leukemia,0.5802,Refractory Acute Undifferentiated Leukemia,0.5755,Refractory Anaplastic Ependymoma,0.5689,Adult Acute Erythroid Leukemia,0.5641,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",0.5615,Refractory Myelodysplastic Syndrome,0.5576,Refractory Acute Bilineal Leukemia,0.5548,Refractory Medulloblastoma,0.5530,Refractory Acute Myelomonocytic Leukemia,0.5517,REFRACTORY ANEMIA WITH EXCESS BLASTS-2,False,False,False
REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",6,2,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.8154,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.7472,Refractory Myelodysplastic Syndrome,0.7371,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.6875,Refractory Cytopenia of Childhood,0.6704,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",0.6675,Refractory Chronic Myelomonocytic Leukemia,0.6584,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",0.6479,Myelodysplastic Syndrome with Ring Sideroblasts,0.6450,Refractory Malignant Mastocytosis,0.6440,Acute Myeloid Leukemia with Multilineage Dysplasia,0.6418,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,0.6163,Refractory Mixed Phenotype Acute Leukemia,0.6104,Recurrent Myelodysplastic Syndrome,0.6102,Refractory Chronic Leukemia,0.6000,Refractory Acute Monoblastic and Monocytic Leukemia,0.5977,Refractory Lymphocyte-Depleted Classic Hodgkin Lymphoma,0.5911,Triple-Class Refractory Multiple Myeloma,0.5875,Myelodysplastic Chronic Myelomonocytic Leukemia,0.5817,Refractory Mantle Cell Lymphoma,0.5811,REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,False,False,False
REGIONAL LYMPH NODE METASTASIS,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,1,2,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.8265,Metastatic Malignant Neoplasm in the Lymph Nodes,0.7287,Malignant Lymph Node Neoplasm,0.6927,Lymph Node Neoplasm,0.6834,Metastatic Melanoma in the Lymph Nodes,0.6796,Metastatic Prostate Carcinoma in the Lymph Nodes,0.6603,Regional Neuroblastoma,0.6005,Metastatic Malignant Neoplasm in the Mediastinal Lymph Nodes,0.5868,Metastatic Pancreatic Neuroendocrine Neoplasm,0.5775,Nodular Melanoma,0.5722,Nodal Marginal Zone Lymphoma,0.5664,Nodal Marginal Zone Lymphoma by Ann Arbor Stage,0.5635,Metastatic Breast Carcinoma in the Lymph Nodes,0.5585,Mucosal Nodular Melanoma,0.5584,Metastatic Neuroendocrine Neoplasm,0.5564,De Novo Nodular Melanoma,0.5563,Cutaneous Nodular Melanoma,0.5539,Nodular Neoplasm,0.5530,Peripheral Neuroblastoma,0.5522,Metastatic Lung Neuroendocrine Neoplasm,0.5515,REGIONAL LYMPH NODE METASTASIS,True,True,True
REGIONAL NODES,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,3,2,Lymph Node Neoplasm,0.7813,Malignant Lymph Node Neoplasm,0.7504,Metastatic Malignant Neoplasm in the Regional Lymph Nodes,0.7340,Metastatic Malignant Neoplasm in the Lymph Nodes,0.6822,Regional Neuroblastoma,0.6612,Benign Lymph Node Neoplasm,0.6472,Peripheral Nervous System,0.6159,Nodular Neoplasm,0.6133,Metastatic Prostate Carcinoma in the Lymph Nodes,0.6096,Primary Neoplasm,0.5898,Neoplasm by Site,0.5876,Peripheral Neuroblastoma,0.5866,Advanced Neuroendocrine Neoplasm,0.5834,Metastatic Melanoma in the Lymph Nodes,0.5825,Metastatic Neoplasm,0.5818,Neoplastic Polyp,0.5776,Paratesticular Neoplasm,0.5764,Advanced Pancreatic Neuroendocrine Neoplasm,0.5703,Secondary Neoplasm,0.5694,Second Primary Neoplasm,0.5690,REGIONAL NODES,False,True,True
REL CELL CARCINOMA,Renal Cell Carcinoma,13,2,Carcinoma,0.7479,Lipid-Rich Carcinoma,0.7432,Glassy Cell Carcinoma,0.7361,Granular Cell Carcinoma,0.7343,Giant Cell Carcinoma,0.7261,Glycogen-Rich Carcinoma,0.7256,Large Cell Carcinoma,0.7182,Retroperitoneal Carcinoma,0.7082,Granular Renal Cell Carcinoma,0.7031,Crooke Cell Tumor,0.7025,Ear Carcinoma,0.6993,Retinal Cell Neoplasm,0.6905,Renal Cell Carcinoma,0.6900,Undifferentiated Carcinoma,0.6894,Transitional Cell Carcinoma,0.6890,Localized Carcinoma,0.6862,Refractory Carcinoma,0.6838,Rectal Carcinoma,0.6829,Neuroendocrine Carcinoma,0.6808,Retinocytoma,0.6792,REL CELL CARCINOMA,False,False,False
"REL ONCOCYTIC NEOPLASM, FAVOR CHROMOPHOBE, EOSINOPHILIC",Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,2,2,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.7198,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,0.7053,Oncocytic Neoplasm,0.6599,Cystic Oncocytic Neoplasm,0.6493,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.6439,Thyroid Gland Oncocytic Neoplasm,0.6375,Oncocytic Adenoma,0.6374,Retinocytoma,0.6259,Oncocytic Adenocarcinoma,0.6235,Thyroid Gland Oncocytic Carcinoma,0.6229,Classic Variant of Chromophobe Renal Cell Carcinoma,0.6195,Pituitary Gland Chromophobe Adenoma,0.6157,Pineocytoma,0.6100,Conjunctival Oncocytoma,0.6077,Kidney Oncocytoma,0.6044,Metastatic Thyroid Gland Oncocytic Carcinoma,0.5971,Refractory Thyroid Gland Oncocytic Carcinoma,0.5968,Thyroid Gland Oncocytic Adenoma,0.5946,Hepatocellular Chromophobe Carcinoma,0.5906,Recurrent Thyroid Gland Oncocytic Carcinoma,0.5905,"REL ONCOCYTIC NEOPLASM, FAVOR CHROMOPHOBE, EOSINOPHILIC",False,True,True
"REL ONCOCYTIC NEOPLASM, FAVOR ONCOCYTOMA",Kidney Oncocytoma,4,2,Oncocytic Neoplasm,0.8059,Oncocytic Adenoma,0.7799,Cystic Oncocytic Neoplasm,0.7490,Kidney Oncocytoma,0.7463,Thyroid Gland Oncocytic Neoplasm,0.7455,Salivary Gland Oncocytoma,0.7250,Oncocytic Adenocarcinoma,0.7232,Thyroid Gland Oncocytic Adenoma,0.7149,Adrenal Cortical Oncocytic Adenoma,0.7139,Thyroid Gland Oncocytic Carcinoma,0.7106,Lacrimal Gland Oncocytoma,0.7004,Spindle Cell Oncocytoma,0.6974,Adrenal Cortical Oncocytic Carcinoma,0.6948,Refractory Thyroid Gland Oncocytic Carcinoma,0.6849,Unresectable Thyroid Gland Oncocytic Carcinoma,0.6821,Locally Advanced Thyroid Gland Oncocytic Carcinoma,0.6775,Parathyroid Gland Oncocytic Adenoma,0.6772,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.6743,Conjunctival Oncocytoma,0.6732,Metastatic Thyroid Gland Oncocytic Carcinoma,0.6655,"REL ONCOCYTIC NEOPLASM, FAVOR ONCOCYTOMA",False,False,True
RELA-FUSION,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",1,2,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",0.5959,Fusion-Positive Alveolar Rhabdomyosarcoma,0.5940,Fusion-Positive Rhabdomyosarcoma,0.5730,Round Cell Sarcoma with FUS-NFATC2 Gene Fusion,0.5724,Fusion-Negative Alveolar Rhabdomyosarcoma,0.5696,Fusion-Negative Rhabdomyosarcoma,0.5428,Supratentorial Ependymoma ZFTA Fusion-Positive,0.5348,Round Cell Sarcoma with EWSR1-NFATC2 Gene Fusion,0.5277,Round Cell Sarcoma with EWSR1-PATZ1 Gene Fusion,0.5207,Adult Supratentorial Ependymoma ZFTA Fusion-Positive,0.5176,Childhood Supratentorial Ependymoma ZFTA Fusion-Positive,0.5099,Supratentorial Ependymoma YAP1 Fusion-Positive,0.5098,ROSE Cluster 7,0.5009,Large B-Cell Lymphoma with IRF4 Rearrangement,0.4995,Refractory Fibrosarcoma,0.4992,Polyposis,0.4937,Composite Lymphoma,0.4933,Beta-Catenin-Activated Inflammatory Hepatocellular Adenoma,0.4931,Glioma,0.4927,Refractory Anemia,0.4915,RELA-FUSION,True,True,True
RELAPSED_AML,Recurrent Acute Myeloid Leukemia,1,2,Recurrent Acute Myeloid Leukemia,0.8163,Recurrent Myeloid Leukemia,0.8116,Recurrent Acute Leukemia,0.8105,Recurrent Myeloid Neoplasm,0.7836,Recurrent Leukemia,0.7827,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,0.7813,Recurrent Acute Monocytic Leukemia,0.7787,Recurrent Acute Undifferentiated Leukemia,0.7619,Recurrent Acute Monoblastic and Monocytic Leukemia,0.7572,Recurrent Acute Erythroid Leukemia,0.7409,Recurrent Adult Acute Myeloid Leukemia,0.7407,Recurrent Myeloid Sarcoma,0.7390,Recurrent Acute Myelomonocytic Leukemia,0.7363,Recurrent Hematologic Malignancy,0.7341,Recurrent Childhood Acute Myeloid Leukemia,0.7288,Recurrent Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,0.7286,"Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related",0.7255,Recurrent Malignant Neoplasm,0.6988,Recurrent Acute Biphenotypic Leukemia,0.6980,Recurrent Endometrial Adenocarcinoma,0.6963,RELAPSED_AML,True,True,True
RENAL ANGIOMYOLIPOMA,Kidney Angiomyolipoma,1,2,Kidney Angiomyolipoma,0.9740,Kidney Classic Angiomyolipoma,0.9414,Childhood Kidney Angiomyolipoma,0.8976,Angiomyolipoma,0.8826,Kidney Epithelioid Angiomyolipoma,0.8825,Liver Angiomyolipoma,0.8488,Kidney Oncocytoma-Like Angiomyolipoma,0.8415,Kidney Angiomyolipoma with Epithelial Cysts,0.8380,Epithelioid Angiomyolipoma,0.8045,Kidney Lipoma,0.7804,Angiolipoma,0.7585,Fibromyxolipoma,0.7555,Kidney Lymphangioma,0.7285,Breast Angiolipoma,0.7274,Kidney Leiomyoma,0.7233,Angioleiomyoma,0.7231,Kidney Hemangioma,0.7203,Intravascular Angioleiomyoma,0.7160,Kidney Angiosarcoma,0.7148,Renal Benign Mesenchymoma,0.7032,RENAL ANGIOMYOLIPOMA,True,True,True
RENAL CANCER,Kidney Carcinoma,2,2,Renal Cell Carcinoma,0.9172,Kidney Carcinoma,0.9050,"Renal Cell Carcinoma, Not Otherwise Specified",0.8263,Malignant Kidney Neoplasm,0.8140,Kidney Neoplasm,0.8020,Advanced Renal Cell Carcinoma,0.7961,Childhood Renal Cell Carcinoma,0.7911,Hereditary Renal Cell Carcinoma,0.7903,Papillary Renal Cell Carcinoma,0.7872,Kidney Medullary Carcinoma,0.7770,Childhood Kidney Carcinoma,0.7744,Localized Renal Cell Carcinoma,0.7618,Non-Clear Cell Renal Cell Carcinoma,0.7613,Clear Cell Renal Cell Carcinoma,0.7601,Advanced Kidney Carcinoma,0.7552,Unresectable Kidney Carcinoma,0.7542,Granular Renal Cell Carcinoma,0.7498,Unresectable Renal Cell Carcinoma,0.7447,Unclassified Renal Cell Carcinoma,0.7440,Refractory Kidney Carcinoma,0.7439,RENAL CANCER,False,True,True
"RENAL CARCINOMA, CLEAR CELL",Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9788,Non-Clear Cell Renal Cell Carcinoma,0.8848,Renal Cell Carcinoma,0.8558,Advanced Clear Cell Renal Cell Carcinoma,0.8433,Early Stage Clear Cell Renal Cell Carcinoma,0.8391,Urinary Tract Clear Cell Adenocarcinoma,0.8297,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.8287,Grade 1 Clear Cell Renal Cell Carcinoma,0.8283,Clear Cell Papillary Renal Tumor,0.8211,Clear Cell Malignant Neoplasm,0.8198,Clear Cell Adenocarcinoma,0.8142,Clear Cell Neoplasm,0.8094,Clear Cell Sarcoma of the Kidney,0.8068,Grade 2 Clear Cell Renal Cell Carcinoma,0.8008,Hereditary Clear Cell Renal Cell Carcinoma,0.7975,Grade 3 Clear Cell Renal Cell Carcinoma,0.7959,"Renal Cell Carcinoma, Not Otherwise Specified",0.7915,Chromophobe Renal Cell Carcinoma,0.7890,Grade 4 Clear Cell Renal Cell Carcinoma,0.7852,Papillary Renal Cell Carcinoma,0.7803,"RENAL CARCINOMA, CLEAR CELL",True,True,True
RENAL CELL CARCINOMA,Renal Cell Carcinoma,1,2,Renal Cell Carcinoma,1.0000,Kidney Carcinoma,0.9066,"Renal Cell Carcinoma, Not Otherwise Specified",0.8908,Clear Cell Renal Cell Carcinoma,0.8818,Non-Clear Cell Renal Cell Carcinoma,0.8682,Papillary Renal Cell Carcinoma,0.8499,Advanced Renal Cell Carcinoma,0.8370,Childhood Renal Cell Carcinoma,0.8232,Localized Renal Cell Carcinoma,0.8218,Granular Renal Cell Carcinoma,0.8183,Hereditary Renal Cell Carcinoma,0.8101,Kidney Medullary Carcinoma,0.7989,Unclassified Renal Cell Carcinoma,0.7833,Locally Advanced Renal Cell Carcinoma,0.7813,Metastatic Renal Cell Carcinoma,0.7806,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.7706,Unresectable Renal Cell Carcinoma,0.7685,"Advanced Renal Cell Carcinoma, Not Otherwise Specified",0.7614,Advanced Clear Cell Renal Cell Carcinoma,0.7604,Malignant Kidney Neoplasm,0.7594,RENAL CELL CARCINOMA,True,True,True
RENAL CLEAR CELL,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.8578,Clear Cell Neoplasm,0.8383,Clear Cell Malignant Neoplasm,0.8155,Clear Cell Adenoma,0.7913,Clear Cell Papillary Renal Tumor,0.7757,Early Stage Clear Cell Renal Cell Carcinoma,0.7711,Non-Clear Cell Renal Cell Carcinoma,0.7677,Renal Cell Carcinoma,0.7676,Lung Clear Cell Tumor,0.7614,Advanced Clear Cell Renal Cell Carcinoma,0.7603,Clear Cell Adenocarcinoma,0.7578,Grade 1 Clear Cell Renal Cell Carcinoma,0.7549,Clear Cell Sarcoma of the Kidney,0.7473,Urinary Tract Clear Cell Adenocarcinoma,0.7398,Ovarian Clear Cell Tumor,0.7362,Hepatocellular Clear Cell Carcinoma,0.7323,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.7322,Grade 4 Clear Cell Renal Cell Carcinoma,0.7301,Grade 2 Clear Cell Renal Cell Carcinoma,0.7178,Lung Clear Cell Adenocarcinoma,0.7169,RENAL CLEAR CELL,True,True,True
RENAL CLEAR CELL CARCINOMA,Clear Cell Renal Cell Carcinoma,1,2,Clear Cell Renal Cell Carcinoma,0.9873,Renal Cell Carcinoma,0.8902,Non-Clear Cell Renal Cell Carcinoma,0.8898,Advanced Clear Cell Renal Cell Carcinoma,0.8552,Early Stage Clear Cell Renal Cell Carcinoma,0.8477,Clear Cell Papillary Renal Tumor,0.8339,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.8272,Urinary Tract Clear Cell Adenocarcinoma,0.8240,Grade 1 Clear Cell Renal Cell Carcinoma,0.8199,Clear Cell Malignant Neoplasm,0.8094,Grade 2 Clear Cell Renal Cell Carcinoma,0.8085,Papillary Renal Cell Carcinoma,0.8072,Clear Cell Neoplasm,0.8060,Clear Cell Adenocarcinoma,0.8060,"Renal Cell Carcinoma, Not Otherwise Specified",0.8051,Hereditary Clear Cell Renal Cell Carcinoma,0.8045,Kidney Carcinoma,0.7994,Chromophobe Renal Cell Carcinoma,0.7935,Grade 3 Clear Cell Renal Cell Carcinoma,0.7896,Clear Cell Sarcoma of the Kidney,0.7894,RENAL CLEAR CELL CARCINOMA,True,True,True
RENAL MEDULLARY CARCINOMA,Kidney Medullary Carcinoma,1,2,Kidney Medullary Carcinoma,0.9745,Advanced Kidney Medullary Carcinoma,0.8726,Metastatic Kidney Medullary Carcinoma,0.8703,Unresectable Kidney Medullary Carcinoma,0.8432,Renal Cell Carcinoma,0.8383,Refractory Kidney Medullary Carcinoma,0.8319,Locally Advanced Kidney Medullary Carcinoma,0.8241,Kidney Carcinoma,0.8076,Recurrent Kidney Medullary Carcinoma,0.8038,Colorectal Medullary Carcinoma,0.7834,Papillary Renal Cell Carcinoma,0.7809,"Medullary Carcinoma, Not Otherwise Specified",0.7777,SMARCB1-Deficient Kidney Medullary Carcinoma,0.7769,Renal Cell Carcinoma with MiT Translocations,0.7760,Thyroid Gland Medullary Carcinoma,0.7751,Tubulocystic Renal Cell Carcinoma,0.7746,Colon Medullary Carcinoma,0.7675,Pancreatic Medullary Carcinoma,0.7567,Breast Medullary Carcinoma,0.7559,"Renal Cell Carcinoma, Not Otherwise Specified",0.7493,RENAL MEDULLARY CARCINOMA,True,True,True
RENAL MUCINOUS TUBULAR SPINDLE CELL CARCINOMA,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1,2,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,0.9026,Sarcomatoid Renal Cell Carcinoma,0.7400,Eosinophilic Solid and Cystic Renal Cell Carcinoma,0.7362,Sarcomatoid Transitional Cell Carcinoma,0.7296,Tubulocystic Renal Cell Carcinoma,0.7179,Granular Renal Cell Carcinoma,0.7162,Kidney Medullary Carcinoma,0.6863,Micropapillary Transitional Cell Carcinoma,0.6783,Bladder Tubulo-Cystic Clear Cell Adenocarcinoma,0.6750,Advanced Sarcomatoid Renal Cell Carcinoma,0.6715,Renomedullary Interstitial Cell Tumor,0.6687,Malignant Mixed Epithelial and Stromal Tumor of the Kidney,0.6660,Renal Cell Carcinoma with MiT Translocations,0.6654,Adrenal Cortical Myxoid Carcinoma,0.6616,Renal Cell Carcinoma,0.6604,Clear Cell Renal Cell Carcinoma,0.6602,SMARCB1-Deficient Kidney Medullary Carcinoma,0.6538,Childhood Eosinophilic Solid and Cystic Renal Cell Carcinoma,0.6537,Spindle Cell Squamous Carcinoma,0.6535,Lung Spindle Cell Carcinoma,0.6534,RENAL MUCINOUS TUBULAR SPINDLE CELL CARCINOMA,True,True,True
RENAL NON-CLEAR CELL CARCINOMA,Renal Cell Carcinoma,3,2,Non-Clear Cell Renal Cell Carcinoma,0.9824,Clear Cell Renal Cell Carcinoma,0.8943,Renal Cell Carcinoma,0.8810,"Renal Cell Carcinoma, Not Otherwise Specified",0.8772,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.8635,Unclassified Renal Cell Carcinoma,0.8122,Papillary Renal Cell Carcinoma,0.7947,Advanced Clear Cell Renal Cell Carcinoma,0.7908,Advanced Renal Cell Carcinoma,0.7896,Early Stage Clear Cell Renal Cell Carcinoma,0.7800,"Advanced Renal Cell Carcinoma, Not Otherwise Specified",0.7796,Granular Renal Cell Carcinoma,0.7785,Unresectable Renal Cell Carcinoma,0.7784,Clear Cell Papillary Renal Tumor,0.7747,Localized Renal Cell Carcinoma,0.7719,Kidney Carcinoma,0.7717,Childhood Renal Cell Carcinoma,0.7713,Resectable Renal Cell Carcinoma,0.7649,Grade 1 Clear Cell Renal Cell Carcinoma,0.7593,Hereditary Clear Cell Renal Cell Carcinoma,0.7574,RENAL NON-CLEAR CELL CARCINOMA,False,True,True
RENAL ONCOCYTOMA,Kidney Oncocytoma,1,2,Kidney Oncocytoma,0.9729,Hereditary Kidney Oncocytoma,0.8571,Oncocytic Variant of Chromophobe Renal Cell Carcinoma,0.8151,Kidney Oncocytoma-Like Angiomyolipoma,0.8094,Adrenal Cortical Oncocytic Carcinoma,0.8092,Adrenal Cortical Oncocytic Adenoma,0.7950,Lacrimal Gland Oncocytoma,0.7903,Cystic Oncocytic Neoplasm,0.7734,Spindle Cell Oncocytoma,0.7733,Oncocytic Adenoma,0.7695,Salivary Gland Oncocytoma,0.7635,Conjunctival Oncocytoma,0.7593,Oncocytic Neoplasm,0.7559,Renal Cell Carcinoma,0.7423,Oncocytic Adenocarcinoma,0.7383,Kidney Carcinoma,0.7348,Kidney Adenoma,0.7320,Thyroid Gland Oncocytic Carcinoma,0.7285,Thyroid Gland Oncocytic Neoplasm,0.7264,Thyroid Gland Oncocytic Adenoma,0.7206,RENAL ONCOCYTOMA,True,True,True
RENAL SPINDLE CELL CARCINOMA,Sarcomatoid Carcinoma,99,2,Sarcomatoid Renal Cell Carcinoma,0.8293,Lung Spindle Cell Carcinoma,0.7844,Advanced Sarcomatoid Renal Cell Carcinoma,0.7570,Spindle Cell Squamous Carcinoma,0.7554,Renal Cell Carcinoma,0.7439,Clear Cell Renal Cell Carcinoma,0.7434,Granular Renal Cell Carcinoma,0.7347,Renal Pelvis Squamous Cell Carcinoma,0.7312,Locally Advanced Sarcomatoid Renal Cell Carcinoma,0.7309,Non-Clear Cell Renal Cell Carcinoma,0.7258,Papillary Renal Cell Carcinoma,0.7197,Eosinophilic Solid and Cystic Renal Cell Carcinoma,0.7197,Unresectable Sarcomatoid Renal Cell Carcinoma,0.7178,Spindle Cell Neoplasm,0.7128,Sinonasal Spindle Cell Squamous Carcinoma,0.7107,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,0.7066,Malignant Spindle Cell Neoplasm,0.7046,Clear Cell Sarcoma of the Kidney,0.6995,Metastatic Sarcomatoid Renal Cell Carcinoma,0.6954,Spindle Cell Sarcoma,0.6951,RENAL SPINDLE CELL CARCINOMA,False,False,False
RENAL_CELL_CARCINOMA,Renal Cell Carcinoma,1,2,Renal Cell Carcinoma,0.9537,"Renal Cell Carcinoma, Not Otherwise Specified",0.8975,Kidney Carcinoma,0.8528,Non-Clear Cell Renal Cell Carcinoma,0.8439,Clear Cell Renal Cell Carcinoma,0.8375,Papillary Renal Cell Carcinoma,0.8054,Advanced Renal Cell Carcinoma,0.7978,Childhood Renal Cell Carcinoma,0.7959,Granular Renal Cell Carcinoma,0.7933,Unclassified Renal Cell Carcinoma,0.7855,Hereditary Renal Cell Carcinoma,0.7734,Localized Renal Cell Carcinoma,0.7732,"Advanced Renal Cell Carcinoma, Not Otherwise Specified",0.7650,Kidney Medullary Carcinoma,0.7562,Metastatic Renal Cell Carcinoma,0.7506,Locally Advanced Renal Cell Carcinoma,0.7484,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.7448,Unresectable Renal Cell Carcinoma,0.7440,Renal Cell Carcinoma with MiT Translocations,0.7400,Transplant-Related Renal Cell Carcinoma,0.7390,RENAL_CELL_CARCINOMA,True,True,True
RETINOBLASTOMA,Retinoblastoma,1,2,Retinoblastoma,1.0000,Sporadic Retinoblastoma,0.9067,Intraocular Retinoblastoma,0.9001,Differentiated Retinoblastoma,0.8896,Diffuse Retinoblastoma,0.8885,Undifferentiated Retinoblastoma,0.8692,Hereditary Retinoblastoma,0.8639,Extraocular Retinoblastoma,0.8595,Spontaneously Regressed Retinoblastoma,0.8398,Childhood Intraocular Retinoblastoma,0.8340,Bilateral Retinoblastoma,0.8331,Unilateral Retinoblastoma,0.8187,Recurrent Retinoblastoma,0.8167,Childhood Extraocular Retinoblastoma,0.8158,Stage I Retinoblastoma,0.7673,Retinal Neuroblastoma,0.7605,Stage IA Retinoblastoma,0.7531,Trilateral Retinoblastoma,0.7382,Stage III Retinoblastoma,0.7289,Retinocytoma,0.7270,RETINOBLASTOMA,True,True,True
RHABDOID CANCER,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9420,Rhabdoid Meningioma,0.8772,Advanced Rhabdoid Tumor,0.8409,Metastatic Rhabdoid Tumor,0.8302,Refractory Rhabdoid Tumor,0.8260,Unresectable Rhabdoid Tumor,0.8178,Rhabdoid Tumor of the Kidney,0.8002,Extrarenal Rhabdoid Tumor,0.7938,Recurrent Rhabdoid Tumor,0.7813,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.7785,Atypical Teratoid/Rhabdoid Tumor,0.7649,Pancreatic Undifferentiated Carcinoma with Rhabdoid Cells,0.7562,Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes,0.7472,Refractory Extrarenal Rhabdoid Tumor,0.7403,Refractory Rhabdoid Tumor of the Kidney,0.7306,Childhood Atypical Teratoid/Rhabdoid Tumor,0.7237,Refractory Atypical Teratoid/Rhabdoid Tumor,0.7174,Atypical Teratoid/Rhabdoid Tumor-TYR,0.7090,Lung Large Cell Carcinoma with Rhabdoid Phenotype,0.7056,Extrarenal Rhabdoid Tumor of the Prostate,0.6828,RHABDOID CANCER,True,True,True
RHABDOID TUMOR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,1.0000,Advanced Rhabdoid Tumor,0.8947,Rhabdoid Meningioma,0.8898,Refractory Rhabdoid Tumor,0.8792,Extrarenal Rhabdoid Tumor,0.8755,Metastatic Rhabdoid Tumor,0.8685,Unresectable Rhabdoid Tumor,0.8560,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.8536,Atypical Teratoid/Rhabdoid Tumor,0.8531,Rhabdoid Tumor of the Kidney,0.8441,Recurrent Rhabdoid Tumor,0.8404,Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes,0.8149,Refractory Extrarenal Rhabdoid Tumor,0.8102,Childhood Atypical Teratoid/Rhabdoid Tumor,0.8018,Atypical Teratoid/Rhabdoid Tumor-TYR,0.7915,Refractory Atypical Teratoid/Rhabdoid Tumor,0.7904,Refractory Rhabdoid Tumor of the Kidney,0.7669,Extrarenal Rhabdoid Tumor of the Prostate,0.7453,Recurrent Extrarenal Rhabdoid Tumor,0.7407,Unresectable Extrarenal Rhabdoid Tumor,0.7341,RHABDOID TUMOR,True,True,True
RHABDOID TUMOUR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9974,Advanced Rhabdoid Tumor,0.8899,Rhabdoid Meningioma,0.8894,Refractory Rhabdoid Tumor,0.8773,Extrarenal Rhabdoid Tumor,0.8768,Metastatic Rhabdoid Tumor,0.8657,Unresectable Rhabdoid Tumor,0.8574,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.8554,Atypical Teratoid/Rhabdoid Tumor,0.8464,Rhabdoid Tumor of the Kidney,0.8442,Recurrent Rhabdoid Tumor,0.8391,Refractory Extrarenal Rhabdoid Tumor,0.8129,Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes,0.8077,Childhood Atypical Teratoid/Rhabdoid Tumor,0.7962,Atypical Teratoid/Rhabdoid Tumor-TYR,0.7867,Refractory Atypical Teratoid/Rhabdoid Tumor,0.7836,Refractory Rhabdoid Tumor of the Kidney,0.7672,Extrarenal Rhabdoid Tumor of the Prostate,0.7438,Recurrent Extrarenal Rhabdoid Tumor,0.7437,Unresectable Extrarenal Rhabdoid Tumor,0.7403,RHABDOID TUMOUR,True,True,True
RHABDOID_TUMOUR,Rhabdoid Tumor,1,2,Rhabdoid Tumor,0.9729,Advanced Rhabdoid Tumor,0.8765,Refractory Rhabdoid Tumor,0.8718,Extrarenal Rhabdoid Tumor,0.8663,Metastatic Rhabdoid Tumor,0.8603,Unresectable Rhabdoid Tumor,0.8587,Rhabdoid Meningioma,0.8583,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.8526,Recurrent Rhabdoid Tumor,0.8373,Rhabdoid Tumor of the Kidney,0.8373,Atypical Teratoid/Rhabdoid Tumor,0.8244,Refractory Extrarenal Rhabdoid Tumor,0.8150,Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes,0.7947,Atypical Teratoid/Rhabdoid Tumor-TYR,0.7851,Refractory Atypical Teratoid/Rhabdoid Tumor,0.7761,Childhood Atypical Teratoid/Rhabdoid Tumor,0.7747,Refractory Rhabdoid Tumor of the Kidney,0.7744,Recurrent Extrarenal Rhabdoid Tumor,0.7513,Unresectable Extrarenal Rhabdoid Tumor,0.7471,Extrarenal Rhabdoid Tumor of the Prostate,0.7471,RHABDOID_TUMOUR,True,True,True
RHABDOMYOSARCOMA,Rhabdomyosarcoma,1,2,Rhabdomyosarcoma,1.0000,Childhood Rhabdomyosarcoma,0.8823,Rhabdomyoma,0.8783,Cardiac Rhabdomyosarcoma,0.8732,Adult Rhabdomyosarcoma,0.8707,Spindle Cell Rhabdomyosarcoma,0.8533,Metastatic Rhabdomyosarcoma,0.8375,Classic Rhabdomyoma,0.8322,Kidney Rhabdomyosarcoma,0.8318,Sclerosing Rhabdomyosarcoma,0.8235,Digestive System Rhabdomyosarcoma,0.8190,Lung Rhabdomyosarcoma,0.8129,Breast Rhabdomyosarcoma,0.8115,Refractory Rhabdomyosarcoma,0.8112,Unresectable Rhabdomyosarcoma,0.8062,Testicular Rhabdomyosarcoma,0.8059,Alveolar Rhabdomyosarcoma,0.8054,Myxosarcoma,0.8032,Embryonal Rhabdomyosarcoma,0.8030,Recurrent Rhabdomyosarcoma,0.7998,RHABDOMYOSARCOMA,True,True,True
"RHABDOMYOSARCOMA, ALVEOLAR",Alveolar Rhabdomyosarcoma,1,2,Alveolar Rhabdomyosarcoma,0.9832,Conventional Alveolar Rhabdomyosarcoma,0.9275,Solid Alveolar Rhabdomyosarcoma,0.9105,Childhood Alveolar Rhabdomyosarcoma,0.9026,Prostate Alveolar Rhabdomyosarcoma,0.8328,Fusion-Negative Alveolar Rhabdomyosarcoma,0.7967,Rhabdomyosarcoma,0.7963,Recurrent Alveolar Rhabdomyosarcoma,0.7955,Refractory Alveolar Rhabdomyosarcoma,0.7941,Orbital Alveolar Rhabdomyosarcoma,0.7938,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.7879,Adult Rhabdomyosarcoma,0.7830,Alveolar Soft Part Sarcoma,0.7698,Bladder Alveolar Rhabdomyosarcoma,0.7689,Abdominal Rhabdomyosarcoma,0.7646,Lung Rhabdomyosarcoma,0.7621,Fusion-Positive Alveolar Rhabdomyosarcoma,0.7558,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.7485,Metastatic Alveolar Soft Part Sarcoma,0.7394,Childhood Alveolar Soft Part Sarcoma,0.7311,"RHABDOMYOSARCOMA, ALVEOLAR",True,True,True
"RHABDOMYOSARCOMA, ALVEOLAR SUBTYPE",Alveolar Rhabdomyosarcoma,1,2,Alveolar Rhabdomyosarcoma,0.9604,Conventional Alveolar Rhabdomyosarcoma,0.9120,Solid Alveolar Rhabdomyosarcoma,0.8926,Childhood Alveolar Rhabdomyosarcoma,0.8698,Prostate Alveolar Rhabdomyosarcoma,0.8038,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.7947,Fusion-Negative Alveolar Rhabdomyosarcoma,0.7802,Refractory Alveolar Rhabdomyosarcoma,0.7775,Rhabdomyosarcoma,0.7739,Orbital Alveolar Rhabdomyosarcoma,0.7636,Recurrent Alveolar Rhabdomyosarcoma,0.7629,Bladder Alveolar Rhabdomyosarcoma,0.7626,Adult Rhabdomyosarcoma,0.7572,Abdominal Rhabdomyosarcoma,0.7489,Alveolar Soft Part Sarcoma,0.7487,Lung Rhabdomyosarcoma,0.7449,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.7437,Fusion-Positive Alveolar Rhabdomyosarcoma,0.7427,Metastatic Alveolar Soft Part Sarcoma,0.7346,Sclerosing Rhabdomyosarcoma,0.7138,"RHABDOMYOSARCOMA, ALVEOLAR SUBTYPE",True,True,True
"RHABDOMYOSARCOMA, EMBRYONAL",Embryonal Rhabdomyosarcoma,1,2,Embryonal Rhabdomyosarcoma,0.9810,Childhood Embryonal Rhabdomyosarcoma,0.9161,Anaplastic Embryonal Rhabdomyosarcoma,0.8464,Metastatic Embryonal Rhabdomyosarcoma,0.8321,Childhood Rhabdomyosarcoma,0.8121,Rhabdomyosarcoma,0.8063,Orbital Embryonal Rhabdomyosarcoma,0.7944,Central Nervous System Rhabdomyosarcoma,0.7912,Bladder Embryonal Rhabdomyosarcoma,0.7788,Esophageal Rhabdomyosarcoma,0.7767,Middle Ear Embryonal Rhabdomyosarcoma,0.7724,Refractory Rhabdomyosarcoma,0.7712,Prostate Embryonal Rhabdomyosarcoma,0.7705,Adult Rhabdomyosarcoma,0.7705,Rectal Rhabdomyosarcoma,0.7691,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.7663,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,0.7553,Refractory Childhood Rhabdomyosarcoma,0.7507,Cardiac Rhabdomyosarcoma,0.7505,Localized Childhood Rhabdomyosarcoma,0.7445,"RHABDOMYOSARCOMA, EMBRYONAL",True,True,True
RMS,Rhabdomyosarcoma,1,2,Rhabdomyosarcoma,1.0000,Childhood Rhabdomyosarcoma,0.8823,Rhabdomyoma,0.8783,Cardiac Rhabdomyosarcoma,0.8732,Adult Rhabdomyosarcoma,0.8707,Spindle Cell Rhabdomyosarcoma,0.8533,Metastatic Rhabdomyosarcoma,0.8375,Classic Rhabdomyoma,0.8322,Kidney Rhabdomyosarcoma,0.8318,Sclerosing Rhabdomyosarcoma,0.8235,Digestive System Rhabdomyosarcoma,0.8190,Lung Rhabdomyosarcoma,0.8129,Breast Rhabdomyosarcoma,0.8115,Refractory Rhabdomyosarcoma,0.8112,Unresectable Rhabdomyosarcoma,0.8062,Testicular Rhabdomyosarcoma,0.8059,Alveolar Rhabdomyosarcoma,0.8054,Myxosarcoma,0.8032,Embryonal Rhabdomyosarcoma,0.8030,Recurrent Rhabdomyosarcoma,0.7998,Rhabdomyosarcoma,True,True,True
ROSAI-DORFMAN DISEASE,Rosai-Dorfman-Destombes Disease,1,2,Rosai-Dorfman-Destombes Disease,0.8417,Cutaneous Rosai-Dorfman-Destombes Disease,0.8236,Central Nervous System Rosai-Dorfman-Destombes Disease,0.8105,Bone Rosai-Dorfman-Destombes Disease,0.8068,Head and Neck Rosai-Dorfman-Destombes Disease,0.7787,Thyroid Gland Rosai-Dorfman-Destombes Disease,0.7549,Hand-Schuller-Christian Disease,0.6295,Histiocytosis,0.5734,Recurrent Langerhans Cell Histiocytosis,0.5609,"Langerhans Cell Histiocytosis, Disseminated",0.5591,Cutaneous Erdheim-Chester Disease,0.5512,Dermatomyofibroma,0.5358,Classic Follicular Lymphoma,0.5355,Malignant Histiocytosis,0.5338,Erdheim-Chester Disease,0.5320,Refractory Histiocytic and Dendritic Cell Neoplasm,0.5301,Langerhans Cell Histiocytosis,0.5299,Conventional Follicular Dendritic Cell Sarcoma,0.5290,Reticulosarcoma,0.5289,Histiocytic and Dendritic Cell Neoplasm,0.5284,ROSAI-DORFMAN DISEASE,True,True,True
ROSETTE-FORMING GLIONEURONAL TUMOR OF THE FOURTH VENTRICLE,Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle,1,2,Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle,1.0000,Rosette-Forming Glioneuronal Tumor,0.8639,Embryonal Tumor with Multilayered Rosettes of the Fourth Ventricle,0.8614,Fourth Ventricle Medulloblastoma,0.6924,Embryonal Tumor with Multilayered Rosettes,0.6859,Stage M4 Embryonal Tumor with Multilayered Rosettes,0.6484,Central Nervous System Embryonal Tumor with Rhabdoid Features,0.6446,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6440,"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6438,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6433,Papillary Glioneuronal Tumor,0.6419,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6407,"Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated",0.6327,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6320,WHO Grade 4 Glioma,0.6265,Glioneuronal Tumor with Neuropil-Like Islands,0.6261,Embryonal Tumor with Multilayered Rosettes without C19MC Alteration,0.6243,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",0.6239,Recurrent Multinodular and Vacuolated Neuronal Tumor,0.6182,Refractory WHO Grade 4 Glioma,0.6182,ROSETTE-FORMING GLIONEURONAL TUMOR OF THE FOURTH VENTRICLE,True,True,True
"ROUND CELL SARCOMA, NOS",Undifferentiated Round Cell Sarcoma,1,2,Undifferentiated Round Cell Sarcoma,0.8992,Round Cell Liposarcoma,0.7868,Small Cell Sarcoma,0.7484,Spindle Cell Sarcoma,0.7317,Fibroblastic Reticular Cell Sarcoma,0.7297,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.7283,Spindle Cell Rhabdomyosarcoma,0.7247,Round Cell Liposarcoma NCI Grade 2,0.7220,Round Cell Liposarcoma NCI Grade 3,0.7164,Reticulosarcoma,0.7089,Undifferentiated Spindle Cell Sarcoma,0.7083,Childhood Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.7042,Desmoplastic Small Round Cell Tumor,0.7034,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.7030,Advanced Round Cell Liposarcoma,0.7015,Metastatic Round Cell Liposarcoma,0.6927,Refractory Spindle Cell Sarcoma,0.6910,Refractory Round Cell Liposarcoma,0.6842,Mast Cell Sarcoma,0.6805,Sarcomatoid Carcinoma,0.6765,"ROUND CELL SARCOMA, NOS",True,True,True
"ROUND CELL SARCOMA, OTHER",Undifferentiated Round Cell Sarcoma,1,2,Undifferentiated Round Cell Sarcoma,0.8565,Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.7698,Childhood Round Cell Sarcoma with EWSR1-non-ETS Fusion,0.7472,Round Cell Liposarcoma,0.7272,Reticulosarcoma,0.7012,Round Cell Sarcoma with EWSR1-NFATC2 Gene Fusion,0.6979,Unresectable Round Cell Liposarcoma,0.6967,Small Cell Sarcoma,0.6917,"Undifferentiated Sarcoma, Not Otherwise Specified",0.6838,Fibroblastic Reticular Cell Sarcoma,0.6836,Unresectable Desmoplastic Small Round Cell Tumor,0.6808,Metastatic Round Cell Liposarcoma,0.6805,Advanced Round Cell Liposarcoma,0.6776,Refractory Round Cell Liposarcoma,0.6775,Round Cell Liposarcoma NCI Grade 3,0.6740,Round Cell Sarcoma with FUS-NFATC2 Gene Fusion,0.6740,Desmoplastic Small Round Cell Tumor,0.6734,Spindle Cell Rhabdomyosarcoma,0.6709,Round Cell Liposarcoma NCI Grade 2,0.6701,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.6638,"ROUND CELL SARCOMA, OTHER",True,True,True
RT,Rhabdoid Tumor,11,2,Refractory Thrombocytopenia,0.6549,Radiation-Related Neoplasm,0.6311,Therapy-Related Neoplasm,0.6176,Retinoblastoma,0.6036,Radiation-Related Malignant Neoplasm,0.6003,Refractory Rhabdoid Tumor,0.5987,Radiation-Related Sarcoma,0.5966,Refractory Testicular Lymphoma,0.5900,Reticulosarcoma,0.5883,Advanced Rhabdoid Tumor,0.5877,Rhabdoid Tumor,0.5849,Refractory Thymus Carcinoma,0.5814,Differentiated Retinoblastoma,0.5806,Retroperitoneal Lymphoma,0.5806,Therapy-Related Malignant Neoplasm,0.5798,Unresectable Rhabdoid Tumor,0.5781,Refractory Atypical Teratoid/Rhabdoid Tumor,0.5779,Refractory Lymphoma,0.5760,Refractory Neoplasm,0.5758,Refractory T Lymphoblastic Lymphoma,0.5757,RT,False,False,False
SALIVARY ADENOCARCINOMA,Salivary Gland Adenocarcinoma,1,2,Salivary Gland Adenocarcinoma,0.9768,Salivary Gland Carcinoma,0.8801,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",0.8795,Major Salivary Gland Adenocarcinoma,0.8717,Salivary Duct Carcinoma,0.8594,Minor Salivary Gland Adenocarcinoma,0.8588,Salivary Gland Mucinous Adenocarcinoma,0.8379,Salivary Gland Adenoma,0.8372,Salivary Gland Oncocytic Adenocarcinoma,0.8354,"Sinonasal Adenocarcinoma, Salivary-Type",0.8188,Salivary Gland Secretory Carcinoma,0.8179,Advanced Salivary Gland Carcinoma,0.8100,Salivary Gland Intestinal-Type Adenocarcinoma,0.8068,Metastatic Salivary Gland Adenocarcinoma,0.8068,Salivary Gland Cystadenocarcinoma,0.8014,Adult Salivary Gland Carcinoma,0.7994,Parotid Gland Adenocarcinoma,0.7959,Salivary Gland Acinic Cell Carcinoma,0.7916,Submandibular Gland Adenocarcinoma,0.7885,Salivary Gland Poorly Differentiated Carcinoma,0.7859,SALIVARY ADENOCARCINOMA,True,True,True
SALIVARY ADENOCARCINOMA NOS,Salivary Gland Adenocarcinoma,1,2,Salivary Gland Adenocarcinoma,0.9658,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",0.9250,Salivary Gland Carcinoma,0.8713,Major Salivary Gland Adenocarcinoma,0.8607,Minor Salivary Gland Adenocarcinoma,0.8506,Salivary Duct Carcinoma,0.8401,"Sinonasal Adenocarcinoma, Salivary-Type",0.8344,"Salivary Gland Low Grade Adenocarcinoma, Not Otherwise Specified",0.8172,Salivary Gland Adenoma,0.8149,Salivary Gland Mucinous Adenocarcinoma,0.8147,Salivary Gland Oncocytic Adenocarcinoma,0.8142,Advanced Salivary Gland Carcinoma,0.8024,Salivary Gland Secretory Carcinoma,0.8017,Salivary Gland Intestinal-Type Adenocarcinoma,0.8012,Adult Salivary Gland Carcinoma,0.7956,"Salivary Gland High Grade Adenocarcinoma, Not Otherwise Specified",0.7913,Metastatic Salivary Gland Adenocarcinoma,0.7900,Salivary Gland Acinic Cell Carcinoma,0.7890,Salivary Gland Cystadenocarcinoma,0.7813,"Metastatic Salivary Gland Adenocarcinoma, Not Otherwise Specified",0.7806,SALIVARY ADENOCARCINOMA NOS,True,True,True
SALIVARY CANCER,Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.9323,Salivary Gland Adenocarcinoma,0.8753,Salivary Gland Neoplasm,0.8721,Salivary Duct Carcinoma,0.8552,Major Salivary Gland Carcinoma,0.8229,Salivary Gland Lymphoma,0.8161,Salivary Gland Secretory Carcinoma,0.8114,Malignant Salivary Gland Neoplasm,0.8092,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",0.8034,Major Salivary Gland Neoplasm,0.8031,Adult Salivary Gland Carcinoma,0.8015,Childhood Salivary Gland Carcinoma,0.7980,Salivary Gland Squamous Cell Carcinoma,0.7934,Advanced Salivary Gland Carcinoma,0.7873,Major Salivary Gland Adenocarcinoma,0.7858,Minor Salivary Gland Carcinoma,0.7848,Salivary Gland High Grade Carcinoma,0.7836,Salivary Gland Adenoma,0.7830,Salivary Gland Undifferentiated Carcinoma,0.7691,Minor Salivary Gland Neoplasm,0.7659,SALIVARY CANCER,True,True,True
SALIVARY CARCINOMA,Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.9727,Salivary Duct Carcinoma,0.9143,Salivary Gland Adenocarcinoma,0.8903,Salivary Gland Secretory Carcinoma,0.8669,Major Salivary Gland Carcinoma,0.8576,Salivary Gland Squamous Cell Carcinoma,0.8475,Adult Salivary Gland Carcinoma,0.8352,Salivary Gland High Grade Carcinoma,0.8252,Advanced Salivary Gland Carcinoma,0.8233,Salivary Gland Undifferentiated Carcinoma,0.8231,Childhood Salivary Gland Carcinoma,0.8218,Minor Salivary Gland Carcinoma,0.8182,Salivary Gland Low Grade Carcinoma,0.8133,Salivary Gland Neoplasm,0.8132,Salivary Gland Poorly Differentiated Carcinoma,0.8118,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",0.8054,Salivary Gland Acinic Cell Carcinoma,0.8004,Salivary Gland Lymphoma,0.7990,Major Salivary Gland Adenocarcinoma,0.7975,Malignant Salivary Gland Neoplasm,0.7956,SALIVARY CARCINOMA,True,True,True
"SALIVARY CARCINOMA, OTHER",Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.8197,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",0.7918,Salivary Gland Undifferentiated Carcinoma,0.7568,Salivary Duct Carcinoma,0.7536,Major Salivary Gland Carcinoma,0.7517,Adult Salivary Gland Carcinoma,0.7460,Salivary Gland Neuroendocrine Carcinoma,0.7410,Unresectable Salivary Gland Carcinoma,0.7406,Salivary Gland Adenocarcinoma,0.7365,Advanced Salivary Gland Carcinoma,0.7364,Minor Salivary Gland Carcinoma,0.7329,Metastatic Salivary Gland Carcinoma,0.7298,Salivary Gland Secretory Carcinoma,0.7278,Salivary Gland Low Grade Carcinoma,0.7254,Salivary Gland Squamous Cell Carcinoma,0.7247,Childhood Salivary Gland Carcinoma,0.7228,"Salivary Gland Low Grade Adenocarcinoma, Not Otherwise Specified",0.7204,Salivary Gland High Grade Carcinoma,0.7203,Salivary Gland Neoplasm,0.7180,Salivary Gland Lymphoma,0.7074,"SALIVARY CARCINOMA, OTHER",True,True,True
SALIVARY DUCT CARCINOMA,Salivary Duct Carcinoma,1,2,Salivary Duct Carcinoma,1.0000,Salivary Gland Carcinoma,0.9034,Salivary Gland Adenocarcinoma,0.8496,Metastatic Salivary Duct Carcinoma,0.8277,Salivary Gland Intraductal Carcinoma,0.8206,Salivary Gland Secretory Carcinoma,0.8119,Salivary Gland Poorly Differentiated Carcinoma,0.8025,Salivary Gland Acinic Cell Carcinoma,0.7907,Major Salivary Gland Carcinoma,0.7858,Salivary Gland Squamous Cell Carcinoma,0.7774,Advanced Salivary Gland Carcinoma,0.7674,Salivary Gland Undifferentiated Carcinoma,0.7660,Recurrent Salivary Duct Carcinoma,0.7625,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",0.7615,Childhood Salivary Gland Carcinoma,0.7588,Adult Salivary Gland Carcinoma,0.7561,Salivary Gland Clear Cell Carcinoma,0.7540,Minor Salivary Gland Carcinoma,0.7530,Salivary Gland High Grade Carcinoma,0.7513,Major Salivary Gland Adenocarcinoma,0.7510,SALIVARY DUCT CARCINOMA,True,True,True
SALIVARY GLAND CANCER,Salivary Gland Carcinoma,1,2,Salivary Gland Carcinoma,0.9594,Salivary Gland Neoplasm,0.8969,Salivary Gland Adenocarcinoma,0.8814,Major Salivary Gland Carcinoma,0.8487,Salivary Duct Carcinoma,0.8486,Malignant Salivary Gland Neoplasm,0.8461,Major Salivary Gland Neoplasm,0.8313,Adult Salivary Gland Carcinoma,0.8230,Salivary Gland Secretory Carcinoma,0.8159,Salivary Gland Lymphoma,0.8125,Salivary Gland High Grade Carcinoma,0.8118,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",0.8065,Salivary Gland Squamous Cell Carcinoma,0.8037,Childhood Salivary Gland Carcinoma,0.8031,Minor Salivary Gland Carcinoma,0.8028,Advanced Salivary Gland Carcinoma,0.8018,Major Salivary Gland Adenocarcinoma,0.7959,Salivary Gland Adenoma,0.7878,Minor Salivary Gland Neoplasm,0.7862,Salivary Gland Low Grade Carcinoma,0.7801,SALIVARY GLAND CANCER,True,True,True
SARC,Sarcoma,1,2,Sarcoma,0.6447,Osteosarcoma,0.6157,Sarcoma by NCI Grade,0.6112,Conventional Osteosarcoma,0.6000,Advanced Sarcoma,0.5984,Sarcoma GX,0.5913,Sarcoma G2,0.5891,Gliosarcoma,0.5878,Rhabdomyosarcoma,0.5876,Lymphosarcoma,0.5834,Sarcoma G3,0.5798,Astrocytoma,0.5782,Sarcoma NCI Grade 1,0.5777,Secretory Meningioma,0.5774,Serous Adenocarcinoma,0.5771,Alveolar Rhabdomyosarcoma,0.5763,Localized Osteosarcoma,0.5761,Intermediate Grade Osteosarcoma,0.5761,Conventional Alveolar Rhabdomyosarcoma,0.5750,Localized Sarcoma,0.5750,SARC,True,True,True
SARC LMS,Uterine Corpus Leiomyosarcoma,99,2,Lymphosarcoma,0.6746,Laryngeal Leiomyosarcoma,0.6691,Localized Leiomyosarcoma,0.6569,Conventional Leiomyosarcoma,0.6563,Childhood Leiomyosarcoma,0.6528,Leiomyosarcoma,0.6514,Cardiac Leiomyosarcoma,0.6492,Locally Advanced Leiomyosarcoma,0.6471,Non-Cutaneous Leiomyosarcoma,0.6470,Central Nervous System Leiomyosarcoma,0.6431,Gastric Leiomyosarcoma,0.6417,Localized Liposarcoma,0.6410,Liposarcoma,0.6397,Liver Leiomyosarcoma,0.6395,Laryngeal Sarcoma,0.6390,Advanced Leiomyosarcoma,0.6381,Tongue Liposarcoma,0.6380,Mediastinal Leiomyosarcoma,0.6367,Mediastinal Liposarcoma,0.6350,Colon Leiomyosarcoma,0.6318,SARC LMS,False,False,False
SARC LS,Liposarcoma,10,2,Lymphosarcoma,0.6178,Sarcoma,0.6055,Localized Sarcoma,0.5982,Advanced Sarcoma,0.5939,Colorectal Serrated Lesions and Polyps,0.5939,Locally Advanced Sarcoma,0.5921,Localized Synovial Sarcoma,0.5911,Sarcoma by NCI Grade,0.5899,Steroid Lipomatosis,0.5898,Liposarcoma,0.5897,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0.5870,Advanced Liposarcoma,0.5837,Sarcoma GX,0.5829,Low Grade Sarcoma,0.5807,Advanced Carcinosarcoma,0.5801,Locally Advanced Synovial Sarcoma,0.5796,Osteosarcoma,0.5783,Splenic Small Lymphocytic Lymphoma,0.5778,Liver Synovial Sarcoma,0.5774,Gallbladder Sarcoma,0.5773,SARC LS,False,False,False
SARCOMA,Sarcoma,1,2,Sarcoma,1.0000,Bone Sarcoma,0.9162,Sarcomatosis,0.8800,Stromal Sarcoma,0.8442,Myeloid Sarcoma,0.8426,Skin Sarcoma,0.8405,Synovial Sarcoma,0.8366,Sarcoma GX,0.8218,Soft Tissue Sarcoma,0.8181,Childhood Sarcoma,0.8158,Sarcoma G1,0.8120,Cardiac Sarcoma,0.8080,Sarcoma NCI Grade 1,0.8064,Localized Sarcoma,0.7991,Advanced Sarcoma,0.7962,Kidney Sarcoma,0.7931,Metastatic Sarcoma,0.7907,Sarcoma G2,0.7902,Colorectal Sarcoma,0.7885,Prostate Sarcoma,0.7841,SARCOMA,True,True,True
SARCOMA LEIOMYO,Uterine Corpus Leiomyosarcoma,99,2,Leiomyosarcoma,0.9242,Bone Leiomyosarcoma,0.8694,Conventional Leiomyosarcoma,0.8599,Digestive System Leiomyosarcoma,0.8499,Leiomyosarcoma of Vessels,0.8366,Lung Leiomyosarcoma,0.8356,Myxoid Leiomyosarcoma,0.8350,Localized Leiomyosarcoma,0.8342,Leiomyoma,0.8340,Non-Cutaneous Leiomyosarcoma,0.8313,Inflammatory Leiomyosarcoma,0.8248,Leiomyomatosis,0.8172,Pleomorphic Leiomyosarcoma,0.8165,Leiomyosarcoma NCI Grade 2,0.8135,Kidney Leiomyosarcoma,0.8125,Leiomyosarcoma of Deep Soft Tissue,0.8125,Cardiac Leiomyosarcoma,0.8122,Colon Leiomyosarcoma,0.8103,Myxoid Leiomyoma,0.8076,Ovarian Leiomyosarcoma,0.8062,SARCOMA LEIOMYO,False,False,False
SARCOMA LIPO,Liposarcoma,1,2,Liposarcoma,0.8715,Skin Liposarcoma,0.8368,Localized Liposarcoma,0.8132,Bone Liposarcoma,0.8129,Fibroblastic Liposarcoma,0.8008,Lipoma,0.7902,Mixed Liposarcoma,0.7871,Adult Liposarcoma,0.7810,Ovarian Liposarcoma,0.7771,Breast Liposarcoma,0.7701,Metastatic Liposarcoma,0.7665,Colon Liposarcoma,0.7659,Advanced Liposarcoma,0.7646,Sarcoma,0.7645,Skin Lipoma,0.7616,Childhood Liposarcoma,0.7607,Gastric Liposarcoma,0.7550,Pleomorphic Liposarcoma,0.7548,Lipoblastoma,0.7548,Conventional Lipoma,0.7543,SARCOMA LIPO,True,True,True
"SARCOMA, NOS",Sarcoma,1,2,Sarcoma,0.9130,Bone Sarcoma,0.8657,Sarcomatosis,0.8554,Soft Tissue Sarcoma,0.7857,Stromal Sarcoma,0.7831,Skin Sarcoma,0.7745,"Undifferentiated Sarcoma, Not Otherwise Specified",0.7722,Synovial Sarcoma,0.7716,Myeloid Sarcoma,0.7668,Sarcoma NCI Grade 1,0.7641,Sarcoma G1,0.7473,Sarcoma GX,0.7420,Sarcoma of the Extremity,0.7380,High Grade Sarcoma,0.7357,Childhood Sarcoma,0.7332,Undifferentiated Soft Tissue Sarcoma,0.7330,Sarcomatoid Carcinoma,0.7312,Undifferentiated Stromal Sarcoma,0.7272,Sarcoma NCI Grade 3,0.7258,Kidney Sarcoma,0.7228,"SARCOMA, NOS",True,True,True
SARCOMATOID,Sarcomatoid Carcinoma,1,2,Sarcomatoid Carcinoma,0.9212,Sarcomatoid Mesothelioma,0.8521,Sarcoma,0.8217,Sarcomatosis,0.8040,Undifferentiated Sarcoma with Epithelioid Features,0.7594,Undifferentiated Soft Tissue Sarcoma,0.7550,Undifferentiated Pleomorphic Sarcoma,0.7525,Sarcoma G2,0.7486,Spindle Cell Sarcoma,0.7467,Bone Sarcoma,0.7444,Sarcoma NCI Grade 1,0.7440,Undifferentiated Spindle Cell Sarcoma,0.7427,Sarcomatoid Transitional Cell Carcinoma,0.7374,Sarcomatoid Renal Cell Carcinoma,0.7371,Synovial Sarcoma,0.7369,Soft Tissue Sarcoma,0.7347,Rectal Sarcomatoid Carcinoma,0.7336,Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation,0.7335,Sarcoma G1,0.7295,Lung Sarcomatoid Carcinoma,0.7271,SARCOMATOID,True,True,True
SARCOMATOID CARCINOMA OF THE LUNG,Lung Sarcomatoid Carcinoma,1,2,Lung Sarcomatoid Carcinoma,0.9572,Lung Spindle Cell Carcinoma,0.8199,Lung Sarcoma,0.7841,Sarcomatoid Carcinoma,0.7748,Lung Pleomorphic Carcinoma,0.7635,Sarcomatoid Renal Cell Carcinoma,0.7471,Lung Carcinosarcoma,0.7445,Lung Squamous Cell Carcinoma,0.7427,Lung Synovial Sarcoma,0.7259,Lung Non-Small Cell Carcinoma,0.7214,Lung Non-Keratinizing Squamous Cell Carcinoma,0.7135,Superior Sulcus Lung Carcinoma,0.7069,Lung Small Cell Carcinoma,0.7057,Lung Carcinoma,0.7037,Lung Non-Small Cell Squamous Carcinoma,0.7019,Adrenal Cortical Sarcomatoid Carcinoma,0.7018,Lung Alveolar Soft Part Sarcoma,0.7016,Lung Monophasic Synovial Sarcoma,0.7013,Lung Adenosquamous Carcinoma,0.7013,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.6982,SARCOMATOID CARCINOMA OF THE LUNG,True,True,True
SARCOMATOID MESOTHELIOMA,Sarcomatoid Mesothelioma,1,2,Sarcomatoid Mesothelioma,1.0000,Pleural Sarcomatoid Mesothelioma,0.8836,Peritoneal Sarcomatoid Mesothelioma,0.8463,Epithelioid Mesothelioma,0.8213,Malignant Mesothelioma,0.8141,Mesothelioma,0.8109,Sarcomatoid Carcinoma,0.8012,Desmoplastic Mesothelioma,0.7958,Biphasic Mesothelioma,0.7813,Paratesticular Sarcomatoid Mesothelioma,0.7717,Diffuse Malignant Mesothelioma,0.7672,Pleural Desmoplastic Mesothelioma,0.7340,Advanced Epithelioid Mesothelioma,0.7278,Metastatic Malignant Mesothelioma,0.7219,Localized Malignant Mesothelioma,0.7133,Pleural Mesothelioma,0.7126,Sarcomatoid Transitional Cell Carcinoma,0.7058,Monophasic Synovial Sarcoma,0.7055,Undifferentiated Sarcoma with Epithelioid Features,0.7053,Spindle Cell Sarcoma,0.7024,SARCOMATOID MESOTHELIOMA,True,True,True
SARCOMATOID RENAL CELL CARCINOMA,Sarcomatoid Renal Cell Carcinoma,1,2,Sarcomatoid Renal Cell Carcinoma,1.0000,Advanced Sarcomatoid Renal Cell Carcinoma,0.8800,Metastatic Sarcomatoid Renal Cell Carcinoma,0.8666,Locally Advanced Sarcomatoid Renal Cell Carcinoma,0.8533,Unresectable Sarcomatoid Renal Cell Carcinoma,0.8156,Sarcomatoid Transitional Cell Carcinoma,0.7997,Sarcomatoid Carcinoma,0.7966,Adrenal Cortical Sarcomatoid Carcinoma,0.7785,Kidney Sarcoma,0.7747,Clear Cell Sarcoma of the Kidney,0.7658,Lung Sarcomatoid Carcinoma,0.7568,Eosinophilic Solid and Cystic Renal Cell Carcinoma,0.7431,Renal Cell Carcinoma,0.7277,Anaplastic Sarcoma of the Kidney,0.7234,Kidney Synovial Sarcoma,0.7229,Non-Clear Cell Renal Cell Carcinoma,0.7227,Clear Cell Renal Cell Carcinoma,0.7224,Metastatic Sarcomatoid Urothelial Carcinoma,0.7193,Granular Renal Cell Carcinoma,0.7153,Kidney Fibrosarcoma,0.7136,SARCOMATOID RENAL CELL CARCINOMA,True,True,True
SARC_DDLPS,Dedifferentiated Liposarcoma,14,2,Colorectal Serrated Lesions and Polyps,0.5977,Autoimmune Lymphoproliferative Syndrome-Related Lymphoma,0.5904,Serrated Lesions and Polyps,0.5715,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.5687,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",0.5552,Lymphosarcoma,0.5530,Advanced Liposarcoma,0.5518,Squamous Papillomatosis,0.5514,Heavy Chain Class-Switched Primary Cutaneous Marginal Zone Lymphoproliferative Disorder,0.5493,Colon Serrated Lesions and Polyps,0.5446,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,0.5443,Poorly Differentiated Synovial Sarcoma,0.5400,Disseminated Peritoneal Leiomyomatosis,0.5377,Dedifferentiated Liposarcoma,0.5367,Advanced Dedifferentiated Liposarcoma,0.5358,Rectal Serrated Lesions and Polyps,0.5358,Steroid Lipomatosis,0.5356,Mixed Liposarcoma,0.5352,Primary Cutaneous Marginal Zone Lymphoproliferative Disorder,0.5344,Localized Liposarcoma,0.5330,SARC_DDLPS,False,False,False
SARC_LMS,Leiomyosarcoma,6,2,Lymphosarcoma,0.6701,Conventional Leiomyosarcoma,0.6541,Locally Advanced Leiomyosarcoma,0.6537,Laryngeal Leiomyosarcoma,0.6500,Non-Cutaneous Leiomyosarcoma,0.6468,Leiomyosarcoma,0.6458,Localized Leiomyosarcoma,0.6405,Childhood Leiomyosarcoma,0.6368,Advanced Leiomyosarcoma,0.6346,Central Nervous System Leiomyosarcoma,0.6329,Locally Advanced Sarcoma,0.6317,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0.6311,Liver Leiomyosarcoma,0.6308,Tongue Liposarcoma,0.6251,Gastric Leiomyosarcoma,0.6232,Cardiac Leiomyosarcoma,0.6214,Liposarcoma,0.6213,Mediastinal Leiomyosarcoma,0.6200,Laryngeal Sarcoma,0.6165,Broad Ligament Leiomyosarcoma,0.6165,SARC_LMS,False,False,False
SARC_OTHER,Sarcoma,10,2,Neoplasm by Special Category,0.6083,Neoplasm by Site,0.5843,Miscellaneous Neoplasm,0.5700,Unresectable Sarcoma,0.5684,Lymphoma by Site,0.5666,Sarcoma by NCI Grade,0.5612,Osteosarcoma,0.5606,Conventional Osteosarcoma,0.5597,Neoplasm by Cause,0.5586,Sarcoma,0.5552,Neoplasm by Morphology,0.5541,Smooth Muscle Neoplasm,0.5493,Advanced Sarcoma,0.5483,Unresectable Osteosarcoma,0.5461,Intermediate Grade Osteosarcoma,0.5434,Smooth Muscle Tumor of Uncertain Malignant Potential,0.5429,Synovial Neoplasm,0.5415,Small Cell Osteosarcoma,0.5415,Mixed Osteosarcoma,0.5415,Benign Skeletal Muscle Neoplasm,0.5389,SARC_OTHER,False,False,False
SBS,Small Intestinal Carcinoma,99,2,Sarcoma,0.6023,Gallbladder Sarcoma,0.6020,Breast Sarcoma,0.5887,Polyposis,0.5850,Synchronous Multifocal Osteosarcoma,0.5822,Telangiectatic Osteosarcoma,0.5750,Cerebellar Sarcoma,0.5749,Stromal Sarcoma,0.5742,Sialoblastoma,0.5730,Benign Stromal Tumor,0.5720,Sporadic Retinoblastoma,0.5714,Advanced Sarcoma,0.5713,Serrated Lesions and Polyps,0.5709,Colorectal Sarcoma,0.5699,Bone Sarcoma,0.5690,Osteosarcoma,0.5683,Secondary Osteosarcoma,0.5661,Malignant Superior Sulcus Neoplasm,0.5633,Superficial Spreading Adenocarcinoma,0.5625,Medulloblastoma,0.5615,SBS,False,False,False
SCC HEAD AND NECK,Head and Neck Squamous Cell Carcinoma,1,2,Head and Neck Squamous Cell Carcinoma,0.8954,Head and Neck Carcinoma,0.8923,Head and Neck Cutaneous Squamous Cell Carcinoma,0.8062,Head and Neck Sebaceous Carcinoma,0.7969,Malignant Head and Neck Neoplasm,0.7954,Head and Neck Neoplasm,0.7859,Head and Neck Sarcoma,0.7784,Advanced Head and Neck Squamous Cell Carcinoma,0.7741,Head and Neck Neuroendocrine Carcinoma,0.7669,Advanced Head and Neck Carcinoma,0.7634,Head and Neck NUT Carcinoma,0.7352,Advanced Head and Neck Cutaneous Squamous Cell Carcinoma,0.7326,Metastatic Head and Neck Carcinoma,0.7287,Head and Neck Lymphoma,0.7269,Head and Neck Neuroendocrine Neoplasm,0.7165,Metastatic Head and Neck Squamous Cell Carcinoma,0.7127,Head and Neck Small Cell Neuroendocrine Carcinoma,0.7079,Head and Neck Synovial Sarcoma,0.7036,ASPH-Positive Head and Neck Squamous Cell Carcinoma,0.7011,Head and Neck Merkel Cell Carcinoma,0.7008,SCC HEAD AND NECK,True,True,True
SCCOHT,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",99,2,Serous Tubal Intraepithelial Carcinoma,0.5939,Childhood Ovarian Sclerosing Stromal Tumor,0.5887,Sebaceous Carcinoma,0.5724,Ovarian Serous Tumor,0.5723,"Childhood Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.5627,Eye Sebaceous Carcinoma,0.5551,"Secondary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1",0.5523,Steatohepatitic Hepatocellular Carcinoma,0.5519,Telangiectatic Osteosarcoma,0.5508,Conjunctival Stromal Tumor,0.5476,Extraocular Sebaceous Carcinoma,0.5469,Sellar Choriocarcinoma,0.5464,High-CSD Melanoma,0.5462,Conjunctival Sebaceous Carcinoma,0.5446,Ovarian Sclerosing Stromal Tumor,0.5438,Cervical Squamotransitional Carcinoma,0.5434,Testicular Sclerosing Sertoli Cell Tumor,0.5429,"Uterine Carcinosarcoma, Homologous Type",0.5425,Strumal Carcinoid,0.5419,Secondary Carcinoma,0.5418,SCCOHT,False,False,False
SCHMINKE TUMOR/LYMPHOEPITHELIAL CARCINOMA,Lymphoepithelial Carcinoma,1,2,Lymphoepithelial Carcinoma,0.8157,Skin Lymphoepithelial Carcinoma,0.7917,Sinonasal Lymphoepithelial Carcinoma,0.7892,Cervical Lymphoepithelioma-Like Carcinoma,0.7553,Lacrimal Drainage System Lymphoepithelial Carcinoma,0.7377,Salivary Gland Lymphoepithelial Carcinoma,0.7354,Lung Lymphoepithelial Carcinoma,0.7227,Trichoepithelial Carcinoma,0.7172,Penile Lymphoepithelioma-Like Carcinoma,0.6990,Laryngeal Lymphoepithelial Carcinoma,0.6985,Invasive Lymphoepithelioma-Like Urothelial Carcinoma,0.6749,Thymus Lymphoepithelial Carcinoma,0.6729,Mucoepidermoid Carcinoma,0.6569,Classic Type Trichoepithelioma,0.6544,Lacrimal Drainage System Mucoepidermoid Carcinoma,0.6512,Extraocular Sebaceous Carcinoma,0.6430,Lacrimal Gland Mucoepidermoid Carcinoma,0.6393,Eye Sebaceous Carcinoma,0.6391,Paranasal Sinus Mucoepidermoid Carcinoma,0.6364,Eyelid Sebaceous Gland Carcinoma,0.6364,SCHMINKE TUMOR/LYMPHOEPITHELIAL CARCINOMA,True,True,True
SCHWANNOMA,Schwannoma,1,2,Schwannoma,1.0000,Conventional Schwannoma,0.9445,Peripheral Nerve Schwannoma,0.9154,Schwannomatosis,0.8968,Skin Schwannoma,0.8958,Bone Schwannoma,0.8930,Cellular Schwannoma,0.8896,Cardiac Schwannoma,0.8820,Ancient Schwannoma,0.8810,Sympathetic Schwannoma,0.8657,Childhood Schwannoma,0.8470,Intraocular Schwannoma,0.8439,Nerve Sheath Neoplasm,0.8422,Trigeminal Schwannoma,0.8382,Plexiform Schwannoma,0.8377,Sinonasal Schwannoma,0.8276,Epithelioid Schwannoma,0.8274,Breast Schwannoma,0.8260,Facial Nerve Schwannoma,0.8222,Colorectal Schwannoma,0.8199,SCHWANNOMA,True,True,True
SCLC,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.9592,"Lung Small Cell Carcinoma, A Subtype",0.9013,Lung Small Cell Carcinoma Molecular Subtypes,0.8675,Occult Lung Small Cell Carcinoma,0.8666,Lung Non-Small Cell Carcinoma,0.8437,Advanced Lung Small Cell Carcinoma,0.8338,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.8330,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.8212,Childhood Lung Small Cell Carcinoma,0.8167,"Lung Small Cell Carcinoma, I Subtype",0.8099,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.8083,"Lung Small Cell Carcinoma, N Subtype",0.8073,Limited Stage Lung Small Cell Carcinoma,0.8064,"Lung Small Cell Carcinoma, Neuroendocrine-Low Subtype",0.8059,Lung Small Cell Carcinoma by AJCC v7 Stage,0.8019,"Lung Small Cell Carcinoma, P Subtype",0.8008,Combined Lung Small Cell and Squamous Cell Carcinoma,0.7948,Locally Advanced Lung Small Cell Carcinoma,0.7909,Combined Lung Small Cell Carcinoma,0.7905,Metastatic Lung Small Cell Carcinoma,0.7866,Small Cell Lung Cancer,True,True,True
SCLEROSING EPITHELIOID FIBROSARCOMA,Sclerosing Epithelioid Fibrosarcoma,1,2,Sclerosing Epithelioid Fibrosarcoma,1.0000,Childhood Sclerosing Epithelioid Fibrosarcoma,0.8290,Epithelioid Myxofibrosarcoma,0.7105,Skin Epithelioid Fibrous Histiocytoma,0.7004,Undifferentiated Sarcoma with Epithelioid Features,0.6914,Epithelioid Sarcoma,0.6906,Soft Tissue Fibrosarcoma,0.6846,Spindle Cell Atypical Fibroxanthoma,0.6805,Solitary Fibrous Tumor,0.6792,Fibrosarcoma,0.6783,Elastofibroma,0.6760,Poorly Differentiated Fibrosarcoma,0.6696,Solitary Adult Fibroma,0.6694,Adult Epithelioid Sarcoma,0.6675,Adult Fibrosarcoma,0.6672,Dedifferentiated Solitary Fibrous Tumor,0.6661,Sarcomatoid Mesothelioma,0.6636,Conventional Fibrosarcoma,0.6610,Superficial Fibromatosis,0.6586,Localized Epithelioid Sarcoma,0.6581,SCLEROSING EPITHELIOID FIBROSARCOMA,True,True,True
SCLEROSING RHABDOMYOSARCOMA,Sclerosing Rhabdomyosarcoma,1,2,Sclerosing Rhabdomyosarcoma,1.0000,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9284,Spindle Cell Rhabdomyosarcoma,0.8480,Rhabdomyosarcoma,0.8235,MYOD1-Mutant Spindle Cell/Sclerosing Rhabdomyosarcoma,0.7813,Metastatic Rhabdomyosarcoma,0.7804,Adult Rhabdomyosarcoma,0.7776,Childhood Spindle Cell Rhabdomyosarcoma,0.7590,Pleomorphic Rhabdomyosarcoma,0.7493,Childhood Rhabdomyosarcoma,0.7368,Unresectable Rhabdomyosarcoma,0.7306,Solid Alveolar Rhabdomyosarcoma,0.7293,Refractory Rhabdomyosarcoma,0.7258,Alveolar Rhabdomyosarcoma,0.7202,Embryonal Rhabdomyosarcoma,0.7173,Adult Pleomorphic Rhabdomyosarcoma,0.7157,Cardiac Rhabdomyosarcoma,0.7096,Rhabdomyoma,0.7096,Sinonasal Rhabdomyosarcoma,0.7087,Fusion-Negative Rhabdomyosarcoma,0.7084,SCLEROSING RHABDOMYOSARCOMA,True,True,True
SEBACEOUS CARCINOMA,Sebaceous Carcinoma,1,2,Sebaceous Carcinoma,1.0000,Advanced Sebaceous Carcinoma,0.8884,Breast Sebaceous Carcinoma,0.8814,Salivary Gland Sebaceous Carcinoma,0.8641,Conjunctival Sebaceous Carcinoma,0.8594,Eye Sebaceous Carcinoma,0.8533,Sebaceous Adenoma,0.8403,Eyelid Sebaceous Gland Carcinoma,0.8360,Skin Basal Cell Carcinoma with Sebaceous Differentiation,0.8359,Sebaceous Gland Neoplasm,0.8355,Metastatic Sebaceous Carcinoma,0.8337,Malignant Sebaceous Gland Neoplasm,0.8237,Extraocular Sebaceous Carcinoma,0.8064,Sebaceoma,0.8018,Head and Neck Sebaceous Carcinoma,0.7919,Vulvar Sebaceous Carcinoma,0.7896,Recurrent Sebaceous Carcinoma,0.7877,Superficial Epithelioma with Sebaceous Differentiation,0.7840,Refractory Sebaceous Carcinoma,0.7676,Sweat Gland Carcinoma,0.7675,SEBACEOUS CARCINOMA,True,True,True
SECOND MALIGNANCY,Secondary Malignant Neoplasm,2,2,Second Primary Malignant Neoplasm,0.9087,Secondary Malignant Neoplasm,0.8981,Secondary Neoplasm,0.8430,Second Primary Neoplasm,0.8363,Metastatic Malignant Neoplasm,0.8308,Metastatic Neoplasm,0.8184,Secondary Carcinoma,0.8143,Metastatic Malignant Solid Neoplasm,0.7745,Recurrent Subsequent Malignant Neoplasm,0.7743,Metachronous Malignant Neoplasm,0.7712,Distantly Metastatic Malignant Neoplasm,0.7705,Metastatic Carcinoma,0.7421,Recurrent Malignant Neoplasm,0.7374,Secondary Osteosarcoma,0.7308,Recurrent Metastatic Malignant Neoplasm,0.7251,Grade 2 Malignant Neoplasm,0.7239,Metastatic Benign Neoplasm,0.7115,Metastatic Malignant Skin Neoplasm,0.7093,Bilateral Malignant Neoplasm,0.6944,Recurrent Malignant Solid Neoplasm,0.6888,SECOND MALIGNANCY,False,True,True
SECONDARY OSTEOSARCOMA,Secondary Osteosarcoma,1,2,Secondary Osteosarcoma,1.0000,Metastatic Osteosarcoma,0.9003,Osteosarcoma,0.8688,Bone Osteosarcoma,0.8538,Primary Bone Osteosarcoma,0.8231,Conventional Osteosarcoma,0.8203,Multifocal Osteosarcoma,0.8195,Extraskeletal Osteosarcoma,0.8163,Osteoblastic Osteosarcoma,0.8152,Metachronous Osteosarcoma,0.8126,Recurrent Osteosarcoma,0.8116,Mixed Osteosarcoma,0.8095,Metastatic Extraskeletal Osteosarcoma,0.8042,Small Cell Osteosarcoma,0.7954,Lung Osteosarcoma,0.7757,High Grade Osteosarcoma,0.7654,Unresectable Osteosarcoma,0.7625,Jaw Osteosarcoma,0.7604,Synchronous Multifocal Osteosarcoma,0.7597,Secondary Neoplasm,0.7580,SECONDARY OSTEOSARCOMA,True,True,True
SELLAR TUMOR,Sellar Region Neoplasm,1,2,Sellar Region Neoplasm,0.9296,Sellar Germ Cell Tumor,0.8120,Sellar Neurocytoma,0.8103,Sellar Meningioma,0.7990,Sellar Paraganglioma,0.7921,Sellar Germinoma,0.7834,Sellar Immature Teratoma,0.7739,Sellar Teratoma,0.7732,Granular Cell Tumor of the Sellar Region,0.7609,Sellar Schwannoma,0.7524,Sellar Solitary Fibrous Tumor,0.7521,Pituitary Gland Neoplasm,0.7506,Sellar Embryonal Carcinoma,0.7504,Sellar Mature Teratoma,0.7293,Sellar Gangliocytoma,0.7269,Sellar Olfactory Neuroblastoma,0.7236,Sellar Yolk Sac Tumor,0.7231,Anterior Pituitary Gland Neoplasm,0.7108,Sellar Chordoma,0.7065,Pituicytoma,0.6997,SELLAR TUMOR,True,True,True
SEMINAL VESICLE CARCINOMA,Malignant Seminal Vesicle Neoplasm,3,2,Seminal Vesicle Squamous Cell Carcinoma,0.9180,Seminal Vesicle Adenocarcinoma,0.8964,Malignant Seminal Vesicle Neoplasm,0.8401,Seminal Vesicle Neoplasm,0.8395,Seminal Versicle Carcinoma,0.8288,Seminal Vesicle Cystadenoma,0.7599,Benign Seminal Vesicle Neoplasm,0.7311,Metastatic Malignant Neoplasm in the Seminal Vesicle,0.7255,Seminal Vesicle Angiosarcoma,0.7224,Seminal Vesicle Schwannoma,0.7115,Seminal Vesicle Leiomyoma,0.6916,Seminal Vesicle Leiomyosarcoma,0.6834,Seminal Vesicle Soft Tissue Neoplasm,0.6722,Epididymal Carcinoma,0.6611,Vaginal Carcinoma,0.6570,Epididymal Squamous Cell Carcinoma,0.6526,Vaginal Neuroendocrine Carcinoma,0.6523,Seminal Vesicle Mixed Epithelial and Stromal Tumor,0.6505,Vaginal Papillary Carcinoma,0.6416,Prostate Squamous Cell Carcinoma,0.6372,SEMINAL VESICLE CARCINOMA,False,True,True
SEMINOMA,Seminoma,1,2,Seminoma,1.0000,Testicular Seminoma,0.9487,Testicular Typical Seminoma,0.9181,Childhood Seminoma,0.8901,Mediastinal Seminoma,0.8833,Intratubular Seminoma,0.8386,"Testicular Seminoma, Tubular Variant",0.8350,Extragonadal Seminoma,0.8211,Testicular Seminoma with Syncytiotrophoblastic Cells,0.7943,Testicular Seminoma with High Mitotic Index,0.7929,"Testicular Seminoma, Pseudoglandular Variant",0.7848,Mixed Teratoma and Seminoma,0.7747,Testicular Spermatocytic Tumor,0.7448,"Testicular Seminoma, Cribriform Variant",0.7038,Intratubular Non-Seminoma,0.7013,Suprasellar Germ Cell Tumor,0.6995,Suprasellar Germinoma,0.6988,Stage I Testicular Seminoma AJCC v6 and v7,0.6975,Sellar Germinoma,0.6898,Testicular Sarcoma,0.6878,SEMINOMA,True,True,True
SEMINOMA; NOS,Seminoma,1,2,Seminoma,0.9570,Testicular Seminoma,0.9229,Testicular Typical Seminoma,0.8933,Mediastinal Seminoma,0.8497,Childhood Seminoma,0.8465,"Testicular Seminoma, Tubular Variant",0.8239,Extragonadal Seminoma,0.8200,Intratubular Seminoma,0.8126,"Testicular Seminoma, Pseudoglandular Variant",0.7704,Testicular Seminoma with Syncytiotrophoblastic Cells,0.7634,Mixed Teratoma and Seminoma,0.7552,Testicular Seminoma with High Mitotic Index,0.7539,Testicular Spermatocytic Tumor,0.6976,Stage I Testicular Seminoma AJCC v6 and v7,0.6948,"Testicular Seminoma, Cribriform Variant",0.6820,Stage III Testicular Seminoma AJCC v6 and v7,0.6757,Testicular Mixed Embryonal Carcinoma and Seminoma,0.6746,Intratubular Non-Seminoma,0.6714,Testicular Spermatocytic Tumor with Sarcoma,0.6684,Suprasellar Germinoma,0.6647,SEMINOMA; NOS,True,True,True
SEROUS BORDERLINE OVARIAN TUMOR,Borderline Ovarian Serous Tumor,1,2,Borderline Ovarian Serous Tumor,0.9827,Borderline Ovarian Serous Surface Papillary Tumor,0.9191,Borderline Peritoneal Serous Tumor,0.8767,Benign Ovarian Serous Tumor,0.8656,Borderline Ovarian Serous Papillary Cystic Tumor,0.8629,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,0.8563,Ovarian Serous Tumor,0.8464,Borderline Fallopian Tube Serous Tumor,0.8294,Borderline Serous Cystadenoma,0.8216,Borderline Ovarian Seromucinous Tumor,0.8174,Borderline Ovarian Epithelial Tumor,0.8163,Borderline Broad Ligament Serous Tumor,0.8107,Borderline Ovarian Serous Cystadenofibroma,0.7991,Serous Neoplasm,0.7941,Borderline Ovarian Mucinous Tumor,0.7876,Borderline Ovarian Serous Adenofibroma,0.7824,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,0.7788,Borderline Papillary Serous Cystadenoma,0.7778,Borderline Serous Cystadenofibroma,0.7722,Malignant Ovarian Serous Tumor,0.7548,SEROUS BORDERLINE OVARIAN TUMOR,True,True,True
"SEROUS BORDERLINE OVARIAN TUMOR, MICROPAPILLARY",Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,2,2,Micropapillary Serous Carcinoma,0.8286,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,0.8261,Borderline Ovarian Serous Surface Papillary Tumor,0.8002,Borderline Ovarian Serous Papillary Cystic Tumor,0.7965,Borderline Ovarian Serous Tumor,0.7864,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor with Microinvasion,0.7680,Borderline Papillary Serous Cystadenoma,0.7613,Borderline Peritoneal Serous Tumor,0.7570,Borderline Serous Cystadenoma,0.7412,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,0.7277,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor with Microinvasion,0.7239,Borderline Fallopian Tube Serous Tumor,0.7086,Micropapillary Carcinoma,0.7080,Borderline Ovarian Mucinous Tumor,0.6998,Borderline Serous Cystadenofibroma,0.6988,Borderline Paratesticular Serous Tumor,0.6985,Serous Surface Papillary Carcinoma,0.6946,Benign Ovarian Serous Tumor,0.6860,Primary Peritoneal Low Grade Serous Adenocarcinoma,0.6859,Borderline Broad Ligament Serous Tumor,0.6851,"SEROUS BORDERLINE OVARIAN TUMOR, MICROPAPILLARY",False,True,True
SEROUS CYSTADENOCARCINOMA,Serous Cystadenocarcinoma,1,2,Serous Cystadenocarcinoma,1.0000,Ovarian Serous Cystadenocarcinoma,0.9317,Serous Cystadenoma,0.9256,Papillary Serous Cystadenocarcinoma,0.9145,Pancreatic Serous Cystadenocarcinoma,0.8855,Serous Adenocarcinoma,0.8671,Ovarian Serous Cystadenoma,0.8613,Papillary Serous Cystadenoma,0.8504,Cystadenocarcinoma,0.8457,Advanced Ovarian Serous Cystadenocarcinoma,0.8320,Salivary Gland Cystadenocarcinoma,0.8287,Mucinous Cystadenocarcinoma,0.8220,Pancreatic Serous Cystadenoma,0.8213,Borderline Serous Cystadenoma,0.8179,Serous Neoplasm,0.8134,Ovarian Cystadenocarcinoma,0.8079,Ovarian Serous Adenocarcinoma,0.8019,Papillary Cystadenocarcinoma,0.7966,Paratesticular Serous Cystadenocarcinoma,0.7924,Endometrial Serous Adenocarcinoma,0.7876,SEROUS CYSTADENOCARCINOMA,True,True,True
SEROUS CYSTADENOMA OF THE PANCREAS,Pancreatic Serous Cystadenoma,1,2,Pancreatic Serous Cystadenoma,0.9687,Pancreatic Serous Cystadenocarcinoma,0.9057,Serous Cystadenoma,0.8772,Papillary Serous Cystadenoma,0.8638,Pancreatic Serous Macrocystic Cystadenoma,0.8413,Ovarian Serous Cystadenoma,0.8271,Pancreatic Serous Neoplasm,0.8253,Serous Cystadenocarcinoma,0.8228,Papillary Serous Cystadenocarcinoma,0.8118,Benign Pancreatic Serous Neoplasm,0.8047,Pancreatic Cystadenoma,0.7958,Pancreatic Solid Serous Microcystic Adenoma,0.7859,Ovarian Serous Cystadenocarcinoma,0.7678,Borderline Serous Cystadenoma,0.7618,Pancreatic Cystadenocarcinoma,0.7616,Pancreatic Mucinous Cystadenoma,0.7601,Borderline Papillary Serous Cystadenoma,0.7561,Paratesticular Serous Cystadenoma,0.7449,Salivary Gland Cystadenoma,0.7421,Primary Peritoneal Serous Adenocarcinoma,0.7375,SEROUS CYSTADENOMA OF THE PANCREAS,True,True,True
SEROUS ENDOMETRIAL ADENOCARCINOMA,Endometrial Serous Adenocarcinoma,1,2,Endometrial Serous Adenocarcinoma,0.9911,Serous Adenocarcinoma,0.9265,Advanced Endometrial Serous Adenocarcinoma,0.9157,Ovarian Serous Adenocarcinoma,0.8744,Cervical Serous Adenocarcinoma,0.8568,Metastatic Endometrial Serous Adenocarcinoma,0.8452,Serous Neoplasm,0.8161,Endometrial Adenocarcinoma,0.8155,Serous Cystadenocarcinoma,0.8053,Uterine Ligament Serous Adenocarcinoma,0.8022,Platinum-Sensitive Endometrial Serous Adenocarcinoma,0.7986,Refractory Endometrial Serous Adenocarcinoma,0.7813,Serous Surface Papillary Carcinoma,0.7805,Primary Peritoneal Serous Adenocarcinoma,0.7802,Serous Endometrial Intraepithelial Carcinoma,0.7753,Endometrial Endometrioid Adenocarcinoma,0.7747,Serous Cystadenoma,0.7747,Recurrent Endometrial Serous Adenocarcinoma,0.7702,Ovarian Serous Cystadenocarcinoma,0.7650,Advanced Ovarian Serous Adenocarcinoma,0.7645,SEROUS ENDOMETRIAL ADENOCARCINOMA,True,True,True
SEROUS OVARIAN CANCER,Ovarian Serous Adenocarcinoma,1,2,Ovarian Serous Adenocarcinoma,0.9111,Ovarian Serous Tumor,0.8782,Serous Adenocarcinoma,0.8778,Malignant Ovarian Serous Tumor,0.8622,Serous Neoplasm,0.8400,Ovarian Serous Cystadenocarcinoma,0.8271,Advanced Ovarian Serous Adenocarcinoma,0.8097,Ovarian Serous Cystadenoma,0.8011,Endometrial Serous Adenocarcinoma,0.7985,Ovarian High Grade Serous Adenocarcinoma,0.7977,Ovarian Low Grade Serous Adenocarcinoma,0.7958,Benign Ovarian Serous Tumor,0.7944,Cervical Serous Adenocarcinoma,0.7922,Serous Surface Papillary Carcinoma,0.7890,Serous Cystadenocarcinoma,0.7796,Advanced Ovarian Serous Cystadenocarcinoma,0.7631,Metastatic Ovarian Serous Adenocarcinoma,0.7594,Pancreatic Serous Neoplasm,0.7584,Unresectable Ovarian Serous Adenocarcinoma,0.7550,Advanced Endometrial Serous Adenocarcinoma,0.7531,SEROUS OVARIAN CANCER,True,True,True
SEROUS_CARCINOMA,Ovarian Serous Adenocarcinoma,6,2,Serous Adenocarcinoma,0.8981,Serous Neoplasm,0.8566,Serous Surface Papillary Carcinoma,0.8346,Serous Cystadenocarcinoma,0.8275,Endometrial Serous Adenocarcinoma,0.8189,Ovarian Serous Adenocarcinoma,0.8161,Cervical Serous Adenocarcinoma,0.8052,Micropapillary Serous Carcinoma,0.7961,Ovarian Serous Tumor,0.7822,Ovarian Serous Cystadenocarcinoma,0.7785,Malignant Ovarian Serous Tumor,0.7755,Advanced Endometrial Serous Adenocarcinoma,0.7661,Serous Endometrial Intraepithelial Carcinoma,0.7625,Serous Cystadenoma,0.7454,Papillary Serous Cystadenocarcinoma,0.7412,Pancreatic Serous Neoplasm,0.7407,Primary Peritoneal Serous Adenocarcinoma,0.7289,Uterine Ligament Serous Adenocarcinoma,0.7252,Broad Ligament Serous Adenocarcinoma,0.7221,Metastatic Endometrial Serous Adenocarcinoma,0.7209,SEROUS_CARCINOMA,False,False,False
SERTOLI-LEYDIG CELL TUMOR,Ovarian Sertoli-Leydig Cell Tumor,1,2,Ovarian Sertoli-Leydig Cell Tumor,0.9382,Sertoli Cell Tumor,0.8965,Testicular Sertoli Cell Tumor,0.8932,Testicular Leydig Cell Tumor,0.8856,Leydig Cell Tumor,0.8770,Ovarian Retiform Sertoli-Leydig Cell Tumor,0.8629,Ovarian Sertoli Cell Tumor,0.8566,Childhood Ovarian Sertoli-Leydig Cell Tumor,0.8560,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements,0.8505,Ovarian Stromal-Leydig Cell Tumor,0.8463,Ovarian Sertoli-Leydig Cell Tumor Molecular Subtypes,0.8442,"Testicular Sertoli Cell Tumor, Lipid Rich Variant",0.8421,Benign Leydig Cell Tumor,0.8372,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,0.8347,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,0.8342,Benign Sertoli Cell Tumor,0.8342,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,0.8303,Ovarian Leydig Cell Tumor,0.8303,Ovarian Sertoli-Stromal Cell Tumor,0.8292,Benign Testicular Sertoli Cell Tumor,0.8272,SERTOLI-LEYDIG CELL TUMOR,True,True,True
SEX CORD STROMAL TUMOR,Sex Cord-Stromal Tumor,1,2,Sex Cord-Stromal Tumor,0.9894,Testicular Sex Cord-Stromal Tumor,0.9222,Ovarian Sex Cord-Stromal Tumor,0.9172,Malignant Sex Cord-Stromal Tumor,0.9079,Adrenal Cortical Sex Cord-Stromal Tumor,0.8836,Ovarian Stromal Tumor with Minor Sex Cord Elements,0.8522,"Testicular Sex Cord-Stromal Tumor, Not Otherwise Specified",0.8490,Malignant Testicular Sex Cord-Stromal Tumor,0.8482,Benign Ovarian Sex Cord-Stromal Tumor,0.8364,Malignant Ovarian Sex Cord-Stromal Tumor,0.8329,"Ovarian Sex Cord-Stromal Tumor, Not Otherwise Specified",0.8325,Testicular Mixed Sex Cord-Stromal Tumor,0.7991,Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7600,Gonadal Myoid Stromal Tumor,0.7530,Uterine Corpus Tumor Resembling Ovarian Sex Cord Tumor,0.7505,Ovarian Sex Cord Tumor with Annular Tubules,0.7434,Stromal Neoplasm,0.7303,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,0.7269,Ovarian Stromal-Leydig Cell Tumor,0.7266,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7241,SEX CORD STROMAL TUMOR,True,True,True
SEX CORD-STROMAL TUMOUR,Sex Cord-Stromal Tumor,1,2,Sex Cord-Stromal Tumor,0.9963,Testicular Sex Cord-Stromal Tumor,0.9355,Ovarian Sex Cord-Stromal Tumor,0.9186,Malignant Sex Cord-Stromal Tumor,0.9110,Adrenal Cortical Sex Cord-Stromal Tumor,0.8975,"Testicular Sex Cord-Stromal Tumor, Not Otherwise Specified",0.8733,Malignant Testicular Sex Cord-Stromal Tumor,0.8612,"Ovarian Sex Cord-Stromal Tumor, Not Otherwise Specified",0.8465,Ovarian Stromal Tumor with Minor Sex Cord Elements,0.8416,Malignant Ovarian Sex Cord-Stromal Tumor,0.8311,Benign Ovarian Sex Cord-Stromal Tumor,0.8302,Testicular Mixed Sex Cord-Stromal Tumor,0.8093,Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7748,Uterine Corpus Tumor Resembling Ovarian Sex Cord Tumor,0.7545,Ovarian Sex Cord Tumor with Annular Tubules,0.7426,Gonadal Myoid Stromal Tumor,0.7377,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7332,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,0.7317,Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7256,Testicular Signet Ring Stromal Tumor,0.7216,SEX CORD-STROMAL TUMOUR,True,True,True
SEZARY SYNDROME,Sezary Syndrome,1,2,Sezary Syndrome,1.0000,Recurrent Sezary Syndrome,0.8756,Refractory Sezary Syndrome,0.8117,Mycosis Fungoides and Sezary Syndrome,0.6983,Recurrent Mycosis Fungoides and Sezary Syndrome,0.6861,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6422,Refractory Mycosis Fungoides and Sezary Syndrome,0.6380,Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6337,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6325,Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6246,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6170,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6157,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6157,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7,0.6024,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6016,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8,0.5989,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7,0.5972,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8,0.5922,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7,0.5893,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8,0.5852,SEZARY SYNDROME,True,True,True
SEZARY_SYNDROME,Sezary Syndrome,1,2,Sezary Syndrome,0.9756,Recurrent Sezary Syndrome,0.8566,Refractory Sezary Syndrome,0.8007,Mycosis Fungoides and Sezary Syndrome,0.7017,Recurrent Mycosis Fungoides and Sezary Syndrome,0.6963,Refractory Mycosis Fungoides and Sezary Syndrome,0.6588,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6499,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6461,Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6422,Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6398,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6291,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6267,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6204,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7,0.6179,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6114,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6084,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7,0.6036,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7,0.6033,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6027,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6008,SEZARY_SYNDROME,True,True,True
SIGNET RING CELL CARCINOMA OF THE STOMACH,Gastric Signet Ring Cell Adenocarcinoma,1,2,Gastric Signet Ring Cell Adenocarcinoma,0.9163,Signet Ring Cell Adenocarcinoma,0.8382,Colon Signet Ring Cell Adenocarcinoma,0.8012,Small Intestinal Signet Ring Cell Adenocarcinoma,0.7981,Colorectal Signet Ring Cell Adenocarcinoma,0.7936,Lung Signet Ring Cell Carcinoma,0.7821,Rectal Signet Ring Cell Adenocarcinoma,0.7785,Gallbladder Signet Ring Cell Adenocarcinoma,0.7749,Pancreatic Signet Ring Cell Adenocarcinoma,0.7732,Rectosigmoid Signet Ring Cell Adenocarcinoma,0.7678,Signet Ring Cell/Histiocytoid Carcinoma,0.7542,Appendix Signet Ring Cell Adenocarcinoma,0.7507,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell-Type",0.7490,Ovarian Signet Ring Cell Adenocarcinoma,0.7372,Breast Signet Ring Cell Adenocarcinoma,0.7349,Metastatic Signet Ring Cell Adenocarcinoma,0.7339,Bladder Signet Ring Cell Adenocarcinoma,0.7172,Signet Ring Melanoma,0.7079,"Thyroid Gland Follicular Carcinoma, Signet Ring Cell Variant",0.7075,High Grade Mucinous Carcinoma Peritonei with Signet Ring Cells,0.7055,SIGNET RING CELL CARCINOMA OF THE STOMACH,True,True,True
SIGNET RING CELL TYPE OF THE APPENDIX,Appendix Signet Ring Cell Adenocarcinoma,1,2,Appendix Signet Ring Cell Adenocarcinoma,0.9076,Signet Ring Cell Adenocarcinoma,0.8593,Colon Signet Ring Cell Adenocarcinoma,0.8125,Colorectal Signet Ring Cell Adenocarcinoma,0.8058,Pancreatic Signet Ring Cell Adenocarcinoma,0.7910,Signet Ring Melanoma,0.7902,Small Intestinal Signet Ring Cell Adenocarcinoma,0.7883,Metastatic Signet Ring Cell Adenocarcinoma,0.7731,Lung Signet Ring Cell Carcinoma,0.7724,Rectal Signet Ring Cell Adenocarcinoma,0.7645,Gastric Signet Ring Cell Adenocarcinoma,0.7635,Signet Ring Cell/Histiocytoid Carcinoma,0.7542,Ovarian Signet Ring Cell Adenocarcinoma,0.7511,Rectosigmoid Signet Ring Cell Adenocarcinoma,0.7457,Ampulla of Vater Signet Ring Cell Adenocarcinoma,0.7434,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell-Type",0.7419,Prostate Acinar Signet Ring Cell-Like Adenocarcinoma,0.7350,Gallbladder Signet Ring Cell Adenocarcinoma,0.7300,High Grade Mucinous Carcinoma Peritonei with Signet Ring Cells,0.7290,Thyroid Gland Signet Ring Cell Follicular Adenoma,0.7254,SIGNET RING CELL TYPE OF THE APPENDIX,True,True,True
SINONASAL ADENOCARCINOMA,Sinonasal Adenocarcinoma,1,2,Sinonasal Adenocarcinoma,1.0000,Sinonasal Carcinoma,0.9024,Paranasal Sinus Adenocarcinoma,0.8421,"Sinonasal Adenocarcinoma, Non-Intestinal-Type",0.8344,Nasal Cavity Adenocarcinoma,0.8223,"Sinonasal Adenocarcinoma, Non-Salivary-Type",0.8205,Malignant Sinonasal Neoplasm,0.8096,"Sinonasal Adenocarcinoma, Intestinal-Type",0.8088,Maxillary Sinus Adenocarcinoma,0.8072,Sinonasal Squamous Cell Carcinoma,0.8036,Sinonasal Neoplasm,0.8036,Sinonasal Poorly Differentiated Carcinoma,0.8018,SMARCB1-Deficient Sinonasal Adenocarcinoma,0.7894,"Sinonasal Adenocarcinoma, Salivary-Type",0.7866,Sinonasal Sarcoma,0.7806,Sinonasal Undifferentiated Carcinoma,0.7730,Sinonasal Lymphoma,0.7631,Sinonasal Ameloblastoma,0.7627,Locally Advanced Sinonasal Carcinoma,0.7605,Metastatic Sinonasal Carcinoma,0.7602,SINONASAL ADENOCARCINOMA,True,True,True
SINONASAL SQUAMOUS CELL CARCINOMA,Sinonasal Squamous Cell Carcinoma,1,2,Sinonasal Squamous Cell Carcinoma,1.0000,Sinonasal Spindle Cell Squamous Carcinoma,0.9310,Sinonasal Carcinoma,0.8964,Sinonasal Non-Keratinizing Squamous Cell Carcinoma,0.8754,Nasal Cavity Squamous Cell Carcinoma,0.8434,Sinonasal Undifferentiated Carcinoma,0.8413,Sinonasal Keratinizing Squamous Cell Carcinoma,0.8326,Sinonasal Poorly Differentiated Carcinoma,0.8259,Sinonasal Neuroendocrine Carcinoma,0.8229,Paranasal Sinus Squamous Cell Carcinoma,0.8169,Metastatic Sinonasal Squamous Cell Carcinoma,0.8143,Sinonasal Small Cell Neuroendocrine Carcinoma,0.8141,Sinonasal Adenocarcinoma,0.8036,Locally Advanced Sinonasal Squamous Cell Carcinoma,0.7935,SWI/SNF Complex-Deficient Sinonasal Carcinoma,0.7802,Maxillary Sinus Squamous Cell Carcinoma,0.7787,Unresectable Sinonasal Squamous Cell Carcinoma,0.7764,Nasopharyngeal Squamous Cell Carcinoma,0.7760,Sinonasal Sarcoma,0.7741,Metastatic Sinonasal Carcinoma,0.7719,SINONASAL SQUAMOUS CELL CARCINOMA,True,True,True
SINONASAL UNDIFFERENTIATED CARCINOMA,Sinonasal Undifferentiated Carcinoma,1,2,Sinonasal Undifferentiated Carcinoma,1.0000,Sinonasal Carcinoma,0.8696,Sinonasal Neuroendocrine Carcinoma,0.8580,Sinonasal Squamous Cell Carcinoma,0.8413,Sinonasal Poorly Differentiated Carcinoma,0.8299,Nasopharyngeal Undifferentiated Carcinoma,0.8146,Sinonasal Small Cell Neuroendocrine Carcinoma,0.8145,Sinonasal Spindle Cell Squamous Carcinoma,0.7900,Sinonasal Large Cell Neuroendocrine Carcinoma,0.7774,Sinonasal Undifferentiated Pleomorphic Sarcoma,0.7773,Locally Advanced Sinonasal Carcinoma,0.7765,Sinonasal NUT Carcinoma,0.7764,Undifferentiated Carcinoma,0.7756,Sinonasal Adenocarcinoma,0.7730,Sinonasal Sarcoma,0.7707,Metastatic Sinonasal Carcinoma,0.7700,Sinonasal Non-Keratinizing Squamous Cell Carcinoma,0.7696,SWI/SNF Complex-Deficient Sinonasal Carcinoma,0.7610,Sinonasal Lymphoepithelial Carcinoma,0.7604,Unresectable Sinonasal Squamous Cell Carcinoma,0.7487,SINONASAL UNDIFFERENTIATED CARCINOMA,True,True,True
SKCM,Cutaneous Melanoma,1,2,Cutaneous Melanoma,1.0000,Dermal Melanoma,0.9082,Melanoma,0.8940,Non-Cutaneous Melanoma,0.8348,Ocular Melanoma,0.8171,Cutaneous Melanocytic Neoplasm,0.8168,Childhood Cutaneous Melanoma,0.7994,Mucosal Melanoma,0.7951,Invasive Cutaneous Melanoma,0.7902,Corneal Melanoma,0.7876,Metastatic Cutaneous Melanoma,0.7812,Uveal Melanoma,0.7809,Cutaneous Melanoma of the Extremity,0.7788,Acral Melanoma,0.7765,Retinal Melanoma,0.7712,Melanocytic Neoplasm,0.7691,Lentigo Maligna Melanoma,0.7675,Conjunctival Melanoma,0.7661,Childhood Melanoma,0.7591,Choroid Melanoma,0.7561,Cutaneous Melanoma,True,True,True
SKIN CANCER,Malignant Skin Neoplasm,3,2,Skin Carcinoma,0.9450,Skin Neoplasm,0.8813,Malignant Skin Neoplasm,0.8795,Skin Epithelial Neoplasm,0.7891,Skin Squamous Cell Carcinoma,0.7842,Childhood Malignant Skin Neoplasm,0.7639,Cutaneous Lymphoma,0.7549,Skin Sarcoma,0.7482,Unresectable Skin Carcinoma,0.7481,Stage 0 Skin Cancer,0.7461,Childhood Skin Neoplasm,0.7446,Early Stage Malignant Skin Neoplasm,0.7358,Advanced Malignant Skin Neoplasm,0.7343,Metastatic Carcinoma in the Skin,0.7309,Dermal Neoplasm,0.7295,Malignant Dermal Neoplasm,0.7271,Benign Skin Neoplasm,0.7223,Cutaneous Melanoma,0.7207,Metastatic Malignant Skin Neoplasm,0.7040,Skin Vascular Neoplasm,0.7030,SKIN CANCER,False,True,True
"SKIN CANCER, NON-MELANOMA",Skin Carcinoma,2,2,Non-Cutaneous Melanoma,0.7896,Skin Carcinoma,0.7471,Stage 0 Skin Cancer,0.7362,Skin Neoplasm,0.7321,Malignant Skin Neoplasm,0.7248,Non-Malignant Neoplasm,0.7238,Benign Skin Neoplasm,0.6930,Non-Hematologic Malignancy,0.6875,Unresectable Skin Carcinoma,0.6543,Cutaneous Melanoma,0.6520,Childhood Malignant Skin Neoplasm,0.6424,Skin Epithelial Neoplasm,0.6423,Metastatic Malignant Neoplasm in the Skin,0.6352,Skin Squamous Cell Carcinoma,0.6317,Early Stage Malignant Skin Neoplasm,0.6295,Benign Skin Epithelial Neoplasm,0.6281,Skin Sarcoma,0.6252,Metastatic Malignant Skin Neoplasm,0.6250,Childhood Skin Neoplasm,0.6243,Cutaneous Melanocytic Neoplasm,0.6216,"SKIN CANCER, NON-MELANOMA",False,True,True
SKIN_CANCER,Malignant Skin Neoplasm,3,2,Skin Carcinoma,0.8840,Skin Neoplasm,0.8409,Malignant Skin Neoplasm,0.8403,Skin Epithelial Neoplasm,0.7523,Unresectable Skin Carcinoma,0.7408,Skin Squamous Cell Carcinoma,0.7312,Stage 0 Skin Cancer,0.7299,Childhood Malignant Skin Neoplasm,0.7236,Cutaneous Lymphoma,0.7199,Skin Sarcoma,0.7198,Metastatic Carcinoma in the Skin,0.7159,Childhood Skin Neoplasm,0.7051,Metastatic Malignant Neoplasm in the Skin,0.6964,Early Stage Malignant Skin Neoplasm,0.6945,Advanced Malignant Skin Neoplasm,0.6923,Benign Skin Neoplasm,0.6914,Malignant Dermal Neoplasm,0.6911,Dermal Neoplasm,0.6886,Malignant Mixed Tumor of the Skin,0.6868,Cutaneous Melanoma,0.6854,SKIN_CANCER,False,True,True
SKIN_SQUAMOUS,Skin Squamous Cell Carcinoma,1,2,Skin Squamous Cell Carcinoma,0.7652,Squamous Cell Neoplasm,0.7644,Benign Squamous Cell Neoplasm,0.7326,Squamous Cell Carcinoma,0.7256,Skin Carcinoma,0.7151,Skin Epithelial Neoplasm,0.7015,Malignant Skin Neoplasm,0.6902,Benign Skin Epithelial Neoplasm,0.6881,Squamous Papilloma,0.6728,Skin Neoplasm,0.6692,Skin Adenosquamous Carcinoma,0.6690,Skin Squamous Cell Carcinoma In Situ,0.6678,Advanced Skin Squamous Cell Carcinoma,0.6621,Skin Sarcoma,0.6580,Stage 0 Squamous Cell Carcinoma,0.6516,Benign Skin Neoplasm,0.6470,Skin Acantholytic Squamous Cell Carcinoma,0.6470,Stage 0 Skin Cancer,0.6444,Squamous Papillomatosis,0.6395,Carcinoma Simplex,0.6348,SKIN_SQUAMOUS,True,True,True
SMALL BOWEL ADENOCARCINOMA,Small Intestinal Adenocarcinoma,1,2,Small Intestinal Adenocarcinoma,0.9539,Small Intestinal Carcinoma,0.8544,Small Intestinal Mucinous Adenocarcinoma,0.8330,Metastatic Small Intestinal Adenocarcinoma,0.8277,Small Intestinal Adenoma,0.8144,Malignant Small Intestinal Neoplasm,0.7983,Intestinal-Type Adenocarcinoma,0.7932,Colorectal Adenocarcinoma,0.7753,Unresectable Small Intestinal Adenocarcinoma,0.7700,Advanced Malignant Small Intestinal Neoplasm,0.7698,Locally Advanced Small Intestinal Adenocarcinoma,0.7693,Small Intestinal Neoplasm,0.7645,Colon Adenocarcinoma,0.7561,Small Intestinal Tubular Adenoma,0.7529,Small Intestinal Adenocarcinoma by AJCC v8 Stage,0.7523,Metastatic Small Intestinal Carcinoma,0.7494,Small Cell Adenocarcinoma,0.7477,Inflammatory Bowel Disease-Associated Colorectal Adenocarcinoma,0.7462,Jejunal Adenocarcinoma,0.7444,Small Intestinal Squamous Cell Carcinoma,0.7401,SMALL BOWEL ADENOCARCINOMA,True,True,True
SMALL BOWEL CANCER,Small Intestinal Carcinoma,1,2,Small Intestinal Carcinoma,0.9009,Small Intestinal Neoplasm,0.8466,Small Intestinal Adenocarcinoma,0.8441,Malignant Small Intestinal Neoplasm,0.8406,Childhood Small Intestinal Carcinoma,0.7921,Metastatic Small Intestinal Carcinoma,0.7731,Childhood Malignant Small Intestinal Neoplasm,0.7598,Small Intestinal Adenoma,0.7461,Advanced Malignant Small Intestinal Neoplasm,0.7455,Metastatic Malignant Small Intestinal Neoplasm,0.7438,Metastatic Small Intestinal Adenocarcinoma,0.7433,Small Intestinal Squamous Cell Carcinoma,0.7416,Small Intestinal Lymphoma,0.7410,Small Intestinal Medullary Carcinoma,0.7410,Small Intestinal Undifferentiated Carcinoma,0.7375,Benign Small Intestinal Neoplasm,0.7368,Small Intestinal Neuroendocrine Carcinoma,0.7327,Metastatic Malignant Neoplasm in the Small Intestine,0.7284,Intestinal Neoplasm,0.7189,Unresectable Small Intestinal Carcinoma,0.7112,SMALL BOWEL CANCER,True,True,True
SMALL BOWEL CARCINOMA,Small Intestinal Carcinoma,1,2,Small Intestinal Carcinoma,0.9352,Small Intestinal Adenocarcinoma,0.8705,Childhood Small Intestinal Carcinoma,0.8133,Malignant Small Intestinal Neoplasm,0.8109,Metastatic Small Intestinal Carcinoma,0.8064,Small Intestinal Squamous Cell Carcinoma,0.8056,Small Intestinal Neoplasm,0.7924,Small Intestinal Medullary Carcinoma,0.7918,Small Intestinal Undifferentiated Carcinoma,0.7839,Small Intestinal Neuroendocrine Carcinoma,0.7652,Metastatic Small Intestinal Adenocarcinoma,0.7636,Unresectable Small Intestinal Carcinoma,0.7497,Colorectal Carcinoma,0.7470,Small Intestinal Mucinous Adenocarcinoma,0.7438,Small Intestinal Small Cell Neuroendocrine Carcinoma,0.7370,Advanced Malignant Small Intestinal Neoplasm,0.7348,Small Intestinal Adenoma,0.7335,Locally Advanced Small Intestinal Carcinoma,0.7309,Metastatic Malignant Small Intestinal Neoplasm,0.7274,Childhood Malignant Small Intestinal Neoplasm,0.7265,SMALL BOWEL CARCINOMA,True,True,True
SMALL BOWEL NEUROENDOCRINE TUMOR,Small Intestinal Neuroendocrine Neoplasm,2,2,Small Intestinal Neuroendocrine Tumor,0.9335,Small Intestinal Neuroendocrine Neoplasm,0.9053,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,0.8628,Intestinal Neuroendocrine Tumor,0.8352,Small Intestinal Neuroendocrine Tumor G1,0.8210,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,0.8208,Intestinal Neuroendocrine Neoplasm,0.8103,Small Intestinal Neuroendocrine Carcinoma,0.8040,Jejunal Neuroendocrine Tumor,0.8030,Small Intestinal Neuroendocrine Tumor G2,0.7964,Colorectal Neuroendocrine Tumor,0.7921,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0.7855,Midgut Neuroendocrine Tumor,0.7824,Ileal Neuroendocrine Tumor,0.7777,Small Intestinal VIP-Producing Neuroendocrine Tumor,0.7767,Jejunal Somatostatin-Producing Neuroendocrine Tumor,0.7710,Small Intestinal Small Cell Neuroendocrine Carcinoma,0.7706,Small Intestinal Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor,0.7660,Small Intestinal Gastrointestinal Stromal Tumor,0.7615,Colon Neuroendocrine Tumor,0.7614,SMALL BOWEL NEUROENDOCRINE TUMOR,False,True,True
SMALL CELL BLADDER CANCER,Bladder Small Cell Neuroendocrine Carcinoma,1,2,Bladder Small Cell Neuroendocrine Carcinoma,0.8817,Bladder Urothelial Carcinoma,0.7757,Metastatic Bladder Small Cell Neuroendocrine Carcinoma,0.7685,Bladder Carcinoma,0.7660,Bladder Neuroendocrine Carcinoma,0.7652,Bladder Squamous Cell Carcinoma,0.7641,Locally Advanced Bladder Small Cell Neuroendocrine Carcinoma,0.7571,Bladder Large Cell Neuroendocrine Carcinoma,0.7541,Unresectable Bladder Small Cell Neuroendocrine Carcinoma,0.7464,Bladder Clear Cell Adenocarcinoma,0.7429,Early Stage Bladder Urothelial Carcinoma,0.7394,Urothelial Carcinoma,0.7279,Bladder Adenocarcinoma,0.7226,Bladder Flat Urothelial Carcinoma,0.7168,Invasive Bladder Microcystic Urothelial Carcinoma,0.7088,Transitional Cell Carcinoma,0.7052,Non-Muscle Invasive Bladder Carcinoma,0.7027,Refractory Bladder Small Cell Neuroendocrine Carcinoma,0.7017,Muscle Invasive Bladder Carcinoma,0.6972,"Bladder Urothelial Carcinoma, High Grade",0.6946,SMALL CELL BLADDER CANCER,True,True,True
SMALL CELL BRONCHIOALVEOLAR CARCINOMA,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.7461,Bronchogenic Carcinoma,0.7143,"Lung Small Cell Carcinoma, A Subtype",0.7137,Lung Non-Small Cell Carcinoma,0.7048,Lung Small Cell Carcinoma Molecular Subtypes,0.6966,Small Cell Adenocarcinoma,0.6886,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.6879,Occult Lung Small Cell Carcinoma,0.6869,Lung Adenosquamous Carcinoma,0.6839,Childhood Lung Small Cell Carcinoma,0.6810,Advanced Lung Small Cell Carcinoma,0.6784,Lung Adenoid Cystic Carcinoma,0.6758,Occult Lung Adenosquamous Carcinoma,0.6716,Breast Small Cell Neuroendocrine Carcinoma,0.6703,Advanced Bronchogenic Carcinoma,0.6702,Breast Acinic Cell Carcinoma,0.6663,Lung Carcinoma,0.6652,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.6589,Bladder Small Cell Neuroendocrine Carcinoma,0.6576,Lung Non-Small Cell Squamous Carcinoma,0.6564,SMALL CELL BRONCHIOALVEOLAR CARCINOMA,True,True,True
SMALL CELL CARCINOMA,Small Cell Neuroendocrine Carcinoma,5,2,Small Cell Adenocarcinoma,0.9128,"Malignant Tumor, Small Cell Type",0.8611,Lung Small Cell Carcinoma,0.8388,Small Cell Intermediate Cell Carcinoma,0.8361,Small Cell Neuroendocrine Carcinoma,0.8334,Non-Small Cell Carcinoma,0.8315,Ovarian Small Cell Carcinoma,0.7986,"Lung Small Cell Carcinoma, A Subtype",0.7752,Non-Small Cell Adenocarcinoma,0.7714,Lung Small Cell Carcinoma Molecular Subtypes,0.7575,Small Cell Sarcoma,0.7514,Small Intestinal Small Cell Neuroendocrine Carcinoma,0.7512,Small Intestinal Carcinoma,0.7397,Micropapillary Carcinoma,0.7395,Kidney Small Cell Neuroendocrine Carcinoma,0.7369,Occult Lung Small Cell Carcinoma,0.7325,Small Intestinal Undifferentiated Carcinoma,0.7311,Non-Keratinizing Small Cell Squamous Cell Carcinoma,0.7295,Minor Salivary Gland Small Cell Neuroendocrine Carcinoma,0.7262,"Lung Small Cell Carcinoma, I Subtype",0.7260,SMALL CELL CARCINOMA,False,False,True
SMALL CELL CARCINOMA OF  GALLBLADDER,Gallbladder Small Cell Neuroendocrine Carcinoma,1,2,Gallbladder Small Cell Neuroendocrine Carcinoma,0.8925,Gallbladder Squamous Cell Carcinoma,0.7988,Gallbladder Undifferentiated Carcinoma,0.7764,Gallbladder Carcinoma,0.7760,Gallbladder Neuroendocrine Carcinoma,0.7720,Gallbladder Large Cell Neuroendocrine Carcinoma,0.7709,Localized Gallbladder Carcinoma,0.7672,Gallbladder Clear Cell Adenocarcinoma,0.7664,Gallbladder Goblet Cell Adenocarcinoma,0.7608,"Gallbladder Adenocarcinoma, Intestinal-Type",0.7353,"Gallbladder Adenocarcinoma, Biliary Type",0.7257,Gallbladder Adenocarcinoma,0.7251,Gallbladder Adenosquamous Carcinoma,0.7242,Gallbladder Carcinosarcoma,0.7222,Metastatic Gallbladder Carcinoma,0.7151,Gastric Small Cell Neuroendocrine Carcinoma,0.7144,Gallbladder Sarcomatoid Carcinoma,0.7127,Gallbladder Signet Ring Cell Adenocarcinoma,0.6996,Gallbladder Mucinous Adenocarcinoma,0.6961,Advanced Gallbladder Carcinoma,0.6958,SMALL CELL CARCINOMA OF  GALLBLADDER,True,True,True
SMALL CELL CARCINOMA OF THE CERVIX,Cervical Small Cell Neuroendocrine Carcinoma,1,2,Cervical Small Cell Neuroendocrine Carcinoma,0.7902,Small Cell Adenocarcinoma,0.7407,Cervical Squamous Cell Carcinoma,0.7407,Small Cell Intermediate Cell Carcinoma,0.7099,Ovarian Small Cell Carcinoma,0.6953,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.6866,Lung Small Cell Carcinoma,0.6864,Non-Small Cell Carcinoma,0.6818,Microinvasive Cervical Squamous Cell Carcinoma,0.6785,Cervical Non-Keratinizing Squamous Cell Carcinoma,0.6745,Small Cell Neuroendocrine Carcinoma,0.6720,"Malignant Tumor, Small Cell Type",0.6687,Cervical Undifferentiated Carcinoma,0.6664,Minor Salivary Gland Small Cell Neuroendocrine Carcinoma,0.6656,Small Intestinal Small Cell Neuroendocrine Carcinoma,0.6630,Cervical Carcinoma,0.6619,Non-Keratinizing Small Cell Squamous Cell Carcinoma,0.6609,Cervical Micropapillary Adenocarcinoma,0.6485,Cervical Esophagus Squamous Cell Carcinoma,0.6472,Salivary Gland Small Cell Neuroendocrine Carcinoma,0.6460,SMALL CELL CARCINOMA OF THE CERVIX,True,True,True
SMALL CELL CARCINOMA OF THE OVARY,Ovarian Small Cell Carcinoma,1,2,Ovarian Small Cell Carcinoma,0.9534,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.8187,"Ovarian Small Cell Carcinoma, Pulmonary-Type",0.7730,Ovarian Squamous Cell Carcinoma,0.7522,"Childhood Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.7474,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.7339,Ovarian Carcinoma,0.7195,Small Cell Adenocarcinoma,0.7167,Ovarian Undifferentiated Carcinoma,0.7027,Ovarian Transitional Cell Carcinoma,0.7021,Ovarian Large Cell Neuroendocrine Carcinoma,0.6749,Ovarian Clear Cell Adenocarcinoma,0.6657,Ovarian Neuroendocrine Carcinoma,0.6578,Ovarian Clear Cell Tumor,0.6565,Small Cell Osteosarcoma,0.6524,Ovarian Adenocarcinoma,0.6510,Lung Small Cell Carcinoma,0.6496,"Malignant Tumor, Small Cell Type",0.6431,Metastatic Ovarian Carcinoma,0.6389,Small Cell Intermediate Cell Carcinoma,0.6363,SMALL CELL CARCINOMA OF THE OVARY,True,True,True
SMALL CELL CARCINOMA OF THE OVARY HYPERCALCEMIC TYPE SCCOHT,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",1,2,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.8977,"Childhood Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.8684,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",0.8454,Ovarian Small Cell Carcinoma,0.7559,Ovarian Squamous Cell Carcinoma,0.6491,Ovarian Undifferentiated Carcinoma,0.6305,Hereditary Ovarian Carcinoma,0.6277,"Ovarian Small Cell Carcinoma, Pulmonary-Type",0.6256,Small Cell Osteosarcoma,0.6169,Ovarian High Grade Serous Adenocarcinoma,0.6163,Well Differentiated Ovarian Steroid Cell Tumor,0.6038,Ovarian Carcinosarcoma,0.5953,Ovarian Clear Cell Tumor,0.5931,Metastatic Ovarian Undifferentiated Carcinoma,0.5913,Ovarian Neuroendocrine Carcinoma,0.5911,Metastatic Microsatellite Stable Ovarian Carcinoma,0.5900,Metastatic Ovarian High Grade Serous Adenocarcinoma,0.5894,Ovarian Carcinoma,0.5876,Microsatellite Stable Ovarian Carcinoma,0.5870,Oropharyngeal Small Cell Neuroendocrine Carcinoma,0.5858,SMALL CELL CARCINOMA OF THE OVARY HYPERCALCEMIC TYPE SCCOHT,True,True,True
SMALL CELL CARCINOMA OF THE STOMACH,Gastric Small Cell Neuroendocrine Carcinoma,1,2,Gastric Small Cell Neuroendocrine Carcinoma,0.8531,Gastric Squamous Cell Carcinoma,0.7761,Advanced Gastric Small Cell Neuroendocrine Carcinoma,0.7644,Small Cell Adenocarcinoma,0.7430,Digestive System Small Cell Neuroendocrine Carcinoma,0.7229,Minor Salivary Gland Small Cell Neuroendocrine Carcinoma,0.7183,Gastric Undifferentiated Carcinoma,0.7050,Salivary Gland Small Cell Neuroendocrine Carcinoma,0.7043,Small Cell Neuroendocrine Carcinoma,0.6982,Gastric Poorly Cohesive Adenocarcinoma,0.6973,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,0.6933,Gastric Neuroendocrine Carcinoma,0.6922,Small Intestinal Small Cell Neuroendocrine Carcinoma,0.6917,Gastric Carcinoma,0.6882,Gastric Large Cell Neuroendocrine Carcinoma,0.6860,Gastric Cardia Squamous Cell Carcinoma,0.6765,Colorectal Small Cell Neuroendocrine Carcinoma,0.6686,Non-Small Cell Carcinoma,0.6642,Gallbladder Small Cell Neuroendocrine Carcinoma,0.6636,Colon Small Cell Neuroendocrine Carcinoma,0.6623,SMALL CELL CARCINOMA OF THE STOMACH,True,True,True
SMALL CELL CARCINOMA OF UNKNOWN PRIMARY,Small Cell Neuroendocrine Carcinoma,15,2,Squamous Cell Carcinoma of Unknown Primary,0.8979,Undifferentiated Carcinoma of Unknown Primary,0.8357,Carcinoma of Unknown Primary,0.8239,Neck Squamous Cell Carcinoma of Unknown Primary,0.8028,Neuroendocrine Carcinoma of Unknown Primary,0.7766,Locally Advanced Squamous Cell Carcinoma of Unknown Primary,0.7469,Adenocarcinoma of Unknown Primary,0.7185,Occult Lung Small Cell Carcinoma,0.7120,Head and Neck Carcinoma of Unknown Primary,0.6959,Advanced Carcinoma Of Unknown Primary,0.6865,Melanoma of Unknown Primary,0.6861,Resectable Carcinoma of Unknown Primary,0.6834,Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary,0.6631,Human Papillomavirus-Negative Neck Squamous Cell Carcinoma of Unknown Primary,0.6615,Small Cell Neuroendocrine Carcinoma,0.6572,Occult Lung Squamous Cell Carcinoma,0.6564,Malignant Neoplasm of Unknown Primary,0.6539,Ureter Small Cell Neuroendocrine Carcinoma,0.6490,"Small Cell Carcinoma, Fusiform Cell Type",0.6431,Non-Small Cell Carcinoma,0.6418,SMALL CELL CARCINOMA OF UNKNOWN PRIMARY,False,False,False
SMALL CELL LUNG CANCER,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.9592,"Lung Small Cell Carcinoma, A Subtype",0.9013,Lung Small Cell Carcinoma Molecular Subtypes,0.8675,Occult Lung Small Cell Carcinoma,0.8666,Lung Non-Small Cell Carcinoma,0.8437,Advanced Lung Small Cell Carcinoma,0.8338,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.8330,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.8212,Childhood Lung Small Cell Carcinoma,0.8167,"Lung Small Cell Carcinoma, I Subtype",0.8099,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.8083,"Lung Small Cell Carcinoma, N Subtype",0.8073,Limited Stage Lung Small Cell Carcinoma,0.8064,"Lung Small Cell Carcinoma, Neuroendocrine-Low Subtype",0.8059,Lung Small Cell Carcinoma by AJCC v7 Stage,0.8019,"Lung Small Cell Carcinoma, P Subtype",0.8008,Combined Lung Small Cell and Squamous Cell Carcinoma,0.7948,Locally Advanced Lung Small Cell Carcinoma,0.7909,Combined Lung Small Cell Carcinoma,0.7905,Metastatic Lung Small Cell Carcinoma,0.7866,SMALL CELL LUNG CANCER,True,True,True
SMALL CELL LUNG CANCER SCLC,Lung Small Cell Carcinoma,1,2,Lung Small Cell Carcinoma,0.8624,"Lung Small Cell Carcinoma, A Subtype",0.8399,"Lung Small Cell Carcinoma, Neuroendocrine-Low Subtype",0.8288,Lung Small Cell Carcinoma Neuroendocrine Subtypes,0.7971,Lung Small Cell Carcinoma Molecular Subtypes,0.7966,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.7959,Limited Stage Lung Small Cell Carcinoma,0.7948,"Lung Small Cell Carcinoma, I Subtype",0.7916,Occult Lung Small Cell Carcinoma,0.7843,"Lung Small Cell Carcinoma, P Subtype",0.7731,"Lung Small Cell Carcinoma, N Subtype",0.7676,Advanced Lung Small Cell Carcinoma,0.7647,Lung Non-Small Cell Carcinoma,0.7615,"Lung Small Cell Carcinoma, Neuroendocrine-High Subtype",0.7555,Childhood Lung Small Cell Carcinoma,0.7521,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,0.7513,Locally Advanced Lung Small Cell Carcinoma,0.7393,Lung Small Cell Carcinoma by AJCC v7 Stage,0.7378,Combined Lung Small Cell and Squamous Cell Carcinoma,0.7254,Laryngeal Small Cell Neuroendocrine Carcinoma,0.7222,SMALL CELL LUNG CANCER SCLC,True,True,True
SMALL CELL NEUROENDOCRINE CARCINOMA OF GALLBLADDER,Gallbladder Small Cell Neuroendocrine Carcinoma,1,2,Gallbladder Small Cell Neuroendocrine Carcinoma,0.9815,Gallbladder Neuroendocrine Carcinoma,0.9027,Gallbladder Large Cell Neuroendocrine Carcinoma,0.8839,Gallbladder Neuroendocrine Tumor G2,0.7970,Gallbladder Neuroendocrine Neoplasm,0.7964,Gastric Small Cell Neuroendocrine Carcinoma,0.7946,Gallbladder Neuroendocrine Tumor,0.7927,Gallbladder Neuroendocrine Tumor G3,0.7867,Gallbladder Squamous Cell Carcinoma,0.7838,Gallbladder Undifferentiated Carcinoma,0.7832,Bladder Small Cell Neuroendocrine Carcinoma,0.7782,Gallbladder Neuroendocrine Tumor G1,0.7522,Small Cell Neuroendocrine Carcinoma,0.7506,Extrahepatic Bile Duct Small Cell Neuroendocrine Carcinoma,0.7481,Gallbladder Carcinosarcoma,0.7460,Gallbladder Mixed Adenoneuroendocrine Carcinoma,0.7453,Gallbladder Carcinoma,0.7436,Breast Small Cell Neuroendocrine Carcinoma,0.7424,Localized Gallbladder Carcinoma,0.7380,Gallbladder Clear Cell Adenocarcinoma,0.7370,SMALL CELL NEUROENDOCRINE CARCINOMA OF GALLBLADDER,True,True,True
SMALL CELL OSTEOSARCOMA,Small Cell Osteosarcoma,1,2,Small Cell Osteosarcoma,1.0000,Conventional Osteosarcoma,0.8367,Low Grade Osteosarcoma,0.8344,Osteosarcoma,0.8277,Bone Osteosarcoma,0.8027,Localized Osteosarcoma,0.7976,Osteoblastic Osteosarcoma,0.7970,Secondary Osteosarcoma,0.7954,Small Cell Sarcoma,0.7800,Fibroblastic Osteosarcoma,0.7786,Extraskeletal Osteosarcoma,0.7708,Metastatic Osteosarcoma,0.7671,Mixed Osteosarcoma,0.7560,Primary Bone Osteosarcoma,0.7537,Localized Extraskeletal Osteosarcoma,0.7483,Low Grade Central Osteosarcoma,0.7446,Childhood Conventional Osteosarcoma,0.7419,High Grade Osteosarcoma,0.7418,Intermediate Grade Osteosarcoma,0.7415,Jaw Osteosarcoma,0.7402,SMALL CELL OSTEOSARCOMA,True,True,True
SMALL INTESTINAL CARCINOMA,Small Intestinal Carcinoma,1,2,Small Intestinal Carcinoma,1.0000,Small Intestinal Adenocarcinoma,0.9140,Small Intestinal Squamous Cell Carcinoma,0.8840,Childhood Small Intestinal Carcinoma,0.8835,Small Intestinal Undifferentiated Carcinoma,0.8588,Metastatic Small Intestinal Carcinoma,0.8540,Malignant Small Intestinal Neoplasm,0.8491,Small Intestinal Medullary Carcinoma,0.8467,Small Intestinal Neoplasm,0.8409,Small Intestinal Neuroendocrine Carcinoma,0.8372,Small Intestinal Small Cell Neuroendocrine Carcinoma,0.8106,Unresectable Small Intestinal Carcinoma,0.8061,Locally Advanced Small Intestinal Carcinoma,0.7966,Small Intestinal Lymphoma,0.7913,Metastatic Small Intestinal Adenocarcinoma,0.7892,Small Intestinal Adenoma,0.7861,Childhood Malignant Small Intestinal Neoplasm,0.7781,Small Intestinal Mucinous Adenocarcinoma,0.7760,Small Intestinal Sarcoma,0.7683,Resectable Small Intestinal Carcinoma,0.7643,SMALL INTESTINAL CARCINOMA,True,True,True
SMALL ROUND BLUE CELL TUMOR,Desmoplastic Small Round Cell Tumor,2,2,Small Cell Neuroendocrine Carcinoma,0.6967,Desmoplastic Small Round Cell Tumor,0.6831,EWSR1-Negative Small Round Cell Tumor,0.6676,Undifferentiated Round Cell Sarcoma,0.6676,"Malignant Tumor, Small Cell Type",0.6573,Microcystic/Reticular Schwannoma,0.6506,Adult Desmoplastic Small Round Cell Tumor,0.6475,Breast Small Cell Neuroendocrine Carcinoma,0.6408,Bladder Small Cell Neuroendocrine Carcinoma,0.6403,Unresectable Desmoplastic Small Round Cell Tumor,0.6395,Childhood Desmoplastic Small Round Cell Tumor,0.6366,Kidney Small Cell Neuroendocrine Carcinoma,0.6362,Round Cell Liposarcoma,0.6357,Glassy Cell Carcinoma,0.6320,Crooke Cell Tumor,0.6317,Small Cell Intermediate Cell Carcinoma,0.6296,Retinocytoma,0.6285,Refractory Desmoplastic Small Round Cell Tumor,0.6267,Gastric Small Cell Neuroendocrine Carcinoma,0.6250,Cribriform Neuroepithelial Tumor,0.6221,SMALL ROUND BLUE CELL TUMOR,False,True,True
SMALL_CELL_ADENOCARCINOMA,Small Cell Adenocarcinoma,1,2,Small Cell Adenocarcinoma,0.9399,Non-Small Cell Adenocarcinoma,0.8492,"Malignant Tumor, Small Cell Type",0.7818,Non-Small Cell Carcinoma,0.7466,Adenocarcinoma,0.7343,Small Intestinal Adenocarcinoma,0.7220,Small Cell Neuroendocrine Carcinoma,0.7126,Acinar Cell Carcinoma,0.7094,Small Cell Intermediate Cell Carcinoma,0.7060,"Lung Small Cell Carcinoma, A Subtype",0.7014,Clear Cell Adenocarcinoma,0.6927,Micropapillary Carcinoma,0.6915,Lung Small Cell Carcinoma,0.6885,Cervical Micropapillary Adenocarcinoma,0.6867,Minor Salivary Gland Acinic Cell Carcinoma,0.6863,Water-Clear Cell Adenocarcinoma,0.6860,Ovarian Small Cell Carcinoma,0.6853,Metastatic Adenocarcinoma,0.6833,Mixed Cell Adenocarcinoma,0.6799,Diffuse Type Adenocarcinoma,0.6775,SMALL_CELL_ADENOCARCINOMA,True,True,True
SMALL_CELL_CARCINOMA,Small Cell Neuroendocrine Carcinoma,4,2,Small Cell Adenocarcinoma,0.8488,"Malignant Tumor, Small Cell Type",0.8424,Non-Small Cell Carcinoma,0.8247,Small Cell Neuroendocrine Carcinoma,0.7995,Small Cell Intermediate Cell Carcinoma,0.7874,Lung Small Cell Carcinoma,0.7840,Ovarian Small Cell Carcinoma,0.7509,Non-Small Cell Adenocarcinoma,0.7421,"Lung Small Cell Carcinoma, A Subtype",0.7416,Lung Small Cell Carcinoma Molecular Subtypes,0.7290,Small Intestinal Small Cell Neuroendocrine Carcinoma,0.7277,Non-Keratinizing Small Cell Squamous Cell Carcinoma,0.7203,Small Cell Sarcoma,0.7191,Micropapillary Carcinoma,0.7109,Small Intestinal Undifferentiated Carcinoma,0.7069,Small Intestinal Carcinoma,0.7057,Cervical Small Cell Neuroendocrine Carcinoma,0.6998,Occult Lung Small Cell Carcinoma,0.6974,Sinonasal Small Cell Neuroendocrine Carcinoma,0.6971,Kidney Small Cell Neuroendocrine Carcinoma,0.6967,SMALL_CELL_CARCINOMA,False,False,True
SMOLDERING MYELOMA,Smoldering Multiple Myeloma,1,2,Smoldering Multiple Myeloma,0.9765,Smoldering Systemic Mastocytosis,0.8249,Multiple Myeloma,0.7858,Non-Secretory Multiple Myeloma,0.7707,"Multiple Myeloma, Not Otherwise Specified",0.7508,Multiple Myeloma Myeloma by DS Stage,0.7348,Osteosclerotic Multiple Myeloma,0.7295,Smoldering Waldenstrom Macroglobulinemia,0.7248,Recurrent Multiple Myeloma,0.7180,Refractory Multiple Myeloma,0.7159,Multiple Myeloma by ISS Stage,0.6813,Multiple Myeloma with Recurrent Genetic Abnormalities,0.6737,Multiple Solitary Plasmacytoma of Bone,0.6598,Solitary Plasmacytoma,0.6540,DS Stage I Multiple Myeloma,0.6500,Plasma Cell Myeloma-Induced Bone Disease,0.6486,Multiple Myeloma with NSD2 Translocation,0.6443,Extramedullary Disease in Multiple Myeloma,0.6406,"IgM Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Type",0.6372,ISS Stage I Multiple Myeloma,0.6294,SMOLDERING MYELOMA,True,True,True
"SOFT TISSUE CANCER, NOS",Malignant Soft Tissue Neoplasm,2,2,Soft Tissue Neoplasm,0.8906,Malignant Soft Tissue Neoplasm,0.8690,Skin Soft Tissue Neoplasm,0.8410,Connective and Soft Tissue Neoplasm,0.8197,Soft Tissue Sarcoma,0.8034,Digestive System Soft Tissue Neoplasm,0.7672,Benign Soft Tissue Neoplasm,0.7577,Metastatic Malignant Neoplasm in the Soft Tissue,0.7543,Cervical Soft Tissue Neoplasm,0.7543,Connective and Soft Tissue Neoplasm by Obsolete Classification,0.7493,Soft Tissue Neoplasm of Uncertain Differentiation,0.7427,Malignant Soft Tissue Neoplasm of Uncertain Differentiation,0.7405,Head and Neck Soft Tissue Neoplasm,0.7396,Malignant Head and Neck Soft Tissue Neoplasm,0.7311,Intestinal Soft Tissue Neoplasm,0.7276,Soft Tissue Fibrosarcoma,0.7262,Lung Soft Tissue Neoplasm,0.7240,Benign Connective and Soft Tissue Neoplasm,0.7224,Gastric Soft Tissue Neoplasm,0.7190,Breast Soft Tissue Neoplasm,0.7122,"SOFT TISSUE CANCER, NOS",False,True,True
SOFT TISSUE MYOEPITHELIAL CARCINOMA,Malignant Myoepithelioma,6,2,Salivary Gland Myoepithelial Carcinoma,0.8006,Myoepithelial Tumor,0.7865,Epithelial-Myoepithelial Carcinoma,0.7711,Salivary Gland Epithelial-Myoepithelial Carcinoma,0.7551,Salivary Gland Myoepithelial Tumor,0.7516,Malignant Myoepithelioma,0.7160,Skin Myoepithelioma,0.7147,Smooth Muscle Tumor of Uncertain Malignant Potential,0.7126,Mixed Endometrial Stromal and Smooth Muscle Neoplasm,0.7123,Sarcomatoid Carcinoma,0.7093,Breast Myoepithelial Tumor,0.7092,Malignant Soft Tissue Neoplasm,0.7062,Soft Tissue Sarcoma,0.7049,Skin Syncytial Myoepithelioma,0.6960,Lung Myoepithelial Carcinoma,0.6912,Salivary Gland Myoepithelioma,0.6866,Benign Myoepithelioma,0.6862,Skin Soft Tissue Neoplasm,0.6845,Soft Tissue Neoplasm,0.6827,Malignant Soft Tissue Neoplasm of Uncertain Differentiation,0.6824,SOFT TISSUE MYOEPITHELIAL CARCINOMA,False,False,False
SOFT TISSUE SARCOMA,Soft Tissue Sarcoma,1,2,Soft Tissue Sarcoma,1.0000,Adult Soft Tissue Sarcoma,0.8780,Localized Soft Tissue Sarcoma,0.8603,Malignant Soft Tissue Neoplasm,0.8590,Soft Tissue Neoplasm,0.8533,Undifferentiated Soft Tissue Sarcoma,0.8325,Advanced Soft Tissue Sarcoma,0.8290,Metastatic Soft Tissue Sarcoma,0.8250,Soft Tissue Fibrosarcoma,0.8237,Childhood Soft Tissue Sarcoma,0.8208,Sarcoma,0.8181,Skin Soft Tissue Neoplasm,0.8023,Bone Sarcoma,0.7951,Soft Tissue Sarcoma of the Trunk and Extremities,0.7937,Metastatic Malignant Neoplasm in the Soft Tissue,0.7806,Benign Soft Tissue Neoplasm,0.7795,Stromal Sarcoma,0.7740,Malignant Soft Tissue Neoplasm of Uncertain Differentiation,0.7654,Soft Tissue Sarcoma by AJCC v8 Stage,0.7555,Low Grade Sarcoma,0.7553,SOFT TISSUE SARCOMA,True,True,True
SOFT TISSUE SARCOMA OTHER,Soft Tissue Sarcoma,1,2,Soft Tissue Sarcoma,0.8921,Adult Soft Tissue Sarcoma,0.8198,Metastatic Soft Tissue Sarcoma,0.8056,Advanced Soft Tissue Sarcoma,0.7992,Soft Tissue Neoplasm,0.7965,Undifferentiated Soft Tissue Sarcoma,0.7942,Malignant Soft Tissue Neoplasm,0.7868,Soft Tissue Sarcoma of the Trunk and Extremities,0.7792,Localized Soft Tissue Sarcoma,0.7657,Unresectable Soft Tissue Sarcoma,0.7635,Skin Soft Tissue Neoplasm,0.7533,Metastatic Malignant Neoplasm in the Soft Tissue,0.7503,Soft Tissue Neoplasm of Uncertain Differentiation,0.7455,Malignant Soft Tissue Neoplasm of Uncertain Differentiation,0.7430,Childhood Soft Tissue Sarcoma,0.7388,Sarcoma,0.7307,Soft Tissue Fibrosarcoma,0.7268,Digestive System Soft Tissue Neoplasm,0.7235,Soft Tissue Sarcoma by AJCC v8 Stage,0.7231,Metastatic Adult Soft Tissue Sarcoma,0.7157,SOFT TISSUE SARCOMA OTHER,True,True,True
SOFT TISSUE TUMOR,Soft Tissue Neoplasm,1,2,Soft Tissue Neoplasm,0.9798,Skin Soft Tissue Neoplasm,0.8853,Benign Soft Tissue Neoplasm,0.8795,Malignant Soft Tissue Neoplasm,0.8620,Connective and Soft Tissue Neoplasm,0.8605,Soft Tissue Sarcoma,0.8602,Soft Tissue Neoplasm of Uncertain Differentiation,0.8283,Soft Tissue Fibrosarcoma,0.8246,Digestive System Soft Tissue Neoplasm,0.8083,Lung Soft Tissue Neoplasm,0.8066,Breast Soft Tissue Neoplasm,0.8030,Benign Connective and Soft Tissue Neoplasm,0.8012,Intestinal Soft Tissue Neoplasm,0.7996,Cervical Soft Tissue Neoplasm,0.7969,Benign Soft Tissue Neoplasm of Uncertain Differentiation,0.7874,Head and Neck Soft Tissue Neoplasm,0.7771,Gastric Soft Tissue Neoplasm,0.7752,Intermediate Soft Tissue Neoplasm,0.7710,Sinonasal Soft Tissue Neoplasm,0.7614,Malignant Soft Tissue Neoplasm of Uncertain Differentiation,0.7564,SOFT TISSUE TUMOR,True,True,True
SOLID ADENOCARCINOMA 82303,Solid Lung Adenocarcinoma,7,2,Solid Carcinoma,0.6519,Adenocarcinoma,0.6291,Serous Adenocarcinoma,0.6253,Mucinous Adenocarcinoma,0.6093,Salivary Gland Mucinous Adenocarcinoma,0.6079,Scirrhous Adenocarcinoma,0.6057,Solid Lung Adenocarcinoma,0.6045,Mucin-Producing Adenocarcinoma,0.6026,Tubular Adenocarcinoma,0.6019,Cervical Serous Adenocarcinoma,0.6006,Malignant Solid Neoplasm,0.5939,Cervical Mucinous Adenocarcinoma,0.5918,Advanced Adenocarcinoma,0.5905,Trabecular Adenocarcinoma,0.5884,Salivary Gland Adenocarcinoma,0.5878,Serous Cystadenocarcinoma,0.5825,Carcinoma,0.5823,Breast Adenocarcinoma,0.5817,Endometrial Serous Adenocarcinoma,0.5804,Mucin-Producing Carcinoma,0.5799,SOLID ADENOCARCINOMA 82303,False,False,False
SOLID PAPILLARY CARCINOMA OF THE BREAST,Breast Solid Papillary Carcinoma,1,2,Breast Solid Papillary Carcinoma,0.9610,Invasive Breast Solid Papillary Carcinoma,0.9184,Breast Papillary Carcinoma,0.8344,Breast Solid Papillary Carcinoma In Situ,0.8269,Invasive Breast Papillary Carcinoma,0.7990,Breast Intracystic Papillary Carcinoma,0.7730,Breast Solid Neuroendocrine Carcinoma,0.7504,Encapsulated Breast Papillary Carcinoma,0.7360,Breast Papillary Neoplasm,0.7051,Encapsulated Breast Papillary Carcinoma with Invasion,0.7006,Invasive Breast Micropapillary Carcinoma,0.6982,"Breast Ductal Carcinoma In Situ, Solid Type",0.6865,"Invasive Breast Lobular Carcinoma, Solid Variant",0.6851,Papillary Carcinoma,0.6803,Sporadic Breast Carcinoma,0.6791,Breast Adenoid Cystic Carcinoma,0.6768,Breast Papillary Ductal Carcinoma In Situ,0.6745,Breast Sebaceous Carcinoma,0.6721,"Prostate Ductal Adenocarcinoma, Solid Pattern",0.6704,Solid Carcinoma,0.6701,SOLID PAPILLARY CARCINOMA OF THE BREAST,True,True,True
SOLID PSEUDOPAPILLARY NEOPLASM OF THE PANCREAS,Solid Pseudopapillary Neoplasm of the Pancreas,1,2,Solid Pseudopapillary Neoplasm of the Pancreas,1.0000,Solid Pseudopapillary Neoplasm,0.9028,Childhood Solid Pseudopapillary Neoplasm of the Pancreas,0.8929,Solid Pseudopapillary Carcinoma of the Pancreas,0.8783,Solid Pseudopapillary Neoplasm of the Ovary,0.8037,Pancreatic Serous Neoplasm,0.6756,Pancreatic Intraductal Tubulopapillary Neoplasm,0.6695,"Prostate Ductal Adenocarcinoma, Solid Pattern",0.6649,Pancreatic Signet Ring Cell Adenocarcinoma,0.6534,Pancreatic Cystic Neoplasm,0.6432,Pancreatic Mucinous-Cystic Neoplasm,0.6430,Pancreatic Solid Serous Microcystic Adenoma,0.6428,Pancreatic Polypeptide Tumor,0.6378,Pancreatic Somatostatin-Producing Neuroendocrine Tumor,0.6360,Pancreatic Serous Cystadenocarcinoma,0.6328,Pancreatic Intraductal Papillary-Mucinous Neoplasm,0.6312,Pancreatic Colloid Carcinoma,0.6282,Pancreatic Neuroendocrine Neoplasm,0.6278,Pancreatic Serous Cystadenoma,0.6274,Benign Pancreatic Serous Neoplasm,0.6225,SOLID PSEUDOPAPILLARY NEOPLASM OF THE PANCREAS,True,True,True
SOLITARY FIBROUS TUMOR,Solitary Fibrous Tumor,1,2,Solitary Fibrous Tumor,1.0000,Kidney Solitary Fibrous Tumor,0.8903,Malignant Solitary Fibrous Tumor,0.8737,Sinonasal Solitary Fibrous Tumor,0.8722,Thyroid Gland Solitary Fibrous Tumor,0.8567,Central Nervous System Solitary Fibrous Tumor,0.8465,Prostate Solitary Fibrous Tumor,0.8417,Pleural Solitary Fibrous Tumor,0.8416,Pericardial Solitary Fibrous Tumor,0.8338,Sellar Solitary Fibrous Tumor,0.8275,Bladder Solitary Fibrous Tumor,0.8254,Liver Solitary Fibrous Tumor,0.8252,Peritoneal Solitary Fibrous Tumor,0.8250,Orbital Solitary Fibrous Tumor,0.8238,Meningeal Solitary Fibrous Tumor,0.8216,Mediastinal Solitary Fibrous Tumor,0.8207,Thymus Solitary Fibrous Tumor,0.8125,Refractory Solitary Fibrous Tumor,0.8050,Digestive System Solitary Fibrous Tumor,0.8020,"Central Nervous System Solitary Fibrous Tumor, Grade 1",0.7959,SOLITARY FIBROUS TUMOR,True,True,True
SOLITARY FIBROUS TUMOR OF THE CENTRAL NERVOUS SYSTEM,Central Nervous System Solitary Fibrous Tumor,1,2,Central Nervous System Solitary Fibrous Tumor,0.9719,"Central Nervous System Solitary Fibrous Tumor, Grade 1",0.8634,"Central Nervous System Solitary Fibrous Tumor, Grade 2",0.8128,Solitary Fibrous Tumor,0.8115,"Central Nervous System Solitary Fibrous Tumor, Grade 3",0.8113,Meningeal Solitary Fibrous Tumor,0.7864,Central Nervous System Dedifferentiated Solitary Fibrous Tumor,0.7860,"Adult Central Nervous System Solitary Fibrous Tumor, Grade 3",0.7791,Sinonasal Solitary Fibrous Tumor,0.7776,Optic Nerve Sheath Solitary Fibrous Tumor,0.7725,Kidney Solitary Fibrous Tumor,0.7613,Sellar Solitary Fibrous Tumor,0.7423,"Meningeal Central Nervous System Solitary Fibrous Tumor, Grade 3",0.7338,Central Nervous System Myofibroblastoma,0.7197,Central Nervous System Fibrosarcoma,0.7162,Refractory Solitary Fibrous Tumor,0.7110,Prostate Solitary Fibrous Tumor,0.7091,Malignant Solitary Fibrous Tumor,0.7070,Mediastinal Solitary Fibrous Tumor,0.7012,Pericardial Solitary Fibrous Tumor,0.6983,SOLITARY FIBROUS TUMOR OF THE CENTRAL NERVOUS SYSTEM,True,True,True
SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA,Solitary Fibrous Tumor,1,2,Solitary Fibrous Tumor,0.8409,Hemangiopericytoma,0.8348,Benign Hemangiopericytoma,0.8215,Conventional Malignant Hemangiopericytoma,0.7815,Peritoneal Solitary Fibrous Tumor,0.7764,Kidney Solitary Fibrous Tumor,0.7715,Infantile Hemangiopericytoma,0.7699,Pericardial Solitary Fibrous Tumor,0.7680,Hemangiopericytic Neoplasm,0.7633,Malignant Hemangiopericytoma,0.7630,Well Differentiated Malignant Hemangiopericytoma,0.7627,Malignant Solitary Fibrous Tumor,0.7625,Primary Malignant Hemangiopericytoma,0.7618,Pleural Solitary Fibrous Tumor,0.7539,Lipomatous Hemangiopericytoma,0.7537,Skin Hemangiopericytoma,0.7515,Malignant Adult Hemangiopericytoma,0.7441,Sinonasal Solitary Fibrous Tumor,0.7423,Benign Kidney Hemangiopericytoma,0.7414,Central Nervous System Solitary Fibrous Tumor,0.7375,SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA,True,True,True
SOMATOSTATINOMA,Somatostatin-Producing Neuroendocrine Tumor,3,2,Pancreatic Somatostatinoma,0.9271,Malignant Somatostatinoma,0.9050,Somatostatin-Producing Neuroendocrine Tumor,0.8443,Malignant Pancreatic Somatostatinoma,0.8299,Pancreatic Somatostatin-Producing Neuroendocrine Tumor,0.7866,Duodenal Somatostatin-Producing Neuroendocrine Tumor,0.7478,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,0.7477,Pancreatic Glucagonoma,0.7140,Pancreatic Insulinoma,0.7033,Islet Cell Adenoma,0.7024,Jejunal Somatostatin-Producing Neuroendocrine Tumor,0.6974,Enteroglucagonoma,0.6911,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,0.6900,Pancreatic Gastrinoma,0.6893,Pancreatic Serotonin-Producing Neuroendocrine Tumor,0.6828,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0.6827,Somatotroph Pituitary Neuroendocrine Tumor,0.6826,Neuroendocrine Tumor,0.6811,Pancreatic Delta Cell Adenoma,0.6790,Pancreatic Delta Cell Neuroendocrine Tumor,0.6742,SOMATOSTATINOMA,False,True,True
SPECIFIC DX AT ACQUISITION MDSMPN,Myelodysplastic/Myeloproliferative Neoplasm,99,2,De Novo Myelodysplastic Syndrome,0.5604,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.5536,Myelodysplastic Syndrome with Genetic Abnormalities,0.5397,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.5384,Alkylating Agent-Related Myelodysplastic Syndrome,0.5373,Adult Myelodysplastic Syndrome,0.5335,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.5322,Myelodysplastic Syndrome with Somatic Mutation,0.5306,Myeloid Leukemia Associated with Down Syndrome,0.5298,DS Stage IA Multiple Myeloma,0.5268,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.5176,Transient Abnormal Myelopoiesis Associated with Down Syndrome,0.5167,Oligometastatic Pancreatic Ductal Adenocarcinoma,0.5103,"Diffuse Astrocytoma, MYB-Altered",0.5102,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0.5101,Central Nervous System SMARCB1/INI1-Deficient Tumor,0.5093,Digital Papillary Adenocarcinoma,0.5065,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.5059,"Diffuse Astrocytoma, MYBL1-Altered",0.5056,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.5050,SPECIFIC DX AT ACQUISITION MDSMPN,False,False,False
SPECIFIC_DX_AT_ACQUISITION_MDSMPN,Myelodysplastic/Myeloproliferative Neoplasm,99,2,"Myelodysplastic Syndrome/Acute Myeloid Leukemia, Not Otherwise Specified",0.5539,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,0.5466,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.5356,Myelodysplastic Syndrome/Acute Myeloid Leukemia,0.5342,Alkylating Agent-Related Myelodysplastic Syndrome,0.5315,Transient Abnormal Myelopoiesis Associated with Down Syndrome,0.5229,Myelodysplastic Syndrome with Somatic Mutation,0.5210,Myelodysplastic Syndrome with Genetic Abnormalities,0.5188,De Novo Myelodysplastic Syndrome,0.5181,DS Stage IA Multiple Myeloma,0.5098,Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome,0.5076,Myeloid Leukemia Associated with Down Syndrome,0.5075,Adult Myelodysplastic Syndrome,0.5018,Deletion of the Short Arm of Chromosome 1 (1p) Associated Meningioma,0.5001,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.4957,Multiple Myeloma with NSD2 Translocation,0.4941,Central Nervous System SMARCB1/INI1-Deficient Tumor,0.4896,Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.4883,Advanced Malignant Mesothelioma,0.4880,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0.4862,SPECIFIC_DX_AT_ACQUISITION_MDSMPN,False,False,False
SPINDLE CELL,Spindle Cell Neoplasm,1,2,Spindle Cell Neoplasm,0.8863,Malignant Spindle Cell Neoplasm,0.8196,Spindle Cell Sarcoma,0.8190,Spindle Cell Squamous Carcinoma,0.8052,Spindle Cell Melanoma,0.7836,Spindle Cell Nevus,0.7478,Spindle Cell Hemangioma,0.7334,Undifferentiated Spindle Cell Sarcoma,0.7303,Skin Spindle Cell Squamous Cell Carcinoma,0.7222,Spindle Cell Synovial Sarcoma,0.7167,Spindle Cell Oncocytoma,0.7004,Type A Spindle Cell Melanoma,0.6932,Lung Spindle Cell Carcinoma,0.6920,Esophageal Spindle Cell Carcinoma,0.6898,Conjunctival Spindle Cell Carcinoma,0.6862,Adenocarcinoma with Spindle Cell Metaplasia,0.6799,Gingival Spindle Cell Carcinoma,0.6668,Ciliary Body Spindle Cell Melanoma,0.6667,Spindle Cell Lipoma,0.6650,Spindle Cell Type Gastrointestinal Stromal Tumor,0.6648,SPINDLE CELL,True,True,True
SPINDLE CELL CARCINOMA OF THE LUNG,Lung Spindle Cell Carcinoma,1,2,Lung Spindle Cell Carcinoma,0.9664,Lung Squamous Cell Carcinoma,0.7916,Lung Sarcomatoid Carcinoma,0.7841,Spindle Cell Squamous Carcinoma,0.7653,Lung Non-Keratinizing Squamous Cell Carcinoma,0.7593,"Lung Squamous Cell Carcinoma, Small Cell Variant",0.7534,Lung Non-Small Cell Squamous Carcinoma,0.7491,"Lung Squamous Cell Carcinoma, Clear Cell Variant",0.7405,Lung Non-Small Cell Carcinoma,0.7388,Lung Pleomorphic Carcinoma,0.7373,"Lung Squamous Cell Carcinoma, Papillary Variant",0.7328,Lung Small Cell Carcinoma,0.7243,Lung Keratinizing Squamous Cell Carcinoma,0.7235,Laryngeal Spindle Cell Squamous Carcinoma,0.7228,Lung Non-Squamous Non-Small Cell Carcinoma,0.7107,Lung Hyalinizing Clear Cell Carcinoma,0.7073,"Lung Small Cell Carcinoma, A Subtype",0.7045,Superior Sulcus Lung Carcinoma,0.6934,Conjunctival Spindle Cell Carcinoma,0.6909,Lung Carcinoma,0.6888,SPINDLE CELL CARCINOMA OF THE LUNG,True,True,True
SPINDLE CELL RHABDOMYOSARCOMA,Spindle Cell Rhabdomyosarcoma,1,2,Spindle Cell Rhabdomyosarcoma,1.0000,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.9143,Childhood Spindle Cell Rhabdomyosarcoma,0.8877,Rhabdomyosarcoma,0.8533,Sclerosing Rhabdomyosarcoma,0.8480,Spindle Cell Sarcoma,0.8058,Pleomorphic Rhabdomyosarcoma,0.8055,Adult Rhabdomyosarcoma,0.7979,Metastatic Rhabdomyosarcoma,0.7778,Childhood Rhabdomyosarcoma,0.7699,Cardiac Rhabdomyosarcoma,0.7639,Adult Pleomorphic Rhabdomyosarcoma,0.7580,Undifferentiated Spindle Cell Sarcoma,0.7552,MYOD1-Mutant Spindle Cell/Sclerosing Rhabdomyosarcoma,0.7467,Undifferentiated Round Cell Sarcoma,0.7441,Refractory Rhabdomyosarcoma,0.7395,Spindle Cell Synovial Sarcoma,0.7388,Embryonal Rhabdomyosarcoma,0.7360,Kidney Rhabdomyosarcoma,0.7356,Sinonasal Rhabdomyosarcoma,0.7318,SPINDLE CELL RHABDOMYOSARCOMA,True,True,True
SPINDLE CELL SARCOMA,Spindle Cell Sarcoma,1,2,Spindle Cell Sarcoma,1.0000,Spindle Cell Synovial Sarcoma,0.8980,Undifferentiated Spindle Cell Sarcoma,0.8882,Spindle Cell Neoplasm,0.8485,Malignant Spindle Cell Neoplasm,0.8382,Spindle Cell Squamous Carcinoma,0.8304,Spindle Cell Rhabdomyosarcoma,0.8058,Stromal Sarcoma,0.7807,Sarcoma,0.7783,Small Cell Sarcoma,0.7759,Skin Spindle Cell Squamous Cell Carcinoma,0.7713,Spindle Cell Hemangioma,0.7656,Spindle Cell Melanoma,0.7649,Refractory Spindle Cell Sarcoma,0.7570,Fibrous Synovial Sarcoma,0.7510,Undifferentiated Stromal Sarcoma,0.7495,Spindle Cell/Sclerosing Rhabdomyosarcoma,0.7486,Sarcomatoid Carcinoma,0.7468,Synovial Sarcoma,0.7444,Spindle Cell Lipoma,0.7406,SPINDLE CELL SARCOMA,True,True,True
SPINDLE CELL/SCLEROSING RHABDOMYOSARCOMA,Spindle Cell/Sclerosing Rhabdomyosarcoma,1,2,Spindle Cell/Sclerosing Rhabdomyosarcoma,1.0000,Sclerosing Rhabdomyosarcoma,0.9284,Spindle Cell Rhabdomyosarcoma,0.9143,Childhood Spindle Cell Rhabdomyosarcoma,0.8095,MYOD1-Mutant Spindle Cell/Sclerosing Rhabdomyosarcoma,0.7967,Rhabdomyosarcoma,0.7838,Adult Rhabdomyosarcoma,0.7539,Spindle Cell Sarcoma,0.7486,Pleomorphic Rhabdomyosarcoma,0.7486,Metastatic Rhabdomyosarcoma,0.7459,Adult Pleomorphic Rhabdomyosarcoma,0.7264,Refractory Spindle Cell Sarcoma,0.7255,Undifferentiated Round Cell Sarcoma,0.7172,Refractory Rhabdomyosarcoma,0.7153,Undifferentiated Spindle Cell Sarcoma,0.7120,Sinonasal Rhabdomyosarcoma,0.7068,Spindle Cell Synovial Sarcoma,0.7049,Embryonal Rhabdomyosarcoma,0.7020,Childhood Rhabdomyosarcoma,0.7007,Unresectable Rhabdomyosarcoma,0.6963,SPINDLE CELL/SCLEROSING RHABDOMYOSARCOMA,True,True,True
SPITZOID MELANOMA,Cutaneous Spitz Melanoma,1,2,Cutaneous Spitz Melanoma,0.9117,Cutaneous Spitz Melanocytoma,0.8228,Cutaneous Spitz Tumor,0.8161,Dermal Spitz Nevus,0.7649,Cutaneous Spitz Nevus,0.7642,Spindle Cell Melanoma,0.7264,Cutaneous Junctional Spitz Nevus,0.7061,Cutaneous Compound Spitz Nevus,0.6947,Melanocytic Matricoma,0.6871,Childhood Cutaneous Spitz Nevus,0.6773,Circumscribed Meningeal Melanocytic Neoplasm,0.6733,Nevoid Melanoma,0.6722,Cutaneous Desmoplastic Spitz Nevus,0.6709,Plexiform Spindle Cell Melanocytoma,0.6611,Type A Spindle Cell Melanoma,0.6374,Type B Spindle Cell Melanoma,0.6332,Low-CSD Melanoma,0.6320,Mixed Epithelioid and Spindle Cell Melanoma,0.6316,Conjunctival Spitz Nevus,0.6296,Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation,0.6253,SPITZOID MELANOMA,True,True,True
SQUAMOUS CELL CARCINOMA,Squamous Cell Carcinoma,1,2,Squamous Cell Carcinoma,1.0000,Squamous Cell Neoplasm,0.8854,Skin Squamous Cell Carcinoma,0.8544,Advanced Squamous Cell Carcinoma,0.8065,Spindle Cell Squamous Carcinoma,0.7788,Lung Squamous Cell Carcinoma,0.7723,Cervical Squamous Cell Carcinoma,0.7591,Papillary Squamous Cell Carcinoma,0.7427,"Squamous Cell Carcinoma, Clear Cell Type",0.7417,Prostate Squamous Cell Carcinoma,0.7396,Thymus Squamous Cell Carcinoma,0.7395,Endometrial Squamous Cell Carcinoma,0.7332,Acantholytic Squamous Cell Carcinoma,0.7331,Keratinizing Squamous Cell Carcinoma,0.7284,Colon Squamous Cell Carcinoma,0.7271,Metastatic Squamous Cell Carcinoma,0.7261,Corneal Squamous Cell Carcinoma,0.7243,Benign Squamous Cell Neoplasm,0.7230,Oral Cavity Squamous Cell Carcinoma,0.7218,Disseminated Squamous Cell Carcinoma,0.7211,SQUAMOUS CELL CARCINOMA,True,True,True
SQUAMOUS CELL CARCINOMA OF GALLBLADDER,Gallbladder Squamous Cell Carcinoma,1,2,Gallbladder Squamous Cell Carcinoma,0.9690,Gallbladder Adenosquamous Carcinoma,0.8043,Gallbladder Adenocarcinoma with Squamous Metaplasia,0.7809,Gallbladder Clear Cell Adenocarcinoma,0.7762,Gallbladder Carcinoma,0.7680,Gallbladder Goblet Cell Adenocarcinoma,0.7557,Gallbladder Small Cell Neuroendocrine Carcinoma,0.7462,Gallbladder Sarcomatoid Carcinoma,0.7419,Gallbladder Undifferentiated Carcinoma,0.7418,Gallbladder Neuroendocrine Carcinoma,0.7299,Gallbladder Adenocarcinoma,0.7156,Gallbladder Large Cell Neuroendocrine Carcinoma,0.7131,"Gallbladder Adenocarcinoma, Biliary Type",0.7101,Gallbladder Carcinosarcoma,0.7096,"Gallbladder Adenocarcinoma, Intestinal-Type",0.7017,Gallbladder Signet Ring Cell Adenocarcinoma,0.6928,Gallbladder Mucinous Adenocarcinoma,0.6907,Gallbladder Hepatoid Adenocarcinoma,0.6862,Gastric Squamous Cell Carcinoma,0.6810,Bladder Squamous Cell Carcinoma,0.6713,SQUAMOUS CELL CARCINOMA OF GALLBLADDER,True,True,True
SQUAMOUS CELL CARCINOMA OF THE VULVA/VAGINA,Vaginal Squamous Cell Carcinoma,3,2,Vulvar Squamous Cell Carcinoma,0.8812,"Vulvar Squamous Cell Carcinoma, Not Otherwise Specified",0.8280,Vaginal Squamous Cell Carcinoma,0.8109,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,0.7776,Vulvar Carcinoma,0.7671,Vulvar Keratinizing Squamous Cell Carcinoma,0.7516,Vulvar Non-Keratinizing Squamous Cell Carcinoma,0.7454,Vulvar Squamous Neoplasm,0.7449,"Vaginal Squamous Cell Carcinoma, Not Otherwise Specified",0.7441,Vulvar Basaloid Squamous Cell Carcinoma,0.7387,Advanced Vaginal Squamous Cell Carcinoma,0.7099,Metastatic Vulvar Squamous Cell Carcinoma,0.7077,Vulvar Warty Carcinoma,0.7054,Vulvar Verrucous Carcinoma,0.7038,Vulvar Sebaceous Carcinoma,0.7028,Vulvar Basal Cell Carcinoma,0.7025,Vulvar Neuroendocrine Carcinoma,0.7019,Vulvar Squamous Cell Carcinoma with Tumor Giant Cells,0.6999,Vulvar Merkel Cell Carcinoma,0.6986,Unresectable Vulvar Squamous Cell Carcinoma,0.6982,SQUAMOUS CELL CARCINOMA OF THE VULVA/VAGINA,False,True,True
"SQUAMOUS CELL CARCINOMA, BUCCAL MUCOSA",Buccal Mucosa Squamous Cell Carcinoma,1,2,Buccal Mucosa Squamous Cell Carcinoma,0.9676,Buccal Mucosa Verrucous Carcinoma,0.7358,Malignant Buccal Mucosa Neoplasm,0.7303,Oral Cavity Squamous Cell Carcinoma,0.7216,Floor of Mouth Basaloid Squamous Cell Carcinoma,0.6866,Submandibular Gland Squamous Cell Carcinoma,0.6817,Buccal Squamous Papilloma,0.6681,Buccal Mucosa Neoplasm,0.6644,Floor of Mouth Squamous Cell Carcinoma,0.6555,Benign Buccal Mucosa Neoplasm,0.6371,Minor Salivary Gland Squamous Cell Carcinoma,0.6353,Lower Alveolar Ridge Squamous Cell Carcinoma,0.6340,Gingival Squamous Cell Carcinoma,0.6334,Lower Gingival Squamous Cell Carcinoma,0.6300,Oropharyngeal Basaloid Squamous Cell Carcinoma,0.6242,Alveolar Ridge Squamous Cell Carcinoma,0.6219,Urethral Squamous Cell Carcinoma,0.6141,Salivary Gland Basal Cell Adenocarcinoma,0.6067,Submandibular Gland Carcinoma,0.6060,Salivary Gland Squamous Cell Carcinoma,0.6053,"SQUAMOUS CELL CARCINOMA, BUCCAL MUCOSA",True,True,True
"SQUAMOUS CELL CARCINOMA, HYPOPHARYNGEAL",Hypopharyngeal Squamous Cell Carcinoma,1,2,Hypopharyngeal Squamous Cell Carcinoma,0.9746,Hypopharyngeal Spindle Cell Squamous Carcinoma,0.9026,Hypopharyngeal Papillary Squamous Cell Carcinoma,0.8585,Hypopharyngeal Carcinoma,0.8425,Hypopharyngeal Basaloid Squamous Cell Carcinoma,0.8199,Advanced Hypopharyngeal Squamous Cell Carcinoma,0.8046,Metastatic Hypopharyngeal Squamous Cell Carcinoma,0.7750,Locally Advanced Hypopharyngeal Squamous Cell Carcinoma,0.7622,Hypopharyngeal Verrucous Carcinoma,0.7585,Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma,0.7176,Recurrent Hypopharyngeal Squamous Cell Carcinoma,0.7064,Refractory Hypopharyngeal Squamous Cell Carcinoma,0.6857,Unresectable Hypopharyngeal Squamous Cell Carcinoma,0.6795,Metastatic Hypopharyngeal Carcinoma,0.6780,Hypopharyngeal Neoplasm,0.6776,Hypopharyngeal Carcinoma by AJCC v6 Stage,0.6717,Head and Neck Squamous Cell Carcinoma,0.6712,Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7,0.6684,Stage II Hypopharyngeal Squamous Cell Carcinoma AJCC v6 and v7,0.6682,Locally Advanced Hypopharyngeal Carcinoma,0.6680,"SQUAMOUS CELL CARCINOMA, HYPOPHARYNGEAL",True,True,True
"SQUAMOUS CELL CARCINOMA, LARYNGEAL",Laryngeal Squamous Cell Carcinoma,1,2,Laryngeal Squamous Cell Carcinoma,0.9729,Laryngeal Spindle Cell Squamous Carcinoma,0.8422,Laryngeal Papillary Squamous Cell Carcinoma,0.8225,Locally Advanced Laryngeal Squamous Cell Carcinoma,0.8129,Advanced Laryngeal Squamous Cell Carcinoma,0.8095,Laryngeal Carcinoma,0.7900,Laryngeal Acantholytic Squamous Cell Carcinoma,0.7880,Lung Squamous Cell Carcinoma,0.7450,Laryngeal Adenosquamous Carcinoma,0.7437,Metastatic Laryngeal Squamous Cell Carcinoma,0.7433,Laryngeal Basaloid Squamous Cell Carcinoma,0.7380,Laryngeal Undifferentiated Carcinoma,0.7352,Supraglottic Squamous Cell Carcinoma,0.7324,Subglottic Squamous Cell Carcinoma,0.7282,Locally Recurrent Laryngeal Squamous Cell Carcinoma,0.7277,Unresectable Laryngeal Squamous Cell Carcinoma,0.7159,Laryngeal Neuroendocrine Carcinoma,0.7055,Laryngeal Small Cell Neuroendocrine Carcinoma,0.6976,Laryngeal Giant Cell Carcinoma,0.6972,Recurrent Laryngeal Squamous Cell Carcinoma,0.6969,"SQUAMOUS CELL CARCINOMA, LARYNGEAL",True,True,True
"SQUAMOUS CELL CARCINOMA, NOS",Squamous Cell Carcinoma,1,2,Squamous Cell Carcinoma,0.9491,Squamous Cell Neoplasm,0.8300,Skin Squamous Cell Carcinoma,0.8234,Advanced Squamous Cell Carcinoma,0.7762,"Squamous Cell Carcinoma, Clear Cell Type",0.7307,Lung Squamous Cell Carcinoma,0.7213,Spindle Cell Squamous Carcinoma,0.7187,Keratinizing Squamous Cell Carcinoma,0.7090,Cervical Squamous Cell Carcinoma,0.7027,Stage 0 Squamous Cell Carcinoma,0.6936,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.6899,Corneal Squamous Cell Carcinoma,0.6881,Advanced Skin Squamous Cell Carcinoma,0.6870,Prostate Squamous Cell Carcinoma,0.6861,Metastatic Squamous Cell Carcinoma,0.6848,Endometrial Squamous Cell Carcinoma,0.6821,Acantholytic Squamous Cell Carcinoma,0.6814,Papillary Squamous Cell Carcinoma,0.6813,Disseminated Squamous Cell Carcinoma,0.6810,Thymus Squamous Cell Carcinoma,0.6764,"SQUAMOUS CELL CARCINOMA, NOS",True,True,True
"SQUAMOUS CELL CARCINOMA, ORAL",Oral Cavity Squamous Cell Carcinoma,1,2,Oral Cavity Squamous Cell Carcinoma,0.9154,Oropharyngeal Squamous Cell Carcinoma,0.7807,Advanced Oral Cavity Squamous Cell Carcinoma,0.7667,Locally Advanced Oral Cavity Squamous Cell Carcinoma,0.7520,Squamous Cell Carcinoma,0.7483,Buccal Mucosa Squamous Cell Carcinoma,0.7465,Alveolar Ridge Squamous Cell Carcinoma,0.7295,Lip and Oral Cavity Squamous Cell Carcinoma,0.7108,Oral Cavity Carcinoma,0.7095,Tongue Squamous Cell Carcinoma,0.7047,Ovarian Squamous Cell Carcinoma,0.7037,Floor of Mouth Squamous Cell Carcinoma,0.6989,Gingival Squamous Cell Carcinoma,0.6983,Metastatic Oral Cavity Squamous Cell Carcinoma,0.6973,Palate Squamous Cell Carcinoma,0.6970,Unresectable Oral Cavity Squamous Cell Carcinoma,0.6957,Urethral Squamous Cell Carcinoma,0.6831,Oropharyngeal Keratinizing Squamous Cell Carcinoma,0.6816,Oral Squamous Papilloma,0.6812,Salivary Gland Squamous Cell Carcinoma,0.6773,"SQUAMOUS CELL CARCINOMA, ORAL",True,True,True
"SQUAMOUS CELL CARCINOMA, PHARYNX",Pharyngeal Squamous Cell Carcinoma,1,2,Pharyngeal Squamous Cell Carcinoma,0.8594,Hypopharyngeal Papillary Squamous Cell Carcinoma,0.7191,Hypopharyngeal Squamous Cell Carcinoma,0.7130,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0.7052,Pyriform Fossa Squamous Cell Carcinoma,0.6869,Pharyngeal Carcinoma,0.6848,Hypopharyngeal Spindle Cell Squamous Carcinoma,0.6815,Advanced Pharyngeal Squamous Cell Carcinoma,0.6681,Parotid Gland Squamous Cell Carcinoma,0.6611,Nasopharyngeal Squamous Cell Carcinoma,0.6548,Hard Palate Squamous Cell Carcinoma,0.6492,Penile Squamous Cell Carcinoma,0.6325,Oropharyngeal Squamous Cell Carcinoma,0.6324,Throat Carcinoma,0.6303,Paranasal Sinus Squamous Cell Carcinoma,0.6242,Squamous Cell Carcinoma,0.6201,Palate Squamous Cell Carcinoma,0.6114,Postcricoid Squamous Cell Carcinoma,0.6094,Gastric Squamous Cell Carcinoma,0.6069,Tonsillar Squamous Cell Carcinoma,0.6044,"SQUAMOUS CELL CARCINOMA, PHARYNX",True,True,True
"SQUAMOUS CELL CARCINOMA, SALIVARY GLAND",Salivary Gland Squamous Cell Carcinoma,1,2,Salivary Gland Squamous Cell Carcinoma,0.9772,Major Salivary Gland Squamous Cell Carcinoma,0.8725,Salivary Gland Poorly Differentiated Squamous Cell Carcinoma,0.8535,Salivary Gland Carcinoma,0.8172,Minor Salivary Gland Squamous Cell Carcinoma,0.8108,Submandibular Gland Squamous Cell Carcinoma,0.7931,Parotid Gland Squamous Cell Carcinoma,0.7869,Salivary Gland Clear Cell Carcinoma,0.7781,Metastatic Salivary Gland Squamous Cell Carcinoma,0.7771,Salivary Gland Secretory Carcinoma,0.7747,Salivary Gland Undifferentiated Carcinoma,0.7717,Salivary Gland Adenosquamous Carcinoma,0.7673,Salivary Gland Sebaceous Carcinoma,0.7546,Salivary Gland Low Grade Carcinoma,0.7492,Salivary Gland Acinic Cell Carcinoma,0.7441,Salivary Gland High Grade Carcinoma,0.7438,Salivary Gland Poorly Differentiated Carcinoma,0.7410,Gingival Squamous Cell Carcinoma,0.7379,Salivary Duct Carcinoma,0.7351,Tongue Squamous Cell Carcinoma,0.7345,"SQUAMOUS CELL CARCINOMA, SALIVARY GLAND",True,True,True
"SQUAMOUS CELL CARCINOMA, TONGUE",Tongue Squamous Cell Carcinoma,1,2,Tongue Squamous Cell Carcinoma,0.9630,Anterior Tongue Squamous Cell Carcinoma,0.8312,Tongue Carcinoma,0.8063,Posterior Tongue Squamous Cell Carcinoma,0.7655,Tongue Adenosquamous Carcinoma,0.7520,Salivary Gland Squamous Cell Carcinoma,0.7192,Anterior Tongue Carcinoma,0.7152,Tongue Sarcoma,0.7094,Gingival Squamous Cell Carcinoma,0.6990,Tongue Verrucous Carcinoma,0.6952,Malignant Tongue Neoplasm,0.6930,Supraglottic Squamous Cell Carcinoma,0.6864,Major Salivary Gland Squamous Cell Carcinoma,0.6827,Oral Cavity Squamous Cell Carcinoma,0.6760,Tongue Neoplasm,0.6734,Gastric Squamous Cell Carcinoma,0.6644,Subglottic Squamous Cell Carcinoma,0.6635,Sublingual Gland Carcinoma,0.6552,Posterior Tongue Carcinoma,0.6491,Lower Gingival Squamous Cell Carcinoma,0.6409,"SQUAMOUS CELL CARCINOMA, TONGUE",True,True,True
"SQUAMOUS CELL CARCINOMA, VULVAR",Vulvar Squamous Cell Carcinoma,1,2,Vulvar Squamous Cell Carcinoma,0.9677,"Vulvar Squamous Cell Carcinoma, Not Otherwise Specified",0.8819,Vulvar Keratinizing Squamous Cell Carcinoma,0.8607,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,0.8511,Vulvar Non-Keratinizing Squamous Cell Carcinoma,0.8457,Vulvar Carcinoma,0.8454,Vulvar Basaloid Squamous Cell Carcinoma,0.8385,Vulvar Squamous Neoplasm,0.8177,Metastatic Vulvar Squamous Cell Carcinoma,0.7970,Vulvar Verrucous Carcinoma,0.7960,Vulvar Sebaceous Carcinoma,0.7958,Vulvar Basal Cell Carcinoma,0.7912,Vulvar Neuroendocrine Carcinoma,0.7634,Vulvar Small Cell Neuroendocrine Carcinoma,0.7565,Vulvar Adenocarcinoma,0.7558,Vulvar Merkel Cell Carcinoma,0.7557,Vulvar Warty Carcinoma,0.7539,Recurrent Vulvar Squamous Cell Carcinoma,0.7507,Vaginal Squamous Cell Carcinoma,0.7477,Vulvar Large Cell Neuroendocrine Carcinoma,0.7459,"SQUAMOUS CELL CARCINOMA, VULVAR",True,True,True
SQUAMOUS_CELL_CARCINOMA,Squamous Cell Carcinoma,1,2,Squamous Cell Carcinoma,0.9384,Squamous Cell Neoplasm,0.8376,Skin Squamous Cell Carcinoma,0.8074,Advanced Squamous Cell Carcinoma,0.7523,Spindle Cell Squamous Carcinoma,0.7317,Carcinoma,0.7169,Cervical Squamous Cell Carcinoma,0.7133,Lung Squamous Cell Carcinoma,0.7085,Skin Carcinoma,0.7038,Oral Cavity Squamous Cell Carcinoma,0.7031,"Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0.7026,Endometrial Squamous Cell Carcinoma,0.7007,Stage 0 Squamous Cell Carcinoma,0.6975,Metastatic Squamous Cell Carcinoma,0.6965,"Squamous Cell Carcinoma, Clear Cell Type",0.6953,Papillary Squamous Cell Carcinoma,0.6950,Carcinoma Unspecified Site,0.6933,Benign Squamous Cell Neoplasm,0.6916,Acantholytic Squamous Cell Carcinoma,0.6881,Keratinizing Squamous Cell Carcinoma,0.6862,SQUAMOUS_CELL_CARCINOMA,True,True,True
ST-RELPOS,"Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive",99,2,Refractory Sarcoma,0.5755,Refractory Leiomyosarcoma,0.5734,Rectal Gastrointestinal Stromal Tumor,0.5701,Rectal Serrated Lesions and Polyps,0.5667,Refractory Solitary Fibrous Tumor,0.5662,Low Risk Gastrointestinal Stromal Tumor,0.5654,Microsatellite Stable Rectal Carcinoma,0.5635,Recurrent Gastrointestinal Stromal Tumor,0.5618,Refractory Small Lymphocytic Lymphoma,0.5615,Refractory Soft Tissue Sarcoma,0.5614,Retroperitoneal Gastrointestinal Stromal Tumor,0.5606,Refractory Microsatellite Stable Endometrial Carcinoma,0.5545,Recurrent Microsatellite Stable Colorectal Carcinoma,0.5544,Refractory Microsatellite Stable Colorectal Carcinoma,0.5530,Low Risk Small Intestinal Gastrointestinal Stromal Tumor,0.5495,Intermediate Risk Gastrointestinal Stromal Tumor,0.5489,High Risk Gastrointestinal Stromal Tumor,0.5459,Refractory Splenic Marginal Zone Lymphoma,0.5457,Refractory Malignant Gastrointestinal Stromal Tumor,0.5454,Recurrent Sarcoma,0.5454,ST-RELPOS,False,False,False
ST-YAP,Supratentorial Ependymoma YAP1 Fusion-Positive,99,2,Adenomatous Polyp,0.5731,Papillary Adenoma,0.5728,Sclerosing Polycystic Adenoma,0.5642,Solid Pseudopapillary Neoplasm,0.5537,Lung Papillary Adenoma,0.5533,Primary Neoplasm,0.5512,Traditional Serrated Adenoma,0.5497,Prostate Osteosarcoma,0.5495,Adenoma,0.5492,Neoplastic Polyp,0.5485,Multiple Adenomatous Polyps,0.5465,Asynchronous Multifocal Osteosarcoma,0.5437,Telangiectatic Osteosarcoma,0.5428,Solid Pseudopapillary Neoplasm of the Ovary,0.5420,Adenocarcinoma of Unknown Primary,0.5418,Oropharyngeal Polyp,0.5410,Askin Tumor,0.5386,Epithelioid Hemangioendothelioma with YAP1-TFE3 Gene Fusion,0.5378,Prostate Solitary Fibrous Tumor,0.5370,Superficial Spreading Adenocarcinoma,0.5368,ST-YAP,False,False,False
STAD,Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,0.9688,Gastric Carcinoma,0.8658,Sporadic Gastric Adenocarcinoma,0.8428,Gastric Diffuse Adenocarcinoma,0.8322,Gastric Tubular Adenocarcinoma,0.8254,Advanced Gastric Adenocarcinoma,0.8239,Proximal Gastric Adenocarcinoma,0.8118,Gastric Intestinal-Type Adenocarcinoma,0.8068,Gastric Cardia Adenocarcinoma,0.8057,Adenocarcinoma,0.7960,Gastric Adenoma,0.7953,Malignant Gastric Neoplasm,0.7842,Sporadic Gastric Diffuse Adenocarcinoma,0.7771,Gastroesophageal Junction Adenocarcinoma,0.7733,Gastric Papillary Adenocarcinoma,0.7701,Gastric Intramucosal Adenocarcinoma,0.7663,Gallbladder Adenocarcinoma,0.7657,Advanced Gastric Carcinoma,0.7648,Gastric Neoplasm,0.7643,Localized Gastric Adenocarcinoma,0.7615,Stomach Adenocarcinoma,True,True,True
STAD_GS,Gastric Adenocarcinoma,99,2,Aggressive Systemic Mastocytosis with an Associated Germ Cell Tumor,0.5692,Systemic Mastocytosis with an Associated Germ Cell Tumor,0.5605,Sporadic Gastric Diffuse Adenocarcinoma,0.5596,Colorectal Adenoma with Severe Dysplasia,0.5492,Superficial Spreading Adenocarcinoma,0.5479,Dedifferentiated Gastrointestinal Stromal Tumor,0.5440,Acute Myeloid Leukemia with STAG2 Mutation,0.5371,Aggressive Systemic Mastocytosis,0.5369,Spiradenocylindroma,0.5364,Disseminated Adenocarcinoma,0.5342,Multiple Myeloma Myeloma by DS Stage,0.5325,Sarcoma GX,0.5304,Multiple Myeloma with NSD2 Translocation,0.5266,Traditional Serrated Adenoma,0.5252,"Lacrimal Drainage System Adenocarcinoma, Not Otherwise Specified",0.5243,Monostotic Fibrous Dysplasia,0.5240,Poorly Differentiated Synovial Sarcoma,0.5218,Smoldering Systemic Mastocytosis,0.5195,Advanced Synovial Sarcoma,0.5194,Advanced Gastrointestinal Stromal Tumor,0.5185,STAD_GS,False,False,False
"STEROID CELL TUMOR, NOS","Ovarian Steroid Cell Tumor, Not Otherwise Specified",2,2,Ovarian Steroid Cell Tumor,0.8511,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0.8145,Leydig Cell Tumor,0.7084,Malignant Ovarian Steroid Cell Tumor,0.6959,Well Differentiated Ovarian Steroid Cell Tumor,0.6928,Endocrine Neoplasm,0.6715,Sertoli Cell Tumor,0.6677,Steroid Lipomatosis,0.6584,Glandular Cell Neoplasm,0.6560,Ovarian Leydig Cell Tumor,0.6523,Adrenal Gland Neoplasm,0.6501,Granulosa Cell Tumor,0.6484,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",0.6479,Adrenal Cortical Neoplasm,0.6439,Testicular Leydig Cell Tumor,0.6405,Ovarian Stromal-Leydig Cell Tumor,0.6387,Adrenal Cortical Sex Cord-Stromal Tumor,0.6258,Germ Cell Tumor,0.6198,Adrenal Rest Tumor,0.6192,Carcinoid Tumor,0.6156,"STEROID CELL TUMOR, NOS",False,True,True
STOMACH ADENOCARCINOMA,Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,0.9688,Gastric Carcinoma,0.8658,Sporadic Gastric Adenocarcinoma,0.8428,Gastric Diffuse Adenocarcinoma,0.8322,Gastric Tubular Adenocarcinoma,0.8254,Advanced Gastric Adenocarcinoma,0.8239,Proximal Gastric Adenocarcinoma,0.8118,Gastric Intestinal-Type Adenocarcinoma,0.8068,Gastric Cardia Adenocarcinoma,0.8057,Adenocarcinoma,0.7960,Gastric Adenoma,0.7953,Malignant Gastric Neoplasm,0.7842,Sporadic Gastric Diffuse Adenocarcinoma,0.7771,Gastroesophageal Junction Adenocarcinoma,0.7733,Gastric Papillary Adenocarcinoma,0.7701,Gastric Intramucosal Adenocarcinoma,0.7663,Gallbladder Adenocarcinoma,0.7657,Advanced Gastric Carcinoma,0.7648,Gastric Neoplasm,0.7643,Localized Gastric Adenocarcinoma,0.7615,STOMACH ADENOCARCINOMA,True,True,True
"STOMACH ADENOCARCINOMA, SIGNET RING TYPE",Gastric Signet Ring Cell Adenocarcinoma,1,2,Gastric Signet Ring Cell Adenocarcinoma,0.9398,Signet Ring Cell Adenocarcinoma,0.8630,Small Intestinal Signet Ring Cell Adenocarcinoma,0.8331,Colon Signet Ring Cell Adenocarcinoma,0.8229,Colorectal Signet Ring Cell Adenocarcinoma,0.8215,Pancreatic Signet Ring Cell Adenocarcinoma,0.8102,Rectal Signet Ring Cell Adenocarcinoma,0.8084,Rectosigmoid Signet Ring Cell Adenocarcinoma,0.8026,Gallbladder Signet Ring Cell Adenocarcinoma,0.7948,Appendix Signet Ring Cell Adenocarcinoma,0.7921,Prostate Acinar Signet Ring Cell-Like Adenocarcinoma,0.7693,Ovarian Signet Ring Cell Adenocarcinoma,0.7628,Breast Signet Ring Cell Adenocarcinoma,0.7618,Metastatic Signet Ring Cell Adenocarcinoma,0.7565,Signet Ring Melanoma,0.7463,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell-Type",0.7411,Ampulla of Vater Signet Ring Cell Adenocarcinoma,0.7347,Bladder Signet Ring Cell Adenocarcinoma,0.7237,Lung Signet Ring Cell Carcinoma,0.7094,Thyroid Gland Signet Ring Cell Follicular Adenoma,0.6975,"STOMACH ADENOCARCINOMA, SIGNET RING TYPE",True,True,True
STOMACH ADENOCARINOMA,Gastric Adenocarcinoma,2,2,Gastric Adenoma,0.7377,Gastric Adenocarcinoma,0.7319,Tongue Adenoid Cystic Carcinoma,0.7226,Salivary Gland Adenoid Cystic Carcinoma,0.7066,Major Salivary Gland Adenoid Cystic Carcinoma,0.7027,Adenoid Cystic Carcinoma,0.7014,"Gastric Adenoma, Gastric-Type",0.6951,Oral Cavity Adenoid Cystic Carcinoma,0.6910,Gastric Carcinoma,0.6871,Minor Salivary Gland Adenoid Cystic Carcinoma,0.6854,Gastric Body Carcinoma,0.6830,Sporadic Gastric Adenocarcinoma,0.6795,Gastric Adenosquamous Carcinoma,0.6777,Anterior Tongue Adenoid Cystic Carcinoma,0.6762,Gastric Lipoma,0.6722,Pharyngeal Adenoid Cystic Carcinoma,0.6720,Gastric Mucinous Adenocarcinoma,0.6709,Advanced Adenoid Cystic Carcinoma,0.6683,Adenomyoma,0.6675,Gastric Mixed Adenoneuroendocrine Carcinoma,0.6671,STOMACH ADENOCARINOMA,False,True,True
STOMACH CANCER,Gastric Carcinoma,1,2,Gastric Carcinoma,0.9102,Gastric Neoplasm,0.8631,Gastric Adenocarcinoma,0.8408,Malignant Gastric Neoplasm,0.8256,Sporadic Gastric Adenocarcinoma,0.7688,Childhood Gastric Carcinoma,0.7585,Digestive System Carcinoma,0.7583,Early Gastric Cancer,0.7564,Gastric Body Carcinoma,0.7539,Gastric Lymphoma,0.7495,Gastric Adenoma,0.7371,Advanced Gastric Carcinoma,0.7364,Gastroesophageal Cancer,0.7355,Gastric Sarcoma,0.7304,Gastric Melanoma,0.7177,Tongue Carcinoma,0.7150,Gastric Squamous Cell Carcinoma,0.7108,Proximal Gastric Adenocarcinoma,0.7086,Advanced Gastric Adenocarcinoma,0.7066,Localized Gastric Carcinoma,0.7060,STOMACH CANCER,True,True,True
"STOMACH, ADENOCARCINOMA, DIFFUSE TYPE",Gastric Diffuse Adenocarcinoma,1,2,Gastric Diffuse Adenocarcinoma,0.9332,Sporadic Gastric Diffuse Adenocarcinoma,0.8556,Diffuse Type Adenocarcinoma,0.8297,Gastric Adenocarcinoma,0.8139,Gastric Intestinal-Type Adenocarcinoma,0.7766,Advanced Gastric Adenocarcinoma,0.7729,Hereditary Gastric Diffuse Adenocarcinoma,0.7721,Gastric Poorly Cohesive Adenocarcinoma,0.7446,Sporadic Gastric Adenocarcinoma,0.7416,Gastric Mixed Adenocarcinoma,0.7381,"Gastric Adenoma, Gastric-Type",0.7346,Metastatic Gastric Adenocarcinoma,0.7285,Gastric Tubular Adenocarcinoma,0.7219,Gastric Cardia Adenocarcinoma,0.7184,Gastric Mucinous Adenocarcinoma,0.7165,Gastric Hepatoid Adenocarcinoma,0.7130,Advanced Gastric Carcinoma,0.7080,Gastric Carcinoma,0.7045,Proximal Gastric Adenocarcinoma,0.6995,Localized Gastric Adenocarcinoma,0.6918,"STOMACH, ADENOCARCINOMA, DIFFUSE TYPE",True,True,True
"STOMACH, ADENOCARCINOMA, NOT OTHERWISE SPECIFIED NOS",Gastric Adenocarcinoma,1,2,Gastric Adenocarcinoma,0.8483,Gastric Carcinoma,0.7624,Advanced Gastric Adenocarcinoma,0.7595,Gastric Diffuse Adenocarcinoma,0.7478,Gastric Intestinal-Type Adenocarcinoma,0.7402,Malignant Gastric Neoplasm,0.7397,Sporadic Gastric Adenocarcinoma,0.7396,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",0.7189,"Gastric Adenoma, Gastric-Type",0.7185,Advanced Gastric Carcinoma,0.7163,Metastatic Gastric Adenocarcinoma,0.6991,"Salivary Gland High Grade Adenocarcinoma, Not Otherwise Specified",0.6976,Gastric Cardia Adenocarcinoma,0.6937,Gastric Tubular Adenocarcinoma,0.6903,Sporadic Gastric Diffuse Adenocarcinoma,0.6883,Proximal Gastric Adenocarcinoma,0.6832,Gastric Mucinous Adenocarcinoma,0.6832,"Salivary Gland Low Grade Adenocarcinoma, Not Otherwise Specified",0.6768,Gastric Adenoma,0.6736,Gastroesophageal Junction Adenocarcinoma,0.6693,"STOMACH, ADENOCARCINOMA, NOT OTHERWISE SPECIFIED NOS",True,True,True
"STOMACH, INTESTINAL ADENOCARCINOMA, MUCINOUS TYPE",Gastric Mucinous Adenocarcinoma,1,2,Gastric Mucinous Adenocarcinoma,0.8636,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.8601,"Endometrial Mucinous Adenocarcinoma, Intestinal-Type",0.8440,Small Intestinal Mucinous Adenocarcinoma,0.8367,Gastric Intestinal-Type Adenocarcinoma,0.8323,"Sinonasal Adenocarcinoma, Intestinal-Type with Mucinous Pattern",0.8247,Colorectal Mucinous Adenocarcinoma,0.8038,"Endometrial Mucinous Adenocarcinoma, Gastric-Type",0.8028,Mucinous Adenocarcinoma,0.7997,Colon Mucinous Adenocarcinoma,0.7877,"Vaginal Mucinous Adenocarcinoma, Intestinal-Type",0.7834,Gastric Intramucosal Adenocarcinoma,0.7830,Appendix Mucinous Adenocarcinoma,0.7745,Salivary Gland Mucinous Adenocarcinoma,0.7597,Gallbladder Mucinous Adenocarcinoma,0.7556,"Gastric Adenoma, Intestinal-Type",0.7544,Ovarian Mucinous Adenocarcinoma,0.7518,Cervical Mucinous Adenocarcinoma,0.7497,Intestinal-Type Adenocarcinoma,0.7478,"Vaginal Mucinous Adenocarcinoma, Gastric-Type",0.7475,"STOMACH, INTESTINAL ADENOCARCINOMA, MUCINOUS TYPE",True,True,True
"STOMACH, INTESTINAL ADENOCARCINOMA, NOT OTHERWISE SPECIFIED NOS",Gastric Intestinal-Type Adenocarcinoma,1,2,Gastric Intestinal-Type Adenocarcinoma,0.8711,"Gastric Adenoma, Intestinal-Type",0.7890,Intestinal-Type Adenocarcinoma,0.7837,Gastric Adenocarcinoma,0.7733,Gastric Intramucosal Adenocarcinoma,0.7323,Salivary Gland Intestinal-Type Adenocarcinoma,0.7212,"Gastrointestinal Tract Adenoma, Intestinal-Type",0.7196,Sporadic Gastric Adenocarcinoma,0.7136,Small Intestinal Adenocarcinoma,0.7117,Gastric Carcinoma,0.7018,"Gallbladder Adenocarcinoma, Intestinal-Type",0.6920,"Sinonasal Adenocarcinoma, Intestinal-Type",0.6809,Inflammatory Bowel Disease-Associated Colorectal Adenocarcinoma,0.6792,Malignant Gastric Neoplasm,0.6773,Gastric Diffuse Adenocarcinoma,0.6753,"Gastric Adenoma, Gastric-Type",0.6727,Intramucosal Adenocarcinoma,0.6699,Advanced Gastric Adenocarcinoma,0.6698,"Salivary Gland Intermediate Grade Adenocarcinoma, Not Otherwise Specified",0.6675,Gastroesophageal Junction Adenocarcinoma,0.6670,"STOMACH, INTESTINAL ADENOCARCINOMA, NOT OTHERWISE SPECIFIED NOS",True,True,True
"STOMACH, INTESTINAL ADENOCARCINOMA, PAPILLARY TYPE",Gastric Papillary Adenocarcinoma,1,2,Gastric Papillary Adenocarcinoma,0.8458,Gastric Intestinal-Type Adenocarcinoma,0.8223,"Sinonasal Adenocarcinoma, Intestinal-Type with Papillary Pattern",0.7748,"Gastric Adenoma, Intestinal-Type",0.7737,Proximal Gastric Adenocarcinoma,0.7480,Intestinal-Type Adenocarcinoma,0.7420,Salivary Gland Intestinal-Type Adenocarcinoma,0.7355,Papillary Adenocarcinoma,0.7261,Invasive Papillary Adenocarcinoma,0.7117,Gastric Adenocarcinoma,0.7089,Gastric Parietal Cell Adenocarcinoma,0.7079,Gastric Intramucosal Adenocarcinoma,0.7010,"Gastrointestinal Tract Adenoma, Intestinal-Type",0.6940,Sporadic Gastric Adenocarcinoma,0.6935,"Gallbladder Adenocarcinoma, Intestinal-Type",0.6871,"Gastric Adenoma, Gastric-Type",0.6845,Gastric Tubular Adenocarcinoma,0.6815,Helicobacter Pylori-Related Gastric Adenocarcinoma,0.6813,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.6786,"Human Papillomavirus-Independent Cervical Adenocarcinoma, Gastric-Type",0.6743,"STOMACH, INTESTINAL ADENOCARCINOMA, PAPILLARY TYPE",True,True,True
"STOMACH, INTESTINAL ADENOCARCINOMA, TUBULAR TYPE",Gastric Tubular Adenocarcinoma,1,2,Gastric Tubular Adenocarcinoma,0.8719,Gastric Intestinal-Type Adenocarcinoma,0.8621,Intestinal-Type Adenocarcinoma,0.8115,"Gastric Adenoma, Intestinal-Type",0.7915,Gastric Tubular Adenoma,0.7782,Tubular Adenocarcinoma,0.7637,"Gastrointestinal Tract Adenoma, Intestinal-Type",0.7603,Gastrointestinal Tract Tubular Adenoma,0.7579,Adenocarcinoma in Tubular Adenoma,0.7498,Salivary Gland Intestinal-Type Adenocarcinoma,0.7326,Small Intestinal Tubular Adenoma,0.7316,Small Intestinal Adenocarcinoma,0.7309,Colon Tubular Adenoma,0.7202,Gastric Adenocarcinoma,0.7194,Gastric Intramucosal Adenocarcinoma,0.7120,Colorectal Tubular Adenoma,0.7020,"Sinonasal Adenocarcinoma, Intestinal-Type",0.6972,Adenocarcinoma In Situ in Tubular Adenoma,0.6965,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",0.6891,Small Intestinal Mucinous Adenocarcinoma,0.6839,"STOMACH, INTESTINAL ADENOCARCINOMA, TUBULAR TYPE",True,True,True
SUPERFICIAL SPREADING,Low-CSD Melanoma,99,2,Superficial Spreading Adenocarcinoma,0.7382,Superficial Fibromatosis,0.6524,Superficial Basal Cell Carcinoma,0.6278,Surface Osteoma,0.6166,Cutaneous Lymphoma,0.5926,Squamous Papillomatosis,0.5844,Melanoma,0.5828,Seborrheic Keratosis,0.5808,Superficial Multifocal Basal Cell Carcinoma,0.5807,Sarcoma,0.5802,Superficial Epithelioma with Sebaceous Differentiation,0.5766,Cutaneous Follicular Lymphoma,0.5746,"Low-CSD Melanoma, Superficial Spreading Melanoma Subtype",0.5710,Superficial Angiomyxoma,0.5699,Carcinoma Simplex,0.5670,Inverted Follicular Keratosis,0.5667,Lymphoma by Site,0.5623,Primary Cutaneous Lymphoma,0.5616,Primary Systemic Amyloidosis,0.5595,Cutaneous Melanoma,0.5593,SUPERFICIAL SPREADING,False,False,False
SUPERFICIAL SPREADING MELANOMA,Low-CSD Melanoma,6,2,Superficial Spreading Adenocarcinoma,0.7838,"Low-CSD Melanoma, Superficial Spreading Melanoma Subtype",0.7812,Cutaneous Spitz Melanoma,0.7046,Melanoma,0.7024,Cutaneous Melanoma,0.6998,Low-CSD Melanoma,0.6899,Spindle Cell Melanoma,0.6886,Metastatic Melanoma,0.6771,Metastatic Cutaneous Melanoma,0.6712,Dermal Melanoma,0.6698,High-CSD Melanoma,0.6649,Solar Radiation-Related Cutaneous Melanoma,0.6544,Melanoma in Intermittently Sun-Exposed Skin,0.6535,Metastatic Melanoma in the Skin,0.6514,Mucosal Melanoma,0.6505,Minimal Deviation Melanoma,0.6492,Metastatic Mucosal Melanoma,0.6465,Superficial Multifocal Basal Cell Carcinoma,0.6453,Melanoma in Chronically Sun-Exposed Skin,0.6415,Invasive Cutaneous Melanoma,0.6387,SUPERFICIAL SPREADING MELANOMA,False,False,False
SWEAT GLAND ADENOCARCINOMA,Eccrine Carcinoma,10,2,Sweat Gland Carcinoma,0.9425,Sweat Gland Adenoma,0.8980,Sweat Gland Tubular Carcinoma,0.8790,Malignant Sweat Gland Neoplasm,0.8704,Sweat Gland Neoplasm,0.8482,Endocrine Mucin-Producing Sweat Gland Carcinoma,0.8147,Ductal Eccrine Adenocarcinoma,0.8076,Benign Sweat Gland Neoplasm,0.7847,Vulvar Adenocarcinoma of Sweat Gland Origin,0.7740,Eccrine Carcinoma,0.7538,Salivary Gland Adenocarcinoma,0.7425,Adnexal Secretory Carcinoma,0.7357,Lacrimal Gland Adenocarcinoma,0.7347,Parotid Gland Adenocarcinoma,0.7301,Salivary Gland Sebaceous Carcinoma,0.7281,Adenocarcinoma,0.7250,Syringoacanthoma,0.7248,Thyroid Gland Adenocarcinoma,0.7242,Apocrine Adenoma,0.7224,Eccrine Neoplasm,0.7222,SWEAT GLAND ADENOCARCINOMA,False,False,False
SWEAT GLAND CARCINOMA/APOCRINE ECCRINE CARCINOMA,Sweat Gland Carcinoma,2,2,Eccrine Carcinoma,0.8324,Sweat Gland Carcinoma,0.8289,Apocrine Carcinoma,0.8134,Ductal Eccrine Adenocarcinoma,0.8067,Sweat Gland Tubular Carcinoma,0.7882,Papillary Eccrine Carcinoma,0.7796,Breast Apocrine Carcinoma,0.7530,Endocrine Mucin-Producing Sweat Gland Carcinoma,0.7463,Adnexal Secretory Carcinoma,0.7427,Squamoid Eccrine Ductal Carcinoma,0.7337,Malignant Eccrine Neoplasm,0.7325,Eccrine Neoplasm,0.7283,Malignant Apocrine Neoplasm,0.7221,Sebaceous Carcinoma,0.7194,Apocrine Neoplasm,0.7170,Sweat Gland Adenoma,0.7110,Apocrine Adenoma,0.7084,Adenocarcinoma with Apocrine Metaplasia,0.7052,Malignant Sweat Gland Neoplasm,0.7048,Salivary Gland Sebaceous Carcinoma,0.7016,SWEAT GLAND CARCINOMA/APOCRINE ECCRINE CARCINOMA,False,True,True
SYNOVIAL,Synovial Neoplasm,2,2,Synovial Sarcoma,0.7955,Synovial Neoplasm,0.7850,Benign Synovial Neoplasm,0.7786,Malignant Synovial Neoplasm,0.7675,Cardiac Synovial Sarcoma,0.7213,Pericardial Synovial Sarcoma,0.7197,Fibrous Synovial Sarcoma,0.7185,Gastric Synovial Sarcoma,0.7117,Advanced Synovial Sarcoma,0.7034,Poorly Differentiated Synovial Sarcoma,0.7000,Spindle Cell Synovial Sarcoma,0.6994,Childhood Synovial Sarcoma,0.6993,Adult Synovial Sarcoma,0.6976,Monophasic Synovial Sarcoma,0.6963,Epithelial Synovial Sarcoma,0.6952,Synovial Chondromatosis,0.6921,Synovial Hemangioma,0.6921,Sinonasal Synovial Sarcoma,0.6902,Sarcoma,0.6900,Localized Synovial Sarcoma,0.6893,SYNOVIAL,False,True,True
SYNOVIAL SARCOMA,Synovial Sarcoma,1,2,Synovial Sarcoma,1.0000,Fibrous Synovial Sarcoma,0.9002,Spindle Cell Synovial Sarcoma,0.8910,Adult Synovial Sarcoma,0.8817,Epithelial Synovial Sarcoma,0.8760,Monophasic Synovial Sarcoma,0.8697,Localized Synovial Sarcoma,0.8625,Poorly Differentiated Synovial Sarcoma,0.8571,Cardiac Synovial Sarcoma,0.8546,Childhood Synovial Sarcoma,0.8519,Sinonasal Synovial Sarcoma,0.8486,Kidney Synovial Sarcoma,0.8450,Advanced Synovial Sarcoma,0.8422,Sarcoma,0.8366,Pericardial Synovial Sarcoma,0.8344,Gastric Synovial Sarcoma,0.8255,Pleural Synovial Sarcoma,0.8238,Prostate Synovial Sarcoma,0.8237,Lung Synovial Sarcoma,0.8220,Metastatic Synovial Sarcoma,0.8207,SYNOVIAL SARCOMA,True,True,True
SYNOVIAL SARCOMA - BIPHASIC,Biphasic Synovial Sarcoma,1,2,Biphasic Synovial Sarcoma,0.9697,Pleural Biphasic Synovial Sarcoma,0.8576,Cardiac Biphasic Synovial Sarcoma,0.8456,Monophasic Synovial Sarcoma,0.8225,Lung Biphasic Synovial Sarcoma,0.8204,Poorly Differentiated Synovial Sarcoma,0.7854,Synovial Sarcoma,0.7819,Spindle Cell Synovial Sarcoma,0.7647,Metastatic Synovial Sarcoma,0.7458,Fibrous Synovial Sarcoma,0.7361,Adult Synovial Sarcoma,0.7339,Biphasic Mesothelioma,0.7258,Pleural Monophasic Synovial Sarcoma,0.7213,Localized Synovial Sarcoma,0.7145,Cardiac Monophasic Synovial Sarcoma,0.7141,Epithelial Synovial Sarcoma,0.7112,Undifferentiated Spindle Cell Sarcoma,0.7086,Sarcoma G2,0.7061,Spindle Cell Sarcoma,0.6990,Biphenotypic Sinonasal Sarcoma,0.6944,SYNOVIAL SARCOMA - BIPHASIC,True,True,True
SYNOVIAL SARCOMA - MONOPHASIC,Monophasic Synovial Sarcoma,1,2,Monophasic Synovial Sarcoma,0.9592,Pleural Monophasic Synovial Sarcoma,0.8399,Synovial Sarcoma,0.8160,Biphasic Synovial Sarcoma,0.8053,Localized Synovial Sarcoma,0.7996,Cardiac Monophasic Synovial Sarcoma,0.7833,Poorly Differentiated Synovial Sarcoma,0.7816,Adult Synovial Sarcoma,0.7731,Fibrous Synovial Sarcoma,0.7673,Spindle Cell Synovial Sarcoma,0.7672,Pleural Biphasic Synovial Sarcoma,0.7444,Lung Monophasic Synovial Sarcoma,0.7437,Pleural Synovial Sarcoma,0.7369,Unresectable Synovial Sarcoma,0.7361,Childhood Synovial Sarcoma,0.7263,Metastatic Synovial Sarcoma,0.7223,Benign Synovial Neoplasm,0.7213,Malignant Synovial Neoplasm,0.7204,Advanced Synovial Sarcoma,0.7193,Sarcoma NCI Grade 1,0.7146,SYNOVIAL SARCOMA - MONOPHASIC,True,True,True
SYNOVIAL_SARCOMA,Synovial Sarcoma,1,2,Synovial Sarcoma,0.9717,Fibrous Synovial Sarcoma,0.8774,Spindle Cell Synovial Sarcoma,0.8648,Adult Synovial Sarcoma,0.8496,Monophasic Synovial Sarcoma,0.8495,Epithelial Synovial Sarcoma,0.8449,Sarcoma,0.8380,Sinonasal Synovial Sarcoma,0.8295,Localized Synovial Sarcoma,0.8284,Poorly Differentiated Synovial Sarcoma,0.8284,Advanced Synovial Sarcoma,0.8248,Kidney Synovial Sarcoma,0.8229,Childhood Synovial Sarcoma,0.8214,Cardiac Synovial Sarcoma,0.8147,Metastatic Synovial Sarcoma,0.8125,Malignant Synovial Neoplasm,0.8108,Synovial Neoplasm,0.8031,Pericardial Synovial Sarcoma,0.7996,Unresectable Synovial Sarcoma,0.7983,Gastric Synovial Sarcoma,0.7940,SYNOVIAL_SARCOMA,True,True,True
SYSTEMIC MASTOCYTOSIS,Systemic Mastocytosis,1,2,Systemic Mastocytosis,1.0000,Mastocytosis,0.8943,Aggressive Systemic Mastocytosis,0.8675,Indolent Systemic Mastocytosis,0.8630,Malignant Mastocytosis,0.8551,Smoldering Systemic Mastocytosis,0.8193,Pure Cutaneous Mastocytosis,0.8052,Cutaneous Mastocytosis,0.7972,Diffuse Cutaneous Mastocytosis,0.7949,Bone Marrow Mastocytosis,0.7823,Mast Cell Sarcoma,0.7671,Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.7621,Mast Cell Leukemia,0.7243,Mastocytoma,0.7242,Solitary Mastocytoma of the Skin,0.7141,Smoldering Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.7023,Mast Cell Neoplasm,0.6977,Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis,0.6870,Recurrent Malignant Mastocytosis,0.6826,Extracutaneous Mastocytoma,0.6812,SYSTEMIC MASTOCYTOSIS,True,True,True
S_T_MDS,Myelodysplastic Syndrome,8,2,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",0.6806,Myelodysplastic Syndrome with Somatic Mutation,0.6471,Secondary Myelodysplastic Syndrome,0.6372,Myelodysplastic/Myeloproliferative Neoplasm with SF3B1 Mutation and Thrombocytosis,0.6304,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.6281,Smoldering Systemic Mastocytosis,0.6275,"Myelodysplastic Syndrome, Not Otherwise Specified",0.6263,Myelodysplastic Syndrome,0.6204,Myeloid Sarcoma,0.6165,Smoldering Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.6133,Seminal Vesicle Mixed Epithelial and Stromal Tumor,0.6118,Myelodysplastic Syndrome with Mutated SF3B1,0.5987,Systemic Mastocytosis,0.5966,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,0.5940,Malignant Superior Sulcus Neoplasm,0.5927,Testicular Myeloid Sarcoma,0.5904,Systemic Mastocytosis with an Associated Myeloid Neoplasm,0.5896,Recurrent Myelodysplastic Syndrome,0.5871,Multiple Myeloma by ISS Stage,0.5842,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",0.5841,S_T_MDS,False,False,False
T-ALL,T Acute Lymphoblastic Leukemia,4,2,Mature T-ALL,0.8836,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.8335,Pre T-ALL,0.8320,T Acute Lymphoblastic Leukemia,0.8314,T Lymphoblastic Lymphoma,0.8219,T Lymphoblastic Leukemia/Lymphoma,0.7865,T-Cell Chronic Lymphocytic Leukemia,0.7680,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7634,Adult T Lymphoblastic Lymphoma,0.7488,T-Cell Non-Hodgkin Lymphoma,0.7429,Adult T-Cell Leukemia/Lymphoma,0.7354,Childhood T Lymphoblastic Lymphoma,0.7340,Adult T Acute Lymphoblastic Leukemia,0.7217,Childhood T Acute Lymphoblastic Leukemia,0.7197,Common Acute Lymphoblastic Leukemia,0.7190,"Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7160,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.7118,Acute Lymphoblastic Leukemia,0.7113,Childhood T Lymphoblastic Leukemia/Lymphoma,0.7070,Lymphoblastic Lymphoma,0.7063,T-ALL,False,False,True
T-CELL ACUTE LYMPHOID LEUKEMIA,T Acute Lymphoblastic Leukemia,1,2,T Acute Lymphoblastic Leukemia,0.9162,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.8620,T Lymphoblastic Leukemia/Lymphoma,0.8344,Acute Adult T-Cell Leukemia/Lymphoma,0.8302,T-Cell Chronic Lymphocytic Leukemia,0.8253,Adult T-Cell Leukemia/Lymphoma,0.8216,Adult T Acute Lymphoblastic Leukemia,0.8127,T Acute Lymphoblastic Leukemia with TAL1 Rearrangement,0.8058,T Lymphoblastic Lymphoma,0.8036,Childhood T Acute Lymphoblastic Leukemia,0.7960,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.7909,T-Cell Large Granular Lymphocyte Leukemia,0.7862,Early T Precursor Acute Lymphoblastic Leukemia,0.7781,T Acute Lymphoblastic Leukemia with TLX1 Rearrangement,0.7699,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.7688,T Acute Lymphoblastic Leukemia with LMO1 Rearrangement,0.7665,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.7650,Infant T Acute Lymphoblastic Leukemia,0.7646,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7627,Adult T Lymphoblastic Lymphoma,0.7591,T-CELL ACUTE LYMPHOID LEUKEMIA,True,True,True
T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA,T-Cell Large Granular Lymphocyte Leukemia,1,2,T-Cell Large Granular Lymphocyte Leukemia,0.9849,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant",0.9123,T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta,0.7954,T Lymphoblastic Leukemia/Lymphoma,0.7944,T Lymphoblastic Lymphoma,0.7813,T-Cell Chronic Lymphocytic Leukemia,0.7705,T Acute Lymphoblastic Leukemia,0.7659,Low Grade T-Cell Lymphoma,0.7617,Refractory T-Cell Large Granular Lymphocyte Leukemia,0.7613,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.7579,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia,0.7501,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7460,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7404,Adult T-Cell Leukemia/Lymphoma,0.7328,Recurrent T-Cell Large Granular Lymphocyte Leukemia,0.7223,Adult T Lymphoblastic Lymphoma,0.7193,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.7166,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.7131,"Peripheral T-Cell Lymphoma, Large Cell",0.7113,Childhood T Lymphoblastic Leukemia/Lymphoma,0.7092,T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA,True,True,True
"T-CELL, NON-HODGKINS, ANAPLASTIC LARGE CELL ALCL",Anaplastic Large Cell Lymphoma,4,2,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,0.7729,"Anaplastic Large Cell Lymphoma, Lymphomatoid Papulosis-Like Histology",0.7561,Common Variant Anaplastic Large Cell Lymphoma,0.7493,Anaplastic Large Cell Lymphoma,0.7469,Lung Anaplastic Large Cell Lymphoma,0.7304,Small Cell Variant Anaplastic Large Cell Lymphoma,0.7222,Adult Anaplastic Large Cell Lymphoma,0.7218,"Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype",0.7198,"Anaplastic Large Cell Lymphoma, ALK-Positive",0.7132,Localized Anaplastic Large Cell Lymphoma,0.7018,"Anaplastic Large Cell Lymphoma, ALK-Negative",0.7004,Advanced Anaplastic Large Cell Lymphoma,0.6951,Primary Cutaneous Anaplastic Large Cell Lymphoma,0.6942,Noncutaneous Anaplastic Large Cell Lymphoma by Ann Arbor Stage,0.6924,"Anaplastic Large Cell Lymphoma, Sarcomatoid Subtype",0.6885,Aggressive T-Cell Non-Hodgkin Lymphoma,0.6870,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.6869,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma,0.6869,"Peripheral T-Cell Lymphoma, Large Cell",0.6793,"Childhood Anaplastic Large Cell Lymphoma, ALK-Positive",0.6753,"T-CELL, NON-HODGKINS, ANAPLASTIC LARGE CELL ALCL",False,False,True
"T-CELL, NON-HODGKINS, CUTANEOUS",Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1,2,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.8720,Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7993,T-Cell Non-Hodgkin Lymphoma,0.7859,Cutaneous Mature T-Cell and NK-Cell Neoplasm,0.7469,"Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7269,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,0.7090,Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7028,Indolent T-Cell Non-Hodgkin Lymphoma,0.7024,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",0.7020,Primary Cutaneous Gamma-Delta T-Cell Lymphoma,0.6867,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.6845,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.6837,Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6833,T-Cell and NK-Cell Neoplasm,0.6806,Primary Central Nervous System T-Cell Non-Hodgkin Lymphoma,0.6732,Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6649,Aggressive T-Cell Non-Hodgkin Lymphoma,0.6628,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.6627,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,0.6615,Low Grade T-Cell Lymphoma,0.6589,"T-CELL, NON-HODGKINS, CUTANEOUS",True,True,True
"T-CELL, NON-HODGKINS, CUTANEOUS, SEZARY SYNDROME",Sezary Syndrome,9,2,Mycosis Fungoides and Sezary Syndrome,0.7449,Recurrent Mycosis Fungoides and Sezary Syndrome,0.7000,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6922,Refractory Mycosis Fungoides and Sezary Syndrome,0.6862,Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6687,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6653,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6608,Stage IVA2 Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6581,Sezary Syndrome,0.6538,Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v7,0.6503,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6451,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6421,Recurrent Sezary Syndrome,0.6335,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7,0.6289,Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6169,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7,0.6169,Stage IIIB Mycosis Fungoides and Sezary Syndrome AJCC v8,0.6082,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7,0.6054,Refractory Sezary Syndrome,0.6013,Mycosis Fungoides and Sezary Syndrome by AJCC v8 Stage,0.5992,"T-CELL, NON-HODGKINS, CUTANEOUS, SEZARY SYNDROME",False,False,False
T-CELL_ALL,T Acute Lymphoblastic Leukemia,7,2,Mature T-ALL,0.8227,Pre T-ALL,0.7689,T-Cell Chronic Lymphocytic Leukemia,0.7608,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7291,T-Cell Non-Hodgkin Lymphoma,0.7274,T Lymphoblastic Lymphoma,0.7256,T Acute Lymphoblastic Leukemia,0.7108,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.7090,Adult T-Cell Leukemia/Lymphoma,0.7089,T Lymphoblastic Leukemia/Lymphoma,0.7014,Aggressive T-Cell Non-Hodgkin Lymphoma,0.6908,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.6882,Chronic Adult T-Cell Leukemia/Lymphoma,0.6846,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.6806,T-Cell and NK-Cell Neoplasm,0.6763,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.6704,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6687,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6650,T-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,0.6646,Adult T Lymphoblastic Lymphoma,0.6624,T-CELL_ALL,False,False,False
T-CELL_LYMPHOMA_OTHER,T-Cell Non-Hodgkin Lymphoma,2,2,"Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.8055,T-Cell Non-Hodgkin Lymphoma,0.7901,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",0.7533,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7262,T Lymphoblastic Lymphoma,0.7185,"Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.7149,Low Grade T-Cell Lymphoma,0.7044,"Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6892,Gastric T-Cell Non-Hodgkin Lymphoma,0.6874,"Follicular Helper T-Cell Lymphoma, Not Otherwise Specified",0.6807,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6796,T-Cell and NK-Cell Neoplasm,0.6782,"Peripheral T-Cell Lymphoma, Large Cell",0.6746,High Grade T-Cell Lymphoma,0.6720,Indolent T-Cell Non-Hodgkin Lymphoma,0.6712,Intestinal T-Cell Lymphoma,0.6657,"Childhood Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6657,Primary Central Nervous System T-Cell Non-Hodgkin Lymphoma,0.6615,Aggressive T-Cell Non-Hodgkin Lymphoma,0.6591,Testicular Nasal Type Extranodal NK/T-Cell Lymphoma,0.6585,T-CELL_LYMPHOMA_OTHER,False,True,True
T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,T Lymphoblastic Leukemia/Lymphoma,1,2,T Lymphoblastic Leukemia/Lymphoma,0.9903,T Lymphoblastic Lymphoma,0.9476,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.9369,T Acute Lymphoblastic Leukemia,0.8960,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.8875,Childhood T Lymphoblastic Leukemia/Lymphoma,0.8834,Childhood T Lymphoblastic Lymphoma,0.8556,Adult T Lymphoblastic Lymphoma,0.8356,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.8260,Early T Precursor Lymphoblastic Leukemia/Lymphoma,0.8238,Adult T-Cell Leukemia/Lymphoma,0.8234,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.7981,T-Cell Large Granular Lymphocyte Leukemia,0.7961,T-Cell Chronic Lymphocytic Leukemia,0.7935,T Acute Lymphoblastic Leukemia with TLX1 Rearrangement,0.7854,Childhood T Acute Lymphoblastic Leukemia,0.7833,T Acute Lymphoblastic Leukemia with TAL1 Rearrangement,0.7818,T Acute Lymphoblastic Leukemia with LMO1 Rearrangement,0.7786,T Acute Lymphoblastic Leukemia with LMO2 Rearrangement,0.7776,T-Cell Non-Hodgkin Lymphoma,0.7763,T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA,True,True,True
TALL,T Acute Lymphoblastic Leukemia,99,2,Lymphoma,0.6398,Leukemia,0.6001,Adult Lymphoma,0.5920,Advanced Lymphoma,0.5827,Adenoma,0.5808,Chronic Leukemia,0.5797,Follicular Lymphoma,0.5726,Childhood Lymphoma,0.5655,Glioblastoma,0.5567,Anaplastic Lymphoma,0.5552,Flat Adenoma,0.5549,Composite Lymphoma,0.5544,Lymphocytic Neoplasm,0.5530,Tonsillar Lymphoma,0.5526,Advanced Fibrosarcoma,0.5521,Neoplasm by Morphology,0.5508,Carcinoma,0.5487,Rare Neoplasm,0.5478,Osteoma,0.5467,Malignant Neoplasm,0.5464,TALL,False,False,False
TALL CELL,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.6497,High Grade T-Cell Lymphoma,0.5976,Follicular Lymphoma,0.5888,Follicular Helper T-Cell Lymphoma,0.5886,Lymphoma,0.5883,Hairy Cell Leukemia Variant,0.5834,Giant Cell Tumor,0.5811,Classic Follicular Lymphoma,0.5805,Giant Cell Neoplasm,0.5714,Anaplastic Lymphoma,0.5695,Chronic Leukemia,0.5679,Hairy Cell Leukemia,0.5639,High Grade Lymphoma,0.5610,Neoplastic C-Cell Hyperplasia,0.5582,"Follicular Helper T-Cell Lymphoma, Follicular-Type",0.5568,Transitional Cell Neoplasm,0.5558,Breast Tall Cell Carcinoma with Reversed Polarity,0.5542,Thyroid Gland Anaplastic Carcinoma,0.5527,Giant Cell Tumor of Bone,0.5522,Adult Lymphoma,0.5490,TALL CELL,True,True,True
TALL CELL VARIANT,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.7179,Hairy Cell Leukemia Variant,0.6348,Refractory Hairy Cell Leukemia Variant,0.5957,High Grade T-Cell Lymphoma,0.5935,Common Variant Anaplastic Large Cell Lymphoma,0.5848,Small Lymphocytic Lymphoma Variant,0.5779,Breast Tall Cell Carcinoma with Reversed Polarity,0.5709,Small Cell Variant Anaplastic Large Cell Lymphoma,0.5698,Anaplastic Lymphoma,0.5638,Aggressive T-Cell Non-Hodgkin Lymphoma,0.5634,Giant Cell Tumor,0.5629,Follicular Helper T-Cell Lymphoma,0.5595,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,0.5584,T-Cell Chronic Lymphocytic Leukemia,0.5578,Recurrent Hairy Cell Leukemia Variant,0.5571,Giant Cell Neoplasm,0.5566,Follicular Lymphoma with Unusual Cytological Features,0.5553,Chronic Leukemia,0.5540,Transformed Chronic Lymphocytic Leukemia to Hodgkin Lymphoma,0.5535,Lymphoma,0.5522,TALL CELL VARIANT,True,True,True
TALL CELL VARIANT  PHENOTYPE CHANGED AFTER CONSENSUS UPSTAGED T,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.5502,Breast Tall Cell Carcinoma with Reversed Polarity,0.5097,Refractory Transformed T-cell Non-Hodgkin Lymphoma,0.5086,"Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.5038,"Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.5006,Primary CD30-Positive T-Cell Lymphoproliferative Disorder,0.4998,Recurrent Transformed T-cell Non-Hodgkin Lymphoma,0.4932,Pre T-ALL,0.4917,Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder,0.4915,Refractory Thrombocytopenia,0.4882,Refractory T-Cell Non-Hodgkin Lymphoma,0.4863,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0.4849,Advanced Transformed Non-Hodgkin Lymphoma,0.4830,Neoplastic Post-Transplant Lymphoproliferative Disorder,0.4789,Refractory Hepatosplenic T-Cell Lymphoma,0.4779,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,0.4778,Monomorphic Post-Transplant Lymphoproliferative Disorder,0.4778,Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.4758,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.4743,Refractory Follicular Helper T-Cell Lymphoma,0.4740,TALL CELL VARIANT  PHENOTYPE CHANGED AFTER CONSENSUS UPSTAGED T,True,True,True
TC:NEC,Thymus Neuroendocrine Carcinoma,10,2,"Central Nervous System Embryonal Tumor, Not Elsewhere Classified",0.6402,"Cerebral Embryonal Tumor, Not Otherwise Specified",0.6118,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.6093,Non-Encapsulated Neoplasm,0.6056,"Adult Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.5939,"Medullary Carcinoma, Not Otherwise Specified",0.5891,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,0.5870,T-Cell and NK-Cell Neoplasm,0.5867,Encapsulated Neoplasm,0.5848,Thymus Neuroendocrine Carcinoma,0.5805,Unresectable Neuroendocrine Carcinoma,0.5800,Unresectable Thyroid Gland Carcinoma,0.5793,Nasal Cavity Neuroendocrine Tumor,0.5793,Nasal Cavity Extranodal NK/T-Cell Lymphoma,0.5781,Testicular Germ Cell Neoplasia In Situ with Extratubular Extension,0.5779,Unresectable Neuroendocrine Tumor,0.5777,Unresectable NUT Carcinoma,0.5749,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified",0.5735,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",0.5735,Mature T-Cell and NK-Cell Neoplasm,0.5727,TC:NEC,False,False,False
TC:SCC,Thymus Squamous Cell Carcinoma,99,2,Carcinoma,0.6816,Secondary Carcinoma,0.6750,Carcinoma Simplex,0.6684,Sebaceous Carcinoma,0.6386,Squamous Cell Carcinoma,0.6379,Skin Carcinoma,0.6341,Solid Carcinoma,0.6338,"Thyroid Gland Anaplastic Carcinoma, Squamous Cell Carcinoma Pattern",0.6305,Serous Tubal Intraepithelial Carcinoma,0.6257,Conjunctival Sebaceous Carcinoma,0.6237,Thyroid Gland Carcinoma,0.6201,Superficial Spreading Adenocarcinoma,0.6192,Skin Squamous Cell Carcinoma,0.6168,Carcinomatosis,0.6132,Transplant-Related Squamous Cell Carcinoma,0.6090,Conjunctival Carcinoma,0.6082,Thyroid Gland Anaplastic Carcinoma,0.6073,Superior Sulcus Lung Carcinoma,0.6057,"Secondary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1",0.6052,Thymus Carcinoma,0.6040,TC:SCC,False,False,False
TELANGIECTATIC OSTEOSARCOMA,Telangiectatic Osteosarcoma,1,2,Telangiectatic Osteosarcoma,1.0000,Osteosarcoma,0.7539,Conventional Osteosarcoma,0.7503,Bone Osteosarcoma,0.7387,Localized Osteosarcoma,0.7081,Osteoblastic Osteosarcoma,0.7050,Secondary Osteosarcoma,0.7043,Primary Bone Osteosarcoma,0.6954,Small Cell Osteosarcoma,0.6947,Jaw Osteosarcoma,0.6905,Childhood Conventional Osteosarcoma,0.6880,Multifocal Osteosarcoma,0.6843,Fibroblastic Osteosarcoma,0.6797,Extraskeletal Osteosarcoma,0.6786,High Grade Osteosarcoma,0.6762,Childhood Osteosarcoma,0.6745,Periosteal Osteosarcoma,0.6736,Hemangioblastoma,0.6720,Refractory Osteosarcoma,0.6712,Unresectable Osteosarcoma,0.6677,TELANGIECTATIC OSTEOSARCOMA,True,True,True
TERATOMA,Teratoma,1,2,Teratoma,1.0000,Mature Teratoma,0.9093,Benign Teratoma,0.9092,Immature Teratoma,0.9054,Childhood Teratoma,0.8945,Malignant Teratoma,0.8820,Adult Teratoma,0.8790,Cardiac Teratoma,0.8705,Cystic Teratoma,0.8658,Gonadal Teratoma,0.8642,Testicular Teratoma,0.8592,Childhood Mature Teratoma,0.8510,Childhood Immature Teratoma,0.8387,Ovarian Teratoma,0.8383,Central Nervous System Teratoma,0.8349,Teratoma with Endocrine Differentiation,0.8333,Pericardial Teratoma,0.8313,Lung Teratoma,0.8234,Nasopharyngeal Teratoma,0.8227,Thyroid Gland Teratoma,0.8225,TERATOMA,True,True,True
TERATOMA IMMATURE,Immature Teratoma,1,2,Immature Teratoma,0.9851,Childhood Immature Teratoma,0.9354,Teratoma,0.9087,Mature Teratoma,0.9051,Central Nervous System Immature Teratoma,0.8994,Childhood Teratoma,0.8899,Childhood Mature Teratoma,0.8866,Childhood Central Nervous System Immature Teratoma,0.8755,Benign Teratoma,0.8725,Intermediate Immature Teratoma,0.8723,Immature Ovarian Teratoma,0.8716,Testicular Immature Teratoma,0.8709,Adult Teratoma,0.8630,Adult Central Nervous System Immature Teratoma,0.8617,Childhood Testicular Immature Teratoma,0.8409,Childhood Ovarian Immature Teratoma,0.8403,Mediastinal Immature Teratoma,0.8399,Immature Extragonadal Teratoma,0.8346,Childhood Central Nervous System Mature Teratoma,0.8289,Childhood Ovarian Mature Teratoma,0.8205,TERATOMA IMMATURE,True,True,True
TERATOMA MATURE,Mature Teratoma,1,2,Mature Teratoma,0.9818,Childhood Mature Teratoma,0.9082,Adult Teratoma,0.8943,Teratoma,0.8886,Central Nervous System Mature Teratoma,0.8848,Immature Teratoma,0.8732,Adult Central Nervous System Mature Teratoma,0.8696,Testicular Mature Teratoma,0.8642,Mature Ovarian Teratoma,0.8579,Malignant Teratoma,0.8534,Childhood Central Nervous System Mature Teratoma,0.8481,Mediastinal Mature Teratoma,0.8476,Benign Teratoma,0.8439,Adult Central Nervous System Immature Teratoma,0.8387,Childhood Teratoma,0.8298,Childhood Testicular Mature Teratoma,0.8293,Pericardial Mature Teratoma,0.8273,Adult Central Nervous System Teratoma,0.8204,Childhood Immature Teratoma,0.8182,Childhood Ovarian Mature Teratoma,0.8150,TERATOMA MATURE,True,True,True
TERATOMA WITH MALIGNANT TRANSFORMATION,Teratoma with Somatic-Type Malignancy,4,2,Central Nervous System Teratoma with Malignant Transformation,0.8973,Malignant Teratoma,0.8621,Teratoma,0.8210,Teratoma with Somatic-Type Malignancy,0.8103,Sellar Teratoma with Malignant Transformation,0.8038,Mature Teratoma,0.7929,Malignant Trophoblastic Teratoma,0.7657,Immature Teratoma,0.7574,Childhood Mature Teratoma,0.7380,Childhood Teratoma,0.7370,Adult Teratoma,0.7343,Benign Teratoma,0.7303,Teratoma with Endocrine Differentiation,0.7254,Pericardial Mature Teratoma,0.7180,Cardiac Teratoma,0.7159,Cystic Teratoma,0.7142,Thyroid Gland Teratoma,0.7139,Malignant Ovarian Teratoma,0.7117,Intermediate Immature Teratoma,0.7103,Testicular Mature Teratoma,0.7077,TERATOMA WITH MALIGNANT TRANSFORMATION,False,False,True
TESTICULAR NON-SEMINOMA,Testicular Non-Seminomatous Germ Cell Tumor,1,2,Testicular Non-Seminomatous Germ Cell Tumor,0.8988,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0.8677,Childhood Testicular Non-Seminomatous Germ Cell Tumor,0.8297,Testicular Typical Seminoma,0.8250,Testicular Seminoma,0.8150,Seminoma,0.7967,"Testicular Seminoma, Tubular Variant",0.7891,Intratubular Non-Seminoma,0.7684,Testicular Spermatocytic Tumor,0.7593,"Testicular Seminoma, Pseudoglandular Variant",0.7546,Extragonadal Seminoma,0.7545,Mediastinal Seminoma,0.7483,Childhood Seminoma,0.7405,Intratubular Seminoma,0.7280,Testicular Seminoma with Syncytiotrophoblastic Cells,0.7246,Testicular Germ Cell Tumor,0.7215,Testicular Neoplasm,0.7173,Nongerminomatous Germ Cell Tumor,0.7148,Testicular Pure Germ Cell Tumor,0.7119,"Testicular Sex Cord-Stromal Tumor, Not Otherwise Specified",0.7095,TESTICULAR NON-SEMINOMA,True,True,True
TESTICULAR SEMINOMA,Testicular Seminoma,1,2,Testicular Seminoma,1.0000,Testicular Typical Seminoma,0.9675,Seminoma,0.9487,Childhood Seminoma,0.8933,"Testicular Seminoma, Tubular Variant",0.8804,Mediastinal Seminoma,0.8649,Intratubular Seminoma,0.8515,Testicular Seminoma with Syncytiotrophoblastic Cells,0.8190,Testicular Seminoma with High Mitotic Index,0.8149,"Testicular Seminoma, Pseudoglandular Variant",0.8120,Extragonadal Seminoma,0.8107,Testicular Spermatocytic Tumor,0.7625,Mixed Teratoma and Seminoma,0.7546,Stage I Testicular Seminoma AJCC v6 and v7,0.7502,"Testicular Seminoma, Cribriform Variant",0.7314,Testicular Mixed Embryonal Carcinoma and Seminoma,0.7150,Testicular Mixed Choriocarcinoma and Seminoma,0.7110,Suprasellar Germ Cell Tumor,0.7091,Testicular Teratoma,0.7060,Stage III Testicular Seminoma AJCC v6 and v7,0.7059,TESTICULAR SEMINOMA,True,True,True
TGCT,Testicular Germ Cell Tumor,99,2,"Tenosynovial Giant Cell Tumor, Diffuse Type",0.9940,Tenosynovial Giant Cell Tumor,0.9206,"Tenosynovial Giant Cell Tumor, Localized Type",0.8809,Malignant Tenosynovial Giant Cell Tumor,0.8804,Childhood Tenosynovial Giant Cell Tumor,0.8260,Giant Cell Tumor of Soft Tissue,0.7295,Giant Cell Tumor,0.7028,Giant Cell Neoplasm,0.6760,Giant Cell Tumor of Bone,0.6578,Giant Cell Sarcoma,0.6332,Tendon Sheath Fibroma,0.6192,Malignant Giant Cell Neoplasm,0.6166,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0.6112,Giant Cell Fibroblastoma,0.6104,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,0.6017,Dedifferentiated Solitary Fibrous Tumor,0.6012,Malignancy in Giant Cell Tumor of Bone,0.5943,Osteoclastic Giant Cell-Rich Tumor of Bone,0.5922,Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells,0.5903,Desmoplastic Small Round Cell Tumor,0.5777,Tenosynovial Giant Cell Tumor Diffuse Type,False,False,False
TGCT NON-SEM,Testicular Non-Seminomatous Germ Cell Tumor,1,2,Testicular Non-Seminomatous Germ Cell Tumor,0.7421,Childhood Testicular Non-Seminomatous Germ Cell Tumor,0.7286,Non-Metastatic Gestational Trophoblastic Tumor,0.7157,Testicular Germ Cell Neoplasia In Situ with Extratubular Extension,0.6986,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0.6944,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0.6883,Testicular Germ Cell Neoplasia In Situ,0.6842,Nongerminomatous Germ Cell Tumor,0.6761,Testicular Granulosa Cell Tumor,0.6621,Familial Testicular Germ Cell Tumor,0.6610,Childhood Nongerminomatous Germ Cell Tumor,0.6542,"Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0.6541,Regressed Testicular Germ Cell Tumor,0.6535,Testicular Pure Germ Cell Tumor,0.6516,Testicular Germ Cell Tumor,0.6435,Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor,0.6417,Juvenile Testicular Granulosa Cell Tumor,0.6365,Adult Testicular Granulosa Cell Tumor,0.6322,"Testicular Sex Cord-Stromal Tumor, Not Otherwise Specified",0.6322,Childhood Testicular Germ Cell Tumor,0.6289,TGCT NON-SEM,True,True,True
TGCT SEM,Testicular Seminoma,99,2,Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor,0.6937,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0.6933,Testicular Myeloid Sarcoma,0.6869,Testicular Granulosa Cell Tumor,0.6638,Systemic Mastocytosis with an Associated Germ Cell Tumor,0.6546,Metastatic Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2,0.6544,Testicular Sarcoma,0.6543,Testicular Mixed Sex Cord-Stromal Tumor,0.6508,Testicular Pure Germ Cell Tumor,0.6498,Mixed Germ Cell-Sex Cord-Stromal Tumor,0.6494,Childhood Testicular Mixed Germ Cell Tumor,0.6484,"Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0.6471,Testicular Mixed Germ Cell Tumor,0.6458,Testicular Germ Cell Tumor,0.6449,Familial Testicular Germ Cell Tumor,0.6443,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,0.6388,Childhood Testicular Germ Cell Tumor,0.6374,Gestational Trophoblastic Tumor by FIGO Stage,0.6359,"Testicular Seminoma, Tubular Variant",0.6353,Testicular Mixed Embryonal Carcinoma and Seminoma,0.6352,TGCT SEM,False,False,False
TGCT_NON-SEMINOMA,Testicular Non-Seminomatous Germ Cell Tumor,1,2,Testicular Non-Seminomatous Germ Cell Tumor,0.8895,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0.8432,Childhood Testicular Non-Seminomatous Germ Cell Tumor,0.8224,Nongerminomatous Germ Cell Tumor,0.7907,Testicular Germ Cell Tumor,0.7643,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0.7632,Germinomatous Germ Cell Tumor,0.7563,Testicular Granulosa Cell Tumor,0.7518,Testicular Pure Germ Cell Tumor,0.7446,"Testicular Seminoma, Tubular Variant",0.7403,Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7394,Ovarian Non-Dysgerminomatous Germ Cell Tumor,0.7339,Testicular Typical Seminoma,0.7305,Extragonadal Seminoma,0.7272,"Testicular Sex Cord-Stromal Tumor, Not Otherwise Specified",0.7272,Intratubular Non-Seminoma,0.7234,Childhood Nongerminomatous Germ Cell Tumor,0.7216,Seminoma,0.7200,Extragonadal Germ Cell Tumor,0.7164,Regressed Testicular Germ Cell Tumor,0.7162,TGCT_NON-SEMINOMA,True,True,True
TGCT_SEMINOMA,Testicular Seminoma,1,2,Testicular Seminoma,0.8889,Seminoma,0.8829,Testicular Typical Seminoma,0.8771,"Testicular Seminoma, Tubular Variant",0.8517,Intratubular Seminoma,0.8340,Childhood Seminoma,0.8195,Extragonadal Seminoma,0.8057,Testicular Seminoma with Syncytiotrophoblastic Cells,0.8036,Testicular Non-Seminomatous Germ Cell Tumor,0.7814,"Testicular Seminoma, Pseudoglandular Variant",0.7793,Mediastinal Seminoma,0.7763,Testicular Seminoma with High Mitotic Index,0.7702,Testicular Spermatocytic Tumor,0.7576,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0.7555,Testicular Germ Cell Tumor,0.7514,Testicular Mixed Embryonal Carcinoma and Seminoma,0.7413,Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor,0.7406,Testicular Pure Germ Cell Tumor,0.7354,Testicular Spermatocytic Tumor with Sarcoma,0.7302,Malignant Testicular Germ Cell Tumor,0.7287,TGCT_SEMINOMA,True,True,True
THCA,Thyroid Gland Carcinoma,99,2,AH Amyloidosis,0.5683,Beta-Catenin-Activated Hepatocellular Adenoma,0.5509,Beta-Catenin-Activated Inflammatory Hepatocellular Adenoma,0.5389,Hepatoblastoma,0.5375,Cholangiocarcinoma,0.5265,Trabecular Adenoma,0.5244,Adult Cholangiocarcinoma,0.5200,Hepatocellular Adenoma,0.5182,Essential Thrombocythemia,0.5174,Trichoblastoma,0.5159,Temporal Lobe Anaplastic Astrocytoma,0.5151,AHL Amyloidosis,0.5142,"T Acute Lymphoblastic Leukemia, HOXA Dysregulated",0.5114,Childhood Adrenal Cortical Adenoma,0.5112,Acanthoma,0.5108,Thymus Hepatoid Adenocarcinoma,0.5105,Non-Teratoid Hepatoblastoma,0.5099,Columnar Trichoblastoma,0.5091,Basal Cell Adenoma,0.5066,Strumal Carcinoid,0.5051,THCA,False,False,False
THERAPY-RELATED MYELODYSPLASTIC SYNDROME,Myelodysplastic Syndrome Post Cytotoxic Therapy,3,2,Refractory Myelodysplastic Syndrome,0.7553,Myelodysplastic Syndrome,0.7226,Myelodysplastic Syndrome Post Cytotoxic Therapy,0.7153,Recurrent Myelodysplastic Syndrome,0.7127,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0.7074,Therapy-Related Leukemia,0.7040,Alkylating Agent-Related Myelodysplastic Syndrome,0.6962,Secondary Myelodysplastic Syndrome,0.6944,Hereditary Myelodysplastic Syndrome,0.6839,Transient Abnormal Myelopoiesis Associated with Down Syndrome,0.6832,Adult Myelodysplastic Syndrome,0.6769,"Myelodysplastic Syndrome, Not Otherwise Specified",0.6734,De Novo Myelodysplastic Syndrome,0.6723,Myelodysplastic Syndrome with Somatic Mutation,0.6572,Hypoplastic Myelodysplastic Syndrome,0.6409,Myelodysplastic Syndrome with Genetic Abnormalities,0.6355,Refractory Myelodysplastic/Myeloproliferative Neoplasm,0.6295,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,0.6247,Childhood Myelodysplastic Syndrome,0.6206,Myelodysplastic Syndrome/Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,0.6186,THERAPY-RELATED MYELODYSPLASTIC SYNDROME,False,True,True
THERAPY-RELATED MYELOID NEOPLASMS,Myeloid Neoplasm Post Cytotoxic Therapy,9,2,Therapy-Related Neoplasm,0.8250,Therapy-Related Malignant Neoplasm,0.8248,Therapy-Related Leukemia,0.7679,Refractory Myeloid Neoplasm,0.7156,Refractory Mature T-Cell and NK-Cell Neoplasm,0.6914,Transplant-Related Hematologic Malignancy,0.6911,Transplant-Related Malignant Neoplasm,0.6867,Refractory T-Cell and NK-Cell Neoplasm,0.6766,Myeloid Neoplasm Post Cytotoxic Therapy,0.6738,Myeloid Neoplasm,0.6722,Radiation-Related Malignant Neoplasm,0.6338,Radiation-Related Neoplasm,0.6273,Virus-Related Malignant Neoplasm,0.6246,Recurrent Myeloid Neoplasm,0.6236,Refractory Myeloproliferative Neoplasm,0.6233,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,0.6230,Refractory Thrombocytopenia,0.6216,Refractory Malignant Lymphoid Neoplasm,0.6198,HTLV-1-Related Malignant Neoplasm,0.6194,Mature T-Cell and NK-Cell Neoplasm,0.6189,THERAPY-RELATED MYELOID NEOPLASMS,False,False,False
THPA,Thyroid Gland Papillary Carcinoma,1,2,Thyroid Gland Papillary Carcinoma,0.9468,Classic Thyroid Gland Papillary Carcinoma,0.9104,Thyroid Gland Papillary and Follicular Carcinoma,0.8260,Papillary Carcinoma,0.8249,Thyroid Gland Carcinoma,0.7934,Childhood Thyroid Gland Papillary Carcinoma,0.7910,Metastatic Thyroid Gland Papillary Carcinoma,0.7801,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.7684,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.7648,Poorly Differentiated Thyroid Gland Carcinoma,0.7648,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0.7635,Papillary Adenocarcinoma,0.7559,Follicular Variant Thyroid Gland Papillary Carcinoma,0.7535,Differentiated Thyroid Gland Carcinoma,0.7468,Multicentric Thyroid Gland Papillary Carcinoma,0.7429,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.7410,Unresectable Thyroid Gland Papillary Carcinoma,0.7370,Thyroid Gland Follicular Carcinoma,0.7360,Thyroid Gland Mixed Medullary and Papillary Carcinoma,0.7326,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,0.7305,Papillary Thyroid Cancer,True,True,True
THPD,Poorly Differentiated Thyroid Gland Carcinoma,1,2,Poorly Differentiated Thyroid Gland Carcinoma,0.9689,Differentiated Thyroid Gland Carcinoma,0.8672,Differentiated High Grade Thyroid Gland Carcinoma,0.7995,Metastatic Poorly Differentiated Thyroid Gland Carcinoma,0.7953,Poorly Differentiated Malignant Neoplasm,0.7952,Advanced Differentiated Thyroid Gland Carcinoma,0.7840,Unresectable Poorly Differentiated Thyroid Gland Carcinoma,0.7700,Thyroid Gland Carcinoma,0.7653,Thyroid Gland Adenocarcinoma,0.7557,Classic Thyroid Gland Papillary Carcinoma,0.7475,Thyroid Gland Anaplastic Carcinoma,0.7473,Thyroid Gland Papillary Carcinoma,0.7462,Advanced Thyroid Gland Carcinoma,0.7343,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.7275,Salivary Gland Poorly Differentiated Carcinoma,0.7272,Hepatocellular Poorly Differentiated Carcinoma,0.7227,Locally Advanced Differentiated Thyroid Gland Carcinoma,0.7203,Thyroid Gland Undifferentiated Small Cell Carcinoma,0.7179,Poorly Differentiated Chordoma,0.7151,Well Differentiated Malignant Neoplasm,0.7147,Poorly Differentiated Thyroid Cancer,True,True,True
THRBCL,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1,2,T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.6594,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.6289,Breast T-Cell Non-Hodgkin Lymphoma,0.6004,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.5944,Gallbladder Lymphoma,0.5904,Composite Lymphoma,0.5758,Trilateral Retinoblastoma,0.5741,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0.5716,Refractory Breast Lymphoma,0.5705,Hereditary Breast Carcinoma,0.5688,Colorectal Lymphoma,0.5677,Breast Lymphoma,0.5664,Cholangiocarcinoma,0.5658,Refractory Transformed Chronic Lymphocytic Leukemia,0.5644,Occult Breast Carcinoma,0.5630,Refractory T Lymphoblastic Lymphoma,0.5605,T Lymphoblastic Leukemia/Lymphoma,0.5603,Tracheal Lymphoma,0.5602,Lymphoma,0.5600,Breast Tall Cell Carcinoma with Reversed Polarity,0.5594,THRBCL,True,True,True
THYM,Thymoma,1,2,Thymoma,1.0000,Mediastinal Thymoma,0.9201,Microscopic Thymoma,0.9109,Malignant Thymoma,0.9102,Benign Thymoma,0.8973,Thymoma Type A,0.8782,Intrathyroidal Thymoma,0.8679,Invasive Thymoma,0.8557,Encapsulated Thymoma,0.8523,Thymoma Type B,0.8355,Noninvasive Malignant Thymoma,0.8320,Minimally Invasive Thymoma,0.8303,Advanced Malignant Thymoma,0.8245,Intrapulmonary Thymoma,0.8181,Thymoma Type B1,0.8167,Widely Invasive Thymoma,0.8146,Atypical Type A Thymoma,0.8119,Invasive Malignant Thymoma,0.8099,Thymoma Type AB,0.8086,Metaplastic Thymoma,0.8078,Thymoma,True,True,True
THYMIC CARCINOMA,Thymus Carcinoma,1,2,Thymus Carcinoma,0.9290,Intrathyroid Thymic Carcinoma,0.8616,"Thymus Carcinoma, Not Otherwise Specified",0.8454,Thymus Adenocarcinoma,0.8342,Advanced Thymus Carcinoma,0.8123,Thymic Epithelial Neoplasm,0.8101,Thymoma,0.8080,Thymus Squamous Cell Carcinoma,0.8037,Metastatic Thymus Carcinoma,0.8019,Thymus Undifferentiated Carcinoma,0.8011,Malignant Thymoma,0.7918,Malignant Thymus Neoplasm,0.7865,Thymus Neuroendocrine Carcinoma,0.7809,Unresectable Thymus Carcinoma,0.7803,Thymus Clear Cell Carcinoma,0.7780,"Thymus Adenocarcinoma, Not Otherwise Specified",0.7714,Tracheal Carcinoma,0.7596,Thymus Neoplasm,0.7584,Thymus Epithelial Neoplasm,0.7565,Thymus Lymphoepithelial Carcinoma,0.7550,THYMIC CARCINOMA,True,True,True
THYMIC EPITHELIAL TUMOR,Thymus Epithelial Neoplasm,2,2,Thymic Epithelial Neoplasm,0.9711,Thymus Epithelial Neoplasm,0.9214,Thymoma,0.8044,Combined Thymus Epithelial Neoplasm,0.7843,Thymus Neoplasm,0.7772,Thymus Lymphoepithelial Carcinoma,0.7685,Thymus Carcinoma,0.7619,Thymus Neuroendocrine Tumor,0.7573,Intrathyroidal Thymoma,0.7541,Thymus Neuroendocrine Neoplasm,0.7536,Intrathyroid Thymic Carcinoma,0.7500,Thymus Adenocarcinoma,0.7407,Benign Thymoma,0.7365,Encapsulated Thymoma,0.7347,Thymus Undifferentiated Carcinoma,0.7339,Mediastinal Thymoma,0.7327,Microscopic Thymoma,0.7325,Thymus Epithelial Neoplasm by AJCC v8 Stage,0.7308,Malignant Thymoma,0.7222,"Thymus Carcinoma, Not Otherwise Specified",0.7172,THYMIC EPITHELIAL TUMOR,False,True,True
THYMIC TUMOR,Thymus Neoplasm,1,2,Thymus Neoplasm,0.9144,Thymic Epithelial Neoplasm,0.8790,Thymoma,0.8564,Thymus Epithelial Neoplasm,0.8328,Thymus Carcinoma,0.8082,Malignant Thymus Neoplasm,0.8012,Thymus Adenocarcinoma,0.7919,Intrathyroidal Thymoma,0.7869,Thymus Neuroendocrine Neoplasm,0.7832,Mediastinal Thymoma,0.7799,Benign Thymoma,0.7760,Thymus Lymphoma,0.7759,Thymus Neuroendocrine Tumor,0.7736,Malignant Thymoma,0.7703,Thoracic Neoplasm,0.7657,Benign Thymus Neoplasm,0.7652,"Thymus Carcinoma, Not Otherwise Specified",0.7645,Intrathyroid Thymic Carcinoma,0.7575,Microscopic Thymoma,0.7555,Thymoma Type A,0.7460,THYMIC TUMOR,True,True,True
THYMOMA,Thymoma,1,2,Thymoma,1.0000,Mediastinal Thymoma,0.9201,Microscopic Thymoma,0.9109,Malignant Thymoma,0.9102,Benign Thymoma,0.8973,Thymoma Type A,0.8782,Intrathyroidal Thymoma,0.8679,Invasive Thymoma,0.8557,Encapsulated Thymoma,0.8523,Thymoma Type B,0.8355,Noninvasive Malignant Thymoma,0.8320,Minimally Invasive Thymoma,0.8303,Advanced Malignant Thymoma,0.8245,Intrapulmonary Thymoma,0.8181,Thymoma Type B1,0.8167,Widely Invasive Thymoma,0.8146,Atypical Type A Thymoma,0.8119,Invasive Malignant Thymoma,0.8099,Thymoma Type AB,0.8086,Metaplastic Thymoma,0.8078,THYMOMA,True,True,True
THYMOMA; TYPE A,Thymoma Type A,1,2,Thymoma Type A,0.9798,Malignant Type A Thymoma,0.9432,Atypical Type A Thymoma,0.9249,Thymoma,0.8681,Malignant Thymoma,0.8508,Intrathyroidal Thymoma,0.8279,Thymoma Type B,0.8163,Thymoma Type AB,0.8154,Microscopic Thymoma,0.8149,Mediastinal Thymoma,0.8126,Benign Thymoma,0.8070,Malignant Type AB Thymoma,0.7898,Stage IVA Thymoma AJCC v8,0.7889,Advanced Malignant Thymoma,0.7841,Thymoma Type B1,0.7765,Noninvasive Malignant Thymoma,0.7659,Invasive Thymoma,0.7636,Malignant Type B1 Thymoma,0.7580,Metaplastic Thymoma,0.7569,Thymoma Type B3,0.7484,THYMOMA; TYPE A,True,True,True
THYMOMA; TYPE AB,Thymoma Type AB,1,2,Thymoma Type AB,0.9664,Malignant Type AB Thymoma,0.9457,Thymoma Type B,0.8608,Thymoma Type A,0.8369,Atypical Type A Thymoma,0.8222,Malignant Type A Thymoma,0.8127,Thymoma,0.8097,Thymoma Type B3,0.8013,Malignant Thymoma,0.7990,Microscopic Thymoma,0.7967,Thymoma Type B2,0.7948,Thymoma Type B1,0.7876,Benign Thymoma,0.7725,Intrathyroidal Thymoma,0.7704,Advanced Malignant Thymoma,0.7680,Malignant Type B2 Thymoma,0.7640,Malignant Type B1 Thymoma,0.7627,Mediastinal Thymoma,0.7599,Invasive Thymoma,0.7319,Stage IVA Thymoma AJCC v8,0.7298,THYMOMA; TYPE AB,True,True,True
THYMOMA; TYPE B1,Thymoma Type B1,1,2,Thymoma Type B1,0.9756,Malignant Type B1 Thymoma,0.9373,Thymoma Type B,0.8654,Thymoma Type B2,0.8477,Thymoma,0.8178,Benign Thymoma,0.8109,Thymoma Type B3,0.8055,Mediastinal Thymoma,0.8008,Thymoma Type A,0.7951,Malignant Type B2 Thymoma,0.7850,Microscopic Thymoma,0.7839,Atypical Type A Thymoma,0.7726,Malignant Thymoma,0.7715,Thymoma Type AB,0.7621,Intrathyroidal Thymoma,0.7605,Malignant Type A Thymoma,0.7502,Noninvasive Malignant Thymoma,0.7389,Malignant Type AB Thymoma,0.7316,Advanced Malignant Thymoma,0.7306,Intrapulmonary Thymoma,0.7303,THYMOMA; TYPE B1,True,True,True
THYMOMA; TYPE B2,Thymoma Type B2,1,2,Thymoma Type B2,0.9772,Malignant Type B2 Thymoma,0.9403,Thymoma Type B,0.9021,Thymoma Type B1,0.8522,Thymoma Type B3,0.8359,Malignant Type B1 Thymoma,0.8141,Thymoma,0.7869,Thymoma Type AB,0.7740,Benign Thymoma,0.7726,Malignant Type AB Thymoma,0.7695,Malignant Thymoma,0.7673,Microscopic Thymoma,0.7667,Mediastinal Thymoma,0.7646,Thymoma Type A,0.7461,Stage IVB Thymoma AJCC v8,0.7299,Advanced Malignant Thymoma,0.7274,Atypical Type A Thymoma,0.7269,Intrathyroidal Thymoma,0.7235,Invasive Thymoma,0.7175,Malignant Type A Thymoma,0.7152,THYMOMA; TYPE B2,True,True,True
THYMOMA; TYPE B3,Thymoma Type B3,1,2,Thymoma Type B3,0.9803,Thymoma Type B,0.8326,Thymoma Type B2,0.8225,Thymoma Type B1,0.8058,Malignant Type B2 Thymoma,0.7817,Thymoma,0.7732,Malignant Type B1 Thymoma,0.7717,Thymoma Type AB,0.7693,Malignant Thymoma,0.7672,Malignant Type AB Thymoma,0.7660,Mediastinal Thymoma,0.7519,Thymoma Type A,0.7510,Benign Thymoma,0.7485,Advanced Malignant Thymoma,0.7379,Microscopic Thymoma,0.7344,Stage III Thymoma AJCC v8,0.7311,Intrathyroidal Thymoma,0.7306,Malignant Type A Thymoma,0.7281,Atypical Type A Thymoma,0.7277,Invasive Thymoma,0.7252,THYMOMA; TYPE B3,True,True,True
THYMOMA; TYPE C,Thymus Carcinoma,99,2,Thymoma Type B,0.8091,Thymoma,0.8087,Malignant Thymoma,0.8037,Thymoma Type A,0.7834,Thymoma Type B3,0.7830,Intrathyroidal Thymoma,0.7699,Mediastinal Thymoma,0.7694,Thymoma Type B2,0.7659,Advanced Malignant Thymoma,0.7651,Atypical Type A Thymoma,0.7643,Microscopic Thymoma,0.7611,Malignant Type A Thymoma,0.7592,Benign Thymoma,0.7509,Encapsulated Thymoma,0.7504,Widely Invasive Thymoma,0.7459,Metaplastic Thymoma,0.7434,Invasive Thymoma,0.7388,Intrathyroid Thymic Carcinoma,0.7361,Thymoma Type B1,0.7359,Malignant Type B2 Thymoma,0.7323,THYMOMA; TYPE C,False,False,False
THYROID CANCER,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9216,Thyroid Gland Adenocarcinoma,0.8388,Thyroid Gland Neoplasm,0.8280,Malignant Thyroid Gland Neoplasm,0.8097,Differentiated Thyroid Gland Carcinoma,0.8011,Thyroid Gland Follicular Carcinoma,0.7654,Thyroid Gland Lymphoma,0.7635,Thyroid Gland Papillary Carcinoma,0.7571,Childhood Thyroid Gland Carcinoma,0.7566,Thyroid Gland Anaplastic Carcinoma,0.7508,Advanced Thyroid Gland Carcinoma,0.7506,Thymus Carcinoma,0.7328,Thyroid Gland Medullary Carcinoma,0.7313,Thyroid Gland Oncocytic Carcinoma,0.7310,Poorly Differentiated Thyroid Gland Carcinoma,0.7202,Metastatic Thyroid Gland Carcinoma,0.7199,Intrathyroid Thymic Carcinoma,0.7163,Thyroid Gland Papillary and Follicular Carcinoma,0.7155,Thyroid Gland Secretory Carcinoma,0.7147,Classic Thyroid Gland Papillary Carcinoma,0.7136,THYROID CANCER,True,True,True
"THYROID CANCER, NOS",Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.8934,Malignant Thyroid Gland Neoplasm,0.7975,Thyroid Gland Adenocarcinoma,0.7962,Thyroid Gland Neoplasm,0.7861,Differentiated Thyroid Gland Carcinoma,0.7624,Thyroid Gland Follicular Carcinoma,0.7280,Thyroid Gland Papillary Carcinoma,0.7257,Childhood Thyroid Gland Carcinoma,0.7132,Thyroid Gland Medullary Carcinoma,0.7103,Advanced Thyroid Gland Carcinoma,0.7086,Thyroid Gland Lymphoma,0.6999,Thyroid Gland Anaplastic Carcinoma,0.6906,Thyroid Gland Oncocytic Carcinoma,0.6819,Thyroid Gland Papillary and Follicular Carcinoma,0.6818,Classic Thyroid Gland Papillary Carcinoma,0.6804,Metastatic Thyroid Gland Carcinoma,0.6797,"Thymus Carcinoma, Not Otherwise Specified",0.6729,Thymus Carcinoma,0.6703,Thyroid Gland Secretory Carcinoma,0.6700,Poorly Differentiated Thyroid Gland Carcinoma,0.6700,"THYROID CANCER, NOS",True,True,True
THYROID CARCINOMA,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9677,Thyroid Gland Adenocarcinoma,0.8636,Differentiated Thyroid Gland Carcinoma,0.8415,Thyroid Gland Papillary Carcinoma,0.8159,Thyroid Gland Follicular Carcinoma,0.8158,Thyroid Gland Medullary Carcinoma,0.8013,Thyroid Gland Anaplastic Carcinoma,0.7947,Malignant Thyroid Gland Neoplasm,0.7843,Carcinoma,0.7830,Advanced Thyroid Gland Carcinoma,0.7827,Classic Thyroid Gland Papillary Carcinoma,0.7719,Poorly Differentiated Thyroid Gland Carcinoma,0.7713,Thyroid Gland Mucinous Carcinoma,0.7686,Thymus Carcinoma,0.7681,Thyroid Gland Oncocytic Carcinoma,0.7639,Thyroid Gland Neoplasm,0.7634,Thyroid Gland Secretory Carcinoma,0.7621,Childhood Thyroid Gland Carcinoma,0.7618,Thyroid Gland Papillary and Follicular Carcinoma,0.7565,Metastatic Thyroid Gland Carcinoma,0.7433,THYROID CARCINOMA,True,True,True
THYROID CARCINOMA OTHER,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.8232,Differentiated Thyroid Gland Carcinoma,0.7523,Thyroid Gland Adenocarcinoma,0.7216,Thyroid Gland Medullary Carcinoma,0.7211,Thyroid Gland Papillary and Follicular Carcinoma,0.7199,Metastatic Thyroid Gland Carcinoma,0.7194,Thyroid Gland Anaplastic Carcinoma,0.7188,Thyroid Gland Follicular Carcinoma,0.7168,Thyroid Gland Papillary Carcinoma,0.7138,Classic Thyroid Gland Papillary Carcinoma,0.7064,Thyroid Gland Oncocytic Carcinoma,0.7060,Thyroid Gland Neoplasm,0.6971,Childhood Thyroid Gland Carcinoma,0.6951,Sporadic Thyroid Gland Medullary Carcinoma,0.6934,Advanced Thyroid Gland Carcinoma,0.6924,Unresectable Thyroid Gland Carcinoma,0.6882,Hereditary Nonmedullary Thyroid Gland Carcinoma,0.6821,NUT Carcinoma,0.6795,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0.6769,Thyroid Gland Mucinous Carcinoma,0.6756,THYROID CARCINOMA OTHER,True,True,True
THYROID PAPILLARY,Thyroid Gland Papillary Carcinoma,1,2,Thyroid Gland Papillary Carcinoma,0.8186,Classic Thyroid Gland Papillary Carcinoma,0.8021,Papillary Adenoma,0.7364,Papillary Neoplasm,0.7350,Papillary Carcinoma,0.7240,Papillary Adenocarcinoma,0.7054,Thyroid Gland Follicular Adenoma with Papillary Architecture,0.7044,Thyroid Gland Papillary and Follicular Carcinoma,0.7003,Papillary Meningioma,0.6964,Childhood Thyroid Gland Papillary Carcinoma,0.6934,Metastatic Thyroid Gland Papillary Carcinoma,0.6888,Aggressive Papillary Tumor,0.6866,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0.6746,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,0.6736,Thyroid Gland Carcinoma,0.6709,Lung Papillary Adenocarcinoma,0.6635,Poorly Differentiated Thyroid Gland Carcinoma,0.6630,Follicular Variant Thyroid Gland Papillary Carcinoma,0.6629,Thyroid Gland Follicular Lymphoma,0.6618,Thyroid Gland Lymphoma,0.6610,THYROID PAPILLARY,True,True,True
THYROID PAPILLARY CARCINOMA - CLASSICAL/USUAL,Classic Thyroid Gland Papillary Carcinoma,1,2,Classic Thyroid Gland Papillary Carcinoma,0.8567,Thyroid Gland Papillary Carcinoma,0.8029,Thyroid Gland Papillary and Follicular Carcinoma,0.7668,Encapsulated Variant Thyroid Gland Papillary Carcinoma,0.7613,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0.7593,Follicular Variant Thyroid Gland Papillary Carcinoma,0.7341,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.7322,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.7287,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.7279,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,0.7212,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,0.7186,Thyroid Gland Mixed Medullary and Papillary Carcinoma,0.7148,Poorly Differentiated Thyroid Gland Carcinoma,0.7067,Unresectable Thyroid Gland Papillary Carcinoma,0.6934,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0.6852,Papillary Carcinoma,0.6847,Childhood Thyroid Gland Papillary Carcinoma,0.6837,Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma,0.6809,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,0.6743,Multicentric Thyroid Gland Papillary Carcinoma,0.6743,THYROID PAPILLARY CARCINOMA - CLASSICAL/USUAL,True,True,True
THYROID PAPILLARY CARCINOMA - FOLLICULAR >= 99% FOLLICULAR PATTERNED,Follicular Variant Thyroid Gland Papillary Carcinoma,1,2,Follicular Variant Thyroid Gland Papillary Carcinoma,0.7122,Thyroid Gland Papillary and Follicular Carcinoma,0.7109,Classic Thyroid Gland Papillary Carcinoma,0.6795,Invasive Follicular Variant Thyroid Gland Papillary Carcinoma,0.6632,Invasive Encapsulated Follicular Variant Thyroid Gland Papillary Carcinoma,0.6553,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,0.6447,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0.6429,Thyroid Gland Papillary Carcinoma,0.6401,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,0.6309,High Grade Follicular Cell-Derived Non-Anaplastic Thyroid Gland Carcinoma,0.6298,Thyroid Gland Follicular Carcinoma,0.6280,Thyroid Gland Follicular Adenoma with Papillary Architecture,0.6248,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,0.6149,Encapsulated Variant Thyroid Gland Papillary Carcinoma,0.6079,Unresectable Thyroid Gland Follicular Carcinoma,0.6068,Metastatic Thyroid Gland Follicular Carcinoma,0.6060,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like/Desmoid-Type Stroma,0.6028,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.6027,"Thyroid Gland Follicular Carcinoma, Clear Cell Variant",0.6001,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0.5963,THYROID PAPILLARY CARCINOMA - FOLLICULAR >= 99% FOLLICULAR PATTERNED,True,True,True
THYROID PAPILLARY CARCINOMA - TALL CELL >= 50% TALL CELL FEATURES,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1,2,Tall Cell Variant Thyroid Gland Papillary Carcinoma,0.7917,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,0.6825,Classic Thyroid Gland Papillary Carcinoma,0.6672,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,0.6595,Thyroid Gland Papillary Carcinoma,0.6446,Clear Cell Variant Thyroid Gland Papillary Carcinoma,0.6255,Oncocytic Variant Thyroid Gland Papillary Carcinoma,0.6254,Thyroid Gland Anaplastic Carcinoma,0.6186,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,0.6167,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,0.6077,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0.6062,Hobnail Variant Thyroid Gland Papillary Carcinoma,0.6036,Follicular Variant Thyroid Gland Papillary Carcinoma,0.5960,Refractory Thyroid Gland Papillary Carcinoma,0.5959,Thyroid Gland Papillary and Follicular Carcinoma,0.5912,Poorly Differentiated Thyroid Gland Carcinoma,0.5881,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",0.5858,Glassy Cell Carcinoma,0.5807,Advanced Thyroid Gland Anaplastic Carcinoma,0.5728,Thyroid Gland Mixed Medullary and Papillary Carcinoma,0.5697,THYROID PAPILLARY CARCINOMA - TALL CELL >= 50% TALL CELL FEATURES,True,True,True
THYROID POORLY DIFFERENTIATED,Poorly Differentiated Thyroid Gland Carcinoma,1,2,Poorly Differentiated Thyroid Gland Carcinoma,0.8736,Differentiated Thyroid Gland Carcinoma,0.8029,Differentiated High Grade Thyroid Gland Carcinoma,0.7628,Poorly Differentiated Malignant Neoplasm,0.7588,Advanced Differentiated Thyroid Gland Carcinoma,0.7497,Metastatic Poorly Differentiated Thyroid Gland Carcinoma,0.7424,Thyroid Gland Well-Differentiated Tumor of Uncertain Malignant Potential,0.7413,Unresectable Poorly Differentiated Thyroid Gland Carcinoma,0.7137,Malignant Thyroid Gland Neoplasm,0.7105,Thyroid Gland Adenocarcinoma,0.7073,Well Differentiated Malignant Neoplasm,0.7040,Advanced Thyroid Gland Carcinoma,0.6990,Thyroid Gland Lymphoma,0.6977,Thyroid Gland Carcinoma,0.6893,Locally Advanced Differentiated Thyroid Gland Carcinoma,0.6891,Poorly Differentiated Chordoma,0.6880,Recurrent Poorly Differentiated Thyroid Gland Carcinoma,0.6737,Thyroid Gland Anaplastic Carcinoma,0.6736,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage,0.6710,Metastatic Differentiated Thyroid Gland Carcinoma,0.6709,THYROID POORLY DIFFERENTIATED,True,True,True
THYROID SARCOMA,Thyroid Gland Sarcoma,1,2,Thyroid Gland Sarcoma,0.9700,Testicular Sarcoma,0.7973,Tracheal Sarcoma,0.7973,Thyroid Gland Leiomyosarcoma,0.7828,Thyroid Gland Follicular Dendritic Cell Sarcoma,0.7735,Sarcoma,0.7703,Cardiac Sarcoma,0.7531,Conjunctival Sarcoma,0.7423,Synovial Sarcoma,0.7406,Thyroid Gland Solitary Fibrous Tumor,0.7397,Kidney Sarcoma,0.7260,Laryngeal Sarcoma,0.7248,Cardiac Synovial Sarcoma,0.7241,Thymus Sarcomatoid Carcinoma,0.7168,Prostate Sarcoma,0.7156,Lung Sarcoma,0.7152,Pericardial Sarcoma,0.7114,Esophageal Synovial Sarcoma,0.7079,Skin Sarcoma,0.7068,Orbital Sarcoma,0.7046,THYROID SARCOMA,True,True,True
THYROID_CARCINOMA,Thyroid Gland Carcinoma,1,2,Thyroid Gland Carcinoma,0.9303,Thyroid Gland Adenocarcinoma,0.8268,Differentiated Thyroid Gland Carcinoma,0.8098,Thyroid Gland Medullary Carcinoma,0.7838,Thyroid Gland Follicular Carcinoma,0.7753,Malignant Thyroid Gland Neoplasm,0.7747,Thyroid Gland Papillary Carcinoma,0.7707,Thyroid Gland Anaplastic Carcinoma,0.7663,Carcinoma,0.7648,Thyroid Gland Mucinous Carcinoma,0.7565,Advanced Thyroid Gland Carcinoma,0.7504,Poorly Differentiated Thyroid Gland Carcinoma,0.7440,Thyroid Gland Papillary and Follicular Carcinoma,0.7411,Thyroid Gland Secretory Carcinoma,0.7402,Thyroid Gland Oncocytic Carcinoma,0.7368,Classic Thyroid Gland Papillary Carcinoma,0.7351,Metastatic Thyroid Gland Carcinoma,0.7309,Thyroid Gland Neoplasm,0.7272,Childhood Thyroid Gland Carcinoma,0.7230,Unresectable Thyroid Gland Carcinoma,0.7169,THYROID_CARCINOMA,True,True,True
THYROID_SARCOMA,Thyroid Gland Sarcoma,1,2,Thyroid Gland Sarcoma,0.9438,Thyroid Gland Leiomyosarcoma,0.7709,Thyroid Gland Follicular Dendritic Cell Sarcoma,0.7591,Testicular Sarcoma,0.7543,Tracheal Sarcoma,0.7536,Sarcoma,0.7480,Thyroid Gland Solitary Fibrous Tumor,0.7376,Cardiac Sarcoma,0.7084,Synovial Sarcoma,0.7045,Conjunctival Sarcoma,0.6912,Thymus Sarcomatoid Carcinoma,0.6909,Thyroid Gland Angiosarcoma,0.6865,Sarcomatosis,0.6845,Thyroid Gland Leiomyoma,0.6801,Cardiac Synovial Sarcoma,0.6780,Kidney Sarcoma,0.6761,Laryngeal Sarcoma,0.6756,Cervical Sarcoma,0.6755,Pericardial Sarcoma,0.6725,Skin Sarcoma,0.6689,THYROID_SARCOMA,True,True,True
TLL,T Lymphoblastic Leukemia/Lymphoma,1,2,T Lymphoblastic Leukemia/Lymphoma,0.9903,T Lymphoblastic Lymphoma,0.9476,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.9369,T Acute Lymphoblastic Leukemia,0.8960,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.8875,Childhood T Lymphoblastic Leukemia/Lymphoma,0.8834,Childhood T Lymphoblastic Lymphoma,0.8556,Adult T Lymphoblastic Lymphoma,0.8356,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.8260,Early T Precursor Lymphoblastic Leukemia/Lymphoma,0.8238,Adult T-Cell Leukemia/Lymphoma,0.8234,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.7981,T-Cell Large Granular Lymphocyte Leukemia,0.7961,T-Cell Chronic Lymphocytic Leukemia,0.7935,T Acute Lymphoblastic Leukemia with TLX1 Rearrangement,0.7854,Childhood T Acute Lymphoblastic Leukemia,0.7833,T Acute Lymphoblastic Leukemia with TAL1 Rearrangement,0.7818,T Acute Lymphoblastic Leukemia with LMO1 Rearrangement,0.7786,T Acute Lymphoblastic Leukemia with LMO2 Rearrangement,0.7776,T-Cell Non-Hodgkin Lymphoma,0.7763,T-Lymphoblastic Leukemia/Lymphoma,True,True,True
TRANSITIONAL CELL CARCINOMA,Transitional Cell Carcinoma,1,2,Transitional Cell Carcinoma,1.0000,Transitional Cell Neoplasm,0.8885,Endometrial Transitional Cell Carcinoma,0.8744,Advanced Transitional Cell Carcinoma,0.8680,Papillary Transitional Cell Carcinoma,0.8575,Urothelial Carcinoma,0.8370,Ovarian Transitional Cell Carcinoma,0.8128,Micropapillary Transitional Cell Carcinoma,0.8128,Sarcomatoid Transitional Cell Carcinoma,0.8104,Locally Advanced Transitional Cell Carcinoma,0.7912,Metastatic Transitional Cell Carcinoma,0.7843,Unresectable Transitional Cell Carcinoma,0.7678,Bladder Urothelial Carcinoma,0.7606,Bartholin Gland Transitional Cell Carcinoma,0.7576,Transitional Cell Papilloma,0.7576,Invasive Tubular Urothelial Carcinoma,0.7466,Urethral Urothelial Carcinoma,0.7461,Fallopian Tube Transitional Cell Carcinoma,0.7412,Bladder Carcinoma,0.7406,Tubulocystic Renal Cell Carcinoma,0.7334,TRANSITIONAL CELL CARCINOMA,True,True,True
TRANSITIONAL_CELL_CARCINOMA,Transitional Cell Carcinoma,1,2,Transitional Cell Carcinoma,0.9410,Transitional Cell Neoplasm,0.8566,Endometrial Transitional Cell Carcinoma,0.8384,Advanced Transitional Cell Carcinoma,0.8333,Papillary Transitional Cell Carcinoma,0.8020,Sarcomatoid Transitional Cell Carcinoma,0.7941,Urothelial Carcinoma,0.7886,Micropapillary Transitional Cell Carcinoma,0.7760,Locally Advanced Transitional Cell Carcinoma,0.7628,Ovarian Transitional Cell Carcinoma,0.7528,Metastatic Transitional Cell Carcinoma,0.7507,Unresectable Transitional Cell Carcinoma,0.7397,Transitional Cell Papilloma,0.7336,Bladder Urothelial Carcinoma,0.7094,Refractory Endometrial Transitional Cell Carcinoma,0.7064,Invasive Tubular Urothelial Carcinoma,0.7047,Urinary Tract Carcinoma,0.7017,Invasive Conventional Urothelial Carcinoma,0.6975,Bladder Carcinoma,0.6956,Transitional Cell Intraepithelial Neoplasia,0.6942,TRANSITIONAL_CELL_CARCINOMA,True,True,True
TRANSLOCATION-ASSOCIATED RENAL CELL CARCINOMA,Renal Cell Carcinoma with MiT Translocations,1,2,Renal Cell Carcinoma with MiT Translocations,0.7942,TFE3-Rearranged Renal Cell Carcinoma,0.7832,TFEB-Rearranged Renal Cell Carcinoma,0.7776,Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations,0.7749,Transplant-Related Renal Cell Carcinoma,0.7687,Childhood Renal Cell Carcinoma with MiT Translocations,0.7323,ELOC-Mutated Renal Cell Carcinoma,0.7161,ALK-Rearranged Renal Cell Carcinoma,0.7092,Renal Cell Carcinoma,0.7074,Acquired Cystic Disease-Associated Renal Cell Carcinoma,0.7062,Tubulocystic Renal Cell Carcinoma,0.7004,Non-Clear Cell Renal Cell Carcinoma,0.6953,Childhood ALK-Rearranged Renal Cell Carcinoma,0.6934,Hereditary Renal Cell Carcinoma,0.6903,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34),0.6900,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.6866,"Renal Cell Carcinoma, Not Otherwise Specified",0.6760,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),0.6727,Renal Cell Carcinoma Associated with inv(X)(p11;q12),0.6636,Renal Cell Carcinoma Associated with Neuroblastoma,0.6629,TRANSLOCATION-ASSOCIATED RENAL CELL CARCINOMA,True,True,True
TREATED PRIMARY GBM,Glioblastoma,5,2,Classical Glioblastoma,0.7022,Unresectable Glioblastoma,0.6859,Secondary Glioblastoma,0.6819,Resectable Glioblastoma,0.6818,Glioblastoma,0.6760,Advanced Glioblastoma,0.6759,Refractory Glioblastoma,0.6742,Supratentorial Glioblastoma,0.6727,Metastatic Glioblastoma,0.6686,Cerebral Glioblastoma,0.6665,Proneural Glioblastoma,0.6665,Metastatic Glioma,0.6663,Refractory WHO Grade 1 Glioma,0.6629,Refractory Malignant Glioma,0.6619,Brain Glioblastoma,0.6592,MGMT-Methylated Glioblastoma,0.6588,Unresectable Glioma,0.6553,Recurrent MGMT-Methylated Glioblastoma,0.6504,Adult Glioblastoma,0.6475,Refractory Glioma,0.6475,TREATED PRIMARY GBM,False,False,True
TRILATERAL,Trilateral Retinoblastoma,1,2,Trilateral Retinoblastoma,0.6905,Splenic T Lymphoblastic Lymphoma,0.5357,Retroperitoneal Lymphoma,0.5186,T Lymphoblastic Leukemia/Lymphoma,0.5178,Refractory T Lymphoblastic Leukemia/Lymphoma,0.5177,T Lymphoblastic Lymphoma,0.5150,Refractory T Lymphoblastic Lymphoma,0.5113,Composite Lymphoma,0.5064,Adult T Lymphoblastic Lymphoma,0.4990,Mediastinal T Lymphoblastic Leukemia/Lymphoma,0.4954,Lymphoma,0.4940,Liver Lymphoma,0.4911,Refractory T Acute Lymphoblastic Leukemia,0.4883,T Acute Lymphoblastic Leukemia with TLX3 Rearrangement,0.4877,Mediastinal T Lymphoblastic Lymphoma,0.4874,Liver Teratoma,0.4869,Refractory Lymphoblastic Lymphoma,0.4865,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.4864,Testicular Leukemia,0.4856,Unfavorable Hodgkin Lymphoma,0.4856,TRILATERAL,True,True,True
TUBULAR STOMACH ADENOCARCINOMA,Gastric Tubular Adenocarcinoma,1,2,Gastric Tubular Adenocarcinoma,0.9696,Gastric Tubular Adenoma,0.8530,Gastric Adenocarcinoma,0.8453,Tubular Adenocarcinoma,0.8379,Proximal Gastric Adenocarcinoma,0.7770,Sporadic Gastric Adenocarcinoma,0.7762,Adenocarcinoma in Tubular Adenoma,0.7718,Gastric Intestinal-Type Adenocarcinoma,0.7714,Gastric Carcinoma,0.7582,Gastric Diffuse Adenocarcinoma,0.7570,Gastric Intramucosal Adenocarcinoma,0.7466,Localized Gastric Adenocarcinoma,0.7463,Gastric Papillary Adenocarcinoma,0.7451,Gastric Adenoma,0.7437,Gastrointestinal Tract Tubular Adenoma,0.7436,Gastric Mucinous Adenocarcinoma,0.7258,Advanced Gastric Adenocarcinoma,0.7218,"Gastric Adenoma, Gastric-Type",0.7208,Sporadic Gastric Diffuse Adenocarcinoma,0.7186,Goblet Cell Adenocarcinoma,0.7170,TUBULAR STOMACH ADENOCARCINOMA,True,True,True
TUBULAR_ADENOCARCINOMA,Tubular Adenocarcinoma,1,2,Tubular Adenocarcinoma,0.9586,Adenocarcinoma in Tubular Adenoma,0.8924,Gastric Tubular Adenocarcinoma,0.8220,Tubular Neoplasm,0.7996,Adenocarcinoma,0.7844,Trabecular Adenocarcinoma,0.7553,Breast Tubular Carcinoma,0.7475,Papillary Adenocarcinoma,0.7343,Adenocarcinoma In Situ in Tubular Adenoma,0.7332,Thyroid Gland Adenocarcinoma,0.7331,Colon Tubular Adenoma,0.7313,Urinary Tract Adenocarcinoma,0.7276,Adenocarcinoma in Tubulovillous Adenoma,0.7159,Comedo-Type Adenocarcinoma,0.7114,Gastrointestinal Tract Tubular Adenoma,0.7112,Bladder Adenocarcinoma,0.7074,Diffuse Type Adenocarcinoma,0.7056,Intestinal-Type Adenocarcinoma,0.7042,Colorectal Tubular Adenoma,0.7025,Epididymal Adenocarcinoma,0.7017,TUBULAR_ADENOCARCINOMA,True,True,True
TUMOR PRIMARY,Primary Neoplasm,1,2,Primary Neoplasm,0.9280,Primary Malignant Neoplasm,0.8345,Primary Brain Neoplasm,0.7084,Second Primary Neoplasm,0.6881,Secondary Neoplasm,0.6801,Primary Peritoneal Adenocarcinoma,0.6741,Primary Central Nervous System Neoplasm,0.6579,Neoplasm by Site,0.6570,Neoplastic Polyp,0.6542,Primary Peritoneal Carcinoma,0.6467,Localized Malignant Neoplasm,0.6448,Primary Brain Stem Neoplasm,0.6426,Localized Neoplasm,0.6372,Malignant Neoplasm of Unknown Primary,0.6344,Pancreatic Polypeptide Tumor,0.6332,Second Primary Malignant Neoplasm,0.6318,Adenoma,0.6318,Primary Bone Osteosarcoma,0.6315,Placental Site Trophoblastic Tumor,0.6285,Peritoneal Neoplasm,0.6280,TUMOR PRIMARY,True,True,True
TYPE A,Thymoma Type A,6,2,Type A Spindle Cell Melanoma,0.6467,Stage A Prostate Cancer,0.6440,Atypical Type A Thymoma,0.6426,Type A Lymphomatoid Papulosis,0.6305,Adenoma,0.6261,Thymoma Type A,0.6183,Diffuse Type Adenocarcinoma,0.6180,Malignant Type A Thymoma,0.6164,Grade 3a Malignant Neoplasm,0.6113,Atypical Adenoma,0.5876,Primary Amyloidosis,0.5866,Luminal A Prostate Carcinoma,0.5859,Flat Adenoma,0.5857,Well Differentiated Malignant Neoplasm,0.5839,Luminal A Breast Carcinoma,0.5832,Stage IVA Rectal Cancer AJCC v8,0.5788,Grade 3a Follicular Lymphoma,0.5783,Stage IIA Rectal Cancer AJCC v8,0.5717,Ameloblastic Carcinoma-Primary Type,0.5674,Foveolar-Type Adenoma,0.5669,TYPE A,False,False,False
TYPE AB,Thymoma Type AB,1,2,Thymoma Type AB,0.6187,Malignant Type AB Thymoma,0.6069,Diffuse Type Adenocarcinoma,0.5653,Trabecular Adenocarcinoma,0.5464,Adult Acute Basophilic Leukemia,0.5463,Barrett Adenocarcinoma,0.5381,Adenoma,0.5362,Trabecular Adenoma,0.5303,Blastoma,0.5270,Benign Anal Granular Cell Tumor,0.5242,Benign Ameloblastoma,0.5235,Acute Basophilic Leukemia,0.5233,Branchioma,0.5220,Granular Cell Ameloblastoma,0.5215,Alpha Heavy Chain Disease,0.5210,Ciliary Body Adenocarcinoma,0.5210,Acute Bilineal Leukemia,0.5204,Ameloblastoma,0.5190,Atypical Adenoma,0.5173,Mixed Cell Adenocarcinoma,0.5156,TYPE AB,True,True,True
TYPE ATHYMOMA,Thymoma Type A,99,2,Adenoma,0.6525,Adenomyoma,0.6433,Angioleiomyoma,0.6294,Atrial Myxoma,0.6292,Myxoma,0.6276,Adenomatoid Tumor,0.6170,Acanthoma,0.6111,Angiomyxoma,0.6109,Classic Type Trichilemmoma,0.6103,Trichilemmoma,0.6090,Solid Angioleiomyoma,0.6084,Ameloblastoma,0.6044,Cardiac Myxoma,0.6043,Trichoblastoma,0.6026,Glomangiomyoma,0.5977,Follicular Myxoma,0.5965,Pilomatricoma,0.5960,Amyloid Tumor,0.5953,Atypical Adenoma,0.5935,Thymoma,0.5928,TYPE ATHYMOMA,False,False,False
TYPE B1,Thymoma Type B1,2,2,Malignant Type B1 Thymoma,0.6913,Thymoma Type B1,0.6695,Astler-Coller B1 Colon Carcinoma,0.5923,Biliary Intraepithelial Neoplasia-1,0.5871,Breast Neuroendocrine Tumor G1,0.5804,Astler-Coller B1 Colorectal Carcinoma,0.5770,Astler-Coller B1 Rectal Carcinoma,0.5749,Blastoma,0.5746,Neuroblastoma,0.5683,Branchioma,0.5673,Gallbladder Neuroendocrine Tumor G1,0.5658,Poorly Differentiated Neuroblastoma,0.5645,Extrahepatic Bile Duct Neuroendocrine Tumor G1,0.5639,Bronchial Intraepithelial Neoplasia,0.5632,Biliary Intraepithelial Neoplasia,0.5613,Stage 1 Neuroblastoma,0.5587,Leukemia,0.5587,Luminal B Breast Carcinoma,0.5554,Gallbladder Flat Biliary Intraepithelial Neoplasia,0.5552,Unilateral Retinoblastoma,0.5546,TYPE B1,False,True,True
TYPE B1THYMOMA,Thymoma Type B1,2,2,Malignant Type B1 Thymoma,0.7105,Thymoma Type B1,0.6800,Thymoma Type A,0.6227,Metaplastic Thymoma,0.6206,Atypical Type A Thymoma,0.6199,Thyroblastoma,0.6126,Thymoma Type AB,0.6121,Noninvasive Malignant Thymoma,0.6080,Intrathyroidal Thymoma,0.6080,Malignant Type A Thymoma,0.6024,Malignant Type AB Thymoma,0.5917,Thymoma Type B,0.5892,Benign Thymoma,0.5871,Thymus Lipofibroadenoma,0.5861,Orbital Meningioma,0.5811,Thymoma,0.5783,Meningioma,0.5771,Microscopic Thymoma,0.5750,Trichoadenoma,0.5693,Grade 1 Meningioma,0.5669,TYPE B1THYMOMA,False,True,True
TYPE B2,Thymoma Type B2,2,2,Malignant Type B2 Thymoma,0.6820,Thymoma Type B2,0.6684,Branchioma,0.6262,Astler-Coller B2 Colon Carcinoma,0.6179,Astler-Coller B2 Colorectal Carcinoma,0.6107,Astler-Coller B2 Rectal Carcinoma,0.6076,Type B Spindle Cell Melanoma,0.6014,Stage IIB Retinoblastoma,0.5942,Stage 2B Neuroblastoma,0.5926,Luminal B Breast Carcinoma,0.5893,Thymoma Type B,0.5856,Diffuse Type Adenocarcinoma,0.5837,Neuroblastoma,0.5829,Barrett Adenocarcinoma,0.5825,Luminal B Prostate Carcinoma,0.5728,BN2 Diffuse Large B-Cell Lymphoma,0.5722,Poorly Differentiated Neuroblastoma,0.5713,Bilateral Retinoblastoma,0.5700,Multiple Endocrine Neoplasia Type 2B,0.5681,Stage IIB Rectal Cancer AJCC v8,0.5664,TYPE B2,False,True,True
TYPE B2THYMOMA,Thymoma Type B2,2,2,Malignant Type B2 Thymoma,0.7012,Thymoma Type B2,0.6797,Metaplastic Thymoma,0.6513,Malignant Type AB Thymoma,0.6500,Thymoma Type AB,0.6494,Thymoma Type B,0.6461,Malignant Type B1 Thymoma,0.6363,Thyroblastoma,0.6261,Thymoma Type B1,0.6105,Atypical Type A Thymoma,0.6043,Thymoma Type B3,0.6032,Thymoma Type A,0.5957,Type B Spindle Cell Melanoma,0.5938,Intrathyroidal Thymoma,0.5876,Transitional Meningioma,0.5859,Malignant Type A Thymoma,0.5835,Noninvasive Malignant Thymoma,0.5816,Breast Myoepithelial Tumor,0.5798,Metastatic Thyroid Gland Anaplastic Carcinoma,0.5788,Malignant Thymoma,0.5779,TYPE B2THYMOMA,False,True,True
TYPE B3,Thymoma Type B3,1,2,Thymoma Type B3,0.6881,Astler-Coller B3 Colon Carcinoma,0.6697,Astler-Coller B3 Colorectal Carcinoma,0.6502,Astler-Coller B3 Rectal Carcinoma,0.6410,Grade 3b Malignant Neoplasm,0.6069,Grade 3b Follicular Lymphoma,0.5983,Diffuse Type Adenocarcinoma,0.5854,Stage III Retinoblastoma,0.5701,Anatomic Stage III Breast Cancer AJCC v8,0.5697,Stage IIIB Retinoblastoma,0.5684,Stage III Breast Cancer AJCC v6,0.5662,Disseminated Adenocarcinoma,0.5609,Stage IVB Gallbladder Cancer AJCC v8,0.5606,Anatomic Stage IIIC Breast Cancer AJCC v8,0.5602,Stage IVB Cervical Cancer AJCC v8,0.5601,Adenocarcinoma,0.5568,Stage IVB Rectal Cancer AJCC v8,0.5550,Stage IIIC Breast Cancer AJCC v6,0.5541,Stage III Prostate Cancer AJCC v8,0.5537,Stage III Breast Cancer AJCC v7,0.5533,TYPE B3,True,True,True
TYPE C,Thymus Carcinoma,99,2,Stage C Prostate Cancer,0.6397,Type C Lymphomatoid Papulosis,0.6350,Stage C Chronic Lymphocytic Leukemia,0.6142,Stage IIIC Prostate Cancer AJCC v8,0.6030,Diffuse Type Adenocarcinoma,0.6006,BCLC Stage C Hepatocellular Carcinoma,0.5982,Stage IIIC Hepatocellular Carcinoma AJCC v7,0.5968,Stage IIIC Rectal Cancer AJCC v8,0.5951,Stage IIIC Colorectal Cancer AJCC v8,0.5925,Stage IIIC Lung Cancer AJCC v8,0.5891,Carcinoma,0.5887,Stage IIIC Colon Cancer AJCC v8,0.5844,Anatomic Stage IIIC Breast Cancer AJCC v8,0.5817,Undifferentiated Carcinoma,0.5810,Stage IIIC Cervical Cancer FIGO 2018,0.5787,Stage IIIC Colorectal Cancer AJCC v7,0.5784,Stage IIIC Cervical Cancer AJCC v9,0.5781,Stage IIC Rectal Cancer AJCC v8,0.5772,Stage IIIC Testicular Cancer AJCC v8,0.5771,Disseminated Carcinoma,0.5755,TYPE C,False,False,False
T_CELL_ALCL,Anaplastic Large Cell Lymphoma,14,2,Adult T-Cell Leukemia/Lymphoma,0.7247,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0.7163,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.7156,"Peripheral T-Cell Lymphoma, Large Cell",0.7068,Chronic Adult T-Cell Leukemia/Lymphoma,0.7043,T-Cell Chronic Lymphocytic Leukemia,0.7032,T Lymphoblastic Leukemia/Lymphoma,0.6957,T-Cell Non-Hodgkin Lymphoma,0.6946,T Lymphoblastic Lymphoma,0.6914,Aggressive T-Cell Non-Hodgkin Lymphoma,0.6888,Lymphohistiocytic Variant Anaplastic Large Cell Lymphoma,0.6816,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma,0.6779,Common Variant Anaplastic Large Cell Lymphoma,0.6773,Anaplastic Large Cell Lymphoma,0.6737,T-Cell Large Granular Lymphocyte Leukemia,0.6712,Adult T Lymphoblastic Lymphoma,0.6666,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.6666,Acute Adult T-Cell Leukemia/Lymphoma,0.6658,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant",0.6615,Mature T-ALL,0.6596,T_CELL_ALCL,False,False,False
T_CELL_CUTANEOUS,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1,2,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.7090,Cutaneous Mature T-Cell and NK-Cell Neoplasm,0.6656,Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6631,Cutaneous Lymphoma,0.6551,Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,0.6422,Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma,0.6372,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",0.6366,"Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified",0.6356,Primary Cutaneous Gamma-Delta T-Cell Lymphoma,0.6336,Cutaneous Mastocytosis,0.6217,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.6182,Cutaneous Adult T-Cell Leukemia/Lymphoma,0.6110,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,0.6084,Primary Cutaneous Lymphoma,0.6073,Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,0.6047,Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma,0.5936,Cutaneous Lymphomatoid Granulomatosis,0.5907,Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma,0.5888,Cutaneous Chronic Lymphocytic Leukemia,0.5880,Cutaneous Hematopoietic and Lymphoid Cell Neoplasm,0.5869,T_CELL_CUTANEOUS,True,True,True
T_CELL_LARGE_GRANULAR_LYMPHOCYTIC_LEUKAEMIA,T-Cell Large Granular Lymphocyte Leukemia,1,2,T-Cell Large Granular Lymphocyte Leukemia,0.9078,"T-Cell Large Granular Lymphocyte Leukemia, Common Variant",0.8437,T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta,0.7669,Refractory T-Cell Large Granular Lymphocyte Leukemia,0.7550,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia,0.7441,Low Grade T-Cell Lymphoma,0.7243,T-Cell Chronic Lymphocytic Leukemia,0.7229,T Lymphoblastic Lymphoma,0.7193,Recurrent T-Cell Large Granular Lymphocyte Leukemia,0.7184,T Lymphoblastic Leukemia/Lymphoma,0.7138,"T Acute Lymphoblastic Leukemia, Not Otherwise Specified",0.7068,T Acute Lymphoblastic Leukemia,0.7008,"T Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified",0.7007,"Peripheral T-Cell Lymphoma, Large Cell",0.6888,Cutaneous T Lymphoblastic Leukemia/Lymphoma,0.6687,High Grade T-Cell Lymphoma,0.6682,Primary Cutaneous Gamma-Delta T-Cell Lymphoma,0.6623,Adult T-Cell Leukemia/Lymphoma,0.6582,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,0.6545,T-Cell Non-Hodgkin Lymphoma,0.6471,T_CELL_LARGE_GRANULAR_LYMPHOCYTIC_LEUKAEMIA,True,True,True
UCEC ENDO,Endometrial Endometrioid Adenocarcinoma,99,2,Endometrial Undifferentiated Carcinoma,0.6835,Esophageal Undifferentiated Carcinoma,0.6662,Undifferentiated Carcinoma,0.6586,Epithelial-Myoepithelial Carcinoma,0.6541,Esophageal Mixed Adenoneuroendocrine Carcinoma,0.6524,Ureter Undifferentiated Carcinoma,0.6493,Colorectal Undifferentiated Carcinoma,0.6421,Colon Undifferentiated Carcinoma,0.6316,Appendix Undifferentiated Carcinoma,0.6283,Endometrial Neuroendocrine Carcinoma,0.6272,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma,0.6194,Colon Neuroendocrine Carcinoma,0.6184,Ureter Small Cell Neuroendocrine Carcinoma,0.6177,Colorectal Mixed Adenoneuroendocrine Carcinoma,0.6124,Cervical Undifferentiated Carcinoma,0.6108,Pancreatic Undifferentiated Carcinoma,0.6070,Microsatellite Stable Endometrial Carcinoma,0.6056,Extrahepatic Bile Duct Undifferentiated Carcinoma,0.6044,Sinonasal Undifferentiated Carcinoma,0.6033,Gallbladder Undifferentiated Carcinoma,0.6031,UCEC ENDO,False,False,False
UCEC SEROUS,Endometrial Serous Adenocarcinoma,1,2,Endometrial Serous Adenocarcinoma,0.7440,Micropapillary Serous Carcinoma,0.7403,Serous Endometrial Intraepithelial Carcinoma,0.7392,Serous Adenocarcinoma,0.7348,Serous Surface Papillary Carcinoma,0.7163,Endometrial Undifferentiated Carcinoma,0.7074,Serous Neoplasm,0.7043,Serous Cystadenocarcinoma,0.6975,Metastatic Endometrial Serous Adenocarcinoma,0.6970,Undifferentiated Carcinoma,0.6918,Advanced Endometrial Serous Adenocarcinoma,0.6865,Cervical Serous Adenocarcinoma,0.6850,Microsatellite Stable Endometrial Carcinoma,0.6734,Serous Cystadenoma,0.6660,Serous Tubal Intraepithelial Carcinoma,0.6626,Appendix Undifferentiated Carcinoma,0.6620,Refractory Endometrial Serous Adenocarcinoma,0.6612,Platinum-Sensitive Endometrial Serous Adenocarcinoma,0.6578,Colorectal Undifferentiated Carcinoma,0.6569,Gastric Undifferentiated Carcinoma,0.6555,UCEC SEROUS,True,True,True
UCS,Uterine Carcinosarcoma,1,2,Uterine Carcinosarcoma,0.8182,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0.8022,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0.7987,"Uterine Carcinosarcoma, Heterologous Type",0.7775,"Uterine Carcinosarcoma, Homologous Type",0.7767,Uterine Corpus Carcinosarcoma,0.7732,Mixed Mesodermal (Mullerian) Tumor,0.7465,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,0.7439,Metastatic Uterine Corpus Carcinosarcoma,0.7188,Mixed Endometrial Stromal and Smooth Muscle Neoplasm,0.7019,Refractory Uterine Corpus Carcinosarcoma,0.6980,Female Reproductive System Carcinosarcoma,0.6947,Uterine Corpus Myxoid Smooth Muscle Tumor of Uncertain Malignant Potential,0.6914,Recurrent Uterine Corpus Carcinosarcoma,0.6912,Uterine Corpus Rhabdomyosarcoma,0.6869,Uterine Corpus Undifferentiated Sarcoma,0.6825,Advanced Uterine Corpus Carcinosarcoma,0.6778,Uterine Corpus Epithelioid Smooth Muscle Tumor of Uncertain Malignant Potential,0.6705,Carcinosarcoma,0.6700,Uterine Corpus Endometrial Stromal Sarcoma,0.6598,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,True,True,True
UM,Uveal Melanoma,1,2,Uveal Melanoma,1.0000,Uveal Melanocytic Neoplasm,0.8820,Uveal Melanocytoma,0.8759,Uveal Epithelioid Cell Melanoma,0.8689,Metastatic Uveal Melanoma,0.8552,Ocular Melanoma,0.8500,Uveal Class 1 Melanoma,0.8448,Malignant Uveal Neoplasm,0.8448,Uveal Class 2 Melanoma,0.8238,Uveal Intermediate Cell Type Melanoma,0.8204,Advanced Uveal Melanoma,0.8077,Choroid Melanoma,0.8017,Retinal Melanoma,0.7875,Uveal Necrotic Melanoma,0.7858,Uveal Class 1a Melanoma,0.7844,Uveal Class 1b Melanoma,0.7829,Cutaneous Melanoma,0.7809,Uveal Spindle Cell Melanoma,0.7790,Iris Melanoma,0.7752,Uveal Neoplasm,0.7716,Uveal Melanoma,True,True,True
UNCLASSIFIED KIDNEY RENAL CELL CARCINOMA,Renal Cell Carcinoma,4,2,Unclassified Renal Cell Carcinoma,0.9692,"Renal Cell Carcinoma, Not Otherwise Specified",0.8195,Non-Clear Cell Renal Cell Carcinoma,0.8077,Renal Cell Carcinoma,0.7869,Unresectable Renal Cell Carcinoma,0.7658,Localized Renal Cell Carcinoma,0.7590,Clear Cell Renal Cell Carcinoma,0.7554,"Unresectable Renal Cell Carcinoma, Not Otherwise Specified",0.7532,"Metastatic Renal Cell Carcinoma, Not Otherwise Specified",0.7510,"Locally Advanced Renal Cell Carcinoma, Not Otherwise Specified",0.7496,Unresectable Kidney Carcinoma,0.7463,Kidney Carcinoma,0.7455,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.7429,Locally Advanced Renal Cell Carcinoma,0.7409,"Advanced Renal Cell Carcinoma, Not Otherwise Specified",0.7351,Granular Renal Cell Carcinoma,0.7327,Childhood Renal Cell Carcinoma,0.7252,Metastatic Renal Cell Carcinoma,0.7230,Papillary Renal Cell Carcinoma,0.7209,Advanced Renal Cell Carcinoma,0.7177,UNCLASSIFIED KIDNEY RENAL CELL CARCINOMA,False,False,True
UNCLASSIFIED RENAL CELL CARCINOMA,Unclassified Renal Cell Carcinoma,1,2,Unclassified Renal Cell Carcinoma,1.0000,"Renal Cell Carcinoma, Not Otherwise Specified",0.8291,Non-Clear Cell Renal Cell Carcinoma,0.8063,Renal Cell Carcinoma,0.7833,Unresectable Renal Cell Carcinoma,0.7748,"Unresectable Renal Cell Carcinoma, Not Otherwise Specified",0.7681,Localized Renal Cell Carcinoma,0.7582,"Locally Advanced Renal Cell Carcinoma, Not Otherwise Specified",0.7553,"Metastatic Renal Cell Carcinoma, Not Otherwise Specified",0.7535,Clear Cell Renal Cell Carcinoma,0.7451,Locally Advanced Renal Cell Carcinoma,0.7389,Non-Hereditary Clear Cell Renal Cell Carcinoma,0.7339,"Advanced Renal Cell Carcinoma, Not Otherwise Specified",0.7333,Granular Renal Cell Carcinoma,0.7317,Metastatic Renal Cell Carcinoma,0.7172,Unresectable Kidney Carcinoma,0.7131,Unresectable Clear Cell Renal Cell Carcinoma,0.7120,Hereditary Renal Cell Carcinoma,0.7063,Childhood Renal Cell Carcinoma,0.7045,Advanced Renal Cell Carcinoma,0.7035,UNCLASSIFIED RENAL CELL CARCINOMA,True,True,True
UNCLASSIFIED SARCOMA,Sarcoma,4,2,"Undifferentiated Sarcoma, Not Otherwise Specified",0.8536,Undifferentiated Soft Tissue Sarcoma,0.7899,Undifferentiated Stromal Sarcoma,0.7844,Sarcoma,0.7557,Unresectable Sarcoma,0.7502,Undifferentiated Spindle Cell Sarcoma,0.7404,Undifferentiated Round Cell Sarcoma,0.7211,Malignant Soft Tissue Neoplasm of Uncertain Differentiation,0.7060,Bone Sarcoma,0.7018,Unresectable Synovial Sarcoma,0.7011,Unresectable Bone Sarcoma,0.6970,Sarcoma NCI Grade 1,0.6959,Unresectable Soft Tissue Sarcoma,0.6952,Low Grade Sarcoma,0.6835,Localized Sarcoma,0.6819,Soft Tissue Neoplasm of Uncertain Differentiation,0.6789,Undifferentiated Pleomorphic Sarcoma,0.6784,Sarcoma NCI Grade 3,0.6779,Stromal Sarcoma,0.6778,Synovial Sarcoma,0.6773,UNCLASSIFIED SARCOMA,False,False,True
UNDIFFERENTIATED CARCINOMA,Undifferentiated Carcinoma,1,2,Undifferentiated Carcinoma,1.0000,Undifferentiated Malignant Neoplasm,0.8887,Endometrial Undifferentiated Carcinoma,0.8391,Cervical Undifferentiated Carcinoma,0.8268,Gastric Undifferentiated Carcinoma,0.8209,Prostate Undifferentiated Carcinoma,0.8121,Colon Undifferentiated Carcinoma,0.8094,Urethral Undifferentiated Carcinoma,0.8079,Colorectal Undifferentiated Carcinoma,0.7891,Salivary Gland Undifferentiated Carcinoma,0.7816,Undifferentiated Carcinoma of Unknown Primary,0.7797,Sinonasal Undifferentiated Carcinoma,0.7756,Ureter Undifferentiated Carcinoma,0.7694,Pancreatic Undifferentiated Carcinoma,0.7614,Carcinoma,0.7597,Ovarian Undifferentiated Carcinoma,0.7577,Nasopharyngeal Undifferentiated Carcinoma,0.7531,Advanced Endometrial Undifferentiated Carcinoma,0.7507,Esophageal Undifferentiated Carcinoma,0.7449,Gallbladder Undifferentiated Carcinoma,0.7400,UNDIFFERENTIATED CARCINOMA,True,True,True
UNDIFFERENTIATED CARCINOMA OF THE PANCREAS,Pancreatic Undifferentiated Carcinoma,1,2,Pancreatic Undifferentiated Carcinoma,0.9434,Undifferentiated Carcinoma,0.7822,Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.7732,Prostate Undifferentiated Carcinoma,0.7732,Parotid Gland Undifferentiated Carcinoma,0.7719,Exocrine Pancreas Carcinoma,0.7457,Pancreatic Neuroendocrine Carcinoma,0.7413,Gastric Undifferentiated Carcinoma,0.7334,Pancreatic Carcinoma,0.7324,Pancreatic Medullary Carcinoma,0.7285,Pancreatic Undifferentiated Carcinoma with Rhabdoid Cells,0.7260,Pancreatic Poorly Cohesive Adenocarcinoma,0.7216,Pancreatic Colloid Carcinoma,0.7181,Salivary Gland Undifferentiated Carcinoma,0.7066,Primary Peritoneal Undifferentiated Carcinoma,0.7056,Undifferentiated Carcinoma of Unknown Primary,0.7038,Pancreatic Small Cell Neuroendocrine Carcinoma,0.6935,Pancreatic Squamous Cell Carcinoma,0.6931,Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma,0.6895,Undifferentiated Malignant Neoplasm,0.6867,UNDIFFERENTIATED CARCINOMA OF THE PANCREAS,True,True,True
UNDIFFERENTIATED MALIGNANT NEOPLASM,Undifferentiated Malignant Neoplasm,1,2,Undifferentiated Malignant Neoplasm,1.0000,Undifferentiated Carcinoma,0.8887,Anaplastic Malignant Neoplasm,0.7646,Malignant Neoplasm,0.7570,"Undifferentiated Sarcoma, Not Otherwise Specified",0.7548,Undifferentiated Soft Tissue Sarcoma,0.7532,Undifferentiated Pleomorphic Sarcoma,0.7494,"Malignant Neoplasm, Uncertain Whether Primary or Metastatic",0.7444,Poorly Differentiated Malignant Neoplasm,0.7434,Neoplasm of Uncertain Malignant Potential,0.7420,Malignant Mixed Neoplasm,0.7338,Prostate Undifferentiated Carcinoma,0.7281,Endometrial Undifferentiated Carcinoma,0.7230,Well Differentiated Malignant Neoplasm,0.7172,Undifferentiated Stromal Sarcoma,0.7155,Undifferentiated Sarcoma with Epithelioid Features,0.7137,Gastric Undifferentiated Carcinoma,0.7125,Undifferentiated Round Cell Sarcoma,0.7109,Undifferentiated Spindle Cell Sarcoma,0.7108,Colon Undifferentiated Carcinoma,0.7086,UNDIFFERENTIATED MALIGNANT NEOPLASM,True,True,True
UNDIFFERENTIATED PLEOMORPHIC SARCOMA MALIGNANT FIBROUS HISTIOCYTOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.8460,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.8202,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 3,0.8105,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 2,0.8028,Fibrous Histiocytoma,0.8023,Adult Undifferentiated Pleomorphic Sarcoma,0.7732,Deep Fibrous Histiocytoma,0.7681,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7635,Skin Fibroblastic Fibrous Histiocytoma,0.7614,Fibrous Histiocytoma of Bone,0.7586,Skin Fibrous Histiocytoma,0.7554,Angiomatoid Fibrous Histiocytoma,0.7489,Advanced Undifferentiated Pleomorphic Sarcoma,0.7483,Metastatic Undifferentiated Pleomorphic Sarcoma,0.7476,Pleomorphic Fibroma,0.7399,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 3,0.7389,Skin Histiocytic Fibrous Histiocytoma,0.7387,Pleomorphic Dermal Sarcoma,0.7290,Prostate Undifferentiated Pleomorphic Sarcoma,0.7241,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7234,UNDIFFERENTIATED PLEOMORPHIC SARCOMA MALIGNANT FIBROUS HISTIOCYTOMA,True,True,True
UNDIFFERENTIATED PLEOMORPHIC SARCOMA UPS,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.8242,Prostate Undifferentiated Pleomorphic Sarcoma,0.7907,Sinonasal Undifferentiated Pleomorphic Sarcoma,0.7685,"Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant",0.7605,Undifferentiated Spindle Cell Sarcoma,0.7593,Undifferentiated Stromal Sarcoma,0.7458,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7450,Metastatic Undifferentiated Pleomorphic Sarcoma,0.7443,Advanced Undifferentiated Pleomorphic Sarcoma,0.7392,Locally Advanced Undifferentiated Pleomorphic Sarcoma,0.7371,Adult Undifferentiated Pleomorphic Sarcoma,0.7340,Undifferentiated Sarcoma with Epithelioid Features,0.7132,Unresectable Undifferentiated Pleomorphic Sarcoma,0.7124,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,0.7120,Penile Undifferentiated Pleomorphic Sarcoma,0.7064,"Undifferentiated Sarcoma, Not Otherwise Specified",0.7022,Resectable Undifferentiated Pleomorphic Sarcoma,0.7018,Undifferentiated Soft Tissue Sarcoma,0.7002,Childhood Undifferentiated Pleomorphic Sarcoma,0.6985,Pleural Monophasic Synovial Sarcoma,0.6968,UNDIFFERENTIATED PLEOMORPHIC SARCOMA UPS,True,True,True
UNDIFFERENTIATED PLEOMORPHIC SARCOMA/MALIGANT FIBROUS HISTIOCYTOMA/HIGH-GRADE SPINDLE CELL SARCOMA,Undifferentiated Pleomorphic Sarcoma,1,2,Undifferentiated Pleomorphic Sarcoma,0.7796,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7685,Advanced Undifferentiated Pleomorphic Sarcoma,0.7292,Undifferentiated Spindle Cell Sarcoma,0.7268,Undifferentiated Soft Tissue Sarcoma,0.7249,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7127,Adult Undifferentiated Pleomorphic Sarcoma,0.7123,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 2,0.7117,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7067,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 3,0.7051,Metastatic Undifferentiated Pleomorphic Sarcoma,0.7050,"Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant",0.7030,Recurrent Undifferentiated Pleomorphic Sarcoma,0.6985,Locally Advanced Undifferentiated Pleomorphic Sarcoma,0.6960,Undifferentiated Stromal Sarcoma,0.6946,"Undifferentiated Sarcoma, Not Otherwise Specified",0.6942,Resectable Undifferentiated Pleomorphic Sarcoma,0.6900,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.6878,Refractory Undifferentiated Pleomorphic Sarcoma,0.6865,Childhood Undifferentiated Pleomorphic Sarcoma,0.6844,UNDIFFERENTIATED PLEOMORPHIC SARCOMA/MALIGANT FIBROUS HISTIOCYTOMA/HIGH-GRADE SPINDLE CELL SARCOMA,True,True,True
UNDIFFERENTIATED SARCOMA,Undifferentiated Soft Tissue Sarcoma,1,2,Undifferentiated Soft Tissue Sarcoma,0.9191,Undifferentiated Stromal Sarcoma,0.9126,Undifferentiated Spindle Cell Sarcoma,0.8962,"Undifferentiated Sarcoma, Not Otherwise Specified",0.8941,Undifferentiated Pleomorphic Sarcoma,0.8772,Undifferentiated Round Cell Sarcoma,0.8374,Undifferentiated Malignant Neoplasm,0.8274,Undifferentiated Sarcoma with Epithelioid Features,0.8159,Sarcoma,0.8152,Adult Undifferentiated Pleomorphic Sarcoma,0.7954,Undifferentiated Carcinoma,0.7936,Sinonasal Undifferentiated Pleomorphic Sarcoma,0.7906,Advanced Undifferentiated Pleomorphic Sarcoma,0.7767,Unresectable Undifferentiated Pleomorphic Sarcoma,0.7687,Ovarian Undifferentiated Sarcoma,0.7680,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,0.7626,Metastatic Undifferentiated Pleomorphic Sarcoma,0.7620,Bone Sarcoma,0.7612,Unresectable Sarcoma,0.7604,Low Grade Sarcoma,0.7526,UNDIFFERENTIATED SARCOMA,True,True,True
UNDIFFERENTIATED STOMACH ADENOCARCINOMA,Gastric Undifferentiated Carcinoma,1,2,Gastric Undifferentiated Carcinoma,0.8822,Gastric Adenocarcinoma,0.8067,Sporadic Gastric Adenocarcinoma,0.7906,Gastric Diffuse Adenocarcinoma,0.7903,Gastric Intramucosal Adenocarcinoma,0.7653,Sporadic Gastric Diffuse Adenocarcinoma,0.7595,Localized Gastric Adenocarcinoma,0.7570,Gastric Poorly Cohesive Adenocarcinoma,0.7548,Gastric Mixed Adenocarcinoma,0.7535,Undifferentiated Carcinoma,0.7516,Unresectable Gastric Adenocarcinoma,0.7482,Locally Advanced Gastric Adenocarcinoma,0.7379,Gastric Tubular Adenocarcinoma,0.7356,Advanced Gastric Adenocarcinoma,0.7334,Gastric Mucinous Adenocarcinoma,0.7325,Proximal Gastric Adenocarcinoma,0.7289,Gallbladder Undifferentiated Carcinoma,0.7209,Gastric Intestinal-Type Adenocarcinoma,0.7196,Gastric Carcinoma,0.7183,Salivary Gland Undifferentiated Carcinoma,0.7166,UNDIFFERENTIATED STOMACH ADENOCARCINOMA,True,True,True
UNDIFFERENTIATED UTERINE SARCOMA,Uterine Corpus Undifferentiated Sarcoma,1,2,Uterine Corpus Undifferentiated Sarcoma,0.8983,Undifferentiated Stromal Sarcoma,0.8510,Undifferentiated Soft Tissue Sarcoma,0.8025,"Undifferentiated Sarcoma, Not Otherwise Specified",0.7953,Vaginal Undifferentiated Sarcoma,0.7901,Uterine Corpus Sarcoma,0.7867,Uterine Carcinosarcoma,0.7838,Ovarian Undifferentiated Sarcoma,0.7702,Undifferentiated Spindle Cell Sarcoma,0.7697,"Uterine Carcinosarcoma, Heterologous Type",0.7583,"Uterine Carcinosarcoma, Homologous Type",0.7567,Uterine Corpus Endometrial Stromal Sarcoma,0.7526,Undifferentiated Round Cell Sarcoma,0.7365,Unresectable Uterine Corpus Sarcoma,0.7340,Uterine Corpus Carcinosarcoma,0.7333,Sinonasal Undifferentiated Pleomorphic Sarcoma,0.7284,Uterine Corpus Low Grade Endometrial Stromal Sarcoma,0.7237,Undifferentiated Sarcoma with Epithelioid Features,0.7137,Sarcoma,0.7122,Undifferentiated Malignant Neoplasm,0.7102,UNDIFFERENTIATED UTERINE SARCOMA,True,True,True
UNDIFFERENTIATED_CARCINOMA,Undifferentiated Carcinoma,1,2,Undifferentiated Carcinoma,0.9616,Undifferentiated Malignant Neoplasm,0.8650,Endometrial Undifferentiated Carcinoma,0.8153,Cervical Undifferentiated Carcinoma,0.7991,Gastric Undifferentiated Carcinoma,0.7821,Urethral Undifferentiated Carcinoma,0.7819,Undifferentiated Carcinoma of Unknown Primary,0.7808,Colon Undifferentiated Carcinoma,0.7740,Prostate Undifferentiated Carcinoma,0.7696,Carcinoma,0.7606,Sinonasal Undifferentiated Carcinoma,0.7578,Colorectal Undifferentiated Carcinoma,0.7530,Salivary Gland Undifferentiated Carcinoma,0.7442,Ureter Undifferentiated Carcinoma,0.7432,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,0.7360,Ovarian Undifferentiated Carcinoma,0.7333,Pancreatic Undifferentiated Carcinoma,0.7232,Advanced Endometrial Undifferentiated Carcinoma,0.7213,Esophageal Undifferentiated Carcinoma,0.7075,Nasopharyngeal Undifferentiated Carcinoma,0.7041,UNDIFFERENTIATED_CARCINOMA,True,True,True
URACHAL ADENOCARCINOMA,Urachal Adenocarcinoma,1,2,Urachal Adenocarcinoma,1.0000,Urachal Carcinoma,0.9596,Urachal Urothelial Carcinoma,0.8848,Urachal Squamous Cell Carcinoma,0.8658,Urinary Tract Adenocarcinoma,0.7847,Metastatic Urachal Urothelial Carcinoma,0.7808,Ureter Adenocarcinoma,0.7462,Urinary Tract Clear Cell Adenocarcinoma,0.7082,Urinary Tract Carcinoma,0.7081,Urethral Adenocarcinoma,0.7058,Bladder Adenocarcinoma,0.6995,Urinary System Carcinoma,0.6987,Vaginal Mesonephric Adenocarcinoma,0.6886,Water-Clear Cell Adenocarcinoma,0.6878,Mesonephric-Like Adenocarcinoma,0.6844,Adenocarcinoma,0.6812,Mesonephric Adenocarcinoma,0.6763,Urethral Clear Cell Adenocarcinoma,0.6759,Clear Cell Adenocarcinoma,0.6754,Accessory Urethral Gland Adenocarcinoma,0.6709,URACHAL ADENOCARCINOMA,True,True,True
URACHAL CARCINOMA,Urachal Carcinoma,1,2,Urachal Carcinoma,1.0000,Urachal Adenocarcinoma,0.9596,Urachal Urothelial Carcinoma,0.9373,Urachal Squamous Cell Carcinoma,0.9103,Metastatic Urachal Urothelial Carcinoma,0.8212,Urinary Tract Carcinoma,0.7543,Urinary Tract Adenocarcinoma,0.7485,Urinary System Carcinoma,0.7425,Urothelial Carcinoma,0.7191,Ureter Carcinoma,0.7098,Ureter Adenocarcinoma,0.7054,Urinary Tract Clear Cell Adenocarcinoma,0.6893,Urethral Carcinoma,0.6767,Urinary Tract Diverticulum Carcinoma,0.6757,Bladder Adenocarcinoma,0.6729,Urethral Urothelial Carcinoma,0.6689,Bladder Carcinoma,0.6674,Ureter Urothelial Carcinoma,0.6641,Renal Cell Carcinoma,0.6626,Renal Pelvis and Ureter Carcinoma,0.6589,URACHAL CARCINOMA,True,True,True
URETHRAL ADENOCARCINOMA,Urethral Adenocarcinoma,1,2,Urethral Adenocarcinoma,1.0000,Urethral Carcinoma,0.9216,Urethral Clear Cell Adenocarcinoma,0.8422,Distal Urethral Carcinoma,0.8385,Accessory Urethral Gland Adenocarcinoma,0.8367,Urethral Urothelial Carcinoma,0.8134,Proximal Urethral Carcinoma,0.8080,Urethral Undifferentiated Carcinoma,0.8070,Ureter Adenocarcinoma,0.8014,Cowper Gland Adenocarcinoma of the Urethra,0.8012,Malignant Urethral Neoplasm,0.7982,Urethral Squamous Cell Carcinoma,0.7935,Advanced Urethral Urothelial Carcinoma,0.7922,Urinary Tract Adenocarcinoma,0.7892,Locally Advanced Urethral Carcinoma,0.7833,Urethra Neoplasm,0.7815,Skene Gland Adenocarcinoma of the Urethra,0.7789,Metastatic Urethral Carcinoma,0.7698,Littre Gland Adenocarcinoma of the Urethra,0.7614,Male Urethral Malignant Neoplasm,0.7570,URETHRAL ADENOCARCINOMA,True,True,True
URETHRAL CANCER,Urethral Carcinoma,1,2,Urethral Carcinoma,0.9572,Urethral Adenocarcinoma,0.9044,Urethral Urothelial Carcinoma,0.8595,Urethral Undifferentiated Carcinoma,0.8379,Malignant Urethral Neoplasm,0.8376,Proximal Urethral Carcinoma,0.8317,Urethra Neoplasm,0.8222,Distal Urethral Carcinoma,0.8128,Urethral Squamous Cell Carcinoma,0.7964,Male Urethral Malignant Neoplasm,0.7941,Metastatic Urethral Carcinoma,0.7699,Prostatic Urethral Malignant Neoplasm,0.7636,Prostatic Urethra Urothelial Carcinoma,0.7630,Advanced Urethral Urothelial Carcinoma,0.7626,Recurrent Urethral Carcinoma,0.7561,Locally Advanced Urethral Carcinoma,0.7527,Unresectable Urethral Urothelial Carcinoma,0.7517,Urethral Melanoma,0.7508,Ureter Carcinoma,0.7430,Urinary Tract Carcinoma,0.7403,URETHRAL CANCER,True,True,True
URETHRAL SQUAMOUS CELL CARCINOMA,Urethral Squamous Cell Carcinoma,1,2,Urethral Squamous Cell Carcinoma,1.0000,Urethral Carcinoma,0.8617,Urethral Urothelial Carcinoma,0.8339,Urethral Undifferentiated Carcinoma,0.8226,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,0.8147,Urinary Tract Squamous Cell Carcinoma,0.8017,Urethral Clear Cell Adenocarcinoma,0.7995,Urethral Adenocarcinoma,0.7935,Ureter Squamous Cell Carcinoma,0.7921,Proximal Urethral Carcinoma,0.7634,Urethral Verrucous Carcinoma,0.7516,Advanced Urethral Urothelial Carcinoma,0.7369,Penile Squamous Cell Carcinoma,0.7335,Locally Advanced Urethral Carcinoma,0.7302,Prostatic Urethra Urothelial Carcinoma,0.7233,Prostate Squamous Cell Carcinoma,0.7209,Distal Urethral Carcinoma,0.7202,Metastatic Urethral Carcinoma,0.7159,Unresectable Urethral Urothelial Carcinoma,0.7122,"Penile Squamous Cell Carcinoma, Usual Type",0.7087,URETHRAL SQUAMOUS CELL CARCINOMA,True,True,True
URETHRAL UROTHELIAL CARCINOMA,Urethral Urothelial Carcinoma,1,2,Urethral Urothelial Carcinoma,1.0000,Urethral Carcinoma,0.9105,Urethral Undifferentiated Carcinoma,0.8975,Prostatic Urethra Urothelial Carcinoma,0.8854,Ureter Urothelial Carcinoma,0.8663,Advanced Urethral Urothelial Carcinoma,0.8634,Unresectable Urethral Urothelial Carcinoma,0.8516,Urothelial Carcinoma,0.8497,Urethral Squamous Cell Carcinoma,0.8339,Locally Advanced Urethral Urothelial Carcinoma,0.8277,Invasive Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,0.8235,Proximal Urethral Carcinoma,0.8193,Bladder Urothelial Carcinoma,0.8185,Urethral Adenocarcinoma,0.8134,Metastatic Urethral Urothelial Carcinoma,0.8128,Refractory Urethral Urothelial Carcinoma,0.8020,Ureter Carcinoma,0.7921,Recurrent Urethral Urothelial Carcinoma,0.7896,Prostatic Duct Urothelial Carcinoma,0.7882,Urachal Urothelial Carcinoma,0.7846,URETHRAL UROTHELIAL CARCINOMA,True,True,True
UROTHELIAL CARCINOMA,Urothelial Carcinoma,1,2,Urothelial Carcinoma,1.0000,Bladder Urothelial Carcinoma,0.9236,Invasive Urothelial Carcinoma,0.8710,Ureter Urothelial Carcinoma,0.8592,Advanced Urothelial Carcinoma,0.8517,Urethral Urothelial Carcinoma,0.8497,Bladder Carcinoma,0.8412,Urothelial Neoplasm,0.8391,Invasive Conventional Urothelial Carcinoma,0.8386,Transitional Cell Carcinoma,0.8370,Urinary Tract Carcinoma,0.8365,Ureter Carcinoma,0.8349,Prostatic Duct Urothelial Carcinoma,0.8205,"Urothelial Carcinoma, High Grade",0.8192,Urachal Urothelial Carcinoma,0.8149,Unresectable Urothelial Carcinoma,0.8062,Urinary System Carcinoma,0.8015,Invasive Bladder Urothelial Carcinoma,0.7925,Invasive Tubular Urothelial Carcinoma,0.7918,Metastatic Urothelial Carcinoma,0.7885,UROTHELIAL CARCINOMA,True,True,True
UROTHELIAL CARCINOMA OTHER,Urothelial Carcinoma,1,2,Urothelial Carcinoma,0.8725,Invasive Conventional Urothelial Carcinoma,0.7961,Bladder Urothelial Carcinoma,0.7954,Unresectable Urothelial Carcinoma,0.7873,Urothelial Neoplasm,0.7845,Invasive Urothelial Carcinoma,0.7805,Urethral Urothelial Carcinoma,0.7645,Invasive Nested Urothelial Carcinoma,0.7641,Advanced Urothelial Carcinoma,0.7627,Ureter Urothelial Carcinoma,0.7624,Metastatic Urothelial Carcinoma,0.7613,"Urothelial Carcinoma, High Grade",0.7608,Ureter Carcinoma,0.7409,Unresectable Bladder Urothelial Carcinoma,0.7372,Invasive Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,0.7369,Urinary Tract Carcinoma,0.7357,Urachal Urothelial Carcinoma,0.7317,Metastatic Nested Urothelial Carcinoma,0.7298,Invasive Large Nested Urothelial Carcinoma,0.7282,Transitional Cell Carcinoma,0.7271,UROTHELIAL CARCINOMA OTHER,True,True,True
UROTHELIAL PAPILLOMA,Urothelial Papilloma,1,2,Urothelial Papilloma,1.0000,Bladder Urothelial Papilloma,0.9477,Urethral Urothelial Papilloma,0.9240,Ureter Urothelial Papilloma,0.9130,Inverted Urothelial Papilloma,0.8788,Renal Pelvis Urothelial Papilloma,0.8569,Papillary Urothelial Neoplasm,0.8450,Transitional Cell Papilloma,0.8415,Bladder Squamous Papilloma,0.8191,Bladder Inverted Papilloma,0.8141,Bladder Papillary Urothelial Neoplasm,0.8081,Papilloma,0.8006,Squamous Papilloma of the Urinary Tract,0.7994,Urothelial Neoplasm,0.7789,Ureter Inverted Papilloma,0.7773,Glandular Papilloma,0.7683,Papillary Transitional Cell Carcinoma,0.7621,Bronchial Papilloma,0.7592,Inverted Transitional Cell Papilloma,0.7567,Papillary Urothelial Neoplasm of Low Malignant Potential,0.7523,UROTHELIAL PAPILLOMA,True,True,True
UTERINE ADENOSARCOMA,Uterine Corpus Adenosarcoma,1,2,Uterine Corpus Adenosarcoma,0.9178,Uterine Angiosarcoma,0.8338,Adenosarcoma,0.7998,Cervical Adenosarcoma,0.7862,Ovarian Adenosarcoma,0.7829,Vaginal Adenosarcoma,0.7775,Fallopian Tube Adenosarcoma,0.7500,Uterine Corpus Adenomyoma,0.7371,Stage IA Uterine Corpus Adenosarcoma AJCC v8,0.7325,Uterine Corpus Adenosarcoma by AJCC v8 Stage,0.7287,Stage I Uterine Corpus Adenosarcoma AJCC v8,0.7226,Broad Ligament Adenosarcoma,0.7202,Stage IVA Uterine Corpus Adenosarcoma AJCC v8,0.7122,Uterine Corpus Adenomatoid Tumor,0.7057,Uterine Carcinosarcoma,0.7024,Uterine Corpus Adenofibroma,0.6879,Uterine Neoplasm,0.6865,Stage IB Uterine Corpus Adenosarcoma AJCC v8,0.6860,Uterine Ligament Adenomyoma,0.6820,Stage III Uterine Corpus Adenosarcoma AJCC v8,0.6745,UTERINE ADENOSARCOMA,True,True,True
UTERINE CARCINOSARCOMA,Uterine Carcinosarcoma,1,2,Uterine Carcinosarcoma,1.0000,Uterine Corpus Carcinosarcoma,0.9073,"Uterine Carcinosarcoma, Homologous Type",0.8593,Carcinosarcoma,0.8367,"Uterine Carcinosarcoma, Heterologous Type",0.8321,Cervical Carcinosarcoma,0.8201,Advanced Uterine Corpus Carcinosarcoma,0.8174,Metastatic Uterine Corpus Carcinosarcoma,0.8152,Ovarian Carcinosarcoma,0.7963,Female Reproductive System Carcinosarcoma,0.7815,Recurrent Uterine Corpus Carcinosarcoma,0.7804,Refractory Uterine Corpus Carcinosarcoma,0.7783,Uterine Corpus Sarcoma,0.7680,Vaginal Carcinosarcoma,0.7679,Uterine Corpus Undifferentiated Sarcoma,0.7647,Uterine Corpus Rhabdomyosarcoma,0.7365,Uterine Corpus Endometrial Stromal Sarcoma,0.7362,Lung Carcinosarcoma,0.7305,Metastatic Carcinosarcoma,0.7257,Uterine Corpus Carcinofibroma,0.7251,UTERINE CARCINOSARCOMA,True,True,True
UTERINE CLEAR CELL CARCINOMA,Endometrial Clear Cell Adenocarcinoma,1,2,Endometrial Clear Cell Adenocarcinoma,0.8276,Clear Cell Adenocarcinoma,0.7802,Clear Cell Renal Cell Carcinoma,0.7606,Urinary Tract Clear Cell Adenocarcinoma,0.7581,Clear Cell Malignant Neoplasm,0.7473,Ovarian Clear Cell Adenocarcinoma,0.7457,Clear Cell Neoplasm,0.7456,Hyalinizing Clear Cell Carcinoma,0.7288,Ovarian Clear Cell Tumor,0.7252,Water-Clear Cell Adenocarcinoma,0.7236,Bladder Clear Cell Adenocarcinoma,0.7215,Vaginal Clear Cell Adenocarcinoma,0.7177,"Squamous Cell Carcinoma, Clear Cell Type",0.7137,Malignant Ovarian Clear Cell Tumor,0.7089,Ovarian Clear Cell Cystadenocarcinoma,0.7087,Fallopian Tube Clear Cell Adenocarcinoma,0.7059,Clear Cell Adenoma,0.6943,Lung Clear Cell Adenocarcinoma,0.6895,Non-Clear Cell Renal Cell Carcinoma,0.6877,Urethral Clear Cell Adenocarcinoma,0.6827,UTERINE CLEAR CELL CARCINOMA,True,True,True
UTERINE DEDIFFERENTIATED CARCINOMA,Endometrial Dedifferentiated Carcinoma,1,2,Endometrial Dedifferentiated Carcinoma,0.9028,Ovarian Dedifferentiated Carcinoma,0.8058,Recurrent Endometrial Dedifferentiated Carcinoma,0.7568,Refractory Endometrial Dedifferentiated Carcinoma,0.7428,Dedifferentiated Chondrosarcoma,0.7273,Dedifferentiated Leiomyosarcoma,0.7219,Dedifferentiated Chordoma,0.7102,Undifferentiated Carcinoma,0.7027,Dedifferentiated Liposarcoma,0.7015,Cervical Undifferentiated Carcinoma,0.6987,Endometrial Undifferentiated Carcinoma,0.6818,Dedifferentiated Gastrointestinal Stromal Tumor,0.6770,Uterine Carcinosarcoma,0.6712,Low Grade Endometrioid Adenocarcinoma,0.6689,Uterine Corpus Undifferentiated Sarcoma,0.6687,Endometrioid Adenocarcinoma,0.6632,Cervical Endometrioid Adenocarcinoma,0.6611,Uterine Corpus Carcinosarcoma,0.6591,Uterine Corpus Degenerated Leiomyoma,0.6545,Uterine Corpus Diffuse Leiomyomatosis,0.6540,UTERINE DEDIFFERENTIATED CARCINOMA,True,True,True
UTERINE ENDOMETRIOID,Endometrial Endometrioid Adenocarcinoma,2,2,Endometrioid Tumor,0.9190,Endometrial Endometrioid Adenocarcinoma,0.9111,Endometrioid Adenocarcinoma,0.9045,Ovarian Endometrioid Tumor,0.8766,Ovarian Endometrioid Adenocarcinoma,0.8529,Benign Ovarian Endometrioid Tumor,0.8519,Malignant Ovarian Endometrioid Tumor,0.8347,Endometrial Low Grade Endometrioid Adenocarcinoma,0.8326,Low Grade Endometrioid Adenocarcinoma,0.8217,Cervical Endometrioid Adenocarcinoma,0.8216,Endometrial High Grade Endometrioid Adenocarcinoma,0.8161,Advanced Endometrial Endometrioid Adenocarcinoma,0.8053,High Grade Endometrioid Adenocarcinoma,0.8026,Endometrial Endometrioid Adenocarcinoma with Metaplastic Changes,0.7980,FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma,0.7962,Urinary Tract Endometrioid Adenocarcinoma,0.7867,Ovarian Endometrioid Cystadenoma,0.7865,Advanced Endometrioid Adenocarcinoma,0.7849,Endometrioid Stromal Sarcoma,0.7834,FIGO Grade 1 Endometrioid Adenocarcinoma,0.7834,UTERINE ENDOMETRIOID,False,True,True
UTERINE ENDOMETRIOID CARCINOMA,Endometrial Endometrioid Adenocarcinoma,1,2,Endometrial Endometrioid Adenocarcinoma,0.9307,Endometrioid Adenocarcinoma,0.9258,Endometrioid Tumor,0.8915,Ovarian Endometrioid Adenocarcinoma,0.8839,Cervical Endometrioid Adenocarcinoma,0.8738,Ovarian Endometrioid Tumor,0.8587,Malignant Ovarian Endometrioid Tumor,0.8480,Endometrial High Grade Endometrioid Adenocarcinoma,0.8273,Advanced Endometrial Endometrioid Adenocarcinoma,0.8243,Endometrial Low Grade Endometrioid Adenocarcinoma,0.8211,High Grade Endometrioid Adenocarcinoma,0.8184,Low Grade Endometrioid Adenocarcinoma,0.8148,Urinary Tract Endometrioid Adenocarcinoma,0.8089,Advanced Endometrioid Adenocarcinoma,0.8058,Endometrial Endometrioid Adenocarcinoma with Metaplastic Changes,0.8029,Benign Ovarian Endometrioid Tumor,0.7991,Bladder Endometrioid Adenocarcinoma,0.7972,Metastatic Endometrioid Adenocarcinoma,0.7951,Metastatic Endometrial Endometrioid Adenocarcinoma,0.7887,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,0.7885,UTERINE ENDOMETRIOID CARCINOMA,True,True,True
UTERINE EPITHELIOID LEIOMYOSARCOMA,Uterine Corpus Epithelioid Leiomyosarcoma,2,2,Epithelioid Leiomyosarcoma,0.9173,Uterine Corpus Epithelioid Leiomyosarcoma,0.9107,Uterine Corpus Epithelioid Leiomyoma,0.8401,Esophageal Leiomyosarcoma,0.7944,Uterine Corpus Leiomyosarcoma,0.7901,Ovarian Leiomyosarcoma,0.7702,Leiomyosarcoma,0.7681,Localized Leiomyosarcoma,0.7665,Uterine Corpus Myxoid Leiomyosarcoma,0.7635,Bone Leiomyosarcoma,0.7509,Myxoid Leiomyosarcoma,0.7490,Digestive System Leiomyosarcoma,0.7473,Conventional Leiomyosarcoma,0.7463,Inflammatory Leiomyosarcoma,0.7438,Esophageal Leiomyoma,0.7435,Uterine Ligament Leiomyoma,0.7397,Gastric Leiomyosarcoma,0.7370,Breast Leiomyosarcoma,0.7329,Myxoid Leiomyoma,0.7318,Well Differentiated Leiomyosarcoma,0.7306,UTERINE EPITHELIOID LEIOMYOSARCOMA,False,True,True
UTERINE LEIOMYOSARCOMA,Uterine Corpus Leiomyosarcoma,2,2,Leiomyosarcoma,0.9151,Uterine Corpus Leiomyosarcoma,0.9134,Bone Leiomyosarcoma,0.8617,Breast Leiomyosarcoma,0.8577,Digestive System Leiomyosarcoma,0.8510,Ovarian Leiomyosarcoma,0.8442,Leiomyoma,0.8442,Localized Leiomyosarcoma,0.8441,Conventional Leiomyosarcoma,0.8428,Gastric Leiomyosarcoma,0.8374,Bladder Leiomyosarcoma,0.8307,Uterine Ligament Leiomyoma,0.8299,Vaginal Leiomyosarcoma,0.8298,Uterine Corpus Myxoid Leiomyosarcoma,0.8265,Cervical Leiomyosarcoma,0.8256,Cardiac Leiomyosarcoma,0.8239,Uterine Corpus Epithelioid Leiomyosarcoma,0.8227,Lung Leiomyosarcoma,0.8227,Leiomyosarcoma of Vessels,0.8199,Esophageal Leiomyosarcoma,0.8198,UTERINE LEIOMYOSARCOMA,False,True,True
UTERINE MYXOID LEIOMYOSARCOMA,Uterine Corpus Myxoid Leiomyosarcoma,1,2,Uterine Corpus Myxoid Leiomyosarcoma,0.8975,Myxoid Leiomyosarcoma,0.8973,Myxoid Leiomyoma,0.8612,Uterine Corpus Myxoid Leiomyoma,0.8354,Uterine Corpus Leiomyosarcoma,0.8283,Leiomyosarcoma,0.8089,Uterine Corpus Epithelioid Leiomyosarcoma,0.7975,Conventional Leiomyosarcoma,0.7830,Bone Leiomyosarcoma,0.7806,Uterine Ligament Leiomyoma,0.7788,Ovarian Leiomyosarcoma,0.7755,Breast Leiomyosarcoma,0.7744,Localized Leiomyosarcoma,0.7710,Mediastinal Leiomyosarcoma,0.7691,Epithelioid Leiomyosarcoma,0.7688,Thyroid Gland Leiomyosarcoma,0.7635,Cardiac Leiomyosarcoma,0.7581,Inflammatory Leiomyosarcoma,0.7564,Digestive System Leiomyosarcoma,0.7549,Lung Leiomyosarcoma,0.7537,UTERINE MYXOID LEIOMYOSARCOMA,True,True,True
UTERINE NEUROENDOCRINE CARCINOMA,Endometrial Neuroendocrine Carcinoma,1,2,Endometrial Neuroendocrine Carcinoma,0.8666,Uterine Corpus Neuroendocrine Neoplasm,0.8459,Endometrial Small Cell Neuroendocrine Carcinoma,0.8058,Cervical Neuroendocrine Carcinoma,0.7996,Uterine Corpus Neuroendocrine Tumor G1,0.7966,Neuroendocrine Carcinoma,0.7965,Endometrial Large Cell Neuroendocrine Carcinoma,0.7914,Ovarian Neuroendocrine Carcinoma,0.7677,Breast Neuroendocrine Carcinoma,0.7583,Uterine Carcinosarcoma,0.7544,Bladder Neuroendocrine Carcinoma,0.7499,Gastric Neuroendocrine Carcinoma,0.7472,Vaginal Neuroendocrine Carcinoma,0.7458,Cervical Small Cell Neuroendocrine Carcinoma,0.7409,Esophageal Neuroendocrine Carcinoma,0.7331,Sinonasal Neuroendocrine Carcinoma,0.7318,Cervical Large Cell Neuroendocrine Carcinoma,0.7290,Nasopharyngeal Neuroendocrine Carcinoma,0.7272,Nasal Cavity Neuroendocrine Carcinoma,0.7264,Uterine Corpus Carcinosarcoma,0.7243,UTERINE NEUROENDOCRINE CARCINOMA,True,True,True
UTERINE PERIVASCULAR EPITHELIOID CELL TUMOR,Uterine Corpus PEComa,6,2,Epithelioid Trophoblastic Tumor,0.7108,Paratesticular Endometrioid Tumor,0.6799,Uterine Corpus Epithelioid Leiomyoma,0.6794,Uterine Corpus Epithelioid Smooth Muscle Tumor of Uncertain Malignant Potential,0.6634,Uterine Corpus Adenomatoid Tumor,0.6582,Uterine Corpus PEComa,0.6579,Endometrioid Tumor,0.6574,Peritoneal Epithelioid Mesothelioma,0.6544,Uterine Corpus Epithelioid Leiomyosarcoma,0.6497,Benign Uterine Corpus PEComa,0.6430,"Endometrioid Tumor, Variant with Squamous Differentiation",0.6425,Pleural Epithelioid Hemangioendothelioma,0.6405,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,0.6394,Uterine Ligament Ependymoma,0.6393,Epithelioid Leiomyosarcoma,0.6373,Epithelioid Mesothelioma,0.6356,Endometrial Neoplasm,0.6350,Endometrioid Stromal and Related Neoplasms,0.6318,Pleural Proximal-Type Epithelioid Sarcoma,0.6316,Endometrial Large Cell Neuroendocrine Carcinoma,0.6271,UTERINE PERIVASCULAR EPITHELIOID CELL TUMOR,False,False,False
UTERINE SARCOMA,Uterine Corpus Sarcoma,1,2,Uterine Corpus Sarcoma,0.8756,Uterine Carcinosarcoma,0.8229,Uterine Corpus Undifferentiated Sarcoma,0.8103,Sarcoma,0.8074,Uterine Corpus Endometrial Stromal Sarcoma,0.7888,Uterine Corpus Leiomyosarcoma,0.7765,Uterine Corpus Carcinosarcoma,0.7630,Bone Sarcoma,0.7608,Metastatic Uterine Corpus Sarcoma,0.7565,Vaginal Sarcoma,0.7556,Stromal Sarcoma,0.7510,Bladder Sarcoma,0.7457,Uterine Angiosarcoma,0.7450,Cervical Sarcoma,0.7440,Breast Sarcoma,0.7410,Uterine Corpus Rhabdomyosarcoma,0.7373,Uterine Neoplasm,0.7358,Pelvic Sarcoma,0.7354,Malignant Uterine Neoplasm,0.7344,Ovarian Sarcoma,0.7341,UTERINE SARCOMA,True,True,True
"UTERINE SARCOMA, OTHER",Uterine Corpus Sarcoma,2,2,Uterine Corpus Undifferentiated Sarcoma,0.7655,Uterine Corpus Sarcoma,0.7644,"Undifferentiated Sarcoma, Not Otherwise Specified",0.7457,Uterine Carcinosarcoma,0.7363,"Uterine Carcinosarcoma, Heterologous Type",0.7299,Unresectable Uterine Corpus Sarcoma,0.7238,"Uterine Carcinosarcoma, Homologous Type",0.7149,Uterine Corpus Endometrial Stromal Sarcoma,0.7043,Undifferentiated Stromal Sarcoma,0.7040,Metastatic Uterine Corpus Sarcoma,0.7028,Uterine Corpus Carcinosarcoma,0.6921,Sarcoma,0.6846,Ovarian Undifferentiated Sarcoma,0.6797,Uterine Corpus Endometrial Stromal and Related Neoplasms,0.6781,Uterine Neoplasm,0.6752,Uterine Corpus Rhabdomyosarcoma,0.6686,Vaginal Undifferentiated Sarcoma,0.6662,Uterine Corpus Leiomyosarcoma,0.6616,Bone Sarcoma,0.6607,Uterine Corpus Sarcoma by AJCC v8 Stage,0.6606,"UTERINE SARCOMA, OTHER",False,True,True
UTERINE SEROUS,Endometrial Serous Adenocarcinoma,2,2,Serous Neoplasm,0.8080,Endometrial Serous Adenocarcinoma,0.7899,Uterine Ligament Serous Adenocarcinoma,0.7537,Serous Adenocarcinoma,0.7535,Ovarian Serous Tumor,0.7469,Malignant Ovarian Serous Tumor,0.7138,Advanced Endometrial Serous Adenocarcinoma,0.7134,Cervical Serous Adenocarcinoma,0.7081,Ovarian Serous Adenocarcinoma,0.7040,Benign Ovarian Serous Tumor,0.7039,Serous Cystadenoma,0.7009,Fallopian Tube Serous Neoplasm,0.6969,Serous Surface Papilloma,0.6926,Uterine Carcinosarcoma,0.6906,Metastatic Endometrial Serous Adenocarcinoma,0.6842,Serous Endometrial Intraepithelial Carcinoma,0.6826,Uterine Corpus Sarcoma,0.6786,Serous Cystadenocarcinoma,0.6756,Pancreatic Serous Neoplasm,0.6752,Serous Surface Papillary Carcinoma,0.6703,UTERINE SEROUS,False,True,True
UTERINE SEROUS CARCINOMA,Endometrial Serous Adenocarcinoma,1,2,Endometrial Serous Adenocarcinoma,0.8529,Serous Adenocarcinoma,0.8298,Cervical Serous Adenocarcinoma,0.8077,Uterine Ligament Serous Adenocarcinoma,0.7999,Serous Endometrial Intraepithelial Carcinoma,0.7936,Serous Neoplasm,0.7895,Ovarian Serous Adenocarcinoma,0.7828,Serous Surface Papillary Carcinoma,0.7813,Advanced Endometrial Serous Adenocarcinoma,0.7653,Ovarian Serous Tumor,0.7515,Serous Cystadenocarcinoma,0.7485,Malignant Ovarian Serous Tumor,0.7374,Uterine Carcinosarcoma,0.7336,Ovarian Serous Cystadenocarcinoma,0.7256,Metastatic Endometrial Serous Adenocarcinoma,0.7242,Micropapillary Serous Carcinoma,0.7226,Uterine Corpus Carcinosarcoma,0.7169,Endometrial Carcinoma,0.7164,Serous Tubal Intraepithelial Carcinoma,0.7132,Endometrial Squamous Cell Carcinoma,0.7066,UTERINE SEROUS CARCINOMA,True,True,True
UTERINE SEROUS CARCINOMA/UTERINE PAPILLARY SEROUS CARCINOMA,Endometrial Serous Adenocarcinoma,2,2,Serous Surface Papillary Carcinoma,0.7664,Endometrial Serous Adenocarcinoma,0.7155,Serous Endometrial Intraepithelial Carcinoma,0.7074,Uterine Ligament Serous Adenocarcinoma,0.6938,Micropapillary Serous Carcinoma,0.6866,Cervical Serous Adenocarcinoma,0.6862,Serous Adenocarcinoma,0.6838,Platinum-Sensitive Endometrial Serous Adenocarcinoma,0.6761,Papillary Serous Cystadenocarcinoma,0.6671,Uterine Corpus Carcinosarcoma,0.6566,Uterine Carcinosarcoma,0.6549,Primary Peritoneal Serous Adenocarcinoma,0.6528,Serous Neoplasm,0.6519,Serous Cystadenocarcinoma,0.6498,Serous Tubal Intraepithelial Carcinoma,0.6431,Advanced Endometrial Serous Adenocarcinoma,0.6415,Ovarian Serous Surface Papillary Adenocarcinoma,0.6348,Uterine Corpus Sarcoma,0.6345,Serous Surface Papilloma,0.6339,Uterine Corpus Undifferentiated Sarcoma,0.6338,UTERINE SEROUS CARCINOMA/UTERINE PAPILLARY SEROUS CARCINOMA,False,True,True
UTERINE SMOOTH MUSCLE TUMOR OF UNCERTAIN MALIGNANT POTENTIAL,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,1,2,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,0.9393,Smooth Muscle Tumor of Uncertain Malignant Potential,0.9132,Uterine Corpus Epithelioid Smooth Muscle Tumor of Uncertain Malignant Potential,0.8902,Female Reproductive System Smooth Muscle Tumor of Uncertain Malignant Potential,0.8832,Uterine Corpus Spindle Smooth Muscle Tumor of Uncertain Malignant Potential,0.8825,Uterine Corpus Myxoid Smooth Muscle Tumor of Uncertain Malignant Potential,0.8699,Vaginal Smooth Muscle Tumor of Uncertain Malignant Potential,0.8470,Ovarian Smooth Muscle Tumor of Uncertain Malignant Potential,0.8464,Sinonasal Smooth Muscle Tumor of Uncertain Malignant Potential,0.8152,Vulvar Smooth Muscle Tumor of Uncertain Malignant Potential,0.7795,Uterine Corpus Smooth Muscle Neoplasm,0.7771,Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,0.7324,Smooth Muscle Neoplasm,0.7286,Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,0.7059,Malignant Smooth Muscle Neoplasm,0.6952,Mixed Endometrial Stromal and Smooth Muscle Neoplasm,0.6883,Myoepithelial Tumor,0.6867,Ovarian Smooth Muscle Neoplasm,0.6823,Uterine Corpus Leiomyosarcoma,0.6814,"Uterine Corpus Leiomyoma, Mitotically Active Variant",0.6777,UTERINE SMOOTH MUSCLE TUMOR OF UNCERTAIN MALIGNANT POTENTIAL,True,True,True
UTERINE_SARCOMA,Uterine Corpus Sarcoma,1,2,Uterine Corpus Sarcoma,0.8492,Uterine Corpus Undifferentiated Sarcoma,0.7977,Uterine Carcinosarcoma,0.7933,Sarcoma,0.7874,Uterine Corpus Endometrial Stromal Sarcoma,0.7699,Metastatic Uterine Corpus Sarcoma,0.7476,Uterine Corpus Leiomyosarcoma,0.7447,Bone Sarcoma,0.7379,Uterine Corpus Carcinosarcoma,0.7358,Uterine Angiosarcoma,0.7336,Stromal Sarcoma,0.7300,Vaginal Sarcoma,0.7261,Undifferentiated Stromal Sarcoma,0.7219,Unresectable Uterine Corpus Sarcoma,0.7200,Uterine Corpus Rhabdomyosarcoma,0.7199,Stage I Uterine Sarcoma AJCC v7,0.7193,Malignant Uterine Neoplasm,0.7190,Recurrent Uterine Corpus Sarcoma,0.7164,Uterine Corpus Sarcoma by AJCC v8 Stage,0.7143,Pelvic Sarcoma,0.7131,UTERINE_SARCOMA,True,True,True
UVEAL MELANOMA,Uveal Melanoma,1,2,Uveal Melanoma,1.0000,Uveal Melanocytic Neoplasm,0.8820,Uveal Melanocytoma,0.8759,Uveal Epithelioid Cell Melanoma,0.8689,Metastatic Uveal Melanoma,0.8552,Ocular Melanoma,0.8500,Uveal Class 1 Melanoma,0.8448,Malignant Uveal Neoplasm,0.8448,Uveal Class 2 Melanoma,0.8238,Uveal Intermediate Cell Type Melanoma,0.8204,Advanced Uveal Melanoma,0.8077,Choroid Melanoma,0.8017,Retinal Melanoma,0.7875,Uveal Necrotic Melanoma,0.7858,Uveal Class 1a Melanoma,0.7844,Uveal Class 1b Melanoma,0.7829,Cutaneous Melanoma,0.7809,Uveal Spindle Cell Melanoma,0.7790,Iris Melanoma,0.7752,Uveal Neoplasm,0.7716,UVEAL MELANOMA,True,True,True
UVEAL_MELANOMA,Uveal Melanoma,1,2,Uveal Melanoma,0.9706,Uveal Melanocytic Neoplasm,0.8680,Uveal Melanocytoma,0.8448,Uveal Epithelioid Cell Melanoma,0.8370,Ocular Melanoma,0.8304,Malignant Uveal Neoplasm,0.8295,Metastatic Uveal Melanoma,0.8254,Uveal Class 1 Melanoma,0.8176,Uveal Class 2 Melanoma,0.7968,Uveal Intermediate Cell Type Melanoma,0.7851,Advanced Uveal Melanoma,0.7813,Choroid Melanoma,0.7701,Retinal Melanoma,0.7631,Cutaneous Melanoma,0.7627,Uveal Melanoma by AJCC v7 Stage,0.7627,Uveal Neoplasm,0.7625,Uveal Necrotic Melanoma,0.7581,Uveal Mixed Epithelioid and Spindle Cell Melanoma,0.7526,Iris Melanoma,0.7484,Uveal Class 1a Melanoma,0.7481,UVEAL_MELANOMA,True,True,True
UVM,Uveal Melanoma,8,2,Solar Radiation-Related Cutaneous Melanoma,0.6664,Malignant Uvula Neoplasm,0.6505,Melanoma in Chronically Sun-Exposed Skin,0.6329,Mucosal Lentiginous Melanoma,0.6173,Mucosal Melanoma,0.6042,Melanoma,0.6042,Vulvar Melanoma,0.6039,Uveal Melanoma,0.6021,Vaginal Melanoma,0.5962,Benign Uvula Neoplasm,0.5955,Melanoma in Intermittently Sun-Exposed Skin,0.5927,Lentigo Maligna Melanoma,0.5918,Low-CSD Melanoma,0.5860,Cutaneous Melanoma,0.5847,Uveal Class 2 Melanoma,0.5794,Minimal Deviation Melanoma,0.5787,Uveal Intermediate Cell Type Melanoma,0.5769,Uveal Class 1 Melanoma,0.5768,Metastatic Mucosal Melanoma,0.5750,Hereditary Melanoma,0.5704,UVM,False,False,False
VAGINAL ADENOCARCINOMA,Vaginal Adenocarcinoma,1,2,Vaginal Adenocarcinoma,1.0000,Vaginal Carcinoma,0.9030,Advanced Vaginal Adenocarcinoma,0.8767,Vaginal Mucinous Adenocarcinoma,0.8628,Vaginal Clear Cell Adenocarcinoma,0.8426,Human Papillomavirus-Related Vaginal Adenocarcinoma,0.8366,Vaginal Adenoma,0.8354,Metastatic Vaginal Adenocarcinoma,0.8301,Vaginal Adenocarcinoma of Skene Gland Origin,0.8078,Advanced Vaginal Carcinoma,0.8047,Malignant Vaginal Neoplasm,0.7995,Vaginal Endometrioid Adenocarcinoma,0.7981,Vulvar Adenocarcinoma,0.7904,Vaginal Neoplasm,0.7850,Vaginal Warty Carcinoma,0.7723,Vaginal Melanoma,0.7716,Cervical Adenocarcinoma,0.7634,"Vaginal Mucinous Adenocarcinoma, Intestinal-Type",0.7613,Vaginal Squamous Cell Carcinoma,0.7609,Vaginal Undifferentiated Carcinoma,0.7591,VAGINAL ADENOCARCINOMA,True,True,True
VAGINAL CANCER,Vaginal Carcinoma,1,2,Vaginal Carcinoma,0.9491,Vaginal Adenocarcinoma,0.8867,Vaginal Neoplasm,0.8702,Malignant Vaginal Neoplasm,0.8310,Advanced Vaginal Carcinoma,0.7932,Vaginal Squamous Cell Carcinoma,0.7849,Vaginal Warty Carcinoma,0.7843,Vaginal Undifferentiated Carcinoma,0.7823,Vaginal Papillary Carcinoma,0.7785,Vaginal Neuroendocrine Carcinoma,0.7761,Vaginal Melanoma,0.7656,Advanced Vaginal Adenocarcinoma,0.7633,Vaginal Glandular Neoplasm,0.7614,Unresectable Vaginal Carcinoma,0.7603,Human Papillomavirus-Related Vaginal Adenocarcinoma,0.7594,Vaginal Squamous Neoplasm,0.7575,Metastatic Vaginal Carcinoma,0.7567,Vaginal Adenoma,0.7500,Metastatic Vaginal Adenocarcinoma,0.7356,Locally Advanced Vaginal Carcinoma,0.7344,VAGINAL CANCER,True,True,True
WALDENSTROM MACROGLOBULINEMIA,Waldenstrom Macroglobulinemia,1,2,Waldenstrom Macroglobulinemia,1.0000,Familial Waldenstrom Macroglobulinemia,0.9558,Smoldering Waldenstrom Macroglobulinemia,0.8812,Recurrent Waldenstrom Macroglobulinemia,0.8438,Refractory Waldenstrom Macroglobulinemia,0.8128,Transformed Waldenstrom Macroglobulinemia to Diffuse Large B-Cell Lymphoma,0.8059,Marginal Zone Lymphoma,0.6507,Nodal Marginal Zone Lymphoma,0.6423,Advanced Marginal Zone Lymphoma,0.6411,Monoclonal B-Cell Lymphocytosis,0.6324,Marginal Zone Lymphoma by Ann Arbor Stage,0.6293,Mediastinal Gray-Zone Lymphoma,0.6278,Monoclonal Gammopathy of Undetermined Significance,0.6232,Non-IgM Monoclonal Gammopathy of Undetermined Significance,0.6229,IgM Monoclonal Gammopathy of Undetermined Significance,0.6220,Nodal Marginal Zone Lymphoma by Ann Arbor Stage,0.6185,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,0.6139,Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma,0.6131,Lymphoplasmacytic Lymphoma by Ann Arbor Stage,0.6060,Lymphoplasmacytic Lymphoma,0.6054,WALDENSTROM MACROGLOBULINEMIA,True,True,True
WELL DIFFERENTIATED LIPOSARCOMA,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,4,2,Localized Liposarcoma,0.8674,Dedifferentiated Liposarcoma,0.8562,Liposarcoma,0.8532,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.8430,Pleomorphic Liposarcoma,0.8412,Adult Liposarcoma,0.8369,Fibroblastic Liposarcoma,0.8324,Myxoid Liposarcoma,0.8241,Advanced Liposarcoma,0.8237,Mixed Liposarcoma,0.8122,Advanced Dedifferentiated Liposarcoma,0.8117,Bone Liposarcoma,0.8110,Lipoma-Like Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.7993,Skin Liposarcoma,0.7915,Locally Advanced Liposarcoma,0.7914,Round Cell Liposarcoma,0.7898,Advanced Pleomorphic Liposarcoma,0.7885,Advanced Myxoid Liposarcoma,0.7834,Metastatic Liposarcoma,0.7832,Breast Liposarcoma,0.7780,WELL DIFFERENTIATED LIPOSARCOMA,False,False,True
WELL-DIFFERENTIATED LEIOMYOSARCOMA RESEMBLING LEIOMYOMA,Well Differentiated Leiomyosarcoma,1,2,Well Differentiated Leiomyosarcoma,0.9463,Conventional Leiomyosarcoma,0.8601,Leiomyosarcoma,0.8411,Localized Leiomyosarcoma,0.8325,Myxoid Leiomyosarcoma,0.8283,Dedifferentiated Leiomyosarcoma,0.8254,Pleomorphic Leiomyosarcoma,0.8228,Epithelioid Leiomyosarcoma,0.8111,Digestive System Leiomyosarcoma,0.8106,Granular Cell Leiomyosarcoma,0.8026,Myxoid Leiomyoma,0.8007,Adult Leiomyosarcoma,0.7992,Leiomyoma,0.7977,Leiomyosarcoma of Deep Soft Tissue,0.7963,Non-Cutaneous Leiomyosarcoma,0.7937,Bone Leiomyosarcoma,0.7913,Deep Leiomyoma,0.7901,Leiomyosarcoma NCI Grade 2,0.7878,Gastric Leiomyosarcoma,0.7850,Inflammatory Leiomyosarcoma,0.7845,WELL-DIFFERENTIATED LEIOMYOSARCOMA RESEMBLING LEIOMYOMA,True,True,True
WELL-DIFFERENTIATED LIPOSARCOMA,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,3,2,Localized Liposarcoma,0.8499,Dedifferentiated Liposarcoma,0.8460,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.8369,Liposarcoma,0.8369,Pleomorphic Liposarcoma,0.8299,Fibroblastic Liposarcoma,0.8233,Adult Liposarcoma,0.8220,Myxoid Liposarcoma,0.8161,Advanced Liposarcoma,0.8060,Advanced Dedifferentiated Liposarcoma,0.7986,Lipoma-Like Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.7952,Bone Liposarcoma,0.7950,Mixed Liposarcoma,0.7887,Advanced Pleomorphic Liposarcoma,0.7767,Round Cell Liposarcoma,0.7765,Advanced Myxoid Liposarcoma,0.7731,Skin Liposarcoma,0.7714,Locally Advanced Liposarcoma,0.7711,Well Differentiated Leiomyosarcoma,0.7660,Metastatic Liposarcoma,0.7657,WELL-DIFFERENTIATED LIPOSARCOMA,False,True,True
WELL-DIFFERENTIATED NEUROENDOCRINE TUMOR OF THE APPENDIX,Appendix Neuroendocrine Tumor,1,2,Appendix Neuroendocrine Tumor,0.7995,Appendix Tubular Neuroendocrine Tumor,0.7791,Appendix Neuroendocrine Neoplasm,0.7707,Appendix Neuroendocrine Tumor G2,0.7629,Appendix Neuroendocrine Tumor G1,0.7535,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0.7423,Childhood Appendix Neuroendocrine Tumor,0.7195,Appendix Neuroendocrine Tumor G3,0.7173,Appendix Neuroendocrine Carcinoma,0.7164,Appendix Small Cell Neuroendocrine Carcinoma,0.6967,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0.6953,Appendix Large Cell Neuroendocrine Carcinoma,0.6940,Low Grade Appendix Mucinous Neoplasm,0.6753,Cecum Neuroendocrine Tumor,0.6741,Stage IV Appendix Neuroendocrine Tumor AJCC v8,0.6712,Appendix Neuroendocrine Tumor by AJCC v8 Stage,0.6712,Advanced Digestive System Neuroendocrine Tumor,0.6687,Descending Colon Neuroendocrine Tumor,0.6671,Ascending Colon Neuroendocrine Tumor,0.6664,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0.6657,WELL-DIFFERENTIATED NEUROENDOCRINE TUMOR OF THE APPENDIX,True,True,True
WELL-DIFFERENTIATED NEUROENDOCRINE TUMORS OF THE STOMACH,Gastric Neuroendocrine Tumor,1,2,Gastric Neuroendocrine Tumor,0.8479,Gastric Neuroendocrine Neoplasm,0.8157,Digestive System Neuroendocrine Tumor,0.8121,Gastric Gastrin-Producing Neuroendocrine Tumor,0.8012,Gastric Neuroendocrine Tumor G1,0.7948,Digestive System Neuroendocrine Tumor G1,0.7842,Digestive System Neuroendocrine Neoplasm,0.7802,Gastric Neuroendocrine Tumor G2,0.7800,Digestive System Neuroendocrine Tumor G2,0.7772,Advanced Digestive System Neuroendocrine Tumor,0.7706,Gastrin-Producing Neuroendocrine Tumor,0.7682,Duodenal Gastrin-Producing Neuroendocrine Tumor,0.7632,Advanced Digestive System Neuroendocrine Neoplasm,0.7484,Duodenal Neuroendocrine Tumor G2,0.7468,Advanced Digestive System Neuroendocrine Tumor G1,0.7456,Neuroendocrine Tumor G2,0.7455,Localized Digestive System Neuroendocrine Tumor G1,0.7416,Gastric Neuroendocrine Carcinoma,0.7402,Duodenal Neuroendocrine Tumor G1,0.7395,Duodenal Neuroendocrine Tumor,0.7350,WELL-DIFFERENTIATED NEUROENDOCRINE TUMORS OF THE STOMACH,True,True,True
WELL-DIFFERENTIATED THYROID CANCER,Differentiated Thyroid Gland Carcinoma,1,2,Differentiated Thyroid Gland Carcinoma,0.8325,Differentiated High Grade Thyroid Gland Carcinoma,0.8018,Poorly Differentiated Thyroid Gland Carcinoma,0.7971,Well Differentiated Malignant Neoplasm,0.7851,Thyroid Gland Well-Differentiated Tumor of Uncertain Malignant Potential,0.7776,Advanced Differentiated Thyroid Gland Carcinoma,0.7533,Hepatocellular Well Differentiated Carcinoma,0.7174,Thyroid Gland Clear Cell Follicular Adenoma,0.7030,Thyroid Gland Carcinoma,0.6959,Well Differentiated Fibrosarcoma,0.6922,Locally Advanced Differentiated Thyroid Gland Carcinoma,0.6906,Benign Thyroid Gland Neoplasm,0.6881,Advanced Thyroid Gland Carcinoma,0.6878,High Grade Follicular Cell-Derived Non-Anaplastic Thyroid Gland Carcinoma,0.6868,Thyroid Gland Adenocarcinoma,0.6861,Classic Thyroid Gland Papillary Carcinoma,0.6854,Thyroid Gland Anaplastic Carcinoma,0.6841,Thyroid Gland Follicular Carcinoma,0.6750,"Thyroid Gland Follicular Carcinoma, Clear Cell Variant",0.6750,Thyroid Gland Undifferentiated Small Cell Carcinoma,0.6712,WELL-DIFFERENTIATED THYROID CANCER,True,True,True
WILMS,Wilms Tumor,1,2,Wilms Tumor,0.9123,Kidney Wilms Tumor,0.8507,Childhood Kidney Wilms Tumor,0.8077,Cervical Wilms Tumor,0.8049,Ovarian Wilms Tumor,0.8042,Adult Kidney Wilms Tumor,0.7883,Prostate Wilms Tumor,0.7828,Hereditary Kidney Wilms Tumor,0.7599,Nonanaplastic Kidney Wilms Tumor,0.7567,Epithelial Predominant Kidney Wilms Tumor,0.7513,Anaplastic Kidney Wilms Tumor,0.7407,Stromal Predominant Kidney Wilms Tumor,0.7296,Refractory Wilms Tumor,0.7114,Mixed Cell Type Kidney Wilms Tumor,0.7083,Stage I Kidney Wilms Tumor,0.6922,Paratesticular Wilms Tumor,0.6911,Stage V Kidney Wilms Tumor,0.6884,Stage IV Kidney Wilms Tumor,0.6840,Metachronous Kidney Wilms Tumor,0.6830,Blastema Predominant Kidney Wilms Tumor,0.6793,WILMS,True,True,True
WILMS TUMOR,Wilms Tumor,1,2,Wilms Tumor,1.0000,Kidney Wilms Tumor,0.9635,Childhood Kidney Wilms Tumor,0.9081,Ovarian Wilms Tumor,0.8761,Prostate Wilms Tumor,0.8713,Hereditary Kidney Wilms Tumor,0.8613,Adult Kidney Wilms Tumor,0.8561,Cervical Wilms Tumor,0.8536,Epithelial Predominant Kidney Wilms Tumor,0.8493,Nonanaplastic Kidney Wilms Tumor,0.8435,Stromal Predominant Kidney Wilms Tumor,0.8350,Anaplastic Kidney Wilms Tumor,0.8176,Mixed Cell Type Kidney Wilms Tumor,0.7900,Refractory Wilms Tumor,0.7801,Blastema Predominant Kidney Wilms Tumor,0.7614,Paratesticular Wilms Tumor,0.7575,Stage I Kidney Wilms Tumor,0.7453,Metachronous Kidney Wilms Tumor,0.7417,Stage V Kidney Wilms Tumor,0.7407,Recurrent Kidney Wilms Tumor,0.7390,WILMS TUMOR,True,True,True
WILMS' TUMOR,Wilms Tumor,1,2,Wilms Tumor,0.9868,Kidney Wilms Tumor,0.9630,Childhood Kidney Wilms Tumor,0.9016,Prostate Wilms Tumor,0.8785,Ovarian Wilms Tumor,0.8731,Adult Kidney Wilms Tumor,0.8609,Hereditary Kidney Wilms Tumor,0.8562,Epithelial Predominant Kidney Wilms Tumor,0.8545,Nonanaplastic Kidney Wilms Tumor,0.8506,Cervical Wilms Tumor,0.8444,Stromal Predominant Kidney Wilms Tumor,0.8433,Anaplastic Kidney Wilms Tumor,0.8278,Mixed Cell Type Kidney Wilms Tumor,0.7865,Paratesticular Wilms Tumor,0.7665,Refractory Wilms Tumor,0.7660,Blastema Predominant Kidney Wilms Tumor,0.7650,Stage I Kidney Wilms Tumor,0.7430,Stage IV Kidney Wilms Tumor,0.7365,Stage V Kidney Wilms Tumor,0.7349,Metachronous Kidney Wilms Tumor,0.7337,WILMS' TUMOR,True,True,True
WILMS' TUMORS,Wilms Tumor,1,2,Wilms Tumor,0.9844,Kidney Wilms Tumor,0.9605,Childhood Kidney Wilms Tumor,0.8999,Prostate Wilms Tumor,0.8818,Ovarian Wilms Tumor,0.8748,Adult Kidney Wilms Tumor,0.8554,Epithelial Predominant Kidney Wilms Tumor,0.8524,Hereditary Kidney Wilms Tumor,0.8518,Nonanaplastic Kidney Wilms Tumor,0.8500,Cervical Wilms Tumor,0.8421,Stromal Predominant Kidney Wilms Tumor,0.8390,Anaplastic Kidney Wilms Tumor,0.8206,Mixed Cell Type Kidney Wilms Tumor,0.7768,Paratesticular Wilms Tumor,0.7682,Blastema Predominant Kidney Wilms Tumor,0.7646,Refractory Wilms Tumor,0.7620,Stage I Kidney Wilms Tumor,0.7393,Metachronous Kidney Wilms Tumor,0.7334,Stage IV Kidney Wilms Tumor,0.7325,Recurrent Kidney Wilms Tumor,0.7314,WILMS' TUMORS,True,True,True
WITH DUCTAL AND LOBULAR PHENOTYPES,Breast Mixed Ductal and Lobular Carcinoma,1,2,Breast Mixed Ductal and Lobular Carcinoma,0.6855,Diffuse Lipomatosis,0.6514,Diffuse Intraductal Papillomatosis,0.6390,Double Pituitary Neuroendocrine Tumors of Distinct Lineages,0.6261,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,0.6235,Breast Ductal Hyperplasia,0.6190,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,0.6123,Breast Ductal Adenoma,0.6070,Breast Papillary Ductal Hyperplasia,0.6028,Lipoma-Like Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.5996,Dedifferentiated Liposarcoma,0.5977,Breast Usual Ductal Hyperplasia,0.5957,Atypical Lipomatous Tumor/Well Differentiated Liposarcoma,0.5942,Liver Dysplastic Nodule,0.5930,Pancreatic Well Differentiated Ductal Adenocarcinoma,0.5900,Diffuse Type Adenocarcinoma,0.5890,Intraductal Papillomatosis,0.5861,Breast Atypical Ductal Hyperplasia,0.5847,Follicular Lymphoma with Predominantly Diffuse Growth Pattern,0.5839,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,0.5825,WITH DUCTAL AND LOBULAR PHENOTYPES,True,True,True
WT,Wilms Tumor,1,2,Wilms Tumor,0.9868,Kidney Wilms Tumor,0.9630,Childhood Kidney Wilms Tumor,0.9016,Prostate Wilms Tumor,0.8785,Ovarian Wilms Tumor,0.8731,Adult Kidney Wilms Tumor,0.8609,Hereditary Kidney Wilms Tumor,0.8562,Epithelial Predominant Kidney Wilms Tumor,0.8545,Nonanaplastic Kidney Wilms Tumor,0.8506,Cervical Wilms Tumor,0.8444,Stromal Predominant Kidney Wilms Tumor,0.8433,Anaplastic Kidney Wilms Tumor,0.8278,Mixed Cell Type Kidney Wilms Tumor,0.7865,Paratesticular Wilms Tumor,0.7665,Refractory Wilms Tumor,0.7660,Blastema Predominant Kidney Wilms Tumor,0.7650,Stage I Kidney Wilms Tumor,0.7430,Stage IV Kidney Wilms Tumor,0.7365,Stage V Kidney Wilms Tumor,0.7349,Metachronous Kidney Wilms Tumor,0.7337,Wilms' Tumor,True,True,True
YOLK SAC TUMOR,Yolk Sac Tumor,1,2,Yolk Sac Tumor,1.0000,Childhood Yolk Sac Tumor,0.9443,Testicular Yolk Sac Tumor,0.9306,Pericardial Yolk Sac Tumor,0.9278,Cardiac Yolk Sac Tumor,0.9262,Ovarian Yolk Sac Tumor,0.9209,Central Nervous System Yolk Sac Tumor,0.9083,Liver Yolk Sac Tumor,0.9005,Childhood Central Nervous System Yolk Sac Tumor,0.8900,Adult Yolk Sac Tumor,0.8894,Cervical Yolk Sac Tumor,0.8887,Vaginal Yolk Sac Tumor,0.8887,Childhood Ovarian Yolk Sac Tumor,0.8885,Childhood Testicular Yolk Sac Tumor,0.8836,Mediastinal Yolk Sac Tumor,0.8733,Sellar Yolk Sac Tumor,0.8665,Pineal Region Yolk Sac Tumor,0.8636,Yolk Sac Tumor with Somatic-Type Malignancy,0.8472,"Ovarian Yolk Sac Tumor, Glandular Pattern",0.7998,Vulvar Yolk Sac Tumor,0.7914,YOLK SAC TUMOR,True,True,True
